Project Title,Application ID,Project Start Date,Project End Date,Funding Mechanism,Fiscal Year,Total Cost,Total Cost (Sub Projects),Funding IC(s),Direct Cost IC,InDirect Cost IC,Total Cost IC
MECHANISMS OF CELLULAR IMMORTALIZATION,2001286,4/1/1989 0:00,12/31/1999 0:00,Non-SBIR/STTR,1997,310857, ,NIA, , ,310857
CALORIE RESTRICTION AGING AND PROGRAMMED CELL DEATH,2001790,7/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,195166, ,NIA, , ,195166
HORMONAL REGULATION OF BREAST CANCER,2007187,8/1/1978 0:00,1/31/2002 0:00,Non-SBIR/STTR,1997,511911, ,NCI, , ,511911
PEDIATRIC ONCOLOGY GROUP,2007226,1/1/1978 0:00,12/31/2000 0:00,Other Research-Related,1997,183458, ,NCI, , ,183458
SUPPRESSOR GENES AND BREAST CANCER,2007261,5/1/1979 0:00,11/30/1998 0:00,Non-SBIR/STTR,1997,230316, ,NCI, , ,230316
CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT,2007289,7/22/1980 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,1912558, ,NCI, , ,1912558
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,2007344,7/15/1981 0:00,5/31/2002 0:00,Non-SBIR/STTR,1997,242534, ,NCI, , ,242534
SLIT SCAN DETECTION OF BLADDER CANCER,2007382,8/1/1982 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,330731, ,NCI, , ,330731
PEDIATRIC ONCOLOGY GROUP,2007386,1/1/1983 0:00,12/31/2000 0:00,Other Research-Related,1997,94276, ,NCI, , ,94276
SOMATIC GENETIC ALTERATIONS IN GASTROINTESTINAL CANCER,2007476,9/30/1988 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997,282622, ,NCI, , ,282622
VIRAL TRANSGENE-ONCOGENE INDUCED TUMORIGENESIS,2007478,12/20/1994 0:00,11/30/1997 0:00,Non-SBIR/STTR,1997,251004, ,NCI, , ,251004
ONCOGENE INDUCED LEUKEMOGENESIS IN TRANSGENIC MICE,2007604,4/1/1987 0:00,11/30/1999 0:00,Non-SBIR/STTR,1997,111094, ,NCI, , ,111094
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,2007607,1/1/1987 0:00,12/31/1998 0:00,Non-SBIR/STTR,1997,307201, ,NCI, , ,307201
CLAM LEUKEMIA--A MODEL FOR ENVIRONMENTAL CARCINOGENESIS,2007624,8/10/1987 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,177368, ,NCI, , ,177368
STATUS OF P53 IN A LFS CANCER PRONE FAMILY,2007645,9/1/1986 0:00,11/30/1998 0:00,Non-SBIR/STTR,1997,311431, ,NCI, , ,311431
MECHANISM OF LARGE T ANTIGEN INDUCED TUMORIGENESIS,2007678,3/1/1988 0:00,12/31/2001 0:00,Non-SBIR/STTR,1997,261502, ,NCI, , ,261502
MECHANISMS OF INDUCTION OF SKIN CANCERS BY UV LIGHT,2007685,7/1/1988 0:00,1/31/2001 0:00,Non-SBIR/STTR,1997,156990, ,NCI, , ,156990
MOLECULAR PATHOLOGY OF GLIOMAS,2007795,1/13/1995 0:00,11/30/1998 0:00,Non-SBIR/STTR,1997,361624, ,NCI, , ,361624
SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY,2007827,5/1/1991 0:00,6/30/2000 0:00,Non-SBIR/STTR,1997,1503245, ,NCI, , ,1503245
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMA,2007855,5/15/1991 0:00,4/30/2001 0:00,Non-SBIR/STTR,1997,903317, ,NCI, , ,903317
FUNCTION OF THE ADENOVIRUS E1B ONCOGENE,2007885,1/1/1991 0:00,12/31/2000 0:00,Non-SBIR/STTR,1997,322229, ,NCI, , ,322229
FLURODEOXYURIDINE MEDIATED RADIOSENSITIZATION,2007889,12/7/1990 0:00,11/30/1998 0:00,Non-SBIR/STTR,1997,210811, ,NCI, , ,210811
HEPATITIS B VIRUS AND HEPATOCELLULAR CARCINOMA,2007934,3/15/1991 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,225703, ,NCI, , ,225703
BIOCHEMICAL AND CYTOGENETIC MARKERS IN RETINOBLASTOMA,2007938,4/1/1991 0:00,3/31/2001 0:00,Non-SBIR/STTR,1997,155856, ,NCI, , ,155856
SUNLIGHT RELATED STEPS IN HUMAN SKIN CANCER,2007998,4/1/1992 0:00,11/30/1998 0:00,Non-SBIR/STTR,1997,188484, ,NCI, , ,188484
PROGRESSION OF T CELL LYMPHOMA LINESTO IL2 INDEPENDENCE,2008018,7/1/1992 0:00,1/31/2002 0:00,Non-SBIR/STTR,1997,340269, ,NCI, , ,340269
REGULATION OF MULTIDRUG RESISTANCE GENE EXPRESSION,2008150,1/1/1993 0:00,12/31/1998 0:00,Non-SBIR/STTR,1997,120056, ,NCI, , ,120056
UV INDUCIBLE INHIBITION IN MELANOMA,2008258,5/5/1993 0:00,1/31/2001 0:00,Non-SBIR/STTR,1997,306834, ,NCI, , ,306834
PREDICTORS OF PROGRESSION IN BARRETTS ESOPHAGUS,2008326,2/7/1995 0:00,11/30/1999 0:00,Non-SBIR/STTR,1997,878028, ,NCI, , ,878028
ONCOGENE-SPECIFIC IMMUNE RESPONSES IN BREAST CANCER,2008328,6/1/1994 0:00,5/31/2000 0:00,Non-SBIR/STTR,1997,227360, ,NCI, , ,227360
SIGNIFICANCE OF MICROMETASTASES IN PROSTATE CANCER,2008398,12/22/1995 0:00,11/30/1999 0:00,Non-SBIR/STTR,1997,105242, ,NCI, , ,105242
MOLECULAR EPIDEMIOLOGY OF BREAST CANCER,2008565,5/1/1997 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,645716, ,NCI, , ,645716
CONTROL OF P53 DEPENDENT APOPTOSIS,2008590,1/1/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1997,140565, ,NCI, , ,140565
CELLULAR TARGETS OF EARLY BREAST TUMORIGENESIS,2008592,1/28/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1997,187925, ,NCI, , ,187925
MECHANISM OF HPV E6 MEDIATED UBIQUITINATION OF P53,2008594,12/29/1994 0:00,11/30/1999 0:00,Non-SBIR/STTR,1997,266842, ,NCI, , ,266842
MAMMALIAN CELL CYCLE CONTROL AND TUMORIGENESIS,2008661,3/1/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1997,168266, ,NCI, , ,168266
STRUCTURAL STUDIES OF THE P53 TUMOR SUPPRESSOR,2008674,1/15/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1997,194050, ,NCI, , ,194050
NEW METHODS FOR CANCER DETECTION,2008700,3/1/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,1997,944370, ,NCI, , ,944370
TARGETED GENE DELIVERY FOR LUNG CANCER GENE THERAPY,2008711,1/3/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1997,102304, ,NCI, , ,102304
FUNCTION OF THE HOMOLOGY REGION BETWEEN PRB AND LARGE T,2008734,1/1/1995 0:00,12/31/1998 0:00,Non-SBIR/STTR,1997,183456, ,NCI, , ,183456
HUMAN ABERRANT CRYPT FOCI--BIOMARKERS FOR COLON CANCER,2008784,2/9/1996 0:00,11/30/2000 0:00,Non-SBIR/STTR,1997,188533, ,NCI, , ,188533
GENETIC ALTERATIONS IN PUVA INDUCED SKIN CANCERS,2008832,3/1/1996 0:00,12/31/1999 0:00,Non-SBIR/STTR,1997,159421, ,NCI, , ,159421
SV40 T ANTIGEN TRANSACTIVATION AND TRANSFORMATION,2008845,9/20/1996 0:00,9/16/1999 0:00,Non-SBIR/STTR,1996,90545, ,OD, , ,90545
ADJUVANT BIOLOGIC THERAPY FOR STAGE III/IV HEAD CANCER,2009066,5/1/1997 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,127700, ,NCI, , ,127700
MECHANISMS OF P53 DEPENDENT APOPTOSIS,2009112,3/1/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,1997,267070, ,NCI, , ,267070
CHEMOPREVENTION OF HEAD AND NECK CANCERS,2009223,9/16/1996 0:00,2/28/1998 0:00,Non-SBIR/STTR,1996,80476, ,NCI, , ,80476
MARKERS FOR LUNG CARCINOGENESIS IN BRONCHIAL EPITHELIUM,2009525,3/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,1997,462106, ,NCI, , ,462106
SYSTEMIC DELIVERY OF P53 INHIBITS BREAST CANCER,2009610,7/15/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1997,96178, ,NCI, , ,96178
EXPRESSION AND FUNCTIONS OF MDM2 PROTEINS,2009762,2/1/1997 0:00,1/31/2002 0:00,Non-SBIR/STTR,1997,63619, ,NCI, , ,63619
MVAC IN BLADDER CANCER BASED ON P53 STATUS,2010238,5/1/1997 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997,467999, ,NCI, , ,467999
EPISOMAL VECTORS FOR COLON CANCER GENE THERAPY,2010801,1/20/1997 0:00,12/31/1999 0:00,Non-SBIR/STTR,1997,156203, ,NCI, , ,156203
REGULATION OF BCL2 BY RAS AND TUMOR SUPPRESSORS,2010835,1/1/1997 0:00,12/31/2001 0:00,Non-SBIR/STTR,1997,192286, ,NCI, , ,192286
EVALUATION OF PREDICTORS FOR RECURRENT ADENOMAS,2010848,2/14/1997 0:00,12/31/1997 0:00,Non-SBIR/STTR,1997,255672, ,NCI, , ,255672
P53 WILD TYPE PEPTIDE BASED IMMUNOTHERAPY,2010970,2/12/1997 0:00,1/31/2000 0:00,Non-SBIR/STTR,1997,159139, ,NCI, , ,159139
H PYLORI PHENOTYPE AND STOMACH CANCER,2011056,1/25/1997 0:00,12/31/2000 0:00,Non-SBIR/STTR,1997,182303, ,NCI, , ,182303
CHEMOSENSITIZATION OF NSCLC THROUGH SIGNAL TRANSDUCTION,2011062,2/1/1997 0:00,1/31/2000 0:00,Non-SBIR/STTR,1997,174593, ,NCI, , ,174593
EXCISION REPAIR OF UV RADIATION-INDUCED DNA DAMAGE,2011078,2/1/1997 0:00,11/30/2000 0:00,Non-SBIR/STTR,1997,292017, ,NCI, , ,292017
ACTIVITY OF PACLITAXEL AGAINST CARCINOMA OF ESOPHAGUS,2011081,12/26/1996 0:00,11/30/1998 0:00,Non-SBIR/STTR,1997,154500, ,NCI, , ,154500
PREDICTING CHEMOTHERAPY RESPONSE IN HEAD AND NECK CANCER,2011869,5/1/1997 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,160907, ,NCI, , ,160907
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA,2012123,5/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,1997,238061, ,NCI, , ,238061
PROGNOSTIC INDICATORS IN LOCALIZED COLON CANCER,2012158,9/17/1997 0:00,8/31/2000 0:00,Non-SBIR/STTR,1997,177731, ,NCI, , ,177731
INHIBITION OF PAPILLOMAVIRUSES IN ORAL EPITHELIUM,2015134,2/1/1994 0:00,1/31/2001 0:00,Non-SBIR/STTR,1997,208949, ,NIDCR, , ,208949
MOLECULAR MARKERS OF ORAL CANCER RISK,2015482,4/1/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,1997,343026, ,NIDCR, , ,343026
RADIATION TOXICITY IN HUMAN BRONCHIAL EPITHELIAL CELLS,2018382,1/1/1995 0:00,12/31/1998 0:00,Non-SBIR/STTR,1997,164006, ,NIEHS, , ,164006
P53 AND THE CELLULAR RESPONSE TO DNA DAMAGE,2018412,1/1/1992 0:00,12/31/2001 0:00,Non-SBIR/STTR,1997,313083, ,NIEHS, , ,313083
LOH AT 3P AND P53 AND K-RAS MUTATION IN LUNG CANCER,2018793,1/1/1997 0:00,12/31/2000 0:00,Non-SBIR/STTR,1997,287205, ,NIEHS, , ,287205
EMF EFFECTS ON CELL REGULATION IN A-T CELLS,2019341,1/10/1997 0:00,12/31/1998 0:00,Non-SBIR/STTR,1997,106400, ,NIEHS, , ,106400
RB-DEPENDENT PATHWAYS AND MURINE LENS DEV,2019569,12/1/1996 0:00, ,"Training, Individual",1997,24677, ,NEI, , ,24677
ROLE AND REGULATION OF CDK4 IN THE NORMAL LENS,2020017,1/26/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,1997,298919, ,NEI, , ,298919
G2/M DNA DAMAGE CHECKPOINT IN BUDDING YEAST,2022428,1/1/1991 0:00,11/30/2000 0:00,Non-SBIR/STTR,1997,198748, ,NIGMS, , ,198748
EXTRAGENIC SUPPRESSORS OF THE TATA-BINDING PROTEIN,2022491,7/1/1991 0:00,12/31/1998 0:00,Non-SBIR/STTR,1997,217367, ,NIGMS, , ,217367
GENETIC APPROACH TO UNDERSTANDING NITRIC OXIDE,2022809,1/1/1994 0:00,12/31/1998 0:00,Non-SBIR/STTR,1997,235800, ,NIGMS, , ,235800
TUMOR SUPPRESSOR P53 AND THE CNS,2037860,5/1/1997 0:00,2/29/2000 0:00,Non-SBIR/STTR,1997,169156, ,NINDS, , ,169156
MECHANISMS OF NEURONAL APOPTOSIS,2039154,4/20/1997 0:00,3/31/2001 0:00,Non-SBIR/STTR,1997,202573, ,NINDS, , ,202573
AGE ASSOCIATED CHANGES IN B LYMPHOCYTE FUNCTION,2049335,8/1/1986 0:00,7/31/1996 0:00,Non-SBIR/STTR,1993,166905, ,NIA, , ,166905
MECHANISMS OF CELLULAR IMMORTALIZATION,2049974,4/1/1989 0:00,12/31/1999 0:00,Non-SBIR/STTR,1995,286288, ,NIA, , ,286288
"CALORIES, FAT, AND SPONTANEOUS PROSTATE CANCER",2051768,5/1/1992 0:00,4/30/1997 0:00, ,1994,168689, ,NIA, , ,168689
"CALORIES, FAT, AND SPONTANEOUS PROSTATE CANCER",2051769,5/1/1992 0:00,4/30/1997 0:00,Non-SBIR/STTR,1995,149752, ,NIA, , ,149752
MOLECULAR BASIS OF SENESCENCE IN BREAST EPITHELIAL CELLS,2052027,8/1/1992 0:00,5/31/1996 0:00,Non-SBIR/STTR,1994,246488, ,NIA, , ,246488
TRANSCRIPTION REGULATOR MUTATIONS IN PROSTATE CANCER,2052512,7/20/1992 0:00,6/30/1996 0:00, ,1994,254846, ,NIA, , ,254846
TRANSCRIPTION REGULATOR MUTATIONS IN PROSTATE CANCER,2052513,7/20/1992 0:00,6/30/1997 0:00,Non-SBIR/STTR,1995,264947, ,NIA, , ,264947
APOPTOSIS AND CERVICAL CANCER,2055774,9/1/1995 0:00,7/31/1999 0:00,Non-SBIR/STTR,1995,184399, ,NIA, , ,184399
CYTOKINE FUSION PROTEINS WITH ENHANCED IMMUNOGENICITY,2073877,9/30/1994 0:00,6/30/1999 0:00, ,1994,157921, ,NIAID, , ,157921
APOPTOSIS--THE ROLES OF P35 AND IAP,2075247,8/1/1995 0:00,7/31/1998 0:00,Non-SBIR/STTR,1995,234444, ,NIAID, , ,234444
PAPILLOMAVIRUS E6 ONCOGENE INTERACTION WITH P53,2077546,2/1/1995 0:00,1/31/2000 0:00,Other Research-Related,1995,75600, ,NIAMS, , ,75600
P53 IN CHRONIC MYELOGENOUS LEUKEMIA,2084077,7/16/1990 0:00,6/30/1995 0:00, ,1994,85590, ,NCI, , ,85590
PREVENTIVE ONCOLOGY,2084214,2/1/1993 0:00,1/31/1998 0:00, ,1994,88236, ,NCI, , ,88236
PREVENTIVE ONCOLOGY,2084215,2/1/1993 0:00,1/31/1998 0:00,Other Research-Related,1995,88236, ,NCI, , ,88236
"RELATIONSHIP BETWEEN DNA DAMAGE, MUTATIONS, AND CANCER",2084394,8/1/1993 0:00,7/31/1997 0:00, ,1994,70640, ,NCI, , ,70640
"RELATIONSHIP BETWEEN DNA DAMAGE, MUTATIONS, AND CANCER",2084395,8/1/1993 0:00,7/31/1997 0:00,Other Research-Related,1995,84394, ,NCI, , ,84394
MOLECULAR PATHOGENESIS OF PARATHYROID NEOPLASIA,2084408,8/1/1993 0:00,7/31/1998 0:00, ,1994,67287, ,NCI, , ,67287
MOLECULAR PATHOGENESIS OF PARATHYROID NEOPLASIA,2084409,8/1/1993 0:00,7/31/1996 0:00,Other Research-Related,1995,80819, ,NCI, , ,80819
ONCOGENES IN HEMATOPOIETIC DIFFERENTIATION AND NEOPLASIA,2086049,9/1/1978 0:00,3/31/1997 0:00, ,1994,94313, ,NCI, , ,94313
ONCOGENES IN HEMATOPOIETIC DIFFERENTIATION AND NEOPLASIA,2086050,9/1/1978 0:00,3/31/1997 0:00,Non-SBIR/STTR,1995,99610, ,NCI, , ,99610
VIRAL GENE FUNCTIONS INVOLVED IN TRANSFORMATION,2086157,5/1/1978 0:00,4/30/1996 0:00, ,1994,255269, ,NCI, , ,255269
VIRAL GENE FUNCTIONS AND REGULATION OF CELL GROWTH,2086184,9/1/1975 0:00,2/28/1998 0:00, ,1994,448078, ,NCI, , ,448078
VIRAL GENE FUNCTIONS AND REGULATION OF CELL GROWTH,2086185,9/1/1975 0:00,2/28/1998 0:00,Non-SBIR/STTR,1995,482714, ,NCI, , ,482714
GENETIC ANALYSIS OF MALIGNANCY,2086771,6/30/1976 0:00,3/31/2000 0:00,Non-SBIR/STTR,1995,441014, ,NCI, , ,441014
DNA DAMAGE /MUTATION IN P53--ROLE IN CELL TRANSFORMATION,2086938,7/1/1988 0:00,6/30/1997 0:00, ,1994,168557, ,NCI, , ,168557
DNA DAMAGE /MUTATION IN P53--ROLE IN CELL TRANSFORMATION,2086939,7/1/1988 0:00,6/30/1997 0:00,Non-SBIR/STTR,1995,186702, ,NCI, , ,186702
CHOLINE DEFICIENCY AND HEPATOCARCINOGENESIS,2087175,4/1/1978 0:00,11/30/1995 0:00, ,1994,244693, ,NCI, , ,244693
SUPPRESSOR GENES AND BREAST CANCER,2087328,5/1/1979 0:00,11/30/1997 0:00, ,1994,203955, ,NCI, , ,203955
SUPPRESSOR GENES AND BREAST CANCER,2087329,5/1/1979 0:00,11/30/1997 0:00,Non-SBIR/STTR,1995,214155, ,NCI, , ,214155
BIOSYNTHESIS OF ADENOVIRUS EARLY RNAS,2087343,4/1/1979 0:00,3/31/2000 0:00,Non-SBIR/STTR,1995,424763, ,NCI, , ,424763
GROWTH FACTORS AND LIVER TUMOR PROMOTION,2087431,7/1/1979 0:00,7/31/1995 0:00, ,1994,212961, ,NCI, , ,212961
CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT,2087595,7/22/1980 0:00,11/30/1997 0:00, ,1994,1984166, ,NCI, , ,1984166
CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT,2087596,7/22/1980 0:00,11/30/1997 0:00,Non-SBIR/STTR,1995,2100130, ,NCI, , ,2100130
TRANSFORMATION IN VITRO OF UROEPITHELIAL CELLS,2087941,2/1/1984 0:00,1/31/1997 0:00, ,1994,247400, ,NCI, , ,247400
TRANSFORMATION IN VITRO OF UROEPITHELIAL CELLS,2087942,2/1/1984 0:00,1/31/1997 0:00,Non-SBIR/STTR,1995,265278, ,NCI, , ,265278
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,2088111,7/15/1981 0:00,1/31/1997 0:00, ,1994,218002, ,NCI, , ,218002
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,2088112,7/15/1981 0:00,1/31/1997 0:00,Non-SBIR/STTR,1995,228972, ,NCI, , ,228972
EXPERIMENTAL BLADDER TUMORS,2088345,9/19/1981 0:00,4/30/1997 0:00, ,1994,234054, ,NCI, , ,234054
EXPERIMENTAL BLADDER TUMORS,2088346,9/19/1981 0:00,4/30/1997 0:00,Non-SBIR/STTR,1995,248669, ,NCI, , ,248669
EXPERIMENTAL BLADDER TUMORS,2088347,9/19/1981 0:00,4/30/1999 0:00,Non-SBIR/STTR,1996,260852, ,NCI, , ,260852
SELECTIVE THERAPY FOR COLON CARCINOMA,2088359,7/1/1983 0:00,2/28/1999 0:00, ,1994,217528, ,NCI, , ,217528
SELECTIVE THERAPY FOR COLON CARCINOMA,2088360,7/1/1983 0:00,2/28/1999 0:00,Non-SBIR/STTR,1995,223151, ,NCI, , ,223151
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA,2088450,6/1/1983 0:00,5/31/2000 0:00,Non-SBIR/STTR,1995,186437, ,NCI, , ,186437
RNA TUMOR VIRUS-HEMATOPOIETIC CELL INTERACTION,2088598,6/1/1983 0:00,3/31/1998 0:00, ,1994,255110, ,NCI, , ,255110
RNA TUMOR VIRUS-HEMATOPOIETIC CELL INTERACTION,2088599,6/1/1983 0:00,3/31/1998 0:00,Non-SBIR/STTR,1995,270965, ,NCI, , ,270965
PANCREATIC DUCT CARCINOGENESIS--SPECIES DIFFERENCES,2088625,2/1/1983 0:00,5/31/1999 0:00,Non-SBIR/STTR,1995,197054, ,NCI, , ,197054
CYTOSKELETAL HYBRIDOMA ANTIBODIES AS DIAGNOSTIC REAGENTS,2089077,3/1/1984 0:00,9/29/1996 0:00, ,1994,192250, ,NCI, , ,192250
CANCER AND LEUKEMIA GROUP B--CORRELATIVE SCIENCES,2089210,4/1/1984 0:00,3/31/1998 0:00, ,1994,829072, ,NCI, , ,829072
CANCER AND LEUKEMIA GROUP B--CORRELATIVE SCIENCES,2089212,4/1/1984 0:00,3/31/1998 0:00,Other Research-Related,1995,733105, ,NCI, , ,733105
SOMATIC GENETIC ALTERATIONS IN GASTROINTESTINAL CANCER,2089589,9/30/1988 0:00,12/31/1997 0:00, ,1994,196144, ,NCI, , ,196144
SOMATIC GENETIC ALTERATIONS IN GASTROINTESTINAL CANCER,2089591,9/30/1988 0:00,12/31/1997 0:00,Non-SBIR/STTR,1995,98702, ,NCI, , ,98702
VIRAL TRANSGENE/ONCOGENE-INDUCED TUMORIGENESIS,2089633,12/1/1984 0:00,11/30/1994 0:00, ,1994,191883, ,NCI, , ,191883
VIRAL TRANSGENE-ONCOGENE INDUCED TUMORIGENESIS,2089634,12/20/1994 0:00,11/30/1997 0:00,Non-SBIR/STTR,1995,232068, ,NCI, , ,232068
GENETIC EPIDEMIOLOGY OF CHILDHOOD SARCOMA,2089673,12/1/1984 0:00,7/31/1996 0:00, ,1994,443942, ,NCI, , ,443942
GENETIC EPIDEMIOLOGY OF CHILDHOOD SARCOMA,2089674,12/1/1984 0:00,7/31/1998 0:00,Non-SBIR/STTR,1995,445015, ,NCI, , ,445015
FUNCTIONAL ANALYSIS OF THE P53 CELLULAR TUMOR ANTIGEN,2090113,8/15/1985 0:00,7/31/1997 0:00, ,1994,154760, ,NCI, , ,154760
FUNCTIONAL ANALYSIS OF THE P53 CELLULAR TUMOR ANTIGEN,2090114,8/15/1985 0:00,7/31/1997 0:00,Non-SBIR/STTR,1995,143815, ,NCI, , ,143815
 EPIDERMAL GROWTH FACTOR AND PANCREATIC CANCER,2090132,4/1/1989 0:00,5/31/1999 0:00,Non-SBIR/STTR,1995,248570, ,NCI, , ,248570
DNA PHOTOLESION STRUCTURE-ACTIVITY RELATIONSHIPS,2090224,7/1/1985 0:00,4/30/1998 0:00, ,1994,243158, ,NCI, , ,243158
DNA PHOTOLESION STRUCTURE-ACTIVITY RELATIONSHIPS,2090225,7/1/1985 0:00,4/30/1998 0:00,Non-SBIR/STTR,1995,257096, ,NCI, , ,257096
COLON CANCER PREVENTION,2090375,9/30/1986 0:00,2/29/2000 0:00,Non-SBIR/STTR,1995,2376469, ,NCI, , ,2376469
TRANSFORMING GROWTH FACTORS IN NEOPLASTIC TRANSFORMATION,2090828,7/1/1986 0:00,4/30/2000 0:00, ,1994,708611, ,NCI, , ,708611
TRANSFORMING GROWTH FACTORS IN NEOPLASTIC TRANSFORMATION,2090829,7/1/1986 0:00,4/30/2000 0:00,Non-SBIR/STTR,1995,744460, ,NCI, , ,744460
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS,2091165,9/30/1986 0:00,7/31/1999 0:00, ,1994,340599, ,NCI, , ,340599
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS,2091167,9/30/1986 0:00,7/31/1999 0:00,Non-SBIR/STTR,1995,355698, ,NCI, , ,355698
P53 GENE IN HUMAN NEOPLASIA,2091181,8/1/1983 0:00,5/31/1996 0:00, ,1994,362266, ,NCI, , ,362266
ONCOGENE-INDUCED LEUKEMOGENESIS IN TRANSGENIC MICE,2091195,4/1/1987 0:00,11/30/1996 0:00, ,1994,129529, ,NCI, , ,129529
ONCOGENE-INDUCED LEUKEMOGENESIS IN TRANSGENIC MICE,2091196,4/1/1987 0:00,11/30/1996 0:00,Non-SBIR/STTR,1995,115282, ,NCI, , ,115282
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,2091246,1/1/1987 0:00,12/31/1995 0:00, ,1994,252557, ,NCI, , ,252557
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,2091247,1/1/1987 0:00,12/31/1995 0:00,Non-SBIR/STTR,1995,271929, ,NCI, , ,271929
RETROVIRUSES AND CANCER GENES,2091417,7/1/1987 0:00,4/30/2001 0:00, ,1994,1394578, ,NCI, , ,1394578
RETROVIRUSES AND CANCER GENES,2091418,7/1/1987 0:00,4/30/2001 0:00,Non-SBIR/STTR,1995,1434183, ,NCI, , ,1434183
CCHARACTERIZATION OF THE RETINOBLASTOMA GENE,2091593,6/1/1987 0:00,3/31/1997 0:00, ,1994,269643, ,NCI, , ,269643
CCHARACTERIZATION OF THE RETINOBLASTOMA GENE,2091594,6/1/1987 0:00,3/31/1997 0:00,Non-SBIR/STTR,1995,278603, ,NCI, , ,278603
STATUS OF P53 IN A LFS CANCER PRONE FAMILY,2091766,9/1/1986 0:00,11/30/1998 0:00,Non-SBIR/STTR,1995,291493, ,NCI, , ,291493
STATUS OF P53 IN A LFS CANCER PRONE FAMILY,2091767,9/1/1986 0:00,11/30/1998 0:00,Non-SBIR/STTR,1995,65766, ,NCI, , ,65766
STATUS OF P53 IN A LFS CANCER PRONE FAMILY,2091768,9/1/1986 0:00,9/30/1996 0:00,Non-SBIR/STTR,1996,300870, ,NCI, , ,300870
STATUS OF P53 IN A LFS CANCER PRONE FAMILY,2091769,9/1/1986 0:00,9/30/1996 0:00,Non-SBIR/STTR,1996,69133, ,NCI, , ,69133
INSTABILITY OF TUMOR PROMOTION IN HEPATOCARCINOGENESIS,2091973,9/1/1987 0:00,3/31/1997 0:00, ,1994,211805, ,NCI, , ,211805
INSTABILITY OF TUMOR PROMOTION IN HEPATOCARCINOGENESIS,2091974,9/1/1987 0:00,3/31/1997 0:00,Non-SBIR/STTR,1995,224643, ,NCI, , ,224643
MOLECULAR CYTOGENETICS--PEDIATRIC CNS TUMORS,2092097,1/13/1989 0:00,12/31/1996 0:00, ,1994,192997, ,NCI, , ,192997
MOLECULAR CYTOGENETICS--PEDIATRIC CNS TUMORS,2092098,1/13/1989 0:00,12/31/1996 0:00,Non-SBIR/STTR,1995,221588, ,NCI, , ,221588
MECHANISMS OF INDUCTION OF SKIN CANCERS BY UV LIGHT,2092189,7/1/1988 0:00,11/30/1995 0:00, ,1994,117256, ,NCI, , ,117256
PATHWAY OF TUMOR SUPPRESSION,2092484,7/1/1988 0:00,4/30/1997 0:00, ,1994,189409, ,NCI, , ,189409
PATHWAY OF TUMOR SUPPRESSION,2092485,7/1/1988 0:00,4/30/1997 0:00,Non-SBIR/STTR,1995,201006, ,NCI, , ,201006
MARKERS FOR DIAGNOSIS AND PROGNOSIS OF BLADDER CANCER,2092596,5/15/1988 0:00,3/31/1996 0:00, ,1994,149637, ,NCI, , ,149637
MARKERS FOR METASTASIS AND RISK IN COLORECTAL CANCER,2092600,4/1/1988 0:00,11/30/1996 0:00, ,1994,204362, ,NCI, , ,204362
MARKERS FOR METASTASIS AND RISK IN COLORECTAL CANCER,2092601,4/1/1988 0:00,11/30/1996 0:00,Non-SBIR/STTR,1995,224382, ,NCI, , ,224382
NEOPLASTIC PROGRESSION IN PAPILLOMAVIRUS TRANSGENIC MICE,2092669,9/1/1988 0:00,2/28/1998 0:00, ,1994,285892, ,NCI, , ,285892
NEOPLASTIC PROGRESSION IN PAPILLOMAVIRUS TRANSGENIC MICE,2092670,9/1/1988 0:00,2/28/1998 0:00,Non-SBIR/STTR,1995,299642, ,NCI, , ,299642
HEPATITIS B VIRUS X ANTIGEN AND PHC,2093013,3/1/1988 0:00,4/30/1998 0:00, ,1994,204088, ,NCI, , ,204088
HEPATITIS B VIRUS X ANTIGEN AND PHC,2093014,3/1/1988 0:00,4/30/1998 0:00,Non-SBIR/STTR,1995,209147, ,NCI, , ,209147
A TUMOR SUPPRESSOR GENE ON HUMAN CHROMOSOME 9P,2093184,1/13/1989 0:00,12/31/1996 0:00, ,1994,192636, ,NCI, , ,192636
A TUMOR SUPPRESSOR GENE ON HUMAN CHROMOSOME 9P,2093185,1/13/1989 0:00,12/31/1996 0:00,Non-SBIR/STTR,1995,207208, ,NCI, , ,207208
TUMOR SUPPRESSION FUNCTION OF RB & P53 IN MAMMARY GLAND,2093378,5/10/1989 0:00,4/30/1999 0:00, ,1994,192648, ,NCI, , ,192648
TUMOR SUPPRESSION FUNCTION OF RB & P53 IN MAMMARY GLAND,2093379,5/10/1989 0:00,4/30/1999 0:00,Non-SBIR/STTR,1995,205617, ,NCI, , ,205617
CANCER CAUSE AND PREVENTION RESEARCH,2093427,8/1/1990 0:00,7/31/1999 0:00, ,1994,1223875, ,NCI, , ,1223875
CANCER CAUSE AND PREVENTION RESEARCH,2093428,8/1/1990 0:00,7/31/1999 0:00,Non-SBIR/STTR,1995,1270070, ,NCI, , ,1270070
DNA METHYLATION IN DEVELOPMENT AND CANCER,2093431,5/1/1989 0:00,2/28/2001 0:00, ,1994,622743, ,NCI, , ,622743
DNA METHYLATION IN DEVELOPMENT AND CANCER,2093432,5/1/1989 0:00,2/28/2001 0:00,Non-SBIR/STTR,1995,648839, ,NCI, , ,648839
MOLECULAR EVENTS IN BLAST CRISIS OF CML,2093690,7/1/1989 0:00,4/30/1995 0:00, ,1993,205382, ,NCI, , ,205382
MECHANISMS OF PROGRESSION IN ONCOGENE INDUCED PROSTATE C,2093858,9/8/1989 0:00,7/31/1996 0:00, ,1994,161834, ,NCI, , ,161834
MECHANISMS OF PROGRESSION IN ONCOGENE INDUCED PROSTATE C,2093859,9/8/1989 0:00,7/31/1996 0:00,Non-SBIR/STTR,1995,171741, ,NCI, , ,171741
MOLECULAR PATHOLOGY OF GLIOMAS,2094024,1/13/1995 0:00,11/30/1998 0:00,Non-SBIR/STTR,1995,346250, ,NCI, , ,346250
CYSTEINE CAPHEPSINS & HUMAN COLORECTAL TUMOR PROGRESSION,2094412,4/15/1993 0:00,1/31/1997 0:00, ,1994,178389, ,NCI, , ,178389
CYSTEINE CATHEPSIN & HUMAN COLORECTAL TUMOR PROGRESSION,2094413,4/15/1993 0:00,1/31/1997 0:00,Non-SBIR/STTR,1995,192216, ,NCI, , ,192216
CYSTEINE CATHEPSIN & HUMAN COLORECTAL TUMOR PROGRESSION,2094414,4/15/1993 0:00,1/31/1999 0:00,Non-SBIR/STTR,1996,200754, ,NCI, , ,200754
EXPRESSION AND MODULATION OF MULTIDRUG RESISTANCE,2094628,4/15/1990 0:00,5/31/1999 0:00,Non-SBIR/STTR,1995,288000, ,NCI, , ,288000
MAMMALIAN GENOME ORGANIZATION AND GENE AMPLIFICATION,2094807,7/1/1990 0:00,4/30/1998 0:00, ,1994,277385, ,NCI, , ,277385
MAMMALIAN GENOME ORGANIZATION AND GENE AMPLIFICATION,2094808,7/1/1990 0:00,4/30/1998 0:00,Non-SBIR/STTR,1995,292597, ,NCI, , ,292597
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,2094853,8/1/1990 0:00,2/28/1999 0:00, ,1994,297035, ,NCI, , ,297035
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,2094854,8/1/1990 0:00,2/28/1999 0:00,Non-SBIR/STTR,1995,305345, ,NCI, , ,305345
LIGASE DEFICIENCY--A MODEL FOR DNA REPAIR SYNDROMES,2094931,8/1/1990 0:00,7/31/1996 0:00, ,1994,250529, ,NCI, , ,250529
MOLECULAR GENETICS OF HUMAN ASTROCYTOMA,2095020,7/1/1990 0:00,6/30/1995 0:00, ,1994,94185, ,NCI, , ,94185
DEVELOPMENTAL CONTROL OF ONCOGENE EXPRESSION,2095182,7/22/1992 0:00,4/30/1997 0:00, ,1994,232398, ,NCI, , ,232398
DEVELOPMENTAL CONTROL OF ONCOGENE EXPRESSION,2095183,7/22/1992 0:00,4/30/1997 0:00,Non-SBIR/STTR,1995,161533, ,NCI, , ,161533
FUNCTION OF THE ADENOVIRUS E1B ONCOGENE,2095291,1/1/1991 0:00,12/31/1995 0:00, ,1994,207405, ,NCI, , ,207405
FUNCTION OF THE ADENOVIRUS E1B ONCOGENE,2095293,1/1/1991 0:00,12/31/1995 0:00,Non-SBIR/STTR,1995,225035, ,NCI, , ,225035
TUMOR SUPPRESSOR GENES IN CHEMICALLY INDUCED SKIN TUMORS,2095462,1/1/1991 0:00,12/31/1995 0:00, ,1994,191080, ,NCI, , ,191080
MECHANISMS OF DNA DAMAGE INDUCED RECOMBINATION,2095676,7/1/1990 0:00,11/30/1998 0:00,Non-SBIR/STTR,1995,176031, ,NCI, , ,176031
MECHANISMS OF DNA DAMAGE INDUCED RECOMBINATION,2095677,7/1/1990 0:00,8/31/1996 0:00,Non-SBIR/STTR,1996,137449, ,NCI, , ,137449
PROTO-ONCOGENES IN MALIGNANT HEMATOPOIESIS,2095883,7/3/1991 0:00,6/30/1995 0:00, ,1993,261790, ,NCI, , ,261790
NOVEL NUCLEAR PROTEINS IN NORMAL AND CANCER CELLS,2095900,3/1/1992 0:00,7/31/1999 0:00,Non-SBIR/STTR,1995,245016, ,NCI, , ,245016
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISM,2095922,4/17/1992 0:00,1/31/1997 0:00, ,1994,588607, ,NCI, , ,588607
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISM,2095923,4/17/1992 0:00,1/31/1997 0:00,Non-SBIR/STTR,1995,622475, ,NCI, , ,622475
RELATION OF HEPATITIS C VIRUS--HEPATOCELLULAR CARCINOMA,2096055,3/15/1992 0:00,2/29/1996 0:00,Non-SBIR/STTR,1994,158146, ,NCI, , ,158146
INACTIVATED P53 GENE IN MICE,2096216,4/15/1992 0:00,9/29/1995 0:00, ,1994,190784, ,NCI, , ,190784
P53 AND CELL PROLIFERATION,2096276,7/15/1991 0:00,6/30/1995 0:00, ,1994,168443, ,NCI, , ,168443
BIOLOGY AND MECHANISM OF AAV REP78 ANTIPROLIFERATION,2096283,4/1/1993 0:00,3/31/1998 0:00, ,1994,98306, ,NCI, , ,98306
BIOLOGY AND MECHANISM OF AAV REP78 ANTIPROLIFERATION,2096284,4/1/1993 0:00,3/31/1998 0:00,Non-SBIR/STTR,1995,102238, ,NCI, , ,102238
THERAPY OF AML,2096370,6/1/1992 0:00,3/31/1996 0:00, ,1994,1759812, ,NCI, , ,1759812
THERAPY OF AML,2096371,6/1/1992 0:00,9/29/1996 0:00,Non-SBIR/STTR,1995,1869189, ,NCI, , ,1869189
THERAPY OF AML,2096372,6/1/1992 0:00,9/29/1996 0:00,Non-SBIR/STTR,1996,286974, ,NCI, , ,286974
MOLECULAR PATHOGENESIS OF TUMORS IN NEUROFIBROMATOSIS,2096378,7/5/1991 0:00,6/30/1996 0:00, ,1994,114954, ,NCI, , ,114954
TUMOR SUPPRESSOR GENE INACTIVATION IN PROSTATE CANCER,2096443,7/1/1991 0:00,5/31/1996 0:00, ,1994,123869, ,NCI, , ,123869
"GLIOMAS--BIOLOGIC, MOLECULAR, AND GENETIC STUDIES",2096482,8/1/1992 0:00,3/31/1996 0:00,Non-SBIR/STTR,1994,784498, ,NCI, , ,784498
CLINICAL & MOLECULAR STUDIES ON AIDS-RELATED LYMPHOMAS,2096662,7/1/1991 0:00,6/30/1995 0:00, ,1993,209919, ,NCI, , ,209919
GROWTH REGULATION & TRANSFORMATION OF OVARIAN EPITHELIUM,2096747,2/1/1992 0:00,1/31/1997 0:00, ,1994,105560, ,NCI, , ,105560
GROWTH REGULATION & TRANSFORMATION OF OVARIAN EPITHELIUM,2096748,2/1/1992 0:00,1/31/1997 0:00,Non-SBIR/STTR,1995,107217, ,NCI, , ,107217
GENETIC ALTERATIONS IN CNS TUMOR DEVELOPMENT,2096840,5/1/1991 0:00,2/28/1995 0:00, ,1994,151872, ,NCI, , ,151872
GENETIC ALTERATIONS IN CNS TUMOR DEVELOPMENT,2096842,5/1/1991 0:00,5/11/1996 0:00,Non-SBIR/STTR,1995,181082, ,NCI, , ,181082
SUNLIGHT-RELATED STEPS IN HUMAN SKIN CANCER,2096853,4/1/1992 0:00,3/31/1996 0:00,Non-SBIR/STTR,1994,155521, ,NCI, , ,155521
ECOGENETICS OF LUNG CANCER IN MINORITY POPULATIONS,2096879,9/30/1991 0:00,8/31/1995 0:00, ,1994,313645, ,NCI, , ,313645
QUANTITATIVE DNA MOLECULAR STUDIES IN PROSTATE CANCER,2096898,4/2/1993 0:00,1/31/1996 0:00, ,1994,675030, ,NCI, , ,675030
"GROWTH GENES, EXTRACELLULAR MATRIX AND ANGIOGENESIS",2096937,7/1/1994 0:00,4/30/1999 0:00, ,1994,172097, ,NCI, , ,172097
"GROWTH GENES, EXTRACELLULAR MATRIX AND ANGIOGENESIS",2096938,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1995,180017, ,NCI, , ,180017
GERM LINE P53 MUTATIONS AND CANCER,2096995,3/10/1992 0:00,2/28/1995 0:00, ,1994,303851, ,NCI, , ,303851
MOLECULAR MECHANISM OF HEMATOLOGICAL MALIGNANCY,2097075,3/4/1992 0:00,2/28/1996 0:00, ,1994,253963, ,NCI, , ,253963
MUCIN GENES AND COLONIC CELL TRANSFORMATION,2097092,2/12/1992 0:00,1/31/1995 0:00, ,1994,189640, ,NCI, , ,189640
BLADDER CANCER--SUPPESSOR GENES AND RADIATION RESPONSE,2097274,4/2/1992 0:00,3/31/1995 0:00, ,1993,44450, ,NCI, , ,44450
P53 MUTATIONAL SPECTRUM IN LUNG TUMORS FROM NONSMOKERS,2097542,1/1/1993 0:00,12/31/1995 0:00, ,1994,280858, ,NCI, , ,280858
P53 IN BREAST CANCER,2097554,5/11/1992 0:00,11/30/1995 0:00,Non-SBIR/STTR,1994,195090, ,NCI, , ,195090
"SITE-SPECIFIC GENE DAMAGE, MUTATION, AND CANCER",2097595,1/1/1993 0:00,12/31/1996 0:00, ,1994,222397, ,NCI, , ,222397
"SITE-SPECIFIC GENE DAMAGE, MUTATION, AND CANCER",2097596,1/1/1993 0:00,12/31/1996 0:00,Non-SBIR/STTR,1995,238140, ,NCI, , ,238140
MAMMARY EPITHELIAL CELL IMMORTALIZATION,2097600,4/1/1992 0:00,3/31/1997 0:00, ,1994,133285, ,NCI, , ,133285
MAMMARY EPITHELIAL CELL IMMORTALIZATION,2097601,4/1/1992 0:00,3/31/1997 0:00,Non-SBIR/STTR,1995,140405, ,NCI, , ,140405
P53 BREAST CANCER MUTATIONS IN HIGH AND LOW RISK GROUPS,2097663,8/5/1992 0:00,7/31/1997 0:00, ,1994,191297, ,NCI, , ,191297
P53 BREAST CANCER MUTATIONS IN HIGH AND LOW RISK GROUPS,2097664,8/5/1992 0:00,5/31/1997 0:00,Non-SBIR/STTR,1995,262201, ,NCI, , ,262201
P53 BREAST CANCER MUTATIONS IN HIGH AND LOW RISK GROUPS,2097665,8/5/1992 0:00,5/31/1998 0:00,Non-SBIR/STTR,1996,263006, ,NCI, , ,263006
MARKERS FOR BLADDER CANCER DIAGNOSIS AND PROGNOSIS,2097741,5/1/1992 0:00,3/31/1996 0:00, ,1994,163384, ,NCI, , ,163384
IMMUNE DYSFUNCTION AND AIDS ASSOCIATED B CELL LYMPHOMA,2097910,4/3/1992 0:00,6/30/1998 0:00,Non-SBIR/STTR,1995,157165, ,NCI, , ,157165
MARKERS FOR MALIGNANT PROGRESSION IN PROSTATE CANCER,2097935,7/23/1992 0:00,6/30/1996 0:00, ,1994,165341, ,NCI, , ,165341
MARKERS FOR MALIGNANT PROGRESSION IN PROSTATE CANCER,2097936,7/23/1992 0:00,6/30/1997 0:00,Non-SBIR/STTR,1995,175466, ,NCI, , ,175466
MOLECULAR EXPRESSION ANALYSIS IN PROSTATE CANCER,2097948,7/20/1992 0:00,6/30/1996 0:00, ,1994,34040, ,NCI, , ,34040
MOLECULAR EXPRESSION ANALYSIS IN PROSTATE CANCER,2097949,7/20/1992 0:00,6/30/1997 0:00,Non-SBIR/STTR,1995,36249, ,NCI, , ,36249
GENETIC LOCI ASSOCIATED WITH PROSTATE CANCER DEVELOPMENT,2097954,7/17/1992 0:00,6/30/1996 0:00, ,1994,137963, ,NCI, , ,137963
GENETIC LOCI ASSOCIATED WITH PROSTATE CANCER DEVELOPMENT,2097955,7/17/1992 0:00,6/30/1997 0:00,Non-SBIR/STTR,1995,144796, ,NCI, , ,144796
TRANSFORMING FUNCTIONS OF MUTANT COLON CANCER ONCOGENES,2097961,7/15/1992 0:00,4/30/1996 0:00, ,1994,207540, ,NCI, , ,207540
RAS ONCOGENE ACTIVATION IN UVR-INDUCED CORNEAL TUMORS,2098112,9/30/1993 0:00,9/29/1996 0:00, ,1994,49657, ,NCI, , ,49657
BIOCHEMICAL ROLE OF THE P53 GENE PRODUCT IN HUMAN CANCER,2098146,9/1/1993 0:00,7/31/1998 0:00, ,1994,92038, ,NCI, , ,92038
BIOCHEMICAL ROLE OF THE P53 GENE PRODUCT IN HUMAN CANCER,2098147,9/1/1993 0:00,10/31/1995 0:00,Non-SBIR/STTR,1995,15293, ,NCI, , ,15293
BIOCHEMICAL ROLE OF THE P53 GENE PRODUCT IN HUMAN CANCER,2098148,9/1/1993 0:00,7/31/1998 0:00,Non-SBIR/STTR,1995,84100, ,NCI, , ,84100
BIOCHEMICAL ROLE OF THE P53 GENE PRODUCT IN HUMAN CANCER,2098149,9/1/1993 0:00,7/31/1998 0:00,Non-SBIR/STTR,1996,104035, ,NCI, , ,104035
P53 & FIBROCYSTIC DISEASE--INCREASED BREAST CANCER RISK,2098168,7/1/1992 0:00,6/30/1996 0:00,Non-SBIR/STTR,1994,187895, ,NCI, , ,187895
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN ASTROCYTOMAS,2098404,8/1/1992 0:00,7/31/1997 0:00, ,1994,281967, ,NCI, , ,281967
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN ASTROCYTOMAS,2098405,8/1/1992 0:00,7/31/1997 0:00,Non-SBIR/STTR,1995,299232, ,NCI, , ,299232
GENE CHANGES AND CHEMOTHERAPY FOR COLON CANCER,2098428,9/10/1992 0:00,7/31/1997 0:00, ,1994,172278, ,NCI, , ,172278
GENE CHANGES AND CHEMOTHERAPY FOR COLON CANCER,2098429,9/10/1992 0:00,7/31/1997 0:00,Non-SBIR/STTR,1995,182567, ,NCI, , ,182567
GENE CHANGES AND CHEMOTHERAPY FOR COLON CANCER,2098430,9/10/1992 0:00,7/31/1998 0:00,Non-SBIR/STTR,1996,198518, ,NCI, , ,198518
ONCOGENE SPECIFIC CYTOTOXIC T LYMPHOCYTES,2098594,8/7/1992 0:00,5/31/1997 0:00, ,1994,148635, ,NCI, , ,148635
GENETIC AND HORMONAL FACTORS IN MAMMARY CARCINOGENESIS,2098700,4/14/1992 0:00,10/5/1994 0:00, ,1994,67752, ,NCI, , ,67752
MOLECULARLY-DEFINED TAA AS HUMAN ANTITUMOR CTL TARGETS,2098718,8/1/1992 0:00,5/31/1997 0:00, ,1994,229949, ,NCI, , ,229949
MOLECULARLY-DEFINED TAA AS HUMAN ANTITUMOR CTL TARGETS,2098719,8/1/1992 0:00,5/31/1997 0:00,Non-SBIR/STTR,1995,257351, ,NCI, , ,257351
MOLECULAR PATHWAY TO PROSTATE CANCER,2098793,9/30/1992 0:00,9/29/1995 0:00, ,1994,214168, ,NCI, , ,214168
GENE TRANSFER FOR SUPPRESSION OF THE TUMOR PHENOTYPE,2099016,5/1/1992 0:00,4/30/1995 0:00, ,1993,169995, ,NCI, , ,169995
DORMANT LYMPHOMA CELLS FROM MICE,2099027,2/3/1993 0:00,1/31/1996 0:00, ,1994,158875, ,NCI, , ,158875
REGULATION OF MULTIDRUG RESISTANCE GENE EXPRESSION,2099140,1/1/1993 0:00,12/31/1997 0:00, ,1994,103706, ,NCI, , ,103706
REGULATION OF MULTIDRUG RESISTANCE GENE EXPRESSION,2099141,1/1/1993 0:00,12/31/1997 0:00,Non-SBIR/STTR,1995,104979, ,NCI, , ,104979
ADENOVIRUS E3 PROTEINS AND TUMOR NECROSIS FACTOR,2099224,9/30/1993 0:00,8/31/1996 0:00, ,1994,108850, ,NCI, , ,108850
P53-GUANINE NUCLEOTIDE REGULATOR,2099295,1/1/1993 0:00,12/31/1995 0:00, ,1994,236977, ,NCI, , ,236977
PATHOLOGY OF GASTRIC CANCER,2099391,2/1/1993 0:00,1/31/1998 0:00, ,1994,142529, ,NCI, , ,142529
PATHOLOGY OF GASTRIC CANCER,2099392,2/1/1993 0:00,1/31/1998 0:00,Non-SBIR/STTR,1995,146942, ,NCI, , ,146942
LOSS OF HETEROZYGOSITY IN BILATERAL BREAST CANCER,2099483,8/13/1993 0:00,7/31/1996 0:00, ,1994,307106, ,NCI, , ,307106
HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIES,2099493,2/4/1994 0:00,12/31/1997 0:00, ,1994,591762, ,NCI, , ,591762
HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIES,2099494,2/4/1994 0:00,12/31/1997 0:00,Non-SBIR/STTR,1995,721628, ,NCI, , ,721628
CATIONIC LIPOSOME-BASED GENE THERAPY FOR LUNG CANCER,2099531,7/1/1993 0:00,4/30/1995 0:00, ,1994,154975, ,NCI, , ,154975
SPONTANEOUS TRANSFORMATION OF HEPATIC STEM CELLS,2100078,4/16/1993 0:00,3/31/1998 0:00, ,1994,174220, ,NCI, , ,174220
SPONTANEOUS TRANSFORMATION OF HEPATIC STEM CELLS,2100079,4/16/1993 0:00,3/31/1998 0:00,Non-SBIR/STTR,1995,189280, ,NCI, , ,189280
STAGES OF EVOLUTION OF HEPATOCARCINOGENESIS IN VITRO,2100097,9/30/1994 0:00,3/31/1998 0:00, ,1994,83830, ,NCI, , ,83830
STAGES OF EVOLUTION OF HEPATOCARCINOGENESIS IN VITRO,2100099,9/30/1994 0:00,3/31/1998 0:00,Non-SBIR/STTR,1995,171306, ,NCI, , ,171306
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,2100284,6/1/1993 0:00,3/31/1998 0:00, ,1994,277528, ,NCI, , ,277528
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,2100285,6/1/1993 0:00,3/31/1998 0:00,Non-SBIR/STTR,1995,295736, ,NCI, , ,295736
FACTORS AFFECTING SURVIVAL OF YOUNG CANCER PATIENTS,2100338,6/5/1993 0:00,3/31/1998 0:00, ,1994,280388, ,NCI, , ,280388
FACTORS AFFECTING SURVIVAL OF YOUNG CANCER PATIENTS,2100339,6/5/1993 0:00,3/31/1998 0:00,Non-SBIR/STTR,1995,288863, ,NCI, , ,288863
NUCLEAR REGULATORS IN MYELOPOIESIS AND LEUKEMIA,2100388,9/1/1994 0:00,8/31/1999 0:00, ,1994,179665, ,NCI, , ,179665
NUCLEAR REGULATORS IN MYELOPOIESIS AND LEUKEMIA,2100389,9/1/1994 0:00,8/31/1999 0:00,Non-SBIR/STTR,1995,211761, ,NCI, , ,211761
P53--MARKER FOR ORAL CAVITY PREMALIGNANCY & CANCER RISK,2100529,4/1/1995 0:00,1/31/1996 0:00,Non-SBIR/STTR,1995,148403, ,NCI, , ,148403
P53--MARKER FOR ORAL CAVITY PREMALIGNANCY & CANCER RISK,2100530,4/1/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1996,144704, ,NCI, , ,144704
CYSTEINE RESIDUES AND P53 FUNCTION,2100715,9/30/1994 0:00,7/31/1997 0:00, ,1994,172343, ,NCI, , ,172343
CYSTEINE RESIDUES AND P53 FUNCTION,2100717,9/30/1994 0:00,7/31/1997 0:00,Non-SBIR/STTR,1995,171675, ,NCI, , ,171675
CYSTEINE RESIDUES AND P53 FUNCTION,2100719,9/30/1994 0:00,7/31/1999 0:00,Non-SBIR/STTR,1996,174208, ,NCI, , ,174208
CYSTEINE RESIDUES AND P53 FUNCTION,2100720,9/30/1994 0:00,7/31/1999 0:00,Non-SBIR/STTR,1996,22169, ,NCI, , ,22169
DNA STUDIES & P53 GENE ABNORMALITIES IN PROSTATE CANCER,2100724,7/1/1993 0:00,6/30/1995 0:00, ,1994,147583, ,NCI, , ,147583
DNA STUDIES & P53 GENE ABNORMALITIES IN PROSTATE CANCER,2100725,7/1/1993 0:00,6/30/1997 0:00,Non-SBIR/STTR,1995,145617, ,NCI, , ,145617
DNA STUDIES & P53 GENE ABNORMALITIES IN PROSTATE CANCER,2100726,7/1/1993 0:00,6/30/1997 0:00,Non-SBIR/STTR,1996,141828, ,NCI, , ,141828
MOLECULAR GENETICS AND ADJUVANT THERAPY OF COLON CANCER,2100728,8/9/1993 0:00,6/30/1997 0:00, ,1994,200528, ,NCI, , ,200528
MOLECULAR GENETICS AND ADJUVANT THERAPY OF COLON CANCER,2100729,8/9/1993 0:00,6/30/1997 0:00,Non-SBIR/STTR,1995,194973, ,NCI, , ,194973
RB1 AND P53 LOSS IN PROGNOSIS OF PEDIATRIC OSTEOSARCOMA,2100752,12/15/1993 0:00,6/30/1997 0:00, ,1994,95768, ,NCI, , ,95768
RB1 AND P53 LOSS IN PROGNOSIS OF PEDIATRIC OSTEOSARCOMA,2100753,12/15/1993 0:00,6/30/1996 0:00,Non-SBIR/STTR,1995,162328, ,NCI, , ,162328
RB1 AND P53 LOSS IN PROGNOSIS OF PEDIATRIC OSTEOSARCOMA,2100754,12/15/1993 0:00,6/30/1998 0:00,Non-SBIR/STTR,1996,161966, ,NCI, , ,161966
LABORATORY-CLINICAL CORRELATIVE STUDIES IN LUNG CANCER,2100756,9/30/1993 0:00,9/29/1996 0:00, ,1994,188335, ,NCI, , ,188335
LABORATORY-CLINICAL CORRELATIVE STUDIES IN LUNG CANCER,2100757,9/30/1993 0:00,9/29/1998 0:00,Non-SBIR/STTR,1995,200541, ,NCI, , ,200541
BRAIN TUMORS,2100859,3/1/1993 0:00,2/28/1996 0:00, ,1994,78000, ,NCI, , ,78000
RECESSIVE MUTATIONS IN THE GENESIS OF PROSTATE CANCER,2101083,9/30/1992 0:00,9/29/1996 0:00, ,1994,178123, ,NCI, , ,178123
TUMOR SUPPRESSOR GENES IN ADULT ALL,2101170,9/30/1993 0:00,6/30/1995 0:00, ,1994,140991, ,NCI, , ,140991
TUMOR SUPPRESSOR GENES IN ADULT ALL,2101171,9/30/1993 0:00,6/30/1997 0:00,Non-SBIR/STTR,1995,148144, ,NCI, , ,148144
DNA REPLICATION PROTEIN COMPLEX A,2101255,7/11/1994 0:00,6/30/1997 0:00, ,1994,155433, ,NCI, , ,155433
DNA REPLICATION PROTEIN COMPLEX A,2101256,7/11/1994 0:00,12/31/1997 0:00,Non-SBIR/STTR,1995,169091, ,NCI, , ,169091
MOLECULAR ANALYSIS OF CHROMOSOME INSTABILITY SYNDROMES,2101335,5/1/1994 0:00,2/28/1999 0:00, ,1994,199602, ,NCI, , ,199602
MOLECULAR ANALYSIS OF CHROMOSOME INSTABILITY SYNDROMES,2101336,5/1/1994 0:00,2/28/1999 0:00,Non-SBIR/STTR,1995,213240, ,NCI, , ,213240
CHROMOSOME 17 IN THE EARLY STAGES OF OVARIAN CANCER,2101390,8/1/1993 0:00,5/31/1997 0:00, ,1994,151925, ,NCI, , ,151925
CHROMOSOME 17 IN THE EARLY STAGES OF OVARIAN CANCER,2101391,8/1/1993 0:00,5/31/1997 0:00,Non-SBIR/STTR,1995,161227, ,NCI, , ,161227
MUTATION-INDEPENDENT ALTERATION OF P53 IN BREAST CANCER,2101412,9/15/1993 0:00,8/31/1998 0:00, ,1994,98627, ,NCI, , ,98627
MUTATION-INDEPENDENT ALTERATION OF P53 IN BREAST CANCER,2101413,9/15/1993 0:00,8/31/1998 0:00,Non-SBIR/STTR,1995,102989, ,NCI, , ,102989
MUTATION-INDEPENDENT ALTERATION OF P53 IN BREAST CANCER,2101414,9/15/1993 0:00,8/31/1998 0:00,Non-SBIR/STTR,1996,107541, ,NCI, , ,107541
GENETIC EPIDEMIOLOGY OF LUNG CANCER,2101444,12/15/1994 0:00,11/30/1998 0:00,Non-SBIR/STTR,1995,384350, ,NCI, , ,384350
ANTIONCOGENES IN CARCINOGEN-INDUCED PANCREATIC CANCER,2101491,7/1/1993 0:00,6/30/1998 0:00, ,1994,105578, ,NCI, , ,105578
MOUSE MODELS FOR PROSTATE CARCINOGENESIS,2101540,5/16/1994 0:00,2/28/1998 0:00, ,1994,296846, ,NCI, , ,296846
MOUSE MODELS FOR PROSTATE CARCINOGENESIS,2101541,5/16/1994 0:00,2/28/1998 0:00,Non-SBIR/STTR,1995,295078, ,NCI, , ,295078
RESPONSE DETERMINANTS IN ADVANCED BREAST CANCER,2101633,7/1/1994 0:00,6/30/1997 0:00, ,1994,243424, ,NCI, , ,243424
PREDICTORS OF PROGRESSION IN BARRETTS ESOPHAGUS,2101917,2/7/1995 0:00,11/30/1999 0:00,Non-SBIR/STTR,1995,810113, ,NCI, , ,810113
ONCOGENE-SPECIFIC IMMUNE RESPONSES IN BREAST CANCER,2101972,6/1/1994 0:00,5/31/1997 0:00, ,1994,206913, ,NCI, , ,206913
ONCOGENE-SPECIFIC IMMUNE RESPONSES IN BREAST CANCER,2101973,6/1/1994 0:00,6/2/1996 0:00,Non-SBIR/STTR,1995,197527, ,NCI, , ,197527
CONSTRUCTION OF VACCINES AGAINST BREAST CANCER,2102174,5/2/1994 0:00,4/30/1997 0:00, ,1994,194606, ,NCI, , ,194606
CONSTRUCTION OF VACCINES AGAINST BREAST CANCER,2102175,5/2/1994 0:00,4/30/1997 0:00,Non-SBIR/STTR,1995,199200, ,NCI, , ,199200
DIET AND SOMATIC MUTATIONS IN COLON CANCER,2102526,8/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1995,743750, ,NCI, , ,743750
NOVEL BREAST CANCER GROWTH SUPPRESSOR GENE,2102710,2/1/1994 0:00,1/31/1997 0:00, ,1994,166938, ,NCI, , ,166938
NOVEL BREAST CANCER GROWTH SUPPRESSOR GENE,2102711,2/1/1994 0:00,1/31/1997 0:00,Non-SBIR/STTR,1995,149650, ,NCI, , ,149650
"P53, MYC, GENETIC INSTABILITY AND CELL SURVIVAL AFTER IR",2102840,3/9/1994 0:00,2/28/1998 0:00, ,1994,197935, ,NCI, , ,197935
"P53, MYC, GENETIC INSTABILITY AND CELL SURVIVAL AFTER IR",2102842,3/9/1994 0:00,2/28/1998 0:00,Non-SBIR/STTR,1995,191091, ,NCI, , ,191091
REGULATION OF RADIATION-INDUCED APOPTOTIC CELL DEATH,2103292,2/1/1994 0:00,1/31/1999 0:00, ,1994,92954, ,NCI, , ,92954
REGULATION OF RADIATION-INDUCED APOPTOTIC CELL DEATH,2103293,2/1/1994 0:00,1/31/1999 0:00,Non-SBIR/STTR,1995,96517, ,NCI, , ,96517
SIGNIFICANCE OF MICROMETASTASES IN PROSTATE CANCER,2103353,12/15/1994 0:00,11/30/1995 0:00,Non-SBIR/STTR,1995,95275, ,NCI, , ,95275
MECHANISMS OF MUTATIONS IN HUMAN TUMOR CELLS,2103368,4/15/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1995,225126, ,NCI, , ,225126
DES AND CANCER OF VAGINA/CERVIX--COLLABORATIVE STUDIES,2104406,9/30/1993 0:00,7/31/1997 0:00, ,1994,538018, ,NCI, , ,538018
DES AND CANCER OF VAGINA/CERVIX--COLLABORATIVE STUDIES,2104407,9/30/1993 0:00,7/31/1997 0:00,Non-SBIR/STTR,1995,512069, ,NCI, , ,512069
DES AND CANCER OF VAGINA/CERVIX--COLLABORATIVE STUDIES,2104408,9/30/1993 0:00,7/31/1999 0:00,Non-SBIR/STTR,1996,378647, ,NCI, , ,378647
CONFERENCE ON HUMAN TUMOR VIRUSES,2104435,2/1/1994 0:00,1/31/1995 0:00, ,1994,8000, ,NCI, , ,8000
ENVIRONMENTAL AND GENETIC DETERMINANTS OF BREAST CANCER,2104475,9/30/1993 0:00,9/29/1997 0:00, ,1994,461424, ,NIEHS, , ,41666
ISOLATION OF A SECOND WILMS TUMOR SUPRESSOR GENE,2104867,6/1/1994 0:00,5/31/1997 0:00, ,1994,181317, ,NCI, , ,181317
ISOLATION OF A SECOND WILMS TUMOR SUPRESSOR GENE,2104868,6/1/1994 0:00,5/31/1997 0:00,Non-SBIR/STTR,1995,223289, ,NCI, , ,223289
TRANSGENIC APPROACH TO ONCOGENE AND DNA REPAIR IMBALANCE,2104908,5/1/1994 0:00,2/28/1999 0:00, ,1994,229408, ,NCI, , ,229408
TRANSGENIC APPROACH TO ONCOGENE AND DNA REPAIR IMBALANCE,2104909,5/1/1994 0:00,2/28/1999 0:00,Non-SBIR/STTR,1995,215800, ,NCI, , ,215800
MUTANT P53 GAIN OF FUNCTION IN TURMORIGENISIS,2104962,4/1/1995 0:00,3/31/1998 0:00,Non-SBIR/STTR,1995,181168, ,NCI, , ,181168
INSTABILITY OF MICROSATELLITES IN MAMMALIAN CELLS,2105009,7/13/1995 0:00,4/30/1999 0:00,Non-SBIR/STTR,1995,196607, ,NCI, , ,196607
ALLELE LOSS IN THE GENESIS OF GASTRIC CANCER,2105073,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1995,95656, ,NCI, , ,95656
PROLIFERATIVE EFFECTS OF HTLV 1,2105244,9/28/1995 0:00,7/31/1998 0:00,Non-SBIR/STTR,1995,222045, ,NCI, , ,222045
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE,2105533,5/1/1994 0:00,2/28/1999 0:00,Non-SBIR/STTR,1994,447521, ,NCI, , ,447521
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE,2105535,5/1/1994 0:00,2/28/1999 0:00,Non-SBIR/STTR,1995,297668, ,NCI, , ,297668
POPULATION BASED GENETIC ANALYSIS OF BREAST CANCER,2105728,7/1/1994 0:00,4/30/1999 0:00, ,1994,167004, ,NCI, , ,167004
POPULATION BASED GENETIC ANALYSIS OF BREAST CANCER,2105729,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1995,158610, ,NCI, , ,158610
DIET AND GENETIC ALTERATIONS IN COLORECTAL NEOPLASIA,2105750,7/1/1994 0:00,4/30/1999 0:00, ,1994,232323, ,NCI, , ,232323
DIET AND GENETIC ALTERATIONS IN COLORECTAL NEOPLASIA,2105751,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1995,213351, ,NCI, , ,213351
MAPPING COLORECTAL CANCER SUSCEPTIBILITY LOCI,2105754,8/1/1994 0:00,5/31/1999 0:00, ,1994,210752, ,NCI, , ,210752
MAPPING COLORECTAL CANCER SUSCEPTIBILITY LOCI,2105755,8/1/1994 0:00,5/31/1999 0:00,Non-SBIR/STTR,1995,223331, ,NCI, , ,223331
GENETIC EPIDEMIOLOGY OF HEREDITARY COLONIC CANCERS,2105757,7/13/1994 0:00,4/30/1999 0:00, ,1994,160168, ,NCI, , ,160168
GENETIC EPIDEMIOLOGY OF HEREDITARY COLONIC CANCERS,2105758,7/13/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1995,166380, ,NCI, , ,166380
HER-2 ONCOGENE AND RESPONSE TO DOSE INTENSIVE THERAPY,2106307,6/10/1994 0:00,3/31/1998 0:00, ,1994,374043, ,NCI, , ,374043
HER-2 ONCOGENE AND RESPONSE TO DOSE INTENSIVE THERAPY,2106308,6/10/1994 0:00,3/31/1998 0:00,Non-SBIR/STTR,1995,341745, ,NCI, , ,341745
IMP DEHYDROGENASE--REGULATION AND FUNCTION,2106508,8/1/1994 0:00,5/31/1998 0:00, ,1994,188005, ,NCI, , ,188005
IMP DEHYDROGENASE--REGULATION AND FUNCTION,2106509,8/1/1994 0:00,5/31/1998 0:00,Non-SBIR/STTR,1995,184791, ,NCI, , ,184791
ROLE OF P53 GENE IN CELLULAR SENSITIVITY TO DNA DAMAGE,2106731,9/30/1994 0:00,9/29/1999 0:00, ,1994,80947, ,NCI, , ,80947
MICE DEFICIENT FOR THE E1A-ASSOCIATED PROTEIN P107,2106847,7/1/1994 0:00,4/30/1997 0:00, ,1994,145295, ,NCI, , ,145295
MICE DEFICIENT FOR THE E1A-ASSOCIATED PROTEIN P107,2106848,7/1/1994 0:00,4/30/1997 0:00,Non-SBIR/STTR,1995,157825, ,NCI, , ,157825
MDM2 ONCOPROTEIN AS A CELL REGULATOR OF P53,2106892,4/1/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1995,89371, ,NCI, , ,89371
GENETIC ALTERATIONS AS BIOMARKERS FOR COLORECTAL CANCER,2106944,9/30/1994 0:00,9/29/1999 0:00, ,1994,75126, ,NCI, , ,75126
MOLECULAR PATHOGENESIS OF CERVICAL CANCER,2106958,4/1/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1995,116979, ,NCI, , ,116979
REGULATION OF P53 IN CERVICAL CARCINOMA BY HEAT/HYPOXIA,2107007,5/3/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1996,182287, ,NCI, , ,182287
FURTHER ANALYSIS OF THE P53-DEFICIENT MOUSE,2107069,8/10/1994 0:00,7/31/1999 0:00, ,1994,64295, ,NCI, , ,64295
FURTHER ANALYSIS OF THE P53-DEFICIENT MOUSE,2107070,8/10/1994 0:00,7/31/1999 0:00,Other Research-Related,1995,67947, ,NCI, , ,67947
MOLECULAR EPIDEMIOLOGY OF EPITHELIAL OVARIAN CANCER,2107170,6/17/1994 0:00,5/31/1996 0:00, ,1994,40837, ,NCI, , ,40837
CONTROL OF P53 DEPENDENT APOPTOSIS,2107499,1/1/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1995,134621, ,NCI, , ,134621
CELLULAR TARGETS OF EARLY BREAST TUMORIGENESIS,2107517,1/28/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1995,176409, ,NCI, , ,176409
VIRAL INTERACTIONS WITH P53 IN HUMAN CANCER,2107554,2/6/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1995,104932, ,NCI, , ,104932
VIRAL INTERACTIONS WITH P53 IN HUMAN CANCER,2107555,2/6/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1996,104505, ,NCI, , ,104505
MECHANISM OF HPV E6 MEDIATED UBIQUITINATION OF P53,2107609,12/29/1994 0:00,11/30/1999 0:00,Non-SBIR/STTR,1995,244050, ,NCI, , ,244050
SPECIMEN PREPARATION FOR IN SITU PCR,2108240,9/30/1994 0:00,6/30/1995 0:00, ,1994,75000, ,NCI, , ,75000
CD4 T CELL DEPENDENT B CELL ACTIVATION IN AIDS LYMPHOMAS,2108353,9/1/1994 0:00,8/31/1997 0:00, ,1994,229420, ,NCI, , ,229420
CD4 T CELL DEPENDENT B CELL ACTIVATION IN AIDS LYMPHOMAS,2108354,9/1/1994 0:00,8/31/1997 0:00,Non-SBIR/STTR,1995,233611, ,NCI, , ,233611
CD4 T CELL DEPENDENT B CELL ACTIVATION IN AIDS LYMPHOMAS,2108355,9/1/1994 0:00,8/31/1998 0:00,Non-SBIR/STTR,1996,249224, ,NCI, , ,249224
MAMMALIAN CELL CYCLE CONTROL AND TUMORIGENESIS,2108605,3/1/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1995,177866, ,NCI, , ,177866
STRUCTURAL STUDIES OF THE P53 TUMOR SUPPRESSOR,2108784,1/15/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1995,182286, ,NCI, , ,182286
THYMIDYLATE SYNTHASE INHIBITORS IN HEAD AND NECK CANCER,2108881,7/11/1995 0:00,6/30/1998 0:00,Non-SBIR/STTR,1995,155576, ,NCI, , ,155576
ROLES OF PLEIOTROPHIN IN NORMAL AND ABNORMAL CELL GROWTH,2109251,6/10/1995 0:00,3/31/1996 0:00,Non-SBIR/STTR,1995,229121, ,NCI, , ,229121
TARGETED GENE DELIVERY FOR LUNG CANCER GENE THERAPY,2109264,1/3/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1995,104098, ,NCI, , ,104098
FUNCTION OF THE HOMOLOGY REGION BETWEEN PRB AND LARGE T,2109532,1/1/1995 0:00,12/31/1998 0:00,Non-SBIR/STTR,1995,178735, ,NCI, , ,178735
CAROTENOIDS--RESPONSIVE GENES IN BREAST CANCER,2109594,5/13/1994 0:00,2/28/1998 0:00, ,1994,196669, ,NCI, , ,196669
CAROTENOIDS--RESPONSIVE GENES IN BREAST CANCER,2109595,5/13/1994 0:00,2/28/1998 0:00,Non-SBIR/STTR,1995,189827, ,NCI, , ,189827
SOUTHERN CALIFORNIA AIDS MALIGNANCY NETWORK,2109919,9/30/1994 0:00,7/31/1998 0:00, ,1994,741747, ,NCI, , ,741747
SOUTHERN CALIFORNIA AIDS MALIGNANCY NETWORK,2109921,9/30/1994 0:00,7/31/1998 0:00,Non-SBIR/STTR,1995,826263, ,NCI, , ,826263
ISOLATION CHROMOSOME 17Q25 GENE INVOLED IN BREAST CANCER,2110033,4/7/1995 0:00,3/31/2000 0:00,Other Research-Related,1995,79920, ,NCI, , ,79920
MOLECULAR GENETIC ALTERATIONS OF ENDOMETRIAL CARCINOMA,2110167,4/1/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1995,113341, ,NCI, , ,113341
GENE ENVIRONMENT INTERACTIONS IN COLORECTAL POLYPS,2110267,9/20/1994 0:00,5/31/1999 0:00, ,1994,207764, ,NCI, , ,207764
GENE ENVIRONMENT INTERACTIONS IN COLORECTAL POLYPS,2110268,9/20/1994 0:00,5/31/1999 0:00,Non-SBIR/STTR,1995,204800, ,NCI, , ,204800
GROWTH AND APOPTOSIS IN HBV ASSOCIATED LIVER CANCER,2110507,4/14/1995 0:00,1/31/2000 0:00,Non-SBIR/STTR,1995,280478, ,NCI, , ,280478
P53 TRAFFICKING DURING CELL CYCLE,2110731,9/30/1995 0:00,6/30/1996 0:00,Non-SBIR/STTR,1995,100000, ,NCI, , ,100000
IN VITRO MODEL OF BLADDER CANCER PATHOGENESIS,2110753,4/1/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1995,239499, ,NCI, , ,239499
RETINOID INDUCED APOPTOSIS OF KAPOSIS SARCOMA CELLS,2111071,4/1/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1995,175797, ,NCI, , ,175797
H FELIS EFFECT ON A GASTRIC CANCER MODEL,2111163,4/1/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1995,210000, ,NCI, , ,210000
NITRIC OXIDE IN HELICOBACTER-ASSOCIATED GASTRIC CANCER,2111212,6/15/1995 0:00,5/31/1998 0:00,Non-SBIR/STTR,1995,200232, ,NCI, , ,200232
P53 AND CARCINOGENESIS AND H FELIS GASTRITIS,2111245,9/1/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1995,119339, ,NCI, , ,119339
"DETECTION OF MUTATIONS IN HUMAN P53, MSH2, MLH1 GENES",2111337,3/1/1995 0:00,9/30/1995 0:00,SBIR/STTR,1995,100000, ,NCI, , ,100000
GENETIC ALTERATIONS IN GASTRIC CARCINOMAS,2111703,8/21/1995 0:00,6/30/1996 0:00,Non-SBIR/STTR,1995,81941, ,NCI, , ,81941
TNE ROLE OF TIAK IN APOPTOTIC CELL DEATH,2111737,9/1/1995 0:00,6/30/2000 0:00,Non-SBIR/STTR,1995,212668, ,NCI, , ,212668
MOUSE MODELS AND SUSCEPTIBILITY GENES IN BREAST CANCER,2111851,8/1/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1995,235261, ,NCI, , ,235261
BIOCHEMOPREVENTION OF ADV PREMALIGNANT LESIONS,2111940,9/14/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1995,222404, ,NCI, , ,222404
HISTOLOGIC AND MOLECULAR CHANGES IN UC TUMORIGENESIS,2111984,7/25/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1995,330629, ,NCI, , ,330629
RAR BETA MEDIATED APOPTOSIS IN BREAST CANCER CELLS,2112092,9/22/1995 0:00,8/31/2000 0:00,Other Research-Related,1995,76680, ,NCI, , ,76680
P53 GENE ALTERATIONS IN X-RAYED TINEA CAPITIS PATIENTS,2112204,9/30/1995 0:00,6/30/1999 0:00,Non-SBIR/STTR,1995,268302, ,NCI, , ,268302
GENETIC POLYMORPHISMS AND HEAD AND NECK CANCER RISK,2112218,9/30/1995 0:00,9/29/2000 0:00,Other Research-Related,1995,83700, ,NCI, , ,83700
P16/P18 FAMILY CDK INHIBITORS,2112323,7/17/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1995,190182, ,NCI, , ,190182
SPORE IN BREAST CANCER,2112387,9/15/1995 0:00,8/31/1998 0:00,Research Centers,1995,1968279, ,NCI, , ,1968279
MAXIMIZING THE THERAPEUTIC INDEX OF CHILDHOOD ALL,2112462,9/30/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1995,1036000, ,NCI, , ,1036000
"COLON CANCER--NONINVASIVE DETECTION, NUTRIENT MODULATION",2112623,9/1/1995 0:00,8/31/1997 0:00,Non-SBIR/STTR,1995,255945, ,NCI, , ,255945
CELL CYCLE REGULATOR P21,2112730,2/23/1996 0:00, ,"Training, Individual",1995,28600, ,NCI, , ,28600
MECHANISMS OF METASTASIS IN EXPERIMENTAL PROSTATE CANCER,2112846,8/1/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1995,208400, ,NCI, , ,208400
P53 CANCER BIOMARKER IN VINYL CHLORIDE WORKERS,2113329,9/30/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1995,164895, ,NCI, , ,164895
P53 CANCER BIOMARKER IN VINYL CHLORIDE WORKERS,2113330,9/30/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1996,170989, ,NCI, , ,170989
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,2113489,9/30/1995 0:00,9/29/1999 0:00,Non-SBIR/STTR,1995,160719, ,NCI, , ,160719
EARLY DETECTION OF COLONIC TUMORS,2113684,4/1/1995 0:00,3/31/1997 0:00,Non-SBIR/STTR,1995,130450, ,NCI, , ,130450
P53 INDUCTION AS A PREDICTOR OF RADIATION COMPLICATIONS,2113742,3/8/1997 0:00, ,"Training, Individual",1996,7700, ,NCI, , ,7700
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM,2114077,7/31/1996 0:00, ,"Training, Individual",1995,13236, ,NCI, , ,13236
HORMONAL EFFECTS ON APOPTOSIS IN BREAST CANCER,2114409,9/30/1995 0:00,9/29/1997 0:00,Non-SBIR/STTR,1995,61400, ,NCI, , ,61400
IMMUNOHISTOCHEMICAL ANALYSIS OF BREAST TISSUE DNA DAMAGE,2114475,9/30/1995 0:00,9/29/1997 0:00,Non-SBIR/STTR,1995,85399, ,NCI, , ,85399
IMMUNOHISTOCHEMICAL ANALYSIS OF BREAST TISSUE DNA DAMAGE,2114476,9/30/1995 0:00,9/29/2000 0:00,Non-SBIR/STTR,1996,85250, ,NCI, , ,85250
BREAST CANCER ETIOLOGY--P53 GAIN OF FUNCTION MUTATIONS,2114528,7/1/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1996,214199, ,NCI, , ,214199
MDAB--DOC-2 AS CANDIDATE TUMOR SUPPRESSOR,2114589,9/6/1996 0:00,9/5/1998 0:00,Non-SBIR/STTR,1996,100000, ,NCI, , ,100000
K-RAS AND P53 MUTATIONS AS BIOMARKERS FOR LUNG CANCER,2115190,8/1/1996 0:00,7/31/1998 0:00,Non-SBIR/STTR,1996,30729, ,NCI, , ,30729
MECHANISM OF ORAL CARCINOGENESIS,2128835,5/1/1995 0:00,4/30/2000 0:00,Other Research-Related,1995,57083, ,NIDCR, , ,57083
DEVELOPING A MOLECULAR MODEL--ORAL CAVITY TUMORIGENESIS,2128850,5/1/1995 0:00,4/30/2000 0:00,Other Research-Related,1995,80600, ,NIDCR, , ,80600
HPV AND OTHER FACTORS IN ORAL CARCINOGENESIS,2131027,9/30/1992 0:00,9/29/1996 0:00, ,1994,143819, ,NIDCR, , ,143819
GENETIC ANALYSIS OF ORAL PRENEOPLASIA AND CARCINOMA,2131393,5/6/1994 0:00,5/5/1997 0:00, ,1994,250082, ,NIDCR, , ,250082
GENETIC ANALYSIS OF ORAL PRENEOPLASIA AND CARCINOMA,2131395,5/6/1994 0:00,5/5/1997 0:00,Non-SBIR/STTR,1995,263301, ,NIDCR, , ,263301
ORAL CANCER--THERAPY VIA TUMOR SUPPRESSOR PROTEINS,2131746,9/15/1995 0:00,9/14/1998 0:00,Non-SBIR/STTR,1995,100000, ,OD, , ,50000
"CELL CYCLE, P53, AND DNA REPAIR IN ORAL CARCINOGENESIS",2132418,9/15/1995 0:00,7/14/1999 0:00,Non-SBIR/STTR,1995,186618, ,NIDCR, , ,186618
GUT ENRICHED KRUPPEL-LIKE FACTOR,2136434,2/1/1996 0:00, ,"Training, Individual",1995,28600, ,NIDDK, , ,28600
ENDOCRINE ASPECTS OF HUMAN NEOPLASIA,2142542,7/1/1991 0:00,6/30/1996 0:00, ,1994,717866, ,NIDDK, , ,717866
BIOMARKERS AS A GUIDE TO SURGICAL MANAGEMENT AND THERAPY,2144587,9/30/1992 0:00,9/29/1997 0:00, ,1994,139710, ,NIDDK, , ,139710
NEOPLASTIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE,2147528,9/30/1993 0:00,8/31/1997 0:00, ,1994,172380, ,NIDDK, , ,172380
NEOPLASTIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE,2147529,9/30/1993 0:00,8/31/1997 0:00,Non-SBIR/STTR,1995,175923, ,NIDDK, , ,175923
GROWTH FACTORS AND MAMMARY TUMORS IN TRANSGENIC MICE,2149544,9/30/1994 0:00,8/31/1998 0:00, ,1994,215866, ,NIDDK, , ,215866
GROWTH FACTORS AND MAMMARY TUMORS IN TRANSGENIC MICE,2149545,9/30/1994 0:00,8/31/1998 0:00,Non-SBIR/STTR,1995,288906, ,NIDDK, , ,234939
POLYAMINES AND CHEMICAL CARCINOGENESIS,2153060,7/1/1981 0:00,3/31/1998 0:00, ,1994,247864, ,NIEHS, , ,247864
POLYAMINES AND CHEMICAL CARCINOGENESIS,2153061,7/1/1981 0:00,3/31/1998 0:00,Non-SBIR/STTR,1995,257779, ,NIEHS, , ,257779
PATHOGENESIS OF MESENCHYMAL TUMORS INDUCED BY ASBESTOS,2153399,6/15/1985 0:00,2/28/1997 0:00, ,1994,185475, ,NIEHS, , ,185475
PATHOGENESIS OF MESENCHYMAL TUMORS INDUCED BY ASBESTOS,2153400,6/15/1985 0:00,2/28/1997 0:00,Non-SBIR/STTR,1995,175848, ,NIEHS, , ,175848
RAINBOW TROUT--A MODEL FOR ENVIRONMENTAL CARCINOGENESIS,2153759,9/19/1988 0:00,4/26/1999 0:00, ,1994,529116, ,NIEHS, , ,529116
RAINBOW TROUT--A MODEL FOR ENVIRONMENTAL CARCINOGENESIS,2153762,9/19/1988 0:00,4/30/1999 0:00,Non-SBIR/STTR,1995,852988, ,NIEHS, , ,852988
BIOLOGICAL MONITORING FOR EXPOSURE TO AFLATOXIN,2153940,1/1/1990 0:00,6/30/1996 0:00, ,1994,197431, ,NIEHS, , ,197431
PLEURAL DOSIMETRY AND BIOMARKERS OF RESPONSE TO FIBERS,2154543,5/1/1992 0:00,4/30/1996 0:00, ,1994,241211, ,NIEHS, , ,241211
RADIATION TOXICITY IN HUMAN BRONCHIAL EPITHELIAL CELLS,2154556,1/1/1995 0:00,12/31/1998 0:00,Non-SBIR/STTR,1995,151633, ,NIEHS, , ,151633
P53 AND THE CELLULAR RESPONSE TO DNA DAMAGE,2154645,1/1/1992 0:00,12/31/1996 0:00, ,1994,222244, ,NIEHS, , ,191029
P53 AND THE CELLULAR RESPONSE TO DNA DAMAGE,2154646,1/1/1992 0:00,12/31/1996 0:00,Non-SBIR/STTR,1995,232177, ,NCI, , ,33277
CELL PROLIFERATION AND MUTATION FIXATION,2155430,7/1/1994 0:00,6/30/1997 0:00, ,1994,145936, ,NIEHS, , ,145936
MOLECULAR EPIDEMIOLOGY OF BLADDER CANCER,2155575,8/1/1993 0:00,7/31/1996 0:00, ,1994,245805, ,NIEHS, , ,245805
MECHANISM OF EMF ACTION IN HUMAN BREAST EPITHELIAL CELLS,2156207,9/30/1994 0:00,8/31/1998 0:00, ,1994,360130, ,NIEHS, , ,360130
MECHANISM OF EMF ACTION IN HUMAN BREAST EPITHELIAL CELLS,2156208,9/30/1994 0:00,8/31/1998 0:00,Non-SBIR/STTR,1995,213542, ,NIEHS, , ,213542
GENE EXPRESSION FOLLOWING 60 HZ EMF EXPOSURE,2156235,9/28/1994 0:00,8/31/1997 0:00, ,1994,231291, ,NIEHS, , ,231291
GENE EXPRESSION FOLLOWING 60 HZ EMF EXPOSURE,2156236,9/28/1994 0:00,8/31/1997 0:00,Non-SBIR/STTR,1995,194936, ,NIEHS, , ,194936
GENE EXPRESSION FOLLOWING 60 HZ EMF EXPOSURE,2156237,9/28/1994 0:00,8/31/1998 0:00,Non-SBIR/STTR,1996,225409, ,NIEHS, , ,225409
IN VITRO CARCINOGENESIS BY ELF MAGNETIC FIELDS,2156247,9/30/1994 0:00,8/31/1998 0:00, ,1994,226193, ,NIEHS, , ,226193
IN VITRO CARCINOGENESIS BY ELF MAGNETIC FIELDS,2156248,9/30/1994 0:00,8/31/1998 0:00,Non-SBIR/STTR,1995,161641, ,NIEHS, , ,161641
MUTAGENIC EFFECTS OF AIRBORNE TOXICANTS IN LUNGS,2156358,8/1/1994 0:00,7/31/1997 0:00, ,1994,1499003, ,NIEHS, , ,1499003
MUTAGENIC EFFECTS OF AIRBORNE TOXICANTS IN LUNGS,2156359,8/1/1994 0:00,7/31/1997 0:00,Non-SBIR/STTR,1995,1467556, ,NIEHS, , ,1467556
P53 PROTEIN EXPRESSION AS A DOSIMETER FOR GENOTOXICITY,2157111,8/1/1995 0:00,7/31/1998 0:00,Non-SBIR/STTR,1995,137252, ,NIEHS, , ,137252
RB PROTEIN INACTIVATION IN THE RETINA OF TRANSGENIC MICE,2162840,8/1/1991 0:00,7/31/1996 0:00, ,1994,166883, ,NEI, , ,166883
CELL CYCLE AND CELL DEATH STUDIES IN THE OCULAR LENS,2164929,9/1/1994 0:00,8/31/1999 0:00, ,1994,228287, ,NEI, , ,228287
CELL CYCLE AND CELL DEATH STUDIES IN THE OCULAR LENS,2164930,9/1/1994 0:00,8/31/1999 0:00,Non-SBIR/STTR,1995,225875, ,NEI, , ,225875
MOLECULAR BASIS OF RETINAL APOPTOSIS AND RETINOBLASTOMA,2165208,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1995,334363, ,NEI, , ,334363
EXTRAGENIC SUPPRESSORS OF THE TATA-BINDING PROTEIN,2183922,7/1/1991 0:00,12/31/1998 0:00,Non-SBIR/STTR,1995,210454, ,NIGMS, , ,210454
REGULATION AND FUNCTION OF PP54 MAP 2 KINASE,2184093,8/1/1991 0:00,7/31/1996 0:00, ,1994,127954, ,NIGMS, , ,127954
REGULATION AND FUNCTION OF PP54 MAP 2 KINASE,2184094,8/1/1991 0:00,3/31/1996 0:00,Non-SBIR/STTR,1995,71983, ,NIGMS, , ,71983
MECHANISMS & REGULATION OF MAMMALIAN GENE AMPLIFICATION,2186935,9/1/1993 0:00,8/31/1997 0:00, ,1994,230235, ,NIGMS, , ,230235
MECHANISMS & REGULATION OF MAMMALIAN GENE AMPLIFICATION,2186936,9/1/1993 0:00,8/31/1997 0:00,Non-SBIR/STTR,1995,255116, ,NIGMS, , ,255116
GENETIC APPROACH TO UNDERSTANDING NITRIC OXIDE,2188213,1/1/1994 0:00,12/31/1997 0:00, ,1994,205084, ,NIGMS, , ,205084
GENETIC APPROACH TO UNDERSTANDING NITRIC OXIDE,2188214,1/1/1994 0:00,12/31/1997 0:00,Non-SBIR/STTR,1995,222687, ,NIGMS, , ,222687
REGULATION OF SICL INHIBITION OF YEAST CDK COMPLEXES,2191587,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1995,171551, ,NIGMS, , ,171551
GENES IN DEVELOPMENT AND CANCER,2203488,2/1/1994 0:00,1/31/1995 0:00, ,1994,19100, ,NICHD, , ,10100
PREDICTIVE TESTING PROGRAM FOR P53 MUTATIONS IN LFS,2208986,4/7/1994 0:00,3/31/1997 0:00, ,1994,314377, ,NHGRI, , ,314377
PREDICTIVE TESTING PROGRAM FOR P53 MUTATIONS IN LFS,2208987,4/7/1994 0:00,3/31/1997 0:00,Non-SBIR/STTR,1995,347677, ,NHGRI, , ,347677
CLONING GENES THAT REGULATE MYOCARDIOCYTE PROLIFERATION,2222147,7/1/1990 0:00,2/28/1999 0:00,Non-SBIR/STTR,1995,237044, ,NHLBI, , ,237044
REGULATION OF NERVE INJURY AND REPAIR,2259478,4/1/1992 0:00,3/31/1997 0:00, ,1994,92178, ,NINDS, , ,92178
REGULATION OF NERVE INJURY AND REPAIR,2259479,4/1/1992 0:00,8/31/1995 0:00, ,1995,38301, ,NINDS, , ,38301
MECHANISMS OF TGF BETA AUTOCRINE REGULATION OF GLIOMAS,2268580,5/1/1992 0:00,3/31/1996 0:00, ,1994,166399, ,NINDS, , ,166399
MOLECULAR DETERMINANTS OF TUMORIGENESIS IN BRAIN TUMORS,2269056,9/1/1992 0:00,8/31/1995 0:00, ,1994,418750, ,NINDS, , ,418750
GENETIC ALTERATIONS IN MULTIFOCAL PRIMARY BRAIN TUMORS,2270311,7/1/1994 0:00,6/30/1999 0:00, ,1994,107631, ,NINDS, , ,107631
GENETIC ALTERATIONS IN MULTIFOCAL PRIMARY BRAIN TUMORS,2270312,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1995,86472, ,NINDS, , ,86472
MUTANT P53 PROTEINS EFFECTS ON GENOMIC STABILITY,2292153,9/1/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1995,20000, ,FIC, , ,20000
LUNG DEVELOPMENT VERSUS CANCER--ROLES OF P53 AND P21,2292679,8/27/1997 0:00, ,Other Research-Related,1996,36000, ,FIC, , ,36000
CONTROL OF THE GI/S TRANSITION IN THE CELL CYCLE,2293160,4/14/1995 0:00, ,Other Research-Related,1994,35300, ,FIC, , ,35300
PAPILLOMAVIRUS E6 ONCOGENE INTERACTION WITH P53,2330576,2/1/1995 0:00,1/31/2000 0:00,Other Research-Related,1997,75600, ,NIAMS, , ,75600
PREVENTIVE ONCOLOGY,2330626,2/1/1993 0:00,1/31/1998 0:00,Other Research-Related,1997,88036, ,NCI, , ,88036
"GLIOMAS--BIOLOGIC, MOLECULAR AND GENETIC STUDIES",2330798,8/1/1992 0:00,1/31/2001 0:00,Non-SBIR/STTR,1997,906527, ,NCI, , ,906527
PATHOLOGY OF GASTRIC CANCER,2330822,2/1/1993 0:00,1/31/1999 0:00,Non-SBIR/STTR,1997,159651, ,NCI, , ,159651
P53--MARKER FOR ORAL CAVITY PREMALIGNANCY & CANCER RISK,2330838,4/1/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1997,150494, ,NCI, , ,150494
REGULATION OF RADIATION-INDUCED APOPTOTIC CELL DEATH,2330859,2/1/1994 0:00,1/31/1999 0:00,Non-SBIR/STTR,1997,108447, ,NCI, , ,108447
MECHANISMS OF MUTATIONS IN HUMAN TUMOR CELLS,2330862,4/15/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1997,234358, ,NCI, , ,234358
VIRAL INTERACTIONS WITH P53 IN HUMAN CANCER,2330897,2/6/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1997,126334, ,NCI, , ,126334
GROWTH AND APOPTOSIS IN HBV ASSOCIATED LIVER CANCER,2330922,4/14/1995 0:00,1/31/2000 0:00,Non-SBIR/STTR,1997,308432, ,NCI, , ,308432
IN VITRO MODEL OF BLADDER CANCER PATHOGENESIS,2330929,4/1/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1997,267947, ,NCI, , ,267947
RETINOID INDUCED APOPTOSIS OF KAPOSIS SARCOMA CELLS,2330939,4/1/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1997,180520, ,NCI, , ,180520
H FELIS EFFECT ON A GASTRIC CANCER MODEL,2330942,4/1/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1997,205221, ,NCI, , ,205221
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,2330960,9/30/1995 0:00,9/29/1999 0:00,Non-SBIR/STTR,1997,636248, ,NCI, , ,636248
DEVELOPMENT OF MOLECULAR MARKERS FOR PROSTATE CANCER,2330962,2/13/1996 0:00,1/31/2001 0:00,Non-SBIR/STTR,1997,103440, ,NCI, , ,103440
SPECIFICATION OF DROSOPHILA C/EBP FUNCTION IN VIVO,2332015,2/1/1996 0:00,1/31/2001 0:00,Non-SBIR/STTR,1997,100955, ,NIGMS, , ,100955
FLOW CYTOMETRY IN PROSTATE CANCER,2338748, , , ,1996, ,0, , , , 
MOLECULAR ANALYSIS OF HUMAN CARCINOMA OF THE PROSTATE,2338749, , , ,1996, ,0, , , , 
PRECLINICAL CHARACTERIZATION OF NATURAL PRODUCT LEADS FOR RESTORATION OF P53,2339245, , , ,1996, ,0, , , , 
STRUCTURAL STUDIES ON NATURAL PRODUCT LEADS FOR RESTORATION OF P53 FUNCTION,2339246, , , ,1996, ,0, , , , 
HUMAN OVARIAN CANCER AND P53 GENE,2341811, , , ,1995, ,0, , , , 
GENETIC ALTERATIONS DURING MULTISTEP CARCINOGENESIS IN MICE AND HUMANS,2342862, , ,Intramural Research,1996, , , , , , 
DEVELOPMENT OF VACCINES FOR ORAL CARCINOMA,2372352,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,1997,741377, ,NIDCR, , ,741377
LINEAGE SPECIFIC ROLE FOR PRB IN AGING AND CANCER,2376176,2/20/1996 0:00, ,"Training, Individual",1997,28600, ,NIA, , ,28600
VIRAL GENE FUNCTIONS AND REGULATION OF CELL GROWTH,2376745,9/1/1975 0:00,3/31/1999 0:00,Non-SBIR/STTR,1997,533717, ,NCI, , ,533717
SELECTIVE THERAPY FOR COLON CARCINOMA,2376767,7/1/1983 0:00,2/28/1999 0:00,Non-SBIR/STTR,1997,241361, ,NCI, , ,241361
NITROAROMATICS AND BREAST CANCER,2376774,7/1/1983 0:00,2/28/2001 0:00,Non-SBIR/STTR,1997,250495, ,NCI, , ,250495
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION,2376796,7/1/1986 0:00,2/28/2001 0:00,Non-SBIR/STTR,1997,1355629, ,NCI, , ,1355629
COLON CANCER PREVENTION,2376797,9/30/1986 0:00,2/29/2000 0:00,Non-SBIR/STTR,1997,2483904, ,NCI, , ,2483904
NEOPLASTIC PROGRESSION IN PAPILLOMAVIRUS TRANSGENIC MICE,2376825,9/1/1988 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997,313432, ,NCI, , ,313432
DNA METHYLATION IN DEVELOPMENT AND CANCER,2376837,5/1/1989 0:00,2/28/2001 0:00,Non-SBIR/STTR,1997,697567, ,NCI, , ,697567
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,2376851,8/1/1990 0:00,2/28/1999 0:00,Non-SBIR/STTR,1997,328693, ,NCI, , ,328693
MOLECULAR ANALYSIS OF CHROMOSOME INSTABILITY SYNDROMES,2376887,5/1/1994 0:00,2/28/1999 0:00,Non-SBIR/STTR,1997,223354, ,NCI, , ,223354
MOUSE MODELS FOR PROSTATE CARCINOGENESIS,2376890,5/16/1994 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997,324014, ,NCI, , ,324014
"P53, MYC, GENETIC INSTABILITY AND CELL SURVIVAL AFTER IR",2376902,3/9/1994 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997,207302, ,NCI, , ,207302
TRANSGENIC APPROACH TO ONCOGENE AND DNA REPAIR IMBALANCE,2376920,5/1/1994 0:00,2/28/1999 0:00,Non-SBIR/STTR,1997,236500, ,NCI, , ,236500
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE,2376926,5/1/1994 0:00,2/28/1999 0:00,Non-SBIR/STTR,1997,594957, ,NCI, , ,594957
REGULATION OF P53 IN CERVICAL CARCINOMA BY HEAT/HYPOXIA,2376936,5/3/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1997,189578, ,NCI, , ,189578
CAROTENOIDS--RESPONSIVE GENES IN BREAST CANCER,2376949,5/13/1994 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997,205316, ,NCI, , ,205316
RISK FACTORS AND BIOMARKERS FOR IN SITU BREAST CANCER,2376965,6/1/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1997,680945, ,NCI, , ,680945
"DETECTION OF MUTATIONS IN HUMAN P53, MSH2 AND MLH1 GENES",2376971,3/15/1996 0:00,8/31/1998 0:00,SBIR/STTR,1997,373684, ,NCI, , ,373684
DOMINANT-NEGATIVE AND GAIN OF FUNCTION P53 MUTATIONS,2376977,5/10/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1997,200263, ,NCI, , ,200263
BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH & PROGRESSION,2376978,5/6/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1997,1334888, ,NCI, , ,1334888
PRIMARY DNA LESIONS AS SIGNALS FOR P53,2377004,5/1/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1997,220277, ,NCI, , ,220277
DNA MUTATION BIOMARKERS FOR NONMELANOMA SKIN CANCER,2377005,5/1/1996 0:00,9/30/1997 0:00,Non-SBIR/STTR,1997,66199, ,NCI, , ,66199
INT-5/AROMATASE--EFFECT OF BREAST ESTROGEN IN NEOPLASIA,2377187,7/15/1997 0:00,6/30/2000 0:00,Non-SBIR/STTR,1997,197704, ,NCI, , ,197704
REGULATION OF P21 (WAF1/C1P1) BY E2A,2377288,9/30/1997 0:00,8/31/2002 0:00,Other Research-Related,1997,79650, ,NCI, , ,79650
REGULATION OF P53 EXPRESSION BY C7 TRANSCRIPTION FACTOR,2378317,3/1/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1997,198726, ,NIGMS, , ,198726
CLONING GENES THAT REGULATE MYOCARDIOCYTE PROLIFERATION,2378762,7/1/1990 0:00,2/28/1999 0:00,Non-SBIR/STTR,1997,290441, ,NHLBI, , ,290441
SIGNAL TRANDUCTION IN POLYCYTHEMIA VERA,2379032,8/1/1997 0:00,6/30/2000 0:00,Non-SBIR/STTR,1997,301496, ,NHLBI, , ,301496
FATTY ACID SYNTHESIS AND THE CELL CYCLE,2382802,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1997,106433, ,NCI, , ,106433
MECHANISMS OF DNA DAMAGE INDUCED RECOMBINATION,2384904,7/1/1990 0:00,11/30/1998 0:00,Non-SBIR/STTR,1997,175561, ,NCI, , ,175561
ECOGENETICS OF PANCREATIC CANCER--FAMILY REGISTRY,2384969,9/30/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,133086, ,NCI, , ,133086
PROTECTIVE ROLE OF APOPTOSIS IN ASBESTOS PLEURAL INJURY,2386253,8/29/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,1997,184011, ,NIEHS, , ,184011
FATTY ACIDS AND TUMOR CHARACTERISTICS IN BREAST CANCER,2386966,9/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,271346, ,NCI, , ,271346
COMBINED SUICIDE GENE THERAPY/RADIOTHERAPY FOR CANCER,2386972,8/1/1997 0:00,7/31/2000 0:00,Non-SBIR/STTR,1997,228109, ,NCI, , ,228109
MUTAGENESIS OF SPECIFIC REGIONS OF THE SV 40 GENOME,2387985,9/1/1978 0:00,4/30/2002 0:00,Non-SBIR/STTR,1997,290797, ,NCI, , ,290797
DNA PHOTOLESION STRUCTURE ACTIVITY RELATIONSHIPS,2389348,7/1/1985 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,303723, ,NCI, , ,303723
GROWTH REGULATION OF PROSTATIC CELLS BY ANDROGEN,2389411,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1997,99524, ,NCI, , ,99524
GENETIC ANALYSIS OF MALIGNANCY,2390621,6/30/1976 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,468323, ,NCI, , ,468323
BIOSYNTHESIS OF ADENOVIRUS EARLY RNAS,2390630,4/1/1979 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,429587, ,NCI, , ,429587
RNA TUMOR VIRUS-HEMATOPOIETIC CELL INTERACTION,2390648,6/1/1983 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997,292842, ,NCI, , ,292842
CANCER AND LEUKEMIA GROUP B--CORRELATIVE SCIENCES,2390656,4/1/1984 0:00,3/31/1998 0:00,Other Research-Related,1997,1166489, ,NCI, , ,1166489
IMMUNOLOGIC & MOLECULAR MARKERS FOR DIAGNOSIS/PROGNOSIS,2390705,5/15/1988 0:00,3/31/1999 0:00,Non-SBIR/STTR,1997,171710, ,NCI, , ,171710
CELL CYCLE REGULATORS AS TUMOR MARKERS IN BLADDER CANCER,2390707,4/10/1988 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,236031, ,NCI, , ,236031
BIOLOGY AND MECHANISM OF AAV REP78 ANTIPROLIFERATION,2390739,4/1/1993 0:00,3/31/1999 0:00,Non-SBIR/STTR,1997,110581, ,NCI, , ,110581
SPONTANEOUS TRANSFORMATION OF HEPATIC STEM CELLS,2390767,4/16/1993 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997,203748, ,NCI, , ,203748
STAGES OF EVOLUTION OF HEPATOCARCINOGENESIS IN VITRO,2390770,9/30/1994 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,184297, ,NCI, , ,184297
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,2390776,6/1/1993 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,325697, ,NCI, , ,325697
FACTORS AFFECTING SURVIVAL OF YOUNG CANCER PATIENTS,2390777,6/5/1993 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,308972, ,NCI, , ,308972
MUTANT P53 GAIN OF FUNCTION IN TURMORIGENISIS,2390813,4/1/1995 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997,189063, ,NCI, , ,189063
HER-2 ONCOGENE AND RESPONSE TO DOSE INTENSIVE THERAPY,2390834,6/10/1994 0:00,3/31/1999 0:00,Non-SBIR/STTR,1997,369728, ,NCI, , ,369728
MDM2 ONCOPROTEIN AS A CELL REGULATOR OF P53,2390842,4/1/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,100626, ,NCI, , ,100626
MOLECULAR PATHOGENESIS OF CERVICAL CANCER,2390844,4/1/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,107386, ,NCI, , ,107386
REACTIVATION OF P53 FUNCTION AND ANTICANCER THERAPY,2390850,4/15/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1997,104161, ,NCI, , ,104161
ROLES OF PLEIOTROPHIN IN NORMAL AND ABNORMAL CELL GROWTH,2390859,6/10/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,286373, ,NCI, , ,286373
ISOLATION CHROMOSOME 17Q25 GENE INVOLED IN BREAST CANCER,2390865,4/7/1995 0:00,3/31/2000 0:00,Other Research-Related,1997,90720, ,NCI, , ,90720
MOLECULAR GENETIC ALTERATIONS OF ENDOMETRIAL CARCINOMA,2390866,4/1/1995 0:00,12/31/1997 0:00,Non-SBIR/STTR,1997,116367, ,NCI, , ,116367
DELETERIOUS MUTATIONS FROM COMBINATION CHEMOTHERAPY,2390892,4/1/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1997,103878, ,NCI, , ,103878
MECHANISMS OF CARCINOGENESIS INVOLVING WILD-TYPE,2390906,4/1/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1997,112896, ,NCI, , ,112896
TRANSCRIPTIONAL REGULATORS IN CANCER,2390925,6/15/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1997,1086616, ,NCI, , ,1086616
PROGNOSTIC INDICATORS IN COLORECTAL CANCER,2390930,4/10/1996 0:00,3/31/1999 0:00,Non-SBIR/STTR,1997,169309, ,NCI, , ,169309
MOLECULAR/CELLULAR PATHWAYS OF BLADDER CA++ PROGRESSION,2390935,4/19/1996 0:00,3/31/2000 0:00,Non-SBIR/STTR,1997,301146, ,NCI, , ,301146
POLYAMINES AND CHEMICAL CARCINOGENESIS,2391554,7/1/1981 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997,250973, ,NIEHS, , ,250973
INDUCTION OF MELANOMA WITH UV-A,2394326,7/2/1997 0:00,9/30/1997 0:00,Non-SBIR/STTR,1997,73293, ,NCI, , ,73293
NEOPLASTIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE,2394434,9/30/1993 0:00,8/31/2001 0:00,Non-SBIR/STTR,1997,214714, ,NIDDK, , ,214714
FUNCTIONAL ANALYSIS OF THE P53 CELLULAR TUMOR ANTIGEN,2395204,8/15/1985 0:00,7/30/2000 0:00,Non-SBIR/STTR,1997,182529, ,NCI, , ,182529
P53 DIRECTED IMMUNOTHERAPY OF BREAST CANCER,2395807,7/10/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1997,106560, ,NCI, , ,106560
DIETARY TOMATO PRODUCTS AND EXPERIMENTAL PROSTATE CANCER,2395810,7/1/1997 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,248286, ,NCI, , ,248286
17Q25 BREAST CANCER GENE--ISOLATION AND ANALYSIS,2395816,9/8/1997 0:00,8/31/2000 0:00,Non-SBIR/STTR,1997,184478, ,NCI, , ,184478
"DNA ADDUCT, P53 MUTATION, AND ETIOLOGY OF BREAST CANCER",2397404,9/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,193347, ,NCI, , ,193347
IN VIVO ROLE OF DNA ALKYLATION REPAIR,2397475,8/8/1997 0:00,5/31/2002 0:00,Non-SBIR/STTR,1997,377711, ,NCI, , ,377711
MOLECULAR MECHANISMS OF GROWTH CONTROL--PROSTATE CANCER,2398746,9/30/1992 0:00,5/31/2001 0:00,Non-SBIR/STTR,1997,220911, ,NCI, , ,220911
GENOMIC INSTABILITY IN TUMORS OF TRANSGENIC MICE,2398884,8/5/1997 0:00,7/31/2000 0:00,Non-SBIR/STTR,1997,254027, ,NIEHS, , ,254027
PILOT STUDY--PHOSPHORYLATION OF P53 PROTEIN IN HUMAN BREAST CANCER CELLS,2402571, , , ,1996, ,136539, , , , 
P53--DUAL GROWTH CONTROL AND DNA DAMAGE SENSITIZATION,2405110,7/7/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1997,132860, ,NCI, , ,132860
FUNCTIONAL ANALYSIS OF MDM2 OVEREXPRESSION,2405112,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,1997,109900, ,NCI, , ,109900
INFLAMMATION AND MULTISTAGE CARCINOGENESIS,2405128,9/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,278952, ,NCI, , ,278952
RANDOMIZED ADJUVANT THERAPY OF HEAD AND NECK CANCER,2405864,9/1/1998 0:00,8/31/2002 0:00,Non-SBIR/STTR,1998,145349, ,NCI, , ,145349
CHILDHOOD SOLID TUMORS,2406225,8/1/1978 0:00,6/30/2002 0:00,Non-SBIR/STTR,1997,1473212, ,NCI, , ,1473212
EBV BZLF1 GENE PRODUCT,2406536,1/1/1993 0:00,12/31/2001 0:00,Non-SBIR/STTR,1998,247612, ,NIGMS, , ,247612
CELL CYCLE RESPONSE TO RADIATION DAMAGE IN YEAST,2406574,8/1/1997 0:00,7/31/2000 0:00,Non-SBIR/STTR,1997,177862, ,NIGMS, , ,177862
DNA PHOTOLESION STRUCTURE-ACTIVITY RELATIONSHIPS,2414137,7/1/1985 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997,281659, ,NCI, , ,281659
GENE REGULATION BY ONCOGENES AND TUMOR SUPPRESSOR GENES,2414143,5/1/1986 0:00,4/30/2001 0:00,Non-SBIR/STTR,1997,1037766, ,NCI, , ,1037766
TRANSFORMING GROWTH FACTORS IN NEOPLASTIC TRANSFORMATION,2414151,7/1/1986 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,787020, ,NCI, , ,787020
RETROVIRUSES AND CANCER GENES,2414160,7/1/1987 0:00,4/30/2001 0:00,Non-SBIR/STTR,1997,1573254, ,NCI, , ,1573254
SOFT TISSUE SARCOMA PROGRAM PROJECT,2414173,1/9/1989 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,1142566, ,NCI, , ,1142566
HEPATITIS B VIRUS X ANTIGEN AND PHC,2414178,3/1/1988 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997,221769, ,NCI, , ,221769
TUMOR SUPPRESSION FUNCTION OF RB & P53 IN MAMMARY GLAND,2414183,5/10/1989 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,216703, ,NCI, , ,216703
MAMMALIAN GENOME ORGANIZATION AND GENE AMPLIFICATION,2414206,7/1/1990 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997,314045, ,NCI, , ,314045
"GROWTH GENES, EXTRACELLULAR MATRIX AND ANGIOGENESIS",2414233,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,216926, ,NCI, , ,216926
DNA SEQUENCE CHANGES INDUCED BY MUTAGENS,2414253,2/1/1993 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,34836, ,NCI, , ,34836
DNA RECOMBINATION AND RADIATION RESISTANCE,2414254,9/30/1992 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,247634, ,NCI, , ,247634
DIET AND SOMATIC MUTATIONS IN COLON CANCER,2414289,8/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,879463, ,NCI, , ,879463
INSTABILITY OF MICROSATELLITES IN MAMMALIAN CELLS,2414311,7/13/1995 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,241995, ,NCI, , ,241995
ALLELE LOSS IN THE GENESIS OF GASTRIC CANCER,2414312,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,94540, ,NCI, , ,94540
POPULATION BASED GENETIC ANALYSIS OF BREAST CANCER,2414323,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,130016, ,NCI, , ,130016
DIET AND GENETIC ALTERATIONS IN COLORECTAL NEOPLASIA,2414324,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,222923, ,NCI, , ,222923
GENETIC EPIDEMIOLOGY OF HEREDITARY COLONIC CANCERS,2414325,7/13/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,180347, ,NCI, , ,180347
MECHANISMS OF HUMAN ESOPHAGEAL CARCINOGENESIS,2414362,5/15/1996 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,267436, ,NCI, , ,267436
P53 TRAFFICKING DURING CELL CYCLE,2414380,7/1/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1997,208134, ,NCI, , ,208134
TAXOL WITH RADIATION FOR PANCREATIC AND GASTRIC CANCER,2414382,7/1/1996 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,74594, ,NCI, , ,74594
MOLECULAR MARKERS OF PROGNOSIS IN MEDULLOBLASTOMA,2414402,7/5/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1997,249546, ,NCI, , ,249546
HISTOLOGIC AND MOLECULAR CHANGES IN UC TUMORIGENESIS,2414403,7/25/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,349989, ,NCI, , ,349989
P16/P18 FAMILY CDK INHIBITORS,2414415,7/17/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,215644, ,NCI, , ,215644
BREAST CANCER ETIOLOGY--P53 GAIN OF FUNCTION MUTATIONS,2414456,7/1/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1997,205923, ,NCI, , ,205923
MECHANISM OF ORAL CARCINOGENESIS,2414678,5/1/1995 0:00,4/30/2000 0:00,Other Research-Related,1997,60784, ,NIDCR, , ,60784
DEVELOPING A MOLECULAR MODEL--ORAL CAVITY TUMORIGENESIS,2414679,5/1/1995 0:00,4/30/2000 0:00,Other Research-Related,1997,96323, ,NIDCR, , ,96323
RAINBOW TROUT--A MODEL FOR ENVIRONMENTAL CARCINOGENESIS,2414952,9/19/1988 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,734059, ,NIEHS, , ,734059
DDT AND RELATED COMPOUNDS AND PANCREAS CANCER,2414974,5/1/1996 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,492356, ,NIEHS, , ,492356
TRANSPLACENTAL CARCINOGENESIS OF HETEROCYCLIC AMINES,2414977,5/1/1996 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,157090, ,NIEHS, , ,157090
MOLECULAR BASIS OF RETINAL APOPTOSIS AND RETINOBLASTOMA,2415037,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,294077, ,NEI, , ,294077
REGULATION OF SIC1 INHIBITION OF YEAST CDK COMPLEXES,2415311,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,198135, ,NIGMS, , ,198135
FUNCTION OF THE HUMAN DNA-ACTIVATED PROTEIN KINASE,2415326,5/1/1996 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997,181814, ,NIGMS, , ,181814
P-21 INDUCTION IN MYELOID DIFFERENTIATION,2415658,5/1/1996 0:00,4/30/2000 0:00,Non-SBIR/STTR,1997,70888, ,NHLBI, , ,70888
GENETIC ALTERATIONS IN MULTIFOCAL PRIMARY BRAIN TUMORS,2416338,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1997,93529, ,NINDS, , ,93529
INDUCTION AND ANALYSIS OF PROSTATE CANCER,2416804,9/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1997,237461, ,NCI, , ,237461
GENETIC EPIDEMIOLOGY OF LUNG CANCER,2420886,12/15/1994 0:00,11/30/1998 0:00,Non-SBIR/STTR,1997,393078, ,NCI, , ,393078
MULTILOCUS MICROTITER IN SITU MOUSE LYMPHOMA ASSAY,2424725,9/30/1997 0:00,9/29/1998 0:00,SBIR/STTR,1997,100000, ,NIEHS, , ,100000
CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT,2429633,7/22/1980 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,95253, ,NCI, , ,95253
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA,2429642,6/1/1983 0:00,5/31/2000 0:00,Non-SBIR/STTR,1997,201651, ,NCI, , ,201651
PANCREATIC DUCT CARCINOGENESIS--SPECIES DIFFERENCES,2429644,2/1/1983 0:00,5/31/1999 0:00,Non-SBIR/STTR,1997,214192, ,NCI, , ,214192
EPIDERMAL GROWTH FACTOR AND PANCREATIC CANCER,2429684,4/1/1989 0:00,5/31/1999 0:00,Non-SBIR/STTR,1997,245049, ,NCI, , ,245049
PROGRESSION MECHANISMS--ONCOGENE INDUCED PROSTATE CANCER,2429722,9/8/1989 0:00,5/31/2001 0:00,Non-SBIR/STTR,1997,268161, ,NCI, , ,268161
EXPRESSION AND MODULATION OF MULTIDRUG RESISTANCE,2429728,4/15/1990 0:00,5/31/1999 0:00,Non-SBIR/STTR,1997,308394, ,NCI, , ,308394
HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIES,2429771,2/4/1994 0:00,9/29/1998 0:00,Non-SBIR/STTR,1997,688850, ,NCI, , ,688850
MAPPING COLORECTAL CANCER SUSCEPTIBILITY LOCI,2429808,8/1/1994 0:00,5/31/1999 0:00,Non-SBIR/STTR,1997,239335, ,NCI, , ,239335
IMP DEHYDROGENASE--REGULATION AND FUNCTION,2429811,8/1/1994 0:00,5/31/1998 0:00,Non-SBIR/STTR,1997,196822, ,NCI, , ,196822
GENE ENVIRONMENT INTERACTIONS IN COLORECTAL POLYPS,2429850,9/20/1994 0:00,5/31/1999 0:00,Non-SBIR/STTR,1997,170164, ,NCI, , ,170164
RISK FACTORS AND BIOMARKERS FOR IN SITU BREAST CANCER,2429852,8/1/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1997,66402, ,NCI, , ,66402
NITRIC OXIDE IN HELICOBACTER-ASSOCIATED GASTRIC CANCER,2429854,6/15/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1997,232570, ,NCI, , ,232570
PROTEIN KINASE C--A NOVEL TARGET FOR CANCER THERAPY,2429861,8/1/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1997,188641, ,NCI, , ,188641
MOUSE MODELS AND SUSCEPTIBILITY GENES IN BREAST CANCER,2429862,8/1/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1997,254458, ,NCI, , ,254458
MECHANISMS OF METASTASIS IN EXPERIMENTAL PROSTATE CANCER,2429874,8/1/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1997,253978, ,NCI, , ,253978
TAILORING ANTICANCER THERAPY TO LOSS OF P53,2429881,6/15/1996 0:00,5/31/1999 0:00,Non-SBIR/STTR,1997,202341, ,NCI, , ,202341
CANDIDATE TUMOR SUPPRESSOR GENE ON CHROMOSOME 17P133,2429898,6/1/1996 0:00,5/31/1999 0:00,Non-SBIR/STTR,1997,286357, ,NCI, , ,286357
ATM GENE AND CELLULAR RESPONSES TO IRRADIATION,2429921,8/15/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1997,208807, ,NCI, , ,208807
DEVELOPING MOLECULAR THERAPY IN HEAD AND NECK CANCER,2430131,8/1/1996 0:00,5/31/2001 0:00,Non-SBIR/STTR,1997,99509, ,NIDCR, , ,99509
GENES FOR ORAL CARCINOGENESIS,2430136,6/1/1996 0:00,5/31/1998 0:00,Non-SBIR/STTR,1997,37637, ,NIDCR, , ,37637
STATUS OF P53 IN A LFS CANCER PRONE FAMILY,2435745,9/1/1986 0:00,11/30/1998 0:00,Non-SBIR/STTR,1997,66058, ,NCI, , ,66058
CLINICAL TRIALS OF ONCOPEPTIDE PULSED DENDRITIC CELLS,2436265,9/15/1997 0:00,8/31/1999 0:00,Non-SBIR/STTR,1997,73311, ,NCI, , ,73311
APOPTOSIS & MALIGNANT PROGRESSION IN MAMMARY TUMOR CELLS,2438483,5/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,1997,253488, ,NIA, , ,253488
CYTOKINE FUSION PROTEINS WITH ENHANCED IMMUNOGENICITY,2442628,9/30/1994 0:00,6/30/1999 0:00,Non-SBIR/STTR,1997,179668, ,NIAID, , ,179668
CELL SURFACE MECHANISMS OF CYTOTOXICITY,2443010,6/1/1992 0:00,6/30/2000 0:00,Non-SBIR/STTR,1997,217026, ,NCI, , ,217026
IMMUNE DYSFUNCTION AND AIDS ASSOCIATED B CELL LYMPHOMA,2443014,4/3/1992 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,217068, ,NCI, , ,217068
ANTIONCOGENES IN CARCINOGEN-INDUCED PANCREATIC CANCER,2443040,7/1/1993 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,112899, ,NCI, , ,112899
MECHANISM OF PDGF INDUCED APOPTOSIS,2443083,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,97331, ,NCI, , ,97331
RACIAL DIFFERENCES IN BREAST CANCER SURVIVAL,2443094,8/5/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,504526, ,NCI, , ,504526
THYMIDYLATE SYNTHASE INHIBITORS IN HEAD AND NECK CANCER,2443123,7/11/1995 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,169007, ,NCI, , ,169007
TNE ROLE OF TIAK IN APOPTOTIC CELL DEATH,2443158,9/1/1995 0:00,9/30/1997 0:00,Non-SBIR/STTR,1997,48722, ,NCI, , ,48722
"BCL-2 GENE FAMILY, APOPTOSIS RESISTANCE AND BREAST CANCE",2443168,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,114550, ,NCI, , ,114550
P53 GENE ALTERATIONS IN X-RAYED TINEA CAPITIS PATIENTS,2443178,9/30/1995 0:00,6/30/1999 0:00,Non-SBIR/STTR,1997,282094, ,NCI, , ,282094
PAPILLOMAVIRUS E6-BINDING,2443234,6/3/1997 0:00, ,"Training, Individual",1997,28600, ,NCI, , ,28600
RAF-1 INDUCED GROWTH AND APOPTOSIS IN BREAST CANCER,2443270,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,78430, ,NCI, , ,78430
ETIOLOGY OF EARLY BREAST MALIGNANCY,2443305,9/1/1996 0:00,6/30/2000 0:00,Non-SBIR/STTR,1997,479250, ,NCI, , ,479250
NUTRITIONAL AND HORMONAL BIOMARKERS IN PROSTATE CANCER,2443307,9/1/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1997,454368, ,NCI, , ,454368
UPSTREAM SIGNALING IN P53 CELL CYCLE RESPONSES,2443313,7/1/1997 0:00, ,"Training, Individual",1997,24420, ,NCI, , ,24420
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR,2445061,7/1/1997 0:00, ,"Training, Individual",1997,31200, ,NHLBI, , ,31200
MECHANISM OF P53 DEPENDENT APOPTOSIS,2447327,12/5/1997 0:00,11/30/2002 0:00,Non-SBIR/STTR,1998,102200, ,NCI, , ,102200
"STRESS, DIFFERENTIATON, GROWTH ARREST AND PROGRAMMED CELL DEATH",2447731, , ,Intramural Research,1996, , , , , , 
DNA DAMAGE AND REPAIR IN BREAST CANCER,2447739, , ,Intramural Research,1996, , , , , , 
REGULATION OF P53 IN CERVICAL CARCINOMA BY HEAT/HYPOXIA,2448866,5/3/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1997,7841, ,NCI, , ,7841
GENETIC EVENTS IN HUMAN PROSTATE CELL TRANSFORMATION,2448911,2/1/1998 0:00,1/31/2003 0:00,Other Research-Related,1998,81270, ,NCI, , ,81270
CLINICAL TRIAL OF IRINOTECAN IN COLON CANCER,2450064,12/5/1997 0:00,11/30/1999 0:00,Non-SBIR/STTR,1998,141820, ,NCI, , ,141820
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES,2450564,9/30/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,1998,703976, ,NCI, , ,703976
BRCAL AND P21 IN CELL CYCLING,2453093,1/7/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,1998,220535, ,NCI, , ,220535
EPIDEMIOLOGY AND PATHOGENESIS OF HEPATITIS B AND C VIRUSES,2456640, , ,Intramural Research,1996, , , , , , 
CONSULTING AND COLLABORATION ON LABORATORY STUDIES,2456749, , ,Intramural Research,1996, , , , , , 
MOLECULAR PATHOLOGY OF PULMONARY CARCINOGENESIS,2456822, , ,Intramural Research,1996, , , , , , 
"ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS",2456830, , ,Intramural Research,1996, , , , , , 
PHARMACOLOGY OF ANTIMETABOLITE AGENTS,2456832, , ,Intramural Research,1996, , , , , , 
MECHANISMS OF ONCOGENE ACTION IN TUMORIGENESIS,2456839, , ,Intramural Research,1996, , , , , , 
PRECLINICAL AND CLINICAL PHARMACOLOGY/EXPERIMENTAL THERAPEUTICS,2456841, , ,Intramural Research,1996, , , , , , 
APOPTOSIS AND CERVICAL CANCER,2457591,9/1/1995 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,199446, ,NIA, , ,199446
APOPTOSIS--THE ROLES OF P35 AND IAP,2457830,8/1/1995 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997,243361, ,NIAID, , ,243361
MOLECULAR PATHOGENESIS OF PARATHYROID NEOPLASIA,2458008,8/1/1993 0:00,7/31/1998 0:00,Other Research-Related,1997,85995, ,NCI, , ,85995
TRANSPLACENTAL PANCREATIC CARCINOGENESIS BY NNK,2458044,9/1/1986 0:00,7/31/2000 0:00,Non-SBIR/STTR,1997,234935, ,NCI, , ,234935
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS,2458045,9/30/1986 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997,382859, ,NCI, , ,382859
CANCER CAUSE AND PREVENTION RESEARCH,2458059,8/1/1990 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997,789403, ,NCI, , ,789403
NOVEL NUCLEAR PROTEINS IN NORMAL AND CANCER CELLS,2458070,3/1/1992 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997,263555, ,NCI, , ,263555
GENETIC ALTERATIONS IN CNS TUMOR DEVELOPMENT,2458074,5/1/1991 0:00,7/31/2000 0:00,Non-SBIR/STTR,1997,181405, ,NCI, , ,181405
BIOCHEMICAL ROLE OF THE P53 GENE PRODUCT IN HUMAN CANCER,2458080,9/1/1993 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997,109233, ,NCI, , ,109233
PROLIFERATIVE EFFECTS OF HTLV 1,2458113,9/28/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1997,229230, ,NCI, , ,229230
RADIOTHERPY OF HS/TK TRANSDUCED TUMORS BY A VIRAL AGENTS,2458122,8/1/1996 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997,239914, ,NCI, , ,239914
FURTHER ANALYSIS OF THE P53-DEFICIENT MOUSE,2458129,8/10/1994 0:00,7/31/1999 0:00,Other Research-Related,1997,67668, ,NCI, , ,67668
SOUTHERN CALIFORNIA AIDS MALIGNANCY NETWORK,2458165,9/30/1994 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997,896499, ,NCI, , ,896499
GENETIC ALTERATIONS IN GASTRIC CARCINOMAS,2458182,8/21/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1997,121446, ,NCI, , ,121446
DIETARY INTERACTIONS WITH APC MUTATION IN COLON CANCER,2458184,9/30/1995 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997,539507, ,NCI, , ,539507
MAXIMIZING THE THERAPEUTIC INDEX OF CHILDHOOD ALL,2458201,9/30/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1997,1114440, ,NCI, , ,1114440
K-RAS AND P53 MUTATIONS AS BIOMARKERS FOR LUNG CANCER,2458271,8/1/1996 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997,31673, ,NCI, , ,31673
REGULATION OF CELL DEATH BY P53 IN MAMMARY TUMORIGENESIS,2458293,7/15/1997 0:00, ,"Training, Individual",1997,7179, ,NCI, , ,7179
"CELL CYCLE, P53, AND DNA REPAIR IN ORAL CARCINOGENESIS",2458634,9/15/1995 0:00,7/14/1999 0:00,Non-SBIR/STTR,1997,200938, ,NIDCR, , ,200938
P53 PROTEIN EXPRESSION AS A DOSIMETER FOR GENOTOXICITY,2459015,8/1/1995 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997,167599, ,NIEHS, , ,167599
PATHWAYS OF INDUCTION OF FUNCTIONAL P53 PROTEIN,2459541,8/1/1996 0:00,7/31/2000 0:00,Non-SBIR/STTR,1997,185405, ,NIGMS, , ,185405
MECHANISMS OF CELL DEATH & COMPENSATION IN PARKINSONS,2460646,9/30/1996 0:00,7/31/2000 0:00,Non-SBIR/STTR,1997,260228, ,NINDS, , ,260228
CENTROSOME HYPERTROPHY IN HUMAN BREAST TUMORS,2462217,1/1/1998 0:00,12/31/2001 0:00,Non-SBIR/STTR,1998,252324, ,NCI, , ,252324
MOLECULAR PROGNOSTIC INDICATORS IN ESOPHAGEAL CANCER,2462932,3/1/1998 0:00,12/31/2001 0:00,Non-SBIR/STTR,1998,409084, ,NCI, , ,409084
MODEL SYSTEMS FOR STUDY OF CHEMICAL CARCINOGENESIS AT THE CELLULAR LEVEL,2463593, , ,Intramural Research,1996, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN CANCER,2463636, , ,Intramural Research,1996, , , , , , 
IN VITRO STUDIES OF HUMAN MESOTHELIAL CELLS,2463654, , ,Intramural Research,1996, , , , , , 
PATHOGENESIS AND EVOLUTION OF HUMAN T CELL LEUKEMIA/LYMPHOTROPIC VIRUSES,2463661, , ,Intramural Research,1996, , , , , , 
GENETIC ALTERATIONS AND ALLELIC LOSS IN HUMAN HEPATOCELLULAR CARCINOMA,2463664, , ,Intramural Research,1996, , , , , , 
MECHANISMS FOR MAMMARY CARCINOGENICITY OF FOOD DERIVED HETEROCYCLIC AMINES,2463684, , ,Intramural Research,1996, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN BREAST CANCER,2463688, , ,Intramural Research,1996, , , , , , 
HUMAN LIVER CARCINOGENESIS,2463703, , ,Intramural Research,1996, , , , , , 
MUTATIONAL AND FUNCTIONAL ANALYSIS OF THE P53 TUMOR SUPPRESSOR GENE,2463704, , ,Intramural Research,1996, , , , , , 
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS,2463710, , ,Intramural Research,1996, , , , , , 
MOLECULAR BIOLOGY OF CELLULAR INJURY,2463721, , ,Intramural Research,1996, , , , , , 
CELLULAR NANOANATOMY AND TOPOCHEMISTRY,2463738, , ,Intramural Research,1996, , , , , , 
THE NORMAL AND ONCOGENIC FUNCTIONS OF SRC AND WNT GENE FAMILIES,2463801, , ,Intramural Research,1996, , , , , , 
ROLE OF TOBACCO RELATED CHEMICAL CARCINOGENS AND OXYRADICALS IN HUMAN CANCER,2463828, , ,Intramural Research,1996, , , , , , 
THE MOLECULAR GENETICS OF GYNECOLOGIC CANCERS,2464414, , ,Intramural Research,1996, , , , , , 
STUDIES ON THE TREATMENT AND CHARACTERISTICS OF THORACIC MALIGNANCIES,2464450, , ,Intramural Research,1996, , , , , , 
MOLECULAR BIOLOGY AND IMMUNOTHERAPY OF CERVICAL CANCER,2464456, , ,Intramural Research,1996, , , , , , 
EXPERIMENTAL THERAPIES TO THE TREATMENT OF BREAST CANCER,2464461, , ,Intramural Research,1996, , , , , , 
MOLECULAR PATHOGENESIS AND TREATMENT OF NONHODGKIN'S LYMPHOMA,2464473, , ,Intramural Research,1996, , , , , , 
SOLID TUMORS,2464475, , ,Intramural Research,1996, , , , , , 
PROTEIN KINASE ANTAGONISTS--PRECLINICAL AND CLINICAL STUDIES,2464490, , ,Intramural Research,1996, , , , , , 
P53 MUTATIONS IN BREAST CANCER WITH C-ERBB2,2464516, , ,Intramural Research,1996, , , , , , 
HISTOLOGICAL FINDINGS IN PREMENOPAUSAL WOMEN WITH BREAST CANCER,2464527, , ,Intramural Research,1996, , , , , , 
DETERMINATION OF GENETIC MUTATIONS IN ATYPICAL AND CANCEROUS BREAST LESIONS,2464534, , ,Intramural Research,1996, , , , , , 
EVALUATION OF GENETIC ALTERATIONS IN NEOPLASTIC & PRENEOPLASTIC GASTRIC CANCER,2464535, , ,Intramural Research,1996, , , , , , 
MOLECULAR AND BIOCHEMICAL CHARACTERIZATION OF THE ANAPLASTIC LYMPHOMA KINASE,2464547, , ,Intramural Research,1996, , , , , , 
MECHANISM OF TAXOL INDUCED APOPTOSIS,2464562, , ,Intramural Research,1996, , , , , , 
PHASE I/II STUDY OF VACCINIA-HPV RECOMBINANT,2464564, , ,Intramural Research,1996, , , , , , 
DIHYDRODIOL DEHYDROGENASE AND PAH METABOLISM/ACTIVATION,2467267,3/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,1998,248050, ,NCI, , ,248050
DNA REPAIR AND CANCER PRONE HEREDITARY HUMAN DISEASE,2467271,2/1/1987 0:00,1/31/2003 0:00,Non-SBIR/STTR,1998,284795, ,NCI, , ,284795
CELL CELL INTERACTIONS IN PROSTATE CANCER,2467952,5/1/1993 0:00,7/31/2002 0:00,Non-SBIR/STTR,1997,249024, ,NCI, , ,249024
REGULATION OF THE STEROL BIOSYNTHESIS PATHWAY IN YEAST,2468085,1/1/1986 0:00,12/31/2001 0:00,Non-SBIR/STTR,1998,301828, ,NIGMS, , ,301828
MECHANISMS OF DIET AND CHEMOPREVENTION IN P53-KNOCKOUT TRANSGENIC MICE,2468420, , ,Intramural Research,1996, , , , , , 
NEW STRATEGIES FOR DRUG DISCOVERY AND DEVELOPMENT,2468445, , ,Intramural Research,1996, , , , , , 
CELL CYCLE CHECKPOINTS AND CHEMOSENSITIVITY OF HUMAN CANCER CELLS,2468446, , ,Intramural Research,1996, , , , , , 
"HORMONES, ANTIHORMONES AND GROWTH FACTORS IN MAMMARY DEVELOPMENT & TUMORIGENESIS",2468447, , ,Intramural Research,1996, , , , , , 
STRUCTURE AND EXPRESSION OF THE C-MYC/PVT 1 MEGAGENE LOCUS,2468467, , ,Intramural Research,1996, , , , , , 
STUDIES OF MEDICAL RADIATION AND OTHER THERAPEUTIC AGENTS,2468499, , ,Intramural Research,1996, , , , , , 
HUMAN MAMMARY EPITHELIAL CELL IMMORTALIZATION,2468714,12/12/1997 0:00,11/30/2002 0:00,Non-SBIR/STTR,1998,219496, ,NCI, , ,219496
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM,2469550,3/18/1994 0:00,12/31/2002 0:00,Non-SBIR/STTR,1998,104678, ,NCI, , ,104678
PATHOGENESIS OF MESENCHYMAL TUMORS INDUCED BY ASBESTOS,2469651,6/15/1985 0:00,2/28/2002 0:00,Non-SBIR/STTR,1998,233902, ,NIEHS, , ,233902
CERAMIDE SIGNALING IN RADIATION INDUCED APOPTOSIS,2470489,7/15/1990 0:00,11/30/2001 0:00,Non-SBIR/STTR,1998,372304, ,NCI, , ,372304
PHOSPHOPEPTIDE MODELS OF P53 PROTEIN FRAGMENTS,2485647,2/1/1998 0:00,1/31/2001 0:00,Non-SBIR/STTR,1998,172910, ,NIGMS, , ,172910
GENETIC ELEMENTS SUPPRESSING P53,2487523,3/1/1998 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,24640, ,FIC, , ,24640
PROGRESSION OF THE TRANSFORMED PHENOTYPE,2501129,4/1/1984 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,219228, ,NCI, , ,219228
FRAGILE SITES AND CHROMOSOME BREAKAGE AND CANCER,2501132,7/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,1998,252470, ,NCI, , ,252470
BCL-2 FAMILY AND P53 GENES ALTER APOPTOSIS IN GLIOMAS,2501472,1/1/1993 0:00,12/31/2001 0:00,Non-SBIR/STTR,1998,203591, ,NINDS, , ,203591
ACTIVATION OF BCL 2 IN HEMATOLOGIC MALIGNANCIES,2503967,8/1/1993 0:00,1/31/2002 0:00,Non-SBIR/STTR,1998,196409, ,NCI, , ,196409
SELENIUM--ANTIOXIDANT OR PROOXIDANT MECHANISM,2504053,12/10/1997 0:00,11/30/2001 0:00,Non-SBIR/STTR,1998,153828, ,NCI, , ,153828
G1/S REGULATION AND RADIATION SENSITIVITY,2517537,9/1/1995 0:00,8/31/1999 0:00,Other Research-Related,1997,88846, ,NCI, , ,88846
NEOADJUVANT THERAPY AND BIO-CORRELATES OF GASTRIC CANCER,2517566,9/30/1991 0:00,8/31/1999 0:00,Non-SBIR/STTR,1997,220345, ,NCI, , ,220345
NUCLEAR REGULATORS IN MYELOPOIESIS AND LEUKEMIA,2517578,9/1/1994 0:00,8/31/1999 0:00,Non-SBIR/STTR,1997,242947, ,NCI, , ,242947
MUTATION-INDEPENDENT ALTERATION OF P53 IN BREAST CANCER,2517582,9/15/1993 0:00,12/31/1998 0:00,Non-SBIR/STTR,1997,112276, ,NCI, , ,112276
MOLECULAR EPIDEMIOLOGY OF CUTANEOUS MALIGNANT MELANOMA,2517609,9/16/1996 0:00,8/31/1999 0:00,Non-SBIR/STTR,1997,255903, ,NCI, , ,255903
P53 AND CARCINOGENESIS AND H FELIS GASTRITIS,2517627,9/1/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997,125273, ,NCI, , ,125273
DISCOVERY OF NATURAL PRODUCTS THAT RESTORE P53 FUNCTION,2517639,9/8/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997,478961, ,NCI, , ,478961
REGULATION OF TUMOR SUPPRESSOR P53 BY PHOSPHORYLATION,2517642,9/1/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1997,89642, ,NCI, , ,89642
BIOCHEMOPREVENTION OF ADV PREMALIGNANT LESIONS,2517645,9/14/1995 0:00,8/31/2000 0:00,Other,1997,235436, ,NCI, , ,235436
RAR BETA MEDIATED APOPTOSIS IN BREAST CANCER CELLS,2517649,9/22/1995 0:00,8/31/2000 0:00,Other Research-Related,1997,77561, ,NCI, , ,77561
LUNG CANCER CHEMOPREVENTION WITH BIOMARKER EVALUATION,2517657,9/30/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997,298693, ,NCI, , ,298693
SPORE IN BREAST CANCER,2517658,9/15/1995 0:00,8/31/1998 0:00,Research Centers,1997,1764667, ,NCI, , ,1764667
P53 CANCER BIOMARKER IN VINYL CHLORIDE WORKERS,2517687,9/30/1995 0:00,8/31/1999 0:00,Non-SBIR/STTR,1997,177830, ,NCI, , ,177830
PAPILLOMAVIRUS TRANSFORMATION,2517689,9/1/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1997,118282, ,NCI, , ,118282
MECHANISMS OF P53 MUTAGENESIS,2517693,9/1/1996 0:00,8/31/1999 0:00,Non-SBIR/STTR,1997,1490761, ,NCI, , ,1490761
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCER,2517716,9/30/1996 0:00,8/31/1999 0:00,Research Centers,1997,1959645, ,NCI, , ,1959645
"PML, PLZF AND NPM IN THE MOLECULAR PATHOGENESIS OF APL",2517744,9/15/1996 0:00,8/31/2000 0:00,Non-SBIR/STTR,1997,263017, ,NCI, , ,263017
TISSUE AND SERUM INDICATORS OF LUNG CANCER RECURRENCE,2517794,9/1/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1997,62148, ,NCI, , ,62148
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS,2517799,9/26/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1997,115334, ,NCI, , ,115334
GROWTH FACTORS AND MAMMARY TUMORS IN TRANSGENIC MICE,2518416,9/30/1994 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997,239979, ,NIDDK, , ,239979
MECHANISM OF EMF ACTION IN HUMAN BREAST EPITHELIAL CELLS,2518672,9/30/1994 0:00,8/31/1999 0:00,Non-SBIR/STTR,1997,274219, ,NIEHS, , ,274219
IN VITRO CARCINOGENESIS BY ELF MAGNETIC FIELDS,2518673,9/30/1994 0:00,3/31/1999 0:00,Non-SBIR/STTR,1997,187927, ,NIEHS, , ,187927
CELL CYCLE AND CELL DEATH STUDIES IN THE OCULAR LENS,2518764,9/1/1994 0:00,8/31/1999 0:00,Non-SBIR/STTR,1997,244307, ,NEI, , ,244307
MUTANT P53 PROTEINS EFFECTS ON GENOMIC STABILITY,2520099,9/1/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997,20000, ,FIC, , ,20000
MORPHOLOGIC SCREEN TO IDENTIFY G2/M CHECKPOINT GENES,2522513,6/4/1998 0:00, ,"Training, Individual",1998,37012, ,NIGMS, , ,37012
P53 MUTATIONAL ANALYSIS FOR BLADDER CANCER PROGNOSIS,2536518,9/17/1998 0:00,2/28/1999 0:00,SBIR/STTR,1998,100000, ,NCI, , ,100000
RECOMBINANT BISPECIFIC ANTITUMOR MOLECULES,2538318,1/15/1998 0:00,6/30/1998 0:00,SBIR/STTR,1998,93000, ,NCI, , ,93000
RARE TARGET SCREENING FOR EARLY DIAGNOSIS OF LUNG CANCER,2540215,9/30/1997 0:00,3/31/1998 0:00,SBIR/STTR,1997,100000, ,NCI, , ,100000
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,2540779,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,1997,244637, ,NIDDK, , ,244637
ROLE OF P53 GENE IN CELLULAR SENSITIVITY TO DNA DAMAGE,2545364,9/30/1994 0:00,9/29/1999 0:00,Other Research-Related,1997,79059, ,NCI, , ,79059
GENETIC ALTERATIONS AS BIOMARKERS FOR COLORECTAL CANCER,2545365,9/30/1994 0:00,9/29/1999 0:00,Other Research-Related,1997,89303, ,NCI, , ,89303
GENETIC POLYMORPHISMS AND HEAD AND NECK CANCER RISK,2545391,9/30/1995 0:00,8/31/1998 0:00,Other Research-Related,1997,94500, ,NCI, , ,94500
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM,2545405,10/1/1997 0:00, ,"Training, Individual",1997,15048, ,NCI, , ,15048
BENIGN BREAST DISEASE--MOLECULAR DIFFERENTIATION OF RISK,2545407,9/30/1996 0:00,9/29/2001 0:00,Non-SBIR/STTR,1997,605488, ,NCI, , ,605488
SINGLE PRIMER MEDIATED CLONING OF P53 REGULATED GENES,2545423,9/30/1996 0:00,9/29/1998 0:00,SBIR/STTR,1997,385027, ,NCI, , ,385027
NOVEL THERAPEUTIC TUMOR-SPECIFIC APOPTOTIC FACTOR,2545536,7/1/1997 0:00,12/31/1998 0:00,SBIR/STTR,1997,100000, ,NCI, , ,100000
CAPILLARY HYBRIDIZATION FOR IDENTIFICATION OF MUTATIONS,2546962,9/30/1997 0:00,9/29/1999 0:00,Non-SBIR/STTR,1997,162311, ,NCI, , ,162311
COLON CANCER PREVENTION,2547636,9/30/1986 0:00,2/29/2000 0:00,Non-SBIR/STTR,1997,75750, ,NCI, , ,75750
PROTECTION AGAINST APOPTOSIS BY SCATTER FACTOR,2550872,3/1/1998 0:00,2/28/2002 0:00,Non-SBIR/STTR,1998,229675, ,NIEHS, , ,229675
TRANSLATIONAL RESEARCH IN LUNG CANCER,2551536,9/30/1997 0:00,9/29/2002 0:00,Other Research-Related,1997,107984, ,NCI, , ,107984
DETACHMENT SENSITIZES CELLS TO TOPOISOMERASE INHIBITORS,2551546,9/30/1997 0:00,9/29/2002 0:00,Other Research-Related,1997,108000, ,NCI, , ,108000
TO ABROGATE BCL-2 MEDIATED RESIST IN PROSTATE CANCER,2552740,9/30/1997 0:00,9/29/1999 0:00,Non-SBIR/STTR,1997,79277, ,NCI, , ,79277
CHEMOPREVENTION FOR WOMEN AT HIGH RISK OF BREAST CANCER,2554744,9/30/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,1997,663572, ,NCI, , ,663572
GENETIC MECHANISM OF BRCA1 LINKED OVARIAN TUMORIGENESIS,2557298,9/30/1996 0:00,8/31/1999 0:00,Non-SBIR/STTR,1997,262350, ,NCI, , ,262350
SV40-LIKE SEQUENCES IN HUMAN TUMORS ANALYSES,2561035,8/1/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,1997,105677, ,NCI, , ,105677
DNA STRAND BREAKS AND THE GENETIC BASIS OF LYMPHOMAS,2563959,8/12/1998 0:00,4/30/2002 0:00,Non-SBIR/STTR,1998,217342, ,NCI, , ,217342
P53 AND REPAIR OF DNA DAMAGE BY ANTICANCER DRUGS,2564632,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,1998,94541, ,NCI, , ,94541
TARGETING CANCER CELL DNA WITH COMBINATORIAL LIGANDS,2564633,4/1/1998 0:00,3/31/2001 0:00,Non-SBIR/STTR,1998,182730, ,NCI, , ,182730
GENOMIC INSTABILITY,2565752, , ,Intramural Research,1996, , , , , , 
BIOLOGY AND MOLECULAR BIOLOGY OF HEPATITIS C VIRUS,2568932, , ,Intramural Research,1996, , , , , , 
MOLECULAR MECHANISMS GOVERNING B AND T CELL DIFFERENTIATION AND NEOPLASIA,2568980, , ,Intramural Research,1996, , , , , , 
DEATH OF EBV-IMMORTALIZED CELLS IS REGULATED BY LACTIC ACID AND IL-6,2568997, , ,Intramural Research,1996, , , , , , 
MOLECULAR SCREENING FOR EARLY STAGE TUMORS,2571443, , ,Intramural Research,1996, , , , , , 
RESEARCH IN BIOSTATISTICAL METHODOLOGY AND MATHEMATICAL MODELING,2571498, , ,Intramural Research,1996, , , , , , 
BIOLOGIC SPECIMEN BANK FOR EARLY LUNG CANCER MARKERS IN CHINESE TIN MINERS,2571507, , ,Intramural Research,1996, , , , , , 
ORAL CARCINOGENESIS,2572356, , ,Intramural Research,1996, , , , , , 
BIOMARKERS FOR ORAL CANCER,2572368, , ,Intramural Research,1996, , , , , , 
ETIOLOGY OF ORAL CANCER,2572404, , ,Intramural Research,1996, , , , , , 
INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR,2573446, , ,Intramural Research,1996, , , , , , 
MOLECULAR ANALYSIS OF CELL CYCLE CONTROL DURING CARCINOGENESIS,2574274, , ,Intramural Research,1996, , , , , , 
TRANSGENIC MOUSE MODELS FOR IDENTIFYING AND CHARACTERIZING CARCINOGENS,2574299, , ,Intramural Research,1996, , , , , , 
IN VITRO MUTAGENESIS STUDIES USING MAMMALIAN CELL LINES,2574302, , ,Intramural Research,1996, , , , , , 
RECOGNITION AND PROCESSING OF ABERRANT P53 PROTEIN IN CANCER CELLS,2574327, , ,Intramural Research,1996, , , , , , 
REGULATION OF SQUAMOUS CELL DIFFERENTIATION,2574333, , ,Intramural Research,1996, , , , , , 
MOLECULAR EPIDEMIOLOGY OF CANCER SUSCEPTIBILITY AND ONCOGENE ACTIVATION,2574359, , ,Intramural Research,1996, , , , , , 
GENETIC ABNORMALITIES IN PRIMARY GLIAL TUMORS,2579596, , ,Intramural Research,1996, , , , , , 
MOLECULAR ANALYSIS OF APOPTOSIS IN TUMORS OF THE CENTRAL NERVOUS SYSTEM,2579678, , ,Intramural Research,1996, , , , , , 
P53 INDUCTION AS A PREDICTOR OF RADIATION COMPLICATIONS,2591018,11/1/1997 0:00, ,"Training, Individual",1998,36012, ,NCI, , ,36012
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION,2591075,5/1/1998 0:00,2/28/2003 0:00,Non-SBIR/STTR,1998,265866, ,NCI, , ,265866
P53-MEDIATED CHEMOSENSITIVITY IN NEUROBLASTOMA,2597606,4/15/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,1998,94715, ,NCI, , ,94715
FUNCTIONS OF DIFFERENT P53 MUTATIONS IN PROSTATE CANCER,2601244,4/15/1998 0:00,3/31/2001 0:00,Non-SBIR/STTR,1998,154888, ,NCI, , ,154888
HMG-1 AND HMG-2 AND EUKARYOTIC TRANSCRIPTION,2603478,7/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,96546, ,OD, , ,96546
IN VIVO SOMATIC MUTATIONS IN CHILDREN WITH CANCER,2604780,9/30/1998 0:00,9/29/2002 0:00,Other Research-Related,1998,129087, ,NCI, , ,129087
DESIGN OF PROGRAMMABLE GENOTOXINS,2604786,6/16/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,1998,362219, ,NCI, , ,362219
ONCOGENE INDUCED LEUKEMOGENESIS IN TRANSGENIC MICE,2608039,4/1/1987 0:00,11/30/1999 0:00,Non-SBIR/STTR,1998,114427, ,NCI, , ,114427
STATUS OF P53 IN A LFS CANCER PRONE FAMILY,2608043,9/1/1986 0:00,11/30/1999 0:00,Non-SBIR/STTR,1998,323888, ,NCI, , ,323888
MOLECULAR PATHOLOGY OF GLIOMAS,2608062,1/13/1995 0:00,11/30/2001 0:00,Non-SBIR/STTR,1998,381868, ,NCI, , ,381868
FLURODEOXYURIDINE MEDIATED RADIOSENSITIZATION,2608076,12/7/1990 0:00,11/30/1998 0:00,Non-SBIR/STTR,1998,219243, ,NCI, , ,219243
MECHANISMS OF DNA DAMAGE INDUCED RECOMBINATION,2608078,7/1/1990 0:00,5/4/1999 0:00,Non-SBIR/STTR,1998,182702, ,NCI, , ,182702
SUNLIGHT RELATED STEPS IN HUMAN SKIN CANCER,2608085,4/1/1992 0:00,11/30/1998 0:00,Non-SBIR/STTR,1998,192242, ,NCI, , ,192242
GENETIC EPIDEMIOLOGY OF LUNG CANCER,2608100,12/15/1994 0:00,5/31/1999 0:00,Non-SBIR/STTR,1998,392790, ,NCI, , ,392790
PREDICTORS OF PROGRESSION IN BARRETTS ESOPHAGUS,2608101,2/7/1995 0:00,11/30/1999 0:00,Non-SBIR/STTR,1998,891621, ,NCI, , ,891621
SIGNIFICANCE OF MICROMETASTASES IN PROSTATE CANCER,2608106,12/22/1995 0:00,11/30/1999 0:00,Non-SBIR/STTR,1998,109391, ,NCI, , ,109391
MECHANISM OF HPV E6 MEDIATED UBIQUITINATION OF P53,2608116,12/29/1994 0:00,11/30/1999 0:00,Non-SBIR/STTR,1998,277517, ,NCI, , ,277517
HUMAN ABERRANT CRYPT FOCI--BIOMARKERS FOR COLON CANCER,2608135,2/9/1996 0:00,11/30/2000 0:00,Non-SBIR/STTR,1998,196073, ,NCI, , ,196073
ACTIVITY OF PACLITAXEL AGAINST CARCINOMA OF ESOPHAGUS,2608159,12/26/1996 0:00,11/30/1998 0:00,Non-SBIR/STTR,1998,154500, ,NCI, , ,154500
G2/M DNA DAMAGE CHECKPOINT IN BUDDING YEAST,2608920,1/1/1991 0:00,11/30/2000 0:00,Non-SBIR/STTR,1998,206445, ,NIGMS, , ,206445
MUTAGENIC EFFECTS OF AIRBORNE TOXICANTS IN LUNGS,2615238,8/1/1994 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997,382911, ,NIEHS, , ,382911
MUTANT P53 GAIN OF FUNCTION IN TUMORIGENESIS,2615991,4/1/1995 0:00,1/31/2003 0:00,Non-SBIR/STTR,1998,228627, ,NCI, , ,228627
PROTEASES AND CHEMOTHERAPY INDUCED APOPTOSIS,2615997,4/1/1995 0:00,2/28/2002 0:00,Non-SBIR/STTR,1998,223026, ,NCI, , ,223026
ANTIAPOPTOTIC MECHANISMS IN PROSTATE CANCER,2616038,4/1/1998 0:00,1/31/2003 0:00,Non-SBIR/STTR,1998,247599, ,NCI, , ,247599
HUMAN MAMMARY CELLS,2619335,9/1/1979 0:00,3/31/2003 0:00,Non-SBIR/STTR,1998,506123, ,NCI, , ,506123
RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONS,2619338,6/1/1983 0:00,3/31/2003 0:00,Non-SBIR/STTR,1998,292997, ,NCI, , ,292997
GENETIC STAGING OF BREAST CANCERS FOR ADJUVANT THERAPY,2624215,7/1/1991 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,215147, ,NCI, , ,215147
MURINE P73 IN TUMORIGENESIS,2631518,6/15/1998 0:00,3/31/2002 0:00,Non-SBIR/STTR,1998,411621, ,NCI, , ,411621
MECHANISMS OF CELLULAR IMMORTALIZATION,2633314,4/1/1989 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,323234, ,NIA, , ,323234
PEDIATRIC ONCOLOGY GROUP,2633706,1/1/1978 0:00,12/31/2000 0:00,Other Research-Related,1998,194033, ,NCI, , ,194033
PEDIATRIC ONCOLOGY GROUP,2633754,1/1/1983 0:00,12/31/2000 0:00,Other Research-Related,1998,96639, ,NCI, , ,96639
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,2633789,1/1/1987 0:00,12/31/1998 0:00,Non-SBIR/STTR,1998,315715, ,NCI, , ,315715
MECHANISM OF LARGE T ANTIGEN INDUCED TUMORIGENESIS,2633799,3/1/1988 0:00,12/31/2001 0:00,Non-SBIR/STTR,1998,332260, ,NCI, , ,332260
FUNCTION OF THE ADENOVIRUS E1B ONCOGENE,2633820,1/1/1991 0:00,12/31/2000 0:00,Non-SBIR/STTR,1998,333149, ,NCI, , ,333149
CONTROL OF P53 DEPENDENT APOPTOSIS,2633880,1/1/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,146156, ,NCI, , ,146156
CELLULAR TARGETS OF EARLY BREAST TUMORIGENESIS,2633881,1/28/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,195443, ,NCI, , ,195443
MAMMALIAN CELL CYCLE CONTROL AND TUMORIGENESIS,2633884,3/1/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,174893, ,NCI, , ,174893
STRUCTURAL STUDIES OF THE P53 TUMOR SUPPRESSOR,2633887,1/15/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,201813, ,NCI, , ,201813
TARGETED GENE DELIVERY FOR LUNG CANCER GENE THERAPY,2633891,1/3/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,107269, ,NCI, , ,107269
FUNCTION OF THE HOMOLOGY REGION BETWEEN PRB AND LARGE T,2633896,1/1/1995 0:00,12/31/1998 0:00,Non-SBIR/STTR,1998,189555, ,NCI, , ,189555
GENETIC ALTERATIONS IN PUVA INDUCED SKIN CANCERS,2633902,3/1/1996 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,160400, ,NCI, , ,160400
MECHANISMS OF P53 DEPENDENT APOPTOSIS,2633912,3/1/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,1998,277753, ,NCI, , ,277753
EPISOMAL VECTORS FOR COLON CANCER GENE THERAPY,2633947,1/20/1997 0:00,3/1/1998 0:00,Non-SBIR/STTR,1998,49024, ,NCI, , ,49024
REGULATION OF BCL2 BY RAS AND TUMOR SUPPRESSORS,2633950,1/1/1997 0:00,12/31/2001 0:00,Non-SBIR/STTR,1998,198055, ,NCI, , ,198055
H PYLORI PHENOTYPE AND STOMACH CANCER,2633956,1/25/1997 0:00,12/31/2000 0:00,Non-SBIR/STTR,1998,160126, ,NCI, , ,160126
EXCISION REPAIR OF UV RADIATION-INDUCED DNA DAMAGE,2633957,2/1/1997 0:00,11/30/2000 0:00,Non-SBIR/STTR,1998,287560, ,NCI, , ,287560
RADIATION TOXICITY IN HUMAN BRONCHIAL EPITHELIAL CELLS,2634332,1/1/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,170566, ,NIEHS, , ,170566
LOH AT 3P AND P53 AND K-RAS MUTATION IN LUNG CANCER,2634345,1/1/1997 0:00,12/31/2000 0:00,Non-SBIR/STTR,1998,298010, ,NIEHS, , ,298010
EMF EFFECTS ON CELL REGULATION IN A-T CELLS,2634364,1/10/1997 0:00,8/31/1999 0:00,Non-SBIR/STTR,1998,108529, ,NIEHS, , ,108529
ROLE AND REGULATION OF CDK4 IN THE NORMAL LENS,2634458,1/26/1996 0:00,6/30/1998 0:00,Non-SBIR/STTR,1998,279170, ,NEI, , ,279170
EXTRAGENIC SUPPRESSORS OF THE TATA-BINDING PROTEIN,2634696,7/1/1991 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,225941, ,NIGMS, , ,225941
MOLECULAR EPIDEMIOLOGY OF BRCA1 RELATED BREAST NEOPLASIA,2637389,9/30/1998 0:00,8/31/2003 0:00,Other Research-Related,1998,81514, ,NCI, , ,81514
CYCLIN D1-PRAD1 IN MAMMARY NEOPLASIA,2639645,2/1/1992 0:00,1/31/2000 0:00,Non-SBIR/STTR,1997,119341, ,NCI, , ,119341
DNA REPLICATION PROTEIN COMPLEX A,2643386,7/11/1994 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997,22142, ,NCI, , ,22142
H PYLORI RELATIONSHIP TO DIGESTIVE DISEASES AND CANCER,2643428,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,1997,88129, ,NCI, , ,88129
CYTOTOXIC MECHANISMS IN CUTANEOUS DISEASE,2644634,1/1/1980 0:00,8/31/2002 0:00,Non-SBIR/STTR,1997,242490, ,NIAMS, , ,242490
REGULATION OF P53 IN CERVICAL CARCINOMA BY HEAT/HYPOXIA,2650129,5/3/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1997,39729, ,NCI, , ,39729
HORMONAL REGULATION OF BREAST CANCER,2653944,8/1/1978 0:00,1/31/2002 0:00,Non-SBIR/STTR,1998,521680, ,NCI, , ,521680
MECHANISMS OF INDUCTION OF SKIN CANCERS BY UV LIGHT,2654033,7/1/1988 0:00,1/31/2001 0:00,Non-SBIR/STTR,1998,161700, ,NCI, , ,161700
"GLIOMAS--BIOLOGIC, MOLECULAR AND GENETIC STUDIES",2654079,8/1/1992 0:00,1/31/2001 0:00,Non-SBIR/STTR,1998,938938, ,NCI, , ,938938
CYCLIN D1-PRAD1 IN MAMMARY NEOPLASIA,2654088,2/1/1992 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998,297874, ,NCI, , ,297874
PROGRESSION OF T CELL LYMPHOMA LINESTO IL2 INDEPENDENCE,2654090,7/1/1992 0:00,5/31/1998 0:00,Non-SBIR/STTR,1998,352661, ,NCI, , ,352661
UV INDUCIBLE INHIBITION IN MELANOMA,2654111,5/5/1993 0:00,1/31/2001 0:00,Non-SBIR/STTR,1998,302959, ,NCI, , ,302959
P53--MARKER FOR ORAL CAVITY PREMALIGNANCY & CANCER RISK,2654112,4/1/1995 0:00,9/30/1999 0:00,Non-SBIR/STTR,1998,112434, ,NCI, , ,112434
REGULATION OF RADIATION-INDUCED APOPTOTIC CELL DEATH,2654130,2/1/1994 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998,114953, ,NCI, , ,114953
MECHANISMS OF MUTATIONS IN HUMAN TUMOR CELLS,2654132,4/15/1995 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998,243733, ,NCI, , ,243733
VIRAL INTERACTIONS WITH P53 IN HUMAN CANCER,2654151,2/6/1995 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998,150370, ,NCI, , ,150370
NEW METHODS FOR CANCER DETECTION,2654157,3/1/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,1998,854568, ,NCI, , ,854568
GROWTH AND APOPTOSIS IN HBV ASSOCIATED LIVER CANCER,2654169,4/14/1995 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998,318845, ,NCI, , ,318845
IN VITRO MODEL OF BLADDER CANCER PATHOGENESIS,2654176,4/1/1995 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998,278665, ,NCI, , ,278665
RETINOID INDUCED APOPTOSIS OF KAPOSIS SARCOMA CELLS,2654186,4/1/1995 0:00,1/31/1999 0:00,Non-SBIR/STTR,1998,187743, ,NCI, , ,187743
H FELIS EFFECT ON A GASTRIC CANCER MODEL,2654189,4/1/1995 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998,213431, ,NCI, , ,213431
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,2654208,9/30/1995 0:00,9/29/1999 0:00,Non-SBIR/STTR,1998,642748, ,NCI, , ,642748
DEVELOPMENT OF MOLECULAR MARKERS FOR PROSTATE CANCER,2654211,2/13/1996 0:00,1/31/2001 0:00,Non-SBIR/STTR,1998,107643, ,NCI, , ,107643
EXPRESSION AND FUNCTIONS OF MDM2 PROTEINS,2654221,2/1/1997 0:00,1/31/2002 0:00,Non-SBIR/STTR,1998,77596, ,NCI, , ,77596
EVALUATION OF PREDICTORS FOR RECURRENT ADENOMAS,2654246,2/14/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,1998,372374, ,NCI, , ,372374
P53 WILD TYPE PEPTIDE BASED IMMUNOTHERAPY,2654250,2/12/1997 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998,160823, ,NCI, , ,160823
CHEMOSENSITIZATION OF NSCLC THROUGH SIGNAL TRANSDUCTION,2654255,2/1/1997 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998,179829, ,NCI, , ,179829
INHIBITION OF PAPILLOMAVIRUSES IN ORAL EPITHELIUM,2654439,2/1/1994 0:00,1/31/2001 0:00,Non-SBIR/STTR,1998,210738, ,NIDCR, , ,210738
MOLECULAR MARKERS OF ORAL CANCER RISK,2654459,4/1/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,1998,311629, ,NIDCR, , ,311629
SPECIFICATION OF DROSOPHILA C/EBP FUNCTION IN VIVO,2655002,2/1/1996 0:00,6/30/1998 0:00,Non-SBIR/STTR,1998,46800, ,NIGMS, , ,46800
PATHOGENESIS OF MALIGNANT FIBROMATOSIS,2655890,3/1/1988 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,217261, ,NCI, , ,217261
SALIVA AS A DIAGNOSTIC FLUID FOR BREAST CANCER IN WOMEN,2656027,9/20/1997 0:00,9/19/1999 0:00,Non-SBIR/STTR,1997,62500, ,OD, , ,25000
LIPOTROPE MEDIATED PROGRAMMED CELL DEATH IN MCF7 CELLS,2656831,6/1/1998 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,35416, ,NCI, , ,35416
CELL CYCLE REGULATORS OF ORAL CANCER,2657493,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,1998,902556, ,NIDCR, , ,902556
FLOW CYTOMETRY IN PROSTATE CANCER,2658493, , , ,1997, , , , , , 
MOLECULAR ANALYSIS OF HUMAN CARCINOMA OF THE PROSTATE,2658494, , , ,1997, , , , , , 
9TH INTERNATIONAL P53 WORKSHOP,2665666,4/1/1998 0:00,3/31/1999 0:00,Other Research-Related,1998,14500, ,NCI, , ,7500
LINEAGE SPECIFIC ROLE FOR PRB IN AGING AND CANCER,2667606,2/20/1998 0:00, ,"Training, Individual",1998,30492, ,NIA, , ,30492
APOPTOSIS & MALIGNANT PROGRESSION IN MAMMARY TUMOR CELLS,2667641,5/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,1998,261094, ,NIA, , ,261094
SELECTIVE THERAPY FOR COLON CARCINOMA,2667858,7/1/1983 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998,251017, ,NCI, , ,251017
NITROAROMATICS AND BREAST CANCER,2667866,7/1/1983 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,289406, ,NCI, , ,289406
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION,2667887,7/1/1986 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,1402919, ,NCI, , ,1402919
COLON CANCER PREVENTION,2667888,9/30/1986 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,2449389, ,NCI, , ,2449389
DNA METHYLATION IN DEVELOPMENT AND CANCER,2667918,5/1/1989 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,722735, ,NCI, , ,722735
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,2667930,8/1/1990 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998,341738, ,NCI, , ,341738
MOLECULAR ANALYSIS OF CHROMOSOME INSTABILITY SYNDROMES,2667953,5/1/1994 0:00,6/30/1998 0:00,Non-SBIR/STTR,1998,147289, ,NCI, , ,147289
TRANSGENIC APPROACH TO ONCOGENE AND DNA REPAIR IMBALANCE,2667973,5/1/1994 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,245960, ,NCI, , ,245960
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE,2667978,5/1/1994 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998,618507, ,NCI, , ,618507
REGULATION OF P53 IN CERVICAL CARCINOMA BY HEAT/HYPOXIA,2667987,5/3/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,197159, ,NCI, , ,197159
RISK FACTORS AND BIOMARKERS FOR IN SITU BREAST CANCER,2668010,6/1/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,739400, ,NCI, , ,739400
DOMINANT-NEGATIVE AND GAIN OF FUNCTION P53 MUTATIONS,2668018,5/10/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,206995, ,NCI, , ,206995
BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH & PROGRESSION,2668019,5/6/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,1384293, ,NCI, , ,1384293
MARKERS FOR LUNG CARCINOGENESIS IN BRONCHIAL EPITHELIUM,2668035,3/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,1998,447907, ,NCI, , ,447907
PRIMARY DNA LESIONS AS SIGNALS FOR P53,2668037,5/1/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,229015, ,NCI, , ,229015
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA,2668077,5/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,1998,244525, ,NCI, , ,244525
REGULATION OF P53 EXPRESSION BY C7 TRANSCRIPTION FACTOR,2668523,3/1/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,204552, ,NIGMS, , ,204552
CLONING GENES THAT REGULATE MYOCARDIOCYTE PROLIFERATION,2668683,7/1/1990 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998,306032, ,NHLBI, , ,306032
TUMOR SUPPRESSOR P53 AND THE CNS,2669039,5/1/1997 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,171024, ,NINDS, , ,171024
1998 ANNUAL SYMPOSIUM ON FUNDAMENTAL CANCER RESEARCH,2669418,8/24/1998 0:00,8/23/1999 0:00,Other Research-Related,1998,5000, ,NCI, , ,5000
MOLECULAR MARKERS AS PREDICTORS OF OUTCOME IN GLIOMAS,2670665,9/1/1998 0:00,5/31/2001 0:00,Non-SBIR/STTR,1998,197505, ,NINDS, , ,197505
CYTOKINE FUSION PROTEINS WITH ENHANCED IMMUNOGENICITY,2672432,9/30/1994 0:00,6/30/1999 0:00,Non-SBIR/STTR,1998,186851, ,NIAID, , ,186851
INHIBITION OF TRANSLATION INITIATION IN CANCER THERAPY,2673244,7/1/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,258275, ,NCI, , ,258275
CANCER VACCINE TO P53,2677313,9/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,264129, ,NCI, , ,264129
MOLECULAR PROGNOSTIC INDICATORS IN COLORECTAL CANCER,2681282,7/1/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,244722, ,NCI, , ,244722
GENETIC ANALYSIS OF MALIGNANCY,2683401,6/30/1976 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,485375, ,NCI, , ,485375
BIOSYNTHESIS OF ADENOVIRUS EARLY RNAS,2683411,4/1/1979 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,446771, ,NCI, , ,446771
SLIT SCAN DETECTION OF BLADDER CANCER,2683424,8/1/1982 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,337047, ,NCI, , ,337047
IMMUNOLOGIC & MOLECULAR MARKERS FOR DIAGNOSIS/PROGNOSIS,2683483,5/15/1988 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,178578, ,NCI, , ,178578
CELL CYCLE REGULATORS AS TUMOR MARKERS IN BLADDER CANCER,2683485,4/10/1988 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,232502, ,NCI, , ,232502
HEPATITIS B VIRUS AND HEPATOCELLULAR CARCINOMA,2683510,3/15/1991 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,232472, ,NCI, , ,232472
BIOCHEMICAL AND CYTOGENETIC MARKERS IN RETINOBLASTOMA,2683511,4/1/1991 0:00,3/31/2001 0:00,Non-SBIR/STTR,1998,158952, ,NCI, , ,158952
MDM2 ONCOPROTEIN AS A CELL REGULATOR OF P53,2683569,4/1/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,104903, ,NCI, , ,104903
MOLECULAR PATHOGENESIS OF CERVICAL CANCER,2683571,4/1/1995 0:00,8/31/1998 0:00,Non-SBIR/STTR,1998,70312, ,NCI, , ,70312
REACTIVATION OF P53 FUNCTION AND ANTICANCER THERAPY,2683575,4/15/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1998,106015, ,NCI, , ,106015
ROLES OF PLEIOTROPHIN IN NORMAL AND ABNORMAL CELL GROWTH,2683586,6/10/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,297407, ,NCI, , ,297407
ISOLATION CHROMOSOME 17Q25 GENE INVOLED IN BREAST CANCER,2683593,4/7/1995 0:00,3/31/2000 0:00,Other Research-Related,1998,90720, ,NCI, , ,90720
MOLECULAR GENETIC ALTERATIONS OF ENDOMETRIAL CARCINOMA,2683594,7/27/1998 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,125185, ,NCI, , ,125185
DELETERIOUS MUTATIONS FROM COMBINATION CHEMOTHERAPY,2683612,4/1/1996 0:00,6/30/1998 0:00,Non-SBIR/STTR,1998,106739, ,NCI, , ,106739
MECHANISMS OF CARCINOGENESIS INVOLVING WILD-TYPE,2683628,4/1/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1998,117412, ,NCI, , ,117412
TRANSCRIPTIONAL REGULATORS IN CANCER,2683648,6/15/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1998,1206892, ,NCI, , ,1206892
MOLECULAR/CELLULAR PATHWAYS OF BLADDER CA++ PROGRESSION,2683656,4/19/1996 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,303926, ,NCI, , ,303926
MECHANISMS OF NEURONAL APOPTOSIS,2685778,4/20/1997 0:00,3/31/2001 0:00,Non-SBIR/STTR,1998,199241, ,NINDS, , ,199241
ANTICANCER PROTEINS/DRUGS--STRUCTURE/FUNCTION/DESIGN,2686789,9/1/1998 0:00,8/31/1999 0:00,Other Research-Related,1998,7000, ,NCI, , ,7000
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER,2688026,9/1/1998 0:00,8/30/2003 0:00,Other Research-Related,1998,79800, ,NCI, , ,79800
IGFIR IN HUMAN GI TUMORS,2688657,7/1/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,233879, ,NCI, , ,233879
P21 INDUCTION BY BRCA2,2689916,8/1/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,1998,100170, ,NCI, , ,100170
NOVEL CARCINOGEN INDUCED CELL CYCLE CHECKPOINT,2691438,8/1/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,1998,124579, ,NIEHS, , ,124579
STATUS OF P53 IN A LFS CANCER PRONE FAMILY,2693700,9/1/1986 0:00,11/30/1999 0:00,Non-SBIR/STTR,1998,68314, ,NCI, , ,68314
SKIN CANCER--ROLE OF UVB INDUCED CELL CYCLE ALTERATIONS,2693846,12/1/1977 0:00,8/31/2001 0:00,Non-SBIR/STTR,1998,268502, ,NIEHS, , ,268502
GENETIC MARKERS FOR THERAPY OF COLON CANCER,2694473,7/13/1998 0:00,6/30/2000 0:00,Other Research-Related,1998,197483, ,NCI, , ,197483
NEW MODEL OF HUMAN BLADDER CANCER PATHOGENESIS,2694967,2/1/1984 0:00,4/30/2003 0:00,Non-SBIR/STTR,1998,265478, ,NCI, , ,265478
MODULATION OF P53 FUNCTION BY BINDING PROTEIN BBP/53BP2,2695000,7/10/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,1998,194678, ,NCI, , ,194678
ALTERATION OF NAD METABOLISM BY CHEMICAL CARCINOGENS,2695746,4/1/1986 0:00,6/30/2003 0:00,Non-SBIR/STTR,1998,323754, ,NCI, , ,323754
BREAST CANCER GROWTH SUPPRESSOR GENE,2696329,2/1/1994 0:00,4/30/2002 0:00,Non-SBIR/STTR,1998,215525, ,NCI, , ,215525
MODULATION OF ARA-C INDUCED APOPTOSIS BY BRYOSTATIN 1,2696334,6/1/1994 0:00,4/30/2003 0:00,Non-SBIR/STTR,1998,255815, ,NCI, , ,255815
ADJUVANT HORMONAL THERAPY IN VIETNAMESE BREAST CANCER,2696335,7/1/1995 0:00,6/30/2003 0:00,Non-SBIR/STTR,1998,240489, ,NCI, , ,240489
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,2696921,6/1/1993 0:00,4/30/2003 0:00,Non-SBIR/STTR,1998,407220, ,NCI, , ,407220
DNA MUTATION BIOMARKERS FOR NONMELANOMA SKIN CANCER,2696933,5/1/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,102924, ,NCI, , ,102924
MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER,2696948,9/1/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,1998,553215, ,NCI, , ,553215
PROSTOGLANDINS AND UVB CARCINOGENESIS,2697584,8/14/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,1998,154952, ,NCI, , ,154952
MUTAGENESIS OF SPECIFIC REGIONS OF THE SV 40 GENOME,2700332,9/1/1978 0:00,4/30/2002 0:00,Non-SBIR/STTR,1998,299519, ,NCI, , ,299519
GENE REGULATION BY ONCOGENES AND TUMOR SUPPRESSOR GENES,2700380,5/1/1986 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,1084624, ,NCI, , ,1084624
TRANSFORMING GROWTH FACTORS IN NEOPLASTIC TRANSFORMATION,2700389,7/1/1986 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,791579, ,NCI, , ,791579
RETROVIRUSES AND CANCER GENES,2700399,7/1/1987 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,1618612, ,NCI, , ,1618612
SOFT TISSUE SARCOMA PROGRAM PROJECT,2700413,1/9/1989 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,1184620, ,NCI, , ,1184620
TUMOR SUPPRESSION FUNCTION OF RB & P53 IN MAMMARY GLAND,2700420,5/10/1989 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,225371, ,NCI, , ,225371
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMA,2700445,5/15/1991 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,906818, ,NCI, , ,906818
"GROWTH GENES, EXTRACELLULAR MATRIX AND ANGIOGENESIS",2700474,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998,225603, ,NCI, , ,225603
DNA SEQUENCE CHANGES INDUCED BY MUTAGENS,2700496,2/1/1993 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,36232, ,NCI, , ,36232
DNA RECOMBINATION AND RADIATION RESISTANCE,2700497,9/30/1992 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,253461, ,NCI, , ,253461
DIET AND SOMATIC MUTATIONS IN COLON CANCER,2700524,8/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,814851, ,NCI, , ,814851
INSTABILITY OF MICROSATELLITES IN MAMMALIAN CELLS,2700546,7/13/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,251617, ,NCI, , ,251617
ALLELE LOSS IN THE GENESIS OF GASTRIC CANCER,2700547,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,101494, ,NCI, , ,101494
POPULATION BASED GENETIC ANALYSIS OF BREAST CANCER,2700557,7/1/1994 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,117649, ,NCI, , ,117649
DIET AND GENETIC ALTERATIONS IN COLORECTAL NEOPLASIA,2700558,7/1/1994 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998,230498, ,NCI, , ,230498
GENETIC EPIDEMIOLOGY OF HEREDITARY COLONIC CANCERS,2700559,7/13/1994 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,187561, ,NCI, , ,187561
MOLECULAR EPIDEMIOLOGY OF BREAST CANCER,2700564,5/1/1997 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,430353, ,NCI, , ,430353
MECHANISMS OF HUMAN ESOPHAGEAL CARCINOGENESIS,2700590,5/15/1996 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,293135, ,NCI, , ,293135
P53 TRAFFICKING DURING CELL CYCLE,2700600,7/1/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,215138, ,NCI, , ,215138
MOLECULAR MARKERS OF PROGNOSIS IN MEDULLOBLASTOMA,2700618,7/5/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,256700, ,NCI, , ,256700
HISTOLOGIC AND MOLECULAR CHANGES IN UC TUMORIGENESIS,2700619,7/25/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,363988, ,NCI, , ,363988
P16/P18 FAMILY CDK INHIBITORS,2700631,7/17/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,212433, ,NCI, , ,212433
ADJUVANT BIOLOGIC THERAPY FOR STAGE III/IV HEAD CANCER,2700641,5/1/1997 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,130860, ,NCI, , ,130860
BREAST CANCER ETIOLOGY--P53 GAIN OF FUNCTION MUTATIONS,2700675,7/1/1996 0:00,12/13/1998 0:00,Non-SBIR/STTR,1998,65920, ,NCI, , ,65920
MVAC IN ORGAN-CONFINED BLADDER CANCER BASED ON P53 STATU,2700701,5/1/1997 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,511486, ,NCI, , ,511486
PREDICTING CHEMOTHERAPY RESPONSE IN HEAD AND NECK CANCER,2700733,5/1/1997 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998,160907, ,NCI, , ,160907
KILLER/DR5 AND TUMORIGENESIS,2700764,9/14/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,204068, ,NCI, , ,204068
G1 AND G2 CHECKPOINTS IN IRRADIATED CELLS,2700770,7/1/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,253916, ,NCI, , ,253916
"DIETARY HETEROCYCLIC AMINES, GENETIC SUSCEPTIBILITY, AND",2700792,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,1998,89502, ,NCI, , ,89502
MECHANISM OF ORAL CARCINOGENESIS,2700982,5/1/1995 0:00,6/30/1998 0:00,Other Research-Related,1998,13727, ,NIDCR, , ,13727
DEVELOPING A MOLECULAR MODEL--ORAL CAVITY TUMORIGENESIS,2700983,5/1/1995 0:00,4/30/2000 0:00,Other Research-Related,1998,96323, ,NIDCR, , ,96323
RAINBOW TROUT--A MODEL FOR ENVIRONMENTAL CARCINOGENESIS,2701300,9/19/1988 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,710588, ,NIEHS, , ,710588
DDT AND RELATED COMPOUNDS AND PANCREAS CANCER,2701321,5/1/1996 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,413780, ,NIEHS, , ,413780
TRANSPLACENTAL CARCINOGENESIS OF HETEROCYCLIC AMINES,2701331,5/1/1996 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998,163082, ,NIEHS, , ,163082
MOLECULAR BASIS OF RETINAL APOPTOSIS AND RETINOBLASTOMA,2701414,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,301806, ,NEI, , ,301806
REGULATION OF SIC1 INHIBITION OF YEAST CDK COMPLEXES,2701678,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,206062, ,NIGMS, , ,206062
P-21 INDUCTION IN MYELOID DIFFERENTIATION,2702279,5/1/1996 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,95265, ,NHLBI, , ,95265
GENETIC ALTERATIONS IN MULTIFOCAL PRIMARY BRAIN TUMORS,2703022,7/1/1994 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,97270, ,NINDS, , ,97270
SPORE IN BREAST CANCER,2703468,9/15/1995 0:00,8/31/2000 0:00,Research Centers,1998,1967058, ,NCI, , ,1967058
MOLECULAR ANALYSIS OF CEP135 IN THE CENTROSOME,2703848,7/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,218591, ,NIGMS, , ,218591
P53 PROTEIN/PROTEIN INTERACTIONS,2704415,8/10/1998 0:00,7/31/2001 0:00,Non-SBIR/STTR,1998,235993, ,NCI, , ,235993
CELL CYCLE AND CELL DEATH STUDIES IN THE OCULAR LENS,2711128,9/1/1994 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998,254079, ,NEI, , ,254079
MOLECULAR BIOMARKERS OF OCCUPATIONAL BENZENE EXPOSURE,2711631, , , ,1998, ,2047, , , , 
ARSENIC BIOMARKER EPIDEMIOLOGY,2711635, , , ,1998, ,2047, , , , 
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,2712557,7/15/1981 0:00,5/31/2002 0:00,Non-SBIR/STTR,1998,247449, ,NCI, , ,247449
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA,2712561,6/1/1983 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,209717, ,NCI, , ,209717
PANCREATIC DUCT CARCINOGENESIS--SPECIES DIFFERENCES,2712562,2/1/1983 0:00,6/30/1999 0:00,Non-SBIR/STTR,1998,222761, ,NCI, , ,222761
EPIDERMAL GROWTH FACTOR AND PANCREATIC CANCER,2712598,4/1/1989 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,253220, ,NCI, , ,253220
PROGRESSION MECHANISMS--ONCOGENE INDUCED PROSTATE CANCER,2712631,9/8/1989 0:00,5/31/2001 0:00,Non-SBIR/STTR,1998,277225, ,NCI, , ,277225
EXPRESSION AND MODULATION OF MULTIDRUG RESISTANCE,2712638,4/15/1990 0:00,5/31/1999 0:00,Non-SBIR/STTR,1998,319418, ,NCI, , ,319418
MOLECULAR MECHANISMS OF GROWTH CONTROL--PROSTATE CANCER,2712665,9/30/1992 0:00,5/31/2001 0:00,Non-SBIR/STTR,1998,220582, ,NCI, , ,220582
MAPPING COLORECTAL CANCER SUSCEPTIBILITY LOCI,2712694,8/1/1994 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,248909, ,NCI, , ,248909
GENE ENVIRONMENT INTERACTIONS IN COLORECTAL POLYPS,2712728,9/20/1994 0:00,5/31/1999 0:00,Non-SBIR/STTR,1998,176045, ,NCI, , ,176045
RISK FACTORS AND BIOMARKERS FOR IN SITU BREAST CANCER,2712729,8/1/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,67844, ,NCI, , ,67844
PROTEIN KINASE C--A NOVEL TARGET FOR CANCER THERAPY,2712735,8/1/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,196187, ,NCI, , ,196187
MOUSE MODELS AND SUSCEPTIBILITY GENES IN BREAST CANCER,2712739,8/1/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,264637, ,NCI, , ,264637
MECHANISMS OF METASTASIS IN EXPERIMENTAL PROSTATE CANCER,2712752,8/1/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,264136, ,NCI, , ,264136
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,2712761,9/30/1995 0:00,9/29/1999 0:00,Non-SBIR/STTR,1998,801370, ,NCI, , ,801370
TAILORING ANTICANCER THERAPY TO LOSS OF P53,2712764,6/15/1996 0:00,5/31/1999 0:00,Non-SBIR/STTR,1998,210434, ,NCI, , ,210434
CANDIDATE TUMOR SUPPRESSOR GENE ON CHROMOSOME 17P133,2712779,6/1/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,297813, ,NCI, , ,297813
ATM GENE AND CELLULAR RESPONSES TO IRRADIATION,2712801,8/15/1996 0:00,6/30/1998 0:00,Non-SBIR/STTR,1998,8367, ,NCI, , ,8367
IN VIVO ROLE OF DNA ALKYLATION REPAIR,2712893,8/8/1997 0:00,5/31/2002 0:00,Non-SBIR/STTR,1998,384186, ,NCI, , ,384186
DEVELOPING MOLECULAR THERAPY IN HEAD AND NECK CANCER,2713281,8/1/1996 0:00,5/31/2001 0:00,Non-SBIR/STTR,1998,103443, ,NIDCR, , ,103443
PAPILLOMAVIRUS E6 ONCOGENE INTERACTION WITH P53,2717130,2/1/1995 0:00,1/31/2000 0:00,Other Research-Related,1998,75600, ,NIAMS, , ,75600
INTRAPERITONEAL AD5-P53 GENE THERAPY FOR OVARIAN CANCER,2718352,7/1/1998 0:00,6/30/2000 0:00,Non-SBIR/STTR,1998,78000, ,NCI, , ,78000
P53 AND BREAST CANCER CHEMOTHERAPEUTIC RESPONSE,2718906,6/1/1998 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,84750, ,NCI, , ,84750
BIOCHEMOPREVENTION IN ADVANCED LARYNGEAL DYSPLASIA,2718907,9/10/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,1998,490545, ,NCI, , ,490545
MUTATIONS IN HUMAN P53 SEQUENCES OF A P53 KNOCK-IN MOUSE,2724736,7/15/1999 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,84592, ,NCI, , ,84592
G2 CHECKPOINT INTEGRITY IN P53 DEPLETED CELLS,2728416,2/16/1999 0:00,1/31/2004 0:00,Other Research-Related,1999,129600, ,NCI, , ,129600
DUAL ROLE OF E2F1 IN TUMORIGENESIS,2728435,1/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,1999,277158, ,NCI, , ,277158
FUNCTION OF HOMOLOGY REGION BETWEEN PRB AND LARGE T,2731090,1/1/1995 0:00,12/31/1998 0:00,Non-SBIR/STTR,1998,64352, ,NCI, , ,64352
ASBESTOS AND NO2 IN ENVIRONMENTAL LUNG DISEASE,2731250,8/15/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,1998,244296, ,NIEHS, , ,244296
CALORIE RESTRICTION AGING AND PROGRAMMED CELL DEATH,2732598,7/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,200956, ,NIA, , ,200956
CHILDHOOD SOLID TUMORS,2732964,8/1/1978 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,1456441, ,NCI, , ,1456441
SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY,2733014,5/1/1991 0:00,1/15/1999 0:00,Non-SBIR/STTR,1998,1055816, ,NCI, , ,1055816
CELL SURFACE MECHANISMS OF CYTOTOXICITY,2733031,6/1/1992 0:00,6/30/1999 0:00,Non-SBIR/STTR,1998,225709, ,NCI, , ,225709
ONCOGENE-SPECIFIC IMMUNE RESPONSES IN BREAST CANCER,2733054,6/1/1994 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,228322, ,NCI, , ,228322
MECHANISM OF PDGF INDUCED APOPTOSIS,2733085,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,101223, ,NCI, , ,101223
RACIAL DIFFERENCES IN BREAST CANCER SURVIVAL,2733095,8/5/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,507890, ,NCI, , ,507890
TNE ROLE OF TIAK IN APOPTOTIC CELL DEATH,2733145,9/1/1995 0:00,6/30/2000 0:00,Non-SBIR/STTR,1998,166038, ,NCI, , ,166038
"BCL-2 GENE FAMILY, APOPTOSIS RESISTANCE AND BREAST CANCE",2733155,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,111955, ,NCI, , ,111955
P53 GENE ALTERATIONS IN X-RAYED TINEA CAPITIS PATIENTS,2733165,9/30/1995 0:00,6/30/2000 0:00,Other,1998,293298, ,NCI, , ,293298
P53--DUAL GROWTH CONTROL AND DNA DAMAGE SENSITIZATION,2733206,7/7/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,132860, ,NCI, , ,132860
INDUCTION AND ANALYSIS OF PROSTATE CANCER,2733208,9/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,233534, ,NCI, , ,233534
PAPILLOMAVIRUS E6-BINDING,2733215,6/3/1998 0:00, ,"Training, Individual",1998,30492, ,NCI, , ,30492
"DNA ADDUCT, P53 MUTATION, AND ETIOLOGY OF BREAST CANCER",2733223,9/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,187237, ,NCI, , ,187237
SYSTEMIC DELIVERY OF P53 INHIBITS BREAST CANCER,2733226,7/15/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,95641, ,NCI, , ,95641
P53 DIRECTED IMMUNOTHERAPY OF BREAST CANCER,2733229,7/10/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,106560, ,NCI, , ,106560
RAF-1 INDUCED GROWTH AND APOPTOSIS IN BREAST CANCER,2733245,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,127501, ,NCI, , ,127501
ETIOLOGY OF EARLY BREAST MALIGNANCY,2733285,9/1/1996 0:00,6/30/2000 0:00,Non-SBIR/STTR,1998,496730, ,NCI, , ,496730
NUTRITIONAL AND HORMONAL BIOMARKERS IN PROSTATE CANCER,2733287,9/1/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,428354, ,NCI, , ,428354
UPSTREAM SIGNALING IN P53 CELL CYCLE RESPONSES,2733293,7/1/1998 0:00, ,"Training, Individual",1998,29160, ,NCI, , ,29160
DIETARY TOMATO PRODUCTS AND EXPERIMENTAL PROSTATE CANCER,2733302,7/1/1997 0:00,6/30/2000 0:00,Non-SBIR/STTR,1998,237357, ,NCI, , ,237357
INFLAMMATION AND MULTISTAGE CARCINOGENESIS,2733319,9/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,280929, ,NCI, , ,280929
INT-5/AROMATASE--EFFECT OF BREAST ESTROGEN IN NEOPLASIA,2733365,7/15/1997 0:00,6/30/2000 0:00,Non-SBIR/STTR,1998,189885, ,NCI, , ,189885
FATTY ACID SYNTHESIS AND THE CELL CYCLE,2733378,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,109254, ,NCI, , ,109254
ECOGENETICS OF PANCREATIC CANCER--FAMILY REGISTRY,2733383,9/30/1997 0:00,12/31/1998 0:00,Non-SBIR/STTR,1998,135904, ,NCI, , ,135904
FATTY ACIDS AND TUMOR CHARACTERISTICS IN BREAST CANCER,2733387,9/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,443371, ,NCI, , ,443371
GROWTH REGULATION OF PROSTATIC CELLS BY ANDROGEN,2733391,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1998,102509, ,NCI, , ,102509
PULMONARY EFFECTS OF HABITUAL USE OF MARIJUANA,2733488,7/1/1982 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,484366, ,NIDA, , ,484366
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR,2735006,7/1/1998 0:00, ,"Training, Individual",1998,25125, ,NHLBI, , ,25125
SIGNAL TRANDUCTION IN POLYCYTHEMIA VERA,2735387,8/1/1997 0:00,6/30/2000 0:00,Non-SBIR/STTR,1998,303089, ,NHLBI, , ,303089
WT1 P53 INTERACTIONS IN IGF I RECEPTOR REGULATION,2736212,9/30/1997 0:00,6/30/2000 0:00,Non-SBIR/STTR,1998,20000, ,FIC, , ,20000
SIGNALING PATHWAYS UTILIZED BY V-ABL AND BCR-ABL,2736610,1/20/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,1999,703720, ,NCI, , ,703720
REGULATION OF P53 FUNCTION BY BRCA1 TUMOR SUPPRESSOR,2736706,12/11/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,1999,179185, ,NCI, , ,179185
HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIES,2737338,2/4/1994 0:00,9/29/1998 0:00,Non-SBIR/STTR,1998,288514, ,NCI, , ,288514
PIK RELATED KINASES IN THE RESPONSE TO DNA DAMAGE BY UV,2738156,6/1/1999 0:00,5/31/2004 0:00,Other Research-Related,1999,109160, ,NIAMS, , ,109160
INDUCTION OF MELANOMA WITH UV-A,2739731,7/2/1997 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,197826, ,NCI, , ,197826
STEM CELL DERIVED IMMUNOTHERAPY,2741667,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,1999,125226, ,NCI, , ,125226
COLON CANCER PREVENTION,2742550,9/30/1986 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,75750, ,NCI, , ,75750
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN GLIOMAS,2744385,8/1/1992 0:00,1/31/2004 0:00,Non-SBIR/STTR,1999,236967, ,NCI, , ,236967
TUMOR SUPPRESSORS AND DIFFERENTIATED THYROID CANCER,2744468,1/5/1999 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,268026, ,NCI, , ,268026
CANCER-RELATED GLYCOLYTIC GENE--REGULATION/TARGETING,2744469,12/11/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,1999,204055, ,NCI, , ,204055
MDM2 AND CELL GROWTH AND TUMORIGENESIS,2745234,3/1/1999 0:00,12/31/2002 0:00,Non-SBIR/STTR,1999,214820, ,NCI, , ,214820
STRUCTURE/FUNCTION OF S100 PROTEIN,2745551,2/1/1999 0:00,1/31/2003 0:00,Non-SBIR/STTR,1999,216594, ,NIGMS, , ,216594
ADENOVIRUS BASED P53 GENE THERAPY FOR OVARIAN CANCER,2746455,12/8/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,1999,104554, ,NCI, , ,104554
PERILLYL ALCOHOL THERAPY IN ADVANCED COLORECTAL CANCER,2747777,8/1/1998 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,69524, ,NCI, , ,69524
APOPTOSIS AND CERVICAL CANCER,2748543,9/1/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,208137, ,NIA, , ,208137
FUNCTIONAL ANALYSIS OF THE P53 CELLULAR TUMOR ANTIGEN,2748701,8/15/1985 0:00,7/30/2000 0:00,Non-SBIR/STTR,1998,173189, ,NCI, , ,173189
TRANSPLACENTAL PANCREATIC CARCINOGENESIS BY NNK,2748705,9/1/1986 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,243196, ,NCI, , ,243196
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS,2748706,9/30/1986 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998,397261, ,NCI, , ,397261
CANCER CAUSE AND PREVENTION RESEARCH,2748719,8/1/1990 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,812315, ,NCI, , ,812315
NOVEL NUCLEAR PROTEINS IN NORMAL AND CANCER CELLS,2748727,3/1/1992 0:00,2/28/2002 0:00,Non-SBIR/STTR,1998,269867, ,NCI, , ,269867
GENETIC ALTERATIONS IN CNS TUMOR DEVELOPMENT,2748730,5/1/1991 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,188662, ,NCI, , ,188662
CELL CELL INTERACTIONS IN PROSTATE CANCER,2748745,5/1/1993 0:00,7/31/2002 0:00,Non-SBIR/STTR,1998,256293, ,NCI, , ,256293
RADIOTHERPY OF HS/TK TRANSDUCED TUMORS BY A VIRAL AGENTS,2748765,8/1/1996 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,247424, ,NCI, , ,247424
FURTHER ANALYSIS OF THE P53-DEFICIENT MOUSE,2748771,8/10/1994 0:00,7/31/1999 0:00,Other Research-Related,1998,67082, ,NCI, , ,67082
GENETIC ALTERATIONS IN GASTRIC CARCINOMAS,2748804,8/21/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,126302, ,NCI, , ,126302
DIETARY INTERACTIONS WITH APC MUTATION IN COLON CANCER,2748805,9/30/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,558813, ,NCI, , ,558813
MAXIMIZING THE THERAPEUTIC INDEX OF CHILDHOOD ALL,2748814,9/30/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,1159021, ,NCI, , ,1159021
DNA MUTATION BIOMARKERS FOR NONMELANOMA SKIN CANCER,2748854,5/1/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1998,21944, ,NCI, , ,21944
COMBINED SUICIDE GENE THERAPY/RADIOTHERAPY FOR CANCER,2748965,8/1/1997 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,227464, ,NCI, , ,227464
CHEMOPREVENTION FOR WOMEN AT HIGH RISK OF BREAST CANCER,2748987,9/30/1997 0:00,7/31/2002 0:00,Other,1998,701566, ,NCI, , ,701566
SV40-LIKE SEQUENCES IN HUMAN TUMORS ANALYSES,2748989,8/1/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,1998,108500, ,NCI, , ,108500
INTERACTION OF APC AND P53 IN COLORECTAL CARCINOGENESIS,2748995,1/1/1999 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,192878, ,NCI, , ,192878
ONCOLYTIC ADENOVIRUSES--CERVICAL CANCER GENE THERAPY,2749010,3/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,1999,182471, ,NCI, , ,182471
"CELL CYCLE, P53, AND DNA REPAIR IN ORAL CARCINOGENESIS",2749342,9/15/1995 0:00,7/14/2000 0:00,Non-SBIR/STTR,1998,206443, ,NIDCR, , ,206443
GENOMIC INSTABILITY IN TUMORS OF TRANSGENIC MICE,2749710,8/5/1997 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,286324, ,NIEHS, , ,286324
PROTECTIVE ROLE OF APOPTOSIS IN ASBESTOS PLEURAL INJURY,2749715,8/29/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,1998,190122, ,NIEHS, , ,190122
PATHWAYS OF INDUCTION OF FUNCTIONAL P53 PROTEIN,2749973,8/1/1996 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,191496, ,NIGMS, , ,191496
CELL CYCLE RESPONSE TO RADIATION DAMAGE IN YEAST,2750134,8/1/1997 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,183198, ,NIGMS, , ,183198
MECHANISMS OF CELL DEATH & COMPENSATION IN PARKINSONS,2750932,9/30/1996 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,270636, ,NINDS, , ,270636
GENETIC EPIDEMIOLOGY OF GASTRIC CANCER,2751372,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,1998,75052, ,NCI, , ,75052
P53S DIRECT ROLE IN MITOCHONDRIAL CONTROL OF APOPTOSIS,2752155,9/15/1993 0:00,12/31/2002 0:00,Non-SBIR/STTR,1999,199339, ,NCI, , ,199339
P53 GENE THERAPY FOR LOCALLY ADVANCED BLADDER CANCER,2752170,1/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,145855, ,NCI, , ,145855
G2 CHECKPOINT CONTROL IN TRANSFORMED HUMAN CELLS,2756659,12/1/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,1999,260741, ,NCI, , ,260741
FUNCTION OF THE HUMAN DNA-ACTIVATED PROTEIN KINASE,2756771,5/1/1996 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998,258031, ,NIGMS, , ,258031
SUNLIGHT RELATED STEPS IN HUMAN SKIN CANCER,2758233,4/1/1992 0:00,12/31/2002 0:00,Non-SBIR/STTR,1999,324535, ,NCI, , ,324535
MECHANISMS OF CARCINOGENESIS INVOLVING WILD-TYPE,2761657,4/1/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1998,15691, ,NCI, , ,15691
AFB1 AND P53 CARCINOGENESIS IN HBSAG TRANSGENIC MICE,2761660,12/15/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,1999,236557, ,NCI, , ,236557
KARP 1 V(D)J RECOMBINATION AND DNA REPAIR,2762246,5/1/1994 0:00,1/31/2002 0:00,Non-SBIR/STTR,1999,302043, ,NIAID, , ,302043
ADDUCT INDUCED FRAMESHIFT MUTAGENESIS,2762299,2/15/1992 0:00,12/31/2003 0:00,Non-SBIR/STTR,1999,211478, ,NCI, , ,211478
NOVEL CYCLINS G1 AND G2,2763571,1/1/1998 0:00,12/31/2002 0:00,Non-SBIR/STTR,1998,161280, ,NIGMS, , ,161280
GENETIC ANALYSIS OF YEAST TRANSCRIPTION FACTORS,2765142, , , ,1998, ,793, , , , 
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,2765348,1/1/1987 0:00,12/31/2003 0:00,Non-SBIR/STTR,1999,318483, ,NCI, , ,318483
INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN D,2765358,12/24/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,1999,224136, ,NCI, , ,224136
PROPERTIES AND REGULATION OF P53 IN TUMOR CELLS,2765370,3/23/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,1999,242153, ,NCI, , ,242153
RAPAMYCIN INDUCED SELECTIVE APOPTOSIS IN MALIGNANT CELLS,2765372,12/1/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,1999,271515, ,NCI, , ,271515
REGULATION OF P53 IN CERVICAL CARCINOMA BY HEAT/HYPOXIA,2765611,5/3/1996 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998,36058, ,NCI, , ,36058
C MYC--TRANSCRIPTION AND APOPTOSIS,2765894,1/1/1990 0:00,1/31/2004 0:00,Non-SBIR/STTR,1999,359039, ,NCI, , ,359039
CYTOTOXIC MECHANISMS IN CUTANEOUS DISEASE,2769553,1/1/1980 0:00,8/31/2002 0:00,Non-SBIR/STTR,1998,244614, ,NIAMS, , ,244614
NEOADJUVANT THERAPY AND BIO-CORRELATES OF GASTRIC CANCER,2769740,9/30/1991 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998,229061, ,NCI, , ,229061
NUCLEAR REGULATORS IN MYELOPOIESIS AND LEUKEMIA,2769756,9/1/1994 0:00,8/31/1999 0:00,Non-SBIR/STTR,1998,252664, ,NCI, , ,252664
MOLECULAR EPIDEMIOLOGY OF CUTANEOUS MALIGNANT MELANOMA,2769774,9/16/1996 0:00,8/31/1999 0:00,Non-SBIR/STTR,1998,266138, ,NCI, , ,266138
REGULATION OF TUMOR SUPPRESSOR P53 BY PHOSPHORYLATION,2769801,9/1/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1998,96524, ,NCI, , ,96524
PAPILLOMAVIRUS TRANSFORMATION,2769829,9/1/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1998,120850, ,NCI, , ,120850
MECHANISMS OF P53 MUTAGENESIS,2769833,9/1/1996 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998,1489761, ,NCI, , ,1489761
FUNCTIONAL ANALYSIS OF MDM2 OVEREXPRESSION,2769847,9/1/1997 0:00,11/30/1998 0:00,Non-SBIR/STTR,1998,42210, ,NCI, , ,42210
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCER,2769857,9/30/1996 0:00,8/31/1999 0:00,Research Centers,1998,2026325, ,NCI, , ,2026325
"PML, PLZF AND NPM IN THE MOLECULAR PATHOGENESIS OF APL",2769877,9/15/1996 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998,273538, ,NCI, , ,273538
GENETIC MECHANISM OF BRCA1 LINKED OVARIAN TUMORIGENESIS,2769880,9/30/1996 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998,272391, ,NCI, , ,272391
17Q25 BREAST CANCER GENE--ISOLATION AND ANALYSIS,2769910,9/8/1997 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998,211051, ,NCI, , ,211051
TISSUE AND SERUM INDICATORS OF LUNG CANCER RECURRENCE,2769931,9/1/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1998,125595, ,NCI, , ,125595
PROGNOSTIC INDICATORS IN LOCALIZED COLON CANCER,2769938,9/17/1997 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998,169342, ,NCI, , ,169342
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS,2769946,9/26/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1998,113196, ,NCI, , ,113196
REGULATION OF P21 (WAF1/C1P1) BY E2A,2769955,9/30/1997 0:00,8/31/2002 0:00,Other Research-Related,1998,79650, ,NCI, , ,79650
CLINICAL TRIALS OF ONCOPEPTIDE PULSED DENDRITIC CELLS,2769983,9/15/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,1998,73861, ,NCI, , ,73861
DEVELOPMENT OF VACCINES FOR ORAL CARCINOMA,2770269,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,1998,758178, ,NIDCR, , ,758178
NEOPLASTIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE,2770448,9/30/1993 0:00,8/31/2001 0:00,Non-SBIR/STTR,1998,207044, ,NIDDK, , ,207044
PROLIFERATIVE EFFECTS OF HTLV 1,2772411,9/28/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,6000, ,NCI, , ,6000
REGULATION OF MAMMALIAN APURINIC ENDONUCLEASE GENE,2772511,8/16/1999 0:00, ,"Training, Individual",1999,45268, ,NCI, , ,45268
IMMUNOLIPOSOME MEDIATED GENE THERAPY FOR PROSTATE CANCER,2777544,3/1/1999 0:00,2/29/2000 0:00,SBIR/STTR,1999,138625, ,NCI, , ,138625
P53 AND HUMAN OVARIAN CANCER,2786495, , , ,1998, ,35168, , , , 
MECHANISMS OF CARCINOGENESIS INVOLVING WILD-TYPE,2791411,4/1/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1998,44849, ,NCI, , ,44849
PROGRAMMABLE DNA/RNA ARRAY SYNTHESIZER,2793039,12/15/1998 0:00,9/14/1999 0:00,SBIR/STTR,1999,103424, ,NHGRI, , ,103424
COLOR DNA SEQUENCING APPARATUS FOR CLINICAL DIAGNOSIS,2793524,7/15/1999 0:00,1/14/2000 0:00,SBIR/STTR,1999,93182, ,NCI, , ,93182
POSTINCORPORATION DYE LABELING FOR DNA SEQUENCING,2794240,1/1/1999 0:00,6/30/1999 0:00,SBIR/STTR,1999,97798, ,NHGRI, , ,97798
DES AND CANCER OF VAGINA/CERVIX--COLLABORATIVE STUDIES,2794741,9/30/1993 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998,76000, ,NCI, , ,76000
"BCL2 GENE FAMILY, APOPTOSIS RESISTANCE AND BREAST CANCE",2795904,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,19435, ,NCI, , ,19435
ROLE OF P53 GENE IN CELLULAR SENSITIVITY TO DNA DAMAGE,2796292,9/30/1994 0:00,9/29/1999 0:00,Other Research-Related,1998,91109, ,NCI, , ,91109
GENETIC ALTERATIONS AS BIOMARKERS FOR COLORECTAL CANCER,2796294,9/30/1994 0:00,9/29/1999 0:00,Other Research-Related,1998,90181, ,NCI, , ,90181
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM,2796316,10/1/1998 0:00, ,"Training, Individual",1998,15462, ,NCI, , ,15462
BENIGN BREAST DISEASE--MOLECULAR DIFFERENTIATION OF RISK,2796319,9/30/1996 0:00,9/29/2001 0:00,Non-SBIR/STTR,1998,533895, ,NCI, , ,533895
TRANSLATIONAL RESEARCH IN LUNG CANCER,2796379,9/30/1997 0:00,3/31/1999 0:00,Other Research-Related,1998,58281, ,NCI, , ,58281
CAPILLARY HYBRIDIZATION FOR IDENTIFICATION OF MUTATIONS,2796389,9/30/1997 0:00,9/29/1999 0:00,Non-SBIR/STTR,1998,131130, ,NCI, , ,131130
DETACHMENT SENSITIZES CELLS TO TOPOISOMERASE INHIBITORS,2796393,9/30/1997 0:00,9/29/2002 0:00,Other Research-Related,1998,152208, ,NCI, , ,152208
TO ABROGATE BCL-2 MEDIATED RESIST IN PROSTATE CANCER,2796404,9/30/1997 0:00,9/29/1999 0:00,Non-SBIR/STTR,1998,79277, ,NCI, , ,79277
H PYLORI RELATIONSHIP TO DIGESTIVE DISEASES AND CANCER,2796412,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,1998,67333, ,NCI, , ,67333
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,2796619,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,1998,273209, ,NIDDK, , ,273209
"RETINOID, INTERFERON AND TAXOL EFFECTS IN BREAST CANCER",2801976,9/30/1998 0:00,9/29/2000 0:00,Non-SBIR/STTR,1998,73278, ,NCI, , ,73278
PCR MS/MS FINGERPRINTS FOR SEQUENCE POLYMORPHISM,2802574,8/1/1998 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,145500, ,NHGRI, , ,70500
MDM2 ONCOGENE AS A TARGET FOR MODULATING CANCER THERAPY,2806110,4/7/1999 0:00,3/31/2003 0:00,Non-SBIR/STTR,1999,180954, ,NCI, , ,180954
"CELL CYCLE, P53, AND DNA REPAIR IN ORAL CARCINOGENESIS",2806411,9/15/1995 0:00,7/14/2000 0:00,Non-SBIR/STTR,1998,42369, ,NIDCR, , ,42369
RAF-1 INDUCED GROWTH AND APOPTOSIS IN BREAST CANCER,2807051,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,1991, ,NCI, , ,1991
MOLECULAR MARKERS OF PROGNOSIS IN MEDULLOBLASTOMA,2807071,7/5/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,22492, ,NCI, , ,22492
MECHANISMS OF ACROLEIN ON PROLIFERATION AND APOPTOSIS,2807358,8/1/1999 0:00,7/31/2003 0:00,Non-SBIR/STTR,1999,207523, ,NIEHS, , ,207523
MULTIPLE GENE CARRIER ADENOVIRAL CONSTRUCTS FOR GLIOMAS,2815974,6/1/1999 0:00,5/31/2002 0:00,Non-SBIR/STTR,1999,199890, ,NCI, , ,199890
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS,2816069,9/26/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1998,9718, ,NCI, , ,9718
EPITOPE BASED T CELL THERAPY FOR EPITHELIAL TUMORS,2822615,5/1/1999 0:00,2/29/2004 0:00,Non-SBIR/STTR,1999,254319, ,NCI, , ,254319
TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS,2824524,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,1999,215197, ,NCI, , ,215197
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER,2824556,9/24/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,1999,327258, ,NIDCR, , ,327258
UBIQUITINATION AND STABILITY OF P53 AND P73,2825461,6/15/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,1999,205673, ,NCI, , ,205673
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN,2825505,9/1/1999 0:00,8/31/2003 0:00,Non-SBIR/STTR,1999,425460, ,NIDCR, , ,425460
GENETIC ALTERATIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARK,2825506,9/1/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,1999,346912, ,NIDCR, , ,346912
EXPERIMENTAL TRANSFORMATION OF HUMAN MELANOCYTES IN VIVO,2826910,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,1999,241882, ,NCI, , ,241882
"AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES",2826920,9/20/1999 0:00,8/31/2004 0:00,Other Research-Related,1999,135783, ,NCI, , ,135783
MONOCLONAL GAMMOPATHIES,2827254,9/30/1994 0:00,1/31/2004 0:00,Non-SBIR/STTR,1999,1130157, ,NCI, , ,1130157
GENETIC EPIDEMIOLOGY OF ORAL PREMALIGNANCIES AND CANCER,2827912,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,1999,124686, ,NIDCR, , ,124686
NEOADJUVANT THERAPY OF ORAL CANCER BY INHIBITING NFK B,2827938,9/30/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,1999,246582, ,NIDCR, , ,246582
THE ROLE OF A NOVEL GAP IN EPITHELIAL ONCOGENESIS,2828533,9/8/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,1999,217054, ,NCI, , ,217054
MECHANISMS OF REPLICATIVE SENESCENCE IN CELLS,2830534,4/1/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,1999,300275, ,NIA, , ,300275
"BCL-2 GENE FAMILY, APOPTOSIS RESISTANCE & BREAST CANCER",2831103,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,23622, ,NCI, , ,23622
IN VITRO SCREENING OF CHEMOPREVENTIVE AGENTS,2833735,6/30/1998 0:00, ,R and D Contracts,1998,415096, ,NCI, , ,415096
IN VITRO SCREENING OF POTENTIAL CHEMOPREVENTIVE AGENTS,2833738,6/30/1998 0:00, ,R and D Contracts,1998,260274, ,NCI, , ,260274
MOLECULAR MARKERS FOR SQUAMOUS CELL CARCINOMA,2836071, , , ,1998, ,0, , , , 
APOPTOSIS INDUCING GENE THERAPY FOR ORAL PREMALIGNANCY,2836074, , , ,1998, ,0, , , , 
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,2836080, , , ,1998, ,0, , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,2836081, , , ,1998, ,0, , , , 
APOPTOSIS IN ORAL CANCER,2836093, , , ,1998, ,0, , , , 
RACIAL DIFFERENCES IN BREAST CANCER SURVIVAL,2837136,8/5/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,39622, ,NCI, , ,39622
ONCOGENE INDUCED LEUKEMOGENESIS IN TRANSGENIC MICE,2837622,4/1/1987 0:00,7/17/2000 0:00,Non-SBIR/STTR,1999,117859, ,NCI, , ,117859
CERAMIDE SIGNALING IN RADIATION INDUCED APOPTOSIS,2837644,7/15/1990 0:00,11/30/2001 0:00,Non-SBIR/STTR,1999,383472, ,NCI, , ,383472
PREDICTORS OF PROGRESSION IN BARRETTS ESOPHAGUS,2837676,2/7/1995 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,818461, ,NCI, , ,818461
SIGNIFICANCE OF MICROMETASTASES IN PROSTATE CANCER,2837679,12/22/1995 0:00,11/30/2000 0:00,Non-SBIR/STTR,1999,113202, ,NCI, , ,113202
MECHANISM OF HPV E6 MEDIATED UBIQUITINATION OF P53,2837684,12/29/1994 0:00,11/30/1999 0:00,Non-SBIR/STTR,1999,288619, ,NCI, , ,288619
HUMAN ABERRANT CRYPT FOCI--BIOMARKERS FOR COLON CANCER,2837693,2/9/1996 0:00,11/30/2000 0:00,Non-SBIR/STTR,1999,203917, ,NCI, , ,203917
HUMAN MAMMARY EPITHELIAL CELL IMMORTALIZATION,2837702,12/12/1997 0:00,11/30/2002 0:00,Non-SBIR/STTR,1999,224669, ,NCI, , ,224669
MECHANISM OF P53 DEPENDENT APOPTOSIS,2837756,12/5/1997 0:00,11/30/2002 0:00,Non-SBIR/STTR,1999,102200, ,NCI, , ,102200
CLINICAL TRIAL OF IRINOTECAN IN COLON CANCER,2837769,12/5/1997 0:00,11/30/2000 0:00,Non-SBIR/STTR,1999,141820, ,NCI, , ,141820
BRCAL AND P21 IN CELL CYCLING,2837783,1/7/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,1999,217773, ,NCI, , ,217773
SELENIUM--ANTIOXIDANT OR PROOXIDANT MECHANISM,2837799,12/10/1997 0:00,11/30/2001 0:00,Non-SBIR/STTR,1999,150877, ,NCI, , ,150877
G2/M DNA DAMAGE CHECKPOINT IN BUDDING YEAST,2838574,1/1/1991 0:00,11/30/2000 0:00,Non-SBIR/STTR,1999,212515, ,NIGMS, , ,212515
MOLECULAR CHARACTERIZATION OF ACF (ABERRANT CRYPT FOCI),2840388,8/1/1999 0:00,5/31/2003 0:00,Non-SBIR/STTR,1999,250120, ,NCI, , ,250120
PROGRESSION OF T CELL LYMPHOMA LINES TO IL2 INDEPENDENCE,2840896,7/1/1992 0:00,1/31/2002 0:00,Non-SBIR/STTR,1999,343983, ,NCI, , ,343983
IDENTIFYING GENOME CHANGES IN CANCER DEVELOPMENT,2840938,9/30/1998 0:00,9/29/2001 0:00,Non-SBIR/STTR,1998,565917, ,NCI, , ,565917
ATM GENE AND CELLULAR RESPONSES TO IRRADIATION,2841576,8/15/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1998,182675, ,NCI, , ,182675
GENETIC DETERMINANTS OF TUMORIGENESIS,2841580,5/1/1999 0:00,2/29/2004 0:00,Non-SBIR/STTR,1999,1082473, ,NCI, , ,1082473
MOLECULAR STAGING AND SCREENING OF LUNG CANCER,2841582,3/1/1998 0:00,2/28/2003 0:00,Other Research-Related,1998,56808, ,NCI, , ,56808
VIRAL GENE FUNCTIONS AND REGULATION OF CELL GROWTH,2842048,9/1/1975 0:00,1/31/2004 0:00,Non-SBIR/STTR,1999,320750, ,NCI, , ,320750
GENETIC EPIDEMIOLOGY OF LUNG CANCER,2842057,12/15/1994 0:00,2/29/2004 0:00,Non-SBIR/STTR,1999,538639, ,NCI, , ,538639
INTRAGENIC SUPPRESSOR MUTATIONS FOR P53 CANCER MUTATIONS,2842129,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,1999,211216, ,NCI, , ,211216
ENVIRONMENTAL AND GENETIC DETERMINANTS OF BREAST CANCER,2844394,9/30/1993 0:00,9/29/1998 0:00,Non-SBIR/STTR,1998,8475, ,NIEHS, , ,8475
MARKERS FOR EARLY LUNG CANCER DETECTION,2844888, , , ,1997, ,310388, , , , 
MUTANT P53 EPITOPE TARGETING IN SCLC,2844890, , , ,1997, ,310388, , , , 
"P53, CHEMICAL CARCINOGEN AND ETHANOL IN ORAL CANCER",2845000, , , ,1997, ,0, , , , 
P53 SEROLOGY AND PROGNOSIS OF ORAL CANCER,2845001, , , ,1997, ,0, , , , 
DEVELOPMENT OF P53 BASED VACCINES FOR ORAL CARCINOMA,2845023, , , ,1997, ,130146, , , , 
ORAL CARCINOMA--SIGNAL TRANSDUCTION IN LYMPHOCYTES,2845025, , , ,1997, ,130146, , , , 
PROTEIN P53 PHOSPHORYLATION STATUS IN PRIMARY BREAST CANCER,2845254, , , ,1997, ,0, , , , 
MECHANISTIC DEVELOPMENT OF PLATINUM BASED DRUGS,2848370,4/1/1999 0:00,3/31/2002 0:00,Non-SBIR/STTR,1999,151153, ,NCI, , ,151153
MOLECULAR REGULATION OF FOLATE AND ANTIFOLATE TRANSPORT,2849502,2/12/1993 0:00,1/31/2004 0:00,Non-SBIR/STTR,1999,202001, ,NCI, , ,202001
CELL GROWTH CONTROL BY BRCA1/ITS RESPONSE TO DNA DAMAGE,2849549,4/1/1999 0:00,1/31/2003 0:00,Non-SBIR/STTR,1999,194810, ,NCI, , ,194810
"ATM, P53, GADD45 AND P21 EFFECTS ON RECOMBINATION",2850025,6/1/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,1999,233753, ,NIEHS, , ,233753
CLAM LEUKEMIA--A MODEL FOR ENVIRONMENTAL CARCINOGENESIS,2850441,8/10/1987 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,188618, ,NCI, , ,188618
EPISOMAL VECTORS FOR COLON CANCER GENE THERAPY,2850462,1/20/1997 0:00,12/31/2000 0:00,Non-SBIR/STTR,1998,101955, ,NCI, , ,101955
"C-, N-, AND L-MYC EFFECTS ON HEMATOPOIETIC CELLS",2850469,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,1999,180866, ,NCI, , ,180866
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS,2852014,9/26/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1998,58304, ,NCI, , ,58304
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE,2852230,5/1/1994 0:00,5/31/2004 0:00,Non-SBIR/STTR,1999,654919, ,NCI, , ,654919
BIOCHEMICAL STUDIES OF HUMAN DNA POLYMERASE DELTA,2852345,4/1/1983 0:00,3/31/2003 0:00,Non-SBIR/STTR,1999,461596, ,NIGMS, , ,461596
V(D)J RECOMBINASE & CHROMOSOME TRANSLOCATION IN LYMPHOMA,2852954,7/7/1999 0:00,6/30/2004 0:00,Other Research-Related,1999,130410, ,NCI, , ,130410
P53 AND THE CELLULAR RESPONSE TO DNA DAMAGE,2854185,1/1/1992 0:00,12/31/2001 0:00,Non-SBIR/STTR,1998,142578, ,NIEHS, , ,142578
APP MEDIATED SIGNALING EVENTS IN P53 INHIBITION,2855089,5/1/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999,89045, ,NIA, , ,89045
MECHANISMS OF CELLULAR IMMORTALIZATION,2855811,4/1/1989 0:00,8/31/2000 0:00,Non-SBIR/STTR,1999,336103, ,NIA, , ,336103
PEDIATRIC ONCOLOGY GROUP,2856193,1/1/1978 0:00,12/31/2000 0:00,Other Research-Related,1999,201927, ,NCI, , ,201927
PEDIATRIC ONCOLOGY GROUP,2856231,1/1/1983 0:00,12/31/2000 0:00,Other Research-Related,1999,86464, ,NCI, , ,86464
NUCLEAR IMAGING OF TUMORS--BIOLOGICAL AND CHEMICAL BASIS,2856236,4/1/1983 0:00,5/31/2002 0:00,Non-SBIR/STTR,1999,316704, ,NCI, , ,316704
MECHANISM OF LARGE T ANTIGEN INDUCED TUMORIGENESIS,2856282,3/1/1988 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,375948, ,NCI, , ,375948
FUNCTION OF THE ADENOVIRUS E1B ONCOGENE,2856302,1/1/1991 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,142839, ,NCI, , ,142839
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM,2856350,3/18/1994 0:00,12/31/2002 0:00,Non-SBIR/STTR,1999,111182, ,NCI, , ,111182
CONTROL OF P53 DEPENDENT APOPTOSIS,2856373,1/1/1995 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,151969, ,NCI, , ,151969
CELLULAR TARGETS OF EARLY BREAST TUMORIGENESIS,2856374,1/28/1995 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,203260, ,NCI, , ,203260
MAMMALIAN CELL CYCLE CONTROL AND TUMORIGENESIS,2856375,3/1/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1999,181784, ,NCI, , ,181784
STRUCTURAL STUDIES OF THE P53 TUMOR SUPPRESSOR,2856378,1/15/1995 0:00,12/31/1999 0:00,Non-SBIR/STTR,1999,209886, ,NCI, , ,209886
TARGETED GENE DELIVERY FOR LUNG CANCER GENE THERAPY,2856382,1/3/1995 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,112486, ,NCI, , ,112486
GENETIC ALTERATIONS IN PUVA INDUCED SKIN CANCERS,2856393,3/1/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,166096, ,NCI, , ,166096
MECHANISMS OF P53 DEPENDENT APOPTOSIS,2856403,3/1/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,288864, ,NCI, , ,288864
MOLECULAR PROGNOSTIC INDICATORS IN ESOPHAGEAL CANCER,2856424,3/1/1998 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,398092, ,NCI, , ,398092
REGULATION OF BCL2 BY RAS AND TUMOR SUPPRESSORS,2856439,1/1/1997 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,203996, ,NCI, , ,203996
CENTROSOME HYPERTROPHY IN HUMAN BREAST TUMORS,2856442,1/1/1998 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,255685, ,NCI, , ,255685
H PYLORI PHENOTYPE AND STOMACH CANCER,2856446,1/25/1997 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,157382, ,NCI, , ,157382
EXCISION REPAIR OF UV RADIATION-INDUCED DNA DAMAGE,2856447,2/1/1997 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,296084, ,NCI, , ,296084
PRECANCEROUS EVENTS IN CLINICALLY NORMAL SKIN,2856505,4/1/1999 0:00,3/31/2002 0:00,Non-SBIR/STTR,1999,249690, ,NCI, , ,249690
LOH AT 3P AND P53 AND K-RAS MUTATION IN LUNG CANCER,2856866,1/1/1997 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,308428, ,NIEHS, , ,308428
ROLE AND REGULATION OF CDK4 IN THE NORMAL LENS,2856947,1/26/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,1998,33900, ,NEI, , ,33900
MORPHOLOGIC SCREEN TO IDENTIFY G2/M CHECKPOINT GENES,2857058,12/10/1998 0:00, ,"Training, Individual",1999,45268, ,NIGMS, , ,45268
REGULATION OF THE STEROL BIOSYNTHESIS PATHWAY IN YEAST,2857109,1/1/1986 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,291339, ,NIGMS, , ,291339
EBV BZLF1 GENE PRODUCT,2857158,1/1/1993 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,254603, ,NIGMS, , ,254603
NOVEL CYCLINS G1 AND G2,2857337,1/1/1998 0:00,12/31/2002 0:00,Non-SBIR/STTR,1999,161280, ,NIGMS, , ,161280
CLONING GENES THAT REGULATE MYOCARDIOCYTE PROLIFERATION,2857802,7/1/1990 0:00,2/28/2003 0:00,Non-SBIR/STTR,1999,325732, ,NHLBI, , ,325732
BCL-2 FAMILY AND P53 GENES ALTER APOPTOSIS IN GLIOMAS,2858142,1/1/1993 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,222593, ,NINDS, , ,222593
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,2859155,8/1/1990 0:00,12/31/2003 0:00,Non-SBIR/STTR,1999,312208, ,NCI, , ,312208
MOLECULAR EPIDEMIOLOGY OF PERSISTENT HPV INFECTION,2859162,9/11/1996 0:00,8/31/2002 0:00,Non-SBIR/STTR,1999,277184, ,NCI, , ,277184
IRSG LABORATORY CORRELATIVE STUDIES,2859817,9/1/1998 0:00,8/31/2000 0:00,Other Research-Related,1998,247671, ,NCI, , ,247671
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCER,2860738,9/30/1996 0:00,8/31/1999 0:00,Research Centers,1998,77424, ,NCI, , ,77424
RAR BETA MEDIATED APOPTOSIS IN BREAST CANCER CELLS,2861892,9/22/1995 0:00,8/31/2000 0:00,Other Research-Related,1998,78028, ,NCI, , ,78028
MEDIATORS OF MYC INDUCED MYELOID LEUKEMIA AND APOPTOSIS,2861914,11/10/1999 0:00, ,"Training, Individual",1999,36700, ,NCI, , ,36700
SRC AS AN E6AP SUBSTRATE,2862742,9/23/1999 0:00, ,"Training, Individual",1999,31720, ,NCI, , ,31720
ISOPEPTIDASES UBIQUITIN DEGRADATION AND PROSTATE CANCER,2866848,9/30/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1998,196605, ,NCI, , ,196605
ONCOLYTIC HERPES SIMPLEX VIRUS TYPE 1 FOR TUMOR THERAPY,2869176,4/1/1999 0:00,3/31/2000 0:00,SBIR/STTR,1999,100674, ,NCI, , ,100674
"HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING",2869460,5/1/1999 0:00,11/30/1999 0:00,SBIR/STTR,1999,100000, ,NCI, , ,100000
PAPILLOMAVIRUS E6 ONCOGENE INTERACTION WITH P53,2871605,2/1/1995 0:00,1/31/2000 0:00,Other Research-Related,1999,105138, ,NIAMS, , ,105138
HORMONAL REGULATION OF BREAST CANCER,2871648,8/1/1978 0:00,1/31/2002 0:00,Non-SBIR/STTR,1999,533545, ,NCI, , ,533545
DIHYDRODIOL DEHYDROGENASE AND PAH METABOLISM/ACTIVATION,2871694,3/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,1999,244770, ,NCI, , ,244770
FRAGILE SITES AND CHROMOSOME BREAKAGE AND CANCER,2871713,7/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,1999,257752, ,NCI, , ,257752
DNA REPAIR AND CANCER PRONE HEREDITARY HUMAN DISEASE,2871718,2/1/1987 0:00,1/31/2003 0:00,Non-SBIR/STTR,1999,293341, ,NCI, , ,293341
MECHANISMS OF INDUCTION OF SKIN CANCERS BY UV LIGHT,2871723,7/1/1988 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,166552, ,NCI, , ,166552
"GLIOMAS--BIOLOGIC, MOLECULAR AND GENETIC STUDIES",2871762,8/1/1992 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,990568, ,NCI, , ,990568
CYCLIN D1-PRAD1 IN MAMMARY NEOPLASIA,2871769,2/1/1992 0:00,3/31/2002 0:00,Non-SBIR/STTR,1999,309787, ,NCI, , ,309787
ACTIVATION OF BCL 2 IN HEMATOLOGIC MALIGNANCIES,2871775,8/1/1993 0:00,1/31/2002 0:00,Non-SBIR/STTR,1999,213985, ,NCI, , ,213985
UV INDUCIBLE INHIBITION IN MELANOMA,2871797,5/5/1993 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,312046, ,NCI, , ,312046
MUTANT P53 GAIN OF FUNCTION IN TUMORIGENESIS,2871826,4/1/1995 0:00,1/31/2003 0:00,Non-SBIR/STTR,1999,234194, ,NCI, , ,234194
NEW METHODS FOR CANCER DETECTION,2871842,3/1/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,878237, ,NCI, , ,878237
GROWTH AND APOPTOSIS IN HBV ASSOCIATED LIVER CANCER,2871853,4/14/1995 0:00,1/31/2000 0:00,Non-SBIR/STTR,1999,329675, ,NCI, , ,329675
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,2871877,9/30/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999,898337, ,NCI, , ,898337
DEVELOPMENT OF MOLECULAR MARKERS FOR PROSTATE CANCER,2871880,2/13/1996 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,112017, ,NCI, , ,112017
EXPRESSION AND FUNCTIONS OF MDM2 PROTEINS,2871892,2/1/1997 0:00,1/31/2002 0:00,Non-SBIR/STTR,1999,114250, ,NCI, , ,114250
EVALUATION OF PREDICTORS FOR RECURRENT ADENOMAS,2871919,2/14/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,345341, ,NCI, , ,345341
P53 WILD TYPE PEPTIDE BASED IMMUNOTHERAPY,2871924,2/12/1997 0:00,1/31/2000 0:00,Non-SBIR/STTR,1999,165417, ,NCI, , ,165417
CHEMOSENSITIZATION OF NSCLC THROUGH SIGNAL TRANSDUCTION,2871930,2/1/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,185226, ,NCI, , ,185226
ANTIAPOPTOTIC MECHANISMS IN PROSTATE CANCER,2871970,4/1/1998 0:00,1/31/2003 0:00,Non-SBIR/STTR,1999,255028, ,NCI, , ,255028
GENETIC EVENTS IN HUMAN PROSTATE CELL TRANSFORMATION,2871984,2/1/1998 0:00,1/31/2003 0:00,Other Research-Related,1999,81270, ,NCI, , ,81270
INHIBITION OF PAPILLOMAVIRUSES IN ORAL EPITHELIUM,2872150,2/1/1994 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,224163, ,NIDCR, , ,224163
MOLECULAR MARKERS OF ORAL CANCER RISK,2872161,4/1/1997 0:00,9/30/1999 0:00,Non-SBIR/STTR,1999,251100, ,NIDCR, , ,251100
PHOSPHOPEPTIDE MODELS OF P53 PROTEIN FRAGMENTS,2872740,2/1/1998 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,172887, ,NIGMS, , ,172887
NEW MODEL FOR COMPARATIVE STUDIES OF LEUKEMIA,2873496,7/1/1996 0:00,12/31/1999 0:00,Non-SBIR/STTR,1998,21600, ,NCI, , ,21600
DETERMINANTS OF HEPATITIS C & E MORBIDITY IN EGYPT,2875415,9/15/2000 0:00,8/31/2005 0:00,Non-SBIR/STTR,2000,448141, ,NICHD, , ,448141
MOLECULAR ANALYSIS OF CHROMOSOME INSTABILITY SYNDROMES,2877659,5/1/1994 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998,85000, ,NCI, , ,85000
MECHANISM OF ORAL CARCINOGENESIS,2879359,5/1/1995 0:00,4/30/2000 0:00,Other Research-Related,1998,49000, ,NIDCR, , ,49000
DIAGNOSIS OF LARGE CELL LYMPHOMA BY SURVIVIN EXPRESSION,2881325,9/7/1999 0:00,8/31/2001 0:00,Non-SBIR/STTR,1999,122625, ,NCI, , ,122625
CDX2 TUMOR SUPPRESSOR PATHWAY DEFECTS IN COLON CANCER,2881974,8/15/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,1999,223324, ,NCI, , ,223324
APOPTOSIS & MALIGNANT PROGRESSION IN MAMMARY TUMOR CELLS,2882081,5/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,267898, ,NIA, , ,267898
NITROAROMATICS AND BREAST CANCER,2882314,7/1/1983 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,306189, ,NCI, , ,306189
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION,2882332,7/1/1986 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,1452107, ,NCI, , ,1452107
COLON CANCER PREVENTION,2882333,9/30/1986 0:00,9/13/2000 0:00,Non-SBIR/STTR,1999,2423579, ,NCI, , ,2423579
DNA METHYLATION IN DEVELOPMENT AND CANCER,2882362,5/1/1989 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,572732, ,NCI, , ,572732
REGULATION OF P53 IN CERVICAL CARCINOMA BY HEAT/HYPOXIA,2882409,5/3/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999,205046, ,NCI, , ,205046
RISK FACTORS AND BIOMARKERS FOR IN SITU BREAST CANCER,2882420,6/1/1996 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,647786, ,NCI, , ,647786
DOMINANT-NEGATIVE AND GAIN OF FUNCTION P53 MUTATIONS,2882426,5/10/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,213997, ,NCI, , ,213997
BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH & PROGRESSION,2882427,5/6/1996 0:00,7/31/2001 0:00,Non-SBIR/STTR,1999,835684, ,NCI, , ,835684
PROTEASES AND CHEMOTHERAPY INDUCED APOPTOSIS,2882430,4/1/1995 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,217474, ,NCI, , ,217474
MARKERS FOR LUNG CARCINOGENESIS IN BRONCHIAL EPITHELIUM,2882443,3/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,460921, ,NCI, , ,460921
PRIMARY DNA LESIONS AS SIGNALS FOR P53,2882445,5/1/1996 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,236194, ,NCI, , ,236194
MVAC IN BLADDER CANCER BASED ON P53 STATUS,2882458,5/1/1997 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,524899, ,NCI, , ,524899
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA,2882479,5/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,251185, ,NCI, , ,251185
MOLECULAR STAGING AND SCREENING OF LUNG CANCER,2882497,3/1/1998 0:00,2/28/2003 0:00,Other Research-Related,1999,79920, ,NCI, , ,79920
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION,2882510,5/1/1998 0:00,2/28/2003 0:00,Non-SBIR/STTR,1999,262062, ,NCI, , ,262062
PATHOGENESIS OF MESENCHYMAL TUMORS INDUCED BY ASBESTOS,2882822,6/15/1985 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,231270, ,NIEHS, , ,231270
PROTECTION AGAINST APOPTOSIS BY SCATTER FACTOR,2882849,3/1/1998 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,236566, ,NIEHS, , ,236566
REGULATION OF P53 EXPRESSION BY C7 TRANSCRIPTION FACTOR,2883039,3/1/1996 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,211075, ,NIGMS, , ,211075
TUMOR SUPPRESSOR P53 AND THE CNS,2883673,5/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,176154, ,NINDS, , ,176154
GENETIC ELEMENTS SUPPRESSING P53,2883763,3/1/1998 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,25220, ,FIC, , ,25220
MOLECULAR EPIDEMIOLOGY OF NON-MELANOMA SKIN CANCER,2884583,9/30/1999 0:00,7/31/2003 0:00,Non-SBIR/STTR,1999,328197, ,NCI, , ,328197
T CELL DEVELOPMENT & LYMPHOMAGENESIS,2884786,9/30/1999 0:00,11/30/1999 0:00,Other Research-Related,1999,11610, ,NIAID, , ,11610
ROLE OF BRCA1 IN NORMAL CELL GROWTH AND TUMORGENESIS,2884846,9/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,1999,171387, ,NCI, , ,171387
BIOCHEMICAL  DISSECTION OF P53 DEPENDENT APOPTOSIS PATHW,2885057,9/1/1999 0:00,8/31/2004 0:00,Other Research-Related,1999,118416, ,NCI, , ,118416
CELL CYCLE CONTROL OF PROTEOLYSIS BY F-BOX PROTEINS,2885135,8/1/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,1999,337298, ,NIGMS, , ,337298
FAS/APO-1 MEDIATED APOPTOSIS,2885559,8/1/1999 0:00,5/31/2003 0:00,Non-SBIR/STTR,1999,168127, ,NCI, , ,168127
MOLECULAR BASIS OF RETINAL APOPTOSIS AND RETINOBLASTOMA,2888462,5/1/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999,315485, ,NEI, , ,315485
PCR MS/MS FINGERPRINTS FOR SEQUENCE POLYMORPHISM,2889703,8/1/1998 0:00,7/31/2001 0:00,Non-SBIR/STTR,1999,145500, ,NHGRI, , ,70500
MECHANISMS OF CELL DEATH & COMPENSATION IN PARKINSONS,2892089,9/30/1996 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999,281461, ,NINDS, , ,281461
MECHANISMS OF NEURONAL APOPTOSIS,2892254,4/20/1997 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,205218, ,NINDS, , ,205218
MOLECULAR MARKERS AS PREDICTORS OF OUTCOME IN GLIOMAS,2892423,9/1/1998 0:00,5/31/2001 0:00,Non-SBIR/STTR,1999,203430, ,NINDS, , ,203430
RADIATION INDUCED G1 CHECKPOINT ARREST IN YEAST,2892600,9/1/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,1999,186266, ,NIGMS, , ,186266
BYSTANDER EFFECTS OF LOW DOSE ALPHA PARTICLES,2892604,9/1/1999 0:00,8/31/2002 0:00,Non-SBIR/STTR,1999,300222, ,NCI, , ,300222
ALTERATIONS OF CELL CYCLE CONTROL IN MELANOCYTIC LESIONS,2892777,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,1999,104647, ,NIAMS, , ,104647
SEQUENTIAL DOXORUBICIN AND VINORELBINE IN BREAST CANCER,2892791,6/14/1999 0:00,5/31/2001 0:00,Non-SBIR/STTR,1999,77446, ,NCI, , ,77446
MOLECULAR ANALYSIS OF SURGICAL MARGINS WITH EIF4E IN CAN,2892802,7/1/1999 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,122235, ,NCI, , ,122235
DETERMINANTS OF CLINICAL OUTCOME/TOXICITY IN HISPANICS,2893234,9/3/1999 0:00,6/30/2003 0:00,Non-SBIR/STTR,1999,277196, ,NCI, , ,116585
"HUMAN MELANOMA--ETIOLOGY, PROGRESSION AND THERAPY",2893729,4/6/1990 0:00,4/30/2004 0:00,Non-SBIR/STTR,1999,1046904, ,NCI, , ,1046904
RESTORATION OF APOPTOSIS IN CANCER,2893736,7/23/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,1999,880827, ,NCI, , ,880827
GENETIC ANALYSIS OF MALIGNANCY,2894470,6/30/1976 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,503111, ,NCI, , ,503111
CHILDHOOD SOLID TUMORS,2894493,8/1/1978 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,1564905, ,NCI, , ,1564905
MUTAGENESIS OF SPECIFIC REGIONS OF THE SV 40 GENOME,2894504,9/1/1978 0:00,4/30/2002 0:00,Non-SBIR/STTR,1999,308506, ,NCI, , ,308506
HUMAN MAMMARY CELLS,2894505,9/1/1979 0:00,3/31/2003 0:00,Non-SBIR/STTR,1999,493678, ,NCI, , ,493678
BIOSYNTHESIS OF ADENOVIRUS EARLY RNAS,2894507,4/1/1979 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999,464643, ,NCI, , ,464643
NEW MODEL OF HUMAN BLADDER CANCER PATHOGENESIS,2894528,2/1/1984 0:00,10/31/1999 0:00,Non-SBIR/STTR,1999,3380, ,NCI, , ,3380
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,2894535,7/15/1981 0:00,10/15/1999 0:00,Non-SBIR/STTR,1999,26733, ,NCI, , ,26733
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA,2894546,6/1/1983 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999,218107, ,NCI, , ,218107
SLIT SCAN DETECTION OF BLADDER CANCER,2894548,8/1/1982 0:00,9/30/2001 0:00,Non-SBIR/STTR,1999,343553, ,NCI, , ,343553
RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONS,2894553,6/1/1983 0:00,3/31/2003 0:00,Non-SBIR/STTR,1999,298775, ,NCI, , ,298775
PROGRESSION OF THE TRANSFORMED PHENOTYPE,2894591,4/1/1984 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,228751, ,NCI, , ,228751
FUNCTIONAL ANALYSIS OF THE P53 CELLULAR TUMOR ANTIGEN,2894636,8/15/1985 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999,178779, ,NCI, , ,178779
DNA PHOTOLESION STRUCTURE ACTIVITY RELATIONSHIPS,2894644,7/1/1985 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,315872, ,NCI, , ,315872
GENE REGULATION BY ONCOGENES AND TUMOR SUPPRESSOR GENES,2894659,5/1/1986 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,1122950, ,NCI, , ,1122950
TRANSFORMING GROWTH FACTORS IN NEOPLASTIC TRANSFORMATION,2894678,7/1/1986 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,815391, ,NCI, , ,815391
TRANSPLACENTAL PANCREATIC CARCINOGENESIS BY NNK,2894684,9/1/1986 0:00,7/31/2001 0:00,Non-SBIR/STTR,1999,273533, ,NCI, , ,273533
ALTERATION OF NAD METABOLISM BY CHEMICAL CARCINOGENS,2894695,4/1/1986 0:00,6/30/2003 0:00,Non-SBIR/STTR,1999,310791, ,NCI, , ,310791
CLAM LEUKEMIA--A MODEL FOR ENVIRONMENTAL CARCINOGENESIS,2894699,8/10/1987 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,174974, ,NCI, , ,174974
RETROVIRUSES AND CANCER GENES,2894700,7/1/1987 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,1686958, ,NCI, , ,1686958
PATHOGENESIS OF MALIGNANT FIBROMATOSIS,2894714,3/1/1988 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,192142, ,NCI, , ,192142
CELL CYCLE REGULATORS AS TUMOR MARKERS IN BLADDER CANCER,2894764,4/10/1988 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,244405, ,NCI, , ,244405
PROGRESSION MECHANISMS--ONCOGENE INDUCED PROSTATE CANCER,2894812,9/8/1989 0:00,5/31/2001 0:00,Non-SBIR/STTR,1999,286575, ,NCI, , ,286575
SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY,2894829,5/1/1991 0:00,5/31/2001 0:00,Non-SBIR/STTR,1999,1099540, ,NCI, , ,1099540
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMA,2894845,5/15/1991 0:00,10/31/2001 0:00,Non-SBIR/STTR,1999,695499, ,NCI, , ,695499
HEPATITIS B VIRUS AND HEPATOCELLULAR CARCINOMA,2894883,3/15/1991 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,239449, ,NCI, , ,239449
BIOCHEMICAL AND CYTOGENETIC MARKERS IN RETINOBLASTOMA,2894886,4/1/1991 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,162138, ,NCI, , ,162138
GENETIC STAGING OF BREAST CANCERS FOR ADJUVANT THERAPY,2894899,7/1/1991 0:00,7/31/1999 0:00,Non-SBIR/STTR,1999,109167, ,NCI, , ,109167
GENETIC ALTERATIONS IN CNS TUMOR DEVELOPMENT,2894916,5/1/1991 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999,196207, ,NCI, , ,196207
MOLECULAR MECHANISMS OF GROWTH CONTROL--PROSTATE CANCER,2894979,9/30/1992 0:00,5/31/2001 0:00,Non-SBIR/STTR,1999,227195, ,NCI, , ,227195
DNA RECOMBINATION AND RADIATION RESISTANCE,2895007,9/30/1992 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,259516, ,NCI, , ,259516
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,2895022,6/1/1993 0:00,4/30/2003 0:00,Non-SBIR/STTR,1999,379201, ,NCI, , ,379201
CELL CELL INTERACTIONS IN PROSTATE CANCER,2895028,5/1/1993 0:00,7/31/2002 0:00,Non-SBIR/STTR,1999,262967, ,NCI, , ,262967
ONCOGENE-SPECIFIC IMMUNE RESPONSES IN BREAST CANCER,2895063,6/1/1994 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,235176, ,NCI, , ,235176
DIET AND SOMATIC MUTATIONS IN COLON CANCER,2895076,8/1/1995 0:00,4/30/2002 0:00,Non-SBIR/STTR,1999,509046, ,NCI, , ,509046
BREAST CANCER GROWTH SUPPRESSOR GENE,2895079,2/1/1994 0:00,4/30/2002 0:00,Non-SBIR/STTR,1999,243738, ,NCI, , ,243738
ALLELE LOSS IN THE GENESIS OF GASTRIC CANCER,2895103,5/1/1995 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,104482, ,NCI, , ,104482
MODULATION OF ARA-C INDUCED APOPTOSIS BY BRYOSTATIN 1,2895120,6/1/1994 0:00,4/30/2003 0:00,Non-SBIR/STTR,1999,259757, ,NCI, , ,259757
MECHANISM OF PDGF INDUCED APOPTOSIS,2895132,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,105272, ,NCI, , ,105272
MOLECULAR EPIDEMIOLOGY OF BREAST CANCER,2895143,5/1/1997 0:00,4/30/2002 0:00,Non-SBIR/STTR,1999,411592, ,NCI, , ,411592
RACIAL DIFFERENCES IN BREAST CANCER SURVIVAL,2895149,8/5/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,528344, ,NCI, , ,528344
ADJUVANT HORMONAL THERAPY IN VIETNAMESE BREAST CANCER,2895151,7/1/1995 0:00,6/30/2003 0:00,Non-SBIR/STTR,1999,284348, ,NCI, , ,284348
MDM2 ONCOPROTEIN AS A CELL REGULATOR OF P53,2895157,4/1/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999,109356, ,NCI, , ,109356
MOLECULAR PATHOGENESIS OF CERVICAL CANCER,2895160,4/1/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999,109347, ,NCI, , ,109347
REACTIVATION OF P53 FUNCTION AND ANTICANCER THERAPY,2895173,4/15/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,107901, ,NCI, , ,107901
MECHANISMS OF HUMAN ESOPHAGEAL CARCINOGENESIS,2895215,5/15/1996 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999,289262, ,NCI, , ,289262
ROLES OF PLEIOTROPHIN IN NORMAL AND ABNORMAL CELL GROWTH,2895222,6/10/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999,308942, ,NCI, , ,308942
ISOLATION CHROMOSOME 17Q25 GENE INVOLED IN BREAST CANCER,2895245,4/7/1995 0:00,3/31/2001 0:00,Other Research-Related,1999,90720, ,NCI, , ,90720
MOLECULAR GENETIC ALTERATIONS OF ENDOMETRIAL CARCINOMA,2895253,7/27/1998 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999,125366, ,NCI, , ,125366
P53 TRAFFICKING DURING CELL CYCLE,2895269,7/1/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,222427, ,NCI, , ,222427
RISK FACTORS AND BIOMARKERS FOR IN SITU BREAST CANCER,2895279,8/1/1996 0:00,7/31/2001 0:00,Non-SBIR/STTR,1999,59430, ,NCI, , ,59430
PROTEIN KINASE C--A NOVEL TARGET FOR CANCER THERAPY,2895305,8/1/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,204034, ,NCI, , ,204034
GENETIC ALTERATIONS IN GASTRIC CARCINOMAS,2895310,8/21/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999,131657, ,NCI, , ,131657
TNE ROLE OF TIAK IN APOPTOTIC CELL DEATH,2895313,9/1/1995 0:00,6/30/2000 0:00,Non-SBIR/STTR,1999,240707, ,NCI, , ,240707
REGULATION OF TUMOR SUPPRESSOR P53 BY PHOSPHORYLATION,2895323,9/1/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1999,102092, ,NCI, , ,102092
MOUSE MODELS AND SUSCEPTIBILITY GENES IN BREAST CANCER,2895327,8/1/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999,275222, ,NCI, , ,275222
"BCL-2 GENE FAMILY, APOPTOSIS RESISTANCE AND BREAST CANCE",2895329,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,84380, ,NCI, , ,84380
MOLECULAR MARKERS OF PROGNOSIS IN MEDULLOBLASTOMA,2895342,7/5/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,264727, ,NCI, , ,264727
HISTOLOGIC AND MOLECULAR CHANGES IN UC TUMORIGENESIS,2895343,7/25/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,1999,378549, ,NCI, , ,378549
P16/P18 FAMILY CDK INHIBITORS,2895370,7/17/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999,292178, ,NCI, , ,292178
SPORE IN BREAST CANCER,2895373,9/15/1995 0:00,8/31/2001 0:00,Research Centers,1999,1922031, ,NCI, , ,1922031
MAXIMIZING THE THERAPEUTIC INDEX OF CHILDHOOD ALL,2895384,9/30/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999,1205625, ,NCI, , ,1205625
MECHANISMS OF METASTASIS IN EXPERIMENTAL PROSTATE CANCER,2895405,8/1/1995 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999,274700, ,NCI, , ,274700
MECHANISMS OF CARCINOGENESIS INVOLVING WILD-TYPE,2895427,4/1/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,122107, ,NCI, , ,122107
PAPILLOMAVIRUS TRANSFORMATION,2895445,9/1/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1999,125683, ,NCI, , ,125683
P53--DUAL GROWTH CONTROL AND DNA DAMAGE SENSITIZATION,2895464,7/7/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,132860, ,NCI, , ,132860
INDUCTION AND ANALYSIS OF PROSTATE CANCER,2895470,9/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,239065, ,NCI, , ,239065
FUNCTIONAL ANALYSIS OF MDM2 OVEREXPRESSION,2895501,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,1999,105000, ,NCI, , ,105000
"DNA ADDUCT, P53 MUTATION, AND ETIOLOGY OF BREAST CANCER",2895508,9/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,191118, ,NCI, , ,191118
INDUCTION OF MELANOMA WITH UV-A,2895510,7/2/1997 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,222517, ,NCI, , ,222517
SYSTEMIC DELIVERY OF P53 INHIBITS BREAST CANCER,2895524,7/15/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,96941, ,NCI, , ,96941
TRANSCRIPTIONAL REGULATORS IN CANCER,2895525,6/15/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,1027230, ,NCI, , ,1027230
BREAST CANCER ETIOLOGY--P53 GAIN OF FUNCTION MUTATIONS,2895530,7/1/1996 0:00,3/28/2000 0:00,Non-SBIR/STTR,1999,239622, ,NCI, , ,239622
P53 DIRECTED IMMUNOTHERAPY OF BREAST CANCER,2895540,7/10/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,105080, ,NCI, , ,105080
MOLECULAR/CELLULAR PATHWAYS OF BLADDER CA++ PROGRESSION,2895548,4/19/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,285035, ,NCI, , ,285035
BENIGN BREAST DISEASE--MOLECULAR DIFFERENTIATION OF RISK,2895553,9/30/1996 0:00,9/29/2001 0:00,Non-SBIR/STTR,1999,469474, ,NCI, , ,469474
ATM GENE AND CELLULAR RESPONSES TO IRRADIATION,2895583,8/15/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999,195976, ,NCI, , ,195976
"PML, PLZF AND NPM IN THE MOLECULAR PATHOGENESIS OF APL",2895626,9/15/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,284480, ,NCI, , ,284480
ETIOLOGY OF EARLY BREAST MALIGNANCY,2895697,9/1/1996 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,542298, ,NCI, , ,542298
NUTRITIONAL AND HORMONAL BIOMARKERS IN PROSTATE CANCER,2895700,9/1/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,419764, ,NCI, , ,419764
DIETARY TOMATO PRODUCTS AND EXPERIMENTAL PROSTATE CANCER,2895738,7/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,203091, ,NCI, , ,203091
17Q25 BREAST CANCER GENE--ISOLATION AND ANALYSIS,2895785,9/8/1997 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,253245, ,NCI, , ,253245
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES,2895793,9/30/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,1999,666179, ,NCI, , ,666179
INFLAMMATION AND MULTISTAGE CARCINOGENESIS,2895808,9/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,336086, ,NCI, , ,336086
TISSUE AND SERUM INDICATORS OF LUNG CANCER RECURRENCE,2895903,9/1/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1999,136150, ,NCI, , ,136150
PROGNOSTIC INDICATORS IN LOCALIZED COLON CANCER,2895936,9/17/1997 0:00,8/31/2000 0:00,Non-SBIR/STTR,1999,163759, ,NCI, , ,163759
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS,2896017,9/26/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,1999,91517, ,NCI, , ,91517
GENETIC EPIDEMIOLOGY OF GASTRIC CANCER,2896064,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,1999,76686, ,NCI, , ,76686
INT-5/AROMATASE--EFFECT OF BREAST ESTROGEN IN NEOPLASIA,2896072,7/15/1997 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,195580, ,NCI, , ,195580
REGULATION OF P21 (WAF1/C1P1) BY E2A,2896090,9/30/1997 0:00,8/31/2002 0:00,Other Research-Related,1999,90450, ,NCI, , ,90450
RETINOID INDUCED TUMOR DIFFERENTIATION AND THE CELL CYCL,2896100,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,1999,131043, ,NCI, , ,131043
FATTY ACID SYNTHESIS AND THE CELL CYCLE,2896116,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,113507, ,NCI, , ,113507
ECOGENETICS OF PANCREATIC CANCER--FAMILY REGISTRY,2896134,9/30/1997 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,143996, ,NCI, , ,143996
MURINE P73 IN TUMORIGENESIS,2896141,6/15/1998 0:00,3/31/2002 0:00,Non-SBIR/STTR,1999,414742, ,NCI, , ,414742
MOLECULAR EPIDEMIOLOGY OF BRCA1 RELATED BREAST NEOPLASIA,2896155,9/30/1998 0:00,8/31/2003 0:00,Other Research-Related,2000,82018, ,NCI, , ,82018
FATTY ACIDS AND TUMOR CHARACTERISTICS IN BREAST CANCER,2896158,9/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,275098, ,NCI, , ,275098
KILLER/DR5 AND TUMORIGENESIS,2896162,9/14/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,201836, ,NCI, , ,201836
COMBINED SUICIDE GENE THERAPY/RADIOTHERAPY FOR CANCER,2896164,8/1/1997 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999,224319, ,NCI, , ,224319
GROWTH REGULATION OF PROSTATIC CELLS BY ANDROGEN,2896170,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,105585, ,NCI, , ,105585
IN VIVO ROLE OF DNA ALKYLATION REPAIR,2896185,8/8/1997 0:00,5/31/2002 0:00,Non-SBIR/STTR,1999,394632, ,NCI, , ,394632
RANDOMIZED ADJUVANT THERAPY OF HEAD AND NECK CANCER,2896189,9/1/1998 0:00,8/31/2002 0:00,Non-SBIR/STTR,1999,148952, ,NCI, , ,148952
MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER,2896233,9/1/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,1999,511674, ,NCI, , ,511674
G1 AND G2 CHECKPOINTS IN IRRADIATED CELLS,2896246,7/1/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,239995, ,NCI, , ,239995
THERAPY OF HEPATOCELLULAR CARCINOMA,2896249,7/28/1998 0:00,6/30/2003 0:00,Other Research-Related,1999,73980, ,NCI, , ,73980
MODULATION OF P53 FUNCTION BY BINDING PROTEIN BBP/53BP2,2896260,7/10/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,1999,194911, ,NCI, , ,194911
P53 PROTEIN/PROTEIN INTERACTIONS,2896268,8/10/1998 0:00,7/31/2001 0:00,Non-SBIR/STTR,1999,243075, ,NCI, , ,243075
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER,2896273,9/1/1998 0:00,8/30/2003 0:00,Other Research-Related,1999,79880, ,NCI, , ,79880
PROSTOGLANDINS AND UVB CARCINOGENESIS,2896297,8/14/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,1999,159851, ,NCI, , ,159851
TRANSLATIONAL RESEARCH IN LUNG CANCER,2896338,9/30/1997 0:00,9/29/2002 0:00,Other Research-Related,1999,162000, ,NCI, , ,162000
DETACHMENT SENSITIZES CELLS TO TOPOISOMERASE INHIBITORS,2896353,9/30/1997 0:00,9/29/2002 0:00,Other Research-Related,1999,154294, ,NCI, , ,154294
CHEMOPREVENTION FOR WOMEN AT HIGH RISK OF BREAST CANCER,2896374,9/30/1997 0:00,6/30/2003 0:00,Other,2000,245885, ,NCI, , ,245885
SV40-LIKE SEQUENCES IN HUMAN TUMORS ANALYSES,2896383,8/1/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,1999,108500, ,NCI, , ,108500
DNA STRAND BREAKS AND THE GENETIC BASIS OF LYMPHOMAS,2896399,8/12/1998 0:00,4/30/2002 0:00,Non-SBIR/STTR,1999,214695, ,NCI, , ,214695
P53 AND REPAIR OF DNA DAMAGE BY ANTICANCER DRUGS,2896406,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,1999,100124, ,NCI, , ,100124
TARGETING CANCER CELL DNA WITH COMBINATORIAL LIGANDS,2896407,4/1/1998 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,176056, ,NCI, , ,176056
P53-MEDIATED CHEMOSENSITIVITY IN NEUROBLASTOMA,2896442,4/15/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,1999,101530, ,NCI, , ,101530
FUNCTIONS OF DIFFERENT P53 MUTATIONS IN PROSTATE CANCER,2896457,4/15/1998 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,154514, ,NCI, , ,154514
IN VIVO SOMATIC MUTATIONS IN CHILDREN WITH CANCER,2896469,9/30/1998 0:00,9/29/2002 0:00,Other Research-Related,1999,160677, ,NCI, , ,160677
DESIGN OF PROGRAMMABLE GENOTOXINS,2896470,6/16/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,1999,345215, ,NCI, , ,345215
H PYLORI RELATIONSHIP TO DIGESTIVE DISEASES AND CANCER,2896500,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,1999,70257, ,NCI, , ,70257
LIPOTROPE MEDIATED PROGRAMMED CELL DEATH IN MCF7 CELLS,2896520,6/1/1998 0:00,5/31/2001 0:00,Non-SBIR/STTR,1999,32952, ,NCI, , ,32952
INHIBITION OF TRANSLATION INITIATION IN CANCER THERAPY,2896564,7/1/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,263823, ,NCI, , ,263823
CANCER VACCINE TO P53,2896574,9/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,272053, ,NCI, , ,272053
MOLECULAR PROGNOSTIC INDICATORS IN COLORECTAL CANCER,2896610,7/1/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,250832, ,NCI, , ,250832
IGFIR IN HUMAN GI TUMORS,2896652,7/1/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,240087, ,NCI, , ,240087
P21 INDUCTION BY BRCA2,2896664,8/1/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,1999,100169, ,NCI, , ,100169
GENETIC MARKERS FOR THERAPY OF COLON CANCER,2896683,7/13/1998 0:00,6/30/2000 0:00,Other Research-Related,1999,188621, ,NCI, , ,188621
"DIETARY HETEROCYCLIC AMINES, GENETIC SUSCEPTIBILITY, AND",2896698,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,1999,104178, ,NCI, , ,104178
INTRAPERITONEAL AD5-P53 GENE THERAPY FOR OVARIAN CANCER,2896733,7/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,78000, ,NCI, , ,78000
BIOCHEMOPREVENTION THERAPY IN ADVANCED LARYNGEAL DYSPLAS,2896736,9/10/1998 0:00,6/30/2003 0:00,Other,1999,556114, ,NCI, , ,556114
PERILLYL ALCOHOL THERAPY IN ADVANCED COLORECTAL CANCER,2896746,8/1/1998 0:00,7/31/2001 0:00,Non-SBIR/STTR,1999,67213, ,NCI, , ,67213
"RETINOID, INTERFERON AND TAXOL EFFECTS IN BREAST CANCER",2896771,9/30/1998 0:00,9/29/2000 0:00,Non-SBIR/STTR,1999,79500, ,NCI, , ,79500
IDENTIFYING GENOME CHANGES IN CANCER DEVELOPMENT,2896786,9/30/1998 0:00,9/29/2001 0:00,Non-SBIR/STTR,1999,520715, ,NCI, , ,520715
IRSG LABORATORY CORRELATIVE STUDIES,2896796,9/1/1998 0:00,8/31/2001 0:00,Other Research-Related,1999,196216, ,NCI, , ,196216
ISOPEPTIDASES UBIQUITIN DEGRADATION AND PROSTATE CANCER,2896802,9/30/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,200442, ,NCI, , ,200442
DEVELOPING A MOLECULAR MODEL--ORAL CAVITY TUMORIGENESIS,2896891,5/1/1995 0:00,10/31/1999 0:00,Other Research-Related,1999,858, ,NIDCR, , ,858
DEVELOPING MOLECULAR THERAPY IN HEAD AND NECK CANCER,2897090,8/1/1996 0:00,5/31/2001 0:00,Non-SBIR/STTR,1999,107532, ,NIDCR, , ,107532
DEVELOPMENT OF VACCINES FOR ORAL CARCINOMA,2897162,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,1999,779553, ,NIDCR, , ,779553
CELL CYCLE REGULATORS OF ORAL CANCER,2897180,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,1999,906552, ,NIDCR, , ,906552
PULMONARY EFFECTS OF HABITUAL USE OF MARIJUANA,2897687,7/1/1982 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,501871, ,NIDA, , ,501871
ENHANCING ACTIVITY OF ALKYLATING AGENTS IN NEUROBLASTOMA,2898580,9/1/1999 0:00,8/31/2002 0:00,Non-SBIR/STTR,1999,221260, ,NCI, , ,221260
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER,2898611,9/30/1999 0:00,9/29/2004 0:00,Non-SBIR/STTR,1999,301978, ,NIDCR, , ,301978
E2 MODULATION OF TUMORIGENESIS IN ERBB2 TRANSGENIC MICE,2898841,8/15/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,1999,195815, ,NCI, , ,195815
APOPTOSIS AND CARCINOGENESIS,2899083,8/13/1999 0:00,2/15/2000 0:00,Non-SBIR/STTR,1999,282604, ,NCI, , ,282604
TAILORING ANTICANCER THERAPY TO LOSS OF P53,2901607,6/15/1996 0:00,6/30/2004 0:00,Non-SBIR/STTR,1999,242493, ,NCI, , ,242493
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS,2901903,9/30/1986 0:00,5/31/2004 0:00,Non-SBIR/STTR,1999,343327, ,NCI, , ,343327
FUNCTIONAL ANALYSIS OF MDM2 OVEREXPRESSION,2902130,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,1998,67690, ,NCI, , ,67690
UNDERSTANDING A NOVEL MODIFIER OF P53 TUMORIGENESIS,2902214,9/1/1999 0:00,8/31/2002 0:00,Other Research-Related,1999,100880, ,NCI, , ,100880
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS,2903068,8/1/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999,186469, ,NCI, , ,186469
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS,2903424,8/1/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,1999,218254, ,NIAID, , ,218254
MOLECULAR DETERMINANTS OF DRUG SENSITIVITY,2903460,7/12/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,1999,139626, ,NCI, , ,139626
NEOPLASTIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE,2905609,9/30/1993 0:00,8/31/2001 0:00,Non-SBIR/STTR,1999,212746, ,NIDDK, , ,212746
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,2906176,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,1999,254922, ,NIDDK, , ,254922
BREAST CANCER REPOSITORY FOR MOLECULAR EPIDEMIOLOGY,2906738,8/13/1999 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,86465, ,NCI, , ,86465
GEMZAR--MECHANISMS OF CYTOTOXICITY & RADIOSENSITIZATION,2906739,7/8/1999 0:00,4/30/2003 0:00,Non-SBIR/STTR,1999,172132, ,NCI, , ,172132
ROLE AND REGULATION OF CDK4 IN THE NORMAL LENS,2906760,1/26/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,325513, ,NEI, , ,325513
POLYAMINE ANALOG AND INHIBITOR REGULATION OF CELL CYCLE,2906955,8/1/1989 0:00,4/30/2004 0:00,Non-SBIR/STTR,1999,234390, ,NCI, , ,234390
TRANSLATIONAL CONTROL OF ONCOPROTEIN MDM2 SYNTHESIS,2906972,7/1/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,1999,199556, ,NCI, , ,199556
ERBB2/P53 AND TAXANE CHEMOTHERAPY FOR BREAST CANCER,2906996,9/14/1999 0:00,8/31/2001 0:00,Non-SBIR/STTR,1999,201478, ,NCI, , ,201478
TREATMENT RESPONSE MARKERS IN ADVANCED LARYNGEAL CANCER,2906997,9/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,1999,206397, ,NCI, , ,206397
MALIGNANT COMPLICATIONS OF CHRONIC HEPATITIS C VIRUS,2907043,9/29/1999 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999,284497, ,NCI, , ,284497
THE ROLE OF INTEGRIN A5B1 IN ANGIOGENESIS & DISEASE,2907644,9/1/1999 0:00,6/30/2003 0:00,Non-SBIR/STTR,1999,261134, ,NCI, , ,261134
RETINOID INDUCED TUMOR DIFFERENTIATION AND THE CELL CYCL,2908782,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,1998,86400, ,NCI, , ,86400
MOLECULAR MECHANISMS OF ANTIMICROTUBULE AGENTS,2908933,8/6/1999 0:00,7/31/2001 0:00,Non-SBIR/STTR,1999,189778, ,NCI, , ,189778
MECHANISM OF ORAL CARCINOGENESIS,2909935,5/1/1995 0:00,8/31/1999 0:00,Other Research-Related,1999,33923, ,NIDCR, , ,33923
REGULATION OF SIC1 INHIBITION OF YEAST CDK COMPLEXES,2910182,5/1/1995 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,214304, ,NIGMS, , ,214304
FUNCTION OF THE HUMAN DNA-ACTIVATED PROTEIN KINASE,2910191,5/1/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,268675, ,NIGMS, , ,268675
P-21 INDUCTION IN MYELOID DIFFERENTIATION,2910581,5/1/1996 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999,107817, ,NHLBI, , ,107817
NUTRIENTS EFFECT ON GENOTYPE IN BREAST CANCER,2910917,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,1999,116492, ,NCI, , ,116492
TR2 AND TR3 ORPHAN RECEPTORS IN PROSTATE CANCER,2910964,9/1/1995 0:00,8/31/2003 0:00,Non-SBIR/STTR,1999,266802, ,NIDDK, , ,266802
THE ROLE OF P53 IN BREAST CANCER,3034266,3/31/1991 0:00, , ,1990,22688, ,NCI, , ,22688
PREVENTIVE ONCOLOGY ACADEMIC AWARD,3076841,2/1/1993 0:00,1/31/1998 0:00, ,1993,73024, ,NCI, , ,73024
NCI CLINICAL INVESTIGATOR AWARD,3079495,9/30/1985 0:00,5/31/1989 0:00, ,1985,63986, ,NCI, , ,63986
NCI CLINICAL INVESTIGATOR AWARD,3079497,9/30/1985 0:00,5/31/1989 0:00, ,1987,64088, ,NCI, , ,64088
NCI CLINICAL INVESTIGATOR AWARD,3079498,9/30/1985 0:00,5/31/1990 0:00, ,1988,73623, ,NCI, , ,73623
MOLECULAR MODELS FOR NEOPLASIA IN THE GLIOMAS,3080053,8/1/1991 0:00,7/31/1992 0:00, ,1991,74295, ,NCI, , ,74295
MOLECULAR MODELS FOR NEOPLASIA IN THE GLIOMAS,3080054,8/1/1991 0:00,7/31/1994 0:00, ,1993,90720, ,NCI, , ,90720
MOLECULAR MODELS FOR NEOPLASIA IN THE GLIOMAS,3080055,8/1/1991 0:00,7/31/1994 0:00, ,1992,79920, ,NCI, , ,79920
"RELATIONSHIP BETWEEN DNA DAMAGE, MUTATIONS, AND CANCER",3080130,8/1/1993 0:00,7/31/1997 0:00, ,1993,64274, ,NCI, , ,64274
MOLECULAR PATHOGENESIS OF HUMAN PARATHYROID NEOPLASIA,3080136,8/1/1993 0:00,7/31/1998 0:00, ,1993,63376, ,NCI, , ,63376
REGULATION OF NERVE INJURY AND REPAIR,3084704,4/1/1992 0:00,3/31/1997 0:00, ,1992,80892, ,NINDS, , ,80892
REGULATION OF NERVE INJURY AND REPAIR,3084705,4/1/1992 0:00,3/31/1997 0:00, ,1993,91800, ,NINDS, , ,91800
P53 IN CHRONIC MYELOGENOUS LEUKEMIA,3085889,7/16/1990 0:00,6/30/1995 0:00, ,1990,63072, ,NCI, , ,63072
P53 IN CHRONIC MYELOGENOUS LEUKEMIA,3085890,7/16/1990 0:00,6/30/1995 0:00, ,1991,10800, ,NCI, , ,10800
P53 IN CHRONIC MYELOGENOUS LEUKEMIA,3085891,7/16/1990 0:00,6/30/1995 0:00, ,1992,17916, ,NCI, , ,17916
P53 IN CHRONIC MYELOGENOUS LEUKEMIA,3085892,7/16/1990 0:00,6/30/1995 0:00, ,1993,85320, ,NCI, , ,85320
ENDOGENOUS NITRITE CARCINOGENESIS IN MAN,3093147,3/1/1980 0:00,2/28/1994 0:00, ,1991,1000000, ,NCI, , ,1000000
ENDOGENOUS NITRITE CARCINOGENESIS IN MAN,3093153,3/1/1980 0:00,2/28/1994 0:00, ,1992,982335, ,NCI, , ,982335
ENDOGENOUS NITRITE CARCINOGENESIS IN MAN,3093154,3/1/1980 0:00,2/28/1994 0:00, ,1993,1026041, ,NCI, , ,1026041
CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT,3093181,7/22/1980 0:00,11/30/1997 0:00, ,1993,1990558, ,NCI, , ,1990558
A PROGRAM IN MEDICAL ONCOLOGY,3093461,4/1/1982 0:00,3/31/1991 0:00, ,1986,847856, ,NCI, , ,847856
A PROGRAM IN MEDICAL ONCOLOGY,3093467,4/1/1982 0:00,3/31/1991 0:00, ,1987,857321, ,NCI, , ,857321
A PROGRAM IN MEDICAL ONCOLOGY,3093468,4/1/1982 0:00,3/31/1991 0:00, ,1988,879698, ,NCI, , ,879698
A PROGRAM IN MEDICAL ONCOLOGY,3093469,4/1/1982 0:00,3/31/1991 0:00, ,1989,822095, ,NCI, , ,822095
A PROGRAM IN MEDICAL ONCOLOGY,3093470,4/1/1982 0:00,11/30/1991 0:00, ,1990,857872, ,NCI, , ,857872
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION,3093835,7/1/1986 0:00,6/30/1991 0:00, ,1986,938437, ,NCI, , ,938437
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION,3093839,7/1/1986 0:00,6/30/1991 0:00, ,1987,1158071, ,NCI, , ,1158071
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION,3093840,7/1/1986 0:00,6/30/1991 0:00, ,1988,1198757, ,NCI, , ,1198757
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION,3093841,7/1/1986 0:00,6/30/1991 0:00, ,1989,1247475, ,NCI, , ,1247475
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION,3093842,7/1/1986 0:00,6/30/1991 0:00, ,1990,1268488, ,NCI, , ,1268488
THERAPY OF AML,3094575,6/1/1992 0:00,3/31/1996 0:00, ,1992,1784999, ,NCI, , ,1784999
THERAPY OF AML,3094577,6/1/1992 0:00,3/31/1996 0:00, ,1993,1674961, ,NCI, , ,1674961
"GLIOMAS--BIOLOGIC, MOLECULAR, AND GENETIC STUDIES",3094584,8/1/1992 0:00,7/31/1995 0:00, ,1992,850000, ,NCI, , ,850000
"GLIOMAS:  BIOLOGIC, MOLECULAR, AND GENETIC STUDIES",3094585,8/1/1992 0:00,7/31/1995 0:00, ,1993,868458, ,NCI, , ,868458
QUANTITATIVE DNA MOLECULAR STUDIES IN PROSTATE CANCER,3094595,4/2/1993 0:00,1/31/1996 0:00, ,1993,678154, ,NCI, , ,678154
ENDOCRINE ASPECTS OF HUMAN NEOPLASIA,3095645,7/1/1991 0:00,6/30/1996 0:00, ,1991,628872, ,NIDDK, , ,628872
ENDOCRINE ASPECTS OF HUMAN NEOPLASIA,3095646,7/1/1991 0:00,6/30/1996 0:00, ,1992,694909, ,NIDDK, , ,694909
ENDOCRINE ASPECTS OF HUMAN NEOPLASIA,3095647,7/1/1991 0:00,6/30/1996 0:00, ,1993,722707, ,NIDDK, , ,722707
BRAIN TUMOR RESEARCH CENTER,3100607,3/1/1993 0:00,2/28/1996 0:00, ,1993,75000, ,NCI, , ,75000
MOLECULAR DETERMINANTS OF TUMORIGENESIS IN BRAIN TUMORS,3100822,9/1/1992 0:00,8/31/1995 0:00, ,1992,393000, ,NINDS, , ,393000
MOLECULAR DETERMINANTS OF TUMORIGENESIS IN BRAIN TUMORS,3100823,9/1/1992 0:00,8/31/1995 0:00, ,1993,393000, ,NINDS, , ,393000
AGE ASSOCIATED CHANGES IN B LYMPHOCYTE FUNCTION,3116484,8/1/1986 0:00,7/31/1994 0:00, ,1991,120867, ,NIA, , ,120867
AGE ASSOCIATED CHANGES IN B LYMPHOCYTE FUNCTION,3116488,8/1/1986 0:00,7/31/1994 0:00, ,1992,137462, ,NIA, , ,137462
"CALORIES, FAT & SPONTANEOUS PROSTATE CANCER IN AGING RAT",3122425,5/1/1992 0:00,4/30/1997 0:00, ,1992,150034, ,NIA, , ,150034
"CALORIES, FAT & SPONTANEOUS PROSTATE CANCER IN AGING RAT",3122426,5/1/1992 0:00,4/30/1997 0:00, ,1993,209178, ,NIA, , ,209178
MOLECULAR BASIS OF SENESCENCE IN BREAST EPITHELIAL CELLS,3122778,8/1/1992 0:00,5/31/1995 0:00, ,1992,219295, ,NIA, , ,219295
MOLECULAR BASIS OF SENESCENCE IN BREAST EPITHELIAL CELLS,3122779,8/1/1992 0:00,5/31/1995 0:00, ,1993,254894, ,NIA, , ,254894
GROWTH DIFFERENTIATION CONTROL IN PRIMARY KERATINOCYTES,3159162,7/1/1988 0:00,6/30/1991 0:00, ,1988,155765, ,NIAMS, , ,155765
GROWTH DIFFERENTIATION CONTROL IN PRIMARY KERATINOCYTES,3159164,8/1/1991 0:00,2/29/1992 0:00, ,1991,49150, ,NIAMS, , ,49150
GROWTH DIFFERENTIATION CONTROL IN PRIMARY KERATINOCYTES,3159166,7/1/1988 0:00,6/30/1991 0:00, ,1989,149409, ,NIAMS, , ,149409
GROWTH DIFFERENTIATION CONTROL IN PRIMARY KERATINOCYTES,3159167,7/1/1988 0:00,2/29/1992 0:00, ,1990,152080, ,NIAMS, , ,152080
ONCOGENES IN HEMATOPOIETIC DIFFERENTIATION & NEOPLASIA,3163634,9/1/1978 0:00,8/31/1993 0:00, ,1990,120571, ,NCI, , ,120571
ONCOGENES IN HEMATOPOIETIC DIFFERENTIATION & NEOPLASIA,3163640,9/1/1978 0:00,8/31/1993 0:00, ,1991,92265, ,NCI, , ,92265
VIRAL GENE FUNCTIONS INVOLVED IN TRANSFORMATION,3163810,5/1/1978 0:00,4/30/1996 0:00, ,1991,238928, ,NCI, , ,238928
VIRAL GENE FUNCTIONS INVOLVED IN TRANSFORMATION,3163816,5/1/1978 0:00,4/30/1996 0:00, ,1992,248548, ,NCI, , ,248548
VIRAL GENE FUNCTIONS INVOLVED IN TRANSFORMATION,3163817,5/1/1978 0:00,4/30/1996 0:00, ,1993,258367, ,NCI, , ,258367
CHOLINE DEFICIENCY AND HEPATOCARCINOGENESIS,3166147,4/1/1978 0:00,11/30/1995 0:00, ,1992,267132, ,NCI, , ,267132
CHOLINE DEFICIENCY AND HEPATOCARCINOGENSIS,3166155,4/1/1978 0:00,11/30/1995 0:00, ,1993,239078, ,NCI, , ,239078
SUPPRESSOR GENES AND BREAST CANCER,3166747,5/1/1979 0:00,11/30/1997 0:00, ,1993,201293, ,NCI, , ,201293
GROWTH FACTORS AND LIVER TUMOR PROMOTION,3167082,7/1/1979 0:00,12/31/1994 0:00, ,1992,209951, ,NCI, , ,209951
GROWTH FACTORS AND LIVER TUMOR PROMOTION,3167089,7/1/1979 0:00,12/31/1994 0:00, ,1993,224401, ,NCI, , ,224401
DIFFERENTIATION & PROLIFERATION OF MYELOID CELLS,3167152,7/1/1979 0:00,12/31/1992 0:00, ,1988,135326, ,NCI, , ,135326
DIFFERENTIATION AND PROLIFERATION OF MYELOID CELLS,3167158,7/1/1979 0:00,12/31/1992 0:00, ,1989,165549, ,NCI, , ,165549
DIFFERENTIATION AND PROLIFERATION OF MYELOID CELLS,3167159,7/1/1979 0:00,12/31/1992 0:00, ,1990,196526, ,NCI, , ,196526
DIFFERENTIATION & PROLIFERATION OF MYELOID CELLS,3167160,7/1/1979 0:00,12/31/1992 0:00, ,1991,205076, ,NCI, , ,205076
DIFFERENTIATION & PROLIFERATION OF MYELOID CELLS,3167161,7/1/1979 0:00,9/30/1992 0:00, ,1992,127177, ,NCI, , ,127177
TRANSFORMATION IN VITRO OF HUMAN UROEPITHELIAL CELLS,3168732,2/1/1984 0:00,3/31/1997 0:00, ,1992,235314, ,NCI, , ,235314
TRANSFORMATION IN VITRO OF HUMAN UROEPITHELIAL CELLS,3168739,2/1/1984 0:00,3/31/1997 0:00, ,1993,241402, ,NCI, , ,241402
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,3169461,7/15/1981 0:00,3/31/1997 0:00, ,1993,217932, ,NCI, , ,217932
EXPERIMENTAL BLADDER TUMORS,3170407,9/19/1981 0:00,4/30/1997 0:00, ,1993,190745, ,NCI, , ,190745
CYTOSKELETAL HYBRIDOMA ANTIBODIES AS DIAGNOSTIC REAGENTS,3173785,3/1/1984 0:00,9/29/1996 0:00, ,1993,189302, ,NCI, , ,189302
SOMATIC GENETIC ALTERATIONS IN GASTROINTESTINAL CANCER,3176649,9/30/1988 0:00,2/28/1998 0:00, ,1993,137987, ,NCI, , ,137987
GENETIC EPIDEMIOLOGY OF CHILDHOOD SARCOMA,3177403,12/1/1984 0:00,7/31/1996 0:00, ,1993,465418, ,NCI, , ,465418
IN-VIVO MICROCAPSULE MONITORING OF CARCINOGENS,3178355,7/1/1988 0:00,8/31/1994 0:00, ,1991,109356, ,NCI, , ,109356
IN-VIVO MICROCAPSULE MONITORING OF CARCINOGENS,3178361,7/1/1988 0:00,8/31/1994 0:00, ,1992,92831, ,NCI, , ,92831
IN-VIVO MICROCAPSULE MONITORING OF CARCINOGENS,3178362,7/1/1988 0:00,8/31/1994 0:00, ,1993,93363, ,NCI, , ,93363
ACTIVATION OF P53 GENE IN TUMOR CELLS,3179418,8/1/1985 0:00,7/31/1988 0:00, ,1985,69721, ,NCI, , ,69721
ACTIVATION OF P53 GENE IN TUMOR CELLS,3179421,8/1/1985 0:00,11/30/1988 0:00, ,1988,25000, ,NCI, , ,25000
ACTIVATION OF P53 GENE IN TUMOR CELLS,3179422,8/1/1985 0:00,7/31/1988 0:00, ,1986,56953, ,NCI, , ,56953
ACTIVATION OF P53 GENE IN TUMOR CELLS,3179423,8/1/1985 0:00,11/30/1988 0:00, ,1987,65518, ,NCI, , ,65518
FUNCTIONAL ANALYSIS OF THE P53 CELLULAR TUMOR ANTIGEN,3179618,8/15/1985 0:00,7/30/1994 0:00, ,1991,91403, ,NCI, , ,91403
FUNCTIONAL ANALYSIS OF THE P53 CELLULAR TUMOR ANTIGEN,3179624,8/15/1985 0:00,7/30/1994 0:00, ,1992,100164, ,NCI, , ,100164
FUNCTIONAL  ANALYSIS OF THE P53 CELLULAR TUMOR ANTIGEN,3179625,8/15/1985 0:00,7/31/1994 0:00, ,1993,97140, ,NCI, , ,97140
FUNCTION OF QUIESCENT CELLS IN PEDIATRIC LEUKEMIA,3181661,4/1/1986 0:00,3/31/1989 0:00, ,1986,160168, ,NCI, , ,160168
FUNCTION OF QUIESCENT CELLS IN PEDIATRIC LEUKEMIA,3181662,4/1/1986 0:00,6/30/1992 0:00, ,1989,201302, ,NCI, , ,201302
THE FUNCTION OF QUIESCENT CELLS IN PEDIATRIC LEUKEMIA,3181663,4/1/1986 0:00,3/31/1989 0:00, ,1987,170860, ,NCI, , ,170860
FUNCTION OF QUIESCENT CELLS IN PEDIATRIC LEUKEMIA,3181664,4/1/1986 0:00,6/30/1989 0:00, ,1988,162922, ,NCI, , ,162922
FUNCTION OF QUIESCENT CELLS IN PEDIATRIC LEUKEMIA,3181665,4/1/1986 0:00,12/31/1990 0:00, ,1990,90195, ,NCI, , ,90195
FUNCTION OF QUIESCENT CELLS IN PEDIATRIC LEUKEMIA,3181666,4/1/1986 0:00,3/31/1994 0:00, ,1992,165846, ,NCI, , ,165846
THE P53 GENE IN HUMAN NEOPLASIA,3185639,8/1/1983 0:00,5/31/1996 0:00, ,1991,295649, ,NCI, , ,295649
P53 GENE IN HUMAN NEOPLASIA,3185644,8/1/1983 0:00,5/31/1996 0:00, ,1992,347148, ,NCI, , ,347148
THE P53 GENE IN HUMAN NEOPLASIA,3185645,8/1/1983 0:00,5/31/1996 0:00, ,1993,360088, ,NCI, , ,360088
EFFECTS OF RETINOIC ACID ON HUMAN NEUROBLASTOMA CELLS,3185698,5/1/1986 0:00,4/30/1988 0:00, ,1986,93612, ,NCI, , ,93612
EFFECTS OF RETINOIC ACID ON HUMAN NEUROBLASTOMA CELLS,3185701,5/1/1986 0:00,4/30/1988 0:00, ,1987,99165, ,NCI, , ,99165
CLONING AND CHARACTERIZATION OF THE RETINOBLASTOMA GENE,3187548,6/1/1987 0:00,5/31/1997 0:00, ,1992,266617, ,NCI, , ,266617
CLONING AND CHARACTERIZATION OF THE RETINOBLASTOMA GENE,3187549,6/1/1987 0:00,5/31/1997 0:00, ,1993,275158, ,NCI, , ,275158
MODIFICATION OF ONCOGENE EXPRESSION,3188216,7/1/1992 0:00,6/30/1995 0:00, ,1992,101328, ,NCI, , ,101328
MODIFICATION OF ONCOGENE EXPRESSION,3188218,7/1/1992 0:00,6/30/1995 0:00, ,1993,105382, ,NCI, , ,105382
TARGETED ONCOGENESIS AND DIABETES IN TRANSGENIC MICE,3188293,8/1/1987 0:00,7/31/1992 0:00, ,1987,288200, ,NCI, , ,288200
TARGETED ONCOGENESIS AND DIABETES,3188296,9/1/1988 0:00,7/31/1992 0:00, ,1989,236298, ,NCI, , ,236298
TARGETED ONCOGENESIS AND DIABETES,3188297,9/1/1988 0:00,7/31/1992 0:00, ,1990,235696, ,NCI, , ,235696
TARGETED ONCOGENESIS AND DIABETES,3188298,9/1/1988 0:00,7/31/1992 0:00, ,1991,249293, ,NCI, , ,249293
TARGETED ONCOGENESIS AND DIABETES IN TRANSGENIC MICE,3188300,9/1/1988 0:00,7/31/1992 0:00, ,1988,207038, ,NCI, , ,207038
INSTABILITY OF TUMOR PROMOTION IN HEPATOCARCINOGENESIS,3188911,9/1/1987 0:00,5/31/1997 0:00, ,1992,201103, ,NCI, , ,201103
INSTABILITY OF TUMOR PROMOTION IN HEPATOCARCINOGENESIS,3188916,9/1/1987 0:00,5/31/1997 0:00, ,1993,209147, ,NCI, , ,209147
MOLECULAR CYTOGENETICS--PEDIATRIC CNS TUMORS,3189499,1/13/1989 0:00,12/31/1996 0:00, ,1992,188181, ,NCI, , ,188181
MOLECULAR CYTOGENETICS: PEDIATRIC CNS TUMORS,3189502,1/13/1989 0:00,12/31/1996 0:00, ,1993,195709, ,NCI, , ,195709
MECHANISMS OF INDUCTION OF SKIN CANCERS BY UV LIGHT,3189794,7/1/1988 0:00,11/30/1995 0:00, ,1992,110372, ,NCI, , ,110372
MECHANISMS OF INDUCTION OF SKIN CANCERS BY UV LIGHT,3189799,7/1/1988 0:00,11/30/1995 0:00, ,1993,115045, ,NCI, , ,115045
ALTERED GROWTH REGULATION IN HUMAN LEUKEMIA,3190172,8/1/1988 0:00,5/31/1993 0:00, ,1989,114514, ,NCI, , ,114514
ALTERED GROWTH REGULATION IN HUMAN LEUKEMIA,3190173,8/1/1988 0:00,5/31/1993 0:00, ,1990,114867, ,NCI, , ,114867
ALTERED GROWTH REGULATION IN HUMAN LEUKEMIA,3190175,8/1/1988 0:00,1/31/1994 0:00, ,1992,127970, ,NCI, , ,127970
ALTERED GROWTH REGULATION IN HUMAN LEUKEMIA,3190176,8/1/1988 0:00,5/31/1993 0:00, ,1991,109190, ,NCI, , ,109190
PATHWAY OF TUMOR SUPPRESSION,3190836,7/1/1988 0:00,6/30/1997 0:00, ,1993,185841, ,NCI, , ,185841
TRANSGENIC MOUSE MODELS OF PANCREATIC CARCINOGENESIS,3190887,4/1/1988 0:00,3/31/1994 0:00, ,1991,251458, ,NCI, , ,251458
TRANSGENIC MOUSE MODELS OF PANCREATIC CARCINOGENESIS,3190892,4/1/1988 0:00,3/31/1994 0:00, ,1992,269918, ,NCI, , ,269918
POLYAMINES IN CELL GROWTH AND RESPONSES TO STRESS,3191022,9/30/1988 0:00,7/31/1993 0:00, ,1990,183882, ,NCI, , ,183882
POLYAMINES IN CELL GROWTH AND RESPONSES TO STRESS,3191023,9/30/1988 0:00,7/31/1993 0:00, ,1991,194411, ,NCI, , ,194411
POLYAMINES IN CELL GROWTH AND RESPONSES TO STRESS,3191024,9/30/1988 0:00,7/31/1994 0:00, ,1992,198896, ,NCI, , ,198896
MARKERS FOR METASTASIS AND RISK IN COLORECTAL CANCER,3191212,4/1/1988 0:00,11/30/1996 0:00, ,1992,214856, ,NCI, , ,214856
MARKERS FOR METASTASIS AND RISK IN COLORECTAL CANCER,3191215,4/1/1988 0:00,11/30/1996 0:00, ,1993,205316, ,NCI, , ,205316
COLONIC PUTATIVE PRENEOPLASTIC FOCI,3191931,7/1/1991 0:00,6/30/1995 0:00, ,1991,155720, ,NCI, , ,155720
COLONIC PUTATIVE PRENEOPLASTIC FOCI,3191934,7/1/1991 0:00,6/30/1995 0:00, ,1992,161949, ,NCI, , ,161949
COLONIC PUTATIVE PRENEOPLASTIC FOCI,3191935,7/1/1991 0:00,6/30/1995 0:00, ,1993,168425, ,NCI, , ,168425
TUMOR SUPPRESSOR GENE ON HUMAN CHROMOSOME 9P,3193093,1/13/1989 0:00,12/31/1996 0:00, ,1992,201250, ,NCI, , ,201250
A TUMOR SUPPRESSOR GENE ON HUMAN CHROMOSOME 9P,3193096,1/13/1989 0:00,6/30/1993 0:00, ,1993,195009, ,NCI, , ,195009
MOLECULAR EVENTS IN BLAST CRISIS OF CML,3194680,7/1/1989 0:00,4/30/1994 0:00, ,1989,173184, ,NCI, , ,173184
MOLECULAR EVENTS IN BLAST CRISIS OF CML,3194682,7/1/1989 0:00,4/30/1994 0:00, ,1990,185512, ,NCI, , ,185512
MOLECULAR EVENTS IN BLAST CRISIS OF CML,3194683,7/1/1989 0:00,4/30/1994 0:00, ,1991,189886, ,NCI, , ,189886
MOLECULAR EVENTS IN BLAST CRISIS OF CML,3194684,7/1/1989 0:00,4/30/1994 0:00, ,1992,197704, ,NCI, , ,197704
MECHANISM-PROGRESSION--ONCOGENE-INDUCED PROSTATE CANCER,3195151,9/8/1989 0:00,7/31/1996 0:00, ,1992,155742, ,NCI, , ,155742
MECHANISMS OF PROGRESSION IN ONCOGENE-INDUCED PROSTATE C,3195154,9/8/1989 0:00,7/31/1996 0:00, ,1993,158728, ,NCI, , ,158728
CHARACTERIZATION OF MOTILITY FACTOR RECEPTOR,3196349,8/1/1991 0:00,5/31/1994 0:00, ,1991,241405, ,NCI, , ,241405
CHARACTERIZATION OF MOTILITY FACTOR RECEPTOR,3196353,8/1/1991 0:00,5/31/1994 0:00, ,1992,238789, ,NCI, , ,238789
CHARACTERIZATION OF MOTILITY FACTOR RECEPTOR,3196354,8/1/1991 0:00,5/31/1994 0:00, ,1993,248342, ,NCI, , ,248342
PATHOLOGY IN ANTICANCER/CANCER SUPPRESSOR REGULATION,3196356,7/16/1991 0:00,6/30/1994 0:00, ,1991,209763, ,NCI, , ,209763
PATHOLOGY IN ANTICANCER/CANCER SUPPRESSOR REGULATION,3196358,7/16/1991 0:00,6/30/1994 0:00, ,1992,218153, ,NCI, , ,218153
PATHOLOGY IN ANTICANCER/CANCER SUPPRESSOR REGULATION,3196359,7/16/1991 0:00,6/30/1994 0:00, ,1993,226880, ,NCI, , ,226880
CYSTEINE CAPHEPSINS & HUMAN COLORECTAL TUMOR PROGRESSION,3196569,4/15/1993 0:00,3/31/1997 0:00, ,1993,174181, ,NCI, , ,174181
MAMMALIAN GENOME ORGANIZATION AND GENE AMPLIFICATION,3197326,7/1/1990 0:00,6/30/1998 0:00, ,1993,240929, ,NCI, , ,240929
LIGASE DEFICIENCY--A MODEL FOR DNA REPAIR SYNDROMES,3197532,8/1/1990 0:00,7/31/1996 0:00, ,1993,268193, ,NCI, , ,268193
DEVELOPMENTAL CONTROL OF ONCOGENE EXPRESSION,3197879,7/22/1992 0:00,6/30/1997 0:00, ,1992,214302, ,NCI, , ,214302
DEVELOPMENTAL CONTROL OF ONCOGENE EXPRESSION,3197880,7/22/1992 0:00,6/30/1997 0:00, ,1993,228914, ,NCI, , ,228914
FUNCTION OF THE ADENOVIRUS E1B ONCOGENE,3198114,1/1/1991 0:00,12/31/1995 0:00, ,1991,215463, ,NCI, , ,215463
FUNCTION OF THE ADENOVIRUS E1B ONCOGENE,3198115,1/1/1991 0:00,12/31/1995 0:00, ,1992,212574, ,NCI, , ,212574
FUNCTION OF THE ADENOVIRUS E1B ONCOGENE,3198116,1/1/1991 0:00,12/31/1995 0:00, ,1993,218462, ,NCI, , ,218462
TUMOR SUPPRESSOR GENES IN CHEMICALLY INDUCED SKIN TUMORS,3198377,1/1/1991 0:00,12/31/1995 0:00, ,1991,173542, ,NCI, , ,173542
TUMOR SUPPRESSOR GENES IN CHEMICALLY INDUCED SKIN TUMORS,3198378,1/1/1991 0:00,12/31/1995 0:00, ,1992,180269, ,NCI, , ,180269
TUMOR SUPPRESSOR GENES IN CHEMICALLY INDUCED SKIN TUMORS,3198379,1/1/1991 0:00,12/31/1995 0:00, ,1993,187480, ,NCI, , ,187480
PROTO-ONCOGENES IN MALIGNANT HEMATOPOIESIS,3198920,7/3/1991 0:00,6/30/1994 0:00, ,1991,176419, ,NCI, , ,176419
PROTO-ONCOGENES IN MALIGNANT HEMATOPOIESIS,3198922,7/3/1991 0:00,6/30/1994 0:00, ,1992,181568, ,NCI, , ,181568
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISM,3198974,4/17/1992 0:00,3/31/1997 0:00, ,1992,542791, ,NCI, , ,542791
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISM,3198975,4/17/1992 0:00,3/31/1997 0:00, ,1993,603065, ,NCI, , ,603065
TUMOR SUPPRESSOR P53 GENE IN VIRAL HEPATOCARCINOMA,3199143,9/25/1991 0:00,8/31/1995 0:00, ,1991,182164, ,NCI, , ,182164
TUMOR SUPPRESSOR P53 GENE IN VIRAL HEPATOCARCINOMA,3199144,9/25/1991 0:00,8/31/1995 0:00, ,1992,163534, ,NCI, , ,163534
TUMOR SUPPRESSOR P53 GENE IN VIRAL HEPATOCARCINOMA,3199145,9/25/1991 0:00,8/31/1995 0:00, ,1993,147372, ,NCI, , ,147372
RELATION OF HEPATITIS C VIRUS - HEPATOCELLULAR CARCINOMA,3199158,3/15/1992 0:00,2/28/1995 0:00, ,1992,168277, ,NCI, , ,168277
RELATION OF HEPATITIS C VIRUS - HEPATOCELLULAR CARCINOMA,3199159,3/15/1992 0:00,2/28/1995 0:00, ,1993,170085, ,NCI, , ,170085
PROTEIN PHOSPHATASE 2A IN TRANSFORMATION BY POLYOMA/SV40,3199244,5/6/1991 0:00,4/30/1995 0:00, ,1991,171690, ,NCI, , ,171690
PROTEIN PHOSPHATASE 2A IN TRANSFORMATION BY POLYOMA/SV40,3199245,5/6/1991 0:00,4/30/1995 0:00, ,1992,161487, ,NCI, , ,161487
PROTEIN PHOSPHATASE 2A IN TRANSFORMATION BY POLYOMA/SV40,3199246,5/6/1991 0:00,4/30/1995 0:00, ,1993,168852, ,NCI, , ,168852
INACTIVATED P53 GENE IN MICE,3199391,4/15/1992 0:00,3/31/1995 0:00, ,1992,197605, ,NCI, , ,197605
INACTIVATED P53 GENE IN MICE,3199392,4/15/1992 0:00,3/31/1995 0:00, ,1993,206101, ,NCI, , ,206101
ROLE OF P53 IN CELL PROLIFERATION,3199467,7/15/1991 0:00,6/30/1995 0:00, ,1991,128847, ,NCI, , ,128847
ROLE OF P53 IN CELL PROLIFERATION,3199468,7/15/1991 0:00,6/30/1995 0:00, ,1992,134773, ,NCI, , ,134773
ROLE OF P53 IN CELL PROLIFERATION,3199469,7/15/1991 0:00,6/30/1995 0:00, ,1993,147159, ,NCI, , ,147159
CLINICAL & MOLECULAR STUDIES ON AIDS-RELATED LYMPHOMAS,3200009,7/1/1991 0:00,6/30/1994 0:00, ,1991,207981, ,NCI, , ,207981
CLINICAL & MOLECULAR STUDIES ON AIDS-RELATED LYMPHOMAS,3200010,7/1/1991 0:00,6/30/1994 0:00, ,1992,201844, ,NCI, , ,201844
GENETIC ALTERATIONS IN CNS TUMOR DEVELOPMENT,3200247,5/1/1991 0:00,2/28/1995 0:00, ,1991,127508, ,NCI, , ,127508
GENETIC ALTERATIONS IN CNS TUMOR DEVELOPMENT,3200248,5/1/1991 0:00,2/28/1995 0:00, ,1992,141384, ,NCI, , ,141384
GENETIC ALTERATIONS IN CNS TUMOR DEVELOPMENT,3200249,5/1/1991 0:00,2/28/1995 0:00, ,1993,149009, ,NCI, , ,149009
SUNLIGHT-RELATED STEPS IN HUMAN SKIN CANCER,3200261,4/1/1992 0:00,3/31/1995 0:00, ,1992,158355, ,NCI, , ,158355
SUNLIGHT-RELATED STEPS IN HUMAN SKIN CANCER,3200262,4/1/1992 0:00,3/31/1995 0:00, ,1993,156914, ,NCI, , ,156914
ECOGENETICS OF LUNG CANCER IN MINORITY POPULATIONS,3200308,9/30/1991 0:00,8/31/1995 0:00, ,1991,138324, ,NCI, , ,138324
ECOGENETICS OF LUNG CANCER IN MINORITY POPULATIONS,3200311,9/30/1991 0:00,8/31/1995 0:00, ,1992,316526, ,NCI, , ,316526
ECOGENETICS OF LUNG CANCER IN MINORITY POPULATIONS,3200312,9/30/1991 0:00,8/31/1995 0:00, ,1993,340785, ,NCI, , ,340785
ROLE OF GERM LINE P53 MUTATIONS IN HUMAN CANCER,3200472,3/10/1992 0:00,2/28/1995 0:00, ,1992,325038, ,NCI, , ,325038
ROLE OF GERM LINE P53 MUTATIONS IN HUMAN CANCER,3200473,3/10/1992 0:00,2/28/1995 0:00, ,1993,309858, ,NCI, , ,309858
MOLECULAR MECHANISM OF HEMATOLOGICAL MALIGNANCY,3200563,3/4/1992 0:00,2/28/1996 0:00, ,1992,243354, ,NCI, , ,243354
MOLECULAR MECHANISM OF HEMATOLOGICAL MALIGNANCY,3200564,3/4/1992 0:00,2/28/1996 0:00, ,1993,248772, ,NCI, , ,248772
MUCIN GENES AND COLONIC CELL TRANSFORMATION,3200576,2/12/1992 0:00,1/31/1995 0:00, ,1992,167824, ,NCI, , ,167824
MUCIN GENES AND COLONIC CELL TRANSFORMATION,3200577,2/12/1992 0:00,1/31/1995 0:00, ,1993,174689, ,NCI, , ,174689
P53 MUTATIONAL SPECTRUM IN LUNG TUMORS FROM NONSMOKERS,3201128,1/1/1993 0:00,12/31/1995 0:00, ,1993,241455, ,NCI, , ,241455
P53 IN HUMAN BREAST CANCER,3201145,5/11/1992 0:00,4/30/1995 0:00, ,1992,189239, ,NCI, , ,189239
P53 IN HUMAN BREAST CANCER,3201146,5/11/1992 0:00,4/30/1995 0:00, ,1993,191413, ,NCI, , ,191413
"SITE-SPECIFIC GENE DAMAGE, MUTATION AND CANCER",3201209,1/1/1993 0:00,12/31/1996 0:00, ,1993,202197, ,NCI, , ,202197
ACTIONS OF THE P53 TUMOR SUPPRESSOR PROTEINS,3201248,5/1/1992 0:00,4/30/1995 0:00, ,1992,213499, ,NCI, , ,213499
ACTIONS OF THE P53 TUMOR SUPPRESSOR PROTEINS,3201249,5/1/1992 0:00,4/30/1995 0:00, ,1993,201185, ,NCI, , ,201185
P53 BREAST CANCER MUTATIONS IN HIGH AND LOW RISK GROUPS,3201300,8/5/1992 0:00,7/31/1997 0:00, ,1992,73748, ,NCI, , ,73748
P53 BREAST CANCER MUTATIONS IN HIGH AND LOW RISK GROUPS,3201301,8/5/1992 0:00,7/31/1997 0:00, ,1992,100000, ,NCI, , ,100000
P53 BREAST CANCER MUTATIONS IN HIGH AND LOW RISK GROUPS,3201303,8/5/1992 0:00,7/31/1994 0:00, ,1993,204631, ,NCI, , ,204631
TRANSFORMING FUNCTIONS OF MUTANT COLON CANCER ONCOGENES,3201506,7/15/1992 0:00,4/30/1996 0:00, ,1992,162805, ,NCI, , ,162805
TRANSFORMING FUNCTIONS OF MUTANT COLON CANCER ONCOGENES,3201507,7/15/1992 0:00,4/30/1996 0:00, ,1993,205531, ,NCI, , ,205531
RAS ONCOGENE ACTIVATION IN UVR-INDUCED CORNEAL TUMORS,3201709,9/30/1993 0:00,9/29/1996 0:00, ,1993,108027, ,NCI, , ,108027
P53 & FIBROCYSTIC DISEASE--INCREASED BREAST CANCER RISK,3201765,7/1/1992 0:00,6/30/1995 0:00, ,1992,243533, ,NCI, , ,243533
P53 & FIBROCYSTIC DISEASE: INCREASED BREAST CANCER RISK,3201766,7/1/1992 0:00,6/30/1995 0:00, ,1993,24976, ,NCI, , ,24976
P53 & FIBROCYSTIC DISEASE: INCREASED BREAST CANCER RISK,3201767,7/1/1992 0:00,2/28/1994 0:00, ,1993,140693, ,NCI, , ,140693
HPVS AND THE PATHOGENESIS OF VULVAR CARCINOMA,3201893,7/23/1992 0:00,6/30/1995 0:00, ,1992,202116, ,NCI, , ,202116
HPVS AND THE PATHOGENESIS OF VULVAR CARCINOMA,3201894,7/23/1992 0:00,6/30/1995 0:00, ,1993,209207, ,NCI, , ,209207
CYTOKINE/CHEMOTHERAPY COMBINATIONS IN MYELOID LEUKEMIA,3201993,8/17/1992 0:00,7/31/1995 0:00, ,1992,163929, ,NCI, , ,163929
CYTOKINE/CHEMOTHERAPY COMBINATIONS IN MYELOID LEUKEMIA,3201994,8/17/1992 0:00,7/31/1995 0:00, ,1993,170486, ,NCI, , ,170486
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN ASTROCYTOMAS,3202050,8/1/1992 0:00,7/31/1997 0:00, ,1992,288486, ,NCI, , ,288486
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN ASTROCYTOMAS,3202051,8/1/1992 0:00,7/31/1997 0:00, ,1993,284676, ,NCI, , ,284676
GENE CHANGES AND CHEMOTHERAPY FOR COLON CANCER,3202068,9/10/1992 0:00,7/31/1997 0:00, ,1992,143371, ,NCI, , ,143371
GENE CHANGES AND CHEMOTHERAPY FOR COLON CANCER,3202069,9/10/1992 0:00,7/31/1997 0:00, ,1993,159687, ,NCI, , ,159687
ONCOGENE SPECIFIC CYTOTOXIC T LYMPHOCYTES,3202193,8/7/1992 0:00,7/31/1997 0:00, ,1992,139278, ,NCI, , ,139278
ONCOGENE SPECIFIC CYTOTOXIC T LYMPHOCYTES,3202194,8/7/1992 0:00,7/31/1997 0:00, ,1993,140976, ,NCI, , ,140976
GENETIC AND HORMONAL FACTORS IN MAMMARY CARCINOGENESIS,3202283,8/14/1992 0:00,7/31/1995 0:00, ,1992,160939, ,NCI, , ,160939
GENETIC AND HORMONAL FACTORS IN MAMMARY CARCINOGENESIS,3202285,8/14/1992 0:00,7/31/1995 0:00, ,1993,174428, ,NCI, , ,174428
MOLECULARLY-DEFINED TAA AS HUMAN ANTI-TUMOR CTL TARGETS,3202302,8/1/1992 0:00,7/31/1997 0:00, ,1992,222591, ,NCI, , ,222591
MOLECULARLY-DEFINED TAA AS HUMAN ANTI-TUMOR CTL TARGETS,3202303,8/1/1992 0:00,7/31/1997 0:00, ,1993,218286, ,NCI, , ,218286
MOLECULAR PATHWAY TO PROSTATE CANCER,3202373,9/30/1992 0:00,9/29/1995 0:00, ,1992,205624, ,NCI, , ,205624
MOLECULAR PATHWAY TO PROSTATE CANCER,3202374,9/30/1992 0:00,9/29/1995 0:00, ,1993,206425, ,NCI, , ,206425
GENE TRANSFER FOR SUPPRESSION OF THE TUMOR PHENOTYPE,3202466,5/1/1992 0:00,4/30/1994 0:00, ,1992,163865, ,NCI, , ,163865
DORMANT LYMPHOMA CELLS (DLC) FROM MICE,3202473,2/3/1993 0:00,1/31/1996 0:00, ,1993,150886, ,NCI, , ,150886
ADENOVIRUS E3 PROTEINS AND TUMOR NECROSIS FACTOR,3202670,9/30/1993 0:00,8/31/1996 0:00, ,1993,104915, ,NCI, , ,104915
P53-GUANINE NUCLEOTIDE REGULATOR,3202766,1/1/1993 0:00,12/31/1995 0:00, ,1993,232512, ,NCI, , ,232512
PATHOLOGY OF GASTRIC CANCER,3202858,2/1/1993 0:00,1/31/1998 0:00, ,1993,158150, ,NCI, , ,158150
LOSS OF HETEROZYGOSITY IN BILATERAL BREAST CANCER,3202946,8/13/1993 0:00,7/31/1994 0:00, ,1993,205596, ,NCI, , ,205596
CATIONIC LIPOSOME-BASED GENE THERAPY FOR LUNG CANCER,3203011,7/1/1993 0:00,6/30/1996 0:00, ,1993,152055, ,NCI, , ,152055
SPONTANEOUS TRANSFORMATION OF HEPATIC STEM CELLS,3203267,4/16/1993 0:00,3/31/1998 0:00, ,1993,171207, ,NCI, , ,171207
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,3203477,6/1/1993 0:00,5/31/1998 0:00, ,1993,286457, ,NCI, , ,286457
FACTORS AFFECTING SURVIVAL OF YOUNG CANCER PATIENTS,3203510,6/5/1993 0:00,5/31/1998 0:00, ,1993,272163, ,NCI, , ,272163
RECESSIVE MUTATIONS IN THE GENESIS OF PROSTATE CANCER,3203969,9/30/1992 0:00,9/29/1996 0:00, ,1992,179290, ,NCI, , ,179290
RECESSIVE MUTATIONS IN THE GENESIS OF PROSTATE CANCER,3203970,9/30/1992 0:00,9/29/1996 0:00, ,1993,174768, ,NCI, , ,174768
CHROMOSOME 17 IN THE EARLY STAGES OF OVARIAN CANCER,3204150,8/1/1993 0:00,7/31/1997 0:00, ,1993,166135, ,NCI, , ,166135
HPV AND OTHER FACTORS IN ORAL CARCINOGENESIS,3223710,9/30/1992 0:00,9/29/1996 0:00, ,1992,134424, ,NIDCR, , ,134424
HPV AND OTHER FACTORS IN ORAL CARCINOGENESIS,3223711,9/30/1992 0:00,9/29/1996 0:00, ,1993,140745, ,NIDCR, , ,140745
BIOMARKERS AS A GUIDE TO SURGICAL MANAGEMENT AND THERAPY,3246881,9/30/1992 0:00,9/29/1997 0:00, ,1992,140259, ,NIDDK, , ,140259
BIOMARKERS AS A GUIDE TO SURGICAL MANAGEMENT AND THERAPY,3246882,9/30/1992 0:00,9/29/1997 0:00, ,1993,134393, ,NIDDK, , ,134393
NEOPLASTIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE,3248902,9/30/1993 0:00,8/31/1997 0:00, ,1993,193505, ,NIDDK, , ,193505
POLYAMINES AND CHEMICAL CARCINOGENESIS,3249570,7/1/1981 0:00,3/31/1998 0:00, ,1993,197289, ,NIEHS, , ,197289
BIOLOGICAL MONITORING FOR EXPOSURE TO AFLATOXIN,3253352,1/1/1990 0:00,6/30/1996 0:00, ,1993,190560, ,NIEHS, , ,190560
PLEURAL DOSIMETRY AND BIOMARKERS OF RESPONSE TO FIBERS,3253998,5/1/1992 0:00,4/30/1996 0:00, ,1992,257503, ,NIEHS, , ,257503
PLEURAL DOSIMETRY AND BIOMARKERS OF RESPONSE TO FIBERS,3253999,5/1/1992 0:00,4/30/1996 0:00, ,1993,207839, ,NIEHS, , ,207839
ROLE OF P53 IN THE CELLULAR RESPONSE TO DNA DAMAGE,3254099,1/1/1992 0:00,12/31/1996 0:00, ,1992,191428, ,NIEHS, , ,165933
ROLE OF P53 IN THE CELLULAR RESPONSE TO DNA DAMAGE,3254100,1/1/1992 0:00,12/31/1996 0:00, ,1993,201781, ,NIEHS, , ,177516
MOLECULAR EPIDEMIOLOGY OF BLADDER CANCER,3254906,8/1/1993 0:00,7/31/1996 0:00, ,1993,239950, ,NIEHS, , ,239950
RB PROTEIN INACTIVATION IN THE RETINA OF TRANSGENIC MICE,3266580,8/1/1991 0:00,7/31/1996 0:00, ,1991,161963, ,NEI, , ,161963
RB PROTEIN INACTIVATION IN THE RETINA OF TRANSGENIC MICE,3266581,8/1/1991 0:00,7/31/1996 0:00, ,1992,164119, ,NEI, , ,164119
RB PROTEIN INACTIVATION IN THE RETINA OF TRANSGENIC MICE,3266582,8/1/1991 0:00,7/31/1996 0:00, ,1993,159071, ,NEI, , ,159071
MECHANISMS & REGULATION OF MAMMALIAN GENE AMPLIFICATION,3308704,9/1/1993 0:00,8/31/1997 0:00, ,1993,268713, ,NIGMS, , ,268713
MECHANISMS OF TGF BETA AUTOCRINE REGULATION OF GLIOMAS,3417528,5/1/1992 0:00,3/31/1996 0:00, ,1992,184793, ,NINDS, , ,184793
MECHANISMS OF TGF BETA AUTOCRINE REGULATION OF GLIOMAS,3417530,5/1/1992 0:00,3/31/1996 0:00, ,1993,163916, ,NINDS, , ,163916
MOLECULAR GENETIC FINDINGS IN COLORECTAL CANCER,3423355,8/15/1991 0:00,7/31/1993 0:00, ,1991,79200, ,NCI, , ,79200
MOLECULAR GENETIC FINDINGS IN COLORECTAL CANCER,3423356,8/15/1991 0:00,7/31/1993 0:00, ,1992,70240, ,NCI, , ,70240
BLADDER CANCER--SUPPESSOR GENES AND RADIATION RESPONSE,3423709,4/2/1992 0:00,3/31/1994 0:00, ,1992,46172, ,NCI, , ,46172
RESOURCE DEVELOPMENT FOR GENETIC STUDY OF BREAST CANCE,3423717,3/9/1992 0:00,7/31/1993 0:00, ,1992,73290, ,NCI, , ,73290
GENE EXPRESSION IN DUKE'S AND C COLORECTAL CANCER,3423724,9/26/1991 0:00,8/31/1994 0:00, ,1993,69293, ,NCI, , ,69293
GENETIC EPIDEMIOLOGY OF IN SITU BREAST CANCER,3423857,9/30/1992 0:00,9/29/1993 0:00, ,1992,82000, ,NCI, , ,82000
THE P53 WORKSHOP,3434158,6/1/1991 0:00,5/31/1992 0:00, ,1991,5000, ,NCI, , ,5000
CONFERENCE ON BREAST AND PROSTATE CANCER,3434209,1/1/1992 0:00,12/31/1992 0:00, ,1992,10000, ,NCI, , ,10000
JOINT CONFERENCE ON NEGATIVE AND POSITIVE GROWTH CONTROL,3434211,1/7/1992 0:00,12/31/1992 0:00, ,1992,5000, ,NCI, , ,5000
MOLECULAR AND GENETIC BASIS FOR CELL PROLIFERATION,3434231,8/1/1991 0:00,7/31/1992 0:00, ,1991,2000, ,NCI, , ,2000
PEPTIDE GROWTH FACTORS IN HUMAN PROSTATE CARCINOGENESIS,3459569,9/30/1989 0:00,8/31/1994 0:00, ,1989,78991, ,NCI, , ,78991
PEPTIDE GROWTH FACTORS IN HUMAN PROSTATE CARCINOGENESIS,3459570,9/30/1989 0:00,8/31/1994 0:00, ,1990,79275, ,NCI, , ,79275
PEPTIDE GROWTH FACTORS IN HUMAN PROSTATE CARCINOGENESIS,3459571,9/30/1989 0:00,8/31/1994 0:00, ,1991,82698, ,NCI, , ,82698
PEPTIDE GROWTH FACTORS IN HUMAN PROSTATE CARCINOGENESIS,3459572,9/30/1989 0:00,8/31/1994 0:00, ,1992,88926, ,NCI, , ,88926
PEPTIDE GROWTH FACTORS IN HUMAN PROSTATE CARCINOGENESIS,3459573,9/30/1989 0:00,8/31/1994 0:00, ,1993,92376, ,NCI, , ,92376
MOLECULAR GENETICS OF HUMAN ASTROCYTOMA,3460000,7/1/1990 0:00,6/30/1995 0:00, ,1990,62865, ,NCI, , ,62865
MOLECULAR GENETICS OF HUMAN ASTROCYTOMA,3460001,7/1/1990 0:00,6/30/1995 0:00, ,1991,92100, ,NCI, , ,92100
MOLECULAR GENETICS OF HUMAN ASTROCYTOMA,3460002,7/1/1990 0:00,6/30/1995 0:00, ,1992,93555, ,NCI, , ,93555
MOLECULAR GENETICS OF HUMAN ASTROCYTOMA,3460003,7/1/1990 0:00,6/30/1995 0:00, ,1993,94185, ,NCI, , ,94185
BIOLOGY AND MECHANISM OF AAV REP78 ANTIPROLIFERATION,3460301,4/1/1993 0:00,3/31/1998 0:00, ,1993,91846, ,NCI, , ,91846
MOLECULAR PATHOGENESIS OF TUMORS IN NEUROFIBROMATOSIS,3460314,7/5/1991 0:00,6/30/1996 0:00, ,1991,99353, ,NCI, , ,99353
MOLECULAR PATHOGENESIS OF TUMORS IN NEUROFIBROMATOSIS,3460315,7/5/1991 0:00,6/30/1996 0:00, ,1992,103092, ,NCI, , ,103092
MOLECULAR PATHOGENESIS OF TUMORS IN NEUROFIBROMATOSIS,3460316,7/5/1991 0:00,6/30/1996 0:00, ,1993,108850, ,NCI, , ,108850
TUMOR SUPPRESSOR GENE INACTIVATION IN PROSTATE CANCER,3460336,7/1/1991 0:00,5/31/1996 0:00, ,1991,92558, ,NCI, , ,92558
TUMOR SUPPRESSOR GENE INACTIVATION IN PROSTATE CANCER,3460337,7/1/1991 0:00,5/31/1996 0:00, ,1992,107760, ,NCI, , ,107760
TUMOR SUPPRESSOR GENE INACTIVATION IN PROSTATE CANCER,3460338,7/1/1991 0:00,5/31/1996 0:00, ,1993,116202, ,NCI, , ,116202
GROWTH REGULATION & TRANSFORMATION OF OVARIAN EPITHELIUM,3460390,2/1/1992 0:00,1/30/1997 0:00, ,1992,106400, ,NCI, , ,106400
GROWTH REGULATION & TRANSFORMATION OF OVARIAN EPITHELIUM,3460391,2/1/1992 0:00,1/31/1997 0:00, ,1993,105560, ,NCI, , ,105560
HUMAN MAMMARY EPITHELIAL CELL IMMORTALIZATION,3460501,4/1/1992 0:00,3/31/1997 0:00, ,1992,89624, ,NCI, , ,89624
HUMAN MAMMARY EPITHELIAL CELL IMMORTALIZATION,3460502,4/1/1992 0:00,3/31/1997 0:00, ,1993,126566, ,NCI, , ,126566
BIOCHEMICAL ROLE OF THE P53 GENE PRODUCT IN HUMAN CANCER,3460548,9/1/1993 0:00,7/31/1998 0:00, ,1993,98471, ,NCI, , ,98471
REGULATION OF MULTIDRUG RESISTANCE GENE EXPRESSION,3460632,1/1/1993 0:00,12/31/1997 0:00, ,1993,96348, ,NCI, , ,96348
MUTATION-INDEPENDENT ALTERATION OF P53 IN BREAST CANCER,3460812,9/15/1993 0:00,8/31/1998 0:00, ,1993,96917, ,NCI, , ,96917
ANTIONCOGENES IN CARCINOGEN-INDUCED PANCREATIC CANCER,3460822,7/1/1993 0:00,6/30/1998 0:00, ,1993,111384, ,NCI, , ,111384
REGULATION AND FUNCTION OF PP54 MAP 2 KINASE,3468635,8/1/1991 0:00,7/31/1996 0:00, ,1991,124028, ,NIGMS, , ,124028
REGULATION AND FUNCTION OF PP54 MAP 2 KINASE,3468636,8/1/1991 0:00,7/31/1996 0:00, ,1992,129783, ,NIGMS, , ,129783
REGULATION AND FUNCTION OF PP54 MAP 2 KINASE,3468637,8/1/1991 0:00,7/31/1996 0:00, ,1993,125651, ,NIGMS, , ,125651
TRANSFORMING GROWTH FACTORS IN NEOPLASTIC TRANSFORMATION,3479451,7/1/1986 0:00,6/30/2000 0:00, ,1993,691657, ,NCI, , ,691657
RNA TUMOR VIRUS-HEMATOPOIETIC CELL INTERACTION,3482287,6/1/1983 0:00,3/31/1998 0:00, ,1993,254334, ,NCI, , ,254334
VIRAL TRANSGENE-ONCOGENE INDUCED TUMORIGENESIS,3482419,12/1/1984 0:00,11/30/1994 0:00, ,1990,174904, ,NCI, , ,174904
VIRAL TRANSGENE-ONCOGENE INDUCED TUMORIGENESIS,3482420,12/1/1984 0:00,11/30/1994 0:00, ,1991,174989, ,NCI, , ,174989
VIRAL TRANSGENE-ONCOGENE INDUCED TUMORIGENESIS,3482421,12/1/1984 0:00,11/30/1994 0:00, ,1992,181987, ,NCI, , ,181987
VIRAL TRANSGENE-ONCOGENE INDUCED TUMORIGENESIS,3482422,12/1/1984 0:00,11/30/1994 0:00, ,1993,189105, ,NCI, , ,189105
DNA PHOTOLESION STRUCTURE-ACTIVITY RELATIONSHIPS,3482471,7/1/1985 0:00,4/30/1998 0:00, ,1993,249250, ,NCI, , ,249250
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,3482550,1/1/1987 0:00,12/31/1995 0:00, ,1991,230761, ,NCI, , ,230761
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,3482551,1/1/1987 0:00,12/31/1995 0:00, ,1992,243784, ,NCI, , ,243784
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,3482552,1/1/1987 0:00,12/31/1995 0:00, ,1993,247798, ,NCI, , ,247798
MABS SPECIFIC TO HUMAN TUMOR SUPPRESSOR PROTEIN P53,3492684,2/1/1991 0:00,12/31/1991 0:00, ,1991,50000, ,NCI, , ,50000
MABS TO TUMOR SUPPRESSOR GENE DCC-ENCODED PROTEIN,3493016,2/6/1992 0:00,7/31/1992 0:00, ,1992,50000, ,NCI, , ,50000
MUTANT P53 PROTEINS IN CANCER PATIENT AND NORMAL SERA,3493125,7/1/1992 0:00,12/31/1992 0:00, ,1992,46357, ,NCI, , ,46357
TRANSCRIPTION REGULATOR MUTATIONS IN PROSTATE CANCER,3546485,7/20/1992 0:00,6/30/1996 0:00, ,1992,235082, ,NIA, , ,235082
TRANSCRIPTION REGULATOR MUTATIONS IN PROSTATE CANCER,3546486,7/20/1992 0:00,6/30/1996 0:00, ,1993,245133, ,NIA, , ,245133
MARKERS FOR DIAGNOSIS AND PROGNOSIS OF BLADDER CANCER,3549118,5/15/1988 0:00,3/31/1996 0:00, ,1992,117643, ,NCI, , ,117643
MARKERS FOR DIAGNOSIS AND PROGNOSIS OF BLADDER CANCER,3549119,5/15/1988 0:00,3/31/1996 0:00, ,1993,146821, ,NCI, , ,146821
MARKERS FOR BLADDER CANCER DIAGNOSIS AND PROGNOSIS,3549839,5/1/1992 0:00,3/31/1996 0:00, ,1992,136380, ,NCI, , ,136380
MARKERS FOR BLADDER CANCER DIAGNOSIS AND PROGNOSIS,3549840,5/1/1992 0:00,3/31/1996 0:00, ,1993,160170, ,NCI, , ,160170
MARKERS FOR MALIGNANT PROGRESSION IN PROSTATE CANCER,3549858,7/23/1992 0:00,6/30/1996 0:00, ,1992,174092, ,NCI, , ,174092
MARKERS FOR MALIGNANT PROGRESSION IN PROSTATE CANCER,3549859,7/23/1992 0:00,6/30/1996 0:00, ,1993,162227, ,NCI, , ,162227
MOLECULAR EXPRESSION ANALYSIS IN PROSTATE CANCER,3549866,7/20/1992 0:00,6/30/1996 0:00, ,1992,127661, ,NCI, , ,127661
MOLECULAR EXPRESSION ANALYSIS IN PROSTATE CANCER,3549867,7/20/1992 0:00,6/30/1996 0:00, ,1993,33398, ,NCI, , ,33398
GENETIC LOCI ASSOCIATED WITH PROSTATE CANCER DEVELOPMENT,3549873,7/17/1992 0:00,6/30/1996 0:00, ,1992,124776, ,NCI, , ,124776
GENETIC LOCI ASSOCIATED WITH PROSTATE CANCER DEVELOPMENT,3549874,7/17/1992 0:00,3/31/1994 0:00, ,1993,81611, ,NCI, , ,81611
DNA STUDIES & P53 GENE ABNORMALITIES IN PROSTATE CANCER,3550070,7/1/1993 0:00,6/30/1997 0:00, ,1993,142099, ,NCI, , ,142099
DNA STUDIES & P53 GENE ABNORMALITIES IN PROSTATE CANCER,3550071,7/1/1993 0:00,6/30/1997 0:00, ,1994,10800, ,NCI, , ,10800
MOLECULAR GENETICS AND ADJUVANT THERAPY OF COLON CANCER,3550073,8/9/1993 0:00,7/31/1997 0:00, ,1993,198481, ,NCI, , ,198481
RB1 AND P53 LOSS IN PROGNOSIS OF PEDIATRIC OSTEOSARCOMA,3550091,12/15/1993 0:00,7/31/1994 0:00, ,1993,94832, ,NCI, , ,94832
LABORATORY-CLINICAL CORRELATIVE STUDIES IN LUNG CANCER,3550093,9/30/1993 0:00,9/29/1996 0:00, ,1993,216248, ,NCI, , ,216248
TUMOR SUPPRESSOR GENES IN ADULT ALL,3550136,9/30/1993 0:00,8/31/1997 0:00, ,1993,157518, ,NCI, , ,157518
DES AND CANCER OF VAGINA/CERVIX--COLLABORATIVE STUDIES,3550235,9/30/1993 0:00,9/29/1997 0:00, ,1993,445040, ,NCI, , ,445040
CANCER AND LEUKEMIA GROUP B--CORRELATIVE SCIENCES,3557943,4/1/1984 0:00,3/31/1998 0:00, ,1993,894853, ,NCI, , ,894853
GENE EXPRESSION IN DUKE'S B AND C COLORECTAL CANCER,3566197,9/28/1990 0:00,9/27/1992 0:00, ,1990,76320, ,NCI, , ,76320
ENVIRONMENTAL AND GENETIC DETERMINANTS OF BREAST CANCER,3567977,9/30/1993 0:00,9/29/1997 0:00, ,1993,305154, , , , , 
PULMONARY EFFECTS OF HABITUAL USE OF MARIJUANA,3569291,7/1/1982 0:00,6/30/2001 0:00, ,1997,466681, ,NIDA, , ,466681
'STUDIES OF PROGNOSTIC MARKERS FOR,3603594,9/30/1992 0:00,9/29/1994 0:00,R and D Contracts,1992,296757, ,NCI, , ,296757
SUPPORT SERVICES FOR OCCUPATIONAL STUDIES,3701690,2/15/1993 0:00,1/31/1997 0:00,R and D Contracts,1993,1205437, ,NCI, , ,1205437
SUPPORT SERVICES FOR OCCUPATIONAL STUDIES,3701693,2/15/1993 0:00, ,R and D Contracts,1994,824879, ,NCI, , ,824879
SUPPORT SERVICES FOR OCCUPATIONAL STUDIES,3701696,2/1/1993 0:00, ,R and D Contracts,1995,1270018, ,NCI, , ,1270018
ROLE OF E7 IN HPV INFECTIONS,3727348, , , ,1995, , , , , , 
P21 (WAF1/CIP1) IN KERATINOCYTE GROWTH REGULATION FOLLOWING DNA DAMAGE,3728200, , , ,1995, , , , , , 
TRANSFORMING GROWTH FACTOR BETA REGULATION OF MAMMARY CELL PROLIFERATION,3728326, , , ,1995, , , , , , 
MOLECULAR ANALYSIS OF CELLULAR RESPONSE TO RADIATION--G1/S TRANSITION,3728731, , , ,1995, , , , , , 
CELL AND MOLECULAR BIOLOGY OF RAT HEPATOCARCINOGENESIS,3729264, , , ,1995, , , , , , 
GENETIC ALTERATIONS DURING GASTRIC TUMOR DEVELOPMENT,3729699, , , ,1995, , , , , , 
"GENETIC ALTERATIONS IN ADENOMATOUS POLYPS--DIETARY FIBER, FAT, AND BILE ACIDS",3730445, , , ,1995, , , , , , 
CYCLE-DEPENDENT MECHANISMS OF CHEMICAL CLASTOGENESIS,3730695, , , ,1995, , , , , , 
HUMAN PAPILLOMAVIRUS AND PROGNOSIS OF FEMALE ANOGENITAL CANCER,3730701, , , ,1995, , , , , , 
FLOW CYTOMETRY IN PROSTATE CANCER,3731349, , , ,1995, , , , , , 
MOLECULAR ANALYSIS OF HUMAN CARCINOMA OF THE PROSTATE,3731350, , , ,1995, , , , , , 
DNA PLOIDY AND MOLECULAR MARKERS OF PROSTATE CANCER,3731461, , , ,1995, , , , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,3731462, , , ,1995, , , , , , 
COMPLEMENTATION OF P53 MUTATION IN ONCOGENE INDUCED PROSTATE CANCER,3731465, , , ,1995, , , , , , 
CONSEQUENCES OF TARGETET GENE EXPRESSION TO THE PROSTATE,3731467, , , ,1995, , , , , , 
CAROLINA BREAST CANCER STUDY,3731487, , , ,1995, , , , , , 
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY,3731488, , , ,1995, , , , , , 
RISK FACTORS FOR ORAL EPIDERMOID CARCINOMA IN MINORITIES,3732628, , , ,1995, , , , , , 
MOLECULAR BIOMARKERS OF OCCUPATIONAL BENZENE EXPOSURE,3733714, , , ,1995, , , , , , 
ARSENIC BIOMARKER EPIDEMIOLOGY,3733718, , , ,1995, , , , , , 
DETECTION OF MUTATIONS IN HUMAN LUNGS,3733965, , , ,1995, , , , , , 
GENETIC ALTERATIONS OF ADENOVIRUSES,3734205, , , ,1995, , , , , , 
TUMOR SUPPRESSOR GENES IN HUMAN MEDULLOBLASTOMA,3738356, , , ,1995, , , , , , 
VITAMINS E AND C--INCREASE AND DECREASE THE RISK OF ASTROCYTOMA,3739060, , , ,1995, , , , , , 
HUMAN OVARIAN CANCER AND P53,3742573, , , ,1995, , , , , , 
VACCINATION AGAINST TUMOR SPECIFIC MUTANT RAS AND P53 PEPTIDES IN CANCER,3742843, , , ,1995, , , , , , 
GENE MAPPING AND ALLELIC ASSOCIATIONS WITH CANCER,3745101, , , ,1995, , , , , , 
DNA REPAIR IN CANCER AND SENESCENCE,3745542, , ,Intramural Research,1994, , , , , , 
GENOMIC INSTABILITY,3745544, , ,Intramural Research,1994, , , , , , 
CONTROL OF C-MYC TRANSCRIPTION BY P107,3748030, , , ,1994, , , , , , 
TRANSFORMING GROWTH FACTOR BETA REGULATION OF MAMMARY CELL PROLIFERATION,3748384, , , ,1994, , , , , , 
MOLECULAR ANALYSIS OF CELLULAR RESPONSE TO RADIATION--G1/S TRANSITION,3748811, , , ,1994, , , , , , 
CELL AND MOLECULAR BIOLOGY OF RAT HEPATOCARCINOGENESIS,3749352, , , ,1994, , , , , , 
GENETIC ALTERATIONS DURING GASTRIC TUMOR DEVELOPMENT,3749788, , , ,1994, , , , , , 
FLOW CYTOMETRY IN PROSTATE CANCER,3751588, , , ,1994, , , , , , 
MOLECULAR ANALYSIS OF HUMAN CARCINOMA OF THE PROSTATE,3751589, , , ,1994, , , , , , 
DNA PLOIDY AND MOLECULAR MARKERS OF PROSTATE CANCER,3751708, , , ,1994, , , , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,3751709, , , ,1994, , , , , , 
COMPLEMENTATION OF P53 MUTATION IN ONCOGENE INDUCED PROSTATE CANCER,3751712, , , ,1994, , , , , , 
CONSEQUENCES OF TARGETET GENE EXPRESSION TO THE PROSTATE,3751714, , , ,1994, , , , , , 
"ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS",3752001, , ,Intramural Research,1994, , , , , , 
MOLECULAR BIOLOGY OF PROGRESSION IN LYMPHOPROLIFERATIVE DISEASES,3752087, , ,Intramural Research,1994, , , , , , 
P53 MUTATIONS IN BREAST CANCER WITH C-ERBB2,3752115, , ,Intramural Research,1994, , , , , , 
BIOLOGY OF SOLID PEDIATRIC TUMORS,3752118, , ,Intramural Research,1994, , , , , , 
TIMP-1 EXPRESSION BY NORMAL LYMPHOCYTES AND IN LYMPHOID NEOPLASMS,3752120, , ,Intramural Research,1994, , , , , , 
GENE EXPRESSION AND GENE THERAPY IN HUMAN BREAST CANCER,3752346, , ,Intramural Research,1994, , , , , , 
MOLECULAR GENETIC EVENTS IN LUNG CANCER,3752360, , ,Intramural Research,1994, , , , , , 
STUDIES ON THE TREATMENT AND CHARACTERISTICS OF THORACIC MALIGNANCIES,3752366, , ,Intramural Research,1994, , , , , , 
BIOLOGY AND TREATMENT OF NONHODGKIN'S LYMPHOMA,3752392, , ,Intramural Research,1994, , , , , , 
MOLECULAR BIOLOGY OF PEDIATRIC SARCOMAS,3752394, , ,Intramural Research,1994, , , , , , 
MOLECULAR BIOLOGY OF CELLULAR INJURY,3752398, , ,Intramural Research,1994, , , , , , 
POLYPEPTIDE INHIBITORS OF CELL CYCLE PROLIFERATION,3752452, , ,Intramural Research,1994, , , , , , 
CELL CYCLE CHECKPOINTS AND CHEMOSENSITIVITY OF HUMAN CANCER CELLS,3752454, , ,Intramural Research,1994, , , , , , 
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY,3752553, , ,Intramural Research,1994, , , , , , 
CELLULAR DIFFERENTIATION IN NORMAL AND NEOPLASTIC RESPIRATORY EPITHELIUM,3752560, , ,Intramural Research,1994, , , , , , 
RATIONAL APPLICATION OF BIOMARKERS IN CLINICAL TRIALS,3752562, , ,Intramural Research,1994, , , , , , 
THE MOLECULAR GENETICS OF GYNECOLOGIC CANCERS,3752572, , ,Intramural Research,1994, , , , , , 
EVALUATION OF MARKERS FOR THE EARLY DETECTION OF LUNG CANCER,3752574, , ,Intramural Research,1994, , , , , , 
MECHANISMS OF DIET AND CHEMOPREVENTION IN P53-KNOCKOUT TRANSGENIC MICE,3752581, , ,Intramural Research,1994, , , , , , 
DEVELOPMENT OF MOLECULAR MARKERS FOR EARLY DETECTION OF EPITHELIAL TUMORS,3752584, , ,Intramural Research,1994, , , , , , 
ROLE OF HUMAN PAPILLOMAVIRUSES IN HUMAN CARCINOGENESIS,3752590, , ,Intramural Research,1993, , , , , , 
CLINICAL EPIDEMIOLOGY OF CANCER,3752596, , ,Intramural Research,1994, , , , , , 
MODEL SYSTEMS FOR STUDY OF CHEMICAL CARCINOGENESIS AT THE CELLULAR LEVEL,3752603, , ,Intramural Research,1994, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN LUNG CANCER,3752664, , ,Intramural Research,1994, , , , , , 
TUMOR SUPPRESSION GENES IN HUMAN CARCINOGENESIS,3752679, , ,Intramural Research,1994, , , , , , 
IN VITRO STUDIES OF HUMAN MESOTHELIAL CELL CARCINOGENESIS,3752700, , ,Intramural Research,1994, , , , , , 
CHARACTERIZATION OF BREAST CANCER SPECIFIC NOVEL GENES,3752718, , ,Intramural Research,1994, , , , , , 
TUMOR SUPPRESSOR GENES IN HUMAN HEPATOCELLULAR CARCINOMA,3752737, , ,Intramural Research,1994, , , , , , 
STUDIES ON THE MAMMARY CARCINOGENICITY OF FOOD-DERIVED HETEROCYCLIC AMINES,3752767, , ,Intramural Research,1994, , , , , , 
MOLECULAR EPIDEMIOLOGY OF BREAST CANCER,3752780, , ,Intramural Research,1994, , , , , , 
BIOMARKERS FOR ORAL CANCER,3753598, , ,Intramural Research,1994, , , , , , 
HUMAN OVARIAN CANCER AND P53 GENE,3754515, , , ,1994, , , , , , 
"IN VIVO DAMAGE, REPAIR, AND MUTAGENESIS OF CANCER GENES",3755047, , , ,1994, , , , , , 
DETECTION OF MUTATIONS IN HUMAN LUNGS,3755342, , , ,1994, , , , , , 
MOLECULAR ANALYSIS OF CELL CYCLE CONTROL DURING CARCINOGENESIS,3755377, , ,Intramural Research,1993, , , , , , 
MOLECULAR GENETICS OF HUMAN GYNECOLOGIC PATHOLOGY,3755408, , ,Intramural Research,1994, , , , , , 
MECHANISMS OF ACTION OF TUMOR SUPPRESSOR PROTEINS,3755411, , ,Intramural Research,1994, , , , , , 
MOLECULAR EPIDEMIOLOGY OF CANCER SUSCEPTIBILITY AND ONCOGENE ACTIVATION,3755437, , ,Intramural Research,1994, , , , , , 
GENETIC ABNORMALITIES IN PRIMARY GLIAL TUMORS,3760308, , ,Intramural Research,1994, , , , , , 
TUMOR SUPPRESSOR GENES IN HUMAN MEDULLOBLASTOMA,3760711, , , ,1994, , , , , , 
INTERACTION OF RECESSIVE AND DOMINANT ONCOGENES,3761060, , , ,1994, , , , , , 
GENE MAPPING AND ALLELIC ASSOCIATIONS WITH CANCER,3767413, , , ,1994, , , , , , 
HUMAN COLON CANCER BIOLOGY,3770376, , ,Intramural Research,1993, , , , , , 
FLOW CYTOMETRY IN PROSTATE CANCER,3773896, , , ,1993, , , , , , 
MOLECULAR ANALYSIS OF HUMAN CARCINOMA OF THE PROSTATE,3773897, , , ,1993, , , , , , 
DNA PLOIDY AND MOLECULAR MARKERS OF PROSTATE CANCER,3774022, , , ,1993, , , , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,3774023, , , ,1993, , , , , , 
COMPLEMENTATION OF P53 MUTATION IN ONCOGENE INDUCED PROSTATE CANCER,3774026, , , ,1993, , , , , , 
CONSEQUENCES OF TARGETET GENE EXPRESSION TO THE PROSTATE,3774028, , , ,1993, , , , , , 
"ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS",3774286, , ,Intramural Research,1993, , , , , , 
MOLECULAR BIOLOGY OF PROGRESSION IN LYMPHOPROLIFERATIVE DISEASES,3774382, , ,Intramural Research,1993, , , , , , 
DETECTION OF P53 MUTATIONS IN SOLID PEDIATRIC TUMORS,3774418, , ,Intramural Research,1993, , , , , , 
TIMP-1 EXPRESSION BY NORMAL LYMPHOCYTES AND IN LYMPHOID NEOPLASMS,3774420, , ,Intramural Research,1993, , , , , , 
PROGNOSTIC TUMOR MARKERS IN PREMENOPAUSAL PATIENTS WITH BREAST CANCER,3774428, , ,Intramural Research,1993, , , , , , 
DIAGNOSTIC ELECTRON MICROSCOPY AND CLINICALLY APPLIED RESEARCH,3774431, , ,Intramural Research,1993, , , , , , 
MOLECULAR MECHANISM OF ACTION OF DNA DAMAGING AGENTS,3774549, , ,Intramural Research,1993, , , , , , 
STUDIES ON THE TREATMENT AND CHARACTERISTICS OF THORACIC MALIGNANCIES,3774606, , ,Intramural Research,1993, , , , , , 
BIOLOGY AND TREATMENT OF NON-HODGKIN'S LYMPHOMA,3774634, , ,Intramural Research,1993, , , , , , 
MOLECULAR BIOLOGY OF PEDIATRIC SARCOMAS,3774636, , ,Intramural Research,1993, , , , , , 
MOLECULAR BIOLOGY OF CELLULAR INJURY,3774641, , ,Intramural Research,1993, , , , , , 
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY,3774731, , ,Intramural Research,1993, , , , , , 
CELLULAR DIFFERENTIATION IN NORMAL AND NEOPLASTIC RESPIRATORY EPITHELIUM,3774738, , ,Intramural Research,1993, , , , , , 
RATIONAL APPLICATION OF BIOMARKERS IN CLINICAL TRIALS,3774740, , ,Intramural Research,1993, , , , , , 
MECHANISMS OF CALORIC RESTRICTION IN CANCER PREVENTION,3774749, , ,Intramural Research,1993, , , , , , 
THE MOLECULAR GENETICS OF GYNECOLOGIC CANCERS,3774752, , ,Intramural Research,1993, , , , , , 
EVALUATION OF MARKERS FOR THE EARLY DETECTION OF LUNG CANCER,3774754, , ,Intramural Research,1993, , , , , , 
CLINICAL EPIDEMIOLOGY OF CANCER,3774760, , ,Intramural Research,1993, , , , , , 
MODEL SYSTEMS FOR STUDY OF CHEMICAL CARCINOGENESIS AT THE CELLULAR LEVEL,3774766, , ,Intramural Research,1993, , , , , , 
GENES INVOLVED IN PRENEOPLASTIC PROGRESSION,3774808, , ,Intramural Research,1993, , , , , , 
ONCOGENE EXPRESSION IN CHEMICALLY INDUCED TUMORS,3774814, , ,Intramural Research,1993, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN LUNG CANCER,3774826, , ,Intramural Research,1993, , , , , , 
TUMOR SUPPRESSION GENES IN HUMAN CARCINOGENESIS,3774840, , ,Intramural Research,1993, , , , , , 
GENE EXPRESSION IN COLON CARCINOMA AND POLYPOSIS,3774854, , ,Intramural Research,1993, , , , , , 
REGULATION OF CELLULAR GENE EXPRESSION BY HUMAN PAPILLOMAVIRUSES,3774867, , ,Intramural Research,1993, , , , , , 
ANALYSIS OF GENETIC ALTERATIONS DURING HEPATOCARCINOGENESIS,3774876, , ,Intramural Research,1993, , , , , , 
MECHANISM OF SUPPRESSOR GENE DELETIONS AND MUTATIONS IN BREAST CANCER,3774882, , ,Intramural Research,1993, , , , , , 
TUMOR SUPPRESSOR GENES IN HUMAN HEPATOCELLULAR CARCINOMA,3774899, , ,Intramural Research,1993, , , , , , 
BIOMARKERS FOR ORAL CANCER,3775748, , ,Intramural Research,1993, , , , , , 
TUMOR SUPPRESSOR GENE (TSG) INACTIVATION IN ORAL CANCER,3775981, , , ,1993, , , , , , 
HUMAN OVARIAN CANCER AND P53 GENE,3776675, , , ,1993, , , , , , 
"IN VIVO DAMAGE, REPAIR, AND MUTAGENESIS OF CANCER GENES",3777163, , , ,1993, , , , , , 
MOLECULAR GENETICS OF HUMAN GYNECOLOGIC PATHOLOGY,3777491, , ,Intramural Research,1993, , , , , , 
MECHANISMS OF ACTION OF TUMOR SUPPRESSOR PROTEINS,3777495, , ,Intramural Research,1993, , , , , , 
MOLECULAR EPIDEMIOLOGY OF CANCER SUSCEPTIBILITY AND ONCOGENE ACTIVATION,3777524, , ,Intramural Research,1993, , , , , , 
PROTO-ONCOGENE EXPRESSION DURING LENS DIFFERENTIATION AND DEVELOPMENT,3777632, , ,Intramural Research,1993, , , , , , 
DEVELOPMENT AND USES OF EUKARYOTIC VECTORS,3778812, , ,Intramural Research,1993, , , , , , 
GENETIC ABNORMALITIES IN PRIMARY GLIAL TUMORS,3782403, , ,Intramural Research,1993, , , , , , 
EXPRESSION OF TUMOR SUPPRESSOR AND DNA POLYMERASE GENES IN BRAIN TUMORS,3783252, , , ,1993, , , , , , 
FLOW CYTOMETRIC ANALYSIS OF GLIAL NEOPLASMS,3783253, , , ,1993, , , , , , 
VITAMIN E AND C--DECREASE OR INCREASE RISK OF ASTROCYTOMA,3783254, , , ,1993, , , , , , 
INTERACTION OF RECESSIVE AND DOMINANT ONCOGENES,3783260, , , ,1993, , , , , , 
DNA PLOIDY AND MOLECULAR MARKERS OF PROSTATE CANCER,3796283, , , ,1992, , , , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,3796284, , , ,1992, , , , , , 
COMPLEMENTATION OF P53 MUTATION IN ONCOGENE INDUCED PROSTATE CANCER,3796287, , , ,1992, , , , , , 
CONSEQUENCES OF TARGETET GENE EXPRESSION TO THE PROSTATE,3796289, , , ,1992, , , , , , 
"ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS",3796428, , ,Intramural Research,1992, , , , , , 
THE IDENTIFICATION AND CHARACTERIZATION OF HUMAN GENES ASSOCIATED WITH NEOPLASIA,3796430, , ,Intramural Research,1992, , , , , , 
PATHOGENESIS OF PLASMA CELL NEOPLASIA--RESISTANCE AND SUSCEPTIBILITY GENES,3796452, , ,Intramural Research,1992, , , , , , 
ANALYSIS OF PAPILLOMAVIRUSES,3796510, , ,Intramural Research,1992, , , , , , 
MOLECULAR BIOLOGY OF PROGRESSION IN LYMPHOPROLIFERATIVE DISEASES,3796533, , ,Intramural Research,1992, , , , , , 
IMMUNOHISTOCHEMICAL DETECTION OF WILD AND MUTANT P53 GENE IN RHABDOMYOSARCOMA,3796566, , ,Intramural Research,1992, , , , , , 
DETECTION OF P53 MUTATIONS IN EWING'S SARCOMA AND RHABDOMYOSARCOMA,3796579, , ,Intramural Research,1992, , , , , , 
THE IDENTIFICATION AND CHARACTERIZATION OF HUMAN GENES ASSOCIATED WITH NEOPLASIA,3808489, , ,Intramural Research,1991, , , , , , 
PATHOGENESIS OF PLASMA CELL NEOPLASIA--RESISTANCE AND SUSCEPTIBILITY GENES,3808512, , ,Intramural Research,1991, , , , , , 
MOLECULAR BIOLOGY OF PROGRESSION IN LYMPHOPROLIFERATIVE DISEASES,3808586, , ,Intramural Research,1991, , , , , , 
IMMUNOHISTOCHEMICAL DETECTION OF WILD AND MUTANT P53 GENE IN RHABDOMYOSARCOMA,3808620, , ,Intramural Research,1991, , , , , , 
P53--A COMMON PROTEIN IN EMBRYONIC DIFFERENTIATION AND IN CELLULAR TRANSFORMATION,3817361, , ,Intramural Research,1989, , , , , , 
TREATMENT OF ACUTE LEUKEMIA,3838114, , ,Intramural Research,1992, , , , , , 
MOLECULAR BIOLOGY OF PEDIATRIC TUMORS,3838118, , ,Intramural Research,1992, , , , , , 
MOLECULAR BIOLOGY OF CELLULAR INJURY,3838124, , ,Intramural Research,1992, , , , , , 
MECHANISMS OF ONCOGENE ACTION IN TUMORIGENESIS,3838142, , ,Intramural Research,1992, , , , , , 
ETIOLOGY OF CUTANEOUS T-CELL LYMPHOMAS,3838144, , ,Intramural Research,1992, , , , , , 
CELLULAR DIFFERENTIATION IN NORMAL AND NEOPLASTIC RESPIRATORY EPITHELIUM,3838283, , ,Intramural Research,1992, , , , , , 
RATIONAL APPLICATION OF BIOMARKERS IN CLINICAL TRIALS,3838285, , ,Intramural Research,1992, , , , , , 
ROLE OF HUMAN PAPILLOMAVIRUSES IN HUMAN CARCINOGENESIS,3838296, , ,Intramural Research,1992, , , , , , 
CLINICAL EPIDEMIOLOGY OF CANCER,3838303, , ,Intramural Research,1992, , , , , , 
GENES INVOLVED IN PRENEOPLASTIC PROGRESSION,3838360, , ,Intramural Research,1992, , , , , , 
ONCOGENE EXPRESSION IN CHEMICALLY INDUCED TUMORS,3838366, , ,Intramural Research,1992, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN LUNG CANCER,3838379, , ,Intramural Research,1992, , , , , , 
CHROMOSOME ALTERATIONS AND PROTO-ONCOGENES TRANSPOSITION IN CARCINOGENESIS,3838383, , ,Intramural Research,1992, , , , , , 
TUMOR SUPPRESSION GENES AND ANTI-METASTASIS IN HUMAN CARCINOGENESIS,3838398, , ,Intramural Research,1992, , , , , , 
GENE EXPRESSION IN COLON CARCINOMA AND POLYPOSIS,3838413, , ,Intramural Research,1992, , , , , , 
IN VITRO STUDIES OF HUMAN MESOTHELIAL CELL CARCINOGENESIS,3838425, , ,Intramural Research,1992, , , , , , 
ANALYSIS OF GENETIC ALTERATIONS DURING HEPATOCARCINOGENESIS,3838444, , ,Intramural Research,1992, , , , , , 
MECHANISM OF SUPPRESSOR GENE DELETIONS AND MUTATIONS IN BREAST CANCER,3838452, , ,Intramural Research,1992, , , , , , 
IMMUNOHISTOCHEMICAL STUDIES OF HUMAN HEPATOCELLULAR CARCINOMA,3838475, , ,Intramural Research,1992, , , , , , 
TUMOR SUPPRESSOR GENE (TSG) INACTIVATION IN ORAL CANCER,3839509, , , ,1992, , , , , , 
HUMAN OVARIAN CANCER AND P53 GENE,3840279, , , ,1992, , , , , , 
"IN VIVO DAMAGE, REPAIR, AND MUTAGENESIS OF CANCER GENES",3840706, , , ,1992, , , , , , 
GENETIC ALTERATIONS DURING MULTISTEP CARCINOGENESIS IN MICE AND HUMANS,3841057, , ,Intramural Research,1992, , , , , , 
MOLECULAR GENETICS OF HUMAN GYNECOLOGIC PATHOLOGY,3841058, , ,Intramural Research,1992, , , , , , 
MOLECULAR EPIDEMIOLOGY OF CANCER SUSCEPTIBILITY AND ONCOGENE ACTIVATION,3841090, , ,Intramural Research,1992, , , , , , 
DEVELOPMENT AND USES OF EUKARYOTIC VECTORS,3842561, , ,Intramural Research,1992, , , , , , 
GENETIC ABNORMALITIES IN PRIMARY GLIAL TUMORS,3846290, , ,Intramural Research,1992, , , , , , 
EXPRESSION OF TUMOR SUPPRESSOR AND DNA POLYMERASE GENES IN BRAIN TUMORS,3847157, , , ,1992, , , , , , 
FLOW CYTOMETRIC ANALYSIS OF GLIAL NEOPLASMS,3847158, , , ,1992, , , , , , 
VITAMIN E AND C--DECREASE OR INCREASE RISK OF ASTROCYTOMA,3847159, , , ,1992, , , , , , 
INTERACTION OF RECESSIVE AND DOMINANT ONCOGENES,3847165, , , ,1992, , , , , , 
"BIOLOGY, GROWTH, AND CHEMOENSITIVITY TESTING",3853208, , ,Intramural Research,1991, , , , , , 
TUMOR SUPPRESSOR GENES IN GENITOURINARY MALIGNANCY,3853216, , ,Intramural Research,1991, , , , , , 
TREATMENT OF ACUTE LEUKEMIA,3853239, , ,Intramural Research,1991, , , , , , 
MOLECULAR BIOLOGY OF PEDIATIRC TUMORS,3853242, , ,Intramural Research,1991, , , , , , 
ETIOLOGY OF CUTANEOUS T-CELL LYMPHOMAS,3853277, , ,Intramural Research,1991, , , , , , 
MOLECULAR PATHOLOGY OF PRE-MALIGNANT LUNG,3853278, , ,Intramural Research,1991, , , , , , 
ROLE OF HUMAN PAPILLOMAVIRUSES IN HUMAN CARCINOGENESIS,3853379, , ,Intramural Research,1991, , , , , , 
"CARCINOGENESIS, CHEMOTHERAPY AND BIOLOGICAL MARKERS IN NONHUMAN PRIMATES",3853380, , ,Intramural Research,1991, , , , , , 
"FAMILIAL, CONGENITAL, AND GENETIC FACTORS IN MALIGNANCY",3853384, , ,Intramural Research,1991, , , , , , 
CLINICAL EPIDEMIOLOGY OF CANCER,3853386, , ,Intramural Research,1991, , , , , , 
RESPIRATORY CARCINOGENESIS BY CHEMICAL AND PHYSICAL FACTORS,3853429, , ,Intramural Research,1991, , , , , , 
GENES INVOLVED IN PRENEOPLASTIC PROGRESSION,3853446, , ,Intramural Research,1991, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN LUNG CANCER,3853466, , ,Intramural Research,1991, , , , , , 
NEOPLASTIC TRANSFORMATION OF HUMAN EPITHELIAL CELLS BY ONCOGENES,3853473, , ,Intramural Research,1991, , , , , , 
TUMOR SUPPRESSION GENES IN HUMAN CARCINOGENESIS,3853487, , ,Intramural Research,1991, , , , , , 
GENE EXPRESSION IN COLON CARCINOMA AND POLYPOSIS,3853509, , ,Intramural Research,1991, , , , , , 
IN VITRO STUDIES OF HUMAN MESOTHELIAL CELL CARCINOGENESIS,3853524, , ,Intramural Research,1991, , , , , , 
ONCOGENE EXPRESSION IN CELL LINES DERIVED FROM HUMAN HEPATOCELLULAR CARCINOMA,3853543, , ,Intramural Research,1991, , , , , , 
DETECTION OF POLYPEPTIDE AND GENETIC ALTERATIONS DURING HEPATOCARCINOGENESIS,3853553, , ,Intramural Research,1991, , , , , , 
GENE EXPRESSION IN OVARIAN NEOPLASIA,3853558, , ,Intramural Research,1991, , , , , , 
MECHANISM OF SUPPRESSOR GENE DELETIONS AND MUTATIONS IN BREAST CANCER,3853562, , ,Intramural Research,1991, , , , , , 
HUMAN OVARIAN CANCER AND P53 GENE,3855299, , , ,1991, , , , , , 
"IN VIVO DAMAGE, REPAIR, AND MUTAGENESIS OF CANCER GENES",3855651, , , ,1991, , , , , , 
GENETIC EVENTS IN MULTISTEP CARCINOGENESIS OF MICE,3855881, , ,Intramural Research,1991, , , , , , 
MOLECULAR EPIDEMIOLOGY OF CANCER SUSCEPTIBILITY AND ONCOGENE ACTIVATION,3855913, , ,Intramural Research,1991, , , , , , 
GENE AND TRANSGENE REGULATION IN THE DEVELOPING MOUSE,3857051, , ,Intramural Research,1991, , , , , , 
DEVELOPMENT AND USES OF EUKARYOTIC VECTORS,3857327, , ,Intramural Research,1991, , , , , , 
INVASIVE & METASTATIC NON SMALL CELL CARCINOMA CELLS EXHIBIT P53 ABNORMALITIES,3871363, , , ,1991, , , , , , 
"DOMINANT/RECESSIVE ONCOGENES, GF, AND HIV LIKE RETROVIRUSES IN LUNG CANCER",3874436, , ,Intramural Research,1990, , , , , , 
TREATMENT OF ACUTE LEUKEMIA,3874476, , ,Intramural Research,1990, , , , , , 
MOLECULAR PATHOLOGY OF PRE-MALIGNANT LUNG,3874504, , ,Intramural Research,1990, , , , , , 
ROLE OF HUMAN PAPILLOMAVIRUSES IN HUMAN CARCINOGENESIS,3874586, , ,Intramural Research,1990, , , , , , 
TUMOR SUPPRESSION AND SOMATIC CELL GENETICS,3874708, , ,Intramural Research,1990, , , , , , 
TRANSFORMATION OF PRIMARY CELLS--COOPERATION OF ETS WITH OTHER ONCOGENES,3874738, , ,Intramural Research,1990, , , , , , 
IN VITRO STUDIES OF HUMAN MESOTHELIAL CELL CARCINOGENESIS,3874756, , ,Intramural Research,1990, , , , , , 
"IN VIVO DAMAGE, REPAIR, AND MUTAGENESIS OF CANCER GENES",3876701, , , ,1990, , , , , , 
GENETIC EVENTS IN MULTISTEP CARCINOGENESIS OF MICE,3876895, , ,Intramural Research,1989, , , , , , 
P53--A COMMON PROTEIN IN EMBRYONIC DIFFERENTIATION AND IN CELLULAR TRANSFORMATION,3916297, , ,Intramural Research,1988, , , , , , 
P53--A COMMON PROTEIN IN EMBRYONIC DIFFERENTIATION AND IN CELLULAR TRANSFORMATION,3939270, , ,Intramural Research,1987, , , , , , 
"ONCOGENES, CHROMOSOMAL DELETIONS & GROWTH FACTORS IN LUNG CANCER",3939544, , ,Intramural Research,1987, , , , , , 
CHRONIC VIRAL INFECTIONS--MOLECULAR BIOLOGY OF HUMAN JC VIRUS,3945180, , ,Intramural Research,1987, , , , , , 
MOLECULAR BIOLOGY AND IMMUNOMODULATION OF LUNG CANCER,3963272, , ,Intramural Research,1986, , , , , , 
HEPATOCELLULAR CARCINOMA--EXPRESSION OF RETROVIRAL ASSOCIATED ONCOGENES,3963540, , ,Intramural Research,1986, , , , , , 
"ISOLATION, FRACTIONATION, AND CHARACTERIZATION OF NATIVE NUCLEOPROTEINS",4691789, , ,Intramural Research,1985, , , , , , 
HEPATOCELLULAR CARCINOMA--EXPRESSION OF RETROVIRAL ASSOCIATED ONCOGENES,4692470, , ,Intramural Research,1985, , , , , , 
CHRONIC VIRAL INFECTIONS--MOLECULAR BIOLOGY OF HUMAN JC VIRUS,4696800, , ,Intramural Research,1985, , , , , , 
DNA REPAIR IN CANCER AND SENESCENCE,5200343, , ,Intramural Research,1995, , , , , , 
GENOMIC INSTABILITY,5200345, , ,Intramural Research,1995, , , , , , 
GENE THERAPY OF CANCER,5200360, , ,Intramural Research,1995, , , , , , 
BIOLOGY AND MOLECULAR BIOLOGY OF HEPATITIS C VIRUS,5200721, , ,Intramural Research,1995, , , , , , 
MOLECULAR MECHANISMS GOVERNING B CELL DIFFERENTIATION AND NEOPLASIA,5200767, , ,Intramural Research,1995, , , , , , 
DEATH OF EBV-IMMORTALIZED CELLS IS REGULATED BY LACTIC ACID AND IL-6,5200782, , ,Intramural Research,1995, , , , , , 
"ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS",5200916, , ,Intramural Research,1995, , , , , , 
STRUCTURE AND FUNCTION OF ONCOGENES AND ANTI-ONCOGENES,5200963, , ,Intramural Research,1995, , , , , , 
MOLECULAR BIOLOGY OF PROGRESSION IN LYMPHOPROLIFERATIVE DISEASES,5201002, , ,Intramural Research,1995, , , , , , 
P53 MUTATIONS IN BREAST CANCER WITH C-ERBB2,5201029, , ,Intramural Research,1995, , , , , , 
FLOW CYTOMETRIC ANALYSIS OF BENIGN AND MALIGNANT TUMORS,5201032, , ,Intramural Research,1995, , , , , , 
HISTOLOGICAL FINDINGS IN PREMENOPAUSAL WOMEN WITH BREAST CANCER,5201038, , ,Intramural Research,1995, , , , , , 
EVALUATION OF GENETIC ALTERATIONS IN NEOPLASTIC & PRENEOPLASTIC GASTRIC CANCER,5201045, , ,Intramural Research,1995, , , , , , 
THE NORMAL AND ONCOGENIC FUNCTIONS OF SRC AND WNT GENE FAMILIES,5201058, , ,Intramural Research,1995, , , , , , 
MOLECULAR GENETIC EVENTS IN LUNG CANCER,5201283, , ,Intramural Research,1995, , , , , , 
STUDIES ON THE TREATMENT AND CHARACTERISTICS OF THORACIC MALIGNANCIES,5201289, , ,Intramural Research,1995, , , , , , 
BIOLOGY AND TREATMENT OF NONHODGKIN'S LYMPHOMA,5201314, , ,Intramural Research,1995, , , , , , 
MOLECULAR BIOLOGY OF PEDIATRIC SARCOMAS,5201316, , ,Intramural Research,1995, , , , , , 
MOLECULAR BIOLOGY OF CELLULAR INJURY,5201320, , ,Intramural Research,1995, , , , , , 
NEW STRATEGIES FOR DRUG DISCOVERY AND DEVELOPMENT,5201360, , ,Intramural Research,1995, , , , , , 
CELL CYCLE CHECKPOINTS AND CHEMOSENSITIVITY OF HUMAN CANCER CELLS,5201364, , ,Intramural Research,1995, , , , , , 
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY,5201400, , ,Intramural Research,1995, , , , , , 
EFFECT OF DIETARY FACTORS ON HUMAN BREAST CANCER CELLS,5201401, , ,Intramural Research,1995, , , , , , 
MOLECULAR PATHOLOGY OF PULMONARY CARCINOGENESIS,5201407, , ,Intramural Research,1995, , , , , , 
THE MOLECULAR GENETICS OF GYNECOLOGIC CANCERS,5201418, , ,Intramural Research,1995, , , , , , 
EVALUATION OF MARKERS FOR THE EARLY DETECTION OF LUNG CANCER,5201420, , ,Intramural Research,1995, , , , , , 
MECHANISMS OF DIET AND CHEMOPREVENTION IN P53-KNOCKOUT TRANSGENIC MICE,5201427, , ,Intramural Research,1995, , , , , , 
MODEL SYSTEMS FOR STUDY OF CHEMICAL CARCINOGENESIS AT THE CELLULAR LEVEL,5201449, , ,Intramural Research,1995, , , , , , 
REGULATION OF STAGES OF CARCINOGENSIS,5201454, , ,Intramural Research,1995, , , , , , 
BIOLOGY AND PATHOLOGY OF NATURAL AND EXPERIMENTALLY INDUCED TUMORS,5201471, , ,Intramural Research,1995, , , , , , 
GENES INVOLVED IN PRENEOPLASTIC PROGRESSION,5201480, , ,Intramural Research,1995, , , , , , 
ONCOGENE EXPRESSION IN CHEMICALLY INDUCED TUMORS,5201486, , ,Intramural Research,1995, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN LUNG CANCER,5201495, , ,Intramural Research,1995, , , , , , 
CHROMOSOME ALTERATIONS AND PROTO-ONCOGENE TRANSPOSITION IN CARCINOGENESIS,5201499, , ,Intramural Research,1995, , , , , , 
IN VITRO STUDIES OF HUMAN MESOTHELIAL AND BRONCHIAL EPITHELIAL CARCINOGENESIS,5201521, , ,Intramural Research,1995, , , , , , 
PATHOGENESIS AND EVOLUTION OF HUMAN T CELL LEUKEMIA/LYMPHOTROPIC VIRUSES,5201529, , ,Intramural Research,1995, , , , , , 
ANALYSIS OF CELLULAR AND GENETIC ALTERATIONS DURING HEPATOCELLULAR CARCINOMA,5201532, , ,Intramural Research,1995, , , , , , 
TRANSGENIC MODELS FOR PROSTATE AND BREAST CANCER,5201563, , ,Intramural Research,1995, , , , , , 
MECHANISMS FOR MAMMARY CARCINOGENICITY OF FOOD DERIVED HETEROCYCLIC AMINES,5201567, , ,Intramural Research,1995, , , , , , 
TRANSGENIC MODELS--COOPERATION OF C MYC AND GROWTH FACTORS IN TUMORIGENESIS,5201568, , ,Intramural Research,1995, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN BREAST CANCER,5201575, , ,Intramural Research,1995, , , , , , 
HUMAN LIVER CARCINOGENESIS,5201595, , ,Intramural Research,1995, , , , , , 
STUDIES OF PERSONS AT HIGH RISK OF CANCER--PHARMACOGENETIC STUDIES,5201604, , ,Intramural Research,1995, , , , , , 
ORAL CARCINOGENESIS,5201815, , ,Intramural Research,1995, , , , , , 
BIOMARKERS FOR ORAL CANCER,5201830, , ,Intramural Research,1995, , , , , , 
ETIOLOGY OF ORAL CANCER,5201867, , ,Intramural Research,1995, , , , , , 
INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR,5202016, , ,Intramural Research,1995, , , , , , 
MOLECULAR ANALYSIS OF CELL CYCLE CONTROL DURING CARCINOGENESIS,5202120, , ,Intramural Research,1995, , , , , , 
MUTAGENESIS AND CARCINOGENESIS STUDIES IN P53 (+/-) OR LACI:P53 (+/-) MICE,5202144, , ,Intramural Research,1995, , , , , , 
APOPTOSIS AND AIDS--ROLE OF TAT GENE,5202155, , ,Intramural Research,1995, , , , , , 
REGULATION OF DIFFERENTIATION OF TRACHEOBRONCHIAL /EPIDERMAL EPITHELIAL CELLS,5202166, , ,Intramural Research,1995, , , , , , 
MOLECULAR EPIDEMIOLOGY OF CANCER SUSCEPTIBILITY AND ONCOGENE ACTIVATION,5202190, , ,Intramural Research,1995, , , , , , 
GENE AND TRANSGENE REGULATION IN THE DEVELOPING MOUSE,5203277, , ,Intramural Research,1995, , , , , , 
DELINEATION OF CHROMOSOMAL ABERRATIONS DURING THE PROGRESSION OF SOLID TUMORS,5203450, , ,Intramural Research,1995, , , , , , 
GENETIC ABNORMALITIES IN PRIMARY GLIAL TUMORS,5203957, , ,Intramural Research,1995, , , , , , 
MOLECULAR ANALYSIS OF APOPTOSIS IN TUMORS OF THE CENTRAL NERVOUS SYSTEM,5204037, , ,Intramural Research,1995, , , , , , 
ROLE OF C/EBP ALPHA IN GROWTH INHIBITION,5205054, , , ,1996, , , , , , 
ROLE OF E7 IN HPV INFECTIONS,5205466, , , ,1996, , , , , , 
P21 (WAF1/CIP1) IN KERATINOCYTE GROWTH REGULATION FOLLOWING DNA DAMAGE,5206298, , , ,1996, , , , , , 
TRANSFORMING GROWTH FACTOR BETA REGULATION OF MAMMARY CELL PROLIFERATION,5206383, , , ,1996, , , , , , 
CHEMOTHERAPEUTIC STUDIES IN SOLID TUMORS,5206390, , , ,1996, , , , , , 
TRANSCRIPTIONAL REGULATION--VIRAL TRANSACTIVATION,5206542, , , ,1996, , , , , , 
MOLECULAR ANALYSIS OF CELLULAR RESPONSE TO RADIATION--G1/S TRANSITION,5206584, , , ,1996, , , , , , 
CELL AND MOLECULAR BIOLOGY OF RAT HEPATOCARCINOGENESIS,5206979, , , ,1996, , , , , , 
CHEMOPREVENTION OF GASTRIC DYSPLASIA,5207095, , , ,1996, , , , , , 
MARKERS OF EVOLUTIONARY STAGES IN BREAST CANCER,5207115, , , ,1996, , , , , , 
TRANSFORMING GROWTH FACTOR ALPHA IN PATHOGENESIS OF BREAST CANCER,5207117, , , ,1996, , , , , , 
CORE--PATHOLOGY FACILITY,5207207, , , ,1996, , , , , , 
GENETIC EPIDEMIOLOGY OF CHILDHOOD SARCOMA,5207216, , , ,1996, , , , , , 
CHARACTERIZATION OF MOLECULAR EVENTS DURING OSTEOSARCOMA DEVELOPMENT,5207217, , , ,1996, , , , , , 
IN VITRO PHENOTYPIC EFFECTS OF GERMLINE P53 MUTATIONS,5207218, , , ,1996, , , , , , 
"GENETIC ALTERATIONS IN ADENOMATOUS POLYPS--DIETARY FIBER, FAT, AND BILE ACIDS",5207297, , , ,1996, , , , , , 
MOLECULAR GENETICS OF WILMS' TUMOR,5207325, , , ,1996, , , , , , 
FUNCTIONAL ANALYSIS OF THE RB TUMOR SUPPRESSOR GENE FAMILY,5207327, , , ,1996, , , , , , 
CYCLE-DEPENDENT MECHANISMS OF CHEMICAL CLASTOGENESIS,5207347, , , ,1996, , , , , , 
HUMAN PAPILLOMAVIRUS AND PROGNOSIS OF FEMALE ANOGENITAL CANCER,5207353, , , ,1996, , , , , , 
MECHANISMS OF CELL ADHESION AND COLON CARCINOMA,5207391, , , ,1996, , , , , , 
ABERRANT GENE EXPRESSION BY COLORECTAL CARCINOMA,5207393, , , ,1996, , , , , , 
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA,5207466, , , ,1996, , , , , , 
CLINICAL TRIALS,5207467, , , ,1996, , , , , , 
FUNCTIONAL AND IMMUNOPHENOTYPIC ANALYSIS OF TUMOR SUPPRESSOR GENES IN STS,5207468, , , ,1996, , , , , , 
SV40 T-RB INTERACTIONS,5207605, , , ,1996, , , , , , 
"HPVE6 ONCOPROTEIN AND ITS ASSOCIATED PROTEIN, E6AP",5207607, , , ,1996, , , , , , 
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,5207807, , , ,1996, , , , , , 
RISK FACTORS FOR ORAL EPIDERMOID CARCINOMA IN MINORITIES,5208862, , , ,1996, , , , , , 
TARGETING EARLY CHANGES FOR NEW SCREENING STRATEGIES,5209189, , , ,1996, , , , , , 
DETECTING GENE ALTERATIONS IN NONMALIGNANT EPITHELIUM OF HIGH RISK PEOPLE,5209191, , , ,1996, , , , , , 
MARKERS OF PROGRESSION AND METASTASES,5209219, , , ,1996, , , , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,5209220, , , ,1996, , , , , , 
GENE THERAPY FOR PROSTATE CANCER,5209222, , , ,1996, , , , , , 
PROSTATE SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE,5209223, , , ,1996, , , , , , 
ROLE OF CDK INHIBITORS IN PROSTATE CANCER,5209226, , , ,1996, , , , , , 
CAROLINA BREAST CANCER STUDY,5209244, , , ,1996, , , , , , 
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY,5209245, , , ,1996, , , , , , 
PROSTATIC TOPOISOMERASES AS THERAPEUTIC DRUG TARGETS,5209256, , , ,1996, , , , , , 
GENETIC ALTERATIONS IN PANCREATIC CARCINOMA AND PRECURSORS,5209334, , , ,1996, , , , , , 
DEVELOPMENT OF IMMUNOTHERAPIES FOR CHRONIC MYELOID LEUKEMIA,5209408, , , ,1996, , , , , , 
"HYPOXIA, P53 AND GENETIC INSTABILITY",5209425, , , ,1996, , , , , , 
CORE--CELL REPOSITORY,5209427, , , ,1996, , , , , , 
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS,5209457, , , ,1996, , , , , , 
REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER,5209458, , , ,1996, , , , , , 
CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY,5209461, , , ,1996, , , , , , 
INITIATION AND TARGETS OF ANTIPROLIFERATIVE SIGNALS IN BREAST EPITHELIAL CELLS,5209472, , , ,1996, , , , , , 
LUNG CANCER SUSCEPTIBILITY IN FORMER SMOKERS,5209475, , , ,1996, , , , , , 
GENOTYPE/PHENOTYPE BIOMARKERS,5209476, , , ,1996, , , , , , 
APOPTOSIS IN ALL--CONTRIBUTION TO THERAPEUTIC INDEX,5209493, , , ,1996, , , , , , 
MECHANISMS OF CHEMICAL CARCINOGEN INDUCED P53 MUTATIONS,5209523, , , ,1996, , , , , , 
MECHANISMS OF ULTRAVIOLET LIGHT INDUCED P53 MUTATIONS,5209524, , , ,1996, , , , , , 
MECHANISMS OF OXIDATIVE DAMAGE INDUCED P53 MUTATIONS,5209525, , , ,1996, , , , , , 
MARKERS FOR EARLY LUNG CANCER DETECTION,5209550, , , ,1996, , , , , , 
MUTANT P53 EPITOPE TARGETING IN SCLC,5209551, , , ,1996, , , , , , 
"P53, CHEMICAL CARCINOGEN AND ETHANOL IN ORAL CANCER",5210230, , , ,1996, , , , , , 
P53 SEROLOGY AND PROGNOSIS OF ORAL CANCER,5210231, , , ,1996, , , , , , 
MOLECULAR MARKERS FOR SQUAMOUS CELL CARCINOMA,5210275, , , ,1996, , , , , , 
APOPTOSIS INDUCING GENE THERAPY FOR ORAL PREMALIGNANCY,5210278, , , ,1996, , , , , , 
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,5210284, , , ,1996, , , , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,5210285, , , ,1996, , , , , , 
APOPTOSIS IN ORAL CANCER,5210296, , , ,1996, , , , , , 
MOLECULAR BIOMARKERS OF OCCUPATIONAL BENZENE EXPOSURE,5211136, , , ,1996, , , , , , 
ARSENIC BIOMARKER EPIDEMIOLOGY,5211140, , , ,1996, , , , , , 
"ONCOGENES, SUPPRESSOR GENES, AND MOLECULAR DOSIMETRY",5211149, , , ,1996, , , , , , 
DETECTION OF MUTATIONS IN HUMAN LUNGS,5211368, , , ,1996, , , , , , 
GENETIC ALTERATIONS OF ADENOVIRUSES,5211592, , , ,1996, , , , , , 
TUMOR SUPPRESSOR GENES IN HUMAN MEDULLOBLASTOMA,5215177, , , ,1996, , , , , , 
ROLE OF RB FAMILY IN JC VIRUS INDUCED GLIOBLASTOMA,5215561, , , ,1996, , , , , , 
VITAMINS E AND C--INCREASE AND DECREASE THE RISK OF ASTROCYTOMA,5215712, , , ,1996, , , , , , 
P53 AND HUMAN OVARIAN CANCER,5220449, , , ,1996, , , , , , 
VACCINATION AGAINST TUMOR SPECIFIC MUTANT RAS AND P53 PEPTIDES IN CANCER,5220924, , , ,1996, , , , , , 
GENE MAPPING AND ALLELIC ASSOCIATIONS WITH CANCER,5225828, , , ,1996, , , , , , 
P53 AND THE CELLULAR RESPONSE TO DNA DAMAGE,6011867,1/1/1992 0:00,12/31/2001 0:00,Non-SBIR/STTR,1999,268589, ,NIEHS, , ,268589
MECHANISMS OF RADIORESISTANCE AND CELL CYCLE PROGRESSION,6011878,5/1/1995 0:00,6/30/2003 0:00,Non-SBIR/STTR,1999,256121, ,NIGMS, , ,256121
TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER,6012124,8/24/1999 0:00,7/31/2001 0:00,Non-SBIR/STTR,1999,162990, ,NCI, , ,162990
CELL CYCLE CHECKPOINT REGULATION AND CANCER,6013613,9/1/1999 0:00, ,"Training, Individual",1999,31720, ,NCI, , ,31720
MOLECULAR PATHOGENESIS OF CERVICAL CANCER,6013757,4/1/1995 0:00,3/31/2000 0:00,Non-SBIR/STTR,1998,49944, ,NCI, , ,49944
MOLECULAR PATHOLOGY OF GLIOMAS,6013868,1/13/1995 0:00,11/30/2001 0:00,Non-SBIR/STTR,1999,382156, ,NCI, , ,382156
DNA MUTATION BIOMARKERS FOR NONMELANOMA SKIN CANCER,6015545,5/1/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,109374, ,NCI, , ,109374
RAF-1 INDUCED GROWTH AND APOPTOSIS IN BREAST CANCER,6015547,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,132601, ,NCI, , ,132601
VIRAL ONCOPROTEIN ACTIVATION IN AIDS RELATED TUMORS,6017629,9/17/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,1999,550283, ,NCI, , ,550283
DEVELOPMENT OF ANTIBODIES TO STUDY OXIDATIVE DNA DAMAGE,6017970,1/6/2000 0:00,1/5/2002 0:00,SBIR/STTR,2000,99953, ,NCI, , ,99953
PATHWAYS OF INDUCTION OF FUNCTIONAL P53 PROTEIN,6019008,8/1/1996 0:00,7/31/2001 0:00,Non-SBIR/STTR,1999,197832, ,NIGMS, , ,197832
CELL CYCLE RESPONSE TO RADIATION DAMAGE IN YEAST,6019246,8/1/1997 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999,188695, ,NIGMS, , ,188695
MOLECULAR ANALYSIS OF CEP135 IN THE CENTROSOME,6019276,7/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,202917, ,NIGMS, , ,202917
NITROAROMATICS AND BREAST CANCER,6019785,7/1/1983 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,22247, ,OD, , ,22247
MODULATION OF ARA-C INDUCED APOPTOSIS BY BRYOSTATIN 1,6020207,6/1/1994 0:00,4/30/2003 0:00,Non-SBIR/STTR,1999,10000, ,NCI, , ,10000
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,6024234,9/30/1999 0:00,9/29/2000 0:00,Non-SBIR/STTR,1999,66098, ,NIDDK, , ,66098
REGULATION OF P53 SUBCELLULAR DISTRIBUTION BY MDM2/ARF,6024271,2/15/2000 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,192002, ,NCI, , ,192002
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,6024392,9/30/1998 0:00,9/29/1999 0:00,Non-SBIR/STTR,1999,48164, ,NIDDK, , ,48164
BREAST CANCER ETIOLOGY--P53 GAIN OF FUNCTION MUTATIONS,6027088,7/1/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998,156265, ,NCI, , ,156265
DNA MUTATION BIOMARKERS FOR NONMELANOMA SKIN CANCER,6027100,5/1/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,1150, ,NCI, , ,1150
CHROMOSOME 22Q GENETIC STUDIES IN THE COLON,6027213,3/1/2000 0:00,2/29/2004 0:00,Non-SBIR/STTR,2000,226075, ,NIDDK, , ,226075
P53 - REGULATORS AND EFFECTORS,6027842,2/16/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2000,1189894, ,NCI, , ,1189894
REGULATION OF P53 IN CERVICAL CARCINOMA BY HEAT/HYPOXIA,6028336,5/3/1996 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999,9039, ,NCI, , ,9039
PROTEIN KINASE C AND THYROID CELL APOPTOSIS,6029543,4/1/2000 0:00,11/30/2002 0:00,Other Research-Related,2000,91703, ,NIDDK, , ,91703
CALORIE RESTRICTION AGING AND PROGRAMMED CELL DEATH,6029808,7/1/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,206919, ,NIA, , ,206919
GRP78 AND HYPERSENSITIVITY TO DNA CROSS LINKING AGENTS,6030066,4/1/2000 0:00,3/31/2005 0:00,Other Research-Related,2000,108000, ,NCI, , ,108000
THE ROLE OF GADD45 IN G2 - M CHECKPOINT,6030069,2/11/2000 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,207866, ,NCI, , ,207866
SIGNAL TRANDUCTION IN POLYCYTHEMIA VERA,6030835,8/1/1997 0:00,6/30/2000 0:00,Non-SBIR/STTR,1999,309451, ,NHLBI, , ,309451
WT1 P53 INTERACTIONS IN IGF I RECEPTOR REGULATION,6031051,9/30/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,20000, ,FIC, , ,20000
STATUS OF P53 IN A LFS CANCER PRONE FAMILY,6031146,9/1/1986 0:00,11/30/1999 0:00,Non-SBIR/STTR,1999,69647, ,OD, , ,69647
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION,6031212,2/9/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2000,369873, ,NCI, , ,369873
SUSCEPTIBILITY TO MOLECULAR ALTERATION--EPITHELIAL CELLS,6031932,9/26/1999 0:00,8/31/2004 0:00,Other Research-Related,1999,118065, ,NIEHS, , ,118065
EXPRESSION PROFILING OF PROGRESSED FOLLICULAR LYMPHOMAS,6031945,1/14/2000 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,112125, ,NCI, , ,112125
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY,6032428,7/15/1988 0:00,9/29/2002 0:00,Non-SBIR/STTR,1999,1098258, ,NCI, , ,1098258
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS,6032882,2/1/2000 0:00,12/31/2003 0:00,Non-SBIR/STTR,2000,237293, ,NCI, , ,237293
INNOVATIVE TUMOR TARGETED THERAPIES FOR LUNG CANCER,6038165,9/1/2000 0:00,6/30/2001 0:00,Other Research-Related,2000,125620, ,NCI, , ,125620
MECHANISMS OF INTESTINAL TUMORIGENESIS,6038528,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2000,370507, ,NCI, , ,370507
MOUSE CANCER MODELS--INACTIVATION OF TUMOR SUPPRESSOR GE,6038572,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,1999,285494, ,NCI, , ,285494
MOUSE MODELS OF BREAST CANCER,6038574,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,1999,244894, ,NCI, , ,244894
"ACUTE PROMYELOCYTIC LEUKEMIA--ABERRANT TRANSCRIPTION, CA",6038935,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,1999,228016, ,NCI, , ,228016
A MOUSE MODEL FOR PROSTATE CANCER,6038936,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,1999,198669, ,NCI, , ,198669
MOUSE MODELS OF LUNG CANCERS,6039341,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,1999,344687, ,NCI, , ,344687
PRECLINICAL MOUSE:  CENTRAL NERVOUS SYSTEM CANCERS,6039349,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,1999,345324, ,NCI, , ,345324
P53 AND MOUSE MAMMARY TUMORIGENESIS,6039355,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2000,315340, ,NCI, , ,315340
BIOCHEMICAL CYTOLOGY OF NORMAL AND MALIGNANT TISSUES,6040645,1/1/1975 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,381167, ,NCI, , ,381167
HEPTOCYTE PROLIFERATION AND AFLATOXIN METABOLISM,6040753,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2000,190927, ,NIEHS, , ,190927
GENE EXPRESSION IN CTCL PATIENTS IN IL 12 CLINICAL TRIAL,6041197,1/1/2000 0:00,12/30/2001 0:00,Non-SBIR/STTR,2000,160904, ,NCI, , ,160904
ROLE FOR RAD51B IN DNA REPAIR AND BREAST CARCINOGENESIS,6041901,4/1/1999 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999,100000, ,NCI, , ,100000
DISSECTION OF THE DNA DAMAGE CHECKPOINT PATHWAYS,6041915,2/1/2000 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,242150, ,NCI, , ,242150
STRUCTURAL FEATURES OF PAPILLOMAVIRUS E6 ONCOPROTEINS,6043283,2/1/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2000,184981, ,NCI, , ,184981
GENOMIC INSTABILITY IN TUMORS OF TRANSGENIC MICE,6043505,8/5/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,1999,278491, ,NIEHS, , ,278491
PROTECTIVE ROLE OF APOPTOSIS IN ASBESTOS PLEURAL INJURY,6043510,8/29/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,1999,195825, ,NIEHS, , ,195825
EFFECTS OF BENZO[A]PYRENE IN TRANSGENIC MODEL OF CERVICA,6043518,2/1/2000 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,193342, ,NIEHS, , ,193342
NOVEL CARCINOGEN INDUCED CELL CYCLE CHECKPOINT,6043522,8/1/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,1999,110514, ,NIEHS, , ,110514
ASBESTOS AND NO2 IN ENVIRONMENTAL LUNG DISEASE,6043527,8/15/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,1999,251434, ,NIEHS, , ,251434
APOPTOSIS SIGNAl--BINDING OF CYTOCHROME C TO APAF 1,6043597,2/1/2000 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,184883, ,NIGMS, , ,184883
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE,6044354,12/29/1994 0:00,11/30/2004 0:00,Non-SBIR/STTR,2000,361286, ,NCI, , ,361286
REGULATION OF MULTIDRUG RESISTANCE PHENOTYPE,6044780,3/15/1996 0:00,12/31/2002 0:00,Non-SBIR/STTR,2000,182755, ,NCI, , ,182755
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7,6044840,2/15/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2000,241559, ,NCI, , ,241559
ESOPHAGO GASTRIC TUMORIGENESIS IN A TRANSGENIC MODEL,6044849,5/1/2000 0:00,4/30/2005 0:00,Other Research-Related,2000,136147, ,NCI, , ,136147
GENETIC PATHWAY TO IGH TRANSLOCATIONS IN LYMPHOMA,6045402,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2000,269242, ,NCI, , ,269242
PROTEIN PHOSPHATASE 1 AND NEOPLASTIC TRNSFORMATION,6050886,9/1/1993 0:00,2/28/2005 0:00,Non-SBIR/STTR,2000,209231, ,NCI, , ,209231
AT: ERRORS IN DOUBLE STRAND BREAK REPAIR,6052017,1/26/2000 0:00,12/31/2003 0:00,Non-SBIR/STTR,2000,223846, ,NCI, , ,223846
LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU,6053644,7/10/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2000,456618, ,NCI, , ,456618
IMPROVING CRYOSURGERY THROUGH UNDERSTANDING APOPTOSIS,6054427,6/15/2000 0:00,6/14/2001 0:00,SBIR/STTR,2000,93970, ,NCRR, , ,93970
THERAPY OF HEPATOCELLULAR CARCINOMA,6054431,7/28/1998 0:00,6/30/2003 0:00,Other Research-Related,1998,73948, ,NCI, , ,73948
EUKARYOTIC DNA ALKYLATION REPAIR,6054974,7/2/1991 0:00,2/28/2005 0:00,Non-SBIR/STTR,2000,497611, ,NCI, , ,497611
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,6055053,9/30/1995 0:00,9/29/1999 0:00,Non-SBIR/STTR,1999,493483, ,NCI, , ,493483
CYTOTOXIC MECHANISMS IN CUTANEOUS DISEASE,6055558,1/1/1980 0:00,8/31/2002 0:00,Non-SBIR/STTR,1999,251954, ,NIAMS, , ,251954
RAR BETA MEDIATED APOPTOSIS IN BREAST CANCER CELLS,6055745,9/22/1995 0:00,12/31/1999 0:00,Other Research-Related,1999,49322, ,NCI, , ,49322
SKIN CANCER--ROLE OF UVB INDUCED CELL CYCLE ALTERATIONS,6055888,12/1/1977 0:00,8/31/2001 0:00,Non-SBIR/STTR,1999,275598, ,NIEHS, , ,275598
ROLE OF AMINO TERMINAL MODIFICATION IN P53 FUNCTION,6062358,4/1/2000 0:00, ,"Training, Individual",2000,37516, ,NCI, , ,37516
DNA MUTATION BIOMARKERS FOR NONMELANOMA SKIN CANCER,6069961,5/1/1996 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,14675, ,NCI, , ,14675
MECHANISMS OF CARCINOGENESIS INVOLVING WILD-TYPE,6070422,4/1/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999,43662, ,NCI, , ,43662
A PROGRAMMABLE DNA ARRAY SYNTHESIZER,6072571,9/30/1999 0:00,9/30/2001 0:00,SBIR/STTR,1999,164003, ,NHGRI, , ,164003
IMMUNOLOGIC & MOLECULAR MARKERS FOR DIAGNOSIS/PROGNOSIS,6074220,5/15/1988 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999,185721, ,NCI, , ,185721
EARLY CANCER DETECTION AND SUSCEPTIBILITY BIOMAKERS,6074236,9/30/1999 0:00,8/31/2004 0:00,Other,1999,559290, ,NCI, , ,559290
INSTABILITY OF MICROSATELLITES IN MAMMALIAN CELLS,6074762,7/13/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999,99900, ,NCI, , ,99900
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,6074821,6/1/1993 0:00,4/30/2003 0:00,Non-SBIR/STTR,1999,81792, ,NCI, , ,81792
NITROAROMATICS AND BREAST CANCER,6076181,7/1/1983 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,88988, ,NCI, , ,88988
P16/P18 FAMILY CDK INHIBITORS,6076822,7/17/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999,23091, ,NCI, , ,23091
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCER,6077102,9/30/1996 0:00,8/31/1999 0:00,Research Centers,1999,925375, ,NCI, , ,925375
MOLECULAR MARKERS OF PROGNOSIS IN MEDULLOBLASTOMA,6079121,7/5/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,68867, ,NCI, , ,68867
EPIDERMAL GROWTH FACTOR AND PANCREATIC CANCER,6081323,4/1/1989 0:00,2/28/2001 0:00,Non-SBIR/STTR,1999,75200, ,NCI, , ,75200
10TH INTERNATIONAL P53 WORKSHOP,6084606,3/1/2000 0:00,2/28/2001 0:00,Other Research-Related,2000,9500, ,NIEHS, , ,2000
NATURAL HISTORY OF HEREDITARY BREAST CANCER,6084929,9/15/2000 0:00,8/31/2003 0:00,Non-SBIR/STTR,2000,225000, ,NCI, , ,225000
TRIGGERING OF ABERRANT CPG ISLAND METHYLATION,6084938,7/1/2000 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,232313, ,NCI, , ,232313
NUCLEAR RECEPTOR COACTIVATORS AND BREAST CANCER,6087980,6/15/2000 0:00,5/31/2005 0:00,Other Research-Related,2000,116087, ,NIEHS, , ,116087
RACIAL DIFFERENCES IN BREAST CANCER SURVIVAL,6088253,8/5/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,9999, ,NCI, , ,9999
P53 AND UV REGULATION OF P53 BINDING PROTEIN BBP/53BP2,6089852,6/7/2000 0:00,5/31/2005 0:00,Other Research-Related,2000,132921, ,NCI, , ,132921
SOFT TISSUE SARCOMA PROGRAM PROJECT,6090282,1/9/1989 0:00,2/28/2005 0:00,Non-SBIR/STTR,2000,1614414, ,NCI, , ,1614414
MOLECULAR MECHANISMS OF IRON CHELATOR CYTOTOXICITY,6090862,6/1/2000 0:00,4/30/2004 0:00,Non-SBIR/STTR,2000,253750, ,NIDDK, , ,253750
TRIMODAL GENE THERAPY FOR PROSTATE CANCER,6092804,7/1/2000 0:00,5/31/2004 0:00,Non-SBIR/STTR,2000,133006, ,NIDDK, , ,133006
MDMX REGULATION OF THE P53 TUMOR SUPPRESSOR PROTEIN,6095234,4/1/1995 0:00,3/31/2005 0:00,Non-SBIR/STTR,2000,225225, ,NCI, , ,225225
GROWTH REGULATION OF PROSTATIC CELLS BY ANDROGEN,6095695,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,1999,46955, ,NCI, , ,46955
E2F AND APOPTOSIS,6097365,2/5/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2000,286010, ,NCI, , ,286010
HPV ETIOLOGY OF A SUBSET OF HEAD AND NECK CANCERS,6097443,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2000,308210, ,NIDCR, , ,308210
BREAST CANCER AND TUMOR PROGRESSION IN THE AGED RAT,6097783, , ,Intramural Research,1998, , , , , , 
"STRESS, DIFFERENTIATION, GROWTH ARREST AND PROGRAMMED CELL DEATH",6097815, , ,Intramural Research,1998, , , , , , 
ROLE OF C/EBP ALPHA IN GROWTH INHIBITION,6098690,4/1/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,211649, , , , 
ROLE OF E7 IN HPV INFECTIONS,6099521,7/1/1998 0:00,8/31/1999 0:00,Non-SBIR/STTR,1998, , , , , , 
"P53, APOPTOSIS AND CHRONIC RHEUMATOID ARTHRITIS",6100509,3/1/1999 0:00,2/29/2000 0:00,Research Centers,1999, ,114229, , , , 
REGULATION OF APOPTOSIS,6100747, , ,Intramural Research,1998, , , , , , 
MECHANISMS OF DIET AND CHEMOPREVENTION IN P53 DEFICIENT MICE,6100753, , ,Intramural Research,1998, , , , , , 
MODEL SYSTEMS FOR STUDY OF CHEMICAL CARCINOGENESIS AT THE CELLULAR LEVEL,6100761, , ,Intramural Research,1998, , , , , , 
BIOLOGY AND PATHOLOGY OF NATURAL AND EXPERIMENTALLY INDUCED TUMORS,6100794, , ,Intramural Research,1998, , , , , , 
ONCOGENE EXPRESSION IN CHEMICALLY INDUCED TUMORS,6100804, , ,Intramural Research,1998, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN CANCER,6100811, , ,Intramural Research,1998, , , , , , 
PATHOGENESIS AND EVOLUTION OF HUMAN T CELL LEUKEMIA/LYMPHOTROPIC VIRUSES,6100839, , ,Intramural Research,1998, , , , , , 
INTERACTION OF HTLV-1 TAX WITH CELLULAR REGULATORY PROTEINS,6100851, , ,Intramural Research,1998, , , , , , 
MUTATIONAL AND FUNCTIONAL ANALYSIS OF THE P53 TUMOR SUPPRESSOR GENE,6100879, , ,Intramural Research,1998, , , , , , 
MOLECULAR BIOLOGY OF CELLULAR INJURY,6100893, , ,Intramural Research,1998, , , , , , 
NEW STRATEGIES FOR DRUG DISCOVERY AND DEVELOPMENT,6100897, , ,Intramural Research,1998, , , , , , 
CELL CYCLE REGULATION AND CHEMOSENSITIVITY,6100899, , ,Intramural Research,1998, , , , , , 
"HORMONES, ANTIHORMONES AND GROWTH FACTORS IN MAMMARY DEVELOPMENT & TUMORIGENESIS",6100905, , ,Intramural Research,1998, , , , , , 
"GENES, MICE, SIGNALING AND CANCER",6100991, , ,Intramural Research,1998, , , , , , 
STRUCTURE AND EXPRESSION OF THE C-MYC/PVT 1 MEGAGENE LOCUS,6101015, , ,Intramural Research,1998, , , , , , 
ROLE OF TOBACCO RELATED CHEMICAL CARCINOGENS AND OXYRADICALS IN HUMAN CANCER,6101025, , ,Intramural Research,1998, , , , , , 
PRECLINICAL MODELS FOR TESTING OF BIOLOGICAL CANCER THERAPEUTICS,6101258, , ,Intramural Research,1998, , , , , , 
CHEMOTHERAPEUTIC STUDIES IN SOLID TUMORS,6101348,5/1/1999 0:00,7/5/2001 0:00,Non-SBIR/STTR,1999, ,188635, , , , 
CANCER THERAPY,6101504,1/1/1999 0:00,12/31/1999 0:00,Non-SBIR/STTR,1999, ,374147, , , , 
MOLECULAR ANALYSIS OF CELLULAR RESPONSE TO RADIATION--G1/S TRANSITION,6101547,6/8/1998 0:00,9/30/2000 0:00,Non-SBIR/STTR,1999, ,80867, , , , 
GENETIC INSTABILITY INDUCED BY VIRAL PROTEINS,6101695,5/7/1999 0:00,2/29/2000 0:00,Non-SBIR/STTR,1999, ,159739, , , , 
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6101817,7/1/1999 0:00,6/30/2000 0:00,Research Centers,1999, ,332337, , , , 
P53 GENE AND CHEMOSENSITIVITY,6101967,7/1/1999 0:00,6/30/2000 0:00,Non-SBIR/STTR,1999, ,167100, , , , 
CORE--MOLECULAR GENETICS,6102050,9/18/1998 0:00,6/30/1999 0:00,Non-SBIR/STTR,1999, , , , , , 
CHEMOPREVENTION OF GASTRIC DYSPLASIA,6102057,3/4/1999 0:00,2/29/2000 0:00,Non-SBIR/STTR,1999, ,297994, , , , 
PROGNOSTIC & PREDICTIVE BIOMARKERS FOR BREAST CANCER,6102072,8/1/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998, ,181487, , , , 
DEVELOPMENTAL & PROGNOSTIC FACTORS IN PREMALIGNANT BREAST DISEASE,6102074,8/1/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998, ,181487, , , , 
CORE--PATHOLOGY FACILITY,6102162,4/29/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,210132, , , , 
GENETIC EPIDEMIOLOGY OF CHILDHOOD SARCOMA,6102171,8/1/1997 0:00,7/31/1999 0:00,Non-SBIR/STTR,1999, ,30000, , , , 
CHARACTERIZATION OF MOLECULAR EVENTS DURING OSTEOSARCOMA DEVELOPMENT,6102172,8/1/1997 0:00,7/31/1999 0:00,Non-SBIR/STTR,1999, ,30000, , , , 
IN VITRO PHENOTYPIC EFFECTS OF GERMLINE P53 MUTATIONS,6102173,8/1/1997 0:00,7/31/1999 0:00,Non-SBIR/STTR,1999, ,30000, , , , 
"GENETIC ALTERATIONS IN ADENOMATOUS POLYPS--DIETARY FIBER, FAT, AND BILE ACIDS",6102264,3/1/1999 0:00,9/13/2000 0:00,Non-SBIR/STTR,1999, ,346226, , , , 
MOLECULAR GENETICS OF WILMS' TUMOR,6102290,5/1/1998 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998, , , , , , 
FUNCTIONAL ANALYSIS OF THE RB TUMOR SUPPRESSOR GENE FAMILY,6102292,5/1/1998 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998, , , , , , 
CYCLE-DEPENDENT MECHANISMS OF CHEMICAL CLASTOGENESIS,6102317,5/1/1998 0:00,4/30/2001 0:00,Non-SBIR/STTR,1998, ,173112, , , , 
HUMAN PAPILLOMAVIRUS AND PROGNOSIS OF FEMALE ANOGENITAL CANCER,6102323,6/1/1998 0:00,5/31/1999 0:00,Non-SBIR/STTR,1998, , , , , , 
MECHANISMS OF CELL ADHESION AND COLON CARCINOMA,6102364,2/1/1998 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998, ,141519, , , , 
ABERRANT GENE EXPRESSION BY COLORECTAL CARCINOMA,6102366,2/1/1998 0:00,1/31/2000 0:00,Non-SBIR/STTR,1998, ,141519, , , , 
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA,6102451,5/1/1998 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998, ,197437, , , , 
CLINICAL TRIALS,6102452,5/1/1998 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998, ,197437, , , , 
FUNCTIONAL AND IMMUNOPHENOTYPIC ANALYSIS OF TUMOR SUPPRESSOR GENES IN STS,6102453,5/1/1998 0:00,2/29/2000 0:00,Non-SBIR/STTR,1998, ,197437, , , , 
CELLULAR TARGETS FOR PAPILLOMAVIRUS E6 ONCOPROTEINS,6102578,5/1/1999 0:00,2/29/2000 0:00,Non-SBIR/STTR,1999, ,283979, , , , 
INDUCTION OF APOPTOSIS IN BREAST CANCER,6102601,6/1/1999 0:00,5/31/2001 0:00,Non-SBIR/STTR,1999, ,256220, , , , 
MOLECULAR DETERMINANTS OF CHEMOTHERAPY RESISTANCE,6102712,6/7/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,163224, , , , 
TARGETING EARLY CHANGES FOR NEW SCREENING STRATEGIES,6102796,7/3/1998 0:00,5/31/1999 0:00,Research Centers,1998, , , , , , 
DETECTING GENE ALTERATIONS IN NONMALIGNANT EPITHELIUM OF HIGH RISK PEOPLE,6102798,7/3/1998 0:00,5/31/1999 0:00,Research Centers,1998, , , , , , 
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6102817,5/1/1999 0:00,4/30/2000 0:00,Research Centers,1999, ,156688, , , , 
MARKERS OF PROGRESSION AND METASTASES,6102831,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,6102832,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
GENE THERAPY FOR PROSTATE CANCER,6102834,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
PROSTATE SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE,6102835,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
ROLE OF CDK INHIBITORS IN PROSTATE CANCER,6102838,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
CAROLINA BREAST CANCER STUDY,6102856,8/5/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,168504, , , , 
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY,6102857,8/5/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,168504, , , , 
PROSTATIC TOPOISOMERASES AS THERAPEUTIC DRUG TARGETS,6102876,7/28/1998 0:00,5/31/1999 0:00,Research Centers,1998, , , , , , 
GENETICALLY MODIFIED DENDRITIC CELLS FOR INDUCTION OF CANCER IMMUNITY,6102914,5/1/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,309237, , , , 
NEW GENETIC MARKERS FOR PANCREATIC CANCER,6102962,1/1/1999 0:00,12/31/1999 0:00,Research Centers,1999, ,219161, , , , 
MOLECULAR MARKERS FOR METASTASIS OF COLORECTAL CANCER,6102966,1/1/1999 0:00,12/31/1999 0:00,Research Centers,1999, ,219161, , , , 
DETECTION OF MUTATIONS IN COLON AND BREAST CANCER,6103020,2/1/1999 0:00,1/31/2000 0:00,Non-SBIR/STTR,1999, ,219559, , , , 
DEVELOPMENT OF IMMUNOTHERAPIES FOR CHRONIC MYELOID LEUKEMIA,6103047,4/20/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,226134, , , , 
"HYPOXIA, P53 AND GENETIC INSTABILITY",6103064,5/13/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,218557, , , , 
CORE--CELL REPOSITORY,6103066,5/13/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,218557, , , , 
PRECLINICAL CHARACTERIZATION OF NATURAL PRODUCT LEADS FOR RESTORATION OF P53,6103095,9/30/1997 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997, , , , , , 
STRUCTURAL STUDIES ON NATURAL PRODUCT LEADS FOR RESTORATION OF P53 FUNCTION,6103096,9/30/1997 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997, , , , , , 
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS,6103104,5/15/1998 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998, , , , , , 
REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER,6103105,5/15/1998 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998, , , , , , 
CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY,6103108,5/15/1998 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998, , , , , , 
DEVELOPMENT OF SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF BREAST CANCER,6103120,9/30/1998 0:00,8/31/1999 0:00,Research Centers,1998, ,327843, , , , 
CORE--PATHOLOGY CORE,6103121,9/30/1998 0:00,8/31/1999 0:00,Research Centers,1998, ,327843, , , , 
LUNG CANCER SUSCEPTIBILITY IN FORMER SMOKERS,6103129,8/1/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1999, ,69313, , , , 
GENOTYPE/PHENOTYPE BIOMARKERS,6103130,8/1/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1999, ,69313, , , , 
APOPTOSIS IN ALL--CONTRIBUTION TO THERAPEUTIC INDEX,6103147,8/1/1999 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999, ,200938, , , , 
MECHANISMS OF CHEMICAL CARCINOGEN INDUCED P53 MUTATIONS,6103188,9/1/1998 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998, ,248294, , , , 
MECHANISMS OF ULTRAVIOLET LIGHT INDUCED P53 MUTATIONS,6103189,9/1/1998 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998, ,248294, , , , 
MECHANISMS OF OXIDATIVE DAMAGE INDUCED P53 MUTATIONS,6103190,9/1/1998 0:00,8/31/2000 0:00,Non-SBIR/STTR,1998, ,248294, , , , 
MARKERS FOR EARLY LUNG CANCER DETECTION,6103222,9/1/1998 0:00,8/31/1999 0:00,Research Centers,1999, ,132196, , , , 
MUTANT P53 EPITOPE TARGETING IN SCLC,6103224,9/1/1998 0:00,8/31/1999 0:00,Research Centers,1999, ,132196, , , , 
GENE MUTATIONS AND APOPTOSIS IN CANCER CHEMOPREVENTION,6103263,7/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999, ,130479, , , , 
CORE--EXPERIMENTAL ANIMALS FACILITY,6103267,7/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999, ,130479, , , , 
GENETIC MANIPULATION OF TUMOR RADIORESISTANCE,6103327,9/30/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998, ,100568, , , , 
RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53,6103328,9/30/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998, ,100568, , , , 
ROLE OF PROSTAGLANDIN H SYNTHASE 2 IN COLON CARCINOGENESIS,6103341,8/10/1998 0:00,5/31/1999 0:00,Non-SBIR/STTR,1998, , , , , , 
TARGETING PCD FOR LEUKEMIA TREATMENT,6103383,2/1/1999 0:00,1/31/2000 0:00,Non-SBIR/STTR,1999, ,198353, , , , 
TARGETING PCD IN BLADDER CANCER,6103384,2/1/1999 0:00,1/31/2000 0:00,Non-SBIR/STTR,1999, ,198353, , , , 
KILLER/DR5 APOPTOSIS IN DNA DAMAGE SENSITIVE CELLS,6103388,6/1/1999 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999, ,183014, , , , 
TUMOR SUPPRESSOR AND GROWTH FACTORS IN TUMORIGENESIS,6103410,5/1/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,250910, , , , 
TUMOR SUPPRESSOR GENETICS OF MOUSE CHRMOSOME 11,6103434,5/11/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,455266, , , , 
MECHANISMS OF PROGRESSION IN RECURRENT PROSTATE CANCER,6103479,8/1/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998, ,84966, , , , 
Biomarkers for Oral Cancer,6104627, , ,Intramural Research,1998, , , , , , 
Genetic Epidemiological Studies of Nasopharyngeal Cancer in China,6104666, , ,Intramural Research,1998, , , , , , 
Molecular basis of squamous differentiation and neoplasia in skin &amp; oral tiss,6104689, , ,Intramural Research,1998, , , , , , 
RISK FACTORS FOR ORAL EPIDERMOID CARCINOMA IN MINORITIES,6104839,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,331736, , , , 
"P53, CHEMICAL CARCINOGEN AND ETHANOL IN ORAL CANCER",6104861,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,202184, , , , 
P53 SEROLOGY AND PROGNOSIS OF ORAL CANCER,6104862,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,12952, , , , 
MOLECULAR MARKERS FOR SQUAMOUS CELL CARCINOMA,6104916,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1999, ,264, , , , 
APOPTOSIS INDUCING GENE THERAPY FOR ORAL PREMALIGNANCY,6104919,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1999, ,264, , , , 
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,6104925,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1999, ,429, , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,6104926,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1999, ,429, , , , 
APOPTOSIS IN ORAL CANCER,6104936,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,89732, , , , 
DEVELOPMENT OF P53 BASED VACCINES FOR ORAL CARCINOMA,6104945,9/1/1998 0:00,8/31/1999 0:00,Non-SBIR/STTR,1998, ,173228, , , , 
ORAL CARCINOMA--SIGNAL TRANSDUCTION IN LYMPHOCYTES,6104947,9/1/1998 0:00,8/31/1999 0:00,Non-SBIR/STTR,1998, ,166679, , , , 
HPV AND CELL CYCLE DYSREGULATION IN ORAL CANCER,6104954,4/1/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,276996, , , , 
CYCLIN D1 AND GENETIC MODEL OF ORAL CARCINOGENESIS,6104955,4/1/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,365748, , , , 
CORE--CELL CULTURE,6104958,4/1/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,0, , , , 
FIBROBLAST GROWTH FACTOR RECEPTOR,6105026, , ,Intramural Research,1998, , , , , , 
Gene Rearrangements in Esophageal Cancer,6105762, , ,Intramural Research,1998, , , , , , 
Pathogenic Factors and Determinants of Prognosis in Patients with Gastrinomas,6105832, , ,Intramural Research,1998, , , , , , 
Clinically Aggressive Thyroid Cancer: Molecular Basis and Treatment Outcome,6105907, , ,Intramural Research,1998, , , , , , 
MOLECULAR BIOMARKERS OF OCCUPATIONAL BENZENE EXPOSURE,6106173,4/1/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,236715, , , , 
ARSENIC BIOMARKER EPIDEMIOLOGY,6106177,4/1/1999 0:00,3/31/2000 0:00,Non-SBIR/STTR,1999, ,236715, , , , 
"ONCOGENES, SUPPRESSOR GENES, AND MOLECULAR DOSIMETRY",6106186,5/1/1998 0:00,4/30/2000 0:00,Non-SBIR/STTR,1998, ,236863, , , , 
GENETIC ALTERATIONS IN LUNG CANCER,6106554, , ,Intramural Research,1998, , , , , , 
AFLATOXIN B1 INDUCED P53 MUTATIONS IN HEPATOCELLULAR CARCINOMAS FROM CHINA,6106555, , ,Intramural Research,1998, , , , , , 
MOLECULAR ANALYSIS OF CELL CYCLE CONTROL DURING CARCINOGENESIS,6106574, , ,Intramural Research,1998, , , , , , 
Application of Transgenic Models for Toxicological Characterization,6106595, , ,Intramural Research,1998, , , , , , 
Carcinogen inactivation of tumor suppressor genes in p53 haploinsufficient mice.,6106597, , ,Intramural Research,1998, , , , , , 
K RAS AND P53 MUTATIONS IN UTERINE SARCOMAS,6106600, , ,Intramural Research,1998, , , , , , 
MOLECULAR GENETICS OF AROMATIC AMINE INDUCED BLADDER CANCER,6106601, , ,Intramural Research,1998, , , , , , 
CARBONYL SULFIDE CLEAN AIR ACT STUDIES,6106606, , ,Intramural Research,1998, , , , , , 
MECHANISM OF CARCINOGENS--GENETIC ALTERATIONS IN RODENT AND HUMAN TUMORS,6106616, , ,Intramural Research,1998, , , , , , 
Risk Factors for Cell Transformation and the Role of Apoptosis,6106624, , ,Intramural Research,1998, , , , , , 
ROLE OF DIETARY RESTRICTION ON CELL TRANSFORMATION,6106626, , ,Intramural Research,1998, , , , , , 
EXPOSURE SPECIFIC MUTATION IN CRITICAL TARGET GENES,6106695, , ,Intramural Research,1998, , , , , , 
MODEL SYSTEMS TO EVALUATE TRANSPOSITION IN EUKARYOTIC CELLS,6106755, , ,Intramural Research,1998, , , , , , 
PROTEIN P53 PHOSPHORYLATION STATUS IN PRIMARY BREAST CANCER,6107071,8/1/1998 0:00,7/31/1999 0:00,Other Research-Related,1998, ,30384, , , , 
GENETIC ALTERATIONS OF ADENOVIRUSES,6107085,1/1/1999 0:00,12/31/1999 0:00,Other Research-Related,1999, ,104931, , , , 
ATAXIA TELANGIECTASIA KNOCK OUT MICE,6108976, , ,Intramural Research,1998, , , , , , 
DELINEATION OF CHROMOSOMAL ABERRATIONS DURING THE PROGRESSION OF SOLID TUMORS,6108984, , ,Intramural Research,1998, , , , , , 
CHARACTERIZATION OF THE ATAXIA-TELANGIECTASIA GENE PRODUCT,6109005, , ,Intramural Research,1998, , , , , , 
GENE THERAPY OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM,6111891, , ,Intramural Research,1998, , , , , , 
PHASE I STUDY OF RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD/NECK,6114578,12/1/1978 0:00,11/30/2003 0:00,Research Centers,1999, ,28966, , , , 
GENE THERAPY--MALIGNANT TUMORS OF LIVER USING SCH 58500 VIA HEPATIC ARTERY,6115222,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,51559, , , , 
CISPLATIN PLUS PACLITAXEL IN ADVANCED CARCINOMA OF THE UROTHELIUM,6115806,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,21006, , , , 
VACCINATION AGAINST TUMOR SPECIFIC MUTANT RAS AND P53 PEPTIDES IN CANCER,6117538,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,34838, , , , 
PHASE I STUDY IN PATIENTS WITH PERITONEAL CARCINOMATOSIS USING SCH58500,6118455,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,1903, , , , 
STRUCTURE DETERMINATION OF PROTEINS ASSOCIATED W/ CANCER,6118645,5/15/1999 0:00,4/30/2000 0:00,Research Centers,1999, ,20331, , , , 
GENE MAPPING AND ALLELIC ASSOCIATIONS WITH CANCER,6123061,8/1/1998 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998, ,96345, , , , 
PILOT STUDY--PHOSPHORYLATION OF P53 PROTEIN IN HUMAN BREAST CANCER CELLS,6123349,9/30/1998 0:00,9/29/1999 0:00,Research Centers,1998, ,172415, , , , 
MOLECULAR PATHOLOGY OF PULMONARY CARCINOGENESIS,6123618, , ,Intramural Research,1998, , , , , , 
THE MOLECULAR GENETICS OF GYNECOLOGIC CANCERS,6123623, , ,Intramural Research,1998, , , , , , 
"ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS",6123644, , ,Intramural Research,1998, , , , , , 
PHARMACOLOGY OF ANTIMETABOLITE AGENTS,6123656, , ,Intramural Research,1998, , , , , , 
MOLECULAR PATHOGENESIS OF MULTIPLE MYELOMA,6123664, , ,Intramural Research,1998, , , , , , 
LYMPHOMA STUDIES,6123680, , ,Intramural Research,1998, , , , , , 
MOLECULAR BIOLOGY OF PEDIATRIC TUMORS,6123690, , ,Intramural Research,1998, , , , , , 
MECHANISMS OF ONCOGENE ACTION IN TUMORIGENESIS,6123696, , ,Intramural Research,1998, , , , , , 
MOLECULAR BIOLOGY OF PROGRESSION IN LYMPHOPROLIFERATIVE DISEASES,6123717, , ,Intramural Research,1998, , , , , , 
P53 MUTATIONS IN BREAST CANCER WITH C-ERBB2,6123722, , ,Intramural Research,1998, , , , , , 
HISTOLOGICAL FINDINGS IN PREMENOPAUSAL WOMEN WITH BREAST CANCER,6123729, , ,Intramural Research,1998, , , , , , 
DETERMINATION OF GENETIC MUTATIONS IN ATYPICAL AND CANCEROUS BREAST LESIONS,6123732, , ,Intramural Research,1998, , , , , , 
CD28 RECEPTOR RESPONSE IN T CELLS MEDIATED BY C-REL AND ATF-1/CREB2 CROSSTALK,6123739, , ,Intramural Research,1998, , , , , , 
ROLE OF HSP90/GFP94 CHAPERONE PROTEINS IN CELLULAR SIGNAL TRANSDUCTION,6123746, , ,Intramural Research,1998, , , , , , 
PHASE I/II STUDY OF VACCINIA-HPV RECOMBINANT,6123747, , ,Intramural Research,1998, , , , , , 
MOLECULAR BIOLOGY OF THORACIC NEOPLASMS,6123758, , ,Intramural Research,1998, , , , , , 
BRCAL AND P21 IN CELL CYCLING,6124445,1/7/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,2000,221931, ,NCI, , ,221931
SELENIUM--ANTIOXIDANT OR PROOXIDANT MECHANISM,6124465,12/10/1997 0:00,11/30/2001 0:00,Non-SBIR/STTR,2000,157722, ,NCI, , ,157722
G2 CHECKPOINT CONTROL IN TRANSFORMED HUMAN CELLS,6124470,12/1/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2000,256339, ,NCI, , ,256339
INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN D,6124481,12/24/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2000,218191, ,NCI, , ,218191
MECHANISM OF P53 DEPENDENT APOPTOSIS,6124491,12/5/1997 0:00,11/30/2002 0:00,Non-SBIR/STTR,2000,102200, ,NCI, , ,102200
HUMAN ABERRANT CRYPT FOCI--BIOMARKERS FOR COLON CANCER,6124508,2/9/1996 0:00,11/30/2000 0:00,Non-SBIR/STTR,2000,212073, ,NCI, , ,212073
HUMAN MAMMARY EPITHELIAL CELL IMMORTALIZATION,6124518,12/12/1997 0:00,11/30/2002 0:00,Non-SBIR/STTR,2000,229343, ,NCI, , ,229343
AFB1 AND P53 CARCINOGENESIS IN HBSAG TRANSGENIC MICE,6124558,12/15/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,2000,235213, ,NCI, , ,235213
CERAMIDE SIGNALING IN RADIATION INDUCED APOPTOSIS,6124606,7/15/1990 0:00,11/30/2001 0:00,Non-SBIR/STTR,2000,394979, ,NCI, , ,394979
RAPAMYCIN INDUCED SELECTIVE APOPTOSIS IN MALIGNANT CELLS,6124635,12/1/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,2000,290291, ,NCI, , ,290291
REGULATION OF P53 FUNCTION BY BRCA1 TUMOR SUPPRESSOR,6124659,12/11/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,2000,184563, ,NCI, , ,184563
CANCER-RELATED GLYCOLYTIC GENE--REGULATION/TARGETING,6124672,12/11/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2000,232398, ,NCI, , ,232398
ADENOVIRUS BASED P53 GENE THERAPY FOR OVARIAN CANCER,6124675,12/8/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2000,107690, ,NCI, , ,107690
"MUTUAL REGULATION OF P53, MDM2 AND NFKB:",6124705,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2000,204557, ,NCI, , ,204557
G2/M DNA DAMAGE CHECKPOINT IN BUDDING YEAST,6125409,1/1/1991 0:00,11/30/2001 0:00,Non-SBIR/STTR,2000,218768, ,NIGMS, , ,218768
STRUCTURE AND FUNCTION OF CTCF--TRANSGENIC MICE STUDIES,6126596,6/5/1996 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,363792, ,NCI, , ,363792
ARF AS A THERAPEUTIC AGENT IN ORAL MALIGNANCIES,6126653,4/1/2000 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,266482, ,NIDCR, , ,266482
MULTISTEP LYMPHOMAGENESIS,6127452,5/1/1997 0:00,4/30/2005 0:00,Non-SBIR/STTR,2000,280757, ,NCI, , ,280757
GELSOLIN--ROLES IN APOPTOSIS AND TUMOR DEVELOPMENT,6128259,5/1/1995 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,301399, ,NHLBI, , ,301399
SOFT TISSUE SARCOMA--P53 AND VEGF INDUCTION,6128862,9/30/1995 0:00,3/30/2005 0:00,Non-SBIR/STTR,2000,236250, ,NCI, , ,236250
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS,6129949,9/1/2000 0:00,8/31/2005 0:00,Non-SBIR/STTR,2000,435532, ,NCI, , ,435532
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER,6130459,5/8/2000 0:00,2/28/2005 0:00,Other,2000,1068291, ,NCI, , ,1068291
GI HORMONES AND OTHER FACTORS IN GROWTH OF GI MUCOSA,6130986,12/1/1977 0:00,3/31/2005 0:00,Non-SBIR/STTR,2000,380671, ,NIDDK, , ,380671
EFFICACY STUDIES OF CHEMOPREVENTIVE AGENTS,6131186,7/15/1999 0:00,6/29/2001 0:00,R and D Contracts,1999,388430, ,NCI, , ,388430
"BCL-2 GENE FAMILY, APOPTOSIS RESISTANCE & BREAST CANCER",6131276,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,74250, ,NCI, , ,74250
INVESTIGATION OF ANGIOGENIC FUNCTION IN CANCER BY MRI,6131614,3/8/2000 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,105280, ,NCI, , ,105280
MOLECULAR EPIDEMIOLOGY OF RENAL CELL CANCER,6131649,5/1/2000 0:00,4/30/2002 0:00,Non-SBIR/STTR,2000,79000, ,NCI, , ,79000
GENETIC ELEMENTS TRANSFORMING MOUSE FIBROBLASTS,6132502,1/3/1994 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,294368, ,NCI, , ,294368
THERAPEUTIC MODULATION OF ANGIOGENESIS IN HUMAN GLIOMAS,6132980,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2000,339930, ,NCI, , ,339930
MULTIDICIPLINARY FUNCTIONAL IMAGING OF CANCER,6132991,7/1/2000 0:00,6/30/2003 0:00,Other,2000,400000, ,NCI, , ,400000
ECOGENETICS OF PANCREATIC CANCER--FAMILY REGISTRY,6133101,9/30/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,140716, ,NCI, , ,140716
MODULATING BASE EXCISION REPAIR IN TUMOR DRUG RESISTANCE,6133292,4/1/2000 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,275400, ,NCI, , ,275400
CLINICAL AND EPIDEMIOLOGIC CENTER FOR BIOMARKERS,6133583,5/1/2000 0:00,2/28/2005 0:00,Other,2000,838449, ,NCI, , ,838449
ADENOVIRAL VECTOR FOR FHIT GENE TRANSFER,6135030,7/1/2000 0:00, ,"Training, Individual",2000,46300, ,NCI, , ,46300
TRANSLATIONAL RESEARCH IN LUNG CANCER,6135128,9/30/1997 0:00,9/29/2002 0:00,Other Research-Related,1998,49703, ,NCI, , ,49703
MECHANISMS OF CELLULAR RADIOSENSITIVITY,6135297,7/1/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,224906, , , , 
IN VIVO IMAGING OF NEOPLASIA,6135908,4/12/2000 0:00,3/31/2003 0:00,Other,2000,400000, ,NCI, , ,400000
PEDIATRIC ONCOLOGY GROUP,6137374,1/1/1978 0:00,12/31/2002 0:00,Other Research-Related,2000,206415, ,NCI, , ,206415
PEDIATRIC ONCOLOGY GROUP,6137412,1/1/1983 0:00,12/31/2002 0:00,Other Research-Related,2000,83583, ,NCI, , ,83583
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,6137446,1/1/1987 0:00,12/31/2003 0:00,Non-SBIR/STTR,2000,326061, ,NCI, , ,326061
MECHANISM OF LARGE T ANTIGEN INDUCED TUMORIGENESIS,6137460,3/1/1988 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,387228, ,NCI, , ,387228
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,6137480,8/1/1990 0:00,12/31/2003 0:00,Non-SBIR/STTR,2000,360850, ,NCI, , ,360850
FUNCTION OF THE ADENOVIRUS E1B ONCOGENE,6137484,1/1/1991 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000,194853, ,NCI, , ,194853
ADDUCT INDUCED FRAMESHIFT MUTAGENESIS,6137495,2/15/1992 0:00,12/31/2003 0:00,Non-SBIR/STTR,2000,217822, ,NCI, , ,217822
SUNLIGHT RELATED STEPS IN HUMAN SKIN CANCER,6137496,4/1/1992 0:00,12/31/2002 0:00,Non-SBIR/STTR,2000,320306, ,NCI, , ,320306
P53S DIRECT ROLE IN MITOCHONDRIAL CONTROL OF APOPTOSIS,6137522,9/15/1993 0:00,12/31/2002 0:00,Non-SBIR/STTR,2000,205321, ,NCI, , ,205321
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM,6137529,3/18/1994 0:00,12/31/2002 0:00,Non-SBIR/STTR,2000,90245, ,NCI, , ,90245
MECHANISMS OF P53 DEPENDENT APOPTOSIS,6137558,3/1/1996 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,300414, ,NCI, , ,300414
MOLECULAR PROGNOSTIC INDICATORS IN ESOPHAGEAL CANCER,6137575,3/1/1998 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,409109, ,NCI, , ,409109
EPISOMAL VECTORS FOR COLON CANCER GENE THERAPY,6137584,1/20/1997 0:00,12/31/2000 0:00,Non-SBIR/STTR,2000,135915, ,NCI, , ,135915
REGULATION OF BCL2 BY RAS AND TUMOR SUPPRESSORS,6137587,1/1/1997 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,210117, ,NCI, , ,210117
CENTROSOME HYPERTROPHY IN HUMAN BREAST TUMORS,6137589,1/1/1998 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,263071, ,NCI, , ,263071
H PYLORI PHENOTYPE AND STOMACH CANCER,6137592,1/25/1997 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,158885, ,NCI, , ,158885
EXCISION REPAIR OF UV RADIATION-INDUCED DNA DAMAGE,6137593,2/1/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,2000,304860, ,NCI, , ,304860
SIGNALING PATHWAYS UTILIZED BY V-ABL AND BCR-ABL,6137618,1/20/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2000,713043, ,NCI, , ,713043
P53 GENE THERAPY FOR LOCALLY ADVANCED BLADDER CANCER,6137634,1/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,2000,144915, ,NCI, , ,144915
MDM2 AND CELL GROWTH AND TUMORIGENESIS,6137670,3/1/1999 0:00,12/31/2002 0:00,Non-SBIR/STTR,2000,241909, ,NCI, , ,241909
PROPERTIES AND REGULATION OF P53 IN TUMOR CELLS,6137671,3/23/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2000,272757, ,NCI, , ,272757
DUAL ROLE OF E2F1 IN TUMORIGENESIS,6137688,1/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2000,322276, ,NCI, , ,322276
TUMOR SUPPRESSORS AND DIFFERENTIATED THYROID CANCER,6137717,1/5/1999 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,249425, ,NCI, , ,249425
ONCOLYTIC ADENOVIRUSES--CERVICAL CANCER GENE THERAPY,6137721,3/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2000,212736, ,NCI, , ,212736
P53 AND THE CELLULAR RESPONSE TO DNA DAMAGE,6138106,1/1/1992 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,276647, ,NIEHS, , ,276647
LOH AT 3P AND P53 AND K-RAS MUTATION IN LUNG CANCER,6138114,1/1/1997 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,336466, ,NIEHS, , ,336466
ROLE AND REGULATION OF CDK4 IN THE NORMAL LENS,6138198,1/26/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,2000,336401, ,NEI, , ,336401
REGULATION OF THE STEROL BIOSYNTHESIS PATHWAY IN YEAST,6138398,1/1/1986 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,331203, ,NIGMS, , ,331203
EBV BZLF1 GENE PRODUCT,6138445,1/1/1993 0:00,8/31/2000 0:00,Non-SBIR/STTR,2000,220544, ,NIGMS, , ,220544
NOVEL CYCLINS G1 AND G2,6138613,1/1/1998 0:00,12/31/2000 0:00,Non-SBIR/STTR,2000,161280, ,NIGMS, , ,161280
BCL-2 FAMILY AND P53 GENES ALTER APOPTOSIS IN GLIOMAS,6139493,1/1/1993 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,224565, ,NINDS, , ,224565
DIHYDRODIOL DEHYDROGENASE AND PAH METABOLISM/ACTIVATION,6140642,3/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,1999,19884, ,NCI, , ,19884
NOVEL GENE THERAPEUTIC FOR THE TREATMENT OF LUNG CANCER,6141760,5/1/2000 0:00,10/31/2001 0:00,SBIR/STTR,2000,238528, ,NCI, , ,238528
P53 MUTATION ANALYSIS FOR BLADDER CANCER PROGNOSIS,6143546,7/1/1998 0:00,5/31/2002 0:00,SBIR/STTR,2000,391995, ,NCI, , ,391995
APOPTOTIC PATHWAYS FOLLOWING CHEMOTHERAPY OR GENE THERAPY OF ORAL CANCER,6144262,8/1/1999 0:00,7/31/2000 0:00,Research Centers,1999, ,129614, , , , 
"BCL-2 GENE FAMILY, APOPTOSIS RESISTANCE AND BREAST CANCE",6145822,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999,12252, ,NCI, , ,12252
HCMV IN AIDS--DISRUPTION OF CELL CYCLE REGULATION,6146752,3/1/2000 0:00,2/28/2005 0:00,Non-SBIR/STTR,2000,283997, ,NIAID, , ,283997
"PML, PLZF AND NPM IN THE MOLECULAR PATHOGENESIS OF APL",6148162,9/15/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999,76852, ,NCI, , ,76852
"DIETARY HETEROCYCLIC AMINES, GENETIC SUSCEPTIBILITY, AND",6148242,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,1999,11678, ,NCI, , ,11678
KARP 1 V(D)J RECOMBINATION AND DNA REPAIR,6149793,5/1/1994 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,296685, ,NIAID, , ,296685
FRAGILE SITES AND CHROMOSOME BREAKAGE AND CANCER,6149954,7/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,265486, ,NCI, , ,265486
DNA REPAIR AND CANCER PRONE HEREDITARY HUMAN DISEASE,6149957,2/1/1987 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,302140, ,NCI, , ,302140
VIRAL GENE FUNCTIONS AND REGULATION OF CELL GROWTH,6149987,9/1/1975 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,378436, ,NCI, , ,378436
HORMONAL REGULATION OF BREAST CANCER,6149993,8/1/1978 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,545765, ,NCI, , ,545765
DIHYDRODIOL DEHYDROGENASE AND PAH METABOLISM/ACTIVATION,6150014,3/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,250564, ,NCI, , ,250564
"C-, N-, AND L-MYC EFFECTS ON HEMATOPOIETIC CELLS",6150036,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,205534, ,NCI, , ,205534
CELL GROWTH CONTROL BY BRCA1/ITS RESPONSE TO DNA DAMAGE,6150038,4/1/1999 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,224463, ,NCI, , ,224463
MECHANISMS OF INDUCTION OF SKIN CANCERS BY UV LIGHT,6150074,7/1/1988 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,171550, ,NCI, , ,171550
C MYC--TRANSCRIPTION AND APOPTOSIS,6150094,1/1/1990 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,364289, ,NCI, , ,364289
MOLECULAR REGULATION OF FOLATE AND ANTIFOLATE TRANSPORT,6150099,2/12/1993 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,229005, ,NCI, , ,229005
"GLIOMAS--BIOLOGIC, MOLECULAR AND GENETIC STUDIES",6150107,8/1/1992 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,1023265, ,NCI, , ,1023265
PROGRESSION OF T CELL LYMPHOMA LINES TO IL2 INDEPENDENCE,6150115,7/1/1992 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,343720, ,NCI, , ,343720
ACTIVATION OF BCL 2 IN HEMATOLOGIC MALIGNANCIES,6150118,8/1/1993 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,227407, ,NCI, , ,227407
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN GLIOMAS,6150127,8/1/1992 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,278443, ,NCI, , ,278443
UV INDUCIBLE INHIBITION IN MELANOMA,6150140,5/5/1993 0:00,1/31/2001 0:00,Non-SBIR/STTR,2000,321408, ,NCI, , ,321408
MONOCLONAL GAMMOPATHIES,6150163,9/30/1994 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,1295729, ,NCI, , ,1295729
MUTANT P53 GAIN OF FUNCTION IN TUMORIGENESIS,6150175,4/1/1995 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,241221, ,NCI, , ,241221
NEW METHODS FOR CANCER DETECTION,6150190,3/1/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000,901039, ,NCI, , ,901039
DEVELOPMENT OF MOLECULAR MARKERS FOR PROSTATE CANCER,6150213,2/13/1996 0:00,1/31/2001 0:00,Non-SBIR/STTR,2000,116572, ,NCI, , ,116572
EXPRESSION AND FUNCTIONS OF MDM2 PROTEINS,6150221,2/1/1997 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,118772, ,NCI, , ,118772
EVALUATION OF PREDICTORS FOR RECURRENT ADENOMAS,6150242,2/14/1997 0:00,6/30/2000 0:00,Non-SBIR/STTR,2000,125899, ,NCI, , ,125899
GENETIC EVENTS IN HUMAN PROSTATE CELL TRANSFORMATION,6150270,2/1/1998 0:00,1/31/2003 0:00,Other Research-Related,2000,92070, ,NCI, , ,92070
ANTIAPOPTOTIC MECHANISMS IN PROSTATE CANCER,6150309,4/1/1998 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,262675, ,NCI, , ,262675
STRUCTURE/FUNCTION OF S100 PROTEIN,6150330,2/1/1999 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,229270, ,NIGMS, , ,229270
G2 CHECKPOINT INTEGRITY IN P53 DEPLETED CELLS,6150351,2/16/1999 0:00,11/30/2000 0:00,Other Research-Related,2000,86733, ,NCI, , ,86733
TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS,6150374,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,243759, ,NCI, , ,243759
EXPERIMENTAL TRANSFORMATION OF HUMAN MELANOCYTES IN VIVO,6150379,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,289570, ,NCI, , ,289570
INTRAGENIC SUPPRESSOR MUTATIONS FOR P53 CANCER MUTATIONS,6150392,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2000,248600, ,NCI, , ,248600
INHIBITION OF PAPILLOMAVIRUSES IN ORAL EPITHELIUM,6150522,2/1/1994 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,228672, ,NIDCR, , ,228672
MOLECULAR MARKERS OF ORAL CANCER RISK,6150530,4/1/1997 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,306929, ,NIDCR, , ,306929
PHOSPHOPEPTIDE MODELS OF P53 PROTEIN FRAGMENTS,6151185,2/1/1998 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,178014, ,NIGMS, , ,178014
TRANSLATIONAL CORRELATES OF AN EPOTHILONE B ANALOG,6152969,4/1/2000 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,83813, ,NCI, , ,83813
SPORE IN BREAST CANCER,6153865,9/15/1995 0:00,8/31/2001 0:00,Research Centers,1999,333333, ,NCI, , ,333333
NOVEL NUCLEAR PROTEINS IN NORMAL AND CANCER CELLS,6155123,3/1/1992 0:00,2/28/2002 0:00,Non-SBIR/STTR,1999,82000, ,NCI, , ,82000
CELL CYCLE AND CELL DEATH STUDIES IN THE OCULAR LENS,6156546,9/1/1994 0:00,8/31/2000 0:00,Non-SBIR/STTR,1999,31080, ,NEI, , ,31080
CATIONIC LIPID/P53 GENE THERAPY IN LUNG CANCER PATIENTS,6157641,3/1/2000 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000,370514, ,NCI, , ,370514
MECHANISMS OF INTESTINAL CARCINOGENESIS OF DISINFECTION,6158348,3/1/2000 0:00,6/30/2000 0:00,Non-SBIR/STTR,2000,16690, ,NIEHS, , ,16690
RODENT PRODUCTION CENTER,6159009,9/28/1999 0:00,9/30/2007 0:00,R and D Contracts,1999,815391, ,NIEHS, , ,815391
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION,6159312,5/1/1998 0:00,2/28/2003 0:00,Non-SBIR/STTR,2000,13344, ,NCI, , ,13344
EFFICACY STUDIES OF CHEMOPREVENTIVE AGENTS,6159881,7/15/1999 0:00,6/29/2001 0:00,R and D Contracts,2000, , , , , , 
"AGING, ANGIOGENESIS, AND THE GROWTH AND SPREAD OF TUMORS",6160397, , ,Intramural Research,1997, , , , , , 
"STRESS, DIFFERENTIATON, GROWTH ARREST AND PROGRAMMED CELL DEATH",6160435, , ,Intramural Research,1997, , , , , , 
GENE THERAPY TO INHIBIT INTIMAL HYPERPLASIA AFTER ENDOVASCULAR INJURY,6160506, , ,Intramural Research,1997, , , , , , 
REGULATION OF APOPTOSIS,6160847, , ,Intramural Research,1997, , , , , , 
MECHANISMS OF DIET AND CHEMOPREVENTION IN P53 DEFICIENT MICE,6160853, , ,Intramural Research,1997, , , , , , 
MODEL SYSTEMS FOR STUDY OF CHEMICAL CARCINOGENESIS AT THE CELLULAR LEVEL,6160861, , ,Intramural Research,1997, , , , , , 
BIOLOGY AND PATHOLOGY OF NATURAL AND EXPERIMENTALLY INDUCED TUMORS,6160894, , ,Intramural Research,1997, , , , , , 
ONCOGENE EXPRESSION IN CHEMICALLY INDUCED TUMORS,6160904, , ,Intramural Research,1997, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN CANCER,6160911, , ,Intramural Research,1997, , , , , , 
PATHOGENESIS AND EVOLUTION OF HUMAN T CELL LEUKEMIA/LYMPHOTROPIC VIRUSES,6160939, , ,Intramural Research,1997, , , , , , 
GENETIC ALTERATIONS AND ALLELIC LOSS IN HUMAN HEPATOCELLULAR CARCINOMA,6160942, , ,Intramural Research,1997, , , , , , 
INTERACTION OF HTLV-1 TAX WITH CELLULAR REGULATORY PROTEINS,6160951, , ,Intramural Research,1997, , , , , , 
MUTATIONAL AND FUNCTIONAL ANALYSIS OF THE P53 TUMOR SUPPRESSOR GENE,6160979, , ,Intramural Research,1997, , , , , , 
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS,6160984, , ,Intramural Research,1997, , , , , , 
MOLECULAR BIOLOGY OF CELLULAR INJURY,6160993, , ,Intramural Research,1997, , , , , , 
NEW STRATEGIES FOR DRUG DISCOVERY AND DEVELOPMENT,6160997, , ,Intramural Research,1997, , , , , , 
CELL CYCLE REGULATION AND CHEMOSENSITIVITY,6160999, , ,Intramural Research,1997, , , , , , 
"HORMONES, ANTIHORMONES AND GROWTH FACTORS IN MAMMARY DEVELOPMENT & TUMORIGENESIS",6161005, , ,Intramural Research,1997, , , , , , 
"GENES, MICE, SIGNALING AND CANCER",6161091, , ,Intramural Research,1997, , , , , , 
STRUCTURE AND EXPRESSION OF THE C-MYC/PVT 1 MEGAGENE LOCUS,6161115, , ,Intramural Research,1997, , , , , , 
ROLE OF TOBACCO RELATED CHEMICAL CARCINOGENS AND OXYRADICALS IN HUMAN CANCER,6161125, , ,Intramural Research,1997, , , , , , 
MOLECULAR MECHANISMS GOVERNING B AND T CELL DIFFERENTIATION AND NEOPLASIA,6161302, , ,Intramural Research,1997, , , , , , 
PRECLINICAL MODELS FOR TESTING OF BIOLOGICAL CANCER THERAPEUTICS,6161318, , ,Intramural Research,1997, , , , , , 
EPIDEMIOLOGY AND PATHOGENESIS OF HEPATITIS B AND C VIRUSES,6161360, , ,Intramural Research,1997, , , , , , 
HEPATITIS B VIRUS AND CELLULAR PROTEINS IN ITS PATHOGENESIS,6161362, , ,Intramural Research,1997, , , , , , 
RESEARCH IN BIOSTATISTICAL METHODOLOGY AND MATHEMATICAL MODELING,6161594, , ,Intramural Research,1997, , , , , , 
BIOLOGIC SPECIMEN BANK FOR EARLY LUNG CANCER MARKERS IN CHINESE TIN MINERS,6161603, , ,Intramural Research,1997, , , , , , 
PHARMACOGENETIC STUDIES,6161628, , ,Intramural Research,1997, , , , , , 
CONSULTING AND COLLABORATION ON LABORATORY STUDIES,6161654, , ,Intramural Research,1997, , , , , , 
STUDIES OF MEDICAL RADIATION AND OTHER THERAPEUTIC AGENTS,6161655, , ,Intramural Research,1997, , , , , , 
ORAL CARCINOGENESIS,6161812, , ,Intramural Research,1997, , , , , , 
BIOMARKERS FOR ORAL CANCER,6161821, , ,Intramural Research,1997, , , , , , 
CASE CONTROL STUDY OF ORAL AND PHARYNGEAL CANCER IN PUERTO RICO,6161840, , ,Intramural Research,1997, , , , , , 
MOLECULAR ANALYSIS OF CELL CYCLE CONTROL DURING CARCINOGENESIS,6162106, , ,Intramural Research,1997, , , , , , 
TRANSGENIC MOUSE MODELS FOR IDENTIFYING AND CHARACTERIZING CARCINOGENS,6162128, , ,Intramural Research,1997, , , , , , 
DEVELOPMENT OF AN IN VIVO MODEL OF GENOMIC INSTABILITY (LACI--P53(+/-)MICE),6162130, , ,Intramural Research,1997, , , , , , 
IN VITRO MUTAGENESIS STUDIES USING MAMMALIAN CELL LINES,6162131, , ,Intramural Research,1997, , , , , , 
K RAS AND P53 MUTATIONS IN UTERINE SARCOMAS,6162133, , ,Intramural Research,1997, , , , , , 
MOLECULAR GENETICS OF AROMATIC AMINE INDUCED BLADDER CANCER,6162134, , ,Intramural Research,1997, , , , , , 
CARBONYL SULFIDE CLEAN AIR ACT STUDIES,6162140, , ,Intramural Research,1997, , , , , , 
RECOGNITION AND PROCESSING OF ABERRANT P53 PROTEIN IN CANCER CELLS,6162157, , ,Intramural Research,1997, , , , , , 
SIGNALING OF APOPTOSIS DURING CELL TRANSFORMATION,6162163, , ,Intramural Research,1997, , , , , , 
ROLE OF DIETARY RESTRICTION ON CELL TRANSFORMATION,6162165, , ,Intramural Research,1997, , , , , , 
RETINOID SIGNALING PATHWAYS,6162175, , ,Intramural Research,1997, , , , , , 
EXPOSURE SPECIFIC MUTATION IN CRITICAL TARGET GENES,6162227, , ,Intramural Research,1997, , , , , , 
DELINEATION OF CHROMOSOMAL ABERRATIONS DURING THE PROGRESSION OF SOLID TUMORS,6162574, , ,Intramural Research,1997, , , , , , 
MOLECULAR ANALYSIS OF APOPTOSIS IN TUMORS OF THE CENTRAL NERVOUS SYSTEM,6163109, , ,Intramural Research,1997, , , , , , 
P53 MUTATIONS IN BREAST CANCER WITH C-ERBB2,6163350, , ,Intramural Research,1997, , , , , , 
IMMUNOCYTOCHEMICAL/MOLECULAR PATHOLOGY TECHNIQUES APPLIED TO CYTOPATHOLOGY,6163430, , ,Intramural Research,1998, , , , , , 
ENHANCEMENT OF ANTICANCER DRUG ACTIVITY BY INTERLEUKIN 1A,6163437, , ,Intramural Research,1998, , , , , , 
APOPTOSIS & MALIGNANT PROGRESSION IN MAMMARY TUMOR CELLS,6163786,5/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,274062, ,NIA, , ,274062
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION,6163895,7/1/1986 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000,1503252, ,NCI, , ,1503252
DNA METHYLATION IN DEVELOPMENT AND CANCER,6164060,5/1/1989 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000,121340, ,NCI, , ,121340
GENETIC EPIDEMIOLOGY OF LUNG CANCER,6164088,12/15/1994 0:00,2/29/2004 0:00,Non-SBIR/STTR,2000,620988, ,NCI, , ,620988
NITROAROMATICS AND BREAST CANCER,6164107,7/1/1983 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000,276609, ,NCI, , ,276609
DOMINANT-NEGATIVE AND GAIN OF FUNCTION P53 MUTATIONS,6164194,5/10/1996 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,221278, ,NCI, , ,221278
BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH & PROGRESSION,6164195,5/6/1996 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000,1506021, ,NCI, , ,1506021
PROTEASES AND CHEMOTHERAPY INDUCED APOPTOSIS,6164199,4/1/1995 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,222856, ,NCI, , ,222856
MARKERS FOR LUNG CARCINOGENESIS IN BRONCHIAL EPITHELIUM,6164212,3/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,453532, ,NCI, , ,453532
DNA MUTATION BIOMARKERS FOR NONMELANOMA SKIN CANCER,6164214,5/1/1996 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,109162, ,NCI, , ,109162
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA,6164235,5/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,258042, ,NCI, , ,258042
GENETIC DETERMINANTS OF TUMORIGENESIS,6164242,5/1/1999 0:00,2/29/2004 0:00,Non-SBIR/STTR,2000,1178123, ,NCI, , ,1178123
MOLECULAR STAGING AND SCREENING OF LUNG CANCER,6164256,3/1/1998 0:00,12/31/2000 0:00,Other Research-Related,2000,90990, ,NCI, , ,90990
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION,6164267,5/1/1998 0:00,2/28/2003 0:00,Non-SBIR/STTR,2000,302775, ,NCI, , ,302775
REGULATION OF MAMMALIAN APURINIC ENDONUCLEASE GENE,6164302,2/12/2000 0:00, ,"Training, Individual",2000,18006, ,NCI, , ,18006
PATHOGENESIS OF MESENCHYMAL TUMORS INDUCED BY ASBESTOS,6164600,6/15/1985 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,229800, ,NIEHS, , ,229800
PROTECTION AGAINST APOPTOSIS BY SCATTER FACTOR,6164621,3/1/1998 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,242717, ,NIEHS, , ,242717
CLONING GENES THAT REGULATE MYOCARDIOCYTE PROLIFERATION,6165022,7/1/1990 0:00,2/28/2003 0:00,Non-SBIR/STTR,2000,334568, ,NHLBI, , ,334568
GENETIC ELEMENTS SUPPRESSING P53,6165463,3/1/1998 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000,25220, ,FIC, , ,25220
BIOCHEMICAL STUDIES OF HUMAN DNA POLYMERASE DELTA,6165928,4/1/1983 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,17998, ,NIGMS, , ,17998
TARGETING THERAPY OF HUMAN BREAST CANCER,6166742,6/1/2001 0:00,5/31/2003 0:00,Non-SBIR/STTR,2001,127875, ,NCI, , ,127875
MOLECULAR MARKERS OF ORAL CANCER RISK,6166918,4/1/1997 0:00,1/31/2001 0:00,Non-SBIR/STTR,1999,69880, ,NIDCR, , ,69880
CALORIE RESTRICTION AGING AND PROGRAMMED CELL DEATH,6168818,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,213063, ,NIA, , ,213063
MECHANISMS OF REPLICATIVE SENESCENCE IN CELLS,6168909,4/1/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,293831, ,NIA, , ,293831
T CELL DEVELOPMENT & LYMPHOMAGENESIS IN TRANSGENIC MICE,6169574,9/30/1999 0:00,8/31/2002 0:00,Other Research-Related,2000,121554, ,NIAID, , ,121554
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS,6170530,8/1/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2000,224803, ,NIAID, , ,224803
PIK RELATED KINASES IN THE RESPONSE TO DNA DAMAGE BY UV,6171512,6/1/1999 0:00,5/31/2004 0:00,Other Research-Related,2000,121882, ,NIAMS, , ,121882
CYTOTOXIC MECHANISMS IN CUTANEOUS DISEASE,6171547,1/1/1980 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,259513, ,NIAMS, , ,259513
ALTERATIONS OF CELL CYCLE CONTROL IN MELANOCYTIC LESIONS,6171766,7/15/1999 0:00,9/29/2000 0:00,Other Research-Related,2000,30092, ,NIAMS, , ,30092
MOLECULAR MECHANISMS OF GROWTH CONTROL--PROSTATE CANCER,6171920,9/30/1992 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,234015, ,NCI, , ,234015
PROGRESSION OF THE TRANSFORMED PHENOTYPE,6171991,4/1/1984 0:00,11/30/2002 0:00,Non-SBIR/STTR,2000,234156, ,NCI, , ,234156
DNA PHOTOLESION STRUCTURE ACTIVITY RELATIONSHIPS,6172039,7/1/1985 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000,328506, ,NCI, , ,328506
GENE REGULATION BY ONCOGENES AND TUMOR SUPPRESSOR GENES,6172051,5/1/1986 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000,1162811, ,NCI, , ,1162811
ALTERATION OF NAD METABOLISM BY CHEMICAL CARCINOGENS,6172056,4/1/1986 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000,91844, ,NCI, , ,91844
RETROVIRUSES AND CANCER GENES,6172071,7/1/1987 0:00,4/30/2002 0:00,Non-SBIR/STTR,2000,1751380, ,NCI, , ,1751380
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,6172097,7/15/1981 0:00,5/31/2002 0:00,Non-SBIR/STTR,2000,228139, ,NCI, , ,228139
CHILDHOOD SOLID TUMORS,6172119,8/1/1978 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,1607746, ,NCI, , ,1607746
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY,6172145,7/15/1988 0:00,9/29/2002 0:00,Non-SBIR/STTR,2000,1497565, ,NCI, , ,1497565
MODULATION OF ARA-C INDUCED APOPTOSIS BY BRYOSTATIN 1,6172159,6/1/1994 0:00,4/30/2003 0:00,Non-SBIR/STTR,2000,266018, ,NCI, , ,266018
BREAST CANCER GROWTH SUPPRESSOR GENE,6172164,2/1/1994 0:00,4/30/2002 0:00,Non-SBIR/STTR,2000,228649, ,NCI, , ,228649
MUTAGENESIS OF SPECIFIC REGIONS OF THE SV 40 GENOME,6172166,9/1/1978 0:00,4/30/2002 0:00,Non-SBIR/STTR,2000,317757, ,NCI, , ,317757
RACIAL DIFFERENCES IN BREAST CANCER SURVIVAL,6172218,8/5/1996 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,460810, ,NCI, , ,460810
PATHOGENESIS OF MALIGNANT FIBROMATOSIS,6172302,3/1/1988 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,230042, ,NCI, , ,230042
BIOCHEMICAL AND CYTOGENETIC MARKERS IN RETINOBLASTOMA,6172350,4/1/1991 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,165423, ,NCI, , ,165423
RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONS,6172360,6/1/1983 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,307736, ,NCI, , ,307736
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE,6172365,5/1/1994 0:00,5/31/2004 0:00,Non-SBIR/STTR,2000,677399, ,NCI, , ,677399
HUMAN MAMMARY CELLS,6172383,9/1/1979 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,507729, ,NCI, , ,507729
MECHANISM OF PDGF INDUCED APOPTOSIS,6172423,7/15/1996 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,109481, ,NCI, , ,109481
ADJUVANT HORMONAL THERAPY IN VIETNAMESE BREAST CANCER,6172429,7/1/1995 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,236059, ,NCI, , ,236059
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,6172525,6/1/1993 0:00,4/30/2003 0:00,Non-SBIR/STTR,2000,468613, ,NCI, , ,468613
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS,6172542,9/30/1986 0:00,5/31/2004 0:00,Non-SBIR/STTR,2000,402935, ,NCI, , ,402935
CELL CELL INTERACTIONS IN PROSTATE CANCER,6172546,5/1/1993 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000,269842, ,NCI, , ,269842
PROGRESSION MECHANISMS--ONCOGENE INDUCED PROSTATE CANCER,6172553,9/8/1989 0:00,5/31/2001 0:00,Non-SBIR/STTR,2000,296303, ,NCI, , ,296303
POLYAMINE ANALOG AND INHIBITOR REGULATION OF CELL CYCLE,6172556,8/1/1989 0:00,4/30/2004 0:00,Non-SBIR/STTR,2000,285371, ,NCI, , ,285371
REACTIVATION OF P53 FUNCTION AND ANTICANCER THERAPY,6172597,4/15/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000,109822, ,NCI, , ,109822
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMA,6172608,5/15/1991 0:00,10/31/2001 0:00,Non-SBIR/STTR,2000,573412, ,NCI, , ,573412
NUCLEAR IMAGING OF TUMORS--BIOLOGICAL AND CHEMICAL BASIS,6172622,4/1/1983 0:00,5/31/2002 0:00,Non-SBIR/STTR,2000,321773, ,NCI, , ,321773
GENETIC STAGING OF BREAST CANCERS FOR ADJUVANT THERAPY,6172623,7/1/1991 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000,215621, ,NCI, , ,215621
IN VIVO ROLE OF DNA ALKYLATION REPAIR,6172685,8/8/1997 0:00,5/31/2001 0:00,Non-SBIR/STTR,2000,404402, ,NCI, , ,404402
MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER,6172721,9/1/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,570235, ,NCI, , ,570235
G1 AND G2 CHECKPOINTS IN IRRADIATED CELLS,6172737,7/1/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,245934, ,NCI, , ,245934
Adenoviral Based Therapy of Hepatocellular Carcinoma,6172740,7/28/1998 0:00,6/30/2003 0:00,Other Research-Related,2000,84780, ,NCI, , ,84780
P53 TRAFFICKING DURING CELL CYCLE,6172757,7/1/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000,230005, ,NCI, , ,230005
REGULATION OF TUMOR SUPPRESSOR P53 BY PHOSPHORYLATION,6172779,9/1/1996 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,107994, ,NCI, , ,107994
"BCL-2 GENE FAMILY, APOPTOSIS RESISTANCE AND BREAST CANCE",6172780,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000,154866, ,NCI, , ,154866
MOLECULAR MARKERS OF PROGNOSIS IN MEDULLOBLASTOMA,6172787,7/5/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000,272792, ,NCI, , ,272792
MECHANISMS OF CARCINOGENESIS INVOLVING WILD-TYPE,6172819,4/1/1996 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,126991, ,NCI, , ,126991
PAPILLOMAVIRUS TRANSFORMATION,6172829,9/1/1996 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,34627, ,NCI, , ,34627
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES,6172854,9/30/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000,688054, ,NCI, , ,688054
INFLAMMATION AND MULTISTAGE CARCINOGENESIS,6172864,9/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,354750, ,NCI, , ,354750
INDUCTION AND ANALYSIS OF PROSTATE CANCER,6172910,9/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,244766, ,NCI, , ,244766
TISSUE AND SERUM INDICATORS OF LUNG CANCER RECURRENCE,6172943,9/1/1996 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,105136, ,NCI, , ,105136
SV40-LIKE SEQUENCES IN HUMAN TUMORS ANALYSES,6172977,8/1/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000,108500, ,NCI, , ,108500
TRANSLATIONAL CONTROL OF ONCOPROTEIN MDM2 SYNTHESIS,6172981,7/1/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2000,221391, ,NCI, , ,221391
TRANSLATIONAL RESEARCH IN LUNG CANCER,6173007,9/30/1997 0:00,9/29/2002 0:00,Other Research-Related,2000,160720, ,NCI, , ,160720
MECHANISTIC DEVELOPMENT OF PLATINUM BASED DRUGS,6173022,4/1/1999 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,155684, ,NCI, , ,155684
P53-MEDIATED CHEMOSENSITIVITY IN NEUROBLASTOMA,6173031,4/15/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,100341, ,NCI, , ,100341
DNA STRAND BREAKS AND THE GENETIC BASIS OF LYMPHOMAS,6173034,8/12/1998 0:00,4/30/2002 0:00,Non-SBIR/STTR,2000,221090, ,NCI, , ,221090
"DNA ADDUCT, P53 MUTATION, AND ETIOLOGY OF BREAST CANCER",6173093,9/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,188930, ,NCI, , ,188930
TARGETING CANCER CELL DNA WITH COMBINATORIAL LIGANDS,6173103,4/1/1998 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000,180184, ,NCI, , ,180184
PROSTOGLANDINS AND UVB CARCINOGENESIS,6173154,8/14/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,2000,164707, ,NCI, , ,164707
FUNCTIONAL ANALYSIS OF MDM2 OVEREXPRESSION,6173173,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,105000, ,NCI, , ,105000
BENIGN BREAST DISEASE--MOLECULAR DIFFERENTIATION OF RISK,6173234,9/30/1996 0:00,9/29/2004 0:00,Non-SBIR/STTR,2000,388968, ,NCI, , ,388968
TRANSCRIPTIONAL REGULATORS IN CANCER,6173244,6/15/1996 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,1080503, ,NCI, , ,1080503
NUTRITIONAL AND HORMONAL BIOMARKERS IN PROSTATE CANCER,6173255,9/1/1996 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,383773, ,NCI, , ,383773
P53 DIRECTED IMMUNOTHERAPY OF BREAST CANCER,6173259,7/10/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,100640, ,NCI, , ,100640
BREAST CANCER ETIOLOGY--P53 GAIN OF FUNCTION MUTATIONS,6173283,7/1/1996 0:00,4/30/2002 0:00,Non-SBIR/STTR,2000,223160, ,NCI, , ,223160
GENETIC EPIDEMIOLOGY OF GASTRIC CANCER,6173288,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,2000,78673, ,NCI, , ,78673
INDUCTION OF MELANOMA WITH UV-A,6173315,7/2/1997 0:00,4/30/2002 0:00,Non-SBIR/STTR,2000,160912, ,NCI, , ,160912
MODULATION OF P53 FUNCTION BY BINDING PROTEIN BBP/53BP2,6173337,7/10/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,2000,198873, ,NCI, , ,198873
MURINE P73 IN TUMORIGENESIS,6173339,6/15/1998 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,427110, ,NCI, , ,427110
P53 PROTEIN/PROTEIN INTERACTIONS,6173363,8/10/1998 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000,250367, ,NCI, , ,250367
TAILORING ANTICANCER THERAPY TO LOSS OF P53,6173377,6/15/1996 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,272313, ,NCI, , ,272313
P53--DUAL GROWTH CONTROL AND DNA DAMAGE SENSITIZATION,6173386,7/7/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,132860, ,NCI, , ,132860
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER,6173388,9/1/1998 0:00,8/31/2003 0:00,Other Research-Related,2000,90480, ,NCI, , ,90480
REGULATION OF P21 (WAF1/C1P1) BY E2A,6173401,9/30/1997 0:00,8/31/2002 0:00,Other Research-Related,2000,90450, ,NCI, , ,90450
RETINOID INDUCED TUMOR DIFFERENTIATION AND THE CELL CYCL,6173407,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,2000,133391, ,NCI, , ,133391
FATTY ACIDS AND TUMOR CHARACTERISTICS IN BREAST CANCER,6173411,9/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,185853, ,NCI, , ,185853
RAF-1 INDUCED GROWTH AND APOPTOSIS IN BREAST CANCER,6173422,7/15/1996 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000,137906, ,NCI, , ,137906
FATTY ACID SYNTHESIS AND THE CELL CYCLE,6173458,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,117422, ,NCI, , ,117422
SYSTEMIC DELIVERY OF P53 INHIBITS BREAST CANCER,6173461,7/15/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,98598, ,NCI, , ,98598
DETACHMENT SENSITIZES CELLS TO TOPOISOMERASE INHIBITORS,6173474,9/30/1997 0:00,9/29/2002 0:00,Other Research-Related,2000,153070, ,NCI, , ,153070
KILLER/DR5 AND TUMORIGENESIS,6173516,9/14/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,207890, ,NCI, , ,207890
P53 AND REPAIR OF DNA DAMAGE BY ANTICANCER DRUGS,6173519,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,105131, ,NCI, , ,105131
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS,6173523,9/26/1996 0:00,8/31/2001 0:00,Non-SBIR/STTR,2000,94205, ,NCI, , ,94205
MOLECULAR EPIDEMIOLOGY OF PERSISTENT HPV INFECTION,6173539,9/11/1996 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,256700, ,NCI, , ,256700
GROWTH REGULATION OF PROSTATIC CELLS BY ANDROGEN,6173549,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,108752, ,NCI, , ,108752
DIAGNOSIS OF LARGE CELL LYMPHOMA BY SURVIVIN EXPRESSION,6173572,9/7/1999 0:00,8/16/2002 0:00,Non-SBIR/STTR,2000,122625, ,NCI, , ,122625
CDX2 TUMOR SUPPRESSOR PATHWAY DEFECTS IN COLON CANCER,6173590,8/15/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2000,261439, ,NCI, , ,261439
MOLECULAR EPIDEMIOLOGY OF NON-MELANOMA SKIN CANCER,6173618,9/30/1999 0:00,7/31/2003 0:00,Non-SBIR/STTR,2000,352932, ,NCI, , ,352932
IN VIVO SOMATIC MUTATIONS IN CHILDREN WITH CANCER,6173638,9/30/1998 0:00,9/29/2002 0:00,Other Research-Related,2000,161163, ,NCI, , ,161163
DESIGN OF PROGRAMMABLE GENOTOXINS,6173640,6/16/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,2000,354253, ,NCI, , ,354253
H PYLORI RELATIONSHIP TO DIGESTIVE DISEASES AND CANCER,6173667,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,2000,142163, ,NCI, , ,142163
V(D)J RECOMBINASE & CHROMOSOME TRANSLOCATION IN LYMPHOMA,6173701,7/7/1999 0:00,6/30/2004 0:00,Other Research-Related,2000,130410, ,NCI, , ,130410
UNDERSTANDING A NOVEL MODIFIER OF P53 TUMORIGENESIS,6173721,9/1/1999 0:00,8/31/2001 0:00,Other Research-Related,2000,61988, ,NCI, , ,61988
NUTRIENTS EFFECT ON GENOTYPE IN BREAST CANCER,6173728,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,2000,136440, ,NCI, , ,136440
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS,6173740,8/1/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2000,209268, ,NCI, , ,209268
STEM CELL DERIVED IMMUNOTHERAPY,6173755,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,2000,125226, ,NCI, , ,125226
FAS/APO-1 MEDIATED APOPTOSIS,6173793,8/1/1999 0:00,5/31/2003 0:00,Non-SBIR/STTR,2000,198307, ,NCI, , ,198307
INHIBITION OF TRANSLATION INITIATION IN CANCER THERAPY,6173811,7/1/1998 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000,269542, ,NCI, , ,269542
MDM2 ONCOGENE AS A TARGET FOR MODULATING CANCER THERAPY,6173813,4/7/1999 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,214495, ,NCI, , ,214495
MULTIPLE GENE CARRIER ADENOVIRAL CONSTRUCTS FOR GLIOMAS,6173824,6/1/1999 0:00,5/31/2002 0:00,Non-SBIR/STTR,2000,193736, ,NCI, , ,193736
EPITOPE BASED T CELL THERAPY FOR EPITHELIAL TUMORS,6173836,5/1/1999 0:00,2/29/2004 0:00,Non-SBIR/STTR,2000,295544, ,NCI, , ,295544
RESTORATION OF APOPTOSIS IN CANCER,6173890,7/23/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2000,1038933, ,NCI, , ,1038933
GEMZAR--MECHANISMS OF CYTOTOXICITY & RADIOSENSITIZATION,6173931,7/8/1999 0:00,4/30/2003 0:00,Non-SBIR/STTR,2000,202459, ,NCI, , ,202459
MOLECULAR PROGNOSTIC INDICATORS IN COLORECTAL CANCER,6173966,7/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,258040, ,NCI, , ,258040
P21 INDUCTION BY BRCA2,6173987,8/1/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,2000,100170, ,NCI, , ,100170
BYSTANDER EFFECTS OF LOW DOSE ALPHA PARTICLES,6173992,9/1/1999 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,306448, ,NCI, , ,306448
CANCER VACCINE TO P53,6174002,9/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,275766, ,NCI, , ,275766
SEQUENTIAL DOXORUBICIN AND VINORELBINE IN BREAST CANCER,6174003,6/14/1999 0:00,5/31/2002 0:00,Non-SBIR/STTR,2000,78463, ,NCI, , ,78463
MOLECULAR ANALYSIS OF SURGICAL MARGINS WITH EIF4E IN CAN,6174010,7/1/1999 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,122714, ,NCI, , ,122714
MUTATIONS IN HUMAN P53 SEQUENCES OF A P53 KNOCK-IN MOUSE,6174020,7/15/1999 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,87131, ,NCI, , ,87131
UBIQUITINATION AND STABILITY OF P53 AND P73,6174039,6/15/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,235865, ,NCI, , ,235865
DETERMINANTS OF CLINICAL OUTCOME/TOXICITY IN HISPANICS,6174056,9/3/1999 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,330859, ,NCI, , ,138960
MOLECULAR DETERMINANTS OF DRUG SENSITIVITY,6174063,7/12/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2000,154634, ,NCI, , ,154634
IGFIR IN HUMAN GI TUMORS,6174084,7/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,247290, ,NCI, , ,247290
THE ROLE OF A NOVEL GAP IN EPITHELIAL ONCOGENESIS,6174087,9/8/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,238544, ,NCI, , ,238544
"AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES",6174106,9/20/1999 0:00,8/31/2004 0:00,Other Research-Related,2000,130259, ,NCI, , ,130259
"DIETARY HETEROCYCLIC AMINES, GENETIC SUSCEPTIBILITY, AND",6174108,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,2000,137280, ,NCI, , ,137280
BIOCHEMOPREVENTION THERAPY IN ADVANCED LARYNGEAL DYSPLAS,6174110,9/10/1998 0:00,6/30/2003 0:00,Other,2000,640505, ,NCI, , ,640505
BIOCHEM DISSECTION OF P53-DEPENDENT APOPTOSIS PATHWAY,6174187,9/1/1999 0:00,10/31/2000 0:00,Other Research-Related,2000,17379, ,NCI, , ,17379
TREATMENT RESPONSE MARKERS IN ADVANCED LARYNGEAL CANCER,6174195,9/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,230386, ,NCI, , ,230386
ROLE OF BRCA1 IN NORMAL CELL GROWTH AND TUMORGENESIS,6174209,9/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,197488, ,NCI, , ,197488
PRECANCEROUS EVENTS IN CLINICALLY NORMAL SKIN,6174296,4/1/1999 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,240401, ,NCI, , ,240401
IDENTIFYING GENOME CHANGES IN CANCER DEVELOPMENT,6174315,9/30/1998 0:00,9/30/2002 0:00,Non-SBIR/STTR,2000,532214, ,NCI, , ,532214
ENHANCING ACTIVITY OF ALKYLATING AGENTS IN NEUROBLASTOMA,6174324,9/1/1999 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,227899, ,NCI, , ,227899
TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER,6174335,8/24/1999 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000,167879, ,NCI, , ,167879
ISOPEPTIDASES UBIQUITIN DEGRADATION AND PROSTATE CANCER,6174343,9/30/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,204396, ,NCI, , ,204396
E2 MODULATION OF TUMORIGENESIS IN ERBB2 TRANSGENIC MICE,6174382,8/15/1999 0:00,5/31/2001 0:00,Non-SBIR/STTR,2000,215705, ,NCI, , ,215705
CHARACTERIZATION OF SRC AS AN E6AP SUBSTRATE,6174394,4/1/2000 0:00, ,"Training, Individual",2000,37516, ,NCI, , ,37516
THE ROLE OF INTEGRIN A5B1 IN ANGIOGENESIS & DISEASE,6174397,9/1/1999 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,278436, ,NCI, , ,278436
FUNCTIONS OF DIFFERENT P53 MUTATIONS IN PROSTATE CANCER,6174408,4/15/1998 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000,158865, ,NCI, , ,158865
MALIGNANT COMPLICATIONS OF CHRONIC HCV,6174411,9/29/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2001,389605, ,NCI, , ,389605
CHARACTERIZATION OF NEW HUMAN P53 DISSOCIATORS,6174477,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2000,278100, ,NCI, , ,278100
ERBB2/P53 AND TAXANE CHEMOTHERAPY FOR BREAST CANCER,6175182,9/14/1999 0:00,8/31/2003 0:00,Non-SBIR/STTR,2000,206502, ,NCI, , ,206502
PULMONARY EFFECTS OF HABITUAL USE OF MARIJUANA,6175199,7/1/1982 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000,516624, ,NIDA, , ,516624
VIRAL ONCOPROTEIN ACTIVATION IN AIDS-RELATED TUMORS,6175245,9/17/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,607462, ,NCI, , ,607462
MOUSE CANCER MODELS BY REGULATED INACTIVATION OF TUMOR S,6175272,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,596102, ,NCI, , ,596102
MOUSE MODELS OF HUMAN BREAST CANCER,6175274,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,508534, ,NCI, , ,508534
EARLY CANCER DETECTION AND SUSCEPTIBILITY BIOMAKERS,6175288,9/30/1999 0:00,8/31/2004 0:00,Other,2000,705359, ,NCI, , ,705359
"THE APL PARADIGM FOR ABERRANT TRANSCRIPTION, CANCER AND",6175341,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,491961, ,NCI, , ,491961
A MOUSE MODEL FOR PROSTATE CANCER,6175342,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,470221, ,NCI, , ,470221
CREATION AND CHARACTERIZATION OF MOUSE MODELS OF HUMAN L,6175345,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,791991, ,NCI, , ,791991
PRECLINICAL MOUSE:  CENTRAL NERVOUS SYSTEM CANCERS,6175347,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,634031, ,NCI, , ,634031
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER,6175890,9/24/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2000,352520, ,NIDCR, , ,352520
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN,6175895,9/1/1999 0:00,8/31/2003 0:00,Non-SBIR/STTR,2000,416339, ,NIDCR, , ,416339
GENETIC ALTERATIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARK,6175896,9/1/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2000,355150, ,NIDCR, , ,355150
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER,6175918,9/30/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2000,366559, ,NIDCR, , ,366559
NEOADJUVANT THERAPY OF OR CANCER BY INHIBITING NF-KAPPAB,6175931,9/30/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2000,244368, ,NIDCR, , ,244368
GENETIC EPIDEMIOLOGY OF ORAL PREMALIGNANCIES AND CANCER,6176050,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,2000,124686, ,NIDCR, , ,124686
CELL CYCLE REGULATORS OF ORAL CANCER,6176053,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,940802, ,NIDCR, , ,940802
DEVELOPMENT OF VACCINES FOR ORAL CARCINOMA,6176146,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,801575, ,NIDCR, , ,801575
TR2 AND TR3 ORPHAN RECEPTORS IN PROSTATE CANCER,6176464,9/1/1995 0:00,8/31/2003 0:00,Non-SBIR/STTR,2000,274525, ,NIDDK, , ,274525
DEVELOPING MOLECULAR THERAPY IN HEAD AND NECK CANCER,6176938,8/1/1996 0:00,5/31/2002 0:00,Non-SBIR/STTR,2000,111786, ,NIDCR, , ,111786
NEOPLASTIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE,6177214,9/30/1993 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,219128, ,NIDDK, , ,219128
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,6177577,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,2000,255152, ,NIDDK, , ,255152
MECHANISMS OF ACROLEIN ON PROLIFERATION AND APOPTOSIS,6178425,8/1/1999 0:00,7/31/2003 0:00,Non-SBIR/STTR,2000,198739, ,NIEHS, , ,198739
"ATM, P53, GADD45 AND P21 EFFECTS ON RECOMBINATION",6178499,6/1/1999 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000,232755, ,NIEHS, , ,232755
NOVEL CARCINOGEN INDUCED CELL CYCLE CHECKPOINT,6178560,8/1/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,2000,110514, ,NIEHS, , ,110514
ASBESTOS AND NO2 IN ENVIRONMENTAL LUNG DISEASE,6178564,8/15/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000,274820, ,NIEHS, , ,274820
PROTECTIVE ROLE OF APOPTOSIS IN ASBESTOS PLEURAL INJURY,6178756,8/29/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000,201700, ,NIEHS, , ,201700
SKIN CANCER--ROLE OF UVB INDUCED CELL CYCLE ALTERATIONS,6178809,12/1/1977 0:00,8/31/2001 0:00,Non-SBIR/STTR,2000,282463, ,NIEHS, , ,282463
SUSCEPTIBILITY TO MOLECULAR ALTERATION: EPITHELIAL CELLS,6178813,9/26/1999 0:00,8/31/2004 0:00,Other Research-Related,2000,118065, ,NIEHS, , ,118065
BIOCHEMICAL STUDIES OF HUMAN DNA POLYMERASE DELTA,6180102,4/1/1983 0:00,3/31/2003 0:00,Non-SBIR/STTR,2000,527832, ,NIGMS, , ,527832
MECHANISMS OF RADIORESISTANCE AND CELL CYCLE PROGRESSION,6180626,5/1/1995 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,290198, ,NIGMS, , ,290198
MOLECULAR ANALYSIS OF CEP135 IN THE CENTROSOME,6181155,7/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,207938, ,NIGMS, , ,207938
RADIATION INDUCED G1 CHECKPOINT ARREST IN YEAST,6181577,9/1/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2000,191855, ,NIGMS, , ,191855
CELL CYCLE CONTROL OF PROTEOLYSIS BY F-BOX PROTEINS,6182228,8/1/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2000,321124, ,NIGMS, , ,321124
MOLECULAR MARKERS AS PREDICTORS OF OUTCOME IN GLIOMAS,6187173,9/1/1998 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,209375, ,NINDS, , ,209375
MECHANISMS OF NEURONAL APOPTOSIS,6187425,4/20/1997 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,211376, ,NINDS, , ,211376
Mentored Patient-Oriented Research Career Development Aw,6188746,8/1/2000 0:00,7/31/2005 0:00,Other Research-Related,2000,118704, ,NCRR, , ,118704
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,6188925,7/15/1981 0:00,5/31/2002 0:00,Non-SBIR/STTR,2000,252279, ,NCI, , ,252279
ROLES AND REGULATION OF P53,6188954,9/30/2000 0:00,7/31/2005 0:00,Non-SBIR/STTR,2000,1915338, ,NCI, , ,1915338
 MECHANISM OF ACTION OF HERCEPTIN R IN BREAST CANCER,6189385,5/1/2000 0:00,4/30/2002 0:00,Non-SBIR/STTR,2000,149250, ,NCI, , ,149250
MOLECULAR  MARKERS IN ESOPHAGEAL ADENOCARCINOMA,6189395,7/18/2000 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,187500, ,NCI, , ,187500
CHARACTERIZATION OF A NEW GENE IN P53 MUTANT LFS FAMILY,6189400,8/4/2000 0:00,7/31/2003 0:00,Other Research-Related,2000,87264, ,NCI, , ,87264
ARF MDM2 P53 TUMOR SUPPRESSION PATHWAY,6189426,8/1/2000 0:00,12/14/2000 0:00,Other Research-Related,2000,38351, ,NCI, , ,38351
MUTATIONAL ANALYSIS OF P53 RELATED GENES,6189739,8/1/2000 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000,129500, ,NCI, , ,129500
NEO ANTIGEN AND IMMUNOBIOLOGY OF MEDULLARY BREAST CANCER,6189742,7/14/2000 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,130500, ,NCI, , ,130500
MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS,6190130,8/4/2000 0:00,7/31/2005 0:00,Other Research-Related,2000,126711, ,NCI, , ,126711
P53--MARKER FOR ORAL CAVITY PREMALIGNANCY & CANCER RISK,6190639,4/1/1995 0:00,7/31/2000 0:00,Non-SBIR/STTR,1998,37474, ,NCI, , ,37474
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION,6190673,9/1/2000 0:00,8/31/2005 0:00,Other Research-Related,2000,126144, ,NCI, , ,126144
GENETIC STAGING OF BREAST CANCERS FOR ADJUVANT THERAPY,6190937,7/1/1991 0:00,4/30/2001 0:00,Non-SBIR/STTR,1999,105000, ,NCI, , ,105000
CPG METHYLATION AND MUTATION,6191118,7/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,275625, ,NCI, , ,275625
"PATHOGENESIS, IMMUNODIAGNOSIS AND THERAPY OF HCC",6191327,7/1/1983 0:00,6/30/2005 0:00,Non-SBIR/STTR,2000,318000, ,NCI, , ,318000
 REPRESSION BY C SKI AND MELANOMA PROGRESION,6191341,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2000,266026, ,NCI, , ,266026
COLON CANCER PREVENTION PROGRAM PROJECT,6191780,9/30/1986 0:00,7/31/2005 0:00,Non-SBIR/STTR,2000,3616037, ,NCI, , ,3616037
DEVELOPING A MOLECULAR MODEL--ORAL CAVITY TUMORIGENESIS,6191821,5/1/1995 0:00,4/30/2000 0:00,Other Research-Related,1999,95465, ,NIDCR, , ,95465
THE ROLE OF P40 IN SQUAMOUS CELL CARCINOMA,6191823,9/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,278801, ,NIDCR, , ,278801
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA,6192152,9/1/1992 0:00,7/31/2005 0:00,Non-SBIR/STTR,2000,228360, ,NCI, , ,228360
MECHANISM OF ANTICARCINOGENIC ACTIVITY--ORGANOSULFIDES,6192153,4/1/1995 0:00,8/31/2004 0:00,Non-SBIR/STTR,2000,224708, ,NCI, , ,224708
"HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING",6192165,5/1/1999 0:00,11/30/2002 0:00,SBIR/STTR,2000,645338, ,NCI, , ,645338
PI 3K PATHWAY IN BCR/ABL INDUCED LEUKEMIAS,6192169,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2000,295200, ,NCI, , ,295200
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION,6192920,6/1/1979 0:00,7/31/2003 0:00,Non-SBIR/STTR,2000,243078, ,NCI, , ,243078
IMMUNOLOGIC SCREENING FOR EARLY STAGE COLORECTAL CANCER,6193153,8/11/2000 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000,141750, ,NCI, , ,141750
FUNCTIOINAL ANALYSIS OF THE P53 TUMOR SUPPRESSOR,6193546,8/15/1985 0:00,7/30/2003 0:00,Non-SBIR/STTR,2000,179017, ,NCI, , ,179017
"OXIDATIVE STRESS, APOPTOSIS AND DRUG RESISTANCE",6193683,7/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,201150, ,NCI, , ,201150
STRESS INDUCED BYSTANDER EFFECT IN CANCER TREATMENT,6194291,6/9/2000 0:00,4/30/2005 0:00,Non-SBIR/STTR,2000,294368, ,NCI, , ,294368
ALPHA6/BETA4-INTEGRIN MEDIATED APOPTOSIS RESISTANCE,6194325,7/1/2000 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,203538, ,NCI, , ,203538
ISOLATION OF THE FANCONI ANEMIA NUCLEAR PROTEIN COMPLEX,6194452,9/10/2000 0:00,8/31/2004 0:00,Non-SBIR/STTR,2000,344800, ,NHLBI, , ,344800
PATHWAYS OF BLADDER TUMORIGENESIS,6194584,3/1/1999 0:00,11/30/1999 0:00,Non-SBIR/STTR,1999, , , , , , 
A ROLE OF RAD51B IN DNA REPAIR AND BREAST CARCINOGENESIS,6194770,6/1/2000 0:00,5/31/2004 0:00,Non-SBIR/STTR,2000,293692, ,NCI, , ,293692
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA,6194778,6/1/1983 0:00,5/31/2005 0:00,Non-SBIR/STTR,2000,289938, ,NCI, , ,289938
A PROGRAMMABLE DNA ARRAY SYNTHESIZER,6194779,9/30/1999 0:00,9/30/2001 0:00,SBIR/STTR,2000,590769, ,NHGRI, , ,590769
BIOLOGICAL ACTIVITY OF HPV E7 IN HUMAN EPITHELIAL CELLS,6195684,4/19/1996 0:00,6/30/2005 0:00,Non-SBIR/STTR,2000,309600, ,NCI, , ,309600
THE MOLECULAR BIOLOGY OF RETINOBLASTOMA,6197405,2/1/1999 0:00,11/30/2004 0:00,Non-SBIR/STTR,2001,324000, ,NEI, , ,324000
SENESCENCE IN EPITHELIAL NEOPLASTIC PROGRESSION,6197809,9/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,252131, ,NIDCR, , ,252131
"KS1, A NOVEL SUPPRESSOR OF NEOPLASTIC TRANSFORMATION",6197832,9/15/2000 0:00,7/31/2004 0:00,Non-SBIR/STTR,2000,182019, ,NIDDK, , ,182019
GENETIC EPIDEMIOLOGY OF CHILDHOOD SARCOMA,6198227,8/23/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,135394, , , , 
MOLECULAR BASIS OF INHERITED CANCER SYNDROMES,6198230,8/23/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,270395, , , , 
GENOMIC INSTABILITY IN FAMILIAL CANCER SYNDROMES,6198231,8/23/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,175907, , , , 
CORE--MUTATION DETECTION & CHARACTERIZATION OF TUMOR SUPPRESSOR GENES,6198235,8/23/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,176326, , , , 
CORE--HIGH THROUGHPUT GENOTYPING AND GENETIC LINKAGE ANALYSIS,6198236,8/23/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,437292, , , , 
ANALYSIS OF P73 FUNCTION AND REGULATION BY E2F 1,6198873,8/1/2000 0:00,7/31/2005 0:00,Other Research-Related,2000,132439, ,NCI, , ,132439
T CELL DEVELOPMENT & LYMPHOMAGENESIS IN TRANSGENIC MICE,6199162,9/30/1999 0:00,8/31/2002 0:00,Other Research-Related,1999,79785, ,NIAID, , ,79785
" 8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA",6199373,7/5/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2000,393833, ,NCI, , ,393833
RECOMBINATION MECHANISMS IN ADENOVIRUS TRANSFECTION,6199701,5/1/1982 0:00,6/30/2004 0:00,Non-SBIR/STTR,2000,338038, ,NIGMS, , ,338038
MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER,6200119,9/18/2000 0:00,8/31/2001 0:00,Non-SBIR/STTR,2000,147000, ,NCI, , ,147000
METABOLIC GENOTYPES & ONCOGENIC DAMAGE IN BREAST CANCER,6200150,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2000,322160, ,NCI, , ,322160
STRUCTURE FUNCTION RELATIONSHIP OF TUMOR SUPRESSORS,6200226,3/1/1996 0:00,5/31/2004 0:00,Non-SBIR/STTR,2000,264450, ,NCI, , ,264450
ROLE OF E7 IN HPV INFECTIONS,6201132,9/1/1999 0:00,8/31/2000 0:00,Non-SBIR/STTR,1999, ,137421, , , , 
RISK FACTORS FOR ORAL EPIDERMOID CARCINOMA IN MINORITIES,6201784,8/1/1999 0:00,7/31/2001 0:00,Research Centers,1999, ,298546, , , , 
"P53, CHEMICAL CARCINOGEN AND ETHANOL IN ORAL CANCER",6201791,8/1/1999 0:00,7/31/2002 0:00,Research Centers,1999, ,208304, , , , 
P53 SEROLOGY AND PROGNOSIS OF ORAL CANCER,6201792,8/1/1999 0:00,7/31/2002 0:00,Research Centers,1999, ,13504, , , , 
APOPTOSIS IN ORAL CANCER,6201797,8/1/1999 0:00,7/31/2000 0:00,Research Centers,1999, ,93518, , , , 
DEVELOPMENT OF P53 BASED VACCINES FOR ORAL CARCINOMA,6201806,9/1/1999 0:00,8/31/2000 0:00,Non-SBIR/STTR,1999, ,177932, , , , 
ORAL CARCINOMA--SIGNAL TRANSDUCTION IN LYMPHOCYTES,6201808,9/1/1999 0:00,8/31/2000 0:00,Non-SBIR/STTR,1999, ,171745, , , , 
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1,6203028,9/30/1999 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999, ,230434, , , , 
PROGNOSTIC & PREDICTIVE BIOMARKERS FOR BREAST CANCER,6203062,8/31/1999 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999, ,181487, , , , 
DEVELOPMENTAL & PROGNOSTIC FACTORS IN PREMALIGNANT BREAST DISEASE,6203064,8/31/1999 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999, ,181487, , , , 
MOLECULAR GENETICS OF WILMS' TUMOR,6203097,8/31/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,135290, , , , 
FUNCTIONAL ANALYSIS OF THE RB TUMOR SUPPRESSOR GENE FAMILY,6203099,8/31/1999 0:00,4/30/2000 0:00,Non-SBIR/STTR,1999, ,135290, , , , 
HUMAN PAPILLOMAVIRUS AND PROGNOSIS OF FEMALE ANOGENITAL CANCER,6203113,6/1/1999 0:00,3/31/2001 0:00,Non-SBIR/STTR,1999, ,280718, , , , 
TARGETING EARLY CHANGES FOR NEW SCREENING STRATEGIES,6203225,7/26/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,98125, , , , 
DETECTING GENE ALTERATIONS IN NONMALIGNANT EPITHELIUM OF HIGH RISK PEOPLE,6203227,7/26/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,98125, , , , 
CAROLINA BREAST CANCER STUDY,6203249,8/5/1999 0:00,7/31/2001 0:00,Research Centers,1999, ,168504, , , , 
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY,6203250,8/5/1999 0:00,7/31/2001 0:00,Research Centers,1999, ,168504, , , , 
PROSTATIC TOPOISOMERASES AS THERAPEUTIC DRUG TARGETS,6203269,8/4/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,168504, , , , 
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS,6203325,3/1/1999 0:00,2/29/2000 0:00,Non-SBIR/STTR,1999, ,150197, , , , 
REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER,6203326,3/1/1999 0:00,2/29/2000 0:00,Non-SBIR/STTR,1999, ,150197, , , , 
CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY,6203329,3/1/1999 0:00,2/29/2000 0:00,Non-SBIR/STTR,1999, ,150197, , , , 
DEVELOPMENT OF SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF BREAST CANCER,6203336,9/24/1999 0:00,8/31/2001 0:00,Research Centers,1999, ,327843, , , , 
CORE--PATHOLOGY CORE,6203337,9/24/1999 0:00,8/31/2001 0:00,Research Centers,1999, ,327843, , , , 
GENETIC MANIPULATION OF TUMOR RADIORESISTANCE,6203410,8/1/1999 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999, ,100568, , , , 
RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53,6203411,8/1/1999 0:00,7/31/2000 0:00,Non-SBIR/STTR,1999, ,100568, , , , 
ROLE OF PROSTAGLANDIN H SYNTHASE 2 IN COLON CARCINOGENESIS,6203416,8/1/1999 0:00,5/31/2000 0:00,Non-SBIR/STTR,1999, ,100568, , , , 
"SENSITIVE, MULTIPLEXED ANALYSIS OF BREAST CANCER MARKERS",6203903,8/28/2000 0:00,2/28/2001 0:00,SBIR/STTR,2000,98000, ,NCI, , ,98000
PROTEIN P53 PHOSPHORYLATION STATUS IN PRIMARY BREAST CANCER,6204107,8/1/1999 0:00,7/31/2000 0:00,Other Research-Related,1999, ,30384, , , , 
PILOT STUDY--PHOSPHORYLATION OF P53 PROTEIN IN HUMAN BREAST CANCER CELLS,6206488,9/30/1999 0:00,9/29/2000 0:00,Research Centers,1999, ,172415, , , , 
SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY,6206787,5/1/1991 0:00,5/31/2001 0:00,Non-SBIR/STTR,2000,76185, ,NCI, , ,76185
IN VITRO SCREENING OF POTENTIAL CHEMOPREVENTIVE AGENTS,6209320,6/30/1998 0:00,6/30/2000 0:00,R and D Contracts,2000, , , , , , 
T CELL RECEPTOR-BASED IMMUNOTHERAPEUTICS FOR CANCER,6210330,3/9/2001 0:00,3/8/2002 0:00,SBIR/STTR,2001,93380, ,NCI, , ,93380
DIHYDRODIOL DEHYDROGENASE AND PAH METABOLISM/ACTIVATION,6216884,3/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,59973, ,NCI, , ,59973
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6217260,7/1/1999 0:00,6/30/2000 0:00,Research Centers,1999, ,332337, , , , 
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6217420,5/1/1999 0:00,4/30/2000 0:00,Research Centers,1999, ,156688, , , , 
MARKERS OF PROGRESSION AND METASTASES,6217434,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,6217435,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
GENE THERAPY FOR PROSTATE CANCER,6217437,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
PROSTATE SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE,6217438,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
ROLE OF CDK INHIBITORS IN PROSTATE CANCER,6217441,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
GENETIC ALTERATIONS OF ADENOVIRUSES,6217784,1/1/1999 0:00,12/31/1999 0:00,Other Research-Related,1999, ,104931, , , , 
CORE--MOLECULAR GENETICS,6218824,7/22/1999 0:00,6/30/2000 0:00,Non-SBIR/STTR,1999, ,76309, , , , 
LUNG CANCER SUSCEPTIBILITY IN FORMER SMOKERS,6218868,9/7/1999 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999, ,69313, , , , 
GENOTYPE/PHENOTYPE BIOMARKERS,6218883,9/7/1999 0:00,6/30/2001 0:00,Non-SBIR/STTR,1999, ,69313, , , , 
GENE MUTATIONS AND APOPTOSIS IN CANCER CHEMOPREVENTION,6218887,7/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999, ,130479, , , , 
CORE--EXPERIMENTAL ANIMALS FACILITY,6218891,7/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999, ,130479, , , , 
MOLECULAR MARKERS FOR SQUAMOUS CELL CARCINOMA,6218958,8/1/1999 0:00,7/31/2000 0:00,Research Centers,1999, ,84125, , , , 
APOPTOSIS INDUCING GENE THERAPY FOR ORAL PREMALIGNANCY,6218961,8/1/1999 0:00,7/31/2000 0:00,Research Centers,1999, ,270888, , , , 
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,6218967,8/1/1999 0:00,7/31/2000 0:00,Research Centers,1999, ,98790, , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,6218968,8/1/1999 0:00,7/31/2000 0:00,Research Centers,1999, ,98555, , , , 
PHASE I STUDY OF RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD/NECK,6219237,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,3034, , , , 
COLOR DNA SEQUENCING APPARATUS FOR CLINICAL DIAGNOSIS,6223568,7/15/1999 0:00,12/31/2001 0:00,SBIR/STTR,2000,448067, ,NCI, , ,448067
A NON MAMMALIAN MODEL FOR HUMAN ALL,6225304,5/1/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,139104, ,OD, , ,139104
MECHANISMS REGULATING REVERSAL OF PREMALIGNANCY,6226788,12/15/2000 0:00,6/30/2001 0:00,Non-SBIR/STTR,2001,64976, ,NCI, , ,64976
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,6227507,9/30/1995 0:00,11/30/2000 0:00,Non-SBIR/STTR,2000,709910, ,NCI, , ,709910
INSTABILITY OF MICROSATELLITES IN MAMMALIAN CELLS,6227659,7/13/1995 0:00,4/30/2000 0:00,Non-SBIR/STTR,2000,58807, ,NCI, , ,58807
Microarray Technology to Study Molecular Pathways in Disease and Apoptosis,6227936, , ,Intramural Research,1999, , , , , , 
Developmental of New Hormone Responsive Models in Mammary Cells,6227950, , ,Intramural Research,1999, , , , , , 
CHROMOSOME ALTERATIONS IN BARRETT'S ESOPHAGUS,6228772,4/1/2001 0:00,3/31/2006 0:00,Other Research-Related,2001,92910, ,NCI, , ,92910
MODULATORS AND EFFECTORS OF MDM2 AND P53,6229388,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2001,288288, ,NCI, , ,288288
 METHYLATION PROFILING IN COLORECTAL CANCER,6229393,3/12/2001 0:00,2/29/2004 0:00,Non-SBIR/STTR,2001,245380, ,NCI, , ,245380
DNA MUTATION BIOMARKERS FOR NONMELANOMA SKIN CANCER,6230300,5/1/1996 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,14675, ,NCI, , ,14675
P53 function and apoptosis in melanoma,6230679,4/6/1990 0:00,4/30/2004 0:00,Non-SBIR/STTR,1999, ,130863, , , , 
Radiation sensitivity/Apoptosis Induction in Cancer Cells--P53 Restoration,6232825,7/23/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,1999, ,176165, , , , 
Fas/FasL. Interactions in P53/ Radiation Induced Apoptosis,6232830,7/23/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,1999, ,176165, , , , 
Strategies for Cell Death Manipulation in Cancer,6232838,7/23/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,1999, ,176165, , , , 
TUMOR SUPPRESSOR LIKE ACTIVITY OF ESTROGEN RECEPTOR,6232981,2/1/2001 0:00,1/31/2005 0:00,Non-SBIR/STTR,2001,219681, ,NCI, , ,219681
"ROLE OF MDM2, P300, P19ARF IN P53 UBIQUITINATION",6233513,4/12/2001 0:00,3/31/2006 0:00,Other Research-Related,2001,135837, ,NCI, , ,135837
"P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?",6233528,1/20/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2001,351731, ,NCI, , ,351731
ROLE OF C/EBP ALPHA IN GROWTH INHIBITION,6234595,4/1/1997 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997, ,201069, , , , 
ROLE OF E7 IN HPV INFECTIONS,6235010,7/1/1997 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997, ,139561, , , , 
PILOT--INTERACTION OF HPV-16 E6 WITH P53 TUMOR SUPPRESSOR PROTEIN,6235749,3/1/1997 0:00,2/28/1998 0:00,Research Centers,1997, ,49723, , , , 
MECHANISMS OF TUMOR INITIATION BY MUTANT P53 PROTEINS,6235751,3/1/1997 0:00,2/28/1998 0:00,Research Centers,1997, ,49723, , , , 
"P53, APOPTOSIS AND CHRONIC RHEUMATOID ARTHRITIS",6235763,3/7/1997 0:00,2/28/1998 0:00,Research Centers,1997, ,115423, , , , 
CHEMOTHERAPEUTIC STUDIES IN SOLID TUMORS,6235900,5/1/1997 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997, ,183434, , , , 
CANCER THERAPY,6236046,2/10/1997 0:00,12/31/1997 0:00,Non-SBIR/STTR,1997, ,358316, , , , 
MOLECULAR ANALYSIS OF CELLULAR RESPONSE TO RADIATION--G1/S TRANSITION,6236089,4/10/1997 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997, ,231540, , , , 
CELL AND MOLECULAR BIOLOGY OF RAT HEPATOCARCINOGENESIS,6236478,2/1/1997 0:00,1/31/1998 0:00,Non-SBIR/STTR,1997, ,219744, , , , 
P53 GENE AND CHEMOSENSITIVITY,6236502,9/1/1997 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997, ,163690, , , , 
CHEMOPREVENTION OF GASTRIC DYSPLASIA,6236590,3/1/1997 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997, ,312594, , , , 
PROGNOSTIC & PREDICTIVE BIOMARKERS FOR BREAST CANCER,6236608,9/17/1997 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997, ,222022, , , , 
DEVELOPMENTAL & PROGNOSTIC FACTORS IN PREMALIGNANT BREAST DISEASE,6236610,9/17/1997 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997, ,222022, , , , 
CORE--PATHOLOGY FACILITY,6236698,6/27/1997 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997, ,250998, , , , 
GENETIC EPIDEMIOLOGY OF CHILDHOOD SARCOMA,6236707,8/1/1997 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997, ,179095, , , , 
CHARACTERIZATION OF MOLECULAR EVENTS DURING OSTEOSARCOMA DEVELOPMENT,6236708,8/1/1997 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997, ,179095, , , , 
IN VITRO PHENOTYPIC EFFECTS OF GERMLINE P53 MUTATIONS,6236709,8/1/1997 0:00,7/31/1999 0:00,Non-SBIR/STTR,1997, ,179095, , , , 
"GENETIC ALTERATIONS IN ADENOMATOUS POLYPS--DIETARY FIBER, FAT, AND BILE ACIDS",6236788,3/1/1997 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997, ,365665, , , , 
MOLECULAR GENETICS OF WILMS' TUMOR,6236816,5/1/1997 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997, ,207553, , , , 
FUNCTIONAL ANALYSIS OF THE RB TUMOR SUPPRESSOR GENE FAMILY,6236818,5/1/1997 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997, ,207553, , , , 
CYCLE-DEPENDENT MECHANISMS OF CHEMICAL CLASTOGENESIS,6236838,5/1/1997 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997, ,167167, , , , 
HUMAN PAPILLOMAVIRUS AND PROGNOSIS OF FEMALE ANOGENITAL CANCER,6236844,6/1/1997 0:00,5/31/1998 0:00,Non-SBIR/STTR,1997, ,265427, , , , 
MECHANISMS OF CELL ADHESION AND COLON CARCINOMA,6236885,3/7/1997 0:00,1/31/1998 0:00,Non-SBIR/STTR,1997, ,184275, , , , 
ABERRANT GENE EXPRESSION BY COLORECTAL CARCINOMA,6236887,3/7/1997 0:00,1/31/1998 0:00,Non-SBIR/STTR,1997, ,184275, , , , 
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA,6236968,5/16/1997 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997, ,190428, , , , 
CLINICAL TRIALS,6236969,5/16/1997 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997, ,190428, , , , 
FUNCTIONAL AND IMMUNOPHENOTYPIC ANALYSIS OF TUMOR SUPPRESSOR GENES IN STS,6236970,5/16/1997 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997, ,190428, , , , 
SV40 T-RB INTERACTIONS,6237096,4/10/1997 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997, ,263880, , , , 
"HPVE6 ONCOPROTEIN AND ITS ASSOCIATED PROTEIN, E6AP",6237098,4/10/1997 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997, ,263880, , , , 
INDUCTION OF APOPTOSIS IN BREAST CANCER,6237121,7/7/1997 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997, ,300649, , , , 
MOLECULAR DETERMINANTS OF CHEMOTHERAPY RESISTANCE,6237225,5/27/1997 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997, ,151217, , , , 
TARGETING EARLY CHANGES FOR NEW SCREENING STRATEGIES,6237295,9/5/1997 0:00,5/31/1998 0:00,Research Centers,1997, ,142988, , , , 
DETECTING GENE ALTERATIONS IN NONMALIGNANT EPITHELIUM OF HIGH RISK PEOPLE,6237297,9/5/1997 0:00,5/31/1998 0:00,Research Centers,1997, ,142988, , , , 
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6237316,5/20/1997 0:00,4/30/1998 0:00,Research Centers,1997, ,154617, , , , 
MARKERS OF PROGRESSION AND METASTASES,6237330,6/1/1997 0:00,5/31/1998 0:00,Research Centers,1997, ,176821, , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,6237331,6/1/1997 0:00,5/31/1998 0:00,Research Centers,1997, ,176821, , , , 
GENE THERAPY FOR PROSTATE CANCER,6237333,6/1/1997 0:00,5/31/1998 0:00,Research Centers,1997, ,176821, , , , 
PROSTATE SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE,6237334,6/1/1997 0:00,5/31/1998 0:00,Research Centers,1997, ,176821, , , , 
ROLE OF CDK INHIBITORS IN PROSTATE CANCER,6237337,6/1/1997 0:00,5/31/1998 0:00,Research Centers,1997, ,176821, , , , 
CAROLINA BREAST CANCER STUDY,6237355,8/5/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,171019, , , , 
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY,6237356,8/5/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,171019, , , , 
PROSTATIC TOPOISOMERASES AS THERAPEUTIC DRUG TARGETS,6237375,9/30/1997 0:00,5/31/1998 0:00,Research Centers,1997, ,162870, , , , 
GENETICALLY MODIFIED DENDRITIC CELLS FOR INDUCTION OF CANCER IMMUNITY,6237415,7/1/1997 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997, ,255596, , , , 
NEW GENETIC MARKERS FOR PANCREATIC CANCER,6237456,2/28/1997 0:00,12/31/1997 0:00,Research Centers,1997, ,108119, , , , 
MOLECULAR MARKERS FOR METASTASIS OF COLORECTAL CANCER,6237460,2/28/1997 0:00,12/31/1997 0:00,Research Centers,1997, ,108119, , , , 
DETECTION OF MUTATIONS IN COLON AND BREAST CANCER,6237513,3/1/1997 0:00,1/31/1998 0:00,Non-SBIR/STTR,1997, ,236092, , , , 
DEVELOPMENT OF IMMUNOTHERAPIES FOR CHRONIC MYELOID LEUKEMIA,6237540,4/25/1997 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997, ,221144, , , , 
"HYPOXIA, P53 AND GENETIC INSTABILITY",6237557,4/1/1997 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997, ,206044, , , , 
CORE--CELL REPOSITORY,6237559,4/1/1997 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997, ,206044, , , , 
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS,6237593,3/17/1997 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997, ,190698, , , , 
REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER,6237594,3/17/1997 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997, ,190698, , , , 
CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY,6237597,3/17/1997 0:00,2/28/1998 0:00,Non-SBIR/STTR,1997, ,190698, , , , 
INITIATION AND TARGETS OF ANTIPROLIFERATIVE SIGNALS IN BREAST EPITHELIAL CELLS,6237604,9/30/1997 0:00,8/31/1998 0:00,Research Centers,1997, ,306611, , , , 
LUNG CANCER SUSCEPTIBILITY IN FORMER SMOKERS,6237607,9/1/1997 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997, ,214571, , , , 
GENOTYPE/PHENOTYPE BIOMARKERS,6237608,9/1/1997 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997, ,214571, , , , 
APOPTOSIS IN ALL--CONTRIBUTION TO THERAPEUTIC INDEX,6237625,8/1/1997 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997, ,185740, , , , 
MECHANISMS OF CHEMICAL CARCINOGEN INDUCED P53 MUTATIONS,6237666,9/1/1997 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997, ,248460, , , , 
MECHANISMS OF ULTRAVIOLET LIGHT INDUCED P53 MUTATIONS,6237667,9/1/1997 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997, ,248460, , , , 
MECHANISMS OF OXIDATIVE DAMAGE INDUCED P53 MUTATIONS,6237668,9/1/1997 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997, ,248460, , , , 
MARKERS FOR EARLY LUNG CANCER DETECTION,6237700,9/5/1997 0:00,8/31/1998 0:00,Research Centers,1997, ,310388, , , , 
MUTANT P53 EPITOPE TARGETING IN SCLC,6237702,9/5/1997 0:00,8/31/1998 0:00,Research Centers,1997, ,310388, , , , 
GENE MUTATIONS AND APOPTOSIS IN CANCER CHEMOPREVENTION,6237735,7/1/1997 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997, ,117975, , , , 
CORE--EXPERIMENTAL ANIMALS FACILITY,6237739,7/1/1997 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997, ,117975, , , , 
RISK FACTORS FOR ORAL EPIDERMOID CARCINOMA IN MINORITIES,6238510,8/1/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,215308, , , , 
"P53, CHEMICAL CARCINOGEN AND ETHANOL IN ORAL CANCER",6238532,8/1/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,200750, , , , 
P53 SEROLOGY AND PROGNOSIS OF ORAL CANCER,6238533,8/1/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,12710, , , , 
MOLECULAR MARKERS FOR SQUAMOUS CELL CARCINOMA,6238587,8/1/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,85292, , , , 
APOPTOSIS INDUCING GENE THERAPY FOR ORAL PREMALIGNANCY,6238590,8/1/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,274610, , , , 
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,6238596,8/1/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,106362, , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,6238597,8/1/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,107660, , , , 
APOPTOSIS IN ORAL CANCER,6238609,8/1/1997 0:00,7/31/1998 0:00,Research Centers,1997, ,101105, , , , 
DEVELOPMENT OF P53 BASED VACCINES FOR ORAL CARCINOMA,6238618,9/1/1997 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997, ,177460, , , , 
ORAL CARCINOMA--SIGNAL TRANSDUCTION IN LYMPHOCYTES,6238620,9/1/1997 0:00,8/31/1998 0:00,Non-SBIR/STTR,1997, ,175160, , , , 
MOLECULAR BIOMARKERS OF OCCUPATIONAL BENZENE EXPOSURE,6239475,4/1/1997 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997, ,194916, , , , 
ARSENIC BIOMARKER EPIDEMIOLOGY,6239479,4/1/1997 0:00,3/31/1998 0:00,Non-SBIR/STTR,1997, ,194916, , , , 
"ONCOGENES, SUPPRESSOR GENES, AND MOLECULAR DOSIMETRY",6239488,5/1/1997 0:00,4/30/1998 0:00,Non-SBIR/STTR,1997, ,244686, , , , 
DETECTION OF MUTATIONS IN HUMAN LUNGS,6239701,8/1/1996 0:00,7/31/1998 0:00,Non-SBIR/STTR,1997, ,54702, , , , 
PROTEIN P53 PHOSPHORYLATION STATUS IN PRIMARY BREAST CANCER,6239958,8/1/1997 0:00,7/31/1998 0:00,Other Research-Related,1997, ,80592, , , , 
GENETIC ALTERATIONS OF ADENOVIRUSES,6239976,1/1/1997 0:00,12/31/1997 0:00,Other Research-Related,1997, ,20223, , , , 
TUMOR SUPPRESSOR GENES IN HUMAN MEDULLOBLASTOMA,6243548,3/1/1997 0:00,2/28/1998 0:00,Research Centers,1997, ,192500, , , , 
ROLE OF RB FAMILY IN JC VIRUS INDUCED GLIOBLASTOMA,6243927,7/1/1997 0:00,6/30/1998 0:00,Non-SBIR/STTR,1997, ,189602, , , , 
PHASE I STUDY OF RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD/NECK,6245712,3/18/1997 0:00,11/30/1997 0:00,Research Centers,1997, ,17579, , , , 
P53 AND HUMAN OVARIAN CANCER,6248250,2/10/1997 0:00,11/30/1997 0:00,Research Centers,1997, ,34065, , , , 
VACCINATION AGAINST TUMOR SPECIFIC MUTANT RAS AND P53 PEPTIDES IN CANCER,6248766,1/6/1997 0:00,11/30/1997 0:00,Research Centers,1997, ,30078, , , , 
P9: WILD TYPE & MUTANT P53 INTERACTIONS W/ HIV LTR DNA: CANCER,6252577,9/1/1997 0:00,8/31/1998 0:00,Research Centers,1997, ,103758, , , , 
"HIERARCHICAL MODELING OF SPECTRUM OF GENETIC MUTATIONS: CANCER, P53 MUTATIONS",6252850,9/30/1997 0:00,9/29/1998 0:00,Research Centers,1997, ,14184, , , , 
PILOT STUDY--PHOSPHORYLATION OF P53 PROTEIN IN HUMAN BREAST CANCER CELLS,6254220,9/30/1997 0:00,9/29/1998 0:00,Research Centers,1997, ,146311, , , , 
Development of immunoconjugate therapy for breast and prostate cancer,6254387,7/15/1988 0:00,9/29/2002 0:00,Non-SBIR/STTR,1999, ,180509, , , , 
MVAC IN ORGAN-CONFINED BLADDER CANCER BASED P53 STATUS,6254699,5/1/1997 0:00,2/28/2003 0:00,Non-SBIR/STTR,2001,456329, ,NCI, , ,456329
EARLY GENETIC EVENTS IN ASTROCYTOMA FORMATION,6254893,9/30/2001 0:00,8/31/2004 0:00,Non-SBIR/STTR,2001,324500, ,NINDS, , ,324500
NITROAROMATICS AND BREAST CANCER,6256859,7/1/1983 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000,88988, ,NCI, , ,88988
THERAPEUTIC VACCINES FOR HPV DISEASES,6259383,2/14/2001 0:00,1/31/2006 0:00,Other Research-Related,2001,134888, ,NCI, , ,134888
Tumor Suppressors in Spontaneous and UV-Induced Melanoma Models,6259579,5/1/1999 0:00,2/29/2004 0:00,Non-SBIR/STTR,1999, ,270618, , , , 
TRANSCRIPTIONAL REPRESSION BY C-SKI AND MELANOMA,6260080,4/1/2000 0:00,6/30/2000 0:00,Non-SBIR/STTR,2000,100000, ,NCI, , ,100000
GENETIC MECHANISM OF BRCA LINKED OVARIAN TUMORIGENESIS,6261180,2/1/2001 0:00,1/31/2005 0:00,Non-SBIR/STTR,2001,278127, ,NCI, , ,278127
GENISTEIN IN INVESTIGATIVE AND CLINICAL DERMATOLOGY,6261199,2/3/2001 0:00,1/31/2006 0:00,Non-SBIR/STTR,2001,307580, ,NCI, , ,307580
MOLECULAR PATHOLOGY OF GLIOMAS,6262139,1/13/1995 0:00,11/30/2001 0:00,Non-SBIR/STTR,2000,54141, ,NCI, , ,54141
ARSENIC TRIOXIDE TREATMENT OF LYMPHOPROLIFERATIVE DISORD,6263001,2/1/2001 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,322262, ,NCI, , ,322262
MOUSE MODEL FOR OXIDATIVE DNA DAMAGE REPAIR,6263004,1/30/2001 0:00,12/31/2004 0:00,Non-SBIR/STTR,2001,306000, ,NCI, , ,306000
DEFECTIVE DNA MISMATCH REPAIR IN ENDOMETRIAL CANCERS,6263173,5/1/1997 0:00,11/30/2004 0:00,Non-SBIR/STTR,2001,304511, ,NCI, , ,304511
GENE THERAPY OF PRIMARY & METASTATIC MALIGNANT LIVER TUMORS USING SCH58500,6263572,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,38778, , , , 
GENE THERAPY FOR PRIMARY & METASTATIC MALIGNANT TUMORS OF LIVER,6263615,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,25114, , , , 
CHEMOPREVENTION OF DEFLUOROMETHYLORNITHINE IN INTESTINAL BARRETTS ESOPHAGUS,6263679,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,206, , , , 
OPEN LABEL RANDOMIZED STUDY TO EVAL EFFECT SAFETY OF 2 TREATMENTS,6264153,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,3034, , , , 
ADENOVIRUS IN BRONCHIOLOALVEOLAR CELL LUNG CARCINOMA,6264585,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,592, , , , 
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER,6265031,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,34838, , , , 
DRUG METABOLIZING ENZYMES-RISK FACTORS IN BLADDER CANCER,6266233,7/1/1994 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,375771, ,NCI, , ,375771
P53 AND DNA PLOIDY IN BARRETT'S METAPLASIA,6266245,1/9/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2001,340507, ,NCI, , ,340507
IR-INDUCED APOPTOSIS IN THE DEVELOPING NERVOUS SYSTEM,6266378,1/15/2001 0:00,12/31/2004 0:00,Non-SBIR/STTR,2001,285750, ,NINDS, , ,285750
UV INDUCIBLE INHIBITION IN MELANOMA,6266788,5/5/1993 0:00,1/31/2006 0:00,Non-SBIR/STTR,2001,332978, ,NCI, , ,332978
ROLE OF C/EBP ALPHA IN GROWTH INHIBITION,6267674,4/1/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,203968, , , , 
"P53, APOPTOSIS AND CHRONIC RHEUMATOID ARTHRITIS",6268375,3/1/1998 0:00,2/28/1999 0:00,Research Centers,1998, ,112284, , , , 
ROLE OF ACTIN CYTOSKELETON ON UVA INDUCED APOPTOSIS,6268387,6/1/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,55018, , , , 
PIK RELATED KINASES IN THE RESPONSE TO DNA DAMAGE BY UV,6268424,4/1/1998 0:00,3/31/1999 0:00,Research Centers,1998, ,65999, , , , 
CHEMOTHERAPEUTIC STUDIES IN SOLID TUMORS,6268504,5/1/1998 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998, ,182227, , , , 
CANCER THERAPY,6268645,1/19/1998 0:00,12/31/1998 0:00,Non-SBIR/STTR,1998, ,364150, , , , 
MOLECULAR ANALYSIS OF CELLULAR RESPONSE TO RADIATION--G1/S TRANSITION,6268688,6/8/1998 0:00,9/30/2000 0:00,Non-SBIR/STTR,1998, ,238725, , , , 
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6268942,9/4/1998 0:00,6/30/1999 0:00,Research Centers,1998, ,317200, , , , 
P53 GENE AND CHEMOSENSITIVITY,6269061,7/1/1998 0:00,6/30/1999 0:00,Non-SBIR/STTR,1998, ,161827, , , , 
CORE--MOLECULAR GENETICS,6269109,9/18/1998 0:00,6/30/1999 0:00,Non-SBIR/STTR,1998, ,393881, , , , 
CHEMOPREVENTION OF GASTRIC DYSPLASIA,6269111,3/1/1998 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998, ,309165, , , , 
CORE--PATHOLOGY FACILITY,6269177,4/1/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,259757, , , , 
"GENETIC ALTERATIONS IN ADENOMATOUS POLYPS--DIETARY FIBER, FAT, AND BILE ACIDS",6269217,3/1/1998 0:00,9/30/1998 0:00,Non-SBIR/STTR,1998, ,360734, , , , 
SV40 T-RB INTERACTIONS,6269422,3/6/1998 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998, ,274097, , , , 
"HPVE6 ONCOPROTEIN AND ITS ASSOCIATED PROTEIN, E6AP",6269424,3/6/1998 0:00,2/28/1999 0:00,Non-SBIR/STTR,1998, ,274097, , , , 
INDUCTION OF APOPTOSIS IN BREAST CANCER,6269433,9/7/1998 0:00,1/15/1999 0:00,Non-SBIR/STTR,1998, ,211163, , , , 
MOLECULAR DETERMINANTS OF CHEMOTHERAPY RESISTANCE,6269500,6/5/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,157196, , , , 
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6269572,5/1/1998 0:00,4/30/1999 0:00,Research Centers,1998, ,162402, , , , 
MARKERS OF PROGRESSION AND METASTASES,6269586,7/3/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,6269587,7/3/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
GENE THERAPY FOR PROSTATE CANCER,6269589,7/3/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
PROSTATE SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE,6269590,7/3/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
ROLE OF CDK INHIBITORS IN PROSTATE CANCER,6269593,7/3/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
GENETICALLY MODIFIED DENDRITIC CELLS FOR INDUCTION OF CANCER IMMUNITY,6269617,5/1/1998 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998, ,278228, , , , 
NEW GENETIC MARKERS FOR PANCREATIC CANCER,6269644,1/1/1998 0:00,12/31/1998 0:00,Research Centers,1998, ,209129, , , , 
MOLECULAR MARKERS FOR METASTASIS OF COLORECTAL CANCER,6269648,1/1/1998 0:00,12/31/1998 0:00,Research Centers,1998, ,209129, , , , 
DETECTION OF MUTATIONS IN COLON AND BREAST CANCER,6269684,2/1/1998 0:00,1/31/1999 0:00,Non-SBIR/STTR,1998, ,213642, , , , 
DEVELOPMENT OF IMMUNOTHERAPIES FOR CHRONIC MYELOID LEUKEMIA,6269694,5/14/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,228568, , , , 
"HYPOXIA, P53 AND GENETIC INSTABILITY",6269705,4/1/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,212333, , , , 
CORE--CELL REPOSITORY,6269707,4/1/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,212333, , , , 
LUNG CANCER SUSCEPTIBILITY IN FORMER SMOKERS,6269722,8/1/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998, ,109111, , , , 
GENOTYPE/PHENOTYPE BIOMARKERS,6269723,8/1/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998, ,109111, , , , 
APOPTOSIS IN ALL--CONTRIBUTION TO THERAPEUTIC INDEX,6269729,8/1/1998 0:00,7/31/1999 0:00,Non-SBIR/STTR,1998, ,193170, , , , 
MARKERS FOR EARLY LUNG CANCER DETECTION,6269753,9/1/1998 0:00,8/31/1999 0:00,Research Centers,1998, ,300536, , , , 
MUTANT P53 EPITOPE TARGETING IN SCLC,6269755,9/1/1998 0:00,8/31/1999 0:00,Research Centers,1998, ,300536, , , , 
GENE MUTATIONS AND APOPTOSIS IN CANCER CHEMOPREVENTION,6269790,7/7/1998 0:00,6/30/1999 0:00,Non-SBIR/STTR,1998, ,125264, , , , 
CORE--EXPERIMENTAL ANIMALS FACILITY,6269794,7/7/1998 0:00,6/30/1999 0:00,Non-SBIR/STTR,1998, ,125264, , , , 
TARGETING PCD FOR LEUKEMIA TREATMENT,6269850,4/1/1998 0:00,1/31/1999 0:00,Non-SBIR/STTR,1998, ,191214, , , , 
TARGETING PCD IN BLADDER CANCER,6269851,4/1/1998 0:00,1/31/1999 0:00,Non-SBIR/STTR,1998, ,191214, , , , 
KILLER/DR5 APOPTOSIS IN DNA DAMAGE SENSITIVE CELLS,6269855,8/17/1998 0:00,5/31/1999 0:00,Non-SBIR/STTR,1998, ,181884, , , , 
TUMOR SUPPRESSOR AND GROWTH FACTORS IN TUMORIGENESIS,6269866,7/15/1998 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998, ,257281, , , , 
TUMOR SUPPRESSOR GENETICS OF MOUSE CHRMOSOME 11,6269884,7/15/1998 0:00,4/30/1999 0:00,Non-SBIR/STTR,1998, ,482824, , , , 
MOLECULAR MARKERS FOR SQUAMOUS CELL CARCINOMA,6270353,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,104430, , , , 
APOPTOSIS INDUCING GENE THERAPY FOR ORAL PREMALIGNANCY,6270356,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,336222, , , , 
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,6270362,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,13075, , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,6270363,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1998, ,131412, , , , 
HPV AND CELL CYCLE DYSREGULATION IN ORAL CANCER,6270376,4/1/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,274765, , , , 
CYCLIN D1 AND GENETIC MODEL OF ORAL CARCINOGENESIS,6270377,4/1/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,366112, , , , 
CORE--CELL CULTURE,6270380,4/1/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, , , , , , 
MOLECULAR BIOMARKERS OF OCCUPATIONAL BENZENE EXPOSURE,6271061,4/1/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,209951, , , , 
ARSENIC BIOMARKER EPIDEMIOLOGY,6271065,4/1/1998 0:00,3/31/1999 0:00,Non-SBIR/STTR,1998, ,209951, , , , 
GENETIC ALTERATIONS OF ADENOVIRUSES,6271508,1/1/1998 0:00,12/31/1998 0:00,Other Research-Related,1998, , , , , , 
TUMOR SUPPRESSOR GENES IN HUMAN MEDULLOBLASTOMA,6273698,3/1/1998 0:00,2/28/1999 0:00,Research Centers,1998, ,192500, , , , 
ROLE OF RB FAMILY IN JC VIRUS INDUCED GLIOBLASTOMA,6273945,7/1/1998 0:00,11/10/1998 0:00,Non-SBIR/STTR,1998, ,191758, , , , 
PHASE I STUDY OF RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD/NECK,6275813,12/1/1997 0:00,11/30/1998 0:00,Research Centers,1998, ,19081, , , , 
CISPLATIN PLUS PACLITAXEL IN ADVANCED CARCINOMA OF THE UROTHELIUM,6277040,12/1/1997 0:00,11/30/1998 0:00,Research Centers,1998, ,20256, , , , 
VACCINATION AGAINST TUMOR SPECIFIC MUTANT RAS AND P53 PEPTIDES IN CANCER,6278733,12/1/1997 0:00,11/30/1998 0:00,Research Centers,1998, ,24725, , , , 
PHASE I STUDY IN PATIENTS WITH PERITONEAL CARCINOMATOSIS,6279650,12/1/1997 0:00,11/30/1998 0:00,Research Centers,1998, ,17678, , , , 
P53 SIGNALING AND CELLULAR RESPONSE AFTER STRESS,6284951,1/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2001,304956, ,NCI, , ,304956
MOLECULAR MECHANISM OF CHEMOPREVENTION BY APIGENIN,6286534,5/1/1996 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,277408, ,NCI, , ,277408
ROLE OF GRP78 IN ALKYLATING AGENT SENSITIVITY,6286680,1/1/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,2001,206550, ,NCI, , ,206550
MOLECULAR BASIS OF P53 INDUCTION TO DNA DAMAGE,6286907,6/15/2001 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,276515, ,NCI, , ,276515
PLASMA PURINE RATIO--A NEW BIOMARKER FOR CANCER RISK,6287272,1/8/2001 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,80749, ,NCI, , ,80749
INK4 FAMILY OF CDK INHIBITORS,6287284,7/17/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,2001,299786, ,NCI, , ,299786
MALDI TOF TECHNOLOGY FOR MOLECULAR ANALYSIS OF CANCER,6288052,5/1/2001 0:00,4/30/2002 0:00,Non-SBIR/STTR,2001,143390, ,NCI, , ,143390
800 MHZ NMR SPECTROMETER,6288309,4/1/2001 0:00,3/31/2002 0:00,Other Research-Related,2001,500000, ,NCRR, , ,500000
"STRESS, DIFFERENTIATION, GROWTH ARREST AND PROGRAMMED CELL DEATH",6288707, , ,Intramural Research,1999, , , , , , 
IMIDODIPEPTIDES AND AMINO ACID METABOLITES IN CELL REGULATION AND CARCINOGENESIS,6289051, , ,Intramural Research,1999, , , , , , 
REGULATION OF APOPTOSIS,6289052, , ,Intramural Research,1999, , , , , , 
DIETARY MODULATION OF CELL CYCLE REGULATORS,6289053, , ,Intramural Research,1999, , , , , , 
MECHANISMS OF DIET AND CHEMOPREVENTION IN P53-DEFICIENT MICE,6289058, , ,Intramural Research,1999, , , , , , 
MODEL SYSTEMS FOR THE STUDY OF CHEMICAL CARCINOGENESIS AT THE CELLULAR LEVEL,6289065, , ,Intramural Research,1999, , , , , , 
MECHANISMS OF TRANSITION METAL-INDUCED CARCINOGENESIS,6289067, , ,Intramural Research,1999, , , , , , 
THE IDENTIFICATION AND CHARACTERIZATION OF HUMAN GENES ASSOCIATED WITH NEOPLASIA,6289071, , ,Intramural Research,1999, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN CANCER,6289109, , ,Intramural Research,1999, , , , , , 
INTERACTION OF HTLV-I TAX WITH CELLULAR REGULATORY PROTEINS,6289144, , ,Intramural Research,1999, , , , , , 
GENOMIC ALTERATIONS IN FOOD-DERIVED HETEROCYCLIC AMINE-INDUCED RAT MAMMARY GLAND,6289155, , ,Intramural Research,1999, , , , , , 
MOLECULAR EPIDEMIOLOGY OF HUMAN BREAST CANCER,6289159, , ,Intramural Research,1999, , , , , , 
MECHANISM OF HEPATITIS VIRUS-MEDIATED LIVER CARCINOGENESIS,6289168, , ,Intramural Research,1999, , , , , , 
MUTATIONAL AND FUNCTIONAL ANALYSIS OF THE P53 TUMOR SUPPRESSOR GENE,6289169, , ,Intramural Research,1999, , , , , , 
CELL CYCLE CONTROL AND TUMOR SUPPRESSORS,6289170, , ,Intramural Research,1999, , , , , , 
MOLECULAR BIOLOGY OF CELLULAR INJURY,6289183, , ,Intramural Research,1999, , , , , , 
NEW STRATEGIES FOR DRUG DISCOVERY: GENE EXPRESSION PROFILING AND BIOINFORMATICS,6289187, , ,Intramural Research,1999, , , , , , 
"CELL CYCLE REGULATION AND CHEMOSENSITIVITY (PI RESIGNED, O'CONNOR)",6289189, , ,Intramural Research,1999, , , , , , 
REGULATION OF GENE ACTIVITY,6289191, , ,Intramural Research,1999, , , , , , 
MOUSE MODELS FOR CANCER AND THE WNT SIGNALING PATHWAY,6289274, , ,Intramural Research,1999, , , , , , 
THE ROLE OF TOBACCO-RELATED CHEMICAL CARCINOGENS AND OXYRADICALS IN HUMAN CANCER,6289305, , ,Intramural Research,1999, , , , , , 
HLA AND INFECTIOUS DISEASE,6289338, , ,Intramural Research,1999, , , , , , 
BIOLOGIC SPECIMEN BANK FOR EARLY LUNG CANCER MARKERS IN CHINESE TIN MINERS,6289515, , ,Intramural Research,1999, , , , , , 
CONSULTING AND COLLABORATION ON LABORATORY STUDIES,6289551, , ,Intramural Research,1999, , , , , , 
BIOMARKERS FOR ORAL CANCER,6289690, , ,Intramural Research,1999, , , , , , 
GENETIC EPIDEMIOLOGICAL STUDIES OF HEAD AND NECK CANCER,6289700, , ,Intramural Research,1999, , , , , , 
MOLECULAR BASIS OF SQUAMOUS DIFFERENTIATION AND NEOPLASIA IN SKIN & ORAL TISSUES,6289712, , ,Intramural Research,1999, , , , , , 
"ION CHANNELS, RECEPTORS AND SECOND MESSENGERS IN THE NERVOUS SYSTEM",6289756, , ,Intramural Research,1999, , , , , , 
GENE REARRANGEMENTS IN ESOPHAGEAL CANCER,6289812, , ,Intramural Research,1999, , , , , , 
PATHOGENIC FACTORS AND DETERMINANTS OF PROGNOSIS IN PATIENTS WITH GASTRINOMAS,6289818, , ,Intramural Research,1999, , , , , , 
INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS,6289832, , ,Intramural Research,1999, , , , , , 
CLINICALLY AGGRESSIVE THYROID CANCER: MOLECULAR BASIS AND TREATMENT OUTCOME,6289833, , ,Intramural Research,1999, , , , , , 
MECHANISM(S) OF LEUKEMOGENESIS IN GENETICALLY-ALTERED MOUSE MODELS,6289887, , ,Intramural Research,1999, , , , , , 
MOLECULAR ANALYSIS OF CELL CYCLE CONTROL DURING CARCINOGENESIS,6289890, , ,Intramural Research,1999, , , , , , 
APPLICATION OF TRANSGENIC MODELS FOR TOXICOLOGICAL CHARACTERIZATION,6289908, , ,Intramural Research,1999, , , , , , 
CARCINOGEN INACTIVATION OF TUMOR SUPPRESSOR GENES IN P53 HAPLOINSUFFICIENT MICE.,6289910, , ,Intramural Research,1999, , , , , , 
CARBONYL SULFIDE CLEAN AIR ACT STUDIES,6289915, , ,Intramural Research,1999, , , , , , 
GENETIC ALTERATIONS DURING MULTISTEP CARCINOGENESIS IN MICE AND HUMANS,6289921, , ,Intramural Research,1999, , , , , , 
MECHANISM OF CARCINOGENS--GENETIC ALTERATIONS IN RODENT AND HUMAN TUMORS,6289924, , ,Intramural Research,1999, , , , , , 
IDENTIFICATION OF BIOACTIVE ISOFORMS OF P53 PROTEIN,6289926, , ,Intramural Research,1999, , , , , , 
RISK FACTORS FOR CELL TRANSFORMATION AND THE ROLE OF APOPTOSIS,6289930, , ,Intramural Research,1999, , , , , , 
GROWTH FACTORS AND INFLAMMATORY MEDIATORS IN ARSENIC-INDUCED TOXICITY,6289943, , ,Intramural Research,1999, , , , , , 
EXPOSURE SPECIFIC MUTATION IN CRITICAL TARGET GENES,6289996, , ,Intramural Research,1999, , , , , , 
HUMAN GENOME CLONING AND ISOLATION OF SPECIFIC DNAS IN YEAST,6290041, , ,Intramural Research,1999, , , , , , 
ISOLATION AND CHARACTERIZATION OF HUMAN GENES AFFECTING CHROMOSOME METABOLISM,6290047, , ,Intramural Research,1999, , , , , , 
MODEL SYSTEMS TO EVALUATE TRANSPOSITION IN EUKARYOTIC CELLS,6290051, , ,Intramural Research,1999, , , , , , 
DRUG DELIVERY TECHNIQUES,6290644, , ,Intramural Research,1999, , , , , , 
MOLECULAR PATHOLOGY OF PULMONARY CARCINOGENESIS,6290714, , ,Intramural Research,1999, , , , , , 
THE MOLECULAR GENETICS OF GYNECOLOGIC CANCERS,6290719, , ,Intramural Research,1999, , , , , , 
"ANTIGEN-SPECIFIC T-CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS",6290740, , ,Intramural Research,1999, , , , , , 
NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS,6290749, , ,Intramural Research,1999, , , , , , 
THE MOLECULAR PHARMACOLOGY OF ANTIMETABOLITE AGENTS,6290752, , ,Intramural Research,1999, , , , , , 
STUDIES OF DRUG RESISTANCE AND MECHANISMS OF RESISTANCE IN VIVO AND IN PATIENTS W,6290771, , ,Intramural Research,1999, , , , , , 
LYMPHOMA STUDIES,6290775, , ,Intramural Research,1999, , , , , , 
MOLECULAR PATHOGENESIS AND TREATMENT OF PEDIATRIC NON-HODGKIN'S LYMPHOMA,6290782, , ,Intramural Research,1999, , , , , , 
MOLECULAR BIOLOGY OF PROGRESSION IN LYMPHOPROLIFERATIVE DISEASES,6290807, , ,Intramural Research,1999, , , , , , 
HISTOLOGICAL FINDINGS IN PREMENOPAUSAL WOMEN WITH BREAST CANCER,6290819, , ,Intramural Research,1999, , , , , , 
DETERMINATION OF GENETIC ALTERATIONS AND PROGNOSTIC MARKERS IN BENIGN AND CANCERO,6290822, , ,Intramural Research,1999, , , , , , 
THE ROLE OF P300-MEDIATED CREB/REL TRANSCRIPTION FACTOR CROSS-TALK IN REGULATING,6290829, , ,Intramural Research,1999, , , , , , 
ROLE OF HSP90 FAMILY CHAPERONE PROTEINS IN CELLULAR SIGNAL TRANSDUCTION,6290836, , ,Intramural Research,1999, , , , , , 
A PHASE I/II STUDY OF A VACCINIA-HPV RECOMBINANT,6290837, , ,Intramural Research,1999, , , , , , 
ANALYSIS OF P53 REGULATION IN NEUROBLASTOMA CELL LINES,6290843, , ,Intramural Research,1999, , , , , , 
MOLECULAR INTERVENTION IN THORACIC MALIGNANCIES,6290847, , ,Intramural Research,1999, , , , , , 
HPV AND RISK OF ORAL CANCER IN THE CZECH REPUBLIC,6291423,6/15/2001 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,40160, ,FIC, , ,40160
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION,6292073,5/1/1998 0:00,2/28/2003 0:00,Non-SBIR/STTR,2000,66041, ,NCI, , ,66041
MOLECULAR MARKERS OF PROGNOSIS IN MEDULLOBLASTOMA,6292078,7/5/1996 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000,70657, ,NCI, , ,70657
MOUSE MODEL FOR THE PEUTZ JEGHERS SYNDROME,6292089,1/3/2001 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,75000, ,NCI, , ,75000
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN,6292521,9/30/1992 0:00,12/31/2005 0:00,Non-SBIR/STTR,2001,289380, ,NCI, , ,289380
RAR BETA MEDIATED APOPTOSIS IN BREAST CANCER CELLS,6292774,9/22/1995 0:00,8/31/2000 0:00,Other Research-Related,1999,29192, ,NCI, , ,29192
IN VITRO MODEL FOR MEASURING SUNSCREEN PROTECTION,6292898,4/1/2001 0:00,9/30/2001 0:00,SBIR/STTR,2001,100000, ,NIAMS, , ,100000
CELL CYCLE CHECKPOINT REGULATION AND CANCER,6293168,8/31/2000 0:00, ,"Training, Individual",2000,37516, ,NCI, , ,37516
TUMOR MARKERS TO PREDICT TREATMENT RESPONSE,6293426,9/10/2001 0:00,8/31/2006 0:00,Other Research-Related,2001,264578, ,NIA, , ,264578
DEATH OF EBV -IMMORTALIZED CELLS IS REGULATED BY LACTIC,6293777, , ,Intramural Research,1999, , , , , , 
MOLECULAR GENETIC EPIDEMIOLOGY OF PRIMARY HEPATOCELLULAR CARCINOMA,6293834, , ,Intramural Research,1999, , , , , , 
CAROTENOID/RETINOID MODULATION OF CELLULAR REDOX STATUS AND CANCER,6293840, , ,Intramural Research,1999, , , , , , 
BREAST CANCER AND THE ENVIRONMENT ON LONG ISLAND,6294756,8/8/1995 0:00,7/31/2005 0:00,Non-SBIR/STTR,2001,446211, ,NCI, , ,446211
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6295836,9/11/1998 0:00,6/30/1999 0:00,Research Centers,1998, ,317200, , , , 
MARKERS OF PROGRESSION AND METASTASES,6296050,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,6296051,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
GENE THERAPY FOR PROSTATE CANCER,6296053,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
PROSTATE SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE,6296054,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
ROLE OF CDK INHIBITORS IN PROSTATE CANCER,6296057,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
MARKERS OF PROGRESSION AND METASTASES,6296062,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,6296063,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
GENE THERAPY FOR PROSTATE CANCER,6296065,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
PROSTATE SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE,6296066,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
ROLE OF CDK INHIBITORS IN PROSTATE CANCER,6296069,6/1/1999 0:00,5/31/2000 0:00,Research Centers,1999, ,174672, , , , 
MARKERS OF PROGRESSION AND METASTASES,6296074,9/30/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,6296075,9/30/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
GENE THERAPY FOR PROSTATE CANCER,6296077,9/30/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
PROSTATE SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE,6296078,9/30/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
ROLE OF CDK INHIBITORS IN PROSTATE CANCER,6296081,9/30/1998 0:00,5/31/1999 0:00,Research Centers,1998, ,180839, , , , 
MUTANT P53 EPITOPE TARGETING IN SCLC,6296131,9/1/1998 0:00,8/31/1999 0:00,Research Centers,1998, ,132196, , , , 
MARKERS FOR EARLY LUNG CANCER DETECTION,6296134,9/1/1998 0:00,8/31/1999 0:00,Research Centers,1998, ,132196, , , , 
GENE MUTATIONS AND APOPTOSIS IN CANCER CHEMOPREVENTION,6296136,7/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999, ,130479, , , , 
CORE--EXPERIMENTAL ANIMALS FACILITY,6296140,7/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,1999, ,130479, , , , 
GENE MUTATIONS AND APOPTOSIS IN CANCER CHEMOPREVENTION,6296142,7/7/1998 0:00,6/30/1999 0:00,Non-SBIR/STTR,1998, ,125264, , , , 
CORE--EXPERIMENTAL ANIMALS FACILITY,6296146,7/7/1998 0:00,6/30/1999 0:00,Non-SBIR/STTR,1998, ,125264, , , , 
APOPTOSIS IN ORAL CANCER,6296323,8/1/1998 0:00,7/31/1999 0:00,Research Centers,1999, ,89732, , , , 
CHEMOPREVENTION OF DEFLUOROMETHYLORNITHINE IN INTESTINAL BARRETTS ESOPHAGUS,6297036,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,206, , , , 
PHASE I STUDY IN PATIENTS WITH PERITONEAL CARCINOMATOSIS USING SCH58500,6297814,12/1/1998 0:00,11/30/1999 0:00,Research Centers,1999, ,1903, , , , 
ROLE OF C/EBP ALPHA IN GROWTH INHIBITION,6299368,4/15/2000 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000, ,211649, , , , 
CHEMOTHERAPEUTIC STUDIES IN SOLID TUMORS,6299882,5/1/1999 0:00,7/5/2001 0:00,Non-SBIR/STTR,2000, ,188635, , , , 
CANCER THERAPY,6299967,1/1/2000 0:00,12/31/2000 0:00,Non-SBIR/STTR,2000, ,374147, , , , 
GENETIC INSTABILITY INDUCED BY VIRAL PROTEINS,6300035,3/1/2000 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000, ,159739, , , , 
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6300102,7/1/1999 0:00,6/30/2000 0:00,Research Centers,2000, ,332337, , , , 
P53 function and apoptosis in melanoma,6300197,5/1/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,130863, , , , 
CHEMOPREVENTION OF GASTRIC DYSPLASIA,6300211,3/10/2000 0:00,2/28/2003 0:00,Non-SBIR/STTR,2000, ,297994, , , , 
MOLECULAR GENETICS OF WILMS' TUMOR,6300266,5/1/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,135290, , , , 
FUNCTIONAL ANALYSIS OF THE RB TUMOR SUPPRESSOR GENE FAMILY,6300268,5/1/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,135290, , , , 
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA,6300315,3/1/2000 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000, ,230631, , , , 
INDUCTION OF APOPTOSIS IN BREAST CANCER,6300360,6/1/1999 0:00,5/31/2001 0:00,Non-SBIR/STTR,2000, ,256220, , , , 
NEW GENETIC MARKERS FOR PANCREATIC CANCER,6300461,1/18/2000 0:00,12/31/2000 0:00,Research Centers,2000, ,219161, , , , 
MOLECULAR MARKERS FOR METASTASIS OF COLORECTAL CANCER,6300465,1/18/2000 0:00,12/31/2000 0:00,Research Centers,2000, ,219161, , , , 
DETECTION OF MUTATIONS IN COLON AND BREAST CANCER,6300474,2/16/2000 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000, ,219559, , , , 
"HYPOXIA, P53 AND GENETIC INSTABILITY",6300484,4/14/2000 0:00,8/31/2001 0:00,Non-SBIR/STTR,2000, ,218557, , , , 
CORE--CELL REPOSITORY,6300486,4/14/2000 0:00,8/31/2001 0:00,Non-SBIR/STTR,2000, ,218557, , , , 
TARGETING PCD FOR LEUKEMIA TREATMENT,6300555,4/12/2000 0:00,1/31/2001 0:00,Non-SBIR/STTR,2000, ,198353, , , , 
TARGETING PCD IN BLADDER CANCER,6300556,4/12/2000 0:00,1/31/2001 0:00,Non-SBIR/STTR,2000, ,198353, , , , 
Tumor Suppressors in Spontaneous and UV-Induced Melanoma Models,6300558,3/10/2000 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000, ,270618, , , , 
KILLER/DR5 APOPTOSIS IN DNA DAMAGE SENSITIVE CELLS,6300563,12/17/1999 0:00,5/31/2000 0:00,Non-SBIR/STTR,2000, ,183014, , , , 
TUMOR SUPPRESSOR AND GROWTH FACTORS IN TUMORIGENESIS,6300586,5/1/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,250910, , , , 
HPV AND CELL CYCLE DYSREGULATION IN ORAL CANCER,6300861,4/1/2000 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000, ,181310, , , , 
CYCLIN D1 AND GENETIC MODEL OF ORAL CARCINOGENESIS,6300862,4/1/2000 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000, ,181310, , , , 
CORE--CELL CULTURE,6300865,4/1/2000 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000, ,181310, , , , 
ARSENIC BIOMARKER EPIDEMIOLOGY,6301351,4/15/2000 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000, ,293470, , , , 
PROTEIN P53 PHOSPHORYLATION STATUS IN PRIMARY BREAST CANCER,6301651,8/1/1999 0:00,7/31/2000 0:00,Other Research-Related,2000, ,30384, , , , 
GENETIC ALTERATIONS OF ADENOVIRUSES,6301659,1/1/2000 0:00,12/31/2000 0:00,Other Research-Related,2000, ,104931, , , , 
GENE THERAPY FOR PRIMARY & METASTATIC MALIGNANT TUMORS OF LIVER,6303318,12/1/1999 0:00,11/30/2000 0:00,Research Centers,2000, ,25114, , , , 
PHASE I STUDY OF RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD/NECK,6304676,12/1/1999 0:00,11/30/2000 0:00,Research Centers,2000, ,3034, , , , 
ADENOVIRUS IN BRONCHIOLOALVEOLAR CELL LUNG CARCINOMA,6305720,12/1/1999 0:00,11/30/2000 0:00,Research Centers,2000, ,592, , , , 
CELLULAR TARGETS FOR PAPILLOMAVIRUS E6 ONCOPROTEINS,6311521,4/27/2000 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000, ,283979, , , , 
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS,6311539,4/21/2000 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000, ,150197, , , , 
REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER,6311540,4/21/2000 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000, ,150197, , , , 
CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY,6311543,4/21/2000 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000, ,150197, , , , 
Radiation sensitivity/Apoptosis Induction in Cancer Cells--P53 Restoration,6311546,5/1/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,176165, , , , 
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION,6311970,7/4/1995 0:00,11/30/2005 0:00,Non-SBIR/STTR,2001,349374, ,NCI, , ,349374
ROLE FOR CELL CYCLE PROTEINS IN HIV ENCEPHALITIS,6312439,2/1/2001 0:00,8/31/2001 0:00,Non-SBIR/STTR,2001,262500, ,NINDS, , ,262500
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM,6312552,8/8/2001 0:00, ,"Training, Individual",2001,22630, ,NCI, , ,22630
INTERACTION OF APC AND P53 IN COLORECTAL CARCINOGENESIS,6313322,1/1/1999 0:00,12/31/2001 0:00,Non-SBIR/STTR,2000,187986, ,NCI, , ,187986
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,6313444,6/1/1993 0:00,4/30/2003 0:00,Non-SBIR/STTR,2000,31634, ,NCI, , ,31634
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER,6313809,9/30/1999 0:00,9/29/2004 0:00,Non-SBIR/STTR,2000,34185, ,NIDCR, , ,34185
DEVELOPMENT OF IMMUNOTHERAPIES FOR CHRONIC MYELOID LEUKEMIA,6314040,5/10/2000 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000, ,226134, , , , 
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6314531,7/1/1999 0:00,6/30/2000 0:00,Research Centers,1999, ,332337, , , , 
Harvard-SDM/Forsyth Collaborative Microarray Core(HFCMC),6314827,4/1/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,215000, ,NIDCR, , ,215000
USE OF THE MOUSE FOR PROSTATE CANCER GENE DISCOVERY,6315923,3/27/2000 0:00,2/28/2005 0:00,Other Research-Related,2000,139320, ,NCI, , ,139320
MARKERS OF PROGRESSION AND METASTASES,6316540,6/1/2000 0:00,5/31/2002 0:00,Research Centers,2000, ,174672, , , , 
MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER,6316541,6/1/2000 0:00,5/31/2002 0:00,Research Centers,2000, ,174672, , , , 
GENE THERAPY FOR PROSTATE CANCER,6316543,6/1/2000 0:00,5/31/2002 0:00,Research Centers,2000, ,174672, , , , 
PROSTATE SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE,6316544,6/1/2000 0:00,5/31/2002 0:00,Research Centers,2000, ,174672, , , , 
ROLE OF CDK INHIBITORS IN PROSTATE CANCER,6316547,6/1/2000 0:00,5/31/2002 0:00,Research Centers,2000, ,174672, , , , 
MECHANISMS OF CELLULAR RADIOSENSITIVITY,6316556,5/25/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,224906, , , , 
Nicotine Derived Nitrosamines & Tobacco Related Cancers,6317557,5/1/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2001,272054, ,NCI, , ,272054
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER,6317594,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,373018, ,NCI, , ,373018
New Molecular Approaches to Inhibit Glioma Angiogenesis,6317879,3/1/2001 0:00,2/28/2004 0:00,Non-SBIR/STTR,2001,259875, ,NCI, , ,259875
IL10 and IGF1 Receptor Axis in Prostate Cancer,6318053,6/5/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2001,281993, ,NCI, , ,281993
KILLER/DR5 APOPTOSIS IN DNA DAMAGE SENSITIVE CELLS,6318312,6/1/2000 0:00,5/31/2001 0:00,Non-SBIR/STTR,2000, ,183014, , , , 
TUMOR SUPPRESSOR GENETICS OF MOUSE CHRMOSOME 11,6318318,6/1/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,455266, , , , 
Apoptosis in Colon Cancer Chemoprevention,6318871,7/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2001,1280347, ,NCI, , ,1280347
BIOLOGY OF ONCOGENES AND TUMOR SUPPRESSOR GENES,6319237,5/1/1986 0:00,4/30/2006 0:00,Non-SBIR/STTR,2001,1506676, ,NCI, , ,1506676
The role of HPV in squamous cell carcinoma,6319561,7/1/2001 0:00, ,"Training, Individual",2000,45154, ,NIAMS, , ,45154
Prospective Studies of Diet and Cancer in Men and Wonen,6320145,8/23/1991 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,3595018, ,NCI, , ,3595018
Childhood Cancer Gene Program Project Grant,6320248,8/1/1996 0:00,5/31/2006 0:00,Non-SBIR/STTR,2001,1723222, ,NCI, , ,1723222
PCR MS/MS FINGERPRINTS FOR SEQUENCE POLYMORPHISM,6320434,8/1/1998 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000,28494, ,NHGRI, , ,28494
Molecular Targeting of the Survivin Pathway in Cancer,6320554,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,305336, ,NCI, , ,305336
P53 Mediated Regulation of Centrosome Duplication,6320730,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,245595, ,NCI, , ,245595
GROWTH REGULATION OF PROSTATIC CELLS BY ANDROGEN,6321011,7/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2000,12358, ,NCI, , ,12358
Tobacco Carcinogenesis and Chemoprevention,6321198,6/17/1996 0:00,2/28/2006 0:00,Non-SBIR/STTR,2001,1210148, ,NCI, , ,1210148
Transcriptional Regulation of Cell Growth,6321761,6/1/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2001,2233611, ,NCI, , ,2233611
POLYOMA HOST INTERACTIONS LEADING TO TUMOR DEVELOPMENT,6322159,9/1/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2001,678691, ,NCI, , ,678691
Flavopiridol Mediated Apoptosis During S Phase in NSCLC,6322220,4/1/2001 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,295410, ,NCI, , ,295410
KILLER/DR5 APOPTOSIS IN DNA DAMAGE SENSITIVE CELLS,6323306,6/1/2000 0:00,5/31/2001 0:00,Non-SBIR/STTR,2000, ,140673, , , , 
Convergent functions of p53 and BRCA1 in gene regulation,6323779,2/16/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2000, ,237979, , , , 
PW1--A mediator of cell survival by NFKB and cell death by p53,6323780,2/16/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2000, ,237979, , , , 
"P13K/PTEN/Akt (PKB), Signaling and genesis of cancer",6323882,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2001,319648, ,NCI, , ,319648
Regulation of Transcription Factor E2F,6324003,5/1/2001 0:00,6/30/2001 0:00,Non-SBIR/STTR,2001,249830, ,NCI, , ,249830
PILOT--MOLECULAR PREDICTORS OF ORAL CANCER DEVELOPMENT,6324038,6/1/2001 0:00,11/30/2005 0:00,Non-SBIR/STTR,2001, ,19000, , , , 
PILOT--INVASION REGULATED BY FIBRONECTIN AND  RECEPTORS,6324039,6/1/2001 0:00,11/30/2005 0:00,Non-SBIR/STTR,2001, ,19000, , , , 
IN VITRO SCREENING OF CHEMOPREVENTIVE AGENTS,6325281,6/30/1998 0:00,12/31/2000 0:00,R and D Contracts,1999,0, , , , , 
FUNCTIONS OF DIFFERENT P53 MUTATIONS IN PROSTATE CANCER,6325606,4/15/1998 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,260010, ,NCI, , ,260010
P53 GENE AND CHEMOSENSITIVITY,6325757,7/3/2000 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000, ,167100, , , , 
APOPTOSIS AND A NEW ADAPTER MOLECULE PATHWAY IN GLIOMA,6326210,4/15/2001 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,221407, ,NCI, , ,221407
Genetic and Molecular Epidemiology of Adult Glioma,6326317,5/15/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2001,1081007, ,NCI, , ,1081007
Targeting Cancer Cell DNA with Combinatorial Ligands,6326504,4/1/1998 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,263936, ,NCI, , ,263936
Function of ATF2 URE binding protein in human melanoma,6326754,1/1/1991 0:00,5/31/2006 0:00,Non-SBIR/STTR,2001,343060, ,NCI, , ,343060
Antineoplastic Agents from Marine Organisms,6326915,9/1/1983 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,300875, ,NCI, , ,300875
The XP Variant:  A Human Mutator Gene for UV Damage,6327308,2/1/1998 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,331875, ,NIEHS, , ,331875
Analysis of the Chemopreventive Activity of FGN 1,6328219,4/1/2001 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,321677, ,NCI, , ,321677
CERAMIDE SIGNALING IN RADIATION INDUCED APOPTOSIS,6328918,7/15/1990 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001,464264, ,NCI, , ,464264
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE,6328944,12/29/1994 0:00,11/30/2004 0:00,Non-SBIR/STTR,2001,371437, ,NCI, , ,371437
HUMAN MAMMARY EPITHELIAL CELL IMMORTALIZATION,6328953,12/12/1997 0:00,11/30/2002 0:00,Non-SBIR/STTR,2001,235254, ,NCI, , ,235254
AFB1 AND P53 CARCINOGENESIS IN HBSAG TRANSGENIC MICE,6328981,12/15/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,2001,241031, ,NCI, , ,241031
INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN D,6328985,12/24/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2001,226060, ,NCI, , ,226060
MECHANISM OF P53 DEPENDENT APOPTOSIS,6328993,12/5/1997 0:00,9/15/2001 0:00,Non-SBIR/STTR,2001,83394, ,NCI, , ,83394
SELENIUM--ANTIOXIDANT OR PROOXIDANT MECHANISM,6329026,12/10/1997 0:00,11/30/2003 0:00,Non-SBIR/STTR,2001,194302, ,NCI, , ,194302
G2 CHECKPOINT CONTROL IN TRANSFORMED HUMAN CELLS,6329030,12/1/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2001,263947, ,NCI, , ,263947
RAPAMYCIN INDUCED SELECTIVE APOPTOSIS IN MALIGNANT CELLS,6329042,12/1/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,2001,233582, ,NCI, , ,233582
REGULATION OF P53 FUNCTION BY BRCA1 TUMOR SUPPRESSOR,6329062,12/11/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,2001,190099, ,NCI, , ,190099
CANCER-RELATED GLYCOLYTIC GENE--REGULATION/TARGETING,6329071,12/11/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2001,239067, ,NCI, , ,239067
ADENOVIRUS BASED P53 GENE THERAPY FOR OVARIAN CANCER,6329074,12/8/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2001,111193, ,NCI, , ,111193
"HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING",6329088,5/1/1999 0:00,11/30/2002 0:00,SBIR/STTR,2001,637606, ,NCI, , ,637606
PROTEIN KINASE C AND THYROID CELL APOPTOSIS,6329262,4/1/2000 0:00,11/30/2002 0:00,Other Research-Related,2001,91703, ,NIDDK, , ,91703
Function of the Adenovirus E1B Oncogene,6330842,1/1/1991 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,304063, ,NCI, , ,304063
Nitroaromatics and Breast Cancer,6333647,7/1/1983 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,293198, ,NCI, , ,293198
Extracellular Matrix Mediated Apoptosis in p53 (-) HMECs,6333764,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,259160, ,NCI, , ,259160
Adenocarinoma of the Lung in Women,6333825,6/13/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2001,557707, ,NCI, , ,557707
Molecular Genetics of HNPCC,6333866,6/1/1997 0:00,5/31/2006 0:00,Non-SBIR/STTR,2001,419439, ,NCI, , ,419439
HORMONAL REGULATION OF BREAST CANCER,6333959,8/1/1978 0:00,1/31/2002 0:00,Non-SBIR/STTR,2001,9805, ,NCI, , ,9805
The IAP BIR Domain: A Novel Target for Cancer Therapy,6333989,6/1/2001 0:00,5/31/2002 0:00,SBIR/STTR,2001,100000, ,NCI, , ,100000
Selection of chemical inhibitors of oncoproteins,6334014,5/25/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,148000, ,NCI, , ,148000
Genetic Control of Susceptibility to Testicular Cancer,6334048,6/1/1998 0:00,4/30/2004 0:00,Non-SBIR/STTR,2001,434416, ,NCI, , ,434416
"Checkpoints, DNA repair & human carcinogenesis",6334373,4/1/1992 0:00,3/31/2005 0:00,Non-SBIR/STTR,2000, ,175236, , , , 
Topoisomerase I Inhibitors in Leukemia and Solid Tumors,6334424,4/1/1997 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,222233, ,NCI, , ,222233
Mechanisms of Genetic Instability and Tumor Suppression,6334425,7/1/1993 0:00,5/31/2006 0:00,Non-SBIR/STTR,2001,557365, ,NCI, , ,557365
Models for DNA repair and cell cycle control variants,6334513,4/10/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,1001412, ,NIEHS, , ,1001412
TEA TARGETING PROTEASOME--A ROLE IN CANCER PREVENTION,6334635,4/1/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,72500, ,NCI, , ,72500
TNF alpha mediated apoptosis in prostate cancer,6334640,3/1/2001 0:00,2/28/2005 0:00,Non-SBIR/STTR,2001,244020, ,NCI, , ,244020
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6334916,7/18/2000 0:00,6/30/2001 0:00,Research Centers,2000, ,332337, , , , 
PROGNOSTIC & PREDICTIVE BIOMARKERS FOR BREAST CANCER,6334929,8/1/2000 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000, ,181487, , , , 
DEVELOPMENTAL & PROGNOSTIC FACTORS IN PREMALIGNANT BREAST DISEASE,6334931,8/1/2000 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000, ,181487, , , , 
MODULATION OF ARA-C INDUCED APOPTOSIS BY BRYOSTATIN 1,6335520,6/1/1994 0:00,4/30/2003 0:00,Non-SBIR/STTR,2001,15835, ,NCI, , ,15835
Epigenetic effects on susceptibility to heavy metal & PAH induced DNA damage,6335585,6/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2000, ,164076, , , , 
CELLULAR AND MOLECULAR TOXICITY IN HUMAN MAMMARY CELLS,6335946,6/1/1988 0:00,5/31/2004 0:00,Other Research-Related,2000, ,31452, , , , 
Xenobiotics and Breast Epithelial Cell-ECM Signaling,6336082,5/3/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2001,260750, ,NIEHS, , ,260750
GENETIC MANIPULATION OF TUMOR RADIORESISTANCE,6336437,8/1/2000 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000, ,100568, , , , 
RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53,6336438,8/1/2000 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000, ,100568, , , , 
APOPTOSIS INDUCING GENE THERAPY FOR ORAL PREMALIGNANCY,6336487,8/1/1999 0:00,7/31/2000 0:00,Research Centers,2000, ,270888, , , , 
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,6336493,8/1/1999 0:00,7/31/2000 0:00,Research Centers,2000, ,98790, , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,6336494,8/1/1999 0:00,7/31/2000 0:00,Research Centers,2000, ,98555, , , , 
APOPTOSIS IN ORAL CANCER,6336504,8/1/1999 0:00,7/31/2000 0:00,Research Centers,2000, ,93518, , , , 
High Resolution Fluorescent Melting Curve Analysis,6337870,7/1/1999 0:00,4/30/2003 0:00,SBIR/STTR,2001,263396, ,NIGMS, , ,263396
INDUCTION OF APOPTOTIC PATHWAY IN CANCER CELL LINES,6338097,3/1/1981 0:00,6/30/2004 0:00,Other Research-Related,2000, ,48533, , , , 
MOLECULAR DETERMINANTS OF CHEMOTHERAPY RESISTANCE,6338688,8/4/2000 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000, ,163224, , , , 
MALIGNANT COMPLICATIONS OF CHRONIC HEPATITIS C VIRUS,6339730,9/29/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2000,318478, ,NCI, , ,318478
HUMAN PAPILLOMAVIRUS AND PROGNOSIS OF FEMALE ANOGENITAL CANCER,6340761,6/1/1999 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000, ,280718, , , , 
GENE MUTATIONS AND APOPTOSIS IN CANCER CHEMOPREVENTION,6340770,7/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,2000, ,130479, , , , 
CORE--EXPERIMENTAL ANIMALS FACILITY,6340774,7/1/1999 0:00,12/31/2000 0:00,Non-SBIR/STTR,2000, ,130479, , , , 
"ATM, P53, GADD45 AND P21 EFFECTS ON RECOMBINATION",6341403,6/1/1999 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000,78473, ,NIEHS, , ,78473
PEDIATRIC ONCOLOGY GROUP,6341826,1/1/1978 0:00,12/31/2002 0:00,Other Research-Related,2001,211683, ,NCI, , ,211683
PEDIATRIC ONCOLOGY GROUP,6341859,1/1/1983 0:00,12/31/2002 0:00,Other Research-Related,2001,86090, ,NCI, , ,86090
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,6341897,1/1/1987 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,333231, ,NCI, , ,333231
MECHANISM OF LARGE T ANTIGEN INDUCED TUMORIGENESIS,6341909,3/1/1988 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,398846, ,NCI, , ,398846
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,6341928,8/1/1990 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,370462, ,NCI, , ,370462
ADDUCT INDUCED FRAMESHIFT MUTAGENESIS,6341938,2/15/1992 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,224355, ,NCI, , ,224355
SUNLIGHT RELATED STEPS IN HUMAN SKIN CANCER,6341939,4/1/1992 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,329917, ,NCI, , ,329917
P53S DIRECT ROLE IN MITOCHONDRIAL CONTROL OF APOPTOSIS,6341959,9/15/1993 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,211480, ,NCI, , ,211480
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM,6341967,3/18/1994 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,117440, ,NCI, , ,117440
REGULATION OF MULTIDRUG RESISTANCE PHENOTYPE,6341988,3/15/1996 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,183602, ,NCI, , ,183602
MOLECULAR PROGNOSTIC INDICATORS IN ESOPHAGEAL CANCER,6342012,3/1/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,421027, ,NCI, , ,421027
REGULATION OF BCL2 BY RAS AND TUMOR SUPPRESSORS,6342019,1/1/1997 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,216419, ,NCI, , ,216419
CENTROSOME HYPERTROPHY IN HUMAN BREAST TUMORS,6342021,1/1/1998 0:00,12/31/2001 0:00,Non-SBIR/STTR,2001,270679, ,NCI, , ,270679
SIGNALING PATHWAYS UTILIZED BY V-ABL AND BCR-ABL,6342043,1/20/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,746950, ,NCI, , ,746950
CHEMOPREVENTION FOR WOMEN AT HIGH RISK OF BREAST CANCER,6342075,9/30/1997 0:00,6/30/2003 0:00,Other,2001,1760323, ,NCI, , ,1760323
MDM2 AND CELL GROWTH AND TUMORIGENESIS,6342090,3/1/1999 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,254790, ,NCI, , ,254790
PROPERTIES AND REGULATION OF P53 IN TUMOR CELLS,6342091,3/23/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,280887, ,NCI, , ,280887
DUAL ROLE OF E2F1 IN TUMORIGENESIS,6342112,1/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,255968, ,NCI, , ,255968
TUMOR SUPPRESSORS AND DIFFERENTIATED THYROID CANCER,6342137,1/5/1999 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,255614, ,NCI, , ,255614
ONCOLYTIC ADENOVIRUSES--CERVICAL CANCER GENE THERAPY,6342141,3/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,219117, ,NCI, , ,219117
COLOR DNA SEQUENCING APPARATUS FOR CLINICAL DIAGNOSIS,6342150,7/15/1999 0:00,12/31/2002 0:00,SBIR/STTR,2001,439469, ,NCI, , ,439469
GENE EXPRESSION IN CTCL PATIENTS IN IL 12 CLINICAL TRIAL,6342165,1/1/2000 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,157466, ,NCI, , ,157466
AT: ERRORS IN DOUBLE STRAND BREAK REPAIR,6342171,1/26/2000 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,221847, ,NCI, , ,221847
EXPRESSION PROFILING OF PROGRESSED FOLLICULAR LYMPHOMAS,6342195,1/14/2000 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,112519, ,NCI, , ,112519
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS,6342200,2/1/2000 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,197732, ,NCI, , ,197732
MECHANISMS OF INTESTINAL TUMORIGENESIS,6342209,1/1/2000 0:00,6/30/2001 0:00,Non-SBIR/STTR,2001,136745, ,NCI, , ,136745
P53 AND MOUSE MAMMARY TUMORIGENESIS,6342215,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2001,324328, ,NCI, , ,324328
GENETIC PATHWAY TO IGH TRANSLOCATIONS IN LYMPHOMA,6342233,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2001,277321, ,NCI, , ,277321
P53 AND THE CELLULAR RESPONSE TO DNA DAMAGE,6342560,1/1/1992 0:00,12/31/2001 0:00,Non-SBIR/STTR,2001,284945, ,NIEHS, , ,284945
REGULATION OF THE STEROL BIOSYNTHESIS PATHWAY IN YEAST,6342803,1/1/1986 0:00,12/31/2001 0:00,Non-SBIR/STTR,2001,338980, ,NIGMS, , ,338980
EBV BZLF1 GENE PRODUCT,6342856,1/1/1993 0:00,4/10/2003 0:00,Non-SBIR/STTR,2001,239669, ,NIGMS, , ,239669
NOVEL CYCLINS G1 AND G2,6342980,1/1/1998 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,164640, ,NIGMS, , ,164640
A PROGRAMMABLE DNA ARRAY SYNTHESIZER,6343266,9/30/1999 0:00,3/31/2002 0:00,SBIR/STTR,2001,396593, ,NHGRI, , ,396593
BCL-2 FAMILY AND P53 GENES ALTER APOPTOSIS IN GLIOMAS,6343837,1/1/1993 0:00,12/31/2001 0:00,Non-SBIR/STTR,2001,226033, ,NINDS, , ,226033
REDOX REGULATION OF TRANSCRIPTION FACTORS,6344112,6/14/1978 0:00,6/30/2004 0:00,Other Research-Related,2000, ,73250, , , , 
PROTECTIVE ROLE OF APOPTOSIS IN ASBESTOS PLEURAL INJURY,6344201,8/29/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,2000,71538, ,NIEHS, , ,71538
Prevention of Skin Cancer by Scutellaria Baicalensis,6344289,9/18/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2000,253403, ,NCCIH, , ,253403
PROTEIN KINASE C--A NOVEL TARGET FOR CANCER THERAPY,6344379,8/1/1996 0:00,12/31/2000 0:00,Non-SBIR/STTR,2000,73431, ,NCI, , ,73431
Molecular Imaging of Responses to Cancer Therapy,6344460,6/6/2001 0:00,5/31/2004 0:00,Other,2001,400000, ,NCI, , ,400000
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1,6344694,8/21/2000 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000, ,230434, , , , 
ROLE OF PROSTAGLANDIN H SYNTHASE 2 IN COLON CARCINOGENESIS,6344749,8/16/2000 0:00,5/31/2001 0:00,Non-SBIR/STTR,2000, ,100568, , , , 
PROTEIN P53 PHOSPHORYLATION STATUS IN PRIMARY BREAST CANCER,6344859,8/1/2000 0:00,1/31/2002 0:00,Other Research-Related,2000, ,30384, , , , 
Genotoxic effects,6345330,12/12/1988 0:00,3/31/2005 0:00,Non-SBIR/STTR,2000, ,73465, , , , 
"HPV, Genetic Instability & Oral Cancer",6345366,8/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,240975, ,NIDCR, , ,240975
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,6346641,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,2000,68034, ,NIDDK, , ,68034
Gene based therapy of human melanoma,6346859,7/20/1997 0:00,6/30/2001 0:00,Research Centers,2000, ,77307, , , , 
Formation of novel p53 nuclear complexes during apoptosis,6346864,7/20/1997 0:00,6/30/2001 0:00,Research Centers,2000, ,77310, , , , 
INT-5/AROMATASE--EFFECT OF BREAST ESTROGEN IN NEOPLASIA,6346904,7/15/1997 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000,15308, ,NCI, , ,15308
Mechanisms of Herbal Radiosensitization of Glioma Cells,6346938,9/20/2000 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,217868, ,NCCIH, , ,217868
ROLE OF E7 IN HPV INFECTIONS,6347198,9/1/1999 0:00,8/31/2000 0:00,Non-SBIR/STTR,2000, ,137421, , , , 
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6347265,8/30/2000 0:00,6/30/2001 0:00,Research Centers,2000, ,254104, , , , 
Development of immunoconjugate therapy for breast and prostate cancer,6347312,9/30/2000 0:00,9/29/2001 0:00,Non-SBIR/STTR,2000, ,180509, , , , 
TRANSPLACENTAL PANCREATIC CARCINOGENESIS BY NNK,6348642,9/1/1986 0:00,7/31/2001 0:00,Non-SBIR/STTR,2000,50750, ,NCI, , ,50750
EPIDERMAL GROWTH FACTOR AND PANCREATIC CANCER,6348702,4/1/1989 0:00,2/28/2001 0:00,Non-SBIR/STTR,2000,63514, ,NCI, , ,63514
ROLE OF E7 IN HPV INFECTIONS,6348891,9/1/2000 0:00,8/31/2001 0:00,Non-SBIR/STTR,2000, ,137421, , , , 
KARP 1 V(D)J RECOMBINATION AND DNA REPAIR,6349820,5/1/1994 0:00,4/30/2001 0:00,Non-SBIR/STTR,2001,119310, ,NIAID, , ,119310
VIRAL GENE FUNCTIONS AND REGULATION OF CELL GROWTH,6350004,9/1/1975 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,387451, ,NCI, , ,387451
HORMONAL REGULATION OF BREAST CANCER,6350006,8/1/1978 0:00,1/31/2002 0:00,Non-SBIR/STTR,2001,558353, ,NCI, , ,558353
DIHYDRODIOL DEHYDROGENASE AND PAH METABOLISM/ACTIVATION,6350050,3/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,256858, ,NCI, , ,256858
FRAGILE SITES AND CHROMOSOME BREAKAGE AND CANCER,6350068,7/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,273452, ,NCI, , ,273452
DNA REPAIR AND CANCER PRONE HEREDITARY HUMAN DISEASE,6350072,2/1/1987 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,311206, ,NCI, , ,311206
C MYC--TRANSCRIPTION AND APOPTOSIS,6350095,1/1/1990 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,371979, ,NCI, , ,371979
MOLECULAR REGULATION OF FOLATE AND ANTIFOLATE TRANSPORT,6350099,2/12/1993 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,235873, ,NCI, , ,235873
PROGRESSION OF T CELL LYMPHOMA LINES TO IL2 INDEPENDENCE,6350106,7/1/1992 0:00,1/31/2002 0:00,Non-SBIR/STTR,2001,351875, ,NCI, , ,351875
ACTIVATION OF BCL 2 IN HEMATOLOGIC MALIGNANCIES,6350110,8/1/1993 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,230166, ,NCI, , ,230166
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN GLIOMAS,6350117,8/1/1992 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,280606, ,NCI, , ,280606
MONOCLONAL GAMMOPATHIES,6350147,9/30/1994 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,1323474, ,NCI, , ,1323474
MUTANT P53 GAIN OF FUNCTION IN TUMORIGENESIS,6350159,4/1/1995 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,248456, ,NCI, , ,248456
EXPRESSION AND FUNCTIONS OF MDM2 PROTEINS,6350192,2/1/1997 0:00,1/31/2002 0:00,Non-SBIR/STTR,2001,123472, ,NCI, , ,123472
ANTIAPOPTOTIC MECHANISMS IN PROSTATE CANCER,6350241,4/1/1998 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,270556, ,NCI, , ,270556
GENETIC EVENTS IN HUMAN PROSTATE CELL TRANSFORMATION,6350257,2/1/1998 0:00,1/31/2003 0:00,Other Research-Related,2001,92070, ,NCI, , ,92070
INTERACTION OF APC AND P53 IN COLORECTAL CARCINOGENESIS,6350294,1/1/1999 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,193626, ,NCI, , ,193626
"C-, N-, AND L-MYC EFFECTS ON HEMATOPOIETIC CELLS",6350303,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,210543, ,NCI, , ,210543
CELL GROWTH CONTROL BY BRCA1/ITS RESPONSE TO DNA DAMAGE,6350306,4/1/1999 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,231197, ,NCI, , ,231197
P53 - REGULATORS AND EFFECTORS,6350340,2/16/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2001,1175362, ,NCI, , ,1175362
TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS,6350357,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,251075, ,NCI, , ,251075
STRUCTURAL FEATURES OF PAPILLOMAVIRUS E6 ONCOPROTEINS,6350360,2/1/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2001,179397, ,NCI, , ,179397
EXPERIMENTAL TRANSFORMATION OF HUMAN MELANOCYTES IN VIVO,6350364,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,320985, ,NCI, , ,320985
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7,6350368,2/15/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2001,248807, ,NCI, , ,248807
INTRAGENIC SUPPRESSOR MUTATIONS FOR P53 CANCER MUTATIONS,6350382,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,256058, ,NCI, , ,256058
THE ROLE OF GADD45 IN G2 - M CHECKPOINT,6350408,2/11/2000 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,204564, ,NCI, , ,204564
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION,6350409,2/9/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2001,363219, ,NCI, , ,363219
DISSECTION OF THE DNA DAMAGE CHECKPOINT PATHWAYS,6350425,2/1/2000 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,266110, ,NCI, , ,266110
E2F AND APOPTOSIS,6350444,2/5/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2001,287040, ,NCI, , ,287040
REGULATION OF P53 SUBCELLULAR DISTRIBUTION BY MDM2/ARF,6350461,2/15/2000 0:00,1/31/2004 0:00,Non-SBIR/STTR,2001,197763, ,NCI, , ,197763
EFFECTS OF BENZO[A]PYRENE IN TRANSGENIC MODEL OF CERVICA,6350820,2/1/2000 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,199142, ,NIEHS, , ,199142
STRUCTURE/FUNCTION OF S100 PROTEIN,6351289,2/1/1999 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,236000, ,NIGMS, , ,236000
APOPTOSIS SIGNAl--BINDING OF CYTOCHROME C TO APAF 1,6351306,2/1/2000 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,183146, ,NIGMS, , ,183146
MOLECULAR PATHOLOGY OF SYNOVIAL SARCOMA,6352247,1/9/1989 0:00,2/28/2005 0:00,Non-SBIR/STTR,2000, ,230631, , , , 
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6352698,7/18/2000 0:00,6/30/2001 0:00,Research Centers,2000, ,254104, , , , 
CORE--MOLECULAR GENETICS,6352724,7/1/2000 0:00,6/30/2001 0:00,Non-SBIR/STTR,2000, ,254104, , , , 
RISK FACTORS FOR ORAL EPIDERMOID CARCINOMA IN MINORITIES,6352850,9/30/1992 0:00,7/31/2001 0:00,Research Centers,2000, ,298546, , , , 
MOLECULAR MARKERS FOR SQUAMOUS CELL CARCINOMA,6352856,9/30/1996 0:00,7/31/2001 0:00,Research Centers,2000, ,45203, , , , 
APOPTOSIS INDUCING GENE THERAPY FOR ORAL PREMALIGNANCY,6352859,9/30/1996 0:00,7/31/2001 0:00,Research Centers,2000, ,145542, , , , 
TRANSCRIPTIONAL REGULATORS IN CANCER,6353330,6/15/1996 0:00,3/31/2001 0:00,Non-SBIR/STTR,2000,32497, ,NCI, , ,32497
PILOT STUDY--PHOSPHORYLATION OF P53 PROTEIN IN HUMAN BREAST CANCER CELLS,6353700,9/30/2000 0:00,9/29/2002 0:00,Research Centers,2000, ,172415, , , , 
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,6354650,9/30/1996 0:00,7/31/2001 0:00,Research Centers,2000, ,114674, , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,6354651,9/30/1996 0:00,7/31/2001 0:00,Research Centers,2000, ,113615, , , , 
APOPTOSIS IN ORAL CANCER,6354655,9/30/1996 0:00,7/31/2001 0:00,Research Centers,2000, ,85079, , , , 
DEVELOPMENT OF P53 BASED VACCINES FOR ORAL CARCINOMA,6354661,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000, ,75207, , , , 
ORAL CARCINOMA--SIGNAL TRANSDUCTION IN LYMPHOCYTES,6354663,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000, ,73043, , , , 
STRUCTURE DETERMINATION OF PROTEINS ASSOCIATED W/ CANCER,6355158,5/1/2000 0:00,4/30/2001 0:00,Research Centers,2000, ,20331, , , , 
ALTERATIONS OF CELL CYCLE CONTROL IN MELANOCYTIC LESIONS,6355480,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,2000,90275, ,NIAMS, , ,90275
"P53, CHEMICAL CARCINOGEN AND ETHANOL IN ORAL CANCER",6355563,9/1/1995 0:00,7/31/2001 0:00,Research Centers,2000, ,208304, , , , 
P53 SEROLOGY AND PROGNOSIS OF ORAL CANCER,6355564,9/1/1995 0:00,7/31/2001 0:00,Research Centers,2000, ,13504, , , , 
CAROLINA BREAST CANCER STUDY,6356224,8/5/1999 0:00,7/31/2001 0:00,Research Centers,2000, ,168504, , , , 
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY,6356225,8/5/1999 0:00,7/31/2001 0:00,Research Centers,2000, ,168504, , , , 
GENETIC EPIDEMIOLOGY OF CHILDHOOD SARCOMA,6357982,9/27/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,135394, , , , 
MOLECULAR BASIS OF INHERITED CANCER SYNDROMES,6357985,9/27/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,270395, , , , 
GENOMIC INSTABILITY IN FAMILIAL CANCER SYNDROMES,6357986,9/27/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,175907, , , , 
CORE--MUTATION DETECTION & CHARACTERIZATION OF TUMOR SUPPRESSOR GENES,6357989,9/27/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,176326, , , , 
CORE--HIGH THROUGHPUT GENOTYPING AND GENETIC LINKAGE ANALYSIS,6357990,9/27/2000 0:00,4/30/2001 0:00,Non-SBIR/STTR,2000, ,437292, , , , 
TRANSCRIPTIONAL REGULATORS IN CANCER,6358240,6/15/1996 0:00,3/31/2002 0:00,Non-SBIR/STTR,2000,32592, ,NCI, , ,32592
A MOUSE MODEL FOR PROSTATE CANCER,6358732,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2000,19593, ,NCI, , ,19593
"THE PanINs OF PANCREATITIS,PANCREAS CANCER AND CONTROLS",6360022,7/1/2001 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,81750, ,NCI, , ,81750
Exploiting IR inducible NQ01 Levels Using Beta Lapachone,6360534,7/1/2001 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,246919, ,NCI, , ,246919
Analysis of Chk2 dependent DNA damage signaling pathway,6361511,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,222233, ,NCI, , ,222233
Molecular Pathogenesis of Ewing Sarcoma,6361731,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,247340, ,NCI, , ,247340
Barrett's Esophagus: Predictors of Progression,6361772,8/16/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,2304955, ,NCI, , ,2304955
APOPTOSIS & MALIGNANT PROGRESSION IN MAMMARY TUMOR CELLS,6362222,5/1/1997 0:00,2/28/2003 0:00,Non-SBIR/STTR,2001,280410, ,NIA, , ,280410
HCMV IN AIDS--DISRUPTION OF CELL CYCLE REGULATION,6362453,3/1/2000 0:00,2/28/2005 0:00,Non-SBIR/STTR,2001,251872, ,NIAID, , ,251872
SOFT TISSUE SARCOMA PROGRAM PROJECT,6362552,1/9/1989 0:00,2/28/2005 0:00,Non-SBIR/STTR,2001,1662853, ,NCI, , ,1662853
PROTEIN PHOSPHATASE 1 AND NEOPLASTIC TRNSFORMATION,6362564,9/1/1993 0:00,2/28/2005 0:00,Non-SBIR/STTR,2001,218661, ,NCI, , ,218661
EUKARYOTIC DNA ALKYLATION REPAIR,6362567,7/2/1991 0:00,5/31/2001 0:00,Non-SBIR/STTR,2001,29635, ,NCI, , ,29635
GENETIC EPIDEMIOLOGY OF LUNG CANCER,6362581,12/15/1994 0:00,2/29/2004 0:00,Non-SBIR/STTR,2001,623451, ,NCI, , ,623451
BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH & PROGRESSION,6362596,5/6/1996 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,600000, ,NCI, , ,600000
PROTEASES AND CHEMOTHERAPY INDUCED APOPTOSIS,6362599,4/1/1995 0:00,2/28/2002 0:00,Non-SBIR/STTR,2001,228399, ,NCI, , ,228399
MARKERS FOR LUNG CARCINOGENESIS IN BRONCHIAL EPITHELIUM,6362608,3/1/1997 0:00,2/28/2003 0:00,Non-SBIR/STTR,2001,438510, ,NCI, , ,438510
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA,6362622,5/1/1997 0:00,2/28/2002 0:00,Non-SBIR/STTR,2001,265444, ,NCI, , ,265444
GENETIC DETERMINANTS OF TUMORIGENESIS,6362628,5/1/1999 0:00,2/29/2004 0:00,Non-SBIR/STTR,2001,1277860, ,NCI, , ,1277860
MOLECULAR STAGING AND SCREENING OF LUNG CANCER,6362640,3/1/1998 0:00,5/31/2004 0:00,Other Research-Related,2002,94543, ,NCI, , ,94543
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION,6362649,5/1/1998 0:00,2/28/2003 0:00,Non-SBIR/STTR,2001,310658, ,NCI, , ,310658
EPITOPE BASED T CELL THERAPY FOR EPITHELIAL TUMORS,6362697,5/1/1999 0:00,2/29/2004 0:00,Non-SBIR/STTR,2001,302526, ,NCI, , ,302526
USE OF THE MOUSE FOR PROSTATE CANCER GENE DISCOVERY,6362739,3/27/2000 0:00,2/28/2005 0:00,Other Research-Related,2001,139320, ,NCI, , ,139320
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER,6362758,5/8/2000 0:00,2/28/2005 0:00,Other,2001,1244611, ,NCI, , ,1244611
INVESTIGATION OF ANGIOGENIC FUNCTION IN CANCER BY MRI,6362760,3/8/2000 0:00,2/28/2003 0:00,Non-SBIR/STTR,2001,105280, ,NCI, , ,105280
CLINICAL AND EPIDEMIOLOGIC CENTER FOR BIOMARKERS OF UPPE,6362769,5/1/2000 0:00,2/28/2005 0:00,Other,2001,976959, ,NCI, , ,976959
CATIONIC LIPID/P53 GENE THERAPY IN LUNG CANCER PATIENTS,6362774,3/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,358741, ,NCI, , ,358741
CHROMOSOME 22Q GENETIC STUDIES IN THE COLON,6363056,3/1/2000 0:00,2/29/2004 0:00,Non-SBIR/STTR,2001,232854, ,NIDDK, , ,232854
PATHOGENESIS OF MESENCHYMAL TUMORS INDUCED BY ASBESTOS,6363072,6/15/1985 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,235494, ,NIEHS, , ,235494
PROTECTION AGAINST APOPTOSIS BY SCATTER FACTOR,6363079,3/1/1998 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,250973, ,NIEHS, , ,250973
MECHANISMS OF INTESTINAL CARCINOGENESIS OF DISINFECTION,6363092,3/1/2000 0:00,2/28/2004 0:00,Non-SBIR/STTR,2001,71001, ,NIEHS, , ,71001
CLONING GENES THAT REGULATE MYOCARDIOCYTE PROLIFERATION,6363514,7/1/1990 0:00,2/28/2003 0:00,Non-SBIR/STTR,2001,344412, ,NHLBI, , ,344412
Modes of Prostate Ca Progression--role of p53 Pathway,6364087,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,240345, ,NCI, , ,240345
Cyclin/cdk Regulation of P53 in Prostate Cancer,6364876,7/1/2001 0:00,6/30/2006 0:00,Other Research-Related,2001,91800, ,NCI, , ,91800
"Characterization of Fortilin, A Novel Anti-p53 Protein",6365303,9/30/2001 0:00,7/31/2005 0:00,Non-SBIR/STTR,2001,224250, ,NHLBI, , ,224250
Deregulation of Cell Pathways by Ad E1B 55K Oncoproteins,6365424,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,270788, ,NCI, , ,270788
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6366903,5/1/1999 0:00,4/30/2000 0:00,Research Centers,2000, ,156688, , , , 
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6367950,5/1/2000 0:00,4/30/2003 0:00,Research Centers,2000, ,156688, , , , 
Molecular Mechanism of Genistein in Prostate Cancer,6369062,7/12/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,266120, ,NCI, , ,266120
Accelerated senescence in tumor cells,6370122,6/1/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2001,256184, ,NCI, , ,256184
"Oxidative DNA Damage, DNA Repair and Oral Cancer",6370707,9/1/2001 0:00,8/31/2006 0:00,Other Research-Related,2001,132850, ,NCI, , ,132850
IGF I survival effects on p53 induced apoptosis,6370793,6/1/2001 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,169875, ,NCI, , ,169875
MECHANISMS OF REPLICATIVE SENESCENCE IN CELLS,6372324,4/1/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,302648, ,NIA, , ,302648
T CELL DEVELOPMENT & LYMPHOMAGENESIS IN TRANSGENIC MICE,6372656,9/30/1999 0:00,12/31/2001 0:00,Other Research-Related,2001,44101, ,NIAID, , ,44101
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS,6373871,8/1/1999 0:00,10/31/2001 0:00,Non-SBIR/STTR,2001,34063, ,NIAID, , ,34063
ALTERATIONS OF CELL CYCLE CONTROL IN MELANOCYTIC LESIONS,6374335,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,2001,126090, ,NIAMS, , ,126090
PIK RELATED KINASES IN THE RESPONSE TO DNA DAMAGE BY UV,6374764,6/1/1999 0:00,5/31/2004 0:00,Other Research-Related,2001,121882, ,NIAMS, , ,121882
CYTOTOXIC MECHANISMS IN CUTANEOUS DISEASE,6374854,1/1/1980 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,265555, ,NIAMS, , ,265555
Prevention of Skin Cancer by Scutellaria Baicalensis,6375454,9/18/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,258730, ,NCCIH, , ,258730
Mechanisms of Herbal Radiosensitization of Glioma Cells,6375456,9/20/2000 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,224171, ,NCCIH, , ,224171
BIOCHEMICAL CYTOLOGY OF NORMAL AND MALIGNANT TISSUES,6375478,1/1/1975 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,388026, ,NCI, , ,388026
POLYAMINE ANALOG AND INHIBITOR REGULATION OF CELL CYCLE,6375597,8/1/1989 0:00,4/30/2004 0:00,Non-SBIR/STTR,2001,293931, ,NCI, , ,293931
CHILDHOOD SOLID TUMORS,6375602,8/1/1978 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,1596749, ,NCI, , ,1596749
MUTAGENESIS OF SPECIFIC REGIONS OF THE SV 40 GENOME,6375610,9/1/1978 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,327295, ,NCI, , ,327295
HUMAN MAMMARY CELLS,6375611,9/1/1979 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,522206, ,NCI, , ,522206
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION,6375614,6/1/1979 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,241956, ,NCI, , ,241956
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,6375640,7/15/1981 0:00,5/31/2003 0:00,Non-SBIR/STTR,2001,269345, ,NCI, , ,269345
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA,6375648,6/1/1983 0:00,8/31/2005 0:00,Non-SBIR/STTR,2001,290764, ,NCI, , ,290764
RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONS,6375658,6/1/1983 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,316969, ,NCI, , ,316969
NUCLEAR IMAGING OF TUMORS--BIOLOGICAL AND CHEMICAL BASIS,6375661,4/1/1983 0:00,5/31/2003 0:00,Non-SBIR/STTR,2001,331427, ,NCI, , ,331427
"PATHOGENESIS, IMMUNODIAGNOSIS AND THERAPY OF HCC",6375694,7/1/1983 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,318000, ,NCI, , ,318000
FUNCTIOINAL ANALYSIS OF THE P53 TUMOR SUPPRESSOR,6375729,8/15/1985 0:00,7/30/2003 0:00,Non-SBIR/STTR,2001,180477, ,NCI, , ,180477
COLON CANCER PREVENTION PROGRAM PROJECT,6375740,9/30/1986 0:00,7/31/2005 0:00,Non-SBIR/STTR,2001,3612549, ,NCI, , ,3612549
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS,6375766,9/30/1986 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,412892, ,NCI, , ,412892
ALTERATION OF NAD METABOLISM BY CHEMICAL CARCINOGENS,6375768,4/1/1986 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,326817, ,NCI, , ,326817
PATHOGENESIS OF MALIGNANT FIBROMATOSIS,6375772,3/1/1988 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,239917, ,NCI, , ,239917
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY,6375810,7/15/1988 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,1490732, ,NCI, , ,1490732
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMA,6375882,5/15/1991 0:00,8/31/2001 0:00,Non-SBIR/STTR,2001,203148, ,NCI, , ,203148
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA,6375916,9/1/1992 0:00,7/31/2005 0:00,Non-SBIR/STTR,2001,230762, ,NCI, , ,230762
MECHANISM OF ANTICARCINOGENIC ACTIVITY--ORGANOSULFIDES,6375917,4/1/1995 0:00,8/31/2004 0:00,Non-SBIR/STTR,2001,202096, ,NCI, , ,202096
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,6375988,6/1/1993 0:00,4/30/2003 0:00,Non-SBIR/STTR,2001,474381, ,NCI, , ,474381
CELL CELL INTERACTIONS IN PROSTATE CANCER,6375996,5/1/1993 0:00,7/31/2002 0:00,Non-SBIR/STTR,2001,276922, ,NCI, , ,276922
GENETIC ELEMENTS TRANSFORMING MOUSE FIBROBLASTS,6376015,1/3/1994 0:00,7/2/2001 0:00,Non-SBIR/STTR,2001,27968, ,NCI, , ,27968
BREAST CANCER GROWTH SUPPRESSOR GENE,6376032,2/1/1994 0:00,4/30/2003 0:00,Non-SBIR/STTR,2001,235508, ,NCI, , ,235508
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE,6376057,5/1/1994 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,710555, ,NCI, , ,710555
MODULATION OF ARA-C INDUCED APOPTOSIS BY BRYOSTATIN 1,6376064,6/1/1994 0:00,4/30/2003 0:00,Non-SBIR/STTR,2001,272468, ,NCI, , ,272468
ADJUVANT HORMONAL THERAPY IN VIETNAMESE BREAST CANCER,6376081,7/1/1995 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,255875, ,NCI, , ,255875
MDMX REGULATION OF THE P53 TUMOR SUPPRESSOR PROTEIN,6376085,4/1/1995 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,225225, ,NCI, , ,225225
BIOLOGICAL ACTIVITY OF HPV E7 IN HUMAN EPITHELIAL CELLS,6376143,4/19/1996 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,309600, ,NCI, , ,309600
SOFT TISSUE SARCOMA--P53 AND VEGF INDUCTION,6376157,9/30/1995 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,236250, ,NCI, , ,236250
STRUCTURE AND FUNCTION OF CTCF--TRANSGENIC MICE STUDIES,6376175,6/5/1996 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,414581, ,NCI, , ,414581
STRUCTURE FUNCTION RELATIONSHIP OF TUMOR SUPRESSORS,6376203,3/1/1996 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,264600, ,NCI, , ,264600
TAILORING ANTICANCER THERAPY TO LOSS OF P53,6376207,6/15/1996 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,278381, ,NCI, , ,278381
P53--DUAL GROWTH CONTROL AND DNA DAMAGE SENSITIZATION,6376209,7/7/1997 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,132860, ,NCI, , ,132860
INDUCTION AND ANALYSIS OF PROSTATE CANCER,6376211,9/1/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,250539, ,NCI, , ,250539
FUNCTIONAL ANALYSIS OF MDM2 OVEREXPRESSION,6376238,9/1/1997 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,101939, ,NCI, , ,101939
MOLECULAR EPIDEMIOLOGY OF PERSISTENT HPV INFECTION,6376243,9/11/1996 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,266077, ,NCI, , ,266077
SYSTEMIC DELIVERY OF P53 INHIBITS BREAST CANCER,6376249,7/15/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,100306, ,NCI, , ,100306
P53 DIRECTED IMMUNOTHERAPY OF BREAST CANCER,6376255,7/10/1997 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,99160, ,NCI, , ,99160
TRANSLATIONAL CONTROL OF ONCOPROTEIN MDM2 SYNTHESIS,6376271,7/1/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2001,227964, ,NCI, , ,227964
MULTISTEP LYMPHOMAGENESIS,6376293,5/1/1997 0:00,4/30/2005 0:00,Non-SBIR/STTR,2001,283500, ,NCI, , ,283500
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES,6376339,9/30/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,705908, ,NCI, , ,705908
GENETIC EPIDEMIOLOGY OF GASTRIC CANCER,6376461,9/30/1998 0:00,9/29/2002 0:00,Other Research-Related,2001,80384, ,NCI, , ,80384
REGULATION OF P21 (WAF1/C1P1) BY E2A,6376478,9/30/1997 0:00,8/31/2002 0:00,Other Research-Related,2001,90450, ,NCI, , ,90450
RETINOID INDUCED TUMOR DIFFERENTIATION AND THE CELL CYCL,6376483,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,2001,135842, ,NCI, , ,135842
FATTY ACID SYNTHESIS AND THE CELL CYCLE,6376492,7/1/1997 0:00,12/31/2002 0:00,Non-SBIR/STTR,2001,122001, ,NCI, , ,122001
MURINE P73 IN TUMORIGENESIS,6376509,6/15/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,2001,439844, ,NCI, , ,439844
MOLECULAR EPIDEMIOLOGY OF BRCA1 RELATED BREAST NEOPLASIA,6376517,9/30/1998 0:00,8/31/2003 0:00,Other Research-Related,2001,82861, ,NCI, , ,82861
KILLER/DR5 AND TUMORIGENESIS,6376520,9/14/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,213151, ,NCI, , ,213151
GROWTH REGULATION OF PROSTATIC CELLS BY ANDROGEN,6376525,7/1/1997 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,112015, ,NCI, , ,112015
IN VIVO ROLE OF DNA ALKYLATION REPAIR,6376532,8/8/1997 0:00,5/31/2003 0:00,Non-SBIR/STTR,2001,429655, ,NCI, , ,429655
RANDOMIZED ADJUVANT THERAPY OF HEAD AND NECK CANCER,6376533,9/1/1998 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,158621, ,NCI, , ,158621
MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER,6376556,9/1/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,603026, ,NCI, , ,603026
Adenoviral Based Therapy of Hepatocellular Carcinoma,6376572,7/28/1998 0:00,6/30/2003 0:00,Other Research-Related,2001,84780, ,NCI, , ,84780
MODULATION OF P53 FUNCTION BY BINDING PROTEIN BBP/53BP2,6376582,7/10/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,2001,203897, ,NCI, , ,203897
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER,6376596,9/1/1998 0:00,8/31/2003 0:00,Other Research-Related,2001,90480, ,NCI, , ,90480
PROSTOGLANDINS AND UVB CARCINOGENESIS,6376612,8/14/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,184510, ,NCI, , ,184510
P53 MUTATION ANALYSIS FOR BLADDER CANCER PROGNOSIS,6376620,7/1/1998 0:00,5/31/2003 0:00,SBIR/STTR,2001,301833, ,NCI, , ,301833
TRANSLATIONAL RESEARCH IN LUNG CANCER,6376632,9/30/1997 0:00,9/29/2003 0:00,Other Research-Related,2001,160909, ,NCI, , ,160909
DETACHMENT SENSITIZES CELLS TO TOPOISOMERASE INHIBITORS,6376638,9/30/1997 0:00,5/31/2002 0:00,Other Research-Related,2001,80050, ,NCI, , ,80050
SV40-LIKE SEQUENCES IN HUMAN TUMORS ANALYSES,6376657,8/1/1997 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,108500, ,NCI, , ,108500
DNA STRAND BREAKS AND THE GENETIC BASIS OF LYMPHOMAS,6376671,8/12/1998 0:00,4/30/2002 0:00,Non-SBIR/STTR,2001,225547, ,NCI, , ,225547
MECHANISTIC DEVELOPMENT OF PLATINUM BASED DRUGS,6376676,4/1/1999 0:00,10/1/2003 0:00,Non-SBIR/STTR,2001,160356, ,NCI, , ,160356
P53 AND REPAIR OF DNA DAMAGE BY ANTICANCER DRUGS,6376677,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,110387, ,NCI, , ,110387
P53-MEDIATED CHEMOSENSITIVITY IN NEUROBLASTOMA,6376712,4/15/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,103301, ,NCI, , ,103301
IN VIVO SOMATIC MUTATIONS IN CHILDREN WITH CANCER,6376745,9/30/1998 0:00,9/29/2002 0:00,Other Research-Related,2001,161244, ,NCI, , ,161244
DESIGN OF PROGRAMMABLE GENOTOXINS,6376747,6/16/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,2001,363563, ,NCI, , ,363563
H PYLORI RELATIONSHIP TO DIGESTIVE DISEASES AND CANCER,6376766,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,2001,152000, ,NCI, , ,152000
V(D)J RECOMBINASE & CHROMOSOME TRANSLOCATION IN LYMPHOMA,6376793,7/7/1999 0:00,6/30/2004 0:00,Other Research-Related,2001,130410, ,NCI, , ,130410
CANCER VACCINE TO P53,6376843,9/1/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,284039, ,NCI, , ,284039
BIOCHEM DISSECTION OF P53-DEPENDENT APOPTOSIS PATHWAY,6376858,9/1/1999 0:00,8/31/2004 0:00,Other Research-Related,2001,152820, ,NCI, , ,152820
MOLECULAR DETERMINANTS OF DRUG SENSITIVITY,6376898,7/12/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2001,158617, ,NCI, , ,158617
"DIETARY HETEROCYCLIC AMINES, GENETIC SUSCEPTIBILITY, AND",6376905,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,2001,138732, ,NCI, , ,138732
GRP78 AND HYPERSENSITIVITY TO DNA CROSS LINKING AGENTS,6376910,4/1/2000 0:00,3/31/2005 0:00,Other Research-Related,2001,160656, ,NCI, , ,160656
MOLECULAR MECHANISMS OF ANTIMICROTUBULE AGENTS,6376912,8/6/1999 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,162013, ,NCI, , ,162013
BIOCHEMOPREVENTION THERAPY IN ADVANCED LARYNGEAL DYSPLAS,6376927,9/10/1998 0:00,6/30/2003 0:00,Other,2001,518859, ,NCI, , ,518859
MUTATIONS IN HUMAN P53 SEQUENCES OF A P53 KNOCK-IN MOUSE,6376937,7/15/1999 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,89744, ,NCI, , ,89744
UNDERSTANDING A NOVEL MODIFIER OF P53 TUMORIGENESIS,6376953,9/1/1999 0:00,7/31/2007 0:00,Other Research-Related,2001,146358, ,NCI, , ,146358
NUTRIENTS EFFECT ON GENOTYPE IN BREAST CANCER,6376960,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,2001,136440, ,NCI, , ,136440
PRE-CLINICAL COMBINATION CHEMO/RADIOANTIBODY THERAPY,6376968,5/6/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,948718, ,NCI, , ,948718
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS,6376981,8/1/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,215547, ,NCI, , ,215547
STEM CELL DERIVED IMMUNOTHERAPY,6376992,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,2001,125226, ,NCI, , ,125226
MDM2 ONCOGENE AS A TARGET FOR MODULATING CANCER THERAPY,6377043,4/7/1999 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,220928, ,NCI, , ,220928
MULTIPLE GENE CARRIER ADENOVIRAL CONSTRUCTS FOR GLIOMAS,6377047,6/1/1999 0:00,5/31/2003 0:00,Non-SBIR/STTR,2001,198233, ,NCI, , ,198233
UBIQUITINATION AND STABILITY OF P53 AND P73,6377074,6/15/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,243731, ,NCI, , ,243731
THE NATURAL HISTORY OF HEREDITARY BREAST CANCER,6377083,9/15/2000 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,225000, ,NCI, , ,225000
"AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES",6377089,9/20/1999 0:00,8/31/2004 0:00,Other Research-Related,2001,128799, ,NCI, , ,128799
A ROLE OF RAD51B IN DNA REPAIR AND BREAST CARCINOGENESIS,6377090,6/1/2000 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,293692, ,NCI, , ,293692
THE ROLE OF A NOVEL GAP IN EPITHELIAL ONCOGENESIS,6377101,9/8/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,245699, ,NCI, , ,245699
METABOLIC GENOTYPES & ONCOGENIC DAMAGE IN BREAST CANCER,6377136,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,325125, ,NCI, , ,325125
LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU,6377148,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,576560, ,NCI, , ,576560
MOLECULAR CHARACTERIZATION OF ACF (ABERRANT CRYPT FOCI),6377156,8/1/1999 0:00,5/31/2003 0:00,Non-SBIR/STTR,2001,234228, ,NCI, , ,234228
ALPHA6/BETA4-INTEGRIN MEDIATED APOPTOSIS RESISTANCE,6377185,7/1/2000 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,209643, ,NCI, , ,209643
PRECANCEROUS EVENTS IN CLINICALLY NORMAL SKIN,6377187,4/1/1999 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,247613, ,NCI, , ,247613
RESTORATION OF APOPTOSIS IN CANCER,6377198,7/23/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2001,1070099, ,NCI, , ,1070099
P21 INDUCTION BY BRCA2,6377215,8/1/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,100170, ,NCI, , ,100170
CHARACTERIZATION OF SRC AS AN E6AP SUBSTRATE,6377251,7/1/2001 0:00, ,"Training, Individual",2001,30459, ,NCI, , ,30459
ANALYSIS OF P73 FUNCTION AND REGULATION BY E2F 1,6377273,8/1/2000 0:00,4/1/2002 0:00,Other Research-Related,2001,102546, ,NCI, , ,102546
"TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER",6377296,4/20/2000 0:00,11/30/2005 0:00,Other Research-Related,2002,132857, ,NCI, , ,132857
CDX2 TUMOR SUPPRESSOR PATHWAY DEFECTS IN COLON CANCER,6377307,8/15/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,266718, ,NCI, , ,266718
MOLECULAR EPIDEMIOLOGY OF NON-MELANOMA SKIN CANCER,6377340,9/30/1999 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,374889, ,NCI, , ,374889
ROLE OF BRCA1 IN NORMAL CELL GROWTH AND TUMORGENESIS,6377351,9/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,203414, ,NCI, , ,203414
FAS/APO-1 MEDIATED APOPTOSIS,6377367,8/1/1999 0:00,5/31/2003 0:00,Non-SBIR/STTR,2001,201504, ,NCI, , ,201504
BYSTANDER EFFECTS OF LOW DOSE ALPHA PARTICLES,6377383,9/1/1999 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,315640, ,NCI, , ,315640
DETERMINANTS OF CLINICAL OUTCOME/TOXICITY IN HISPANICS,6377394,9/3/1999 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,338699, ,NCI, , ,338699
ENHANCING ACTIVITY OF ALKYLATING AGENTS IN NEUROBLASTOMA,6377430,9/1/1999 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,234734, ,NCI, , ,234734
E2 MODULATION OF TUMORIGENESIS IN ERBB2 TRANSGENIC MICE,6377436,8/15/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,214636, ,NCI, , ,214636
GEMZAR--MECHANISMS OF CYTOTOXICITY & RADIOSENSITIZATION,6377479,7/8/1999 0:00,4/30/2003 0:00,Non-SBIR/STTR,2001,207241, ,NCI, , ,207241
TREATMENT RESPONSE MARKERS IN ADVANCED LARYNGEAL CANCER,6377481,9/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,229356, ,NCI, , ,229356
THE ROLE OF INTEGRIN A5B1 IN ANGIOGENESIS & DISEASE,6377493,9/1/1999 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,287734, ,NCI, , ,287734
CELL CYCLE CHECKPOINT REGULATION AND CANCER,6377524,8/31/2001 0:00, ,"Training, Individual",2002,4900, ,NCI, , ,4900
VIRAL ONCOPROTEIN ACTIVATION IN AIDS-RELATED TUMORS,6377531,9/17/1999 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,599515, ,NCI, , ,599515
" 8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA",6377543,7/5/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,405649, ,NCI, , ,405649
PI 3K PATHWAY IN BCR/ABL INDUCED LEUKEMIAS,6377544,7/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,283950, ,NCI, , ,283950
TRIGGERING OF ABERRANT CPG ISLAND METHYLATION,6377606,7/1/2000 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,232313, ,NCI, , ,232313
INNOVATIVE TUMOR TARGETED THERAPIES FOR LUNG CANCER,6377655,9/1/2000 0:00,8/31/2005 0:00,Other Research-Related,2002,125620, ,NCI, , ,125620
MOUSE CANCER MODELS BY REGULATED INACTIVATION OF TUMOR S,6377673,9/30/1999 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001,727970, ,NCI, , ,727970
MOUSE MODELS OF HUMAN BREAST CANCER,6377675,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,470311, ,NCI, , ,470311
 REPRESSION BY C SKI AND MELANOMA PROGRESION,6377679,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,219100, ,NCI, , ,219100
"THE APL PARADIGM FOR ABERRANT TRANSCRIPTION, CANCER AND",6377682,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,506721, ,NCI, , ,506721
A MOUSE MODEL FOR PROSTATE CANCER,6377683,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,484325, ,NCI, , ,484325
CREATION AND CHARACTERIZATION OF MOUSE MODELS OF HUMAN L,6377686,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,798688, ,NCI, , ,798688
PRECLINICAL MOUSE:  CENTRAL NERVOUS SYSTEM CANCERS,6377688,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,906052, ,NCI, , ,906052
IMMUNOLOGIC SCREENING FOR EARLY STAGE COLORECTAL CANCER,6377695,8/11/2000 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,141750, ,NCI, , ,141750
"OXIDATIVE STRESS, APOPTOSIS AND DRUG RESISTANCE",6377709,7/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,201150, ,NCI, , ,201150
CPG METHYLATION AND MUTATION,6377710,7/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,275625, ,NCI, , ,275625
ROLE OF AMINO TERMINAL MODIFICATION IN P53 FUNCTION,6377734,4/1/2001 0:00, ,"Training, Individual",2001,41996, ,NCI, , ,41996
EARLY CANCER DETECTION AND SUSCEPTIBILITY BIOMAKERS,6377761,9/30/1999 0:00,8/31/2004 0:00,Other,2001,789750, ,NCI, , ,789750
P53 AND UV REGULATION OF P53 BINDING PROTEIN BBP/53BP2,6377807,6/7/2000 0:00,8/31/2001 0:00,Other Research-Related,2001,10176, ,NCI, , ,10176
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS,6377858,9/1/2000 0:00,8/31/2005 0:00,Non-SBIR/STTR,2001,500866, ,NCI, , ,500866
MOLECULAR EPIDEMIOLOGY OF RENAL CELL CANCER,6377881,5/1/2000 0:00,4/30/2002 0:00,Non-SBIR/STTR,2001,79000, ,NCI, , ,79000
THERAPEUTIC MODULATION OF ANGIOGENESIS IN HUMAN GLIOMAS,6377905,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,338220, ,NCI, , ,338220
MULTIDICIPLINARY FUNCTIONAL IMAGING OF CANCER,6377906,7/1/2000 0:00,6/30/2003 0:00,Other,2001,400000, ,NCI, , ,400000
MODULATING BASE EXCISION REPAIR IN TUMOR DRUG RESISTANCE,6377910,4/1/2000 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,275400, ,NCI, , ,275400
IN VIVO IMAGING OF NEOPLASIA,6377927,4/12/2000 0:00,3/31/2002 0:00,Other,2001,400000, ,NCI, , ,400000
TRANSLATIONAL CORRELATES OF AN EPOTHILONE B ANALOG,6377952,4/1/2000 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001,83750, ,NCI, , ,83750
CHARACTERIZATION OF NEW HUMAN P53 DISSOCIATORS,6378026,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,277200, ,NCI, , ,277200
ROLES AND REGULATION OF P53,6378031,9/30/2000 0:00,7/31/2005 0:00,Non-SBIR/STTR,2001,1539307, ,NCI, , ,1539307
CHARACTERIZATION OF A NEW GENE IN P53 MUTANT LFS FAMILY,6378045,8/4/2000 0:00,7/31/2003 0:00,Other Research-Related,2001,119557, ,NCI, , ,119557
ARF MDM2 P53 TUMOR SUPPRESSION PATHWAY,6378048,8/1/2000 0:00,3/31/2006 0:00,Other Research-Related,2002,141681, ,NCI, , ,141681
 MECHANISM OF ACTION OF HERCEPTIN R IN BREAST CANCER,6378060,5/1/2000 0:00,4/30/2003 0:00,Non-SBIR/STTR,2001,149500, ,NCI, , ,149500
MOLECULAR  MARKERS IN ESOPHAGEAL ADENOCARCINOMA,6378064,7/18/2000 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,187500, ,NCI, , ,187500
MUTATIONAL ANALYSIS OF P53 RELATED GENES,6378070,8/1/2000 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,127500, ,NCI, , ,127500
NEO ANTIGEN AND IMMUNOBIOLOGY OF MEDULLARY BREAST CANCER,6378071,7/14/2000 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,130500, ,NCI, , ,130500
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION,6378095,9/1/2000 0:00,8/31/2005 0:00,Other Research-Related,2001,132840, ,NCI, , ,132840
STRESS INDUCED BYSTANDER EFFECT IN CANCER TREATMENT,6378130,6/9/2000 0:00,4/30/2002 0:00,Non-SBIR/STTR,2001,294368, ,NCI, , ,294368
MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS,6378173,8/4/2000 0:00,7/31/2005 0:00,Other Research-Related,2001,126711, ,NCI, , ,126711
GENETIC EPIDEMIOLOGY OF ORAL PREMALIGNANCIES AND CANCER,6379682,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,2001,124686, ,NIDCR, , ,124686
DEVELOPMENT OF VACCINES FOR ORAL CARCINOMA,6379811,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,2001,824210, ,NIDCR, , ,824210
CELL CYCLE REGULATORS OF ORAL CANCER,6379824,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,964514, ,NIDCR, , ,964514
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER,6379911,9/24/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2001,353094, ,NIDCR, , ,353094
HPV ETIOLOGY OF A SUBSET OF HEAD AND NECK CANCERS,6379913,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,312933, ,NIDCR, , ,312933
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN,6379918,9/1/1999 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,575738, ,NIDCR, , ,575738
GENETIC ALTERATIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARK,6379919,9/1/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2001,362247, ,NIDCR, , ,362247
ARF AS A THERAPEUTIC AGENT IN ORAL MALIGNANCIES,6379923,4/1/2000 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,243946, ,NIDCR, , ,243946
SENESCENCE IN EPITHELIAL NEOPLASTIC PROGRESSION,6379924,9/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,252131, ,NIDCR, , ,252131
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER,6379951,9/30/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2001,376661, ,NIDCR, , ,376661
THE ROLE OF P40 IN SQUAMOUS CELL CARCINOMA,6379976,9/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,277951, ,NIDCR, , ,277951
NEOADJUVANT THERAPY OF OR CANCER BY INHIBITING NF-KAPPAB,6380002,9/30/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2001,251074, ,NIDCR, , ,251074
GI HORMONES AND OTHER FACTORS IN GROWTH OF GI MUCOSA,6380377,12/1/1977 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,392090, ,NIDDK, , ,392090
TR2 AND TR3 ORPHAN RECEPTORS IN PROSTATE CANCER,6380836,9/1/1995 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,281242, ,NIDDK, , ,281242
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,6381097,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,2001,261050, ,NIDDK, , ,261050
"KS1, A NOVEL SUPPRESSOR OF NEOPLASTIC TRANSFORMATION",6381661,9/15/2000 0:00,7/31/2004 0:00,Non-SBIR/STTR,2001,182019, ,NIDDK, , ,182019
MOLECULAR MECHANISMS OF IRON CHELATOR CYTOTOXICITY,6381823,6/1/2000 0:00,4/30/2004 0:00,Non-SBIR/STTR,2001,253021, ,NIDDK, , ,253021
TRIMODAL GENE THERAPY FOR PROSTATE CANCER,6381832,7/1/2000 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,136996, ,NIDDK, , ,136996
SUSCEPTIBILITY TO MOLECULAR ALTERATION: EPITHELIAL CELLS,6382047,9/26/1999 0:00,8/31/2004 0:00,Other Research-Related,2001,118065, ,NIEHS, , ,118065
NUCLEAR RECEPTOR COACTIVATORS AND BREAST CANCER,6382049,6/15/2000 0:00,5/31/2005 0:00,Other Research-Related,2001,116775, ,NIEHS, , ,116775
PROTECTIVE ROLE OF APOPTOSIS IN ASBESTOS PLEURAL INJURY,6382227,8/29/1997 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,206540, ,NIEHS, , ,206540
HEPTOCYTE PROLIFERATION AND AFLATOXIN METABOLISM,6382259,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,196655, ,NIEHS, , ,196655
"ATM, P53, GADD45 AND P21 EFFECTS ON RECOMBINATION",6382260,6/1/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2001,261356, ,NIEHS, , ,261356
NOVEL CARCINOGEN INDUCED CELL CYCLE CHECKPOINT,6382264,8/1/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,2001,110514, ,NIEHS, , ,110514
ASBESTOS AND NO2 IN ENVIRONMENTAL LUNG DISEASE,6382271,8/15/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,2001,286368, ,NIEHS, , ,286368
MECHANISMS OF ACROLEIN ON PROLIFERATION AND APOPTOSIS,6382288,8/1/1999 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,204560, ,NIEHS, , ,204560
Structural Determinants in Cell Growth Control by p21,6383011,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,307707, ,NCI, , ,307707
Molecular Mechanisms of Ara-C Therapy in Man,6383164,9/15/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2001,284759, ,NCI, , ,284759
Transcriptional Control of Gastrin,6383314,9/1/1993 0:00,7/31/2006 0:00,Non-SBIR/STTR,2001,246803, ,NIDDK, , ,246803
Cyclin G in p53 mediated pathways and breast cancer,6383532,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,267750, ,NCI, , ,267750
MECHANISMS OF INTESTINAL CARCINOGENESIS OF DISINFECTION,6383829,3/1/2000 0:00,2/28/2002 0:00,Non-SBIR/STTR,2000,54143, ,NIEHS, , ,54143
Predictors of Progression in Barret's Esophagus,6383983,2/7/1995 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,1283007, ,NCI, , ,1283007
Molecular cytology of human telomeres-telomere protein,6384075,5/1/1993 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,371363, ,NIGMS, , ,371363
RECOMBINATION MECHANISMS IN ADENOVIRUS TRANSFECTION,6385468,5/1/1982 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,338410, ,NIGMS, , ,338410
BIOCHEMICAL STUDIES OF HUMAN DNA POLYMERASE DELTA,6385484,4/1/1983 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,525133, ,NIGMS, , ,525133
MECHANISMS OF RADIORESISTANCE AND CELL CYCLE PROGRESSION,6386141,5/1/1995 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,350262, ,NIGMS, , ,350262
CELL CYCLE CONTROL OF PROTEOLYSIS BY F-BOX PROTEINS,6386578,8/1/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2001,330669, ,NIGMS, , ,330669
MOLECULAR ANALYSIS OF CEP135 IN THE CENTROSOME,6386688,7/1/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,212383, ,NIGMS, , ,212383
RADIATION INDUCED G1 CHECKPOINT ARREST IN YEAST,6387056,9/1/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2001,200632, ,NIGMS, , ,200632
DETERMINANTS OF HEPATITIS C & E MORBIDITY IN EGYPT,6387766,9/15/2000 0:00,8/31/2005 0:00,Non-SBIR/STTR,2001,409519, ,NICHD, , ,409519
GELSOLIN: ROLES IN APOPTOSIS AND TUMOR DEVELOPMENT,6389466,5/1/1995 0:00,3/31/2004 0:00,Non-SBIR/STTR,2001,301399, ,NHLBI, , ,301399
ISOLATION OF THE FANCONI ANEMIA NUCLEAR PROTEIN COMPLEX,6390558,9/10/2000 0:00,8/31/2004 0:00,Non-SBIR/STTR,2001,361888, ,NHLBI, , ,361888
Mentored Patient-Oriented Research Career Development Aw,6394878,8/1/2000 0:00,7/31/2005 0:00,Other Research-Related,2001,118391, ,NCRR, , ,118391
Lymphomagenesis as a Response to Antigenic Stimulation,6395262,8/6/2001 0:00,6/30/2006 0:00,Other Research-Related,2001,131058, ,NCI, , ,131058
"MUTUAL REGULATION OF P53, MDM2 AND NFKB:",6397734,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2001,203499, ,NCI, , ,203499
"MyD118, CR6 and GADD45 in Genotoxic Stress",6398986,7/1/2001 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,249830, ,NCI, , ,249830
Mechanisms in Wilms Tumorigenesis,6399208,8/23/2001 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,276390, ,NCI, , ,276390
Mrad9 Radioresistance Gene,6399553,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,305079, ,NCI, , ,305079
Progression/Oncogene Induced Prostate Cancer,6399798,9/8/1989 0:00,5/31/2006 0:00,Non-SBIR/STTR,2001,312115, ,NCI, , ,312115
Strategies to Enhance Adenoviral Mediated Tumor Killing,6400032,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2001,275809, ,NCI, , ,275809
Epidemiology of HPV and p53 Mutations in NM Skin Cancer,6400553,8/1/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2001,516119, ,NCI, , ,516119
Determinants of Breast Cancer Survival,6400962,6/1/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2002,681469, ,NCI, , ,681469
Rapid in Vivo Assay for Oral Cancer Chemoprevention,6401093,7/1/2001 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,69717, ,NCI, , ,69717
Novel Technology for the Analysis of Gene Expression,6401292,8/1/1999 0:00,6/30/2004 0:00,SBIR/STTR,2001,598064, ,NCI, , ,598064
Role of CDK4 in Cell Cycle Progression and Cancer,6401416,9/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,376250, ,NIA, , ,376250
"SENSITIVE, MULTIPLEXED ANALYSIS OF BREAST CANCER MARKERS",6401824,8/28/2000 0:00,2/28/2003 0:00,SBIR/STTR,2001,399795, ,NCI, , ,399795
ESOPHAGO GASTRIC TUMORIGENESIS IN A TRANSGENIC MODEL,6402513,5/1/2000 0:00,4/30/2005 0:00,Other Research-Related,2001,136147, ,NCI, , ,136147
EBV BZLF1 GENE PRODUCT,6402930,1/1/1993 0:00,1/31/2002 0:00,Non-SBIR/STTR,2000,37031, ,NIGMS, , ,37031
BRCAL AND P21 IN CELL CYCLING,6403174,1/7/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,2001,226627, ,NCI, , ,226627
Chk2--Roles in Checkpoint and Breast Tumor Suppression,6405218,1/1/2002 0:00, ,"Training, Individual",2001,34832, ,NCI, , ,34832
DNA Damage Checkpoints,6405276,8/10/1998 0:00,6/30/2006 0:00,Non-SBIR/STTR,2001,272813, ,NCI, , ,272813
"TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER",6405356,4/20/2000 0:00,11/30/2005 0:00,Other Research-Related,2000,132759, ,NCI, , ,132759
MOLECULAR CHARACTERIZATION OF ACF (ABERRANT CRYPT FOCI),6405357,8/1/1999 0:00,5/31/2003 0:00,Non-SBIR/STTR,2001,215309, ,NCI, , ,215309
TRANSGENIC MOUSE MODELS OF HEAD AND NECK CANCER,6405539,9/15/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,40625, ,NIDCR, , ,40625
"Role of Na,K ATPase in the development of carcinoma",6406130,9/12/2001 0:00, ,"Training, Individual",2001,23550, ,NCI, , ,23550
RODENT PRODUCTION CENTER,6406991,9/28/1999 0:00,9/29/2007 0:00,R and D Contracts,2000,833803, ,NIEHS, , ,833803
BIOCHEM DISSECTION OF P53-DEPENDENT APOPTOSIS PATHWAY,6408588,9/1/1999 0:00,8/31/2004 0:00,Other Research-Related,2000,136332, ,NCI, , ,136332
CANCER THERAPY,6410168,1/1/2001 0:00,12/31/2001 0:00,Non-SBIR/STTR,2001, ,228401, , , , 
BIOCHEMICAL STUDIES OF HUMAN DNA POLYMERASE DELTA,6412451,4/1/1983 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001,17998, ,NIGMS, , ,17998
MOLECULAR MECHANISMS OF SQUAMOUS DIFFERENTIATION,6413322, , ,Intramural Research,2000, , , , , , 
ANTIPROLIFERATIVE EFFECTS OF SMALL MOLECULES,6413843, , ,Intramural Research,2000, , , , , , 
REGULATION OF MUTANT P53,6413944, , ,Intramural Research,2000, , , , , , 
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER,6414473,12/1/2000 0:00,11/30/2001 0:00,Research Centers,2001, ,321374, , , , 
VACCINATION AGAINST TUMOR SPECIFIC MUTANT RAS AND P53 PEPTIDES IN CANCER,6414549,12/1/2000 0:00,11/30/2001 0:00,Research Centers,2001, ,321374, , , , 
Repair of Genotoxic Damage in Chromatin,6415146,1/1/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2002,317118, ,NCI, , ,317118
EVALUATION OF PREDICTORS FOR RECURRENT ADENOMAS,6415172,2/14/1997 0:00,1/31/2003 0:00,Non-SBIR/STTR,2000,189854, ,NCI, , ,189854
GENE THERAPY OF PRIMARY & METASTATIC MALIGNANT LIVER TUMORS USING SCH58500,6415317,12/1/2000 0:00,11/30/2001 0:00,Research Centers,2001, ,293069, , , , 
BENIGN BREAST DISEASE--MOLECULAR DIFFERENTIATION OF RISK,6415610,9/30/1996 0:00,9/29/2002 0:00,Non-SBIR/STTR,2001,17046, ,NCI, , ,17046
Convergent functions of p53 and BRCA1 in gene regulation,6416245,2/1/2001 0:00,1/31/2002 0:00,Non-SBIR/STTR,2001, ,237979, , , , 
PW1--A mediator of cell survival by NFKB and cell death by p53,6416246,2/1/2001 0:00,1/31/2002 0:00,Non-SBIR/STTR,2001, ,237979, , , , 
RADIATION INDUCED G1 CHECKPOINT ARREST IN YEAST,6416770,9/1/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2001,28992, ,NIGMS, , ,28992
TARGETING PCD FOR LEUKEMIA TREATMENT,6416848,2/5/2001 0:00,1/31/2002 0:00,Non-SBIR/STTR,2001, ,115227, , , , 
TARGETING PCD IN BLADDER CANCER,6416849,2/5/2001 0:00,1/31/2002 0:00,Non-SBIR/STTR,2001, ,115227, , , , 
Mechanisms of the Hormonal Prevention of Breast Cancer,6417264,8/1/1995 0:00,4/30/2007 0:00,Non-SBIR/STTR,2002,1042720, ,NCI, , ,1042720
Mouse Models of Gastric Cancer,6417554,5/1/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2001,285171, ,NCI, , ,285171
BIOCHEMICAL EFFECTORS OF GENE MUTATED IN COLON CANCER,6418170,7/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2001, ,130479, , , , 
CORE--EXPERIMENTAL ANIMAL FACILITY,6418174,7/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2001, ,130479, , , , 
Regulation and Function of ECK in Apoptosis,6418332,1/18/2002 0:00,12/31/2005 0:00,Non-SBIR/STTR,2002,280914, ,NCI, , ,280914
dUTPase As A Prognostic Marker in Colon Cancer,6418699,4/1/2002 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,153063, ,NCI, , ,153063
SENESCENCE IN EPITHELIAL NEOPLASTIC PROGRESSION,6418763,9/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,21250, ,NIDCR, , ,21250
The BRCA1-GADD45 Pathway and Genomic Stability,6419778,3/1/2002 0:00,2/28/2006 0:00,Non-SBIR/STTR,2002,248932, ,NCI, , ,248932
REGULATION AND FUNCTION OF P53 TUMOR SUPPRESSOR PROTEIN,6419888, , ,Intramural Research,2000, , , , , , 
Characterization of the p53 Apoptotic Target Gene PERP,6419923,1/1/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2002,279683, ,NCI, , ,279683
Study of a FACTp140-SSRP1-associated p53 Kinase,6420078,1/10/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2002,283995, ,NCI, , ,283995
GENETIC RISK TO AFLATOXIN INDUCED HEPATOCELLULAR CANCER,6420281, , ,Intramural Research,2000, , , , , , 
Effects of DNA Damaging Agents on G2 Phase Checkpoint,6420344,7/11/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,249375, ,NCI, , ,249375
Inflammatory Breast Cancer,6421073, , ,Intramural Research,2000, , , , , , 
Molecular Basis of Young Onset Colorectal Cancer,6421362,8/26/2002 0:00,4/30/2007 0:00,Other Research-Related,2002,125226, ,NCI, , ,125226
Mechanisms of Cancer Chemoprevention by Diet,6422408,9/28/2001 0:00,7/31/2002 0:00,Other,2001,169855, ,NCI, , ,169855
Role of the p53 homolog p73 in cancer,6422548,1/14/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2002,301376, ,NCI, , ,301376
Structure/Function of Human Papillomavirus Oncoproteins,6422780,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,402558, ,NCI, , ,402558
Timing of Dietary Exposures and Breast Cancer Risk,6422821,9/19/2001 0:00,4/30/2003 0:00,Other,2001,114328, ,NCI, , ,114328
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION,6423627,5/1/1998 0:00,2/28/2003 0:00,Non-SBIR/STTR,2001,72608, ,NCI, , ,72608
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA,6424524,3/1/2001 0:00,2/28/2002 0:00,Non-SBIR/STTR,2001, ,230631, , , , 
MOLECULAR PATHOLOGY OF SYNOVIAL SARCOMA,6424530,3/1/2001 0:00,2/28/2002 0:00,Non-SBIR/STTR,2001, ,230631, , , , 
Stabilization of MDM2 by mutant p53,6430175,7/1/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,241063, ,NCI, , ,241063
MECHANISMS OF G2 / M CELL CYCLE CHECKPOINT CONTROLS,6430331, , ,Intramural Research,2000, , , , , , 
Mechanism of Apoptosis by Par4,6431200,9/30/1995 0:00,12/31/2006 0:00,Non-SBIR/STTR,2002,296840, ,NCI, , ,296840
CELLULAR RESPONSES TO STRESS IN NORMAL AND AGED CELLS,6431487, , ,Intramural Research,2000, , , , , , 
Genetic Epidemiological Studies of Oral Cancer,6432037, , ,Intramural Research,2000, , , , , , 
"ION CHANNELS, RECEPTORS AND SECOND MESSENGERS IN THE NERVOUS SYSTEM",6432098, , ,Intramural Research,2000, , , , , , 
Pathogenic Factors and Determinants of Prognosis in Patients with Gastrinomas,6432153, , ,Intramural Research,2000, , , , , , 
INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS,6432168, , ,Intramural Research,2000, , , , , , 
Clinically Aggressive Thyroid Cancer: Molecular Basis and Treatment Outcome,6432169, , ,Intramural Research,2000, , , , , , 
ELUCIDATION OF THE STRUCTURE AND FUNCTION OF SIGMA RECEPTORS,6432188, , ,Intramural Research,2000, , , , , , 
Mechanism(s) of Leukemogenesis in Genetically-Altered Mouse Models,6432229, , ,Intramural Research,2000, , , , , , 
MOLECULAR ANALYSIS OF CELL CYCLE CONTROL DURING CARCINOGENESIS,6432231, , ,Intramural Research,2000, , , , , , 
Application of Transgenic Models for Toxicological Characterization,6432250, , ,Intramural Research,2000, , , , , , 
CARBONYL SULFIDE CLEAN AIR ACT STUDIES,6432257, , ,Intramural Research,2000, , , , , , 
Carotenoid/Retinoid Modulation of Cellular Redox/Cancer,6432261, , ,Intramural Research,2000, , , , , , 
GENETIC ALTERATIONS DURING MULTISTEP CARCINOGENESIS IN MICE AND HUMANS,6432265, , ,Intramural Research,2000, , , , , , 
MECHANISM OF CARCINOGENS--GENETIC ALTERATIONS IN RODENT AND HUMAN TUMORS,6432267, , ,Intramural Research,2000, , , , , , 
IDENTIFICATION OF BIOACTIVE ISOFORMS OF P53 PROTEIN,6432268, , ,Intramural Research,2000, , , , , , 
Risk Factors for Cell Transformation and the Role of Apoptosis,6432272, , ,Intramural Research,2000, , , , , , 
Growth Factors and Inflammatory Mediators in Arsenic-Induced Toxicity,6432284, , ,Intramural Research,2000, , , , , , 
EXPOSURE SPECIFIC MUTATION IN CRITICAL TARGET GENES,6432336, , ,Intramural Research,2000, , , , , , 
HUMAN GENOME CLONING AND ISOLATION OF SPECIFIC DNAS IN YEAST,6432378, , ,Intramural Research,2000, , , , , , 
ISOLATION AND CHARACTERIZATION OF HUMAN GENES AFFECTING CHROMOSOME METABOLISM,6432384, , ,Intramural Research,2000, , , , , , 
MODEL SYSTEMS TO EVALUATE TRANSPOSITION IN EUKARYOTIC CELLS,6432388, , ,Intramural Research,2000, , , , , , 
Developmental of New Hormone Responsive Models from cancer Cells,6432406, , ,Intramural Research,2000, , , , , , 
DRUG DELIVERY TECHNIQUES,6432906, , ,Intramural Research,2000, , , , , , 
Imidodipeptides and Amino Acid Metabolites in Cell Regulation and Carcinogenesis,6432983, , ,Intramural Research,2000, , , , , , 
T-Cell Antigen Recognition and Tumor Antigens ,6432987, , ,Intramural Research,2000, , , , , , 
Gene Regulation and Function: The B-ZIP Proteins ,6433011, , ,Intramural Research,2000, , , , , , 
Oncogenesis in Animal Models of Human Cancers ,6433023, , ,Intramural Research,2000, , , , , , 
Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Ma,6433026, , ,Intramural Research,2000, , , , , , 
Molecular Epidemiology of Human Cancer ,6433029, , ,Intramural Research,2000, , , , , , 
T-cell Transformation by Oncoviruses ,6433047, , ,Intramural Research,2000, , , , , , 
Aquisition of Genomic Alterations During Mammary Gland Cancer Induction in Rats ,6433060, , ,Intramural Research,2000, , , , , , 
Transgenic Models for Cooperation of c-myc and Growth Factors in Tumorigenesis ,6433061, , ,Intramural Research,2000, , , , , , 
Mutational and Functional Analysis of the p53 Tumor Suppressor Gene ,6433066, , ,Intramural Research,2000, , , , , , 
Cell Cycle Control and Tumor Suppressors ,6433067, , ,Intramural Research,2000, , , , , , 
Molecular Biology of Cellular Injury ,6433079, , ,Intramural Research,2000, , , , , , 
New strategies for drug discovery: Gene expression profiling and bioinformatics ,6433081, , ,Intramural Research,2000, , , , , , 
Regulation of Gene Activity ,6433085, , ,Intramural Research,2000, , , , , , 
Genetically Engineered Mice as Models to Study Receptor Tyrosine Kinase Function,6433107, , ,Intramural Research,2000, , , , , , 
Genetic Effects on Infectious Disease ,6433114, , ,Intramural Research,2000, , , , , , 
Laboratory and Clinical Translational Studies of Drug Resistance ,6433119, , ,Intramural Research,2000, , , , , , 
Lymphoma Studies ,6433122, , ,Intramural Research,2000, , , , , , 
Molecular analysis of growth regulation ,6433133, , ,Intramural Research,2000, , , , , , 
The Role of Tobacco-Related Chemical Carcinogens and Oxyradicals in Human Cancer,6433193, , ,Intramural Research,2000, , , , , , 
DNA Repair ,6433225, , ,Intramural Research,2000, , , , , , 
Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners ,6433262, , ,Intramural Research,2000, , , , , , 
Epidemiology of Oncogenic Viruses ,6433270, , ,Intramural Research,2000, , , , , , 
Studies of Atomic Bomb Survivors ,6433299, , ,Intramural Research,2000, , , , , , 
Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma ,6433304, , ,Intramural Research,2000, , , , , , 
Molecular Pathology of Pulmonary Carcinogenesis ,6433315, , ,Intramural Research,2000, , , , , , 
The Molecular Genetics of Gynecologic Cancers ,6433320, , ,Intramural Research,2000, , , , , , 
"Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS ",6433339, , ,Intramural Research,2000, , , , , , 
Nitroxides as Protectors Against Oxidative Stress ,6433348, , ,Intramural Research,2000, , , , , , 
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction ,6433418, , ,Intramural Research,2000, , , , , , 
Analysis of p53 regulation in neuroblastoma cell lines ,6433426, , ,Intramural Research,2000, , , , , , 
Molecular Intervention in Thoracic Malignancies ,6433428, , ,Intramural Research,2000, , , , , , 
Identification of mechanisms and consequences of chromosomal aneuploidy and chro,6433451, , ,Intramural Research,2000, , , , , , 
Mechanisms of Induction of Skin Cancers By UV Light,6433920,7/1/1988 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,213750, ,NCI, , ,213750
Mechanisms of Growth Inhibition by Helicobacter Pylori,6434556,9/30/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,75500, ,NIMHD, , ,75500
DETERMINATION OF GENETIC ALTERATIONS & PROGNOSTIC MARKER,6435308, , ,Intramural Research,2000, , , , , , 
A PHASE I/II STUDY OF A VACCINIA-HPV RECOMBINANT,6435317, , ,Intramural Research,2000, , , , , , 
MOLECULAR PATHOGENESIS OF MULTIPLE MYELOMA,6435498, , ,Intramural Research,2000, , , , , , 
Role of 53BP1 during the DNA damage response,6435556,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,259966, ,NIGMS, , ,259966
Oncogenes and loss of ER in a new p53 breast tumor model,6435646,5/10/1989 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,302450, ,NCI, , ,302450
Role of IGFBP -3 in mediating p53-induced apoptosis,6435658,8/15/2002 0:00,6/30/2007 0:00,Other Research-Related,2002,131652, ,NIDDK, , ,131652
NEW METHODS FOR CANCER DETECTION,6436102,3/1/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,2001,275197, ,NCI, , ,275197
HPV AND CELL CYCLE DYSREGULATION IN ORAL CANCER,6438175,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001, ,131308, , , , 
CYCLIN D1 AND GENETIC MODEL OF ORAL CARCINOGENESIS,6438176,4/1/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001, ,182133, , , , 
CHILDHOOD SOLID TUMORS,6438561,8/1/1978 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001,50000, ,NCI, , ,50000
Regulation of p21 induction by butyrate in colonic cells,6439367,4/1/2002 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,75200, ,NCI, , ,75200
Growth Inhibition by the ARF Tumor Suppressor,6439385,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,258481, ,NCI, , ,258481
P53 GENE AND CHEMOSENSITIVITY,6440480,7/3/2000 0:00,6/30/2001 0:00,Non-SBIR/STTR,2001, ,285821, , , , 
Role of E6-AP in the Development of Prostate Cancer,6442101,9/30/2001 0:00,8/31/2005 0:00,Non-SBIR/STTR,2001,225750, ,NIDDK, , ,225750
VIROLOGIC/GENETIC FACTORS OF HPV NEOPLASMS,6442268,4/10/1987 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001, ,280718, , , , 
Tumor Suppressors in Spontaneous and UV-Induced Melanoma Models,6442487,3/1/2001 0:00,2/28/2002 0:00,Non-SBIR/STTR,2001, ,243335, , , , 
Genotoxic effects,6442527,4/1/2001 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001, ,73465, , , , 
CORE--MOLECULAR EPIDEMIOLOGY AND ECOGENETICS,6442961,4/1/1996 0:00,3/31/2006 0:00,Research Centers,2001, ,117873, , , , 
Epigenetic effects on susceptibility to heavy metal & PAH induced DNA damage,6442969,4/1/2001 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001, ,164076, , , , 
MOLECULAR STAGING AND SCREENING OF LUNG CANCER,6443296,3/1/1998 0:00,5/31/2003 0:00,Other Research-Related,2001,94543, ,NCI, , ,94543
ARSENIC BIOMARKER EPIDEMIOLOGY,6443890,4/1/2001 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001, ,293470, , , , 
"Checkpoints, DNA repair & human carcinogenesis",6443925,4/1/2001 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001, ,175236, , , , 
Immunoliposome-Mediated Gene Therapy for Prostate Cancer,6444304,3/1/1999 0:00,8/31/2004 0:00,SBIR/STTR,2002,317330, ,NCI, , ,317330
Snap-To-It PNA Arrays,6444802,5/1/2002 0:00,10/31/2003 0:00,SBIR/STTR,2002,196642, ,NCI, , ,196642
Targeting Stealth Liposome for Cancer Gene Therapy,6444919,6/1/2002 0:00,5/30/2003 0:00,SBIR/STTR,2002,138762, ,NCI, , ,138762
Transcription Factor P53 in Terminal Nephron Different,6445321,7/1/2002 0:00,6/30/2005 0:00,"Training, Individual",2002,50116, ,NIDDK, , ,50116
Suramin to Enchance Paclitaxel and Carboplatin in NSCLC,6446609,9/19/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,330938, ,NCI, , ,330938
"ATM, P53, GADD45 AND P21 EFFECTS ON RECOMBINATION",6447049,6/1/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2000,1533, ,NIEHS, , ,1533
MECHANISMS OF CELLULAR RADIOSENSITIVITY,6447054,5/1/2001 0:00,4/30/2002 0:00,Non-SBIR/STTR,2001, ,294139, , , , 
Nutritional Regulation of Catalase and Colorectal Cancer,6447246,9/30/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,77996, ,NIEHS, , ,77996
"Oxidative mutagenesis:Iron, Ascorbic Acid and Genes",6447620,9/15/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2001,74042, ,NIEHS, , ,74042
Biologic Activity of Lycopene,6447784,9/15/2001 0:00,8/30/2003 0:00,Non-SBIR/STTR,2001,80000, ,NIEHS, , ,80000
Validation of Biomarkers in Humans Exposed to PAHs,6448386,1/1/2002 0:00,12/31/2004 0:00,Non-SBIR/STTR,2002,252000, ,NIOSH, , ,252000
HORMONAL REGULATION OF BREAST CANCER,6449726,8/1/1978 0:00,1/31/2002 0:00,Non-SBIR/STTR,2001,43406, ,NCI, , ,43406
MALIGNANT COMPLICATIONS OF CHRONIC HEPATITIS C VIRUS,6449937,9/29/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2001,50619, ,NCI, , ,50619
COLON CANCER PREVENTION PROGRAM PROJECT,6449970,9/30/1986 0:00,7/31/2005 0:00,Non-SBIR/STTR,2001,116994, ,NCI, , ,116994
DIHYDRODIOL DEHYDROGENASE AND PAH METABOLISM/ACTIVATION,6450180,3/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,62024, ,NCI, , ,62024
Human Neurotropic JC Virus and CNS Diseases,6450522,3/4/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2002,310367, ,NCI, , ,310367
P53 Biomaker and Intervention in Occupational Cancer,6451442,6/1/2002 0:00,5/31/2005 0:00,Non-SBIR/STTR,2002,157689, ,NIOSH, , ,157689
MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER,6451443,9/1/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,2001,21406, ,NCI, , ,21406
Melanoma in p16INK4a and p19ARF Deficient Mice,6452373,2/15/2002 0:00,8/31/2002 0:00,Other Research-Related,2002,104504, ,NCI, , ,104504
CELLULAR AND MOLECULAR TOXICITY IN HUMAN MAMMARY CELLS,6452775,6/1/2001 0:00,5/31/2002 0:00,Other Research-Related,2001, ,31452, , , , 
TUMOR SUPPRESSOR GENETICS OF MOUSE CHRMOSOME 11,6453010,5/11/2001 0:00,4/30/2002 0:00,Non-SBIR/STTR,2001, ,145657, , , , 
Radiation sensitivity/Apoptosis Induction in Cancer Cells--P53 Restoration,6454205,5/15/2001 0:00,4/30/2002 0:00,Non-SBIR/STTR,2001, ,279549, , , , 
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,6454395,9/30/1997 0:00,9/29/2002 0:00,Non-SBIR/STTR,2001,1555, ,NIDDK, , ,1555
ARF MDM2 P53 TUMOR SUPPRESSION PATHWAY,6455750,8/1/2000 0:00,3/31/2006 0:00,Other Research-Related,2000,54318, ,NCI, , ,54318
Modeling the effects of INK4 alpha ARF loss on gliomas,6456862,8/1/2001 0:00,7/31/2004 0:00,Non-SBIR/STTR,2001,257447, ,NCI, , ,257447
Contributions of Akt to Glioblastoma Formation,6458159,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,334028, ,NCI, , ,334028
Unique BRCA1 transcriptional response leading to repair,6458258,4/22/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,317396, ,NCI, , ,317396
P53 function and apoptosis in melanoma,6459005,5/1/2001 0:00,4/30/2002 0:00,Non-SBIR/STTR,2001, ,312755, , , , 
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER,6459102,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,356556, ,NCI, , ,356556
"Metallothionein, Environment Insult and Bladder Cancer",6459490,4/1/2002 0:00,8/31/2002 0:00,Non-SBIR/STTR,2002,125099, ,NCI, , ,125099
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6459537,5/1/2001 0:00,4/30/2003 0:00,Research Centers,2001, ,61783, , , , 
The Interplay Between the Repressor MDM2 and Coactivator,6459979,3/1/2002 0:00,2/28/2006 0:00,Non-SBIR/STTR,2002,268780, ,NCI, , ,268780
Vaccine Development for Oral Carcinoma,6462941,9/1/1997 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002,926163, ,NIDCR, , ,926163
Cyclin Kinase Inhibitors as Molecular Targets for Cancer,6463655,4/1/2002 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,148375, ,NCI, , ,148375
MECHANISM OF PDGF INDUCED APOPTOSIS,6463740,7/15/1996 0:00,2/28/2002 0:00,Non-SBIR/STTR,2001,37250, ,NCI, , ,37250
"Gastric Cancer Prognosis--MSI, BAX, DCC, & p53 LOH",6463920,8/6/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2001,283358, ,NCI, , ,283358
RANDOMIZED ADJUVANT THERAPY OF HEAD AND NECK CANCER,6464086,9/1/1998 0:00,8/31/2002 0:00,Non-SBIR/STTR,2000,152661, ,NCI, , ,152661
The role of Inil in chromatin  development and cancer,6464449,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,346831, ,NCI, , ,346831
Function & Purification of the Fanconi Anemia Protein C*,6464948,7/1/2002 0:00,5/31/2007 0:00,Other Research-Related,2002,100845, ,NHLBI, , ,100845
P53 in BBD and Breast Cancer Risk: A Multicenter Cohort,6465679,5/1/2002 0:00,4/30/2007 0:00,Non-SBIR/STTR,2002,816422, ,NCI, , ,816422
Mechanistic Analyses of Protein Deacetylation,6465730,3/1/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2002,244440, ,NIGMS, , ,244440
Molecular Alterations in Lobular/Ductal Breast Cancer,6465799,4/1/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,369064, ,NCI, , ,369064
Development of Assays for DNA Damage Checkpoints,6465990,4/1/2002 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,156086, ,NCI, , ,156086
Mitotic Checkpoint Proteins in Tumorigenesis,6466338,7/18/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,353143, ,NCI, , ,353143
Heat Shock Protein Function for Drug Discovery,6466716,5/1/2002 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,151500, ,NCI, , ,151500
P21 transcriptional inhibitors as proapoptotic compounds,6466727,9/6/2002 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,155870, ,NCI, , ,155870
SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY,6468381,5/1/1991 0:00,11/30/2004 0:00,Non-SBIR/STTR,1999,250155, ,NCI, , ,250155
"P27Kipl deficiency, potential promoter of carcinogenesis",6469160,4/1/2002 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,77935, ,NCI, , ,77935
ALTERATION OF NAD METABOLISM BY CHEMICAL CARCINOGENS,6469170,4/1/1986 0:00,6/30/2003 0:00,Non-SBIR/STTR,2000,235867, ,NCI, , ,235867
Function of MDM2 and its Alternatively spliced Isoforms,6469446,3/5/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2002,213275, ,NCI, , ,213275
Polyoma Virus Disrupts ARF Signaling to p53,6469893,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,300625, ,NCI, , ,300625
KILLER/DR5 APOPTOSIS IN DNA DAMAGE SENSITIVE CELLS,6470071,6/29/2001 0:00,5/31/2002 0:00,Non-SBIR/STTR,2001, ,140673, , , , 
MECHANISMS OF CARCINOGENESIS INVOLVING WILD-TYPE,6470202,4/1/1996 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001,22035, ,NCI, , ,22035
A mouse model for UV-induced junctional melanoma,6471581,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,338200, ,NCI, , ,338200
Molecular Pathobiology of Langerhans Cell Histiocytosis,6471618,4/1/2002 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002,319692, ,NIAID, , ,319692
PROGRESSION OF THE TRANSFORMED PHENOTYPE,6471658,4/1/1984 0:00,11/30/2002 0:00,Non-SBIR/STTR,2001,48965, ,NCI, , ,48965
APOPTOSIS IN ORAL CANCER,6471777,8/1/2000 0:00,7/31/2002 0:00,Research Centers,2001, ,103677, , , , 
Diet and Somatic Mutations in Colon Cancer,6471825,8/1/1995 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002,1035013, ,NCI, , ,1035013
Natural Product Antitumor Inducers of Apoptosis,6472057,9/6/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2002,228321, ,NCI, , ,228321
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,6472274,8/1/2000 0:00,1/31/2002 0:00,Research Centers,2001, ,268419, , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,6472275,8/1/2000 0:00,1/31/2002 0:00,Research Centers,2001, ,268419, , , , 
Nitroaromatics and Breast Cancer,6472303,7/1/1983 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001,107999, ,NCI, , ,107999
MOLECULAR MECHANISMS OF DIET-INDUCED CARCINOGENESIS,6472497,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,295119, ,NCI, , ,295119
PROSPECTIVE STUDY OF DIET AND COLORECTAL NEOPLASIA,6472765,8/23/1991 0:00,3/31/2006 0:00,Non-SBIR/STTR,2001, ,279549, , , , 
TGFBeta1 signaling and radiation response in pancreas CA,6473001,3/1/2002 0:00,2/28/2005 0:00,Non-SBIR/STTR,2002,240136, ,NCI, , ,240136
MOLECULAR MECHANISMS OF GROWTH CONTROL--PROSTATE CANCER,6473201,9/30/1992 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001,42971, ,NCI, , ,42971
Methylation and Oxidation in Breast Cancer Epidemiology,6473202,6/1/2002 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,691138, ,NCI, , ,691138
"p53-independent Role of MDM2, TGFb Resistance and Cancer",6473318,3/1/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2002,329656, ,NCI, , ,329656
Investigation of xrcc5 Mutant Mice,6473340,7/7/1997 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,259509, ,NCI, , ,259509
Molecular Markers as Predictors of Outcome in Gliomas,6473792,9/1/1998 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,346888, ,NINDS, , ,346888
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION,6473842,2/9/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2001,108360, ,NCI, , ,108360
EUKARYOTIC DNA ALKYLATION REPAIR,6474001,7/2/1991 0:00,2/28/2005 0:00,Non-SBIR/STTR,2001,420429, ,NCI, , ,420429
STRUCTURAL FEATURES OF PAPILLOMAVIRUS E6 ONCOPROTEINS,6474099,2/1/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2001,71399, ,NCI, , ,71399
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,6474301,9/30/1995 0:00,11/30/2006 0:00,Non-SBIR/STTR,2001,105708, ,NCI, , ,105708
Regulation of Astrocytoma Growth,6474424,4/15/2002 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,252201, ,NINDS, , ,252201
E2F-1 Cancer Gene Therapy,6474625,9/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2002,237741, ,NCI, , ,237741
GENETIC MANIPULATION OF TUMOR RADIORESISTANCE,6475011,8/1/2001 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001, ,184121, , , , 
RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53,6475012,8/1/2001 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001, ,184121, , , , 
MECHANISMS REGULATING REVERSAL OF PREMALIGNANCY,6475807,12/15/2000 0:00,11/30/2005 0:00,Non-SBIR/STTR,2002,209520, ,NCI, , ,209520
RAPAMYCIN INDUCED SELECTIVE APOPTOSIS IN MALIGNANT CELLS,6475815,12/1/1998 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,225703, ,NCI, , ,225703
REGULATION OF P53 FUNCTION BY BRCA1 TUMOR SUPPRESSOR,6475830,12/11/1998 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,195801, ,NCI, , ,195801
CANCER-RELATED GLYCOLYTIC GENE--REGULATION/TARGETING,6475839,12/11/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2002,245162, ,NCI, , ,245162
ADENOVIRUS BASED P53 GENE THERAPY FOR OVARIAN CANCER,6475842,12/8/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2002,114527, ,NCI, , ,114527
"HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING",6475854,5/1/1999 0:00,11/30/2003 0:00,SBIR/STTR,2002,656094, ,NCI, , ,656094
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE,6475879,12/29/1994 0:00,11/30/2004 0:00,Non-SBIR/STTR,2002,426641, ,NCI, , ,426641
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION,6475882,7/4/1995 0:00,11/30/2005 0:00,Non-SBIR/STTR,2002,331751, ,NCI, , ,331751
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,6475884,9/30/1995 0:00,11/30/2005 0:00,Non-SBIR/STTR,2002,2785121, ,NCI, , ,2785121
HUMAN MAMMARY EPITHELIAL CELL IMMORTALIZATION,6475898,12/12/1997 0:00,11/30/2002 0:00,Non-SBIR/STTR,2002,241342, ,NCI, , ,241342
DEFECTIVE DNA MISMATCH REPAIR IN ENDOMETRIAL CANCERS,6475904,5/1/1997 0:00,11/30/2004 0:00,Non-SBIR/STTR,2002,308000, ,NCI, , ,308000
G2 CHECKPOINT CONTROL IN TRANSFORMED HUMAN CELLS,6475915,12/1/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2002,285367, ,NCI, , ,285367
BRCAL AND P21 IN CELL CYCLING,6475920,1/7/1998 0:00,11/30/2002 0:00,Non-SBIR/STTR,2002,231466, ,NCI, , ,231466
INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN D,6475932,12/24/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2002,232840, ,NCI, , ,232840
MECHANISM OF P53 DEPENDENT APOPTOSIS,6475940,12/5/1997 0:00,11/30/2002 0:00,Non-SBIR/STTR,2001,18806, ,NCI, , ,18806
AFB1 AND P53 CARCINOGENESIS IN HBSAG TRANSGENIC MICE,6475945,12/15/1998 0:00,2/15/2003 0:00,Non-SBIR/STTR,2002,219125, ,NCI, , ,219125
PROTEIN KINASE C AND THYROID CELL APOPTOSIS,6476090,4/1/2000 0:00,11/30/2002 0:00,Other Research-Related,2002,97103, ,NIDDK, , ,97103
THE MOLECULAR BIOLOGY OF RETINOBLASTOMA,6476290,2/1/1999 0:00,11/30/2004 0:00,Non-SBIR/STTR,2002,324000, ,NEI, , ,324000
INDUCTION OF APOPTOTIC PATHWAY IN CANCER CELL LINES,6477438,7/1/2001 0:00,6/30/2002 0:00,Other Research-Related,2001, ,48533, , , , 
Analysis of Group I and II Introns in Mammalian Cells,6477880,9/30/1995 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,331296, ,NIGMS, , ,331296
Role of Receptor Tyrosine Kinases in Gliomagenesis,6478214,7/30/2001 0:00, ,"Training, Individual",2001,40196, ,NCI, , ,40196
Function of the p53 tumor-suppressor in C.elegans,6478532,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,311629, ,NCI, , ,311629
Seroepidemiologic Study of HPV and Oral Cancer,6479114,9/24/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,261077, ,NIDCR, , ,261077
Ceramide Synthase in Radiation-Induced Apoptosis,6479266,7/15/1990 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,391938, ,NCI, , ,391938
Genetic Alterations of p53r2 and Colorectal Adenoma,6479736,4/1/2002 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,72438, ,NCI, , ,72438
Apoptosis in Drosophila-From Reaper to Death,6480495,5/1/1997 0:00,4/30/2006 0:00,Non-SBIR/STTR,2002,354650, ,NIGMS, , ,354650
Multiplexed DNA-Mediated Electochemical Sensors,6480642,4/4/2002 0:00,10/3/2003 0:00,SBIR/STTR,2002,99300, ,NCI, , ,99300
REDOX REGULATION OF TRANSCRIPTION FACTORS,6481224,7/1/2001 0:00,6/30/2002 0:00,Other Research-Related,2001, ,73250, , , , 
KARP 1 V(D)J RECOMBINATION AND DNA REPAIR,6481528,5/1/1994 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,174042, ,NIAID, , ,174042
CORE--AUTOMATED CYTOMETRY & CELL SORTER LABORATORY/CONFOCAL MICROSCOPY,6481853,8/1/2001 0:00,6/30/2002 0:00,Research Centers,2001, ,254104, , , , 
Transduction of Tumor Suppressor Proteins into Gliomas,6482108,9/5/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2001,248886, ,NCI, , ,248886
Dysregulation of TGF Beta Action Pancreatic Cancer,6483256,9/30/1997 0:00,3/31/2007 0:00,Non-SBIR/STTR,2002,326487, ,NCI, , ,326487
CAROLINA BREAST CANCER STUDY,6483386,8/5/1999 0:00,7/31/2001 0:00,Research Centers,2001, ,168504, , , , 
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY,6483387,8/5/1999 0:00,7/31/2001 0:00,Research Centers,2001, ,168504, , , , 
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS,6483662,7/12/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,1009078, ,NCI, , ,1009078
Oxidative damage to gastric epithelial cells by H pylori,6484863,9/21/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2001,233100, ,NIDDK, , ,233100
TRANSCRIPTIONAL REGULATORS IN CANCER,6485177,6/15/1996 0:00,3/31/2002 0:00,Non-SBIR/STTR,2001,78500, ,NCI, , ,78500
INNOVATIVE TUMOR TARGETED THERAPIES FOR LUNG CANCER,6485212,9/1/2000 0:00,8/31/2005 0:00,Other Research-Related,2001,125620, ,NCI, , ,125620
Targeted Delivery of Protectant p53 Inhibitors,6485854,4/1/2002 0:00,3/31/2003 0:00,SBIR/STTR,2002,160600, ,NCI, , ,160600
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS,6485989,8/6/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001, ,196218, , , , 
REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER,6485990,8/6/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001, ,196218, , , , 
CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY,6485993,8/6/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2001, ,196218, , , , 
STRUCTURE/FUNCTION OF S100 PROTEIN,6486966,2/1/1999 0:00,1/31/2003 0:00,Non-SBIR/STTR,2001,56000, ,NIGMS, , ,56000
DEVELOPMENT OF P53 BASED VACCINES FOR ORAL CARCINOMA,6487769,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,2001, ,75207, , , , 
ORAL CARCINOMA--SIGNAL TRANSDUCTION IN LYMPHOCYTES,6487771,9/1/1997 0:00,8/31/2002 0:00,Non-SBIR/STTR,2001, ,73043, , , , 
Characterization of the Ews/Fli-1 Chimeric Gene,6487814,9/1/2002 0:00, ,"Training, Individual",2002,23294, ,NCI, , ,23294
Partnership to Increase Hispanic Cancer Research for Co*,6488587,9/20/2002 0:00,7/31/2005 0:00,Research Centers,2002,94254, ,NCI, , ,94254
PEDIATRIC ONCOLOGY GROUP,6489018,1/1/1978 0:00,3/31/2003 0:00,Other Research-Related,2002,90884, ,NCI, , ,90884
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,6489076,1/1/1987 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,340616, ,NCI, , ,340616
SIGNALING PATHWAYS UTILIZED BY V-ABL AND BCR-ABL,6489110,1/20/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,751428, ,NCI, , ,751428
CHEMOPREVENTION FOR WOMEN AT HIGH RISK OF BREAST CANCER,6489130,9/30/1997 0:00,6/30/2003 0:00,Other,2002,1793476, ,NCI, , ,1793476
MDM2 AND CELL GROWTH AND TUMORIGENESIS,6489143,3/1/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,279140, ,NCI, , ,279140
PROPERTIES AND REGULATION OF P53 IN TUMOR CELLS,6489144,3/23/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,289263, ,NCI, , ,289263
DUAL ROLE OF E2F1 IN TUMORIGENESIS,6489162,1/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,263590, ,NCI, , ,263590
ONCOLYTIC ADENOVIRUSES--CERVICAL CANCER GENE THERAPY,6489188,3/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,225693, ,NCI, , ,225693
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,6489208,8/1/1990 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,457612, ,NCI, , ,457612
ADDUCT INDUCED FRAMESHIFT MUTAGENESIS,6489219,2/15/1992 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,231089, ,NCI, , ,231089
SUNLIGHT RELATED STEPS IN HUMAN SKIN CANCER,6489220,4/1/1992 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,339813, ,NCI, , ,339813
REGULATION OF MULTIDRUG RESISTANCE PHENOTYPE,6489233,3/15/1996 0:00,12/31/2002 0:00,Non-SBIR/STTR,2002,189114, ,NCI, , ,189114
P53 SIGNALING AND CELLULAR RESPONSE AFTER STRESS,6489240,1/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2002,313500, ,NCI, , ,313500
Apoptosis in Colon Cancer Chemoprevention,6489251,7/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2002,1313750, ,NCI, , ,1313750
P53S DIRECT ROLE IN MITOCHONDRIAL CONTROL OF APOPTOSIS,6489260,9/15/1993 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,217827, ,NCI, , ,217827
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN,6489263,9/30/1992 0:00,12/31/2005 0:00,Non-SBIR/STTR,2002,269880, ,NCI, , ,269880
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM,6489277,3/18/1994 0:00,12/31/2002 0:00,Non-SBIR/STTR,2002,120713, ,NCI, , ,120713
P53 AND DNA PLOIDY IN BARRETT'S METAPLASIA,6489308,1/9/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2002,339123, ,NCI, , ,339123
AT: ERRORS IN DOUBLE STRAND BREAK REPAIR,6489309,1/26/2000 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,226834, ,NCI, , ,226834
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS,6489338,2/1/2000 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,203335, ,NCI, , ,203335
MECHANISMS OF INTESTINAL TUMORIGENESIS,6489345,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2002,348379, ,NCI, , ,348379
P53 AND MOUSE MAMMARY TUMORIGENESIS,6489351,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2002,331313, ,NCI, , ,331313
MOUSE MODEL FOR OXIDATIVE DNA DAMAGE REPAIR,6489385,1/30/2001 0:00,12/31/2004 0:00,Non-SBIR/STTR,2002,305500, ,NCI, , ,305500
GENETIC PATHWAY TO IGH TRANSLOCATIONS IN LYMPHOMA,6489393,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2002,285638, ,NCI, , ,285638
"P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?",6489416,1/20/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2002,351731, ,NCI, , ,351731
PLASMA PURINE RATIO--A NEW BIOMARKER FOR CANCER RISK,6489433,1/8/2001 0:00,12/31/2002 0:00,Non-SBIR/STTR,2002,81164, ,NCI, , ,81164
MOUSE MODEL FOR THE PEUTZ JEGHERS SYNDROME,6489438,1/3/2001 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,75000, ,NCI, , ,75000
NOVEL CYCLINS G1 AND G2,6490138,1/1/1998 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,164640, ,NIGMS, , ,164640
IR-INDUCED APOPTOSIS IN THE DEVELOPING NERVOUS SYSTEM,6490966,1/15/2001 0:00,12/31/2004 0:00,Non-SBIR/STTR,2002,261625, ,NINDS, , ,261625
INDUCTION OF APOPTOSIS IN BREAST CANCER,6491805,6/1/2001 0:00,11/30/2002 0:00,Non-SBIR/STTR,1999, ,256220, , , , 
FUNCTION OF INK4A/ARF IN PEDIATRIC NEOPLASIA,6492304,8/1/1996 0:00,5/31/2006 0:00,Non-SBIR/STTR,2001, ,241412, , , , 
Partnership To Increase Hispanic Cancer Res/Edu. in Col.,6493139,9/16/2002 0:00,7/31/2005 0:00,Research Centers,2002,200165, ,NCI, , ,200165
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1,6493590,8/1/2001 0:00,7/31/2002 0:00,Non-SBIR/STTR,2001, ,434203, , , , 
NEW METHODS FOR CANCER DETECTION,6494923,3/1/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,2001,137598, ,NCI, , ,137598
APOPTOSIS IN ORAL CANCER,6495371,8/1/2001 0:00,7/31/2002 0:00,Research Centers,2001, ,103677, , , , 
CORE--MOLECULAR EPIDEMIOLOGY AND ECOGENETICS,6495703,4/1/2001 0:00,3/31/2002 0:00,Research Centers,2001, ,73467, , , , 
BENIGN BREAST DISEASE--MOLECULAR DIFFERENTIATION OF RISK,6495850,9/30/1996 0:00,9/29/2004 0:00,Non-SBIR/STTR,2001,113828, ,NCI, , ,113828
CLINICAL AND EPIDEMIOLOGIC CENTER FOR BIOMARKERS OF UPPE,6496578,5/1/2000 0:00,2/28/2005 0:00,Other,2001,100000, ,NCI, , ,100000
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY,6496689,9/30/2001 0:00,4/30/2002 0:00,Non-SBIR/STTR,2001, ,250404, , , , 
MOLECULAR REGULATION OF FOLATE AND ANTIFOLATE TRANSPORT,6497331,2/12/1993 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,242949, ,NCI, , ,242949
VIRAL GENE FUNCTIONS AND REGULATION OF CELL GROWTH,6497358,9/1/1975 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,410145, ,NCI, , ,410145
"C-, N-, AND L-MYC EFFECTS ON HEMATOPOIETIC CELLS",6497484,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,215701, ,NCI, , ,215701
CELL GROWTH CONTROL BY BRCA1/ITS RESPONSE TO DNA DAMAGE,6497487,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,238131, ,NCI, , ,238131
P53 - REGULATORS AND EFFECTORS,6497515,2/16/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2002,1208978, ,NCI, , ,1208978
TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS,6497532,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,258605, ,NCI, , ,258605
STRUCTURAL FEATURES OF PAPILLOMAVIRUS E6 ONCOPROTEINS,6497535,2/1/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2002,352976, ,NCI, , ,352976
EXPERIMENTAL TRANSFORMATION OF HUMAN MELANOCYTES IN VIVO,6497538,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,377593, ,NCI, , ,377593
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7,6497542,2/15/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2002,256270, ,NCI, , ,256270
INTRAGENIC SUPPRESSOR MUTATIONS FOR P53 CANCER MUTATIONS,6497556,4/1/1999 0:00,7/31/2002 0:00,Non-SBIR/STTR,2002,101638, ,NCI, , ,101638
TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER,6497577,8/24/1999 0:00,7/31/2003 0:00,Non-SBIR/STTR,2001,329937, ,NCI, , ,329937
DIHYDRODIOL DEHYDROGENASE AND PAH METABOLISM/ACTIVATION,6497611,3/1/1986 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002,263336, ,NCI, , ,263336
FRAGILE SITES AND CHROMOSOME BREAKAGE AND CANCER,6497625,7/1/1986 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002,281657, ,NCI, , ,281657
DNA REPAIR AND CANCER PRONE HEREDITARY HUMAN DISEASE,6497627,2/1/1987 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002,320542, ,NCI, , ,320542
C MYC--TRANSCRIPTION AND APOPTOSIS,6497648,1/1/1990 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,380076, ,NCI, , ,380076
ANTIAPOPTOTIC MECHANISMS IN PROSTATE CANCER,6497659,4/1/1998 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,278673, ,NCI, , ,278673
GENETIC EVENTS IN HUMAN PROSTATE CELL TRANSFORMATION,6497673,2/1/1998 0:00,1/31/2003 0:00,Other Research-Related,2002,92070, ,NCI, , ,92070
MONOCLONAL GAMMOPATHIES,6497699,9/30/1994 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,1401624, ,NCI, , ,1401624
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN GLIOMAS,6497705,8/1/1992 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,286534, ,NCI, , ,286534
MUTANT P53 GAIN OF FUNCTION IN TUMORIGENESIS,6497721,4/1/1995 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002,255909, ,NCI, , ,255909
ROLE OF GRP78 IN ALKYLATING AGENT SENSITIVITY,6497748,1/1/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,2002,206550, ,NCI, , ,206550
UV INDUCIBLE INHIBITION IN MELANOMA,6497749,5/5/1993 0:00,1/31/2006 0:00,Non-SBIR/STTR,2002,332978, ,NCI, , ,332978
INK4 FAMILY OF CDK INHIBITORS,6497754,7/17/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,2002,300211, ,NCI, , ,300211
GENETIC MECHANISM OF BRCA LINKED OVARIAN TUMORIGENESIS,6497770,2/1/2001 0:00,1/31/2005 0:00,Non-SBIR/STTR,2002,281385, ,NCI, , ,281385
THE ROLE OF GADD45 IN G2 - M CHECKPOINT,6497944,2/11/2000 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,210291, ,NCI, , ,210291
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION,6497945,2/9/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2002,559874, ,NCI, , ,559874
DISSECTION OF THE DNA DAMAGE CHECKPOINT PATHWAYS,6497959,2/1/2000 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,288809, ,NCI, , ,288809
GENISTEIN IN INVESTIGATIVE AND CLINICAL DERMATOLOGY,6497975,2/3/2001 0:00,1/31/2006 0:00,Non-SBIR/STTR,2002,286455, ,NCI, , ,286455
THERAPEUTIC VACCINES FOR HPV DISEASES,6497980,2/14/2001 0:00,1/31/2006 0:00,Other Research-Related,2002,135555, ,NCI, , ,135555
ARSENIC TRIOXIDE TREATMENT OF LYMPHOPROLIFERATIVE DISORD,6497988,2/1/2001 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,322262, ,NCI, , ,322262
E2F AND APOPTOSIS,6497996,2/5/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2002,287040, ,NCI, , ,287040
REGULATION OF P53 SUBCELLULAR DISTRIBUTION BY MDM2/ARF,6498034,2/15/2000 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,203696, ,NCI, , ,203696
TUMOR SUPPRESSOR LIKE ACTIVITY OF ESTROGEN RECEPTOR,6498064,2/1/2001 0:00,1/31/2005 0:00,Non-SBIR/STTR,2002,223500, ,NCI, , ,223500
EFFECTS OF BENZO[A]PYRENE IN TRANSGENIC MODEL OF CERVICA,6498275,2/1/2000 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,205118, ,NIEHS, , ,205118
APOPTOSIS SIGNAl--BINDING OF CYTOCHROME C TO APAF 1,6498692,2/1/2000 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002,184315, ,NIGMS, , ,184315
STRUCTURE/FUNCTION OF S100 PROTEIN,6498756,2/1/1999 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002,242931, ,NIGMS, , ,242931
CORE--MOLECULAR GENETICS,6499798,9/7/2001 0:00,8/31/2002 0:00,Non-SBIR/STTR,2001, ,296752, , , , 
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,6500635,8/1/1990 0:00,12/31/2003 0:00,Non-SBIR/STTR,2001,18750, ,NCI, , ,18750
P53 GENE AND CHEMOSENSITIVITY,6500717,7/1/2001 0:00,6/30/2002 0:00,Non-SBIR/STTR,2001, ,285821, , , , 
MOLECULAR PATHOLOGY OF ORAL NEOPLASMS WITH HPV INFECTION,6501049,8/1/2001 0:00,1/31/2002 0:00,Research Centers,2001, ,268419, , , , 
ROLE OF NUTRITIONAL AND OTHER FACTORS IN ETIOLOGY OF ORAL CANCER,6501050,8/1/2001 0:00,1/31/2002 0:00,Research Centers,2001, ,268419, , , , 
Cellular Responses To Stress In Normal And Aged Cells,6501325, , ,Intramural Research,2001, , , , , , 
MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER,6501372,9/18/2000 0:00,8/31/2002 0:00,Non-SBIR/STTR,2001,249345, ,NCI, , ,249345
CORE--MICROARRAY,6501421,6/21/2001 0:00,4/30/2002 0:00,Research Centers,2001, ,183723, , , , 
MECHANISMS OF INTESTINAL TUMORIGENESIS,6502342,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2001,215572, ,NCI, , ,215572
ROLE FOR CELL CYCLE PROTEINS IN HIV ENCEPHALITIS,6503798,2/1/2001 0:00,8/31/2001 0:00,Non-SBIR/STTR,2001,50000, ,NINDS, , ,50000
CORE--MOLECULAR ANALYSIS AND HIGH THROUGHPUT GENOTYPING,6503948,9/30/1992 0:00,7/31/2006 0:00,Research Centers,2001, ,168504, , , , 
Gene Regulation--Development/Progression of Breast Cance,6504692, , ,Intramural Research,2001, , , , , , 
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6504943,5/1/2000 0:00,4/30/2003 0:00,Research Centers,2001, ,61783, , , , 
NEOPLASTIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE,6506013,9/30/1993 0:00,8/31/2002 0:00,Non-SBIR/STTR,2001,117318, ,NCI, , ,117318
2002 Gordon Research Conference on Cell Death,6506128,5/1/2002 0:00,4/30/2007 0:00,Other Research-Related,2002,13000, ,NCI, , ,5000
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6506224,5/1/2000 0:00,4/30/2003 0:00,Research Centers,2001, ,61783, , , , 
MTOR as a Therapeutic Target in Childhood Cancer,6507220,9/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2002,300375, ,NCI, , ,300375
Interferon-inducible Transcription Factors: Roles In Ocu,6507394, , ,Intramural Research,2001, , , , , , 
Regulation of Stat3 by p53 in cancer Cells,6507529,8/9/2002 0:00,7/31/2006 0:00,Non-SBIR/STTR,2002,245643, ,NCI, , ,245643
MECHANISMS OF ARSENIC CARCINOGENESIS,6507760,7/12/2002 0:00,4/30/2006 0:00,Non-SBIR/STTR,2002,400241, ,NIEHS, , ,400241
Structural basis for CBP/p300 transcriptional regulation,6508035,6/10/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2002,412070, ,NCI, , ,412070
Elucidation Of The Structure And Function Of Sigma Recep,6509001, , ,Intramural Research,2001, , , , , , 
MECHANISMS OF REPLICATIVE SENESCENCE IN CELLS,6509638,4/1/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,311725, ,NIA, , ,311725
HCMV IN AIDS--DISRUPTION OF CELL CYCLE REGULATION,6511295,3/1/2000 0:00,2/28/2005 0:00,Non-SBIR/STTR,2002,251872, ,NIAID, , ,251872
ALTERATIONS OF CELL CYCLE CONTROL IN MELANOCYTIC LESIONS,6511825,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,2002,126090, ,NIAMS, , ,126090
PIK RELATED KINASES IN THE RESPONSE TO DNA DAMAGE BY UV,6512007,6/1/1999 0:00,3/31/2003 0:00,Other Research-Related,2002,76067, ,NIAMS, , ,76067
Prevention of Skin Cancer by Scutellaria Baicalensis,6512033,9/18/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,264217, ,NCCIH, , ,264217
Mechanisms of Herbal Radiosensitization of Glioma Cells,6512035,9/20/2000 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,230663, ,NCCIH, , ,230663
The role of HPV in squamous cell carcinoma,6512185,7/1/2002 0:00, ,"Training, Individual",2002,53570, ,NIAMS, , ,53570
BIOCHEMICAL CYTOLOGY OF NORMAL AND MALIGNANT TISSUES,6512269,1/1/1975 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,399365, ,NCI, , ,399365
BIOLOGY OF ONCOGENES AND TUMOR SUPPRESSOR GENES,6512368,5/1/1986 0:00,4/30/2006 0:00,Non-SBIR/STTR,2002,1551611, ,NCI, , ,1551611
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS,6512392,9/30/1986 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,424197, ,NCI, , ,424197
ALTERATION OF NAD METABOLISM BY CHEMICAL CARCINOGENS,6512396,4/1/1986 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,335192, ,NCI, , ,335192
PEDIATRIC ONCOLOGY GROUP,6512424,1/1/1983 0:00,12/31/2002 0:00,Other Research-Related,2002,88673, ,NCI, , ,88673
RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONS,6512429,6/1/1983 0:00,5/31/2003 0:00,Non-SBIR/STTR,2002,326478, ,NCI, , ,326478
Nitroaromatics and Breast Cancer,6512464,7/1/1983 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,295970, ,NCI, , ,295970
"PATHOGENESIS, IMMUNODIAGNOSIS AND THERAPY OF HCC",6512465,7/1/1983 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,318000, ,NCI, , ,318000
Antineoplastic Agents from Marine Organisms,6512469,9/1/1983 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,280125, ,NCI, , ,280125
POLYAMINE ANALOG AND INHIBITOR REGULATION OF CELL CYCLE,6512549,8/1/1989 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,302748, ,NCI, , ,302748
HUMAN MAMMARY CELLS,6512556,9/1/1979 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,537128, ,NCI, , ,537128
SOFT TISSUE SARCOMA PROGRAM PROJECT,6512609,1/9/1989 0:00,2/28/2005 0:00,Non-SBIR/STTR,2002,1712713, ,NCI, , ,1712713
"DIET, ACTIVITY & REPRODUCTION--RISKS FOR RECTAL CANCER",6512632,3/15/1991 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,1054864, ,NCI, , ,1054864
Progression/Oncogene Induced Prostate Cancer,6512655,9/8/1989 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,312288, ,NCI, , ,312288
Function of ATF2 URE binding protein in human melanoma,6512675,1/1/1991 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,351713, ,NCI, , ,351713
Genetic and Molecular Epidemiology of Adult Glioma,6512685,5/15/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2002,1383097, ,NCI, , ,1383097
Function of the Adenovirus E1B Oncogene,6512695,1/1/1991 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,303854, ,NCI, , ,303854
PROTEIN PHOSPHATASE 1 AND NEOPLASTIC TRNSFORMATION,6512707,9/1/1993 0:00,2/28/2005 0:00,Non-SBIR/STTR,2002,253685, ,NCI, , ,253685
Transcriptional Regulation of Cell Growth,6512710,6/1/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2002,2344299, ,NCI, , ,2344299
EUKARYOTIC DNA ALKYLATION REPAIR,6512715,7/2/1991 0:00,2/28/2005 0:00,Non-SBIR/STTR,2002,484909, ,NCI, , ,484909
Prospective Studies of Diet and Cancer in Men and Wonen,6512717,8/23/1991 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,3718472, ,NCI, , ,3718472
STRUCTURE AND FUNCTION OF CTCF--TRANSGENIC MICE STUDIES,6512768,6/5/1996 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,427018, ,NCI, , ,427018
STRUCTURE FUNCTION RELATIONSHIP OF TUMOR SUPRESSORS,6512798,3/1/1996 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,265425, ,NCI, , ,265425
TAILORING ANTICANCER THERAPY TO LOSS OF P53,6512801,6/15/1996 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,284632, ,NCI, , ,284632
Molecular Genetics of HNPCC,6512823,6/1/1997 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,426891, ,NCI, , ,426891
MDMX REGULATION OF THE P53 TUMOR SUPPRESSOR PROTEIN,6512827,4/1/1995 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,225225, ,NCI, , ,225225
BIOLOGICAL ACTIVITY OF HPV E7 IN HUMAN EPITHELIAL CELLS,6512871,4/19/1996 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,309600, ,NCI, , ,309600
SOFT TISSUE SARCOMA--P53 AND VEGF INDUCTION,6512892,9/30/1995 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,236250, ,NCI, , ,236250
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE,6512907,5/1/1994 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,745698, ,NCI, , ,745698
MODULATION OF ARA-C INDUCED APOPTOSIS BY BRYOSTATIN 1,6512935,6/1/1994 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,314725, ,NCI, , ,314725
PATHOGENESIS OF HUMAN PROSTATE CARCINOMAS,6512936,6/1/1993 0:00,7/31/2003 0:00,Non-SBIR/STTR,2002,482392, ,NCI, , ,482392
ADJUVANT HORMONAL THERAPY IN VIETNAMESE BREAST CANCER,6512941,7/1/1995 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,263362, ,NCI, , ,263362
GENETIC EPIDEMIOLOGY OF LUNG CANCER,6512972,12/15/1994 0:00,2/29/2004 0:00,Non-SBIR/STTR,2002,639888, ,NCI, , ,639888
GENETIC ELEMENTS TRANSFORMING MOUSE FIBROBLASTS,6512974,1/3/1994 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,266400, ,NCI, , ,266400
Mechanisms of Genetic Instability and Tumor Suppression,6512982,7/1/1993 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,572477, ,NCI, , ,572477
DRUG METABOLIZING ENZYMES-RISK FACTORS IN BLADDER CANCER,6512990,7/1/1994 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,385755, ,NCI, , ,385755
Tobacco Carcinogenesis and Chemoprevention,6513010,6/17/1996 0:00,2/28/2006 0:00,Non-SBIR/STTR,2002,1395941, ,NCI, , ,1395941
TRANSLATIONAL CONTROL OF ONCOPROTEIN MDM2 SYNTHESIS,6513014,7/1/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,255737, ,NCI, , ,255737
MULTISTEP LYMPHOMAGENESIS,6513022,5/1/1997 0:00,4/30/2005 0:00,Non-SBIR/STTR,2002,283500, ,NCI, , ,283500
Childhood Cancer Gene Program Project Grant,6513026,8/1/1996 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,1785841, ,NCI, , ,1785841
MVAC IN ORGAN-CONFINED BLADDER CANCER BASED P53 STATUS,6513027,5/1/1997 0:00,7/6/2003 0:00,Non-SBIR/STTR,2002,503260, ,NCI, , ,503260
MOLECULAR MECHANISM OF CHEMOPREVENTION BY APIGENIN,6513048,5/1/1996 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,242515, ,NCI, , ,242515
Topoisomerase I Inhibitors in Leukemia and Solid Tumors,6513061,4/1/1997 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,222233, ,NCI, , ,222233
Genetic Control of Susceptibility to Testicular Cancer,6513100,6/1/1998 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,465042, ,NCI, , ,465042
GENETIC DETERMINANTS OF TUMORIGENESIS,6513103,5/1/1999 0:00,2/29/2004 0:00,Non-SBIR/STTR,2002,1305747, ,NCI, , ,1305747
MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCER,6513136,9/1/1998 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,425589, ,NCI, , ,425589
ESOPHAGO GASTRIC TUMORIGENESIS IN A TRANSGENIC MODEL,6513139,5/1/2000 0:00,4/30/2005 0:00,Other Research-Related,2002,79419, ,NCI, , ,79419
Adenoviral Based Therapy of Hepatocellular Carcinoma,6513143,7/28/1998 0:00,6/30/2004 0:00,Other Research-Related,2002,84780, ,NCI, , ,84780
MOLECULAR DETERMINANTS OF DRUG SENSITIVITY,6513152,7/12/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,162713, ,NCI, , ,162713
ALPHA6/BETA4-INTEGRIN MEDIATED APOPTOSIS RESISTANCE,6513155,7/1/2000 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,215932, ,NCI, , ,215932
RESTORATION OF APOPTOSIS IN CANCER,6513163,7/23/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,1102200, ,NCI, , ,1102200
GRP78 AND HYPERSENSITIVITY TO DNA CROSS LINKING AGENTS,6513185,4/1/2000 0:00,3/31/2005 0:00,Other Research-Related,2002,158923, ,NCI, , ,158923
BIOCHEMOPREVENTION THERAPY IN ADVANCED LARYNGEAL DYSPLAS,6513193,9/10/1998 0:00,6/30/2005 0:00,Other,2002,443311, ,NCI, , ,443311
DESIGN OF PROGRAMMABLE GENOTOXINS,6513219,6/16/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002,373152, ,NCI, , ,373152
V(D)J RECOMBINASE & CHROMOSOME TRANSLOCATION IN LYMPHOMA,6513248,7/7/1999 0:00,6/30/2004 0:00,Other Research-Related,2002,130410, ,NCI, , ,130410
MODULATION OF P53 FUNCTION BY BINDING PROTEIN BBP/53BP2,6513315,7/10/1998 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002,209096, ,NCI, , ,209096
P53-MEDIATED CHEMOSENSITIVITY IN NEUROBLASTOMA,6513373,4/15/1998 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002,106344, ,NCI, , ,106344
P53 AND REPAIR OF DNA DAMAGE BY ANTICANCER DRUGS,6513385,4/1/1998 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,115906, ,NCI, , ,115906
Targeting Cancer Cell DNA with Combinatorial Ligands,6513386,4/1/1998 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,271120, ,NCI, , ,271120
FUNCTIONS OF DIFFERENT P53 MUTATIONS IN PROSTATE CANCER,6513389,4/15/1998 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,261270, ,NCI, , ,261270
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION,6513398,5/1/1998 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,318779, ,NCI, , ,318779
NUTRIENTS EFFECT ON GENOTYPE IN BREAST CANCER,6513422,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,2002,136485, ,NCI, , ,136485
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS,6513437,8/1/1999 0:00,8/30/2002 0:00,Non-SBIR/STTR,2002,16481, ,NCI, , ,16481
STEM CELL DERIVED IMMUNOTHERAPY,6513447,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,2002,125226, ,NCI, , ,125226
MDM2 ONCOGENE AS A TARGET FOR MODULATING CANCER THERAPY,6513479,4/7/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,227557, ,NCI, , ,227557
EPITOPE BASED T CELL THERAPY FOR EPITHELIAL TUMORS,6513482,5/1/1999 0:00,2/29/2004 0:00,Non-SBIR/STTR,2002,309716, ,NCI, , ,309716
UBIQUITINATION AND STABILITY OF P53 AND P73,6513498,6/15/1999 0:00,2/1/2003 0:00,Non-SBIR/STTR,2002,251045, ,NCI, , ,251045
A ROLE OF RAD51B IN DNA REPAIR AND BREAST CARCINOGENESIS,6513509,6/1/2000 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,293692, ,NCI, , ,293692
THE ROLE OF A NOVEL GAP IN EPITHELIAL ONCOGENESIS,6513518,9/8/1999 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,253067, ,NCI, , ,253067
METABOLIC GENOTYPES & ONCOGENIC DAMAGE IN BREAST CANCER,6513546,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,324000, ,NCI, , ,324000
LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU,6513554,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,580875, ,NCI, , ,580875
MOLECULAR CHARACTERIZATION OF ACF (ABERRANT CRYPT FOCI),6513559,8/1/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,235811, ,NCI, , ,235811
CDX2 TUMOR SUPPRESSOR PATHWAY DEFECTS IN COLON CANCER,6513612,8/15/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,272442, ,NCI, , ,272442
"MUTUAL REGULATION OF P53, MDM2 AND NFKB:",6514064,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,202943, ,NCI, , ,202943
ROLE OF BRCA1 IN NORMAL CELL GROWTH AND TUMORGENESIS,6514085,9/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,209516, ,NCI, , ,209516
Structural Determinants in Cell Growth Control by p21,6514097,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,244435, ,NCI, , ,244435
FAS/APO-1 MEDIATED APOPTOSIS,6514107,8/1/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,204801, ,NCI, , ,204801
Analysis of the Chemopreventive Activity of FGN 1,6514125,4/1/2001 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,315607, ,NCI, , ,315607
DETERMINANTS OF CLINICAL OUTCOME/TOXICITY IN HISPANICS,6514129,9/3/1999 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,348860, ,NCI, , ,348860
E2 MODULATION OF TUMORIGENESIS IN ERBB2 TRANSGENIC MICE,6514157,8/15/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,217564, ,NCI, , ,217564
GEMZAR--MECHANISMS OF CYTOTOXICITY & RADIOSENSITIZATION,6514175,7/8/1999 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002,212851, ,NCI, , ,212851
TREATMENT RESPONSE MARKERS IN ADVANCED LARYNGEAL CANCER,6514176,9/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,234264, ,NCI, , ,234264
THE ROLE OF INTEGRIN A5B1 IN ANGIOGENESIS & DISEASE,6514182,9/1/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,296368, ,NCI, , ,296368
Novel Technology for the Analysis of Gene Expression,6514201,8/1/1999 0:00,6/30/2004 0:00,SBIR/STTR,2002,604343, ,NCI, , ,604343
VIRAL ONCOPROTEIN ACTIVATION IN AIDS-RELATED TUMORS,6514203,9/17/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,540840, ,NCI, , ,540840
Molecular Mechanism of Genistein in Prostate Cancer,6514209,7/12/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,257055, ,NCI, , ,257055
" 8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA",6514210,7/5/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,417819, ,NCI, , ,417819
PI 3K PATHWAY IN BCR/ABL INDUCED LEUKEMIAS,6514211,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,283950, ,NCI, , ,283950
USE OF THE MOUSE FOR PROSTATE CANCER GENE DISCOVERY,6514251,3/27/2000 0:00,2/28/2005 0:00,Other Research-Related,2002,139320, ,NCI, , ,139320
APOPTOSIS AND A NEW ADAPTER MOLECULE PATHWAY IN GLIOMA,6514260,4/15/2001 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,223325, ,NCI, , ,223325
MOUSE CANCER MODELS BY REGULATED INACTIVATION OF TUMOR S,6514282,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,703046, ,NCI, , ,703046
MOUSE MODELS OF HUMAN BREAST CANCER,6514284,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,777399, ,NCI, , ,777399
 REPRESSION BY C SKI AND MELANOMA PROGRESION,6514289,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,318222, ,NCI, , ,318222
"THE APL PARADIGM FOR ABERRANT TRANSCRIPTION, CANCER AND",6514292,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,521922, ,NCI, , ,521922
A MOUSE MODEL FOR PROSTATE CANCER,6514293,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,498535, ,NCI, , ,498535
CREATION AND CHARACTERIZATION OF MOUSE MODELS OF HUMAN L,6514296,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,1106479, ,NCI, , ,1106479
PRECLINICAL MOUSE:  CENTRAL NERVOUS SYSTEM CANCERS,6514298,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,1108628, ,NCI, , ,1108628
"OXIDATIVE STRESS, APOPTOSIS AND DRUG RESISTANCE",6514315,7/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,201150, ,NCI, , ,201150
CPG METHYLATION AND MUTATION,6514317,7/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,275625, ,NCI, , ,275625
ROLE OF AMINO TERMINAL MODIFICATION IN P53 FUNCTION,6514336,4/1/2002 0:00, ,"Training, Individual",2002,48148, ,NCI, , ,48148
TRIGGERING OF ABERRANT CPG ISLAND METHYLATION,6514395,7/1/2000 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,232313, ,NCI, , ,232313
MOLECULAR BASIS OF P53 INDUCTION TO DNA DAMAGE,6514435,6/15/2001 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,235281, ,NCI, , ,235281
Cyclin G in p53 mediated pathways and breast cancer,6514436,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,267750, ,NCI, , ,267750
P53 AND UV REGULATION OF P53 BINDING PROTEIN BBP/53BP2,6514448,6/7/2000 0:00,5/31/2005 0:00,Other Research-Related,2002,132921, ,NCI, , ,132921
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER,6514518,5/8/2000 0:00,2/28/2005 0:00,Other,2002,1253944, ,NCI, , ,1253944
THERAPEUTIC MODULATION OF ANGIOGENESIS IN HUMAN GLIOMAS,6514550,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,337320, ,NCI, , ,337320
MULTIDICIPLINARY FUNCTIONAL IMAGING OF CANCER,6514554,7/1/2000 0:00,8/31/2003 0:00,Other,2002,400000, ,NCI, , ,400000
MODULATING BASE EXCISION REPAIR IN TUMOR DRUG RESISTANCE,6514558,4/1/2000 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,275400, ,NCI, , ,275400
CLINICAL AND EPIDEMIOLOGIC CENTER FOR BIOMARKERS OF UPPE,6514566,5/1/2000 0:00,2/28/2005 0:00,Other,2002,1006268, ,NCI, , ,1006268
CATIONIC LIPID/P53 GENE THERAPY IN LUNG CANCER PATIENTS,6514601,3/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,423535, ,NCI, , ,423535
TARGETING THERAPY OF HUMAN BREAST CANCER,6514639,6/1/2001 0:00,5/31/2003 0:00,Non-SBIR/STTR,2002,127875, ,NCI, , ,127875
CHARACTERIZATION OF NEW HUMAN P53 DISSOCIATORS,6514653,7/1/2000 0:00,7/31/2002 0:00,Non-SBIR/STTR,2002,4500, ,NCI, , ,4500
TNF alpha mediated apoptosis in prostate cancer,6514673,3/1/2001 0:00,2/28/2005 0:00,Non-SBIR/STTR,2002,244020, ,NCI, , ,244020
Adenocarinoma of the Lung in Women,6514708,6/13/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,589718, ,NCI, , ,589718
STRESS INDUCED BYSTANDER EFFECT IN CANCER TREATMENT,6514735,6/9/2000 0:00,4/30/2005 0:00,Non-SBIR/STTR,2002,266400, ,NCI, , ,266400
"SENSITIVE, MULTIPLEXED ANALYSIS OF BREAST CANCER MARKERS",6514764,8/28/2000 0:00,2/28/2003 0:00,SBIR/STTR,2002,334047, ,NCI, , ,334047
Extracellular Matrix Mediated Apoptosis in p53 (-) HMECs,6514779,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,237160, ,NCI, , ,237160
Strategies to Enhance Adenoviral Mediated Tumor Killing,6514809,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,279572, ,NCI, , ,279572
CHROMOSOME ALTERATIONS IN BARRETT'S ESOPHAGUS,6514817,4/1/2001 0:00,3/31/2006 0:00,Other Research-Related,2002,94973, ,NCI, , ,94973
Lymphomagenesis as a Response to Antigenic Stimulation,6514820,8/6/2001 0:00,7/31/2002 0:00,Other Research-Related,2002,10922, ,NCI, , ,10922
MODULATORS AND EFFECTORS OF MDM2 AND P53,6514829,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2002,273663, ,NCI, , ,273663
 METHYLATION PROFILING IN COLORECTAL CANCER,6514831,3/12/2001 0:00,2/29/2004 0:00,Non-SBIR/STTR,2002,245245, ,NCI, , ,245245
Mechanisms in Wilms Tumorigenesis,6514837,8/23/2001 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,276390, ,NCI, , ,276390
IGF I survival effects on p53 induced apoptosis,6514838,6/1/2001 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,169875, ,NCI, , ,169875
"ROLE OF MDM2, P300, P19ARF IN P53 UBIQUITINATION",6514866,4/12/2001 0:00,12/31/2002 0:00,Other Research-Related,2002,157437, ,NCI, , ,157437
Accelerated senescence in tumor cells,6514875,6/1/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,256184, ,NCI, , ,256184
"MyD118, CR6 and GADD45 in Genotoxic Stress",6514883,7/1/2001 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,249830, ,NCI, , ,249830
Rapid in Vivo Assay for Oral Cancer Chemoprevention,6514890,7/1/2001 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,69082, ,NCI, , ,69082
Mrad9 Radioresistance Gene,6514893,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,306682, ,NCI, , ,306682
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM,6514923,2/8/2002 0:00, ,"Training, Individual",2002,2888, ,NCI, , ,2888
New Molecular Approaches to Inhibit Glioma Angiogenesis,6514938,3/1/2001 0:00,2/28/2004 0:00,Non-SBIR/STTR,2002,259875, ,NCI, , ,259875
IL10 and IGF1 Receptor Axis in Prostate Cancer,6514956,6/5/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2002,281993, ,NCI, , ,281993
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER,6514962,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,369265, ,NCI, , ,369265
P53 Mediated Regulation of Centrosome Duplication,6514969,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,253980, ,NCI, , ,253980
Flavopiridol Mediated Apoptosis During S Phase in NSCLC,6514995,4/1/2001 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,294550, ,NCI, , ,294550
"P13K/PTEN/Akt (PKB), Signaling and genesis of cancer",6515005,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2002,355841, ,NCI, , ,355841
Nicotine Derived Nitrosamines & Tobacco Related Cancers,6515016,5/1/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2002,275625, ,NCI, , ,275625
Molecular Targeting of the Survivin Pathway in Cancer,6515027,4/1/2001 0:00,8/16/2002 0:00,Non-SBIR/STTR,2002,120098, ,NCI, , ,120098
Selection of chemical inhibitors of oncoproteins,6515050,5/25/2001 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,148000, ,NCI, , ,148000
TEA TARGETING PROTEASOME--A ROLE IN CANCER PREVENTION,6515078,4/1/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002,72500, ,NCI, , ,72500
Molecular Imaging of Responses to Cancer Therapy,6515132,6/6/2001 0:00,5/31/2004 0:00,Other,2002,400000, ,NCI, , ,400000
"THE PanINs OF PANCREATITIS,PANCREAS CANCER AND CONTROLS",6515154,7/1/2001 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,81750, ,NCI, , ,81750
Molecular Pathogenesis of Ewing Sarcoma,6515173,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,249000, ,NCI, , ,249000
Cyclin/cdk Regulation of P53 in Prostate Cancer,6515174,7/1/2001 0:00,6/30/2006 0:00,Other Research-Related,2002,93744, ,NCI, , ,93744
Modes of Prostate Ca Progression--role of p53 Pathway,6515185,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,240345, ,NCI, , ,240345
Deregulation of Cell Pathways by Ad E1B 55K Oncoproteins,6515186,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,270788, ,NCI, , ,270788
Exploiting IR inducible NQ01 Levels Using Beta Lapachone,6515188,7/1/2001 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,246919, ,NCI, , ,246919
Analysis of Chk2 dependent DNA damage signaling pathway,6515195,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,222233, ,NCI, , ,222233
Mouse Models of Gastric Cancer,6515265,5/1/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2002,270990, ,NCI, , ,270990
GENETIC EPIDEMIOLOGY OF ORAL PREMALIGNANCIES AND CANCER,6516340,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,2002,124686, ,NIDCR, , ,124686
CELL CYCLE REGULATORS OF ORAL CANCER,6516498,4/1/1998 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,1070464, ,NIDCR, , ,1070464
HPV ETIOLOGY OF A SUBSET OF HEAD AND NECK CANCERS,6516545,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,312694, ,NIDCR, , ,312694
ARF AS A THERAPEUTIC AGENT IN ORAL MALIGNANCIES,6516551,4/1/2000 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002,243946, ,NIDCR, , ,243946
SENESCENCE IN EPITHELIAL NEOPLASTIC PROGRESSION,6516552,9/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,252131, ,NIDCR, , ,252131
THE ROLE OF P40 IN SQUAMOUS CELL CARCINOMA,6516596,9/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,277951, ,NIDCR, , ,277951
"HPV, Genetic Instability & Oral Cancer",6516667,8/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,240188, ,NIDCR, , ,240188
GI HORMONES AND OTHER FACTORS IN GROWTH OF GI MUCOSA,6516970,12/1/1977 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,403852, ,NIDDK, , ,403852
CHROMOSOME 22Q GENETIC STUDIES IN THE COLON,6517669,3/1/2000 0:00,2/29/2004 0:00,Non-SBIR/STTR,2002,239842, ,NIDDK, , ,239842
MOLECULAR MECHANISMS OF IRON CHELATOR CYTOTOXICITY,6517764,6/1/2000 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,252146, ,NIDDK, , ,252146
TRIMODAL GENE THERAPY FOR PROSTATE CANCER,6517772,7/1/2000 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,141106, ,NIDDK, , ,141106
NUCLEAR RECEPTOR COACTIVATORS AND BREAST CANCER,6518010,6/15/2000 0:00,5/31/2005 0:00,Other Research-Related,2002,117099, ,NIEHS, , ,117099
The XP Variant:  A Human Mutator Gene for UV Damage,6518111,2/1/1998 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,331875, ,NIEHS, , ,331875
HEPTOCYTE PROLIFERATION AND AFLATOXIN METABOLISM,6518130,4/1/2000 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002,202557, ,NIEHS, , ,202557
"ATM, P53, GADD45 AND P21 EFFECTS ON RECOMBINATION",6518131,6/1/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,268310, ,NIEHS, , ,268310
Xenobiotics and Breast Epithelial Cell-ECM Signaling,6518191,5/3/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2002,260750, ,NIEHS, , ,260750
Models for DNA repair and cell cycle control variants,6518223,4/10/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,823866, ,NIEHS, , ,823866
RECOMBINATION MECHANISMS IN ADENOVIRUS TRANSFECTION,6519084,5/1/1982 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,338795, ,NIGMS, , ,338795
BIOCHEMICAL STUDIES OF HUMAN DNA POLYMERASE DELTA,6519096,4/1/1983 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,485179, ,NIGMS, , ,485179
Molecular cytology of human telomeres-telomere protein,6519524,5/1/1993 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,374392, ,NIGMS, , ,374392
MECHANISMS OF RADIORESISTANCE AND CELL CYCLE PROGRESSION,6519644,5/1/1995 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,360669, ,NIGMS, , ,360669
A novel regulator of p53 function,6521549,8/15/2002 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,288063, ,NCI, , ,288063
Regulation Of Mutant P53,6521712, , ,Intramural Research,2001, , , , , , 
MOLECULAR EPIDEMIOLOGY OF NON-MELANOMA SKIN CANCER,6522289,9/30/1999 0:00,7/31/2003 0:00,Non-SBIR/STTR,2002,387679, ,NCI, , ,387679
TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER,6522341,8/24/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,329638, ,NCI, , ,329638
RETINOID INDUCED TUMOR DIFFERENTIATION AND THE CELL CYCL,6522389,9/30/1998 0:00,9/29/2003 0:00,Other Research-Related,2002,138400, ,NCI, , ,138400
MOLECULAR EPIDEMIOLOGY OF BRCA1 RELATED BREAST NEOPLASIA,6522394,9/30/1998 0:00,8/31/2003 0:00,Other Research-Related,2002,83726, ,NCI, , ,83726
DNA Damage Checkpoints,6522404,8/10/1998 0:00,7/31/2006 0:00,Non-SBIR/STTR,2002,277087, ,NCI, , ,277087
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER,6522407,9/1/1998 0:00,8/31/2003 0:00,Other Research-Related,2002,90480, ,NCI, , ,90480
PROSTOGLANDINS AND UVB CARCINOGENESIS,6522410,8/14/1998 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,187119, ,NCI, , ,187119
BIOCHEM DISSECTION OF P53-DEPENDENT APOPTOSIS PATHWAY,6522438,9/1/1999 0:00,8/31/2004 0:00,Other Research-Related,2002,152820, ,NCI, , ,152820
P21 INDUCTION BY BRCA2,6522453,8/1/1998 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,100170, ,NCI, , ,100170
"DIETARY HETEROCYCLIC AMINES, GENETIC SUSCEPTIBILITY, AND",6522459,9/30/1998 0:00,9/29/2004 0:00,Other Research-Related,2002,141700, ,NCI, , ,141700
THE NATURAL HISTORY OF HEREDITARY BREAST CANCER,6522492,9/15/2000 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,180000, ,NCI, , ,180000
"AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES",6522493,9/20/1999 0:00,8/31/2004 0:00,Other Research-Related,2002,61257, ,NCI, , ,61257
Modeling the effects of INK4 alpha ARF loss on gliomas,6522509,8/1/2001 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,256725, ,NCI, , ,256725
Epidemiology of HPV and p53 Mutations in NM Skin Cancer,6522523,8/1/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2002,522427, ,NCI, , ,522427
EARLY CANCER DETECTION AND SUSCEPTIBILITY BIOMAKERS,6522550,9/30/1999 0:00,8/31/2004 0:00,Other,2002,738378, ,NCI, , ,738378
TUMOR MARKERS TO PREDICT TREATMENT RESPONSE,6522586,9/10/2001 0:00,8/31/2006 0:00,Other Research-Related,2002,268833, ,NIA, , ,268833
MALIGNANT COMPLICATIONS OF CHRONIC HCV,6522592,9/29/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,398862, ,NCI, , ,398862
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS,6522601,9/1/2000 0:00,8/31/2005 0:00,Non-SBIR/STTR,2002,500886, ,NCI, , ,500886
POLYOMA HOST INTERACTIONS LEADING TO TUMOR DEVELOPMENT,6522665,9/1/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2002,720803, ,NCI, , ,720803
Suramin to Enchance Paclitaxel and Carboplatin in NSCLC,6522678,9/19/2001 0:00,8/31/2005 0:00,Non-SBIR/STTR,2002,331875, ,NCI, , ,331875
"Oxidative DNA Damage, DNA Repair and Oral Cancer",6522788,9/1/2001 0:00,8/31/2006 0:00,Other Research-Related,2002,66825, ,NCI, , ,66825
ROLES AND REGULATION OF P53,6522799,9/30/2000 0:00,7/31/2005 0:00,Non-SBIR/STTR,2002,1768593, ,NCI, , ,1768593
CHARACTERIZATION OF A NEW GENE IN P53 MUTANT LFS FAMILY,6522804,8/4/2000 0:00,7/31/2005 0:00,Other Research-Related,2002,117935, ,NCI, , ,117935
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION,6522808,9/1/2000 0:00,8/31/2005 0:00,Other Research-Related,2002,154440, ,NCI, , ,154440
MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS,6522835,8/4/2000 0:00,7/31/2005 0:00,Other Research-Related,2002,63356, ,NCI, , ,63356
MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER,6522873,9/18/2000 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,234124, ,NCI, , ,234124
"Gastric Cancer Prognosis--MSI, BAX, DCC, & p53 LOH",6522929,8/6/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2002,291857, ,NCI, , ,291857
Transduction of Tumor Suppressor Proteins into Gliomas,6522938,9/5/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2002,248886, ,NCI, , ,248886
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER,6523868,9/24/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,361251, ,NIDCR, , ,361251
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN,6523872,9/1/1999 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002,591665, ,NIDCR, , ,591665
GENETIC ALTERATIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARK,6523873,9/1/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,370486, ,NIDCR, , ,370486
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER,6523882,9/30/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,391091, ,NIDCR, , ,391091
NEOADJUVANT THERAPY OF OR CANCER BY INHIBITING NF-KAPPAB,6524011,9/30/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,258607, ,NIDCR, , ,258607
Transcriptional Control of Gastrin,6524165,9/1/1993 0:00,7/31/2006 0:00,Non-SBIR/STTR,2002,385150, ,NIDDK, , ,385150
TRANSGENIC MOUSE MODELS OF HEAD AND NECK CANCER,6524187,9/15/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,40625, ,NIDCR, , ,40625
TR2 AND TR3 ORPHAN RECEPTORS IN PROSTATE CANCER,6524199,9/1/1995 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,288159, ,NIDDK, , ,288159
Mechanisms of Growth Inhibition by Helicobacter Pylor,6524466,9/30/2001 0:00,11/30/2004 0:00,Non-SBIR/STTR,2002,75500, ,NIDDK, , ,75500
"KS1, A NOVEL SUPPRESSOR OF NEOPLASTIC TRANSFORMATION",6524562,9/15/2000 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,182019, ,NIDDK, , ,182019
Role of E6-AP in the Development of Prostate Cancer,6524667,9/30/2001 0:00,9/2/2002 0:00,Non-SBIR/STTR,2002,12000, ,NIDDK, , ,12000
SUSCEPTIBILITY TO MOLECULAR ALTERATION: EPITHELIAL CELLS,6524698,9/26/1999 0:00,8/31/2004 0:00,Other Research-Related,2002,118065, ,NIEHS, , ,118065
Nutritional Regulation of Catalase and Colorectal Cancer,6524842,9/30/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,77996, ,NIEHS, , ,77996
"Oxidative mutagenesis:Iron, Ascorbic Acid and Genes",6524846,9/15/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,74250, ,NIEHS, , ,74250
Biologic Activity of Lycopene,6524857,9/15/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,80000, ,NIEHS, , ,80000
Oxidative damage to gastric epithelal cells by H pylori,6525238,9/21/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2002,233100, ,NIDDK, , ,233100
MECHANISMS OF ACROLEIN ON PROLIFERATION AND APOPTOSIS,6525285,8/1/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,210622, ,NIEHS, , ,210622
CELL CYCLE CONTROL OF PROTEOLYSIS BY F-BOX PROTEINS,6526130,8/1/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,340499, ,NIGMS, , ,340499
RADIATION INDUCED G1 CHECKPOINT ARREST IN YEAST,6526204,9/1/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,206560, ,NIGMS, , ,206560
DETERMINANTS OF HEPATITIS C & E MORBIDITY IN EGYPT,6526396,9/15/2000 0:00,8/31/2005 0:00,Non-SBIR/STTR,2002,500332, ,NICHD, , ,500332
ISOLATION OF THE FANCONI ANEMIA NUCLEAR PROTEIN COMPLEX,6527245,9/10/2000 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,368702, ,NHLBI, , ,368702
"Characterization of Fortilin, A Novel Anti-p53 Protein",6527784,9/30/2001 0:00,7/31/2005 0:00,Non-SBIR/STTR,2002,224250, ,NHLBI, , ,224250
EARLY GENETIC EVENTS IN ASTROCYTOMA FORMATION,6529664,9/30/2001 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,386012, ,NINDS, , ,386012
Mentored Patient-Oriented Research Career Development Aw,6529945,8/1/2000 0:00,7/31/2005 0:00,Other Research-Related,2002,118068, ,NCRR, , ,118068
Design And Development Of Experimental Therapeutics,6530309, , ,Intramural Research,2001, , , , , , 
Cellular And Molecular Pathogenesis Of Alzheimer's,6530312, , ,Intramural Research,2001, , , , , , 
CLONING GENES THAT REGULATE MYOCARDIOCYTE PROLIFERATION,6530649,7/1/1990 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002,353669, ,NHLBI, , ,353669
Studies of Childhood Solid Tumors,6531320,8/1/1978 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,1554855, ,NCI, , ,1554855
Biomarkers in Phototherapy of Barrett's Esophagus,6531392,9/30/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002,321513, ,NCI, , ,321513
MD Anderson Cancer Center SPORE in Head and Neck Cancer,6531499,9/30/2002 0:00,7/31/2007 0:00,Research Centers,2002,2316943, ,NCI, , ,1242226
Genetic Epidemiological Studies Of Oral Cancer,6531934, , ,Intramural Research,2001, , , , , , 
Role of survivin in nonmelanoma skin cancer,6532309,9/1/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2002,75000, ,NIAMS, , ,75000
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS,6532747,8/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,231874, ,NIAID, , ,231874
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION,6533113,6/1/1979 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,241956, ,NCI, , ,241956
FUNCTIOINAL ANALYSIS OF THE P53 TUMOR SUPPRESSOR,6533117,8/15/1985 0:00,7/31/2003 0:00,Non-SBIR/STTR,2002,186590, ,NCI, , ,186590
COLON CANCER PREVENTION PROGRAM PROJECT,6533119,9/30/1986 0:00,7/31/2005 0:00,Non-SBIR/STTR,2002,3626437, ,NCI, , ,3626437
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA,6533134,9/1/1992 0:00,7/31/2005 0:00,Non-SBIR/STTR,2002,237687, ,NCI, , ,237687
BREAST CANCER AND THE ENVIRONMENT ON LONG ISLAND,6533158,8/8/1995 0:00,7/31/2005 0:00,Non-SBIR/STTR,2002,408729, ,NCI, , ,408729
Molecular Mechanisms of Ara-C Therapy in Man,6534583,9/15/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2002,283930, ,NCI, , ,283930
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA,6534585,6/1/1983 0:00,8/31/2005 0:00,Non-SBIR/STTR,2002,290764, ,NCI, , ,290764
MECHANISM OF ANTICARCINOGENIC ACTIVITY--ORGANOSULFIDES,6534595,4/1/1995 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,201423, ,NCI, , ,201423
Genetic Alterations During Multistep Carcinogenesis In M,6534974, , ,Intramural Research,2001, , , , , , 
Exposure Specific Mutation In Critical Target Genes,6535072, , ,Intramural Research,2001, , , , , , 
Genes Affecting Chromosome matabolism,6535123, , ,Intramural Research,2001, , , , , , 
Development of New Hormone Responsive Models from Cancer,6535172, , ,Intramural Research,2001, , , , , , 
Insulin-like Growth Factor Binding Proteins,6535234, , ,Intramural Research,2001, , , , , , 
Antiproliferative Effects Of Small Molecules,6535288, , ,Intramural Research,2001, , , , , , 
Mda-7: Novel Cancer Therapeutic Gene,6535735,9/10/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002,291030, ,NCI, , ,291030
"Role of Na,K ATPase in the development of carcinoma",6536073,9/12/2002 0:00, ,"Training, Individual",2002,24835, ,NCI, , ,24835
GELSOLIN: ROLES IN APOPTOSIS AND TUMOR DEVELOPMENT,6537178,5/1/1995 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,301399, ,NHLBI, , ,301399
HPV AND RISK OF ORAL CANCER IN THE CZECH REPUBLIC,6540820,6/15/2001 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,40160, ,FIC, , ,40160
MECHANISMS REGULATING REVERSAL OF PREMALIGNANCY,6540880,12/15/2000 0:00,11/30/2005 0:00,Non-SBIR/STTR,2001,141612, ,NCI, , ,141612
Statistical And Computational Methods For Gene Expressio,6540965, , ,Intramural Research,2001, , , , , , 
Studies of Materials with Physiological Properties,6541091,9/1/1988 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,537858, ,NIGMS, , ,537858
Analysis Of The S Phase Checkpoint In Higher Eukaryotes,6541235, , ,Intramural Research,2001, , , , , , 
GENETIC ELEMENTS TRANSFORMING MOUSE FIBROBLASTS,6541285,1/3/1994 0:00,6/30/2004 0:00,Non-SBIR/STTR,2001,266400, ,NCI, , ,266400
Development of P53-Based Vaccines for Oral Cancer,6541364,9/1/1997 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002, ,130265, , , , 
Cyclin B-1 As a Tumor-specific Antigen in Oral Carcinoma,6541368,9/1/1997 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002, ,129469, , , , 
CORE--TISSUE PROCUREMENT/DC LABORATORY,6541377,9/1/1997 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002, ,104330, , , , 
Specificity of Ubiquitination: the HPVE6/E6AP Paradigm,6541407,12/13/1996 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,280120, ,NCI, , ,280120
Cellular Stress Response Signaling Pathways,6541550,1/1/1992 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,337500, ,NIEHS, , ,337500
THE FUNCTION OF NONMUSCLE MYOSIN II HEAVY CHAINS,6541704, , ,Intramural Research,2001, , , , , , 
 Model of Tumor Suppression by BRCA1,6541737,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,339424, ,NCI, , ,339424
Interaction Between SV40 Large T and p185 Cullin,6542212,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,368068, ,NCI, , ,368068
Exploring How HTLV-1 Tax Induces T Cell Leukemia,6542491,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,320400, ,NCI, , ,320400
"Heterogeneity of Human Melanoma, Cytokines and iNOS",6542526,7/12/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,267000, ,NCI, , ,267000
Leukotriene Biosynthesis: Inflammation and Cancer,6542647,8/1/1988 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,262500, ,NIAID, , ,262500
Statistical Methods in Genetic Epidemiology,6542816,6/1/1997 0:00,7/31/2006 0:00,Non-SBIR/STTR,2002,256580, ,NIA, , ,256580
DUAL ROLE OF E2F1 IN TUMORIGENESIS,6543159,1/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2002,69000, ,NCI, , ,69000
INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN D,6543313,12/24/1998 0:00,11/30/2003 0:00,Non-SBIR/STTR,2002,59196, ,NCI, , ,59196
The Role of RR in Chemotherapeutic Drug Resistance,6543497,4/1/1997 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,249375, ,NCI, , ,249375
Microarray Analysis of HNSCC as a Predictor of Treatment,6543577,9/1/2002 0:00,8/31/2006 0:00,Other Research-Related,2002,135000, ,NIDCR, , ,135000
NEW MODELS FOR COMPARATIVE STUDIES OF GONADAL TUMORS,6543578,12/16/1993 0:00,7/31/2007 0:00,Non-SBIR/STTR,2002,282250, ,NIEHS, , ,282250
Mechanistic Studies on New Platinum Clinical Agents,6545213,9/30/1998 0:00,7/31/2007 0:00,Non-SBIR/STTR,2002,317250, ,NCI, , ,317250
P53 AND UV REGULATION OF P53 BINDING PROTEIN BBP/53BP2,6545539,6/7/2000 0:00,5/31/2005 0:00,Other Research-Related,2001,122745, ,NCI, , ,122745
Mechanism of Meclp in the Checkpoint Response,6546646,9/1/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002,223500, ,NIGMS, , ,223500
Pathogenic Factors And Determinants Of Prognosis In Pati,6546655, , ,Intramural Research,2001, , , , , , 
Clinically Aggressive Thyroid Cancer: Molecular Basis An,6546665, , ,Intramural Research,2001, , , , , , 
Leukemogenesis In Genetically-altered Models,6546696, , ,Intramural Research,2001, , , , , , 
Molecular Analysis Of Cell Cycle Control in Carcinogenes,6546697, , ,Intramural Research,2001, , , , , , 
Role of Tumor Suppressor p53 in Breast Cancer,6546878,8/1/2002 0:00, ,"Training, Individual",2002,26613, ,NCI, , ,26613
CONTRAST ASSISTED ULTRASOUND IMAGING OF TUMORS,6547640,12/11/1997 0:00,12/31/2006 0:00,Non-SBIR/STTR,2003,258896, ,NCI, , ,258896
Antitumor Activity of Inducible Nitric Oxide Synthase,6547745,9/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2002,251038, ,NCI, , ,251038
EPIDEMIOLOGY AND PATHOGENESIS OF HEPATITIS B AND C VIRUS,6547865, , ,Intramural Research,1998, , , , , , 
HEPATITIS B VIRUS AND CELLULAR PROTEINS IN ITS PATHOGENE,6547871, , ,Intramural Research,1998, , , , , , 
HPV INTEGRATION AS A BIOMARKER FOR CIN BEHAVIOR,6548232,7/3/2002 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,74500, ,NCI, , ,74500
Biomarker modulation/COX-2 inhibitor/Breast Cancer,6548233,9/15/2002 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,75500, ,NCI, , ,75500
Molecular Markers of Colon Cancer: Racial Differences,6548366,9/23/2002 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,71750, ,NCI, , ,71750
Role of ATM in Radiosensitivity of Gliomas,6548515,9/10/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2002,271263, ,NCI, , ,271263
MOLECULAR BEACONS FOR PROTEIN DETECTION,6548831,8/1/2002 0:00,7/31/2004 0:00,Non-SBIR/STTR,2002,146438, ,NCI, , ,146438
Chemoresistance in Renal Cell Cancer,6549325,7/8/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2002,382188, ,NCI, , ,382188
MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER,6551080,9/18/2000 0:00,8/31/2002 0:00,Non-SBIR/STTR,2002,22800, ,NCI, , ,22800
Structure-function analysis of HPV E6 proteins,6552390,8/1/2002 0:00, ,"Training, Individual",2002,38320, ,NCI, , ,38320
Molecular Diagnostics for Breast Cancer,6553061,8/2/2002 0:00,7/31/2005 0:00,Non-SBIR/STTR,2002,486672, ,NCI, , ,486672
Carotenoid/retinoid Modulation Of Cellular Redox Status,6553190, , ,Intramural Research,2001, , , , , , 
Identification Of Bioactive Isoforms Of P53 Protein,6553194, , ,Intramural Research,2001, , , , , , 
EARLY CANCER DETECTION AND SUSCEPTIBILITY BIOMARKERS,6553773,9/30/1999 0:00,8/31/2004 0:00,Other,2002,76612, ,NCI, , ,76612
Papillomavirus Inhibitors for AIDS-related Malignancies,6553831,7/29/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,279388, ,NCI, , ,279388
Hamster Model for AIDS Lymphomas,6553952,9/1/2002 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,150500, ,NCI, , ,150500
SUPPRESSION OF B-LYMPHOMAS VIA INDUCTION OF INTERFERONS,6553976,7/1/2002 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,237750, ,NCI, , ,237750
DISSECTION OF THE DNA DAMAGE CHECKPOINT PATHWAYS,6555076,12/1/2001 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,41614, ,NCI, , ,41614
MECHANISM OF P53 DEPENDENT APOPTOSIS,6555295,12/5/1997 0:00,8/14/2002 0:00,Non-SBIR/STTR,2002,71327, ,NCI, , ,71327
Role of p53 in Osteoblast Differentiation,6556100,6/1/2003 0:00,5/31/2007 0:00,Non-SBIR/STTR,2003,138400, ,NCI, , ,138400
ROLE FOR CELL CYCLE PROTEINS IN HIV ENCEPHALITIS,6556225,2/1/2001 0:00,11/30/2004 0:00,Non-SBIR/STTR,2002,277375, ,NINDS, , ,277375
Upper Gastrointestinal Cancer Genetic Studies,6556251, , ,Intramural Research,2001, , , , , , 
Biologic Specimen Bank for Early Lung Cancer Markers in,6556256, , ,Intramural Research,2001, , , , , , 
Epidemiology of Oncogenic Viruses,6556508, , ,Intramural Research,2001, , , , , , 
Consulting and Collaboration on Laboratory Studies,6556686, , ,Intramural Research,2001, , , , , , 
Genetic Epidemiology of Primary Hepatocellular Carcinoma,6556702, , ,Intramural Research,2001, , , , , , 
Genetics and Aflatoxin-Induced Hepatocellular Carcinoma,6556727, , ,Intramural Research,2001, , , , , , 
Molecular Calssification of Basal Cell Carcinomas,6557262,8/26/2003 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,163500, ,NCI, , ,163500
Characterization of Mouse CD8+ CTL/Tumor Interactions,6557471, , ,Intramural Research,2001, , , , , , 
Developmental Therapeutics,6557512, , ,Intramural Research,2001, , , , , , 
Imidodipeptides/Amino Acid Metabolite in Cell Regulation,6557519, , ,Intramural Research,2001, , , , , , 
Molecular Mechanism for HCMV Mediated Atherogenesis,6558076,9/30/2002 0:00,6/30/2003 0:00,Non-SBIR/STTR,2002,180286, ,NHLBI, , ,180286
Molecular Pathology of Pulmonary Carcinogenesis,6558108, , ,Intramural Research,2001, , , , , , 
Molecular Genetics of Gynecologic Cancers,6558155, , ,Intramural Research,2001, , , , , , 
Antigen-specific T-cell activation--cancer /AIDS vaccine,6558253, , ,Intramural Research,2001, , , , , , 
Laboratory and Clinical Translational Studies of Drug Re,6558370, , ,Intramural Research,2001, , , , , , 
Lymphoma Studies,6558374, , ,Intramural Research,2001, , , , , , 
Nitric Oxide as a Modifier of Oxidative Stress,6558396, , ,Intramural Research,2001, , , , , , 
Role of TRRAP in the p53-Mediated Transcription of mdm2,6558414,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,291055, ,NCI, , ,291055
HSP90 Family Chaperone Proteins Role In Cellular Signal,6558615, , ,Intramural Research,2001, , , , , , 
Analysis of p53 regulation in neuroblastoma cell lines,6558688, , ,Intramural Research,2001, , , , , , 
Molecular Intervention in Thoracic Malignancies,6558691, , ,Intramural Research,2001, , , , , , 
Inflammatory Breast Cancer,6558696, , ,Intramural Research,2001, , , , , , 
APPROACHES TO ENHANCE CANCER GENE THERAPY,6558728, , ,Intramural Research,2001, , , , , , 
Mechanism /Consequence of Chromosome Aneuploidy/Transloc,6558744, , ,Intramural Research,2001, , , , , , 
Viral RNA Splicing and Tumorigenesis,6558763, , ,Intramural Research,2001, , , , , , 
T Cell Antigen Recognition and Tumor Antigens,6558861, , ,Intramural Research,2001, , , , , , 
Interaction of Chemical Carcinogens with DNA,6558876, , ,Intramural Research,2001, , , , , , 
Gene Regulation and Function: The B-ZIP Proteins,6558890, , ,Intramural Research,2001, , , , , , 
Mechanisms of Induction and Suppression of Viral and Tum,6558895, , ,Intramural Research,2001, , , , , , 
Analysis of Pathways that Suppress or Accelerate Premali,6558908, , ,Intramural Research,2001, , , , , , 
Molecular Epidemiology of Human Cancer,6558912, , ,Intramural Research,2001, , , , , , 
Regulation of papillomavirus gene expression,6558915, , ,Intramural Research,2001, , , , , , 
"Tumor Suppressor Protein, p53",6558937, , ,Intramural Research,2001, , , , , , 
T-cell Transformation by Oncoviruses,6558942, , ,Intramural Research,2001, , , , , , 
Acquisition of Genomic Alterations During Mammary Gland,6558967, , ,Intramural Research,2001, , , , , , 
Mutational and Functional Analysis of the p53 Tumor Supp,6558974, , ,Intramural Research,2001, , , , , , 
DNA Repair and Cell Cycle Checkpoints as Targets for Ant,6558978, , ,Intramural Research,2001, , , , , , 
Molecular Biology of Cellular Injury,6558987, , ,Intramural Research,2001, , , , , , 
New strategies for drug discovery: Gene expression profi,6558989, , ,Intramural Research,2001, , , , , , 
Regulation of Gene Activity,6558994, , ,Intramural Research,2001, , , , , , 
Computer Analysis of Nucleic Acid Structure,6559004, , ,Intramural Research,2001, , , , , , 
Oncogenes & tumor suppressors in acute myeloid leukemia,6559029, , ,Intramural Research,2001, , , , , , 
Molecular analysis of growth regulation,6559033, , ,Intramural Research,2001, , , , , , 
In Vivo Ras-induced Senescence and Tumorigenesis,6559037,4/18/2003 0:00,2/28/2008 0:00,Non-SBIR/STTR,2003,352663, ,NCI, , ,352663
Roles of Nitric Oxide and Oxyradicals in Cancer,6559111, , ,Intramural Research,2001, , , , , , 
DNA Repair,6559155, , ,Intramural Research,2001, , , , , , 
Cellular gene expression--HPV infection /cervical cancer,6559190, , ,Intramural Research,2001, , , , , , 
Regulation and Function of p53 Tumor Suppressor Protein,6559207, , ,Intramural Research,2001, , , , , , 
Mechanisms of G2/M cell cycle checkpoint controls,6559275, , ,Intramural Research,2001, , , , , , 
Chk1 signaling in the G2 DNA damage checkpoint,6559471,2/1/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2003,344085, ,NCI, , ,344085
Regulation of Irreversible Growth Arrest by p53,6560938,4/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2003,241538, ,NCI, , ,241538
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7,6561769,2/15/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2002,54525, ,NCI, , ,54525
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE,6561775,12/29/1994 0:00,11/30/2004 0:00,Non-SBIR/STTR,2002,45112, ,NCI, , ,45112
MOLECULAR MECHANISM OF CHEMOPREVENTION BY APIGENIN,6561825,5/1/1996 0:00,2/28/2003 0:00,Non-SBIR/STTR,2002,69000, ,NCI, , ,69000
Novel Approaches for Pancreatic Cancer Therapy,6561863,1/21/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2003,363788, ,NCI, , ,363788
Allelic Deletion in Lung Cancers of Smokers & Nonsmokers,6562455,5/1/2003 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,175000, ,NCI, , ,175000
NEUROONCOLOGY,6563773,1/11/2002 0:00,12/31/2002 0:00,Other Research-Related,2002, ,78870, , , , 
GENETIC ALTERATIONS AND MYLTIPLE MYELOMA--EFFECTS ON CELL GROWTH & APOPTOSIS,6563837,2/6/2002 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002, ,228401, , , , 
BIOCHEMICAL EFFECTORS OF GENE MUTATED IN COLON CANCER,6563868,1/1/2002 0:00,12/31/2002 0:00,Non-SBIR/STTR,2002, ,130479, , , , 
CORE--EXPERIMENTAL ANIMAL FACILITY,6563871,1/1/2002 0:00,12/31/2002 0:00,Non-SBIR/STTR,2002, ,130479, , , , 
Convergent functions of p53 and BRCA1 in gene regulation,6563939,2/1/2002 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002, ,237979, , , , 
PW1--A mediator of cell survival by NFKB and cell death by p53,6563940,2/1/2002 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002, ,237979, , , , 
Core--Gene knockout cell line,6563941,2/1/2002 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002, ,237978, , , , 
PATHWAYS OF BLADDER TUMORIGENESIS,6564310,12/1/2001 0:00,11/30/2002 0:00,Non-SBIR/STTR,2002, ,165355, , , , 
GENE THERAPY OF PRIMARY & METASTATIC MALIGNANT LIVER TUMORS USING SCH58500,6565712,12/1/2001 0:00,11/30/2002 0:00,Research Centers,2002, ,293069, , , , 
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER,6567625,12/1/2001 0:00,11/30/2002 0:00,Research Centers,2002, ,321374, , , , 
VACCINATION AGAINST TUMOR SPECIFIC MUTANT RAS AND P53 PEPTIDES IN CANCER,6567702,12/1/2001 0:00,11/30/2002 0:00,Research Centers,2002, ,321374, , , , 
Bioflavonoid apigenin induces phosphorylation of p53,6569858,3/10/2003 0:00,2/29/2008 0:00,Other Research-Related,2003,93255, ,NCI, , ,93255
Prognostic Molecular Markers of Colorectal Cancer,6570471,1/16/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2003,287359, ,NCI, , ,287359
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,6571586,9/30/1997 0:00,12/31/2002 0:00,Non-SBIR/STTR,2002,66709, ,NIDDK, , ,66709
NEW METHODS FOR CANCER DETECTION,6572677,3/1/1997 0:00,6/30/2006 0:00,Non-SBIR/STTR,2002,3453975, ,NCI, , ,3453975
Hepatitis HBx-Mediated Pathogenesis,6572895,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,301376, ,NCI, , ,301376
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION,6573096,5/1/1998 0:00,1/14/2003 0:00,Non-SBIR/STTR,2002,76975, ,NCI, , ,76975
Aldo-Keto Reductases and PAH Metabolism/Activation,6573157,3/1/1986 0:00,1/31/2008 0:00,Non-SBIR/STTR,2003,297980, ,NCI, , ,297980
Molecular Epidemiology of Secondary Lung Cancer,6573220,1/15/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2003,593059, ,NCI, , ,593059
Prognostic Markers in Trials for Head and Neck Cancer,6573288,6/1/2003 0:00,1/31/2004 0:00,Non-SBIR/STTR,2003,271343, ,NCI, , ,271343
"Hypoxia, Genetic Instability and DNA Mismatch Repair",6573292,9/30/1992 0:00,1/31/2008 0:00,Non-SBIR/STTR,2003,321862, ,NIEHS, , ,321862
Mutant p53 Gain of Function in Tumorigenesis,6573428,4/1/1995 0:00,1/31/2008 0:00,Non-SBIR/STTR,2003,317250, ,NCI, , ,317250
Phase II Doxorubicin/Vinorelbine in wtp53 Breast Cancer,6573502,2/5/2003 0:00,1/31/2006 0:00,Non-SBIR/STTR,2003,255060, ,NCI, , ,255060
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1,6574079,2/15/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2003,281572, ,NCI, , ,281572
Role of the Oxidative Stress Pathway in Drug Resistance,6574506,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2003,282625, ,NCI, , ,282625
The PLZF Protein of t(11;17)-Promyelocytic Leukemia,6574565,4/1/1993 0:00,1/31/2008 0:00,Non-SBIR/STTR,2003,403531, ,NCI, , ,403531
P53 and Organismal Aging,6574627,9/15/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2002,390650, ,NIA, , ,390650
MYB GENE AND HUMAN HEMATOPOIESIS,6574773,3/1/2002 0:00,2/28/2003 0:00,Non-SBIR/STTR,2002, ,348824, , , , 
NEW METHODS FOR CANCER DETECTION,6575080,3/1/1997 0:00,7/31/2002 0:00,Non-SBIR/STTR,2002,275197, ,NCI, , ,275197
DNA Repair and Checkpoint Interactions in Mammals,6575409,5/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2003,334106, ,NCI, , ,334106
Chemoprevention of Bladder Cancer by soybean,6575544,6/1/2003 0:00,5/31/2007 0:00,Non-SBIR/STTR,2003,302600, ,NCI, , ,302600
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS,6575593,8/1/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2001,197482, ,NIAID, , ,197482
CELLULAR TARGETS FOR PAPILLOMAVIRUS E6 ONCOPROTEINS,6575618,3/1/2002 0:00,2/28/2003 0:00,Non-SBIR/STTR,2002, ,228401, , , , 
"Checkpoints, DNA repair & human carcinogenesis",6577226,4/1/2002 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,175236, , , , 
Role of H. Pylori Infection in Esophageal Adenocarcinoma,6577365,9/30/2002 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,168500, ,NIDDK, , ,168500
Transgenic Mouse Model for Barrett's Esophagus,6577587,9/30/2002 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,158500, ,NIDDK, , ,158500
NQO1 in Protection Against Benzene Toxicicity,6577685,7/15/1998 0:00,11/30/2007 0:00,Non-SBIR/STTR,2003,303666, ,NIEHS, , ,303666
CORE--RADIOBIOLOGY AND ENVIRONMENTAL CARCINOGENESIS,6577751,4/1/2002 0:00,3/31/2003 0:00,Research Centers,2002, ,228547, , , , 
Epigenetic effects on susceptibility to heavy metal & PAH induced DNA damage,6577816,4/1/2002 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,164076, , , , 
Early Events in Colitis-Associated Colorectal Cancer,6578587,9/30/2002 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,85000, ,NCI, , ,85000
Genotoxic effects,6578787,4/1/2002 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,73465, , , , 
"A Novel Gene, WTH3,  and Multidrug Resistance",6579174,9/26/2003 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,214463, ,NCI, , ,214463
Genetic Control of Susceptibility to Testicular Cancer,6579283,6/1/1998 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,30600, ,NCI, , ,30600
TARGETING PCD FOR LEUKEMIA TREATMENT,6579399,4/1/2002 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002, ,115227, , , , 
TARGETING PCD IN BLADDER CANCER,6579400,4/1/2002 0:00,1/31/2003 0:00,Non-SBIR/STTR,2002, ,115227, , , , 
Molecular Epidemiology of Persistent HPV Infection,6579757,9/11/1996 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,270000, ,NCI, , ,270000
Differential Transcription Factor Activation by H. pylor,6579774,9/30/1997 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,252046, ,NIDDK, , ,252046
VIROLOGIC/GENETIC FACTORS OF HPV NEOPLASMS,6580338,4/1/2002 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,280718, , , , 
Sequence Distribution of Tobacco Carcinogen-DNA Adducts,6580998,12/1/2002 0:00,11/30/2006 0:00,Non-SBIR/STTR,2003,220094, ,NCI, , ,220094
Chromosomal Abnormalities in Myeloma as Detected by FISH,6581097,4/1/2000 0:00,2/29/2004 0:00,Non-SBIR/STTR,2003,327892, ,NCI, , ,327892
Role of AML1-ETO in Acute Leukemia,6581100,7/1/1994 0:00,2/28/2008 0:00,Non-SBIR/STTR,2003,319365, ,NCI, , ,319365
The Bcl-2/Bcl-X Pathway in Myc-Induced Lymphomagenesis,6581705,12/15/1997 0:00,12/31/2007 0:00,Non-SBIR/STTR,2003,282000, ,NCI, , ,282000
Molecular Pathobiology of Langerhans Cell Histiocytosis,6582410,4/15/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2003,360702, ,NIAID, , ,360702
Functional studies of the top 1-binding protein topors,6582748,5/1/1999 0:00,7/31/2007 0:00,Non-SBIR/STTR,2003,328883, ,NCI, , ,328883
Murine p73 in Tumorigenesis,6583651,6/15/1998 0:00,4/30/2008 0:00,Non-SBIR/STTR,2003,372508, ,NCI, , ,372508
MECHANISMS OF CELLULAR RADIOSENSITIVITY,6584603,5/1/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,294139, , , , 
Targeted Gene Knockouts of p14ARF and p16INK4a,6585054,9/1/2003 0:00,8/31/2006 0:00,"Training, Individual",2003,48148, ,NCI, , ,48148
INHIBITION OF RIBONUCLEOTIDE REDUCTASE IN GLIOMAS,6585400,7/10/2003 0:00,7/9/2006 0:00,"Training, Individual",2003,51904, ,NCI, , ,51904
Fast Mutation Detection by Tandem SSCP/HA on Microchips,6585482,9/12/2003 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,148500, ,NCI, , ,148500
 MECHANISM OF ACTION OF HERCEPTIN R IN BREAST CANCER,6585831,5/1/2000 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002,150500, ,NCI, , ,150500
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA,6585959,4/19/2002 0:00,2/28/2003 0:00,Non-SBIR/STTR,2002, ,230631, , , , 
MOLECULAR PATHOLOGY OF SYNOVIAL SARCOMA,6585965,4/19/2002 0:00,2/28/2003 0:00,Non-SBIR/STTR,2002, ,230631, , , , 
"Checkpoints, DNA repair & human carcinogenesis",6587630,4/1/2002 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,175236, , , , 
Tumor Suppressors in Spontaneous and UV-Induced Melanoma Models,6588435,5/1/2002 0:00,2/28/2003 0:00,Non-SBIR/STTR,2002, ,243335, , , , 
Mechanisms of Growth Inhibition by Helicobacter Pylori,6589502,9/30/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002,79426, ,NIDDK, , ,79426
CORE--MOLECULAR EPIDEMIOLOGY AND ECOGENETICS,6590000,4/1/2002 0:00,3/31/2003 0:00,Research Centers,2002, ,73467, , , , 
TUMOR SUPPRESSOR GENETICS OF MOUSE CHRMOSOME 11,6590264,5/1/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,145657, , , , 
Radiation sensitivity/Apoptosis Induction in Cancer Cells--P53 Restoration,6591270,5/7/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,279549, , , , 
Fas/FasL. Interactions in P53/ Radiation Induced Apoptosis,6591271,5/7/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,279549, , , , 
Strategies for Cell Death Manipulation in Cancer,6591272,5/7/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,279549, , , , 
MURINE P73 IN TUMORIGENESIS,6592070,6/15/1998 0:00,7/31/2002 0:00,Non-SBIR/STTR,2002,38823, ,NCI, , ,38823
CORE--MICROARRAY,6592161,2/1/2002 0:00,4/30/2002 0:00,Research Centers,2002, ,183723, , , , 
DETACHMENT SENSITIZES CELLS TO TOPOISOMERASE INHIBITORS,6593350,9/30/1997 0:00,9/30/2003 0:00,Other Research-Related,2001,72003, ,NCI, , ,72003
ROLE OF SAMe IN LIVER FUNCTION AND INJURY,6594157,9/20/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2002,367959, ,NCCIH, , ,367959
P53 function and apoptosis in melanoma,6594578,5/1/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,312755, , , , 
FUNCTION OF INK4A/ARF IN PEDIATRIC NEOPLASIA,6595011,6/1/2002 0:00,5/31/2003 0:00,Non-SBIR/STTR,2002, ,241412, , , , 
Novel Agents Targeted To p53-Mdm2 Pathways,6595796,6/1/2003 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,143000, ,NCI, , ,143000
RESTORATION OF APOPTOSIS IN CANCER,6597285,7/23/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2002,43500, ,NCI, , ,43500
SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY,6597302,5/1/1991 0:00,11/30/2004 0:00,Non-SBIR/STTR,2002,444098, ,NCI, , ,444098
PROSPECTIVE STUDY OF DIET AND COLORECTAL NEOPLASIA,6597572,4/1/2002 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,279549, , , , 
Molecular Epidemiology of Fatal Prostate Cancer,6597792,4/30/2003 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,511516, ,NCI, , ,511516
MOLECULAR MECHANISM OF CHEMOPREVENTION BY APIGENIN,6597834,5/1/1996 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,23001, ,NCI, , ,23001
The Apoptotic Role of MEKK1 in Cancer Chemotherapy,6597850,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2003,271450, ,NCI, , ,271450
Radiation sensitivity/Apoptosis Induction in Cancer Cells--P53 Restoration,6598172,5/7/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,279549, , , , 
Fas/FasL. Interactions in P53/ Radiation Induced Apoptosis,6598173,5/7/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,279549, , , , 
Strategies for Cell Death Manipulation in Cancer,6598174,5/7/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,279549, , , , 
RhoB Signaling in Cancer Suppression and Cell Suicide,6598431,5/15/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2003,328370, ,NCI, , ,328370
MALDI TOF TECHNOLOGY FOR MOLECULAR ANALYSIS OF CANCER,6598810,5/1/2001 0:00,6/30/2004 0:00,Non-SBIR/STTR,2002,311409, ,NCI, , ,311409
INDUCTION OF APOPTOSIS IN BREAST CANCER,6598847,6/1/2001 0:00,11/30/2002 0:00,Non-SBIR/STTR,2002, ,256220, , , , 
Replication checkpoint and genomic fidelity in skin,6599154,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,362918, ,NIAMS, , ,362918
Timing of Rectal Cancer Response to Chemoradiation,6599213,9/16/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,652862, ,NCI, , ,652862
CORE--MICROARRAY,6599278,6/11/2002 0:00,4/30/2003 0:00,Research Centers,2002, ,183723, , , , 
THERAPEUTIC MODULATION OF ANGIOGENESIS IN HUMAN GLIOMAS,6599531,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,57631, ,NCI, , ,57631
Regulation and Role of ODC in Apoptosis and Cancer,6599592,3/4/2003 0:00,2/29/2008 0:00,Non-SBIR/STTR,2003,331183, ,NCI, , ,331183
Regulation of MDM2 by the ribosomal protein L11,6599724,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2003,335975, ,NCI, , ,335975
Molecular Pathogenesis of Breast Cancer,6599951,4/18/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2003,2505821, ,NCI, , ,2505821
Gene Networks for Prostate Cancer Progression,6600230,8/5/2003 0:00,7/31/2006 0:00,Other Research-Related,2003,159300, ,NCI, , ,159300
p53 in Cellular Response to ROS-Mediated DNA Damage,6600252,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2003,302378, ,NCI, , ,302378
HAUSP-mediated Deubiquitination of p53,6600681,4/1/2003 0:00,3/30/2008 0:00,Non-SBIR/STTR,2003,281240, ,NCI, , ,281240
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER,6602544,9/30/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,4137, ,NIDCR, , ,4137
Molecular Characterization of p53R2 in Cancer,6602739,5/1/2003 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,187500, ,NCI, , ,187500
IL10 and IGF1 Receptor Axis in Prostate Cancer,6603132,6/5/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,281993, ,NCI, , ,281993
"OXIDATIVE STRESS, APOPTOSIS AND DRUG RESISTANCE",6603352,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,201150, ,NCI, , ,201150
"ATM, P53, GADD45 AND P21 EFFECTS ON RECOMBINATION",6603407,6/1/1999 0:00,5/31/2005 0:00,Non-SBIR/STTR,2003,276240, ,NIEHS, , ,276240
P53 in BBD and Breast Cancer Risk: A Multicenter Cohort,6603422,5/1/2002 0:00,4/30/2007 0:00,Non-SBIR/STTR,2003,757685, ,NCI, , ,757685
Xenobiotics and Breast Epithelial Cell-ECM Signaling,6603464,5/3/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,260750, ,NIEHS, , ,260750
THE ROLE OF A NOVEL GAP IN EPITHELIAL ONCOGENESIS,6603476,9/8/1999 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,250765, ,NCI, , ,250765
PIK RELATED KINASES IN THE RESPONSE TO DNA DAMAGE BY UV,6603862,6/1/1999 0:00,5/31/2004 0:00,Other Research-Related,2003,122282, ,NIAMS, , ,122282
Leukotriene Biosynthesis: Inflammation and Cancer,6603863,8/1/1988 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,262500, ,NIAID, , ,262500
Interaction Between SV40 Large T and p185 Cullin,6603874,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,366834, ,NCI, , ,366834
"HPV, Genetic Instability & Oral Cancer",6604192,8/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,240188, ,NIDCR, , ,240188
Models for DNA repair and cell cycle control variants,6604692,4/10/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,848287, ,NIEHS, , ,848287
SUPPRESSION OF B-LYMPHOMAS VIA INDUCTION OF INTERFERONS,6604916,7/1/2002 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,237750, ,NCI, , ,237750
RECOMBINATION MECHANISMS IN ADENOVIRUS TRANSFECTION,6604928,5/1/1982 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,339194, ,NIGMS, , ,339194
Specificity of Ubiquitination: the HPVE6/E6AP Paradigm,6605882,12/13/1996 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,280120, ,NCI, , ,280120
THE ROLE OF P40 IN SQUAMOUS CELL CARCINOMA,6606168,9/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,277951, ,NIDCR, , ,277951
BIOLOGICAL ACTIVITY OF HPV E7 IN HUMAN EPITHELIAL CELLS,6606231,4/19/1996 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,394550, ,NCI, , ,394550
Stat3 and anti-VEGF therapy in cancer,6606289,2/21/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2003,286432, ,NCI, , ,286432
Etiology and Prevention of Oral Cancer,6606404,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2003,320222, ,NCI, , ,320222
Biology of Breast Cancers Arising in Older Women,6606452,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2003,562420, ,NIA, , ,562420
PLK3 in the DNA damage checkpoint and tumor suppression,6606593,12/15/1997 0:00,3/31/2008 0:00,Non-SBIR/STTR,2003,323960, ,NCI, , ,323960
TAILORING ANTICANCER THERAPY TO LOSS OF P53,6606928,6/15/1996 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,291070, ,NCI, , ,291070
Modes of Prostate Ca Progression--role of p53 Pathway,6606966,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,240345, ,NCI, , ,240345
Strategies to Enhance Adenoviral Mediated Tumor Killing,6607161,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,314185, ,NCI, , ,314185
METABOLIC GENOTYPES & ONCOGENIC DAMAGE IN BREAST CANCER,6607182,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,291600, ,NCI, , ,291600
Effects of DNA Damaging Agents on G2 Phase Checkpoint,6607254,7/11/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,249375, ,NCI, , ,249375
HPV INTEGRATION AS A BIOMARKER FOR CIN BEHAVIOR,6607280,7/3/2002 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,74500, ,NCI, , ,74500
Mrad9 Radioresistance Gene,6607412,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,308410, ,NCI, , ,308410
DRUG METABOLIZING ENZYMES-RISK FACTORS IN BLADDER CANCER,6607421,7/1/1994 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,395999, ,NCI, , ,395999
Deregulation of Cell Pathways by Ad E1B 55K Oncoproteins,6607457,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,270788, ,NCI, , ,270788
Transcriptional Control of Gastrin,6607516,9/1/1993 0:00,7/31/2006 0:00,Non-SBIR/STTR,2003,408966, ,NIDDK, , ,408966
Function of the Adenovirus E1B Oncogene,6607547,1/1/1991 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,303640, ,NCI, , ,303640
ROLE OF BRCA1 IN NORMAL CELL GROWTH AND TUMORGENESIS,6607597,9/1/1999 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,215802, ,NCI, , ,215802
DNA Damage Checkpoints,6607622,8/10/1998 0:00,7/31/2006 0:00,Non-SBIR/STTR,2003,281530, ,NCI, , ,281530
Chemoresistance in Renal Cell Cancer,6607671,7/8/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,328188, ,NCI, , ,328188
Genetic and Molecular Epidemiology of Adult Glioma,6607700,5/15/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,1421404, ,NCI, , ,1421404
GENETIC ELEMENTS TRANSFORMING MOUSE FIBROBLASTS,6607725,1/3/1994 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,266400, ,NCI, , ,266400
The XP Variant:  A Human Mutator Gene for UV Damage,6608083,2/1/1998 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,331875, ,NIEHS, , ,331875
Cyclin/cdk Regulation of P53 in Prostate Cancer,6608854,7/1/2001 0:00,6/30/2006 0:00,Other Research-Related,2003,95746, ,NCI, , ,95746
Thioredoxin Inhibition of Apoptosis and Cancer Treatment,6609608,12/18/1998 0:00,1/31/2008 0:00,Non-SBIR/STTR,2003,284820, ,NCI, , ,284820
Nitroaromatics and Breast Cancer,6610819,6/1/2002 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,113981, ,NCI, , ,113981
BIOLOGY OF ONCOGENES AND TUMOR SUPPRESSOR GENES,6611046,5/1/1986 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,1594788, ,NCI, , ,1594788
Oncogenes and loss of ER in a new p53 breast tumor model,6611395,5/10/1989 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,303000, ,NCI, , ,303000
The Role of RR in Chemotherapeutic Drug Resistance,6611435,4/1/1997 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,249375, ,NCI, , ,249375
Gene Expression Profiles in Human Liver Cancers,6611754,9/11/2003 0:00,8/31/2008 0:00,Other Research-Related,2003,127170, ,NCI, , ,127170
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors,6611824,8/5/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2003,235376, ,NCI, , ,235376
"Characterization of Fortilin, A Novel Anti-p53 Protein",6612582,9/30/2001 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,224250, ,NHLBI, , ,224250
"Heterogeneity of Human Melanoma, Cytokines and iNOS",6612606,7/12/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,267000, ,NCI, , ,267000
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS,6612648,7/12/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,1004570, ,NCI, , ,1004570
MOLECULAR MECHANISM OF CHEMOPREVENTION BY APIGENIN,6612694,5/1/1996 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,219488, ,NCI, , ,219488
MECHANISMS OF ARSENIC CARCINOGENESIS,6612725,7/12/2002 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,363430, ,NIEHS, , ,363430
Correlative Studies of erbB-2/HER2 and p53 in CALGB Pro.,6613178,5/1/2003 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,482857, ,NCI, , ,482857
CLINICAL AND EPIDEMIOLOGIC CENTER FOR BIOMARKERS OF UPPE,6613429,5/1/2000 0:00,2/28/2005 0:00,Other,2003,1036455, ,NCI, , ,1036455
MCAV in Organ-Confined Bladder CA based on p53 Status,6613578,5/1/1997 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,551197, ,NCI, , ,551197
SELECTIVE THERAPY FOR COLON CARCINOMA,6613590,7/1/1983 0:00,3/31/2008 0:00,Non-SBIR/STTR,2003,317250, ,NCI, , ,317250
Mitotic Checkpoint Proteins in Tumorigenesis,6613745,7/18/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,378028, ,NCI, , ,378028
PI 3K PATHWAY IN BCR/ABL INDUCED LEUKEMIAS,6613757,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,283950, ,NCI, , ,283950
Transduction of Tumor Suppressor Proteins into Gliomas,6613762,9/5/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2003,248886, ,NCI, , ,248886
Structure-function analysis of HPV E6 proteins,6613791,8/1/2002 0:00, ,"Training, Individual",2003,46420, ,NCI, , ,46420
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA,6613828,9/1/1992 0:00,7/31/2006 0:00,Non-SBIR/STTR,2003,66709, ,NCI, , ,66709
Analysis of Chk2 dependent DNA damage signaling pathway,6613886,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,222233, ,NCI, , ,222233
Modeling the effects of INK4 alpha ARF loss on gliomas,6615139,8/1/2001 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,256725, ,NCI, , ,256725
MOLECULAR BEACONS FOR PROTEIN DETECTION,6615517,8/1/2002 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,147000, ,NCI, , ,147000
STRESS INDUCED BYSTANDER EFFECT IN CANCER TREATMENT,6615549,6/9/2000 0:00,4/30/2004 0:00,Non-SBIR/STTR,2003,266400, ,NCI, , ,266400
INDUCTION OF FAS AND FAS LIGAND EXPRESSION IN T CELLS,6615808,8/1/1999 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,246441, ,NIAID, , ,246441
Role of survivin in nonmelanoma skin cancer,6616054,9/1/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,75000, ,NIAMS, , ,75000
KILLER/DR5 APOPTOSIS IN DNA DAMAGE SENSITIVE CELLS,6616899,7/22/2002 0:00,5/31/2003 0:00,Non-SBIR/STTR,2002, ,140673, , , , 
DNA Adducts of Aromatic Amines: Analysis by HPLC-MS,6617061,5/18/1996 0:00,2/28/2007 0:00,Non-SBIR/STTR,2003,236750, ,NCI, , ,236750
Normal and Neoplastic Growth Regulation in the Brain,6617404,4/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2003,1354332, ,NCI, , ,1354332
Involvement of APC in DNA Repair,6617515,5/16/2003 0:00,4/30/2007 0:00,Non-SBIR/STTR,2003,258100, ,NCI, , ,258100
MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS,6617849,8/4/2000 0:00,7/31/2005 0:00,Other Research-Related,2003,126711, ,NCI, , ,126711
Differential Gene Expression Induced by Antioxidants,6618480,4/1/2003 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,75500, ,NCI, , ,75500
Chemo-prevention of UVB-induced Basal Cell Carcinomas,6618488,5/1/2003 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,81750, ,NCI, , ,81750
Chemoprevention of Oral Cancer with BBIC,6618829,3/14/1997 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,736992, ,NCI, , ,736992
MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER,6619089,9/18/2000 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,22800, ,NCI, , ,22800
Diverse Natural Products That Stabilize Microtubules,6619166,7/6/1999 0:00,4/30/2007 0:00,Non-SBIR/STTR,2003,370690, ,NCI, , ,370690
Genomic Plasticity in the Human U2 snRNA Gene Cluster,6619192,4/1/1989 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,333520, ,NIGMS, , ,333520
ROLES AND REGULATION OF P53,6619480,9/30/2000 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,1766652, ,NCI, , ,1766652
Papillomavirus Inhibitors for AIDS-related Malignancies,6619504,7/29/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,279388, ,NCI, , ,279388
GENETIC ALTERATIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARK,6619569,9/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,378970, ,NIDCR, , ,378970
PREDICTING RESPONSE TO THERAPY: DETECTION OF ORAL CANCER,6619571,9/30/1999 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,391443, ,NIDCR, , ,391443
CELL CYCLE CONTROL OF PROTEOLYSIS BY F-BOX PROTEINS,6619650,8/1/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2003,346077, ,NIGMS, , ,346077
"KS1, A NOVEL SUPPRESSOR OF NEOPLASTIC TRANSFORMATION",6619708,9/15/2000 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,182019, ,NIDDK, , ,182019
"Gastric Cancer Prognosis--MSI, BAX, DCC, & p53 LOH",6619822,8/6/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2003,298339, ,NCI, , ,298339
Mechanistic Studies on New Platinum Clinical Agents,6619888,9/30/1998 0:00,7/31/2007 0:00,Non-SBIR/STTR,2003,306250, ,NCI, , ,306250
Growth Inhibition by the ARF Tumor Suppressor,6620008,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,261484, ,NCI, , ,261484
PRE-CLINICAL COMBINATION CHEMO- AND RADIOANTIBODY THERAP,6620132,5/6/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,922425, ,NCI, , ,922425
"TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER",6620134,4/20/2000 0:00,11/30/2005 0:00,Other Research-Related,2003,132857, ,NCI, , ,132857
Determinants of Breast Cancer Survival,6620206,6/1/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2003,733517, ,NCI, , ,733517
Repair of Genotoxic Damage in Chromatin,6620308,1/1/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2003,317619, ,NCI, , ,317619
Mechanisms of the Hormonal Prevention of Breast Cancer,6620427,8/1/1995 0:00,4/30/2007 0:00,Non-SBIR/STTR,2003,1030606, ,NCI, , ,1030606
Regulation and Function of ECK in Apoptosis,6620499,1/18/2002 0:00,12/31/2005 0:00,Non-SBIR/STTR,2003,286509, ,NCI, , ,286509
dUTPase As A Prognostic Marker in Colon Cancer,6620544,4/1/2002 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,138875, ,NCI, , ,138875
The BRCA1-GADD45 Pathway and Genomic Stability,6620610,3/1/2002 0:00,2/28/2006 0:00,Non-SBIR/STTR,2003,253334, ,NCI, , ,253334
Characterization of the p53 Apoptotic Target Gene PERP,6620628,1/1/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2003,287605, ,NCI, , ,287605
Study of a FACTp140-SSRP1-associated p53 Kinase,6620642,1/10/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2003,287013, ,NCI, , ,287013
Role of the p53 homolog p73 in cancer,6620858,1/14/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2003,301376, ,NCI, , ,301376
Structure/Function of Human Papillomavirus Oncoproteins,6620885,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,372503, ,NCI, , ,372503
Stabilization of MDM2 by mutant p53,6621050,7/1/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,241063, ,NCI, , ,241063
Mechanism of Apoptosis by Par4,6621255,9/30/1995 0:00,12/31/2006 0:00,Non-SBIR/STTR,2003,296840, ,NCI, , ,296840
Mechanisms of Induction of Skin Cancers By UV Light,6621337,7/1/1988 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,213750, ,NCI, , ,213750
Role of 53BP1 during the DNA damage response,6621653,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,260239, ,NIGMS, , ,260239
Regulation of p21 induction by butyrate in colonic cells,6622130,4/1/2002 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,75200, ,NCI, , ,75200
Transcription Factor P53 in Terminal Nephron Different,6622337,7/1/2002 0:00, ,"Training, Individual",2003,53944, ,NIDDK, , ,53944
Validation of Biomarkers in Humans Exposed to PAHs,6622510,1/1/2002 0:00,12/31/2004 0:00,Non-SBIR/STTR,2003,235625, ,NIOSH, , ,235625
Human Neurotropic JC Virus and CNS Diseases,6622576,3/4/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2003,299131, ,NCI, , ,299131
P53 Biomaker and Intervention in Occupational Cancer,6622617,6/1/2002 0:00,5/31/2005 0:00,Non-SBIR/STTR,2003,204375, ,NIOSH, , ,204375
Melanoma in p16INK4a and p19ARF Deficient Mice,6622625,2/15/2002 0:00,11/30/2006 0:00,Other Research-Related,2002,31013, ,NCI, , ,31013
Contributions of Akt to Glioblastoma Formation,6622841,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,336532, ,NCI, , ,336532
Unique BRCA1 transcriptional response leading to repair,6622853,4/22/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,317396, ,NCI, , ,317396
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER,6622903,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,358225, ,NCI, , ,358225
"Metallothionein, Environment Insult and Bladder Cancer",6622958,4/1/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,134781, ,NCI, , ,134781
The Interplay Between the Repressor MDM2 and Coactivator,6622983,3/1/2002 0:00,2/28/2006 0:00,Non-SBIR/STTR,2003,268780, ,NCI, , ,268780
Cyclin Kinase Inhibitors as Molecular Targets for Cancer,6623163,4/1/2002 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,148500, ,NCI, , ,148500
The role of Inil in chromatin  development and cancer,6623286,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,353775, ,NCI, , ,353775
Function & Purification of the Fanconi Anemia Protein C*,6623345,7/1/2002 0:00,5/31/2007 0:00,Other Research-Related,2003,100845, ,NHLBI, , ,100845
Mechanistic Analyses of Protein Deacetylation,6623442,3/1/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2003,259943, ,NIGMS, , ,259943
Molecular Alterations in Lobular/Ductal Breast Cancer,6623448,4/1/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,373149, ,NCI, , ,373149
Development of Assays for DNA Damage Checkpoints,6623461,4/1/2002 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,156504, ,NCI, , ,156504
Heat Shock Protein Function for Drug Discovery,6623536,5/1/2002 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,151500, ,NCI, , ,151500
"P27Kipl deficiency, potential promoter of carcinogenesis",6623657,4/1/2002 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,77935, ,NCI, , ,77935
Function of MDM2 and its Alternatively spliced Isoforms,6623679,3/5/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2003,250818, ,NCI, , ,250818
Polyoma Virus Disrupts ARF Signaling to p53,6623705,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,302878, ,NCI, , ,302878
A mouse model for UV-induced junctional melanoma,6623970,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,338200, ,NCI, , ,338200
MOLECULAR MECHANISMS OF DIET-INDUCED CARCINOGENESIS,6624133,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,295369, ,NCI, , ,295369
TGFBeta1 signaling and radiation response in pancreas CA,6624206,3/1/2002 0:00,2/28/2005 0:00,Non-SBIR/STTR,2003,228936, ,NCI, , ,228936
Methylation and Oxidation in Breast Cancer Epidemiology,6624242,6/1/2002 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,615129, ,NCI, , ,615129
"p53-independent Role of MDM2, TGFb Resistance and Cancer",6624266,3/1/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2003,329656, ,NCI, , ,329656
Investigation of xrcc5 Mutant Mice,6624273,7/7/1997 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,259880, ,NCI, , ,259880
Molecular Markers as Predictors of Outcome in Gliomas,6624331,9/1/1998 0:00,2/28/2006 0:00,Non-SBIR/STTR,2003,332418, ,NINDS, , ,332418
Regulation of Astrocytoma Growth,6624388,4/15/2002 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,252035, ,NINDS, , ,252035
MECHANISMS REGULATING REVERSAL OF PREMALIGNANCY,6624671,12/15/2000 0:00,11/30/2005 0:00,Non-SBIR/STTR,2003,209520, ,NCI, , ,209520
CANCER-RELATED GLYCOLYTIC GENE--REGULATION/TARGETING,6624686,12/11/1998 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,251278, ,NCI, , ,251278
ADENOVIRUS BASED P53 GENE THERAPY FOR OVARIAN CANCER,6624687,12/8/1998 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,117966, ,NCI, , ,117966
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE,6624712,12/29/1994 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,461543, ,NCI, , ,461543
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION,6624715,7/4/1995 0:00,11/30/2005 0:00,Non-SBIR/STTR,2003,341704, ,NCI, , ,341704
DEFECTIVE DNA MISMATCH REPAIR IN ENDOMETRIAL CANCERS,6624728,5/1/1997 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,308000, ,NCI, , ,308000
G2 CHECKPOINT CONTROL IN TRANSFORMED HUMAN CELLS,6624731,12/1/1998 0:00,4/7/2004 0:00,Non-SBIR/STTR,2003,293849, ,NCI, , ,293849
INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN D,6624734,12/24/1998 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,246551, ,NCI, , ,246551
THE MOLECULAR BIOLOGY OF RETINOBLASTOMA,6624940,2/1/1999 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,324000, ,NEI, , ,324000
Analysis of Group I and II Introns in Mammalian Cells,6625660,9/30/1995 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,319100, ,NIGMS, , ,319100
Function of the p53 tumor-suppressor in C.elegans,6625758,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,320573, ,NCI, , ,320573
Ceramide Synthase in Radiation-Induced Apoptosis,6625822,7/15/1990 0:00,3/31/2007 0:00,Non-SBIR/STTR,2003,396250, ,NCI, , ,396250
Genetic Alterations of p53r2 and Colorectal Adenoma,6625879,4/1/2002 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,72688, ,NCI, , ,72688
Apoptosis in Drosophila-From Reaper to Death,6625951,5/1/1997 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,354650, ,NIGMS, , ,354650
Dysregulation of TGF Beta Action Pancreatic Cancer,6625993,9/30/1997 0:00,9/30/2003 0:00,Non-SBIR/STTR,2003,119689, ,NCI, , ,119689
GROWTH CONTROL AND CYTOGENETICS OF MALIGNANT GLIOMAS,6626569,1/1/1987 0:00,12/31/2003 0:00,Non-SBIR/STTR,2003,347675, ,NCI, , ,347675
SIGNALING PATHWAYS UTILIZED BY V-ABL AND BCR-ABL,6626593,1/20/1999 0:00,12/31/2004 0:00,Non-SBIR/STTR,2003,771475, ,NCI, , ,771475
CHEMOPREVENTION FOR WOMEN AT HIGH RISK OF BREAST CANCER,6626597,9/30/1997 0:00,6/30/2005 0:00,Other,2003,470369, ,NCI, , ,470369
PROPERTIES AND REGULATION OF P53 IN TUMOR CELLS,6626607,3/23/1999 0:00,7/1/2004 0:00,Non-SBIR/STTR,2003,297890, ,NCI, , ,297890
DUAL ROLE OF E2F1 IN TUMORIGENESIS,6626617,1/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2003,271445, ,NCI, , ,271445
ONCOLYTIC ADENOVIRUSES--CERVICAL CANCER GENE THERAPY,6626632,3/18/1999 0:00,12/31/2004 0:00,Non-SBIR/STTR,2003,232461, ,NCI, , ,232461
TARGETING ONCOGENE EXPRESSION TO SKIN IN TRANSGENIC MICE,6626638,8/1/1990 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,470125, ,NCI, , ,470125
ADDUCT INDUCED FRAMESHIFT MUTAGENESIS,6626645,2/15/1992 0:00,12/31/2003 0:00,Non-SBIR/STTR,2003,238020, ,NCI, , ,238020
P53 SIGNALING AND CELLULAR RESPONSE AFTER STRESS,6626660,1/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2003,322459, ,NCI, , ,322459
Apoptosis in Colon Cancer Chemoprevention,6626669,7/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2003,1328371, ,NCI, , ,1328371
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN,6626676,9/30/1992 0:00,12/31/2005 0:00,Non-SBIR/STTR,2003,269880, ,NCI, , ,269880
P53 AND DNA PLOIDY IN BARRETT'S METAPLASIA,6626705,1/9/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2003,244302, ,NCI, , ,244302
AT: ERRORS IN DOUBLE STRAND BREAK REPAIR,6626706,1/26/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2003,231976, ,NCI, , ,231976
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS,6626727,2/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2003,209107, ,NCI, , ,209107
MECHANISMS OF INTESTINAL TUMORIGENESIS,6626732,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2003,358831, ,NCI, , ,358831
P53 AND MOUSE MAMMARY TUMORIGENESIS,6626737,1/1/2000 0:00,12/31/2004 0:00,Non-SBIR/STTR,2003,366676, ,NCI, , ,366676
MOUSE MODEL FOR OXIDATIVE DNA DAMAGE REPAIR,6626764,1/30/2001 0:00,12/31/2004 0:00,Non-SBIR/STTR,2003,305000, ,NCI, , ,305000
GENETIC PATHWAY TO IGH TRANSLOCATIONS IN LYMPHOMA,6626770,1/1/2000 0:00,12/31/2003 0:00,Non-SBIR/STTR,2003,294210, ,NCI, , ,294210
"P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?",6626792,1/20/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2003,351731, ,NCI, , ,351731
IR-INDUCED APOPTOSIS IN THE DEVELOPING NERVOUS SYSTEM,6627692,1/15/2001 0:00,12/31/2004 0:00,Non-SBIR/STTR,2003,262500, ,NINDS, , ,262500
MOLECULAR REGULATION OF FOLATE AND ANTIFOLATE TRANSPORT,6628043,2/12/1993 0:00,4/30/2004 0:00,Non-SBIR/STTR,2003,250239, ,NCI, , ,250239
VIRAL GENE FUNCTIONS AND REGULATION OF CELL GROWTH,6628056,9/1/1975 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,420034, ,NCI, , ,420034
"C-, N-, AND L-MYC EFFECTS ON HEMATOPOIETIC CELLS",6628149,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2003,221014, ,NCI, , ,221014
P53 - REGULATORS AND EFFECTORS,6628174,2/16/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,1272839, ,NCI, , ,1272839
TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS,6628184,4/1/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,266361, ,NCI, , ,266361
STRUCTURAL FEATURES OF PAPILLOMAVIRUS E6 ONCOPROTEINS,6628187,2/1/2000 0:00,10/31/2003 0:00,Non-SBIR/STTR,2003,287816, ,NCI, , ,287816
EXPERIMENTAL TRANSFORMATION OF HUMAN MELANOCYTES IN VIVO,6628189,4/1/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,384401, ,NCI, , ,384401
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7,6628191,2/15/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,263958, ,NCI, , ,263958
INTRAGENIC SUPPRESSOR MUTATIONS FOR P53 CANCER MUTATIONS,6628200,4/1/1999 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,263815, ,NCI, , ,263815
C MYC--TRANSCRIPTION AND APOPTOSIS,6628259,1/1/1990 0:00,1/31/2004 0:00,Non-SBIR/STTR,2003,388896, ,NCI, , ,388896
MONOCLONAL GAMMOPATHIES,6628279,9/30/1994 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,1428411, ,NCI, , ,1428411
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN GLIOMAS,6628282,8/1/1992 0:00,1/31/2004 0:00,Non-SBIR/STTR,2003,292637, ,NCI, , ,292637
ROLE OF GRP78 IN ALKYLATING AGENT SENSITIVITY,6628301,1/1/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,2003,206550, ,NCI, , ,206550
UV INDUCIBLE INHIBITION IN MELANOMA,6628302,5/5/1993 0:00,1/31/2006 0:00,Non-SBIR/STTR,2003,332978, ,NCI, , ,332978
INK4 FAMILY OF CDK INHIBITORS,6628307,7/17/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,2003,300211, ,NCI, , ,300211
GENETIC MECHANISM OF BRCA LINKED OVARIAN TUMORIGENESIS,6628320,2/1/2001 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,281385, ,NCI, , ,281385
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION,6628428,2/9/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,385337, ,NCI, , ,385337
DISSECTION OF THE DNA DAMAGE CHECKPOINT PATHWAYS,6628438,2/1/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,282317, ,NCI, , ,282317
GENISTEIN IN INVESTIGATIVE AND CLINICAL DERMATOLOGY,6628448,2/3/2001 0:00,1/31/2006 0:00,Non-SBIR/STTR,2003,286455, ,NCI, , ,286455
THERAPEUTIC VACCINES FOR HPV DISEASES,6628453,2/14/2001 0:00,1/31/2006 0:00,Other Research-Related,2003,136728, ,NCI, , ,136728
ARSENIC TRIOXIDE TREATMENT OF LYMPHOPROLIFERATIVE DISORD,6628458,2/1/2001 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,322262, ,NCI, , ,322262
E2F AND APOPTOSIS,6628465,2/5/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,287040, ,NCI, , ,287040
REGULATION OF P53 SUBCELLULAR DISTRIBUTION BY MDM2/ARF,6628484,2/15/2000 0:00,7/31/2004 0:00,Non-SBIR/STTR,2003,209806, ,NCI, , ,209806
TUMOR SUPPRESSOR LIKE ACTIVITY OF ESTROGEN RECEPTOR,6628507,2/1/2001 0:00,1/31/2005 0:00,Non-SBIR/STTR,2003,283850, ,NCI, , ,283850
2002 Gordon Research Conference on Cell Death,6629432,5/1/2002 0:00,4/30/2007 0:00,Other Research-Related,2004,10000, ,NCI, , ,5000
Structural basis for CBP/p300 transcriptional regulation,6629461,6/10/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2003,412070, ,NCI, , ,412070
MECHANISMS OF REPLICATIVE SENESCENCE IN CELLS,6629828,4/1/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,321077, ,NIA, , ,321077
ALTERATIONS OF CELL CYCLE CONTROL IN MELANOCYTIC LESIONS,6630367,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,2003,126090, ,NIAMS, , ,126090
DETERMINANTS OF HEPATITIS C & E MORBIDITY IN EGYPT,6630390,9/15/2000 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,502136, ,NICHD, , ,502136
DDR1 in p53-mediated suppression and in breast cancer,6630740,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,302600, ,NCI, , ,302600
Diagnostic Therapeutic Targets in Prostate Cancer,6630983,6/12/2003 0:00,5/31/2004 0:00,Non-SBIR/STTR,2003,331525, ,NCI, , ,331525
Actin-regulated Apoptosis in Mammary Tumorigenesis,6631045,8/1/2003 0:00,7/31/2004 0:00,Other Research-Related,2003,128730, ,NCI, , ,128730
Mechanisms of Radioresistance and Cell Cycle Progression,6631179,5/1/1995 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,358391, ,NIGMS, , ,358391
HCMV IN AIDS--DISRUPTION OF CELL CYCLE REGULATION,6632291,3/1/2000 0:00,2/28/2005 0:00,Non-SBIR/STTR,2003,251872, ,NIAID, , ,251872
Prevention of Skin Cancer by Scutellaria Baicalensis,6632693,9/18/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,269866, ,NCCIH, , ,269866
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS,6632879,9/30/1986 0:00,5/31/2004 0:00,Non-SBIR/STTR,2003,435948, ,NCI, , ,435948
Nitroaromatics and Breast Cancer,6632921,7/1/1983 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,295970, ,NCI, , ,295970
"PATHOGENESIS, IMMUNODIAGNOSIS AND THERAPY OF HCC",6632922,7/1/1983 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,318000, ,NCI, , ,318000
Antineoplastic Agents from Marine Organisms,6632925,9/1/1983 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,280125, ,NCI, , ,280125
POLYAMINE ANALOG AND INHIBITOR REGULATION OF CELL CYCLE,6632965,8/1/1989 0:00,4/30/2004 0:00,Non-SBIR/STTR,2003,311831, ,NCI, , ,311831
SOFT TISSUE SARCOMA PROGRAM PROJECT,6633001,1/9/1989 0:00,2/28/2005 0:00,Non-SBIR/STTR,2003,1764115, ,NCI, , ,1764115
Progression/Oncogene Induced Prostate Cancer,6633021,9/8/1989 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,312288, ,NCI, , ,312288
Function of ATF2 URE binding protein in human melanoma,6633029,1/1/1991 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,351713, ,NCI, , ,351713
PROTEIN PHOSPHATASE 1 AND NEOPLASTIC TRNSFORMATION,6633048,9/1/1993 0:00,2/28/2005 0:00,Non-SBIR/STTR,2003,256334, ,NCI, , ,256334
EUKARYOTIC DNA ALKYLATION REPAIR,6633053,7/2/1991 0:00,2/28/2005 0:00,Non-SBIR/STTR,2003,499557, ,NCI, , ,499557
Prospective Studies of Diet and Cancer in Men and Wonen,6633055,8/23/1991 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,3852407, ,NCI, , ,3852407
STRUCTURE FUNCTION RELATIONSHIP OF TUMOR SUPRESSORS,6633099,3/1/1996 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,265500, ,NCI, , ,265500
Molecular Genetics of HNPCC,6633111,6/1/1997 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,439698, ,NCI, , ,439698
MDMX REGULATION OF THE P53 TUMOR SUPPRESSOR PROTEIN,6633114,4/1/1995 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,225225, ,NCI, , ,225225
SOFT TISSUE SARCOMA--P53 AND VEGF INDUCTION,6633145,9/30/1995 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,236250, ,NCI, , ,236250
GENETIC EPIDEMIOLOGY OF LUNG CANCER,6633176,12/15/1994 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,653221, ,NCI, , ,653221
Mechanisms of Genetic Instability and Tumor Suppression,6633181,7/1/1993 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,575795, ,NCI, , ,575795
Tobacco Carcinogenesis and Chemoprevention,6633193,6/17/1996 0:00,2/28/2006 0:00,Non-SBIR/STTR,2003,1419959, ,NCI, , ,1419959
TRANSLATIONAL CONTROL OF ONCOPROTEIN MDM2 SYNTHESIS,6633196,7/1/1999 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,241026, ,NCI, , ,241026
MULTISTEP LYMPHOMAGENESIS,6633202,5/1/1997 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,216701, ,NCI, , ,216701
Childhood Cancer Gene Program Project Grant,6633205,8/1/1996 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,1813364, ,NCI, , ,1813364
Topoisomerase I Inhibitors in Leukemia and Solid Tumors,6633226,4/1/1997 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,222233, ,NCI, , ,222233
Genetic Control of Susceptibility to Testicular Cancer,6633237,6/1/1998 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,460873, ,NCI, , ,460873
GENETIC DETERMINANTS OF TUMORIGENESIS,6633238,5/1/1999 0:00,2/28/2006 0:00,Non-SBIR/STTR,2003,1328824, ,NCI, , ,1328824
MOLECULAR DETERMINANTS OF DRUG SENSITIVITY,6633248,7/12/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2003,166940, ,NCI, , ,166940
RESTORATION OF APOPTOSIS IN CANCER,6633251,7/23/1999 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,1135263, ,NCI, , ,1135263
GRP78 AND HYPERSENSITIVITY TO DNA CROSS LINKING AGENTS,6633259,4/1/2000 0:00,3/31/2005 0:00,Other Research-Related,2003,157588, ,NCI, , ,157588
Targeting Cancer Cell DNA with Combinatorial Ligands,6633306,4/1/1998 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,271120, ,NCI, , ,271120
FUNCTIONS OF DIFFERENT P53 MUTATIONS IN PROSTATE CANCER,6633308,4/15/1998 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,261480, ,NCI, , ,261480
NUTRIENTS EFFECT ON GENOTYPE IN BREAST CANCER,6633316,7/15/1999 0:00,6/30/2004 0:00,Other Research-Related,2003,135621, ,NCI, , ,135621
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS,6633328,8/1/1999 0:00,5/31/2007 0:00,Non-SBIR/STTR,2003,286449, ,NCI, , ,286449
STEM CELL DERIVED IMMUNOTHERAPY,6633332,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,2003,125226, ,NCI, , ,125226
EPITOPE BASED T CELL THERAPY FOR EPITHELIAL TUMORS,6633350,5/1/1999 0:00,9/1/2004 0:00,Non-SBIR/STTR,2003,317121, ,NCI, , ,317121
UBIQUITINATION AND STABILITY OF P53 AND P73,6633358,6/15/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2003,243413, ,NCI, , ,243413
A ROLE OF RAD51B IN DNA REPAIR AND BREAST CARCINOGENESIS,6633366,6/1/2000 0:00,5/31/2004 0:00,Non-SBIR/STTR,2003,293692, ,NCI, , ,293692
CDX2 TUMOR SUPPRESSOR PATHWAY DEFECTS IN COLON CANCER,6633414,8/15/1999 0:00,7/31/2004 0:00,Non-SBIR/STTR,2003,278263, ,NCI, , ,278263
"MUTUAL REGULATION OF P53, MDM2 AND NFKB:",6633453,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,202943, ,NCI, , ,202943
Structural Determinants in Cell Growth Control by p21,6633470,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,249000, ,NCI, , ,249000
Analysis of the Chemopreventive Activity of FGN 1,6633483,4/1/2001 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,313740, ,NCI, , ,313740
E2 MODULATION OF TUMORIGENESIS IN ERBB2 TRANSGENIC MICE,6633500,8/15/1999 0:00,5/31/2005 0:00,Non-SBIR/STTR,2003,225684, ,NCI, , ,225684
TREATMENT RESPONSE MARKERS IN ADVANCED LARYNGEAL CANCER,6633512,9/1/1999 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,239324, ,NCI, , ,239324
Novel Technology for the Analysis of Gene Expression,6633525,8/1/1999 0:00,6/30/2005 0:00,SBIR/STTR,2003,914409, ,NCI, , ,914409
Molecular Mechanism of Genistein in Prostate Cancer,6633529,7/12/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,246887, ,NCI, , ,246887
" 8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA",6633530,7/5/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,430353, ,NCI, , ,430353
USE OF THE MOUSE FOR PROSTATE CANCER GENE DISCOVERY,6633554,3/27/2000 0:00,8/31/2003 0:00,Other Research-Related,2003,40430, ,NCI, , ,40430
APOPTOSIS AND A NEW ADAPTER MOLECULE PATHWAY IN GLIOMA,6633559,4/15/2001 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,225300, ,NCI, , ,225300
MOUSE MODELS OF HUMAN BREAST CANCER,6633577,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,802824, ,NCI, , ,802824
 REPRESSION BY C SKI AND MELANOMA PROGRESION,6633580,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,269100, ,NCI, , ,269100
"THE APL PARADIGM FOR ABERRANT TRANSCRIPTION, CANCER AND",6633583,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,537580, ,NCI, , ,537580
A MOUSE MODEL FOR PROSTATE CANCER,6633584,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,513125, ,NCI, , ,513125
CPG METHYLATION AND MUTATION,6633601,7/1/2000 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,275625, ,NCI, , ,275625
MOLECULAR BASIS OF P53 INDUCTION TO DNA DAMAGE,6633668,6/15/2001 0:00,7/31/2004 0:00,Non-SBIR/STTR,2003,235305, ,NCI, , ,235305
Cyclin G in p53 mediated pathways and breast cancer,6633669,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,267750, ,NCI, , ,267750
P53 AND UV REGULATION OF P53 BINDING PROTEIN BBP/53BP2,6633679,6/7/2000 0:00,5/31/2005 0:00,Other Research-Related,2003,132921, ,NCI, , ,132921
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER,6633718,5/8/2000 0:00,2/28/2005 0:00,Other,2003,1283443, ,NCI, , ,1283443
MODULATING BASE EXCISION REPAIR IN TUMOR DRUG RESISTANCE,6633736,4/1/2000 0:00,8/31/2004 0:00,Non-SBIR/STTR,2003,275400, ,NCI, , ,275400
CHARACTERIZATION OF NEW HUMAN P53 DISSOCIATORS,6633784,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,268200, ,NCI, , ,268200
TNF alpha mediated apoptosis in prostate cancer,6633798,3/1/2001 0:00,2/28/2005 0:00,Non-SBIR/STTR,2003,244020, ,NCI, , ,244020
Adenocarinoma of the Lung in Women,6633818,6/13/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,596626, ,NCI, , ,596626
Extracellular Matrix Mediated Apoptosis in p53 (-) HMECs,6633866,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,237160, ,NCI, , ,237160
CHROMOSOME ALTERATIONS IN BARRETT'S ESOPHAGUS,6633883,4/1/2001 0:00,3/31/2006 0:00,Other Research-Related,2003,96850, ,NCI, , ,96850
MODULATORS AND EFFECTORS OF MDM2 AND P53,6633893,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2003,273663, ,NCI, , ,273663
 METHYLATION PROFILING IN COLORECTAL CANCER,6633895,3/12/2001 0:00,2/29/2004 0:00,Non-SBIR/STTR,2003,245103, ,NCI, , ,245103
IGF I survival effects on p53 induced apoptosis,6633899,6/1/2001 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,205616, ,NCI, , ,205616
"ROLE OF MDM2, P300, P19ARF IN P53 UBIQUITINATION",6633921,4/12/2001 0:00,3/31/2006 0:00,Other Research-Related,2004,157437, ,NCI, , ,157437
Accelerated senescence in tumor cells,6633927,6/1/2001 0:00,8/31/2003 0:00,Non-SBIR/STTR,2003,106294, ,NCI, , ,106294
"MyD118, CR6 and GADD45 in Genotoxic Stress",6633930,7/1/2001 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,249830, ,NCI, , ,249830
New Molecular Approaches to Inhibit Glioma Angiogenesis,6633959,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2003,259875, ,NCI, , ,259875
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER,6633978,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,378376, ,NCI, , ,378376
P53 Mediated Regulation of Centrosome Duplication,6633984,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,253980, ,NCI, , ,253980
Flavopiridol Mediated Apoptosis During S Phase in NSCLC,6634005,4/1/2001 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,294120, ,NCI, , ,294120
"P13K/PTEN/Akt (PKB), Signaling and genesis of cancer",6634013,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2003,355841, ,NCI, , ,355841
Nicotine Derived Nitrosamines & Tobacco Related Cancers,6634023,5/1/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,275625, ,NCI, , ,275625
Molecular Targeting of the Survivin Pathway in Cancer,6634032,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,296933, ,NCI, , ,296933
Molecular Pathogenesis of Ewing Sarcoma,6634081,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,249000, ,NCI, , ,249000
Mouse Models of Gastric Cancer,6634111,5/1/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,269431, ,NCI, , ,269431
GENETIC EPIDEMIOLOGY OF ORAL PREMALIGNANCIES AND CANCER,6634569,5/1/1999 0:00,4/30/2004 0:00,Other Research-Related,2003,124686, ,NIDCR, , ,124686
HPV ETIOLOGY OF A SUBSET OF HEAD AND NECK CANCERS,6634653,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,312694, ,NIDCR, , ,312694
ARF AS A THERAPEUTIC AGENT IN ORAL MALIGNANCIES,6634658,4/1/2000 0:00,9/30/2004 0:00,Non-SBIR/STTR,2003,256700, ,NIDCR, , ,256700
SENESCENCE IN EPITHELIAL NEOPLASTIC PROGRESSION,6634659,9/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,252131, ,NIDCR, , ,252131
GI HORMONES AND OTHER FACTORS IN GROWTH OF GI MUCOSA,6634839,12/1/1977 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,415966, ,NIDDK, , ,415966
CHROMOSOME 22Q GENETIC STUDIES IN THE COLON,6635201,3/1/2000 0:00,2/29/2004 0:00,Non-SBIR/STTR,2003,247035, ,NIDDK, , ,247035
MOLECULAR MECHANISMS OF IRON CHELATOR CYTOTOXICITY,6635270,6/1/2000 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,252000, ,NIDDK, , ,252000
TRIMODAL GENE THERAPY FOR PROSTATE CANCER,6635278,7/1/2000 0:00,5/31/2004 0:00,Non-SBIR/STTR,2003,145339, ,NIDDK, , ,145339
NUCLEAR RECEPTOR COACTIVATORS AND BREAST CANCER,6635418,6/15/2000 0:00,5/31/2005 0:00,Other Research-Related,2003,117302, ,NIEHS, , ,117302
HEPTOCYTE PROLIFERATION AND AFLATOXIN METABOLISM,6635483,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,218843, ,NIEHS, , ,218843
Molecular cytology of human telomeres-telomere protein,6636074,5/1/1993 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,377420, ,NIGMS, , ,377420
Epidemiology of HPV and p53 Mutations in NM Skin Cancer,6637100,8/1/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2003,548433, ,NCI, , ,548433
MALIGNANT COMPLICATIONS OF CHRONIC HCV,6637104,9/29/1999 0:00,5/31/2005 0:00,Non-SBIR/STTR,2003,346317, ,NCI, , ,346317
Mentored Patient-Oriented Research Career Development Aw,6637374,8/1/2000 0:00,2/29/2004 0:00,Other Research-Related,2003,117736, ,NCRR, , ,117736
GELSOLIN: ROLES IN APOPTOSIS AND TUMOR DEVELOPMENT,6638407,5/1/1995 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,301399, ,NHLBI, , ,301399
HPV AND RISK OF ORAL CANCER IN THE CZECH REPUBLIC,6639973,6/15/2001 0:00,5/31/2005 0:00,Non-SBIR/STTR,2003,40160, ,FIC, , ,40160
Studies of Materials with Physiological Properties,6640026,9/1/1988 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,530266, ,NIGMS, , ,530266
 Model of Tumor Suppression by BRCA1,6640060,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,339424, ,NCI, , ,339424
Exploring How HTLV-1 Tax Induces T Cell Leukemia,6640124,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,320400, ,NCI, , ,320400
Mechanism of Meclp in the Checkpoint Response,6640383,9/1/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2003,223500, ,NIGMS, , ,223500
Molecular Diagnostics for Breast Cancer,6640605,8/2/2002 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,480039, ,NCI, , ,480039
Prevention of ER-negative Breast Cancer,6641058,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2003,464524, ,NCI, , ,464524
Role of Tumor Suppressor p53 in Breast Cancer,6641163,8/1/2002 0:00, ,"Training, Individual",2003,30183, ,NCI, , ,30183
Chemoprevention of Carcinogen-Induced Lung Cancer,6641360,5/1/2003 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,422083, ,NCI, , ,422083
NEOADJUVANT THERAPY OF OR CANCER BY INHIBITING NF-KAPPAB,6641981,9/30/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2003,266365, ,NIDCR, , ,266365
BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH & PROGRESSION,6642578,5/6/1996 0:00,3/31/2005 0:00,Non-SBIR/STTR,2002,507388, ,NCI, , ,507388
E2F-1 Cancer Gene Therapy,6642806,9/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,243002, ,NCI, , ,243002
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1,6642888,8/1/2002 0:00,7/31/2003 0:00,Non-SBIR/STTR,2002, ,434203, , , , 
Cancer Genotyping by Peptide Mass Spectrometry,6643223,3/1/2000 0:00,4/30/2005 0:00,SBIR/STTR,2003,474813, ,NIGMS, , ,474813
Statistical Methods in Genetic Epidemiology,6643370,6/1/1997 0:00,7/31/2006 0:00,Non-SBIR/STTR,2003,259500, ,NIA, , ,259500
Role of CDK4 in Cell Cycle Progression and Cancer,6643402,9/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,376250, ,NIA, , ,376250
"Oxidative DNA Damage, DNA Repair and Oral Cancer",6643459,9/1/2001 0:00,8/31/2006 0:00,Other Research-Related,2003,133650, ,NCI, , ,133650
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS,6643605,8/6/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,196218, , , , 
REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER,6643606,8/6/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,196218, , , , 
CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY,6643609,8/6/2001 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,196218, , , , 
Profiling of signal transduction pathways in cancer,6643965,4/9/2003 0:00,3/31/2005 0:00,SBIR/STTR,2003,146750, ,NCI, , ,146750
Transcriptional Regulation of Cell Growth,6644133,6/1/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2003,2411844, ,NCI, , ,2411844
Regulation of Stat3 by p53 in cancer Cells,6644212,8/9/2002 0:00,7/31/2006 0:00,Non-SBIR/STTR,2003,254363, ,NCI, , ,254363
ARSENIC BIOMARKER EPIDEMIOLOGY,6644272,8/6/2002 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,293470, , , , 
Role of E6-AP in the Development of Prostate Cancer,6645332,9/30/2001 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,201750, ,NIDDK, , ,201750
POLYOMA HOST INTERACTIONS LEADING TO TUMOR DEVELOPMENT,6646456,9/1/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,742158, ,NCI, , ,742158
Molecular Mechanisms of Ara-C Therapy in Man,6646580,9/15/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,283860, ,NCI, , ,283860
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA,6646590,6/1/1983 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,290764, ,NCI, , ,290764
Role of IGFBP -3 in mediating p53-induced apoptosis,6647015,8/15/2002 0:00,6/30/2007 0:00,Other Research-Related,2003,132732, ,NIDDK, , ,132732
Exploiting IR inducible NQ01 Levels Using Beta Lapachone,6647108,7/1/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,246919, ,NCI, , ,246919
A novel regulator of p53 function,6647144,8/15/2002 0:00,7/31/2007 0:00,Non-SBIR/STTR,2003,270560, ,NCI, , ,270560
Characterization of the Ews/Fli-1 Chimeric Gene,6647177,9/1/2002 0:00,3/31/2004 0:00,"Training, Individual",2003,16826, ,NCI, , ,16826
131IMIBG Escalating Dose Rapid Sequence Double Infusion,6647508,6/20/2003 0:00,5/31/2005 0:00,Non-SBIR/STTR,2003,261006, ,NCI, , ,261006
Cellular Stress Response Signaling Pathways,6647647,1/1/1992 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,337500, ,NIEHS, , ,337500
Barrett's Esophagus: Predictors of Progression,6647703,8/16/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,2237165, ,NCI, , ,2237165
ESOPHAGO GASTRIC TUMORIGENESIS IN A TRANSGENIC MODEL,6647737,5/1/2000 0:00,4/30/2005 0:00,Other Research-Related,2003,136147, ,NCI, , ,136147
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE,6647774,5/1/1994 0:00,5/31/2004 0:00,Non-SBIR/STTR,2003,782953, ,NCI, , ,782953
SUSCEPTIBILITY TO MOLECULAR ALTERATION: EPITHELIAL CELLS,6648319,9/26/1999 0:00,8/31/2004 0:00,Other Research-Related,2003,118065, ,NIEHS, , ,118065
Vaccine Development for Oral Carcinoma,6648461,9/1/1997 0:00,8/31/2007 0:00,Non-SBIR/STTR,2003,944598, ,NIDCR, , ,944598
THERAPEUTIC MODULATION OF ANGIOGENESIS IN HUMAN GLIOMAS,6649336,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,477178, ,NCI, , ,477178
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI,6649539,9/30/1997 0:00,12/31/2002 0:00,Non-SBIR/STTR,2002,63420, ,NIDDK, , ,63420
CATIONIC LIPID/P53 GENE THERAPY IN LUNG CANCER PATIENTS,6650276,3/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,436083, ,NCI, , ,436083
Hamster Model for AIDS Lymphomas,6650339,9/1/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,150500, ,NCI, , ,150500
QUANTITATIVE CARCINOGENESIS IN CULTURED EPITHELIAL CELLS,6650513,7/15/1981 0:00,5/31/2003 0:00,Non-SBIR/STTR,2002,34579, ,NCI, , ,34579
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER,6650560,9/24/1999 0:00,8/31/2004 0:00,Non-SBIR/STTR,2002,394947, ,NIDCR, , ,394947
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY,6650587,5/1/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,250404, , , , 
ARF MDM2 P53 TUMOR SUPPRESSION PATHWAY,6650905,8/1/2000 0:00,3/31/2006 0:00,Other Research-Related,2003,143942, ,NCI, , ,143942
EARLY GENETIC EVENTS IN ASTROCYTOMA FORMATION,6651035,9/30/2001 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,348307, ,NINDS, , ,348307
RADIATION INDUCED G1 CHECKPOINT ARREST IN YEAST,6651040,9/1/1999 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,212664, ,NIGMS, , ,212664
Molecular Basis of Young Onset Colorectal Cancer,6651078,8/26/2002 0:00,4/30/2007 0:00,Other Research-Related,2003,125226, ,NCI, , ,125226
Microarray Analysis of HNSCC as a Predictor of Treatment,6651155,9/1/2002 0:00,8/31/2006 0:00,Other Research-Related,2003,135000, ,NIDCR, , ,135000
CORE--MOLECULAR GENETICS,6651267,9/1/2002 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002, ,296752, , , , 
MTOR as a Therapeutic Target in Childhood Cancer,6651547,9/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,300375, ,NCI, , ,300375
Diet and Somatic Mutations in Colon Cancer,6651611,8/1/1995 0:00,8/31/2007 0:00,Non-SBIR/STTR,2003,1065826, ,NCI, , ,1065826
Antitumor Activity of Inducible Nitric Oxide Synthase,6651656,9/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,251038, ,NCI, , ,251038
NEW METHODS FOR CANCER DETECTION,6652144,3/1/1997 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,2908154, ,NCI, , ,2908154
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,6652557,9/30/1995 0:00,11/30/2005 0:00,Non-SBIR/STTR,2003,2046132, ,NCI, , ,2046132
NEW MODELS FOR COMPARATIVE STUDIES OF GONADAL TUMORS,6653137,12/16/1993 0:00,7/31/2007 0:00,Non-SBIR/STTR,2003,257250, ,NIEHS, , ,257250
Oxidative damage to gastric epithelal cells by H pylori,6653169,9/21/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,233100, ,NIDDK, , ,233100
"AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES",6653173,9/20/1999 0:00,8/31/2004 0:00,Other Research-Related,2003,123080, ,NCI, , ,123080
CORE--MICROARRAY,6653304,8/29/2002 0:00,4/30/2003 0:00,Research Centers,2002, ,183723, , , , 
CORE--MOLECULAR GENETICS,6653308,9/1/2002 0:00,8/31/2003 0:00,Non-SBIR/STTR,2002, ,296752, , , , 
COLON CANCER PREVENTION PROGRAM PROJECT,6653712,9/30/1986 0:00,7/31/2005 0:00,Non-SBIR/STTR,2002,120505, ,NCI, , ,120505
MECHANISM OF ANTICARCINOGENIC ACTIVITY--ORGANOSULFIDES,6653765,4/1/1995 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,200751, ,NCI, , ,200751
BIOCHEM DISSECTION OF P53-DEPENDENT APOPTOSIS PATHWAY,6653796,9/1/1999 0:00,8/31/2004 0:00,Other Research-Related,2003,152820, ,NCI, , ,152820
Studies of Childhood Solid Tumors,6653850,8/1/1978 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,1558131, ,NCI, , ,1558131
Molecular Basis of KSHV Pathogenesis,6654228,6/15/1999 0:00,3/31/2008 0:00,Non-SBIR/STTR,2003,357435, ,NCI, , ,357435
P21 transcriptional inhibitors as proapoptotic compounds,6654371,9/6/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,155870, ,NCI, , ,155870
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION,6654919,9/1/2000 0:00,8/31/2005 0:00,Other Research-Related,2003,154440, ,NCI, , ,154440
MOUSE CANCER MODELS BY REGULATED INACTIVATION OF TUMOR S,6654956,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,698719, ,NCI, , ,698719
Natural Product Antitumor Inducers of Apoptosis,6655589,9/6/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,241962, ,NCI, , ,241962
Biomarker modulation/COX-2 inhibitor/Breast Cancer,6655615,9/15/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,75500, ,NCI, , ,75500
"Role of Na,K ATPase in the development of carcinoma",6655637,9/12/2002 0:00, ,"Training, Individual",2003,27588, ,NCI, , ,27588
Mda-7: Novel Cancer Therapeutic Gene,6655682,9/10/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2003,291030, ,NCI, , ,291030
Molecular Imaging of Responses to Cancer Therapy,6656223,6/6/2001 0:00,5/31/2005 0:00,Other,2003,400000, ,NCI, , ,400000
Partnership To Increase Hispanic Cancer Res/Edu. in Col.,6656344,9/16/2002 0:00,7/31/2005 0:00,Research Centers,2003,216001, ,NCI, , ,216001
Role of ATM in Radiosensitivity of Gliomas,6656378,9/10/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,271263, ,NCI, , ,271263
LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU,6656897,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,607762, ,NCI, , ,607762
Oxidative damage to gastric epithelal cells by H pylori,6657213,9/21/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2002,44400, ,NIDDK, , ,44400
ROLE OF CHROMOSOME 3 IN LUNG TUMORIGENESIS,6657493,5/1/2000 0:00,4/30/2003 0:00,Research Centers,2002, ,61783, , , , 
PRECLINICAL MOUSE:  CENTRAL NERVOUS SYSTEM CANCERS,6658009,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,1403087, ,NCI, , ,1403087
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER,6658168,9/24/1999 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,775418, ,NIDCR, , ,775418
TUMOR MARKERS TO PREDICT TREATMENT RESPONSE,6658202,9/10/2001 0:00,8/31/2006 0:00,Other Research-Related,2003,281695, ,NIA, , ,281695
EARLY CANCER DETECTION AND SUSCEPTIBILITY BIOMAKERS,6658923,9/30/1999 0:00,8/31/2004 0:00,Other,2003,755694, ,NCI, , ,755694
MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER,6659011,9/18/2000 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,241107, ,NCI, , ,241107
Partnership to Increase Hispanic Cancer Research for Co*,6659083,9/20/2002 0:00,7/31/2005 0:00,Research Centers,2003,79462, ,NCI, , ,79462
P53 function and apoptosis in melanoma,6659185,5/1/2002 0:00,4/30/2003 0:00,Non-SBIR/STTR,2002, ,312755, , , , 
CORE--MOLECULAR ANALYSIS AND HIGH THROUGHPUT GENOTYPING,6659187,9/13/2002 0:00,7/31/2003 0:00,Research Centers,2002, ,168504, , , , 
ISOLATION OF THE FANCONI ANEMIA NUCLEAR PROTEIN COMPLEX,6659774,9/10/2000 0:00,5/31/2005 0:00,Non-SBIR/STTR,2003,368650, ,NHLBI, , ,368650
COLON CANCER PREVENTION PROGRAM PROJECT,6660678,9/30/1986 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,3653320, ,NCI, , ,3653320
INNOVATIVE TUMOR TARGETED THERAPIES FOR LUNG CANCER,6660710,9/1/2000 0:00,8/31/2005 0:00,Other Research-Related,2003,125620, ,NCI, , ,125620
Molecular Markers of Colon Cancer: Racial Differences,6660738,9/23/2002 0:00,8/31/2004 0:00,Non-SBIR/STTR,2003,71750, ,NCI, , ,71750
MOLECULAR GENETICS & EPIGENETICS OF COLORECTAL ADENOMAS,6660917,9/19/2002 0:00,7/31/2003 0:00,Non-SBIR/STTR,2002, ,241412, , , , 
CREATION AND CHARACTERIZATION OF MOUSE MODELS OF HUMAN L,6661273,9/30/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,1240360, ,NCI, , ,1240360
VIRAL ONCOPROTEIN ACTIVATION IN AIDS-RELATED TUMORS,6661928,9/17/1999 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,550485, ,NCI, , ,550485
MOLECULAR GENETICS & EPIGENETICS OF COLORECTAL ADENOMAS,6662105,9/19/2002 0:00,7/31/2003 0:00,Non-SBIR/STTR,2002, ,241412, , , , 
GENETIC MODULATION OF CELLULAR RADIATION RESPONSES,6663032,9/30/1998 0:00,7/31/2003 0:00,Non-SBIR/STTR,2002,364575, ,NCI, , ,364575
Molecular Mechanism for HCMV Mediated Atherogenesis,6663821,9/30/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,376250, ,NHLBI, , ,376250
ROLE OF SAMe IN LIVER FUNCTION AND INJURY,6663885,9/20/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2003,350716, ,NCCIH, , ,350716
Genetic Epidemiological Studies Of Oral Cancer,6664127, , ,Intramural Research,2002, , , , , , 
Molecular Genetics Of Adrenocortical Tumors And Related,6664171, , ,Intramural Research,2002, , , , , , 
TRANSLATIONAL RESEARCH IN LUNG CANCER,6664194,9/30/1997 0:00,9/29/2003 0:00,Other Research-Related,2002,162000, ,NCI, , ,162000
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY,6664290,7/15/1988 0:00,3/31/2004 0:00,Non-SBIR/STTR,2002,420273, ,NCI, , ,420273
Transgenic Mouse Model for Barrett's Esophagus,6665306,9/30/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,158500, ,NIDDK, , ,158500
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS,6665308,9/1/2000 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,653041, ,NCI, , ,653041
Role of H. Pylori Infection in Esophageal Adenocarcinoma,6665481,9/30/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,169000, ,NIDDK, , ,169000
MD Anderson Cancer Center SPORE in Head and Neck Cancer,6665523,9/30/2002 0:00,7/31/2007 0:00,Research Centers,2003,2350707, ,NCI, , ,1909865
NEUROONCOLOGY,6665605,1/1/2002 0:00,12/31/2002 0:00,Other Research-Related,2002, ,78870, , , , 
"Checkpoints, DNA repair & human carcinogenesis",6666417,4/1/2002 0:00,3/31/2003 0:00,Non-SBIR/STTR,2002, ,175236, , , , 
P53 and Organismal Aging,6666650,9/15/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2003,403498, ,NIA, , ,403498
Early Events in Colitis-Associated Colorectal Cancer,6666674,9/30/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,85000, ,NCI, , ,85000
Melanoma in p16INK4a and p19ARF Deficient Mice,6666921,2/15/2002 0:00,11/30/2006 0:00,Other Research-Related,2003,130918, ,NCI, , ,130918
P53 AND DNA PLOIDY IN BARRETT'S METAPLASIA,6667047,1/9/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2002,9513, ,NCI, , ,9513
Biomarkers in Phototherapy of Barrett's Esophagus,6667258,9/30/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2003,321513, ,NCI, , ,321513
BREAST CANCER AND THE ENVIRONMENT ON LONG ISLAND,6667287,8/8/1995 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,408009, ,NCI, , ,408009
Response of p53 promoter to hydrogen peroxide,6668191,8/15/2003 0:00,7/31/2006 0:00,Non-SBIR/STTR,2003,211800, ,NCI, , ,211800
The role of hBUB1-p53 pathway in genomic stability.,6668416,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2003,323404, ,NCI, , ,323404
Regulation Of Mutant P53,6668436, , ,Intramural Research,2002, , , , , , 
Immunoliposome-Mediated Gene Therapy for Prostate Cancer,6668686,3/1/1999 0:00,8/31/2004 0:00,SBIR/STTR,2003,317330, ,NCI, , ,317330
Cell cycle regulatory proteins in UVB-skin carcinogenes,6668793,4/21/2003 0:00,3/31/2008 0:00,Other Research-Related,2003,123660, ,NIAMS, , ,123660
Molecular Mechanisms Of Human Retrovirus Trans-regulator,6669515, , ,Intramural Research,2002, , , , , , 
Mechanisms of cyclin E associated tumorigenesis,6669577,7/1/2003 0:00,6/30/2008 0:00,Other Research-Related,2003,133585, ,NCI, , ,133585
ARF ACTIVATION BY POLYOMA VIRUS T-ANTIGEN,6669720,7/25/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,269670, ,NCI, , ,269670
Nuclear Signaling by TRADD,6669726,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,307800, ,NINDS, , ,307800
Viral Model for Tumor Pathogenesis in Brain,6670921,9/30/1996 0:00,5/31/2008 0:00,Non-SBIR/STTR,2003,1299030, ,NINDS, , ,1299030
Molecular Targets for Drug and Radiation Sensitivity,6671114,8/17/1998 0:00,5/31/2008 0:00,Non-SBIR/STTR,2003,1445623, ,NCI, , ,1445623
Bifunctional T cell receptor based immunotherapeutics,6671152,7/26/2002 0:00,7/14/2003 0:00,SBIR/STTR,2002,100000, ,NCI, , ,100000
The Molecular Biology Of The Mammalian Brain,6671390, , ,Intramural Research,2002, , , , , , 
Genetic Alterations During Multistep Carcinogenesis In M,6672839, , ,Intramural Research,2002, , , , , , 
Statistical Methods For Gene/environment Interaction And,6672916, , ,Intramural Research,2002, , , , , , 
NIEHS Statistical Consulting Service,6672923, , ,Intramural Research,2002, , , , , , 
Development Of New Hormone Responsive Models From Cancer,6673232, , ,Intramural Research,2002, , , , , , 
Pathogenic Factors And Determinants Of Prognosis In Pati,6673791, , ,Intramural Research,2002, , , , , , 
Insulin-like Growth Factor Binding Proteins,6673822, , ,Intramural Research,2002, , , , , , 
Clinically Aggressive Thyroid Cancer: Molecular Basis An,6673823, , ,Intramural Research,2002, , , , , , 
Insulin-like Growth Factor-1 Receptor,6673825, , ,Intramural Research,2002, , , , , , 
Elucidation Of The Structure And Function Of Sigma Recep,6673850, , ,Intramural Research,2002, , , , , , 
Use of Beta-Lapachone for Lung Cancer Chemotherapy,6674794,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2003,324901, ,NCI, , ,324901
Molecular Analysis of Esophageal Cancer Survival,6676049,7/3/2003 0:00,6/30/2008 0:00,Other Research-Related,2003,135837, ,NCI, , ,135837
Function of the ATR-ATRIP complex,6677169,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,268780, ,NCI, , ,268780
Normal and Neoplastic Regulation of Cyclin E,6677518,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,384925, ,NCI, , ,384925
MUTANT LINES OF ZEBRAFISH HIGHLY SENSITIVE TO NEOPLASIA,6677858,8/1/2004 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,141500, ,NIEHS, , ,141500
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER,6677950,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,265220, ,NCI, , ,265220
Functional analysis of the p53 tumor suppressor,6678398,8/15/1985 0:00,7/31/2008 0:00,Non-SBIR/STTR,2003,215200, ,NCI, , ,215200
Mdm2 in Lymphoma Development,6678876,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,321140, ,NCI, , ,321140
Regulation of p53-mediated apoptosis in gliomas,6679005,7/17/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,260247, ,NCI, , ,260247
Role of E6-AP in the Development of Prostate Cancer,6679141,9/30/2001 0:00,8/31/2005 0:00,Non-SBIR/STTR,2002,213750, ,NIDDK, , ,213750
Expression of Simian Virus 40 T antigens in Intestine,6679254,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,327307, ,NCI, , ,327307
Quantitative Gene Expression in Human Lung Epithelium,6679431,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,345130, ,NCI, , ,345130
Expression of Proapoptotic Genes for Cancer Therapy,6679539,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,330982, ,NCI, , ,330982
Molecular Epidemiology of Non-Melanoma Skin Cancer,6679653,9/30/1999 0:00,7/31/2007 0:00,Non-SBIR/STTR,2003,420475, ,NCI, , ,420475
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS,6679890,8/1/1999 0:00,5/31/2004 0:00,Non-SBIR/STTR,2002,234878, ,NCI, , ,234878
Regulation of p53 in response to genotoxic stress,6680615,8/1/2003 0:00,7/31/2007 0:00,Non-SBIR/STTR,2003,298775, ,NIGMS, , ,298775
Microsatellite instability and cancer gene expression,6680627,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,427200, ,NCI, , ,427200
RNA Tumor Virus-Hematopoietic cell Interaction,6680954,6/1/1983 0:00,5/31/2008 0:00,Non-SBIR/STTR,2003,335228, ,NCI, , ,335228
Centrosomes in the Control of Mitosis and Interphase,6681092,5/1/1982 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,397500, ,NIGMS, , ,397500
Quantitative FDG-PET for Hepatomacellular Carcinoma,6681264,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,368389, ,NCI, , ,368389
Inhibition of the TNF Apoptotic Pathway by HPV 16 E6,6681391,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,288360, ,NCI, , ,288360
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,6681477,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2003,319526, ,NCI, , ,319526
p53 loss in HMECs: a model of breast cancer prevention,6681584,7/3/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,330635, ,NCI, , ,330635
Mechanisms of luteinization in the primate ovary,6681593,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2003,293278, ,NICHD, , ,293278
Mechanism(s) Of Leukemogenesis In Genetically-altered Mo,6681831, , ,Intramural Research,2002, , , , , , 
Carotenoid/retinoid Modulation Of Cellular Redox Status,6681901, , ,Intramural Research,2002, , , , , , 
Identification Of Bioactive Isoforms Of P53 Protein,6681921, , ,Intramural Research,2002, , , , , , 
Exposure Specific Mutation In Critical Target Genes,6681960, , ,Intramural Research,2002, , , , , , 
Genetic Susceptibility And The Environment In Cancer Ris,6681961, , ,Intramural Research,2002, , , , , , 
Isolation And Characterization Of Human Genes Affecting,6681983, , ,Intramural Research,2002, , , , , , 
Human and Murine Models of BRCA1 Tumorigenesis,6682122,1/7/1998 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,277375, ,NCI, , ,277375
PPMP as a Ceramide Catabolism Inhibitor for Chemotherapy,6682533,7/11/2003 0:00,6/30/2004 0:00,SBIR/STTR,2003,249947, ,NCI, , ,249947
Adjuvant Hormonal therapy in Vietnamese Breast Cancer,6682594,7/1/1995 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,346550, ,NCI, , ,346550
MALDI TOF TECHNOLOGY FOR MOLECULAR ANALYSIS OF CANCER,6682786,5/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,255216, ,NCI, , ,255216
"Novel Pathway Involving E2F1, ATM and NBS1",6682988,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,335975, ,NCI, , ,335975
ROLE FOR CELL CYCLE PROTEINS IN HIV ENCEPHALITIS,6683281,2/1/2001 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,277375, ,NINDS, , ,277375
Rapamycin-induced Selective Apoptosis in Malignant Cells,6683699,12/1/1998 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,282000, ,NCI, , ,282000
Molecular Mechanisms Of Skin Tumorigenesis,6683947, , ,Intramural Research,2002, , , , , , 
MOLECULAR MECHANISMS OF CHEMOTHERAPY-INDUCED HAIR LOSS,6683973,6/16/2003 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,268494, ,NCI, , ,268494
Enhancement of Ad-p53 Therapy with Intratumoral Taxane,6684340,7/3/2003 0:00,4/30/2005 0:00,Non-SBIR/STTR,2003,151000, ,NIDCR, , ,151000
"Mechanisms of mutagenesis in "" hot spots"" causing cancer",6684524,2/1/2004 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,205923, ,NCI, , ,205923
Models for DNA repair and cell cycle control variants,6684531,4/10/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,16199, ,NIEHS, , ,16199
Genetic Alterations in Breast Cells from BRCA1 Carriers,6684636,9/8/2003 0:00,8/31/2008 0:00,Other Research-Related,2003,136890, ,NCI, , ,136890
INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN D,6684653,12/24/1998 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,69230, ,NCI, , ,69230
Cancer Biology in the Zebrafish,6684662,7/3/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,359894, ,NCI, , ,359894
Effect of mutant p53 on stress-response,6684884,8/12/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2003,254363, ,NCI, , ,254363
Genetics of Tobacco and Alcohol Related Cancers,6685047,9/1/2003 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,463264, ,NCI, , ,463264
DEFECTIVE DNA MISMATCH REPAIR IN ENDOMETRIAL CANCERS,6686373,5/1/1997 0:00,7/31/2005 0:00,Non-SBIR/STTR,2004,308000, ,NCI, , ,308000
Nanocapillary Electrophoresis for Profiling Cancer,6686701,7/16/2003 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,166922, ,NCI, , ,166922
Study of a FACTp140-SSRP1-associated p53 Kinase,6686790,1/10/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2004,299427, ,NCI, , ,299427
MECHANISMS REGULATING REVERSAL OF PREMALIGNANCY,6686793,12/15/2000 0:00,11/30/2005 0:00,Non-SBIR/STTR,2004,209520, ,NCI, , ,209520
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN,6686800,9/30/1992 0:00,12/31/2005 0:00,Non-SBIR/STTR,2004,269880, ,NCI, , ,269880
Function of Human Damaged DNA Binding Protein (DDB),6686947,6/1/2000 0:00,5/31/2008 0:00,Non-SBIR/STTR,2004,362027, ,NIGMS, , ,362027
Models of DRA growth suppression in colon cancer,6687012,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,259880, ,NCI, , ,259880
Small Molecule Kinase Inhibitor for Malignant Glioma,6687119,7/10/2003 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,77686, ,NCI, , ,77686
Arsenic Induced Miotic Arrest Associated Apoptosis,6687343,8/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2003,268660, ,NIEHS, , ,268660
Breast Cancer Therapy by Differentiation Gene Activation,6687426,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,302600, ,NCI, , ,302600
Molecular Epidemiology of Smoking & Breast Cancer,6687461,9/1/2003 0:00,8/31/2006 0:00,Non-SBIR/STTR,2003,259880, ,NCI, , ,259880
Sunlight-Related Steps in Human Skin Cancer,6687525,4/1/1992 0:00,6/30/2007 0:00,Non-SBIR/STTR,2003,327000, ,NCI, , ,327000
Role of the p53 homolog p73 in cancer,6687834,1/14/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2004,301376, ,NCI, , ,301376
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE,6687835,12/29/1994 0:00,11/30/2004 0:00,Non-SBIR/STTR,2004,459312, ,NCI, , ,459312
NQO1 in Protection Against Benzene Toxicicity,6687842,7/15/1998 0:00,11/30/2007 0:00,Non-SBIR/STTR,2004,306834, ,NIEHS, , ,306834
Genomic & Genetic Characterization of Amplicons in GBMs,6688068,9/24/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2003,304380, ,NCI, , ,304380
THE MOLECULAR BIOLOGY OF RETINOBLASTOMA,6688296,2/1/1999 0:00,7/31/2005 0:00,Non-SBIR/STTR,2004,324000, ,NEI, , ,324000
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE,6688850,12/29/1994 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,78154, ,NCI, , ,78154
P53 AND MOUSE MAMMARY TUMORIGENESIS,6688998,1/1/2000 0:00,12/31/2005 0:00,Non-SBIR/STTR,2004,374931, ,NCI, , ,374931
Characterization of the p53 Apoptotic Target Gene PERP,6689008,1/1/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2004,287931, ,NCI, , ,287931
P53 AND DNA PLOIDY IN BARRETT'S METAPLASIA,6689567,1/9/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2004,253994, ,NCI, , ,253994
MOUSE MODEL FOR OXIDATIVE DNA DAMAGE REPAIR,6689632,1/30/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2004,305000, ,NCI, , ,305000
"TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER",6689968,4/20/2000 0:00,11/30/2005 0:00,Other Research-Related,2004,132857, ,NCI, , ,132857
P53 SIGNALING AND CELLULAR RESPONSE AFTER STRESS,6690034,1/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2004,332134, ,NCI, , ,332134
In Vivo Role of DNA Alkylation Repair,6690169,8/8/1997 0:00,6/30/2008 0:00,Non-SBIR/STTR,2003,464222, ,NCI, , ,464222
Dna Damage Response In Eukaryotic Cells,6690531, , ,Intramural Research,2002, , , , , , 
PS-341 in Hepatocellular Carcinoma: A Phase II Trial,6690699,9/18/2003 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,313507, ,NCI, , ,313507
Sequence Distribution of Tobacco Carcinogen-DNA Adducts,6690739,12/1/2002 0:00,11/30/2006 0:00,Non-SBIR/STTR,2004,200094, ,NCI, , ,200094
Small molecule inhibitors of p53 in cancer treatment,6691491,9/12/2003 0:00,8/31/2004 0:00,SBIR/STTR,2003,95710, ,NCI, , ,95710
Mechanism of Apoptosis by Par4,6691657,9/30/1995 0:00,12/31/2006 0:00,Non-SBIR/STTR,2004,296840, ,NCI, , ,296840
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION,6692127,7/4/1995 0:00,11/30/2005 0:00,Non-SBIR/STTR,2004,351956, ,NCI, , ,351956
INTRAGENIC SUPPRESSOR MUTATIONS FOR P53 CANCER MUTATIONS,6693738,4/1/1999 0:00,1/31/2004 0:00,Non-SBIR/STTR,2002,162102, ,NCI, , ,162102
"Metallothionein, Environment Insult and Bladder Cancer",6693760,4/1/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2003,243980, ,NCI, , ,243980
"P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?",6693775,1/20/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2004,351731, ,NCI, , ,351731
Regulation and Function of ECK in Apoptosis,6693806,1/18/2002 0:00,12/31/2005 0:00,Non-SBIR/STTR,2004,291030, ,NCI, , ,291030
MECHANISMS OF INTESTINAL TUMORIGENESIS,6693813,1/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2004,369596, ,NCI, , ,369596
CHARACTERIZATION OF NEW HUMAN P53 DISSOCIATORS,6694011,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2002,272700, ,NCI, , ,272700
DUAL ROLE OF E2F1 IN TUMORIGENESIS,6694166,1/18/1999 0:00,12/31/2003 0:00,Non-SBIR/STTR,2003,69000, ,NCI, , ,69000
UV INDUCIBLE INHIBITION IN MELANOMA,6694417,5/5/1993 0:00,1/31/2005 0:00,Non-SBIR/STTR,2004,332978, ,NCI, , ,332978
The Bcl-2/Bcl-X Pathway in Myc-Induced Lymphomagenesis,6694816,12/15/1997 0:00,12/31/2007 0:00,Non-SBIR/STTR,2004,282000, ,NCI, , ,282000
Mechanisms of carcinogenesis by CRC-susceptibility genes,6695326,8/29/2003 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,84000, ,NCI, , ,84000
Repair of Genotoxic Damage in Chromatin,6695622,1/1/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2004,295369, ,NCI, , ,295369
Chk1 signaling in the G2 DNA damage checkpoint,6697077,2/1/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,344085, ,NCI, , ,344085
TUMOR SUPPRESSOR LIKE ACTIVITY OF ESTROGEN RECEPTOR,6697078,2/1/2001 0:00,1/31/2006 0:00,Non-SBIR/STTR,2004,223500, ,NCI, , ,223500
CONTRAST ASSISTED ULTRASOUND IMAGING OF TUMORS,6697139,12/11/1997 0:00,12/31/2006 0:00,Non-SBIR/STTR,2004,272573, ,NCI, , ,272573
Molecular Epidemiology of Secondary Lung Cancer,6697297,1/15/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2004,618513, ,NCI, , ,618513
Mutant p53 Gain of Function in Tumorigenesis,6697452,4/1/1995 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,317250, ,NCI, , ,317250
Prognostic Molecular Markers of Colorectal Cancer,6697514,1/16/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2004,287359, ,NCI, , ,287359
Apoptosis in Colon Cancer Chemoprevention,6697519,7/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2004,1363917, ,NCI, , ,1363917
Novel Approaches for Pancreatic Cancer Therapy,6698527,1/21/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2004,363788, ,NCI, , ,363788
IR-INDUCED APOPTOSIS IN THE DEVELOPING NERVOUS SYSTEM,6698562,1/15/2001 0:00,12/31/2004 0:00,Non-SBIR/STTR,2004,262500, ,NINDS, , ,262500
DISSECTION OF THE DNA DAMAGE CHECKPOINT PATHWAYS,6699256,2/1/2000 0:00,1/31/2004 0:00,Non-SBIR/STTR,2003,41945, ,NCI, , ,41945
USE OF THE MOUSE FOR PROSTATE CANCER GENE DISCOVERY,6699352,3/27/2000 0:00,2/28/2005 0:00,Other Research-Related,2004,139320, ,NCI, , ,139320
GENETIC MECHANISM OF BRCA LINKED OVARIAN TUMORIGENESIS,6700738,2/1/2001 0:00,1/31/2006 0:00,Non-SBIR/STTR,2004,281385, ,NCI, , ,281385
Inhibitors of Dynamin as Novel Anti-Cancer Therapeutics,6700914,3/12/2004 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,168930, ,NCI, , ,168930
INK4 FAMILY OF CDK INHIBITORS,6701830,7/17/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,2004,300211, ,NCI, , ,300211
Phase II Doxorubicin/Vinorelbine in wtp53 Breast Cancer,6702211,2/5/2003 0:00,1/31/2006 0:00,Non-SBIR/STTR,2004,268397, ,NCI, , ,268397
Cytoplasmic Reactivation of p53 Family Members,6702527,4/1/2004 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,219000, ,NCI, , ,219000
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7,6702606,2/15/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2004,217355, ,NCI, , ,217355
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION,6702639,2/9/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2004,396897, ,NCI, , ,396897
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1,6703113,2/15/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,285114, ,NCI, , ,285114
Role of RNase L in the Biology of Prostate Cancer,6703242,2/16/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2004,313650, ,NCI, , ,313650
GENISTEIN IN INVESTIGATIVE AND CLINICAL DERMATOLOGY,6703674,2/3/2001 0:00,1/31/2006 0:00,Non-SBIR/STTR,2004,286455, ,NCI, , ,286455
P53 Fibril Formation and Disease,6703870,3/1/2004 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,135000, ,NCI, , ,135000
Thioredoxin Inhibition of Apoptosis and Cancer Treatment,6704171,12/18/1998 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,284820, ,NCI, , ,284820
Antineoplastic Agents from Marine Organisms,6705028,9/1/1983 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,280125, ,NCI, , ,280125
Aldo-Keto Reductases and PAH Metabolism/Activation,6705058,3/1/1986 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,297980, ,NCI, , ,297980
MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS,6706211,8/4/2000 0:00,7/31/2005 0:00,Other Research-Related,2004,126711, ,NCI, , ,126711
The BRCA1-GADD45 Pathway and Genomic Stability,6706233,3/1/2002 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,252206, ,NCI, , ,252206
E2F AND APOPTOSIS,6706278,2/5/2000 0:00,1/31/2006 0:00,Non-SBIR/STTR,2004,287040, ,NCI, , ,287040
Tobacco Carcinogenesis and Chemoprevention,6706283,6/17/1996 0:00,9/10/2004 0:00,Non-SBIR/STTR,2004,1395357, ,NCI, , ,1395357
"MUTUAL REGULATION OF P53, MDM2 AND NFKB:",6706285,4/1/2000 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,202943, ,NCI, , ,202943
TGFBeta1 signaling and radiation response in pancreas CA,6706365,3/1/2002 0:00,4/30/2005 0:00,Non-SBIR/STTR,2004,133962, ,NCI, , ,133962
GRP78 AND HYPERSENSITIVITY TO DNA CROSS LINKING AGENTS,6706395,4/1/2000 0:00,3/31/2005 0:00,Other Research-Related,2004,156163, ,NCI, , ,156163
Stat3 and anti-VEGF therapy in cancer,6706879,2/21/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,290140, ,NCI, , ,290140
HCMV IN AIDS--DISRUPTION OF CELL CYCLE REGULATION,6706960,3/1/2000 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,251872, ,NIAID, , ,251872
MOLECULAR MECHANISMS OF DIET-INDUCED CARCINOGENESIS,6706997,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,310369, ,NCI, , ,310369
Molecular Mechanism of E2F Specificity,6707877,9/30/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,342650, ,NCI, , ,342650
Mechanistic Analyses of Protein Deacetylation,6708088,3/1/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2004,259943, ,NIGMS, , ,259943
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER,6708109,4/1/2002 0:00,9/29/2004 0:00,Non-SBIR/STTR,2004,358225, ,NCI, , ,358225
Molecular Targeting of the Survivin Pathway in Cancer,6709221,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2002,185238, ,NCI, , ,185238
Novel Celecoxib Derivatives as Chemopreventive Agents,6709260,9/1/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,134550, ,NCI, , ,134550
TNF alpha mediated apoptosis in prostate cancer,6710025,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,244020, ,NCI, , ,244020
EUKARYOTIC DNA ALKYLATION REPAIR,6710028,7/2/1991 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,514427, ,NCI, , ,514427
Function of MDM2 and its Alternatively spliced Isoforms,6710134,3/5/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2004,250818, ,NCI, , ,250818
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM,6710276,3/18/1994 0:00,12/31/2003 0:00,Non-SBIR/STTR,2003,134083, ,NCI, , ,134083
"AGE, CELL CYCLE MARKERS AND BREAST CANCER OUTCOMES",6710683,9/20/1999 0:00,8/31/2005 0:00,Other Research-Related,2004,61257, ,NCI, , ,61257
Melanoma in p16INK4a and p19ARF Deficient Mice,6711043,2/15/2002 0:00,11/30/2006 0:00,Other Research-Related,2004,130918, ,NCI, , ,130918
THERAPEUTIC VACCINES FOR HPV DISEASES,6711045,2/14/2001 0:00,1/31/2006 0:00,Other Research-Related,2004,136728, ,NCI, , ,136728
MODULATORS AND EFFECTORS OF MDM2 AND P53,6711083,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,273663, ,NCI, , ,273663
HPV ETIOLOGY OF A SUBSET OF HEAD AND NECK CANCERS,6711087,4/1/2000 0:00,3/31/2005 0:00,Non-SBIR/STTR,2004,312694, ,NIDCR, , ,312694
The PLZF Protein of t(11;17)-Promyelocytic Leukemia,6711130,4/1/1993 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,379845, ,NCI, , ,379845
"P13K/PTEN/Akt (PKB), Signaling and genesis of cancer",6711134,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,355841, ,NCI, , ,355841
DNA Adducts of Aromatic Amines: Analysis by HPLC-MS,6711144,5/18/1996 0:00,2/28/2007 0:00,Non-SBIR/STTR,2004,236050, ,NCI, , ,236050
Nitroaromatics and Breast Cancer,6711329,6/1/2002 0:00,3/31/2005 0:00,Non-SBIR/STTR,2003,137963, ,NCI, , ,137963
Regulation of apoptosis and tumor growth by galectin-7,6711412,3/5/2004 0:00,2/28/2007 0:00,Non-SBIR/STTR,2004,74250, ,NIAMS, , ,74250
Role of AML1-ETO in Acute Leukemia,6711717,7/1/1994 0:00,2/28/2008 0:00,Non-SBIR/STTR,2004,319365, ,NCI, , ,319365
Nitroaromatics and Breast Cancer,6711806,7/1/1983 0:00,9/10/2004 0:00,Non-SBIR/STTR,2004,295970, ,NCI, , ,295970
Regulation and Role of ODC in Apoptosis and Cancer,6712073,3/4/2003 0:00,2/29/2008 0:00,Non-SBIR/STTR,2004,333750, ,NCI, , ,333750
Analysis of the Chemopreventive Activity of FGN 1,6712081,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,313740, ,NCI, , ,313740
"p53-independent Role of MDM2, TGFb Resistance and Cancer",6712107,3/1/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2004,329656, ,NCI, , ,329656
The Interplay Between the Repressor MDM2 and Coactivator,6712793,3/1/2002 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,268780, ,NCI, , ,268780
Bioflavonoid apigenin induces phosphorylation of p53,6712860,3/10/2003 0:00,2/28/2005 0:00,Other Research-Related,2004,122666, ,NCI, , ,122666
PROTEIN PHOSPHATASE 1 AND NEOPLASTIC TRNSFORMATION,6712876,9/1/1993 0:00,8/31/2005 0:00,Non-SBIR/STTR,2004,264024, ,NCI, , ,264024
GENETIC ALTERATIONS AND MYLTIPLE MYELOMA--EFFECTS ON CELL GROWTH & APOPTOSIS,6713213, , ,Non-SBIR/STTR,2003, ,228401, , , , 
p53 TARGETS AND CHEMO /RADIOSENSITIVITY,6716671,8/25/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2003, ,140673, , , , 
Role of 53BP1 during the DNA damage response,6717718,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,259875, ,NIGMS, , ,259875
Regulated Proteolysis in RAS Signal Transduction,6717938,5/1/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2004,243375, ,NIGMS, , ,243375
p53 target Genes in Apoptosis,6718332,4/1/2004 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,278595, ,NCI, , ,278595
Targeting Calpain for Novel Anticancer Agents,6718554,5/1/2004 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,130480, ,NCI, , ,130480
Molecular Functions of the Adenoviral E1B 55 kDa Protein,6718702,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,391467, ,NIAID, , ,391467
Molecular Markers as Predictors of Outcome in Gliomas,6718946,9/1/1998 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,330344, ,NINDS, , ,330344
Analysis of Group I and II Introns in Mammalian Cells,6718971,9/30/1995 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,319100, ,NIGMS, , ,319100
Dysregulation of TGF Beta Action Pancreatic Cancer,6719614,9/30/1997 0:00,2/28/2007 0:00,Non-SBIR/STTR,2004,351749, ,NCI, , ,351749
Targeting Cancer Cell DNA with Combinatorial Ligands,6719639,4/1/1998 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,271120, ,NCI, , ,271120
Contributions of Akt to Glioblastoma Formation,6719650,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,337088, ,NCI, , ,337088
Telomere-Mediated Protective Responses in Skin,6720277,4/8/2004 0:00,2/29/2008 0:00,Non-SBIR/STTR,2004,326032, ,NCI, , ,326032
Apoptogenic Role of p53 at the Mitochondria,6720858,9/15/1993 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,273600, ,NCI, , ,273600
Mechanisms of Induction of Skin Cancers By UV Light,6721136,7/1/1988 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,213750, ,NCI, , ,213750
SELECTIVE THERAPY FOR COLON CARCINOMA,6721140,7/1/1983 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,317250, ,NCI, , ,317250
Chromosomal Abnormalities in Myeloma as Detected by FISH,6721178,4/1/2000 0:00,2/28/2008 0:00,Non-SBIR/STTR,2004,333359, ,NCI, , ,333359
Extracellular Matrix Mediated Apoptosis in p53 (-) HMECs,6721241,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,237160, ,NCI, , ,237160
The Role of HOXA5 in Breast Cancer,6721557,3/15/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004,329968, ,NCI, , ,329968
Chk2--Roles in Checkpoint and Breast Tumor Suppression,6722333,1/1/2002 0:00,12/3/2003 0:00,"Training, Individual",2003,43430, ,NCI, , ,43430
Dual Role of E2F1 in Tumorigenesis,6723531,1/18/1999 0:00,1/31/2009 0:00,Non-SBIR/STTR,2004,331029, ,NCI, , ,331029
Investigation of xrcc5 Mutant Mice,6723677,7/7/1997 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,259880, ,NCI, , ,259880
Molecular Epidemiology Of Ovarian Cancer,6723950,9/1/1998 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,641878, ,NCI, , ,641878
FIBRONECTIN REGULATION OF CARCINOMA APOPTOSIS,6724555,9/15/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,327038, ,NIDCR, , ,327038
The role of Inil in chromatin  development and cancer,6724771,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,353775, ,NCI, , ,353775
ROLE FOR CELL CYCLE PROTEINS IN HIV ENCEPHALITIS,6724894,2/1/2001 0:00,3/14/2005 0:00,Non-SBIR/STTR,2004,277375, ,NINDS, , ,277375
Differential Gene Expression Induced by Antioxidants,6724910,4/1/2003 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,75500, ,NCI, , ,75500
Transformation of human mammary epithelium by c-Myc,6724996,5/1/1997 0:00,12/31/2008 0:00,Non-SBIR/STTR,2004,349200, ,NIA, , ,349200
NEURAL TRANSCRIPTION FACTOR IN LUNG CANCER EVOLUTION,6725211,6/1/1996 0:00,8/31/2007 0:00,Non-SBIR/STTR,2003,275620, ,NCI, , ,275620
PRE-CLINICAL COMBINATION CHEMO- AND RADIOANTIBODY THERAP,6725403,5/6/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,977147, ,NCI, , ,977147
HAUSP-mediated Deubiquitination of p53,6726006,4/1/2003 0:00,3/30/2008 0:00,Non-SBIR/STTR,2004,281240, ,NCI, , ,281240
Growth Inhibition by the ARF Tumor Suppressor,6726016,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,261705, ,NCI, , ,261705
MDMX REGULATION OF THE P53 TUMOR SUPPRESSOR PROTEIN,6726031,4/1/1995 0:00,12/27/2005 0:00,Non-SBIR/STTR,2004,225225, ,NCI, , ,225225
Normal and Neoplastic Growth Regulation in the Brain,6726128,4/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,1386209, ,NCI, , ,1386209
Southwest Oncology Group,6726341,2/1/1993 0:00,12/31/2009 0:00,Other Research-Related,2004,236651, ,NCI, , ,236651
G2 Checkpoint Control In Transformed Human Cells,6726547,12/1/1998 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004,337860, ,NCI, , ,337860
ESOPHAGO GASTRIC TUMORIGENESIS IN A TRANSGENIC MODEL,6727413,5/1/2000 0:00,4/30/2005 0:00,Other Research-Related,2004,136147, ,NCI, , ,136147
APOPTOSIS AND A NEW ADAPTER MOLECULE PATHWAY IN GLIOMA,6727445,4/15/2001 0:00,3/31/2005 0:00,Non-SBIR/STTR,2004,227334, ,NCI, , ,227334
GI HORMONES AND OTHER FACTORS IN GROWTH OF GI MUCOSA,6727505,12/1/1977 0:00,3/31/2005 0:00,Non-SBIR/STTR,2004,428143, ,NIDDK, , ,428143
Nicotine Derived Nitrosamines & Tobacco Related Cancers,6727660,5/1/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,275625, ,NCI, , ,275625
Base Pairing and Mutagenesis,6727956,12/1/1988 0:00,11/30/2007 0:00,Non-SBIR/STTR,2004,342146, ,NIGMS, , ,342146
Topoisomerase I Inhibitors in Leukemia and Solid Tumors,6728214,4/1/1997 0:00,8/1/2006 0:00,Non-SBIR/STTR,2004,222233, ,NCI, , ,222233
CORE--ENVIRONMENT /GENE INTERACTIONS,6728345,4/1/2003 0:00,3/31/2008 0:00,Research Centers,2003, ,174086, , , , 
CORE--MOLECULAR EPIDEMIOLOGY AND ECOGENETICS,6728369, , ,Research Centers,2003, ,73467, , , , 
COX-2 and p53 interactions and cancer prevention,6728606,9/30/2003 0:00,8/31/2005 0:00,Non-SBIR/STTR,2003,76000, ,NCI, , ,76000
"ROLE OF MDM2, P300, P19ARF IN P53 UBIQUITINATION",6728900,4/12/2001 0:00,3/31/2006 0:00,Other Research-Related,2003,157437, ,NCI, , ,157437
The Role of Phosphatase CL100/MKP1 in Human Cancer,6728991,2/5/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2004,244529, ,NCI, , ,244529
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER,6729073,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,387760, ,NCI, , ,387760
P53 Mediated Regulation of Centrosome Duplication,6729189,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,253980, ,NCI, , ,253980
In Vitro and In Vivo Analyses of 14-O-Acylanthracyclines,6729349,4/1/2004 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,296848, ,NCI, , ,296848
Leukemogenic Slug Pathway in Hematopoietic Cell Survival,6729417,5/1/1993 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004,427500, ,NCI, , ,427500
Mouse Models of Human Breast Cancer,6729697,9/30/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,850000, ,NCI, , ,850000
Regulation of Irreversible Growth Arrest by p53,6729975,4/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,241538, ,NCI, , ,241538
"P38, G2 Arrest, and Temozolomide Resistance in Gliomas",6730145,2/1/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2004,310575, ,NCI, , ,310575
Novel p53 target gene ASC in apoptosis & mammary tumorig,6730710,4/1/1999 0:00,9/15/2004 0:00,Non-SBIR/STTR,2004,75754, ,NCI, , ,75754
P53 - REGULATORS AND EFFECTORS,6731163,2/16/2000 0:00,8/16/2005 0:00,Non-SBIR/STTR,2004,1349000, ,NCI, , ,1349000
CHROMOSOME ALTERATIONS IN BARRETT'S ESOPHAGUS,6731175,4/1/2001 0:00,3/31/2006 0:00,Other Research-Related,2004,98783, ,NCI, , ,98783
FUNCTIONS OF DIFFERENT P53 MUTATIONS IN PROSTATE CANCER,6731206,4/15/1998 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,261480, ,NCI, , ,261480
A mouse model for UV-induced junctional melanoma,6731225,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,338200, ,NCI, , ,338200
Analysis of signaling to and from p53 in cancer,6731232,9/30/2003 0:00,8/31/2004 0:00,Non-SBIR/STTR,2003,265220, ,NCI, , ,265220
Transcriptional Responses in Neurodegenerative Diseases,6731286,1/1/2004 0:00,12/31/2007 0:00,Non-SBIR/STTR,2004,261000, ,NINDS, , ,261000
Regulation of Gene Expression by PML,6731288,9/30/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,302378, ,NCI, , ,302378
Convergent functions of p53 and BRCA1 in gene regulation,6731489, , ,Non-SBIR/STTR,2003, ,237979, , , , 
PW1--A mediator of cell survival by NFKB and cell death by p53,6731490, , ,Non-SBIR/STTR,2003, ,237979, , , , 
Core--Gene knockout cell line,6731491, , ,Non-SBIR/STTR,2003, ,237978, , , , 
Genotoxic effects,6731493, , ,Non-SBIR/STTR,2003, ,73465, , , , 
p63 Signaling in Epithelial Cell Growth and Cancer,6731635,3/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004,309550, ,NCI, , ,309550
"Hypoxia, Genetic Instability and DNA Mismatch Repair",6731985,9/30/1992 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,327000, ,NIEHS, , ,327000
THERAPEUTIC MODULATION OF ANGIOGENESIS IN HUMAN GLIOMAS,6732017,4/1/2000 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,527139, ,NCI, , ,527139
PLK3 in the DNA damage checkpoint and tumor suppression,6732085,12/15/1997 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,324220, ,NCI, , ,324220
Polyoma Virus Disrupts ARF Signaling to p53,6732112,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,303379, ,NCI, , ,303379
Ceramide Synthase in Radiation-Induced Apoptosis,6732129,7/15/1990 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,396250, ,NCI, , ,396250
Genomic Plasticity in the Human U2 snRNA Cluster,6732134,4/1/1989 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,333520, ,NIGMS, , ,333520
Models for DNA repair and cell cycle control variants,6732173,4/10/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,902318, ,NIEHS, , ,902318
Epigenetic factors governing SOD2 gene expression,6732485,4/6/1998 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,307050, ,NCI, , ,307050
Differential Transcription Factor Activation by H. pylor,6732630,9/30/1997 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,252051, ,NIDDK, , ,252051
Function of the p53 tumor-suppressor in C.elegans,6732715,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,290986, ,NCI, , ,290986
SOFT TISSUE SARCOMA--P53 AND VEGF INDUCTION,6732755,9/30/1995 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,236250, ,NCI, , ,236250
Structure/Function of Human Papillomavirus Oncoproteins,6732762,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,382744, ,NCI, , ,382744
Tumor Suppressors in Spontaneous and UV-Induced Melanoma Models,6732833, , ,Non-SBIR/STTR,2003, ,243335, , , , 
"Checkpoints, DNA repair & human carcinogenesis",6733005, , ,Non-SBIR/STTR,2003, ,175236, , , , 
Mechanisms of T Cell Tumorigenesis,6733365,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,252000, ,NCI, , ,252000
TARGETING PCD FOR LEUKEMIA TREATMENT,6733645, , ,Non-SBIR/STTR,2003, ,115227, , , , 
TARGETING PCD IN BLADDER CANCER,6733646, , ,Non-SBIR/STTR,2003, ,115227, , , , 
VACCINATION AGAINST TUMOR SPECIFIC MUTANT RAS AND P53 PEPTIDES IN CANCER,6733692, , ,Research Centers,2003, ,321374, , , , 
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER,6733747, , ,Research Centers,2003, ,321374, , , , 
Profiling of signal transduction pathways in cancer,6734153,4/9/2003 0:00,3/31/2005 0:00,SBIR/STTR,2004,145634, ,NCI, , ,145634
The Apoptotic Role of MEKK1 in Cancer Chemotherapy,6734710,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2004,271450, ,NCI, , ,271450
Molecular Pathobiology of Langerhans Cell Histiocytosis,6734733,4/15/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,360628, ,NIAID, , ,360628
Molecular Basis of KSHV Pathogenesis,6735596,6/15/1999 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,380935, ,NCI, , ,380935
CLINICAL AND EPIDEMIOLOGIC CENTER FOR BIOMARKERS OF UPPE,6735599,5/1/2000 0:00,8/31/2005 0:00,Other,2004,381736, ,NCI, , ,381736
Enhancement of Tumor-Targeted Transgene Expression,6736018,9/1/2004 0:00,8/31/2005 0:00,SBIR/STTR,2004,201742, ,NCI, , ,201742
Etiology and Prevention of Oral Cancer,6736261,5/1/2003 0:00,9/10/2004 0:00,Non-SBIR/STTR,2004,319136, ,NCI, , ,319136
Murine p73 in Tumorigenesis,6736963,6/15/1998 0:00,4/30/2008 0:00,Non-SBIR/STTR,2004,397738, ,NCI, , ,397738
PEI Aerosol Delivery of ssDNA Expression Vector,6737034,3/1/2004 0:00,2/28/2006 0:00,SBIR/STTR,2004,100000, ,NCI, , ,100000
Molecular Characterization of ACF (Abberant Crypt Foci),6738606,8/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2004,261000, ,NCI, , ,261000
Cancer Genotyping by Peptide Mass Spectrometry,6739623,3/1/2000 0:00,4/30/2006 0:00,SBIR/STTR,2004,472940, ,NIGMS, , ,472940
In Vivo Ras-induced Senescence and Tumorigenesis,6739634,4/18/2003 0:00,2/28/2008 0:00,Non-SBIR/STTR,2004,352663, ,NCI, , ,352663
Apoptosis in Drosophila-From Reaper to Death,6739687,5/1/1997 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,354650, ,NIGMS, , ,354650
Role of PCAF/GCN5 Acetylation on p53 Transactivation,6740083,4/1/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,340573, ,NCI, , ,340573
THERAPEUTIC MODULATION OF ANGIOGENESIS IN HUMAN GLIOMAS,6740084,4/1/2000 0:00,2/29/2004 0:00,Non-SBIR/STTR,2003,69079, ,NCI, , ,69079
Cell cycle regulatory proteins in UVB-skin carcinogenes,6740110,4/21/2003 0:00,3/31/2008 0:00,Other Research-Related,2004,123660, ,NIAMS, , ,123660
MECHANISMS OF CELLULAR RADIOSENSITIVITY,6740310, , ,Non-SBIR/STTR,2003, ,294139, , , , 
Two Novel Sir2-Interacting Proteins in Yeast,6740518,2/1/2004 0:00,1/31/2007 0:00,"Training, Individual",2004,42976, ,NIGMS, , ,42976
SIGNALING PATHWAYS REGULATING EPITHELIAL CELL SURVIVAL,6740682,5/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,225000, ,NIDDK, , ,225000
p53 in Cellular Response to ROS-Mediated DNA Damage,6740834,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2004,302378, ,NCI, , ,302378
Molecular Pathogenesis of Breast Cancer,6740874,4/18/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,2563491, ,NCI, , ,2563491
Prospective Studies of Diet and Cancer in Men and Wonen,6740905,8/23/1991 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,4040496, ,NCI, , ,4040496
PIK RELATED KINASES IN THE RESPONSE TO DNA DAMAGE BY UV,6741211,6/1/1999 0:00,5/31/2004 0:00,Other Research-Related,2002,45815, ,NIAMS, , ,45815
Mouse Models of Gastric Cancer,6741827,5/1/2001 0:00,5/31/2004 0:00,Non-SBIR/STTR,2004,114241, ,NCI, , ,114241
Molecular Basis of Young Onset Colorectal Cancer,6741829,8/26/2002 0:00,4/30/2007 0:00,Other Research-Related,2004,125226, ,NCI, , ,125226
Allelic Deletion in Lung Cancers of Smokers & Nonsmokers,6742525,5/1/2003 0:00,4/30/2005 0:00,Non-SBIR/STTR,2004,175000, ,NCI, , ,175000
Apoptosis in Colon Cancer Chemoprevention,6742834,7/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2003,27818, ,NCI, , ,27818
Correlative Studies of erbB-2/HER2 and p53 in CALGB Pro.,6743150,5/1/2003 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,453203, ,NCI, , ,453203
Molecular Characterization of p53R2 in Head and Neck Ca,6743247,5/1/2003 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,187500, ,NCI, , ,187500
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY,6743257, , ,Non-SBIR/STTR,2003, ,250404, , , , 
Role of the Oxidative Stress Pathway in Drug Resistance,6743721,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2004,282625, ,NCI, , ,282625
Molecular Epidemiology of Fatal Prostate Cancer,6743964,4/30/2003 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,501022, ,NCI, , ,501022
STRESS INDUCED BYSTANDER EFFECT IN CANCER TREATMENT,6744070,6/9/2000 0:00,4/30/2005 0:00,Non-SBIR/STTR,2004,275400, ,NCI, , ,275400
Xenobiotics and Breast Epithelial Cell-ECM Signaling,6744112,5/3/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,260750, ,NIEHS, , ,260750
Chemo-prevention of UVB-induced Basal Cell Carcinomas+/*,6744144,5/1/2003 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,81750, ,NCI, , ,81750
Chemoprevention of Carcinogen-Induced Lung Cancer,6744172,5/1/2003 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,422500, ,NCI, , ,422500
Molecular Mechanism for HCMV Mediated Atherogenesis,6744288,9/30/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2002,259713, ,NHLBI, , ,259713
DNA Repair and Checkpoint Interactions in Mammals,6744317,5/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,334106, ,NCI, , ,334106
Transcriptional Regulation of Cell Growth,6744320,6/1/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,2481428, ,NCI, , ,2481428
Mechanisms of the Hormonal Prevention of Breast Cancer,6744714,8/1/1995 0:00,4/30/2007 0:00,Non-SBIR/STTR,2004,1057696, ,NCI, , ,1057696
"Metallothionein, Environment Insult and Bladder Cancer",6745144,4/1/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,249556, ,NCI, , ,249556
CORE--MICROARRAY,6745222, , ,Research Centers,2003, ,183723, , , , 
Genetic and Molecular Epidemiology of Adult Glioma,6745579,5/15/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,1284254, ,NCI, , ,1284254
Targeting LANA Function to Develop KSHV Antivirals,6745740,3/1/2004 0:00,10/31/2004 0:00,Non-SBIR/STTR,2004,137700, ,NCI, , ,137700
SOFT TISSUE SARCOMA PROGRAM PROJECT,6746961,1/9/1989 0:00,2/28/2006 0:00,Non-SBIR/STTR,2004,1817039, ,NCI, , ,1817039
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA,6747005, , ,Non-SBIR/STTR,2003, ,230631, , , , 
MOLECULAR PATHOLOGY OF SYNOVIAL SARCOMA,6747008, , ,Non-SBIR/STTR,2003, ,230631, , , , 
Paradoxical Effects of Bax and Bcl-2 on Oncogenesis,6747038,9/26/2003 0:00,9/25/2006 0:00,"Training, Individual",2003,26246, ,NCI, , ,26246
HEPTOCYTE PROLIFERATION AND AFLATOXIN METABOLISM,6747297,4/1/2000 0:00,9/30/2006 0:00,Non-SBIR/STTR,2004,211527, ,NIEHS, , ,211527
CELLULAR TARGETS FOR PAPILLOMAVIRUS E6 ONCOPROTEINS,6747406, , ,Non-SBIR/STTR,2003, ,228401, , , , 
Nuclear Signaling by TRADD,6748125,7/1/2003 0:00,9/14/2004 0:00,Non-SBIR/STTR,2004,15426, ,NINDS, , ,15426
ARF MDM2 P53 TUMOR SUPPRESSION PATHWAY,6748160,8/1/2000 0:00,8/31/2004 0:00,Other Research-Related,2004,21980, ,NCI, , ,21980
P53 in BBD and Breast Cancer Risk: A Multicenter Cohort,6748171,5/1/2002 0:00,4/30/2007 0:00,Non-SBIR/STTR,2004,759331, ,NCI, , ,759331
Molecular Alterations in Lobular/Ductal Breast Cancer,6748202,4/1/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,384342, ,NCI, , ,384342
Accelerated senescence in tumor cells,6748213,6/1/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,273900, ,NCI, , ,273900
Molecular Targets for Drug and Radiation Sensitivity,6748362,8/17/1998 0:00,5/31/2008 0:00,Non-SBIR/STTR,2003,149989, ,NCI, , ,149989
RhoB Signaling in Cancer Suppression and Cell Suicide,6748527,5/15/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2004,333750, ,NCI, , ,333750
"PATHOGENESIS, IMMUNODIAGNOSIS AND THERAPY OF HCC",6748547,7/1/1983 0:00,6/30/2005 0:00,Non-SBIR/STTR,2004,318000, ,NCI, , ,318000
NUCLEAR RECEPTOR COACTIVATORS AND BREAST CANCER,6748965,6/15/2000 0:00,5/31/2005 0:00,Other Research-Related,2004,117504, ,NIEHS, , ,117504
Involvement of APC in DNA Repair,6749055,5/16/2003 0:00,4/30/2007 0:00,Non-SBIR/STTR,2004,258842, ,NCI, , ,258842
Structural Determinants in Cell Growth Control by p21,6749501,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,249000, ,NCI, , ,249000
Training in Molecular Basis of Skin Pathobiology,6749958,6/1/2004 0:00,5/31/2009 0:00,"Training, Institutional",2004,240532, ,NCI, , ,240532
Expression of Simian Virus 40 T antigens in Intestine,6750109,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,326070, ,NCI, , ,326070
MECHANISMS OF ARSENIC CARCINOGENESIS,6750145,7/12/2002 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,367875, ,NIEHS, , ,367875
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,6750182,9/30/1995 0:00,11/30/2005 0:00,Non-SBIR/STTR,2004,2158168, ,NCI, , ,2158168
Structural basis for CBP/p300 transcriptional regulation,6750633,6/10/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2004,412070, ,NCI, , ,412070
Diverse Natural Products That Stabilize Microtubules,6750755,7/6/1999 0:00,4/30/2007 0:00,Non-SBIR/STTR,2004,370690, ,NCI, , ,370690
Function & Purification of the Fanconi Anemia Protein C*,6750770,7/1/2002 0:00,5/31/2007 0:00,Other Research-Related,2004,100845, ,NHLBI, , ,100845
ROLE OF SAMe IN LIVER FUNCTION AND INJURY,6751143,9/20/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2004,349051, ,NCCIH, , ,349051
RESTORATION OF APOPTOSIS IN CANCER,6751382,7/23/1999 0:00,4/30/2004 0:00,Non-SBIR/STTR,2003,1730, ,NCI, , ,1730
"HPV, Genetic Instability & Oral Cancer",6751554,8/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,240188, ,NIDCR, , ,240188
Chemoprevention of Bladder CA by soybean bioactive comp.,6751663,6/1/2003 0:00,5/31/2007 0:00,Non-SBIR/STTR,2004,302600, ,NCI, , ,302600
P53 AND UV REGULATION OF P53 BINDING PROTEIN BBP/53BP2,6751876,6/7/2000 0:00,5/31/2005 0:00,Other Research-Related,2004,132921, ,NCI, , ,132921
Prevention of ER-negative Breast Cancer: Identification*,6751943,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2004,465456, ,NCI, , ,465456
Molecular cytology of human telomeres-telomere protein,6751956,5/1/1993 0:00,6/30/2005 0:00,Non-SBIR/STTR,2004,377420, ,NIGMS, , ,377420
Unique BRCA1 transcriptional response leading to repair,6752100,4/22/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,359101, ,NCI, , ,359101
Adenocarinoma of the Lung in Women,6752126,6/13/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,614505, ,NCI, , ,614505
RNA Tumor Virus-Hematopoietic cell Interaction,6752453,6/1/1983 0:00,5/31/2008 0:00,Non-SBIR/STTR,2004,335228, ,NCI, , ,335228
Mechanisms of Growth Inhibition by Helicobacter Pylor,6752694,6/1/2003 0:00,11/30/2003 0:00,Non-SBIR/STTR,2003,50736, ,NIDDK, , ,50736
Novel Technology for the Analysis of Gene Expression,6752720,8/1/1999 0:00,6/30/2004 0:00,SBIR/STTR,2003,46797, ,NCI, , ,46797
Role of IGFBP -3 in mediating p53-induced apoptosis,6752760,8/15/2002 0:00,6/30/2007 0:00,Other Research-Related,2004,131652, ,NIDDK, , ,131652
Leukotriene Biosynthesis: Inflammation and Cancer,6752898,8/1/1988 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,262500, ,NIAID, , ,262500
Molecular Genetic Basis for Gynecologic Neoplasias,6753256, , ,Intramural Research,2002, , , , , , 
P53 Biomaker and Intervention in Occupational Cancer,6753496,6/1/2002 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,209280, ,NIOSH, , ,209280
Rapamycin-induced Selective Apoptosis in Malignant Cells,6753505,12/1/1998 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,282000, ,NCI, , ,282000
Expression of Proapoptotic Genes for Cancer Therapy,6753594,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,333252, ,NCI, , ,333252
Childhood Cancer Gene Program Project Grant,6753692,8/1/1996 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,1867761, ,NCI, , ,1867761
FUNCTION OF INK4A/ARF IN PEDIATRIC NEOPLASIA,6753711, , ,Non-SBIR/STTR,2003, ,241412, , , , 
Methylation and Oxidation in Breast Cancer Epidemiology,6754441,6/1/2002 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,595445, ,NCI, , ,595445
Progression/Oncogene Induced Prostate Cancer,6754461,9/8/1989 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,312288, ,NCI, , ,312288
Function of ATF2 URE binding protein in human melanoma,6754472,1/1/1991 0:00,5/31/2005 0:00,Non-SBIR/STTR,2004,351713, ,NCI, , ,351713
Mechanisms of Genetic Instability and Tumor Suppression,6754549,7/1/1993 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,578555, ,NCI, , ,578555
Roles of DMP1 in Ras signaling and lung cancer,6754825,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,264988, ,NCI, , ,264988
Upper Gastrointestinal Cancer Genetic Studies,6754967, , ,Intramural Research,2002, , , , , , 
Gastroenterological Cancer Studies,6754986, , ,Intramural Research,2002, , , , , , 
PILOT--MOLECULAR PREDICTORS OF ORAL CANCER DEVELOPMENT,6755263, , ,Non-SBIR/STTR,2003, ,19000, , , , 
PILOT--INVASION REGULATED BY FIBRONECTIN AND  RECEPTORS,6755264, , ,Non-SBIR/STTR,2003, ,19000, , , , 
Consulting and Collaboration on Laboratory Studies,6755528, , ,Intramural Research,2002, , , , , , 
Studies of Medical Radiation and Other Therapeutic Agent,6755529, , ,Intramural Research,2002, , , , , , 
Molecular Genetic Epidemiology of Primary Hepatocellular,6755578, , ,Intramural Research,2002, , , , , , 
Genetic Predisposition to Aflatoxin-Induced Hepatocellul,6755593, , ,Intramural Research,2002, , , , , , 
Studies of Rare Cancers,6755644, , ,Intramural Research,2002, , , , , , 
Molecular Pathology of Pulmonary Carcinogenesis,6755718, , ,Intramural Research,2002, , , , , , 
The Molecular Genetics of Gynecologic Cancers,6755730, , ,Intramural Research,2002, , , , , , 
Molecular Mechanism of Genistein in Prostate Cancer,6755970,7/12/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,216423, ,NCI, , ,216423
ARSENIC BIOMARKER EPIDEMIOLOGY,6756047, , ,Non-SBIR/STTR,2003, ,293470, , , , 
Apoptotic Response to DNA Damage Initiated by PUMA,6756165,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,274213, ,NCI, , ,274213
"Antigen-specific T-cell activation, application to vacci",6756237, , ,Intramural Research,2002, , , , , , 
Laboratory and Clinical Translational Studies of Drug Re,6756296, , ,Intramural Research,2002, , , , , , 
IL10 and IGF1 Receptor Axis in Prostate Cancer,6756456,6/5/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,281993, ,NCI, , ,281993
Epigenetic effects on susceptibility to heavy metal & PAH induced DNA damage,6756657, , ,Non-SBIR/STTR,2003, ,164076, , , , 
Nitric Oxide as a Modifier of Oxidative Stress,6756837, , ,Intramural Research,2002, , , , , , 
Role of HSP90 Family Chaperone Proteins in Cellular Sign,6757105, , ,Intramural Research,2002, , , , , , 
HPV E6 protein regulation of the hTERT promoter,6757107,9/16/2004 0:00,8/31/2009 0:00,Non-SBIR/STTR,2004,314280, ,NCI, , ,314280
Mechanisms of luteinization in the primate ovary,6757247,7/1/2003 0:00,4/1/2005 0:00,Non-SBIR/STTR,2004,282476, ,NICHD, , ,282476
Analysis of p53 regulation in neuroblastoma cell lines,6757423, , ,Intramural Research,2002, , , , , , 
The replication checkpoint and genomic fidelity in skin,6757512,6/1/2004 0:00,5/31/2009 0:00,Other Research-Related,2004,104220, ,NIAMS, , ,104220
Role of CDK4 in Cell Cycle Progression and Cancer,6757938,9/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,376250, ,NIA, , ,376250
Effects of DNA Damaging Agents on G2 Phase Checkpoint,6757988,7/11/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,249375, ,NCI, , ,249375
Inflammatory Breast Cancer,6758273, , ,Intramural Research,2002, , , , , , 
The Evaluation of Novel Therapeutics for Genitourinary M,6758275, , ,Intramural Research,2002, , , , , , 
Identification of mechanisms and consequences of chromos,6758335, , ,Intramural Research,2002, , , , , , 
Characterization of Mouse CD8+ CTL/Tumor Interactions In,6758400, , ,Intramural Research,2002, , , , , , 
Lung cancer molecular markers by sex: intergroup study,6759057,4/15/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,482797, ,NCI, , ,482797
Inhibition of the TNF Apoptotic Pathway by HPV 16 E6,6759361,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,288360, ,NCI, , ,288360
DDR1 in p53-mediated suppression and in breast cancer,6759390,7/1/2003 0:00,9/15/2004 0:00,Non-SBIR/STTR,2004,22773, ,NCI, , ,22773
"Characterization of Fortilin, A Novel Anti-p53 Protein",6759422,9/30/2001 0:00,7/31/2007 0:00,Non-SBIR/STTR,2004,267361, ,NHLBI, , ,267361
Diagnostic Therapeutic Targets in Prostate Cancer,6759439,6/12/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2004,340425, ,NCI, , ,340425
Determinants of Breast Cancer Survival,6759467,6/1/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2004,638634, ,NCI, , ,638634
Normal and Neoplastic Growth Regulation in the Brain,6759969,7/1/2002 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,330950, ,NCI, , ,330950
Structure-Function of Protein Deacetylases,6760491,3/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004,303873, ,NCI, , ,303873
COLON CANCER PREVENTION PROGRAM PROJECT,6760599,9/30/1986 0:00,7/31/2005 0:00,Non-SBIR/STTR,2003,124119, ,NCI, , ,124119
The role of p53 in remodeling DNA methylation in cancer,6760821,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,260140, ,NCI, , ,260140
MOLECULAR MECHANISMS OF CHEMOTHERAPY-INDUCED HAIR LOSS,6760913,6/16/2003 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,306850, ,NCI, , ,306850
Imidodipeptides and Amino Acid Metabolites in Cell Regul,6761403, , ,Intramural Research,2002, , , , , , 
T-Cell Antigen Recognition and Tumor Antigens,6761410, , ,Intramural Research,2002, , , , , , 
Gene Regulation and Function: The B-ZIP Proteins,6761456, , ,Intramural Research,2002, , , , , , 
Mechanisms of Induction and Suppression of Viral and Tum,6761464, , ,Intramural Research,2002, , , , , , 
Analysis of Pathways that Suppress or Accelerate Premali,6761545, , ,Intramural Research,2002, , , , , , 
Molecular Epidemiology of Human Cancer,6761550, , ,Intramural Research,2002, , , , , , 
Regulation of papillomavirus gene expression,6761551, , ,Intramural Research,2002, , , , , , 
T-cell Transformation by Oncoviruses,6761578, , ,Intramural Research,2002, , , , , , 
Mechanism of viral hepatitis-mediated hepatocarcinogenes,6761638, , ,Intramural Research,2002, , , , , , 
Mutational and Functional Analysis of the p53 Tumor Supp,6761640, , ,Intramural Research,2002, , , , , , 
DNA Repair and Cell Cycle Checkpoints as Targets for Ant,6761648, , ,Intramural Research,2002, , , , , , 
DNA Topoisomerases as Target of Action of Anticancer Dru,6761650, , ,Intramural Research,2002, , , , , , 
Molecular Biology of Cellular Injury,6761681, , ,Intramural Research,2002, , , , , , 
New strategies for drug discovery: Gene expression profi,6761684, , ,Intramural Research,2002, , , , , , 
Computer Analysis of Nucleic Acid Structure,6762009, , ,Intramural Research,2002, , , , , , 
Oncogenes and tumor suppressors in murine acute myeloid,6762086, , ,Intramural Research,2002, , , , , , 
Molecular analysis of growth regulation,6762094, , ,Intramural Research,2002, , , , , , 
The Role of Tobacco-Related Chemical Carcinogens and Oxy,6762649, , ,Intramural Research,2002, , , , , , 
DNA Repair,6762962, , ,Intramural Research,2002, , , , , , 
Genetics Susceptibility to Development of Skin Tumors,6762971, , ,Intramural Research,2002, , , , , , 
Structure-function analysis of HPV E6 proteins,6763042,8/1/2002 0:00,7/31/2005 0:00,"Training, Individual",2004,48928, ,NCI, , ,48928
Mechanisms of Radioresistance and Cell Cycle Progression,6763089,5/1/1995 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,367875, ,NIGMS, , ,367875
Function of the ATR-ATRIP complex,6763248,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,268780, ,NCI, , ,268780
Analysis of cellular gene expression in HPV infection an,6763497, , ,Intramural Research,2002, , , , , , 
Molecular profiling of hepatocellular carcinoma,6763500, , ,Intramural Research,2002, , , , , , 
Regulation and Function of the p53 Tumor Suppressor Prot,6763536, , ,Intramural Research,2002, , , , , , 
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium,6763687,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,275828, ,NCI, , ,275828
Mechanisms of G2/M cell cycle checkpoint controls,6763835, , ,Intramural Research,2002, , , , , , 
Developmental Therapeutics,6763853, , ,Intramural Research,2002, , , , , , 
131 I-MIBG Escalating Dose Rapid Sequence Double Infusi*,6763972,6/20/2003 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,261006, ,NCI, , ,261006
Quantitative Gene Expression in Human Lung Epithelium,6764070,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,355150, ,NCI, , ,355150
Prevention of Skin Cancer by Scutellaria Baicalensis,6764986,9/18/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,77699, ,NCCIH, , ,77699
Molecular Pathogenesis of Ewing Sarcoma,6765146,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,249000, ,NCI, , ,249000
Molecular Targeting of the Survivin Pathway in Cancer,6765309,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,296933, ,NCI, , ,296933
"Heterogeneity of Human Melanoma, Cytokines and iNOS",6765807,7/12/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,267000, ,NCI, , ,267000
Prevention of Skin Cancer by Scutellaria Baicalensis,6766005,9/18/2000 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,355716, ,NCCIH, , ,355716
Regulation of Astrocytoma Growth,6766706,4/15/2002 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,252035, ,NINDS, , ,252035
Stabilization of MDM2 by mutant p53,6766767,7/1/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,241063, ,NCI, , ,241063
PI 3K PATHWAY IN BCR/ABL INDUCED LEUKEMIAS,6766814,7/1/2000 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,283950, ,NCI, , ,283950
CHARACTERIZATION OF NEW HUMAN P53 DISSOCIATORS,6766815,7/1/2000 0:00,6/30/2005 0:00,Non-SBIR/STTR,2004,272700, ,NCI, , ,272700
Hepatitis HBx-Mediated Pathogenesis,6766936,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,301376, ,NCI, , ,301376
Oncogenes and loss of ER in a new p53 breast tumor model,6766971,5/10/1989 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,303000, ,NCI, , ,303000
Studies of p53 and Amyloidogenic Proteins,6767023,7/1/2004 0:00,6/30/2008 0:00,Other Research-Related,2004, ,216497, , , , 
Sunlight-Related Steps in Human Skin Cancer,6767548,4/1/1992 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,327000, ,NCI, , ,327000
Role of TRRAP in the p53-Mediated Transcription of mdm2,6767562,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,295577, ,NCI, , ,295577
Models of DRA growth suppression in colon cancer,6767565,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,259880, ,NCI, , ,259880
Barrett's Esophagus: Predictors of Progression,6767580,8/16/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,2256290, ,NCI, , ,2256290
Microsatellite instability and cancer gene expression,6767682,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,427200, ,NCI, , ,427200
Normal and Neoplastic Regulation of Cyclin E,6767695,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,384925, ,NCI, , ,384925
Human and Murine Models of BRCA1 Tumorigenesis,6768606,1/7/1998 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,277375, ,NCI, , ,277375
Centrosomes in the Control of Mitosis and Interphase,6768669,5/1/1982 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,395258, ,NIGMS, , ,395258
METABOLIC GENOTYPES & ONCOGENIC DAMAGE IN BREAST CANCER,6768855,7/1/2000 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,259200, ,NCI, , ,259200
Functions of Human Papillomavirus E6,6768985,4/8/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,293355, ,NCI, , ,293355
"Oxidative DNA Damage, DNA Repair and Oral Cancer",6769372,9/1/2001 0:00,8/31/2006 0:00,Other Research-Related,2004,133650, ,NCI, , ,133650
 Model of Tumor Suppression by BRCA1,6769419,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,339424, ,NCI, , ,339424
Exploring How HTLV-1 Tax Induces T Cell Leukemia,6769460,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,365150, ,NCI, , ,365150
" 8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA",6769534,7/5/2000 0:00,9/30/2004 0:00,Non-SBIR/STTR,2004,104671, ,NCI, , ,104671
NEW METHODS FOR CANCER DETECTION,6769555,3/1/1997 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,2984622, ,NCI, , ,2984622
The XP Variant:  A Human Mutator Gene for UV Damage,6769587,2/1/1998 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,331875, ,NIEHS, , ,331875
Modes of Prostate Ca Progression--role of p53 Pathway,6769610,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,240345, ,NCI, , ,240345
MCAV in Organ-Confined Bladder CA based on p53 Status,6769882,5/1/1997 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,548428, ,NCI, , ,548428
Specificity of Ubiquitination: the HPVE6/E6AP Paradigm,6769954,12/13/1996 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,280120, ,NCI, , ,280120
Quantitative FDG-PET for Imaging Woodchuck HCC,6769980,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,371281, ,NCI, , ,371281
Breast Cancer Therapy by Differentiation Gene Activation,6769986,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,302600, ,NCI, , ,302600
Molecular Analysis of Esophageal Cancer Survival,6770097,7/3/2003 0:00,6/30/2008 0:00,Other Research-Related,2004,135837, ,NCI, , ,135837
"A Novel Pathway Involving E2F1, ATM and NBS1",6770197,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,335975, ,NCI, , ,335975
The Role of Mdm2 in Lymphoma Development,6770198,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,314769, ,NCI, , ,314769
Mechanisms of cyclin E associated tumorigenesis,6770211,7/1/2003 0:00,6/30/2008 0:00,Other Research-Related,2004,133566, ,NCI, , ,133566
p53 loss in HMECs: a model of breast cancer prevention,6771129,7/3/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,308385, ,NCI, , ,308385
Mrad9 Radioresistance Gene,6771164,7/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,308410, ,NCI, , ,308410
Mitotic Checkpoint Proteins in Tumorigenesis,6771203,7/18/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,378028, ,NCI, , ,378028
The Role of p53 and 14-3-3 in Genomic Instability,6771438,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,277903, ,NCI, , ,277903
Enhancement of Ad-p53 Therapy with Intratumoral Taxane,6771740,7/3/2003 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,151000, ,NIDCR, , ,151000
Regulation of p53-mediated apoptosis in gliomas,6771742,7/17/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,268780, ,NCI, , ,268780
In Vivo Role of DNA Alkylation Repair,6771835,8/8/1997 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,469915, ,NCI, , ,469915
Cancer Biology in the Zebrafish,6771868,7/3/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,360450, ,NCI, , ,360450
Cellular Stress Response Signaling Pathways,6771905,1/1/1992 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,337500, ,NIEHS, , ,337500
Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family Members,6772180,4/1/2004 0:00,3/31/2008 0:00,Other Research-Related,2004, ,136968, , , , 
Tumor Suppression by Protein Kinase C-delta,6772199,4/1/2004 0:00,3/31/2008 0:00,Other Research-Related,2004, ,74384, , , , 
BIOLOGICAL ACTIVITY OF HPV E7 IN HUMAN EPITHELIAL CELLS,6772389,4/19/1996 0:00,6/30/2005 0:00,Non-SBIR/STTR,2004,394550, ,NCI, , ,394550
Deregulation of Cell Pathways by Ad E1B 55K Oncoproteins,6772514,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,271721, ,NCI, , ,271721
DRUG METABOLIZING ENZYMES-RISK FACTORS IN BLADDER CANCER,6772517,7/1/1994 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,406508, ,NCI, , ,406508
The replication checkpoint and genomic fidelity in skin,6772679,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,362918, ,NIAMS, , ,362918
POLYAMINE ANALOG REGULATION OF CELL CYCLE AND APOPTOSIS,6772985,8/1/1989 0:00,4/30/2008 0:00,Non-SBIR/STTR,2004,348607, ,NCI, , ,348607
Adenocarcinoma of the Lung: role of NNK susceptibility,6773011,9/30/1991 0:00,4/30/2009 0:00,Non-SBIR/STTR,2004,631073, ,NCI, , ,631073
THE ROLE OF SPARC IN GLIOMA INVASION,6773028,7/1/2000 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,259200, ,NCI, , ,259200
Function of Mammalian SIRT1 in Aging,6773056,5/1/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2004,400965, ,NIA, , ,400965
Biology of Breast Cancers Arising in Older Women,6773200,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,555085, ,NIA, , ,555085
The MED1 Protein in DNA Damage Response and Repair,6773651,7/1/1998 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004,357223, ,NCI, , ,357223
Mechanisms of tumor promotion and carcinogenesis,6774616,1/1/1994 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,262800, ,NCI, , ,262800
Small Molecule Kinase Inhibitor for Malignant Glioma,6774691,7/10/2003 0:00,6/30/2005 0:00,Non-SBIR/STTR,2004,77307, ,NCI, , ,77307
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,6774769,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,350400, ,NCI, , ,350400
Role of WISp39 and Ubiquitination in p21 Function,6775035,4/9/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,343724, ,NCI, , ,343724
T cell activation and crypt cell apoptosis,6775326,2/15/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,294690, ,NIDDK, , ,294690
Microarray Analysis of HNSCC as a Predictor of Treatment,6775717,9/1/2002 0:00,8/31/2006 0:00,Other Research-Related,2004,135000, ,NIDCR, , ,135000
Strategies to Enhance Adenoviral Mediated Tumor Killing,6776429,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,314340, ,NCI, , ,314340
Cell Cycle Dysregulation in Oral Cancer,6777135,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004,423966, ,NIDCR, , ,423966
Monoclonal Antibody Therapy in B-Cell CLL,6777334,6/1/2004 0:00,5/31/2009 0:00,Other Research-Related,2004,131814, ,NCI, , ,131814
JC Virus and Tumor Formation in the Human Colon,6777346,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,274725, ,NCI, , ,274725
Papillomavirus Inhibitors for AIDS-related Malignancies,6777522,7/29/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,279388, ,NCI, , ,279388
Studies of Materials with Physiological Properties,6777610,9/1/1988 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,546026, ,NIGMS, , ,546026
ENDOGENOUS MODULATION OF COCHLEA INJURY,6777783,7/1/1994 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,325325, ,NIDCD, , ,325325
Molecular Mechanisms by which Rexinoids Prevent BRCA,6778023,4/6/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2004,342682, ,NCI, , ,342682
Role of E6-AP in the Development of Prostate Cancer,6778265,9/30/2001 0:00,11/30/2004 0:00,Non-SBIR/STTR,2004,64394, ,NIDDK, , ,64394
NEW MODELS FOR COMPARATIVE STUDIES OF GONADAL TUMORS,6778390,12/16/1993 0:00,7/31/2007 0:00,Non-SBIR/STTR,2004,257250, ,NIEHS, , ,257250
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS,6778614,4/1/1980 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,281250, ,NCI, , ,281250
Regulation of Stat3 by p53 in cancer Cells,6779707,8/9/2002 0:00,8/31/2004 0:00,Non-SBIR/STTR,2004,11638, ,NCI, , ,11638
P53 and Organismal Aging,6779736,9/15/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2004,567233, ,NIA, , ,567233
Breast Carcinoma In-Situ: Mammographic Risk Factors,6780152,6/1/2004 0:00,5/31/2008 0:00,Non-SBIR/STTR,2004,364367, ,NCI, , ,364367
Role of Prdx 1 in Natural Killer Cells and Tumorigenesis,6780310,9/2/2005 0:00,7/31/2008 0:00,Other Research-Related,2005,108000, ,NIEHS, , ,108000
Cyclin G in p53 mediated pathways and breast cancer,6780883,7/1/2001 0:00,9/15/2004 0:00,Non-SBIR/STTR,2004,110550, ,NCI, , ,110550
Mechanistic Studies on New Platinum Clinical Agents,6780926,9/30/1998 0:00,7/31/2007 0:00,Non-SBIR/STTR,2004,305500, ,NCI, , ,305500
ARF ACTIVATION BY POLYOMA VIRUS T-ANTIGEN,6781095,7/25/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,269670, ,NCI, , ,269670
Functional studies of the top 1-binding protein topors,6781100,5/1/1999 0:00,7/31/2007 0:00,Non-SBIR/STTR,2004,328883, ,NCI, , ,328883
Methylation of the Calcitonin Gene in Human Tumors,6781257,9/30/1986 0:00,5/31/2009 0:00,Non-SBIR/STTR,2004,449625, ,NCI, , ,449625
Role of Mdm2 in Cell Growth and Tumorigenesis,6781437,3/1/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,326532, ,NCI, , ,326532
Transcriptional Control of Gastrin,6781725,9/1/1993 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,421235, ,NIDDK, , ,421235
CHARACTERIZATION OF A NEW GENE IN P53 MUTANT LFS FAMILY,6781747,8/4/2000 0:00,7/31/2005 0:00,Other Research-Related,2003,162000, ,NCI, , ,162000
Mechanism of mitotic exit in budding yeast,6782257,8/1/1999 0:00,3/31/2008 0:00,Non-SBIR/STTR,2004,255128, ,NIGMS, , ,255128
Epidemiology of HPV and p53 Mutations in NM Skin Cancer,6782543,8/1/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,562396, ,NCI, , ,562396
Molecular Genetics of HNPCC,6782664,6/1/1997 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,452889, ,NCI, , ,452889
Bladder Tumor Targeting by Intravesical Paclitaxel,6783099,8/1/2004 0:00,7/31/2006 0:00,SBIR/STTR,2004,300157, ,NCI, , ,300157
CHARACTERIZATION OF A NEW GENE IN P53 MUTANT LFS FAMILY,6783432,8/4/2000 0:00,7/31/2006 0:00,Other Research-Related,2004,163798, ,NCI, , ,163798
Yeast Assay for p53 Molecular Analysis in Bladder Cancer,6783913,4/1/2004 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,133280, ,NCI, , ,133280
Biology of CHK2 Kinase In Lung Cancer,6783924,4/1/2004 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,73000, ,NCI, , ,73000
DNA Damage Checkpoints,6784008,8/10/1998 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,326152, ,NCI, , ,326152
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS,6784157,7/12/2002 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,523113, ,NCI, , ,523113
Translation of tumor suppressor genes to lung cancer the,6784251,8/1/2003 0:00,4/30/2008 0:00,Research Centers,2003, ,308700, , , , 
 anti-tumor activity of deacetylase inhibitors,6784351,4/8/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,286344, ,NCI, , ,286344
Phase II Study of Sulindac in Oral Premalignant Lesions,6784389,9/1/2005 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,65350, ,NCI, , ,65350
THE MOLECULAR BIOLOGY OF RETINOBLASTOMA,6784491,2/1/1999 0:00,11/30/2004 0:00,Non-SBIR/STTR,2003,180368, ,NEI, , ,180368
Regulation of p53 in reespnse to genotoxic stress,6784580,8/1/2003 0:00,7/31/2007 0:00,Non-SBIR/STTR,2004,298775, ,NIGMS, , ,298775
Studies of Childhood Solid Tumors,6784612,8/1/1978 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,1604058, ,NCI, , ,1604058
"Gastric Cancer Prognosis--MSI, BAX, DCC, & p53 LOH",6784647,8/6/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,304145, ,NCI, , ,304145
Partnership to Increase Hispanic Cancer Research for Co*,6784688,9/20/2002 0:00,7/31/2006 0:00,Research Centers,2004,86849, ,NCI, , ,86849
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors,6784707,8/5/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,224140, ,NCI, , ,224140
Hormonal regulation of p53 activity in mammary tissue,6784932,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,285975, ,NCI, , ,285975
Arsenic Induced Miotic Arrest Associated Apoptosis,6785259,8/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2004,279300, ,NIEHS, , ,279300
INNOVATIVE TUMOR TARGETED THERAPIES FOR LUNG CANCER,6785262,9/1/2000 0:00,8/31/2006 0:00,Other Research-Related,2004,125620, ,NCI, , ,125620
INHIBITION OF RIBONUCLEOTIDE REDUCTASE IN GLIOMAS,6785423,7/10/2003 0:00,7/9/2006 0:00,"Training, Individual",2004,54352, ,NCI, , ,54352
Chemoresistance in Renal Cell Cancer,6785510,7/8/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,282108, ,NCI, , ,282108
GENISTEIN IN INVESTIGATIVE AND CLINICAL DERMATOLOGY,6785642,2/3/2001 0:00,1/31/2006 0:00,Non-SBIR/STTR,2003,49562, ,NCI, , ,49562
PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS,6785690,5/1/2004 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,140124, ,NCI, , ,140124
Diverse Natural Products That Stabilize Microtubules,6785715,7/6/1999 0:00,6/30/2004 0:00,Non-SBIR/STTR,2003,98113, ,NCI, , ,98113
Use of Beta-Lapachone for Lung Cancer Chemotherapy,6785862,8/1/2003 0:00,6/30/2005 0:00,Non-SBIR/STTR,2004,311651, ,NCI, , ,311651
Regulation of MDM2 by the ribosomal protein L11,6785918,8/1/2003 0:00,8/31/2004 0:00,Non-SBIR/STTR,2004,11125, ,NCI, , ,11125
Biomarkers in Phototherapy of Barrett's Esophagus,6785968,9/30/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2004,321513, ,NCI, , ,321513
Function of the Adenovirus E1B Oncogene,6785973,1/1/1991 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,303419, ,NCI, , ,303419
Actin-regulated Apoptosis in Mammary Tumorigenesis,6785995,8/1/2003 0:00,7/31/2008 0:00,Other Research-Related,2004,159810, ,NCI, , ,159810
Cyclin/cdk Regulation of P53 in Prostate Cancer,6786037,7/1/2001 0:00,12/31/2004 0:00,Other Research-Related,2004,97809, ,NCI, , ,97809
Molecular Epidemiology of Non-Melanoma Skin Cancer,6786055,9/30/1999 0:00,7/31/2007 0:00,Non-SBIR/STTR,2004,422853, ,NCI, , ,422853
The role of hBUB1-p53 pathway in genomic stability.,6786057,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,287470, ,NCI, , ,287470
 REPRESSION BY C SKI AND MELANOMA PROGRESION,6786619,7/1/2000 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,269100, ,NCI, , ,269100
MOLECULAR MECHANISMS OF IRON CHELATOR CYTOTOXICITY,6786803,6/1/2000 0:00,4/30/2004 0:00,Non-SBIR/STTR,2003,36720, ,NIDDK, , ,36720
Role of ATM in Radiosensitivity of Gliomas,6787206,9/10/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,271263, ,NCI, , ,271263
COLON CANCER PREVENTION PROGRAM PROJECT,6787305,9/30/1986 0:00,7/31/2005 0:00,Non-SBIR/STTR,2004,3303120, ,NCI, , ,3303120
Oxidative damage to gastric epithelal cells by H pylori,6787315,9/21/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,266400, ,NIDDK, , ,266400
Gene Networks for Prostate Cancer Progression,6787320,8/5/2003 0:00,7/31/2006 0:00,Other Research-Related,2004,159300, ,NCI, , ,159300
Interaction Between SV40 Large T and p185 Cullin,6787332,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,366834, ,NCI, , ,366834
MOLECULAR GENETICS & EPIGENETICS OF COLORECTAL ADENOMAS,6787343, , ,Non-SBIR/STTR,2003, ,241412, , , , 
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER,6788042,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,265220, ,NCI, , ,265220
LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU,6788067,7/1/2000 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,642897, ,NCI, , ,642897
Functional analysis of the p53 tumor suppressor,6788197,8/15/1985 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,215200, ,NCI, , ,215200
Telomere homolog oligonucleotides for cancer therapy,6788416,3/5/2004 0:00,8/28/2005 0:00,SBIR/STTR,2004,212520, ,NCI, , ,212520
DNA Repair and p53 in Oral Cancer,6788579,5/15/2004 0:00,3/31/2006 0:00,Non-SBIR/STTR,2004,76667, ,NIDCR, , ,76667
Function of the Adenovirus E1B Oncogene,6788638,1/1/1991 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,102534, ,NCI, , ,102534
Partnership To Increase Hispanic Cancer Res/Edu. in Col.,6788762,9/16/2002 0:00,7/31/2006 0:00,Research Centers,2004,205433, ,NCI, , ,205433
Snap-To-It PNA Arrays,6789179,5/1/2002 0:00,10/31/2004 0:00,SBIR/STTR,2003,87086, ,NCI, , ,87086
Mechanism of Meclp in the Checkpoint Response,6789328,9/1/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2004,223500, ,NIGMS, , ,223500
Molecular Diagnostics for Breast Cancer,6789419,8/2/2002 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,493233, ,NCI, , ,493233
Effect of mutant p53 on stress-response,6789874,8/12/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,254363, ,NCI, , ,254363
Detection of Tumor RNA Variants using PMSG,6790180,4/6/2004 0:00,10/5/2004 0:00,SBIR/STTR,2004,99671, ,NCI, , ,99671
TUMOR MARKERS TO PREDICT TREATMENT RESPONSE,6790615,9/10/2001 0:00,8/31/2006 0:00,Other Research-Related,2004,279393, ,NIA, , ,279393
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1,6790688, , ,Non-SBIR/STTR,2003, ,434203, , , , 
PROGNOSTIC & PREDICTIVE  FACTORS IN OUTCOME OF PATIENTS WITH COLORECTAL CANCER:,6791840,4/1/2004 0:00,3/31/2009 0:00,Research Centers,2004, ,178725, , , , 
MOLECULAR CHANGES IN THE NKFB PATHWAY IN RESPONSE TO CHEMORADIATION THERAPY IN RE,6791844,4/1/2004 0:00,3/31/2009 0:00,Research Centers,2004, ,186624, , , , 
Molecular Mechanism for HCMV Mediated Atherogenesis,6792643,9/30/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,376250, ,NHLBI, , ,376250
Statistical Methods in Genetic Epidemiology,6792666,6/1/1997 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,256580, ,NIA, , ,256580
Functional Dissection of Signaling Pathways,6792857,3/11/2004 0:00,8/31/2005 0:00,SBIR/STTR,2004,103553, ,NCI, , ,103553
Transduction of Tumor Suppressor Proteins into Gliomas,6793571,9/5/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,248886, ,NCI, , ,248886
MTOR as a Therapeutic Target in Childhood Cancer,6794142,9/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,300375, ,NCI, , ,300375
Mda-7: Novel Cancer Therapeutic Gene,6794169,9/10/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2004,291030, ,NCI, , ,291030
Function of the Adenovirus E1B Oncogene,6794307,1/1/1991 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,45678, ,NCI, , ,45678
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS,6794667,9/1/2000 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,483863, ,NCI, , ,483863
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER,6794746,5/8/2000 0:00,2/28/2005 0:00,Non-SBIR/STTR,2004,1256115, ,NCI, , ,1256115
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA,6794775,6/1/1983 0:00,8/31/2005 0:00,Non-SBIR/STTR,2004,290764, ,NCI, , ,290764
Genetics of Tobacco and Alcohol Related Cancers,6794946,9/1/2003 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,516278, ,NCI, , ,516278
Molecular Targets for Drug and Radiation Sensitivity,6794947,8/17/1998 0:00,5/31/2008 0:00,Non-SBIR/STTR,2004,1527092, ,NCI, , ,1527092
BIOLOGY OF ONCOGENES AND TUMOR SUPPRESSOR GENES,6794951,5/1/1986 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,1639261, ,NCI, , ,1639261
Molecular Calssification of Basal Cell Carcinomas,6795058,8/26/2003 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,163500, ,NCI, , ,163500
Development of P53-Based Vaccines for Oral Cancer,6795862, , ,Non-SBIR/STTR,2003, ,134173, , , , 
Vaccine Development for Oral Carcinoma,6795866,9/1/1997 0:00,8/31/2007 0:00,Non-SBIR/STTR,2004,970214, ,NIDCR, , ,970214
POLYOMA HOST INTERACTIONS LEADING TO TUMOR DEVELOPMENT,6795869,9/1/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,763109, ,NCI, , ,763109
Natural Product Antitumor Inducers of Apoptosis,6795880,9/6/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2004,72311, ,NCI, , ,72311
Analysis of Chk2 dependent DNA damage signaling pathway,6795884,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,222233, ,NCI, , ,222233
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE,6796113,3/1/1988 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004,457839, ,NCI, , ,457839
Targeted Gene Knockouts of p14ARF and p16INK4a,6796233,9/1/2003 0:00,8/31/2006 0:00,"Training, Individual",2004,50548, ,NCI, , ,50548
Molecular Epidemiology of Smoking & Breast Cancer,6796241,9/1/2003 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,259880, ,NCI, , ,259880
Molecular Mechanisms of Ara-C Therapy in Man,6796284,9/15/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,283860, ,NCI, , ,283860
Human Neurotropic JC Virus and CNS Diseases,6796319,3/4/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2004,299131, ,NCI, , ,299131
P53 and Organismal Aging,6796432,9/15/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2003,150500, ,NIA, , ,150500
Role of survivin in nonmelanoma skin cancer,6796719,9/1/2002 0:00,8/31/2005 0:00,Non-SBIR/STTR,2004,75000, ,NIAMS, , ,75000
Mechanisms of carcinogenesis by CRC-susceptibility genes,6796840,8/29/2003 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,84250, ,NCI, , ,84250
Transcripitonal and Genetic Profiles in HNSCCs,6796971,3/1/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2004,312225, ,NIDCR, , ,312225
P63 mediators as therapeutic targets in HNSCC,6796974,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004,365654, ,NIDCR, , ,365654
Study of genomic instability caused by HPV16 E6 and E7,6796975,5/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2004,372872, ,NIDCR, , ,372872
E2F-1 Cancer Gene Therapy,6797897,9/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,244388, ,NCI, , ,244388
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION,6798139,9/1/2000 0:00,8/31/2006 0:00,Other Research-Related,2004,154440, ,NCI, , ,154440
BREAST CANCER AND THE ENVIRONMENT ON LONG ISLAND,6798630,8/8/1995 0:00,7/31/2007 0:00,Non-SBIR/STTR,2004,418443, ,NCI, , ,418443
Antitumor Activity of Inducible Nitric Oxide Synthase,6798701,9/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,251038, ,NCI, , ,251038
Genetic Alterations in Breast Cells from BRCA1 Carriers,6799270,9/8/2003 0:00,6/30/2005 0:00,Other Research-Related,2004,114883, ,NCI, , ,114883
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1,6800650,2/15/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,43301, ,NCI, , ,43301
V(D)J RECOMBINASE & CHROMOSOME TRANSLOCATION IN LYMPHOMA,6800678,7/7/1999 0:00,6/30/2005 0:00,Other Research-Related,2003,130410, ,NCI, , ,130410
MULTISTEP LYMPHOMAGENESIS,6800713,5/1/1997 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,283500, ,NCI, , ,283500
Accelerated senescence in tumor cells,6800941,6/1/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2003,164093, ,NCI, , ,164093
"Role of Na,K ATPase in the development of carcinoma",6801050,9/12/2002 0:00,3/31/2005 0:00,"Training, Individual",2004,19941, ,NCI, , ,19941
ROLES AND REGULATION OF P53,6801107,9/30/2000 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,1738801, ,NCI, , ,1738801
Timing of Rectal Cancer Response to Chemoradiation,6801384,9/16/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,604039, ,NCI, , ,604039
Gene Expression Profiles in Human Liver Cancers,6801533,9/11/2003 0:00,8/31/2008 0:00,Other Research-Related,2004,148770, ,NCI, , ,148770
Role of Tumor Suppressor p53 in Breast Cancer,6801860,8/1/2002 0:00,9/29/2005 0:00,"Training, Individual",2004,30166, ,NCI, , ,30166
MD Anderson Cancer Center SPORE in Head and Neck Cancer,6801959,9/30/2002 0:00,7/31/2007 0:00,Research Centers,2004,2351588, ,NIDCR, , ,806588
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA,6801991,9/1/1992 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,213942, ,NCI, , ,213942
PS-341 in Hepatocellular Carcinoma: A Phase II Trial,6802030,9/18/2003 0:00,8/31/2007 0:00,Non-SBIR/STTR,2004,312833, ,NCI, , ,312833
THE ROLE OF INTEGRIN A5B1 IN ANGIOGENESIS & DISEASE,6802112,9/1/1999 0:00,3/31/2004 0:00,Non-SBIR/STTR,2003,64600, ,NCI, , ,64600
DETERMINANTS OF HEPATITIS C & E MORBIDITY IN EGYPT,6802279,9/15/2000 0:00,2/28/2007 0:00,Non-SBIR/STTR,2004,513919, ,NICHD, , ,513919
Mechanisms in Wilms Tumorigenesis,6802921,8/23/2001 0:00,6/30/2005 0:00,Non-SBIR/STTR,2003,276390, ,NCI, , ,276390
The Role of RR in Chemotherapeutic Drug Resistance,6803160,4/1/1997 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,259375, ,NCI, , ,259375
Genomic & Genetic Characterization of Amplicons in GBMs,6803172,9/24/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,304380, ,NCI, , ,304380
Adjuvant Hormonal therapy in Vietnamese Breast Cancer,6803470,7/1/1995 0:00,1/31/2005 0:00,Non-SBIR/STTR,2004,363591, ,NCI, , ,363591
A novel regulator of p53 function,6803610,8/15/2002 0:00,7/31/2007 0:00,Non-SBIR/STTR,2004,270560, ,NCI, , ,270560
Studies of Materials with Physiological Properties,6804355,9/1/1988 0:00,6/30/2006 0:00,Non-SBIR/STTR,2003,1366000, ,OD, , ,1366000
"A Novel Gene, WTH3,  and Multidrug Resistance",6804694,9/26/2003 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,214463, ,NCI, , ,214463
Epigenetic factors governing SOD2 gene expression,6804724,4/6/1998 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,262550, ,NCI, , ,262550
"New Proteins Binding Apoptotic Stimulator of p53, ASPP2",6804766,7/1/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,208515, ,NCI, , ,208515
COX-2 and p53 interactions and cancer prevention,6804993,9/30/2003 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,76000, ,NCI, , ,76000
Chemoprevention of Oral Cancer with BBIC,6805128,3/14/1997 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,732915, ,NCI, , ,732915
A NEURAL TRANSCRIPTION FACTOR IN LUNG CANCER EVOLUTION,6805753,6/1/1996 0:00,8/31/2007 0:00,Non-SBIR/STTR,2004,384225, ,NCI, , ,384225
Viral Model for Tumor Pathogenesis in Brain,6805954,9/30/1996 0:00,5/31/2008 0:00,Non-SBIR/STTR,2004,1280279, ,NINDS, , ,1280279
Modulators of p53 Expression and Function,6806005,9/1/1997 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,287640, ,NCI, , ,287640
The Molecular Epidemiology Of Ovarian Cancer,6806049,9/1/1998 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,638080, ,NCI, , ,638080
Diagnostic Assays of p53 DNA Binding Activity,6806122,7/14/2004 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,225750, ,NCI, , ,225750
Gordon Research Conference on Mammary Gland Biology,6806388,5/1/2004 0:00,4/30/2007 0:00,Other Research-Related,2004,3000, ,NCI, , ,3000
Molecular Mechanism of E2F Specificity,6806498,9/30/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,342650, ,NCI, , ,342650
AMID in Apoptosis and p53-Mediated Downstream Effects,6806721,7/14/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,279702, ,NCI, , ,279702
Regulation of Gene Expression by PML,6807029,9/30/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,302378, ,NCI, , ,302378
Visualizing Clonal Expansion in Living Mice,6808540,8/1/2004 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,138578, ,NCI, , ,138578
Regulation of the KSHV latent promoter,6810167,8/1/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,237931, ,NCI, , ,237931
Elucidation Of The Structure And Function Of Sigma Recep,6810567, , ,Intramural Research,2003, , , , , , 
Ubiquitin-Mediated Regulation of DNA Repair,6811094,7/7/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,295200, ,NCI, , ,295200
Physical and Functional Interactions Between PML & MDM2,6811808,8/1/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,240188, ,NCI, , ,240188
SPORE in Head and Neck Cancer,6812970,7/1/2004 0:00,6/30/2009 0:00,Research Centers,2004,2300000, ,NCI, , ,2300000
Molecular Epidemiology of Esophageal Cancer Prognosis,6813650,8/5/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,444604, ,NCI, , ,444604
Alteration of Rb in HTLV-1 transformed cells,6814535,6/15/2004 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,229500, ,NIAID, , ,229500
Oral Carcinogenesis: Human Gingival Keratinocytes,6814537, , ,Intramural Research,2003, , , , , , 
Regulation Of Mutant P53,6814901, , ,Intramural Research,2003, , , , , , 
USE OF THE MOUSE FOR PROSTATE CANCER GENE DISCOVERY,6814966,3/27/2000 0:00,2/28/2005 0:00,Other Research-Related,2003,98890, ,NCI, , ,98890
Synaptic Plasticity /Aging /Neurodegenerative Disorders,6815140, , ,Intramural Research,2003, , , , , , 
Investigating the Role of Cyr61 in Breast Cancer,6815787,7/26/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,243304, ,NCI, , ,243304
Modulators of p53 Expression and Function,6817389,9/1/1997 0:00,8/31/2008 0:00,Non-SBIR/STTR,2003,287640, ,NCI, , ,287640
Dna Damage Response In Eukaryotic Cells,6817841, , ,Intramural Research,2003, , , , , , 
DDB in checkpoint control and carcinogenesis,6817864,1/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,271674, ,NCI, , ,271674
Control of c-Myc Function by the Tumor Suppressor p19ARF,6817948,7/6/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,278595, ,NCI, , ,278595
Altered Proteoglycan Gene Expression and Cancer,6819188,9/1/1988 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,363918, ,NCI, , ,363918
Nitrosourea-induced growth arrest and apoptotic pathways,6819210,8/20/2004 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,229293, ,NCI, , ,229293
Selenium and prostate cancer apoptosis pathways,6819307,9/1/2004 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,266500, ,NCI, , ,266500
Self-Renewal of Normal and Leukemic Stem Cells,6820015,9/20/2004 0:00,8/31/2009 0:00,Non-SBIR/STTR,2004,282285, ,NCI, , ,282285
p53 and checkpoint pathways in cancer cell repliction,6820092,7/11/1994 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,342000, ,NCI, , ,342000
Role of Parc in the p53 Pathway,6820714,8/15/2004 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,254683, ,NCI, , ,254683
Pathways of Bladder Tumorgenesis,6820733,7/1/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004, ,292272, , , , 
p53-Mediated Transcription and Apoptosis,6821050,4/1/1999 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,301590, ,NCI, , ,301590
BRCA1 function in  G2-M checkpoint and mitosis,6821160,12/11/1998 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,252165, ,NCI, , ,252165
Cervical Cancer Cofactors and HPV DNA Integration,6821609,9/1/2004 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,169875, ,NCI, , ,169875
Potentials of reactivated mutant p53,6821828,7/1/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,313650, ,NCI, , ,313650
Analysis of a Novel Cancer Pathway Containing PML & HIRA,6821957,7/1/2004 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,153000, ,NCI, , ,153000
Role of RHO in Farnesyltransferase Inhibitor Responses,6822064,9/30/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,324000, ,NCI, , ,324000
Molecular pathogenesis of UVB-induced skin cancer,6822387,8/15/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,330050, ,NCI, , ,330050
Nucleoside Phosphonate Analogs and HPV Positive Cancers,6822722,7/1/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,289050, ,NCI, , ,289050
Targeting Oncogene Expression to Skin in Transgenic Mice,6822730,8/1/1990 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,473219, ,NCI, , ,473219
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,6822804,8/15/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,295515, ,NCI, , ,295515
RAS INDUCED SENESCENCE AND TUMOR PROGRESSION,6822832,7/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,390832, ,NIA, , ,390832
Novel Ceramide-based Chemotherapy for Acute Leukemia,6823787,8/10/2004 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,249772, ,NCI, , ,249772
p53 localization in normal and human tumor cells,6823880,6/15/1999 0:00,8/31/2007 0:00,Non-SBIR/STTR,2004,248544, ,NCI, , ,248544
Biomarkers for margin analysis and prognosis in HNSCC,6824185,9/1/1999 0:00,4/30/2008 0:00,Non-SBIR/STTR,2004,388313, ,NIDCR, , ,388313
CELL CYCLE TRANSCRIPTION REGULATION IN MEDULLOBLASTOMAS,6825070,9/30/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2003, ,259805, , , , 
TUMOR SUPPRESSOR RB FAMILY/PRB2 IN MEDULLOBLASTOMA,6825071,9/30/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2003, ,259805, , , , 
Brain tumor angiogenesis: Integrin ceramide signaling,6825097,8/1/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,303172, ,NCI, , ,303172
Regulation of DNA Double-Strand Break Repair,6825277,7/26/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,263835, ,NCI, , ,263835
Mechanisms linking ASPP2 to the Rb/E2F and p53 pathways,6825521,9/1/2004 0:00,8/31/2009 0:00,Non-SBIR/STTR,2004,243558, ,NCI, , ,243558
PAC1 in Signaling Apoptosis and Tumor Suppression,6825956,8/1/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,264040, ,NCI, , ,264040
Chromosome 22q genetic studies in the colon,6826020,3/1/2000 0:00,5/31/2008 0:00,Non-SBIR/STTR,2004,340775, ,NIDDK, , ,340775
15-Lipoxygenase 2 is a Prostate Senescence Gene,6826196,9/1/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004,295448, ,NIA, , ,295448
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors,6826346,7/15/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,664478, ,NCI, , ,664478
Signal Transduction Pathways In The Eye Of Transgenic Mi,6826530, , ,Intramural Research,2003, , , , , , 
Dysregulation of TGF Beta Action Pancreatic Cancer,6826674,9/30/1997 0:00,2/28/2007 0:00,Non-SBIR/STTR,2003,209148, ,NCI, , ,209148
Minority Predoctoral Fellowship Program,6827137,7/2/2004 0:00,7/1/2009 0:00,"Training, Individual",2004,42605, ,NCI, , ,42605
Leptomycin B Analogs,6827562,8/1/2004 0:00,7/31/2006 0:00,SBIR/STTR,2004,300000, ,NCI, , ,300000
Sequence Distribution of Tobacco Carcinogen-DNA Adducts,6827848,12/1/2002 0:00,11/30/2006 0:00,Non-SBIR/STTR,2005,200094, ,NCI, , ,200094
MECHANISMS REGULATING REVERSAL OF PREMALIGNANCY,6827873,12/15/2000 0:00,8/29/2006 0:00,Non-SBIR/STTR,2005,209520, ,NCI, , ,209520
Proteome analysis of malignant astrocytes,6827878,7/15/2004 0:00,2/28/2007 0:00,Non-SBIR/STTR,2004,350575, ,NINDS, , ,350575
Polo-like Kinase Functions in Normal and Tumor Cells,6827912,9/1/2000 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,452901, ,NIGMS, , ,452901
Cellular Senescence in Aging and Cancer,6828129,8/4/1999 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,455036, ,NCI, , ,455036
Association of inflammatory genes and prostate cancer,6828454,9/24/2004 0:00,8/31/2009 0:00,Non-SBIR/STTR,2004,522927, ,NCI, , ,522927
Minority Predoctoral Fellowship Program,6828660,8/1/2004 0:00,7/31/2009 0:00,"Training, Individual",2004,33167, ,NCI, , ,33167
Bin1 in E2F1-Mediated Tumor Growth Suppression,6828673,8/1/2004 0:00,7/31/2007 0:00,"Training, Individual",2004,35846, ,NCI, , ,35846
Transcriptional Responses in Neurodegenerative Diseases,6829662,1/1/2004 0:00,12/31/2007 0:00,Non-SBIR/STTR,2005,260611, ,NINDS, , ,260611
Base Pairing and Mutagenesis,6830237,12/1/1988 0:00,11/30/2007 0:00,Non-SBIR/STTR,2005,342146, ,NIGMS, , ,342146
NQO1 in Protection Against Benzene Toxicicity,6830279,7/15/1998 0:00,11/30/2007 0:00,Non-SBIR/STTR,2005,308000, ,NIEHS, , ,308000
Apoptosis in Colon Cancer Chemoprevention,6830330,7/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2004,35071, ,NCI, , ,35071
Tobacco Carcinogen Oral Cancer Model,6830343,9/20/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,77500, ,NCI, , ,77500
Apoptosis in Colon Cancer Chemoprevention,6830695,7/1/1997 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,1404831, ,NCI, , ,1404831
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN,6831636,9/30/1992 0:00,6/30/2005 0:00,Non-SBIR/STTR,2005,177906, ,NCI, , ,177906
CONTRAST ASSISTED ULTRASOUND IMAGING OF TUMORS,6831644,12/11/1997 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,272573, ,NCI, , ,272573
The Bcl-2/Bcl-X Pathway in Myc-Induced Lymphomagenesis,6832172,12/15/1997 0:00,12/31/2007 0:00,Non-SBIR/STTR,2005,282000, ,NCI, , ,282000
P53 AND DNA PLOIDY IN BARRETT'S METAPLASIA,6832199,1/9/2001 0:00,12/31/2007 0:00,Non-SBIR/STTR,2005,262844, ,NCI, , ,262844
Bifunctional T cell receptor based immunotherapeutics,6833209,7/26/2002 0:00,8/31/2006 0:00,SBIR/STTR,2004,542687, ,NCI, , ,542687
Validation of Biomarkers in Humans Exposed to PAHs,6833257,1/1/2002 0:00,12/31/2004 0:00,Non-SBIR/STTR,2004,236250, ,NIOSH, , ,236250
"P27KIP1 EXPRESSION, A PROGNOSTIC INDICATOR==BUT WHY?",6833487,1/20/2001 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,351731, ,NCI, , ,351731
Mechanism of Apoptosis by Par4,6834583,9/30/1995 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,296840, ,NCI, , ,296840
Characterization of the p53 Apoptotic Target Gene PERP,6834592,1/1/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,288270, ,NCI, , ,288270
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION,6835112,7/4/1995 0:00,9/24/2006 0:00,Non-SBIR/STTR,2005,363673, ,NCI, , ,363673
Thioredoxin Inhibition of Apoptosis and Cancer Treatment,6835115,12/18/1998 0:00,8/15/2005 0:00,Non-SBIR/STTR,2005,273057, ,NCI, , ,273057
Reinstallation of functional p53 in glial tumors in vivo,6835245,8/1/2004 0:00,7/31/2007 0:00,"Training, Individual",2004,47296, ,NCI, , ,47296
Dissection of the p53 Pathway and its Role in Cancer,6835887,7/1/2004 0:00,6/30/2005 0:00,"Training, Individual",2004,48928, ,NCI, , ,48928
Paradoxical Effects of Bax and Bcl-2 on Oncogenesis,6836026,9/26/2003 0:00,9/25/2006 0:00,"Training, Individual",2004,28908, ,NCI, , ,28908
In Vitro Peptide Mass-Signature Genotyping of Tumor DNA,6836392,7/9/2004 0:00,12/31/2004 0:00,SBIR/STTR,2004,99966, ,NCI, , ,99966
Molecular Epidemiology of Secondary Lung Cancer,6836440,1/15/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2005,620322, ,NCI, , ,620322
Molecular Markers: Response to Chemo-immunotherapy in CL,6836931,7/1/2004 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,294270, ,NCI, , ,294270
Mechanism(s) Of Leukemogenesis In Genetically-altered Mo,6837354, , ,Intramural Research,2003, , , , , , 
Carcinogen Inactivation Of Tumor Suppressor Genes In P53,6837393, , ,Intramural Research,2003, , , , , , 
Genetic Alterations During Multistep Carcinogenesis In M,6837419, , ,Intramural Research,2003, , , , , , 
Site-Specific Phosphorylation of p53 in Apoptosis and Gr,6837424, , ,Intramural Research,2003, , , , , , 
Regulation Of Differentiation In Lung And Epidermal Kera,6837504, , ,Intramural Research,2003, , , , , , 
Statistical Models In Toxicology And Biochemistry,6837560, , ,Intramural Research,2003, , , , , , 
Analysis of Somatic Mutations in Cancer of the Kidney,6838276,9/30/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,71500, ,NCI, , ,71500
Exposure Specific Mutation In Critical Target Genes,6838351, , ,Intramural Research,2003, , , , , , 
Kinetics of Keratinocyte Stem Cell Division,6838520,9/30/2004 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,80500, ,NIAMS, , ,80500
Isolation And Characterization Of Human Genes Affecting,6838549, , ,Intramural Research,2003, , , , , , 
Transcriptional Functions of Nuclear Receptors in Cancer,6838568, , ,Intramural Research,2003, , , , , , 
Molecular Mechanisms Of Skin Tumorigenesis,6838649, , ,Intramural Research,2003, , , , , , 
Repair of Genotoxic Damage in Chromatin,6839418,1/1/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,295369, ,NCI, , ,295369
Molecular Mechanisms of Epithelial Differentiation,6839813, , ,Intramural Research,2003, , , , , , 
Study of a FACTp140-SSRP1-associated p53 Kinase,6839982,1/10/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,301152, ,NCI, , ,301152
Melanoma in p16INK4a and p19ARF Deficient Mice,6840519,2/15/2002 0:00,11/30/2006 0:00,Other Research-Related,2005,130918, ,NCI, , ,130918
Regulation and Function of ECK in Apoptosis,6840521,1/18/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,291030, ,NCI, , ,291030
P53 SIGNALING AND CELLULAR RESPONSE AFTER STRESS,6841124,1/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2005,342098, ,NCI, , ,342098
Aldo-Keto Reductases and PAH Metabolism/Activation,6841125,3/1/1986 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,297980, ,NCI, , ,297980
"TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER",6841607,4/20/2000 0:00,11/30/2005 0:00,Other Research-Related,2005,132857, ,NCI, , ,132857
Prognostic Molecular Markers of Colorectal Cancer,6841957,1/16/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2005,287359, ,NCI, , ,287359
Mutant p53 Gain of Function in Tumorigenesis,6843087,4/1/1995 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,317250, ,NCI, , ,317250
ROLE OF GRP78 IN ALKYLATING AGENT SENSITIVITY,6843743,1/1/1995 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,190350, ,NCI, , ,190350
Structure/function studies of S100 proteins and p53,6843784,2/1/1999 0:00,1/31/2007 0:00,Non-SBIR/STTR,2005,289575, ,NIGMS, , ,289575
Lana and Cellular Gene Expression in Kaposis Sarcoma,6844247,7/1/2000 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004,239084, ,NCI, , ,239084
Human Neurotropic JC Virus and CNS Diseases,6844311,3/4/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,299131, ,NCI, , ,299131
MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS,6844726,8/4/2000 0:00,7/31/2005 0:00,Other Research-Related,2005,63355, ,NCI, , ,63355
ESOPHAGO GASTRIC TUMORIGENESIS IN A TRANSGENIC MODEL,6845136,5/1/2000 0:00,4/30/2007 0:00,Other Research-Related,2005,56728, ,NCI, , ,56728
"Mechanisms of mutagenesis in "" hot spots"" causing cancer",6846042,2/1/2004 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,224795, ,NCI, , ,224795
Apoptosis by FADD in normal and cancerous cells,6846760,2/22/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2005,304150, ,NCI, , ,304150
Two Novel Sir2-Interacting Proteins in Yeast,6847103,2/1/2004 0:00,1/31/2007 0:00,"Training, Individual",2005,48296, ,NIGMS, , ,48296
"Hypoxia, Genetic Instability and DNA Mismatch Repair",6847160,9/30/1992 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,327000, ,NIEHS, , ,327000
Molecular Markers as Predictors of Outcome in Gliomas,6847398,9/1/1998 0:00,2/28/2006 0:00,Non-SBIR/STTR,2005,328877, ,NINDS, , ,328877
Bioflavonoid apigenin induces phosphorylation of p53,6847826,3/10/2003 0:00,9/15/2005 0:00,Other Research-Related,2005,146974, ,NCI, , ,146974
"P38, G2 Arrest, and Temozolomide Resistance in Gliomas",6847844,2/1/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2005,310575, ,NCI, , ,310575
The PLZF Protein of t(11;17)-Promyelocytic Leukemia,6848339,4/1/1993 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,390258, ,NCI, , ,390258
INK4 FAMILY OF CDK INHIBITORS,6848356,7/17/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,2005,300211, ,NCI, , ,300211
EARLY DETECTION OF URINARY BLADDER CANCER,6848379,9/30/1999 0:00,8/31/2009 0:00,Non-SBIR/STTR,2004,471643, ,NCI, , ,471643
Dual Role of E2F1 in Tumorigenesis,6849325,1/18/1999 0:00,1/31/2009 0:00,Non-SBIR/STTR,2005,339750, ,NCI, , ,339750
Targeting LANA Function to Develop KSHV Antivirals,6849739,7/5/2004 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,130950, ,NCI, , ,130950
Role of AML1-ETO in Acute Leukemia,6850654,7/1/1994 0:00,2/28/2008 0:00,Non-SBIR/STTR,2005,319365, ,NCI, , ,319365
"Oxidative DNA Damage, DNA Repair and Oral Cancer",6850656,9/1/2001 0:00,8/31/2006 0:00,Other Research-Related,2005,133650, ,NCI, , ,133650
The Role of Phosphatase CL100/MKP1 in Human Cancer,6850799,2/5/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2005,247640, ,NCI, , ,247640
Function of MDM2 and its Alternatively spliced Isoforms,6850837,3/5/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,213750, ,NCI, , ,213750
The BRCA1-GADD45 Pathway and Genomic Stability,6850886,3/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2005,251580, ,NCI, , ,251580
Mechanism of SAG apoptosis protection under hypoxia,6851100,2/1/2005 0:00,1/31/2009 0:00,Non-SBIR/STTR,2005,299663, ,NCI, , ,299663
Transformation of human mammary epithelium by c-Myc,6853493,5/1/1997 0:00,12/31/2008 0:00,Non-SBIR/STTR,2005,349200, ,NIA, , ,349200
Regulation and Role of ODC in Apoptosis and Cancer,6854503,3/4/2003 0:00,2/29/2008 0:00,Non-SBIR/STTR,2005,333750, ,NCI, , ,333750
"Metallothionein, Environment Insult and Bladder Cancer",6855739,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,249556, ,NCI, , ,249556
Novel Approaches for Pancreatic Cancer Therapy,6855793,1/21/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2005,363788, ,NCI, , ,363788
Role of RNase L in the Biology of Prostate Cancer,6856518,2/16/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2005,313650, ,NCI, , ,313650
UV INDUCIBLE INHIBITION IN MELANOMA,6856556,5/5/1993 0:00,1/31/2006 0:00,Non-SBIR/STTR,2005,375214, ,NCI, , ,375214
Investigation of xrcc5 Mutant Mice,6857070,7/7/1997 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,259880, ,NCI, , ,259880
Transcripitonal and Genetic Profiles in HNSCCs,6857090,3/1/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2005,300350, ,NIDCR, , ,300350
Interactions and Functions of p14ARF in Cancer,6858441,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2005,390730, ,NCI, , ,390730
NORTHERN CALIFORNIA COOPERATIVE FAMILY REGISTRY,6858662,9/30/1995 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,2249017, ,NCI, , ,2249017
P53 Fibril Formation and Disease,6858779,3/1/2004 0:00,2/28/2006 0:00,Non-SBIR/STTR,2005,135000, ,NCI, , ,135000
Antineoplastic Agents from Marine Organisms,6858818,9/1/1983 0:00,9/25/2006 0:00,Non-SBIR/STTR,2005,280125, ,NCI, , ,280125
Analysis of p53 function in aging and tumor suppression,6858871,1/15/2005 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,189375, ,NIA, , ,189375
MDM2 AS A NEGATIVE REGULATOR OF P21 WAF1/CIP1,6859145,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2005,267064, ,NCI, , ,267064
Transcriptional Control of Gastrin,6859707,9/1/1993 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,57022, ,NIDDK, , ,57022
Monitoring mechanisms in mammalian ribosome biogenesis,6859747,2/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2005,277308, ,NIGMS, , ,277308
In Vivo Ras-induced Senescence and Tumorigenesis,6860072,4/18/2003 0:00,2/28/2008 0:00,Non-SBIR/STTR,2005,352663, ,NCI, , ,352663
MODULATORS AND EFFECTORS OF MDM2 AND P53,6860097,3/1/2001 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,273663, ,NCI, , ,273663
Structure-Function of Protein Deacetylases,6860102,3/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,308648, ,NCI, , ,308648
Planning a Trial of Sulindac for Oral Leukoplakia,6860950,9/28/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,145930, ,NIDCR, , ,145930
Targeting Cancer Cell DNA with Combinatorial Ligands,6861015,4/1/1998 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,271120, ,NCI, , ,271120
Apoptotic Response to DNA Damage Initiated by PUMA,6861036,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,273983, ,NCI, , ,273983
p53 target Genes in Apoptosis,6861741,4/1/2004 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,278595, ,NCI, , ,278595
p63 Signaling in Epithelial Cell Growth and Cancer,6863674,3/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,309550, ,NCI, , ,309550
Cell Cycle Dysregulation in Oral Cancer,6863760,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,442039, ,NIDCR, , ,442039
The Pathogenesis of Dyskeratosis Congenita,6864286,2/8/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2005,302175, ,NCI, , ,302175
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER,6864445,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,325963, ,NCI, , ,325963
"p53-independent Role of MDM2, TGFb Resistance and Cancer",6864892,3/1/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,329656, ,NCI, , ,329656
THERAPEUTIC VACCINES FOR HPV DISEASES,6864894,2/14/2001 0:00,1/31/2006 0:00,Other Research-Related,2005,136728, ,NCI, , ,136728
"Cadmium, Metallothionein and Breast Cancer Progression",6865116,4/1/2005 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,276007, ,NCI, , ,276007
Mechanisms of Cell Cycle Associated Neoplasia,6866106,2/16/2000 0:00,1/31/2010 0:00,Non-SBIR/STTR,2005,367625, ,NCI, , ,367625
Hormonal regulation of p53 activity in mammary tissue,6866382,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,285975, ,NCI, , ,285975
Mechanistic Analyses of Protein Deacetylation,6866386,3/1/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,259943, ,NIGMS, , ,259943
THE ROLE OF SPARC IN GLIOMA INVASION,6866432,7/1/2000 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,304648, ,NCI, , ,304648
"P13K/PTEN/Akt (PKB), Signaling and genesis of cancer",6866717,3/1/2001 0:00,2/28/2006 0:00,Non-SBIR/STTR,2005,355841, ,NCI, , ,355841
MOLECULAR MECHANISMS OF DIET-INDUCED CARCINOGENESIS,6867366,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,295369, ,NCI, , ,295369
Genomic Plasticity in the Human U2 snRNA Cluster,6867375,4/1/1989 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,333520, ,NIGMS, , ,333520
Extracellular Matrix Mediated Apoptosis in p53 (-) HMECs,6867439,4/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,237160, ,NCI, , ,237160
Inductible mouse models for oral cancer,6867805,1/13/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2005,363750, ,NIDCR, , ,363750
Cell cycle regulatory proteins in UVB-skin carcinogenes,6868120,4/21/2003 0:00,3/31/2008 0:00,Other Research-Related,2005,123660, ,NIAMS, , ,123660
Regulation of apoptosis and tumor growth by galectin-7,6868159,3/5/2004 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,74250, ,NIAMS, , ,74250
PRE-CLINICAL COMBINATION CHEMO- AND RADIOANTIBODY THERAP,6868172,5/6/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,1006461, ,NCI, , ,1006461
Stat3 and anti-VEGF therapy in cancer,6868219,2/21/2003 0:00,7/31/2005 0:00,Non-SBIR/STTR,2005,140568, ,NCI, , ,140568
Enhancing Activity of Alkylating Agents in Neuroblastoma,6868369,9/1/1999 0:00,12/31/2009 0:00,Non-SBIR/STTR,2005,253199, ,NCI, , ,253199
FDH: A Novel Determinant of Tumor Suppression,6868586,3/1/2005 0:00,2/28/2010 0:00,Non-SBIR/STTR,2005,259515, ,NCI, , ,259515
"Diet, DNA Repair Genes and Breast Cancer Risk",6868749,9/27/2005 0:00,8/17/2006 0:00,Other Research-Related,2005,113603, ,NCI, , ,113603
Molecular Epidemiology of Fatal Prostate Cancer,6868831,4/30/2003 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,491009, ,NCI, , ,491009
Analysis of Group I and II Introns in Mammalian Cells,6868876,9/30/1995 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,319100, ,NIGMS, , ,319100
Growth Inhibition by the ARF Tumor Suppressor,6868926,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,381564, ,NCI, , ,381564
Prostate Cancer Prevention by n-3 Unsaturated Fatty Acids,6869143,6/28/2005 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,530000, ,NCI, , ,281989
Oncogenic Gene Regulatory Networks,6869233,2/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2005,299589, ,NCI, , ,299589
DNA Adducts of Aromatic Amines: Analysis by HPLC-MS,6869534,5/18/1996 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,235650, ,NCI, , ,235650
SELECTIVE THERAPY FOR COLON CARCINOMA,6869541,7/1/1983 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,317250, ,NCI, , ,317250
"cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma",6869666,1/1/2005 0:00,12/31/2008 0:00,Non-SBIR/STTR,2005,237088, ,NCI, , ,237088
Genetic Mechanisms in Experimental Pancreatic Cancer,6870021,9/1/1998 0:00,3/31/2010 0:00,Non-SBIR/STTR,2005,276335, ,NCI, , ,276335
Regulation and Function of C/EBP in UVB Responses,6870075,1/3/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2005,308202, ,NIEHS, , ,308202
MONOCLONAL GAMMOPATHIES,6870131,9/30/1994 0:00,1/31/2005 0:00,Non-SBIR/STTR,2004,205383, ,NCI, , ,205383
Inhibitors of Dynamin as Novel Anti-Cancer Therapeutics,6870261,3/12/2004 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,168930, ,NCI, , ,168930
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE,6870300,3/1/1988 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,471578, ,NCI, , ,471578
"Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma",6870365,5/1/2005 0:00,12/9/2005 0:00,Non-SBIR/STTR,2005,301583, ,NCI, , ,301583
NOVEL APPROACHES TO GENE PROFILING IN OVARIAN CANCER,6870870,5/1/2005 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,146200, ,NCI, , ,146200
Multi-institutional trial: molecular analysis of margins,6870902,2/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2005,229100, ,NCI, , ,229100
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER,6871249,4/1/2001 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,397425, ,NCI, , ,397425
Leukemogenic Slug Pathway in Hematopoietic Cell Survival,6871271,5/1/1993 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,427500, ,NCI, , ,427500
Role of JNK in Mammary tumor development,6871436,9/29/2004 0:00,8/31/2009 0:00,Non-SBIR/STTR,2004,297940, ,NCI, , ,297940
DNA Damage and Tobacco-Induced Lung Cancer,6871512,5/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,333775, ,NCI, , ,333775
The Role of NF-kappaB in Chemotherapy Resistance,6871719,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2005,358750, ,NCI, , ,358750
Role of Neuregulin-1 in Schwann Cell Neoplasia,6871935,9/15/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2004,268250, ,NINDS, , ,268250
Contributions of Akt to Glioblastoma Formation,6871993,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,337088, ,NCI, , ,337088
Mechanisms of tumor promotion and carcinogenesis,6872168,1/1/1994 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,262800, ,NCI, , ,262800
T cell activation and crypt cell apoptosis,6872169,2/15/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,294690, ,NIDDK, , ,294690
The Role of HOXA5 in Breast Cancer,6872220,3/15/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,301658, ,NCI, , ,301658
Phase II Doxorubicin/Vinorelbine in wtp53 Breast Cancer,6872340,2/5/2003 0:00,1/31/2009 0:00,Non-SBIR/STTR,2005,268397, ,NCI, , ,268397
The MED1 Protein in DNA Damage Response and Repair,6872458,7/1/1998 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,355212, ,NCI, , ,355212
Regulation of esophageal epithelial biology,6872591,8/1/2005 0:00,7/31/2008 0:00,Other Research-Related,2005,133272, ,NIDDK, , ,133272
Mechanisms of Intestinal Tumorigenesis,6872751,1/1/2000 0:00,3/31/2010 0:00,Non-SBIR/STTR,2005,372027, ,NCI, , ,372027
Chemoprevention of Carcinogen-Induced Lung Cancer,6872927,5/1/2003 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,422500, ,NCI, , ,422500
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS,6873051,4/1/1980 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,297360, ,NCI, , ,297360
The Role of E2F1 in UV-induced DNA Damage Response,6873534,5/3/2005 0:00,4/30/2010 0:00,Other Research-Related,2005,97362, ,NCI, , ,97362
Normal and Neoplastic Growth Regulation in the Brain,6873663,4/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,1765653, ,NCI, , ,1765653
The role of Inil in chromatin  development and cancer,6873706,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,353775, ,NCI, , ,353775
Molecular Functions of the Adenoviral E1B 55 kDa Protein,6873735,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,391467, ,NIAID, , ,391467
ENDOGENOUS MODULATION OF COCHLEA INJURY,6873746,7/1/1994 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,325325, ,NIDCD, , ,325325
Roles of DMP1 in Ras signaling and lung cancer,6874903,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,264758, ,NCI, , ,264758
P53 in BBD and Breast Cancer Risk: A Multicenter Cohort,6874965,5/1/2002 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,762575, ,NCI, , ,762575
Molecular Pathobiology of Langerhans Cell Histiocytosis,6875010,4/15/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,360628, ,NIAID, , ,360628
HAUSP-mediated Deubiquitination of p53,6875046,4/1/2003 0:00,3/30/2008 0:00,Non-SBIR/STTR,2005,281240, ,NCI, , ,281240
Molecular Basis of KSHV Pathogenesis,6875226,6/15/1999 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,357435, ,NCI, , ,357435
DNA Repair and Checkpoint Interactions in Mammals,6875237,5/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,334106, ,NCI, , ,334106
"Telomerase in Development, Senescence and Neoplasia",6875393,1/1/2000 0:00,12/31/2009 0:00,Non-SBIR/STTR,2005,567763, ,NCI, , ,567763
Mustard Gas Exposure and Carcinogenesis of the Lung,6875435,7/18/2006 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,137560, ,NIEHS, , ,137560
The Role of p53 and 14-3-3 in Genomic Instability,6875799,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,277673, ,NCI, , ,277673
PLK3 in the DNA damage checkpoint and tumor suppression,6877036,12/15/1997 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,324480, ,NCI, , ,324480
A mouse model for UV-induced junctional melanoma,6877200,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,338200, ,NCI, , ,338200
Genetic modifiers of mammary tumor susceptibility,6877239,2/15/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2005,309026, ,NCI, , ,309026
Mechanisms of T Cell Tumorigenesis,6877760,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,252000, ,NCI, , ,252000
P63 mediators as therapeutic targets in HNSCC,6877965,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,393750, ,NIDCR, , ,393750
Regulated Proteolysis in RAS Signal Transduction,6878040,5/1/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,243375, ,NIGMS, , ,243375
CHROMOSOME ALTERATIONS IN BARRETT'S ESOPHAGUS,6878088,4/1/2001 0:00,5/31/2006 0:00,Other Research-Related,2005,100775, ,NCI, , ,100775
Study of the clock-controlled DNA-damage response,6878171,9/22/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,75000, ,NCI, , ,75000
Differential Transcription Factor Activation by H. pylor,6878252,9/30/1997 0:00,3/31/2005 0:00,Non-SBIR/STTR,2004,32088, ,NIDDK, , ,32088
Prevention of bladder cancer progression by sulforaphane,6878391,9/30/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,85000, ,NCI, , ,85000
Genetic Modifiers of p53,6878411,9/22/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,73500, ,NCI, , ,73500
MCAV in Organ-Confined Bladder CA based on p53 Status,6878498,5/1/1997 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,638420, ,NCI, , ,638420
Biology of CHK2 Kinase In Lung Cancer,6878511,4/1/2004 0:00,3/31/2006 0:00,Non-SBIR/STTR,2005,73000, ,NCI, , ,73000
Yeast Assay for p53 Molecular Analysis in Bladder Cancer,6878544,4/1/2004 0:00,3/31/2006 0:00,Non-SBIR/STTR,2005,133280, ,NCI, , ,133280
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium,6878563,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,275828, ,NCI, , ,275828
Novel p53 target gene ASC in apoptosis & mammary tumorig,6878581,4/1/1999 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,288665, ,NCI, , ,288665
Ceramide Synthase in Radiation-Induced Apoptosis,6878621,7/15/1990 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,396250, ,NCI, , ,396250
Diverse Natural Products That Stabilize Microtubules,6878635,7/6/1999 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,370690, ,NCI, , ,370690
JC Virus and Tumor Formation in the Human Colon,6878649,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,274500, ,NCI, , ,274500
Etiology and Prevention of Oral Cancer,6879212,5/1/2003 0:00,2/29/2008 0:00,Non-SBIR/STTR,2006,285609, ,NCI, , ,285609
Role of PCAF/GCN5 Acetylation on p53 Transactivation,6879224,4/1/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,344574, ,NCI, , ,344574
STRUCTURAL FEATURES OF PAPILLOMAVIRUS E6 ONCOPROTEINS,6879479,2/1/2000 0:00,1/31/2006 0:00,Non-SBIR/STTR,2004,242344, ,NCI, , ,242344
Molecular Mechanisms by which Rexinoids Prevent BRCA,6879674,4/6/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,342308, ,NCI, , ,342308
In Vitro and In Vivo Analyses of 14-O-Acylanthracyclines,6879685,4/1/2004 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,299300, ,NCI, , ,299300
Unique BRCA1 transcriptional response leading to repair,6880008,4/22/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,388891, ,NCI, , ,388891
Mechanism of mitotic exit in budding yeast,6880019,8/1/1999 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,255128, ,NIGMS, , ,255128
Molecular Alterations in Lobular/Ductal Breast Cancer,6880043,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,408856, ,NCI, , ,408856
Role of 53BP1 during the DNA damage response,6880062,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,259875, ,NIGMS, , ,259875
The role of p53 in remodeling DNA methylation in cancer,6880143,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,257775, ,NCI, , ,257775
Differential Transcription Factor Activation by H. pylor,6881069,9/30/1997 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,252051, ,NIDDK, , ,252051
POLYAMINE ANALOG REGULATION OF CELL CYCLE AND APOPTOSIS,6881180,8/1/1989 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,353426, ,NCI, , ,353426
Models for DNA repair and cell cycle control variants,6881441,4/10/2001 0:00,12/31/2005 0:00,Non-SBIR/STTR,2005,810259, ,NIEHS, , ,810259
GENISTEIN IN INVESTIGATIVE AND CLINICAL DERMATOLOGY,6881484,2/3/2001 0:00,1/31/2007 0:00,Non-SBIR/STTR,2005,286455, ,NCI, , ,286455
Molecular Pathogenesis of Breast Cancer,6881487,4/18/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,2592021, ,NCI, , ,2592021
Apoptosis in Drosophila-From Reaper to Death,6881498,5/1/1997 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,354650, ,NIGMS, , ,354650
Molecular Targeting of the Survivin Pathway in Cancer,6881562,4/1/2001 0:00,3/31/2006 0:00,Non-SBIR/STTR,2005,296933, ,NCI, , ,296933
P53 Mediated Regulation of Centrosome Duplication,6881574,4/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,253980, ,NCI, , ,253980
Structure/Function of Human Papillomavirus Oncoproteins,6881606,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,393293, ,NCI, , ,393293
Polyoma Virus Disrupts ARF Signaling to p53,6881640,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,303379, ,NCI, , ,303379
Screen for MURF-1 inhibitors to treat myopathy,6881721,3/1/2005 0:00,2/28/2007 0:00,SBIR/STTR,2005,266848, ,NIA, , ,266848
Functions of Human Papillomavirus E6,6882006,4/8/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,293355, ,NCI, , ,293355
G2 Checkpoint Control In Transformed Human Cells,6882025,12/1/1998 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,337860, ,NCI, , ,337860
Function of Human Damaged DNA Binding Protein (DDB),6882033,6/1/2000 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,361892, ,NIGMS, , ,361892
 anti-tumor activity of deactylase inhibitors,6882614,4/8/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,286344, ,NCI, , ,286344
Role of WISp39 and Ubiquitination in p21 Function,6882664,4/9/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,343724, ,NCI, , ,343724
The Apoptotic Role of MEKK1 in Cancer Chemotherapy,6882674,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,271450, ,NCI, , ,271450
Telomere-Mediated Protective Responses in Skin,6882710,4/8/2004 0:00,2/29/2008 0:00,Non-SBIR/STTR,2005,331075, ,NCI, , ,331075
Structural basis for CBP/p300 transcriptional regulation,6883930,6/10/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,412070, ,NCI, , ,412070
Chromosomal Abnormalities in Myeloma as Detected by FISH,6884660,4/1/2000 0:00,2/28/2008 0:00,Non-SBIR/STTR,2005,333359, ,NCI, , ,333359
Mechanisms of luteinization in the primate ovary,6884880,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,293290, ,NICHD, , ,293290
Role of the Oxidative Stress Pathway in Drug Resistance,6884884,5/1/2003 0:00,8/31/2005 0:00,Non-SBIR/STTR,2005,106876, ,NCI, , ,106876
Lung cancer molecular markers by sex: intergroup study,6886126,4/15/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,639589, ,NCI, , ,639589
The Role of Mdm2 in Cell Growth and Tumorigenesis,6886785,3/1/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,328050, ,NCI, , ,328050
Integration of Oncogenic Networks in Cancer Phenotypes,6887072,9/30/2004 0:00,8/31/2009 0:00,Research Centers,2004,2255805, ,NCI, , ,2255805
Bortezomib and Idarubicin in the Treatment of AML,6887118,9/20/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,257563, ,NCI, , ,257563
Conference on Cellular Senescene and Cell Death,6887137,3/1/2005 0:00,2/28/2006 0:00,Other Research-Related,2005,7000, ,NCI, , ,7000
ROLE OF GRP78 IN ALKYLATING AGENT SENSITIVITY,6887648,1/1/1995 0:00,1/31/2006 0:00,Non-SBIR/STTR,2004,190350, ,NCI, , ,190350
12th International p53 Workshop,6887931,9/1/2004 0:00,4/30/2007 0:00,Other Research-Related,2004,13000, ,NCI, , ,13000
PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS,6888307,5/1/2004 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,139884, ,NCI, , ,139884
Nitroaromatics and Breast Cancer,6888399,7/1/1983 0:00,9/10/2004 0:00,Non-SBIR/STTR,2004,20790, ,NCI, , ,20790
Novel Agents Targeted To p53-Mdm2 Pathways,6888478,6/1/2003 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,28305, ,NCI, , ,28305
Nicotine Derived Nitrosamines & Tobacco Related Cancers,6888486,5/1/2001 0:00,10/31/2006 0:00,Non-SBIR/STTR,2005,275625, ,NCI, , ,275625
Study of genomic instability caused by HPV16 E6 and E7,6889222,5/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,369600, ,NIDCR, , ,369600
Targeting Calpain for Novel Anticancer Agents,6889227,5/1/2004 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,118980, ,NCI, , ,118980
Prognostic Markers in Trials for Head and Neck Cancer,6889381,6/1/2003 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004,264330, ,NCI, , ,264330
Chk1 signaling in the G2 DNA damage checkpoint,6889648,2/1/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,344085, ,NCI, , ,344085
ROLE OF SAMe IN LIVER FUNCTION AND INJURY,6889863,9/20/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,347336, ,NCCIH, , ,347336
Molecular Basis of Young Onset Colorectal Cancer,6889907,8/26/2002 0:00,4/30/2007 0:00,Other Research-Related,2005,125226, ,NCI, , ,125226
Mouse Models of Gastric Cancer,6890337,5/1/2001 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,256246, ,NCI, , ,256246
RhoB Signaling in Cancer Suppression and Cell Suicide,6890358,5/15/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,333750, ,NCI, , ,333750
Arsenic Induced Miotic Arrest Associated Apoptosis,6890459,8/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,279300, ,NIEHS, , ,279300
Gordon Research Conference on Mammary Gland Biology,6891286,5/1/2004 0:00,4/30/2007 0:00,Other Research-Related,2005,8000, ,NIDDK, , ,2000
Dysregulation of TGF Beta Action Pancreatic Cancer,6891344,9/30/1997 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,355406, ,NCI, , ,355406
"Characterization of Fortilin, A Novel Anti-p53 Protein",6891788,9/30/2001 0:00,7/31/2005 0:00,Non-SBIR/STTR,2004,7201, ,NHLBI, , ,7201
p53 in Cellular Response to ROS-Mediated DNA Damage,6891840,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,302378, ,NCI, , ,302378
Involvement of APC in DNA Repair,6891842,5/16/2003 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,258990, ,NCI, , ,258990
Xenobiotics and Breast Epithelial Cell-ECM Signaling,6892032,5/3/2001 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,260750, ,NIEHS, , ,260750
MECHANISMS OF ARSENIC CARCINOGENESIS,6892083,7/12/2002 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,367875, ,NIEHS, , ,367875
BIOLOGY OF ONCOGENES AND TUMOR SUPPRESSOR GENES,6892100,5/1/1986 0:00,9/14/2006 0:00,Non-SBIR/STTR,2005,1685077, ,NCI, , ,1685077
Methylation and Oxidation in Breast Cancer Epidemiology,6892136,6/1/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,561381, ,NCI, , ,561381
Correlative Studies of erbB-2/HER2 and p53 in CALGB Pro.,6892171,5/1/2003 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,453275, ,NCI, , ,453275
Minority Predoctoral Fellowship Program,6893095,9/16/2004 0:00,9/15/2007 0:00,"Training, Individual",2004,26967, ,NIGMS, , ,26967
Minority Predoctoral Fellowship Program,6893223,3/20/2005 0:00,3/19/2008 0:00,"Training, Individual",2004,30464, ,NCI, , ,30464
DNA Repair and p53 in Oral Cancer,6893326,5/15/2004 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,77126, ,NIDCR, , ,77126
Molecular Characterization of ACF (Abberant Crypt Foci),6893443,8/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,275500, ,NCI, , ,275500
Training in Molecular Basis of Skin Pathobiology,6893453,6/1/2004 0:00,5/31/2009 0:00,"Training, Institutional",2005,244126, ,NCI, , ,244126
Progression/Oncogene Induced Prostate Cancer,6893659,9/8/1989 0:00,5/31/2006 0:00,Non-SBIR/STTR,2005,312288, ,NCI, , ,312288
PILOT--MOLECULAR PREDICTORS OF ORAL CANCER DEVELOPMENT,6893684,6/1/2004 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004, ,20762, , , , 
PILOT--INVASION REGULATED BY FIBRONECTIN AND  RECEPTORS,6893685,6/1/2004 0:00,5/31/2006 0:00,Non-SBIR/STTR,2004, ,20762, , , , 
The replication checkpoint and genomic fidelity in skin,6894094,6/1/2004 0:00,12/31/2005 0:00,Other Research-Related,2005,61965, ,NIAMS, , ,61965
Function & Purification of the Fanconi Anemia Protein C*,6894307,7/1/2002 0:00,5/31/2007 0:00,Other Research-Related,2005,100845, ,NHLBI, , ,100845
MOLECULAR MECHANISMS OF CHEMOTHERAPY-INDUCED HAIR LOSS,6894680,6/16/2003 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,306850, ,NCI, , ,306850
Accelerated senescence in tumor cells,6895131,6/1/2001 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,273900, ,NCI, , ,273900
Role of IGFBP -3 in mediating p53-induced apoptosis,6895209,8/15/2002 0:00,6/30/2007 0:00,Other Research-Related,2005,131652, ,NIDDK, , ,131652
Function of Mammalian SIRT1 in Aging,6895441,5/1/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,407694, ,NIA, , ,407694
IL10 and IGF1 Receptor Axis in Prostate Cancer,6895464,6/5/2001 0:00,5/31/2006 0:00,Non-SBIR/STTR,2005,281993, ,NCI, , ,281993
Function of the p53 tumor-suppressor in C.elegans,6895729,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,290899, ,NCI, , ,290899
Regulation of Irreversible Growth Arrest by p53,6896149,4/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,241538, ,NCI, , ,241538
Expression of Simian Virus 40 T antigens in Intestine,6896179,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,325897, ,NCI, , ,325897
"ROLE OF MDM2, P300, P19ARF IN P53 UBIQUITINATION",6896793,4/12/2001 0:00,3/31/2006 0:00,Other Research-Related,2005,157437, ,NCI, , ,157437
Prevention of ER-negative Breast Cancer: Identification*,6896907,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,487994, ,NCI, , ,487994
Chemoprevention of Bladder CA by soybean bioactive comp.,6897037,6/1/2003 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,302600, ,NCI, , ,302600
Mechanisms of Radioresistance and Cell Cycle Progression,6897167,5/1/1995 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,367875, ,NIGMS, , ,367875
Adenocarcinoma of the Lung: role of NNK susceptibility,6897239,9/30/1991 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,651408, ,NCI, , ,651408
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1,6897567,2/15/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,285114, ,NCI, , ,285114
Breast Carcinoma In-Situ: Mammographic Risk Factors,6897898,6/1/2004 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,322843, ,NCI, , ,322843
Murine p73 in Tumorigenesis,6897999,6/15/1998 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,398325, ,NCI, , ,398325
Mechanisms of the Hormonal Prevention of Breast Cancer,6898197,8/1/1995 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,1088976, ,NCI, , ,1088976
Structural Determinants in Cell Growth Control by p21,6898230,7/1/2001 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,249000, ,NCI, , ,249000
Mechanisms of Genetic Instability and Tumor Suppression,6898288,7/1/1993 0:00,9/27/2006 0:00,Non-SBIR/STTR,2005,595914, ,NCI, , ,595914
Monoclonal Antibody Therapy in B-Cell CLL.,6898478,6/1/2004 0:00,5/31/2009 0:00,Other Research-Related,2005,131814, ,NCI, , ,131814
Chromosome 22q genetic studies in the colon,6898830,3/1/2000 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,340775, ,NIDDK, , ,340775
Breast Cancer Therapy by Differentiation Gene Activation,6899331,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,300820, ,NCI, , ,300820
Transcriptional repression in response to p53,6899420,3/1/2005 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,216000, ,NIGMS, , ,216000
Function of ATF2 URE binding protein in human melanoma,6899704,1/1/1991 0:00,5/31/2006 0:00,Non-SBIR/STTR,2005,396325, ,NCI, , ,396325
Methylation of the Calcitonin Gene in Human Tumors,6899854,9/30/1986 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,449625, ,NCI, , ,449625
RNA Tumor Virus-Hematopoietic cell Interaction,6899866,6/1/1983 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,335228, ,NCI, , ,335228
Childhood Cancer Gene Program Project Grant,6899895,8/1/1996 0:00,5/31/2006 0:00,Non-SBIR/STTR,2005,1923795, ,NCI, , ,1923795
Biomarkers for margin analysis and prognosis in HNSCC,6901056,9/1/1999 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,386090, ,NIDCR, , ,386090
Diagnostic Therapeutic Targets in Prostate Cancer,6901131,6/12/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,340425, ,NCI, , ,340425
Biology of Breast Cancers Arising in Older Women,6901838,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2005,564728, ,NIA, , ,564728
Alteration of Rb in HTLV-1 transformed cells,6901886,6/15/2004 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,191250, ,NIAID, , ,191250
HTP assays of inhibitors of protein-protein interactions,6902052,4/15/2005 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,319736, ,NCI, , ,319736
Microarray Analysis of HNSCC as a Predictor of Treatment,6902120,9/1/2002 0:00,8/31/2006 0:00,Other Research-Related,2004,864, ,NIDCR, , ,864
Diverse Natural Products That Stabilize Microtubules,6902309,7/6/1999 0:00,4/30/2007 0:00,Non-SBIR/STTR,2004,16283, ,NCI, , ,16283
Microsatellite instability and cancer gene expression,6902656,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,427200, ,NCI, , ,427200
Sunlight-Related Steps in Human Skin Cancer,6902688,4/1/1992 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,327000, ,NCI, , ,327000
In Vivo Role of DNA Alkylation Repair,6903419,8/8/1997 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,484014, ,NCI, , ,484014
Prognostic Markers in Trials for Head and Neck Cancer,6903631,6/1/2003 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,264330, ,NCI, , ,264330
Nucleoside Phosphonate Analogs and HPV Positive Cancers,6905661,7/1/2004 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,289050, ,NCI, , ,289050
INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN D,6906355,12/24/1998 0:00,11/30/2004 0:00,Non-SBIR/STTR,2004,54180, ,NCI, , ,54180
Molecular Genetics of HNPCC,6906598,6/1/1997 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,466476, ,NCI, , ,466476
The XP Variant:  A Human Mutator Gene for UV Damage,6908109,2/1/1998 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,331875, ,NIEHS, , ,331875
The Role of Mdm2 in Lymphoma Development,6908149,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,294368, ,NCI, , ,294368
p53 loss in HMECs: a model of breast cancer prevention,6908248,7/3/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,308385, ,NCI, , ,308385
"Breast Cancer, Radiation and the ATM-CHEK2 Pathway",6908338,6/1/2005 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,502390, ,NCI, , ,502390
Molecular Pathogenesis of Ewing Sarcoma,6908952,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,249000, ,NCI, , ,249000
Quantitative Gene Expression in Human Lung Epithelium,6908983,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,365501, ,NCI, , ,365501
Stabilization of MDM2 by mutant p53,6909035,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,241063, ,NCI, , ,241063
Cyclin/cdk Regulation of P53 in Prostate Cancer,6909063,7/1/2001 0:00,6/30/2007 0:00,Other Research-Related,2005,99933, ,NCI, , ,99933
DDR1 in p53-mediated suppression and in breast cancer,6909083,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,311500, ,NCI, , ,311500
Modes of Prostate Ca Progression--role of p53 Pathway,6910768,7/1/2001 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,240345, ,NCI, , ,240345
Transcriptional Regulation of Cell Growth,6910918,6/1/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2005,2553083, ,NCI, , ,2553083
Mechanisms of Radioresistance and Cell Cycle Progression,6911189,5/1/1995 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,122625, ,NIGMS, , ,122625
Function of the ATR-ATRIP complex,6911692,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,268780, ,NCI, , ,268780
Redox Effects of Selenium for Prostate Cancer Prevention,6911862,4/18/2005 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,287363, ,NCI, , ,287363
Imaging Lung Cancer in Mice To Improve Radiation Therapy,6912110,8/3/2005 0:00,7/31/2010 0:00,Other Research-Related,2005,136289, ,NCI, , ,136289
Mitotic Checkpoint Proteins in Tumorigenesis,6912547,7/18/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,378028, ,NCI, , ,378028
"Heterogeneity of Human Melanoma, Cytokines and iNOS",6912755,7/12/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,267000, ,NCI, , ,267000
Regulation of p53-mediated apoptosis in gliomas,6912812,7/17/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,268780, ,NCI, , ,268780
Rapamycin-induced Selective Apoptosis in Malignant Cells,6913562,12/1/1998 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,282000, ,NCI, , ,282000
Determinants of Breast Cancer Survival,6913579,6/1/2002 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,598685, ,NCI, , ,598685
p53-Mediated Transcription and Apoptosis,6913723,4/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,304200, ,NCI, , ,304200
Altered Proteoglycan Gene Expression and Cancer,6914150,9/1/1988 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,375211, ,NCI, , ,375211
Role of CDK4 in Cell Cycle Progression and Cancer,6914181,9/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,376250, ,NIA, , ,376250
Effects of DNA Damaging Agents on G2 Phase Checkpoint,6914436,7/11/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,249375, ,NCI, , ,249375
Analysis of a Novel Cancer Pathway Containing PML & HIRA,6914447,7/1/2004 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,152100, ,NCI, , ,152100
Chemoresistance in Renal Cell Cancer,6914816,7/8/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,269848, ,NCI, , ,269848
Expression of Proapoptotic Genes for Cancer Therapy,6914844,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,335975, ,NCI, , ,335975
The Role of RR in Chemotherapeutic Drug Resistance,6915053,4/1/1997 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,249375, ,NCI, , ,249375
Gene Networks for Prostate Cancer Progression,6915067,8/5/2003 0:00,7/31/2006 0:00,Other Research-Related,2005,159300, ,NCI, , ,159300
ARF MDM2 P53 TUMOR SUPPRESSION PATHWAY,6915078,8/1/2000 0:00,3/31/2006 0:00,Other Research-Related,2005,148626, ,NCI, , ,148626
Specificity of Ubiquitination: the HPVE6/E6AP Paradigm,6915157,12/13/1996 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,280120, ,NCI, , ,280120
Deregulation of Cell Pathways by Ad E1B 55K Oncoproteins,6915232,7/1/2001 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,271721, ,NCI, , ,271721
Oncogenes and loss of ER in a new p53 breast tumor model,6915756,5/10/1989 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,305000, ,NCI, , ,305000
Molecular Epidemiology of Non-Melanoma Skin Cancer,6915777,9/30/1999 0:00,7/31/2007 0:00,Non-SBIR/STTR,2005,431864, ,NCI, , ,431864
p53 and checkpoint pathways in cancer cell repliction,6916265,7/11/1994 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,343125, ,NCI, , ,343125
Cellular Stress Response Signaling Pathways,6916269,1/1/1992 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,337500, ,NIEHS, , ,337500
Centrosomes in the Control of Mitosis and Interphase,6916275,5/1/1982 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,397500, ,NIGMS, , ,397500
Normal and Neoplastic Regulation of Cyclin E,6916340,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,384925, ,NCI, , ,384925
ARF ACTIVATION BY POLYOMA VIRUS T-ANTIGEN,6916455,7/25/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,269670, ,NCI, , ,269670
Control of c-Myc Function by the Tumor Suppressor p19ARF,6916533,7/6/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,278595, ,NCI, , ,278595
Function of the Adenovirus E1B Oncogene,6916549,1/1/1991 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,303192, ,NCI, , ,303192
Molecular Markers: Response to Chemo-immunotherapy in C*,6916555,7/1/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,269520, ,NCI, , ,269520
Models of DRA growth suppression in colon cancer,6916557,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,259880, ,NCI, , ,259880
Potentials of reactivated mutant p53,6916567,7/1/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,313650, ,NCI, , ,313650
Cancer Biology in the Zebrafish,6917001,7/3/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,360450, ,NCI, , ,360450
SPORE in Head and Neck Cancer,6917011,7/1/2004 0:00,6/30/2009 0:00,Research Centers,2005,2419163, ,NCI, , ,2419163
Analysis of Chk2 dependent DNA damage signaling pathway,6917169,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,222233, ,NCI, , ,222233
Mechanisms of cyclin E associated tumorigenesis,6917179,7/1/2003 0:00,6/30/2008 0:00,Other Research-Related,2005,133650, ,NCI, , ,133650
INHIBITION OF RIBONUCLEOTIDE REDUCTASE IN GLIOMAS,6917263,7/10/2003 0:00,7/9/2006 0:00,"Training, Individual",2005,57536, ,NCI, , ,57536
Role of DN-p63 in Preservation of Self Renewal,6917604,4/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2005,240461, ,NCI, , ,240461
Prognosis in BRCA1 Associated Breast Cancer,6917668,6/20/2005 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,471855, ,NCI, , ,471855
The Apoptogenic Role of p53 at the Mitochondria,6917909,9/15/1993 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,276300, ,NCI, , ,276300
Exploring How HTLV-1 Tax Induces T Cell Leukemia,6917935,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,447012, ,NCI, , ,447012
Viral Model for Tumor Pathogenesis in Brain,6917977,9/30/1996 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,1279069, ,NINDS, , ,1279069
Anti-cancer effects by the green tea catechins,6918263,4/6/2005 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,124528, ,NCI, , ,124528
Proteome analysis of malignant astrocytes,6918502,7/15/2004 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,350575, ,NINDS, , ,350575
Ubiquitin-Mediated Regulation of DNA Repair,6918588,7/7/2004 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,295200, ,NCI, , ,295200
Polo-like Kinase Functions in Normal and Tumor Cells,6918595,9/1/2000 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,466390, ,NIGMS, , ,466390
Statistical Methods in Genetic Epidemiology,6918621,6/1/1997 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,259500, ,NIA, , ,259500
Role of TRRAP in the p53-Mediated Transcription of mdm2,6918636,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,300280, ,NCI, , ,300280
Human and Murine Models of BRCA1 Tumorigenesis,6918664,1/7/1998 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,277375, ,NCI, , ,277375
Translational Control by elF2 Kinase during ER Stress,6918835,8/1/2001 0:00,7/31/2009 0:00,Non-SBIR/STTR,2005,280337, ,NIGMS, , ,280337
Interaction Between SV40 Large T and p185 Cullin,6919302,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,366834, ,NCI, , ,366834
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,6919312,8/15/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,295515, ,NCI, , ,295515
2002 Gordon Research Conference on Cell Death,6919329,5/1/2002 0:00,4/30/2007 0:00,Other Research-Related,2006,10000, ,NCI, , ,5000
The Role of P40 in Squamous Cell Carcinomas,6919407,12/1/1999 0:00,8/31/2010 0:00,Non-SBIR/STTR,2005,348591, ,NIDCR, , ,348591
Regulation of Mdm2 compartmentalization,6919409,5/11/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,241740, ,NCI, , ,241740
Studies of Materials with Physiological Properties,6919877,9/1/1988 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,562258, ,NIGMS, , ,562258
PROHIBITIN GENE IN GROWTH CONTROL AND TUMOR SUPPRESSION,6920145,9/30/1999 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,282043, ,NCI, , ,282043
Functional Characterization of the ATM Gene Product,6920225,8/15/1996 0:00,5/31/2010 0:00,Non-SBIR/STTR,2005,375000, ,NCI, , ,375000
UNDERSTANDING A NOVEL MODIFIER OF P53 TUMORIGENESIS,6920256,9/1/1999 0:00,7/31/2007 0:00,Other Research-Related,2004,156791, ,NCI, , ,156791
Nuclear-targeted nanoparticles for gene delivery,6920391,9/1/2005 0:00,6/30/2009 0:00,Non-SBIR/STTR,2005,287100, ,NIBIB, , ,287100
"HPV, Genetic Instability & Oral Cancer",6920713,8/1/2001 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,240188, ,NIDCR, , ,240188
Papillomavirus Inhibitors for AIDS-related Malignancies,6920811,7/29/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,279388, ,NCI, , ,279388
Effects of mutant beta-catenin on hepatocellular cancer,6921096,6/1/2005 0:00,5/31/2008 0:00,Other Research-Related,2005,93960, ,NCRR, , ,93960
Regulation of p53 in reespnse to genotoxic stress,6921329,8/1/2003 0:00,7/31/2007 0:00,Non-SBIR/STTR,2005,298775, ,NIGMS, , ,298775
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors,6921427,8/5/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2005,223388, ,NCI, , ,223388
Mouse Model of Pancreatic Cancer Progression-Maintenance,6921547,9/21/2005 0:00,8/31/2010 0:00,Other Research-Related,2005,137700, ,NCI, , ,137700
Cell and tumor genetics of mitotic arrest checkpoints,6921619,2/1/2000 0:00,3/31/2010 0:00,Non-SBIR/STTR,2005,333873, ,NCI, , ,333873
The Role of p73 in Upper Gastrointestinal Carcinomas,6921826,4/1/2005 0:00,9/30/2005 0:00,Non-SBIR/STTR,2005,270846, ,NCI, , ,270846
Role of the p53 homolog p73 in cancer,6921975,1/14/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2005,301376, ,NCI, , ,301376
AMID in Apoptosis and p53-Mediated Downstream Effects,6922103,7/14/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,279702, ,NCI, , ,279702
Gastrointestinal Cell Proliferation and Cell Cycle,6922525,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,306520, ,NCI, , ,306520
Novel Proapoptotic BH3-only Proteins in Cancer Apoptosis,6922748,5/16/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,221068, ,NCI, , ,221068
Molecular Analysis of Esophageal Cancer Survival,6922863,7/3/2003 0:00,6/30/2008 0:00,Other Research-Related,2005,135837, ,NCI, , ,135837
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors,6922876,7/15/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,684760, ,NCI, , ,684760
Brain tumor angiogenesis: Integrin ceramide signaling,6922911,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,280994, ,NCI, , ,280994
Sphingosine Phosphate:Regulation and Role in Cancer,6923064,9/1/1998 0:00,3/31/2010 0:00,Non-SBIR/STTR,2005,340213, ,NCI, , ,340213
Bladder Tumor Targeting by Intravesical Paclitaxel,6923709,8/1/2004 0:00,7/31/2008 0:00,SBIR/STTR,2005,300157, ,NCI, , ,300157
Regulation of Stat3 by p53 in cancer Cells,6923736,8/9/2002 0:00,7/31/2007 0:00,Non-SBIR/STTR,2005,231087, ,NCI, , ,231087
"Gastric Cancer Prognosis--MSI, BAX, DCC, & p53 LOH",6923737,8/6/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2005,313272, ,NCI, , ,313272
NEW MODELS FOR COMPARATIVE STUDIES OF GONADAL TUMORS,6923921,12/16/1993 0:00,7/31/2007 0:00,Non-SBIR/STTR,2005,257250, ,NIEHS, , ,257250
Proteomic Study of Novel Platinum Compounds in Glioma,6924153,5/23/2005 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,150000, ,NCI, , ,150000
Molecular Mechanism of E2F Specificity,6924613,9/30/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,342650, ,NCI, , ,342650
Bladder Cancer Prognostic Indicators,6924749,9/1/2005 0:00,8/31/2010 0:00,Other Research-Related,2005,138847, ,NCI, , ,138847
DNA damage response and DDB,6924893,5/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,301860, ,NIA, , ,301860
Quantum Dots as Single Molecule Intracellular Probes,6925070,6/1/2005 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,132040, ,NIGMS, , ,132040
Transcriptional Control of Gastrin,6925283,9/1/1993 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,58734, ,NIDDK, , ,58734
Transcriptional Control of Gastrin,6925527,9/1/1993 0:00,9/29/2007 0:00,Non-SBIR/STTR,2005,554862, ,NIDDK, , ,554862
Barrett's Esophagus: Predictors of Progression,6926147,8/16/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,2615324, ,NCI, , ,2615324
Effect of mutant p53 on stress-response,6926156,8/12/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,254363, ,NCI, , ,254363
Functional Analysis of p53 Polymorphic Variants,6926438,6/1/2005 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,317567, ,NCI, , ,317567
Viral Pathogenesis in Human Colon Cancer,6926609,9/23/2005 0:00,8/31/2010 0:00,Other Research-Related,2005,141993, ,NCI, , ,141993
Biomarkers of Prostate Cancer Radiation Outcome,6926834,4/6/2005 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,398781, ,NCI, , ,398781
Southwest Oncology Group,6926958,2/1/1993 0:00,12/31/2009 0:00,Other Research-Related,2005,317259, ,NCI, , ,317259
Oxidative damage to gastric epithelal cells by H pylori,6926978,9/21/2001 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,266400, ,NIDDK, , ,266400
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS,6927164,7/12/2002 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,1051799, ,NCI, , ,1051799
PAC1 in Signaling Apoptosis and Tumor Suppression,6927261,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,264040, ,NCI, , ,264040
DNA Damage/Repair and Cell Death,6927467,4/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2005,300857, ,NINDS, , ,300857
"A Novel Pathway Involving E2F1, ATM and NBS1",6927955,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,335975, ,NCI, , ,335975
Studies of Childhood Solid Tumors,6928006,8/1/1978 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,1648971, ,NCI, , ,1648971
ROLE FOR CELL CYCLE PROTEINS IN HIV ENCEPHALITIS,6928181,2/1/2001 0:00,3/14/2005 0:00,Non-SBIR/STTR,2004,42232, ,NINDS, , ,42232
Investigating the Role of Cyr61 in Breast Cancer,6928476,7/26/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,267634, ,NCI, , ,267634
Regulation of MDM2 by the ribosomal protein L11,6928526,8/1/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,313725, ,NCI, , ,313725
Biomarkers in Phototherapy of Barrett's Esophagus,6928550,9/30/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,321513, ,NCI, , ,321513
Molecular Targets for Drug and Radiation Sensitivity,6928560,8/17/1998 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,1585979, ,NCI, , ,1585979
Hepatitis HBx-Mediated Pathogenesis,6928570,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,301376, ,NCI, , ,301376
Regulation of DNA Double-Strand Break Repair,6928617,7/26/2004 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,263835, ,NCI, , ,263835
Leptomycin B Analogs,6929027,8/1/2004 0:00,7/31/2006 0:00,SBIR/STTR,2005,300000, ,NCI, , ,300000
Genomic & Genetic Characterization of Amplicons in GBMs,6929047,9/24/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,304380, ,NCI, , ,304380
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA,6929092,9/1/1992 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,216324, ,NCI, , ,216324
Transduction of Tumor Suppressor Proteins into Gliomas,6929106,9/5/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2005,248886, ,NCI, , ,248886
Prospective Studies of Diet and Cancer in Men and Wonen,6929328,8/23/1991 0:00,11/30/2006 0:00,Non-SBIR/STTR,2005,4155034, ,NCI, , ,4155034
Development Therapy for Metastatic Colorectal Cancer,6929464,5/1/2005 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,296250, ,NCI, , ,296250
Epigenetic factors governing SOD2 gene expression,6929717,4/6/1998 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,262550, ,NCI, , ,262550
Modulators of p53 Expression and Function,6929728,9/1/1997 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,287640, ,NCI, , ,287640
Regulation of the KSHV latent promoter,6929781,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,251728, ,NCI, , ,251728
A novel regulator of p53 function,6929886,8/15/2002 0:00,7/31/2007 0:00,Non-SBIR/STTR,2005,270560, ,NCI, , ,270560
UV and p21 Degradation,6930037,6/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2005,344243, ,NCI, , ,344243
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2,6930190,4/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2005, ,225115, , , , 
Functional analysis of the p53 tumor suppressor,6930486,8/15/1985 0:00,7/31/2008 0:00,Non-SBIR/STTR,2005,215200, ,NCI, , ,215200
Mechanism of Meclp in the Checkpoint Response,6930490,9/1/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,223500, ,NIGMS, , ,223500
Visualizing Clonal Expansion in Living Mice,6930528,8/1/2004 0:00,5/30/2007 0:00,Non-SBIR/STTR,2005,138578, ,NCI, , ,138578
Physical and Functional Interactions Between PML & MDM2,6930623,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,240188, ,NCI, , ,240188
Mechanistic Studies on New Platinum Clinical Agents,6931019,9/30/1998 0:00,7/31/2007 0:00,Non-SBIR/STTR,2005,305500, ,NCI, , ,305500
Role of DDB in checkpoint control and carcinogenesis,6931211,1/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2005,271674, ,NCI, , ,271674
The role of hBUB1-p53 pathway in genomic stability.,6931528,8/1/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,287470, ,NCI, , ,287470
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,6931655,8/1/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,399200, ,NCI, , ,399200
MUTANT LINES OF ZEBRAFISH HIGHLY SENSITIVE TO NEOPLASIA,6931960,8/1/2004 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,141500, ,NIEHS, , ,141500
Minority Predoctoral Fellowship Program,6932394,8/1/2004 0:00,7/31/2009 0:00,"Training, Individual",2005,34988, ,NCI, , ,34988
Minority Predoctoral Fellowship Program,6932396,7/2/2004 0:00,7/1/2009 0:00,"Training, Individual",2005,42002, ,NCI, , ,42002
NEW METHODS FOR CANCER DETECTION,6932406,3/1/1997 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,3069259, ,NCI, , ,3069259
DNA Damage Checkpoints,6932983,8/10/1998 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,330958, ,NCI, , ,330958
MTOR as a Therapeutic Target in Childhood Cancer,6933098,9/1/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,300375, ,NCI, , ,300375
Molecular Epidemiology of Esophageal Cancer Prognosis,6933870,8/5/2004 0:00,5/31/2006 0:00,Non-SBIR/STTR,2005,407160, ,NCI, , ,407160
P53 and Organismal Aging,6934481,9/15/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,580861, ,NIA, , ,580861
Novel Ceramide-based Chemotherapy for Acute Leukemia,6935338,8/10/2004 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,249772, ,NCI, , ,249772
Selenium and prostate cancer apoptosis pathways,6935410,9/1/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,246000, ,NCI, , ,246000
RAS INDUCED SENESCENCE AND TUMOR PROGRESSION,6935819,7/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2005,498514, ,NIA, , ,498514
CLINICAL EVALUATION OF A POXVIRUS VACCINE TARGETING P53,6936311,4/19/2005 0:00,3/31/2007 0:00,Non-SBIR/STTR,2005,300398, ,NCI, , ,300398
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER,6936549,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,265220, ,NCI, , ,265220
Microarray Analysis of HNSCC as a Predictor of Treatment,6936620,9/1/2002 0:00,8/31/2006 0:00,Other Research-Related,2005,135000, ,NIDCR, , ,135000
Role of Parc in the p53 Pathway,6936648,8/15/2004 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,255333, ,NCI, , ,255333
Use of Beta-Lapachone for Lung Cancer Chemotherapy,6936668,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2005,339065, ,NCI, , ,339065
Molecular pathogenesis of UVB-induced skin cancer,6937034,8/15/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,330050, ,NCI, , ,330050
Function of the Adenovirus E1B Oncogene,6938439,1/1/1991 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,105144, ,NCI, , ,105144
SIGNALING PATHWAYS REGULATING EPITHELIAL CELL SURVIVAL,6938464,5/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2005,225000, ,NIDDK, , ,225000
Perinatal Breast Cancer Programming--Fat and estrogens,6938771,7/1/2005 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,139250, ,NIEHS, , ,139250
A Novel Dosing Schedule of Flavopiridol in CLL,6938883,3/2/2005 0:00,2/28/2007 0:00,Non-SBIR/STTR,2005,295263, ,NCI, , ,295263
15-Lipoxygenase 2 is a Prostate Senescence Gene,6940606,9/1/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2005,295448, ,NIA, , ,295448
Role of RHO in Farnesyltransferase Inhibitor Responses,6940692,9/30/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,324000, ,NCI, , ,324000
Development of P53-Based Vaccines for Oral Cancer,6940816, , ,Non-SBIR/STTR,2004, ,138199, , , , 
Vaccine Development for Oral Carcinoma,6940820,9/1/1997 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,999323, ,NIDCR, , ,999323
In utero dietary exposure to endocrine disruptors,6940954,5/1/2005 0:00,2/28/2008 0:00,Non-SBIR/STTR,2005,155200, ,NIEHS, , ,155200
PHTHALATE-INDUCED MURINE TESTICULAR DYSGENESIS AND P53,6940964,5/1/2005 0:00,2/28/2008 0:00,Non-SBIR/STTR,2005,155000, ,NIEHS, , ,155000
Antitumor Activity of Inducible Nitric Oxide Synthase,6941278,9/1/2002 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,251038, ,NCI, , ,251038
Lana and Cellular Gene Expression in Kaposis Sarcoma,6941359,7/1/2000 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,239084, ,NCI, , ,239084
Adjuvant Hormonal therapy in Vietnamese Breast Cancer,6941368,7/1/1995 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,383248, ,NCI, , ,383248
MOLECULAR MECHANISM OF CHEMOPREVENTION BY APIGENIN,6941508,5/1/1996 0:00,1/31/2008 0:00,Non-SBIR/STTR,2004,280881, ,NCI, , ,280881
Nitrosourea-induced growth arrest and apoptotic pathways,6941571,8/20/2004 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,229163, ,NCI, , ,229163
Alternate Pathways for Interferon and Cytokine Signaling,6942224,7/12/2004 0:00,3/31/2010 0:00,Non-SBIR/STTR,2005, ,255708, , , , 
TUMOR MARKERS TO PREDICT TREATMENT RESPONSE,6942285,9/10/2001 0:00,8/31/2008 0:00,Other Research-Related,2005,281752, ,NIA, , ,281752
Regulation of Gene Expression by PML,6942449,9/30/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,302378, ,NCI, , ,302378
Chemoprevention of Oral Cancer with BBIC,6942455,3/14/1997 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,700341, ,NCI, , ,700341
Cervical Cancer Cofactors and HPV DNA Integration,6942673,9/1/2004 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,169875, ,NCI, , ,169875
Molecular Mechanisms of Ara-C Therapy in Man,6942752,9/15/2001 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,283860, ,NCI, , ,283860
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER,6942911,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,65487, ,NCI, , ,65487
E2F-1 Cancer Gene Therapy,6942994,9/1/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,244388, ,NCI, , ,244388
Epidemiology of HPV and p53 Mutations in NM Skin Cancer,6943040,8/1/2001 0:00,7/31/2008 0:00,Non-SBIR/STTR,2005,547725, ,NCI, , ,547725
Novel Celecoxib Derivatives as Chemopreventive Agents,6943151,9/1/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2005,134550, ,NCI, , ,134550
Molecular Mechanism for HCMV Mediated Atherogenesis,6943447,9/30/2002 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,376250, ,NHLBI, , ,376250
"A Novel Gene, WTH3,  and Multidrug Resistance",6943512,9/26/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,214463, ,NCI, , ,214463
Analysis of Somatic Mutations in Cancer of the Kidney,6943973,9/30/2004 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,71417, ,NCI, , ,71417
12th International p53 Workshop,6944062,9/1/2004 0:00,4/30/2007 0:00,Other Research-Related,2006,1000, ,NCI, , ,1000
 Model of Tumor Suppression by BRCA1,6944399,7/1/2002 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,339424, ,NCI, , ,339424
Mechanisms linking ASPP2 to the Rb/E2F and p53 pathways,6944746,9/1/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2005,278595, ,NCI, , ,278595
Reinstallation of functional p53 in glial tumors in vivo,6944830,8/1/2004 0:00,7/31/2007 0:00,"Training, Individual",2005,49928, ,NCI, , ,49928
Molecular Epidemiology of Smoking & Breast Cancer,6944868,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,259880, ,NCI, , ,259880
Computer Analysis of Nucleic Acid Structure,6945082, , ,Intramural Research,2003, , , , , , 
BRCA1 function in  G2-M checkpoint and mitosis,6945225,12/11/1998 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,254250, ,NCI, , ,254250
Genetic and Molecular Epidemiology of Adult Glioma,6945451,5/15/1991 0:00,4/30/2006 0:00,Non-SBIR/STTR,2005,997717, ,NCI, , ,997717
GENISTEIN IN INVESTIGATIVE AND CLINICAL DERMATOLOGY,6945538,2/3/2001 0:00,1/31/2006 0:00,Non-SBIR/STTR,2004,77970, ,NCI, , ,77970
Mechanisms of the Hormonal Prevention of Breast Cancer,6945629,8/1/1995 0:00,4/30/2007 0:00,Non-SBIR/STTR,2004,54000, ,NCI, , ,54000
The Molecular Epidemiology Of Ovarian Cancer,6945753,9/1/1998 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,655811, ,NCI, , ,655811
Inhibition of the TNF Apoptotic Pathway by HPV 16 E6,6945904,9/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,288360, ,NCI, , ,288360
Targeting Oncogene Expression to Skin in Transgenic Mice,6945906,8/1/1990 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,487415, ,NCI, , ,487415
POLYOMA HOST INTERACTIONS LEADING TO TUMOR DEVELOPMENT,6945942,9/1/2001 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,783207, ,NCI, , ,783207
The Molecular Genetics of Gynecologic Cancers,6946111, , ,Intramural Research,2003, , , , , , 
p53 localization in normal and human tumor cells,6946513,6/15/1999 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,253531, ,NCI, , ,253531
Targeted Gene Knockouts of p14ARF and p16INK4a,6946880,9/1/2003 0:00,8/31/2006 0:00,"Training, Individual",2005,53492, ,NCI, , ,53492
A NEURAL TRANSCRIPTION FACTOR IN LUNG CANCER EVOLUTION,6946890,6/1/1996 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,384225, ,NCI, , ,384225
Gene Expression Profiles in Human Liver Cancers,6946927,9/11/2003 0:00,8/31/2008 0:00,Other Research-Related,2005,148770, ,NCI, , ,148770
Laboratory and Clinical Translational Studies of Drug Re,6947455, , ,Intramural Research,2003, , , , , , 
Cell and Molecular Genetic Analysis of Pediatric Tumors,6947472, , ,Intramural Research,2003, , , , , , 
Nitric Oxide as a Modifier of Oxidative Stress,6947586, , ,Intramural Research,2003, , , , , , 
The Role of Kaposi's Sarcoma-Associated Herpesvirus in t,6948060, , ,Intramural Research,2003, , , , , , 
DISSECTION OF THE DNA DAMAGE CHECKPOINT PATHWAYS,6948069,2/1/2000 0:00,1/31/2005 0:00,Non-SBIR/STTR,2004,136056, ,NCI, , ,136056
Inhibition of the TNF Apoptotic Pathway by HPV 16 E6,6948081,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,52200, ,NCI, , ,52200
Chromosomal Abnormalities in Myeloma as Detected by FISH,6948085,4/1/2000 0:00,2/28/2008 0:00,Non-SBIR/STTR,2004,71896, ,NCI, , ,71896
Role of HSP90 Family Chaperone Proteins in Cellular Sign,6948086, , ,Intramural Research,2003, , , , , , 
Inflammatory Breast Cancer,6948108, , ,Intramural Research,2003, , , , , , 
Evaluation of Novel Therapeutics for Genitourinary Malig,6948110, , ,Intramural Research,2003, , , , , , 
Identification of mechanisms and consequences of chromos,6948135, , ,Intramural Research,2003, , , , , , 
Viral RNA splicing and tumorigenesis,6948140, , ,Intramural Research,2003, , , , , , 
The Interplay Between the Repressor MDM2 and Coactivator,6948270,3/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2005,268780, ,NCI, , ,268780
Role of Neuregulin-1 in Schwann Cell Neoplasia,6948758,9/15/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,268250, ,NINDS, , ,268250
Bifunctional T cell receptor based immunotherapeutics,6948820,7/26/2002 0:00,8/31/2006 0:00,SBIR/STTR,2005,569336, ,NCI, , ,569336
Functional studies of the top 1-binding protein topors,6949006,5/1/1999 0:00,8/31/2007 0:00,Non-SBIR/STTR,2004,68420, ,NCI, , ,68420
FIBRONECTIN REGULATION OF CARCINOMA APOPTOSIS,6949169,9/15/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,327038, ,NIDCR, , ,327038
Imidodipeptides and Amino Acid Metabolites in Cell Regul,6949456, , ,Intramural Research,2003, , , , , , 
T-Cell Antigen Recognition and Tumor Antigens,6949461, , ,Intramural Research,2003, , , , , , 
Actin-regulated Apoptosis in Mammary Tumorigenesis,6949524,8/1/2003 0:00,7/31/2008 0:00,Other Research-Related,2005,161730, ,NCI, , ,161730
Paradoxical Effects of Bax and Bcl-2 on Oncogenesis,6949536,9/26/2003 0:00,9/25/2007 0:00,"Training, Individual",2005,28908, ,NCI, , ,28908
HPV E6 protein regulation of the hTERT promoter,6949542,9/16/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2005,314280, ,NCI, , ,314280
Functional studies of the top 1-binding protein topors,6949546,5/1/1999 0:00,7/31/2007 0:00,Non-SBIR/STTR,2005,328883, ,NCI, , ,328883
Quantitative FDG-PET for Imaging Woodchuck HCC,6949550,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,382417, ,NCI, , ,382417
Adenocarinoma of the Lung in Women,6949690,6/13/2001 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,632943, ,NCI, , ,632943
Mda-7: Novel Cancer Therapeutic Gene,6949697,9/10/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,291030, ,NCI, , ,291030
Gene Regulation and Function: The B-ZIP Proteins,6949801, , ,Intramural Research,2003, , , , , , 
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER,6949821,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2004,263700, ,NCI, , ,263700
Analysis of Pathways that Suppress or Accelerate Premali,6949859, , ,Intramural Research,2003, , , , , , 
Molecular Epidemiology of Human Cancer,6949863, , ,Intramural Research,2003, , , , , , 
Regulation of papillomavirus gene expression,6949869, , ,Intramural Research,2003, , , , , , 
Genetics of Tobacco and Alcohol Related Cancers,6950063,9/1/2003 0:00,5/31/2007 0:00,Non-SBIR/STTR,2005,429672, ,NCI, , ,429672
Self-Renewal of Normal and Leukemic Stem Cells,6950064,9/20/2004 0:00,10/31/2005 0:00,Non-SBIR/STTR,2005,282285, ,NCI, , ,282285
"Tumor Suppressor Protein, p53",6950116, , ,Intramural Research,2003, , , , , , 
Mutational /Functional Analysis of p53 Tumor Suppressor,6950165, , ,Intramural Research,2003, , , , , , 
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targ",6950173, , ,Intramural Research,2003, , , , , , 
Molecular Biology of Cellular Injury,6950191, , ,Intramural Research,2003, , , , , , 
Bortezomib and Idarubicin in the Treatment of AML,6950294,9/20/2004 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,240714, ,NCI, , ,240714
New strategies for cancer drug discovery,6950478, , ,Intramural Research,2003, , , , , , 
Regulation of EGFR Gene Activity,6950482, , ,Intramural Research,2003, , , , , , 
Genetically Engineered Mice as Models to Study Receptor,6950511, , ,Intramural Research,2003, , , , , , 
Molecular/Cellular Regulation of Hematopoiesis - Gene Th,6950607, , ,Intramural Research,2003, , , , , , 
Genetics of Susceptibility to Mouse Plasma Cell Tumors,6950616, , ,Intramural Research,2003, , , , , , 
Role of Tobacco-Related Chemical Carcinogens /Oxyradical,6950641, , ,Intramural Research,2003, , , , , , 
Tobacco Carcinogen Oral Cancer Model,6950796,9/20/2004 0:00,8/31/2006 0:00,Non-SBIR/STTR,2005,77500, ,NCI, , ,77500
DNA Repair,6950977, , ,Intramural Research,2003, , , , , , 
Genetics of Susceptibility to Development of Skin Tumors,6950986, , ,Intramural Research,2003, , , , , , 
Cellular gene expression in HPV infection & cervical can,6951272, , ,Intramural Research,2003, , , , , , 
EARLY DETECTION OF URINARY BLADDER CANCER,6951589,9/30/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2005,540874, ,NCI, , ,540874
Design of Drugs Against Cancer and Viral Diseases,6951657, , ,Intramural Research,2003, , , , , , 
Developmental Therapeutics,6951759, , ,Intramural Research,2003, , , , , , 
Diet and Somatic Mutations in Colon Cancer,6951847,8/1/1995 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,738065, ,NCI, , ,738065
Study of the clock-controlled DNA-damage response,6951869,9/22/2004 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,75000, ,NCI, , ,75000
Prevention of bladder cancer progression by sulforaphane,6951880,9/30/2004 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,85000, ,NCI, , ,85000
MD Anderson Cancer Center SPORE in Head and Neck Cancer,6951910,9/30/2002 0:00,7/31/2007 0:00,Research Centers,2005,2367370, ,NIDCR, , ,800431
Genetic Modifiers of p53,6951921,9/22/2004 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,73500, ,NCI, , ,73500
Transcription Factor P53 in Terminal Nephron Different,6952096,7/1/2002 0:00,6/30/2006 0:00,"Training, Individual",2004,56536, ,NIDDK, , ,56536
Identification of Modifier Gene of Tumors Associated wit,6952159, , ,Intramural Research,2003, , , , , , 
Molecular Mechanisms of Proliferation and Infiltration o,6952160, , ,Intramural Research,2003, , , , , , 
Development of Mouse Astrocytoma Model for Preclinical T,6952161, , ,Intramural Research,2003, , , , , , 
Upper Gastrointestinal Cancer Genetic Studies,6952217, , ,Intramural Research,2003, , , , , , 
Association of inflammatory genes and prostate cancer,6952298,9/24/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2005,503814, ,NCI, , ,503814
Bin1 in E2F1-Mediated Tumor Growth Suppression,6952318,8/1/2004 0:00,7/31/2007 0:00,"Training, Individual",2005,39323, ,NCI, , ,39323
Cellular Senescence in Aging and Cancer,6952401,8/4/1999 0:00,6/30/2009 0:00,Non-SBIR/STTR,2005,449669, ,NCI, , ,449669
Epidemiology of Oncogenic Viruses,6952481, , ,Intramural Research,2003, , , , , , 
MOLECULAR BEACONS FOR PROTEIN DETECTION,6952613,8/1/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,226032, ,NCI, , ,226032
Timing of Rectal Cancer Response to Chemoradiation,6952769,9/16/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,641205, ,NCI, , ,641205
MOLECULAR BEACONS FOR PROTEIN DETECTION,6952834,8/1/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,198909, ,NCI, , ,198909
Mouse Models of Human Breast Cancer,6953210,9/30/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,830735, ,NCI, , ,830735
The Kinetics of Keratinocyte Stem Cell Division,6953260,9/30/2004 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,80500, ,NIAMS, , ,80500
Molecular Genetic Epidemiology of Primary Hepatocellular,6954016, , ,Intramural Research,2003, , , , , , 
Molecular Genetic Epidemiology of leading U.S. Cancers,6954017, , ,Intramural Research,2003, , , , , , 
Genetic Predisposition to Aflatoxin-Induced Hepatocellul,6954025, , ,Intramural Research,2003, , , , , , 
Studies of Rare Cancers,6954037, , ,Intramural Research,2003, , , , , , 
The role of JNK in Mammary tumor development,6954161,9/29/2004 0:00,4/30/2006 0:00,Non-SBIR/STTR,2005,139751, ,NCI, , ,139751
Planning a Trial of Sulindac for Oral Leukoplakia,6954197,9/28/2004 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,144069, ,NIDCR, , ,144069
Integration of Oncogenic Networks in Cancer Phenotypes,6954708,9/30/2004 0:00,8/31/2009 0:00,Research Centers,2005,2263995, ,NCI, , ,2263995
The role of selenoproteins in the etiology of cancer,6955370,6/10/2005 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,265934, ,NCI, , ,265934
Minority Predoctoral Fellowship Program,6957980,9/16/2004 0:00,9/15/2007 0:00,"Training, Individual",2005,26967, ,NIGMS, , ,26967
wnt Signaling in Liver Development and Disease,6959519,7/15/2005 0:00,6/30/2010 0:00,Other Research-Related,2005,132300, ,NIDDK, , ,132300
Nuclear Signaling by TRADD,6960032,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2004,291305, ,NINDS, , ,291305
Etiology and Prevention of Oral Cancer,6961928,5/1/2003 0:00,2/29/2008 0:00,Non-SBIR/STTR,2005,304108, ,NCI, , ,304108
Nitroaromatics and Breast Cancer,6961934,7/1/1983 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,291763, ,NCI, , ,291763
Tobacco Carcinogenesis and Chemoprevention,6961941,6/17/1996 0:00,2/28/2009 0:00,Non-SBIR/STTR,2005,1433809, ,NCI, , ,1433809
Control of Sir2 by Nuclear NAD Salvage Pathways,6963039,8/1/2005 0:00,7/31/2009 0:00,Non-SBIR/STTR,2005,253764, ,NIGMS, , ,253764
NF Center: From Animal Models to Therapeutics,6965239,9/20/2005 0:00,4/30/2010 0:00,Research Centers,2005,1253377, ,NINDS, , ,1253377
Cables and the colonocyte,6965250,8/1/2005 0:00,5/31/2009 0:00,Non-SBIR/STTR,2005,299693, ,NCI, , ,299693
Oral Carcinogenesis: Studies With Human Gingival Keratin,6966498, , ,Intramural Research,2004, , , , , , 
Antiproliferative Effects Of Small Molecules: Basic And,6966517, , ,Intramural Research,2004, , , , , , 
Molecular Epidemiology of Colorectal Cancer Subtypes,6966760,9/15/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2005,287385, ,NCI, , ,287385
"Kinetics, Regulation, And Mechanisms Of Biochemical Rxns",6966844, , ,Intramural Research,2004, , , , , , 
DNA Damage Response In Eukaryotic Cells,6966933, , ,Intramural Research,2004, , , , , , 
ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICE,6967026,4/1/1987 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,183600, ,NCI, , ,183600
Identification of Downstream Signals for Pitx2a,6967041, , ,Intramural Research,2004, , , , , , 
Transcriptional Repression by CtBP at the p21 Promoter,6967743,7/1/2005 0:00,6/30/2010 0:00,Other Research-Related,2005,136980, ,NCI, , ,136980
Molecular Mechanisms of Hormone-independence of Prostate Cancer,6968119,7/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,263959, ,NCI, , ,263959
In vivo pathogenesis of Helicobacter pylori,6968168,9/1/1996 0:00,2/28/2010 0:00,Non-SBIR/STTR,2005,344250, ,NIAID, , ,344250
Hypoxia and Gene Repression,6968311,7/1/2000 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,333050, ,NCI, , ,333050
Regulation Of Mutant P53,6968656, , ,Intramural Research,2004, , , , , , 
"Telomeres, Telomerase and Tumor Progerssion",6968727,8/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2005,309722, ,NCI, , ,309722
p38 MAPK in Ras-induced Senescence and Transformation,6968820,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,330437, ,NCI, , ,330437
Role of sestrin family genes in antioxidant defense,6968867,9/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2005,306000, ,NIA, , ,306000
Genetic Regulators of Human Melanocytic Neoplasia,6968973,7/1/2005 0:00,3/31/2010 0:00,Other Research-Related,2005,118071, ,NIAMS, , ,118071
Comparative Bioinformatics and TP53 Expression,6969522,9/30/2005 0:00,9/29/2010 0:00,Other,2005,295387, ,NLM, , ,295387
Endoscopic Therapy of Early Cancer in Barretts Esophagus,6969891,9/16/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2005,344533, ,NCI, , ,344533
Novel Targets/Protection of T Cells From Tumor-Induced,6970179,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2005,283483, ,NCI, , ,283483
Dietary Prevention of Cancer,6970345,7/1/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2005,302175, ,NCI, , ,302175
p53 Responses and Lung Cancer Risk,6974361,4/20/2004 0:00,3/31/2005 0:00,Research Centers,2004, ,38, , , , 
Phase I Trial of Intraperitoneal Adenoviral p53 Gene Therapy in Ovarian Cancer,6975048,4/20/2004 0:00,3/31/2005 0:00,Research Centers,2004, ,221, , , , 
p53 - Regulators and Effectors,6976913,2/16/2000 0:00,6/30/2010 0:00,Non-SBIR/STTR,2005,1349000, ,NCI, , ,1349000
Molecular Biology of Retinoblastoma,6979881,7/1/1976 0:00,7/31/2007 0:00,Non-SBIR/STTR,2005,181875, ,NEI, , ,181875
Modeling ovarian carcinoma by defined genetic alterations,6983701,9/1/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2005,280845, ,NCI, , ,280845
NQO1 in Protection Against Benzene Toxicicity,6984132,7/15/1998 0:00,11/30/2007 0:00,Non-SBIR/STTR,2006,300762, ,NIEHS, , ,300762
Biosynthesis and Hypoxia in Gliomas,6984627,5/10/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004, ,100554, , , , 
Genomic Instability and Senescence in Cancer,6985441,9/14/2005 0:00,8/31/2010 0:00,Other Research-Related,2005,124644, ,NCI, , ,124644
Altered Expression of Protein Tyrosine Phosphatase by Methylation,6986003,7/1/2005 0:00,6/30/2011 0:00,Non-SBIR/STTR,2006, ,198950, , , , 
Pathology,6986013,7/1/2005 0:00,6/30/2011 0:00,Non-SBIR/STTR,2006, ,208536, , , , 
Base Pairing and Mutagenesis,6986170,12/1/1988 0:00,11/30/2007 0:00,Non-SBIR/STTR,2006,334106, ,NIGMS, , ,334106
Apoptosis in Colon Cancer Chemoprevention,6986565,7/1/1997 0:00,12/31/2005 0:00,Non-SBIR/STTR,2005,35071, ,NCI, , ,35071
Methods For Gene Expression Microarrays,6988064, , ,Intramural Research,2003, , , , , , 
A Functional Census of p53 Cancer and Suppressor Mutants,6989008,8/1/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2005,363175, ,NCI, , ,363175
Sequence Distribution of Tobacco Carcinogen-DNA Adducts,6989127,12/1/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2006,195392, ,NCI, , ,195392
Prevention of quinone toxicity and mutagenicity,6989233,8/1/1996 0:00,7/31/2010 0:00,Non-SBIR/STTR,2005,356250, ,NIEHS, , ,356250
Progesterone-mediated protection against ovarian cancer,6989296,9/1/2005 0:00,9/29/2005 0:00,Non-SBIR/STTR,2005,15109, ,NCI, , ,15109
Interactions of the SV40 Small T Antigen and PP2A in Human Cell Transformation,6989676,4/27/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004, ,128175, , , , 
Cellular Targets of Papillomavirus Oncoproteins,6989677,4/27/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2004, ,390887, , , , 
Role of H2AX and ATM in Suppression of Thymic Lymphomas,6989691,8/11/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004, ,387450, , , , 
"Characterization of Mutational Spectra, Mechanisms of Toxicity and Homologous Rec",6990331,4/13/2004 0:00,12/31/2008 0:00,Non-SBIR/STTR,2004, ,271489, , , , 
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHN,6990396,7/1/2004 0:00,6/30/2009 0:00,Research Centers,2004, ,153880, , , , 
The Molecular Biology Of The Mammalian Brain,6990661, , ,Intramural Research,2004, , , , , , 
Molecular Mechanisms of UVA apotosis  and carcinogenesis,6991757,7/1/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004, ,293917, , , , 
Phase I/II study of topical agents for chemoprevention,6991764,7/1/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2004, ,477280, , , , 
Transcripitonal and Genetic Profiles in HNSCCs,6992715,3/1/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2006,293292, ,NIDCR, , ,293292
Regulation of Stat3 by p53 in cancer Cells,6993231,8/9/2002 0:00,7/31/2006 0:00,Non-SBIR/STTR,2004,242725, ,NCI, , ,242725
Human Neurotropic JC Virus and CNS Diseases,6993610,3/4/2002 0:00,12/31/2006 0:00,Non-SBIR/STTR,2006,292101, ,NCI, , ,292101
Regulation of MDM2 by the ribosomal protein L11,6994082,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2004,324850, ,NCI, , ,324850
MKP-8: NOVEL PHOSPHATASE OVEREXPRESSED IN NEUROBLASTOMA,6994134,8/1/2005 0:00,7/31/2006 0:00,"Training, Individual",2005,51548, ,NCI, , ,51548
Generation of faithful mouse model of Li Fraumeni Syndro,6994137,9/1/2005 0:00,8/31/2008 0:00,"Training, Individual",2005,29063, ,NIGMS, , ,29063
MDM2 AS A NEGATIVE REGULATOR OF P21 WAF1/CIP1,6994432,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2006,262139, ,NCI, , ,262139
GENETIC ALTERATION IN THE EPITHELIAL AND STROMAL,6995148,9/15/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2004, ,278124, , , , 
Melanoma in p16INK4a and p19ARF Deficient Mice,6997813,2/15/2002 0:00,11/30/2006 0:00,Other Research-Related,2006,130918, ,NCI, , ,130918
Mechanism of Apoptosis by Par4,6998397,9/30/1995 0:00,12/31/2007 0:00,Non-SBIR/STTR,2006,289865, ,NCI, , ,289865
The Role of NF-kappaB in Chemotherapy Resistance,6998451,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2006,350320, ,NCI, , ,350320
The role of Met proto-oncogene in breast tumorigenesis,6998571,8/1/2005 0:00,7/31/2008 0:00,"Training, Individual",2005,49928, ,NCI, , ,49928
Molecular Mechanisms of SUMO Activation and Recognition,6998689,9/1/2005 0:00,8/31/2008 0:00,"Training, Individual",2005,42068, ,NIGMS, , ,42068
Mouse Models of Endometriosis and Ovarian Cancer,6998726,7/1/2005 0:00,12/31/2005 0:00,"Training, Individual",2005,26746, ,NCI, , ,26746
"cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma",6999704,1/1/2005 0:00,12/31/2008 0:00,Non-SBIR/STTR,2006,231516, ,NCI, , ,231516
Transformation of human mammary epithelium by c-Myc,7000334,5/1/1997 0:00,12/31/2008 0:00,Non-SBIR/STTR,2006,340993, ,NIA, , ,340993
Repair of Genotoxic Damage in Chromatin,7000344,1/1/2002 0:00,9/27/2007 0:00,Non-SBIR/STTR,2006,288427, ,NCI, , ,288427
Novel Approaches for Pancreatic Cancer Therapy,7000418,1/21/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2006,355239, ,NCI, , ,355239
Third International Mdm2 Workshop,7000510,9/15/2005 0:00,9/14/2006 0:00,Other Research-Related,2005,10000, ,NCI, , ,10000
THE MOLECULAR BIOLOGY OF RETINOBLASTOMA,7000542,2/1/1999 0:00,7/31/2005 0:00,Non-SBIR/STTR,2005,62713, ,NEI, , ,62713
Interactions and Functions of p14ARF in Cancer,7001275,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2006,381549, ,NCI, , ,381549
Transcriptional Responses in Neurodegenerative Diseases,7002180,1/1/2004 0:00,12/31/2007 0:00,Non-SBIR/STTR,2006,254486, ,NINDS, , ,254486
Mechanisms of Intestinal Tumorigenesis,7002212,1/1/2000 0:00,2/28/2010 0:00,Non-SBIR/STTR,2006,372154, ,NCI, , ,372154
Enhancing Activity of Alkylating Agents in Neuroblastoma,7002353,9/1/1999 0:00,12/31/2009 0:00,Non-SBIR/STTR,2006,247248, ,NCI, , ,247248
Molecular Characterization of Inflammatory Breast Cancer,7002442,9/1/2005 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,76500, ,NCI, , ,76500
Mouse Models of Gastric Cancer,7002627,5/1/2001 0:00,4/30/2006 0:00,Non-SBIR/STTR,2004,154005, ,NCI, , ,154005
Characterization of the p53 Apoptotic Target Gene PERP,7004496,1/1/2002 0:00,4/18/2007 0:00,Non-SBIR/STTR,2006,281840, ,NCI, , ,281840
ARF MDM2 P53 TUMOR SUPPRESSION PATHWAY,7004989,8/1/2000 0:00,3/31/2006 0:00,Other Research-Related,2004,124278, ,NCI, , ,124278
Effectors of p53 Pro-Survival & Pro-Apoptotic Signaling,7005291,7/1/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2005, ,314466, , , , 
Molecular Interactions and Regulation of p53,7005294,7/1/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2005, ,187918, , , , 
p53 Pathway in Postnatal Growth and Stem Cell Behavior,7005295,7/1/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2005, ,194437, , , , 
Regulation and Function of C/EBP in UVB Responses,7005391,1/3/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2006,300483, ,NIEHS, , ,300483
The Bcl-2/Bcl-X Pathway in Myc-Induced Lymphomagenesis,7005417,12/15/1997 0:00,10/31/2006 0:00,Non-SBIR/STTR,2006,275373, ,NCI, , ,275373
" 8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA",7006296,7/5/2000 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,338483, ,NCI, , ,338483
Mechanism(s) Of Leukemogenesis In Disease Models,7006469, , ,Intramural Research,2004, , , , , , 
Carcinogen Inactivation Of Tumor Suppressor Genes In p53,7006523, , ,Intramural Research,2004, , , , , , 
Site-Specific Phosphorylation of p53 in Apoptosis,7006568, , ,Intramural Research,2004, , , , , , 
Mechanisms of Cell Cycle Associated Neoplasia,7006935,2/16/2000 0:00,1/31/2010 0:00,Non-SBIR/STTR,2006,358985, ,NCI, , ,358985
"P38, G2 Arrest, and Temozolomide Resistance in Gliomas",7006940,2/1/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2006,303277, ,NCI, , ,303277
Regulation Of Differentiation In Lung Keratinocytes,7007108, , ,Intramural Research,2004, , , , , , 
Human Genes Affecting Chromosome Metabolism,7007441, , ,Intramural Research,2004, , , , , , 
Genetic and environmental factors in cancer,7007531, , ,Intramural Research,2004, , , , , , 
Analysis of p53 function in aging and tumor suppression,7007682,1/15/2005 0:00,12/31/2006 0:00,Non-SBIR/STTR,2006,147940, ,NIA, , ,147940
CONTRAST ASSISTED ULTRASOUND IMAGING OF TUMORS,7007704,12/11/1997 0:00,12/31/2007 0:00,Non-SBIR/STTR,2006,266168, ,NCI, , ,266168
Inductible mouse models for oral cancer,7007722,1/13/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2006,355202, ,NIDCR, , ,355202
Monitoring mechanisms in mammalian ribosome biogenesis,7008102,2/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2006,232708, ,NIGMS, , ,232708
Nuclear Signaling by TRADD,7008205,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,329175, ,NINDS, , ,329175
Role of the p53 homolog p73 in cancer,7008208,1/14/2002 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,294294, ,NCI, , ,294294
Structure-Function of Protein Deacetylases,7008493,3/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,306244, ,NCI, , ,306244
Role of RNase L in the Biology of Prostate Cancer,7008850,2/16/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2006,306280, ,NCI, , ,306280
A role for p53/MyoD redundancy in myogenesis?,7009150,9/5/2005 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,203057, ,NIAMS, , ,203057
Multi-institutional trial: molecular analysis of margins,7009647,2/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2006,223716, ,NCI, , ,223716
Two Novel Sir2-Interacting Proteins in Yeast,7009981,2/1/2004 0:00,1/31/2007 0:00,"Training, Individual",2006,50428, ,NIGMS, , ,50428
Study of genomic instability caused by HPV16 E6 and E7,7010343,5/1/2004 0:00,7/31/2006 0:00,Non-SBIR/STTR,2006,139950, ,NIDCR, , ,139950
Study of a FACTp140-SSRP1-associated p53 Kinase,7010349,1/10/2002 0:00,7/14/2007 0:00,Non-SBIR/STTR,2006,286481, ,NCI, , ,286481
Aldo-Keto Reductases and PAH Metabolism/Activation,7010378,3/1/1986 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,290977, ,NCI, , ,290977
Oncogenic Gene Regulatory Networks,7010391,2/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2006,292548, ,NCI, , ,292548
Thioredoxin Inhibition of Apoptosis and Cancer Treatment,7010728,12/18/1998 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,277209, ,NCI, , ,277209
The Role of Phosphatase CL100/MKP1 in Human Cancer,7010738,2/5/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2006,241820, ,NCI, , ,241820
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1,7010749,2/15/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,278413, ,NCI, , ,278413
Molecular Epidemiology of Secondary Lung Cancer,7012225,1/15/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2006,862767, ,NCI, , ,862767
Mechanism of SAG apoptosis protection under hypoxia,7012235,2/1/2005 0:00,1/31/2009 0:00,Non-SBIR/STTR,2006,295074, ,NCI, , ,295074
DNA Damage/Repair and Cell Death,7012331,4/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2006,295142, ,NINDS, , ,295142
"Hypoxia, Genetic Instability and DNA Mismatch Repair",7012809,9/30/1992 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,319316, ,NIEHS, , ,319316
Mutant p53 Gain of Function in Tumorigenesis,7013155,4/1/1995 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,309795, ,NCI, , ,309795
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1,7013409,2/15/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,47232, ,NCI, , ,47232
Stat3 and anti-VEGF therapy in cancer,7013591,2/21/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,293751, ,NCI, , ,293751
"Mechanisms of mutagenesis in "" hot spots"" causing cancer",7013630,2/1/2004 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,221191, ,NCI, , ,221191
Stress- and Promoter-Specific Mechanisms of Transcritpional Activation by p53,7013701,5/26/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2006,211580, ,NCI, , ,211580
Prognostic Molecular Markers of Colorectal Cancer,7014086,1/16/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2006,280606, ,NCI, , ,280606
Chk1 signaling in the G2 DNA damage checkpoint,7014491,2/1/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,335999, ,NCI, , ,335999
Functional analysis of signaling to and from p53 in ca,7014849,9/30/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2004,272340, ,NCI, , ,272340
The Pathogenesis of Dyskeratosis Congenita,7015021,2/8/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2006,295074, ,NCI, , ,295074
Telomere-Mediated Protective Responses in Skin,7015064,4/8/2004 0:00,2/29/2008 0:00,Non-SBIR/STTR,2006,355795, ,NCI, , ,355795
The PLZF Protein of t(11;17)-Promyelocytic Leukemia,7015647,4/1/1993 0:00,6/30/2006 0:00,Non-SBIR/STTR,2006,390382, ,NCI, , ,390382
Regulation and Role of ODC in Apoptosis and Cancer,7016280,3/4/2003 0:00,10/31/2006 0:00,Non-SBIR/STTR,2006,178428, ,NCI, , ,178428
HAUSP-mediated Deubiquitination of p53,7017132,4/1/2003 0:00,3/30/2008 0:00,Non-SBIR/STTR,2006,274631, ,NCI, , ,274631
FDH: A Novel Determinant of Tumor Suppression,7017706,3/1/2005 0:00,2/28/2010 0:00,Non-SBIR/STTR,2006,253417, ,NCI, , ,253417
Cell Cycle Dysregulation in Oral Cancer,7018534,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,451024, ,NIDCR, , ,451024
Dual Role of E2F1 in Tumorigenesis,7018537,1/18/1999 0:00,1/31/2009 0:00,Non-SBIR/STTR,2006,331767, ,NCI, , ,331767
Genetic modifiers of mammary tumor susceptibility,7018539,2/15/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2006,284486, ,NCI, , ,284486
"Oxidative DNA Damage, DNA Repair and Oral Cancer",7019080,9/1/2001 0:00,8/31/2006 0:00,Other Research-Related,2006,66825, ,NCI, , ,66825
Role of E6-AP in the Development of Prostate Cancer,7019806,9/30/2001 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,158789, ,NIDDK, , ,158789
Cellular and molecular basis of malignant astrocytoma,7019857,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,319350, ,NINDS, , ,319350
Function of MDM2 and its Alternatively spliced Isoforms,7020024,3/5/2002 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,233027, ,NCI, , ,233027
"p53-independent Role of MDM2, TGFb Resistance and Cancer",7020750,3/1/2002 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,321909, ,NCI, , ,321909
Role of AML1-ETO in Acute Leukemia,7021348,7/1/1994 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,311860, ,NCI, , ,311860
p63 Signaling in Epithelial Cell Growth and Cancer,7021402,3/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,302276, ,NCI, , ,302276
Leukemogenic Slug Pathway in Hematopoietic Cell Survival,7021460,5/1/1993 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,417454, ,NCI, , ,417454
Apoptosis by FADD in normal and cancerous cells,7021465,2/22/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2006,297002, ,NCI, , ,297002
Dysregulation of TGF Beta Action Pancreatic Cancer,7022205,9/30/1997 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,347417, ,NCI, , ,347417
DNA Adducts of Aromatic Amines: Analysis by HPLC-MS,7022934,5/18/1996 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,229966, ,NCI, , ,229966
In Vivo Ras-induced Senescence and Tumorigenesis,7023080,4/18/2003 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,344375, ,NCI, , ,344375
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE,7023265,3/1/1988 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,474305, ,NCI, , ,474305
A flexible somatic and sporadic mouse model for pancreatic ductal adenocarcinoma,7023515,2/1/2006 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,154177, ,NCI, , ,154177
Minority Predoctoral Fellowship Program,7023757,3/20/2005 0:00,9/18/2006 0:00,"Training, Individual",2006,18472, ,NCI, , ,18472
Chromosomal Abnormalities in Myeloma as Detected by FISH,7024063,4/1/2000 0:00,2/28/2008 0:00,Non-SBIR/STTR,2005,99023, ,NCI, , ,99023
p53 target Genes in Apoptosis,7025082,4/1/2004 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,272048, ,NCI, , ,272048
A Novel Dosing Schedule of Flavopiridol in CLL,7025086,3/2/2005 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,288324, ,NCI, , ,288324
Molecular Functions of the Adenoviral E1B 55 kDa Protein,7025826,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,385718, ,NIAID, , ,385718
The MED1 Protein in DNA Damage Response and Repair,7026533,7/1/1998 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,368125, ,NCI, , ,368125
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER,7026972,4/1/2002 0:00,3/31/2010 0:00,Non-SBIR/STTR,2006,286472, ,NCI, , ,286472
ENDOGENOUS MODULATION OF COCHLEA INJURY,7027117,7/1/1994 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,317680, ,NIDCD, , ,317680
Mechanisms of tumor promotion and carcinogenesis,7027545,1/1/1994 0:00,3/31/2009 0:00,Non-SBIR/STTR,2005,50953, ,NCI, , ,50953
DDR1 in p53-mediated suppression and in breast cancer,7027584,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2004,287707, ,NCI, , ,287707
Apoptotic Response to DNA Damage Initiated by PUMA,7027647,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,267544, ,NCI, , ,267544
G2 Checkpoint Control In Transformed Human Cells,7027686,12/1/1998 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,329920, ,NCI, , ,329920
Role of PCAF/GCN5 Acetylation on p53 Transactivation,7027756,4/1/1999 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,340520, ,NCI, , ,340520
Cyclin G in p53 mediated pathways and breast cancer,7028026,7/1/2001 0:00,6/30/2006 0:00,Non-SBIR/STTR,2004,159552, ,NCI, , ,159552
Novel p53 target gene ASC in apoptosis & mammary tumorig,7028102,4/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2004,210683, ,NCI, , ,210683
Contributions of Akt to Glioblastoma Formation,7028265,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2006,329166, ,NCI, , ,329166
The Role of HOXA5 in Breast Cancer,7028276,3/15/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,294569, ,NCI, , ,294569
P63 mediators as therapeutic targets in HNSCC,7028347,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,384498, ,NIDCR, , ,384498
MOLECULAR MECHANISMS OF DIET-INDUCED CARCINOGENESIS,7028946,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2006,288427, ,NCI, , ,288427
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS,7028949,4/1/1980 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,290123, ,NCI, , ,290123
Role of 53BP1 during the DNA damage response,7028983,4/1/2002 0:00,7/31/2007 0:00,Non-SBIR/STTR,2006,253768, ,NIGMS, , ,253768
Mammalian Polyamine Metabolism,7029256,12/1/1975 0:00,11/30/2010 0:00,Non-SBIR/STTR,2006,323033, ,NCI, , ,323033
SELECTIVE THERAPY FOR COLON CARCINOMA,7029735,7/1/1983 0:00,3/31/2007 0:00,Non-SBIR/STTR,2006,309795, ,NCI, , ,309795
Dual Role of E2F1 in Tumorigenesis,7029935,1/18/1999 0:00,1/31/2009 0:00,Non-SBIR/STTR,2005,69460, ,NCI, , ,69460
HCV NS5A protein and pathogenesis,7029939,2/15/1999 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,294000, ,NIAID, , ,294000
Characterization:novel genotoxic stress-regulated gene,7030099,3/1/2006 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,228000, ,NIEHS, , ,228000
Molecular Basis of Aneuploidy,7030179,3/7/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2006,232525, ,NCI, , ,232525
Mechanisms of tumor promotion and carcinogenesis,7030965,1/1/1994 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,256624, ,NCI, , ,256624
Biomimetic Synthesis of Complex Natural Products,7031951,2/1/2006 0:00,1/31/2010 0:00,Non-SBIR/STTR,2006,292828, ,NIGMS, , ,292828
Genomic Plasticity in the Human U2 snRNA Cluster,7032317,4/1/1989 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,325682, ,NIGMS, , ,325682
THE ROLE OF SPARC IN GLIOMA INVASION,7032336,7/1/2000 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,253109, ,NCI, , ,253109
Growth Inhibition by the ARF Tumor Suppressor,7032458,4/1/2002 0:00,9/28/2007 0:00,Non-SBIR/STTR,2006,370587, ,NCI, , ,370587
DNA Repair and Checkpoint Interactions in Mammals,7033020,5/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,326255, ,NCI, , ,326255
 anti-tumor activity of deactylase inhibitors,7033091,4/8/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,279615, ,NCI, , ,279615
Role of WISp39 and Ubiquitination in p21 Function,7033099,4/9/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,335646, ,NCI, , ,335646
p53 Signaling and Cellular Response After Stress,7033409,1/1/1997 0:00,12/31/2010 0:00,Non-SBIR/STTR,2006,338490, ,NCI, , ,338490
The Role of p53 and 14-3-3 in Genomic Instability,7033879,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,271822, ,NCI, , ,271822
Molecular Pathobiology of Langerhans Cell Histiocytosis,7033933,4/15/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,352153, ,NIAID, , ,352153
Using Zebrafish to Identify and Analyze Cancer Genes,7033990,3/7/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2006,283721, ,NCI, , ,283721
Pathways of Therapy-induced Senescence in Cancer,7034406,3/17/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2006,242998, ,NCI, , ,242998
Roles of DMP1 in Ras signaling and lung cancer,7034559,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,258536, ,NCI, , ,258536
"Allergies, Genetic Susceptibility and Adult Glioma Risk",7034760,3/10/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2006,369620, ,NCI, , ,369620
Tumor Host Range Mutants of Polyoma and Their Targets,7035151,9/1/2001 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006,596859, ,NCI, , ,596859
Regulation of Irreversible Growth Arrest by p53,7035395,4/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,235861, ,NCI, , ,235861
T cell activation and crypt cell apoptosis,7035403,2/15/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,287765, ,NIDDK, , ,287765
Glucocorticoids & Vitamin D: Role In Anti-Tumor Effects,7035493,2/1/2000 0:00,6/30/2010 0:00,Non-SBIR/STTR,2005,382266, ,NCI, , ,382266
Differential Transcription Factor Activation by H. pylor,7035747,9/30/1997 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,247347, ,NIDDK, , ,247347
Mechanism of mitotic exit in budding yeast,7035814,8/1/1999 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,249133, ,NIGMS, , ,249133
"Cadmium, Metallothionein and Breast Cancer Progression",7035910,4/1/2005 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,269231, ,NCI, , ,269231
Deciphering how MdmX deregulation impacts the p53 pathway,7036425,4/1/1995 0:00,11/30/2010 0:00,Non-SBIR/STTR,2006,221507, ,NCI, , ,221507
Cellular Senescence and Control of Gene Expression,7036435,9/1/1990 0:00,6/30/2011 0:00,Non-SBIR/STTR,2006,484489, ,NIA, , ,484489
Structural basis of signaling by ING2 PHD,7036477,9/6/2006 0:00,8/31/2011 0:00,Non-SBIR/STTR,2006,202312, ,NCI, , ,202312
Structure/Function of Human Papillomavirus Oncoproteins,7036505,4/1/2002 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,393724, ,NCI, , ,393724
Biomarkers for margin analysis and prognosis in HNSCC,7036530,9/1/1999 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,369762, ,NIDCR, , ,369762
Lung cancer molecular markers by sex: intergroup study,7036575,4/15/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,638179, ,NCI, , ,638179
Polyoma Virus Disrupts ARF Signaling to p53,7036593,4/1/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2006,296249, ,NCI, , ,296249
MECHANISMS OF ESTROGEN RECEPTOR REGULATION,7036928,2/1/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2006,250347, ,NCI, , ,250347
"PLM, PLZF, NPM and NuMA in the Molecular Pathogenesis of APL",7036952,9/15/1996 0:00,12/31/2010 0:00,Non-SBIR/STTR,2006,371378, ,NCI, , ,371378
The role of Inil in chromatin  development and cancer,7037542,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2006,345461, ,NCI, , ,345461
Proj. 1: Genetic Pathways Governing Pancreatic Ductal Adenocarcinoma,7037880,12/1/2005 0:00,11/30/2010 0:00,Non-SBIR/STTR,2006, ,190354, , , , 
The RAS and P13K Pathways in Pancreatic Adenocarcinoma,7037882,12/1/2005 0:00,11/30/2010 0:00,Non-SBIR/STTR,2006, ,326760, , , , 
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer,7037884,12/1/2005 0:00,11/30/2010 0:00,Non-SBIR/STTR,2006, ,259371, , , , 
Core B: Experimental Pathology Core,7037892,12/1/2005 0:00,11/30/2010 0:00,Non-SBIR/STTR,2006, ,154264, , , , 
The role of glutathione peroxidase in the pathogenesis of intestinal cancer,7037966,3/1/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2006,269978, ,NCI, , ,269978
Upper Gastrointestinal Cancer Genetic Studies,7038077, , ,Intramural Research,2004, , , , , , 
Imidodipeptides and Amino Acid Metabolites in Cell Regul,7038101, , ,Intramural Research,2004, , , , , , 
T-Cell Antigen Recognition and Tumor Antigens,7038111, , ,Intramural Research,2004, , , , , , 
The role of p53 in remodeling DNA methylation in cancer,7038307,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,251602, ,NCI, , ,251602
In Vitro and In Vivo Analyses of 14-O-Acylanthracyclines,7038329,4/1/2004 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,292267, ,NCI, , ,292267
JC Virus and Tumor Formation in the Human Colon,7038330,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,268049, ,NCI, , ,268049
Molecular Basis of KSHV Pathogenesis,7038340,6/15/1999 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,371983, ,NCI, , ,371983
Ceramide Synthase in Radiation-Induced Apoptosis,7038378,7/15/1990 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,386938, ,NCI, , ,386938
Gene Regulation and Function: The B-ZIP Proteins,7038491, , ,Intramural Research,2004, , , , , , 
Pathways that Suppress/Accelerate Premalignant Progress,7038527, , ,Intramural Research,2004, , , , , , 
Regulation of papillomavirus gene expression,7038536, , ,Intramural Research,2004, , , , , , 
"Tumor Suppressor Protein, p53",7038598, , ,Intramural Research,2004, , , , , , 
Inhibition of p53 Tumor Suppressor Function by HTLV-I,7038630, , ,Intramural Research,2004, , , , , , 
A Novel Vitamin D Target in Human Prostate Cancer,7038692,3/1/2006 0:00,2/29/2008 0:00,Non-SBIR/STTR,2006,116407, ,NCI, , ,116407
Chromosomal Abnormalities in Myeloma as Detected by FISH,7039010,4/1/2000 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,325526, ,NCI, , ,325526
Molecular Markers as Predictors of Outcome in Gliomas,7039303,9/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2006,334125, ,NINDS, , ,334125
Effects of chemopreventive agents on DNA damage response,7044530,9/27/2005 0:00,8/31/2007 0:00,Non-SBIR/STTR,2005,73500, ,NCI, , ,73500
Molecular Pathogenesis of Breast Cancer,7046109,4/18/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,2590529, ,NCI, , ,2590529
Functions of Human Papillomavirus E6,7046152,4/8/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,286461, ,NCI, , ,286461
Sphingosine Phosphate:Regulation and Role in Cancer,7046177,9/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2006,385831, ,NCI, , ,385831
p53 in Cellular Response to ROS-Mediated DNA Damage,7046178,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,295271, ,NCI, , ,295271
Role of DN-p63 in Preservation of Self Renewal,7046188,4/1/2005 0:00,2/28/2010 0:00,Non-SBIR/STTR,2006,234994, ,NCI, , ,234994
Prevention of Oral Cancer by Tea: A mechanism Study,7046305,3/16/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2006,346728, ,NCI, , ,346728
A mouse model for UV-induced junctional melanoma,7046688,4/1/2002 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,330252, ,NCI, , ,330252
The Role of p73 in Upper Gastrointestinal Carcinomas,7046787,4/28/2006 0:00,3/31/2010 0:00,Non-SBIR/STTR,2006,271513, ,NCI, , ,271513
Homologous Recombination & Human Cell Radiosensitivity,7047272,2/7/2006 0:00,1/31/2010 0:00,Non-SBIR/STTR,2006,353750, ,NCI, , ,353750
Genomic Methylation: A Mechanism to Alter Tumor Phenotype,7047572,5/1/1996 0:00,7/31/2010 0:00,Non-SBIR/STTR,2005,250038, ,NCI, , ,250038
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium,7047854,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,269345, ,NCI, , ,269345
Studies of Histone Functions in Chromatin; H2AX and DNA,7048118, , ,Intramural Research,2004, , , , , , 
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targ",7048142, , ,Intramural Research,2004, , , , , , 
Molecular Biology of Cellular Injury,7048178, , ,Intramural Research,2004, , , , , , 
New strategies for cancer drug discovery: Integrative ph,7048181, , ,Intramural Research,2004, , , , , , 
Regulation of EGFR Gene Activity,7048200, , ,Intramural Research,2004, , , , , , 
DNA Deformations and Interactions with Proteins,7048215, , ,Intramural Research,2004, , , , , , 
Computer Analysis of Nucleic Acid Structure,7048219, , ,Intramural Research,2004, , , , , , 
Mice as Models to Study Receptor Tyrosine Kinase Funct.,7048302, , ,Intramural Research,2004, , , , , , 
PLK3 in the DNA damage checkpoint and tumor suppression,7048463,12/15/1997 0:00,7/31/2006 0:00,Non-SBIR/STTR,2006,106255, ,NCI, , ,106255
Adenocarcinoma of the Lung: role of NNK susceptibility,7048555,9/30/1991 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,655751, ,NCI, , ,655751
Molecular Epidemiology of Fatal Prostate Cancer,7048698,4/30/2003 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,476732, ,NCI, , ,476732
Genetics of Susceptibility to Mouse Plasma Cell Tumors,7049208, , ,Intramural Research,2004, , , , , , 
c-Myc-induced B cell and plasma cell neoplasms in mice,7049255, , ,Intramural Research,2004, , , , , , 
"Telomerase in Development, Senescence and Neoplasia",7049483,1/1/2000 0:00,12/31/2009 0:00,Non-SBIR/STTR,2006,573479, ,NCI, , ,573479
CORE--ENVIRONMENT /GENE INTERACTIONS,7049572, , ,Research Centers,2005, ,174086, , , , 
HTP assays of inhibitors of protein-protein interactions,7049593,4/15/2005 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,315233, ,NCI, , ,315233
Inflammation and Cancer,7049720, , ,Intramural Research,2004, , , , , , 
Molecular Mechanisms of Growth Factor Modulated Prolifer,7049742, , ,Intramural Research,2004, , , , , , 
DNA Repair,7049802, , ,Intramural Research,2004, , , , , , 
Genetics of Susceptibility to Development of Skin Tumors,7049810, , ,Intramural Research,2004, , , , , , 
Cellular gene exp. in HPV infection and cervical cancer,7049872, , ,Intramural Research,2004, , , , , , 
NEW METHODS FOR CANCER DETECTION,7049995,3/1/1997 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,30582, ,NCI, , ,30582
Southwest Oncology Group,7050109,2/1/1993 0:00,12/31/2009 0:00,Other Research-Related,2006,258128, ,NCI, , ,258128
Hormonal regulation of p53 activity in mammary tissue,7050156,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,279254, ,NCI, , ,279254
Anti-cancer effects by the green tea catechins,7050219,4/6/2005 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,212803, ,NCI, , ,212803
Biomarkers of Prostate Cancer Radiation Outcome,7050232,4/6/2005 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,279725, ,NCI, , ,279725
MCAV in Organ-Confined Bladder CA based on p53 Status,7050609,5/1/1997 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,269741, ,NCI, , ,269741
Etiology of Balkan endemic nephropathy,7050797,4/1/2006 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,37595, ,NIEHS, , ,37595
Oncolytic Viral Delivery of Oncogene siRNA,7051523,9/13/2006 0:00,8/31/2008 0:00,SBIR/STTR,2006,124640, ,NCI, , ,124640
Function of the p53 tumor-suppressor in C.elegans,7052046,4/1/2002 0:00,3/31/2007 0:00,Non-SBIR/STTR,2006,283976, ,NCI, , ,283976
Design of Drugs Against Cancer and Viral Diseases,7052672, , ,Intramural Research,2004, , , , , , 
Role of Neuregulin-1 in Schwann Cell Neoplasia,7052823,9/15/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,261947, ,NINDS, , ,261947
Mechanisms of T Cell Tumorigenesis,7053380,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,246078, ,NCI, , ,246078
Regulated Proteolysis in RAS Signal Transduction,7053409,5/1/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,237656, ,NIGMS, , ,237656
Analysis of Tumor RNA Variants using PMSG,7053677,4/21/2006 0:00,3/31/2008 0:00,SBIR/STTR,2006,646382, ,NCI, , ,646382
Murine p73 in Tumorigenesis,7054090,6/15/1998 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,388964, ,NCI, , ,388964
Developmental Therapeutics,7054368, , ,Intramural Research,2004, , , , , , 
Cyclins and Cyclin-dependent kinases as targets for protection against radiation-,7054546,9/1/2005 0:00,7/31/2010 0:00,Non-SBIR/STTR,2005, ,268132, , , , 
SV40 st induced cell transformation via PP2A inhibition,7054582,7/1/2006 0:00,6/30/2008 0:00,"Training, Individual",2006,45976, ,NCI, , ,45976
Redox Effects of Selenium for Prostate Cancer Prevention,7054645,4/18/2005 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,280610, ,NCI, , ,280610
Cell and tumor genetics of mitotic arrest checkpoints,7054702,2/1/2000 0:00,10/31/2006 0:00,Non-SBIR/STTR,2006,315511, ,NCI, , ,315511
Role of the Oxidative Stress Pathway in Drug Resistance,7054707,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,274361, ,NCI, , ,274361
CORE--MOLECULAR EPIDEMIOLOGY AND ECOGENETICS,7054743, , ,Research Centers,2005, ,73467, , , , 
CLINICAL EVALUATION OF A POXVIRUS VACCINE TARGETING P53,7055284,4/19/2005 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,293338, ,NCI, , ,293338
DNA Damage and Tobacco-Induced Lung Cancer,7055300,5/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,355932, ,NCI, , ,355932
Cell cycle regulatory proteins in UVB-skin carcinogenes,7055375,4/21/2003 0:00,3/31/2008 0:00,Other Research-Related,2006,123660, ,NIAMS, , ,123660
Molecular Genetic Basis for Gynecologic Neoplasias,7055463, , ,Intramural Research,2004, , , , , , 
Molecular Targets Development Program,7055482, , ,Intramural Research,2004, , , , , , 
Genetic Mechanisms in Experimental Pancreatic Cancer,7056122,9/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2006,269842, ,NCI, , ,269842
" Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma",7056125,5/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,282924, ,NCI, , ,282924
Molecular Mechanisms by which Rexinoids Prevent BRCA,7056129,4/6/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,337663, ,NCI, , ,337663
RhoB Signaling in Cancer Suppression and Cell Suicide,7056751,5/15/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,325907, ,NCI, , ,325907
Molecular Characterization of ACF (Abberant Crypt Foci),7057216,8/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,252186, ,NCI, , ,252186
Functional analysis of signaling to and from p53 in ca,7057265,9/30/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2005,272340, ,NCI, , ,272340
PHTHALATE-INDUCED MURINE TESTICULAR DYSGENESIS AND P53,7057742,5/1/2005 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,151358, ,NIEHS, , ,151358
The Apoptotic Role of MEKK1 in Cancer Chemotherapy,7057752,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,265071, ,NCI, , ,265071
Mechanistic Analyses of Protein Deacetylation,7057773,3/1/2002 0:00,7/31/2006 0:00,Non-SBIR/STTR,2006,28832, ,NIGMS, , ,28832
Prevention of ER-negative Breast Cancer: Identification*,7057822,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,477939, ,NCI, , ,477939
Zebrafish Screens for Genetic Modifiers and Human Application in T-ALL,7058457,12/1/2005 0:00,11/30/2010 0:00,Non-SBIR/STTR,2006, ,216446, , , , 
Involvement of APC in DNA Repair,7058760,5/16/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,252904, ,NCI, , ,252904
Mechanisms of the Hormonal Prevention of Breast Cancer,7059304,8/1/1995 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,1094097, ,NCI, , ,1094097
RAS INDUCED SENESCENCE AND TUMOR PROGRESSION,7059792,7/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2005,35107, ,NIA, , ,35107
The Role of Mdm2 in Cell Growth and Tumorigenesis,7059987,3/1/1999 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,321083, ,NCI, , ,321083
NOVEL APPROACHES TO GENE PROFILING IN OVARIAN CANCER,7060081,5/1/2005 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,142764, ,NCI, , ,142764
In utero dietary exposure to endocrine disruptors and l*,7060414,5/1/2005 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,151553, ,NIEHS, , ,151553
POLYAMINE ANALOG REGULATION OF CELL CYCLE AND APOPTOSIS,7060418,8/1/1989 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,349967, ,NCI, , ,349967
The Role of E2F1 in UV-induced DNA Damage Response,7060450,5/3/2005 0:00,4/30/2010 0:00,Other Research-Related,2006,99352, ,NCI, , ,99352
Development Therapy for Metastatic Colorectal Cancer,7060749,5/1/2005 0:00,12/31/2006 0:00,Non-SBIR/STTR,2006,282595, ,NCI, , ,282595
Identification of Modifier Gene of Tumors Associated wit,7061049, , ,Intramural Research,2004, , , , , , 
Molecular Mechanisms of Proliferation and Infiltration o,7061109, , ,Intramural Research,2004, , , , , , 
Development of Mouse Astrocytoma Model for Preclinical T,7061110, , ,Intramural Research,2004, , , , , , 
Molecular Basis of Young Onset Colorectal Cancer,7061247,8/26/2002 0:00,4/30/2007 0:00,Other Research-Related,2006,125226, ,NCI, , ,125226
Regulation of apoptosis and tumor growth by galectin-7,7061272,3/5/2004 0:00,2/28/2007 0:00,Non-SBIR/STTR,2006,72505, ,NIAMS, , ,72505
Mouse Models of Human Breast Cancer,7061651,9/30/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,837723, ,NCI, , ,837723
CORE--MICROARRAY,7061792, , ,Research Centers,2005, ,183723, , , , 
Arsenic Induced Miotic Arrest Associated Apoptosis,7062060,8/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,272736, ,NIEHS, , ,272736
Monoclonal Antibody Therapy in B-Cell CLL.,7062434,6/1/2004 0:00,5/31/2009 0:00,Other Research-Related,2006,131814, ,NCI, , ,131814
Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family Members,7063075, , ,Other Research-Related,2005, ,111667, , , , 
Tumor Suppression by Protein Kinase C-delta,7063084, , ,Other Research-Related,2005, ,73466, , , , 
"Characterization of Mutational Spectra, Mechanisms of Toxicity and Homologous Rec",7063124, , ,Non-SBIR/STTR,2005, ,279631, , , , 
Biosynthesis and Hypoxia in Gliomas,7063282, , ,Non-SBIR/STTR,2005, ,103570, , , , 
The replication checkpoint and genomic fidelity in skin,7064228,6/1/2004 0:00,5/31/2009 0:00,Other Research-Related,2006,99792, ,NIAMS, , ,99792
Expression of Proapoptotic Genes for Cancer Therapy,7064270,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,328079, ,NCI, , ,328079
P53 in BBD and Breast Cancer Risk: A Multicenter Cohort,7064276,5/1/2002 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,729783, ,NCI, , ,729783
Diagnostic Therapeutic Targets in Prostate Cancer,7064286,6/12/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,332425, ,NCI, , ,332425
Regulation of Mdm2 compartmentalization,7064306,5/11/2005 0:00,12/31/2006 0:00,Non-SBIR/STTR,2006,236059, ,NCI, , ,236059
Cancer Vaccines and Modulation of Checkpoint Controls,7064499, , ,Intramural Research,2004, , , , , , 
Modulation of radiosensitivity in zebrafish,7064645,9/12/2005 0:00,9/11/2009 0:00,"Training, Individual",2005,35351, ,NCI, , ,35351
RNA Tumor Virus-Hematopoietic cell Interaction,7064788,6/1/1983 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,327350, ,NCI, , ,327350
Normal and Neoplastic Growth Regulation in the Brain,7064825,4/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,1772819, ,NCI, , ,1772819
FUNCTION OF INK4A/ARF IN PEDIATRIC NEOPLASIA,7064868, , ,Non-SBIR/STTR,2005, ,241412, , , , 
DNA damage response and DDB,7064901,5/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,294766, ,NIA, , ,294766
"Dysfunctional Telomeres, Checkpoints and Aging",7065017,9/30/2006 0:00,8/31/2011 0:00,Non-SBIR/STTR,2006,286340, ,NIA, , ,286340
PILOT--MOLECULAR PREDICTORS OF ORAL CANCER DEVELOPMENT,7065173, , ,Non-SBIR/STTR,2005, ,21385, , , , 
PILOT--INVASION REGULATED BY FIBRONECTIN AND  RECEPTORS,7065174, , ,Non-SBIR/STTR,2005, ,21385, , , , 
Mol. Genetic Epidem. of Primary Hepatocellular Carcinoma,7065494, , ,Intramural Research,2004, , , , , , 
Molecular Genetic Epidemiology of leading U.S. Cancers,7065500, , ,Intramural Research,2004, , , , , , 
Mechanisms of the Hormonal Prevention of Breast Cancer,7065540,8/1/1995 0:00,4/30/2007 0:00,Non-SBIR/STTR,2005,69000, ,NCI, , ,69000
FIBRONECTIN REGULATION OF CARCINOMA APOPTOSIS,7066044,9/15/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,317265, ,NIDCR, , ,317265
Genetic Predisposition to Aflatoxin-Induced Hepatocellul,7066164, , ,Intramural Research,2004, , , , , , 
Studies of Rare Cancers,7066211, , ,Intramural Research,2004, , , , , , 
Exploring How HTLV-1 Tax Induces T Cell Leukemia,7066555,7/1/2002 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,434245, ,NCI, , ,434245
Models of DRA growth suppression in colon cancer,7066556,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,253695, ,NCI, , ,253695
Functional Characterization of the ATM Gene Product,7066604,8/15/1996 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,366188, ,NCI, , ,366188
Novel Proapoptotic BH3-only Proteins in Cancer Apoptosis,7066656,5/16/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,227942, ,NCI, , ,227942
Molecular Pathology of Pulmonary Carcinogenesis,7066749, , ,Intramural Research,2004, , , , , , 
The Molecular Genetics of Gynecologic Cancers,7066772, , ,Intramural Research,2004, , , , , , 
Lymphoma Studies,7066911, , ,Intramural Research,2004, , , , , , 
Cell and Molecular Genetic Analysis of Pediatric Tumors,7066913, , ,Intramural Research,2004, , , , , , 
In vivo pathogenesis of Helicobacter pylori,7067207,9/1/1996 0:00,2/28/2010 0:00,Non-SBIR/STTR,2006,395483, ,NIAID, , ,395483
 Gastrointestinal Cell Proliferation and Cell Cycle,7067214,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,299317, ,NCI, , ,299317
Methylation of the Calcitonin Gene in Human Tumors,7068500,9/30/1986 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,439060, ,NCI, , ,439060
Chemoprevention of Bladder CA by soybean bioactive comp.,7068530,6/1/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,295489, ,NCI, , ,295489
Nitric Oxide as a Modifier of Oxidative Stress,7068839, , ,Intramural Research,2004, , , , , , 
HSP90 Family Chaperones in Cellular Signal Transduction,7068913, , ,Intramural Research,2004, , , , , , 
Targeting the Epigenome for the Treatment and Prevention,7068921, , ,Intramural Research,2004, , , , , , 
Chromosomal aneuploidy on the cancer transcriptome,7068946, , ,Intramural Research,2004, , , , , , 
Proteomic Study of Novel Platinum Compounds in Glioma,7069170,5/23/2005 0:00,4/30/2007 0:00,Non-SBIR/STTR,2006,146475, ,NCI, , ,146475
Normal and Neoplastic Regulation of Cyclin E,7069493,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,375879, ,NCI, , ,375879
Breast Carcinoma In-Situ: Mammographic Risk Factors,7069541,6/1/2004 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,324908, ,NCI, , ,324908
p38 MAPK in Ras-induced Senescence and Transformation,7069993,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,369147, ,NCI, , ,369147
Function of Human Damaged DNA Binding Protein (DDB),7070030,6/1/2000 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,353110, ,NIGMS, , ,353110
Regulation of p53-mediated apoptosis in gliomas,7070073,7/17/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,262464, ,NCI, , ,262464
Function & Purification of the Fanconi Anemia Protein C*,7070099,7/1/2002 0:00,5/31/2007 0:00,Other Research-Related,2006,100845, ,NHLBI, , ,100845
"Heterogeneity of Human Melanoma, Cytokines and iNOS",7070115,7/12/2002 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,260726, ,NCI, , ,260726
Oncovirus gene expression and tumorigenesis,7070798, , ,Intramural Research,2004, , , , , , 
Regulation of the cell cycle by cyclin-dependent kinases,7070812, , ,Intramural Research,2004, , , , , , 
Breast Cancer Therapy by Differentiation Gene Activation,7071076,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,293751, ,NCI, , ,293751
Diverse Natural Products That Stabilize Microtubules,7071194,7/6/1999 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,361979, ,NCI, , ,361979
p53 loss in HMECs: a model of breast cancer prevention,7071234,7/3/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,267678, ,NCI, , ,267678
Chromosome 22q genetic studies in the colon,7071262,3/1/2000 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,332766, ,NIDDK, , ,332766
ROLE OF SAMe IN LIVER FUNCTION AND INJURY,7071635,9/20/2002 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,337448, ,NCCIH, , ,337448
Quantum Dots as Single Molecule Intracellular Probes,7071651,6/1/2005 0:00,5/31/2007 0:00,Non-SBIR/STTR,2006,87885, ,NIGMS, , ,87885
Functional Analysis of p53 Polymorphic Variants,7072303,6/1/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,307302, ,NCI, , ,307302
Effects of mutant beta-catenin on hepatocellular cancer,7072610,6/1/2005 0:00,7/15/2007 0:00,Other Research-Related,2006,93531, ,NCRR, , ,93531
"Breast Cancer, Radiation and the ATM-CHEK2 Pathway",7072835,6/1/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,473378, ,NCI, , ,473378
Chromosome instability resulting from double-strand breaks near telomeres,7073078,7/6/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,264469, ,NCI, , ,264469
Role of TRRAP in the p53-Mediated Transcription of mdm2,7073495,7/1/2003 0:00,12/1/2006 0:00,Non-SBIR/STTR,2006,259249, ,NCI, , ,259249
The role of selenoproteins in the etiology of cancer,7073977,6/10/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,230659, ,NCI, , ,230659
Targeting Oncogene Expression to Skin in Transgenic Mice,7073987,8/1/1990 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,490241, ,NCI, , ,490241
Training in Molecular Basis of Skin Pathobiology,7074076,6/1/2004 0:00,5/31/2009 0:00,"Training, Institutional",2006,250334, ,NCI, , ,250334
Gordon Research Conference on Mammary Gland Biology,7074612,5/1/2004 0:00,4/30/2007 0:00,Other Research-Related,2006,6000, ,NCI, , ,3000
Oncogenes and loss of ER in a new p53 breast tumor model,7074710,5/10/1989 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,297833, ,NCI, , ,297833
BRCA1 function in  G2-M checkpoint and mitosis,7075362,12/11/1998 0:00,6/30/2006 0:00,Non-SBIR/STTR,2006,248275, ,NCI, , ,248275
Structural basis for CBP/p300 transcriptional regulation,7075444,6/10/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2006,402386, ,NCI, , ,402386
Roles and Regulation of p53,7076793,9/30/2000 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006,1663000, ,NCI, , ,1663000
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors,7076835,7/15/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,687888, ,NCI, , ,687888
Unique BRCA1 transcriptional response leading to repair,7076976,4/22/2002 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,379751, ,NCI, , ,379751
Role of DDB in checkpoint control and carcinogenesis,7077588,1/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2006,265290, ,NCI, , ,265290
Microsatellite instability and cancer gene expression,7077710,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,417160, ,NCI, , ,417160
Ubiquitin-Mediated Regulation of DNA Repair,7077712,7/7/2004 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,288262, ,NCI, , ,288262
Markers of Early Pancreatic Cancer,7078264,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,286606, ,NCI, , ,286606
UV and p21 Degradation,7078605,6/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,334996, ,NCI, , ,334996
Translational Control by elF2 Kinase during ER Stress,7078656,8/1/2001 0:00,7/31/2009 0:00,Non-SBIR/STTR,2006,273648, ,NIGMS, , ,273648
Mitotic Checkpoint Proteins in Tumorigenesis,7079356,7/18/2002 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,369143, ,NCI, , ,369143
Sunlight-Related Steps in Human Skin Cancer,7079362,4/1/1992 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,319316, ,NCI, , ,319316
Barrett's Esophagus: Predictors of Progression,7079427,8/16/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2006,2119036, ,NCI, , ,2119036
Molecular mediators of metastasis in hepatocellular carcinoma,7079859,4/1/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2006,288216, ,NCI, , ,288216
Role of CDK4 in Cell Cycle Progression and Cancer,7080436,9/1/2002 0:00,6/30/2009 0:00,Non-SBIR/STTR,2006,367408, ,NIA, , ,367408
Prognosis in BRCA1 Associated Breast Cancer,7080481,6/20/2005 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,467257, ,NCI, , ,467257
Cellular Targets of Papillomavirus Oncoproteins,7081260, , ,Non-SBIR/STTR,2005, ,402971, , , , 
Interactions of the SV40 Small T Antigen and PP2A in Human Cell Transformation,7081262, , ,Non-SBIR/STTR,2005, ,132447, , , , 
Quantitative Gene Expression in Human Lung Epithelium,7081343,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,367323, ,NCI, , ,367323
Function of the Adenovirus E1B Oncogene,7081946,1/1/1991 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,107830, ,NCI, , ,107830
Perinatal Breast Cancer Programming: fat and estrogens,7082042,7/1/2005 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,124504, ,NIEHS, , ,124504
Nucleoside Phosphonate Analogs and HPV Positive Cancers,7082203,7/1/2004 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,282258, ,NCI, , ,282258
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction,7082243,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,276569, ,NCI, , ,276569
Nitric oxide eluting therapies for vascular surgery,7082488,9/15/2006 0:00,6/30/2011 0:00,Other Research-Related,2006,123380, ,NHLBI, , ,123380
Quantitative FDG-PET for Imaging Woodchuck HCC,7082894,7/1/2003 0:00,6/30/2009 0:00,Non-SBIR/STTR,2006,385834, ,NCI, , ,385834
Hepatitis HBx-Mediated Pathogenesis,7083633,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,294294, ,NCI, , ,294294
Control of c-Myc Function by the Tumor Suppressor p19ARF,7083668,7/6/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,272048, ,NCI, , ,272048
Cancer Biology in the Zebrafish,7083695,7/3/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,351979, ,NCI, , ,351979
Function of the ATR-ATRIP complex,7083700,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,262464, ,NCI, , ,262464
Viral Model for Tumor Pathogenesis in Brain,7083714,9/30/1996 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,936563, ,NINDS, , ,936563
Role of IGFBP -3 in mediating p53-induced apoptosis,7084607,8/15/2002 0:00,6/30/2008 0:00,Other Research-Related,2006,131652, ,NIDDK, , ,131652
Potentials of reactivated mutant p53,7084621,7/1/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,306280, ,NCI, , ,306280
Stem Cells and Gastric Cancer,7085045,9/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006,461288, ,NCI, , ,461288
Mechanisms of Radioresistance and Cell Cycle Progression,7085418,5/1/1995 0:00,9/27/2007 0:00,Non-SBIR/STTR,2006,359230, ,NIGMS, , ,359230
Transcriptional Repression by CtBP at the p21 Promoter,7085523,7/1/2005 0:00,6/30/2010 0:00,Other Research-Related,2006,137700, ,NCI, , ,137700
Prostate Cancer Prevention by n-3 Unsaturated Fatty Acids,7086318,6/28/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,532290, ,NCI, , ,532290
Hypoxia and Gene Repression,7086377,7/1/2000 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,324037, ,NCI, , ,324037
Specificity of Ubiquitination: the HPVE6/E6AP Paradigm,7086824,12/13/1996 0:00,6/30/2007 0:00,Non-SBIR/STTR,2006,273537, ,NCI, , ,273537
Mechanisms of cyclin E associated tumorigenesis,7086888,7/1/2003 0:00,6/30/2008 0:00,Other Research-Related,2006,133650, ,NCI, , ,133650
Centrosomes in the Control of Mitosis and Interphase,7087035,5/1/1982 0:00,6/30/2007 0:00,Non-SBIR/STTR,2006,388159, ,NIGMS, , ,388159
Chemoresistance in Renal Cell Cancer,7087930,7/8/2002 0:00,9/30/2011 0:00,Non-SBIR/STTR,2006,261855, ,NCI, , ,261855
Mechanisms of Radioresistance and Cell Cycle Progression,7088264,5/1/1995 0:00,6/30/2007 0:00,Non-SBIR/STTR,2005,107516, ,NIGMS, , ,107516
Non-Peptide Small-Molecule Inhibitors of the MDM2-p53 interaction,7088301,5/1/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2006,434268, ,NCI, , ,434268
"CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER",7088494,5/1/2006 0:00,4/30/2011 0:00,Research Centers,2006, ,205000, , , , 
Expression of Simian Virus 40 T antigens in Intestine,7088820,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,318062, ,NCI, , ,318062
"Applications of ""Recombomice"" for Cancer Research",7089573,4/15/2006 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,275644, ,NCI, , ,275644
ARF ACTIVATION BY POLYOMA VIRUS T-ANTIGEN,7089791,7/25/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,263333, ,NCI, , ,263333
Genetic Regulators of Human Melanocytic Neoplasia,7090072,7/1/2005 0:00,3/31/2010 0:00,Other Research-Related,2006,118535, ,NIAMS, , ,118535
Biology of Breast Cancers Arising in Older Women,7090081,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,560556, ,NIA, , ,560556
Dietary Prevention of Cancer,7090128,7/1/2005 0:00,6/29/2006 0:00,Non-SBIR/STTR,2006,38737, ,NCI, , ,38737
PROHIBITIN GENE IN GROWTH CONTROL AND TUMOR SUPPRESSION,7090137,9/30/1999 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,275415, ,NCI, , ,275415
Lana and Cellular Gene Expression in Kaposis Sarcoma,7090809,7/1/2000 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,233465, ,NCI, , ,233465
Cellular Stress Response Signaling Pathways,7090840,1/1/1992 0:00,6/30/2007 0:00,Non-SBIR/STTR,2006,329570, ,NIEHS, , ,329570
Rapamycin-induced Selective Apoptosis in Malignant Cells,7090871,12/1/1998 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,275373, ,NCI, , ,275373
Analysis of 53BP1 function in DNA Damage-signaled pathway and Tumorigenesis,7091285,5/9/2003 0:00,9/30/2006 0:00,Non-SBIR/STTR,2006,63084, ,NCI, , ,63084
Regulation of DNA Double-Strand Break Repair,7091594,7/26/2004 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,293831, ,NCI, , ,293831
wnt Signaling in Liver Development and Disease,7091656,7/15/2005 0:00,6/30/2010 0:00,Other Research-Related,2006,133110, ,NIDDK, , ,133110
Function of Mammalian SIRT1 in Aging,7091660,5/1/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,409911, ,NIA, , ,409911
p53-Mediated Transcription and Apoptosis,7091691,4/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,297051, ,NCI, , ,297051
p53 and checkpoint pathways in cancer cell repliction,7092026,7/11/1994 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,335062, ,NCI, , ,335062
"A Novel Pathway Involving E2F1, ATM and NBS1",7092199,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,328079, ,NCI, , ,328079
Progesterone-mediated protection against ovarian cancer,7092201,9/1/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2006,266434, ,NCI, , ,266434
Investigating the Role of Cyr61 in Breast Cancer,7092204,7/26/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,287478, ,NCI, , ,287478
15-Lipoxygenase 2 is a Prostate Senescence Gene,7092599,9/1/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2006,288504, ,NIA, , ,288504
AMID in Apoptosis and p53-Mediated Downstream Effects,7092608,7/14/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,273129, ,NCI, , ,273129
Interaction Between SV40 Large T and p185 Cullin,7092646,7/1/2002 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,398213, ,NCI, , ,398213
Genomic targets of oncoproteins and tumor suppressors,7093400,5/18/2006 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,782188, ,NCI, , ,782188
Phase I/II study of topical agents for chemoprevention,7093499, , ,Non-SBIR/STTR,2005, ,441844, , , , 
Molecular Mechanisms of UVA apotosis  and carcinogenesis,7093500, , ,Non-SBIR/STTR,2005, ,281856, , , , 
The MRAD9 Radioresistance Gene,7093942,12/1/2000 0:00,3/31/2010 0:00,Non-SBIR/STTR,2006,320390, ,NIGMS, , ,320390
Control of Sir2 by Nuclear NAD Salvage Pathways,7094174,8/1/2005 0:00,7/31/2009 0:00,Non-SBIR/STTR,2006,251669, ,NIGMS, , ,251669
Nuclear Signaling by TRADD,7095054,7/1/2003 0:00,6/30/2007 0:00,Non-SBIR/STTR,2006,321440, ,NINDS, , ,321440
Pathways of Bladder Tumorgenesis,7095836, , ,Non-SBIR/STTR,2005, ,309124, , , , 
Molecular Mechanisms of Hormone-independence of Prostate Cancer,7096007,7/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,257756, ,NCI, , ,257756
Targeting Cell Cycle Checkpoints in Cancer Therapeutics,7096080,8/1/2006 0:00,7/31/2011 0:00,Other Research-Related,2006,133893, ,NCI, , ,133893
Novel p53 target gene ASC in apoptosis & mammary tumorig,7096583,4/1/1999 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,281881, ,NCI, , ,281881
The Apoptogenic Role of p53 at the Mitochondria,7096602,9/15/1993 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,272444, ,NCI, , ,272444
Bin1 in E2F1-Mediated Tumor Growth Suppression,7097230,8/1/2004 0:00,7/31/2007 0:00,"Training, Individual",2006,40062, ,NCI, , ,40062
Mechanistic Studies on New Platinum Clinical Agents,7097323,9/30/1998 0:00,7/31/2007 0:00,Non-SBIR/STTR,2006,298321, ,NCI, , ,298321
Reinstallation of functional p53 in glial tumors in vivo,7097339,8/1/2004 0:00,7/31/2007 0:00,"Training, Individual",2006,52048, ,NCI, , ,52048
DDR1 in p53-mediated suppression and in breast cancer,7097402,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,304180, ,NCI, , ,304180
Translation of tumor suppressor genes to lung cancer the,7097437, , ,Research Centers,2005, ,308700, , , , 
Prevention of quinone toxicity and mutagenicity,7097497,8/1/1996 0:00,7/31/2007 0:00,Non-SBIR/STTR,2006,347879, ,NIEHS, , ,347879
Genetic and Molecular Epidemiology of Adult Glioma,7097519,5/15/1991 0:00,4/30/2011 0:00,Non-SBIR/STTR,2006,1227655, ,NCI, , ,1227655
UNDERSTANDING A NOVEL MODIFIER OF P53 TUMORIGENESIS,7097717,9/1/1999 0:00,7/31/2007 0:00,Other Research-Related,2005,154336, ,NCI, , ,154336
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D,7097833,1/1/1999 0:00,2/28/2011 0:00,Non-SBIR/STTR,2006,246424, ,NCI, , ,246424
Functional properties of centrosomes in somatic cells,7097834,5/1/1999 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,323529, ,NIGMS, , ,323529
A novel regulator of p53 function,7098109,8/15/2002 0:00,8/31/2007 0:00,Non-SBIR/STTR,2006,264202, ,NCI, , ,264202
Methylation in Cancer Progression of Barrett's Esophagus,7098419,7/20/2006 0:00,6/30/2011 0:00,Other Research-Related,2006,133850, ,NIDDK, , ,133850
Proteome analysis of malignant astrocytes,7098724,7/15/2004 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,342337, ,NINDS, , ,342337
NEW MODELS FOR COMPARATIVE STUDIES OF GONADAL TUMORS,7099468,12/16/1993 0:00,7/31/2009 0:00,Non-SBIR/STTR,2006,251205, ,NIEHS, , ,251205
The role of Met proto-oncogene in breast tumorigenesis,7099519,8/1/2005 0:00,7/31/2008 0:00,"Training, Individual",2006,52048, ,NCI, , ,52048
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHN,7099611, , ,Research Centers,2005, ,153880, , , , 
SPORE in Head and Neck Cancer,7099615,7/1/2004 0:00,6/30/2009 0:00,Research Centers,2006,2362312, ,NCI, , ,2362312
Role of RHO in Farnesyltransferase Inhibitor Responses,7099671,9/30/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,316386, ,NCI, , ,316386
Altered Proteoglycan Gene Expression and Cancer,7100130,9/1/1988 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,375156, ,NCI, , ,375156
Regulation of MDM2 by the ribosomal protein L11,7100176,8/1/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,317216, ,NCI, , ,317216
Selenium and prostate cancer apoptosis pathways,7100204,9/1/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,240219, ,NCI, , ,240219
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,7100209,8/15/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,288570, ,NCI, , ,288570
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN,7100485,9/30/1992 0:00,7/31/2006 0:00,Non-SBIR/STTR,2005,102761, ,NCI, , ,102761
Regulation of p53 in reespnse to genotoxic stress,7100964,8/1/2003 0:00,7/31/2007 0:00,Non-SBIR/STTR,2006,291754, ,NIGMS, , ,291754
Minority Predoctoral Fellowship Program,7101043,9/16/2004 0:00,5/30/2007 0:00,"Training, Individual",2006,20043, ,NIGMS, , ,20043
Clinical Investigator Development in Solid Tumor Oncology,7101255,9/1/2000 0:00,6/30/2011 0:00,Other Research-Related,2006,151487, ,NCI, , ,151487
Genomic & Genetic Characterization of Amplicons in GBMs,7101818,9/24/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,297227, ,NCI, , ,297227
Functional analysis of the p53 tumor suppressor,7101826,8/15/1985 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,210143, ,NCI, , ,210143
PAC1 in Signaling Apoptosis and Tumor Suppression,7101891,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,257835, ,NCI, , ,257835
Studies of p53 and Amyloidogenic Proteins,7101952, , ,Other Research-Related,2005, ,185640, , , , 
SIGNALING PATHWAYS REGULATING EPITHELIAL CELL SURVIVAL,7102584,5/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2006,219713, ,NIDDK, , ,219713
Actin-regulated Apoptosis in Mammary Tumorigenesis,7102667,8/1/2003 0:00,7/31/2008 0:00,Other Research-Related,2006,161730, ,NCI, , ,161730
Molecular Analysis of Esophageal Cancer Survival,7102689,7/3/2003 0:00,6/30/2008 0:00,Other Research-Related,2006,135837, ,NCI, , ,135837
RAS INDUCED SENESCENCE AND TUMOR PROGRESSION,7102697,7/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2006,498501, ,NIA, , ,498501
The role of hBUB1-p53 pathway in genomic stability.,7102699,8/1/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,280714, ,NCI, , ,280714
Mechanisms of Particulate Matter Induced Death,7102957,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,336700, ,NIEHS, , ,336700
Functional studies of the top 1-binding protein topors,7103371,5/1/1999 0:00,7/31/2007 0:00,Non-SBIR/STTR,2005,68420, ,NCI, , ,68420
The Role of Mdm2 in Lymphoma Development,7103423,7/1/2003 0:00,12/1/2006 0:00,Non-SBIR/STTR,2006,287450, ,NCI, , ,287450
Mechanism of Meclp in the Checkpoint Response,7103430,9/1/2002 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,218248, ,NIGMS, , ,218248
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors,7103579,8/5/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,214971, ,NCI, , ,214971
Effect of mutant p53 on stress-response,7103617,8/12/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,248385, ,NCI, , ,248385
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,7103687,8/1/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,343751, ,NCI, , ,343751
A Functional Census of p53 Cancer and Suppressor Mutants,7103691,8/1/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2006,356838, ,NCI, , ,356838
Cables and the colonocyte,7103704,8/1/2005 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,292651, ,NCI, , ,292651
Functional studies of the top 1-binding protein topors,7103718,5/1/1999 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,321154, ,NCI, , ,321154
Novel Ceramide-based Chemotherapy for Acute Leukemia,7104219,8/10/2004 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,243902, ,NCI, , ,243902
Molecular Epidemiology of Non-Melanoma Skin Cancer,7104298,9/30/1999 0:00,6/1/2009 0:00,Non-SBIR/STTR,2006,426115, ,NCI, , ,426115
Brain tumor angiogenesis: Integrin ceramide signaling,7104361,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,274390, ,NCI, , ,274390
Expression of Class I Specific Receptors in NK Cells,7104515,4/1/1996 0:00,3/31/2010 0:00,Non-SBIR/STTR,2006,337172, ,NIAID, , ,337172
Genetic Control of Susceptibility to Testicular Cancer,7104705,6/1/1998 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,456082, ,NCI, , ,456082
Molecular pathogenesis of UVB-induced skin cancer,7104843,8/15/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,322294, ,NCI, , ,322294
Role of Parc in the p53 Pathway,7104928,8/15/2004 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,249996, ,NCI, , ,249996
Regulation of esophageal epithelial biology,7105052,8/1/2005 0:00,7/31/2008 0:00,Other Research-Related,2006,133920, ,NIDDK, , ,133920
Mda-7: Novel Cancer Therapeutic Gene,7105063,9/10/2002 0:00,12/31/2007 0:00,Non-SBIR/STTR,2006,284191, ,NCI, , ,284191
Physical and Functional Interactions Between PML & MDM2,7105102,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,234544, ,NCI, , ,234544
Biology of the papillomavirus E5 oncoprotein family,7105323,1/1/1991 0:00,2/28/2011 0:00,Non-SBIR/STTR,2006,471013, ,NCI, , ,471013
Imaging Lung Cancer in Mice To Improve Radiation Therapy,7105544,8/3/2005 0:00,7/31/2007 0:00,Other Research-Related,2006,137099, ,NCI, , ,137099
Nitrosourea-induced growth arrest and apoptotic pathways,7105556,8/20/2004 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,223778, ,NCI, , ,223778
In Vivo Role of DNA Alkylation Repair,7105629,8/8/1997 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,486818, ,NCI, , ,486818
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS,7105633,7/12/2002 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,1051181, ,NCI, , ,1051181
A PTEN-Dependent Size Checkpoint in Human Cancer Cells,7105903,5/11/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2006,247932, ,NCI, , ,247932
Regulatory Functions of APE1-An Essential Repair Protein,7106036,12/1/1996 0:00,4/30/2011 0:00,Non-SBIR/STTR,2006,322763, ,NIEHS, , ,322763
Studies of Materials with Physiological Properties,7106119,9/1/1988 0:00,6/30/2006 0:00,Non-SBIR/STTR,2005,69426, ,NIGMS, , ,69426
Determinants of Breast Cancer Survival,7106357,6/1/2002 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,410721, ,NCI, , ,410721
 Model of Tumor Suppression by BRCA1,7107258,7/1/2002 0:00,6/30/2007 0:00,Non-SBIR/STTR,2006,297227, ,NCI, , ,297227
Functional Dissection of Signaling Pathways,7108172,3/11/2004 0:00,5/31/2008 0:00,SBIR/STTR,2006,648354, ,NCI, , ,648354
Biomarkers in Phototherapy of Barrett's Esophagus,7108543,9/30/2002 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,313957, ,NCI, , ,313957
"Telomeres,  Telomerase and Tumor Progerssion",7109250,8/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2006,302427, ,NCI, , ,302427
Molecular Mechanism of E2F Specificity,7109354,9/30/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,334597, ,NCI, , ,334597
Development of P53-Based Vaccines for Oral Cancer,7109392, , ,Non-SBIR/STTR,2005, ,142346, , , , 
Vaccine Development for Oral Carcinoma,7109396,9/1/1997 0:00,8/31/2007 0:00,Non-SBIR/STTR,2006,1005116, ,NIDCR, , ,1005116
Molecular Biology of Retinoblastoma,7110231,7/1/1976 0:00,7/31/2007 0:00,Non-SBIR/STTR,2006,177602, ,NEI, , ,177602
Polo-like Kinase Functions in Normal and Tumor Cells,7110351,9/1/2000 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,468995, ,NIGMS, , ,468995
p53 - Regulators and Effectors,7111849,2/16/2000 0:00,6/30/2010 0:00,Non-SBIR/STTR,2006,1335012, ,NCI, , ,1335012
p53 and Chemosensitivity in a Mouse Lymphoma Model,7112857,4/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006, ,330417, , , , 
Molecular Studies of the p53 Pathway in Human Cancer,7112860,4/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006, ,361837, , , , 
MD Anderson Cancer Center SPORE in Head and Neck Cancer,7112910,9/30/2002 0:00,7/31/2008 0:00,Research Centers,2006,2376493, ,NIDCR, , ,742969
Modulators of p53 Expression and Function,7113101,9/1/1997 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,280880, ,NCI, , ,280880
EARLY DETECTION OF URINARY BLADDER CANCER,7113134,9/30/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2006,515000, ,NCI, , ,515000
Bladder Cancer Prognostic Indicators,7113825,9/1/2005 0:00,8/31/2010 0:00,Other Research-Related,2006,142639, ,NCI, , ,142639
Role of HPV16 E7/E2F6 interaction in viral oncogenesis,7114002,6/6/2006 0:00,6/5/2007 0:00,"Training, Individual",2006,50428, ,NCI, , ,50428
Phase II Study of Sulindac in Oral Premalignant Lesions,7114261,9/1/2005 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,64960, ,NCI, , ,64960
Regulation of the KSHV latent promoter,7114374,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,232340, ,NCI, , ,232340
Molecular Mechanisms of SUMO Activation and Recognition,7114465,9/1/2005 0:00,9/2/2007 0:00,"Training, Individual",2006,45976, ,NIGMS, , ,45976
HPV E6 protein regulation of the hTERT promoter,7114631,9/16/2004 0:00,8/31/2009 0:00,Non-SBIR/STTR,2005,25000, ,NCI, , ,25000
P53 and Organismal Aging,7114886,9/15/2002 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,580921, ,NIA, , ,580921
HPV E6 protein regulation of the hTERT promoter,7115758,9/16/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2006,306894, ,NCI, , ,306894
Mechanisms linking ASPP2 to the Rb/E2F and p53 pathways,7115854,9/1/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2006,310423, ,NCI, , ,310423
Minority Predoctoral Fellowship Program,7116271,7/2/2004 0:00,7/1/2009 0:00,"Training, Individual",2006,42605, ,NCI, , ,42605
Cellular Senescence in Aging and Cancer,7116343,8/4/1999 0:00,6/30/2009 0:00,Non-SBIR/STTR,2006,451213, ,NCI, , ,451213
The Role of P40 in Squamous Cell Carcinomas,7116420,12/1/1999 0:00,8/31/2010 0:00,Non-SBIR/STTR,2006,341442, ,NIDCR, , ,341442
The role of JNK in Mammary tumor development,7116437,9/29/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,286218, ,NCI, , ,286218
Functional analysis of signaling to and from p53 in ca,7116441,9/30/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,265940, ,NCI, , ,265940
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER,7116793,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,258987, ,NCI, , ,258987
Molecular Targets for Drug and Radiation Sensitivity,7117261,8/17/1998 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,1591052, ,NCI, , ,1591052
Active Immune Therapy ot Leukemia Associated Antigens and Gene Therapy,7117530,6/10/2005 0:00,3/31/2011 0:00,Non-SBIR/STTR,2006, ,203931, , , , 
Signal Transduction and Kinase Inhibition in CLL,7117534,6/10/2005 0:00,3/31/2011 0:00,Non-SBIR/STTR,2006, ,211154, , , , 
The replication checkpoint and genomic fidelity in skin,7117633,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,326427, ,NIAMS, , ,326427
Human and Murine Models of BRCA1 Tumorigenesis,7117739,1/7/1998 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,270857, ,NCI, , ,270857
Mechanisms of luteinization in the primate ovary,7117775,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,283257, ,NICHD, , ,283257
p53 localization in normal and human tumor cells,7117863,6/15/1999 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,247573, ,NCI, , ,247573
Determination of regulatory mechanisms for BLM helicase,7117931,8/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,52731, ,FIC, , ,25865
Molecular Targets for Drug and Radiation Sensitivity,7117952,8/17/1998 0:00,5/31/2008 0:00,Non-SBIR/STTR,2005,260821, ,NCI, , ,260821
Regulation of Gene Expression by PML,7118005,9/30/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,295271, ,NCI, , ,295271
Genetic Epidemiology of Familial Childhood Cancer,7118384,4/1/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2006, ,156000, , , , 
Molecular Genetic Anatomy of Li Fraumeni Syndrome (LFS),7118385,4/1/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2006, ,228483, , , , 
Mouse Models for Li Fraumeni Syndrome,7118386,4/1/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2006, ,200847, , , , 
Genomic Instability in Familial Cancer Syndromes,7118388,4/1/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2006, ,115935, , , , 
Nucleic Acids Isolation and DNA Analysis Facility,7118393,4/1/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2006, ,156455, , , , 
High-Throughput Genotyping and Genetic Linkage Analysis Facility,7118394,4/1/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2006, ,208415, , , , 
Minority Predoctoral Fellowship Program,7118505,8/1/2004 0:00,7/31/2009 0:00,"Training, Individual",2006,34151, ,NCI, , ,34151
Molecular Characterization of Inflammatory Breast Cancer,7118533,9/1/2005 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,74214, ,NCI, , ,74214
A NEURAL TRANSCRIPTION FACTOR IN LUNG CANCER EVOLUTION,7118560,6/1/1996 0:00,8/31/2009 0:00,Non-SBIR/STTR,2006,375197, ,NCI, , ,375197
Chemoprevention of Oral Cancer with BBIC,7118593,3/14/1997 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,499018, ,NCI, , ,499018
Modeling ovarian carcinoma by defined genetic alterations,7118757,9/1/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2006,294763, ,NCI, , ,294763
Role of Prdx 1 in Natural Killer Cells and Tumorigenesis,7118959,9/2/2005 0:00,7/31/2008 0:00,Other Research-Related,2006,105462, ,NIEHS, , ,105462
Epigenetic factors governing SOD2 gene expression,7118977,4/6/1998 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,256380, ,NCI, , ,256380
ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICE,7119513,4/1/1987 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,179285, ,NCI, , ,179285
Inhibition of the TNF Apoptotic Pathway by HPV 16 E6,7119648,9/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,281584, ,NCI, , ,281584
Integration of Oncogenic Networks in Cancer Phenotypes,7120106,9/30/2004 0:00,8/31/2009 0:00,Research Centers,2006,2213596, ,NCI, , ,2213596
Role of sestrin family genes in antioxidant defense,7120504,9/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2006,301739, ,NIA, , ,301739
GENETIC ALTERATION IN THE EPITHELIAL AND STROMAL,7120661, , ,Non-SBIR/STTR,2005, ,286183, , , , 
"Characterization of Fortilin, A Novel Anti-p53 Protein",7121371,9/30/2001 0:00,7/31/2006 0:00,Non-SBIR/STTR,2005,44550, ,NHLBI, , ,44550
Molecular Epidemiology of Esophageal Cancer Prognosis,7122044,8/5/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,356422, ,NCI, , ,356422
Gene Expression Profiles in Human Liver Cancers,7122435,9/11/2003 0:00,8/31/2008 0:00,Other Research-Related,2006,148770, ,NCI, , ,148770
Genomic Instability and Senescence in Cancer,7122526,9/14/2005 0:00,8/31/2010 0:00,Other Research-Related,2006,127412, ,NCI, , ,127412
Molecular Epidemiology of Colorectal Cancer Subtypes,7122544,9/15/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2006,383486, ,NCI, , ,383486
Studies of Childhood Solid Tumors,7122843,8/1/1978 0:00,9/17/2007 0:00,Non-SBIR/STTR,2006,1656211, ,NCI, , ,1656211
PROGNOSTIC & PREDICTIVE  FACTORS IN OUTCOME OF PATIENTS WITH COLORECTAL CANCER:,7122846, , ,Research Centers,2005, ,154047, , , , 
MOLECULAR CHANGES IN THE NKFB PATHWAY IN RESPONSE TO CHEMORADIATION THERAPY IN RE,7122847, , ,Research Centers,2005, ,192034, , , , 
The Molecular Epidemiology Of Ovarian Cancer,7122865,9/1/1998 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,595605, ,NCI, , ,595605
Role of H2AX and ATM in Suppression of Thymic Lymphomas,7122961, , ,Non-SBIR/STTR,2005, ,399074, , , , 
Endoscopic Therapy of Early Cancer in Barretts Esophagus,7123421,9/16/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2006,339592, ,NCI, , ,339592
Diet and Somatic Mutations in Colon Cancer,7123433,8/1/1995 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,520891, ,NCI, , ,520891
ROLES AND REGULATION OF P53,7123753,9/30/2000 0:00,1/31/2006 0:00,Non-SBIR/STTR,2005,333000, ,NCI, , ,333000
NF Center: From Animal Models to Therapeutics,7123763,9/20/2005 0:00,4/30/2010 0:00,Research Centers,2006,1217085, ,NINDS, , ,1217085
Use of Beta-Lapachone for Lung Cancer Chemotherapy,7123893,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,341115, ,NCI, , ,341115
Self-Renewal of Normal and Leukemic Stem Cells,7124201,9/20/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2006,290719, ,NCI, , ,290719
Mouse Model of Pancreatic Cancer Progression-Maintenance,7124361,9/21/2005 0:00,8/31/2010 0:00,Other Research-Related,2006,160110, ,NCI, , ,160110
Generation of a faithful mouse model of Li Fraumeni Syndrome,7124621,9/1/2005 0:00,8/31/2008 0:00,"Training, Individual",2006,29063, ,NIGMS, , ,29063
Viral Pathogenesis in Human Colon Cancer,7124677,9/23/2005 0:00,7/20/2007 0:00,Other Research-Related,2006,141993, ,NCI, , ,141993
Association of inflammatory genes and prostate cancer,7125154,9/24/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2006,449348, ,NCI, , ,449348
Genomic Methylation: A Mechanism to Alter Tumor Phenotype,7126006,5/1/1996 0:00,7/31/2010 0:00,Non-SBIR/STTR,2006,244769, ,NCI, , ,244769
"Diet, DNA Repair Genes and Breast Cancer Risk",7126011,9/27/2005 0:00,8/31/2009 0:00,Other Research-Related,2007,114924, ,NCI, , ,114924
Effects of chemopreventive agents on DNA damage response,7126064,9/27/2005 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,71773, ,NCI, , ,71773
"Chaperones, immunophilins and nuclear receptor shuttling",7126122,12/1/2006 0:00,11/30/2009 0:00,Non-SBIR/STTR,2007,39998, ,FIC, , ,39998
RhoB Signaling in Cancer Suppression and Cell Suicide,7126134,5/15/2003 0:00,9/16/2005 0:00,Non-SBIR/STTR,2005,30088, ,NCI, , ,30088
Study of HPV infection and esophageal cancer in China,7126155,8/25/2006 0:00,5/31/2007 0:00,Non-SBIR/STTR,2006,52731, ,FIC, , ,25865
Comparative Bioinformatics and TP53 Expression,7126817,9/30/2005 0:00,9/29/2010 0:00,Other,2006,285315, ,NLM, , ,285315
Glucocorticoids & Vitamin D: Role In Anti-Tumor Effects,7126818,2/1/2000 0:00,6/30/2010 0:00,Non-SBIR/STTR,2006,378257, ,NCI, , ,378257
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors,7130431,7/31/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,285500, ,NCI, , ,285500
Disruption of TGF-beta pathway in mouse pancreatic cancer development,7131605,8/1/2006 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,115140, ,NCI, , ,115140
Oxidative DNA Damage And Repair In Prostate Cancer,7132274, , ,Intramural Research,2005, , , , , , 
Proteolytic disregulation S326C mutant OGG1 DNA repair,7132278, , ,Intramural Research,2005, , , , , , 
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer,7135604,8/4/2006 0:00,6/30/2011 0:00,Other Research-Related,2006,140620, ,NCI, , ,140620
Soft Tissue Sarcoma Program Project,7139478,5/16/1997 0:00,6/30/2011 0:00,Non-SBIR/STTR,2006,1732032, ,NCI, , ,1732032
Effect of caffeine on UVB-induced skin cancer,7139568,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,298073, ,NCI, , ,298073
Hypoxia signaling to checkpoint activation and apoptosis,7139624,8/4/2006 0:00,7/30/2011 0:00,Non-SBIR/STTR,2006,274469, ,NCI, , ,274469
Role and therapeutical potential of Cdk4/6 in B-lymphoma,7139849,7/10/2006 0:00,11/15/2006 0:00,Non-SBIR/STTR,2006,46146, ,NCI, , ,46146
Study the Role of Chfr in Tumorigenesis,7140776,7/1/2006 0:00,9/30/2006 0:00,Non-SBIR/STTR,2006,4947, ,NCI, , ,4947
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma,7141201,7/1/2006 0:00,6/30/2011 0:00,Non-SBIR/STTR,2006, ,133801, , , , 
P53 Biomarker and Intervention in Occupational Cancer,7141536,7/1/2006 0:00,6/30/2010 0:00,Non-SBIR/STTR,2006,326570, ,NIOSH, , ,326570
p53-mediated control of numeral integrity of centrosomes,7141545,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,253781, ,NCI, , ,253781
Thioredoxin Inhibition of Apoptosis and Cancer Treatment,7141689,12/18/1998 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,11763, ,NCI, , ,11763
Elucidate the role of p63 in prostate cancer progression,7142458,7/13/2006 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,136325, ,NCI, , ,136325
Restoration of Tumor Suppression Activity in Malignant Melanoma,7142504,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,496909, ,NCI, , ,496909
Mechanisms Regulating Reversal of Malignancy,7142681,8/30/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2006,216030, ,NCI, , ,216030
Role of the chronic inflammatory mediator NO in early mammary tumorigenesis,7142854,8/1/2006 0:00,7/31/2009 0:00,Other Research-Related,2006,145034, ,NCI, , ,145034
Stat3 and anti-VEGF therapy in cancer,7143009,2/21/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2005,156457, ,NCI, , ,156457
Molecular Mechanisms of Lymphomagenesis,7143095,8/1/2006 0:00,7/30/2010 0:00,Non-SBIR/STTR,2006,298200, ,NCI, , ,298200
Mechanisms of tumor suppression by Fbw7,7143540,7/26/2006 0:00,6/30/2011 0:00,Other Research-Related,2006,140535, ,NCI, , ,140535
Mechanism of Redox Regulation by Ape1/Ref-1,7144509,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,242021, ,NCI, , ,242021
Mechanisms of SAG Inhibition of Carcinogenesis & Apoptosis,7145233,9/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006,269707, ,NCI, , ,269707
A Pathway of Tumor Suppression,7145698,7/1/1988 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,244020, ,NCI, , ,244020
Functional and Structural Studies of CD74 Activation,7146881,6/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,412188, ,NIAID, , ,412188
Reversing Electrostatic Interactions for Improved Gene Delivery,7147317,7/14/2006 0:00,4/30/2010 0:00,Non-SBIR/STTR,2006,359775, ,NIBIB, , ,359775
Molecular targeting of the survivin pathway in cancer,7147639,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,297399, ,NCI, , ,297399
Genetic Epidemiology of Melanoma,7149743,9/30/2001 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006,812038, ,NCI, , ,812038
Role of the STK Receptor in Erythropoiesis,7150198,12/1/2000 0:00,7/31/2010 0:00,Non-SBIR/STTR,2006,310147, ,NHLBI, , ,310147
Epithelial Positioning Organization and Ovarian Cancer,7150244,3/1/2002 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,372866, ,NCI, , ,372866
ECM-Mediated Apoptosis in p53 (-) HMECs,7150344,7/1/2000 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,217693, ,NCI, , ,217693
Activation of checkpoint pathways in cancer,7150541,7/19/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2006,191700, ,NCI, , ,191700
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein,7150673,9/30/1992 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006,240563, ,NCI, , ,240563
Repair of Endogenous Damage in Mammalian Genomes,7150880,2/11/1991 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,338430, ,NCI, , ,338430
Biomarkers of Heavy Metal Exposure Related to Pancreatic Cancer Genetic Mutations,7150916,9/1/2006 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,86526, ,NCI, , ,86526
Salivary Acinar Cell Apoptosis: Regulation of p53 by Akt,7151011,7/7/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2006,398150, ,NIDCR, , ,398150
Base Pairing and Mutagenesis,7151165,12/1/1988 0:00,11/30/2009 0:00,Non-SBIR/STTR,2007,324417, ,NIGMS, , ,324417
Chemoprevention Through Activation of Estrogen Receptor Alpha-Induced Senescence,7151278,7/11/2006 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,75750, ,NCI, , ,75750
Differential Regulation of p53 function by Lysine Acetylation,7151747,7/6/2006 0:00,6/30/2008 0:00,Non-SBIR/STTR,2006,84750, ,NCI, , ,84750
Selective Recognition of Folded RNA by Small Oligomers,7152077, , ,Intramural Research,2005, , , , , , 
NQO1 in Protection Against Benzene Toxicicity,7152528,7/15/1998 0:00,11/30/2009 0:00,Non-SBIR/STTR,2007,292040, ,NIEHS, , ,292040
Regulation and Function of C/EBP in UVB Responses,7152567,1/3/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,341263, ,NIEHS, , ,341263
"Kinetics, Regulation, And Mechanisms Of Biochemical Reac",7154186, , ,Intramural Research,2005, , , , , , 
Bioflavonoid apigenin induces phosphorylation of p53,7154511,3/10/2003 0:00,2/29/2008 0:00,Other Research-Related,2006,152053, ,NCI, , ,152053
The Bcl-2/Bcl-X Pathway in Myc-Induced Lymphomagenesis,7155527,12/15/1997 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,254225, ,NCI, , ,254225
A polymorphism in the Mdm2 promoter enhances cancer risk,7156472,7/20/2006 0:00,8/19/2007 0:00,"Training, Individual",2006,50428, ,NCI, , ,50428
Lineage Tracy in Murine Pancreatic Cancer Metastasis,7156529,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2006,41796, ,NCI, , ,41796
TGFBeta1 signaling and radiation response in pancreas CA,7156576,3/1/2002 0:00,2/28/2007 0:00,Non-SBIR/STTR,2004,94974, ,NCI, , ,94974
Pre-Clinical Evaluation of Novel Therapeutics for PDA,7157374,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2006,38976, ,NCI, , ,38976
Inductible mouse models for oral cancer,7157638,1/13/2005 0:00,8/31/2007 0:00,Non-SBIR/STTR,2007,52401, ,NIDCR, , ,52401
Dna Damage Response In Eukaryotic Cells,7157866, , ,Intramural Research,2005, , , , , , 
An ORFeome fusion library approach to studying ubiquitylation,7158078,7/10/2006 0:00,7/9/2008 0:00,"Training, Individual",2006,45976, ,NCI, , ,45976
Clinical Activity of 17-AAG in Lymphoma,7158956,9/29/2006 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,218680, ,NCI, , ,218680
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE,7161318,12/29/1994 0:00,11/30/2009 0:00,Non-SBIR/STTR,2007,550839, ,NCI, , ,550839
Deciphering how MdmX deregulation impacts the p53 pathway,7161741,4/1/1995 0:00,11/30/2010 0:00,Non-SBIR/STTR,2007,215084, ,NCI, , ,215084
Molecular Markers as Predictors of Outcome in Gliomas,7161746,9/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2007,324435, ,NINDS, , ,324435
Mammalian Polyamine Metabolism,7161767,12/1/1975 0:00,11/30/2010 0:00,Non-SBIR/STTR,2007,313665, ,NCI, , ,313665
Leukemogenesis In Genetically-altered Mouse Models,7161813, , ,Intramural Research,2005, , , , , , 
"cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma",7162899,1/1/2005 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,224802, ,NCI, , ,224802
Transcripitonal and Genetic Profiles in HNSCCs,7163769,3/1/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,284786, ,NIDCR, , ,284786
Prognostic Molecular Markers of Colorectal Cancer,7163774,1/16/2003 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,279026, ,NCI, , ,279026
Novel Approaches for Pancreatic Cancer Therapy,7163792,1/21/2003 0:00,12/31/2007 0:00,Non-SBIR/STTR,2007,268720, ,NCI, , ,268720
Transcriptional Responses in Neurodegenerative Diseases,7163801,1/1/2004 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,247106, ,NINDS, , ,247106
Enhancing Activity of Alkylating Agents in Neuroblastoma,7166034,9/1/1999 0:00,12/31/2010 0:00,Non-SBIR/STTR,2007,62346, ,NCI, , ,62346
Mechanism of SAG apoptosis protection under hypoxia,7166045,2/1/2005 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,286517, ,NCI, , ,286517
Role of the Oxidative Stress Pathway in Drug Resistance,7166925,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2005,174362, ,NCI, , ,174362
MDM2 AS A NEGATIVE REGULATOR OF P21 WAF1/CIP1,7167158,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,254536, ,NCI, , ,254536
Models for DNA repair and cell cycle control variants,7167591,4/10/2001 0:00,3/31/2008 0:00,Non-SBIR/STTR,2005,120486, ,NIEHS, , ,120486
Phosphorylation of p53 in Apoptosis and Growth Arrest in,7168257, , ,Intramural Research,2005, , , , , , 
The Role of NF-kappaB in Chemotherapy Resistance,7168800,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,340162, ,NCI, , ,340162
Interactions and Functions of p14ARF in Cancer,7169230,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,370484, ,NCI, , ,370484
Natural Product Antitumor Inducers of Apoptosis,7169537,9/6/2002 0:00,8/31/2006 0:00,Non-SBIR/STTR,2004,169405, ,NCI, , ,169405
Multi-institutional trial: molecular analysis of margins,7169546,2/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,212005, ,NCI, , ,212005
Monitoring mechanisms in mammalian ribosome biogenesis,7169644,2/1/2005 0:00,8/15/2007 0:00,Non-SBIR/STTR,2007,99866, ,NIGMS, , ,99866
Isolation/Characterization Human Genes--Chromosome,7169977, , ,Intramural Research,2005, , , , , , 
The Environment and Epigenetic Gene Silencing in Cancer,7171722,9/30/2006 0:00,6/30/2010 0:00,Non-SBIR/STTR,2006,719056, ,NIEHS, , ,719056
Role of RNase L in the Biology of Prostate Cancer,7171854,2/16/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,297398, ,NCI, , ,297398
Aldo-Keto Reductases and PAH Metabolism/Activation,7172657,3/1/1986 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,282539, ,NCI, , ,282539
Mutant p53 Gain of Function in Tumorigenesis,7172975,4/1/1995 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,300812, ,NCI, , ,300812
Transformation of human mammary epithelium by c-Myc,7173358,5/1/1997 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,331104, ,NIA, , ,331104
Biomimetic Synthesis of Complex Natural Products,7173411,2/1/2006 0:00,1/31/2010 0:00,Non-SBIR/STTR,2007,297951, ,NIGMS, , ,297951
Oncogenic Gene Regulatory Networks,7173731,2/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,284064, ,NCI, , ,284064
Chk1 signaling in the G2 DNA damage checkpoint,7173872,2/1/2003 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,326255, ,NCI, , ,326255
Cell Cycle Dysregulation in Oral Cancer,7173881,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,458345, ,NIDCR, , ,458345
The Role of Phosphatase CL100/MKP1 in Human Cancer,7174306,2/5/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,234807, ,NCI, , ,234807
Mechanisms of Cell Cycle Associated Neoplasia,7174826,2/16/2000 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,348574, ,NCI, , ,348574
Apoptosis by FADD in normal and cancerous cells,7175308,2/22/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,288389, ,NCI, , ,288389
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1,7175321,2/15/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2007,270340, ,NCI, , ,270340
GENES CONTROLLING NEOPLASIA OF THE INTESTINAL EPITHELIUM,7175323,9/22/1993 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,878085, ,NCI, , ,878085
MECHANISMS OF ESTROGEN RECEPTOR REGULATION,7175483,2/1/2006 0:00,12/31/2010 0:00,Non-SBIR/STTR,2007,231383, ,NCI, , ,231383
Chromosomal Abnormalities in Myeloma as Detected by FISH,7176048,4/1/2000 0:00,11/29/2008 0:00,Non-SBIR/STTR,2007,316085, ,NCI, , ,316085
Mechanisms of mutagenesis in  hot spots causing cancer,7176153,2/1/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,216252, ,NCI, , ,216252
The PLZF Protein of t(11;17)-Promyelocytic Leukemia,7176220,4/1/1993 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,382145, ,NCI, , ,382145
Regulation and Role of ODC in Apoptosis and Cancer,7176766,3/4/2003 0:00,2/29/2008 0:00,Non-SBIR/STTR,2006,170190, ,NCI, , ,170190
Dual Role of E2F1 in Tumorigenesis,7176859,1/18/1999 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,322145, ,NCI, , ,322145
"P38, G2 Arrest, and Temozolomide Resistance in Gliomas",7176884,2/1/2004 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,294482, ,NCI, , ,294482
"Hypoxia, Genetic Instability and DNA Mismatch Repair",7176917,9/30/1992 0:00,1/31/2008 0:00,Non-SBIR/STTR,2007,310055, ,NIEHS, , ,310055
Genetic alterations of KLF4 in human pancreatic cancer,7177052,9/27/2006 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,68838, ,NCI, , ,68838
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1,7177377,2/15/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2006,48453, ,NCI, , ,48453
Homologous Recombination & Human Cell Radiosensitivity,7177470,2/7/2006 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,343492, ,NCI, , ,343492
Leukemogenic Slug Pathway in Hematopoietic Cell Survival,7177477,5/1/1993 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,405347, ,NCI, , ,405347
"Telomere dysfunction, p53 and tumorigenesis",7177883,7/1/2007 0:00,6/30/2012 0:00,Other Research-Related,2007,121656, ,NCI, , ,121656
The role of glutathione peroxidase in the pathogenesis of intestinal cancer,7178499,3/1/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2007,295781, ,NCI, , ,295781
The MED1 Protein in DNA Damage Response and Repair,7179292,7/1/1998 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,357358, ,NCI, , ,357358
P63 mediators as therapeutic targets in HNSCC,7183536,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,373347, ,NIDCR, , ,373347
Role of AML1-ETO in Acute Leukemia,7183545,7/1/1994 0:00,11/30/2008 0:00,Non-SBIR/STTR,2007,302817, ,NCI, , ,302817
Study of genomic instability caused by HPV16 E6 and E7,7183615,5/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,256010, ,NIDCR, , ,256010
FDH: A Novel Determinant of Tumor Suppression,7184330,3/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2007,246068, ,NCI, , ,246068
Stat3 and anti-VEGF therapy in cancer,7185041,2/21/2003 0:00,1/31/2008 0:00,Non-SBIR/STTR,2007,285231, ,NCI, , ,285231
Activating liver carcinogens in yeast by expressing CYP450 polymorphisms,7185311,9/14/2007 0:00,9/15/2007 0:00,Non-SBIR/STTR,2007,177500, ,NCI, , ,177500
The Pathogenesis of Dyskeratosis Congenita,7186656,2/8/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,286517, ,NCI, , ,286517
Telomere-Mediated Protective Responses in Skin,7186697,4/8/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,345477, ,NCI, , ,345477
Targeting Signal Transduction Pathways for Cancer Drug Discovery,7186767,2/5/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,1835922, ,NCI, , ,1835922
Genetic modifiers of mammary tumor susceptibility,7187435,2/15/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,280344, ,NCI, , ,280344
Role of p53 and ptc tumor suppressive pathways in BCCs development and prevention,7187867,9/30/2006 0:00,4/30/2007 0:00,Non-SBIR/STTR,2006,402500, ,NIEHS, , ,402500
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,7187894,5/1/1997 0:00,8/31/2011 0:00,Non-SBIR/STTR,2006,1388333, ,NCI, , ,1388333
p63 Signaling in Epithelial Cell Growth and Cancer,7189355,3/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,293511, ,NCI, , ,293511
In Vivo Ras-induced Senescence and Tumorigenesis,7190456,4/18/2003 0:00,2/28/2010 0:00,Non-SBIR/STTR,2007,334387, ,NCI, , ,334387
The Role of HOXA5 in Breast Cancer,7190548,3/15/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,286025, ,NCI, , ,286025
p53 target Genes in Apoptosis,7191580,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,264158, ,NCI, , ,264158
HAUSP-mediated Deubiquitination of p53,7191611,4/1/2003 0:00,3/30/2008 0:00,Non-SBIR/STTR,2007,266666, ,NCI, , ,266666
In vivo pathogenesis of Helicobacter pylori,7191686,9/1/1996 0:00,2/28/2010 0:00,Non-SBIR/STTR,2007,384013, ,NIAID, , ,384013
"Characterization of Mutational Spectra, Mechanisms of Toxicity and Homologous Rec",7191734, , ,Non-SBIR/STTR,2006, ,288021, , , , 
Expression of Class I Specific Receptors in NK Cells,7191743,4/1/1996 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,326926, ,NIAID, , ,326926
p53 Signaling and Cellular Response After Stress,7191744,1/1/1997 0:00,12/31/2010 0:00,Non-SBIR/STTR,2007,330289, ,NCI, , ,330289
Structure-Function of Protein Deacetylases,7191757,3/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,302257, ,NCI, , ,302257
Rac GTPases as Targets in Lymphomagenesis,7191892,2/10/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,285000, ,NCI, , ,285000
PHTHALATE-INDUCED MURINE TESTICULAR DYSGENESIS AND P53,7192426,5/1/2005 0:00,2/29/2008 0:00,Non-SBIR/STTR,2007,146968, ,NIEHS, , ,146968
In utero dietary exposure to endocrine disruptors,7192451,5/1/2005 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,147158, ,NIEHS, , ,147158
Etiology and Prevention of Oral Cancer,7192530,5/1/2003 0:00,2/28/2010 0:00,Non-SBIR/STTR,2007,277326, ,NCI, , ,277326
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE,7192536,3/1/1988 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,474367, ,NCI, , ,474367
Transfected cell arrays for cancer research,7192889,9/24/2007 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,182125, ,NCI, , ,182125
Nanoscale Functional Dendrimer-DNA Assemblies,7193251,12/4/2006 0:00,11/30/2009 0:00,Non-SBIR/STTR,2007,162500, ,NCI, , ,162500
Mox 1: A Novel Mitogenic Oxidase,7194027,1/5/2000 0:00,2/29/2012 0:00,Non-SBIR/STTR,2007,269909, ,NCI, , ,269909
Using Zebrafish to Identify and Analyze Cancer Genes,7195039,3/7/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2007,359136, ,NCI, , ,359136
"Telomerase in Development, Senescence and Neoplasia",7195083,1/1/2000 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,574079, ,NCI, , ,574079
Thioredoxin Inhibition of Apoptosis and Cancer Treatment,7195084,12/18/1998 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,269170, ,NCI, , ,269170
Lipid peroxidation product induced DNA damage in the p53 gene and liver cancer,7195526,9/28/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006,400000, ,NIEHS, , ,400000
The MRAD9 Radioresistance Gene,7195709,12/1/2000 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,311099, ,NIGMS, , ,311099
Murine Neuroblastoma Models for Preclinical Therapeutics,7195952,7/1/2003 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006,267910, ,NCI, , ,267910
HTP assays of inhibitors of protein-protein interactions,7196409,4/15/2005 0:00,3/31/2008 0:00,Non-SBIR/STTR,2007,315273, ,NCI, , ,315273
Molecular Basis of Aneuploidy,7196478,3/7/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2007,225782, ,NCI, , ,225782
Novel p53 target gene ASC in apoptosis & mammary tumorigenesis,7196524,4/1/1999 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,273706, ,NCI, , ,273706
G2 Checkpoint Control In Transformed Human Cells,7196526,12/1/1998 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,320353, ,NCI, , ,320353
SUMO conjugation in cell biology and Development,7196827,9/15/2001 0:00,11/30/2010 0:00,Non-SBIR/STTR,2007,240375, ,NIGMS, , ,240375
Small Molecule Activators of p53,7197173, , ,Intramural Research,2005, , , , , , 
MYC's Role in the Initiation and Maintenance of Cancer,7197601,12/1/2000 0:00,2/29/2012 0:00,Non-SBIR/STTR,2007,375138, ,NCI, , ,375138
Molecular and Cellular Origins of Pancreatic Cancer,7197737,5/18/2007 0:00,4/30/2010 0:00,Other Research-Related,2007,135270, ,NCI, , ,135270
Mechanisms of tumor promotion and carcinogenesis,7197791,1/1/1994 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,52306, ,NCI, , ,52306
The Role of p53 and 14-3-3 in Genomic Instability,7197980,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,264158, ,NCI, , ,264158
"Allergies, Genetic Susceptibility and Adult Glioma Risk",7198131,3/10/2006 0:00,1/31/2008 0:00,Non-SBIR/STTR,2007,399509, ,NCI, , ,399509
"Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B",7198291,11/1/2006 0:00,7/31/2011 0:00,Research Centers,2006, ,186816, , , , 
An in vivo Screen for Radiation Sensitizers,7199477,5/1/2007 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,181446, ,NIDCR, , ,181446
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA,7199514,5/1/1997 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,280617, ,NCI, , ,280617
Pathways of Therapy-induced Senescence in Cancer,7208020,3/17/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2007,235952, ,NCI, , ,235952
The Structure and Function of S100 Proteins,7208282,2/1/1999 0:00,1/31/2011 0:00,Non-SBIR/STTR,2007,304425, ,NIGMS, , ,304425
Prevention of Oral Cancer by Tea: A mechanism Study,7209014,3/16/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2007,338954, ,NCI, , ,338954
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS,7209057,4/1/1980 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,281457, ,NCI, , ,281457
Role of DN-p63 in Preservation of Self Renewal,7209060,4/1/2005 0:00,2/28/2010 0:00,Non-SBIR/STTR,2007,228179, ,NCI, , ,228179
Molecular Pathobiology of Langerhans Cell Histiocytosis,7209754,4/15/2003 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,341941, ,NIAID, , ,341941
Mechanisms of tumor promotion and carcinogenesis,7209837,1/1/1994 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,249183, ,NCI, , ,249183
"Obesity, H pylori and Risk of Barrett's Esophagus",7210092,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,569414, ,NCI, , ,569414
Development and testing of a silibin-containing sunscreen,7210773,6/21/2007 0:00,5/31/2010 0:00,SBIR/STTR,2007,108177, ,NCI, , ,108177
Mechanism of mitotic exit in budding yeast,7211433,8/1/1999 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,241908, ,NIGMS, , ,241908
FHIT Gene Therapy in Cancer Prevention and Treatment,7211572,12/1/2006 0:00,11/30/2011 0:00,Non-SBIR/STTR,2007,228000, ,NCI, , ,228000
TGF-beta signaling and colon cancer,7211867,1/1/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2007,340523, ,NCI, , ,340523
Carcinogen Exposure and Adult Cancer Risk,7211941,9/21/2007 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,277400, ,NCI, , ,277400
Roles of DMP1 in Ras signaling and lung cancer,7212264,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,251038, ,NCI, , ,251038
Targeting JAB1 Oncogenic Function in Breast Cancer,7212684,4/1/2001 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,255009, ,NCI, , ,255009
Targeting Relaxin Signaling in Prostate Cancer,7212754,1/19/2007 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,180000, ,NCI, , ,180000
Non-Myeloablative Host Conditioning that Protects Against GVHD,7212900,3/1/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2007, ,277128, , , , 
Mechanisms of Genetic Instability and Tumor Suppression,7213090,7/1/1993 0:00,7/31/2011 0:00,Non-SBIR/STTR,2006,519756, ,NCI, , ,519756
The role of p53 in remodeling DNA methylation in cancer,7213257,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,244189, ,NCI, , ,244189
Molecular Basis of KSHV Pathogenesis,7213269,6/15/1999 0:00,12/31/2007 0:00,Non-SBIR/STTR,2007,338914, ,NCI, , ,338914
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium,7213355,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,261534, ,NCI, , ,261534
THE ROLE OF SPARC IN GLIOMA INVASION,7214102,7/1/2000 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,245769, ,NCI, , ,245769
JC Virus and Tumor Formation in the Human Colon,7214190,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,260276, ,NCI, , ,260276
Mouse Medel of Esophageal Adenocarcinoma,7214263,9/15/2006 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,60203, ,NCI, , ,60203
Targeting RhoA Lymphomagenesis,7214271,9/15/2006 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,75000, ,NCI, , ,75000
Chemoprevention Potential of Calpain Inhibitors,7214481,9/15/2006 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,73000, ,NCI, , ,73000
Targeting of MDM2 Family Proteins in Cancer,7214564,12/1/2006 0:00,11/30/2011 0:00,Non-SBIR/STTR,2007, ,295993, , , , 
Development of Proteasome Selective Inhibitors for Cancer Therapy,7214567,12/1/2006 0:00,11/30/2011 0:00,Non-SBIR/STTR,2007, ,281391, , , , 
"Cadmium, Metallothionein and Breast Cancer Progression",7214615,4/1/2005 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,261423, ,NCI, , ,261423
Cell and tumor genetics of mitotic arrest checkpoints,7214664,2/1/2000 0:00,2/28/2010 0:00,Non-SBIR/STTR,2007,344054, ,NCI, , ,344054
Lung cancer molecular markers by sex: intergroup study,7214720,4/15/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,633153, ,NCI, , ,633153
Etiology of Balkan endemic nephropathy,7214766,4/1/2006 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,36505, ,NIEHS, , ,32000
Biomarkers for margin analysis and prognosis in HNSCC,7214866,9/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,358467, ,NIDCR, , ,358467
The Role of Mdm2 in Cell Growth and Tumorigenesis,7214883,3/1/1999 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,312012, ,NCI, , ,312012
Hormonal regulation of p53 activity in mammary tissue,7215206,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,271155, ,NCI, , ,271155
Functions of Human Papillomavirus E6,7215243,4/8/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,310653, ,NCI, , ,310653
Role of PCAF/GCN5 Acetylation on p53 Transactivation,7215619,4/1/1999 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,334708, ,NCI, , ,334708
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia,7216229,9/15/1996 0:00,8/31/2007 0:00,Non-SBIR/STTR,2007,374556, ,NCI, , ,374556
DNA Repair and Checkpoint Interactions in Mammals,7216379,5/1/2003 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,316794, ,NCI, , ,316794
Role of WISp39 and Ubiquitination in p21 Function,7216403,4/9/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,325911, ,NCI, , ,325911
Progesterone-mediated protection against ovarian cancer,7216589,9/1/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2005,272846, ,NCI, , ,272846
Models for DNA repair and cell cycle control variants,7216662,4/10/2001 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,613571, ,NIEHS, , ,613571
SELECTIVE THERAPY FOR COLON CARCINOMA,7216682,7/1/1983 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,309836, ,NCI, , ,309836
Molecular mediators of metastasis in hepatocellular carcinoma,7216796,4/1/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2007,280074, ,NCI, , ,280074
T cell activation and crypt cell apoptosis,7216918,2/15/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,279420, ,NIDDK, , ,279420
Southwest Oncology Group,7217325,2/1/1993 0:00,12/31/2009 0:00,Other Research-Related,2007,252261, ,NCI, , ,252261
CORE--ENVIRONMENT /GENE INTERACTIONS,7217372, , ,Research Centers,2006, ,174086, , , , 
Genetic Regulators of Human Melanocytic Neoplasia,7217530,7/1/2005 0:00,5/31/2008 0:00,Other Research-Related,2007,19835, ,NIAMS, , ,19835
Molecular Functions of the Adenoviral E1B 55 kDa Protein,7217983,4/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,374531, ,NIAID, , ,374531
Novel Methods for Molecular Analysis of Colorectal Polyps,7218506,9/27/2006 0:00,8/31/2008 0:00,SBIR/STTR,2006,187062, ,NCI, , ,187062
 anti-tumor activity of deacetylase inhibitors,7218632,4/8/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,271505, ,NCI, , ,271505
p53 loss in HMECs: a model of breast cancer prevention,7218638,7/3/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,292405, ,NCI, , ,292405
Mechanisms of T Cell Tumorigenesis,7218670,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,238942, ,NCI, , ,238942
Genetic Mechanisms in Experimental Pancreatic Cancer,7218707,9/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2007,262017, ,NCI, , ,262017
Sphingosine Phosphate:Regulation and Role in Cancer,7218723,9/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2007,378232, ,NCI, , ,378232
Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family Members,7219470, , ,Other Research-Related,2006, ,114957, , , , 
Tumor Suppression by Protein Kinase C-delta,7219479, , ,Other Research-Related,2006, ,75609, , , , 
Biology of EGFR and P53 in esophageal epithelial cells,7219886,12/1/2006 0:00,11/30/2009 0:00,"Training, Individual",2006,45976, ,NIDDK, , ,45976
In Vivo Role of DNA Alkylation Repair,7219944,8/8/1997 0:00,7/31/2008 0:00,Non-SBIR/STTR,2007,486882, ,NCI, , ,486882
Microsatellite instability and cancer gene expression,7219945,7/1/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,405062, ,NCI, , ,405062
Non-Peptide Small-Molecule Inhibitors of the MDM2-p53 interaction,7219951,5/1/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2007,420850, ,NCI, , ,420850
Ubiquitin-Mediated Regulation of DNA Repair,7221197,7/7/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,279902, ,NCI, , ,279902
Molecular Epidemiology of Secondary Lung Cancer,7221216,1/15/2003 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,476951, ,NCI, , ,476951
"Applications of ""Recombomice"" for Cancer Research",7221218,4/15/2006 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,272319, ,NCI, , ,272319
Regulated Proteolysis in RAS Signal Transduction,7221224,5/1/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,230764, ,NIGMS, , ,230764
Characterization of prostatic stem cells and prostate cancer-initiating cells,7221466,9/1/2007 0:00,8/31/2008 0:00,Other Research-Related,2007,87210, ,NCI, , ,87210
Cellular Targets of Papillomavirus Oncoproteins,7223405, , ,Non-SBIR/STTR,2006, ,412990, , , , 
Interactions of the SV40 Small T Antigen and PP2A in Human Cell Transformation,7223407, , ,Non-SBIR/STTR,2006, ,173009, , , , 
Cellular and molecular basis of malignant astrocytoma,7223428,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,309361, ,NINDS, , ,309361
The Role of E2F1 in UV-induced DNA Damage Response,7223457,5/3/2005 0:00,4/30/2010 0:00,Other Research-Related,2007,136944, ,NCI, , ,136944
Regulation of p53-mediated apoptosis in gliomas,7223477,7/17/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,254853, ,NCI, , ,254853
The Apoptogenic Role of p53 at the Mitochondria,7223525,9/15/1993 0:00,1/30/2009 0:00,Non-SBIR/STTR,2007,264543, ,NCI, , ,264543
The Role of Mdm2 in Lymphoma Development,7224208,7/1/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,291296, ,NCI, , ,291296
Nordion Research Irradiator,7224458,4/1/2007 0:00,3/31/2008 0:00,Other Research-Related,2007,425826, ,NCRR, , ,425826
Nucleoside Phosphonate Analogs and HPV Positive Cancers,7224848,7/1/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,274073, ,NCI, , ,274073
Lana and Cellular Gene Expression in Kaposis Sarcoma,7224919,7/1/2000 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,226694, ,NCI, , ,226694
Apoptotic Response to DNA Damage Initiated by PUMA,7224924,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,259785, ,NCI, , ,259785
Control of c-Myc Function by the Tumor Suppressor p19ARF,7224928,7/6/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,264158, ,NCI, , ,264158
Molecular Epidemiology of Esophageal Cancer Prognosis,7225124,8/5/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,383371, ,NCI, , ,383371
The Apoptotic Role of MEKK1 in Cancer Chemotherapy,7225168,5/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2007,257383, ,NCI, , ,257383
DNA Damage/Repair and Cell Death,7225187,4/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,287460, ,NINDS, , ,287460
Altered Proteoglycan Gene Expression and Cancer,7225198,9/1/1988 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,373046, ,NCI, , ,373046
Murine p73 in Tumorigenesis,7225215,6/15/1998 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,377685, ,NCI, , ,377685
Mechanisms of Intestinal Tumorigenesis,7225217,1/1/2000 0:00,2/28/2010 0:00,Non-SBIR/STTR,2007,369627, ,NCI, , ,369627
PLK3 in the DNA damage checkpoint and tumor suppression,7225247,12/15/1997 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,315555, ,NCI, , ,315555
Normal and Neoplastic Growth Regulation in the Brain,7225276,4/1/2003 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,1770072, ,NCI, , ,1770072
Tumor Suppression,7225421,1/1/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2007, ,646450, , , , 
DNA Damage and Tobacco-Induced Lung Cancer,7225504,5/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,316480, ,NCI, , ,316480
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,7225518,8/15/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,280202, ,NCI, , ,280202
Dietary Prevention of Cancer,7225535,7/1/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,263847, ,NCI, , ,263847
p53-Mediated Transcription and Apoptosis,7225590,4/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,288437, ,NCI, , ,288437
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D,7225609,1/1/1999 0:00,2/28/2011 0:00,Non-SBIR/STTR,2007,238892, ,NCI, , ,238892
Analysis of Tumor RNA Variants using PMSG,7225620,4/21/2006 0:00,3/31/2009 0:00,SBIR/STTR,2007,581738, ,NCI, , ,581738
Rapamycin-induced Selective Apoptosis in Malignant Cells,7225900,12/1/1998 0:00,4/6/2008 0:00,Non-SBIR/STTR,2007,267387, ,NCI, , ,267387
Development Therapy for Metastatic Colorectal Cancer,7226179,5/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,253422, ,NCI, , ,253422
Redox Effects of Selenium for Prostate Cancer Prevention,7226232,4/18/2005 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,272472, ,NCI, , ,272472
RhoB Signaling in Cancer Suppression and Cell Suicide,7226264,5/15/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2007,316456, ,NCI, , ,316456
Hypoxia and Gene Repression,7226292,7/1/2000 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,314651, ,NCI, , ,314651
DDR1 in p53-mediated suppression and in breast cancer,7226708,7/1/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,295358, ,NCI, , ,295358
Mechanisms of luteinization in the primate ovary,7226974,7/1/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,275467, ,NICHD, , ,275467
Investigating the Role of Cyr61 in Breast Cancer,7226975,7/26/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,303229, ,NCI, , ,303229
Molecular Characterization of ACF (Abberant Crypt Foci),7227020,8/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,243043, ,NCI, , ,243043
p53 and checkpoint pathways in cancer cell repliction,7227128,7/11/1994 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,325345, ,NCI, , ,325345
Biology of the papillomavirus E5 oncoprotein family,7227132,1/1/1991 0:00,2/28/2011 0:00,Non-SBIR/STTR,2007,485884, ,NCI, , ,485884
POLYAMINE ANALOG REGULATION OF CELL CYCLE AND APOPTOSIS,7227133,8/1/1989 0:00,4/30/2008 0:00,Non-SBIR/STTR,2007,344666, ,NCI, , ,344666
AMID in Apoptosis and p53-Mediated Downstream Effects,7227149,7/14/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,265208, ,NCI, , ,265208
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors,7227166,7/15/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,686328, ,NCI, , ,686328
Brain tumor angiogenesis: Integrin ceramide signaling,7227715,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,266432, ,NCI, , ,266432
Potentials of reactivated mutant p53,7227737,7/1/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,297398, ,NCI, , ,297398
Cables and the colonocyte,7228113,8/1/2005 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,284164, ,NCI, , ,284164
Analysis of 53BP1 function in DNA Damage-signaled pathway and Tumorigenesis,7228118,5/9/2003 0:00,4/30/2011 0:00,Non-SBIR/STTR,2007,314414, ,NCI, , ,314414
Regulatory Functions of APE1 - An Essential Repair Protein,7228137,12/1/1996 0:00,4/30/2011 0:00,Non-SBIR/STTR,2007,313402, ,NIEHS, , ,313402
Novel Proapoptotic BH3-only Proteins in Cancer Apoptosis,7228138,5/16/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,210156, ,NCI, , ,210156
The Role of p73 in Upper Gastrointestinal Carcinomas,7228185,4/28/2006 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,264718, ,NCI, , ,264718
Functional properties of centrosomes in somatic cells,7228195,5/1/1999 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,322673, ,NIGMS, , ,322673
Adenocarcinoma of the Lung: role of NNK susceptibility,7228206,9/30/1991 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,642351, ,NCI, , ,642351
Novel Ceramide-based Chemotherapy for Acute Leukemia,7228416,8/10/2004 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,58786, ,NCI, , ,58786
ARF ACTIVATION BY POLYOMA VIRUS T-ANTIGEN,7228424,7/25/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,255696, ,NCI, , ,255696
Quantitative Gene Expression in Human Lung Epithelium,7228465,7/1/2003 0:00,1/17/2008 0:00,Non-SBIR/STTR,2007,200200, ,NCI, , ,200200
Arsenic Induced Miotic Arrest Associated Apoptosis,7228506,8/1/2003 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,264826, ,NIEHS, , ,264826
Targeting Oncogene Expression to Skin in Transgenic Mice,7228581,8/1/1990 0:00,4/30/2008 0:00,Non-SBIR/STTR,2007,490305, ,NCI, , ,490305
DNA damage response and DDB,7228937,5/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,286218, ,NIA, , ,286218
ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICE,7228951,4/1/1987 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,174086, ,NCI, , ,174086
Molecular Mechanisms of Hormone-independence of Prostate Cancer,7229053,7/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,250280, ,NCI, , ,250280
The role of JNK in Mammary tumor development,7229192,9/29/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2005,154794, ,NCI, , ,154794
Role of the Oxidative Stress Pathway in Drug Resistance,7229446,5/1/2003 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,266404, ,NCI, , ,266404
Regulation of Mdm2 compartmentalization,7229474,5/11/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,226405, ,NCI, , ,226405
Role of TRRAP in the p53-Mediated Transcription of mdm2,7229476,7/1/2003 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,261603, ,NCI, , ,261603
PROHIBITIN GENE IN GROWTH CONTROL AND TUMOR SUPPRESSION,7229494,9/30/1999 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,267428, ,NCI, , ,267428
"A Novel Pathway Involving E2F1, ATM and NBS1",7229507,7/1/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,318565, ,NCI, , ,318565
p38 MAPK in Ras-induced Senescence and Transformation,7229535,7/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,358441, ,NCI, , ,358441
Cancer Biology in the Zebrafish,7229567,7/3/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2007,341771, ,NCI, , ,341771
p53 in Cellular Response to ROS-Mediated DNA Damage,7229589,5/1/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,286708, ,NCI, , ,286708
A flexible somatic and sporadic mouse model for pancreatic ductal adenocarcinoma,7229894,2/1/2006 0:00,7/31/2008 0:00,Non-SBIR/STTR,2007,179878, ,NCI, , ,179878
Characterization:novel genotoxic stress-regulated gene,7229934,3/1/2006 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,184490, ,NIEHS, , ,184490
A Novel Vitamin D Target in Human Prostate Cancer,7230010,3/1/2006 0:00,2/29/2008 0:00,Non-SBIR/STTR,2007,113523, ,NCI, , ,113523
T cell activation and crypt cell apoptosis,7230352,2/15/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,125000, ,NIDDK, , ,125000
The replication checkpoint and genomic fidelity in skin,7230395,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2005,353781, ,NIAMS, , ,353781
The replication checkpoint and genomic fidelity in skin,7230396,6/1/2004 0:00,5/31/2009 0:00,Other Research-Related,2005,43065, ,NIAMS, , ,43065
Function of Human Damaged DNA Binding Protein (DDB),7230487,6/1/2000 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,342575, ,NIGMS, , ,342575
BRCA1 function in  G2-M checkpoint and mitosis,7230557,12/11/1998 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,216896, ,NCI, , ,216896
Expression of Simian Virus 40 T antigens in Intestine,7231473,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2007,308660, ,NCI, , ,308660
Function of the ATR-ATRIP complex,7231481,7/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,254852, ,NCI, , ,254852
Molecular Mechanisms by which Rexinoids Prevent Breast Cancer,7231650,4/6/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,337707, ,NCI, , ,337707
Role of Neuregulin-1 in Schwann Cell Neoplasia,7231947,9/15/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,254350, ,NINDS, , ,254350
Prevention of Estrogen Receptor-negative Breast Cancer,7231999,5/1/2003 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,475923, ,NCI, , ,475923
A PTEN-Dependent Size Checkpoint in Human Cancer Cells,7232030,5/11/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2007,240742, ,NCI, , ,240742
Functional Characterization of the ATM Gene Product,7232068,8/15/1996 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,355567, ,NCI, , ,355567
Perinatal Breast Cancer Programming--Fat and estrogens,7232106,7/1/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,144958, ,NIEHS, , ,144958
Monoclonal Antibody Therapy in B-Cell CLL.,7232662,6/1/2004 0:00,5/31/2009 0:00,Other Research-Related,2007,131814, ,NCI, , ,131814
Diagnostic Therapeutic Targets in Prostate Cancer,7233212,6/12/2003 0:00,7/31/2007 0:00,Non-SBIR/STTR,2007,27693, ,NCI, , ,27693
Functional and Structural Studies of CD74 Activation,7233272,6/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,400538, ,NIAID, , ,400538
Genomic targets of oncoproteins and tumor suppressors,7233677,5/18/2006 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,780607, ,NCI, , ,780607
Endoscopic Therapy of Early Cancer in Barretts Esophagus,7234009,9/16/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,323869, ,NCI, , ,323869
NF Center: From Animal Models to Therapeutics,7234103,9/20/2005 0:00,4/30/2010 0:00,Research Centers,2007,1305442, ,NINDS, , ,1305442
Cell cycle regulatory proteins in UVB-skin carcinogenes,7234141,4/21/2003 0:00,3/31/2009 0:00,Other Research-Related,2007,123660, ,NIAMS, , ,123660
Regulation of the KSHV latent promoter,7234371,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,225602, ,NCI, , ,225602
Role of RHO in Farnesyltransferase Inhibitor Responses,7234448,9/30/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,307211, ,NCI, , ,307211
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION,7234558,7/4/1995 0:00,11/30/2006 0:00,Non-SBIR/STTR,2006,73000, ,NCI, , ,73000
RNA Tumor Virus-Hematopoietic cell Interaction,7234686,6/1/1983 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,317857, ,NCI, , ,317857
Effect of mutant p53 on stress-response,7235315,8/12/2003 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,241182, ,NCI, , ,241182
Phase I/II study of topical agents for chemoprevention,7235690, , ,Non-SBIR/STTR,2006, ,452786, , , , 
Molecular Mechanisms of UVA apotosis  and carcinogenesis,7235691, , ,Non-SBIR/STTR,2006, ,289038, , , , 
Biosynthesis and Hypoxia in Gliomas,7236105, , ,Non-SBIR/STTR,2006, ,106401, , , , 
Stress- and Promoter-Specific Mechanisms of Transcritpional Activation by p53,7236656,5/26/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2007,302728, ,NCI, , ,302728
Prostate Cancer Prevention by n-3 Unsaturated Fatty Acids,7236723,6/28/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,531601, ,NCI, , ,531601
Functional Analysis of p53 Polymorphic Variants,7237222,6/1/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,316480, ,NCI, , ,316480
PAC1 in Signaling Apoptosis and Tumor Suppression,7237286,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,314822, ,NCI, , ,314822
Functional Dissection of Signaling Pathways,7237300,3/11/2004 0:00,5/31/2009 0:00,SBIR/STTR,2007,799825, ,NCI, , ,799825
Nuclear-targeted nanoparticles for gene delivery,7237325,9/1/2005 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,263690, ,NIBIB, , ,263690
FIBRONECTIN REGULATION OF CARCINOMA APOPTOSIS,7237882,9/15/2004 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,308064, ,NIDCR, , ,308064
Role of Parc in the p53 Pathway,7237903,8/15/2004 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,243417, ,NCI, , ,243417
Molecular pathogenesis of UVB-induced skin cancer,7237964,8/15/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,312948, ,NCI, , ,312948
The role of hBUB1-p53 pathway in genomic stability.,7237971,8/1/2003 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,272573, ,NCI, , ,272573
Study of genomic instability caused by HPV16 E6 and E7,7238212,5/1/2004 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,170746, ,NIDCR, , ,170746
Tumor targeted RNAi by novel nanovectors for molecular therapy of prostate cancer,7238432,8/1/2007 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,97280, ,NCI, , ,97280
Chromosome 22q genetic studies in the colon,7238488,3/1/2000 0:00,9/28/2008 0:00,Non-SBIR/STTR,2007,323117, ,NIDDK, , ,323117
Human and Murine Models of BRCA1 Tumorigenesis,7238638,1/7/1998 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,263002, ,NCI, , ,263002
Mouse Models of Human Breast Cancer,7238658,9/30/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,836156, ,NCI, , ,836156
Methylation of the Calcitonin Gene in Human Tumors,7238673,9/30/1986 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,426327, ,NCI, , ,426327
Genomic Methylation: A Mechanism to Alter Tumor Phenotype,7239481,5/1/1996 0:00,7/31/2010 0:00,Non-SBIR/STTR,2007,237671, ,NCI, , ,237671
Regulation of DNA Double-Strand Break Repair,7239485,7/26/2004 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,250163, ,NCI, , ,250163
Prognosis in BRCA1 Associated Breast Cancer,7239486,6/20/2005 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,326746, ,NCI, , ,326746
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,7240501,8/1/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2007,334587, ,NCI, , ,334587
wnt Signaling in Liver Development and Disease,7241456,7/15/2005 0:00,6/30/2010 0:00,Other Research-Related,2007,133920, ,NIDDK, , ,133920
Integration of Oncogenic Networks in Cancer Phenotypes,7242419,9/30/2004 0:00,8/31/2009 0:00,Research Centers,2006,8766, ,NCI, , ,8766
Nitrosourea-induced growth arrest and apoptotic pathways,7242530,8/20/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,217289, ,NCI, , ,217289
Function of Mammalian SIRT1 in Aging,7243376,5/1/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,409821, ,NIA, , ,409821
Genetic and Molecular Epidemiology of Adult Glioma,7243491,5/15/1991 0:00,3/31/2011 0:00,Non-SBIR/STTR,2007,1779888, ,NCI, , ,1779888
The role of selenoproteins in the etiology of cancer,7243506,6/10/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,223970, ,NCI, , ,223970
Elf/Smad4 in Gastrointestinal Cell Proliferation and Cell Cycle Progression,7244447,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,313662, ,NCI, , ,313662
"Breast Cancer, Radiation and the ATM-CHEK2 Pathway",7245108,6/1/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,416842, ,NCI, , ,416842
Klf4 in tumor initiation and maintenance of squamous cell carcinoma,7245988,3/1/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2007,275500, ,NCI, , ,275500
Cell Cycle Check Points,7246099,4/1/2007 0:00,3/31/2012 0:00,Non-SBIR/STTR,2007, ,291100, , , , 
Murine & Human In Vivo Models of Melanoma Formation,7246102,4/1/2007 0:00,3/31/2012 0:00,Non-SBIR/STTR,2007, ,333709, , , , 
Checkpoint Response and Platinum Drug Sensitivity,7246275,5/1/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2007,263340, ,NCI, , ,263340
Regulation of Gene Expression by PML,7246574,9/30/2003 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,286708, ,NCI, , ,286708
Genomic & Genetic Characterization of Amplicons in GBMs,7246663,9/24/2003 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,288607, ,NCI, , ,288607
Mechanisms linking ASPP2 to the Rb/E2F and p53 pathways,7248021,9/1/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,301542, ,NCI, , ,301542
Impact of BRG1 Loss in Lung Cancer Development,7248488,9/27/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,273980, ,NCI, , ,273980
Cellular Senescence and Control of Gene Expression,7248660,9/1/1990 0:00,6/30/2011 0:00,Non-SBIR/STTR,2007,492785, ,NIA, , ,492785
Clinical Investigator Development in Solid Tumor Oncology,7248672,9/1/2000 0:00,6/30/2011 0:00,Other Research-Related,2007,153090, ,NCI, , ,153090
UV and p21 Degradation,7248752,6/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,325281, ,NCI, , ,325281
Role of Slug in Regulation of Hematopietic Stem Cells,7248985,9/10/2007 0:00,7/31/2010 0:00,Other Research-Related,2007,131441, ,NIDDK, , ,131441
Mechanisms of the Hormonal Prevention of Breast Cancer,7249048,8/1/1995 0:00,4/30/2007 0:00,Non-SBIR/STTR,2006,69000, ,NCI, , ,69000
Fast Mutation Detection by Tandem SSCP/HA on Microchips,7249869,9/12/2003 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,235917, ,NCI, , ,235917
Study the Role of Chfr in Tumorigenesis,7250168,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,284382, ,NCI, , ,284382
"Telomeres,  Telomerase and Tumor Progression",7250274,8/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,293771, ,NCI, , ,293771
Functional analysis of signaling to and from p53 in cancer,7250288,9/30/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,258227, ,NCI, , ,258227
Full Project 1: Tumor-targeted MR Contrast Enhancement Using Molecular Imaging Te,7250610,12/1/2006 0:00,8/31/2011 0:00,Research Centers,2006, ,81062, , , , 
Role of H2AX and ATM in Suppression of Thymic Lymphomas,7250863, , ,Non-SBIR/STTR,2006, ,411047, , , , 
Restoration of Tumor Suppression Activity in Malignant Melanoma,7250875,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,486085, ,NCI, , ,486085
Mechanisms of tumor promotion and carcinogenesis,7251082,1/1/1994 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,15000, ,NCI, , ,15000
Training in Molecular Basis of Skin Pathobiology,7251424,6/1/2004 0:00,5/31/2009 0:00,"Training, Institutional",2007,254571, ,NCI, , ,254571
The replication checkpoint and genomic fidelity in skin,7251485,6/1/2004 0:00,5/31/2009 0:00,Other Research-Related,2007,99792, ,NIAMS, , ,99792
Glucocorticoids & Vitamin D: Role in Antitumor Effects,7251489,2/1/2000 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,372262, ,NCI, , ,372262
Mechanisms of SAG Inhibition of Carcinogenesis & Apoptosis,7251511,9/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,261886, ,NCI, , ,261886
Breast Carcinoma In-Situ: Mammographic Risk Factors,7251931,6/1/2004 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,295329, ,NCI, , ,295329
Markers of Early Pancreatic Cancer,7251940,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,282587, ,NCI, , ,282587
Translation of tumor suppressor genes to lung cancer the,7251950, , ,Research Centers,2006, ,308700, , , , 
Selenium and prostate cancer apoptosis pathways,7251981,9/1/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,233253, ,NCI, , ,233253
Role of sestrin family genes in antioxidant defense,7252511,9/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,292988, ,NIA, , ,292988
Bioflavonoid apigenin induces phosphorylation of p53,7252609,3/10/2003 0:00,2/28/2010 0:00,Other Research-Related,2007,155004, ,NCI, , ,155004
ATM Regulation via PP2A and Ceramide,7252898,3/1/2007 0:00,9/30/2011 0:00,Non-SBIR/STTR,2007,203000, ,NIGMS, , ,203000
Mechanisms of Particulate Matter Induced Death,7253148,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,338655, ,NIEHS, , ,338655
A Functional Census of p53 Cancer and Suppressor Mutants,7253241,8/1/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,333814, ,NCI, , ,333814
Epigenetic factors governing SOD2 gene expression,7253330,4/6/1998 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,248945, ,NCI, , ,248945
Molecular Pathogenesis of Breast Cancer,7253334,4/18/2003 0:00,9/29/2009 0:00,Non-SBIR/STTR,2007,2574847, ,NCI, , ,2574847
Biomarkers of Prostate Cancer Radiation Outcome,7253362,4/6/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,266796, ,NCI, , ,266796
p53-mediated control of numeral integrity of centrosomes,7253398,4/1/2001 0:00,5/31/2008 0:00,Non-SBIR/STTR,2007,246421, ,NCI, , ,246421
Mechanisms of Radioresistance and Cell Cycle Progression,7253627,5/1/1995 0:00,9/27/2007 0:00,Non-SBIR/STTR,2006,104545, ,NIGMS, , ,104545
"Diet, DNA Repair Genes and Breast Cancer Risk",7253716,9/27/2005 0:00,8/31/2009 0:00,Other Research-Related,2006,114923, ,NCI, , ,114923
The San Francisco Bay Area Adult Glioma Survival Study,7253800,5/1/2007 0:00,4/30/2012 0:00,Research Centers,2007, ,321228, , , , 
Normal and Neoplastic Regulation of Cyclin E,7253916,7/1/2003 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,364978, ,NCI, , ,364978
Effect of caffeine on UVB-induced skin cancer,7254150,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,273412, ,NCI, , ,273412
Genetic Control of Susceptibility to Testicular Cancer,7254184,6/1/1998 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,453388, ,NCI, , ,453388
"Chemosensitization of Pancreatic Tumors via Inhibition of a DNA BER Enzyme, Ape1",7254589,5/1/2007 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,151500, ,NCI, , ,151500
Mechanism of Redox Regulation by Ape1/Ref-1,7254734,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,235002, ,NCI, , ,235002
Molecular Mechanism of E2F Specificity,7254923,9/30/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,324894, ,NCI, , ,324894
Prospective Studies of Diet and Cancer in Men and Wonen,7255066,8/23/1991 0:00,11/30/2006 0:00,Non-SBIR/STTR,2006,490980, ,NCI, , ,490980
Association of inflammatory genes and prostate cancer,7255604,9/24/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,437498, ,NCI, , ,437498
Progesterone-mediated protection against ovarian cancer,7255653,9/1/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,258707, ,NCI, , ,258707
Modeling ovarian carcinoma by defined genetic alterations,7255706,9/1/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,266292, ,NCI, , ,266292
Studies of p53 and Amyloidogenic Proteins,7255718, , ,Other Research-Related,2006, ,191209, , , , 
Inhibition of the TNF Apoptotic Pathway by HPV 16 E6,7256460,9/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,273418, ,NCI, , ,273418
Differential Regulation of p53 function by Lysine Acetylation,7257003,7/6/2006 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,82292, ,NCI, , ,82292
Role and therapeutical potential of Cdk4/6 in B-lymphoma,7257010,7/10/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,190886, ,NCI, , ,190886
BK Virus as a Co-Factor in Prostate Cancer,7257449,8/1/2007 0:00,7/31/2010 0:00,Non-SBIR/STTR,2007,285198, ,NCI, , ,285198
Functional studies of the top 1-binding protein topors,7257471,5/1/1999 0:00,7/31/2008 0:00,Non-SBIR/STTR,2006,68420, ,NCI, , ,68420
p53-Independent Pathways in Mdm2-Mediated Transformation,7257504,4/9/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2007,302560, ,NCI, , ,302560
Chromosome instability resulting from double-strand breaks near telomeres,7257814,7/6/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,238816, ,NCI, , ,238816
Salivary Acinar Cell Apoptosis: Regulation of p53 by Akt,7257889,7/7/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2007,354642, ,NIDCR, , ,354642
CPEB and Cell Senescence,7258286,4/1/2007 0:00,3/31/2012 0:00,Non-SBIR/STTR,2007,333125, ,NIA, , ,333125
Biology of Breast Cancers Arising in Older Women,7258976,8/1/2003 0:00,7/31/2010 0:00,Non-SBIR/STTR,2007,558296, ,NIA, , ,558296
Methylation in Cancer Progression of Barrett's Esophagus,7259338,7/20/2006 0:00,6/30/2011 0:00,Other Research-Related,2007,133850, ,NIDDK, , ,133850
Epithelial Positioning Organization and Ovarian Cancer,7259346,3/1/2002 0:00,11/1/2007 0:00,Non-SBIR/STTR,2007,225090, ,NCI, , ,225090
Chemoprevention Through Activation of Estrogen Receptor Alpha-Induced Senescence,7259375,7/11/2006 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,73553, ,NCI, , ,73553
Cellular Senescence in Aging and Cancer,7259525,8/4/1999 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,450243, ,NCI, , ,450243
Somatic genetic predictors of response to therapy in metastatic melanoma,7259563,9/13/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,314179, ,NCI, , ,314179
Cooperation of oncogenic mutations in the control of malignancy,7259967,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,292600, ,NCI, , ,292600
Minority Predoctoral Fellowship Program,7260290,7/2/2004 0:00,7/1/2009 0:00,"Training, Individual",2007,28199, ,NCI, , ,28199
Repair of Endogenous Damage in Mammalian Genomes,7260309,2/11/1991 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,231436, ,NCI, , ,231436
A Pathway of Tumor Suppression,7260507,7/1/1988 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,236943, ,NCI, , ,236943
Hepatitis HBx-Mediated Pathogenesis,7260515,7/1/2003 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,285759, ,NCI, , ,285759
Cooperation of PTEN and SHIP as tumor suppressors in B-Cells,7260559,9/30/2007 0:00,8/31/2012 0:00,Other Research-Related,2007,105460, ,NCI, , ,105460
Recognition and Presentation of Alpha Helices using Nanoparticle Receptors,7260749,3/8/2007 0:00,2/28/2011 0:00,Non-SBIR/STTR,2007,261530, ,NIGMS, , ,261530
Transcriptional Activator/Coactivator Interactions,7260950,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,343084, ,NCI, , ,343084
UV regulation of anti-apoptotic co-repressor CtBP,7261124,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,292600, ,NCI, , ,292600
Reversing Electrostatic Interactions for Improved Gene Delivery,7261234,7/14/2006 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,348583, ,NIBIB, , ,348583
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors,7261263,8/5/2003 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,208737, ,NCI, , ,208737
Soft Tissue Sarcoma Program Project,7261327,5/16/1997 0:00,6/30/2011 0:00,Non-SBIR/STTR,2007,1718617, ,NCI, , ,1718617
Cutaneous Biology KIT Ligand,7261475,1/1/1997 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,294000, ,OD, , ,294000
Hormonal regulation of p53 activity in mammary tissue,7261571,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2006,45899, ,NCI, , ,45899
Regulation and Function of C/EBP in UVB Responses,7261612,1/3/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2006,21869, ,NIEHS, , ,21869
Role of Prdx 1 in Natural Killer Cells and Tumorigenesis,7261896,9/2/2005 0:00,7/31/2008 0:00,Other Research-Related,2007,105462, ,NIEHS, , ,105462
Determination of regulatory mechanisms for BLM helicase,7261942,8/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,51202, ,NCI, , ,26087
Characterization of the p53 Apoptotic Target Gene Perp,7262168,1/1/2002 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,283177, ,NCI, , ,283177
SV40 st induced cell transformation via PP2A inhibition,7262426,7/1/2006 0:00,6/30/2008 0:00,"Training, Individual",2007,48796, ,NCI, , ,48796
Generation of a faithful mouse model of Li Fraumeni Syndrome,7262528,9/1/2005 0:00,4/30/2008 0:00,"Training, Individual",2007,22139, ,NIGMS, , ,22139
Mustard Gas Exposure and Carcinogenesis of the Lung,7262617,7/18/2006 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,133571, ,NIEHS, , ,133571
Activation of checkpoint pathways in cancer,7263049,7/19/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,186141, ,NCI, , ,186141
Role of the chronic inflammatory mediator NO in early mammary tumorigenesis,7263116,8/1/2006 0:00,7/31/2009 0:00,Other Research-Related,2007,147766, ,NCI, , ,147766
ECM-Mediated Apoptosis in p53 (-) HMECs,7263127,7/1/2000 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,347191, ,NCI, , ,347191
Mechanisms of tumor suppression by Fbw7,7263137,7/26/2006 0:00,6/30/2011 0:00,Other Research-Related,2007,140535, ,NCI, , ,140535
Physical and Functional Interactions Between PML & MDM2,7263223,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,227742, ,NCI, , ,227742
Discovering TREX1 and TREX2 Function in Mammalian Cells and Mice,7263286,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,277400, ,NCI, , ,277400
Nuclear Accumulation of Cyclin D1 and Oncogenesis,7263299,7/1/2001 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,301746, ,NCI, , ,301746
Growth Control and Anti-Cancer Mechanisms,7263307,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,295450, ,NCI, , ,295450
Structure and function of the U3 RNA-protein complex,7263671,4/1/2007 0:00,3/31/2011 0:00,Non-SBIR/STTR,2007,288800, ,NIGMS, , ,288800
Regulation of p53 function by Daxx,7263774,5/3/2001 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,253024, ,NCI, , ,253024
Mechanisms of cyclin E associated tumorigenesis,7263987,7/1/2003 0:00,8/31/2007 0:00,Other Research-Related,2007,32975, ,NCI, , ,32975
Molecular targeting of the survivin pathway in cancer,7264004,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,288775, ,NCI, , ,288775
p53 and pathways of apoptosis,7264316,8/7/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,299250, ,NCI, , ,299250
Use of Beta-Lapachone for Lung Cancer Chemotherapy,7264602,8/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,331223, ,NCI, , ,331223
" Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma",7264669,5/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,274719, ,NCI, , ,274719
Intracellular Mechanisms of Glucocorticoid Action,7264856,7/1/1986 0:00,6/30/2012 0:00,Non-SBIR/STTR,2007,273625, ,NIDDK, , ,273625
"PDRG, a novel p53 and DNA damage-regulated gene and colorectal cancer",7265025,5/18/2007 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,235000, ,NIEHS, , ,235000
Functional analysis of the p53 tumor suppressor,7265192,8/15/1985 0:00,7/31/2008 0:00,Non-SBIR/STTR,2007,204049, ,NCI, , ,204049
Characterization of a putative GTP-binding protein as a novel tumor marker.,7266108,6/12/2007 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,78333, ,NCI, , ,78333
Cell fate decision in response to p53-dependent DNA damage/genotoxic stress,7266154,1/1/2000 0:00,12/31/2011 0:00,Non-SBIR/STTR,2007,273221, ,NCI, , ,273221
Development of Statistical Approaches Allowing for Genetic Covariates,7266172,4/1/2007 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,77000, ,NCI, , ,77000
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS,7266316,9/22/1981 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,564298, ,NCI, , ,564298
Regulation of esophageal epithelial biology,7266337,8/1/2005 0:00,7/31/2008 0:00,Other Research-Related,2007,134649, ,NIDDK, , ,134649
THE THERAPY OF AML,7266430,5/27/1997 0:00,8/31/2012 0:00,Non-SBIR/STTR,2007,2404845, ,NCI, , ,2404845
Cell Survival and Death in Oxidant Lung Injury,7266475,7/1/2002 0:00,3/31/2011 0:00,Non-SBIR/STTR,2007,385000, ,NHLBI, , ,385000
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer,7266500,3/7/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2007,311283, ,NCI, , ,311283
Etiologic Role of HPV in Keratinocyte Carcinomas,7266514,5/1/2007 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,321986, ,NCI, , ,321986
PROGNOSTIC & PREDICTIVE  FACTORS IN OUTCOME OF PATIENTS WITH COLORECTAL CANCER:,7266880, , ,Research Centers,2006, ,160327, , , , 
MOLECULAR CHANGES IN THE NKFB PATHWAY IN RESPONSE TO CHEMORADIATION THERAPY IN RE,7266881, , ,Research Centers,2006, ,203950, , , , 
The role of Met proto-oncogene in breast tumorigenesis,7266997,8/1/2005 0:00,7/31/2008 0:00,"Training, Individual",2007,53992, ,NCI, , ,53992
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction,7267049,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,268298, ,NCI, , ,268298
A Nested Case-Control Study of Prostate Carcinogenesis,7267538,9/30/2000 0:00,2/28/2012 0:00,Non-SBIR/STTR,2007,609939, ,NIEHS, , ,609939
Fast Mutation Detection by Tandem SSCP/HA on Microchips,7267709,9/12/2003 0:00,8/31/2007 0:00,Non-SBIR/STTR,2007,62554, ,NCI, , ,62554
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHN,7267742, , ,Research Centers,2006, ,153880, , , , 
SPORE in Head and Neck Cancer,7267746,7/1/2004 0:00,6/30/2009 0:00,Research Centers,2007,2184766, ,NCI, , ,2184766
Control of Sir2 by Nuclear NAD Salvage Pathways,7267771,8/1/2005 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,244191, ,NIGMS, , ,244191
Elucidate the role of p63 in prostate cancer progression,7267959,7/13/2006 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,132372, ,NCI, , ,132372
Disruption of TGF-beta pathway in mouse pancreatic cancer development,7268148,8/1/2006 0:00,7/31/2008 0:00,Non-SBIR/STTR,2007,195652, ,NCI, , ,195652
Targeting Cell Cycle Checkpoints in Cancer Therapeutics,7268782,8/1/2006 0:00,7/31/2011 0:00,Other Research-Related,2007,133893, ,NCI, , ,133893
Center for digestive and liver diseases,7269118,7/1/1998 0:00,6/30/2012 0:00,Research Centers,2007,1145813, ,NIDDK, , ,1145813
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors,7269241,7/31/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,277591, ,NCI, , ,277591
Role of damaged DNA binding protein (DDB) in checkpoint control & carcinogenesis,7269288,1/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,257597, ,NCI, , ,257597
Molecular Mechanisms of Lymphomagenesis,7269520,8/1/2006 0:00,7/30/2010 0:00,Non-SBIR/STTR,2007,289553, ,NCI, , ,289553
Imaging Lung Cancer in Mice To Improve Radiation Therapy,7269833,8/3/2005 0:00,7/31/2010 0:00,Other Research-Related,2007,130329, ,NCI, , ,130329
RAS INDUCED SENESCENCE AND TUMOR PROGRESSION,7270003,7/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,405752, ,NIA, , ,405752
Polo-like Kinase Functions in Normal and Tumor Cells,7270004,9/1/2000 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,468964, ,NIGMS, , ,468964
Targeting Regulators of Apoptosis in AML,7270264,4/1/2007 0:00,3/31/2012 0:00,Non-SBIR/STTR,2007, ,345826, , , , 
Prevention of quinone toxicity and mutagenicity,7270449,8/1/1996 0:00,7/31/2010 0:00,Non-SBIR/STTR,2007,337789, ,NIEHS, , ,337789
T-Cell Defined Oral Carcinoma Antigens,7270531, , ,Non-SBIR/STTR,2006, ,157030, , , , 
Development of P53-Based Vaccines for Oral Cancer,7270532, , ,Non-SBIR/STTR,2006, ,146616, , , , 
Cyclin B-1 As a Tumor-specific Antigen in Oral Carcinoma,7270533, , ,Non-SBIR/STTR,2006, ,145720, , , , 
CORE--TISSUE PROCUREMENT/DC LABORATORY,7270534, , ,Non-SBIR/STTR,2006, ,110670, , , , 
CORE--CLINICAL SUPPORT/BIOSTATISTICS,7270535, , ,Non-SBIR/STTR,2006, ,88198, , , , 
Transcriptional Repression by CtBP at the p21 Promoter,7271331,7/1/2005 0:00,6/30/2010 0:00,Other Research-Related,2007,137700, ,NCI, , ,137700
15-Lipoxygenase 2 is a Prostate Senescence Gene,7271336,9/1/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,280138, ,NIA, , ,280138
Mouse Models of Human Breast Cancer,7271739,9/30/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2006,40758, ,NCI, , ,40758
Translational Control by elF2 Kinase during ER Stress,7271914,8/1/2001 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,265611, ,NIGMS, , ,265611
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer,7271972,8/4/2006 0:00,6/30/2011 0:00,Other Research-Related,2007,141750, ,NCI, , ,141750
Hypoxia signaling to checkpoint activation and apoptosis,7272050,8/4/2006 0:00,7/30/2011 0:00,Non-SBIR/STTR,2007,267266, ,NCI, , ,267266
"Identification of Novel, Drug-like Inhibitors of Hsp90",7272121,9/30/2007 0:00,8/31/2009 0:00,SBIR/STTR,2007,235600, ,NCI, , ,235600
Minority Predoctoral Fellowship Program,7272811,8/1/2004 0:00,7/31/2009 0:00,"Training, Individual",2007,40690, ,NCI, , ,40690
The Role of P40 in Squamous Cell Carcinomas,7273492,12/1/1999 0:00,8/31/2010 0:00,Non-SBIR/STTR,2007,332385, ,NIDCR, , ,332385
HPV E6 protein regulation of the hTERT promoter,7274152,9/16/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,297995, ,NCI, , ,297995
Actin-regulated Apoptosis in Mammary Tumorigenesis,7274182,8/1/2003 0:00,7/31/2008 0:00,Other Research-Related,2007,161730, ,NCI, , ,161730
A polymorphism in the Mdm2 promoter enhances cancer risk,7275334,7/20/2006 0:00,8/19/2007 0:00,"Training, Individual",2007,4337, ,NCI, , ,4337
Role of the STK Receptor in Erythropoiesis,7275357,12/1/2000 0:00,7/31/2010 0:00,Non-SBIR/STTR,2007,299277, ,NHLBI, , ,299277
An Exploratory Study of UCN-01 and Irinotecan in Advanced Triple Negative Breast,7275903,9/24/2007 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,278385, ,NCI, , ,278385
Regulation of MDM2 by the ribosomal protein L11,7275907,8/1/2003 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,308017, ,NCI, , ,308017
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein,7276563,9/30/1992 0:00,5/31/2008 0:00,Non-SBIR/STTR,2007,245889, ,NCI, , ,245889
Timing of Rectal Cancer Response to Chemoradiation,7276761,9/16/2003 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,647788, ,NCI, , ,647788
Mechanisms of transcriptional repression by p53 during hypoxic stress,7276847,12/1/2007 0:00,11/30/2010 0:00,"Training, Individual",2007,52898, ,NCI, , ,52898
Control of p53 function by Mdm2 E3 ubiquitin ligase,7276868,7/1/2007 0:00,6/30/2010 0:00,"Training, Individual",2007,52898, ,NCI, , ,52898
Cellular Consequences of Snf5 Tumor Suppressor Loss,7276908,7/1/2007 0:00,6/30/2010 0:00,"Training, Individual",2007,52898, ,NCI, , ,52898
p53 - Regulators and Effectors,7277296,2/16/2000 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,1335182, ,NCI, , ,1335182
SIGNALING PATHWAYS REGULATING EPITHELIAL CELL SURVIVAL,7277593,5/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,213341, ,NIDDK, , ,213341
Bladder Cancer Prognostic Indicators,7277612,9/1/2005 0:00,8/31/2010 0:00,Other Research-Related,2007,144180, ,NCI, , ,144180
EARLY DETECTION OF URINARY BLADDER CANCER,7277613,9/30/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,513620, ,NCI, , ,513620
Pathways of Bladder Tumorgenesis,7277696, , ,Non-SBIR/STTR,2006, ,310073, , , , 
Molecular Epidemiology of Colorectal Cancer Subtypes,7277762,9/15/2005 0:00,6/30/2011 0:00,Non-SBIR/STTR,2007,140450, ,NCI, , ,140450
Chemoprevention of Oral Cancer with BBIC,7278200,3/14/1997 0:00,8/31/2011 0:00,Non-SBIR/STTR,2007,439408, ,NCI, , ,439408
Roles and Regulation of p53,7278246,9/30/2000 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,1583080, ,NCI, , ,1583080
Regulation of Irreversible Growth Arrest by p53,7278650,4/1/2003 0:00,3/31/2008 0:00,Non-SBIR/STTR,2007,229022, ,NCI, , ,229022
The replication checkpoint and genomic fidelity in skin,7278730,9/1/2003 0:00,3/31/2010 0:00,Non-SBIR/STTR,2007,316960, ,NIAMS, , ,316960
The role of JNK in Mammary tumor development,7279893,9/29/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,278349, ,NCI, , ,278349
Function of the Adenovirus E1B Oncogene,7279925,1/1/1991 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,306291, ,NCI, , ,306291
Genomic Instability and Senescence in Cancer,7280320,9/14/2005 0:00,8/31/2010 0:00,Other Research-Related,2007,130262, ,NCI, , ,130262
P53 Biomark er and Intervention in Occupational Cancer,7280321,7/1/2006 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,239637, ,NIOSH, , ,239637
Molecular Epidemiology Of Ovarian Cancer,7280504,9/1/1998 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,526618, ,NCI, , ,526618
Molecular Targets for Drug and Radiation Sensitivity,7280510,8/17/1998 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,1326588, ,NCI, , ,1326588
Development of Selectors for Cancer Mutation Analysis,7280527,8/10/2007 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,236750, ,NCI, , ,236750
SPORE in Head and Neck Cancer,7281105,7/1/2004 0:00,6/30/2009 0:00,Research Centers,2006,200000, ,NCI, , ,200000
Gene Expression Profiles in Human Liver Cancers,7281612,9/11/2003 0:00,8/31/2009 0:00,Other Research-Related,2007,148770, ,NCI, , ,148770
Molecular Analysis of Esophageal Cancer Survival,7281994,7/3/2003 0:00,6/30/2008 0:00,Other Research-Related,2007,135837, ,NCI, , ,135837
Mechanisms Regulating Reversal of Malignancy,7282068,8/30/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,199529, ,NCI, , ,199529
Regulation of the KSHV latent promoter,7282904,8/1/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2006,100000, ,NCI, , ,100000
Biomarkers of Heavy Metal Exposure Related to Pancreatic Cancer Genetic Mutations,7283033,9/1/2006 0:00,7/31/2010 0:00,Non-SBIR/STTR,2007,73248, ,NCI, , ,73248
Diet and Somatic Mutations in Colon Cancer,7283047,8/1/1995 0:00,8/31/2010 0:00,Non-SBIR/STTR,2007,485047, ,NCI, , ,485047
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER,7283054,9/1/2003 0:00,8/31/2011 0:00,Non-SBIR/STTR,2007,251476, ,NCI, , ,251476
Tumor Host Range Mutants of Polyoma and Their Targets,7283116,9/1/2001 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,597353, ,NCI, , ,597353
Stem Cells and Gastric Cancer,7283238,9/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,445533, ,NCI, , ,445533
SPORE in Head and Neck Cancer,7283517,7/1/2004 0:00,6/30/2009 0:00,Research Centers,2006,88643, ,NCI, , ,88643
Imidodipeptides and Amino Acid Metabolites in Cell Regulation and Carcinogenesis,7283948, , ,Intramural Research,2005, , , , , , 
T-Cell Antigen Recognition and Tumor Antigens,7283954, , ,Intramural Research,2005, , , , , , 
GENETIC ALTERATION IN THE EPITHELIAL AND STROMAL,7284174, , ,Non-SBIR/STTR,2006, ,293658, , , , 
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER,7284738,9/1/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2006,82880, ,NCI, , ,82880
Structural basis of signaling by ING2 PHD,7284905,9/6/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,196348, ,NCI, , ,196348
Comparative Bioinformatics and TP53 Expression,7284996,9/30/2005 0:00,9/29/2010 0:00,Other,2007,277041, ,NLM, , ,277041
Control of Retrovirus CNS Disease by redox modulation,7285393,6/18/2002 0:00,1/31/2011 0:00,Non-SBIR/STTR,2007,395579, ,NINDS, , ,395579
Nitric oxide eluting therapies for vascular surgery,7285701,9/15/2006 0:00,6/30/2011 0:00,Other Research-Related,2007,127358, ,NHLBI, , ,127358
Pre-Clinical Evaluation of Novel Therapeutics for PDA,7285867,3/25/2007 0:00, ,"Training, Individual",2006,7000, ,NCI, , ,7000
Lineage Tracy in Murine Pancreatic Cancer Metastasis,7285881,3/21/2007 0:00, ,"Training, Individual",2006,7000, ,NCI, , ,7000
Paradoxical Effects of Bax and Bcl-2 on Oncogenesis,7286147,9/26/2003 0:00,9/25/2007 0:00,"Training, Individual",2006,28202, ,NCI, , ,28202
Chemoprevention Potential of Calpain Inhibitors,7286351,9/15/2006 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,70883, ,NCI, , ,70883
Mouse Medel of Esophageal Adenocarcinoma,7286650,9/15/2006 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,58754, ,NCI, , ,58754
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,7286687,5/1/1997 0:00,8/31/2011 0:00,Non-SBIR/STTR,2007,1379869, ,NCI, , ,1379869
Targeting RhoA Lymphomagenesis,7286691,9/15/2006 0:00,8/31/2008 0:00,Non-SBIR/STTR,2007,72825, ,NCI, , ,72825
Nitroaromatics and Breast Cancer,7287062,7/1/1983 0:00,8/31/2007 0:00,Non-SBIR/STTR,2006,143420, ,NCI, , ,143420
Integration of Oncogenic Networks in Cancer Phenotypes,7287716,9/30/2004 0:00,8/31/2009 0:00,Research Centers,2007,2106993, ,NCI, , ,2106993
An ORFeome fusion library approach to studying ubiquitylation,7288683,7/10/2006 0:00,7/31/2007 0:00,"Training, Individual",2007,2438, ,NCI, , ,2438
Cancer Risk and Environmental Exposures,7288869, , ,Intramural Research,2005, , , , , , 
Molecular Genetic Epidemiology of Primary Hepatocellular,7288880, , ,Intramural Research,2005, , , , , , 
Genetic Predisposition to Aflatoxin-Induced Hepatocellul,7288887, , ,Intramural Research,2005, , , , , , 
Studies of Rare Cancers,7288897, , ,Intramural Research,2005, , , , , , 
Gene Regulation and Function: The B-ZIP Proteins,7288933, , ,Intramural Research,2005, , , , , , 
Self-Renewal of Normal and Leukemic Stem Cells,7289310,9/20/2004 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,282663, ,NCI, , ,282663
Genetic Epidemiology of Melanoma,7289337,9/30/2001 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,1022023, ,NCI, , ,1022023
Analysis of Pathways that Suppress or Accelerate Premali,7289376, , ,Intramural Research,2005, , , , , , 
Regulation of papillomavirus gene expression,7289380, , ,Intramural Research,2005, , , , , , 
P53-dependent responses to toxicants in parous and nulliparous breast,7289413,9/7/2007 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,382403, ,NIEHS, , ,382403
Screen for TIP60 Inhibitors,7289666,9/30/2007 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,189375, ,OD, , ,189375
"Dysfunctional Telomeres, Checkpoints and Aging",7289887,9/30/2006 0:00,8/31/2011 0:00,Non-SBIR/STTR,2007,277187, ,NIA, , ,277187
Viral Model for Tumor Pathogenesis in Brain,7290350,9/30/1996 0:00,5/31/2008 0:00,Non-SBIR/STTR,2007,909402, ,NINDS, , ,909402
The Environment and Epigenetic Gene Silencing in Cancer,7290364,9/30/2006 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,696018, ,NIEHS, , ,696018
Studies of Histone Functions in Chromatin; H2AX and DNA,7290494, , ,Intramural Research,2005, , , , , , 
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targ",7290495, , ,Intramural Research,2005, , , , , , 
Genotyping Molecular Signatures of CRC using Polymer Microchip-CE and FSCE,7290605,8/6/2007 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,190310, ,NCI, , ,190310
Peptide-based Inhibitors of HDM2 Protein and Integrase,7290829, , ,Intramural Research,2005, , , , , , 
Mechanisms of Genetic Instability and Tumor Suppression,7290983,7/1/1993 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,517915, ,NCI, , ,517915
Regulation of EGFR Gene Activity,7291135, , ,Intramural Research,2005, , , , , , 
Role of p53 and ptc tumor suppressive pathways in BCCs development and prevention,7291657,9/30/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,319725, ,NIEHS, , ,319725
Role of CEBP transcription factors in regulating cell gr,7291710, , ,Intramural Research,2005, , , , , , 
Design of Drugs Against Cancer and Viral Diseases,7291738, , ,Intramural Research,2005, , , , , , 
The Genetics of Susceptibility to Mouse Plasma Cell Tumo,7291743, , ,Intramural Research,2005, , , , , , 
Inflammation and Cancer,7291773, , ,Intramural Research,2005, , , , , , 
Molecular Mechanisms of Growth Factor Modulated Prolifer,7291797, , ,Intramural Research,2005, , , , , , 
DNA Repair,7291824, , ,Intramural Research,2005, , , , , , 
Identification of Modifier Gene of Tumors Associated wit,7291902, , ,Intramural Research,2005, , , , , , 
Molecular Mechanisms of Proliferation and Infiltration o,7291904, , ,Intramural Research,2005, , , , , , 
Development of Mouse Astrocytoma Model for Preclinical T,7291906, , ,Intramural Research,2005, , , , , , 
p53 and its cancer-causing mutants,7291942, , ,Intramural Research,2005, , , , , , 
The Use of Cancer Vaccines and Combination Therapies,7291944, , ,Intramural Research,2005, , , , , , 
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,7291977,8/1/2003 0:00,5/31/2008 0:00,Non-SBIR/STTR,2006,132595, ,NCI, , ,132595
Molecular Pathology of Pulmonary Carcinogenesis,7291988, , ,Intramural Research,2005, , , , , , 
The Molecular Genetics of Gynecologic Cancers,7291990, , ,Intramural Research,2005, , , , , , 
Nitric Oxide as a Modifier of Oxidative Stress,7292044, , ,Intramural Research,2005, , , , , , 
Role of HSP90 Family Chaperone Proteins in Cellular Sign,7292064, , ,Intramural Research,2005, , , , , , 
Consequences of chromosomal aneuploidy on the cancer,7292083, , ,Intramural Research,2005, , , , , , 
Gene expression and post-transcriptional regulation of o,7292089, , ,Intramural Research,2005, , , , , , 
Regulation of the cell cycle by cyclin-dependent kinases,7292096, , ,Intramural Research,2005, , , , , , 
Molecular Genetic Basis for Gynecologic Neoplasias,7292167, , ,Intramural Research,2005, , , , , , 
Modulation of radiosensitivity in zebrafish,7292180,9/12/2005 0:00,9/11/2009 0:00,"Training, Individual",2006,36001, ,NCI, , ,36001
Lipid peroxidation product induced DNA damage in the p53 gene and liver cancer,7292703,9/28/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,349525, ,NIEHS, , ,349525
Murine Neuroblastoma Models for Preclinical Therapeutics,7292826,7/1/2003 0:00,7/31/2011 0:00,Non-SBIR/STTR,2007,260988, ,NCI, , ,260988
Intracellular protein degradation is a major post-transl,7292877, , ,Intramural Research,2005, , , , , , 
Cancer Vaccines and Modulation of Checkpoint Controls in,7292922, , ,Intramural Research,2005, , , , , , 
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS,7293524,7/12/2002 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,502200, ,NCI, , ,502200
Modulation of radiosensitivity in zebrafish,7293559,9/12/2005 0:00,9/11/2009 0:00,"Training, Individual",2007,37166, ,NCI, , ,37166
Mouse Model of Pancreatic Cancer Progression-Maintenance,7294260,9/21/2005 0:00,8/31/2010 0:00,Other Research-Related,2007,160920, ,NCI, , ,160920
Genetic alterations of KLF4 in human pancreatic cancer,7294330,9/27/2006 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,67290, ,NCI, , ,67290
Integral activity of the p53 family and its role in progression of colon tumors,7295071,9/18/2007 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,181118, ,NCI, , ,181118
Clinical Activity of 17-AAG in Lymphoma,7295716,9/29/2006 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,212338, ,NCI, , ,212338
Ultra Fast and Sensitive Fluorescence-Based Clinical Assays,7296106,7/1/2008 0:00,6/30/2012 0:00,Other Research-Related,2008,127440, ,NIBIB, , ,127440
Breast Cancer Prevention by Dietary Phytochemicals,7297476,9/7/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,282150, ,NCI, , ,282150
Telomere induced senescence as a supressor of tumorigenesis,7298033,8/8/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,292600, ,NCI, , ,292600
"HPV: Biology, Clinical Significance and Epidemiology",7298629,6/1/1997 0:00,6/30/2012 0:00,Non-SBIR/STTR,2007,1958158, ,NCI, , ,1958158
Mechanisms of p53 target gene activation in DNA damage responses,7299807,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,729461, ,NCI, , ,729461
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS,7300321,7/1/2007 0:00,6/30/2012 0:00,Non-SBIR/STTR,2007, ,378962, , , , 
The Role of Bcl2L12 in the Genesis of Malignant Glioma,7301147,8/17/2007 0:00,6/30/2009 0:00,Other Research-Related,2007,90000, ,NCI, , ,90000
Study the Role of Chfr in Tumorigenesis,7302876,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2006,287301, ,NCI, , ,287301
Analysis of 53BP1 function in DNA Damage-signaled pathway and Tumorigenesis,7302914,5/9/2003 0:00,4/30/2011 0:00,Non-SBIR/STTR,2006,253716, ,NCI, , ,253716
Cell and tumor genetics of mitotic arrest checkpoints,7303115,2/1/2000 0:00,2/28/2010 0:00,Non-SBIR/STTR,2006,10872, ,NCI, , ,10872
Pre-Clinical Evaluation of Novel Therapeutics for PDA,7303124,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2007,41796, ,NCI, , ,41796
Lineage Tracy in Murine Pancreatic Cancer Metastasis,7303128,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2007,43428, ,NCI, , ,43428
Regulatory Networks in Human Embryonic Stem Cells,7303597,9/1/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2007,1866043, ,NIGMS, , ,1866043
Genomic Profiling and clinical Outcome in Chronic Lymphocytic Leukemia,7303648,7/1/2007 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,182400, ,NCI, , ,182400
Regulation of the p53 gene during osteoblast differentiation.,7304507,9/1/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2007,209995, ,NIAMS, , ,209995
The meiotic role of dtopors in male Drosophila,7304661,7/1/2007 0:00,6/30/2011 0:00,Non-SBIR/STTR,2007,209250, ,NIGMS, , ,209250
Cyclins and Cyclin-dependent kinases as targets for protection against radiation-,7310402, , ,Non-SBIR/STTR,2006, ,268833, , , , 
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2,7310821, , ,Non-SBIR/STTR,2006, ,231869, , , , 
Effectors of p53 Pro-Survival & Pro-Apoptotic Signaling,7311073, , ,Non-SBIR/STTR,2006, ,323903, , , , 
Molecular Interactions and Regulation of p53,7311074, , ,Non-SBIR/STTR,2006, ,193556, , , , 
p53 Pathway in Postnatal Growth and Stem Cell Behavior,7311075, , ,Non-SBIR/STTR,2006, ,200270, , , , 
Cancer cell telomere dynamics and responses to perturbations,7313047,9/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,302453, ,NCI, , ,302453
p53 signatures and pelvic serous carcinoma,7313083,9/20/2007 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,171341, ,NCI, , ,171341
Activating liver carcinogens in yeast by expressing CYP450 polymorphisms,7313275,8/1/2007 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,266250, ,NIEHS, , ,266250
Molecular Pathways in Suppression and Development of T Lineage Lymphomas,7313293,7/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,313500, ,NCI, , ,313500
P53 Based Vaccine for Small Cell Lung Cancer,7313951,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,303647, ,NCI, , ,303647
MTOR AS A THERAPEUTIC TARGET IN PEDIATRIC SOLID TUMORS,7313994,7/1/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007, ,247610, , , , 
Selenium protection of bone marrow during chemotherapy,7314294,8/1/2007 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,227250, ,NHLBI, , ,227250
The Effect of Radiation on Androgen Receptor Expression and Activity in Prostate,7314870,7/1/2007 0:00,6/30/2012 0:00,Research Centers,2007, ,258451, , , , 
Biological Function of the Retinoblastoma Gene Product,7315279,5/3/1994 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,342397, ,NCI, , ,342397
Selective Forces Operative in FeLV Infection,7315781,2/28/2000 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,238863, ,NCI, , ,238863
Determinants of Metastatic Progression,7316372,7/23/2002 0:00,7/31/2008 0:00,Non-SBIR/STTR,2007,287424, ,OD, , ,287424
Albany 2007:  The 15th Conversation,7316479,6/15/2007 0:00,5/31/2008 0:00,Other Research-Related,2007,5000, ,NIGMS, , ,5000
Role of C/EBP in Cell Survival and Neoplasia,7317140,5/1/1990 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,255984, ,NCI, , ,255984
NITROAROMATICS AND BREAST CANCER,7317472,7/1/1983 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,333404, ,NCI, , ,333404
Molecular Mechanisms of p53 dependent longevity regulation,7317798,8/1/2007 0:00,7/31/2009 0:00,Other Research-Related,2007,90000, ,NIA, , ,90000
Dietary Prevention of Cancer,7318190,7/1/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2006,252559, ,NCI, , ,252559
Study on the intracellular Network of TBX3,7318509,8/1/2007 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,227442, ,NCI, , ,227442
Oral Carcinogenesis,7318817, , ,Intramural Research,2006, , , , , , 
Structure and Function of DNA Regulatory Proteins,7319249,1/1/1997 0:00,8/31/2011 0:00,Non-SBIR/STTR,2007,292953, ,NIGMS, , ,292953
Role of MDM2 in Cell Proliferation and Tumorigenesis,7320035,7/1/1999 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,277695, ,NCI, , ,277695
Structural basis for CBP/p300 transcriptional regulation,7320056,6/10/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,413092, ,NCI, , ,413092
Deciphering how MdmX deregulation impacts the p53 pathway,7320260,4/1/1995 0:00,11/30/2010 0:00,Non-SBIR/STTR,2008,215084, ,NCI, , ,215084
Mammalian Polyamine Metabolism,7320653,12/1/1975 0:00,11/30/2010 0:00,Non-SBIR/STTR,2008,313665, ,NCI, , ,313665
A high resolution comparative analysis of early onset breast cancer by race,7320731,9/27/2007 0:00,9/26/2009 0:00,"Training, Individual",2007,28894, ,NCI, , ,28894
Induction of MGMT as a Strategy for Chemoprevention,7320998,8/10/2007 0:00,7/31/2009 0:00,Non-SBIR/STTR,2007,74250, ,NCI, , ,74250
Dietary Chemopreventive Components/Oncogene Interaction and Cancer,7321920,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,275500, ,NCI, , ,275500
Targeting transforming growth factor beta for cancer treatment,7321936,7/15/1997 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,218928, ,NCI, , ,218928
Chk2 as a target for regulating senescence in skin neoplasia,7321973,7/3/2007 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,80500, ,NCI, , ,80500
Function and regulation of SirT1 in cancer,7322604,7/11/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,283860, ,NCI, , ,283860
FHIT Gene Therapy in Cancer Prevention and Treatment,7322808,12/1/2006 0:00,11/30/2011 0:00,Non-SBIR/STTR,2008,228000, ,NCI, , ,228000
BubR1 in Cancer and Aging,7322952,7/1/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,301377, ,NCI, , ,301377
Chemoprevention of Lung Cancer with Anti-tumor B,7323586,9/30/2007 0:00,8/31/2011 0:00,Non-SBIR/STTR,2007,389250, ,NCCIH, , ,389250
A novel regulator of p53,7323606,8/15/2002 0:00,10/31/2007 0:00,Non-SBIR/STTR,2007,68982, ,NCI, , ,68982
Gene targets of OLIG2 in malignant glioma stem cells,7323849,7/15/2007 0:00,4/30/2011 0:00,Non-SBIR/STTR,2007,427500, ,NINDS, , ,427500
PLK3 in the DNA damage checkpoint and tumor suppression,7324017,12/15/1997 0:00,3/31/2008 0:00,Non-SBIR/STTR,2006,216000, ,NCI, , ,216000
Characterization of prostatic stem cells and prostate cancer-initiating cells,7324066,9/1/2007 0:00,8/31/2009 0:00,Other Research-Related,2008,89179, ,NCI, , ,89179
Biology of EGFR and P53 in esophageal epithelial cells,7324095,12/1/2006 0:00,11/30/2008 0:00,"Training, Individual",2008,48796, ,NIDDK, , ,48796
The Molecular Biology Of The Mammalian Brain,7324367, , ,Intramural Research,2006, , , , , , 
Genetic Susceptibility to Loss of Tumor Suppressor Gene,7327256, , ,Intramural Research,2006, , , , , , 
Role of p53 in Apoptosis and Growth Arrest in Neuronal C,7327280, , ,Intramural Research,2006, , , , , , 
"cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma",7327772,1/1/2005 0:00,12/31/2008 0:00,Non-SBIR/STTR,2008,224802, ,NCI, , ,224802
"Role Of Lipids In Colon, Breast, And Other Cancers",7327819, , ,Intramural Research,2006, , , , , , 
Isolation And Characterization Of Human Genes Affecting,7328483, , ,Intramural Research,2006, , , , , , 
Role of the p53/p63 Target Gene Perp in Mammary Gland Morphogenesis and Cancer,7328810,8/16/2007 0:00,8/15/2008 0:00,"Training, Individual",2007,46826, ,NCI, , ,46826
"Telomerase in Development, Senescence and Neoplasia",7329190,1/1/2000 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,578964, ,NCI, , ,578964
SUMO conjugation in cell biology and Development,7329793,9/15/2001 0:00,11/30/2010 0:00,Non-SBIR/STTR,2008,239693, ,NIGMS, , ,239693
Cancer Risk and Environmental Exposures,7330725, , ,Intramural Research,2006, , , , , , 
Molecular Genetic Epidemiology of Primary Hepatocellular,7330791, , ,Intramural Research,2006, , , , , , 
Studies of Rare Cancers,7330814, , ,Intramural Research,2006, , , , , , 
"p53, Rb and Ras Pathways in Neural Stem Cell Homeostasis and Transformation",7330917,6/15/2007 0:00,6/14/2010 0:00,"Training, Individual",2007,49646, ,NINDS, , ,49646
Molecular Pathology of Pulmonary Carcinogenesis,7331344, , ,Intramural Research,2006, , , , , , 
The Molecular Genetics of Gynecologic Cancers,7331345, , ,Intramural Research,2006, , , , , , 
Molecular Pathogenesis of Multiple Myeloma,7331392, , ,Intramural Research,2006, , , , , , 
Nitric Oxide as a Modifier of Oxidative Stress,7331411, , ,Intramural Research,2006, , , , , , 
Role of HSP90 Family Chaperone Proteins in Cellular Sign,7331432, , ,Intramural Research,2006, , , , , , 
Gene Expression and Post-Transcriptional Regulation of D,7331612, , ,Intramural Research,2006, , , , , , 
Regulation of the cell cycle by cyclin-dependent kinases,7331678, , ,Intramural Research,2006, , , , , , 
"Characterization of Mutational Spectra, Mechanisms of Toxicity and Homologous Rec",7333242, , ,Non-SBIR/STTR,2007, ,470604, , , , 
International Mdm2 Workshop IV,7334570,9/4/2007 0:00,9/3/2008 0:00,Other Research-Related,2007,15000, ,NCI, , ,15000
MDM2 AS A NEGATIVE REGULATOR OF P21 WAF1/CIP1,7334739,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,254536, ,NCI, , ,254536
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia,7334761,9/15/1996 0:00,12/31/2010 0:00,Non-SBIR/STTR,2008,348711, ,NCI, , ,348711
Interactions and Functions of p14ARF in Cancer,7334763,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,370484, ,NCI, , ,370484
p53 Signaling and Cellular Response After Stress,7334770,1/1/1997 0:00,12/31/2010 0:00,Non-SBIR/STTR,2008,330828, ,NCI, , ,330828
Inductible mouse models for oral cancer,7335597,1/13/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,350204, ,NIDCR, , ,350204
MBRA SUBRPOJECT 2:THE ROLE OF GENE EXPRESSION IN BREAST CANCER PREVENTION,7335969,6/1/2006 0:00,5/31/2007 0:00,Research Centers,2006, ,35043, , , , 
ID PROTEIN FAMILY EXPRESSION AND FUNCTION IN PROSTATE CANCER,7336085,6/1/2006 0:00,5/31/2007 0:00,Research Centers,2006, ,115940, , , , 
Regulation and Function of C/EBP in UVB Responses,7336769,1/3/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,298269, ,NIEHS, , ,298269
TGF-beta signaling and colon cancer,7336783,1/1/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2008,339257, ,NCI, , ,339257
Small Molecule Activators of p53,7337605, , ,Intramural Research,2006, , , , , , 
Enzymes and Substrates of the Ubiquitin Conjugating Syst,7337722, , ,Intramural Research,2006, , , , , , 
Molecular Technologies,7337750, , ,Intramural Research,2006, , , , , , 
T-Cell Antigen Recognition and Tumor Antigens,7337777, , ,Intramural Research,2006, , , , , , 
Alterations in Interacting Signaling Pathways that Initi,7337781, , ,Intramural Research,2006, , , , , , 
Gene Regulation and Function: The B-ZIP Proteins,7337841, , ,Intramural Research,2006, , , , , , 
Molecular Epidemiology and Molecular Carcinogenesis of H,7337863, , ,Intramural Research,2006, , , , , , 
Investigations on the integrated behavior of molecular r,7337939, , ,Intramural Research,2006, , , , , , 
Peptide-based Inhibitors of HDM2 Protein,7337943, , ,Intramural Research,2006, , , , , , 
Regulation of EGFR Gene Activity,7337946, , ,Intramural Research,2006, , , , , , 
Genetically Engineered Mice as Models to Study Receptor,7338120, , ,Intramural Research,2006, , , , , , 
The Genetics of Susceptibility to Mouse Plasma Cell Tumo,7338203, , ,Intramural Research,2006, , , , , , 
Biology of Mammary Gland Development and Tumorigenesis,7338273, , ,Intramural Research,2006, , , , , , 
Inflammation and Cancer,7338279, , ,Intramural Research,2006, , , , , , 
Molecular Mechanisms of Growth Factor Modulated Prolifer,7338285, , ,Intramural Research,2006, , , , , , 
DNA Repair,7338299, , ,Intramural Research,2006, , , , , , 
Maryland Breast Cancer Case-Control Study,7338384, , ,Intramural Research,2006, , , , , , 
Role of CEBP transcription factors in regulating cell gr,7338458, , ,Intramural Research,2006, , , , , , 
Design of Drugs Against Cancer and Viral Diseases,7338492, , ,Intramural Research,2006, , , , , , 
Development of Mouse Astrocytoma Model for Preclinical T,7338619, , ,Intramural Research,2006, , , , , , 
Identification of Modifier Gene of Tumors Associated wit,7338620, , ,Intramural Research,2006, , , , , , 
Molecular Mechanisms of Proliferation and Infiltration o,7338623, , ,Intramural Research,2006, , , , , , 
p53 and its cancer-causing mutants,7338730, , ,Intramural Research,2006, , , , , , 
Metabolic Mechanisms for Programmed Cell Death,7338799, , ,Intramural Research,2006, , , , , , 
Clinical trial development in cancer vaccines,7338825, , ,Intramural Research,2006, , , , , , 
The Role of NF-kappaB in Chemotherapy Resistance,7339035,1/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,340162, ,NCI, , ,340162
monoclonal antibody,7339468,8/1/2007 0:00,7/31/2012 0:00,Research Centers,2007, ,95554, , , , 
Mechanistic Analyses of Protein Deacetylation,7340032,3/1/2002 0:00,2/28/2008 0:00,Non-SBIR/STTR,2006,220743, ,NIGMS, , ,220743
Role of RNase L in the Biology of Prostate Cancer,7340175,2/16/2004 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,297398, ,NCI, , ,297398
Mechanism of SAG apoptosis protection under hypoxia,7340430,2/1/2005 0:00,7/31/2009 0:00,Non-SBIR/STTR,2008,286517, ,NCI, , ,286517
Dual Role of E2F1 in Tumorigenesis,7340519,1/18/1999 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,305646, ,NCI, , ,305646
The Role of Phosphatase CL100/MKP1 in Human Cancer,7340540,2/5/2004 0:00,1/31/2010 0:00,Non-SBIR/STTR,2008,234807, ,NCI, , ,234807
Mechanisms of Cell Cycle Associated Neoplasia,7340703,2/16/2000 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,348574, ,NCI, , ,348574
Monitoring mechanisms in mammalian ribosome biogenesis,7340764,2/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2008,230749, ,NIGMS, , ,230749
The Structure and Function of S100 Proteins,7341698,2/1/1999 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,304425, ,NIGMS, , ,304425
Targeting Relaxin Signaling in Prostate Cancer,7341750,1/19/2007 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,150000, ,NCI, , ,150000
Stress- and Promoter-Specific Mechanisms of Transcritpional Activation by p53,7342125,5/26/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,240398, ,NCI, , ,240398
Molecular Determinants for the Bioactivity of the Flavonoid Quercetin,7342172,8/1/2008 0:00,7/31/2011 0:00,Other Research-Related,2008,135250, ,NIGMS, , ,135250
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1,7342177,2/15/2003 0:00,8/31/2008 0:00,Non-SBIR/STTR,2007,49711, ,NCI, , ,49711
The Pathogenesis of Dyskeratosis Congenita,7342389,2/8/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,286517, ,NCI, , ,286517
Structure-Function of Protein Deacetylases,7342753,3/1/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,303213, ,NCI, , ,303213
The role of p53 in remodeling DNA methylation in cancer,7343167,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2008,244189, ,NCI, , ,244189
Biomimetic Synthesis of Complex Natural Products,7344789,2/1/2006 0:00,1/31/2010 0:00,Non-SBIR/STTR,2008,297951, ,NIGMS, , ,297951
Apoptosis by FADD in normal and cancerous cells,7344847,2/22/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,288389, ,NCI, , ,288389
Oncogenic Gene Regulatory Networks,7346961,2/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,284064, ,NCI, , ,284064
Lung cancer molecular markers by sex: intergroup study,7347000,4/15/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,559505, ,NCI, , ,559505
Enhancing Direct Tumor Cell Cytotoxicity By Manipulating Growth Factor Signaling,7348009,9/7/2001 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008, ,200411, , , , 
Ultra-Rare Circulating Tumor DNA Detection with PAP & Digital Bead Technologies,7348452,6/1/2008 0:00,5/31/2010 0:00,SBIR/STTR,2008,210039, ,NCI, , ,210039
T cell activation and crypt cell apoptosis,7348635,2/15/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,33975, ,NIDDK, , ,33975
T cell activation and crypt cell apoptosis,7348789,2/15/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,9492, ,NIDDK, , ,9492
"P38, G2 Arrest, and Temozolomide Resistance in Gliomas",7350198,2/1/2004 0:00,1/31/2010 0:00,Non-SBIR/STTR,2008,303277, ,NCI, , ,303277
Role of DN-p63 in Preservation of Self Renewal,7350203,4/1/2005 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,228179, ,NCI, , ,228179
Mechanisms of Intestinal Tumorigenesis,7350239,1/1/2000 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,370797, ,NCI, , ,370797
The Role of p53 and 14-3-3 in Genomic Instability,7350860,4/1/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,264158, ,NCI, , ,264158
Multi-institutional trial: molecular analysis of margins,7350863,2/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,213420, ,NCI, , ,213420
Roles of DMP1 in Ras signaling and lung cancer,7350938,4/1/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,251038, ,NCI, , ,251038
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D,7350950,1/1/1999 0:00,2/28/2011 0:00,Non-SBIR/STTR,2008,238892, ,NCI, , ,238892
Targeting Signal Transduction Pathways for Cancer Drug Discovery,7350953,2/5/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,1888951, ,NCI, , ,1888951
Role of TRRAP in the p53-Mediated Transcription of mdm2,7352520,7/1/2003 0:00,4/30/2008 0:00,Non-SBIR/STTR,2006,38750, ,NCI, , ,38750
Rac GTPases as Targets in Lymphomagenesis,7352666,2/10/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,285000, ,NCI, , ,285000
MECHANISMS OF ESTROGEN RECEPTOR REGULATION,7352699,2/1/2006 0:00,12/31/2010 0:00,Non-SBIR/STTR,2008,231383, ,NCI, , ,231383
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium,7354802,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2008,261534, ,NCI, , ,261534
HUMAN TRAP/MEDIATOR,7355080,3/1/2006 0:00,2/28/2007 0:00,Research Centers,2006, ,3700, , , , 
p63 Signaling in Epithelial Cell Growth and Cancer,7355575,3/1/2004 0:00,11/30/2009 0:00,Non-SBIR/STTR,2008,293511, ,NCI, , ,293511
The MED1 Protein in DNA Damage Response and Repair,7356380,7/1/1998 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,357262, ,NCI, , ,357262
Genetic Mechanisms in Experimental Pancreatic Cancer,7356399,9/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,262017, ,NCI, , ,262017
Mechanisms of T Cell Tumorigenesis,7356401,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2008,238942, ,NCI, , ,238942
FDH: A Novel Determinant of Tumor Suppression,7356442,3/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2008,246068, ,NCI, , ,246068
Role of Germ Cell Nuclear Factor in Restricting hESC Pluripotency,7356522, , ,Non-SBIR/STTR,2007, ,268625, , , , 
DATA COLLECTION FROM CRYSTALS OF PROTEIN COMPLEXES,7357745,7/1/2006 0:00,6/30/2007 0:00,Research Centers,2006, ,12216, , , , 
STRUCTURE-BASED DESIGN OF P53 STABILIZING COMPOUNDS WITH LARGE-SCALE VIRTUAL-SC,7358581,9/30/2006 0:00,7/31/2007 0:00,Research Centers,2006, ,1012, , , , 
"Allergies, Genetic Susceptibility and Adult Glioma Risk",7359625,3/10/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,371078, ,NCI, , ,371078
JC Virus and Tumor Formation in the Human Colon,7359626,4/1/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,260276, ,NCI, , ,260276
Genetic modifiers of mammary tumor susceptibility,7359638,2/15/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,286406, ,NCI, , ,286406
Cell and tumor genetics of mitotic arrest checkpoints,7359639,2/1/2000 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,344054, ,NCI, , ,344054
 anti-tumor activity of deacetylase inhibitors,7359670,4/8/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,271505, ,NCI, , ,271505
Cell fate decision in response to p53-dependent DNA damage/genotoxic stress,7359676,7/1/2001 0:00,12/31/2011 0:00,Non-SBIR/STTR,2008,281138, ,NCI, , ,281138
Role of PCAF/GCN5 Acetylation on p53 Transactivation,7361359,4/1/1999 0:00,4/30/2009 0:00,Non-SBIR/STTR,2008,344670, ,NCI, , ,344670
Molecular Markers as Predictors of Outcome in Gliomas,7361362,9/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,324435, ,NINDS, , ,324435
Using Zebrafish to Identify and Analyze Cancer Genes,7361369,3/7/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,398901, ,NCI, , ,398901
Klf4 in tumor initiation and maintenance of squamous cell carcinoma,7361376,3/1/2007 0:00,11/15/2008 0:00,Non-SBIR/STTR,2008,275500, ,NCI, , ,275500
Small RNA targeted gene activation for the treatment of prostate cancer,7361525,1/1/2008 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,208238, ,NCI, , ,208238
Functional Characterization of WTX in Renal Development,7361683,9/30/2007 0:00,8/31/2012 0:00,Other Research-Related,2007,136350, ,NIDDK, , ,136350
Control of Retrovirus CNS Disease by redox modulation,7362371,6/18/2002 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,409079, ,NINDS, , ,409079
The Role of HOXA5 in Breast Cancer,7362395,3/15/2004 0:00,2/28/2011 0:00,Non-SBIR/STTR,2008,286025, ,NCI, , ,286025
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE,7362427,3/1/1988 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,479600, ,NCI, , ,479600
Mechanisms of tumor promotion and carcinogenesis,7362455,1/1/1994 0:00,2/28/2011 0:00,Non-SBIR/STTR,2008,249183, ,NCI, , ,249183
Southwest Oncology Group,7362458,2/1/1993 0:00,12/31/2009 0:00,Other Research-Related,2008,256651, ,NCI, , ,256651
Cooperation of oncogenic mutations in the control of malignancy,7363652,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,292600, ,NCI, , ,292600
G2 Checkpoint Control In Transformed Human Cells,7363719,12/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,323425, ,NCI, , ,323425
Regulation and Role of ODC in Apoptosis and Cancer,7364199,3/4/2003 0:00,11/30/2008 0:00,Non-SBIR/STTR,2007,365189, ,NCI, , ,365189
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS,7364201,4/1/1980 0:00,11/28/2009 0:00,Non-SBIR/STTR,2008,281195, ,NCI, , ,281195
Molecular mediators of metastasis in hepatocellular carcinoma,7364203,4/1/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2008,280074, ,NCI, , ,280074
Transcriptional Control of Gastrin,7364468,9/1/1993 0:00,9/29/2007 0:00,Non-SBIR/STTR,2007,136629, ,NIDDK, , ,136629
Prevention of Oral Cancer by Tea: A mechanism Study,7364554,3/16/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,347852, ,NCI, , ,347852
The role of glutathione peroxidase in the pathogenesis of intestinal cancer,7364572,3/1/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,262148, ,NCI, , ,262148
Phenolic component of tobacco smoke as tumor promoter,7364736,2/1/2008 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,214500, ,NCI, , ,214500
Role of WISp39 and Ubiquitination in p21 Function,7365173,4/9/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,280537, ,NCI, , ,280537
"Cadmium, Metallothionein and Breast Cancer Progression",7365239,4/1/2005 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,269231, ,NCI, , ,269231
Hormonal regulation of p53 activity in mammary tissue,7365433,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,54393, ,NCI, , ,54393
Novel p53 target gene ASC in apoptosis & mammary tumorigenesis,7367002,4/1/1999 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,273706, ,NCI, , ,273706
Functions of Human Papillomavirus E6,7367032,4/8/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,310653, ,NCI, , ,310653
Apoptotic Response to DNA Damage Initiated by PUMA,7367047,4/1/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,259785, ,NCI, , ,259785
The Role of Mdm2 in Cell Growth and Tumorigenesis,7367070,3/1/1999 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,312012, ,NCI, , ,312012
Sphingosine Phosphate:Regulation and Role in Cancer,7367206,9/1/1998 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,322582, ,NCI, , ,322582
Mechanistic Studies of Mediator and the p53 Tumor Suppressor,7368393,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,227412, ,NCI, , ,227412
Role and therapeutical potential of Cdk4/6 in B-lymphoma,7368467,7/10/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2006,158148, ,NCI, , ,158148
Regulation of Mdm2 compartmentalization,7368491,5/11/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2006,226967, ,NCI, , ,226967
Redox Effects of Selenium for Prostate Cancer Prevention,7369882,4/18/2005 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,272472, ,NCI, , ,272472
Polyoma Virus Disrupts ARF Signaling to p53,7370294,7/1/2001 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,307243, ,NCI, , ,307243
Mechanisms of tumor promotion and carcinogenesis,7370931,1/1/1994 0:00,2/28/2009 0:00,Non-SBIR/STTR,2007,53700, ,NCI, , ,53700
Molecular Basis of Aneuploidy,7371051,3/7/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2008,232676, ,NCI, , ,232676
Enhancing Activity of Alkylating Agents in Neuroblastoma,7371065,9/1/1999 0:00,6/30/2008 0:00,Non-SBIR/STTR,2008,210659, ,NCI, , ,210659
Transcriptional Activator/Coactivator Interactions,7371103,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,325660, ,NCI, , ,325660
Pathways of Therapy-induced Senescence in Cancer,7371110,3/17/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,235952, ,NCI, , ,235952
P63 mediators as therapeutic targets in HNSCC,7371113,4/1/2004 0:00,2/28/2009 0:00,Non-SBIR/STTR,2008,369240, ,NIDCR, , ,369240
Cell Cycle Dysregulation in Oral Cancer,7371115,4/1/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,474445, ,NIDCR, , ,474445
Dynamics of Signaling Pathways: Mechanism and Function,7371188,3/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,321100, ,NIGMS, , ,321100
Role of an unusual GTPase in DNA damage response and carcinogenesis,7371220,12/1/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2008,352219, ,NCI, , ,352219
Host Immunity to EBV Infection in Vitro and in VIvo,7371359,9/1/1981 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,410729, ,NIAID, , ,410729
Quantitative Measurements and Modeling of the Mitotic Checkpoint,7371808,9/28/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2007,350000, ,NIGMS, , ,350000
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer,7371996,3/7/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,311600, ,NCI, , ,311600
MDM2 regulates XIAP gene expression in cancer treatment,7372276,12/15/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2008,256678, ,NCI, , ,256678
Nuclear Function of Abl in DNA Damage Response,7372354,8/1/1986 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,397022, ,NCI, , ,397022
Role of PP2A in Lung Cancer,7372697,1/1/2008 0:00,12/31/2011 0:00,Non-SBIR/STTR,2008,320588, ,NCI, , ,320588
Phase I Study of ALT-801 in Metastatic Melanoma/Kidney Cancer Patients,7373338,12/15/2007 0:00,11/30/2009 0:00,Non-SBIR/STTR,2008,193715, ,FDA, , ,193715
Hormonal regulation of p53 activity in mammary tissue,7373562,4/1/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,271155, ,NCI, , ,271155
Recognition and Presentation of Alpha Helices using Nanoparticle Receptors,7373582,3/8/2007 0:00,2/28/2011 0:00,Non-SBIR/STTR,2008,261254, ,NIGMS, , ,261254
Regulation WRN deacetylation by SIRT1 after DNA damage,7373995,2/15/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,270075, ,NIA, , ,270075
The Role of PTEN in Endothelial Biology,7374082,2/15/2008 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,390000, ,NHLBI, , ,390000
DFMO AND SULINDAC,7374247,4/1/2006 0:00,11/30/2006 0:00,Research Centers,2006, ,2628, , , , 
"A PHASE I STUDY OF ORAL IRINOTECAN, TEMOZOLOMIDE, AND CEFIXIME IN CHILDREN WI",7374993,12/1/2005 0:00,11/30/2006 0:00,Research Centers,2006, ,310, , , , 
A PHASE I STUDY OF SAHA (NSC #701852) IN PEDIATRIC PATIENTS WITH RECURRENT OR,7375020,12/1/2005 0:00,11/30/2006 0:00,Research Centers,2006, ,1551, , , , 
GENETIC DEFINITION AND PHENOTYPE DETERMINANTS OF HUMAN OVARIAN CARCINOMA,7376018,12/1/2005 0:00,11/30/2006 0:00,Research Centers,2006, ,6171, , , , 
GENOTYPIC AND PHENOTYPIC RESPONSE OF BREAST EPITHELIAL CELLS FROM WOMEN,7376114,12/1/2005 0:00,11/30/2006 0:00,Research Centers,2006, ,2013, , , , 
MOLECULAR EPIDEMIOLOGY OF HEAD AND NECK CANCER,7376131,12/1/2005 0:00,11/30/2006 0:00,Research Centers,2006, ,19102, , , , 
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER,7376134,12/1/2005 0:00,11/30/2006 0:00,Research Centers,2006, ,47498, , , , 
Molecular dissection of pancreatic ductal adenocarcinoma,7377658,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,357227, ,NCI, , ,357227
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER FOR CANCER,7378244,4/1/2006 0:00,3/31/2007 0:00,Research Centers,2006, ,245032, , , , 
INDIVIDUALIZED TX OF BREAST CANCER BASED ON TUMOR MOLECULAR CHARACTERISTICS,7378275,4/1/2006 0:00,3/31/2007 0:00,Research Centers,2006, ,20576, , , , 
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY,7378298,4/1/2006 0:00,3/31/2007 0:00,Research Centers,2006, ,29460, , , , 
COG ADVL0416: A STUDY OF SAHA IN PEDIATRIC PATIENTS WTH RECURRENT SOLID TUMORS,7379449,4/1/2006 0:00,3/31/2007 0:00,Research Centers,2006, ,2481, , , , 
Development of Statistical Approaches Allowing for Genetic Covariates,7380043,4/1/2007 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,77000, ,NCI, , ,77000
TARGET FACULTY/SENESCENCE SIGNALING THROUGH P53,7381463,6/1/2006 0:00,5/31/2007 0:00,Research Centers,2006, ,188125, , , , 
"COBRE: U KS: P1: ID OF HSP90 COCHAPERONES, IMMUNOPHILINS &  PROTEINS",7381953,7/1/2006 0:00,6/30/2007 0:00,Research Centers,2006, ,27228, , , , 
Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors,7382342,12/7/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2008,300875, ,NCI, , ,300875
Function of MEF in Hematopoietic Cells,7382446,1/1/1997 0:00,6/30/2012 0:00,Non-SBIR/STTR,2008,403219, ,NIDDK, , ,403219
Discovering TREX1 and TREX2 Function in Mammalian Cells and Mice,7382540,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,277400, ,NCI, , ,277400
CPEB and Cell Senescence,7383095,4/1/2007 0:00,3/31/2012 0:00,Non-SBIR/STTR,2008,326463, ,NIA, , ,326463
"Obesity, H pylori and Risk of Barrett's Esophagus",7383135,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,562889, ,NCI, , ,562889
Transcripitonal and Genetic Profiles in HNSCCs,7383933,3/1/2004 0:00,1/31/2011 0:00,Non-SBIR/STTR,2008,281653, ,NIDCR, , ,281653
Biosynthesis of Adenovirus Early RNA's,7384281,4/1/1979 0:00,3/31/2012 0:00,Non-SBIR/STTR,2008,689977, ,NCI, , ,689977
T cell activation and crypt cell apoptosis,7384290,2/15/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,131959, ,NIDDK, , ,131959
T cell activation and crypt cell apoptosis,7384291,2/15/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,27651, ,NIDDK, , ,27651
Methylation of the Calcitonin Gene in Human Tumors,7384498,9/30/1986 0:00,4/30/2009 0:00,Non-SBIR/STTR,2008,418048, ,NCI, , ,418048
T cell activation and crypt cell apoptosis,7384502,2/15/1999 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,370823, ,NIDDK, , ,370823
Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis,7384600,7/1/2000 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,247822, ,NCI, , ,247822
Breast Cancer Therapeutic Agents Based on Telomerase Misfunction,7384761,12/1/2007 0:00,11/30/2012 0:00,Research Centers,2008, ,143984, , , , 
Testing the Cancer Stem Cell Hypothesis: Role of CD133+ Cells as Tumor Stem Cells,7385332,9/1/2007 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,189219, ,NINDS, , ,189219
Combination Chemoprevention: Prevention of Both ER-Positive & ER-Negative BC,7385530,12/1/2007 0:00,11/30/2012 0:00,Research Centers,2008, ,155438, , , , 
MT COBRE: EFFECT OF METAL MIXTURES ON GENE EXPRESSION & CARCINOGENESIS,7385765,7/1/2006 0:00,6/30/2007 0:00,Research Centers,2006, ,156514, , , , 
Growth Inhibition by the ARF Tumor Suppressor,7386097,4/1/2001 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,265940, ,NCI, , ,265940
"Applications of ""Recombomice"" for Cancer Research",7386642,4/15/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,272319, ,NCI, , ,272319
Homologous Recombination & Human Cell Radiosensitivity,7386707,2/7/2006 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,343492, ,NCI, , ,343492
Biology of the papillomavirus E5 oncoprotein family,7386793,1/1/1991 0:00,2/28/2011 0:00,Non-SBIR/STTR,2008,492122, ,NCI, , ,492122
The Role of Ape1 in Neurotoxicity of Cancer Treatments,7386800,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,434754, ,NCI, , ,434754
Mechanisms of Radioresistance and Cell Cycle Progression,7386915,9/28/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,360812, ,NCI, , ,360812
Modulation of DNA methylation status by dietary zinc: role in cancer prevention,7386958,1/25/2008 0:00,8/31/2008 0:00,Non-SBIR/STTR,2008,202500, ,NCI, , ,202500
In vivo pathogenesis of Helicobacter pylori,7387482,9/1/1996 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,376716, ,NIAID, , ,376716
Mitochondrial translocation of p53 and its interaction with manganese superoxide ,7387967,9/27/2007 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,73250, ,NCI, , ,73250
Cellular Stress Response Signaling Pathways,7387999,1/1/1992 0:00,6/30/2012 0:00,Non-SBIR/STTR,2007,412500, ,NIEHS, , ,412500
Modulation of a novel cell cycle checkpoint by the HPV oncogene E6,7388406,1/15/2008 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,243750, ,NIAID, , ,243750
Prostaglandin D and skin cancer prevention,7388737,9/24/2007 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,65651, ,NCI, , ,65651
Cell Survival and Death in Oxidant Lung Injury,7388820,7/1/2002 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,385000, ,NHLBI, , ,385000
Nanoscale Functional Dendrimer-DNA Assemblies,7390402,12/4/2006 0:00,11/30/2009 0:00,Non-SBIR/STTR,2008,162500, ,NCI, , ,162500
The Role of p73 in Upper Gastrointestinal Carcinomas,7390418,4/28/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,4368, ,NCI, , ,4368
Biosynthesis and Hypoxia in Gliomas,7390727, , ,Non-SBIR/STTR,2007, ,152819, , , , 
Structure and function of the U3 RNA-protein complex,7391540,4/1/2007 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,288800, ,NIGMS, , ,288800
Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family Members,7391697, , ,Other Research-Related,2007, ,220035, , , , 
Tumor Suppression by Protein Kinase C-delta,7391706, , ,Other Research-Related,2007, ,144685, , , , 
Nuclear Accumulation of Cyclin D1 and Oncogenesis,7391838,7/1/2001 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,294539, ,NCI, , ,294539
Determination of regulatory mechanisms for BLM helicase,7392251,8/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,50178, ,NCI, , ,26087
Growth Control and Anti-Cancer Mechanisms,7392414,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,295450, ,NCI, , ,295450
Expression of Class I Specific Receptors in NK Cells,7392662,4/1/1996 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,320208, ,NIAID, , ,320208
CORE--ENVIRONMENT /GENE INTERACTIONS,7392681,4/1/2007 0:00,3/31/2008 0:00,Research Centers,2007, ,62742, , , , 
Molecular Functions of the Adenoviral E1B 55 kDa Protein,7392693,4/1/2004 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,367415, ,NIAID, , ,367415
Leukemogenic Slug Pathway in Hematopoietic Cell Survival,7392732,5/1/1993 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,405347, ,NCI, , ,405347
Intracellular Mechanisms of Glucocorticoid Action,7392747,7/1/1986 0:00,6/30/2012 0:00,Non-SBIR/STTR,2008,268142, ,NIDDK, , ,268142
The MRAD9 Radioresistance Gene,7392863,12/1/2000 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,311099, ,NIGMS, , ,311099
Study of genomic instability caused by HPV16 E6 and E7,7393075,5/1/2004 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,249199, ,NIDCR, , ,249199
An in vivo Screen for Radiation Sensitizers,7393308,5/1/2007 0:00,2/28/2011 0:00,Non-SBIR/STTR,2008,203557, ,NIDCR, , ,203557
p53 and checkpoint pathways in cancer cell repliction,7393309,7/11/1994 0:00,4/30/2009 0:00,Non-SBIR/STTR,2008,325345, ,NCI, , ,325345
Novel Proapoptotic BH3-only Proteins in Cancer Apoptosis,7393738,5/16/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,211686, ,NCI, , ,211686
Potentials of reactivated mutant p53,7393770,7/1/2004 0:00,4/30/2009 0:00,Non-SBIR/STTR,2008,297398, ,NCI, , ,297398
p53-Mediated Transcription and Apoptosis,7394466,4/1/1999 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,288437, ,NCI, , ,288437
Functional Analysis of p53 Polymorphic Variants,7394473,6/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,316480, ,NCI, , ,316480
p53-Independent Pathways in Mdm2-Mediated Transformation,7394923,4/9/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2008,291850, ,NCI, , ,291850
Altered Proteoglycan Gene Expression and Cancer,7395027,9/1/1988 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,374657, ,NCI, , ,374657
Small Molecules Inducing BTG1 Transcription,7404208,2/1/2008 0:00,7/31/2008 0:00,SBIR/STTR,2008,107001, ,NIGMS, , ,107001
Dietary Prevention of Cancer,7405370,7/1/2005 0:00,4/30/2009 0:00,Non-SBIR/STTR,2008,274345, ,NCI, , ,274345
The role of selenoproteins in the etiology of cancer,7405404,6/10/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,223970, ,NCI, , ,223970
Non-Peptide Small-Molecule Inhibitors of the MDM2-p53 interaction,7405474,5/1/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,425060, ,NCI, , ,425060
Defining PAH-mediated carcinogenesis in lung: CYP metabolism and B[a]P transport,7406263,9/30/2007 0:00,9/29/2010 0:00,"Training, Individual",2007,46826, ,NIEHS, , ,46826
Analysis of 53BP1 function in DNA Damage-signaled pathway and Tumorigenesis,7406767,5/9/2003 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,315208, ,NCI, , ,315208
The role of stem cells in longevity suppression by p44 (deltaN-p53),7407096,9/2/2008 0:00,12/29/2010 0:00,"Training, Individual",2008,30218, ,NINDS, , ,30218
The Role of Insulin/IGF-1 Signaling in Tumor Supression and Aging,7407650,4/1/2008 0:00,6/30/2008 0:00,"Training, Individual",2008,14995, ,NIGMS, , ,14995
AMID in Apoptosis and p53-Mediated Downstream Effects,7408606,7/14/2004 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,265208, ,NCI, , ,265208
BRCA1 function in  G2-M checkpoint and mitosis,7408996,12/11/1998 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,216896, ,NCI, , ,216896
Functional Characterization of the ATM Gene Product,7409069,8/15/1996 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,355568, ,NCI, , ,355568
Characterization of the p53 Apoptotic Target Gene Perp,7409123,1/1/2002 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,284246, ,NCI, , ,284246
Cellular Targets of Papillomavirus Oncoproteins,7409184, , ,Non-SBIR/STTR,2007, ,579048, , , , 
Interactions of the SV40 Small T Antigen and PP2A in Human Cell Transformation,7409186, , ,Non-SBIR/STTR,2007, ,248508, , , , 
Understanding the Role of TAF1 Double-Bromodomain in p53-mediated Transcription,7409442,3/24/2008 0:00,3/31/2008 0:00,"Training, Individual",2007,462, ,NCI, , ,462
Etiologic Role of HPV in Keratinocyte Carcinomas,7409534,5/1/2007 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,307108, ,NCI, , ,307108
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction,7409609,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,268039, ,NCI, , ,268039
UV and p21 Degradation,7409661,6/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,325281, ,NCI, , ,325281
Genomic targets of oncoproteins and tumor suppressors,7409989,5/18/2006 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,786514, ,NCI, , ,786514
Prostate Cancer Prevention by n-3 Unsaturated Fatty Acids,7410050,6/28/2005 0:00,4/30/2011 0:00,Non-SBIR/STTR,2008,536186, ,NCI, , ,536186
DNA Damage and Tobacco-Induced Lung Cancer,7410077,5/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,331480, ,NCI, , ,331480
Investigating the Role of Cyr61 in Breast Cancer,7410130,7/26/2004 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,297342, ,NCI, , ,297342
Control of c-Myc Function by the Tumor Suppressor p19ARF,7410135,7/6/2004 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,264158, ,NCI, , ,264158
Hypoxia and Gene Repression,7413258,7/1/2000 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,314665, ,NCI, , ,314665
PROHIBITIN GENE IN GROWTH CONTROL AND TUMOR SUPPRESSION,7413414,9/30/1999 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,272261, ,NCI, , ,272261
" Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma",7413461,5/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,274719, ,NCI, , ,274719
Regulated Proteolysis in RAS Signal Transduction,7413568,5/1/2004 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,230763, ,NIGMS, , ,230763
Targeting JAB1 Oncogenic Function in Breast Cancer,7413658,4/1/2002 0:00,1/31/2012 0:00,Non-SBIR/STTR,2008,255009, ,NCI, , ,255009
Functional properties of centrosomes in somatic cells,7413737,5/1/1999 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,321845, ,NIGMS, , ,321845
Nuclear-targeted nanoparticles for gene delivery,7413802,9/1/2005 0:00,6/30/2009 0:00,Non-SBIR/STTR,2006,271565, ,NIBIB, , ,271565
Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette Smoke,7413918,5/1/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2008,285745, ,NCI, , ,285745
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors,7413945,7/15/2004 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,691465, ,NCI, , ,691465
Molecular Characterization of ACF (Abberant Crypt Foci),7414003,8/1/1999 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,243043, ,NCI, , ,243043
ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICE,7414101,4/1/1987 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,174086, ,NCI, , ,174086
Adenocarcinoma of the Lung: role of NNK susceptibility,7414536,9/30/1991 0:00,4/30/2011 0:00,Non-SBIR/STTR,2008,582839, ,NCI, , ,582839
Arsenic Induced Miotic Arrest Associated Apoptosis,7414686,8/1/2003 0:00,4/30/2009 0:00,Non-SBIR/STTR,2007,5414, ,NIEHS, , ,5414
"Chemosensitization of Pancreatic Tumors via Inhibition of a DNA BER Enzyme, Ape1",7414742,5/1/2007 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,181800, ,NCI, , ,181800
The Molecular Epidemiology of Bladder Cancer,7414757,5/1/2007 0:00,2/28/2012 0:00,Non-SBIR/STTR,2008,388525, ,NCI, , ,388525
The Role of E2F1 in UV-induced DNA Damage Response,7414868,5/3/2005 0:00,4/30/2010 0:00,Other Research-Related,2008,139847, ,NCI, , ,139847
Checkpoint Response and Platinum Drug Sensitivity,7414869,5/1/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2008,263340, ,NCI, , ,263340
Transformation of human mammary epithelium by c-Myc,7415039,5/1/1997 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,324481, ,NIA, , ,324481
DNA damage response and DDB,7415137,5/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,280493, ,NIA, , ,280493
MYC's Role in the Initiation and Maintenance of Cancer,7415161,6/1/2001 0:00,2/29/2012 0:00,Non-SBIR/STTR,2008,379965, ,NCI, , ,379965
Reversing Electrostatic Interactions for Improved Gene Delivery,7415176,7/14/2006 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,336476, ,NIBIB, , ,336476
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2 (LMP1 AND LMP2),7416651, , ,Non-SBIR/STTR,2007, ,346813, , , , 
Molecular Mechanisms by which Rexinoids Prevent Breast Cancer,7416721,4/6/1999 0:00,9/27/2009 0:00,Non-SBIR/STTR,2008,205205, ,NCI, , ,205205
Molecular Epidemiology of Esophageal Cancer Prognosis,7417437,8/5/2004 0:00,4/30/2011 0:00,Non-SBIR/STTR,2008,356765, ,NCI, , ,356765
A PTEN-Dependent Size Checkpoint in Human Cancer Cells,7417921,5/11/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,240742, ,NCI, , ,240742
Salivary Acinar Cell Apoptosis: Regulation of p53 by Akt,7417923,7/7/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2008,361262, ,NIDCR, , ,361262
p38 MAPK in Ras-induced Senescence and Transformation,7417969,7/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,319381, ,NCI, , ,319381
Genetic and Molecular Epidemiology of Adult Glioma,7417974,5/15/1991 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,1133948, ,NCI, , ,1133948
ECM-Mediated Apoptosis in p53 (-) HMECs,7418254,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,347277, ,NCI, , ,347277
NEW METHODS FOR CANCER DETECTION,7418399,3/1/1997 0:00,6/30/2007 0:00,Non-SBIR/STTR,2007,67005, ,NCI, , ,67005
Genetic Epidemiology of Familial Childhood Cancer Syndromes,7418585, , ,Non-SBIR/STTR,2007, ,239137, , , , 
Genomic Instability in Familial Cancer Syndromes,7418587, , ,Non-SBIR/STTR,2007, ,178035, , , , 
Molecular Genetic Anatomy of Li Fraumeni Syndrome (LFS),7418589, , ,Non-SBIR/STTR,2007, ,344779, , , , 
Mouse Models for Li Fraumeni Syndrome,7418590, , ,Non-SBIR/STTR,2007, ,308221, , , , 
High-Throughput Genotyping and Genetic Linkage Analysis Facility,7418593, , ,Non-SBIR/STTR,2007, ,313934, , , , 
Nucleic Acids Isolation and DNA Analysis Facility,7418594, , ,Non-SBIR/STTR,2007, ,230074, , , , 
Etiology of Balkan endemic nephropathy,7418616,4/1/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,36505, ,NIEHS, , ,32000
Molecular Mechanisms of Hormone-independence of Prostate Cancer,7418706,7/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,250280, ,NCI, , ,250280
IDENTIFICATION OF P53 ASSOCIATED PROTEIN COMPLEXES,7420685,9/20/2006 0:00,8/31/2007 0:00,Research Centers,2006, ,2859, , , , 
"TARGETED PROTEOMIC ANALYSIS OF 14-3-3 SIGMA, A P53 EFFECTOR COMMONLY SILENCED I",7420736,9/20/2006 0:00,8/31/2007 0:00,Research Centers,2006, ,2859, , , , 
Cables and the colonocyte,7420967,8/1/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,284164, ,NCI, , ,284164
Minority Predoctoral Fellowship Program,7421074,7/2/2004 0:00,5/7/2009 0:00,"Training, Individual",2008,26057, ,NCI, , ,26057
Mox 1: A Novel Mitogenic Oxidase,7422287,1/5/2000 0:00,2/29/2012 0:00,Non-SBIR/STTR,2008,269909, ,NCI, , ,269909
Fast Mutation Detection by Tandem SSCP/HA on Microchips,7422303,12/14/2007 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,249018, ,NCI, , ,249018
Regulatory Functions of APE1 - An Essential Repair Protein,7422319,12/1/1996 0:00,4/30/2011 0:00,Non-SBIR/STTR,2008,307134, ,NIEHS, , ,307134
Regulation of the KSHV latent promoter,7422376,8/1/2004 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,225602, ,NCI, , ,225602
Repair of Endogenous Damage in Mammalian Genomes,7422388,2/11/1991 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,328615, ,NCI, , ,328615
Epithelial Positioning Organization and Ovarian Cancer,7424068,3/1/2002 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,323942, ,NCI, , ,323942
Mechanism of Redox Regulation by Ape1/Ref-1,7424924,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,233196, ,NCI, , ,233196
The role of JNK in Mammary tumor development,7424977,9/29/2004 0:00,11/30/2010 0:00,Non-SBIR/STTR,2008,278349, ,NCI, , ,278349
Effect of caffeine on UVB-induced skin cancer,7424994,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,260528, ,NCI, , ,260528
Restoration of Tumor Suppression Activity in Malignant Melanoma,7424998,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,487128, ,NCI, , ,487128
Predictive Molecular Markers of Colorectal Cancer For African American Patients,7425151,9/30/2007 0:00,8/31/2011 0:00,Research Centers,2007, ,89600, , , , 
Elf/Smad4 in Gastrointestinal Cell Proliferation and Cell Cycle Progression,7425327,7/1/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,313662, ,NCI, , ,313662
Physical and Functional Interactions Between PML & MDM2,7425780,8/1/2004 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,227742, ,NCI, , ,227742
Molecular pathogenesis of UVB-induced skin cancer,7425781,8/15/2004 0:00,5/31/2009 0:00,Non-SBIR/STTR,2008,312948, ,NCI, , ,312948
A Functional Census of p53 Cancer and Suppressor Mutants,7426313,8/1/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,335397, ,NCI, , ,335397
Molecular and Cellular Origins of Pancreatic Cancer,7426354,5/18/2007 0:00,4/30/2010 0:00,Other Research-Related,2008,135270, ,NCI, , ,135270
"PDRG, a novel p53 and DNA damage-regulated gene and colorectal cancer",7426429,5/18/2007 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,192325, ,NIEHS, , ,192325
Activation of checkpoint pathways in cancer,7426455,7/19/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,186141, ,NCI, , ,186141
"CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER",7426467, , ,Research Centers,2007, ,322405, , , , 
Lana and Cellular Gene Expression in Kaposis Sarcoma,7426488,7/1/2000 0:00,2/28/2011 0:00,Non-SBIR/STTR,2008,226694, ,NCI, , ,226694
Mechanisms Regulating Reversal of Malignancy,7426783,8/30/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,197947, ,NCI, , ,197947
Study the Role of Chfr in Tumorigenesis,7426813,7/1/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2008,285172, ,NCI, , ,285172
PAC1 in Signaling Apoptosis and Tumor Suppression,7426827,8/1/2004 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,314822, ,NCI, , ,314822
A Nested Case-Control Study of Prostate Carcinogenesis,7426848,9/30/2000 0:00,2/28/2012 0:00,Non-SBIR/STTR,2008,588386, ,NIEHS, , ,588386
p53-Independent Cell Death Signaling by Mitomycin DNA Adducts,7427239,8/6/2008 0:00,7/31/2012 0:00,Other Research-Related,2008,329000, ,NCI, , ,329000
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors,7428779,7/31/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,277591, ,NCI, , ,277591
Role of Neuregulin-1 in Schwann Cell Neoplasia,7428840,9/15/2004 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,254350, ,NINDS, , ,254350
DNA Damage/Repair and Cell Death,7428843,4/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,287679, ,NINDS, , ,287679
Progesterone-mediated protection against ovarian cancer,7428867,9/1/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,258707, ,NCI, , ,258707
A Pathway of Tumor Suppression,7429670,7/1/1988 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,236943, ,NCI, , ,236943
Brain tumor angiogenesis: Integrin ceramide signaling,7429686,8/1/2004 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,266432, ,NCI, , ,266432
Chromosome instability resulting from double-strand breaks near telomeres,7429764,7/6/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,239592, ,NCI, , ,239592
p53-mediated control of numeral integrity of centrosomes,7430370,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,262217, ,NCI, , ,262217
SPORE in Prostate Cancer,7430975,8/1/1997 0:00,5/31/2013 0:00,Research Centers,2008,2300000, ,NCI, , ,2300000
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia,7431000,8/5/2003 0:00,4/30/2013 0:00,Research Centers,2008,2300000, ,NCI, , ,2300000
Training in Molecular Basis of Skin Pathobiology,7431561,6/1/2004 0:00,9/21/2009 0:00,"Training, Institutional",2008,227813, ,NCI, , ,227813
SPORE in Lung Cancer,7432315,9/15/2008 0:00,8/31/2013 0:00,Research Centers,2008,2000000, ,NCI, , ,2000000
Mechanisms of Particulate Matter Induced Death,7432478,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,331601, ,NIEHS, , ,331601
Cellular and molecular basis of malignant astrocytoma,7432528,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,309361, ,NINDS, , ,309361
wnt Signaling in Liver Development and Disease,7432529,7/15/2005 0:00,9/30/2008 0:00,Other Research-Related,2008,25717, ,NIDDK, , ,25717
Role and therapeutical potential of Cdk4/6 in B-lymphoma,7433277,7/10/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,193715, ,NCI, , ,193715
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,7433346,8/15/1999 0:00,8/31/2009 0:00,Non-SBIR/STTR,2008,280202, ,NCI, , ,280202
Markers of Early Pancreatic Cancer,7433347,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,282659, ,NCI, , ,282659
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas,7434225,9/11/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,311250, ,NCI, , ,311250
Molecular targeting of the survivin pathway in cancer,7434357,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,288775, ,NCI, , ,288775
Functional and Structural Studies of CD74 Activation,7434452,6/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,394019, ,NIAID, , ,394019
Phase I & II studies of topical agents for chemoprevention of skin cancer,7434456, , ,Non-SBIR/STTR,2007, ,1860081, , , , 
Molecular Mechanisms of UVA induced apotosis and carcinogenesis,7434457, , ,Non-SBIR/STTR,2007, ,1188058, , , , 
"Telomeres, Telomerase and Tumor Progression",7434484,8/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,328430, ,NCI, , ,328430
Genetic Control of Susceptibility to Testicular Cancer,7435240,6/1/1998 0:00,5/31/2009 0:00,Non-SBIR/STTR,2008,464235, ,NCI, , ,464235
Role of sestrin family genes in antioxidant defense,7435260,9/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,287127, ,NIA, , ,287127
The replication checkpoint and genomic fidelity in skin,7436267,6/1/2004 0:00,6/30/2009 0:00,Other Research-Related,2008,99792, ,NIAMS, , ,99792
Modeling ovarian carcinoma by defined genetic alterations,7436299,9/1/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,266292, ,NCI, , ,266292
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling,7436922,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,313533, ,NCI, , ,313533
Project 2- Radiation Biology,7438430,6/4/2007 0:00,5/31/2010 0:00,Research Centers,2007, ,16966, , , , 
Imaging Core,7438489,6/5/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2008, ,320044, , , , 
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer,7440209,8/4/2006 0:00,6/30/2011 0:00,Other Research-Related,2008,142560, ,NCI, , ,142560
Function of Mammalian SIRT1 in Aging,7440246,5/1/1999 0:00,5/31/2009 0:00,Non-SBIR/STTR,2008,413534, ,NIA, , ,413534
Function of the Adenovirus E1B Oncogene,7440304,1/1/1991 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,308663, ,NCI, , ,308663
Targeted Therapies in Melanoma,7440745,5/16/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2008,2332585, ,NCI, , ,2332585
Targeting the MAP and PI3 Kinase Pathways in Melanoma,7445504,4/1/2008 0:00,3/31/2013 0:00,Non-SBIR/STTR,2008, ,322681, , , , 
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity,7445507,4/1/2008 0:00,3/31/2013 0:00,Non-SBIR/STTR,2008, ,380128, , , , 
Cellular Senescence in Aging and Cancer,7446066,8/4/1999 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,453735, ,NCI, , ,453735
Characterization of a putative GTP-binding protein as a novel tumor marker.,7446107,6/12/2007 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,78500, ,NCI, , ,78500
Targeting Oncogene Expression to Skin in Transgenic Mice,7447403,8/1/1990 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,487219, ,NCI, , ,487219
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma,7448522, , ,Non-SBIR/STTR,2007, ,298204, , , , 
Soft Tissue Sarcoma Program Project,7448526,5/16/1997 0:00,6/30/2011 0:00,Non-SBIR/STTR,2008,1729965, ,NCI, , ,1729965
Therapeutic Potential and Mechanism of Action of Potent Small Molecule Inhibitors,7448851,7/1/2008 0:00,6/30/2013 0:00,Research Centers,2008, ,135761, , , , 
"Role of Soy Isoflavones, Smoking Abstinence and Molecular Markers in Prevention",7448852,7/1/2008 0:00,6/30/2013 0:00,Research Centers,2008, ,283027, , , , 
P-53-Based Vaccine for Small Cell Lung Cancer,7449124,9/15/2008 0:00,8/31/2012 0:00,Research Centers,2008, ,186853, , , , 
Role of TRPM1 (Melastatin1) in the Biology of Human Melanocytes,7450396,3/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2008,326700, ,NIAMS, , ,326700
UV regulation of anti-apoptotic co-repressor CtBP,7450879,8/1/2007 0:00,7/31/2008 0:00,Non-SBIR/STTR,2008,59746, ,NCI, , ,59746
Methylation in Cancer Progression of Barrett's Esophagus,7452293,7/20/2006 0:00,6/30/2011 0:00,Other Research-Related,2008,133850, ,NIDDK, , ,133850
Association of inflammatory genes and prostate cancer,7452328,9/24/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,441199, ,NCI, , ,441199
Transcriptional Repression by CtBP at the p21 Promoter,7452538,7/1/2005 0:00,6/30/2010 0:00,Other Research-Related,2008,137700, ,NCI, , ,137700
"Voltammetric, Surface, and Kinetic Studies of p53 and Amyloidogenic Proteins",7454135, , ,Other Research-Related,2007, ,599848, , , , 
"p53, Rb and Ras Pathways in Neural Stem Cell Homeostasis and Transformation",7454143,6/15/2007 0:00,6/14/2010 0:00,"Training, Individual",2008,51278, ,NINDS, , ,51278
Nuclear-targeted nanoparticles for gene delivery,7454388,9/1/2005 0:00,6/30/2011 0:00,Non-SBIR/STTR,2008,258417, ,NIBIB, , ,258417
Mechanisms linking ASPP2 to the Rb/E2F and p53 pathways,7455249,9/1/2004 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,301542, ,NCI, , ,301542
Function of MEF in Hematopoietic Cells,7455413,1/1/1997 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,500000, ,OD, , ,500000
Glucocorticoids & Vitamin D: Role in Antitumor Effects,7455731,2/1/2000 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,377384, ,NCI, , ,377384
Nitric oxide eluting therapies for vascular surgery,7455763,9/15/2006 0:00,6/30/2011 0:00,Other Research-Related,2008,127358, ,NHLBI, , ,127358
"Telomere dysfunction, p53 and tumorigenesis",7455773,7/1/2007 0:00,4/30/2009 0:00,Other Research-Related,2008,124552, ,NCI, , ,124552
Molecular Pathways in Suppression and Development of T Lineage Lymphomas,7455902,7/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,312629, ,NCI, , ,312629
Cellular Senescence and Control of Gene Expression,7456437,9/1/1990 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,504244, ,NIA, , ,504244
CDC25 PHOSPHATASES IN CELL CYCLE CONTROL AND CANCER,7457619,2/1/1992 0:00,3/31/2012 0:00,Non-SBIR/STTR,2008,315000, ,NIGMS, , ,315000
Role of MDM2 in Cell Proliferation and Tumorigenesis,7457718,7/1/1999 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,277695, ,NCI, , ,277695
Structural basis for CBP/p300 transcriptional regulation,7457719,6/10/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,419962, ,NCI, , ,419962
BubR1 in Cancer and Aging,7457969,7/1/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,301377, ,NCI, , ,301377
Selective Forces Operative in FeLV Infection,7458076,2/28/2000 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,268515, ,NCI, , ,268515
ECM-Mediated Apoptosis in p53 (-) HMECs,7458573,7/1/2000 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,79998, ,NCI, , ,79998
Center for digestive and liver diseases,7458718,7/1/1998 0:00,6/30/2012 0:00,Research Centers,2008,1145813, ,NIDDK, , ,1145813
Regulation of p53 function by Daxx,7458889,5/3/2001 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,253024, ,NCI, , ,253024
Genomic Profiling and clinical Outcome in Chronic Lymphocytic Leukemia,7459009,7/1/2007 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,149048, ,NCI, , ,149048
Mechanism of p63-Dependent Tumor Suppression,7459110,7/1/2003 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,297265, ,NCI, , ,297265
Oncogenic Function of a P53-Induced Phosphatase,7459478,4/1/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,266843, ,NCI, , ,266843
Cellular Stress Response Signaling Pathways,7459508,1/1/1992 0:00,4/30/2012 0:00,Non-SBIR/STTR,2008,411600, ,NIEHS, , ,411600
Functional analysis of a putative ATM/ATR substrate RFWD3,7460173,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,291650, ,NIGMS, , ,291650
Sequence distribution of tobacco carcinogen-DNA adducts,7460467,12/1/2002 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,210576, ,NCI, , ,210576
Mechanisms of tumor suppression by Fbw7,7460650,7/26/2006 0:00,6/30/2011 0:00,Other Research-Related,2008,140535, ,NCI, , ,140535
Chk2 as a target for regulating senescence in skin neoplasia,7460804,7/3/2007 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,80500, ,NCI, , ,80500
Mechanisms of Neuroprotection by Histone Deacetylase Inhibition,7461900,3/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2008,341250, ,NINDS, , ,341250
Analysis of the p53  in vivo using a unique mouse model,7461975,3/15/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2008,335365, ,NCI, , ,335365
The Role of Syndecan-1 in Mouse Mammary Neoplasia,7462004,12/21/2001 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,295173, ,NCI, , ,295173
"Breast Cancer, Radiation and the ATM-CHEK2 Pathway",7462345,6/1/2005 0:00,12/31/2010 0:00,Non-SBIR/STTR,2008,437161, ,NCI, , ,437161
"Structure, Function and Inhibition of Human Methionine Aminopeptidases",7462726,6/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,376391, ,NCI, , ,376391
Cancer Biology in the Zebrafish,7462902,7/3/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2008,367235, ,NCI, , ,367235
Development of cambinol analogues as antilymphoma agents,7463042,4/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2008,365200, ,NCI, , ,365200
Functional study of C53 protein as a novel regulator of checkpoint kinases,7463681,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,239913, ,NIGMS, , ,239913
Targeting Raf in Melanoma: Mechanisms for Effect & Resistance & Opportunities for,7464270,3/1/2008 0:00,2/28/2013 0:00,Research Centers,2008, ,249158, , , , 
Terminal Differentiation of the Renal Epithelium,7464550,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2008,284963, ,NIDDK, , ,284963
Cell Growth Signaling in Cancer Development,7464742,4/8/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,399870, ,NCI, , ,399870
Mechanisms of Cancer Initiation by TRIM32,7464831,5/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,344637, ,NCI, , ,344637
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1,7465014,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,304917, ,NCI, , ,304917
Gene targets of OLIG2 in malignant glioma stem cells,7465355,7/15/2007 0:00,4/30/2011 0:00,Non-SBIR/STTR,2008,427500, ,NINDS, , ,427500
Biological Function of the Retinoblastoma Gene Product,7465476,5/3/1994 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,342397, ,NCI, , ,342397
Survivorship research established investigator award,7466151,6/1/2008 0:00,5/31/2013 0:00,Other Research-Related,2008,152955, ,NCI, , ,152955
Mechanism of p53-Mediated Tumor Suppression,7466607,12/5/1997 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,306143, ,NCI, , ,306143
Mechanistic Studies on New Platinum Clinical Agents,7466829,9/30/1998 0:00,2/28/2013 0:00,Non-SBIR/STTR,2008,311523, ,NCI, , ,311523
Aflatoxin Biosynthesis and Iterative Type I Polyketide Synthases,7466922,2/1/1978 0:00,3/31/2013 0:00,Non-SBIR/STTR,2008,514167, ,NIEHS, , ,514167
Determinants of Metastatic Progression,7466961,7/23/2002 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,270291, ,NCI, , ,270291
Induction of genomic instability by HPV E6 and E7,7467125,9/8/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,305492, ,NCI, , ,305492
Role of RHO in Farnesyltransferase Inhibitor Responses,7467329,9/30/1999 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,307211, ,NCI, , ,307211
Mechanisms of Genetic Instability and Tumor Suppression,7467347,7/1/1993 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,507934, ,NCI, , ,507934
Function and regulation of SirT1 in cancer,7467380,7/11/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,283860, ,NCI, , ,283860
Self-Renewal of Normal and Leukemic Stem Cells,7468404,9/20/2004 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,283054, ,NCI, , ,283054
Endoscopic Therapy of Early Cancer in Barretts Esophagus,7468433,9/16/2005 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,315983, ,NCI, , ,315983
Pathways of Bladder Tumorgenesis,7468461,7/1/2007 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007, ,311506, , , , 
Preclinical Evaluation and Clinical Development of Potent Small-Molecule,7468644,6/1/2008 0:00,5/31/2013 0:00,Research Centers,2008, ,278234, , , , 
P53 Activation as Novel Therapeutic Stratgey for Acute Myelogenous Leukemia,7468678,5/1/2008 0:00,4/30/2013 0:00,Research Centers,2008, ,196116, , , , 
Molecular Mechanisms of Lymphomagenesis,7469965,8/1/2006 0:00,7/30/2010 0:00,Non-SBIR/STTR,2008,289553, ,NCI, , ,289553
The Role of P40 in Squamous Cell Carcinomas,7470155,9/1/2000 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,328730, ,NIDCR, , ,328730
Role of p53 and ptc tumor suppressive pathways in BCCs development and prevention,7470198,9/30/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,316789, ,NIEHS, , ,316789
Characterizing Potential Redox Mechanisms of Prostate Cancer Chemoprevention by E,7471362,5/1/2008 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,77000, ,NCI, , ,77000
Tumor Host Range Mutants of Polyoma and Their Targets,7471532,9/1/2001 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,617981, ,NCI, , ,617981
Mechanisms of p53 target gene activation in DNA damage responses,7471546,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,791377, ,NCI, , ,791377
Reactivation of the p53-mediated pro-Apoptotic Pathway Using Stapled Peptides,7471803,7/1/2008 0:00,6/30/2011 0:00,Other Research-Related,2008,162396, ,NCI, , ,162396
The Roles of HBXAP Gene in Ovarian Cancer,7471941,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,340300, ,NCI, , ,340300
Mutagenesis of p53 by reactive PAH and ROS,7471955,4/8/2008 0:00,3/31/2013 0:00,Non-SBIR/STTR,2008,313516, ,NIEHS, , ,313516
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,7471963,9/1/2008 0:00,8/31/2013 0:00,Other Research-Related,2008,161259, ,NCI, , ,161259
ATM Regulation via PP2A and Ceramide,7472184,3/1/2007 0:00,9/30/2011 0:00,Non-SBIR/STTR,2007,31054, ,NIGMS, , ,31054
Control of p53 function by Mdm2 E3 ubiquitin ligase,7472305,7/1/2007 0:00,6/30/2010 0:00,"Training, Individual",2008,54842, ,NCI, , ,54842
BK Virus as a Co-Factor in Prostate Cancer,7472467,8/1/2007 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,285018, ,NCI, , ,285018
Role of C/EBP in Cell Survival and Neoplasia,7472478,5/1/1990 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,255984, ,NCI, , ,255984
Genomic Methylation: A Mechanism to Alter Tumor Phenotype,7472480,5/1/1996 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,237671, ,NCI, , ,237671
Mechanisms of SAG Inhibition of Carcinogenesis & Apoptosis,7472518,9/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,261394, ,NCI, , ,261394
Cellular Consequences of Snf5 Tumor Suppressor Loss,7472522,7/1/2007 0:00,6/30/2010 0:00,"Training, Individual",2008,54842, ,NCI, , ,54842
The Environment and Epigenetic Gene Silencing in Cancer,7472592,9/30/2006 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,688149, ,NIEHS, , ,688149
Dietary Chemopreventive Components/Oncogene Interaction and Cancer,7472597,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,275500, ,NCI, , ,275500
Role of the STK Receptor in Erythropoiesis,7473899,8/15/2001 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,297176, ,NHLBI, , ,297176
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,7474129,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2008,365158, ,NCI, , ,365158
Regulation of MMP-9 mRNA stability and tumor growth by alpha3 beta1 integrin,7474354,9/26/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,325775, ,NCI, , ,325775
15-Lipoxygenase 2 is a Prostate Senescence Gene,7474522,9/1/2004 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,274534, ,NIA, , ,274534
Molecular Mechanisms of p53 dependent longevity regulation,7474684,8/1/2007 0:00,12/31/2008 0:00,Other Research-Related,2008,90000, ,NIA, , ,90000
Use of Beta-Lapachone for Lung Cancer Chemotherapy,7474860,8/1/2003 0:00,7/31/2008 0:00,Non-SBIR/STTR,2007,26169, ,NCI, , ,26169
Tumor targeted RNAi by novel nanovectors for molecular therapy of prostate cancer,7475129,8/1/2007 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,127680, ,NCI, , ,127680
Rapamycin-Induced Selective Apoptosis in Malignant Cells,7475318,12/1/1998 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,307071, ,NCI, , ,307071
Epigenetic Regulation of Cell and Tissue Aging,7476015,9/30/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2007,314675, ,NIA, , ,314675
Mechanistic Studies on New Platinum Clinical Agents,7476038,9/30/1998 0:00,4/30/2008 0:00,Non-SBIR/STTR,2007,281400, ,OD, , ,281400
Lipid peroxidation product induced DNA damage in the p53 gene and liver cancer,7476322,9/28/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,361563, ,NIEHS, , ,361563
Role of damaged DNA binding protein (DDB) in checkpoint control & carcinogenesis,7476340,1/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2008,257597, ,NCI, , ,257597
Genetic Epidemiology of Melanoma,7476354,9/30/2001 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,602074, ,NCI, , ,602074
Translational Control by elF2 Kinase during ER Stress,7476368,8/1/2001 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,265504, ,NIGMS, , ,265504
RAS INDUCED SENESCENCE AND TUMOR PROGRESSION,7476398,7/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2008,409452, ,NIA, , ,409452
SIGNALING PATHWAYS REGULATING EPITHELIAL CELL SURVIVAL,7476498,5/1/1999 0:00,7/31/2009 0:00,Non-SBIR/STTR,2008,209073, ,NIDDK, , ,209073
Murine Neuroblastoma Models for Preclinical Therapeutics,7477073,7/1/2003 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,261694, ,NCI, , ,261694
Control of Sir2 by Nuclear NAD Salvage Pathways,7477117,8/1/2005 0:00,9/29/2009 0:00,Non-SBIR/STTR,2008,244004, ,NIGMS, , ,244004
Activating liver carcinogens in yeast by expressing CYP450 polymorphisms,7477314,8/1/2007 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,217438, ,NIEHS, , ,217438
Stem Cells and Gastric Cancer,7477350,9/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,448475, ,NCI, , ,448475
Selenium protection of bone marrow during chemotherapy,7477652,8/1/2007 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,226500, ,NHLBI, , ,226500
Study on the intracellular Network of TBX3,7477694,8/1/2007 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,226875, ,NCI, , ,226875
Role of the chronic inflammatory mediator NO in early mammary tumorigenesis,7477843,8/1/2006 0:00,7/31/2009 0:00,Other Research-Related,2008,149580, ,NCI, , ,149580
"HPV: Biology, Clinical Significance and Epidemiology",7477983,6/1/1997 0:00,6/30/2012 0:00,Non-SBIR/STTR,2008,2263372, ,NCI, , ,2263372
Hypoxia signaling to checkpoint activation and apoptosis,7478395,8/4/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,346013, ,NCI, , ,346013
Altered Expression of Protein Tyrosine Phosphatase by Methylation,7478439, , ,Non-SBIR/STTR,2007, ,305254, , , , 
Pathology,7478443, , ,Non-SBIR/STTR,2007, ,319401, , , , 
Zebrafish Screens for Genetic Modifiers and Human Application in T-ALL,7478490, , ,Non-SBIR/STTR,2007, ,294496, , , , 
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein,7478514,9/30/1992 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,306916, ,NCI, , ,306916
Minority Predoctoral Fellowship Program,7478855,8/1/2004 0:00,7/31/2009 0:00,"Training, Individual",2008,42432, ,NCI, , ,42432
Functional Mimicry of the p53 C-terminal Tail by the Ubiquitin-like Molecule SUMO,7479043,4/15/2008 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,207225, ,NCI, , ,207225
Targeting Cell Cycle Checkpoints in Cancer Therapeutics,7479272,8/1/2006 0:00,7/31/2011 0:00,Other Research-Related,2008,133893, ,NCI, , ,133893
Genotyping Molecular Signatures of CRC using Polymer Microchip-CE and FSCE,7479576,8/6/2007 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,149160, ,NCI, , ,149160
"Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B",7479890, , ,Research Centers,2007, ,309081, , , , 
Telomere induced senescence as a supressor of tumorigenesis,7480280,8/8/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,292600, ,NCI, , ,292600
p53 and pathways of apoptosis,7480388,8/7/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,299250, ,NCI, , ,299250
NF Center: From Animal Models to Therapeutics,7482986,9/20/2005 0:00,4/30/2010 0:00,Research Centers,2008,1277420, ,NINDS, , ,1277420
Genomic Instability and Senescence in Cancer,7483121,9/14/2005 0:00,8/31/2010 0:00,Other Research-Related,2008,154797, ,NCI, , ,154797
Development of Selectors for Cancer Mutation Analysis,7483184,8/10/2007 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,197500, ,NCI, , ,197500
Role of H2AX and ATM in Suppression of Thymic Lymphomas,7483245, , ,Non-SBIR/STTR,2007, ,553367, , , , 
EARLY DETECTION OF URINARY BLADDER CANCER,7483250,9/30/1999 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,527583, ,NCI, , ,527583
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHN,7483254, , ,Research Centers,2007, ,377462, , , , 
SPORE in Head and Neck Cancer,7483258,7/1/2004 0:00,6/30/2010 0:00,Research Centers,2008,2184766, ,NCI, , ,2184766
Induction of MGMT as a Strategy for Chemoprevention,7483274,8/10/2007 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,74250, ,NCI, , ,74250
"UV-induced and NOS-mediated Zn elevation, translation regulatin and apoptosis.",7483439,9/1/2000 0:00,8/31/2008 0:00,Non-SBIR/STTR,2007,206388, ,OD, , ,206388
Sequence Distribution of Tabacco Carcinogen-DNA Adducts,7484005,4/1/2002 0:00,8/31/2008 0:00,Non-SBIR/STTR,2007,206858, ,OD, , ,206858
GENETIC ALTERATION IN EPITHELIAL AND STROMAL COMPARTMENT OF BREAST ADENOCARCINOMA,7484269, , ,Non-SBIR/STTR,2007, ,476934, , , , 
Prevention of quinone toxicity and mutagenicity,7484911,8/1/1996 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,331034, ,NIEHS, , ,331034
"Dysfunctional Telomeres, Checkpoints and Aging",7484951,9/30/2006 0:00,8/31/2011 0:00,Non-SBIR/STTR,2008,270786, ,NIA, , ,270786
Mouse Models of Human Breast Cancer,7485131,9/30/1999 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,831781, ,NCI, , ,831781
Role of Kruppel-Like Factor 4 in Wnt and Notch Signaling in the Intestinal Tract,7485349,8/1/2008 0:00,7/31/2011 0:00,"Training, Individual",2008,54842, ,NCI, , ,54842
Fast Mutation Detection by Tandem SSCP/HA on Microchips,7485498,12/14/2007 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,173000, ,NCI, , ,173000
Structural basis of signaling by ING2 PHD,7485606,9/6/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,196247, ,NCI, , ,196247
"Diet, DNA Repair Genes and Breast Cancer Risk",7485723,9/27/2005 0:00,8/31/2011 0:00,Other Research-Related,2008,114924, ,NCI, , ,114924
Effectors of p53 Pro-Survival & Pro-Apoptotic Signaling,7485763, , ,Non-SBIR/STTR,2007, ,535350, , , , 
Molecular Interactions and Regulation of p53,7485764, , ,Non-SBIR/STTR,2007, ,319911, , , , 
p53 Pathway in Postnatal Growth and Stem Cell Behavior,7485765, , ,Non-SBIR/STTR,2007, ,331009, , , , 
p53 - Regulators and Effectors,7485767,2/16/2000 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,1348536, ,NCI, , ,1348536
Mouse Model of Pancreatic Cancer Progression-Maintenance,7485838,9/21/2005 0:00,8/31/2010 0:00,Other Research-Related,2008,161730, ,NCI, , ,161730
The Role of Bcl2L12 in the Genesis of Malignant Glioma,7486342,8/17/2007 0:00,1/31/2009 0:00,Other Research-Related,2008,90000, ,NCI, , ,90000
Mouse Models of Human Breast Cancer,7487164,9/30/1999 0:00,3/31/2009 0:00,Non-SBIR/STTR,2007,43919, ,NCI, , ,43919
Southwest Oncology Group,7487679,2/1/1993 0:00,12/31/2009 0:00,Other Research-Related,2007,20000, ,NCI, , ,20000
Role of the p53 homolog p73 in cancer,7487702,1/14/2002 0:00,7/31/2008 0:00,Non-SBIR/STTR,2007,77500, ,NCI, , ,77500
MD Anderson Cancer Center SPORE in Head and Neck Cancer,7487716,9/30/2002 0:00,7/31/2008 0:00,Research Centers,2007,1150000, ,NCI, , ,1150000
Structure and Function of DNA Regulatory Proteins,7487979,1/1/1997 0:00,8/31/2011 0:00,Non-SBIR/STTR,2008,304530, ,NIGMS, , ,304530
Curcumin inhbits BPDE-induced damage by lowering the threshold of p53 activation,7488074,5/1/2008 0:00,3/31/2011 0:00,"Training, Individual",2008,28283, ,NIEHS, , ,28283
MD Anderson Cancer Center SPORE in Head and Neck Cancer,7488146,9/30/2002 0:00,7/31/2008 0:00,Research Centers,2007,750000, ,NIDCR, , ,750000
Bladder Cancer Prognostic Indicators,7488313,9/1/2005 0:00,8/31/2010 0:00,Other Research-Related,2008,144180, ,NCI, , ,144180
Cancer cell telomere dynamics and responses to perturbations,7488390,9/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,308158, ,NCI, , ,308158
Regulatory Networks in Human Embryonic Stem Cells,7488555,9/1/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2008,1790227, ,NIGMS, , ,1790227
HPV E6 protein regulation of the hTERT promoter,7488862,9/16/2004 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,297995, ,NCI, , ,297995
SPORE in Head and Neck Cancer,7489072,7/1/2004 0:00,6/30/2009 0:00,Research Centers,2007,200000, ,NCI, , ,200000
Sequence Distribution of Tabacco Carcinogen-DNA Adducts,7489139,4/1/2002 0:00,8/31/2008 0:00,Non-SBIR/STTR,2007,30140, ,NCI, , ,30140
Functional analysis of the p53 tumor suppressor,7489247,8/15/1985 0:00,7/30/2013 0:00,Non-SBIR/STTR,2008,215047, ,NCI, , ,215047
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,7489389,5/1/1997 0:00,8/31/2011 0:00,Non-SBIR/STTR,2008,1391271, ,NCI, , ,1391271
NITROAROMATICS AND BREAST CANCER,7489924,7/1/1983 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,13409, ,NCI, , ,13409
Targeting transforming growth factor beta for cancer treatment,7489971,7/15/1997 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,218928, ,NCI, , ,218928
PROGNOSTIC & PREDICTIVE  FACTORS IN OUTCOME OF PATIENTS WITH COLORECTAL CANCER:,7490493, , ,Research Centers,2007, ,271039, , , , 
MOLECULAR CHANGES IN THE NKFB PATHWAY IN RESPONSE TO CHEMORADIATION THERAPY IN RE,7490494, , ,Research Centers,2007, ,339285, , , , 
Cooperation of PTEN and SHIP as tumor suppressors in B-Cells,7491073,9/30/2007 0:00,8/31/2012 0:00,Other Research-Related,2008,108558, ,NCI, , ,108558
Modulation of radiosensitivity in zebrafish,7491214,9/12/2005 0:00,9/11/2009 0:00,"Training, Individual",2008,39373, ,NCI, , ,39373
A novel regulator of p53,7491822,8/15/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,253086, ,NCI, , ,253086
Testing the Cancer Stem Cell Hypothesis: Role of CD133+ Cells as Tumor Stem Cells,7492254,9/1/2007 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,227063, ,NINDS, , ,227063
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER,7492504,9/1/2003 0:00,8/31/2009 0:00,Non-SBIR/STTR,2007,82880, ,NCI, , ,82880
Clinical Investigator Development in Solid Tumor Oncology,7492614,9/1/2000 0:00,6/30/2011 0:00,Other Research-Related,2008,153090, ,NCI, , ,153090
Cyclins and Cyclin-dependent kinases as targets for protection against radiation,7493028, , ,Non-SBIR/STTR,2007, ,300307, , , , 
Diagnostic Therapeutic Targets in Prostate Cancer,7493173,6/12/2003 0:00,5/31/2009 0:00,Non-SBIR/STTR,2007,369102, ,NCI, , ,369102
Monoclonal Antibody Therapy in B-Cell CLL.,7493381,6/1/2004 0:00,5/31/2009 0:00,Other Research-Related,2008,131814, ,NCI, , ,131814
Breast Cancer Prevention by Dietary Phytochemicals,7493526,9/7/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,282150, ,NCI, , ,282150
Pre-Clinical Evaluation of Novel Therapeutics for PDA,7494023,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2008,43428, ,NCI, , ,43428
Lineage Tracy in Murine Pancreatic Cancer Metastasis,7494031,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2008,45048, ,NCI, , ,45048
P53-dependent responses to toxicants in parous and nulliparous breast,7494463,9/7/2007 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,359795, ,NIEHS, , ,359795
Pre-Clinical Evaluation of Novel Therapeutics for PDA,7494797,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2007,7000, ,NCI, , ,7000
Lineage Tracy in Murine Pancreatic Cancer Metastasis,7494803,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2007,7000, ,NCI, , ,7000
Genomic Analysis of the p53 Pathway in Normal and Cancer Cells,7495190, , ,Non-SBIR/STTR,2007, ,381935, , , , 
p53 and Chemosensitivity in a Mouse Lymphoma Model,7495191, , ,Non-SBIR/STTR,2007, ,403944, , , , 
Molecular Studies of the p53 Pathway in Human Cancer,7495192, , ,Non-SBIR/STTR,2007, ,416746, , , , 
Roles and Regulation of p53,7495193,9/30/2000 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,1594789, ,NCI, , ,1594789
Role of Slug in Regulation of Hematopietic Stem Cells,7495197,9/10/2007 0:00,7/31/2010 0:00,Other Research-Related,2008,131441, ,NIDDK, , ,131441
Molecular Epidemiology of Colorectal Cancer Subtypes,7496492,9/15/2005 0:00,6/30/2011 0:00,Non-SBIR/STTR,2008,326923, ,NCI, , ,326923
Translation of tumor suppressor genes into new lung cancer therapeutics,7496565, , ,Research Centers,2007, ,308700, , , , 
Somatic genetic predictors of response to therapy in metastatic melanoma,7496600,9/13/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,314405, ,NCI, , ,314405
Inductible mouse models for oral cancer,7496741,1/13/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2007,300300, ,NIDCR, , ,300300
Chemoprevention of Lung Cancer with Anti-tumor B,7497162,9/30/2007 0:00,8/31/2011 0:00,Non-SBIR/STTR,2008,368725, ,NCCIH, , ,368725
Integral activity of the p53 family and its role in progression of colon tumors,7497907,9/18/2007 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,153500, ,NCI, , ,153500
Dual Role of E2F1 in Tumorigenesis,7498286,1/18/1999 0:00,1/31/2009 0:00,Non-SBIR/STTR,2007,47655, ,NCI, , ,47655
An Exploratory Study of UCN-01 and Irinotecan in Advanced Triple Negative Breast,7498461,9/24/2007 0:00,8/31/2011 0:00,Non-SBIR/STTR,2008,269233, ,NCI, , ,269233
p53 signatures and pelvic serous carcinoma,7498471,9/20/2007 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,143004, ,NCI, , ,143004
THE THERAPY OF AML,7498503,5/27/1997 0:00,8/31/2012 0:00,Non-SBIR/STTR,2008,2374635, ,NCI, , ,2374635
Integration of Oncogenic Networks in Cancer Phenotypes,7498506,9/30/2004 0:00,2/28/2011 0:00,Research Centers,2008,2045871, ,NCI, , ,2045871
SPORE in Head and Neck Cancer,7498674,7/1/2004 0:00,6/30/2009 0:00,Research Centers,2007,350000, ,NCI, , ,350000
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA,7498909,5/1/1997 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,280617, ,NCI, , ,280617
Polyoma Virus Disrupts ARF Signaling to p53,7498942,4/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,308158, ,NCI, , ,308158
Carcinogen Exposure and Adult Cancer Risk,7498957,9/21/2007 0:00,7/31/2011 0:00,Non-SBIR/STTR,2008,277400, ,NCI, , ,277400
Epigenetic Regulation of Cell and Tissue Aging,7499013,9/30/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2008,308382, ,NIA, , ,308382
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer,7499091,9/8/1989 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,325941, ,NCI, , ,325941
Molecular dissection of pancreatic ductal adenocarcinoma,7499106,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,387206, ,NCI, , ,387206
Mechanistic Studies of Mediator and the p53 Tumor Suppressor,7499116,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,227326, ,NCI, , ,227326
Transfected cell arrays for cancer research,7499610,9/24/2007 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,145665, ,NCI, , ,145665
Imaging Lung Cancer in Mice To Improve Radiation Therapy,7500118,8/3/2005 0:00,7/31/2010 0:00,Other Research-Related,2008,130329, ,NCI, , ,130329
Functional Characterization of WTX in Renal Development,7500170,9/30/2007 0:00,8/31/2012 0:00,Other Research-Related,2008,137160, ,NIDDK, , ,137160
Full Project 1: Tumor-targeted MR Contrast Enhancement Using Molecular Imaging Te,7500240, , ,Research Centers,2007, ,149910, , , , 
Use of Beta-Lapachone for Lung Cancer Chemotherapy,7500392,8/1/2003 0:00,6/30/2008 0:00,Non-SBIR/STTR,2007,78500, ,NCI, , ,78500
Zinc Finger Recombinases for Endogenous Genome Tailoring,7500623,9/1/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,209700, ,NCI, , ,209700
Mitochondrial translocation of p53 and its interaction with manganese superoxide ,7501346,9/27/2007 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,73250, ,NCI, , ,73250
Quantitative Measurements and Modeling of the Mitotic Checkpoint,7501493,9/28/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2008,350000, ,NIGMS, , ,350000
Impact of BRG1 Loss in Lung Cancer Development,7501507,9/27/2007 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,273980, ,NCI, , ,273980
Prostaglandin D and skin cancer prevention,7502019,9/24/2007 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,65651, ,NCI, , ,65651
Defining PAH-mediated carcinogenesis in lung: CYP metabolism and B[a]P transport,7502209,9/30/2007 0:00,9/29/2010 0:00,"Training, Individual",2008,49646, ,NIEHS, , ,49646
MOLECULAR BIOMARKERS FOR ENVIRONMENTAL TOXICANTS,7502308,6/1/1997 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,1856927, ,NIEHS, , ,1856927
Role of Bub1 in SV40 large T antigen mediated transformation and replication,7502382,9/10/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2008,373497, ,NIAID, , ,373497
Mechanisms of Radioresistance and Cell Cycle Progression,7502577,9/28/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,360812, ,NCI, , ,360812
Ultrasensitive Nanoscale Magnetic Sensors for Label-free Analysis of Cancer,7503218,9/24/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,191066, ,NCI, , ,191066
Growth Inhibition by the ARF Tumor Suppressor,7503374,4/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,265940, ,NCI, , ,265940
Sphingolipids in Cancer Biology and Therapy,7503605,8/1/2003 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,1115156, ,NCI, , ,1115156
FAK Signals Controlling Endothelial Cell Survival and Motility,7504814,9/1/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2008,483094, ,NHLBI, , ,483094
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development,7506515,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,340300, ,NCI, , ,340300
P-4: Targeting activation of NFkB pathways in MM,7507317,7/1/2008 0:00,6/30/2013 0:00,Research Centers,2008, ,211553, , , , 
Regulation and Function of the p14ARF/topoisomerase I Complex in Cancer,7508133,7/10/2008 0:00,5/31/2009 0:00,Non-SBIR/STTR,2008,404625, ,NCI, , ,404625
MicroRNA Function in the Immune System,7508149,5/15/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2008,401250, ,NIAID, , ,401250
P-1:  Intrinsic Apoptosis Phenotype and Susceptibility to Squamous Cell Carcinoma,7510668,8/1/2008 0:00,7/31/2013 0:00,Research Centers,2008, ,169505, , , , 
P2:  Cancer Risk Assessment in Patients with Oral Premalignant Lesions,7510672,8/1/2008 0:00,7/31/2013 0:00,Research Centers,2008, ,220258, , , , 
Project 4: NOX1 Involvement In Colon Cancer,7511070,7/1/2008 0:00,6/30/2013 0:00,Non-SBIR/STTR,2008, ,135673, , , , 
Molecular Pathology of t-AML,7512201,7/1/2008 0:00,6/30/2013 0:00,Non-SBIR/STTR,2008, ,424551, , , , 
The Role of Geminin in Hematopoiesis,7512718,9/19/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,228750, ,NHLBI, , ,228750
A high resolution comparative analysis of early onset breast cancer by race,7512958,9/27/2007 0:00,9/26/2009 0:00,"Training, Individual",2008,30000, ,NCI, , ,30000
Role of p53 and the p53-inducible Sestrin1 and 2 genes in hepatocarcinogenesis,7513043,8/1/2008 0:00,6/30/2010 0:00,Other Research-Related,2008,78214, ,NIDDK, , ,78214
Role of PUMA in EGFR targeted therapy in HNSCC,7514220,8/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,314363, ,NCI, , ,314363
"Characterization of Mutagenesis, Mutational Spectra and Mechanisms of Toxicity",7514462,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2009, ,359886, , , , 
Redox Regulation of Tumor Suppression by MnSOD,7514522,9/1/1998 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,383990, ,NCI, , ,383990
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression,7514779,9/3/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,233704, ,NCI, , ,233704
p63/p73 Signaling Axis as a Target for Treatment of Triple-Negative Breast Cancer,7515256,9/11/2008 0:00,5/31/2013 0:00,Research Centers,2008, ,236780, , , , 
Mechanisms of transcriptional repression by p53 during hypoxic stress,7515446,12/1/2007 0:00,5/31/2010 0:00,"Training, Individual",2009,55310, ,NCI, , ,55310
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman),7515836,9/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008, ,409002, , , , 
High Throughput Screening,7516326,2/1/2007 0:00,1/31/2012 0:00,Research Centers,2007, ,128405, , , , 
Monitoring mechanisms in mammalian ribosome biogenesis,7516545,2/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2007,132141, ,NIGMS, , ,132141
High Throughput Screen for Small Molecule Inhibitors of Colorectal Cancer Cell Pr,7522200,6/1/2008 0:00,5/31/2009 0:00,Non-SBIR/STTR,2008,25000, ,OD, , ,25000
Oligoclonal T Cell Expansion and Rheumatoid Arthritis,7523762,9/30/1993 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,341000, ,NIAMS, , ,341000
Biomarkers of survival in glioma epidemiology,7523958,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,416687, ,NCI, , ,416687
Role of EGFR in DNA Repair and Radiation Response in Non Small Cell Lung Cancer,7524320,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,260620, ,NCI, , ,260620
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis,7524357,9/15/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,307100, ,NCI, , ,307100
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK,7524819,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,315400, ,NCI, , ,315400
Epithelial Stem Cell Programs,7525372,8/1/2008 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,380250, ,NIGMS, , ,380250
"UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis",7525846,9/1/2000 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,209081, ,NCI, , ,209081
Correlative Studies for NCI Study #7977: Phase I trial of ABT-888 Plus Irinotecan,7525941,7/1/2008 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,350813, ,NCI, , ,350813
Androgen and Soluble Guanylyl Cyclase Signaling in Prostate Cancer,7526149,7/1/2008 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,187920, ,NCI, , ,187920
The role of p63 and p73 in cancer,7526775,1/14/2002 0:00,4/30/2013 0:00,Non-SBIR/STTR,2008,235373, ,NCI, , ,235373
Interaction Between SV40 Large T and P185 Cullin,7526929,7/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,282001, ,NCI, , ,282001
"Spindle Assembly Checkpoint, Chromosomal Instability, and Cancer",7527089,9/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,318513, ,NCI, , ,318513
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer,7527760,9/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,247478, ,NCI, , ,247478
Role of Proline in Redox Homeostasis and Apoptosis,7527949,8/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,282829, ,NIGMS, , ,282829
The Role of Fbxw7 in genetic instability and cancer,7528085,9/1/2008 0:00,10/31/2008 0:00,Non-SBIR/STTR,2008,41452, ,NCI, , ,41452
Treatment of Melanoma with wild-type P53 and detectable S100B using pentamidine: ,7529101,7/1/2008 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,311250, ,NCI, , ,311250
The role of cyclin E deregulation in breast tumorigenesis,7529227,9/1/2008 0:00,8/31/2011 0:00,Other Research-Related,2008,153209, ,NCI, , ,153209
Mechanisms of IGF-1 mediated rescue of radiation-induced salivary gland dysfuncti,7530790,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,335683, ,NIDCR, , ,335683
FHIT Gene Therapy in Cancer Prevention and Treatment,7531058,12/1/2006 0:00,11/30/2009 0:00,Non-SBIR/STTR,2009,228000, ,NCI, , ,228000
Role of ATM in Cardiac Myocyte Loss and Myocardial Remodeling,7531442,8/1/2008 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,213000, ,NHLBI, , ,213000
Studying the control of Cytokinesis as an Evolved Complex System,7532221,8/1/1999 0:00,7/31/2012 0:00,Non-SBIR/STTR,2008,314519, ,NIGMS, , ,314519
"BRM promoter polymorphism, a marker for cancer risks",7532235,9/15/2008 0:00,6/30/2009 0:00,Non-SBIR/STTR,2008,77250, ,NCI, , ,77250
p53 Acetylation and Deacetylation in Tumorigenesis,7532350,4/1/2000 0:00,4/30/2013 0:00,Non-SBIR/STTR,2008,290920, ,NCI, , ,290920
Radiation-induced Nitric Oxide & Cellular Radiosensitivity,7533221,7/10/2002 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,273561, ,NCI, , ,273561
Regulation of p53 tumor suppressor protein,7533334,2/1/1993 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,516136, ,NCI, , ,516136
ROLE OF HISTONE H4 N-TERMINAL TAIL IN TRANSCRIPTION REGULATION,7533491,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,347461, ,NIGMS, , ,347461
Oxidative Injury to Gastric Epithelial Cells by H. pylori,7533775,9/21/2001 0:00,4/30/2012 0:00,Non-SBIR/STTR,2008,321938, ,NIDDK, , ,321938
Molecular Studies on MUC4 Mucin Gene,7533778,9/1/2008 0:00,6/30/2012 0:00,Non-SBIR/STTR,2008,224040, ,NCI, , ,224040
Genetic analysis of genomic instability and cancer in zebrafish,7533835,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,309497, ,NCI, , ,309497
Studies on the Post-translational processing of MUC1,7533934,9/1/1992 0:00,4/30/2013 0:00,Non-SBIR/STTR,2008,263177, ,NCI, , ,263177
Role of Sphingosine Kinase in p53 Cancer Biology,7534138,8/1/2003 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008, ,152945, , , , 
Mechanisms of cyclin E associated tumorigenesis,7534164,7/1/2003 0:00,6/30/2008 0:00,Other Research-Related,2007,100675, ,NCI, , ,100675
Inductible mouse models for oral cancer,7534328,1/13/2005 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,350204, ,NIDCR, , ,350204
Radioprotection by targeted siRNA delivery to salivary gland,7534718,8/1/2008 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,192500, ,NIDCR, , ,192500
Deciphering how MdmX deregulation impacts the p53 pathway,7534763,4/1/1995 0:00,11/30/2010 0:00,Non-SBIR/STTR,2009,215084, ,NCI, , ,215084
Role of an unusual GTPase in DNA damage response and carcinogenesis,7535027,12/1/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2009,352219, ,NCI, , ,352219
MECHANISMS OF ESTROGEN RECEPTOR REGULATION,7535261,2/1/2006 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,231383, ,NCI, , ,231383
Targeting p53 for colon cancer treatment & prevention,7535437,9/1/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,216892, ,NCI, , ,216892
Mammalian Polyamine Metabolism,7535608,12/1/1975 0:00,11/30/2010 0:00,Non-SBIR/STTR,2009,313665, ,NCI, , ,313665
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer,7535750,9/8/1989 0:00,5/31/2012 0:00,Non-SBIR/STTR,2007,325941, ,NCI, , ,325941
Mouse Model of Pancreatic Tumorigenesis with Dysregulation of  mTOR,7535942,6/6/2008 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,77000, ,NCI, , ,77000
"Telomerase in Development, Senescence and Neoplasia",7536022,1/1/2000 0:00,12/31/2009 0:00,Non-SBIR/STTR,2009,595470, ,NCI, , ,595470
Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors,7537237,12/7/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2009,300875, ,NCI, , ,300875
Interactions and Functions of p14ARF in Cancer,7538353,1/1/2005 0:00,3/10/2009 0:00,Non-SBIR/STTR,2009,83239, ,NCI, , ,83239
Oncogenic Gene Regulatory Networks,7539157,2/1/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2009,284064, ,NCI, , ,284064
Mechanisms of Cell Cycle Associated Neoplasia,7539932,2/16/2000 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,348574, ,NCI, , ,348574
Rapid release paclitaxel nanoparticles for bladder cancer intravestical therapy,7539992,8/1/2004 0:00,8/31/2010 0:00,SBIR/STTR,2008,730684, ,NCI, , ,730684
The Role of Non-C anonical Bax/Bak Direct Activators in Hematological Cancers,7540006,8/25/2008 0:00,8/24/2011 0:00,"Training, Individual",2008,49646, ,NCI, , ,49646
Modulators of p53 Expression and Function,7540786,9/1/1997 0:00,6/30/2009 0:00,Non-SBIR/STTR,2007,343545, ,NCI, , ,343545
p53 Signaling and Cellular Response After Stress,7541004,1/1/1997 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,330828, ,NCI, , ,330828
Glucose Metabolism and p53 in Leukemia,7541047,8/20/2008 0:00,8/19/2011 0:00,"Training, Individual",2008,29636, ,NHLBI, , ,29636
Multi-institutional trial: molecular analysis of margins,7541359,2/1/2005 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,214028, ,NCI, , ,214028
MDM2 regulates XIAP gene expression in cancer treatment,7541424,12/15/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2009,257300, ,NCI, , ,257300
Small RNA targeted gene activation for the treatment of prostate cancer,7541428,1/1/2008 0:00,6/30/2010 0:00,Non-SBIR/STTR,2009,173813, ,NCI, , ,173813
Nanoscale Functional Dendrimer-DNA Assemblies,7541466,12/4/2006 0:00,11/30/2010 0:00,Non-SBIR/STTR,2009,162500, ,NCI, , ,162500
The Molecular Epidemiology of Bladder Cancer,7541681,5/1/2007 0:00,2/28/2012 0:00,Non-SBIR/STTR,2007,428943, ,NCI, , ,428943
Role of PP2A in Lung Cancer,7541803,1/1/2008 0:00,12/31/2011 0:00,Non-SBIR/STTR,2009,320588, ,NCI, , ,320588
Development of MDMX Inhibitors for Retinoblastoma,7544296,8/1/2008 0:00,5/15/2009 0:00,"Training, Individual",2008,40850, ,NCI, , ,40850
Identification of Genes Required for Cellular Senescence,7544312,12/1/2008 0:00,11/30/2010 0:00,"Training, Individual",2008,46826, ,NCI, , ,46826
The Pathogenesis of Dyskeratosis Congenita,7544510,2/8/2005 0:00,8/17/2010 0:00,Non-SBIR/STTR,2009,286517, ,NCI, , ,286517
Prolactin as a risk biomarker of ovarian cancer,7544632,8/8/2008 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,75750, ,NCI, , ,75750
Host Immunity to EBV Infection in Vitro and in VIvo,7544933,9/1/1981 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,411979, ,NIAID, , ,411979
Defining the Contributions of Pancreatic Ductal and Acinar Cells to Tumorigenesis,7545709,7/3/2008 0:00,7/2/2010 0:00,"Training, Individual",2008,51278, ,NCI, , ,51278
Alternate Pathways for Interferon and Cytokine Signaling,7546130, , ,Non-SBIR/STTR,2007, ,402511, , , , 
FoxM1 and Oncogenic Pathways in Hepatocellular Carcinoma,7546376,1/1/2009 0:00,12/31/2011 0:00,"Training, Individual",2008,45972, ,NCI, , ,45972
Klf4 in tumor initiation and maintenance of squamous cell carcinoma,7546582,3/1/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2009,278350, ,NCI, , ,278350
Cell fate decision in response to p53-dependent DNA damage/genotoxic stress,7546594,7/1/2001 0:00,12/31/2011 0:00,Non-SBIR/STTR,2009,273221, ,NCI, , ,273221
Apoptosis by FADD in normal and cancerous cells,7546653,2/22/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2009,288389, ,NCI, , ,288389
MDM2 AS A NEGATIVE REGULATOR OF P21 WAF1/CIP1,7546657,1/1/2005 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,145536, ,NCI, , ,145536
Enhancing Activity of Alkylating Agents in Neuroblastoma,7546971,9/1/1999 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,231069, ,NCI, , ,231069
TGF-beta signaling and colon cancer,7547050,1/1/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2009,324058, ,NCI, , ,324058
Discovering TREX1 and TREX2 Function in Mammalian Cells and Mice,7548181,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,277400, ,NCI, , ,277400
Active Immune Therapy ot Leukemia Associated Antigens and Gene Therapy,7550204, , ,Non-SBIR/STTR,2007, ,276593, , , , 
Signal Transduction and Kinase Inhibition in CLL,7550207, , ,Non-SBIR/STTR,2007, ,286908, , , , 
Integration of Ocogenic Networks in Cancer Phenotypes,7550558, , ,Research Centers,2007, ,2106993, , , , 
CELL CYCLE TRANSCRIPTION REGULATION IN MEDULLOBLASTOMAS,7553659, , ,Non-SBIR/STTR,2004, ,256055, , , , 
TUMOR SUPPRESSOR RB FAMILY/PRB2 IN MEDULLOBLASTOMA,7553660, , ,Non-SBIR/STTR,2004, ,256053, , , , 
CELL CYCLE TRANSCRIPTION REGULATION IN MEDULLOBLASTOMAS,7553664, , ,Non-SBIR/STTR,2005, ,255813, , , , 
TUMOR SUPPRESSOR RB FAMILY/PRB2 IN MEDULLOBLASTOMA,7553665, , ,Non-SBIR/STTR,2005, ,255913, , , , 
CELL CYCLE TRANSCRIPTION REGULATION IN MEDULLOBLASTOMAS,7553669, , ,Non-SBIR/STTR,2006, ,255813, , , , 
TUMOR SUPPRESSOR RB FAMILY/PRB2 IN MEDULLOBLASTOMA,7553670, , ,Non-SBIR/STTR,2006, ,255913, , , , 
CELL CYCLE TRANSCRIPTION REGULATION IN MEDULLOBLASTOMAS,7553674, , ,Non-SBIR/STTR,2007, ,181837, , , , 
TUMOR SUPPRESSOR RB FAMILY/PRB2 IN MEDULLOBLASTOMA,7553675, , ,Non-SBIR/STTR,2007, ,181943, , , , 
Modulation of a novel cell cycle checkpoint by the HPV oncogene E6,7554131,1/15/2008 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,203125, ,NIAID, , ,203125
Bim regulation by HHV-8 vIRF-1,7554328,8/5/2008 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,184500, ,NCI, , ,184500
Growth Control and Anti-Cancer Mechanisms,7554656,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,295450, ,NCI, , ,295450
A novel regulator of p53,7554732,8/15/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2007,201390, ,NCI, , ,201390
Rac GTPases as Targets in Lymphomagenesis,7555041,2/10/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,285000, ,NCI, , ,285000
Research Career Development in HIV-Related Anal Dysplasia/Carcinoma Prevention an,7555115,9/15/2008 0:00,8/31/2013 0:00,Other Research-Related,2008,113586, ,NIAID, , ,113586
Cooperation of oncogenic mutations in the control of malignancy,7555355,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,292600, ,NCI, , ,292600
The Role of NF-kappaB in Chemotherapy Resistance,7555380,1/1/2005 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,340162, ,NCI, , ,340162
Triple threat screening for modifiers of Protein Ser/Thr Phosphatase 2C,7555514,6/15/2008 0:00,5/31/2010 0:00,Non-SBIR/STTR,2008,151500, ,OD, , ,151500
Study of a FACTp140-SSRP1-associated p53 Kinase,7555535,1/10/2002 0:00,12/31/2008 0:00,Non-SBIR/STTR,2006,7550, ,NCI, , ,7550
NF Center: From Animal Models to Therapeutics,7557440, , ,Research Centers,2007, ,217573, , , , 
Nuclear Accumulation of Cyclin D1 and Oncogenesis,7558265,7/1/2001 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,291081, ,NCI, , ,291081
FDH: A Novel Determinant of Tumor Suppression,7558315,3/1/2005 0:00,1/31/2010 0:00,Non-SBIR/STTR,2009,246068, ,NCI, , ,246068
The role of glutathione peroxidase in the pathogenesis of intestinal cancer,7559559,3/1/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,262148, ,NCI, , ,262148
Modulation of DNA methylation status by dietary zinc: role in cancer prevention,7559577,1/25/2008 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,156431, ,NCI, , ,156431
Genetic modifiers of mammary tumor susceptibility,7559622,2/15/2005 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,286406, ,NCI, , ,286406
Prevention of Oral Cancer by Tea: A mechanism Study,7559962,3/16/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,284153, ,NCI, , ,284153
Transcriptional Activator/Coactivator Interactions,7560419,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,326088, ,NCI, , ,326088
Genetic Pathways Governing Pancreatic Ductal Adenocarcinoma,7560581, , ,Non-SBIR/STTR,2007, ,212639, , , , 
The RAS and P13K Pathways in Pancreatic Adenocarcinoma,7560582, , ,Non-SBIR/STTR,2007, ,366179, , , , 
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer,7560583, , ,Non-SBIR/STTR,2007, ,290661, , , , 
Experimental Pathology Core,7560586, , ,Non-SBIR/STTR,2007, ,172426, , , , 
MBRA SUBRPOJECT 2:THE ROLE OF GENE EXPRESSION IN BREAST CANCER PREVENTION,7561446,6/1/2007 0:00,5/31/2008 0:00,Research Centers,2007, ,36074, , , , 
ASSESSMENT OF ANTICANCER PROPERTIES/ACTIVITIES OF PURIFIED EXTRACTS OF VERONIA A,7561481,6/1/2007 0:00,5/31/2008 0:00,Research Centers,2007, ,93673, , , , 
THE STUDY AND CHARACTERIZATION OF XENOESTROGEN EFFECTS,7561482,6/1/2007 0:00,5/31/2008 0:00,Research Centers,2007, ,124898, , , , 
ID PROTEIN FAMILY EXPRESSION AND FUNCTION IN PROSTATE CANCER,7561510,6/1/2007 0:00,5/31/2008 0:00,Research Centers,2007, ,87411, , , , 
"Characterization of Mutational Spectra, Mechanisms of Toxicity and Homologous Rec",7561695, , ,Non-SBIR/STTR,2008, ,557446, , , , 
Aflatoxin Biosynthesis and Iterative Type I Polyketide Synthases,7561699,2/1/1978 0:00,3/31/2013 0:00,Non-SBIR/STTR,2009,419154, ,NIEHS, , ,419154
Stress- and Promoter-Specific Mechanisms of Transcritpional Activation by p53,7561755,5/26/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,205444, ,NCI, , ,205444
DOWNREGULATION OF P53 PROTEIN BY KSHV VIRF1,7562089,5/1/2007 0:00,4/30/2008 0:00,Research Centers,2007, ,58033, , , , 
"Obesity, H pylori and Risk of Barrett's Esophagus",7564034,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,564445, ,NCI, , ,564445
Prostate cancer chemoprevention by penta-galloyl-glucose,7564247,1/1/2009 0:00,11/30/2013 0:00,Non-SBIR/STTR,2009,316438, ,NCI, , ,316438
Regulation and Function of C/EBP in UVB Responses,7564694,1/3/2005 0:00,12/31/2011 0:00,Non-SBIR/STTR,2009,298269, ,NIEHS, , ,298269
Mechanisms of Neuroprotection by Histone Deacetylase Inhibition,7564727,3/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,341250, ,NINDS, , ,341250
Regulation WRN deacetylation by SIRT1 after DNA damage,7564746,2/15/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,257262, ,NIA, , ,257262
Molecular mechanisms in the regulation of p53 functions by PAD4,7566649,2/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2009,269143, ,NCI, , ,269143
Checkpoint Response and Platinum Drug Sensitivity,7567551,5/1/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2009,263340, ,NCI, , ,263340
Defining critical p53 therapeutic targets and mechanisms,7567632,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2009,393005, ,NCI, , ,393005
Sphingosine Phosphate:Regulation and Role in Cancer,7568216,9/1/1998 0:00,2/28/2011 0:00,Non-SBIR/STTR,2009,322582, ,NCI, , ,322582
Southwest Oncology Group,7568723,2/1/1993 0:00,12/31/2009 0:00,Other Research-Related,2009,262855, ,NCI, , ,262855
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D,7568858,1/1/1999 0:00,2/28/2011 0:00,Non-SBIR/STTR,2009,238892, ,NCI, , ,238892
Dynamics of Signaling Pathways: Mechanism and Function,7568985,3/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,321733, ,NIGMS, , ,321733
Pathways of Therapy-induced Senescence in Cancer,7568990,3/17/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,235952, ,NCI, , ,235952
The Role of PTEN in Endothelial Biology,7569421,2/15/2008 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,390000, ,NHLBI, , ,390000
SUMO conjugation in cell biology and Development,7569505,9/15/2001 0:00,11/30/2010 0:00,Non-SBIR/STTR,2009,238941, ,NIGMS, , ,238941
Biomarkers in Head and Neck Cancer Progression,7570766,4/17/2009 0:00,3/31/2014 0:00,Other Research-Related,2009,94454, ,NIDCR, , ,94454
Biomimetic Synthesis of Complex Natural Products,7571635,2/1/2006 0:00,4/14/2010 0:00,Non-SBIR/STTR,2009,297951, ,NIGMS, , ,297951
Identifying Events and Genetic Regulators of Melanoma Progression,7571782,1/10/2009 0:00,12/31/2009 0:00,Other Research-Related,2009,91800, ,NIAMS, , ,91800
Regulatory Mechanisms of DEAF-1 in Development,7573426,8/15/2009 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,218250, ,NICHD, , ,218250
Recognition and Presentation of Alpha Helices using Nanoparticle Receptors,7574390,3/8/2007 0:00,2/28/2011 0:00,Non-SBIR/STTR,2009,260964, ,NIGMS, , ,260964
Molecular Markers as Predictors of Outcome in Gliomas,7574534,9/1/1998 0:00,2/14/2011 0:00,Non-SBIR/STTR,2009,291993, ,NINDS, , ,291993
p53-Independent Pathways in Mdm2-Mediated Transformation,7575088,4/9/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2009,329378, ,NCI, , ,329378
Control of Retrovirus CNS Disease by redox modulation,7575122,6/18/2002 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,409079, ,NINDS, , ,409079
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer,7575162,3/7/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2009,311600, ,NCI, , ,311600
Role of TRPM1 (Melastatin1) in the Biology of Human Melanocytes,7575231,3/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,326700, ,NIAMS, , ,326700
Targeting JAB1 Oncogenic Function in Breast Cancer,7575240,4/1/2002 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,255009, ,NCI, , ,255009
Analysis of the p53  in vivo using a unique mouse model,7575254,3/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,344459, ,NCI, , ,344459
MYC's Role in the Initiation and Maintenance of Cancer,7575277,6/1/2001 0:00,2/29/2012 0:00,Non-SBIR/STTR,2009,391431, ,NCI, , ,391431
Hormonal regulation of p53 activity in mammary tissue,7575460,4/1/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,55861, ,NCI, , ,55861
"Structure, Function and Inhibition of Human Methionine Aminopeptidases",7575735,6/1/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,376391, ,NCI, , ,376391
Nuclear Function of Abl in DNA Damage Response,7575739,8/1/1986 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,419984, ,NCI, , ,419984
Cell and tumor genetics of mitotic arrest checkpoints,7575754,2/1/2000 0:00,2/29/2012 0:00,Non-SBIR/STTR,2009,344054, ,NCI, , ,344054
Monitoring mechanisms in mammalian ribosome biogenesis,7575779,2/1/2005 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,230749, ,NIGMS, , ,230749
Role of DN-p63 in Preservation of Self Renewal,7575824,4/1/2005 0:00,8/28/2010 0:00,Non-SBIR/STTR,2009,228179, ,NCI, , ,228179
Molecular Basis of Aneuploidy,7576183,3/7/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2009,232676, ,NCI, , ,232676
Investigation of the Function and Regulationof Peroxiredoxins Prdx1 and Prdx6 in ,7576644,1/1/2009 0:00,12/31/2011 0:00,Non-SBIR/STTR,2009,213458, ,NCI, , ,213458
Mechanisms of BMP Receptor Kinase Dysregulation in Skeletal Dysplasias,7576671,12/15/2008 0:00,11/30/2011 0:00,Non-SBIR/STTR,2009,73250, ,NIAMS, , ,73250
Molecular mediators of metastasis in hepatocellular carcinoma,7576815,4/1/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2009,280074, ,NCI, , ,280074
Anticarcinogenic Effect of ITCs Against Prostate Cancer,7577052,7/14/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2009,329208, ,NCI, , ,329208
Cell Survival and Death in Oxidant Lung Injury,7577427,7/1/2002 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,385000, ,NHLBI, , ,385000
Genetic Mechanisms in Experimental Pancreatic Cancer,7577526,9/1/1998 0:00,2/28/2011 0:00,Non-SBIR/STTR,2009,262017, ,NCI, , ,262017
Translational Machinery in Stress Signaling and Tumor Suppression,7577945,5/15/2009 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,253622, ,NIEHS, , ,253622
"Inhibitory effects of caffeine, exercise and lipectomy on UVB-induced skin cancer",7578038,9/18/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,247780, ,NCI, , ,247780
DEAF-1 Interactions and Protein Modifications in Prostate Cells,7578045,7/17/2009 0:00,6/30/2012 0:00,Non-SBIR/STTR,2009,218250, ,NCI, , ,218250
Development of cambinol analogues as antilymphoma agents,7578307,4/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,365200, ,NCI, , ,365200
Biology of the papillomavirus E5 oncoprotein family,7578852,1/1/1991 0:00,2/28/2011 0:00,Non-SBIR/STTR,2009,390569, ,NCI, , ,390569
Mox 1: A Novel Mitogenic Oxidase,7578929,1/5/2000 0:00,2/29/2012 0:00,Non-SBIR/STTR,2009,269909, ,NCI, , ,269909
Mechanisms of Intestinal Tumorigenesis,7578998,1/1/2000 0:00,3/31/2010 0:00,Non-SBIR/STTR,2009,379393, ,NCI, , ,379393
High Throughput Screening,7579078, , ,Research Centers,2008, ,130540, , , , 
In vivo pathogenesis of Helicobacter pylori,7579915,9/1/1996 0:00,2/29/2012 0:00,Non-SBIR/STTR,2009,376716, ,NIAID, , ,376716
Homologous Recombination & Human Cell Radiosensitivity,7579984,2/7/2006 0:00,12/31/2011 0:00,Non-SBIR/STTR,2009,343492, ,NCI, , ,343492
The Role of PKR in a Novel IL-3 Signal Transduction Pathway,7580107,4/1/1996 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,366250, ,NHLBI, , ,366250
The Structure and Function of S100 Proteins,7580924,2/1/1999 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,304425, ,NIGMS, , ,304425
Targeting Signal Transduction Pathways for Cancer Drug Discovery,7581046,2/5/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,1950419, ,NCI, , ,1950419
Characterization of RNF5 - A Novel RING Finger Protein,7582260,7/1/2002 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,384693, ,NCI, , ,384693
The Roles of HBXAP Gene in Ovarian Cancer,7582307,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,340300, ,NCI, , ,340300
Humanized Mouse Models for the p53 R72P SNP,7582903,12/1/2008 0:00,11/30/2013 0:00,Non-SBIR/STTR,2009,309080, ,NIEHS, , ,309080
In vivo function and mechanism of the r-protein-Mdm2-p53 pathway,7583472,8/1/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,319299, ,NCI, , ,319299
Non-Peptide Small-Molecule Inhibitors of the MDM2-p53 interaction,7583984,5/1/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,437813, ,NCI, , ,437813
CPEB and Cell Senescence,7584079,4/1/2007 0:00,3/31/2012 0:00,Non-SBIR/STTR,2009,326463, ,NIA, , ,326463
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis,7584403,1/1/2009 0:00,11/30/2013 0:00,Non-SBIR/STTR,2009,315666, ,NCI, , ,315666
Adenovirus E1B55K Functions Related to Oncolytic Replication,7584520,3/1/2009 0:00,12/31/2012 0:00,Non-SBIR/STTR,2009,276390, ,NCI, , ,276390
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia,7585213,9/15/1996 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,348711, ,NCI, , ,348711
Role of hsnf5/BAF47 Loss in Human Cancer Development,7585343,3/1/2002 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,268981, ,NCI, , ,268981
Functional study of C53 protein as a novel regulator of checkpoint kinases,7585680,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,249900, ,NIGMS, , ,249900
Deregulation of the Ubiquitin/26S Proteasome Pathway in AT cells: Role of ISG15,7585942,9/1/2008 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,155313, ,NINDS, , ,155313
Oncogenic Function of a P53-Induced Phosphatase,7586156,4/1/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,266843, ,NCI, , ,266843
p53-mediated control of numeral integrity of centrosomes,7586772,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,263665, ,NCI, , ,263665
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling,7586836,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,313533, ,NCI, , ,313533
Cancer Biology in the Zebrafish,7588080,7/3/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,369046, ,NCI, , ,369046
The role of melanocyte precursors in zebrafish pigmentation disorders,7589040,1/1/2009 0:00,12/31/2013 0:00,Other Research-Related,2009,126900, ,NIAMS, , ,126900
The Function and Regulation of  Trefoil Factor Family 2 (TFF2),7589122,4/1/2001 0:00,6/30/2012 0:00,Non-SBIR/STTR,2008,340638, ,NIDDK, , ,340638
Functional Components of the Rb/E2F and p53 Pathways,7589237,9/30/2008 0:00,9/29/2010 0:00,Other Research-Related,2008,90000, ,NLM, , ,90000
Characterization of the inducible-beta-cell-specific p53 knockout mice,7589322,5/15/2009 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,242625, ,NCRR, , ,242625
Mycn and Medulloblastoma,7589636,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2009,320588, ,NCI, , ,320588
" Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma",7589723,5/1/2005 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,274719, ,NCI, , ,274719
Mechanisms of Mdm2/Mdmx in repressing p53,7589942,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2009,328652, ,NCI, , ,328652
MicroRNAs and chromosome 22q in the colon,7590152,3/1/2000 0:00,5/31/2013 0:00,Non-SBIR/STTR,2008,327356, ,NIDDK, , ,327356
Novel Proapoptotic BH3-only Proteins in Cancer Apoptosis,7590339,5/16/2005 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,214702, ,NCI, , ,214702
DNA Damage and Tobacco-Induced Lung Cancer,7590368,5/1/2005 0:00,3/31/2012 0:00,Non-SBIR/STTR,2009,331480, ,NCI, , ,331480
DNA Damage/Repair and Cell Death,7590464,4/1/2005 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,287679, ,NINDS, , ,287679
Chromosome 22q genetic studies in the colon,7590697,3/1/2000 0:00,9/28/2008 0:00,Non-SBIR/STTR,2008,126800, ,NIDDK, , ,126800
An Intra-Neoplasm Genetic Diversity Assay,7590704,9/17/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,104250, ,NCI, , ,104250
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,7590802,6/10/2009 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,315400, ,NCI, , ,239400
Investigating the role of p73 and its isoforms in tumorigenesis and metastasis,7590945,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2009,319550, ,NCI, , ,319550
Regulation of Ionizing Radiation Induced DNA Damage Response,7591296,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2009,308345, ,NCI, , ,308345
Regulations of DNA Alkylation/Deamination Damage Repair,7591475,3/1/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2009,266843, ,NCI, , ,266843
Biosynthesis and Hypoxia in Gliomas,7591648, ,8/31/2011 0:00,Non-SBIR/STTR,2008, ,152636, , , , 
Expression of Class I Specific Receptors in NK Cells,7591789,4/1/1996 0:00,5/12/2010 0:00,Non-SBIR/STTR,2009,319652, ,NIAID, , ,319652
Genetic Pathways Governing Pancreatic Ductal Adenocarcinoma,7591823, , ,Non-SBIR/STTR,2008, ,213765, , , , 
The RAS and P13K Pathways in Pancreatic Adenocarcinoma,7591824, , ,Non-SBIR/STTR,2008, ,369799, , , , 
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer,7591825, , ,Non-SBIR/STTR,2008, ,293541, , , , 
Experimental Pathology Core,7591828, , ,Non-SBIR/STTR,2008, ,173297, , , , 
Biosynthesis of Adenovirus Early RNA's,7591849,4/1/1979 0:00,3/31/2012 0:00,Non-SBIR/STTR,2009,725237, ,NCI, , ,725237
Lymphomas And Retroviral Pathogenesis,7592247, , ,Intramural Research,2007,1305511, ,NIAID, , ,1305511
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS,7592372, , ,Intramural Research,2007,804869, ,NIAID, , ,804869
T-Cell Antigen Recognition and Tumor Antigens,7592506, , ,Intramural Research,2007,275470, ,NCI, , ,275470
Chromosomal Proteins and Chromosomal Functions,7592507, , ,Intramural Research,2007,1593875, ,NCI, , ,1593875
Alterations in Interacting Signaling Pathways that Initiate Squamous Carcinogene,7592508, , ,Intramural Research,2007,1269850, ,NCI, , ,1269850
Gene Regulation and Function: The B-ZIP Proteins,7592520, , ,Intramural Research,2007,1009978, ,NCI, , ,1009978
Molecular Epidemiology and Molecular Carcinogenesis of Human Cancer,7592530, , ,Intramural Research,2007,1571163, ,NCI, , ,1571163
"Tumor Suppressor Protein, p53",7592540, , ,Intramural Research,2007,826409, ,NCI, , ,826409
Inhibition of p53 Tumor Suppressor Function by HTLV-I,7592548, , ,Intramural Research,2007,1299586, ,NCI, , ,1299586
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",7592558, , ,Intramural Research,2007,731268, ,NCI, , ,731268
Investigations on the integrated behavior of molecular regulatory networks that ,7592565, , ,Intramural Research,2007,455938, ,NCI, , ,455938
Peptide-based Inhibitors of HDM2 Protein,7592569, , ,Intramural Research,2007,31897, ,NCI, , ,31897
Regulation of EGFR Gene Activity,7592572, , ,Intramural Research,2007,135956, ,NCI, , ,135956
Genetically Engineered Mice as Models to Study Receptor Tyrosine Kinase Function,7592585, , ,Intramural Research,2007,1750631, ,NCI, , ,1750631
Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,7592607, , ,Intramural Research,2007,679733, ,NCI, , ,679733
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,7592617, , ,Intramural Research,2007,1243881, ,NCI, , ,1243881
Inflammation and Cancer,7592630, , ,Intramural Research,2007,1618774, ,NCI, , ,1618774
Molecular Cytogenetics of Solid Tumors,7592632, , ,Intramural Research,2007,1281723, ,NCI, , ,1281723
Molecular Mechanisms of Growth Factor Modulated Proliferation,7592636, , ,Intramural Research,2007,714590, ,NCI, , ,714590
DNA Repair,7592647, , ,Intramural Research,2007,2066801, ,NCI, , ,2066801
Enzymes and Substrates of the Ubiquitin Conjugating System,7592649, , ,Intramural Research,2007,504801, ,NCI, , ,504801
Role of CEBP transcription factors in regulating cell growth and tumorigenesis,7592664, , ,Intramural Research,2007,1638462, ,NCI, , ,1638462
Design of Drugs Against Cancer and Viral Diseases,7592678, , ,Intramural Research,2007,1280818, ,NCI, , ,1280818
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,7592751, , ,Intramural Research,2007,653611, ,NCI, , ,653611
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,7592752, , ,Intramural Research,2007,817015, ,NCI, , ,817015
Development of Mouse Astrocytoma Model for Preclinical Testing of Experimental T,7592753, , ,Intramural Research,2007,163403, ,NCI, , ,163403
Zebrafish models of human leukemia and sarcoma,7592759, , ,Intramural Research,2007,1630493, ,NCI, , ,1630493
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,7592807, , ,Intramural Research,2007,943099, ,NCI, , ,943099
Molecular Technologies,7592820, , ,Intramural Research,2007,219984, ,NCI, , ,219984
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,7592876, , ,Intramural Research,2007,154572, ,NCI, , ,154572
Metabolic Mechanisms for Programmed Cell Death,7592898, , ,Intramural Research,2007,762485, ,NCI, , ,762485
Clinical trial development in cancer vaccines,7592908, , ,Intramural Research,2007,398219, ,NCI, , ,398219
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,7592949, , ,Intramural Research,2007,291218, ,NCI, , ,291218
Cancer Risk and Environmental Exposures,7593167, , ,Intramural Research,2007,1279, ,NCI, , ,1279
Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,7593178, , ,Intramural Research,2007,1212701, ,NCI, , ,1212701
Molecular Genetic Epidemiology of leading U.S. Cancers,7593179, , ,Intramural Research,2007,293848, ,NCI, , ,293848
Studies of Rare Cancers,7593192, , ,Intramural Research,2007,1393921, ,NCI, , ,1393921
Molecular Therapy Of Neoplasms Affecting Human Communication,7593327, , ,Intramural Research,2007,2339016, ,NIDCD, , ,2339016
Oral Carcinogenesis,7593368, , ,Intramural Research,2007,1804461, ,NIDCR, , ,1804461
Small Molecule Activators of p53,7593520, , ,Intramural Research,2007,292932, ,NIDDK, , ,292932
Cellular Responses to DNA Damage,7593640, , ,Intramural Research,2007,410651, ,NIDDK, , ,410651
Molecular aspects of gastrinoma,7593658, , ,Intramural Research,2007,352681, ,NIDDK, , ,352681
Characterization of mice carrying mutations of BRCA1 interacting proteins,7593701, , ,Intramural Research,2007,265073, ,NIDDK, , ,265073
"BRCA1, DNA damage response and aging",7593704, , ,Intramural Research,2007,265073, ,NIDDK, , ,265073
Physical Biochemistry Of Macromolecules,7593808, , ,Intramural Research,2007,26395, ,NIBIB, , ,26395
"Characterization of epidermal stem cells: biology, carcinogenesis, and function",7593863, , ,Intramural Research,2007,1474513, ,NIEHS, , ,1474513
Genetic Susceptibility to Loss of Tumor Suppressor Gene Function,7593866, , ,Intramural Research,2007,721570, ,NIEHS, , ,721570
"Role of p53 in Apoptosis, Growth Arrest and Differentiation in Neuronal Cells",7593873, , ,Intramural Research,2007,518666, ,NIEHS, , ,518666
"Role Of Lipids In Colon, Breast, And Other Cancers",7593927, , ,Intramural Research,2007,457604, ,NIEHS, , ,457604
Isolation And Characterization Of Human Genes Affecting Chromosome Metabolism,7593946, , ,Intramural Research,2007,782678, ,NIEHS, , ,782678
Genetic Analyses of Endometrial Cancer,7594344, , ,Intramural Research,2007,766047, ,NHGRI, , ,766047
Mechanisms Of Action Of Psychoactive Drugs,7594503, , ,Intramural Research,2007,2039503, ,NIMH, , ,2039503
The Molecular Biology Of The Mammalian Brain,7594672, , ,Intramural Research,2007,2350200, ,NINDS, , ,2350200
Molecular Pathology of Pulmonary Carcinogenesis,7594743, , ,Intramural Research,2007,1133324, ,NCI, , ,1133324
The Molecular Genetics of Gynecologic Cancers,7594744, , ,Intramural Research,2007,994788, ,NCI, , ,994788
The Immunotherapy of Animal and Human Cancer,7594752, , ,Intramural Research,2007,3172648, ,NCI, , ,3172648
Lymphoma Studies,7594773, , ,Intramural Research,2007,555012, ,NCI, , ,555012
Nitric Oxide as a Modifier of Oxidative Stress,7594782, , ,Intramural Research,2007,1315756, ,NCI, , ,1315756
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,7594799, , ,Intramural Research,2007,3013746, ,NCI, , ,3013746
Investigation of Germ-line Genetic Variation and Susceptibility to Cancer and it,7594800, , ,Intramural Research,2007,1095659, ,NCI, , ,1095659
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,7594817, , ,Intramural Research,2007,905733, ,NCI, , ,905733
Regulation of the cell cycle by cyclin-dependent kinases,7594821, , ,Intramural Research,2007,1193664, ,NCI, , ,1193664
The Role of Ape1 in Neurotoxicity of Cancer Treatments,7595260,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,404126, ,NCI, , ,404126
Structure and function of the U3 RNA-protein complex,7595911,4/1/2007 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,288800, ,NIGMS, , ,288800
Using Zebrafish to Identify and Analyze Cancer Genes,7596285,3/7/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,410867, ,NCI, , ,410867
The MRAD9 Radioresistance Gene,7596432,12/1/2000 0:00,3/31/2010 0:00,Non-SBIR/STTR,2009,311099, ,NIGMS, , ,311099
Mechanisms of Cancer Initiation by TRIM32,7596482,5/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,344637, ,NCI, , ,344637
Stochastic dynamics for multiscale biology,7596501,9/1/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2008,319129, ,NIGMS, , ,319129
Translational Pathology Core Facility,7596672, , ,Research Centers,2007, ,809573, , , , 
A Nested Case-Control Study of Prostate Carcinogenesis,7596885,9/30/2000 0:00,2/28/2012 0:00,Non-SBIR/STTR,2009,592441, ,NIEHS, , ,592441
p38 MAPK in Ras-induced Senescence and Transformation,7596890,7/1/2005 0:00,3/31/2010 0:00,Non-SBIR/STTR,2009,319381, ,NCI, , ,319381
A PTEN-Dependent Size Checkpoint in Human Cancer Cells,7597077,5/11/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,180099, ,NCI, , ,180099
HUMAN TRAP/MEDIATOR,7597440,5/1/2007 0:00,2/29/2008 0:00,Research Centers,2007, ,5631, , , , 
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY,7597612,2/1/2007 0:00,1/31/2008 0:00,Research Centers,2007, ,1130, , , , 
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1,7599098,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,304917, ,NCI, , ,304917
The Role of Syndecan-1 in Mouse Mammary Neoplasia,7599101,12/21/2001 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,295173, ,NCI, , ,295173
CDC25 PHOSPHATASES IN CELL CYCLE CONTROL AND CANCER,7599710,2/1/1992 0:00,3/31/2012 0:00,Non-SBIR/STTR,2009,315000, ,NIGMS, , ,315000
Cellular Targets of Papillomavirus Oncoproteins,7600638, , ,Non-SBIR/STTR,2008, ,582125, , , , 
Interactions of the SV40 Small T Antigen and PP2A in Human Cell Transformation,7600640, , ,Non-SBIR/STTR,2008, ,251034, , , , 
STRUCTURE-BASED DESIGN OF P53 STABILIZING COMPOUNDS WITH LARGE-SCALE VIRTUAL-SC,7601427,8/1/2007 0:00,7/31/2008 0:00,Research Centers,2007, ,298, , , , 
Selective Forces Operative in FeLV Infection,7602992,2/28/2000 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,268582, ,NCI, , ,268582
DNA damage response and DDB,7603020,5/15/2005 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,280493, ,NIA, , ,280493
Regulation of Mdm2 compartmentalization,7603135,5/11/2005 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,226218, ,NCI, , ,226218
COG ADVL0416: A PHASE 1 STUDY OF SAHA IN PEDIATRIC PATIENTS WITH RECURRENT,7603565,4/1/2007 0:00,9/16/2007 0:00,Research Centers,2007, ,153, , , , 
EVALUATION OF THE USE OF POXVIRUS VACCINES TO STIMULATE P53 SPECIFIC IMMUNITY,7603874,12/1/2006 0:00,11/30/2007 0:00,Research Centers,2007, ,968, , , , 
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER FOR CANCER,7605684,4/1/2007 0:00,3/31/2008 0:00,Research Centers,2007, ,196074, , , , 
INDIVIDUALIZED TX OF BREAST CANCER BASED ON TUMOR MOLECULAR CHARACTERISTICS,7605704,4/1/2007 0:00,3/31/2008 0:00,Research Centers,2007, ,61938, , , , 
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY,7605716,4/1/2007 0:00,3/31/2008 0:00,Research Centers,2007, ,9862, , , , 
"A PHASE I STUDY OF ORAL IRINOTECAN, TEMOZOLOMIDE, AND CEFIXIME IN CHILDREN WI",7605875,2/15/2007 0:00,11/30/2007 0:00,Research Centers,2007, ,2636, , , , 
"A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTOMY RTVP-1 GEN",7605944,2/15/2007 0:00,11/30/2007 0:00,Research Centers,2007, ,5565, , , , 
OVARIAN TISSUE AND CLINICAL DATABASE CORE FACILITY,7606127,2/1/2007 0:00,11/30/2007 0:00,Research Centers,2007, ,107, , , , 
DFMO AND SULINDAC,7606602,12/1/2006 0:00,11/30/2007 0:00,Research Centers,2007, ,7752, , , , 
GENOTYPIC AND PHENOTYPIC RESPONSE OF BREAST EPITHELIAL CELLS FROM WOMEN,7608281,12/1/2006 0:00,11/30/2007 0:00,Research Centers,2007, ,21231, , , , 
MOLECULAR EPIDEMIOLOGY OF HEAD AND NECK CANCER,7608293,12/1/2006 0:00,11/30/2007 0:00,Research Centers,2007, ,2224, , , , 
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER,7608297,12/1/2006 0:00,11/30/2007 0:00,Research Centers,2007, ,125222, , , , 
MOLECULAR EPIDEMIOLOGY OF HEAD AND NECK CANCER,7608442,5/1/2007 0:00,3/31/2008 0:00,Research Centers,2007, ,43867, , , , 
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER,7608443,5/1/2007 0:00,3/31/2008 0:00,Research Centers,2007, ,87734, , , , 
GENOTYPIC& PHENOTYPIC RESPONSE  BREAST EPITHELIAL CELLS FROM WOMEN- MAMMOPLASTY,7608463,5/1/2007 0:00,3/31/2008 0:00,Research Centers,2007, ,34271, , , , 
Epithelial Positioning Organization and Ovarian Cancer,7608573,3/1/2002 0:00,5/31/2011 0:00,Non-SBIR/STTR,2007,136963, ,NCI, , ,136963
Rapamycin-Induced Selective Apoptosis in Malignant Cells,7608645,12/1/1998 0:00,5/17/2010 0:00,Non-SBIR/STTR,2009,308448, ,NCI, , ,308448
p53 Fusion Protein as an Oncology Therapeutic,7608803,9/18/2007 0:00,2/28/2009 0:00,SBIR/STTR,2007,100000, ,NCI, , ,100000
Mutagenesis of p53 by reactive PAH and ROS,7609208,4/8/2008 0:00,3/31/2013 0:00,Non-SBIR/STTR,2009,313516, ,NIEHS, , ,313516
Role of the p53 homolog p73 in cancer,7609517,1/14/2002 0:00,7/31/2008 0:00,Non-SBIR/STTR,2008,77268, ,NCI, , ,77268
TARGET FACULTY GARY/SENESCENCE SIGNALING THROUGH P53,7610092,6/1/2007 0:00,5/31/2008 0:00,Research Centers,2007, ,182568, , , , 
MT COBRE: EFFECT OF METAL MIXTURES ON GENE EXPRESSION & CARCINOGENESIS,7610423,7/15/2007 0:00,5/31/2008 0:00,Research Centers,2007, ,161761, , , , 
DISSECTING ROLES OF MTBP IN OSTEOSARCOMA METASTASIS,7610681,8/1/2007 0:00,7/31/2008 0:00,Research Centers,2007, ,335181, , , , 
Cell Growth Signaling in Cancer Development,7610894,4/8/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,406715, ,NCI, , ,406715
Determination of regulatory mechanisms for BLM helicase,7610934,8/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,50178, ,NCI, , ,26087
A Functional Census of p53 Cancer and Suppressor Mutants,7613343,8/1/2005 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,342292, ,NCI, , ,342292
PROHIBITIN GENE IN GROWTH CONTROL AND TUMOR SUPPRESSION,7613521,9/30/1999 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,273469, ,NCI, , ,273469
Normal and Neoplastic Regulation of Cyclin E,7613856,7/1/2003 0:00,12/31/2013 0:00,Non-SBIR/STTR,2009,382446, ,NCI, , ,382446
Role of microRNAs in genetic mouse models of pancreatic cancer,7614143,1/1/2009 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,243448, ,NCI, , ,243448
Functional Mimicry of the p53 C-terminal Tail by the Ubiquitin-like Molecule SUMO,7614242,4/15/2008 0:00,3/31/2010 0:00,Non-SBIR/STTR,2009,172688, ,NCI, , ,172688
Alternate Pathways for Interferon and Cytokine Signaling,7614430, , ,Non-SBIR/STTR,2008, ,404153, , , , 
CDK6 in T cell development and cancer,7615450,1/15/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2009,334075, ,NCI, , ,334075
 Gastrointestinal Cell Proliferation and Cell Cycle,7615576,7/1/2005 0:00,3/2/2010 0:00,Non-SBIR/STTR,2009,292115, ,NCI, , ,292115
Non-Myeloablative Host Conditioning that Protects Against GVHD,7615604, , ,Non-SBIR/STTR,2008, ,311594, , , , 
Gene targets of OLIG2 in malignant glioma stem cells,7615708,7/15/2007 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,427500, ,NINDS, , ,427500
Role of ROS-Induced DNA Damage in Mitochondria-Regulated Apoptosis,7615810,2/1/2009 0:00,10/31/2013 0:00,"Training, Individual",2009,27516, ,NIEHS, , ,27516
Molecular Mechanisms of Hormone-independence of Prostate Cancer,7616338,7/15/2005 0:00,4/30/2010 0:00,Non-SBIR/STTR,2008,58349, ,NCI, , ,58349
Functional Characterization of the ATM Gene Product,7616494,8/15/1996 0:00,4/30/2010 0:00,Non-SBIR/STTR,2009,355568, ,NCI, , ,355568
Effect of caffeine on UVB-induced skin cancer,7616537,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,270365, ,NCI, , ,270365
Characterizing Potential Redox Mechanisms of Prostate Cancer Chemoprevention by E,7616576,5/1/2008 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,76813, ,NCI, , ,76813
"Telomeres, Telomerase and Tumor Progression",7616582,8/15/2005 0:00,4/30/2012 0:00,Non-SBIR/STTR,2009,294015, ,NCI, , ,294015
ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICE,7616590,4/1/1987 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,174086, ,NCI, , ,174086
Mechanism of Redox Regulation by Ape1/Ref-1,7616748,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,229944, ,NCI, , ,229944
Reversing Electrostatic Interactions for Improved Gene Delivery,7617092,7/14/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,335665, ,NIBIB, , ,335665
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2 (LMP1 AND LMP2),7617146, , ,Non-SBIR/STTR,2008, ,350326, , , , 
Analysis of 53BP1 function in DNA Damage-signaled pathway and Tumorigenesis,7617172,5/9/2003 0:00,6/30/2009 0:00,Non-SBIR/STTR,2009,45887, ,NCI, , ,45887
Mouse Models of Human Breast Cancer,7617300,9/30/1999 0:00,3/31/2010 0:00,Non-SBIR/STTR,2008,43919, ,NCI, , ,43919
Identification of Small Molecules for Reactivation of p53 Cancer Mutants,7617518,9/30/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2008,146159, ,OD, , ,146159
Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette Smoke,7617544,5/1/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,285824, ,NCI, , ,285824
UV and p21 Degradation,7617692,6/15/2005 0:00,6/30/2009 0:00,Non-SBIR/STTR,2009,52556, ,NCI, , ,52556
Molecular Mechanisms of Hormone-independence of Prostate Cancer,7617716,7/15/2005 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,250280, ,NCI, , ,250280
Etiologic Role of HPV in Keratinocyte Carcinomas,7617870,5/1/2007 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,306741, ,NCI, , ,306741
Active Immune Therapy ot Leukemia Associated Antigens and Gene Therapy,7617958, , ,Non-SBIR/STTR,2008, ,278017, , , , 
Signal Transduction and Kinase Inhibition in CLL,7617961, , ,Non-SBIR/STTR,2008, ,289786, , , , 
Functional properties of centrosomes in somatic cells,7617995,5/1/1999 0:00,4/30/2010 0:00,Non-SBIR/STTR,2009,330626, ,NIGMS, , ,330626
Repair of Endogenous Damage in Mammalian Genomes,7618265,2/11/1991 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,328615, ,NCI, , ,328615
Regulatory Functions of APE1 - An Essential Repair Protein,7618681,12/1/1996 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,307134, ,NIEHS, , ,307134
Mechanistic Studies on New Platinum Clinical Agents,7618730,9/30/1998 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,312194, ,NCI, , ,312194
Genetic Epidemiology of Familial Childhood Cancer Syndromes,7618758, , ,Non-SBIR/STTR,2008, ,243762, , , , 
Genomic Instability in Familial Cancer Syndromes,7618760, , ,Non-SBIR/STTR,2008, ,182340, , , , 
Molecular Genetic Anatomy of Li Fraumeni Syndrome (LFS),7618762, , ,Non-SBIR/STTR,2008, ,353974, , , , 
Mouse Models for Li Fraumeni Syndrome,7618763, , ,Non-SBIR/STTR,2008, ,315131, , , , 
High-Throughput Genotyping and Genetic Linkage Analysis Facility,7618766, , ,Non-SBIR/STTR,2008, ,322307, , , , 
Nucleic Acids Isolation and DNA Analysis Facility,7618767, , ,Non-SBIR/STTR,2008, ,235770, , , , 
Salivary Acinar Cell Apoptosis: Regulation of p53 by Akt,7618820,7/7/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,372099, ,NIDCR, , ,372099
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction,7618829,7/1/2005 0:00,4/30/2012 0:00,Non-SBIR/STTR,2009,267772, ,NCI, , ,267772
Molecular and Cellular Origins of Pancreatic Cancer,7619469,5/18/2007 0:00,9/30/2011 0:00,Other Research-Related,2009,109553, ,NCI, , ,109553
Function of MEF in Hematopoietic Cells,7619619,1/1/1997 0:00,6/30/2012 0:00,Non-SBIR/STTR,2009,402900, ,NIDDK, , ,402900
Role of sestrin family genes in antioxidant defense,7619953,9/15/2005 0:00,5/31/2010 0:00,Non-SBIR/STTR,2009,287127, ,NIA, , ,287127
Role of PUMA in EGFR targeted therapy in HNSCC,7620091,8/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,314363, ,NCI, , ,314363
Curcumin inhbits BPDE-induced damage by lowering the threshold of p53 activation,7620098,5/1/2008 0:00,3/31/2011 0:00,"Training, Individual",2009,26684, ,NIEHS, , ,26684
ECM-Mediated Apoptosis in p53 (-) HMECs,7620217,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,81951, ,NCI, , ,81951
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer,7620985,9/8/1989 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,325941, ,NCI, , ,325941
Restoration of Tumor Suppression Activity in Malignant Melanoma,7621011,7/1/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,497921, ,NCI, , ,497921
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors,7621014,7/31/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,277591, ,NCI, , ,277591
Role of C/EBP in Cell Survival and Neoplasia,7622069,5/1/1990 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,256774, ,NCI, , ,256774
p53 Acetylation and Deacetylation in Tumorigenesis,7622170,4/1/2000 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,291865, ,NCI, , ,291865
The Role of p73 in Upper Gastrointestinal Carcinomas,7622547,4/28/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,264933, ,NCI, , ,264933
Study on the intracellular Network of TBX3,7622698,8/1/2007 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,226235, ,NCI, , ,226235
Repair of oxidative DNA damage in mammalian cells,7622903,3/10/2003 0:00,5/31/2009 0:00,Non-SBIR/STTR,2008,226908, ,OD, , ,226908
PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS,7622961,5/1/2004 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,658595, ,NCI, , ,658595
Function and regulation of SirT1 in cancer,7623048,7/11/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,285428, ,NCI, , ,285428
Mechanisms of p53 target gene activation in DNA damage responses,7623140,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,815597, ,NCI, , ,815597
Genetic and Molecular Epidemiology of Adult Glioma,7623150,5/15/1991 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,1110511, ,NCI, , ,1110511
Mechanisms Regulating Reversal of Malignancy,7623187,8/30/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,197947, ,NCI, , ,197947
UV regulation of anti-apoptotic co-repressor CtBP,7623447,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,291729, ,NCI, , ,291729
Project 2- Radiation Biology,7623552, , ,Research Centers,2008, ,20369, , , , 
MicroRNA Function in the Immune System,7623605,5/15/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,401250, ,NIAID, , ,401250
Novel Approaches for Pancreatic Cancer Therapy,7623678,1/21/2003 0:00,12/31/2008 0:00,Non-SBIR/STTR,2007,75540, ,NCI, , ,75540
Chromosome instability resulting from double-strand breaks near telomeres,7623945,7/6/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,239656, ,NCI, , ,239656
Structural basis for CBP/p300 transcriptional regulation,7623959,6/10/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,419962, ,NCI, , ,419962
Role of MDM2 in Cell Proliferation and Tumorigenesis,7623972,7/1/1999 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,277695, ,NCI, , ,277695
Dietary Chemopreventive Components/Oncogene Interaction and Cancer,7623980,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,275500, ,NCI, , ,275500
Molecular Pathways in Suppression and Development of T Lineage Lymphomas,7624244,7/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,312550, ,NCI, , ,312550
Targeted Therapies in Melanoma,7624249,5/16/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,2374988, ,NCI, , ,2374988
"CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER",7624397, , ,Research Centers,2008, ,319325, , , , 
Comparative functional genomics for lung cancer gene discovery,7624476,9/23/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,574485, ,NCI, , ,574485
Mechanisms of Particulate Matter Induced Death,7624658,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,331311, ,NIEHS, , ,331311
ECM-Mediated Apoptosis in p53 (-) HMECs,7624678,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,222477, ,NCI, , ,222477
Function of the Adenovirus E1B Oncogene,7625190,1/1/1991 0:00,6/30/2012 0:00,Non-SBIR/STTR,2009,317236, ,NCI, , ,317236
Study the Role of Chfr in Tumorigenesis,7626047,7/1/2006 0:00,6/30/2009 0:00,Non-SBIR/STTR,2009,88670, ,NCI, , ,88670
Functional and Structural Studies of CD74 Activation,7626431,6/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,394118, ,NIAID, , ,394118
Cellular and molecular basis of malignant astrocytoma,7626465,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,309361, ,NINDS, , ,309361
Functional Role of ATM-Ab1-RNAP II Signaling Pathway,7626650,9/10/2001 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,265125, ,OD, , ,265125
Role and therapeutical potential of Cdk4/6 in B-lymphoma,7626799,7/10/2006 0:00,12/31/2011 0:00,Non-SBIR/STTR,2009,193715, ,NCI, , ,193715
BubR1 in Cancer and Aging,7626820,7/1/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,301377, ,NCI, , ,301377
P53-dependent responses to toxicants in parous and nulliparous breast,7627331,9/7/2007 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,363933, ,NIEHS, , ,363933
Markers of Early Pancreatic Cancer,7627982,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,282659, ,NCI, , ,282659
Reactivation of the p53-mediated pro-Apoptotic Pathway Using Stapled Peptides,7628106,7/1/2008 0:00,6/30/2010 0:00,Other Research-Related,2009,162540, ,NCI, , ,162540
Progesterone-mediated protection against ovarian cancer,7628673,9/1/2005 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,258707, ,NCI, , ,258707
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines,7628935,4/1/2009 0:00,3/31/2012 0:00,Non-SBIR/STTR,2009,256080, ,NCI, , ,256080
The Molecular Epidemiology of Bladder Cancer,7629012,5/1/2007 0:00,2/28/2012 0:00,Non-SBIR/STTR,2009,398652, ,NCI, , ,398652
Biological Function of the Retinoblastoma Gene Product,7629623,5/3/1994 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,342397, ,NCI, , ,342397
Molecular targeting of the survivin pathway in cancer,7629684,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,288775, ,NCI, , ,288775
A Pathway of Tumor Suppression,7630405,7/1/1988 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,236943, ,NCI, , ,236943
Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis,7630533,7/1/2000 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,247664, ,NCI, , ,247664
Mechanisms of esophageal carcinogenesis,7630987,8/15/2003 0:00,6/30/2014 0:00,Non-SBIR/STTR,2009,1656404, ,NCI, , ,1656404
p53 and pathways of apoptosis,7631227,8/7/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,299250, ,NCI, , ,299250
wnt Signaling in Liver Development and Disease,7631399,7/15/2005 0:00,6/30/2011 0:00,Other Research-Related,2009,136958, ,NIDDK, , ,136958
The San Francisco Bay Area Adult Glioma Survival Study,7631429, , ,Research Centers,2008, ,332157, , , , 
Homologous Recombination in Genome Stability and Tumor Suppression,7631620,6/8/2009 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,361050, ,NCI, , ,361050
Mechanisms of tumor suppression by Fbw7,7632257,7/26/2006 0:00,6/30/2011 0:00,Other Research-Related,2009,140535, ,NCI, , ,140535
Methylation in Cancer Progression of Barrett's Esophagus,7633166,7/20/2006 0:00,8/31/2009 0:00,Other Research-Related,2009,25875, ,NIDDK, , ,25875
Intracellular Mechanisms of Glucocorticoid Action,7633229,7/1/1986 0:00,6/30/2012 0:00,Non-SBIR/STTR,2009,351251, ,NIDDK, , ,351251
Redox Regulation of Tumor Suppression by MnSOD,7633230,9/1/1998 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,372365, ,NCI, , ,372365
Mouse Model of Pancreatic Tumorigenesis with Dysregulation of  mTOR,7633372,6/6/2008 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,77000, ,NCI, , ,77000
Characterization of the p53 Apoptotic Target Gene Perp,7633417,1/1/2002 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,284434, ,NCI, , ,284434
Androgen and Soluble Guanylyl Cyclase Signaling in Prostate Cancer,7634430,7/1/2008 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,281066, ,NCI, , ,281066
Cellular Senescence and Control of Gene Expression,7634455,9/1/1990 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,596414, ,NIA, , ,596414
Studies on the Post-translational processing of MUC1,7634563,9/1/1992 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,263177, ,NCI, , ,263177
Terminal Differentiation of the Renal Epithelium,7636240,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,284963, ,NIDDK, , ,284963
Functions of mir-34 microRNAs in the p53 tumor suppressor pathway,7636600,8/1/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2009,318513, ,NCI, , ,318513
Glucocorticoids & Vitamin D: Role In Anti-Tumor Effects,7636769,2/1/2000 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,382661, ,NCI, , ,382661
Oxidative Injury to Gastric Epithelial Cells by H. pylori,7637368,9/21/2001 0:00,4/30/2012 0:00,Non-SBIR/STTR,2009,321938, ,NIDDK, , ,321938
Cellular Consequences of Snf5 Tumor Suppressor Loss,7637470,7/1/2007 0:00,6/30/2010 0:00,"Training, Individual",2009,57194, ,NCI, , ,57194
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,7637755,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,364432, ,NCI, , ,364432
The Role of E2F1 in UV-induced DNA Damage Response,7637980,5/3/2005 0:00,10/30/2010 0:00,Other Research-Related,2009,139847, ,NCI, , ,139847
Treatment of Melanoma with wild-type P53 and detectable S100B using pentamidine: ,7642487,7/1/2008 0:00,6/30/2013 0:00,Non-SBIR/STTR,2009,311250, ,NCI, , ,311250
Stem Cells and Gastric Cancer,7643366,9/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,460414, ,NCI, , ,460414
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK,7643423,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,315400, ,NCI, , ,315400
Nitric oxide eluting therapies for vascular surgery,7643860,9/15/2006 0:00,6/30/2011 0:00,Other Research-Related,2009,127358, ,NHLBI, , ,127358
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development,7643866,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,340300, ,NCI, , ,340300
Control of p53 function by Mdm2 E3 ubiquitin ligase,7643944,7/1/2007 0:00,10/9/2009 0:00,"Training, Individual",2009,17495, ,NCI, , ,17495
Molecular Epidemiology of Colorectal Cancer Subtypes,7643948,9/15/2005 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,190878, ,NCI, , ,190878
Role of EGFR in DNA Repair and Radiation Response in Non Small Cell Lung Cancer,7644001,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,260620, ,NCI, , ,260620
Role of p53 and ptc tumor suppressive pathways in BCCs development and prevention,7644022,9/30/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,337488, ,NIEHS, , ,337488
Correlative Studies for NCI Study #7977: Phase I trial of ABT-888 Plus Irinotecan,7644394,7/1/2008 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,338176, ,NCI, , ,338176
Gene targets of OLIG2 in malignant glioma stem cells,7644787,7/15/2007 0:00,4/30/2011 0:00,Non-SBIR/STTR,2008,85500, ,NINDS, , ,85500
Mechanisms of SAG Inhibition of Carcinogenesis & Apoptosis,7645060,9/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,260972, ,NCI, , ,260972
BK Virus as a Co-Factor in Prostate Cancer,7645064,8/1/2007 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,284829, ,NCI, , ,284829
Re-replication of chromosomes and cancer,7645425,7/11/1994 0:00,2/28/2014 0:00,Non-SBIR/STTR,2009,331591, ,NCI, , ,331591
Biomarkers of survival in glioma epidemiology,7645800,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,424086, ,NCI, , ,424086
Regulation of p53 tumor suppressor protein,7645851,2/1/1993 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,531121, ,NCI, , ,531121
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma,7645864, , ,Non-SBIR/STTR,2008, ,300220, , , , 
Soft Tissue Sarcoma Program Project,7645868,5/16/1997 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,1776015, ,NCI, , ,1776015
Center for digestive and liver diseases,7646522,7/1/1998 0:00,6/30/2012 0:00,Research Centers,2009,1145813, ,NIDDK, , ,1145813
Molecular Pathogenesis of Basal-like Breast Cancer,7646625,4/18/2003 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,911582, ,NCI, , ,911582
Genetic analysis of genomic instability and cancer in zebrafish,7647153,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,310912, ,NCI, , ,310912
Collaborating Mutations in Medulloblastoma,7647495,4/1/2003 0:00,3/31/2014 0:00,Non-SBIR/STTR,2009, ,309568, , , , 
The Role of Polyoma Small T in Regulating Cell Survival,7647586,3/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2009, ,566520, , , , 
Papillomavirus E2 Growth Suppression Mechanisms,7647591,3/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2009, ,574098, , , , 
DNA Adduct-Induced Mutagenesis,7647846,2/15/1992 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,251664, ,NCI, , ,251664
Radiation-induced Nitric Oxide & Cellular Radiosensitivity,7647901,7/10/2002 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,274403, ,NCI, , ,274403
Ultra Fast and Sensitive Fluorescence-Based Clinical Assays,7647960,7/1/2008 0:00,8/11/2009 0:00,Other Research-Related,2009,32016, ,NIBIB, , ,32016
Endoscopic Therapy of Early Cancer in Barretts Esophagus,7648125,9/16/2005 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,313725, ,NCI, , ,313725
"UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis",7648270,9/1/2000 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,209081, ,NCI, , ,209081
Activation of checkpoint pathways in cancer,7649313,7/19/2006 0:00,5/31/2010 0:00,Non-SBIR/STTR,2009,186141, ,NCI, , ,186141
Hypoxia and Gene Repression,7649387,7/1/2000 0:00,4/30/2010 0:00,Non-SBIR/STTR,2009,314678, ,NCI, , ,314678
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer,7649662,3/2/2009 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,347625, ,NIDCR, , ,347625
Cellular Stress Response Signaling Pathways,7650435,1/1/1992 0:00,4/30/2012 0:00,Non-SBIR/STTR,2009,411600, ,NIEHS, , ,411600
Mechanism of p63-Dependent Tumor Suppression,7650452,7/1/2003 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,297265, ,NCI, , ,297265
Cell Cycle Check Points,7650456, , ,Non-SBIR/STTR,2008, ,341922, , , , 
Murine & Human In Vivo Models of Melanoma Formation,7650457, , ,Non-SBIR/STTR,2008, ,415642, , , , 
Mechanism of P73-Dependent Tumor Suppression,7650655,5/1/1999 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,302253, ,NCI, , ,302253
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck Cancer,7650859,3/2/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2009,625911, ,NCI, , ,625911
Acid- and salt-dependent interactions in proteins,7650967,5/1/1998 0:00,3/31/2013 0:00,Non-SBIR/STTR,2009,325083, ,NIGMS, , ,325083
Mouse models of genomic instability and birth defects,7651663,4/1/2009 0:00,3/31/2014 0:00,Non-SBIR/STTR,2009,310219, ,NICHD, , ,310219
Multi-Modal Lysosomotropic Death Therapy for Malignant Peripheral Nerve Sheath Tu,7651766,5/1/2009 0:00,4/30/2012 0:00,Non-SBIR/STTR,2009,242844, ,NCI, , ,242844
p63-Dependent Checkpoints in Oocytes,7652006,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,484670, ,NICHD, , ,484670
Telomere induced senescence as a supressor of tumorigenesis,7652538,8/8/2007 0:00,6/30/2010 0:00,Non-SBIR/STTR,2009,292600, ,NCI, , ,292600
"Studying the initiation, progression and therapy of lung cancer in mouse models",7652544,4/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2009,345416, ,NCI, , ,345416
The in vivo role of the mitochondrial p53 cell death program,7653382,9/15/1993 0:00,2/28/2014 0:00,Non-SBIR/STTR,2009,272728, ,NCI, , ,272728
Tip60 in p38 and PRAK Mediated Oncogene-Induced Senescence and Tumor Suppression,7653558,6/1/2009 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,394043, ,NCI, , ,394043
Regulation and Function of the p14ARF/topoisomerase I Complex in Cancer,7653663,7/10/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,373500, ,NCI, , ,373500
"Dysfunctional Telomeres, Checkpoints and Aging",7653672,9/30/2006 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,269903, ,NIA, , ,269903
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA,7653689,5/1/1997 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,280617, ,NCI, , ,280617
LC-MS Analysis of DNA Adducts of Aromatic Amines: Relationship to Bladder Cancer,7653883,5/18/1996 0:00,7/31/2014 0:00,Non-SBIR/STTR,2009,233155, ,NCI, , ,233155
Walleye Dermal Sarcooma Virus Accessory Protein Function,7654674,6/1/2002 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,251891, ,NCI, , ,251891
Role of P53 in LITAF Process,7654785,2/5/2009 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,203125, ,NIAID, , ,203125
Hormone Regulation and Pathogenesis of Pituitary Tumors,7654824,3/1/1989 0:00,7/31/2009 0:00,Non-SBIR/STTR,2008,335161, ,OD, , ,335161
c-Met/PTEN Interactions in Gliomas,7654849,7/15/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,331406, ,NINDS, , ,331406
P63 mediators as therapeutic targets in HNSCC,7654917,4/1/2004 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,437474, ,NIDCR, , ,437474
Genetic Mouse Models of Glioma,7655161,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2009,396279, ,NCI, , ,396279
Role of H2AX and ATM in Suppression of Thymic Lymphomas,7655559, , ,Non-SBIR/STTR,2008, ,558569, , , , 
Transcriptional Repression by Maf1 in Yeast,7656040,3/1/2009 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,465140, ,NIGMS, , ,465140
Lipid-Peroxidation Induced Cyclic Adducts in Hepatocarcinogenesis,7656102,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2009,463845, ,NCI, , ,463845
Role of Proline in Redox Homeostasis and Apoptosis,7656823,8/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,271604, ,NIGMS, , ,271604
Recovery of functional p53 as a therapeutic approach for breast cancer,7656966,7/1/2000 0:00,7/31/2010 0:00,Non-SBIR/STTR,2008,311187, ,OD, , ,311187
Role of MetAP-2 in Angiogenesis and Wnt Signaling,7657082,7/9/1999 0:00,1/31/2014 0:00,Non-SBIR/STTR,2009,413750, ,NCI, , ,413750
Inhibition of Autophagy: A Novel Therapeutic Strategy for Advanced Solid Tumors,7657242,7/17/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,333347, ,NCI, , ,333347
P53 Biomark er and Intervention in Occupational Cancer,7657375,7/1/2006 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,342124, ,NIOSH, , ,342124
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHN,7658093, , ,Research Centers,2008, ,405477, , , , 
Murine Neuroblastoma Models for Preclinical Therapeutics,7658132,7/1/2003 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,261694, ,NCI, , ,261694
Molecular Mechanisms of Lymphomagenesis,7658155,8/1/2006 0:00,7/30/2012 0:00,Non-SBIR/STTR,2009,289553, ,NCI, , ,289553
The Role of P40 in Squamous Cell Carcinomas,7658181,9/1/2000 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,328730, ,NIDCR, , ,328730
Structural basis of signaling by ING2 PHD,7658826,9/6/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,196142, ,NCI, , ,196142
The Environment and Epigenetic Gene Silencing in Cancer,7658891,9/30/2006 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,589543, ,NIEHS, , ,589543
Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M,7659127,8/15/2003 0:00,3/31/2014 0:00,Non-SBIR/STTR,2009, ,718803, , , , 
Mechanistic Studies of Mediator and the p53 Tumor Suppressor,7659488,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,227237, ,NCI, , ,227237
Genomic Methylation: A Mechanism to Alter Tumor Phenotype,7659596,5/1/1996 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,237671, ,NCI, , ,237671
The role of p63 and p73 in cancer,7659627,1/14/2002 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,312641, ,NCI, , ,312641
Mechanisms of p53 activation in tumorsuppression,7660909,5/15/2003 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,309962, ,NCI, , ,309962
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas,7660999,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2009,298800, ,NCI, , ,298800
Understanding the Structural Mechanism of Puma-induced Apoptosis,7661177,4/1/2009 0:00,2/28/2013 0:00,Non-SBIR/STTR,2009,336000, ,NIGMS, , ,336000
Transcriptional Repression by CtBP at the p21 Promoter,7661642,7/1/2005 0:00,6/30/2011 0:00,Other Research-Related,2009,137700, ,NCI, , ,137700
Clinical Investigator Development in Solid Tumor Oncology,7661663,9/1/2000 0:00,6/30/2011 0:00,Other Research-Related,2009,153090, ,NCI, , ,153090
Pathways of Bladder Tumorgenesis,7662283, , ,Non-SBIR/STTR,2008, ,313242, , , , 
Epithelial Stem Cell Programs,7662450,8/1/2008 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,381282, ,NIGMS, , ,381282
A novel enzymatic activity of WSTF and its role in tumorigenesis,7662654,7/1/2009 0:00,12/31/2009 0:00,Other Research-Related,2009,53611, ,NCI, , ,53611
Resolution of Epithelial Cell Hyperplasia,7663024,9/15/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2009,444506, ,NIEHS, , ,444506
Mechanisms of IGF-1 mediated rescue of radiation-induced salivary gland dysfuncti,7663151,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,335650, ,NIDCR, , ,335650
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival,7663557,7/17/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,75322, ,NCI, , ,75322
PCAF/GCN5 Acetylation on p53 Transactivation,7663643,4/1/1999 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,354807, ,NCI, , ,354807
Phase I & II studies of topical agents for chemoprevention of skin cancer,7663975, , ,Non-SBIR/STTR,2008, ,1796242, , , , 
Molecular Mechanisms of UVA induced apotosis and carcinogenesis,7663976, , ,Non-SBIR/STTR,2008, ,1147898, , , , 
Tumor Host Range Mutants of Polyoma and Their Targets,7664551,9/1/2001 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,634992, ,NCI, , ,634992
Genetic Epidemiology of Melanoma,7664552,9/30/2001 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,637867, ,NCI, , ,637867
Determinants of Metastatic Progression,7665055,7/23/2002 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,270128, ,NCI, , ,270128
ROLE OF HISTONE H4 N-TERMINAL TAIL IN TRANSCRIPTION REGULATION,7665067,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,313763, ,NIGMS, , ,313763
Prevention of quinone toxicity and mutagenicity,7665176,8/1/1996 0:00,6/19/2011 0:00,Non-SBIR/STTR,2009,331034, ,NIEHS, , ,331034
Role of Id1 in NSCLC Progression and Metastasis,7665277,7/17/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,346525, ,NCI, , ,346525
Studying the control of Cytokinesis as an Evolved Complex System,7665363,8/1/1999 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,307854, ,NIGMS, , ,307854
PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS,7665372,5/1/2004 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,585012, ,NCI, , ,585012
Role of p53 and the p53-inducible Sestrin1 and 2 genes in hepatocarcinogenesis,7665514,8/1/2008 0:00,6/30/2010 0:00,Other Research-Related,2009,78214, ,NIDDK, , ,78214
Role of ATM in Cardiac Myocyte Loss and Myocardial Remodeling,7665579,8/1/2008 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,177500, ,NHLBI, , ,177500
Molecular Determinants for the Bioactivity of the Flavonoid Quercetin,7666038,8/1/2008 0:00,7/31/2011 0:00,Other Research-Related,2009,110250, ,NIGMS, , ,110250
Epigenetic Regulation of Cell and Tissue Aging,7666127,9/30/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,308382, ,NIA, , ,308382
Targeting Cell Cycle Checkpoints in Cancer Therapeutics,7666190,8/1/2006 0:00,12/23/2009 0:00,Other Research-Related,2009,133893, ,NCI, , ,133893
Imaging Lung Cancer in Mice To Improve Radiation Therapy,7666193,8/3/2005 0:00,7/31/2010 0:00,Other Research-Related,2009,130329, ,NCI, , ,130329
Radioprotection by targeted siRNA delivery to salivary gland,7666257,8/1/2008 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,231000, ,NIDCR, , ,231000
monoclonal antibody,7666677, , ,Research Centers,2008, ,110511, , , , 
Impact of BRG1 Loss in Lung Cancer Development,7666712,9/27/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,278350, ,NCI, , ,278350
Modeling ovarian carcinoma by defined genetic alterations,7666760,9/1/2005 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,266292, ,NCI, , ,266292
"Telomere dysfunction, p53 and tumorigenesis",7666826,7/1/2007 0:00,6/30/2012 0:00,Other Research-Related,2009,151832, ,NCI, , ,151832
Functional analysis of a putative ATM/ATR substrate RFWD3,7666860,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,291650, ,NIGMS, , ,291650
Genomic Instability and Senescence in Cancer,7667209,9/14/2005 0:00,8/31/2011 0:00,Other Research-Related,2009,157820, ,NCI, , ,157820
Mechanisms of Radioresistance and Cell Cycle Progression,7667330,9/28/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,360812, ,NCI, , ,360812
A novel regulator of p53,7667423,8/15/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,260621, ,NCI, , ,260621
DNA Repair and Checkpoint Interactions in Mammals,7667582,5/1/2003 0:00,3/31/2009 0:00,Non-SBIR/STTR,2008,28425, ,NCI, , ,28425
Cancer cell telomere dynamics and responses to perturbations,7667848,9/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,308158, ,NCI, , ,308158
Mouse Model of Pancreatic Cancer Progression-Maintenance,7667857,9/21/2005 0:00,8/31/2010 0:00,Other Research-Related,2009,162540, ,NCI, , ,162540
PROGNOSTIC & PREDICTIVE  FACTORS IN OUTCOME OF PATIENTS WITH COLORECTAL CANCER:,7667861, , ,Research Centers,2008, ,262157, , , , 
MOLECULAR CHANGES IN THE NKFB PATHWAY IN RESPONSE TO CHEMORADIATION THERAPY IN RE,7667862, , ,Research Centers,2008, ,341169, , , , 
Bim regulation by HHV-8 vIRF-1,7667943,8/5/2008 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,221400, ,NCI, , ,221400
Lipid peroxidation product induced DNA damage in the p53 gene and liver cancer,7668030,9/28/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,361563, ,NIEHS, , ,361563
Growth Inhibition by the ARF Tumor Suppressor,7668052,4/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,265940, ,NCI, , ,265940
Predictive Molecular Markers of Colorectal Cancer,7668295,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,73208, ,NCI, , ,73208
Polyoma Virus Disrupts ARF Signaling to p53,7668343,4/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,308158, ,NCI, , ,308158
Role of Kruppel-Like Factor 4 in Wnt and Notch Signaling in the Intestinal Tract,7668400,8/1/2008 0:00,7/31/2011 0:00,"Training, Individual",2009,57194, ,NCI, , ,57194
"Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B",7668452, , ,Research Centers,2008, ,309081, , , , 
MTOR AS A THERAPEUTIC TARGET IN PEDIATRIC SOLID TUMORS,7668516, , ,Non-SBIR/STTR,2008, ,275002, , , , 
Altered Expression of Protein Tyrosine Phosphatase by Methylation,7668535, , ,Non-SBIR/STTR,2008, ,300447, , , , 
Pathology,7668539, , ,Non-SBIR/STTR,2008, ,321393, , , , 
Breast Cancer Prevention by Dietary Phytochemicals,7668746,9/7/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,282150, ,NCI, , ,282150
Intracellular Mechanisms of Glucocorticoid Action,7668811,7/1/1986 0:00,6/30/2012 0:00,Non-SBIR/STTR,2008,80965, ,NIDDK, , ,80965
RECEPTOR-TARGETED COPPER RADIOPHARMACEUTICALS FOR CANCER IMAGING AND THERAPY,7668843,7/18/1994 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,292410, ,NCI, , ,292410
p53 Fusion Protein as an Oncology Therapeutic,7668874,9/18/2007 0:00,8/31/2011 0:00,SBIR/STTR,2009,367754, ,NCI, , ,367754
Selenium protection of bone marrow during chemotherapy,7669111,8/1/2007 0:00,6/30/2012 0:00,Non-SBIR/STTR,2009,226500, ,NHLBI, , ,226500
NITROAROMATICS AND BREAST CANCER,7669127,7/1/1983 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,356452, ,NCI, , ,356452
Mechanisms of Genetic Instability and Tumor Suppression,7669138,7/1/1993 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,520392, ,NCI, , ,520392
p53-Independent Cell Death Signaling by Mitomycin DNA Adducts,7670282,8/6/2008 0:00,7/31/2012 0:00,Other Research-Related,2009,329000, ,NCI, , ,329000
Stochastic dynamics for multiscale biology,7670408,9/1/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,311541, ,NIGMS, , ,311541
Effectors of p53 Pro-Survival & Pro-Apoptotic Signaling,7670410, , ,Non-SBIR/STTR,2008, ,540697, , , , 
Molecular Interactions and Regulation of p53,7670411, , ,Non-SBIR/STTR,2008, ,323113, , , , 
p53 Pathway in Postnatal Growth and Stem Cell Behavior,7670412, , ,Non-SBIR/STTR,2008, ,334322, , , , 
p53 - Regulators and Effectors,7670414,2/16/2000 0:00,6/30/2010 0:00,Non-SBIR/STTR,2009,1388997, ,NCI, , ,1388997
Prolactin as a risk biomarker of ovarian cancer,7671332,8/8/2008 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,75750, ,NCI, , ,75750
Role of the STK Receptor in Erythropoiesis,7671454,8/15/2001 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,294822, ,NHLBI, , ,294822
Mechanism of p53-Mediated Tumor Suppression,7671498,12/5/1997 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,306143, ,NCI, , ,306143
Identifying Small Molecule Inhibitors of HdmX using Cell-based Screening,7671725,4/1/2009 0:00,3/31/2011 0:00,SBIR/STTR,2009,188748, ,NCI, , ,188748
Soluble TCR-IL15 Fusions as Targeted Therapeutics for Cancer,7671903,4/3/2009 0:00,4/2/2010 0:00,SBIR/STTR,2009,202736, ,NCI, , ,202736
Quantitative Measurements and Modeling of the Mitotic Checkpoint,7672313,9/28/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,350000, ,NIGMS, , ,350000
p53-independent PUMA induction in anti-cancer therapies,7672824,1/1/2010 0:00,12/31/2012 0:00,"Training, Individual",2009,50054, ,NCI, , ,50054
Zinc Finger Recombinases for Endogenous Genome Tailoring,7673561,9/1/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,251641, ,NCI, , ,251641
Targeting transforming growth factor beta for cancer treatment,7673571,7/15/1997 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,218928, ,NCI, , ,218928
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS,7673691, , ,Non-SBIR/STTR,2008, ,415175, , , , 
"HPV: Biology, Clinical Significance and Epidemiology",7673696,6/1/1997 0:00,6/30/2012 0:00,Non-SBIR/STTR,2009,2414027, ,NCI, , ,2414027
Zebrafish Screens for Genetic Modifiers and Human Application in T-ALL,7673914, , ,Non-SBIR/STTR,2008, ,296757, , , , 
Functional Characterization of WTX in Renal Development,7674515,9/30/2007 0:00,8/31/2012 0:00,Other Research-Related,2009,137970, ,NIDDK, , ,137970
Hypoxia signaling to checkpoint activation and apoptosis,7674603,8/4/2006 0:00,2/28/2010 0:00,Non-SBIR/STTR,2009,267266, ,NCI, , ,267266
GENETIC ALTERATION IN EPITHELIAL AND STROMAL COMPARTMENT OF BREAST ADENOCARCINOMA,7674761, , ,Non-SBIR/STTR,2008, ,480072, , , , 
Cooperation of PTEN and SHIP as tumor suppressors in B-Cells,7675335,9/30/2007 0:00,8/31/2012 0:00,Other Research-Related,2009,110843, ,NCI, , ,110843
The role of DEK in breast cancer development and therapy,7675800,9/15/2009 0:00,9/14/2011 0:00,"Training, Individual",2009,47210, ,NCI, , ,47210
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,7676762,9/1/2008 0:00,8/31/2013 0:00,Other Research-Related,2009,164476, ,NCI, , ,164476
Molecular dissection of pancreatic ductal adenocarcinoma,7676812,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,395825, ,NCI, , ,395825
The role of stem cells in longevity suppression by p44 (deltaN-p53),7676822,9/2/2008 0:00,12/29/2010 0:00,"Training, Individual",2009,30549, ,NINDS, , ,30549
Integration of Ocogenic Networks in Cancer Phenotypes,7676877, , ,Research Centers,2008, ,2045871, , , , 
Oligoclonal T Cell Expansion and Rheumatoid Arthritis,7677380,9/30/1993 0:00,11/30/2009 0:00,Non-SBIR/STTR,2009,81000, ,NIAMS, , ,81000
SPORE in Prostate Cancer,7677844,8/1/1997 0:00,5/31/2013 0:00,Research Centers,2009,2300000, ,NCI, , ,2300000
NF Center: From Animal Models to Therapeutics,7678397, , ,Research Centers,2008, ,212903, , , , 
NF Center: From Animal Models to Therapeutics,7678402,9/20/2005 0:00,8/14/2010 0:00,Research Centers,2009,1297473, ,NINDS, , ,1297473
Chemoprevention of Lung Cancer with Anti-tumor B,7678414,9/30/2007 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,368725, ,NCCIH, , ,368725
Role of Germ Cell Nuclear Factor in Restricting hESC Pluripotency,7678450, , ,Non-SBIR/STTR,2008, ,267699, , , , 
Regulatory Networks in Human Embryonic Stem Cells,7678455,9/1/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,1820990, ,NIGMS, , ,1820990
MbSOD in chemotherapeutic-Induced Cardiac Injury,7678676,9/25/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,270000, ,NCI, , ,270000
GENES CONTROLLING NEOPLASIA OF THE INTESTINAL EPITHELIUM,7678682,9/22/1993 0:00,12/31/2008 0:00,Non-SBIR/STTR,2008,39828, ,NCI, , ,39828
FAK Signals Controlling Endothelial Cell Survival and Motility,7678921,9/1/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,491200, ,NHLBI, , ,491200
"Allergies, Genetic Susceptibility and Adult Glioma Risk",7679103,3/10/2006 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,406175, ,NCI, , ,406175
Timing of Rectal Cancer Response to Chemoradiation,7679361,9/16/2003 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,960599, ,NCI, , ,960599
MOLECULAR BIOMARKERS FOR ENVIRONMENTAL TOXICANTS,7679443,6/1/1997 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,1831811, ,NIEHS, , ,1831811
Defining PAH-mediated carcinogenesis in lung: CYP metabolism and B[a]P transport,7679487,9/30/2007 0:00,9/29/2010 0:00,"Training, Individual",2009,51710, ,NIEHS, , ,51710
Targeting p53 for colon cancer treatment & prevention,7679510,9/1/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,170325, ,NCI, , ,170325
Regulation of p53 function by Daxx,7679526,5/3/2001 0:00,5/31/2012 0:00,Non-SBIR/STTR,2009,253024, ,NCI, , ,253024
The role of cyclin E deregulation in breast tumorigenesis,7679541,9/1/2008 0:00,8/31/2011 0:00,Other Research-Related,2009,154292, ,NCI, , ,154292
Genetic modifiers of mammary tumor susceptibility,7679752,2/15/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2008,33416, ,NCI, , ,33416
Bladder Cancer Prognostic Indicators,7680246,9/1/2005 0:00,8/31/2011 0:00,Other Research-Related,2009,144180, ,NCI, , ,144180
Cyclins and Cyclin-dependent kinases as targets for protection against radiation,7680290, , ,Non-SBIR/STTR,2008, ,266836, , , , 
Role of p53 in cell cycle checkpoints,7680589,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2009,351713, ,NCI, , ,351713
Telomere induced senescence as a supressor of tumorigenesis,7680867,8/8/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,86117, ,NCI, , ,86117
Targeting Signal Transduction Pathways for Cancer Drug Discovery,7680888,2/5/2007 0:00, ,Non-SBIR/STTR,2008,41871, ,NCI, , ,41871
Deregulation of the Ubiquitin/26S Proteasome Pathway in AT cells: Role of ISG15,7681075,9/1/2008 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,186375, ,NINDS, , ,186375
Structure and Function of DNA Regulatory Proteins,7681133,1/1/1997 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,313688, ,NIGMS, , ,313688
Genomic Analysis of the p53 Pathway in Normal and Cancer Cells,7681200, , ,Non-SBIR/STTR,2008, ,382343, , , , 
p53 and Chemosensitivity in a Mouse Lymphoma Model,7681201, , ,Non-SBIR/STTR,2008, ,394677, , , , 
Molecular Studies of the p53 Pathway in Human Cancer,7681202, , ,Non-SBIR/STTR,2008, ,395814, , , , 
Roles and Regulation of p53,7681203,9/30/2000 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,1639011, ,NCI, , ,1639011
Functional analysis of the p53 tumor suppressor,7681557,8/15/1985 0:00,7/30/2013 0:00,Non-SBIR/STTR,2009,221499, ,NCI, , ,221499
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein,7682095,9/30/1992 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,306714, ,NCI, , ,306714
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression,7682268,9/3/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,233704, ,NCI, , ,233704
"Spindle Assembly Checkpoint, Chromosomal Instability, and Cancer",7682858,9/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,318513, ,NCI, , ,318513
Molecular Studies on MUC4 Mucin Gene,7682901,9/1/2008 0:00,6/30/2012 0:00,Non-SBIR/STTR,2009,224040, ,NCI, , ,224040
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer,7682906,9/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,248170, ,NCI, , ,248170
Somatic genetic predictors of response to therapy in metastatic melanoma,7682948,9/13/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,309344, ,NCI, , ,309344
Sequence distribution of tobacco carcinogen-DNA adducts,7682985,12/1/2002 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,210520, ,NCI, , ,210520
Role of Bub1 in SV40 large T antigen mediated transformation and replication,7683275,9/10/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,373339, ,NIAID, , ,373339
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia,7683525,8/5/2003 0:00,4/30/2013 0:00,Research Centers,2008,40163, ,NCI, , ,40163
SPORE in Head and Neck Cancer,7683529,7/1/2004 0:00,6/30/2010 0:00,Research Centers,2008,52930, ,NCI, , ,52930
Epithelial Positioning Organization and Ovarian Cancer,7683865,3/1/2002 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,307831, ,NCI, , ,307831
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia,7683911,8/5/2003 0:00,4/30/2013 0:00,Research Centers,2009,2300000, ,NCI, , ,2300000
Induction of genomic instability by HPV E6 and E7,7684264,9/8/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,306347, ,NCI, , ,306347
SPORE in Head and Neck Cancer,7684550,7/1/2004 0:00,6/30/2010 0:00,Research Centers,2008,350000, ,NCI, , ,350000
The Effect of Radiation on Androgen Receptor Expression and Activity in Prostate,7684768, , ,Research Centers,2008, ,274592, , , , 
A PTEN-Dependent Size Checkpoint in Human Cancer Cells,7685028,5/11/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2008,60643, ,NCI, , ,60643
Comparative Bioinformatics and TP53 Expression,7685409,9/30/2005 0:00,9/30/2012 0:00,Non-SBIR/STTR,2009,271777, ,NLM, , ,271777
Role of Slug in Regulation of Hematopietic Stem Cells,7685451,9/10/2007 0:00,7/31/2011 0:00,Other Research-Related,2009,131441, ,NIDDK, , ,131441
Full Project 1: Tumor-targeted MR Contrast Enhancement Using Molecular Imaging Te,7685496, , ,Research Centers,2008, ,151087, , , , 
Lineage Tracy in Murine Pancreatic Cancer Metastasis,7685674,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2008,7000, ,NCI, , ,7000
Pre-Clinical Evaluation of Novel Therapeutics for PDA,7685893,9/25/2006 0:00,9/24/2009 0:00,"Training, Individual",2008,7000, ,NCI, , ,7000
Interaction Between SV40 Large T and P185 Cullin,7686128,7/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,281356, ,NCI, , ,281356
Defining the Contributions of Pancreatic Ductal and Acinar Cells to Tumorigenesis,7686161,7/3/2008 0:00,7/2/2010 0:00,"Training, Individual",2009,53354, ,NCI, , ,53354
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas,7686218,9/11/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,311250, ,NCI, , ,311250
Study on the intracellular Network of TBX3,7686585,8/1/2007 0:00,5/31/2011 0:00,Non-SBIR/STTR,2008,50683, ,NCI, , ,50683
"BRM promoter polymorphism, a marker for cancer risks",7686741,9/15/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,73250, ,NCI, , ,73250
Research Career Development in HIV-Related Anal Dysplasia/Carcinoma Prevention an,7686760,9/15/2008 0:00,8/31/2013 0:00,Other Research-Related,2009,114513, ,NIAID, , ,114513
The Function and Regulation of  Trefoil Factor Family 2 (TFF2),7686924,4/1/2001 0:00,6/30/2012 0:00,Non-SBIR/STTR,2009,340638, ,NIDDK, , ,340638
The Role of Fbxw7 in genetic instability and cancer,7687508,9/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,355982, ,NCI, , ,355982
THE THERAPY OF AML,7687598,5/27/1997 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,2440745, ,NCI, , ,2440745
SPORE in Lung Cancer,7687973,9/15/2008 0:00,8/31/2013 0:00,Research Centers,2009,2000000, ,NCI, , ,2000000
Sphingolipids in Cancer Biology and Therapy,7687976,8/1/2003 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,1144225, ,NCI, , ,1144225
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis,7687985,9/15/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,308051, ,NCI, , ,308051
An Intra-Neoplasm Genetic Diversity Assay,7688488,9/17/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,59228, ,NCI, , ,59228
"Inhibitory effects of caffeine, exercise and lipectomy on UVB-induced skin cancer",7688537,9/18/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,247774, ,NCI, , ,247774
SPORE in Head and Neck Cancer,7688781,7/1/2004 0:00,6/30/2010 0:00,Research Centers,2008,350000, ,NCI, , ,350000
Mechanisms of CDX2 regulation of the IGF axis,7688927,4/1/2009 0:00,3/31/2013 0:00,Non-SBIR/STTR,2009, , , , , , 
The Role of Geminin in Hematopoiesis,7689196,9/19/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,190625, ,NHLBI, , ,190625
Functional Components of the Rb/E2F and p53 Pathways,7689222,9/30/2008 0:00,9/29/2010 0:00,Other Research-Related,2009,90000, ,NLM, , ,90000
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,7689935,5/1/1997 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,1430618, ,NCI, , ,1430618
Rapid release paclitaxel nanoparticles for bladder cancer intravestical therapy,7689982,8/1/2004 0:00,8/31/2013 0:00,SBIR/STTR,2009,645019, ,NCI, , ,645019
Tumor Suppression,7690492, , ,Non-SBIR/STTR,2008, ,718040, , , , 
Comparative functional genomics for lung cancer gene discovery,7691776,9/23/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,573992, ,NCI, , ,573992
Dynamics of Signaling Pathways: Mechanism and Function,7691903,3/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2008,80000, ,NIGMS, , ,80000
Ultrasensitive Nanoscale Magnetic Sensors for Label-free Analysis of Cancer,7692257,9/24/2008 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,159490, ,NCI, , ,159490
MbSOD in chemotherapeutic-Induced Cardiac Injury,7692946,9/25/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,270000, ,NCI, , ,270000
Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,7693473,9/30/2009 0:00,8/31/2014 0:00,Other Research-Related,2009,355027, ,NIAID, , ,355027
Regulation of MMP-9 mRNA stability and tumor growth by alpha3 beta1 integrin,7693719,9/26/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,325775, ,NCI, , ,325775
MicroRNAs and chromosome 22q in the colon,7693835,3/1/2000 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,397532, ,NIDDK, , ,397532
Chemical Modulation of the Siah-1 Pathway,7694153,4/15/2009 0:00,3/31/2010 0:00,Non-SBIR/STTR,2009,25000, ,OD, , ,25000
Graduate Training at the Chemistry Biology Interface,7694518,7/1/2004 0:00,6/30/2014 0:00,"Training, Institutional",2009,135400, ,NIGMS, , ,135400
Identification of Genes Required for Cellular Senescence,7695008,12/1/2008 0:00,11/30/2010 0:00,"Training, Individual",2010,50474, ,NCI, , ,50474
Cancer cell adaptation to metabolic stress,7695290,9/10/2004 0:00,8/31/2014 0:00,Non-SBIR/STTR,2009,1160298, ,NCI, , ,1160298
Flow Cytometry,7695941,8/28/2008 0:00,6/30/2013 0:00,Research Centers,2008, ,359564, , , , 
TGF-beta Signaling in Pancreatic Cancer Progression,7696142,9/1/2009 0:00,7/31/2014 0:00,Non-SBIR/STTR,2009,340300, ,NCI, , ,340300
The Role of Non-C anonical Bax/Bak Direct Activators in Hematological Cancers,7697111,8/25/2008 0:00,8/24/2011 0:00,"Training, Individual",2009,51710, ,NCI, , ,51710
UT M.D. Anderson Cancer Center Lymphoma SPORE,7697409,9/1/2009 0:00,8/31/2012 0:00,Research Centers,2009,500000, ,NCI, , ,500000
The Control of Centriole Duplication and Degeneration,7697740,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2009,361998, ,NIGMS, , ,361998
Interplay between Cdh1 and major regulatory pathways in human cancer,7698539,8/6/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2009,345600, ,NIGMS, , ,345600
Targeting Glucose Metabolism in Cancer,7699623,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,245680, ,NCI, , ,245680
Mechanisms of Liver Cell Injury,7706662,9/30/1992 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010,394250, ,NIDDK, , ,394250
Mechanisms of p53 activation during stress response,7707784,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,346525, ,NCI, , ,346525
Using p53 Knock-In Mice to Understand p53's Role in Pancreatic Cancer,7707938,7/1/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,183850, ,NCI, , ,183850
caBIG-ICR Software Development Support for REMBRANDT,7713483, , ,Interagency Agreements,2008,245318, ,NCI, , ,245318
caBIG ICR Software Development Sprt National Cancer Institute Ctr Bioinformatics,7713589, , ,Interagency Agreements,2008,140055, ,NCI, , ,140055
Genomic stability of human pluripotent stem cells,7714486,9/1/2009 0:00,8/31/2011 0:00,Other Research-Related,2009,97200, ,NICHD, , ,97200
Intravenous Protein Therapy for Myotonic Dystrophy Type 1,7714687,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,141092, ,NINDS, , ,141092
Pre-Clinical and Clinical Development of Silvestrol in Chronic Lymphocytic,7715179,7/1/2009 0:00,6/30/2014 0:00,Research Centers,2009, ,269233, , , , 
Non-genotoxic p53 activation as novel therapeutic concept for lymphoma,7715218,9/1/2009 0:00,8/31/2012 0:00,Research Centers,2009, ,67984, , , , 
THE STUDY AND CHARACTERIZATION OF XENOESTROGEN EFFECTS,7715353,9/26/2008 0:00,5/31/2009 0:00,Research Centers,2008, ,135417, , , , 
ID PROTEIN FAMILY EXPRESSION AND FUNCTION IN PROSTATE CANCER,7715356,9/1/2008 0:00,6/30/2009 0:00,Research Centers,2008, ,189195, , , , 
ESTROGEN-MEDIATED CELL CYCLE ARREST VIA P53 AND P21,7715991,5/1/2008 0:00,4/30/2009 0:00,Research Centers,2008, ,27704, , , , 
EVALUATION OF THE USE OF POXVIRUS VACCINES TO STIMULATE P53 SPECIFIC IMMUNITY,7716642,4/20/2008 0:00,11/30/2008 0:00,Research Centers,2008, ,1201, , , , 
"CLINICAL TRIAL: A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTO",7717745,12/1/2007 0:00,11/30/2008 0:00,Research Centers,2008, ,11600, , , , 
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER FOR CANCER,7718388,4/1/2008 0:00,3/31/2009 0:00,Research Centers,2008, ,41296, , , , 
CLINICAL TRIAL: INDIVIDUALIZED TX OF BREAST CANCER BASED ON TUMOR MOLECULAR CHAR,7718400,4/1/2008 0:00,3/31/2009 0:00,Research Centers,2008, ,2166, , , , 
"SYNTHETIC PEPTIDES IN ADJUVANT VACCINATION IN OVARIAN, PERITONEAL, FALLOPIAN CA",7718569,3/1/2008 0:00,2/28/2009 0:00,Research Centers,2008, ,15512, , , , 
GENOTYPIC AND PHENOTYPIC RESPONSE OF BREAST EPITHELIAL CELLS FROM WOMEN,7719026,4/1/2008 0:00,3/31/2009 0:00,Research Centers,2008, ,3425, , , , 
MOLECULAR EPIDEMIOLOGY OF HEAD AND NECK CANCER,7719033,4/1/2008 0:00,3/31/2009 0:00,Research Centers,2008, ,64923, , , , 
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER,7719035,4/1/2008 0:00,3/31/2009 0:00,Research Centers,2008, ,37099, , , , 
RETINOID THERAPY,7719709, , ,Non-SBIR/STTR,2007, ,178327, , , , 
RETINOID THERAPY,7719718, , ,Non-SBIR/STTR,2008, ,182528, , , , 
"COBRE: U KS: P1: ID OF HSP90 COCHAPERONES, IMMUNOPHILINS &  PROTEINS",7720669,5/15/2008 0:00,3/31/2009 0:00,Research Centers,2008, ,26054, , , , 
PROJECT 9: STEM CELL FUNCTION & GENOME INSTABILITY IN LYMPHOMYELOID NEOPLASIA,7720707,9/4/2008 0:00,5/31/2009 0:00,Research Centers,2008, ,288973, , , , 
DISSECTING ROLES OF MTBP IN OSTEOSARCOMA METASTASIS,7720778,8/1/2008 0:00,7/31/2009 0:00,Research Centers,2008, ,346252, , , , 
COBRE P2:  CYP1B1 INDUCTION IN TOBACCO-RELATED ORAL CARCINOGENESIS,7720802,6/1/2008 0:00,5/31/2009 0:00,Research Centers,2008, ,127286, , , , 
MAMMALIAN PROLINE METABOLISM AND OXIDATIVE STRESS,7720828,8/1/2008 0:00,7/31/2009 0:00,Research Centers,2008, ,140873, , , , 
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY,7721486,2/1/2008 0:00,1/31/2009 0:00,Research Centers,2008, ,531, , , , 
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS,7722425,5/1/2008 0:00,4/30/2009 0:00,Research Centers,2008, ,29268, , , , 
OPTICAL IMAGING OF TUMOR ANGIOGENESIS AND CHEMOTHERAPY,7722575,4/15/2008 0:00,3/31/2009 0:00,Research Centers,2008, ,2075, , , , 
THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY,7724198,6/1/2008 0:00,5/31/2009 0:00,Research Centers,2008, ,9019, , , , 
Glucose Metabolism and p53 in Leukemia,7724839,8/20/2008 0:00,8/19/2011 0:00,"Training, Individual",2009,28092, ,NHLBI, , ,28092
SENESCENCE SIGNALING THROUGH P53,7725220,6/1/2008 0:00,5/31/2009 0:00,Research Centers,2008, ,182980, , , , 
Translational Pathology Core Facility,7726558, , ,Research Centers,2008, ,719937, , , , 
Targeting Regulators of Apoptosis in AML,7726843, , ,Non-SBIR/STTR,2008, ,348258, , , , 
Molecular Mechanism of Translocations in B-Cell Lymphoma,7726906, , ,Non-SBIR/STTR,2007, ,413856, , , , 
Molecular Mechanism of Translocations in B-Cell Lymphoma,7726915, , ,Non-SBIR/STTR,2008, ,425988, , , , 
Targeting of MDM2 Family Proteins in Cancer,7726948, , ,Non-SBIR/STTR,2008, ,305067, , , , 
Development of Proteasome Selective Inhibitors for Cancer Therapy,7726950, , ,Non-SBIR/STTR,2008, ,289499, , , , 
Predictive Molecular Markers of Colorectal Cancer For African American Patients,7726959,9/30/2005 0:00, ,Research Centers,2008, ,90668, , , , 
Repair of oxidative DNA damage in mammalian cells,7727956,3/10/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2009,242053, ,NCI, , ,242053
DNA Methyltrasferase Gene Expression in Colon Cancer,7728015,4/1/1991 0:00,3/31/2014 0:00,Non-SBIR/STTR,2009,550876, ,NIEHS, , ,550876
Biomarkers for Margin Analysis and Prognosis in HNSCC,7728604,9/1/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2009,427054, ,NIDCR, , ,427054
Expression of Simiam Virus 40 T Antigens in Intestine,7728907,7/1/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,335900, ,NCI, , ,335900
Regulation of the mTOR Pathway By Nutrients,7728966,3/23/2004 0:00,5/31/2014 0:00,Non-SBIR/STTR,2009,390408, ,NCI, , ,390408
Mechanisms of Pituitary Tumorigenesis,7728998,12/15/1998 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,285664, ,NCI, , ,285664
Death Receptors in Bladder Cancer Therapy,7729506,9/1/2008 0:00,8/31/2011 0:00,Research Centers,2008, ,186043, , , , 
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer,7729711,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2009,321631, ,NCI, , ,321631
Role of Focal Adhesion Kinase In Tumorigenesis,7729765,7/1/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2009,302154, ,NCI, , ,302154
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes,7729870,9/18/2006 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,177099, ,NCI, , ,177099
Mechanisms of RelA Activation in Cancer,7730305,9/19/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,225003, ,NCI, , ,225003
Dmp1-p53/YY1 interplays and their roles in lung cancer development,7730396,4/1/2004 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,266677, ,NCI, , ,266677
Differential regulation of cardiomyocyte survival and hypertrophy,7730407,9/1/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,568420, ,NHLBI, , ,568420
Structural and Functional Characterization of BRCA1/BARD1,7730658,12/21/1998 0:00,6/30/2013 0:00,Non-SBIR/STTR,2009,409735, ,NIGMS, , ,409735
SUMO conjugation in cell biology and Development,7730842,9/15/2001 0:00,11/30/2012 0:00,Non-SBIR/STTR,2010,235735, ,NIGMS, , ,235735
Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction,7731107,9/5/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2009,356250, ,NIAAA, , ,356250
Novel Roles of p53 & ROS in Therapy of Refractory CLL,7731919,5/1/2003 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,299699, ,NCI, , ,299699
Embryonic Stem Cell Derived Cardiac Myocytes,7732331, , ,Intramural Research,2008,654506, ,NIA, , ,654506
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS,7732671, , ,Intramural Research,2008,744264, ,NIAID, , ,744264
T-Cell Antigen Recognition and Tumor Antigens,7732858, , ,Intramural Research,2008,241663, ,NCI, , ,241663
Chromosomal Proteins and Chromosomal Functions,7732859, , ,Intramural Research,2008,1393486, ,NCI, , ,1393486
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,7732860, , ,Intramural Research,2008,1022419, ,NCI, , ,1022419
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,7732864, , ,Intramural Research,2008,909452, ,NCI, , ,909452
Regulation of HTLV-I Transcription,7732865, , ,Intramural Research,2008,583273, ,NCI, , ,583273
Gene Regulation and Function: The B-ZIP Proteins,7732870, , ,Intramural Research,2008,953630, ,NCI, , ,953630
Inhibition of p53 Tumor Suppressor Function by HTLV-I,7732896, , ,Intramural Research,2008,972122, ,NCI, , ,972122
Transgenic Models for Prostate and Breast Cancer,7732899, , ,Intramural Research,2008,1938182, ,NCI, , ,1938182
p53 Tumor Suppressor Pathway,7732903, , ,Intramural Research,2008,735101, ,NCI, , ,735101
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",7732906, , ,Intramural Research,2008,799704, ,NCI, , ,799704
Investigating regulatory networks that control cell proliferation and apoptosis,7732912, , ,Intramural Research,2008,512614, ,NCI, , ,512614
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,7732929, , ,Intramural Research,2008,1038185, ,NCI, , ,1038185
Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,7732948, , ,Intramural Research,2008,660219, ,NCI, , ,660219
Regulation of Lymphocyte Proliferation and Replicative Capacity,7732954, , ,Intramural Research,2008,535509, ,NCI, , ,535509
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,7732958, , ,Intramural Research,2008,406240, ,NCI, , ,406240
Inflammation and Cancer,7732971, , ,Intramural Research,2008,735101, ,NCI, , ,735101
Molecular Mechanisms of Growth Factor Modulated Proliferation,7732977, , ,Intramural Research,2008,752616, ,NCI, , ,752616
DNA Repair,7732985, , ,Intramural Research,2008,788201, ,NCI, , ,788201
Enzymes and Substrates of the Ubiquitin Conjugating System,7732986, , ,Intramural Research,2008,552414, ,NCI, , ,552414
Role of CEBP transcription factors in regulating cell growth and tumorigenesis,7733000, , ,Intramural Research,2008,1366455, ,NCI, , ,1366455
Role of Trk Receptors in the Development and Function of Non-neuronal Structures,7733024, , ,Intramural Research,2008,588598, ,NCI, , ,588598
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,7733075, , ,Intramural Research,2008,698325, ,NCI, , ,698325
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,7733076, , ,Intramural Research,2008,349162, ,NCI, , ,349162
Development of Mouse Astrocytoma Model for Preclinical Testing,7733077, , ,Intramural Research,2008,116387, ,NCI, , ,116387
Zebrafish Models of Cancer,7733083, , ,Intramural Research,2008,1031640, ,NCI, , ,1031640
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,7733116, , ,Intramural Research,2008,1035251, ,NCI, , ,1035251
Vaccine and Drug Combination Therapy for Human Cancers,7733137, , ,Intramural Research,2008,480181, ,NCI, , ,480181
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,7733168, , ,Intramural Research,2008,112553, ,NCI, , ,112553
Metabolic Mechanisms for Programmed Cell Death,7733187, , ,Intramural Research,2008,663560, ,NCI, , ,663560
Clinical trial development in cancer vaccines,7733197, , ,Intramural Research,2008,193479, ,NCI, , ,193479
Molecular Alterations of Primary Breast Cancer and Metastasis,7733201, , ,Intramural Research,2008,224353, ,NCI, , ,224353
Genetic Investigation of NPC and HCC in a Chinese Population,7733235, , ,Intramural Research,2008,123250, ,NCI, , ,123250
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,7733238, , ,Intramural Research,2008,365255, ,NCI, , ,365255
Consequences of Genomic Instability and Aneuploidy on the Colorectal Cancer     ,7733268, , ,Intramural Research,2008,555767, ,NCI, , ,555767
DNA Folding in Chromatin and Interaction with Transcription Factors,7733277, , ,Intramural Research,2008,310597, ,NCI, , ,310597
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,7733293, , ,Intramural Research,2008,511345, ,NCI, , ,511345
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,7733302, , ,Intramural Research,2008,530353, ,NCI, , ,530353
Novel Markers for Disease Outcome in Breast Cancer,7733307, , ,Intramural Research,2008,224251, ,NCI, , ,224251
Tumor models for the study of inflammation and oncogenesis,7733312, , ,Intramural Research,2008,270744, ,NCI, , ,270744
Redox Mechanism Process of Angiogenesis and Wound Healing,7733314, , ,Intramural Research,2008,436316, ,NCI, , ,436316
Cell and Cancer Biology Branch Confocal Microscopy Core,7733355, , ,Intramural Research,2008,860235, ,NCI, , ,860235
Vaccine and radiation for the therapy of human cancers,7733380, , ,Intramural Research,2008,411584, ,NCI, , ,411584
Collaborative Pathways that Lead to Leukemia,7733386, , ,Intramural Research,2008,344087, ,NCI, , ,344087
Gene therapy of cancer,7733389, , ,Intramural Research,2008,1488319, ,NCI, , ,1488319
Modeling Molecular of Interactions Regulating the Activity of the p53 Protein,7733473, , ,Intramural Research,2008,127785, ,NCI, , ,127785
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,7733494, , ,Intramural Research,2008,273549, ,NCI, , ,273549
Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,7733507, , ,Intramural Research,2008,520139, ,NCI, , ,520139
Epigenetic Alterations Induced by Tobacco Smoke,7733514, , ,Intramural Research,2008,624166, ,NCI, , ,624166
Molecular Mechanism of Lymphomagenesis,7733524, , ,Intramural Research,2008,203233, ,NCI, , ,203233
Cancer Risk and Environmental Exposures,7733701, , ,Intramural Research,2008,106318, ,NCI, , ,106318
Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,7733711, , ,Intramural Research,2008,1576967, ,NCI, , ,1576967
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,7733714, , ,Intramural Research,2008,1012, ,NCI, , ,1012
Studies of Rare Cancers,7733723, , ,Intramural Research,2008,983415, ,NCI, , ,983415
Signal and Transcription Factor Network interactions in Head and Neck Cancer,7733889, , ,Intramural Research,2008,606727, ,NIDCD, , ,606727
Genomics and Proteomics of Head and Neck Cancer,7733890, , ,Intramural Research,2008,606727, ,NIDCD, , ,606727
Oral Carcinogenesis,7733911, , ,Intramural Research,2008,1822650, ,NIDCR, , ,1822650
Small Molecule Activators of p53,7734055, , ,Intramural Research,2008,301734, ,NIDDK, , ,301734
Molecular aspects of gastrinoma,7734187, , ,Intramural Research,2008,356814, ,NIDDK, , ,356814
Characterization of mice carrying mutations of BRCA1 interacting proteins,7734225, , ,Intramural Research,2008,240057, ,NIDDK, , ,240057
"BRCA1, DNA damage response and aging",7734228, , ,Intramural Research,2008,240057, ,NIDDK, , ,240057
Advanced Mass Spectrometry Facility,7734285, , ,Intramural Research,2008,783233, ,NIDDK, , ,783233
Genetic Susceptibility to Loss of Tumor Suppressor Gene Function,7734407, , ,Intramural Research,2008,146781, ,NIEHS, , ,146781
"Role Of Lipids In Colon, Breast, And Other Cancers",7734463, , ,Intramural Research,2008,380285, ,NIEHS, , ,380285
Isolation And Characterization Of Human Genes Affecting Chromosome Metabolism,7734481, , ,Intramural Research,2008,1013937, ,NIEHS, , ,1013937
Effect of mitochondria on nculear gene expression,7734854, , ,Intramural Research,2008,23531, ,NICHD, , ,23531
POSITIONAL CLONING OF THE MEN1 GENE,7734860, , ,Intramural Research,2008,1167081, ,NHGRI, , ,1167081
"Kinetics, Regulation, And Mechanisms Of Biochemical Reactions",7734932, , ,Intramural Research,2008,1356108, ,NHLBI, , ,1356108
The Molecular Genetics of Gynecologic Cancers,7735347, , ,Intramural Research,2008,576752, ,NCI, , ,576752
Nitroxides as Protectors Against Oxidative Stress,7735362, , ,Intramural Research,2008,448821, ,NCI, , ,448821
Molecular Pathogenesis of Multiple Myeloma,7735366, , ,Intramural Research,2008,751353, ,NCI, , ,751353
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,7735368, , ,Intramural Research,2008,432302, ,NCI, , ,432302
Lymphoma Studies,7735372, , ,Intramural Research,2008,337660, ,NCI, , ,337660
Nitric Oxide as a Modifier of Oxidative Stress,7735381, , ,Intramural Research,2008,436316, ,NCI, , ,436316
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,7735397, , ,Intramural Research,2008,663995, ,NCI, , ,663995
Targeting the Epigenome for Lung Cancer Therapy,7735400, , ,Intramural Research,2008,936250, ,NCI, , ,936250
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,7735411, , ,Intramural Research,2008,1003067, ,NCI, , ,1003067
Molecular Classification of Human and Mouse Hepatocellular Carcinoma,7735423, , ,Intramural Research,2008,561870, ,NCI, , ,561870
Cellular Responses to p53 Activation by Nutlin-3a,7735485,7/13/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2009,311250, ,NCI, , ,311250
Stable isotopomer analysis of anabolic metabolic pathways in breast cancer,7735895,7/1/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,195360, ,NCI, , ,195360
Epigenetic Regulation of Medulloblastoma,7736097,6/8/2009 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,353441, ,NCI, , ,353441
Molecular Pathogenesis of Multiple Myeloma,7736610,6/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,332000, ,NCI, , ,332000
Ras Induced Senescence and Tumor Suppression,7736663,7/1/1999 0:00,8/31/2014 0:00,Non-SBIR/STTR,2009,344400, ,NIA, , ,344400
Energy Restrction and Mammary Cancer,7736687,8/1/1990 0:00,2/28/2014 0:00,Non-SBIR/STTR,2009,323019, ,NCI, , ,323019
Role of Estrogen Receptor alpha-p53 Interaction in Resistance to Tamoxifen Therap,7736988,7/16/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,321845, ,NCI, , ,321845
Humanized Mouse Models for the p53 R72P SNP,7737359,12/1/2008 0:00,11/30/2013 0:00,Non-SBIR/STTR,2010,292624, ,NIEHS, , ,292624
BRCA1 and progesterone receptors in breast cancer,7737743,9/1/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,317475, ,NCI, , ,317475
The role of ghrelin in cisplatin-induced infertility,7737802,9/3/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,223295, ,NICHD, , ,223295
MDM2 regulates XIAP gene expression in cancer treatment,7738950,12/15/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2010,257300, ,NCI, , ,257300
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model,7739224,9/25/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2009,482978, ,NCI, , ,482978
Role of Polo-like kinase (Plk-1) in Hepatitis B Virus-mediated Hepatocellular Car,7739422,6/1/2009 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,201300, ,NCI, , ,201300
Role of Matrix Metalloproteinase-1 in Endothelial Cell Senescence,7739924,9/30/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,152211, ,NIA, , ,152211
Exploiting mouse models of pediatric cancers and epigenetics for therapy,7739931,9/10/2004 0:00,7/31/2014 0:00,Non-SBIR/STTR,2009,835000, ,NCI, , ,835000
Human Papillomavirus Association with Subsets of Colorectal Cancer,7739978,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,88000, ,NCI, , ,88000
Deciphering how MdmX deregulation impacts the p53 pathway,7740213,4/1/1995 0:00,11/30/2011 0:00,Non-SBIR/STTR,2010,215084, ,NCI, , ,215084
Integrative genomic characterization of lung cancer metastasis in mouse and human,7740464,9/30/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2009,773385, ,NCI, , ,773385
Bid regulation of cutaneous photodamage responses,7740500,8/5/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,131775, ,NIAMS, , ,131775
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma:  Environmental Co,7740758,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,319323, ,NCI, , ,319323
Mammalian Polyamine Metabolism,7740837,12/1/1975 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,313665, ,NCI, , ,313665
Role of an unusual GTPase in DNA damage response and carcinogenesis,7740869,12/1/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2010,352219, ,NCI, , ,352219
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D,7740929,5/1/1995 0:00,5/31/2014 0:00,Non-SBIR/STTR,2009,424859, ,NCI, , ,424859
Genetic modifiers of mammary tumor susceptibility,7740940,2/15/2005 0:00,12/31/2009 0:00,Non-SBIR/STTR,2009,65320, ,NCI, , ,65320
FOXO1 Inhibition in Genotoxic Stress Response and Prostate Cancer Survival,7740978,6/16/2009 0:00,3/31/2014 0:00,Non-SBIR/STTR,2009,313325, ,NCI, , ,313325
Role of the Mullerian Tract in Ovarian Cancer Development,7741149,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2009,338225, ,NCI, , ,338225
Role of PALB2 in the DNA damage response and breast cancer suppression,7741534,7/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2009,323700, ,NCI, , ,323700
Modulation of sensitivity & imaging therapeutic response of hypoxic cancer cells,7741767,5/18/2009 0:00,2/28/2010 0:00,Non-SBIR/STTR,2009,321813, ,NCI, , ,321813
"Interplay of Myc, Tumor Supressors and Regulators of Differentiation in Lymphoma",7742428,12/15/1997 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,367778, ,NCI, , ,367778
The role of Aurora Kinase A in Upper Gastrointestinal Adenocarcinomas,7742588,6/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,314534, ,NCI, , ,314534
Anticarcinogenic Effect of ITCs Against Prostate Cancer,7742685,7/14/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2010,329208, ,NCI, , ,329208
MicroRNAs and chromosome 22q in the colon,7742693,3/1/2000 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,29677, ,NIDDK, , ,29677
Novel Suppressors of Pancreatic Cancer,7742785,7/10/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,198000, ,NCI, , ,198000
Regulations of DNA Alkylation/Deamination Damage Repair,7743093,3/1/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2010,266843, ,NCI, , ,266843
FHIT Gene Therapy in Cancer Prevention and Treatment,7743487,12/1/2006 0:00,11/30/2011 0:00,Non-SBIR/STTR,2010,228000, ,NCI, , ,228000
USC Research Center for Liver Disease,7743629,3/1/1997 0:00,2/28/2015 0:00,Research Centers,2010,1210578, ,NIDDK, , ,1210578
Molecular Mechanisms of p53 dependent longevity regulation,7743670,8/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,249000, ,NIA, , ,249000
MECHANISMS OF ESTROGEN RECEPTOR REGULATION,7743797,2/1/2006 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,231383, ,NCI, , ,231383
Role of PP2A in Lung Cancer,7743993,1/1/2008 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,320588, ,NCI, , ,320588
Mechanisms of transcriptional repression by p53 during hypoxic stress,7744004,12/1/2007 0:00,5/31/2010 0:00,"Training, Individual",2010,28843, ,NCI, , ,28843
Mechanisms of BMP Receptor Kinase Dysregulation in Skeletal Dysplasias,7745475,12/15/2008 0:00,11/30/2011 0:00,Non-SBIR/STTR,2010,72518, ,NIAMS, , ,72518
TGF-beta signaling and colon cancer,7745523,1/1/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,322452, ,NCI, , ,322452
Novel Methods for Molecular Analysis of Colorectal Cancer Tissue,7747002,9/27/2006 0:00,6/30/2012 0:00,SBIR/STTR,2009,524547, ,NCI, , ,524547
p53 Signaling and Cellular Response After Stress,7747942,1/1/1997 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,330828, ,NCI, , ,330828
Mycn and Medulloblastoma,7748006,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2010,320588, ,NCI, , ,320588
Investigating the role of p73 and its isoforms in tumorigenesis and metastasis,7749568,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2010,319550, ,NCI, , ,319550
Cell fate decision in response to p53-dependent DNA damage/genotoxic stress,7749577,7/1/2001 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,273221, ,NCI, , ,273221
The Identification and characterization of the methylation of Retinablastoma,7749817,9/1/2009 0:00,8/31/2011 0:00,"Training, Individual",2009,30666, ,NIA, , ,30666
Mechanisms of Mdm2/Mdmx in repressing p53,7749950,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2010,329891, ,NCI, , ,329891
Molecular Therapeutics of Cancer Conference,7750298,8/1/2006 0:00,6/30/2010 0:00,Other Research-Related,2009,8000, ,NCI, , ,8000
Role of microRNAs in genetic mouse models of pancreatic cancer,7750587,1/1/2009 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,139113, ,NCI, , ,139113
Normal and Neoplastic Regulation of Cyclin E,7750620,7/1/2003 0:00,12/31/2013 0:00,Non-SBIR/STTR,2010,382446, ,NCI, , ,382446
p53 Acetylation as a Mechanism in Chemoprevention by Aspirin,7751188,7/17/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,74250, ,NCI, , ,74250
Prostate cancer chemoprevention by penta-galloyl-glucose,7751267,1/1/2009 0:00,11/30/2013 0:00,Non-SBIR/STTR,2010,316438, ,NCI, , ,316438
Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors,7751842,12/7/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2010,300875, ,NCI, , ,300875
Enhancing Activity of Alkylating Agents in Neuroblastoma,7752523,9/1/1999 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,1, ,NCI, , ,1
Dynamics of Signaling Pathways: Mechanism and Function,7752552,3/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,318830, ,NIGMS, , ,318830
Synergistic anticancer effects of docosahexanoic acid and curcumin,7752876,7/8/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,67500, ,NCI, , ,67500
Role of cellular senescence in mammary cancer prevention by Rexinoids.,7753115,7/17/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,78500, ,NCI, , ,78500
The role of melanocyte precursors in zebrafish pigmentation disorders,7753168,1/1/2009 0:00,12/31/2013 0:00,Other Research-Related,2010,126900, ,NIAMS, , ,126900
Pathways of Therapy-induced Senescence in Cancer,7753627,3/17/2006 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,235952, ,NCI, , ,235952
UV regulation of anti-apoptotic co-repressor CtBP,7753818,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2008,232854, ,NCI, , ,232854
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis,7753898,1/1/2009 0:00,11/30/2013 0:00,Non-SBIR/STTR,2010,313366, ,NCI, , ,313366
Id2 enhances radiation resistance in glioma and is regulated by p53.,7753947,8/1/2009 0:00,7/31/2012 0:00,"Training, Individual",2009,32912, ,NINDS, , ,32912
Discovering TREX1 and TREX2 Function in Mammalian Cells and Mice,7754073,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,277400, ,NCI, , ,277400
Biomarker Models of Prostate Cancer Outcome After Radiotherapy,7754667,1/1/2009 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,198806, ,NCI, , ,198806
Genetic Pathways Governing Pancreatic Ductal Adenocarcinoma,7754676, , ,Non-SBIR/STTR,2009, ,218959, , , , 
The RAS and P13K Pathways in Pancreatic Adenocarcinoma,7754677, , ,Non-SBIR/STTR,2009, ,380488, , , , 
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer,7754678, , ,Non-SBIR/STTR,2009, ,302018, , , , 
Experimental Pathology Core,7754681, , ,Non-SBIR/STTR,2009, ,177465, , , , 
Signal Transduction by Non-transmembrane PTPs,7754773,12/1/1988 0:00,1/31/2014 0:00,Non-SBIR/STTR,2009,337930, ,NCI, , ,337930
Nuclear Function of Abl in DNA Damage Response,7755022,8/1/1986 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,414776, ,NCI, , ,414776
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1,7755359,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,304917, ,NCI, , ,304917
Targeting JAB1 Oncogenic Function in Breast Cancer,7755399,4/1/2002 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,255009, ,NCI, , ,255009
"Allergies, Genetic Susceptibility and Adult Glioma Risk",7755426,3/10/2006 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,1, ,NCI, , ,1
Using Zebrafish to Identify and Analyze Cancer Genes,7755871,3/7/2006 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,419081, ,NCI, , ,419081
Mechanisms of Cancer Initiation by TRIM32,7755895,5/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,344637, ,NCI, , ,344637
EBNA3C and tumor supressors,7756469,7/16/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,317683, ,NCI, , ,317683
Modulation of Apoptosis by IRF-4 in EBV transformation,7756516,8/4/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,272880, ,NCI, , ,272880
Genetic Mouse Models of Glioma,7756644,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2010,403255, ,NCI, , ,403255
Regulatory Networks in Human Embryonic Stem Cells,7757815,9/1/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,14353, ,NIGMS, , ,14353
Prevention of Oral Cancer by Tea: A mechanism Study,7758237,3/16/2006 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,266623, ,NCI, , ,266623
Oncogenic Function of a P53-Induced Phosphatase,7758309,4/1/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,266843, ,NCI, , ,266843
CDK6 in T cell development and cancer,7758353,1/15/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2010,334075, ,NCI, , ,334075
The Structure and Function of S100 Proteins,7758359,2/1/1999 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,433361, ,NIGMS, , ,433361
The role of glutathione peroxidase in the pathogenesis of intestinal cancer,7758745,3/1/2006 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,262148, ,NCI, , ,262148
Transcriptional Activator/Coactivator Interactions,7758766,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,323063, ,NCI, , ,323063
"Obesity, H pylori and Risk of Barrett's Esophagus",7758789,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,553291, ,NCI, , ,553291
The Role of Syndecan-1 in Mouse Mammary Neoplasia,7758832,12/21/2001 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,295173, ,NCI, , ,295173
Rapamycin-Induced Selective Apoptosis in Malignant Cells,7759126,12/1/1998 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,264384, ,NCI, , ,264384
Cooperation of oncogenic mutations in the control of malignancy,7759204,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,292600, ,NCI, , ,292600
Targeting Signal Transduction Pathways for Cancer Drug Discovery,7759306,2/5/2007 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,86169, ,NCI, , ,86169
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling,7759525,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,313533, ,NCI, , ,313533
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer,7759541,3/7/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,311600, ,NCI, , ,311600
Cell Growth Signaling in Cancer Development,7759621,4/8/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,423772, ,NCI, , ,423772
Nuclear Accumulation of Cyclin D1 and Oncogenesis,7760068,7/1/2001 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,291081, ,NCI, , ,291081
Novel Ceramide-based Chemotherapy for Acute Leukemia,7760241,8/10/2004 0:00,5/31/2010 0:00,Non-SBIR/STTR,2007,178044, ,NCI, , ,178044
Host Immunity to EBV Infection in Vitro and in VIvo,7760526,9/1/1981 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,408375, ,NIAID, , ,408375
Functional study of C53 protein as a novel regulator of checkpoint kinases,7760597,4/1/2008 0:00,8/31/2010 0:00,Non-SBIR/STTR,2010,179401, ,NIGMS, , ,179401
Growth Control and Anti-Cancer Mechanisms,7760644,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,295450, ,NCI, , ,295450
The Roles of HBXAP Gene in Ovarian Cancer,7760912,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,340300, ,NCI, , ,340300
Quantitative Gene Expression in Human Lung Epithelium,7761166,7/1/2003 0:00,4/30/2010 0:00,Non-SBIR/STTR,2007,166884, ,NCI, , ,166884
The Role of Ape1 in Neurotoxicity of Cancer Treatments,7761280,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,414074, ,NCI, , ,414074
Rac GTPases as Targets in Lymphomagenesis,7761287,2/10/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,285000, ,NCI, , ,285000
Characterization of the p53 Apoptotic Target Gene Perp,7761297,1/1/2002 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,284630, ,NCI, , ,284630
Control of Retrovirus CNS Disease by redox modulation,7761722,6/18/2002 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,404989, ,NINDS, , ,404989
Molecular mechanisms in the regulation of p53 functions by PAD4,7762767,2/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2010,269295, ,NCI, , ,269295
c-Met/PTEN Interactions in Gliomas,7762821,7/15/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,328093, ,NINDS, , ,328093
p53-Independent Pathways in Mdm2-Mediated Transformation,7763777,4/9/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2010,290620, ,NCI, , ,290620
The Role of PTEN in Endothelial Biology,7763912,2/15/2008 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,390000, ,NHLBI, , ,390000
Chemical Modulators for p53 Functions in Transcriptional Regulation,7764598,12/11/2009 0:00,11/30/2012 0:00,Non-SBIR/STTR,2010,312215, ,NCI, , ,312215
Stress- and Promoter-Specific Mechanisms of Transcritpional Activation by p53,7764740,5/26/2006 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,205444, ,NCI, , ,205444
Role of P53 in LITAF Process,7764791,2/5/2009 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,241313, ,NIAID, , ,241313
The Role of Bcl2L12 in the Genesis of Malignant Glioma,7765140,8/17/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2009,249000, ,NCI, , ,249000
Checkpoint Response and Platinum Drug Sensitivity,7765477,5/1/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2010,263340, ,NCI, , ,263340
The in vivo role of the mitochondrial p53 cell death program,7765517,9/15/1993 0:00,2/28/2014 0:00,Non-SBIR/STTR,2010,273881, ,NCI, , ,273881
Analysis of the p53  in vivo using a unique mouse model,7765630,3/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,345666, ,NCI, , ,345666
Molecular Mechanisms of p53 dependent longevity regulation,7766213,8/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,246509, ,NIA, , ,246509
Mechanistic Studies on New Platinum Clinical Agents,7766244,9/30/1998 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,299758, ,NCI, , ,299758
The Role of White Matter Progenitors in Glioma Formation and Progression,7766343,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,351549, ,NINDS, , ,351549
Targeting ROS by a p53-activating agent for selective killing of cancer cells,7766562,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,358877, ,NCI, , ,358877
Berberine downregulates MDM2 by interaction with DAXX in cancer cells,7766637,1/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,321625, ,NCI, , ,321625
A metabolic role for PML in tumor suppression,7766688,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,360359, ,NCI, , ,360359
Role of ROS-Induced DNA Damage in Mitochondria-Regulated Apoptosis,7766949,2/1/2009 0:00,10/31/2013 0:00,"Training, Individual",2010,27720, ,NIEHS, , ,27720
Role of MetAP-2 in Angiogenesis and Wnt Signaling,7767690,7/9/1999 0:00,1/31/2014 0:00,Non-SBIR/STTR,2010,460628, ,NCI, , ,460628
Targeting of MDM2 Family Proteins in Cancer,7767735, , ,Non-SBIR/STTR,2009, ,329392, , , , 
Development of Proteasome Selective Inhibitors for Cancer Therapy,7767737, , ,Non-SBIR/STTR,2009, ,311318, , , , 
Targeting Signal Transduction Pathways for Cancer Drug Discovery,7767743,2/5/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,1992373, ,NCI, , ,1992373
Development of cambinol analogues as antilymphoma agents,7768411,4/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,365200, ,NCI, , ,365200
Molecular mediators of metastasis in hepatocellular carcinoma,7768412,4/1/2006 0:00,2/28/2011 0:00,Non-SBIR/STTR,2010,280074, ,NCI, , ,280074
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D,7768494,1/1/1999 0:00,2/28/2012 0:00,Non-SBIR/STTR,2010,238892, ,NCI, , ,238892
Molecular Targeting of Diffuse Large B-cell Lymphoma,7768562,1/20/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,633103, ,NCI, , ,633103
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia,7769465,9/15/1996 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,348711, ,NCI, , ,348711
Recognition and Presentation of Alpha Helices using Nanoparticle Receptors,7769473,3/8/2007 0:00,3/31/2011 0:00,Non-SBIR/STTR,2010,258052, ,NIGMS, , ,258052
Role of TRPM1 (Melastatin1) in the Biology of Human Melanocytes,7769851,3/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,323433, ,NIAMS, , ,323433
Molecular Basis of Aneuploidy,7769897,3/7/2006 0:00,2/28/2012 0:00,Non-SBIR/STTR,2010,232676, ,NCI, , ,232676
MYC's Role in the Initiation and Maintenance of Cancer,7769908,6/1/2001 0:00,2/29/2012 0:00,Non-SBIR/STTR,2010,399339, ,NCI, , ,399339
"The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer",7769987,2/1/2010 0:00,11/30/2014 0:00,Non-SBIR/STTR,2010,334695, ,NCI, , ,334695
Regulation of Cytokinesis and Tumor Formation by RhoA,7770196,1/1/2010 0:00,12/31/2011 0:00,Other Research-Related,2010,90000, ,NIGMS, , ,90000
The Structure and Function of S100 Proteins,7771219,2/1/1999 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,135000, ,NIGMS, , ,135000
A Nested Case-Control Study of Prostate Carcinogenesis,7771626,9/30/2000 0:00,2/28/2012 0:00,Non-SBIR/STTR,2010,584188, ,NIEHS, , ,584188
Biology of the papillomavirus E5 oncoprotein family,7771629,1/1/1991 0:00,2/28/2011 0:00,Non-SBIR/STTR,2010,395287, ,NCI, , ,395287
Role of p53 in cell cycle checkpoints,7771754,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2010,351713, ,NCI, , ,351713
"(IND 102,133) Inhibition of Aurora Kinase A as Treatment For Melanoma",7771855,9/10/2010 0:00,9/9/2016 0:00,Non-SBIR/STTR,2010,399999, ,FDA, , ,399999
Biochemical Analysis of a p53 Isoform that Accelerates Mammalian Aging,7773565,2/1/2010 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,62115, ,NIA, , ,62115
Defective p53 synthesis following DNA damage and cancer development,7773947,4/1/2010 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,80000, ,NIEHS, , ,80000
Targeting the ARF/CtBP Axis in Pancreatic Cancer,7774126,9/29/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,82042, ,NCI, , ,82042
The Molecular Epidemiology of Bladder Cancer,7774344,5/1/2007 0:00,2/28/2012 0:00,Non-SBIR/STTR,2010,404668, ,NCI, , ,404668
Modulation of Glioma Growth and Invasion by HCMV Glycoprotein B,7774667,9/20/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,253050, ,NINDS, , ,253050
Function and regulation of MDMX,7774908,7/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2010,272673, ,NCI, , ,272673
Mechanisms of Neuroprotection by Histone Deacetylase Inhibition,7774999,3/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,337838, ,NINDS, , ,337838
P53 Biomark er and Intervention in Occupational Cancer,7776597,5/1/2009 0:00,6/30/2010 0:00,Non-SBIR/STTR,2008,342124, ,NIOSH, , ,342124
Cancer Biology in the Zebrafish,7776885,7/3/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,372487, ,NCI, , ,372487
Biosynthesis of Adenovirus Early RNA's,7776992,4/1/1979 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,735983, ,NCI, , ,735983
Adenovirus E1B55K Functions Related to Oncolytic Replication,7777755,3/1/2009 0:00,12/31/2012 0:00,Non-SBIR/STTR,2010,276390, ,NCI, , ,276390
Transcriptional Repression by Maf1 in Yeast,7777870,3/1/2009 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,463214, ,NIGMS, , ,463214
Chemoprevention of lung cancer with red ginseng extracts,7777978,9/30/2009 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,512870, ,OD, , ,200000
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer,7778358,3/2/2009 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,344149, ,NIDCR, , ,344149
Defining critical p53 therapeutic targets and mechanisms,7778388,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2010,393005, ,NCI, , ,393005
Probes for Cytometry,7778481,10/1/1990 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,412410, ,NCI, , ,412410
Mox 1: A Novel Mitogenic Oxidase,7778853,1/5/2000 0:00,2/29/2012 0:00,Non-SBIR/STTR,2010,269909, ,NCI, , ,269909
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck Cancer,7778901,3/2/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2010,634010, ,NCI, , ,634010
The ARF Tumor Suppressor,7779140,1/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,362088, ,NCI, , ,362088
Functional Analysis of p53 Polymorphic Variants,7779236,6/1/2005 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,336581, ,NCI, , ,336581
Signal Transduction by Non-transmembrane PTPs,7780018,12/1/1988 0:00,1/31/2014 0:00,Non-SBIR/STTR,2010,344692, ,NCI, , ,344692
Cell Survival and Death in Oxidant Lung Injury,7780040,7/1/2002 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,385000, ,NHLBI, , ,385000
Translational Pathology Core Facility,7780343, , ,Research Centers,2009, ,840907, , , , 
Non-Peptide Small-Molecule Inhibitors of the MDM2-p53 interaction,7780377,5/1/2006 0:00,3/31/2013 0:00,Non-SBIR/STTR,2010,446566, ,NCI, , ,446566
High Throughput Screening,7780398, , ,Research Centers,2009, ,140799, , , , 
Functional Determinants of Metastatic Dormancy,7781144,4/1/2005 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,326938, ,NCI, , ,326938
Therapeutic Targeting of Oncogenic Stress in Cancer Treatment,7781703,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,318513, ,NCI, , ,318513
Mechanisms of Synergistic Regulation of Stem/Progenitors,7783237,4/1/1996 0:00,12/31/2013 0:00,Non-SBIR/STTR,2010,385000, ,NHLBI, , ,385000
p63 and p73 Signaling in Cell Growth and Cancer,7783757,3/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2010,310324, ,NCI, , ,310324
Mutagenesis of p53 by reactive PAH and ROS,7783761,4/8/2008 0:00,3/31/2013 0:00,Non-SBIR/STTR,2010,310381, ,NIEHS, , ,310381
Next generation strategies to intercept ErbB signaling,7784201,4/25/1997 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010,237319, ,NCI, , ,237319
Bifunctional T cell receptor based immunotherapeutics,7784269,7/26/2002 0:00,8/31/2012 0:00,SBIR/STTR,2009,1000000, ,NCI, , ,1000000
Tumor Suppression,7784562, , ,Non-SBIR/STTR,2009, ,713324, , , , 
Regulation of Basal-Like and Her2+ Breast Cancer Phenotypes by IKK/NF-kappaB,7785321,2/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,305763, ,NCI, , ,305763
A Role for RIP1 in Gliomagenesis,7785369,9/29/2009 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,314000, ,NINDS, , ,314000
Search for the Molecular Causes of Diabetic Embryopathy,7785426,8/1/1998 0:00,2/28/2014 0:00,Non-SBIR/STTR,2010,403750, ,NIDDK, , ,403750
Telomerase in Development Senescence and Neoplasia,7785621,1/1/2000 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,671830, ,NCI, , ,671830
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str,7785652,2/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,529299, ,NCI, , ,529299
"Studying the initiation, progression and therapy of lung cancer in mouse models",7786279,4/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2010,352223, ,NCI, , ,352223
Understanding the Structural Mechanism of Puma-induced Apoptosis,7787004,4/1/2009 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,332640, ,NIGMS, , ,332640
RECEPTOR-TARGETED COPPER RADIOPHARMACEUTICALS FOR CANCER IMAGING AND THERAPY,7787454,7/18/1994 0:00,12/31/2012 0:00,Non-SBIR/STTR,2010,292410, ,NCI, , ,292410
Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis,7787513,7/1/2000 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,58188, ,NCI, , ,58188
The Role of Bone Marrow Derived Cells in Skin Cancer,7787632,1/25/2010 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,195359, ,NCI, , ,195359
Mouse models of genomic instability and birth defects,7788092,4/1/2009 0:00,3/31/2014 0:00,Non-SBIR/STTR,2010,313665, ,NICHD, , ,313665
Transposon-insertional Mutagenesis to Decipher Osteosarcomagenesis,7788272,9/28/2009 0:00,8/31/2014 0:00,Other Research-Related,2009,179280, ,NCI, , ,179280
Analysis of 53BP1 function in DNA Damage-signaled pathway and Tumorigenesis,7789617,5/9/2003 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,293453, ,NCI, , ,293453
Selective Forces Operative in FeLV Infection,7789660,2/28/2000 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,268650, ,NCI, , ,268650
Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette Smoke,7789663,5/1/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,285906, ,NCI, , ,285906
The Role of KLF6 Tumor Suppressor in Hepatocellular Cancer,7790800,9/30/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,420063, ,NIDDK, , ,420063
CBP Bromodomain Antagonists Block Androgen Receptor in Prostate Cancer,7791094,9/28/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,84750, ,NCI, , ,84750
"Ovulation, inclusion cysts, and p53 mutations in a mouse model of ovarian cancer",7791277,9/29/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,78500, ,NCI, , ,78500
Genetic and Molecular Epidemiology of Adult Glioma,7791425,5/15/1991 0:00,6/2/2011 0:00,Non-SBIR/STTR,2010,907868, ,NCI, , ,907868
"Phosphosulindac, miRNAs and cancer racial disparity",7791635,2/5/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,307561, ,NCI, , ,307561
Comparative Bioinformatics and TP53 Expression,7791656,9/30/2005 0:00,9/29/2010 0:00,Non-SBIR/STTR,2008,271777, ,NLM, , ,271777
The Role of p73 in Upper Gastrointestinal Carcinomas,7792374,4/28/2006 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,260565, ,NCI, , ,260565
CDC25 PHOSPHATASES IN CELL CYCLE CONTROL AND CANCER,7792444,2/1/1992 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,376200, ,NIGMS, , ,376200
Non-Myeloablative Host Conditioning that Protects Against GVHD,7793523, , ,Non-SBIR/STTR,2009, ,320160, , , , 
MicroRNA Function in the Immune System,7793604,5/15/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,397238, ,NIAID, , ,397238
Regulation WRN deacetylation by SIRT1 after DNA damage,7794845,2/15/2008 0:00,4/30/2010 0:00,Non-SBIR/STTR,2010,113866, ,NIA, , ,113866
Aflatoxin Biosynthesis and Iterative Type I Polyketide Synthases,7794909,2/1/1978 0:00,3/31/2013 0:00,Non-SBIR/STTR,2010,426546, ,NIEHS, , ,426546
Klf4 in tumor initiation and maintenance of squamous cell carcinoma,7795119,3/1/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,278350, ,NCI, , ,278350
A PTEN-Dependent Size Checkpoint in Human Cancer Cells,7795200,5/11/2006 0:00,3/31/2011 0:00,Non-SBIR/STTR,2010,240742, ,NCI, , ,240742
CPEB and Cell Senescence,7795784,4/1/2007 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,323198, ,NIA, , ,323198
Structure and function of the U3 RNA-protein complex,7797395,4/1/2007 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,285912, ,NIGMS, , ,285912
Role of p53 homologs in DNA repair in human keratinocytes,7797798,10/1/2009 0:00,9/30/2013 0:00,Non-SBIR/STTR,2009, , , , , , 
Acid- and salt-dependent interactions in proteins,7798136,5/1/1998 0:00,3/31/2013 0:00,Non-SBIR/STTR,2010,298900, ,NIGMS, , ,298900
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines,7798156,4/1/2009 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,298760, ,NCI, , ,298760
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2 (LMP1 AND LMP2),7798189, , ,Non-SBIR/STTR,2009, ,360885, , , , 
p53 Acetylation and Deacetylation in Tumorigenesis,7798634,4/1/2000 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,292853, ,NCI, , ,292853
Alternate Pathways for Interferon and Cytokine Signaling,7798999, , ,Non-SBIR/STTR,2009, ,413911, , , , 
Multi-Modal Lysosomotropic Death Therapy for Malignant Peripheral Nerve Sheath Tu,7800299,5/1/2009 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,243190, ,NCI, , ,243190
Studies on the Post-translational processing of MUC1,7800427,9/1/1992 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,263177, ,NCI, , ,263177
Nanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCV,7800515,9/15/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2009,386729, ,NIAAA, , ,386729
Repair of Endogenous Damage in Mammalian Genomes,7802084,2/11/1991 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,328615, ,NCI, , ,328615
Active Immune Therapy ot Leukemia Associated Antigens and Gene Therapy,7802151, , ,Non-SBIR/STTR,2009, ,293215, , , , 
Signal Transduction and Kinase Inhibition in CLL,7802154, , ,Non-SBIR/STTR,2009, ,307061, , , , 
A New Approach for the Non-Invasive Detection of Bladder Cancer,7802474,9/28/2009 0:00,9/27/2011 0:00,SBIR/STTR,2009,187175, ,NCI, , ,187175
FoxM1 and Oncogenic Pathways in Hepatocellular Carcinoma,7802825,1/1/2009 0:00,12/31/2011 0:00,"Training, Individual",2010,46380, ,NCI, , ,46380
Dysregulation of microRNAs in HPV-Positive Oropharyngeal Cancers,7804911,1/15/2010 0:00,1/14/2013 0:00,"Training, Individual",2010,42180, ,NIDCR, , ,42180
Role of Sphingosine Kinase 1 in the p53-dependent DNA Damage Response,7804918,12/1/2009 0:00,11/30/2012 0:00,"Training, Individual",2010,39025, ,NIEHS, , ,39025
Heat Shock Protein-Induced Protection Against Cisplatin-Induced Hair Cell Death,7804981,9/28/2009 0:00,9/27/2015 0:00,"Training, Individual",2009,34475, ,NIDCD, , ,34475
Regulation of p53 by BRCA1 in Breast Cancer,7805872,9/1/2011 0:00,8/31/2014 0:00,"Training, Individual",2010,52154, ,NCI, , ,52154
Role and regulation of GnRH and receptors in Cisplatin resistant ovarian cancer,7805941,5/12/2010 0:00,5/11/2011 0:00,"Training, Individual",2009,54820, ,NCI, , ,54820
Phase I Study of ALT-801 in Metastatic Melanoma/Kidney Cancer Patients,7806244,12/15/2007 0:00,11/30/2009 0:00,Non-SBIR/STTR,2009,63244, ,FDA, , ,63244
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,7806384,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,379806, ,NCI, , ,379806
Mechanism of Redox Regulation by Ape1/Ref-1,7806505,7/1/2006 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,229792, ,NCI, , ,229792
Regulatory Functions of APE1 - An Essential Repair Protein,7806552,12/1/1996 0:00,4/30/2012 0:00,Non-SBIR/STTR,2010,304063, ,NIEHS, , ,304063
The role of p63 and p73 in cancer,7806553,1/14/2002 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,314296, ,NCI, , ,314296
The Role of PKR in a Novel IL-3 Signal Transduction Pathway,7806601,4/1/1996 0:00,2/28/2013 0:00,Non-SBIR/STTR,2010,366250, ,NHLBI, , ,366250
Study the Role of Chfr in Tumorigenesis,7806610,7/1/2006 0:00,11/30/2011 0:00,Non-SBIR/STTR,2010,265424, ,NCI, , ,265424
Mechanism of p53-Mediated Tumor Suppression,7807120,12/5/1997 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,306143, ,NCI, , ,306143
Biomarkers in Head and Neck Cancer Progression,7807128,4/17/2009 0:00,3/31/2014 0:00,Other Research-Related,2010,94454, ,NIDCR, , ,94454
Dynamics of Signaling Pathways: Mechanism and Function,7807436,9/30/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,333888, ,NIGMS, , ,333888
Pten-loss Dysregulated Pathways in Prostate Cancer,7807816,9/25/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2009,366250, ,NIMHD, , ,366250
Molecular Pathogenesis of Diamond Blackfan Anemia,7808388,1/7/2010 0:00,12/31/2013 0:00,Non-SBIR/STTR,2010,385000, ,NHLBI, , ,385000
Oxidative Injury to Gastric Epithelial Cells by H. pylori,7808833,9/21/2001 0:00,4/30/2012 0:00,Non-SBIR/STTR,2010,318718, ,NIDDK, , ,318718
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer,7808835,9/8/1989 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,325941, ,NCI, , ,325941
Molecular Mechanisms of Hormone-independence of Prostate Cancer,7809352,7/15/2005 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,59064, ,NCI, , ,59064
Kinetic analysis of Myc-induced carcinogenesis in vivo,7810404,9/30/2009 0:00,9/29/2011 0:00,Non-SBIR/STTR,2009,464598, ,NCI, , ,464598
Targeting the MAP and PI3 Kinase Pathways in Melanoma,7810523, , ,Non-SBIR/STTR,2009, ,472518, , , , 
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity,7810526, , ,Non-SBIR/STTR,2009, ,557335, , , , 
Targeted Therapies in Melanoma,7810530,5/16/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,2542174, ,NCI, , ,2542174
Role of C/EBP in Cell Survival and Neoplasia,7810612,5/1/1990 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,256846, ,NCI, , ,256846
MTA1 in Oncogenesis,7811951,9/30/2009 0:00,9/29/2012 0:00,Non-SBIR/STTR,2009,646348, ,NCI, , ,646348
Mechanism of p63-Dependent Tumor Suppression,7812263,7/1/2003 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,297265, ,NCI, , ,297265
The role of Klf5 in GI epithelial homeostasis and disease,7812268,9/30/2009 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,319167, ,NIDDK, , ,319167
Restoration of Tumor Suppression Activity in Malignant Melanoma,7812305,9/17/2009 0:00,10/31/2011 0:00,Non-SBIR/STTR,2009,376297, ,NCI, , ,376297
Humanized Mouse Models for the p53 R72P SNP,7812646,9/17/2009 0:00,3/16/2012 0:00,Non-SBIR/STTR,2009,693000, ,NIEHS, , ,693000
wnt Signaling in Liver Development and Disease,7813266,7/15/2005 0:00,6/30/2010 0:00,Other Research-Related,2008,109013, ,NIDDK, , ,109013
Regulation and Function of the p14ARF/topoisomerase I Complex in Cancer,7813636,9/30/2009 0:00,9/29/2012 0:00,Non-SBIR/STTR,2009,313200, ,NCI, , ,313200
Regulation of Ionizing Radiation Induced DNA Damage Response,7813809,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2010,308345, ,NCI, , ,308345
Biological Function of the Retinoblastoma Gene Product,7813879,5/3/1994 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,342397, ,NCI, , ,342397
Re-replication of chromosomes and cancer,7813968,7/11/1994 0:00,2/28/2014 0:00,Non-SBIR/STTR,2010,331591, ,NCI, , ,331591
Role of the Mullerian Tract in Ovarian Cancer Development,7813990,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2010,336841, ,NCI, , ,336841
Nuclear Function of Abl in DNA Damage Response,7814434,9/30/2009 0:00,9/29/2011 0:00,Non-SBIR/STTR,2009,418301, ,NCI, , ,418301
Mechanisms of p27Kipl Proteolysis in Cancer Cells,7815900,9/30/2009 0:00,9/29/2013 0:00,Non-SBIR/STTR,2009,342296, ,NCI, , ,342296
MODELING  AND RESCUE OF DBA IN THE MOUSE,7816208,4/1/2010 0:00,6/30/2010 0:00,Non-SBIR/STTR,2010,235146, ,NIDDK, , ,235146
Molecular Determinants Affecting FLT-PET in Colorectal Cancer,7816526,9/30/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,499637, ,OD, , ,499637
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas,7816696,5/1/2009 0:00,2/28/2011 0:00,Non-SBIR/STTR,2010,298800, ,NCI, , ,298800
Role of MDM2 in Cell Proliferation and Tumorigenesis,7816712,7/1/1999 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,277695, ,NCI, , ,277695
Molecular targeting of the survivin pathway in cancer,7816713,4/1/2001 0:00,9/15/2010 0:00,Non-SBIR/STTR,2010,288775, ,NCI, , ,288775
Role of PUMA in EGFR targeted therapy in HNSCC,7816921,8/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,314363, ,NCI, , ,314363
Cellular Stress Response Signaling Pathways,7817021,1/1/1992 0:00,4/30/2012 0:00,Non-SBIR/STTR,2010,407484, ,NIEHS, , ,407484
Molecular Basis of Aneuploidy,7818672,9/30/2009 0:00,2/28/2011 0:00,Non-SBIR/STTR,2009,459538, ,NCI, , ,459538
Role of the STK Receptor in Erythropoiesis,7819133,6/1/2009 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,16040, ,OD, , ,16040
The Role of PKR in a Novel IL-3 Signal Transduction Pathway,7819168,6/8/2009 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,16994, ,OD, , ,8497
Energy Restrction and Mammary Cancer,7821390,8/1/1990 0:00,2/28/2014 0:00,Non-SBIR/STTR,2010,323019, ,NCI, , ,323019
Determinants of Metastatic Progression,7822799,7/23/2002 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,269961, ,NCI, , ,269961
Genetic Epidemiology of Familial Childhood Cancer Syndromes,7822814, , ,Non-SBIR/STTR,2009, ,250457, , , , 
Genomic Instability in Familial Cancer Syndromes,7822816, , ,Non-SBIR/STTR,2009, ,188221, , , , 
Molecular Genetic Anatomy of Li Fraumeni Syndrome (LFS),7822817, , ,Non-SBIR/STTR,2009, ,366237, , , , 
Mouse Models for Li Fraumeni Syndrome,7822818, , ,Non-SBIR/STTR,2009, ,324736, , , , 
High-Throughput Genotyping and Genetic Linkage Analysis Facility,7822821, , ,Non-SBIR/STTR,2009, ,333473, , , , 
Nucleic Acids Isolation and DNA Analysis Facility,7822822, , ,Non-SBIR/STTR,2009, ,243498, , , , 
Role of EGFR in DNA Repair and Radiation Response in Non Small Cell Lung Cancer,7825271,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,260620, ,NCI, , ,260620
Structural basis for CBP/p300 transcriptional regulation,7825409,6/10/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,419962, ,NCI, , ,419962
The role of Aurora Kinase A in Upper Gastrointestinal Adenocarcinomas,7826665,6/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,319343, ,NCI, , ,319343
Mechanisms of p53 activation in tumorsuppression,7826735,5/15/2003 0:00,4/30/2011 0:00,Non-SBIR/STTR,2010,311068, ,NCI, , ,311068
P53 Activation as Novel Therapeutic Stratgey for Acute Myelogenous Leukemia,7826869, , ,Research Centers,2009, ,290026, , , , 
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia,7826877,8/5/2003 0:00,4/30/2013 0:00,Research Centers,2010,2158273, ,NCI, , ,2158273
Project 2- Radiation Biology,7826889, , ,Research Centers,2009, ,20909, , , , 
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia,7827527,8/5/2003 0:00,4/30/2013 0:00,Research Centers,2009,52857, ,NCI, , ,52857
Cell Cycle Check Points,7828009, , ,Non-SBIR/STTR,2009, ,349200, , , , 
Murine & Human In Vivo Models of Melanoma Formation,7828010, , ,Non-SBIR/STTR,2009, ,434463, , , , 
Model systems for hematologic disorders caused by ribosomal protein deficiency,7828266,9/30/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,499999, ,NIDDK, , ,499999
Rac GTPases as targets in lymphomagenesis,7834611,9/30/2009 0:00,9/29/2012 0:00,Non-SBIR/STTR,2009,645498, ,NCI, , ,645498
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development,7835547,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,340300, ,NCI, , ,340300
"Structure, Function and Inhibition of Human Methionine Aminopeptidases",7835697,6/1/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,376391, ,NCI, , ,376391
Characterization of the inducible-beta-cell-specific p53 knockout mice,7835859,5/15/2009 0:00,4/30/2012 0:00,Non-SBIR/STTR,2010,199856, ,NCRR, , ,199856
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors,7837568,7/31/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,277591, ,NCI, , ,277591
A Pathway of Tumor Suppression,7837636,7/1/1988 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,236943, ,NCI, , ,236943
Molecular Pathogenesis of Multiple Myeloma,7840488,6/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,332000, ,NCI, , ,332000
Markers of Early Pancreatic Cancer,7840518,7/1/2006 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,282659, ,NCI, , ,282659
Radiation-induced Nitric Oxide & Cellular Radiosensitivity,7841765,7/10/2002 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,274479, ,NCI, , ,274479
Molecular Pathways in Suppression and Development of T Lineage Lymphomas,7841774,7/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,312550, ,NCI, , ,312550
Mechanisms of p53 target gene activation in DNA damage responses,7841871,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,828389, ,NCI, , ,828389
PCAF/GCN5 Acetylation on p53 Transactivation,7841876,4/1/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2010,358126, ,NCI, , ,358126
Epithelial Positioning Organization and Ovarian Cancer,7841887,3/1/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,323942, ,NCI, , ,323942
Enhancing Direct Tumor Cell Cytotoxicity By Manipulating Growth Factor Signaling,7843236,9/7/2001 0:00, ,Non-SBIR/STTR,2009, ,205126, , , , 
Breast Cancer Therapeutic Agents Based on Telomerase Misfunction,7843345, , ,Research Centers,2009, ,205580, , , , 
BubR1 in Cancer and Aging,7843455,7/1/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,301377, ,NCI, , ,301377
Regulation of p53 tumor suppressor protein,7843456,2/1/1993 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,543349, ,NCI, , ,543349
Using p53 Knock-In Mice to Understand p53's Role in Pancreatic Cancer,7843586,7/1/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,219494, ,NCI, , ,219494
"P2 - CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER",7843712,5/12/2009 0:00,4/30/2011 0:00,Research Centers,2009, ,318569, , , , 
High throughput screen for inhibitors of the mdm2/mdmx interaction,7844780,2/1/2010 0:00,11/30/2011 0:00,Non-SBIR/STTR,2010,47625, ,OD, , ,47625
Tip60 in p38 and PRAK Mediated Oncogene-Induced Senescence and Tumor Suppression,7844918,6/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,394043, ,NCI, , ,394043
Translational Machinery in Stress Signaling and Tumor Suppression,7844993,5/15/2009 0:00,4/30/2012 0:00,Non-SBIR/STTR,2010,200626, ,NIEHS, , ,200626
Genetic analysis of genomic instability and cancer in zebrafish,7845016,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,310746, ,NCI, , ,310746
Functional and Structural Studies of CD74 Activation,7845067,6/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,390178, ,NIAID, , ,390178
P53 Biomark er and Intervention in Occupational Cancer,7845219,7/1/2006 0:00,6/30/2010 0:00,Non-SBIR/STTR,2007,102487, ,NIOSH, , ,102487
Activating liver carcinogens in yeast by expressing CYP450 polymorphisms,7845329,8/1/2007 0:00,10/31/2009 0:00,Non-SBIR/STTR,2009,17242, ,OD, , ,17242
Modulation of sensitivity & imaging therapeutic response of hypoxic cancer cells,7845480,5/18/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2010,321833, ,NCI, , ,321833
Epithelial Stem Cell Programs,7845493,8/1/2008 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,377561, ,NIGMS, , ,377561
Imaging Core,7845647, , ,Non-SBIR/STTR,2009, ,329294, , , , 
SPORE in Prostate Cancer,7845920,6/1/2009 0:00,9/30/2010 0:00,Research Centers,2009,163548, ,OD, , ,163548
DNA Methyltrasferase Gene Expression in Colon Cancer,7846183,4/1/1991 0:00,3/31/2014 0:00,Non-SBIR/STTR,2010,564264, ,NIEHS, , ,564264
Curcumin inhbits BPDE-induced damage by lowering the threshold of p53 activation,7846237,5/1/2008 0:00,8/31/2011 0:00,"Training, Individual",2010,24118, ,NIEHS, , ,24118
Center for digestive and liver diseases,7846289,7/1/1998 0:00,5/31/2011 0:00,Research Centers,2009,48844, ,OD, , ,24422
CDK6 in T cell development and cancer,7846307,1/15/2009 0:00,9/30/2010 0:00,Non-SBIR/STTR,2009,38160, ,NCI, , ,38160
Mechanisms of Pituitary Tumorigenesis,7847469,12/15/1998 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,285664, ,NCI, , ,285664
Determination of regulatory mechanisms for BLM helicase,7847492,8/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,50178, ,FIC, , ,24091
p63/p73 Signaling Axis as a Target for Treatment of Triple-Negative Breast Cancer,7847494, , ,Research Centers,2009, ,366496, , , , 
Effect of caffeine on UVB-induced skin cancer,7847543,7/1/2006 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,274013, ,NCI, , ,274013
Mechanism of P73-Dependent Tumor Suppression,7847677,5/1/1999 0:00,4/30/2011 0:00,Non-SBIR/STTR,2010,303406, ,NCI, , ,303406
Role of Polo-like kinase (Plk-1) in Hepatitis B Virus-mediated Hepatocellular Car,7847688,6/1/2009 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,167750, ,NCI, , ,167750
Role of PALB2 in the DNA damage response and breast cancer suppression,7847709,7/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,323700, ,NCI, , ,323700
Cellular and molecular basis of malignant astrocytoma,7848078,7/1/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,306267, ,NINDS, , ,306267
Regulation of p53 function by Daxx,7848254,5/3/2001 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,253024, ,NCI, , ,253024
UV regulation of anti-apoptotic co-repressor CtBP,7848312,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,290780, ,NCI, , ,290780
In vivo function and mechanism of the r-protein-Mdm2-p53 pathway,7848350,8/1/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,319477, ,NCI, , ,319477
p53-mediated control of numeral integrity of centrosomes,7848823,4/1/2001 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,263797, ,NCI, , ,263797
Chromosome instability resulting from double-strand breaks near telomeres,7848838,7/6/2006 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,239656, ,NCI, , ,239656
Function and regulation of SirT1 in cancer,7848846,7/11/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,285570, ,NCI, , ,285570
Androgen and Soluble Guanylyl Cyclase Signaling in Prostate Cancer,7848848,7/1/2008 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,270081, ,NCI, , ,270081
Biomarkers of survival in glioma epidemiology,7848862,7/1/2008 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,186337, ,NCI, , ,186337
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK,7848997,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,315400, ,NCI, , ,315400
Biomarker Models of Prostate Cancer Outcome After Radiotherapy,7849245,1/1/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,178380, ,NCI, , ,178380
Study on the intracellular Network of TBX3,7849304,8/1/2007 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,57222, ,NCI, , ,57222
The Role of Phosphatase CL100/MKP1 in Human Cancer,7849369,2/5/2004 0:00,1/31/2010 0:00,Non-SBIR/STTR,2009,59282, ,NCI, , ,59282
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman),7849771, , ,Non-SBIR/STTR,2009, ,404705, , , , 
P53-dependent responses to toxicants in parous and nulliparous breast,7851205,9/7/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,360179, ,NIEHS, , ,360179
Oligoclonal T Cell Expansion and Rheumatoid Arthritis,7851255,9/30/1993 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,348480, ,NIAMS, , ,348480
Mechanisms of tumor suppression by Fbw7,7851284,7/26/2006 0:00,2/29/2012 0:00,Other Research-Related,2010,140535, ,NCI, , ,140535
Role of p53 and ptc tumor suppressive pathways in BCCs development and prevention,7851292,9/30/2006 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,334113, ,NIEHS, , ,334113
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer,7851492,8/4/2006 0:00,6/30/2012 0:00,Other Research-Related,2010,144180, ,NCI, , ,144180
The Role of PTEN in Endothelial Biology,7851908,2/15/2008 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,23213, ,NHLBI, , ,23213
Arsenic Induced Miotic Arrest Associated Apoptosis,7852204,6/1/2009 0:00,10/31/2009 0:00,Non-SBIR/STTR,2009,9765, ,NIEHS, , ,9765
Lung Toxicity of Carbon Nanotubes in Models of Pre-Existing Respiratory Disease,7853611,9/27/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,540474, ,OD, , ,540373
A Blueprint for Oncogenic Epigenetic Reprogramming,7853988,9/30/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2009,2310000, ,OD, , ,2310000
Study on the intracellular Network of TBX3,7858014,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,225512, ,NCI, , ,225512
Regulation and Function of the p14ARF/topoisomerase I Complex in Cancer,7858180,7/10/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,356145, ,NCI, , ,356145
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D,7858427,5/1/1995 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,431016, ,NCI, , ,431016
Recognition and Presentation of Alpha Helices using Nanoparticle Receptors,7859837,7/17/2009 0:00,9/30/2010 0:00,Non-SBIR/STTR,2009,235078, ,NIGMS, , ,235078
p53 and pathways of apoptosis,7860452,8/7/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,299250, ,NCI, , ,299250
Epigenetic Regulation of Medulloblastoma,7860587,6/8/2009 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,356209, ,NCI, , ,356209
Homologous Recombination in Genome Stability and Tumor Suppression,7860606,6/8/2009 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,361050, ,NCI, , ,361050
Novel Roles of p53 & ROS in Therapy of Refractory CLL,7860695,5/1/2003 0:00,5/31/2011 0:00,Non-SBIR/STTR,2010,299699, ,NCI, , ,299699
The Role of Bcl2L12 in the Genesis of Malignant Glioma,7862398,8/17/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2010,249000, ,NCI, , ,249000
ECM-Mediated Apoptosis in p53 (-) HMECs,7862517,4/1/2001 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,222477, ,NCI, , ,222477
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells,7863413,3/17/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,464834, ,NCI, , ,464834
Restoration of Tumor Suppression Activity in Malignant Melanoma,7864126,7/1/2006 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,496770, ,NCI, , ,496770
Medulloblastoma and Metastases,7865415,5/4/2010 0:00,2/28/2015 0:00,Non-SBIR/STTR,2010,557223, ,NCI, , ,557223
Expression of Simiam Virus 40 T Antigens in Intestine,7866487,7/1/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,322853, ,NCI, , ,322853
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,7866596,6/10/2009 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,315400, ,NCI, , ,239400
Characterizing mechanisms of transcriptional activation using live cell imaging,7866654,8/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2010,321860, ,NIGMS, , ,321860
Mechanisms of Particulate Matter Induced Death,7868046,7/1/2006 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,327702, ,NIEHS, , ,327702
Center for digestive and liver diseases,7868613,7/17/2009 0:00,6/30/2011 0:00,Research Centers,2009,282993, ,NIDDK, , ,282993
Dmp1-p53/YY1 interplays and their roles in lung cancer development,7869333,4/1/2004 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,266677, ,NCI, , ,266677
Molecular Epidemiology of Colorectal Cancer Subtypes,7869345,9/15/2005 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,76001, ,NCI, , ,76001
Control of c-Myc Function by the Tumor Suppressor p19ARF,7870547,7/6/2004 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,278992, ,OD, , ,278992
The role of p53 and 14-3-3 in genomic instability,7870550,4/1/2004 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,272082, ,OD, , ,272082
Spread of Replicating Adenovirus in Solid Tumors,7870556,6/1/2003 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,365220, ,OD, , ,365220
Chk1 signaling in the G2 DNA damage checkpoint,7870560,2/1/2003 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,336042, ,OD, , ,336042
Role of the Oxidative Stress Pathway in Drug Resistance,7870561,5/1/2003 0:00,6/30/2011 0:00,Non-SBIR/STTR,2009,351000, ,OD, , ,351000
wnt Signaling in Liver Development and Disease,7872206,7/15/2005 0:00,6/30/2011 0:00,Other Research-Related,2009,50760, ,NIDDK, , ,50760
HTLV I Tax1 protein chemosensitization of p53 mutant tumors,7872281,4/1/2010 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,179981, ,NCI, , ,179981
Center for digestive and liver diseases,7872789,7/1/1998 0:00,6/30/2012 0:00,Research Centers,2010,1181250, ,NIDDK, , ,1181250
FOXO1 Inhibition in Genotoxic Stress Response and Prostate Cancer Survival,7872839,6/16/2009 0:00,10/31/2010 0:00,Non-SBIR/STTR,2010,313325, ,NCI, , ,313325
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma,7872947, , ,Non-SBIR/STTR,2009, ,308254, , , , 
Soft Tissue Sarcoma Program Project,7872951,5/16/1997 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,1805746, ,NCI, , ,1805746
Preclinical Evaluation and Clinical Development of Potent Small-Molecule,7872983, , ,Research Centers,2009, ,279175, , , , 
SPORE in Prostate Cancer,7872989,8/1/1997 0:00,5/31/2013 0:00,Research Centers,2010,2300000, ,NCI, , ,2300000
p53 - Regulators and Effectors,7873648,2/16/2000 0:00,6/30/2015 0:00,Non-SBIR/STTR,2010,1505746, ,NCI, , ,1505746
Nitric oxide eluting therapies for vascular surgery,7874429,9/15/2006 0:00,6/30/2011 0:00,Other Research-Related,2010,127358, ,NHLBI, , ,127358
Stable isotopomer analysis of anabolic metabolic pathways in breast cancer,7876986,7/1/2009 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,162800, ,NCI, , ,162800
Molecular Studies on MUC4 Mucin Gene,7877014,9/1/2008 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,224040, ,NCI, , ,224040
Mechanisms of p53 activation during stress response,7877023,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,346525, ,NCI, , ,346525
Terminal Differentiation of the Renal Epithelium,7877070,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2010,282112, ,NIDDK, , ,282112
Molecular Toxicology of DNA Adducts,7877241,3/1/1997 0:00,4/30/2012 0:00,Non-SBIR/STTR,2009,126009, ,NIEHS, , ,126009
Mechanisms of RelA Activation in Cancer,7877763,9/19/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,225003, ,NCI, , ,225003
Intracellular Mechanisms of Glucocorticoid Action,7877778,7/1/1986 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,265439, ,NIDDK, , ,265439
Stem Cells and Gastric Cancer,7877787,9/1/2006 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,468120, ,NCI, , ,468120
Interactions and Functions of p14ARF in Cancer,7878221,1/1/2005 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,271271, ,NCI, , ,271271
Graduate Training at the Chemistry Biology Interface,7878506,7/1/2004 0:00,6/30/2014 0:00,"Training, Institutional",2010,136282, ,NIGMS, , ,136282
Mechanisms of IGF-1 mediated rescue of radiation-induced salivary gland dysfuncti,7879108,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,5877, ,NIDCR, , ,5877
Role of Sphingosine Kinase in p53 Cancer Biology,7879395,8/1/2003 0:00, ,Non-SBIR/STTR,2009, ,239405, , , , 
Sphingolipids in Cancer Biology and Therapy,7879400,8/1/2003 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,1167501, ,NCI, , ,1167501
Biomarkers for Margin Analysis and Prognosis in HNSCC,7879431,9/1/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2010,406962, ,NIDCR, , ,406962
Mechanistic Studies of Mediator and the p53 Tumor Suppressor,7879510,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,227146, ,NCI, , ,227146
"Inhibitory effects of caffeine, exercise and lipectomy on UVB-induced skin cancer",7879524,9/18/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,247767, ,NCI, , ,247767
Growth Inhibition by the ARF Tumor Suppressor,7879750,4/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,18222, ,NCI, , ,18222
Mechanisms of SAG Inhibition of Carcinogenesis & Apoptosis,7880040,9/1/2006 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,261886, ,NCI, , ,261886
Regulation of MMP-9 mRNA stability and tumor growth by alpha3 beta1 integrin,7880042,9/26/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,325775, ,NCI, , ,325775
Molecular dissection of pancreatic ductal adenocarcinoma,7880057,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,386785, ,NCI, , ,386785
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma:  Environmental Co,7880633,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,331526, ,NCI, , ,331526
Tumor Host Range Mutants of Polyoma and Their Targets,7880696,9/1/2001 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,646176, ,NCI, , ,646176
Novel Methods for Molecular Analysis of Colorectal Cancer Tissue,7880753,9/27/2006 0:00,6/30/2012 0:00,SBIR/STTR,2010,524547, ,NCI, , ,524547
Clinical Investigator Development in Solid Tumor Oncology,7880842,9/1/2000 0:00,6/30/2012 0:00,Other Research-Related,2010,153090, ,NCI, , ,153090
Structural and Functional Characterization of BRCA1/BARD1,7881691,12/21/1998 0:00,6/30/2013 0:00,Non-SBIR/STTR,2010,374448, ,NIGMS, , ,374448
Biological Effects of DNA Adducts Formed by Nitroaromatic Compounds,7882190,2/1/1998 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,329539, ,NIEHS, , ,329539
Ultra Fast and Sensitive Fluorescence-Based Clinical Assays,7882292,7/1/2008 0:00,6/30/2012 0:00,Other Research-Related,2010,160085, ,NIBIB, , ,160085
Methylation in Cancer Progression of Barrett's Esophagus,7882309,7/20/2006 0:00,10/31/2011 0:00,Other Research-Related,2010,133170, ,NIDDK, , ,133170
Mechanisms of esophageal carcinogenesis,7882333,8/15/2003 0:00,6/30/2014 0:00,Non-SBIR/STTR,2010,1648834, ,NCI, , ,1648834
Salivary Acinar Cell Apoptosis: Regulation of p53 by Akt,7882450,7/7/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2010,379312, ,NIDCR, , ,379312
Mechanisms of Genetic Instability and Tumor Suppression,7882565,7/1/1993 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,528044, ,NCI, , ,528044
Effectors of p53 Pro-Survival & Pro-Apoptotic Signaling,7882633, , ,Non-SBIR/STTR,2009, ,556919, , , , 
Molecular Interactions and Regulation of p53,7882634, , ,Non-SBIR/STTR,2009, ,332805, , , , 
p53 Pathway in Postnatal Growth and Stem Cell Behavior,7882635, , ,Non-SBIR/STTR,2009, ,344354, , , , 
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12,7883003,8/1/2002 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,289818, ,NCI, , ,289818
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS,7883489, , ,Non-SBIR/STTR,2009, ,423614, , , , 
"HPV: Biology, Clinical Significance and Epidemiology",7883494,6/1/1997 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,2278913, ,NCI, , ,2278913
SPORE in Lung Cancer,7883902,9/1/2009 0:00,8/31/2011 0:00,Research Centers,2009,158568, ,NCI, , ,158568
The role of cyclin E deregulation in breast tumorigenesis,7884539,9/1/2008 0:00,12/31/2011 0:00,Other Research-Related,2010,155408, ,NCI, , ,155408
"Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B",7884640, , ,Research Centers,2009, ,317168, , , , 
Role of a novel Notch1 target gene in skin carcinogenesis,7884701,3/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,318418, ,NCI, , ,318418
Function of MEF in Hematopoietic Cells,7885407,1/1/1997 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,398871, ,NIDDK, , ,398871
Hypoxia signaling to checkpoint activation and apoptosis,7885415,8/4/2006 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,266285, ,NCI, , ,266285
Project 4: NOX1 Involvement In Colon Cancer,7885518, , ,Non-SBIR/STTR,2009, ,139829, , , , 
The San Francisco Bay Area Adult Glioma Survival Study,7885642, , ,Research Centers,2009, ,320560, , , , 
Altered Proteoglycan Gene Expression and Cancer,7886089,9/1/1988 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,379752, ,NCI, , ,379752
Mechanism of mitotic exit in budding yeast,7886112,7/20/2009 0:00,3/31/2010 0:00,Non-SBIR/STTR,2009,90165, ,NIGMS, , ,90165
UV and p21 Degradation,7886222,6/15/2005 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,269870, ,NCI, , ,269870
Role of WISp39 and Ubiquitination in p21 Function,7886250,4/9/2004 0:00,2/28/2010 0:00,Non-SBIR/STTR,2008,51188, ,NCI, , ,51188
"Chemoprevention of Colon Cancer, HDAC Inhibition, and Histone Status",7886293,3/17/2003 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010, ,169512, , , , 
"Spindle Assembly Checkpoint, Chromosomal Instability, and Cancer",7886634,9/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,318513, ,NCI, , ,318513
The Function and Regulation of  Trefoil Factor Family 2 (TFF2),7886835,4/1/2001 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,338704, ,NIDDK, , ,338704
Hypoxia and Gene Repression,7886961,7/1/2000 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,334079, ,NCI, , ,334079
Functional study of C53 protein as a novel regulator of checkpoint kinases,7887118,8/10/2009 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,127409, ,NIGMS, , ,127409
Modeling glioma with sporadic co-LOH of p53 and NF1 using a mouse genetic mosaic,7887125,9/1/2009 0:00,6/30/2010 0:00,Non-SBIR/STTR,2009,100000, ,NCI, , ,100000
P38 MAPK in Ras-induced Senescence and Transformation,7888045,7/1/2005 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,329657, ,NCI, , ,329657
Regulation of the mTOR Pathway By Nutrients,7888314,3/23/2004 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,390408, ,NCI, , ,390408
Synergistic anticancer effects of docosahexanoic acid and curcumin,7888328,7/8/2009 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,67500, ,NCI, , ,67500
Regulation of NF-Kappa B,7888623,9/30/2000 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010,745119, ,NIAID, , ,745119
Role of Rb Family in Lung Epithelial Response to Injury,7889200,4/1/2005 0:00,3/31/2014 0:00,Non-SBIR/STTR,2010,380626, ,NHLBI, , ,380626
Mechanisms of Intestinal Tumorigenesis,7889526,1/1/2000 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,395882, ,NCI, , ,395882
Functions of Papillomavirus E6,7889755,4/8/2004 0:00,7/17/2010 0:00,Non-SBIR/STTR,2010,77568, ,NCI, , ,77568
Mechanisms and Treatment of PTEN Mutant Prostate Tumorigenesis,7890143,4/1/2010 0:00,1/31/2014 0:00,Non-SBIR/STTR,2010,288840, ,NCI, , ,288840
Targeting Glucose Metabolism in Cancer,7890507,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,184260, ,NCI, , ,184260
Coordinately regulated alternative splicing in DNA damage and cancer,7890944,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,268920, ,NCI, , ,268920
Biological Effects of DNA Adducts Formed by Nitroaromatic Compounds,7891046,2/1/1998 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,392750, ,OD, , ,392750
Structural basis of signaling by ING2 PHD,7891253,9/6/2006 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,196032, ,NCI, , ,196032
Functional analysis of the p53 tumor suppressor,7891256,8/15/1985 0:00,7/30/2013 0:00,Non-SBIR/STTR,2010,225928, ,NCI, , ,225928
Novel Suppressors of Pancreatic Cancer,7891308,7/10/2009 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,165000, ,NCI, , ,165000
Mechanisms of Chemoprevention by Isothiocyanates,7891996,9/1/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,325653, ,NCI, , ,325653
Role of p300/CBP and hHR23 Proteins in p53 Regulation,7892214,4/19/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,296182, ,NCI, , ,296182
MbSOD in chemotherapeutic-Induced Cardiac Injury,7892269,9/25/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,270000, ,NCI, , ,270000
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein,7892270,9/30/1992 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,306714, ,NCI, , ,306714
Cellular Responses to p53 Activation by Nutlin-3a,7892313,7/13/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,311250, ,NCI, , ,311250
A novel regulator of p53,7892414,8/15/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,260621, ,NCI, , ,260621
Therapeutic Potential and Mechanism of Action of Potent Small Molecule Inhibitors,7892546, , ,Research Centers,2009, ,225991, , , , 
"Role of Soy Isoflavones, Smoking Abstinence and Molecular Markers in Prevention",7892547, , ,Research Centers,2009, ,469959, , , , 
Functional analysis of a putative ATM/ATR substrate RFWD3,7892934,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,288734, ,NIGMS, , ,288734
Zebrafish Screens for Genetic Modifiers and Human Application in T-ALL,7893020, , ,Non-SBIR/STTR,2009, ,304947, , , , 
Sequence distribution of tobacco carcinogen-DNA adducts,7893065,12/1/2002 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,225787, ,NCI, , ,225787
Functional analysis of a putative ATM/ATR substrate RFWD3,7893391,8/31/2009 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,115125, ,NIGMS, , ,115125
Integration of Oncogenic Networks in Cancer Phenotypes,7893472,9/30/2004 0:00,2/28/2011 0:00,Research Centers,2009,1015966, ,NCI, , ,1015966
Functions of mir-34 microRNAs in the p53 tumor suppressor pathway,7893610,8/1/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2010,318513, ,NCI, , ,318513
Comparative functional genomics for lung cancer gene discovery,7893665,9/23/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,569332, ,NCI, , ,569332
Growth Inhibition by the ARF Tumor Suppressor,7893692,4/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,265940, ,NCI, , ,265940
Role of Kruppel-Like Factor 4 in Wnt and Notch Signaling in the Intestinal Tract,7893855,8/1/2008 0:00,7/31/2011 0:00,"Training, Individual",2010,59918, ,NCI, , ,59918
The Role of Non-C anonical Bax/Bak Direct Activators in Hematological Cancers,7893859,8/25/2008 0:00,8/24/2011 0:00,"Training, Individual",2010,53810, ,NCI, , ,53810
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis,7893869,9/15/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,308138, ,NCI, , ,308138
Transcriptional Repression by Maf1 in Yeast,7894176,8/13/2009 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,220357, ,NIGMS, , ,220357
ROLE OF HISTONE H4 N-TERMINAL TAIL IN TRANSCRIPTION REGULATION,7894600,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,308912, ,NIGMS, , ,308912
Gene targets of OLIG2 in malignant glioma stem cells,7894631,7/15/2007 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,423225, ,NINDS, , ,423225
Walleye Dermal Sarcooma Virus Accessory Protein Function,7894670,6/1/2002 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,248467, ,NCI, , ,248467
"Interplay of Myc, Tumor Supressors and Regulators of Differentiation in Lymphoma",7894749,12/15/1997 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,367778, ,NCI, , ,367778
Role of Estrogen Receptor alpha-p53 Interaction in Resistance to Tamoxifen Therap,7894751,7/16/2009 0:00,6/30/2013 0:00,Non-SBIR/STTR,2010,325629, ,NCI, , ,325629
DNA Adduct-Induced Mutagenesis,7894762,2/15/1992 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,251664, ,NCI, , ,251664
p53 Acetylation as a Mechanism in Chemoprevention by Aspirin,7894783,7/17/2009 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,74250, ,NCI, , ,74250
Role of cellular senescence in mammary cancer prevention by Rexinoids.,7894809,7/17/2009 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,78500, ,NCI, , ,78500
Role of Id1 in NSCLC Progression and Metastasis,7894831,7/17/2009 0:00,11/30/2011 0:00,Non-SBIR/STTR,2010,345576, ,NCI, , ,345576
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival,7894833,7/17/2009 0:00,12/31/2010 0:00,Non-SBIR/STTR,2010,44975, ,NCI, , ,44975
Characterization of RNF5 - A Novel RING Finger Protein,7894929,7/1/2002 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,384693, ,NCI, , ,384693
Inhibition of Autophagy: A Novel Therapeutic Strategy for Advanced Solid Tumors,7894958,7/17/2009 0:00,6/30/2013 0:00,Non-SBIR/STTR,2010,321474, ,NCI, , ,321474
Human Papillomavirus Association with Subsets of Colorectal Cancer,7895038,8/1/2009 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,88000, ,NCI, , ,88000
EBNA3C and tumor supressors,7895101,7/16/2009 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,319550, ,NCI, , ,319550
Role of hsnf5/BAF47 Loss in Human Cancer Development,7895675,3/1/2002 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,268981, ,NCI, , ,268981
Telomere induced senescence as a supressor of tumorigenesis,7895737,8/8/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,314450, ,NCI, , ,314450
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA,7895803,5/1/1997 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,280617, ,NCI, , ,280617
Interaction Between SV40 Large T and P185 Cullin,7895908,7/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,280692, ,NCI, , ,280692
SPORE in Head and Neck Cancer,7896361,7/1/2004 0:00,6/30/2010 0:00,Research Centers,2009,1092383, ,NCI, , ,1092383
The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAs,7896368,4/8/2010 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010,354150, ,NIEHS, , ,354150
Intravenous Protein Therapy for Myotonic Dystrophy Type 1,7896503,8/1/2009 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,195590, ,NINDS, , ,195590
Somatic genetic predictors of response to therapy in metastatic melanoma,7896541,9/13/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,308319, ,NCI, , ,308319
Molecular Mechanism of Translocations in B-Cell Lymphoma,7896687, , ,Non-SBIR/STTR,2009, ,507327, , , , 
Molecular Interactions and Regulation of p53,7896964,7/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2010, ,208604, , , , 
The Role of Fbxw7 in genetic instability and cancer,7897041,9/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2008,279136, ,NCI, , ,279136
Role of Heat Shock Factor 1 in Doxorubincin-Induced Cardiotoxicity,7897367,4/2/2010 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,228750, ,NHLBI, , ,228750
MicroRNAs and chromosome 22q in the colon,7897807,3/1/2000 0:00,5/31/2013 0:00,Non-SBIR/STTR,2010,362448, ,NIDDK, , ,362448
Polyoma Virus Disrupts ARF Signaling to p53,7897924,4/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,308158, ,NCI, , ,308158
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy,7898374,3/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,313408, ,NCI, , ,313408
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer,7898567,9/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,248170, ,NCI, , ,248170
The role of DNA polymerase eta in DNA damage response and p53 activation,7898966,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,285728, ,NCI, , ,285728
ROLE OF HISTONE H4 N-TERMINAL TAIL IN TRANSCRIPTION REGULATION,7899288,8/31/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,215416, ,NIGMS, , ,215416
Redox Regulation of Tumor Suppression by MnSOD,7899770,9/1/1998 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,372365, ,NCI, , ,372365
Induction of genomic instability by HPV E6 and E7,7900009,9/8/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,307204, ,NCI, , ,307204
Mechanisms of IGF-1 mediated rescue of radiation-induced salivary gland dysfuncti,7900030,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,333153, ,NIDCR, , ,333153
Comparative Bioinformatics and TP53 Expression,7900314,8/19/2009 0:00,8/18/2011 0:00,Non-SBIR/STTR,2009,69066, ,NLM, , ,69066
p53-Independent Cell Death Signaling by Mitomycin DNA Adducts,7900414,8/6/2008 0:00,7/31/2012 0:00,Other Research-Related,2010,304000, ,NCI, , ,304000
The MRAD9 Radioresistance Gene,7900685,12/1/2000 0:00,3/31/2014 0:00,Non-SBIR/STTR,2010,337733, ,NIGMS, , ,337733
p63-Dependent Checkpoints in Oocytes,7900949,8/1/2009 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,489014, ,NICHD, , ,489014
NITROAROMATICS AND BREAST CANCER,7901003,7/1/1983 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,304309, ,NCI, , ,304309
Molecular Determinants for the Bioactivity of the Flavonoid Quercetin,7901375,8/1/2008 0:00,7/31/2011 0:00,Other Research-Related,2010,73500, ,NIGMS, , ,73500
Altered Expression of Protein Tyrosine Phosphatase by Methylation,7901424, , ,Non-SBIR/STTR,2009, ,302829, , , , 
Pathology,7901428, , ,Non-SBIR/STTR,2009, ,331401, , , , 
Predictive Molecular Markers of Colorectal Cancer,7901545,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,73250, ,NCI, , ,73250
Murine Neuroblastoma Models for Preclinical Therapeutics,7901591,7/1/2003 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,261694, ,NCI, , ,261694
RETINOID THERAPY,7901622, , ,Non-SBIR/STTR,2009, ,247481, , , , 
Cancer cell telomere dynamics and responses to perturbations,7901675,9/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,308158, ,NCI, , ,308158
EARLY DETECTION OF URINARY BLADDER CANCER,7901737,9/30/1999 0:00,6/30/2010 0:00,Non-SBIR/STTR,2009,394690, ,NCI, , ,394690
Oxidative Injury to Gastric Epithelial Cells by H. pylori,7901972,9/15/2009 0:00,7/30/2011 0:00,Non-SBIR/STTR,2009,93563, ,NIDDK, , ,93563
MicroRNAs and chromosome 22q in the colon,7901975,9/20/2009 0:00,2/29/2012 0:00,Non-SBIR/STTR,2009,77977, ,NIDDK, , ,77977
Mechanisms of Radioresistance and Cell Cycle Progression,7902036,9/28/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,360812, ,NCI, , ,360812
Lipid-Peroxidation Induced Cyclic Adducts in Hepatocarcinogenesis,7902080,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,445590, ,NCI, , ,445590
The Effect of Radiation on Androgen Receptor Expression and Activity in Prostate,7902178, , ,Research Centers,2009, ,277144, , , , 
The Control of Centriole Duplication and Degeneration,7903077,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,359083, ,NIGMS, , ,359083
Targeting transforming growth factor beta for cancer treatment,7903139,7/15/1997 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,218928, ,NCI, , ,218928
"UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis",7903388,9/1/2000 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,209081, ,NCI, , ,209081
TGF-beta Signaling in Pancreatic Cancer Progression,7903958,9/1/2009 0:00,7/31/2014 0:00,Non-SBIR/STTR,2010,340300, ,NCI, , ,340300
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer,7903997,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,323500, ,NCI, , ,323500
Role of Proline in Redox Homeostasis and Apoptosis,7904340,8/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,268888, ,NIGMS, , ,268888
Studying the control of Cytokinesis as an Evolved Complex System,7905029,8/1/1999 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,319396, ,NIGMS, , ,319396
BRCA1 and progesterone receptors in breast cancer,7905680,9/1/2009 0:00,3/31/2012 0:00,Non-SBIR/STTR,2010,317475, ,NCI, , ,317475
Breast Cancer Prevention by Dietary Phytochemicals,7905829,9/7/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,282150, ,NCI, , ,282150
Lipid peroxidation product induced DNA damage in the p53 gene and liver cancer,7905832,9/28/2006 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,357947, ,NIEHS, , ,357947
Genomic Analysis of the p53 Pathway in Normal and Cancer Cells,7905841, , ,Non-SBIR/STTR,2009, ,393527, , , , 
p53 and Chemosensitivity in a Mouse Lymphoma Model,7905842, , ,Non-SBIR/STTR,2009, ,406228, , , , 
Molecular Studies of the p53 Pathway in Human Cancer,7905843, , ,Non-SBIR/STTR,2009, ,404960, , , , 
Roles and Regulation of p53,7905844,9/30/2000 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,1668201, ,NCI, , ,1668201
Modulation of Apoptosis by IRF-4 in EBV transformation,7905900,8/4/2009 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,272802, ,NCI, , ,272802
Interplay between Cdh1 and major regulatory pathways in human cancer,7906975,8/6/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2010,344273, ,NIGMS, , ,344273
The replication checkpoint and genomic fidelity in skin,7907453,9/1/2003 0:00,2/28/2015 0:00,Non-SBIR/STTR,2010,442018, ,NIAMS, , ,442018
Glucose Metabolism and p53 in Leukemia,7907712,8/20/2008 0:00,5/19/2011 0:00,"Training, Individual",2010,24749, ,NHLBI, , ,24749
Id2 enhances radiation resistance in glioma and is regulated by p53.,7907760,8/1/2009 0:00,7/31/2012 0:00,"Training, Individual",2010,33116, ,NINDS, , ,33116
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,7907938,5/1/1997 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,1456859, ,NCI, , ,1456859
AMID in Apoptosis and p53-Mediated Downstream Effects,7908140,7/14/2004 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,124809, ,NCI, , ,124809
"Telomeres, Telomerase and Tumor Progression",7908535,8/1/2009 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,95000, ,NCI, , ,95000
Bid Regulation of Cutaneous Photodamage Responses,7908747,8/5/2009 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,228430, ,NIAMS, , ,228430
Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette Smoke,7909165,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,384336, ,NCI, , ,384336
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,7909298,8/15/1999 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,305550, ,OD, , ,305550
Targeting of 6-Phosphofructo-2 kinase in Cancer,7909318,8/19/2005 0:00,1/31/2011 0:00,Non-SBIR/STTR,2009,256921, ,OD, , ,256921
Structural basis for CBP/p300 transcriptional regulation,7909484,8/1/2009 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,55502, ,NCI, , ,55502
Altered Proteoglycan Gene Expression and Cancer,7909761,8/1/2009 0:00,4/30/2010 0:00,Non-SBIR/STTR,2009,145075, ,NCI, , ,145075
Molecular Studies on MUC4 Mucin Gene,7909936,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,133919, ,NCI, , ,133919
"Dysfunctional Telomeres, Checkpoints and Aging",7910424,9/30/2006 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,266304, ,NIA, , ,266304
PDZ-targeted Therapeutics for Cervical Cancer,7910783,7/1/2010 0:00,12/31/2011 0:00,SBIR/STTR,2010,208622, ,NCI, , ,208622
SPORE in Head and Neck Cancer,7910938,8/1/2009 0:00,7/31/2010 0:00,Research Centers,2009,230569, ,NCI, , ,230569
"Interactions between NEDD9, AURKA, and p53 in mammary tumor development",7911084,9/1/2010 0:00,8/31/2012 0:00,"Training, Individual",2010,47606, ,NCI, , ,47606
Selective Forces Operative in FeLV Infection,7911087,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,254201, ,NCI, , ,254201
p53 signatures and pelvic serous carcinoma,7911245,8/1/2009 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,105987, ,NCI, , ,105987
NF Center: From Animal Models to Therapeutics,7911627, , ,Research Centers,2009, ,218133, , , , 
P63 mediators as therapeutic targets in HNSCC,7911727,4/1/2004 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,442500, ,NIDCR, , ,442500
FAK Signals Controlling Endothelial Cell Survival and Motility,7911751,9/1/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,489557, ,NHLBI, , ,489557
Chemoprevention of Lung Cancer with Anti-tumor B,7911813,9/30/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2010,365038, ,NCCIH, , ,365038
Role of Bub1 in SV40 large T antigen mediated transformation and replication,7911859,9/10/2008 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,369445, ,NIAID, , ,369445
Etiologic Role of HPV in Keratinocyte Carcinomas,7912035,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,306121, ,NCI, , ,306121
Functional properties of centrosomes in somatic cells,7912058,9/11/2009 0:00,4/30/2010 0:00,Non-SBIR/STTR,2009,117259, ,NIGMS, , ,117259
Study the Role of Chfr in Tumorigenesis,7912218,7/1/2006 0:00,4/30/2011 0:00,Non-SBIR/STTR,2009,182915, ,NCI, , ,182915
Analysis of 53BP1 function in DNA Damage-signaled pathway and Tumorigenesis,7912236,5/9/2003 0:00,3/31/2011 0:00,Non-SBIR/STTR,2009,250755, ,NCI, , ,250755
Feedback regulation of p53 through the REDD1 pathway,7912519,5/1/2010 0:00,4/30/2013 0:00,"Training, Individual",2010,50474, ,NCI, , ,50474
Stochastic dynamics for multiscale biology,7912919,9/1/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,304151, ,NIGMS, , ,304151
Research Career Development in HIV-Related Anal Dysplasia/Carcinoma Prevention an,7912944,9/15/2008 0:00,8/31/2013 0:00,Other Research-Related,2010,117138, ,NIAID, , ,117138
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression,7912961,9/3/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,233704, ,NCI, , ,233704
Quantitative Measurements and Modeling of the Mitotic Checkpoint,7913001,9/28/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,346500, ,NIGMS, , ,346500
Multi-institutional trial: molecular analysis of margins,7913476,8/1/2009 0:00,7/31/2010 0:00,Non-SBIR/STTR,2009,103502, ,NCI, , ,103502
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,7913508,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,276166, ,NCI, , ,276166
Cancer cell telomere dynamics and responses to perturbations,7913694,8/1/2009 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,298479, ,NCI, , ,298479
The Role of Ape1 in Neurotoxicity of Cancer Treatments,7913841,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,358757, ,NCI, , ,358757
Cellular Senescence and Control of Gene Expression,7914133,9/1/1990 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,620645, ,NIA, , ,620645
"Mechanisms of DNA damage-induced, p53-dependent repression of the Cdc25C Phosphat",7914522,11/16/2010 0:00,6/19/2012 0:00,"Training, Individual",2010,33383, ,NCI, , ,33383
Role of Germ Cell Nuclear Factor in Restricting hESC Pluripotency,7915183, , ,Non-SBIR/STTR,2009, ,274274, , , , 
Regulatory Networks in Human Embryonic Stem Cells,7915188,9/1/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,1557723, ,NIGMS, , ,1557723
Differential regulation of cardiomyocyte survival and hypertrophy,7915295,9/1/2009 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,585472, ,NHLBI, , ,585472
Role of DN-p63 in Preservation of Self Renewal,7915957,8/1/2009 0:00,1/31/2012 0:00,Non-SBIR/STTR,2009,227780, ,NCI, , ,227780
p53-independent function of Mdmx in tumorigenesis,7916961,7/1/2010 0:00,6/30/2014 0:00,"Training, Individual",2010,41380, ,NCI, , ,41380
Molecular dissection of pancreatic ductal adenocarcinoma,7917016,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2009,87268, ,NCI, , ,87268
Characterization of prostatic stem cells and prostate cancer-initiating cells,7917091,9/1/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,249000, ,NCI, , ,249000
Epigenetic Regulation of Cell and Tissue Aging,7917307,9/30/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,305298, ,NIA, , ,305298
P-4: Targeting activation of NFkB pathways in MM,7917453, , ,Research Centers,2009, ,289170, , , , 
The Role of Fbxw7 in genetic instability and cancer,7917484,9/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,355982, ,NCI, , ,355982
FDH: A Novel Determinant of Tumor Suppression,7918678,3/1/2005 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010,256053, ,NCI, , ,256053
Epithelial Positioning Organization and Ovarian Cancer,7918680,3/1/2002 0:00,5/31/2011 0:00,Non-SBIR/STTR,2009,85680, ,NCI, , ,85680
Epigenetic Regulation of Cell and Tissue Aging,7919013,9/30/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,179595, ,NIA, , ,179595
SPORE in Lung Cancer,7919122,9/1/2009 0:00,8/31/2011 0:00,Research Centers,2009,158500, ,NCI, , ,158500
Predictive Molecular Markers of Colorectal Cancer For African American Patients,7919392,9/30/2005 0:00, ,Research Centers,2009, ,70898, , , , 
The role of stem cells in longevity suppression by p44 (deltaN-p53),7919448,9/2/2008 0:00,12/29/2010 0:00,"Training, Individual",2010,14523, ,NINDS, , ,14523
Targeting Raf in Melanoma: Mechanisms for Effect & Resistance & Opportunities for,7919454, , ,Research Centers,2009, ,320636, , , , 
Molecular Pathology of t-AML,7919469, , ,Non-SBIR/STTR,2009, ,452006, , , , 
Activating liver carcinogens in yeast by expressing CYP450 polymorphisms,7919901,9/17/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,222920, ,NIEHS, , ,222920
The Identification and characterization of the methylation of Retinablastoma,7920790,9/1/2009 0:00,8/31/2011 0:00,"Training, Individual",2010,31140, ,NIA, , ,31140
monoclonal antibody,7920985, , ,Research Centers,2009, ,111189, , , , 
Mechanisms of tumor promotion and carcinogenesis,7921141,1/1/1994 0:00,2/28/2010 0:00,Non-SBIR/STTR,2009,25000, ,NCI, , ,25000
SPORE in Head and Neck Cancer,7921217,7/1/2004 0:00,6/30/2010 0:00,Research Centers,2009,300000, ,NCI, , ,300000
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,7921307,9/30/2009 0:00,9/29/2011 0:00,Other Research-Related,2009,109616, ,NCI, , ,109616
UT M.D. Anderson Cancer Center Lymphoma SPORE,7922023,9/1/2009 0:00,8/31/2012 0:00,Research Centers,2010,500000, ,NCI, , ,500000
Integration of Oncogenic Networks in Cancer Phenotypes,7922451,9/30/2004 0:00,2/28/2011 0:00,Research Centers,2009,443034, ,NCI, , ,443034
Cooperation of PTEN and SHIP as tumor suppressors in B-Cells,7922520,9/30/2007 0:00,8/31/2012 0:00,Other Research-Related,2010,113196, ,NCI, , ,113196
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,7922754,9/1/2008 0:00,8/31/2013 0:00,Other Research-Related,2010,167791, ,NCI, , ,167791
Mechanisms of tumor suppression by Fbw7,7922961,9/1/2009 0:00,2/29/2012 0:00,Other Research-Related,2009,136565, ,NCI, , ,136565
Targeting Cell Cycle Checkpoints in Cancer Therapeutics,7923009,8/1/2006 0:00,12/23/2009 0:00,Other Research-Related,2009,105684, ,NCI, , ,105684
P-53-Based Vaccine for Small Cell Lung Cancer,7923281, , ,Research Centers,2009, ,350392, , , , 
SPORE in Lung Cancer,7923287,9/15/2008 0:00,8/31/2013 0:00,Research Centers,2010,2000000, ,NCI, , ,2000000
Bladder Cancer Prognostic Indicators,7923435,9/1/2005 0:00,8/31/2011 0:00,Other Research-Related,2009,104710, ,NCI, , ,104710
Mouse Models of Human Breast Cancer,7923496,9/30/1999 0:00,3/31/2010 0:00,Non-SBIR/STTR,2009,382538, ,NCI, , ,382538
Cyclins and Cyclin-dependent kinases as targets for protection against radiation,7923839, , ,Non-SBIR/STTR,2009, ,266836, , , , 
p53 Fusion Protein as an Oncology Therapeutic,7924089,9/18/2007 0:00,4/30/2012 0:00,SBIR/STTR,2010,367754, ,NCI, , ,367754
Exploiting mouse models of pediatric cancers and epigenetics for therapy,7924209,9/10/2004 0:00,7/31/2014 0:00,Non-SBIR/STTR,2010,851851, ,NCI, , ,851851
Regulated Proteolysis in RAS Signal Transduction,7924261,9/30/2009 0:00,12/31/2009 0:00,Non-SBIR/STTR,2009,37657, ,NIGMS, , ,37657
Ras Induced Senescence and Tumor Suppression,7924586,7/1/1999 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,353133, ,NIA, , ,353133
Integrative genomic characterization of lung cancer metastasis in mouse and human,7924626,9/30/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2010,790696, ,NCI, , ,790696
"Telomere dysfunction, p53 and tumorigenesis",7924857,7/1/2007 0:00,6/30/2012 0:00,Other Research-Related,2010,154984, ,NCI, , ,154984
Functional Characterization of WTX in Renal Development,7924889,9/30/2007 0:00,8/31/2012 0:00,Other Research-Related,2010,137970, ,NIDDK, , ,137970
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes,7925627,9/18/2006 0:00,7/31/2014 0:00,Non-SBIR/STTR,2010,164803, ,NCI, , ,164803
Characterization of prostatic stem cells and prostate cancer-initiating cells,7925733,9/1/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,249000, ,NCI, , ,249000
Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction,7925760,9/5/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2010,352688, ,NIAAA, , ,352688
The role of ghrelin in cisplatin-induced infertility,7926993,9/3/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,191858, ,NICHD, , ,191858
The role of DEK in breast cancer development and therapy,7928091,9/15/2009 0:00,9/14/2011 0:00,"Training, Individual",2010,50474, ,NCI, , ,50474
MTOR AS A THERAPEUTIC TARGET IN PEDIATRIC SOLID TUMORS,7928166, , ,Non-SBIR/STTR,2009, ,283375, , , , 
Timing of Rectal Cancer Response to Chemoradiation,7928480,9/16/2003 0:00,6/30/2010 0:00,Non-SBIR/STTR,2009,425857, ,NCI, , ,425857
Resolution of Epithelial Cell Hyperplasia,7928863,9/15/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2010,548264, ,NIEHS, , ,548264
Flow Cytometry,7928901, , ,Research Centers,2009, ,566884, , , , 
Targeting Regulators of Apoptosis in AML,7928918, , ,Non-SBIR/STTR,2009, ,349419, , , , 
THE THERAPY OF AML,7928928,5/27/1997 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,2483417, ,NCI, , ,2483417
Prognostic Molecular Markers of Colorectal Cancer,7929935,9/30/2009 0:00,9/29/2010 0:00,Non-SBIR/STTR,2009,85908, ,NCI, , ,85908
Genetic and Molecular Epidemiology of Adult Glioma,7929941,9/30/2009 0:00,9/29/2011 0:00,Non-SBIR/STTR,2009,496140, ,NCI, , ,496140
Structure and Function of DNA Regulatory Proteins,7930625,1/1/1997 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,310551, ,NIGMS, , ,310551
Structural and Functional Characterization of BRCA1/BARD1,7931268,9/30/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,198342, ,NIGMS, , ,198342
Strategies for gene and protein delivery for cancer therapy,7931674,4/1/2010 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011, , , , , , 
Characterization of Human Epidermal Stem Cells,7931700,10/1/2010 0:00,9/30/2014 0:00,Non-SBIR/STTR,2011, , , , , , 
Repair of oxidative DNA damage in mammalian cells,7932115,3/10/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,242053, ,NCI, , ,242053
Death Receptors in Bladder Cancer Therapy,7932246, , ,Research Centers,2009, ,241581, , , , 
Regulatory Networks in Human Embryonic Stem Cells,7932410,9/30/2009 0:00,8/31/2012 0:00,Non-SBIR/STTR,2009,1261211, ,NIGMS, , ,1261211
"Telomere dysfunction, p53 and tumorigenesis",7932617,9/30/2009 0:00,9/29/2011 0:00,Other Research-Related,2009,92114, ,NCI, , ,92114
Role of Focal Adhesion Kinase In Tumorigenesis,7932790,7/1/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,302154, ,NCI, , ,302154
TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8461 UNDER,7933253,1/1/2006 0:00,12/31/2009 0:00,R and D Contracts,2009,1206941, ,NCI, , ,1206941
Sphingolipids in Cancer Biology and Therapy,7933403,8/1/2003 0:00,7/31/2013 0:00,Non-SBIR/STTR,2009,36107, ,NCI, , ,36107
The Role of E2F1 in UV-induced DNA Damage Response,7933438,9/30/2009 0:00,9/29/2010 0:00,Other Research-Related,2009,50000, ,NCI, , ,50000
Cell fate decision in response to p53-dependent DNA damage/genotoxic stress,7933491,9/1/2009 0:00,8/31/2010 0:00,Non-SBIR/STTR,2009,132791, ,NCI, , ,132791
Nanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCV,7933535,9/15/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2010,380903, ,NIAAA, , ,380903
Intrinsic Apoptosis Phenotype and Susceptibility to Squamous Cell Carcinoma,7934013, , ,Research Centers,2009, ,261699, , , , 
Cancer Risk Assessment in Patients with Oral Premalignant Lesions,7934014, , ,Research Centers,2009, ,354491, , , , 
FIBRONECTIN REGULATION OF CARCINOMA APOPTOSIS,7934164,9/15/2004 0:00,6/30/2010 0:00,Non-SBIR/STTR,2009,51499, ,NIDCR, , ,51499
The Molecular Epidemiology of Bladder Cancer,7934210,5/1/2007 0:00,9/29/2012 0:00,Non-SBIR/STTR,2009,408096, ,NCI, , ,408096
Biomarkers of survival in glioma epidemiology,7934298,7/1/2008 0:00,9/29/2011 0:00,Non-SBIR/STTR,2009,464455, ,NCI, , ,464455
Reactivation of the p53-mediated pro-Apoptotic Pathway Using Stapled Peptides,7934322,9/30/2009 0:00,9/29/2011 0:00,Other Research-Related,2009,96768, ,NCI, , ,96768
Role of Matrix Metalloproteinase-1 in Endothelial Cell Senescence,7934615,9/30/2009 0:00,11/30/2011 0:00,Non-SBIR/STTR,2010,182655, ,NIA, , ,182655
SPORE in Lung Cancer,7934988,9/15/2008 0:00,8/31/2011 0:00,Research Centers,2009,256642, ,NCI, , ,256642
Genetic Epidemiology of Melanoma,7935181,9/30/2001 0:00,3/31/2013 0:00,Non-SBIR/STTR,2010,622906, ,NCI, , ,622906
Modulation of Glioma Growth and Invasion by HCMV Glycoprotein B,7935186,9/20/2009 0:00,12/31/2012 0:00,Non-SBIR/STTR,2010,208766, ,NINDS, , ,208766
Chemoprevention of lung cancer with red ginseng extracts,7936365,9/30/2009 0:00,8/31/2013 0:00,Non-SBIR/STTR,2010,486114, ,OD, , ,200000
Mechanisms of Cancer Initiation by TRIM32,7936498,9/29/2009 0:00,1/31/2013 0:00,Non-SBIR/STTR,2009,29670, ,NCI, , ,29670
Role and regulation of GnRH and receptors in Cisplatin resistant ovarian cancer,7937435,5/13/2010 0:00, ,"Training, Individual",2009,7850, ,NCI, , ,7850
"HPV: Biology, Clinical Significance and Epidemiology",7937530,9/28/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2009,215373, ,NCI, , ,215373
Biomimetic Synthesis of Complex Natural Products,7937641,9/30/2009 0:00,12/31/2010 0:00,Non-SBIR/STTR,2009,109801, ,NIGMS, , ,109801
Cancer cell adaptation to metabolic stress,7937714,9/10/2004 0:00,8/31/2014 0:00,Non-SBIR/STTR,2010,1230346, ,NCI, , ,1230346
Bifunctional T cell receptor based immunotherapeutics,7937794,7/26/2002 0:00,8/31/2012 0:00,SBIR/STTR,2010,990016, ,NCI, , ,990016
LC-MS Analysis of DNA Adducts of Aromatic Amines: Relationship to Bladder Cancer,7937927,5/18/1996 0:00,7/31/2014 0:00,Non-SBIR/STTR,2010,233155, ,NCI, , ,233155
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model,7938605,9/25/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2010,492416, ,NCI, , ,492416
Model systems for hematologic disorders caused by ribosomal protein deficiency,7938697,9/30/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2010,497825, ,NIDDK, , ,497825
Impact of BRG1 Loss in Lung Cancer Development,7938815,9/27/2007 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,1, ,NCI, , ,1
Pten-loss Dysregulated Pathways in Prostate Cancer,7938940,9/25/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,366250, ,NIMHD, , ,366250
Mechanisms Regulating Reversal of Malignancy,7939057,8/1/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2009,96935, ,NCI, , ,96935
Full Project 1: Tumor-targeted MR Contrast Enhancement Using Molecular Imaging Te,7939594, , ,Research Centers,2009, ,142952, , , , 
The Role of KLF6 Tumor Suppressor in Hepatocellular Cancer,7939671,9/30/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,420063, ,NIDDK, , ,420063
Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,7939737,9/30/2009 0:00,8/31/2014 0:00,Other Research-Related,2010,362588, ,NIAID, , ,362588
CBP Bromodomain Antagonists Block Androgen Receptor in Prostate Cancer,7939793,9/28/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,84750, ,NCI, , ,84750
Rapid release paclitaxel nanoparticles for bladder cancer intravestical therapy,7940123,8/1/2004 0:00,8/31/2012 0:00,SBIR/STTR,2009,400000, ,NCI, , ,400000
Ultra Fast and Sensitive Fluorescence-Based Clinical Assays,7940143,7/1/2008 0:00,6/30/2012 0:00,Other Research-Related,2009,123504, ,NIBIB, , ,123504
Lung Toxicity of Carbon Nanotubes in Models of Pre-Existing Respiratory Disease,7940856,9/27/2009 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,586570, ,NIEHS, , ,586570
Training Program in Molecular Genetics of Cancer,7941363,9/30/1978 0:00,6/30/2015 0:00,"Training, Institutional",2010,411822, ,NCI, , ,411822
A Chemical Biology Approach for Discovery of HDAC Inhibitors,7941595,9/1/2010 0:00,8/31/2013 0:00,Other Research-Related,2010,145475, ,NIGMS, , ,145475
Transposon-insertional Mutagenesis to Decipher Osteosarcomagenesis,7941837,9/28/2009 0:00,8/31/2014 0:00,Other Research-Related,2010,179280, ,NCI, , ,179280
Targeting the ARF/CtBP Axis in Pancreatic Cancer,7942815,9/29/2009 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,82250, ,NCI, , ,82250
A Role for RIP1 in Gliomagenesis,7942913,9/29/2009 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,310860, ,NINDS, , ,310860
"Ovulation, inclusion cysts, and p53 mutations in a mouse model of ovarian cancer",7943114,9/29/2009 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,78500, ,NCI, , ,78500
Molecular Determinants Affecting FLT-PET in Colorectal Cancer,7944026,9/30/2009 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,498631, ,OD, , ,498631
Molecular Pathogenesis of Basal-like Breast Cancer,7944046,4/18/2003 0:00,8/31/2011 0:00,Non-SBIR/STTR,2010,918901, ,NCI, , ,918901
Hepatitis C and Tumor Suppressors in Hepatocellular,7944563,9/28/2009 0:00,8/31/2012 0:00,Research Centers,2009, ,298854, , , , 
Growth Control and Genomic Stability,7944583,4/14/2009 0:00,11/30/2013 0:00,Research Centers,2009, ,25729, , , , 
"""Protein protein interaction directed libraries""",7944809,9/1/2010 0:00,6/30/2013 0:00,Research Centers,2010,326650, ,OD, , ,326650
p53-independent PUMA induction in anti-cancer therapies,7945306,1/1/2010 0:00,1/31/2011 0:00,"Training, Individual",2011,3692, ,NCI, , ,3692
Heat Shock Protein-Induced Protection Against Cisplatin-Induced Hair Cell Death,7945372,9/28/2009 0:00,9/27/2015 0:00,"Training, Individual",2010,34679, ,NIDCD, , ,34679
FRET-based Biosensors to Monitor Redox in Cell Cycle Regulation,7946135,9/1/2010 0:00,8/31/2013 0:00,Non-SBIR/STTR,2010,304682, ,NCI, , ,304682
BIOMEDICAL (BASIC),7946617,9/30/2009 0:00,3/31/2010 0:00,R and D Contracts,2009,148725, ,NCI, , ,148725
Simultaneous Targeting of p53 to the Nucleus and Mitochondria for Cancer Therapy,7946638,7/1/2010 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,312288, ,NCI, , ,312288
Organic cation transporter 2 and cisplatin nephrotoxicity,7949784,7/12/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,411104, ,NCI, , ,411104
"CLINICAL TRIAL: A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTO",7950689,12/1/2008 0:00,11/30/2009 0:00,Research Centers,2009, ,9776, , , , 
CLINICAL TRIAL: TREATMENT OF MELANOMA WITH WILD-TYPE P53 AND  A 100B USING PENTA,7951182,3/1/2009 0:00,6/30/2010 0:00,Research Centers,2009, ,9629, , , , 
GENOTYPIC AND PHENOTYPIC RESPONSE OF BREAST EPITHELIAL CELLS FROM WOMEN,7951967,4/1/2009 0:00,3/31/2010 0:00,Research Centers,2009, ,7511, , , , 
MOLECULAR EPIDEMIOLOGY OF HEAD AND NECK CANCER,7951971,4/1/2009 0:00,3/31/2010 0:00,Research Centers,2009, ,3452, , , , 
TARGETED NANOCOMPLEXED IRON OXIDE FOR EARLY DETECTION WITH HYPERTHERMIA TREATMEN,7952337,9/30/2009 0:00,3/30/2010 0:00,R and D Contracts,2009,199735, ,NCI, , ,199735
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY,7953921,2/1/2009 0:00,1/31/2010 0:00,Research Centers,2009, ,8730, , , , 
CRYSTAL STRUCTURE DETERMINATION OF MYELIN PROTEINS,7954503,3/1/2009 0:00,2/28/2010 0:00,Research Centers,2009, ,618, , , , 
OPTICAL IMAGING OF TUMOR ANGIOGENESIS AND CHEMOTHERAPY,7954803,4/1/2009 0:00,3/31/2010 0:00,Research Centers,2009, ,1828, , , , 
HYPEROXIC RESPIRATORY CHALLENGES TO MONITOR CHEMOTHERAPY EFFECTS,7954885,4/1/2009 0:00,3/31/2010 0:00,Research Centers,2009, ,3016, , , , 
THE ARF-P53 TUMOR SUPPRESSOR SIGNALING PATHWAY,7957391,6/1/2009 0:00,5/31/2010 0:00,Research Centers,2009, ,13792, , , , 
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS,7957608,6/15/2009 0:00,3/31/2010 0:00,Research Centers,2009, ,46752, , , , 
ID PROTEIN FAMILY EXPRESSION AND FUNCTION IN PROSTATE CANCER,7959170,7/1/2009 0:00,6/30/2010 0:00,Research Centers,2009, ,250050, , , , 
COBRE P2:  CYP1B1 INDUCTION IN TOBACCO-RELATED ORAL CARCINOGENESIS,7959779,6/1/2009 0:00,5/31/2010 0:00,Research Centers,2009, ,156157, , , , 
4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT,7960396,6/1/2009 0:00,5/31/2010 0:00,Research Centers,2009, ,243975, , , , 
DISSECTING ROLES OF MTBP IN OSTEOSARCOMA METASTASIS,7960535,9/17/2004 0:00,7/31/2010 0:00,Research Centers,2009, ,220991, , , , 
Properties and regulation of p53 in tumor cells,7961869,3/23/1999 0:00,2/28/2015 0:00,Non-SBIR/STTR,2010,141514, ,NCI, , ,141514
Prostate Cancer Prevention by Diallyl Trisulfide,7961922,4/1/2005 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,146110, ,NCI, , ,146110
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma,7962113,3/1/2010 0:00,2/28/2015 0:00,Research Centers,2010, ,605257, , , , 
SBIR PROPOSAL FOR PHS 2009-1 TOPIC 266 FOR A TARGETED NANOCOMPLIX FOR EARLY DETE,7962885,9/30/2009 0:00,3/30/2010 0:00,R and D Contracts,2009,199978, ,NCI, , ,199978
Embryonic Stem Cell Derived Cardiac Myocytes,7964064, , ,Intramural Research,2009,655077, ,NIA, , ,655077
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS,7964638, , ,Intramural Research,2009,590778, ,NIAID, , ,590778
Chromosomal Proteins and Chromosomal Functions,7964993, , ,Intramural Research,2009,986978, ,NCI, , ,986978
Mammary Tumorigenesis in Inbred and Feral Mice,7965001, , ,Intramural Research,2009,1095394, ,NCI, , ,1095394
Regulation of HTLV-I Transcription,7965005, , ,Intramural Research,2009,532000, ,NCI, , ,532000
Gene Regulation and Function: The B-ZIP Proteins,7965017, , ,Intramural Research,2009,1168458, ,NCI, , ,1168458
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,7965031, , ,Intramural Research,2009,1192142, ,NCI, , ,1192142
Molecular Epidemiology of Human Lung Cancer,7965039, , ,Intramural Research,2009,786156, ,NCI, , ,786156
Inhibition of p53 Tumor Suppressor Function by HTLV-I,7965069, , ,Intramural Research,2009,709332, ,NCI, , ,709332
Transgenic Models for Prostate and Breast Cancer,7965074, , ,Intramural Research,2009,1214015, ,NCI, , ,1214015
p53 Tumor Suppressor Pathway,7965083, , ,Intramural Research,2009,786156, ,NCI, , ,786156
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",7965087, , ,Intramural Research,2009,1103955, ,NCI, , ,1103955
Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis,7965093, , ,Intramural Research,2009,537572, ,NCI, , ,537572
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,7965124, , ,Intramural Research,2009,1199947, ,NCI, , ,1199947
Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,7965161, , ,Intramural Research,2009,548685, ,NCI, , ,548685
Regulation of Lymphocyte Proliferation and Replicative Capacity,7965172, , ,Intramural Research,2009,923719, ,NCI, , ,923719
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,7965179, , ,Intramural Research,2009,448310, ,NCI, , ,448310
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,7965187, , ,Intramural Research,2009,385579, ,NCI, , ,385579
Molecular Mechanisms of Growth Factor Modulated Proliferation,7965213, , ,Intramural Research,2009,247942, ,NCI, , ,247942
DNA Repair,7965225, , ,Intramural Research,2009,1063847, ,NCI, , ,1063847
Enzymes and Substrates of the Ubiquitin Conjugating System,7965226, , ,Intramural Research,2009,690006, ,NCI, , ,690006
Role of CEBP transcription factors in regulating cell growth and tumorigenesis,7965252, , ,Intramural Research,2009,1212905, ,NCI, , ,1212905
Role of Neurotrophins in the Development of the Mammalian Nervous System,7965297, , ,Intramural Research,2009,581426, ,NCI, , ,581426
Role of Trk Receptors in the Development and Function of Non-neuronal Structures,7965298, , ,Intramural Research,2009,581426, ,NCI, , ,581426
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,7965405, , ,Intramural Research,2009,802295, ,NCI, , ,802295
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,7965407, , ,Intramural Research,2009,401147, ,NCI, , ,401147
Development of Mouse Astrocytoma Model for Preclinical Testing,7965409, , ,Intramural Research,2009,133716, ,NCI, , ,133716
Zebrafish Models of Cancer,7965417, , ,Intramural Research,2009,1223960, ,NCI, , ,1223960
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,7965477, , ,Intramural Research,2009,665816, ,NCI, , ,665816
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,7965561, , ,Intramural Research,2009,119623, ,NCI, , ,119623
Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers,7965572, , ,Intramural Research,2009,755654, ,NCI, , ,755654
Metabolic Mechanisms for Programmed Cell Death,7965590, , ,Intramural Research,2009,573011, ,NCI, , ,573011
Extracellular Matrix and Stress Substrates: the Role of Prolidase,7965594, , ,Intramural Research,2009,286505, ,NCI, , ,286505
Clinical trial development in cancer vaccines,7965612, , ,Intramural Research,2009,367265, ,NCI, , ,367265
Molecular Alterations of Primary Breast Cancer and Metastasis,7965620, , ,Intramural Research,2009,260049, ,NCI, , ,260049
Differentiation of tissue- and devlopment of tumor stem cells,7965686, , ,Intramural Research,2009,342691, ,NCI, , ,342691
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,7965695, , ,Intramural Research,2009,744376, ,NCI, , ,744376
DNA Folding in Chromatin and Interaction with Transcription Factors,7965752, , ,Intramural Research,2009,317472, ,NCI, , ,317472
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,7965773, , ,Intramural Research,2009,184607, ,NCI, , ,184607
Inhibitor of Normal Growth (ING),7965778, , ,Intramural Research,2009,733746, ,NCI, , ,733746
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,7965790, , ,Intramural Research,2009,644453, ,NCI, , ,644453
Tumor models for the study of inflammation and oncogenesis,7965808, , ,Intramural Research,2009,301959, ,NCI, , ,301959
Redox Mechanism Process of Angiogenesis and Wound Healing,7965811, , ,Intramural Research,2009,396676, ,NCI, , ,396676
Vaccine and radiation for the therapy of human cancers,7965895, , ,Intramural Research,2009,384564, ,NCI, , ,384564
Collaborative Pathways that Lead to Leukemia,7965901, , ,Intramural Research,2009,379578, ,NCI, , ,379578
Gene therapy of cancer,7965907, , ,Intramural Research,2009,1715772, ,NCI, , ,1715772
Immunobiology of Pediatric Tumors,7966027, , ,Intramural Research,2009,348659, ,NCI, , ,348659
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,7966057, , ,Intramural Research,2009,732632, ,NCI, , ,732632
Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,7966079, , ,Intramural Research,2009,689820, ,NCI, , ,689820
Molecular Mechanisms of Lymphomagenesis,7966110, , ,Intramural Research,2009,201659, ,NCI, , ,201659
Inflammation and Prostate Carcinogenesis,7966155, , ,Intramural Research,2009,249121, ,NCI, , ,249121
Genomic Classification of Human Liver Cancer,7966159, , ,Intramural Research,2009,813986, ,NCI, , ,813986
Validation of Therapeutic Target Genes in Human Liver Cancer,7966161, , ,Intramural Research,2009,542657, ,NCI, , ,542657
Diazeniumdiolates as Broad-Spectrum Anticancer Agents,7966182, , ,Intramural Research,2009,585804, ,NCI, , ,585804
Preclinical Mouse Model of Thyroid Carcinogenesis,7966189, , ,Intramural Research,2009,722498, ,NCI, , ,722498
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,7966198, , ,Intramural Research,2009,419401, ,NCI, , ,419401
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,7966629, , ,Intramural Research,2009,68, ,NCI, , ,68
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,7966641, , ,Intramural Research,2009,5624794, ,NCI, , ,5624794
Studies of Rare Cancers,7966658, , ,Intramural Research,2009,1537322, ,NCI, , ,1537322
NF-kappaB in pathogenesis and therapy of head and neck cancer,7966957, , ,Intramural Research,2009,599577, ,NIDCD, , ,599577
Signal and Transcription Factor Network interactions in Head and Neck Cancer,7967001, , ,Intramural Research,2009,599577, ,NIDCD, , ,599577
Genomics and Proteomics of Head and Neck Cancer,7967002, , ,Intramural Research,2009,595986, ,NIDCD, , ,595986
Oral Carcinogenesis,7967056, , ,Intramural Research,2009,1622112, ,NIDCR, , ,1622112
Small Molecule Activators of p53,7967311, , ,Intramural Research,2009,358535, ,NIDDK, , ,358535
"BRCA1, DNA damage response and aging",7967610, , ,Intramural Research,2009,436301, ,NIDDK, , ,436301
"Characterization of epidermal stem cells: biology, carcinogenesis, and function",7967954, , ,Intramural Research,2009,400989, ,NIEHS, , ,400989
Genetic Susceptibility to Loss of Tumor Suppressor Gene Function,7967960, , ,Intramural Research,2009,89699, ,NIEHS, , ,89699
"Role Of Lipids In Colon, Breast, And Other Cancers",7968060, , ,Intramural Research,2009,467820, ,NIEHS, , ,467820
Human Genes Affecting Chromosome Metabolism and Stress Response,7968088, , ,Intramural Research,2009,952141, ,NIEHS, , ,952141
"Nuclear receptors: action, functions, and roles in disease",7968178, , ,Intramural Research,2009,1302356, ,NIEHS, , ,1302356
POSITIONAL CLONING OF THE MEN1 GENE,7968837, , ,Intramural Research,2009,544018, ,NHGRI, , ,544018
The role of energy in stress signaling,7969027, , ,Intramural Research,2009,1912161, ,NHLBI, , ,1912161
Blood Studies of Endothelial Function and Systemic Inflammation,7969174, , ,Intramural Research,2009,119785, ,NHLBI, , ,119785
Evolutionary Analysis and Comparative Genomics of Protein Superfamilies,7969254, , ,Intramural Research,2009,221141, ,NLM, , ,221141
The Molecular Genetics of Gynecologic Cancers,7969719, , ,Intramural Research,2009,280075, ,NCI, , ,280075
Nitroxides as Protectors Against Oxidative Stress,7969755, , ,Intramural Research,2009,546120, ,NCI, , ,546120
Molecular Pathogenesis of Multiple Myeloma,7969758, , ,Intramural Research,2009,823605, ,NCI, , ,823605
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,7969760, , ,Intramural Research,2009,480075, ,NCI, , ,480075
Lymphoma Studies,7969768, , ,Intramural Research,2009,358868, ,NCI, , ,358868
Nitric Oxide as a Modifier of Oxidative Stress,7969782, , ,Intramural Research,2009,396676, ,NCI, , ,396676
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,7969811, , ,Intramural Research,2009,650522, ,NCI, , ,650522
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,7969832, , ,Intramural Research,2009,1163601, ,NCI, , ,1163601
Molecular Targets Development Program,7969934, , ,Intramural Research,2009,5405638, ,NCI, , ,5405638
CCR Confocal Microscopy Core,7969952, , ,Intramural Research,2009,773393, ,NCI, , ,773393
Cell and Cancer Biology Branch Confocal Microscopy Core,7969977, , ,Intramural Research,2009,457582, ,NCI, , ,457582
Modeling Molecular of Interactions Regulating the Activity of the p53 Protein,7970026, , ,Intramural Research,2009,128556, ,NCI, , ,128556
Immunohistochemistry Core Laboratory,7970034, , ,Intramural Research,2009,1310784, ,NCI, , ,1310784
Advanced Mass Spectrometry Facility,7970069, , ,Intramural Research,2009,938947, ,NIDDK, , ,938947
Bioinformatic Tools in Cancer Research,7970387, , ,Intramural Research,2009,969012, ,NCI, , ,969012
Methylation in Cancer Progression of Barrett's Esophagus,7975858,7/20/2006 0:00,6/30/2011 0:00,Other Research-Related,2009,107975, ,NIDDK, , ,107975
P3 - TARGETING THE HDM-2 E3 LIGASE IN MULTIPLE MYELOMA,7975984,7/1/2010 0:00,6/30/2015 0:00,Research Centers,2010, ,178869, , , , 
Novel Molecular Mechanism of Glioma Pathogenesis,7976424,7/1/2010 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,206190, ,NCI, , ,206190
"Function of a novel, sirtuin-regulated acetylation site on p53.",7978929,7/1/2010 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,168236, ,NCI, , ,168236
Mechanism of BCL6-dependent stem cell maintenance in B cell lineage leukemia,7979235,7/1/2010 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,208800, ,NCI, , ,208800
Mechanisms of MnSOD expression in normal and tumor cells,7980368,12/1/1989 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,246550, ,NCI, , ,246550
Intervention Trials in Persons at Increased Genetic Risk of Cancer,7981277, , ,Intramural Research,2009,1639865, ,NCI, , ,1639865
PUMA-mediated apoptosis in human cancer cells,7982243,4/1/2004 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,270385, ,NCI, , ,270385
ROLE OF CRYPTOCHROME IN DNA DAMAGE RESPONSES AND THE CIRCADIAN CLOCK,7982471,8/1/1982 0:00,6/30/2014 0:00,Non-SBIR/STTR,2010,547293, ,NIGMS, , ,547293
NYU Lung Cancer Biomarker Center,7982801,5/8/2000 0:00,6/30/2015 0:00,Non-SBIR/STTR,2010,800160, ,NCI, , ,800160
Image-Guided Nanoembolization for the Treatment of Pancreatic Cancer,7983874,9/1/2010 0:00,7/31/2015 0:00,Research Centers,2010, ,111295, , , , 
Multi-Modal Gene Therapy for Pancreatic Cancer using Targeted Nanovectors,7984276,9/1/2010 0:00,7/31/2015 0:00,Research Centers,2010, ,199009, , , , 
Effects of Stochastic Gene Alterations on Intestinal Tumorigenesis in the Mouse,7984638,12/1/1983 0:00,7/31/2014 0:00,Non-SBIR/STTR,2010,424243, ,NIGMS, , ,424243
Cyclin E Regulation in Normal and Neoplastic Hematopoiesis,7984791,8/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2010,377533, ,NHLBI, , ,377533
Aspects of MUC13 Mucin in Cancer,7984891,7/1/2010 0:00,4/30/2014 0:00,Non-SBIR/STTR,2010,329906, ,NCI, , ,329906
p53 Family in Gastric Cancer Development,7984959,8/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,165070, ,NCI, , ,165070
Functional Genomic Dissection of Refractory Anemia,7984984,9/15/2005 0:00,6/30/2014 0:00,Non-SBIR/STTR,2010,413800, ,NHLBI, , ,413800
Role of Slug in Regulation of Hematopietic Stem Cells,7985277,12/10/2009 0:00,5/9/2011 0:00,Other Research-Related,2010,54000, ,NIDDK, , ,54000
Identification and characterization of the functional role of miRNA in prostate c,7986361,7/9/2010 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,285728, ,NCI, , ,285728
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",7986363,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,244650, ,NCI, , ,244650
Local Immunoregulation of Carcinogenesis,7986477,7/13/2003 0:00,5/31/2015 0:00,Non-SBIR/STTR,2010,365894, ,NCI, , ,365894
The Role of Cul4A in Genome Stability and Cancer Development,7986716,7/9/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2010,313751, ,NCI, , ,313751
The Study of the Circadian Rhythm in p53 Signaling,7986752,9/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2010,295404, ,NCI, , ,295404
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer,7986836,7/15/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2010,321868, ,NCI, , ,321868
The role of the Ras effector Nore1a in tumor suppression,7986980,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,278258, ,NCI, , ,278258
The Role of ATF3 in the DNA Damage Response,7987379,9/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2010,262280, ,NCI, , ,262280
Terminal Differentiation of the Renal Epithelium,7987596,12/1/2009 0:00,11/30/2010 0:00,Non-SBIR/STTR,2010,73618, ,NIDDK, , ,73618
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance,7988603,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,325775, ,NCI, , ,325775
The effects of Age on Cancer Signaling Pathways in Mice,7989355,7/1/2010 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,188805, ,NIA, , ,188805
Defining the role of the tumor-initiating cell niche in breast cancer,7989362,9/1/2010 0:00,8/31/2012 0:00,Other Research-Related,2010,139334, ,NCI, , ,139334
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis,7989407,1/1/2009 0:00,11/30/2013 0:00,Non-SBIR/STTR,2011,303465, ,NCI, , ,303465
Transcriptional Control of Stroma Dependent Apoptosis in MDS,7989434,9/2/2010 0:00,5/31/2015 0:00,Other Research-Related,2010,129870, ,NIDDK, , ,129870
Defining a New Role for Alpha-MSH: Antioxidant in UVB-Irradiated Melanocytes,7990289,7/7/2010 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,235500, ,NIEHS, , ,235500
Sunlight and Melanomagenesis,7991048,7/15/2010 0:00,6/30/2012 0:00,Non-SBIR/STTR,2010,185000, ,NIEHS, , ,185000
"p53, Rb and Ras Pathways in Neural Stem Cell Homeostasis and Transformation",7991308,6/15/2007 0:00,12/14/2010 0:00,"Training, Individual",2009,39583, ,NINDS, , ,39583
Prostate cancer chemoprevention by penta-galloyl-glucose,7991350,1/1/2009 0:00,1/14/2011 0:00,Non-SBIR/STTR,2011,306945, ,NCI, , ,306945
Mechanisms of Cytotoxicity and Radiosensitization for Antimetabolites,7991748,7/8/1999 0:00,6/30/2015 0:00,Non-SBIR/STTR,2010,278551, ,NCI, , ,278551
Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors,7991856,12/7/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2011,291849, ,NCI, , ,291849
Role of an unusual GTPase in DNA damage response and carcinogenesis,7991871,12/1/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2011,341652, ,NCI, , ,341652
Risk for in vivo mutagenesis of the P53 gene by nucleoside analog antiviral drug,7991946,9/28/2010 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,75834, ,NCI, , ,75834
p53-GAMT pathway in cancer cell metabolism and DNA damage-induced carcinogenesis,7991978,5/13/2010 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010,353279, ,NCI, , ,353279
The Role of MDM Proteins in Cell Growth and Tumorigenesis,7992038,3/1/1999 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,325327, ,NCI, , ,325327
Molecular interactions and restoration strategies of PTEN and p53 in gliomas,7992586,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,319550, ,NCI, , ,319550
Lapatinib and Obatoclax combination therapy,7992730,7/7/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2010,155106, ,NCI, , ,155106
Chemical Inhibitors of CREB-mediated Gene Transcription,7993339,9/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2010,326240, ,NIGMS, , ,326240
Development of a HTS-assay for inhibitors of  a type 2C protein phosphatase  (PPM,7993354,6/1/2010 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,148333, ,OD, , ,148333
Gonadotropins & Cox-2 in Ovarian Cancer Prevention,7993465,5/1/2003 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010,400502, ,NCI, , ,400502
MDM2 regulates XIAP gene expression in cancer treatment,7993541,12/15/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2011,249581, ,NCI, , ,249581
p63 and p73 Signaling in Cell Growth and Cancer,7994245,3/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2011,301824, ,NCI, , ,301824
Anticarcinogenic Effect of ITCs Against Prostate Cancer,7994868,7/14/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2011,319332, ,NCI, , ,319332
Role of PP2A in Lung Cancer,7995206,1/1/2008 0:00,12/31/2011 0:00,Non-SBIR/STTR,2011,310970, ,NCI, , ,310970
FHIT Gene Therapy in Cancer Prevention and Treatment,7995225,12/1/2006 0:00,11/30/2012 0:00,Non-SBIR/STTR,2011,221160, ,NCI, , ,221160
Humanized Mouse Models for the p53 R72P SNP,7996051,12/1/2008 0:00,11/30/2013 0:00,Non-SBIR/STTR,2011,289698, ,NIEHS, , ,289698
Focal Adhesion Kinase - Tumor Biology and Therapeutics,7996483,9/30/1996 0:00,7/31/2015 0:00,Non-SBIR/STTR,2010,299657, ,NCI, , ,299657
Regulations of DNA Alkylation/Deamination Damage Repair,7996576,3/1/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2011,258838, ,NCI, , ,258838
Normal and Neoplastic Regulation of Cyclin E,7997178,7/1/2003 0:00,12/31/2013 0:00,Non-SBIR/STTR,2011,370973, ,NCI, , ,370973
Role of Sphingosine Kinase 1 in the p53-dependent DNA Damage Response,7997195,12/1/2009 0:00,11/30/2012 0:00,"Training, Individual",2011,39445, ,NIEHS, , ,39445
Klf4 in tumor initiation and maintenance of squamous cell carcinoma,7998180,3/1/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2011,270000, ,NCI, , ,270000
Transcriptional dynamics and cellular function of p53 pulses,7999076,7/2/2010 0:00,7/1/2013 0:00,"Training, Individual",2010,47606, ,NIGMS, , ,47606
Mechanisms of BMP Receptor Kinase Dysregulation in Skeletal Dysplasias,7999252,12/15/2008 0:00,11/30/2012 0:00,Non-SBIR/STTR,2011,69617, ,NIAMS, , ,69617
Targeting Microenvironment / Leukemia Cell Interactions in CML,8000073,7/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2010, ,196061, , , , 
Structural basis for functional modulation of CBP/p300 by the HPV oncoprotein E7,8002568,9/1/2010 0:00,9/29/2013 0:00,"Training, Individual",2010,45590, ,NIGMS, , ,45590
Therapeutic use of let-7 and miR-34 microRNAs for the prevention and treatment of,8003034,9/1/2010 0:00,8/31/2013 0:00,"Training, Individual",2010,47606, ,NCI, , ,47606
Ras-Induced Autophagic Growth-Arrest in Immortalized Human Epithelial Cells,8003682,6/28/2010 0:00,6/27/2011 0:00,"Training, Individual",2010,26608, ,NCI, , ,26608
Function and regulation of MDMX,8004084,7/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2011,264493, ,NCI, , ,264493
Chemical Modulators for p53 Functions in Transcriptional Regulation,8004108,12/11/2009 0:00,11/30/2012 0:00,Non-SBIR/STTR,2011,307045, ,NCI, , ,307045
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer,8005558,3/7/2007 0:00,12/31/2011 0:00,Non-SBIR/STTR,2011,302252, ,NCI, , ,302252
Mechanisms of Mdm2/Mdmx in repressing p53,8006388,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2011,321226, ,NCI, , ,321226
Investigating the role of p73 and its isoforms in tumorigenesis and metastasis,8006441,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2011,309964, ,NCI, , ,309964
Regulation of tumorigenic spliced isoforms in cancer,8007270,8/1/2010 0:00,3/31/2011 0:00,"Training, Individual",2010,26890, ,NCI, , ,26890
CDK6 in T cell development and cancer,8007389,1/15/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2011,324053, ,NCI, , ,324053
The effect of p53 signaling on the metabolism and therapeutic response of glioma,8008525,6/29/2010 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,161886, ,NCI, , ,161886
Enhancing glioma chemotherapy by suppressing Notch signaling,8008619,3/1/1988 0:00,5/31/2015 0:00,Non-SBIR/STTR,2010,359844, ,NINDS, , ,359844
A Functional Census of p53 Cancer and Suppressor Mutants,8009396,8/1/2005 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,419372, ,NCI, , ,419372
The Roles of HBXAP Gene in Ovarian Cancer,8009489,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,330091, ,NCI, , ,330091
TGF-beta signaling and colon cancer,8009509,1/1/2007 0:00,6/30/2012 0:00,Non-SBIR/STTR,2011,312778, ,NCI, , ,312778
Chemoprevention of tobacco carcinogen-induced bladder cancer,8009718,9/1/2010 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,77000, ,NCI, , ,77000
Adenovirus E1B55K Functions Related to Oncolytic Replication,8009780,3/1/2009 0:00,12/31/2012 0:00,Non-SBIR/STTR,2011,268099, ,NCI, , ,268099
Cell fate decision in response to p53-dependent DNA damage/genotoxic stress,8010141,7/1/2001 0:00,2/29/2012 0:00,Non-SBIR/STTR,2011,265025, ,NCI, , ,265025
Berberine downregulates MDM2 by interaction with DAXX in cancer cells,8010178,1/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,311976, ,NCI, , ,311976
Genetic Mouse Models of Glioma,8010613,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2011,390256, ,NCI, , ,390256
Mycn and Medulloblastoma,8010619,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2011,310970, ,NCI, , ,310970
"Pubertal high fat diet: effects on inflammation, mammary development and cancer",8010706,9/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2010,456000, ,NIEHS, , ,456000
The role of melanocyte precursors in zebrafish pigmentation disorders,8010834,1/1/2009 0:00,12/31/2013 0:00,Other Research-Related,2011,126900, ,NIAMS, , ,126900
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str,8010878,2/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,495460, ,NCI, , ,495460
Molecular mechanisms in the regulation of p53 functions by PAD4,8011088,2/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2011,261010, ,NCI, , ,261010
Functional Analysis of p53 Polymorphic Variants,8011308,6/1/2005 0:00,11/29/2011 0:00,Non-SBIR/STTR,2011,326484, ,NCI, , ,326484
Regulation of Cytokinesis and Tumor Formation by RhoA,8011320,1/1/2010 0:00,6/30/2011 0:00,Other Research-Related,2011,45000, ,NIGMS, , ,45000
The ARF Tumor Suppressor,8011341,1/1/2010 0:00,11/29/2011 0:00,Non-SBIR/STTR,2011,351225, ,NCI, , ,351225
Luciferase-based screening for p53 conformational activators,8011584,6/15/2010 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,38625, ,OD, , ,38625
Molecular Pathogenesis of Diamond Blackfan Anemia,8011700,1/7/2010 0:00,11/7/2011 0:00,Non-SBIR/STTR,2011,385000, ,NHLBI, , ,385000
Mechanisms of Synergistic Regulation of Stem/Progenitors,8011981,4/1/1996 0:00,12/31/2013 0:00,Non-SBIR/STTR,2011,385000, ,NHLBI, , ,385000
Enhancing Activity of Alkylating Agents in Neuroblastoma,8013315,9/1/1999 0:00,12/31/2013 0:00,Non-SBIR/STTR,2011,229187, ,NCI, , ,229187
Role of p53 in cell cycle checkpoints,8013861,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2011,341162, ,NCI, , ,341162
Host Immunity to EBV Infection in Vitro and in VIvo,8013864,9/1/1981 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,404291, ,NIAID, , ,404291
Defining critical p53 therapeutic targets and mechanisms,8013884,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2011,381215, ,NCI, , ,381215
The Role of Syndecan-1 in Mouse Mammary Neoplasia,8014914,12/21/2001 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,286318, ,NCI, , ,286318
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1,8014916,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,295769, ,NCI, , ,295769
"Telomerase in Development, Senescence and Neoplasia",8014948,1/1/2000 0:00,12/31/2011 0:00,Non-SBIR/STTR,2011,648194, ,NCI, , ,648194
Nuclear Accumulation of Cyclin D1 and Oncogenesis,8014986,7/1/2001 0:00,9/29/2012 0:00,Non-SBIR/STTR,2011,282349, ,NCI, , ,282349
Transcriptional Activator/Coactivator Interactions,8015022,4/1/2007 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,304243, ,NCI, , ,304243
Molecular Mechanisms by which Rexinoids Prevent Breast Cancer,8015149,4/6/1999 0:00,4/30/2012 0:00,Non-SBIR/STTR,2008,135880, ,NCI, , ,135880
Molecular Targeting of Diffuse Large B-cell Lymphoma,8015285,1/20/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,587846, ,NCI, , ,587846
Regulation of Basal-Like and Her2+ Breast Cancer Phenotypes by IKK/NF-kappaB,8015337,2/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,296590, ,NCI, , ,296590
Discovering TREX1 and TREX2 Function in Mammalian Cells and Mice,8015359,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2011,269078, ,NCI, , ,269078
Genetic Pathways Governing Pancreatic Ductal Adenocarcinoma,8015366, , ,Non-SBIR/STTR,2010, ,221884, , , , 
The RAS and P13K Pathways in Pancreatic Adenocarcinoma,8015367, , ,Non-SBIR/STTR,2010, ,393191, , , , 
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer,8015368, , ,Non-SBIR/STTR,2010, ,307397, , , , 
Experimental Pathology Core,8015371, , ,Non-SBIR/STTR,2010, ,179790, , , , 
Role of MetAP-2 in Angiogenesis and Wnt Signaling,8015637,7/9/1999 0:00,1/31/2014 0:00,Non-SBIR/STTR,2011,407511, ,NCI, , ,407511
Nuclear Function of Abl in DNA Damage Response,8016072,8/1/1986 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,400438, ,NCI, , ,400438
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling,8016109,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,304127, ,NCI, , ,304127
GI Hormones and Other Factors in Growth of Mucosa,8016152,12/1/1977 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010,541619, ,NIDDK, , ,541619
Targeting Signal Transduction Pathways for Cancer Drug Discovery,8016168,2/5/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2010,88675, ,NCI, , ,88675
Cooperation of oncogenic mutations in the control of malignancy,8016553,4/1/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,283822, ,NCI, , ,283822
Characterization of the p53 Apoptotic Target Gene Perp,8016599,1/1/2002 0:00,1/31/2012 0:00,Non-SBIR/STTR,2011,276291, ,NCI, , ,276291
Biochemical Analysis of a p53 Isoform that Accelerates Mammalian Aging,8016662,2/1/2010 0:00,1/31/2012 0:00,Non-SBIR/STTR,2011,59705, ,NIA, , ,59705
The Role of Bone Marrow Derived Cells in Skin Cancer,8016702,1/25/2010 0:00,6/30/2012 0:00,Non-SBIR/STTR,2011,160869, ,NCI, , ,160869
"Characterization of Mutagenesis, Mutational Spectra and Mechanisms of Toxicity",8017419, , ,Non-SBIR/STTR,2010, ,367263, , , , 
Cell Growth Signaling in Cancer Development,8017442,4/8/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,410787, ,NCI, , ,410787
Targeting ROS by a p53-activating agent for selective killing of cancer cells,8017460,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,348111, ,NCI, , ,348111
Oncogenic Function of a P53-Induced Phosphatase,8018191,4/1/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,258838, ,NCI, , ,258838
Dynamics of Signaling Pathways: Mechanism and Function,8018200,3/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,315642, ,NIGMS, , ,315642
Targeting JAB1 Oncogenic Function in Breast Cancer,8018460,4/1/2002 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,247358, ,NCI, , ,247358
Tumor Suppression,8018467, , ,Non-SBIR/STTR,2010, ,753240, , , , 
A metabolic role for PML in tumor suppression,8018511,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,350219, ,NCI, , ,350219
Rac GTPases as Targets in Lymphomagenesis,8018514,2/10/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2011,276450, ,NCI, , ,276450
The Role of White Matter Progenitors in Glioma Formation and Progression,8018552,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,345144, ,NINDS, , ,345144
High throughput screen for inhibitors of the mdm2/mdmx interaction,8018614,2/1/2010 0:00,11/30/2011 0:00,Non-SBIR/STTR,2011,47149, ,OD, , ,47149
Growth Control and Anti-Cancer Mechanisms,8018674,4/1/2007 0:00,1/31/2012 0:00,Non-SBIR/STTR,2011,286587, ,NCI, , ,286587
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer,8018848,8/4/2006 0:00,6/30/2011 0:00,Other Research-Related,2009,143370, ,NCI, , ,143370
The Role of PTEN in Endothelial Biology,8019006,2/15/2008 0:00,1/31/2012 0:00,Non-SBIR/STTR,2011,390000, ,NHLBI, , ,390000
Functional study of C53 protein as a novel regulator of checkpoint kinases,8019064,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,248259, ,NIGMS, , ,248259
RECEPTOR-TARGETED COPPER RADIOPHARMACEUTICALS FOR CANCER IMAGING AND THERAPY,8019111,7/18/1994 0:00,12/31/2011 0:00,Non-SBIR/STTR,2011,315154, ,NCI, , ,315154
Mechanisms of Cancer Initiation by TRIM32,8019258,5/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,57243, ,NCI, , ,57243
Role of ROS-Induced DNA Damage in Mitochondria-Regulated Apoptosis,8019544,2/1/2009 0:00,10/31/2013 0:00,"Training, Individual",2011,28140, ,NIEHS, , ,28140
p53-Independent Pathways in Mdm2-Mediated Transformation,8020066,4/9/2007 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,281892, ,NCI, , ,281892
Mechanisms of Cancer Initiation by TRIM32,8020896,5/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,334297, ,NCI, , ,334297
The Role of Ape1 in Neurotoxicity of Cancer Treatments,8021035,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,403464, ,NCI, , ,403464
Phase 2  Irinotecan for Treatment of p53 WT Gastric Adenocarcinoma,8021498,9/10/2010 0:00,7/1/2011 0:00,Non-SBIR/STTR,2010,184266, ,FDA, , ,184266
"Phosphosulindac, miRNAs and cancer racial disparity",8021862,2/5/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,305043, ,NCI, , ,305043
Visualizing the effect of epigenetic modifications on transcription and mutation,8022970,9/15/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2010,380700, ,OD, , ,380700
Mox 1: A Novel Mitogenic Oxidase,8024536,1/5/2000 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,261812, ,NCI, , ,261812
Role of the Mullerian Tract in Ovarian Cancer Development,8024548,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,326066, ,NCI, , ,326066
Cancer Biology in the Zebrafish,8025986,7/3/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,364298, ,NCI, , ,364298
DUSP26: A Novel Therapeutic Target in Neuroblastoma,8026739,3/1/2011 0:00,2/28/2015 0:00,Non-SBIR/STTR,2011,342344, ,NINDS, , ,342344
Defining novel pathways that arrest genetically unstable tetraploid cells,8027587,8/16/2011 0:00,7/31/2013 0:00,Other Research-Related,2011,149904, ,NCI, , ,149904
Regulation WRN deacetylation by SIRT1 after DNA damage,8027734,2/15/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,232859, ,NIA, , ,232859
Molecular Mechanisms of p53 dependent longevity regulation,8027747,8/1/2007 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,236946, ,NIA, , ,236946
Search for the Molecular Causes of Diabetic Embryopathy,8027758,8/1/1998 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,348840, ,NIDDK, , ,348840
Role of nutrient sensor O-GlcNAc transferase in regulating cancer,8028550,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2011,327520, ,NCI, , ,327520
The Role of Bcl2L12 in the Genesis of Malignant Glioma,8029579,8/17/2007 0:00,2/29/2012 0:00,Non-SBIR/STTR,2011,241530, ,NCI, , ,241530
Mechanisms and Treatment of PTEN Mutant Prostate Tumorigenesis,8033168,4/1/2010 0:00,1/31/2014 0:00,Non-SBIR/STTR,2011,240475, ,NCI, , ,240475
FoxM1 and Oncogenic Pathways in Hepatocellular Carcinoma,8033261,1/1/2009 0:00,12/31/2011 0:00,"Training, Individual",2011,46800, ,NCI, , ,46800
"The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer",8033693,2/1/2010 0:00,11/30/2014 0:00,Non-SBIR/STTR,2011,314790, ,NCI, , ,314790
Checkpoint Response and Platinum Drug Sensitivity,8033774,5/1/2007 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,255440, ,NCI, , ,255440
Targeting of MDM2 Family Proteins in Cancer,8034260, , ,Non-SBIR/STTR,2010, ,336925, , , , 
Development of Proteasome Selective Inhibitors for Cancer Therapy,8034262, , ,Non-SBIR/STTR,2010, ,317179, , , , 
Targeting Signal Transduction Pathways for Cancer Drug Discovery,8034268,2/5/2007 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,1930691, ,NCI, , ,1930691
MYC's Role in the Initiation and Maintenance of Cancer,8034323,6/1/2001 0:00,2/29/2012 0:00,Non-SBIR/STTR,2011,387426, ,NCI, , ,387426
A Nested Case-Control Study of Prostate Carcinogenesis,8034747,9/30/2000 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,556565, ,NIEHS, , ,556565
Role of a novel Notch1 target gene in skin carcinogenesis,8034794,3/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,308512, ,NCI, , ,308512
Analysis of the p53  in vivo using a unique mouse model,8034854,3/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,334263, ,NCI, , ,334263
Intracellular Mechanisms of Glucocorticoid Action,8034952,4/1/2010 0:00,3/31/2011 0:00,Non-SBIR/STTR,2010,16610, ,NIDDK, , ,16610
Regulation of Ionizing Radiation Induced DNA Damage Response,8035267,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,299095, ,NCI, , ,299095
The in vivo role of the mitochondrial p53 cell death program,8035276,9/15/1993 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,266225, ,NCI, , ,266225
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines,8035283,4/1/2009 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,289797, ,NCI, , ,289797
Transcriptional Repression by Maf1 in Yeast,8035335,3/1/2009 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,458465, ,NIGMS, , ,458465
Coordinately regulated alternative splicing in DNA damage and cancer,8035397,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,260853, ,NCI, , ,260853
The role of DNA polymerase eta in DNA damage response and p53 activation,8035416,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,277684, ,NCI, , ,277684
Mechanistic Studies on New Platinum Clinical Agents,8035451,9/30/1998 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,303155, ,NCI, , ,303155
Worker Genetic Susceptibility to Mutagenic Risk,8035781,7/1/2001 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,282600, ,NIOSH, , ,282600
"Obesity, H pylori and Risk of Barrett's Esophagus",8036057,4/1/2007 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,505005, ,NCI, , ,505005
A novel enzymatic activity of WSTF and its role in tumorigenesis,8036443,7/1/2009 0:00,6/30/2010 0:00,Other Research-Related,2009,72040, ,NCI, , ,72040
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy,8037077,3/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,303684, ,NCI, , ,303684
Development of cambinol analogues as antilymphoma agents,8037215,4/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,354244, ,NCI, , ,354244
Understanding the Structural Mechanism of Puma-induced Apoptosis,8037225,4/1/2009 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,329314, ,NIGMS, , ,329314
Regultion of p53 Deubiquitination,8037330,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2011,327228, ,NCI, , ,327228
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,8037373,8/15/1999 0:00,7/31/2016 0:00,Non-SBIR/STTR,2011,271250, ,NCI, , ,271250
Role of TRPM1 (Melastatin1) in the Biology of Human Melanocytes,8037724,3/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,310496, ,NIAMS, , ,310496
Re-replication of chromosomes and cancer,8038275,7/11/1994 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,321644, ,NCI, , ,321644
USC Research Center for Liver Disease,8038379,3/1/1997 0:00,2/28/2015 0:00,Research Centers,2011,1190967, ,NIDDK, , ,1190967
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas,8038452,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,318015, ,NCI, , ,318015
Role of Rb Family in Lung Epithelial Response to Injury,8039164,4/1/2005 0:00,3/31/2014 0:00,Non-SBIR/STTR,2011,382188, ,NHLBI, , ,382188
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention,8039663,6/1/2005 0:00,11/30/2015 0:00,Non-SBIR/STTR,2011,285581, ,NCI, , ,285581
Mouse Models to Dissect p53 Tumor Suppressor Function,8039867,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2011,342415, ,NCI, , ,342415
Altered Proteoglycan Gene Expression and Cancer,8039921,9/1/1988 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,367191, ,NCI, , ,367191
c-Met/PTEN Interactions in Gliomas,8040005,7/15/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,324778, ,NINDS, , ,324778
Functional Determinants of Metastatic Dormancy,8040019,4/1/2005 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,317129, ,NCI, , ,317129
Self-renewal of Normal and Leukemic Stem Cells,8040457,9/20/2004 0:00,11/30/2015 0:00,Non-SBIR/STTR,2011,290366, ,NCI, , ,290366
Disrupting Protein-Protein Interactions With Bis-peptides,8041596,1/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2011,292253, ,NIGMS, , ,292253
Role of Cdc25A in breast cancer,8042051,9/1/2005 0:00,6/30/2016 0:00,Non-SBIR/STTR,2011,281717, ,NCI, , ,281717
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,8042164,9/30/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2010,372500, ,NIDDK, , ,372500
Molecular mechanisms of GBM radioresistance and strategies for radiosensitization,8042256,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2011,328888, ,NCI, , ,328888
"Role of mTOR, a Component of the Akt Pathway, in Regulating Cardiac Function",8042531,7/1/2005 0:00,11/30/2014 0:00,Non-SBIR/STTR,2011,378524, ,NHLBI, , ,378524
Signal Transduction by Non-transmembrane PTPs,8043617,12/1/1988 0:00,1/31/2014 0:00,Non-SBIR/STTR,2011,334064, ,NCI, , ,334064
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer,8043620,3/2/2009 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,333825, ,NIDCR, , ,333825
The Role of PKR in a Novel IL-3 Signal Transduction Pathway,8043628,4/1/1996 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,366250, ,NHLBI, , ,366250
Regulation of NF-Kappa B,8043646,9/30/2000 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,715263, ,NIAID, , ,715263
The replication checkpoint and genomic fidelity in skin,8044034,9/1/2003 0:00,2/28/2015 0:00,Non-SBIR/STTR,2011,412130, ,NIAMS, , ,412130
The MRAD9 Radioresistance Gene,8044877,12/1/2000 0:00,3/31/2014 0:00,Non-SBIR/STTR,2011,334719, ,NIGMS, , ,334719
Role of IL-6/STAT3 Signaling in the Neoplastic Progression of Barrett's Esophagus,8045096,10/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011, , , , , , 
Mechanisms of Liver Cell Injury,8045441,9/30/1992 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,323955, ,NIDDK, , ,323955
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells,8045452,3/17/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,494417, ,NCI, , ,494417
The Role of Polyoma Small T in Regulating Cell Survival,8046359, , ,Non-SBIR/STTR,2010, ,579833, , , , 
Papillomavirus E2 Growth Suppression Mechanisms,8046361, , ,Non-SBIR/STTR,2010, ,586502, , , , 
Regulation of Myc-Mediated Tumorigenesis,8047681,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2011,388417, ,NCI, , ,388417
Probes for Cytometry,8048119,10/1/1990 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,389810, ,NCI, , ,389810
Biomarkers for Margin Analysis and Prognosis in HNSCC,8048137,9/1/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2011,394770, ,NIDCR, , ,394770
Prevention of Melanoma by Targeting Tyrosinase with Dietary Quercetin,8048368,1/4/2011 0:00,12/31/2012 0:00,Non-SBIR/STTR,2011,164756, ,NCI, , ,164756
Mechanism of P73-Dependent Tumor Suppression,8049569,5/1/1999 0:00,3/31/2016 0:00,Non-SBIR/STTR,2011,303406, ,NCI, , ,303406
Mechanisms of Neuroprotection by Histone Deacetylase Inhibition,8049647,3/1/2008 0:00,2/28/2013 0:00,Non-SBIR/STTR,2011,334425, ,NINDS, , ,334425
P38 MAPK in Ras-induced Senescence and Transformation,8049760,7/1/2005 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,319767, ,NCI, , ,319767
FOXO1 Inhibition in Genotoxic Stress Response and Prostate Cancer Survival,8050187,6/16/2009 0:00,7/31/2011 0:00,Non-SBIR/STTR,2011,92767, ,NCI, , ,92767
Biosynthesis of Adenovirus Early RNA's,8050605,4/1/1979 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,710365, ,NCI, , ,710365
p53 Acetylation and Deacetylation in Tumorigenesis,8050695,4/1/2000 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,285072, ,NCI, , ,285072
Role of DDB2 in chemotherapeutic agents-induced apoptosis and platinum resistance,8050717,9/1/2011 0:00,7/31/2015 0:00,Non-SBIR/STTR,2011,253150, ,NCI, , ,253150
Aflatoxin Biosynthesis and Iterative Type I Polyketide Synthases,8051633,2/1/1978 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,434109, ,NIEHS, , ,434109
MODELS FOR GENETIC ASSESSMENT OF TUMOR MAINTENANCE GENES IN PDAC,8052116,1/1/2011 0:00,12/31/2011 0:00,Non-SBIR/STTR,2011, ,356107, , , , 
 Gastrointestinal Cell Proliferation and Cell Cycle,8052539,7/1/2005 0:00,4/30/2013 0:00,Non-SBIR/STTR,2009,22178, ,NCI, , ,22178
Mutagenesis of p53 by reactive PAH and ROS,8052754,4/8/2008 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,307277, ,NIEHS, , ,307277
PCAF/GCN5 Acetylation on p53 Transactivation,8052820,4/1/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2011,343243, ,NCI, , ,343243
Mechanisms of Intestinal Tumorigenesis,8052908,1/1/2000 0:00,8/31/2011 0:00,Non-SBIR/STTR,2011,380854, ,NCI, , ,380854
CPEB and Cell Senescence,8053411,4/1/2007 0:00,3/31/2012 0:00,Non-SBIR/STTR,2011,310658, ,NIA, , ,310658
Acid- and salt-dependent interactions in proteins,8053767,5/1/1998 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,295911, ,NIGMS, , ,295911
HTLV I Tax1 protein chemosensitization of p53 mutant tumors,8053781,4/1/2010 0:00,3/31/2012 0:00,Non-SBIR/STTR,2011,209498, ,NCI, , ,209498
Dmp1-p53/YY1 interplays and their roles in lung cancer development,8053783,4/1/2004 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,258676, ,NCI, , ,258676
Therapeutic Targeting of Oncogenic Stress in Cancer Treatment,8053835,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,308957, ,NCI, , ,308957
Oligoclonal T Cell Expansion and Rheumatoid Arthritis,8054114,9/30/1993 0:00,5/31/2013 0:00,Non-SBIR/STTR,2009,268387, ,NIAMS, , ,268387
Biomarkers in Head and Neck Cancer Progression,8054173,4/17/2009 0:00,3/31/2014 0:00,Other Research-Related,2011,94454, ,NIDCR, , ,94454
Multi-Modal Lysosomotropic Death Therapy for Malignant Peripheral Nerve Sheath Tu,8054271,5/1/2009 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,235894, ,NCI, , ,235894
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8054526,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2011,323700, ,NCI, , ,323700
DNA Methyltrasferase Gene Expression in Colon Cancer,8054788,4/1/1991 0:00,3/31/2014 0:00,Non-SBIR/STTR,2011,559208, ,NIEHS, , ,559208
Mouse models of genomic instability and birth defects,8054813,4/1/2009 0:00,3/31/2014 0:00,Non-SBIR/STTR,2011,300791, ,NICHD, , ,300791
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12,8054917,8/1/2002 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,284596, ,NCI, , ,284596
CDC25 PHOSPHATASES IN CELL CYCLE CONTROL AND CANCER,8054956,2/1/1992 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,372438, ,NIGMS, , ,372438
High Throughput Screening,8055330, , ,Research Centers,2010, ,138522, , , , 
Role of Heat Shock Factor 1 in Doxorubincin-Induced Cardiotoxicity,8055539,4/2/2010 0:00,3/31/2012 0:00,Non-SBIR/STTR,2011,190625, ,NHLBI, , ,190625
Quantitative Measurements and Modeling of the Mitotic Checkpoint,8055637,5/1/2010 0:00,4/30/2011 0:00,Non-SBIR/STTR,2010,130403, ,NIGMS, , ,130403
Collaborating Mutations in Medulloblastoma,8056131,4/1/2003 0:00, ,Non-SBIR/STTR,2010, ,315760, , , , 
Enhancing Direct Tumor Cell Cytotoxicity By Manipulating Growth Factor Signaling,8056467,9/7/2001 0:00, ,Non-SBIR/STTR,2010, ,202364, , , , 
Translational Pathology Core Facility,8056490, , ,Research Centers,2010, ,829092, , , , 
Mechanisms of RelA Activation in Cancer,8056602,9/19/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,218253, ,NCI, , ,218253
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck Cancer,8056815,3/2/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2011,597734, ,NCI, , ,597734
Functions of Papillomavirus E6,8058622,4/8/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,282715, ,NCI, , ,282715
The role of p63 and p73 in cancer,8058629,1/14/2002 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,305188, ,NCI, , ,305188
Studies on the Post-translational processing of MUC1,8058631,9/1/1992 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,255282, ,NCI, , ,255282
The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAs,8058634,4/8/2010 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,339026, ,NIEHS, , ,339026
Targeting invasion and DNA DSB repair in glioma with a multi-pronged approach.,8059203,12/15/2010 0:00,11/30/2012 0:00,Non-SBIR/STTR,2011,162581, ,NCI, , ,162581
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,8059689,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,366633, ,NCI, , ,366633
Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette Smoke,8060592,5/1/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,277361, ,NCI, , ,277361
Basis for Lineage-Specific Control of PTEN Expression by Rpl22,8061235,3/1/2011 0:00,2/29/2012 0:00,"Training, Individual",2011,51326, ,NIAID, , ,51326
Molecular Pathogenesis of Multiple Myeloma,8061624,6/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,322040, ,NCI, , ,322040
Biological Function of the Retinoblastoma Gene Product,8061985,5/3/1994 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,332126, ,NCI, , ,332126
International Symposium on Proline Metabolism and Human Health,8062829,9/30/2010 0:00,9/29/2011 0:00,Other Research-Related,2010,20000, ,NIAMS, , ,3000
Energy Restrction and Mammary Cancer,8063038,8/1/1990 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,313329, ,NCI, , ,313329
Repair of oxidative DNA damage in mammalian cells,8063044,3/10/2003 0:00,10/1/2011 0:00,Non-SBIR/STTR,2011,234791, ,NCI, , ,234791
Targeting Glucose Metabolism in Cancer,8063108,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,178732, ,NCI, , ,178732
Imaging Core,8063124, , ,Non-SBIR/STTR,2010, ,335884, , , , 
Dysregulation of microRNAs in HPV-Positive Oropharyngeal Cancers,8063635,1/15/2010 0:00,6/30/2012 0:00,"Training, Individual",2011,42600, ,NIDCR, , ,42600
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,8063669,6/10/2009 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,308218, ,NCI, , ,232218
MicroRNA Function in the Immune System,8063925,5/15/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,393265, ,NIAID, , ,393265
Cell and tumor genetics of mitotic arrest checkpoints,8064224,2/1/2000 0:00,2/29/2012 0:00,Non-SBIR/STTR,2010,50850, ,NCI, , ,50850
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer,8064225,9/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,30000, ,NCI, , ,30000
In vivo function and mechanism of the r-protein-Mdm2-p53 pathway,8064314,8/1/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,309893, ,NCI, , ,309893
GI Hormones and Other Factors in Growth of Mucosa,8064664,12/1/1977 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,509244, ,NIDDK, , ,509244
Role of C/EBP in Cell Survival and Neoplasia,8064805,5/1/1990 0:00,5/31/2015 0:00,Non-SBIR/STTR,2011,249141, ,NCI, , ,249141
SBIR PROPOSAL FOR PHS 2009-1 TOPIC 266 FOR A TARGETED NANOCOMPLIX FOR EARLY DETE,8065610,9/30/2009 0:00,3/30/2011 0:00,R and D Contracts,2010,498331, ,NCI, , ,498331
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma:  Environmental Co,8066379,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,150411, ,NCI, , ,150411
Mechanisms of p53 activation during stress response,8066461,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,336129, ,NCI, , ,336129
Role of p300/CBP and hHR23 Proteins in p53 Regulation,8066637,4/19/2004 0:00,6/30/2011 0:00,Non-SBIR/STTR,2011,218971, ,NCI, , ,218971
Genetic Epidemiology of Familial Childhood Cancer Syndromes,8066792, ,9/30/2012 0:00,Non-SBIR/STTR,2010, ,253626, , , , 
Genomic Instability in Familial Cancer Syndromes,8066794, ,9/30/2012 0:00,Non-SBIR/STTR,2010, ,191477, , , , 
Molecular Genetic Anatomy of Li Fraumeni Syndrome (LFS),8066795, ,9/30/2012 0:00,Non-SBIR/STTR,2010, ,373403, , , , 
Mouse Models for Li Fraumeni Syndrome,8066796, ,9/30/2012 0:00,Non-SBIR/STTR,2010, ,329789, , , , 
High-Throughput Genotyping and Genetic Linkage Analysis Facility,8066799, ,9/30/2012 0:00,Non-SBIR/STTR,2010, ,340001, , , , 
Nucleic Acids Isolation and DNA Analysis Facility,8066800, ,9/30/2012 0:00,Non-SBIR/STTR,2010, ,247833, , , , 
The role of Aurora Kinase A in Upper Gastrointestinal Adenocarcinomas,8067775,6/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,313654, ,NCI, , ,313654
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer,8067808,9/8/1989 0:00,5/31/2012 0:00,Non-SBIR/STTR,2011,316164, ,NCI, , ,316164
Structural basis for CBP/p300 transcriptional regulation,8067819,6/10/2002 0:00,5/31/2012 0:00,Non-SBIR/STTR,2011,407364, ,NCI, , ,407364
Biological Effects of DNA Adducts Formed by Nitroaromatic Compounds,8067870,2/1/1998 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,314838, ,NIEHS, , ,314838
Function and regulation of SirT1 in cancer,8067889,7/11/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2011,277003, ,NCI, , ,277003
Expression of Simiam Virus 40 T Antigens in Intestine,8068015,7/1/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,312997, ,NCI, , ,312997
Mechanism of p53-Mediated Tumor Suppression,8068208,12/5/1997 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,296959, ,NCI, , ,296959
Mechanism of p63-Dependent Tumor Suppression,8068211,7/1/2003 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,288347, ,NCI, , ,288347
Growth Control and Genomic Stability,8068226, , ,Research Centers,2010, ,24819, , , , 
Active Immune Therapy ot Leukemia Associated Antigens and Gene Therapy,8068811, , ,Non-SBIR/STTR,2010, ,297769, , , , 
Signal Transduction and Kinase Inhibition in CLL,8068814, , ,Non-SBIR/STTR,2010, ,313273, , , , 
"Structure, Function and Inhibition of Human Methionine Aminopeptidases",8069166,6/1/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,365100, ,NCI, , ,365100
BubR1 in Cancer and Aging,8069182,7/1/2002 0:00,8/31/2012 0:00,Non-SBIR/STTR,2011,292335, ,NCI, , ,292335
Medulloblastoma and Metastases,8069240,5/4/2010 0:00,2/28/2015 0:00,Non-SBIR/STTR,2011,506777, ,NCI, , ,506777
Cellular Stress Response Signaling Pathways,8069823,1/1/1992 0:00,10/31/2011 0:00,Non-SBIR/STTR,2011,159925, ,NIEHS, , ,159925
Regulation of the mTOR Pathway By Nutrients,8069916,3/23/2004 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,378696, ,NCI, , ,378696
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK,8069926,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,305938, ,NCI, , ,305938
Pten-loss Dysregulated Pathways in Prostate Cancer,8070557,9/25/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,362588, ,NIMHD, , ,362588
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer,8071226,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,313959, ,NCI, , ,313959
Terminal Differentiation of the Renal Epithelium,8072173,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,279290, ,NIDDK, , ,279290
Molecular Pathways in Suppression and Development of T Lineage Lymphomas,8072550,7/1/2007 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,303174, ,NCI, , ,303174
Radiation-induced Nitric Oxide & Cellular Radiosensitivity,8072559,7/10/2002 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,266245, ,NCI, , ,266245
Dietary Chemopreventive Components/Oncogene Interaction and Cancer,8072637,8/1/2007 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,273686, ,NCI, , ,273686
p53-GAMT pathway in cancer cell metabolism and DNA damage-induced carcinogenesis,8072670,5/13/2010 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,342273, ,NCI, , ,342273
Activating liver carcinogens in yeast by expressing CYP450 polymorphisms,8072914,8/1/2007 0:00,8/31/2010 0:00,Non-SBIR/STTR,2010,18392, ,NIEHS, , ,18392
Mechanisms of Liver Cell Injury,8072922,9/30/1992 0:00,3/31/2015 0:00,Non-SBIR/STTR,2010,12395, ,NIDDK, , ,12395
Mechanisms of p53 target gene activation in DNA damage responses,8073432,8/1/2007 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,799836, ,NCI, , ,799836
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D,8073549,5/1/1995 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,424249, ,NCI, , ,424249
Cellular Responses to p53 Activation by Nutlin-3a,8073582,7/13/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,301913, ,NCI, , ,301913
Hypoxia and Gene Repression,8073662,7/1/2000 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,324174, ,NCI, , ,324174
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development,8074090,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,330091, ,NCI, , ,330091
Epithelial Stem Cell Programs,8074103,8/1/2008 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,373786, ,NIGMS, , ,373786
Cancer cell adaptation to metabolic stress,8074193,9/10/2004 0:00,8/31/2014 0:00,Non-SBIR/STTR,2010,40000, ,NCI, , ,40000
Rapamycin-Induced Selective Apoptosis in Malignant Cells,8074408,12/1/1998 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,256452, ,NCI, , ,256452
The Control of Centriole Duplication and Degeneration,8074471,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,355492, ,NIGMS, , ,355492
FDH: A Novel Determinant of Tumor Suppression,8075580,3/1/2005 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,248371, ,NCI, , ,248371
Regulation and Function of C/EBP in UVB Responses,8076147,1/3/2005 0:00,12/31/2011 0:00,Non-SBIR/STTR,2010,12549, ,NIEHS, , ,12549
Role of EGFR in DNA Repair and Radiation Response in Non Small Cell Lung Cancer,8076180,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,252801, ,NCI, , ,252801
Determinants of Metastatic Progression,8076276,7/23/2002 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,261695, ,NCI, , ,261695
Role of PUMA in EGFR targeted therapy in HNSCC,8076394,8/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,304932, ,NCI, , ,304932
Mutagenesis of p53 by reactive PAH and ROS,8076428,6/1/2010 0:00,8/6/2011 0:00,Non-SBIR/STTR,2010,7196, ,NIEHS, , ,7196
Regulation of p53 tumor suppressor protein,8076713,2/1/1993 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,526765, ,NCI, , ,526765
Next generation strategies to intercept ErbB signaling,8076728,4/25/1997 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,230202, ,NCI, , ,230202
Cell Cycle Check Points,8077268, , ,Non-SBIR/STTR,2010, ,353762, , , , 
Murine & Human In Vivo Models of Melanoma Formation,8077269, , ,Non-SBIR/STTR,2010, ,436825, , , , 
Lipid-Peroxidation Induced Cyclic Adducts in Hepatocarcinogenesis,8077431,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,420347, ,NCI, , ,420347
THE ROLE OF P21 IN THE REPLICATION OF DAMAGED DNA,8077755,6/1/2011 0:00,6/1/2014 0:00,Non-SBIR/STTR,2011,52272, ,FIC, , ,52272
Role of PALB2 in the DNA damage response and breast cancer suppression,8078115,7/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,313989, ,NCI, , ,313989
Study on the intracellular Network of TBX3,8078443,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,57659, ,NCI, , ,57659
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman),8078950, , ,Non-SBIR/STTR,2010, ,412617, , , , 
UV regulation of anti-apoptotic co-repressor CtBP,8079122,8/1/2007 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,281979, ,NCI, , ,281979
Plk1 in Chemo-resistance of Cancer,8079388,9/1/2011 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,251347, ,NCI, , ,251347
Androgen and Soluble Guanylyl Cyclase Signaling in Prostate Cancer,8079600,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,182282, ,NCI, , ,182282
Regulation and Function of the p14ARF/topoisomerase I Complex in Cancer,8079688,7/10/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,362295, ,NCI, , ,362295
Mouse models of genomic instability and birth defects,8080051,7/20/2010 0:00,6/30/2011 0:00,Non-SBIR/STTR,2010,157528, ,NICHD, , ,157528
Aspects of MUC13 Mucin in Cancer,8080408,7/1/2010 0:00,4/30/2014 0:00,Non-SBIR/STTR,2011,306622, ,NCI, , ,306622
Regulation of Lung Cancer Metastasis by miR-200,8080659,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2011,339229, ,NCI, , ,339229
Discovery of New Genes for Inherited Predisposition to Breast Cancer by Exome Seq,8080780,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2011,578253, ,NCI, , ,578253
Oligoclonal T Cell Expansion and Rheumatoid Arthritis,8080918,9/30/1993 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,334541, ,NIAMS, , ,334541
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance,8081306,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2011,346239, ,NCI, , ,346239
Genetic analysis of genomic instability and cancer in zebrafish,8081724,7/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,301102, ,NCI, , ,301102
MicroRNAs and chromosome 22q in the colon,8081852,3/1/2000 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,328027, ,NIDDK, , ,328027
PUMA-mediated apoptosis in human cancer cells,8081872,4/1/2004 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,262197, ,NCI, , ,262197
Targeting the ATR pathway in p53-deficient cancers,8082529,7/13/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2011,340300, ,NCI, , ,340300
Selective Forces Operative in FeLV Infection,8082723,2/28/2000 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,231959, ,NCI, , ,231959
Gonadotropins & Cox-2 in Ovarian Cancer Prevention,8082725,5/1/2003 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,375772, ,NCI, , ,375772
Regulation of p53 function by Daxx,8082742,5/3/2001 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,245434, ,NCI, , ,245434
Preclinical Evaluation and Clinical Development of Potent Small-Molecule,8082761, , ,Research Centers,2010, ,279934, , , , 
SPORE in Prostate Cancer,8082767,8/1/1997 0:00,5/31/2013 0:00,Research Centers,2011,2185000, ,NCI, , ,2185000
p53 and pathways of apoptosis,8082770,8/7/2007 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,290273, ,NCI, , ,290273
Targeting the MAP and PI3 Kinase Pathways in Melanoma,8082796, , ,Non-SBIR/STTR,2010, ,516128, , , , 
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity,8082799, , ,Non-SBIR/STTR,2010, ,611248, , , , 
Targeted Therapies in Melanoma,8082803,5/16/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,2355621, ,NCI, , ,2355621
Role of Focal Adhesion Kinase In Tumorigenesis,8082807,7/1/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,293090, ,NCI, , ,293090
Non-Myeloablative Host Conditioning that Protects Against GVHD,8085855, , ,Non-SBIR/STTR,2010, ,325205, , , , 
Structural and Functional Characterization of BRCA1/BARD1,8088075,12/21/1998 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,370628, ,NIGMS, , ,370628
The Study of the Circadian Rhythm in p53 Signaling,8088132,9/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2011,289164, ,NCI, , ,289164
Luciferase-based screening for p53 conformational activators,8089367,6/15/2010 0:00,5/31/2012 0:00,Non-SBIR/STTR,2011,37466, ,OD, , ,37466
Molecular interactions and restoration strategies of PTEN and p53 in gliomas,8089451,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,309964, ,NCI, , ,309964
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer,8089907,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2011,345583, ,NCI, , ,345583
Center for digestive and liver diseases,8090426,7/1/1998 0:00,6/30/2012 0:00,Research Centers,2011,1162114, ,NIDDK, , ,1162114
Ultra Fast and Sensitive Fluorescence-Based Clinical Assays,8090469,7/1/2008 0:00,6/30/2013 0:00,Other Research-Related,2011,163592, ,NIBIB, , ,163592
Common Pathogenetic Mechanisms of Lung Cancer and COPD,8090990,7/1/2011 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,718596, ,NHLBI, , ,718596
Functions of mir-34 microRNAs in the p53 tumor suppressor pathway,8091424,8/1/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2011,308957, ,NCI, , ,308957
Prostate Cancer Prevention by Diallyl Trisulfide,8092747,4/1/2005 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,318883, ,NCI, , ,318883
"P2 - CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER",8092831,5/1/2010 0:00,4/30/2011 0:00,Research Centers,2010, ,318563, , , , 
Force field development for zinc metalloproteins,8093181,9/1/2011 0:00,8/31/2013 0:00,Non-SBIR/STTR,2011,208926, ,NIGMS, , ,208926
Novel Molecular Mechanism of Glioma Pathogenesis,8094270,7/1/2010 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,166671, ,NCI, , ,166671
"Telomere dysfunction, p53 and tumorigenesis",8097439,7/1/2007 0:00,6/30/2013 0:00,Other Research-Related,2011,119695, ,NCI, , ,119695
Mechanisms of Chemoprevention by Isothiocyanates,8097518,9/1/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,326276, ,NCI, , ,326276
Molecular Mechanisms of Hormone-independence of Prostate Cancer,8097687,7/15/2005 0:00,12/31/2010 0:00,Non-SBIR/STTR,2010,25005, ,NCI, , ,25005
Overlapping Airway Basal Cell Transcriptome Reprogramming in COPD and Lung Cancer,8097786,6/15/2011 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,1028637, ,NHLBI, , ,1028637
Epigenetic Changes Link COPD and Lung Cancer,8097889,8/4/2011 0:00,5/30/2015 0:00,Non-SBIR/STTR,2011,849498, ,NCI, , ,849498
Molecular Studies on MUC4 Mucin Gene,8098144,9/1/2008 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,217319, ,NCI, , ,217319
Resolution of Epithelial Cell Hyperplasia,8098240,9/15/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2011,542916, ,NIEHS, , ,542916
HCS Assay to Identify Disruptors of AR-TIF2 Protein-Protein Interactions,8098598,4/1/2011 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,151500, ,OD, , ,151500
Function of MEF in Hematopoietic Cells,8098941,1/1/1997 0:00,5/2/2012 0:00,Non-SBIR/STTR,2011,286363, ,NIDDK, , ,286363
LC-MS Analysis of DNA Adducts of Aromatic Amines: Relationship to Bladder Cancer,8099008,5/18/1996 0:00,7/31/2014 0:00,Non-SBIR/STTR,2011,228036, ,NCI, , ,228036
The San Francisco Bay Area Adult Glioma Survival Study,8099448, , ,Research Centers,2010, ,320006, , , , 
Mechanistic Studies of Mediator and the p53 Tumor Suppressor,8099570,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,220332, ,NCI, , ,220332
Project 4: NOX1 Involvement In Colon Cancer,8099689,7/1/2010 0:00,6/30/2013 0:00,Non-SBIR/STTR,2010, ,138289, , , , 
Feedback regulation of p53 through the REDD1 pathway,8099704,5/1/2010 0:00,4/30/2013 0:00,"Training, Individual",2011,53042, ,NCI, , ,53042
The Function and Regulation of  Trefoil Factor Family 2 (TFF2),8100189,4/1/2001 0:00,6/30/2014 0:00,Non-SBIR/STTR,2011,335316, ,NIDDK, , ,335316
Redox Regulation of Tumor Suppression by MnSOD,8100227,9/1/1998 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,361194, ,NCI, , ,361194
"Inhibitory effects of caffeine, exercise and lipectomy on UVB-induced skin cancer",8100325,9/18/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,240319, ,NCI, , ,240319
The effect of p53 signaling on the metabolism and therapeutic response of glioma,8100327,6/29/2010 0:00,5/31/2012 0:00,Non-SBIR/STTR,2011,130375, ,NCI, , ,130375
Mechanism of BCL6-dependent stem cell maintenance in B cell lineage leukemia,8100384,7/1/2010 0:00,6/30/2012 0:00,Non-SBIR/STTR,2011,168781, ,NCI, , ,168781
Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M,8100470,8/15/2003 0:00, ,Non-SBIR/STTR,2010, ,726557, , , , 
Mechanisms of esophageal carcinogenesis,8100477,8/15/2003 0:00,6/30/2014 0:00,Non-SBIR/STTR,2011,1609038, ,NCI, , ,1609038
Novel Methods for Molecular Analysis of Colorectal Cancer Tissue,8100480,9/27/2006 0:00,6/30/2014 0:00,SBIR/STTR,2011,524547, ,NCI, , ,524547
Simultaneous Targeting of p53 to the Nucleus and Mitochondria for Cancer Therapy,8100507,7/1/2010 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,301073, ,NCI, , ,301073
Lung Cancer Recurrence and Survival: Statistical Methods and Models for Ethnic an,8100795,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2011,349428, ,NCI, , ,349428
Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis,8101190,7/1/2000 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,183634, ,NCI, , ,183634
Role of Proline in Redox Homeostasis and Apoptosis,8101348,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,266200, ,NIGMS, , ,266200
Genetic and molecular epidemiology of adult glioma,8101691,5/15/1991 0:00,3/31/2016 0:00,Non-SBIR/STTR,2011,1461568, ,NCI, , ,1461568
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance,8101949,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,316002, ,NCI, , ,316002
The effects of Age on Cancer Signaling Pathways in Mice,8101987,7/1/2010 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,151233, ,NIA, , ,151233
Sequence distribution of tobacco carcinogen-DNA adducts,8102772,12/1/2002 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,206609, ,NCI, , ,206609
Growth Inhibition by the ARF Tumor Suppressor,8103019,4/1/2002 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,257962, ,NCI, , ,257962
"Function of a novel, sirtuin-regulated acetylation site on p53.",8103173,7/1/2010 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,196207, ,NCI, , ,196207
Mechanisms of MnSOD expression in normal and tumor cells,8103281,12/1/1989 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,239153, ,NCI, , ,239153
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",8103316,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,305890, ,NCI, , ,305890
The role of the Ras effector Nore1a in tumor suppression,8103822,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,269911, ,NCI, , ,269911
Induction of genomic instability by HPV E6 and E7,8103880,9/8/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,297988, ,NCI, , ,297988
Functional Genomic Dissection of Refractory Anemia,8103943,9/15/2005 0:00,6/30/2014 0:00,Non-SBIR/STTR,2011,414588, ,NHLBI, , ,414588
Molecular dissection of pancreatic ductal adenocarcinoma,8103949,9/21/2007 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,309358, ,NCI, , ,309358
Interplay between Cdh1 and major regulatory pathways in human cancer,8104114,8/6/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2011,341075, ,NIGMS, , ,341075
Intracellular Mechanisms of Glucocorticoid Action,8104269,7/1/1986 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,262773, ,NIDDK, , ,262773
The Role of MDM Proteins in Cell Growth and Tumorigenesis,8105055,3/1/1999 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,315567, ,NCI, , ,315567
"UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis",8105060,9/1/2000 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,202809, ,NCI, , ,202809
Imaging Based Dosimetry for Individualized Internal Emitter Therapy,8105754,4/1/1999 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,481328, ,NIBIB, , ,481328
Prevention of quinone toxicity and mutagenicity,8105943,8/1/1996 0:00,2/29/2016 0:00,Non-SBIR/STTR,2011,337500, ,NIEHS, , ,337500
Role of beta-endorphin in cancer therapy induced fatigue,8105969,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2011,353979, ,NCI, , ,353979
Defining a New Role for Alpha-MSH: Antioxidant in UVB-Irradiated Melanocytes,8106444,7/7/2010 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,194288, ,NIEHS, , ,194288
"Mitosis, Aneuploidy and Cancer",8107151,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2011,304917, ,NCI, , ,304917
Lapatinib and Obatoclax combination therapy,8107683,7/7/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,338520, ,NCI, , ,338520
Mechanisms of cell competition that regulate growth during development,8108385,8/1/2006 0:00,3/31/2015 0:00,Non-SBIR/STTR,2011,317948, ,NIGMS, , ,317948
SPORE in Lung Cancer,8108532,9/15/2008 0:00,8/31/2013 0:00,Research Centers,2010,158568, ,NCI, , ,158568
Lentiviral Vectors to Model Human Gliomas in Mice,8109129,9/30/1994 0:00,5/31/2015 0:00,Non-SBIR/STTR,2011,687125, ,NHLBI, , ,687125
A Chemical Biology Approach for Discovery of HDAC Inhibitors,8109275,9/1/2010 0:00,8/31/2013 0:00,Other Research-Related,2011,151965, ,NIGMS, , ,151965
Identification and characterization of the functional role of miRNA in prostate c,8109332,7/9/2010 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,277986, ,NCI, , ,277986
The Role of Cul4A in Genome Stability and Cancer Development,8109361,7/9/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2011,291763, ,NCI, , ,291763
A novel regulator of p53,8109367,8/15/2002 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,252802, ,NCI, , ,252802
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes,8109844,9/18/2006 0:00,7/31/2014 0:00,Non-SBIR/STTR,2011,159760, ,NCI, , ,159760
Organic cation transporter 2 and cisplatin nephrotoxicity,8109848,7/12/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,398671, ,NCI, , ,398671
Regulation of MMP-9 mRNA stability and tumor growth by alpha3 beta1 integrin,8110520,9/26/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,85592, ,NCI, , ,85592
Pre-Clinical and Clinical Development of Silvestrol in Chronic Lymphocytic,8110627, , ,Research Centers,2010, ,270642, , , , 
Local Immunoregulation of Carcinogenesis,8110697,7/13/2003 0:00,5/31/2015 0:00,Non-SBIR/STTR,2011,354917, ,NCI, , ,354917
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer,8110715,7/15/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2011,312326, ,NCI, , ,312326
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis,8111200,9/15/2008 0:00,6/30/2012 0:00,Non-SBIR/STTR,2011,298893, ,NCI, , ,298893
ROLE OF HISTONE H4 N-TERMINAL TAIL IN TRANSCRIPTION REGULATION,8111706,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,305823, ,NIGMS, , ,305823
Mechanisms of IGF-1 mediated rescue of radiation-induced salivary gland dysfuncti,8111787,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,323033, ,NIDCR, , ,323033
Sunlight and Melanomagenesis,8111834,7/15/2010 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,197277, ,NIEHS, , ,197277
Transposon-insertional Mutagenesis to Decipher Osteosarcomagenesis,8111902,9/28/2009 0:00,8/31/2014 0:00,Other Research-Related,2011,179280, ,NCI, , ,179280
p53 Family in Gastric Cancer Development,8111998,8/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,348725, ,NCI, , ,348725
A Functional Census of p53 Cancer and Suppressor Mutants,8112008,8/1/2005 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,363318, ,NCI, , ,363318
Targeting transforming growth factor beta for cancer treatment,8113152,7/15/1997 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,212360, ,NCI, , ,212360
p53-Independent Cell Death Signaling by Mitomycin DNA Adducts,8113210,8/6/2008 0:00,7/31/2012 0:00,Other Research-Related,2011,294880, ,NCI, , ,294880
Enhancing glioma chemotherapy by suppressing Notch signaling,8113312,3/1/1988 0:00,5/31/2015 0:00,Non-SBIR/STTR,2011,352647, ,NINDS, , ,352647
Comparative functional genomics for lung cancer gene discovery,8113469,9/23/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,536945, ,NCI, , ,536945
SPORE in Lung Cancer,8113537,9/15/2008 0:00,8/31/2013 0:00,Research Centers,2010,158648, ,NCI, , ,158648
Enhancing glioma chemotherapy by suppressing Notch signaling,8113656,3/1/1988 0:00,5/31/2015 0:00,Non-SBIR/STTR,2010,82250, ,NINDS, , ,82250
Molecular Mechanism of Translocations in B-Cell Lymphoma,8113947, ,6/30/2013 0:00,Non-SBIR/STTR,2010, ,513565, , , , 
Functional analysis of the p53 tumor suppressor,8113997,8/15/1985 0:00,7/30/2013 0:00,Non-SBIR/STTR,2011,225725, ,NCI, , ,225725
Cancer cell telomere dynamics and responses to perturbations,8114109,9/1/2002 0:00,8/7/2012 0:00,Non-SBIR/STTR,2011,298913, ,NCI, , ,298913
Id2 enhances radiation resistance in glioma and is regulated by p53.,8115040,8/1/2009 0:00,7/31/2012 0:00,"Training, Individual",2011,33536, ,NINDS, , ,33536
Biomarkers of survival in glioma epidemiology,8115135,7/1/2008 0:00,5/31/2014 0:00,Non-SBIR/STTR,2011,400461, ,NCI, , ,400461
MbSOD in chemotherapeutic-Induced Cardiac Injury,8115187,9/25/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,261900, ,NCI, , ,261900
Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer,8115651,3/4/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2011,303988, ,NCI, , ,303988
Ecd as a regulator of cell cycle and breast oncogenesis,8115725,3/1/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2011,308138, ,NCI, , ,308138
Mechanisms of Radioresistance and Cell Cycle Progression,8115777,9/28/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,349988, ,NCI, , ,349988
Characterizing mechanisms of transcriptional activation using live cell imaging,8116406,8/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2011,318641, ,NIGMS, , ,318641
MTOR AS A THERAPEUTIC TARGET IN PEDIATRIC SOLID TUMORS,8117102, , ,Non-SBIR/STTR,2010, ,288945, , , , 
"Spindle Assembly Checkpoint, Chromosomal Instability, and Cancer",8117132,9/1/2008 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,308957, ,NCI, , ,308957
Molecular dissection of pancreatic ductal adenocarcinoma,8117420,9/21/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2010,89842, ,NCI, , ,89842
Altered Expression of Protein Tyrosine Phosphatase by Methylation,8117627, , ,Non-SBIR/STTR,2010, ,297330, , , , 
Pathology,8117631, , ,Non-SBIR/STTR,2010, ,337691, , , , 
P5 - P-53-Based Vaccine for Small Cell Lung Cancer,8118132,9/1/2010 0:00,8/31/2013 0:00,Research Centers,2010, ,363048, , , , 
SPORE in Lung Cancer,8118138,9/15/2008 0:00,8/31/2013 0:00,Research Centers,2011,1900000, ,NCI, , ,1900000
FAK Signals Controlling Endothelial Cell Survival and Motility,8118168,9/1/2008 0:00,8/31/2013 0:00,Non-SBIR/STTR,2011,498035, ,NHLBI, , ,498035
Mechanisms of IGF-1 mediated rescue of radiation-induced salivary gland dysfuncti,8118679,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,15562, ,NIDCR, , ,15562
Studying the control of Cytokinesis as an Evolved Complex System,8118808,8/1/1999 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,314843, ,NIGMS, , ,314843
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS,8118869, , ,Non-SBIR/STTR,2010, ,430239, , , , 
"HPV: Biology, Clinical Significance and Epidemiology",8118874,6/1/1997 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,1952686, ,NCI, , ,1952686
Breast Cancer Prevention by Dietary Phytochemicals,8119093,9/7/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,273686, ,NCI, , ,273686
TGF-beta Signaling in Pancreatic Cancer Progression,8119396,9/1/2009 0:00,7/31/2014 0:00,Non-SBIR/STTR,2011,330091, ,NCI, , ,330091
Cyclin E Regulation in Normal and Neoplastic Hematopoiesis,8119546,8/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2011,377422, ,NHLBI, , ,377422
Interaction Between SV40 Large T and P185 Cullin,8119596,7/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,271609, ,NCI, , ,271609
Epigenetic Regulation of Cell and Tissue Aging,8119610,9/30/2007 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,293452, ,NIA, , ,293452
Intrinsic Apoptosis Phenotype and Susceptibility to Squamous Cell Carcinoma,8119668, , ,Research Centers,2010, ,289681, , , , 
Cancer Risk Assessment in Patients with Oral Premalignant Lesions,8119669, , ,Research Centers,2010, ,392398, , , , 
Genomic Analysis of the p53 Pathway in Normal and Cancer Cells,8119754, , ,Non-SBIR/STTR,2010, ,401114, , , , 
p53 and Chemosensitivity in a Mouse Lymphoma Model,8119755, , ,Non-SBIR/STTR,2010, ,414058, , , , 
Molecular Studies of the p53 Pathway in Human Cancer,8119756, , ,Non-SBIR/STTR,2010, ,410358, , , , 
NITROAROMATICS AND BREAST CANCER,8119760,7/1/1983 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,292895, ,NCI, , ,292895
Training Program in Molecular Genetics of Cancer,8119779,9/30/1978 0:00,6/30/2015 0:00,"Training, Institutional",2011,395907, ,NCI, , ,395907
Characterization of prostatic stem cells and prostate cancer-initiating cells,8119823,9/1/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2010,51582, ,NCI, , ,51582
Non-genotoxic p53 activation as novel therapeutic concept for lymphoma,8120289, , ,Research Centers,2010, ,68059, , , , 
UT M.D. Anderson Cancer Center Lymphoma SPORE,8120295,9/1/2009 0:00,8/31/2013 0:00,Research Centers,2011,475000, ,NCI, , ,475000
Characterization of prostatic stem cells and prostate cancer-initiating cells,8120409,9/1/2007 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,234496, ,NCI, , ,234496
Hepatitis C and Tumor Suppressors in Hepatocellular,8120644, , ,Research Centers,2010, ,291609, , , , 
Molecular Pathology of t-AML,8120883, , ,Non-SBIR/STTR,2010, ,481023, , , , 
Molecular Analysis of Proliferative and Apoptotic Pathways in Soft Tissue Sarcoma,8120927, , ,Non-SBIR/STTR,2010, ,313457, , , , 
Functions of Papillomavirus E6,8121162,4/8/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2010,252560, ,NCI, , ,252560
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas,8121606,5/3/2011 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,316002, ,NCI, , ,316002
Mechanisms of Delta-N-p63-alpha transcriptional repression and its role in squamo,8122059,8/1/2011 0:00,7/31/2014 0:00,"Training, Individual",2011,56750, ,NCI, , ,56750
The Role of Caspase Activation in the Differentiation-Dependent Life Cycle of HPV,8122505,9/20/2008 0:00,8/31/2013 0:00,Non-SBIR/STTR,2010,249000, ,NCI, , ,249000
Understanding the origin and pathogenesis of epithelial ovarian cancer,8122609,7/1/2011 0:00,6/30/2014 0:00,"Training, Individual",2011,53042, ,NCI, , ,53042
Quantitative Measurements and Modeling of the Mitotic Checkpoint,8123147,9/28/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2011,452798, ,NIGMS, , ,452798
Research Career Development in HIV-Related Anal Dysplasia/Carcinoma Prevention an,8123231,9/15/2008 0:00,8/31/2013 0:00,Other Research-Related,2011,119842, ,NIAID, , ,119842
A Luciferase Fusion Library of High Throughput Profiling of Protein Stability,8123965,8/1/2011 0:00,7/31/2014 0:00,"Training, Individual",2011,53042, ,NCI, , ,53042
Zebrafish Screens for Genetic Modifiers and Human Application in T-ALL,8125016, ,4/30/2013 0:00,Non-SBIR/STTR,2010, ,310368, , , , 
Functional study of C53 protein as a novel regulator of checkpoint kinases,8125497,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,75990, ,NIGMS, , ,75990
Modulation of sensitivity & imaging therapeutic response of hypoxic cancer cells,8126433,5/18/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,312178, ,NCI, , ,312178
A Novel Human DNA Damage Response Which Directly Alters DNA Polymerase Delta,8127402,6/15/2011 0:00,6/14/2016 0:00,"Training, Individual",2011,26014, ,NIEHS, , ,26014
Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction,8127669,9/5/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,339003, ,NIAAA, , ,339003
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression,8127759,9/3/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,226693, ,NCI, , ,226693
Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,8127815,9/30/2009 0:00,8/31/2014 0:00,Other Research-Related,2011,358962, ,NIAID, , ,358962
Graduate Training at the Chemistry Biology Interface,8127855,7/1/2004 0:00,6/30/2014 0:00,"Training, Institutional",2011,138096, ,NIGMS, , ,138096
Bifunctional T cell receptor based immunotherapeutics,8128463,7/26/2002 0:00,8/31/2013 0:00,SBIR/STTR,2011,979275, ,NCI, , ,979275
FRET-based Biosensors to Monitor Redox in Cell Cycle Regulation,8129427,9/1/2010 0:00,8/31/2013 0:00,Non-SBIR/STTR,2011,269295, ,NCI, , ,269295
Heat Shock Protein-Induced Protection Against Cisplatin-Induced Hair Cell Death,8129472,9/28/2009 0:00,9/27/2015 0:00,"Training, Individual",2011,35099, ,NIDCD, , ,35099
Apoptosis Regulation by Adenovirus and Cellular Genes,8130173,8/1/1999 0:00,4/30/2016 0:00,Non-SBIR/STTR,2011,288011, ,NCI, , ,288011
P-2:  The Effect of Rad on Androgen Receptor Expression and Activity in Prostate,8130547,9/1/2010 0:00,8/31/2012 0:00,Research Centers,2010, ,297580, , , , 
Targeting Raf in Melanoma: Mechanisms for Effect & Resistance & Opportunities for,8130560, , ,Research Centers,2010, ,326994, , , , 
NYU Lung Cancer Biomarker Center,8130732,5/8/2000 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011,763892, ,NCI, , ,763892
Ras Induced Senescence and Tumor Suppression,8130771,7/1/1999 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,353216, ,NIA, , ,353216
Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer,8130849,9/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,240725, ,NCI, , ,240725
Impact of BRG1 Loss in Lung Cancer Development,8130964,9/27/2007 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,270000, ,NCI, , ,270000
The Role of ATF3 in the DNA Damage Response,8131106,9/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011,254412, ,NCI, , ,254412
Impact of molecular phenotype on glioma metabolism and growth,8131294,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2011,414281, ,NCI, , ,414281
Role of Sphingosine Kinase in p53 Cancer Biology,8131769,8/1/2003 0:00, ,Non-SBIR/STTR,2010, ,243936, , , , 
Sphingolipids in Cancer Biology and Therapy,8131774,8/1/2003 0:00,2/28/2012 0:00,Non-SBIR/STTR,2011,1127363, ,NCI, , ,1127363
The Role of Fbxw7 in genetic instability and cancer,8131803,9/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,345303, ,NCI, , ,345303
Role of Germ Cell Nuclear Factor in Restricting hESC Pluripotency,8132417, , ,Non-SBIR/STTR,2010, ,266333, , , , 
Regulatory Networks in Human Embryonic Stem Cells,8132421,9/1/2007 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,1542872, ,NIGMS, , ,1542872
Sphingolipids in Cancer Biology and Therapy,8132635,8/1/2003 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,39388, ,NCI, , ,39388
"UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis",8132772,9/1/2000 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,4335, ,NCI, , ,4335
Full Project 1: Tumor-targeted MR Contrast Enhancement Using Molecular Imaging Te,8133112, , ,Research Centers,2010, ,145442, , , , 
Nanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCV,8133144,9/15/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,366123, ,NIAAA, , ,366123
Somatic genetic predictors of response to therapy in metastatic melanoma,8133381,9/13/2007 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,299308, ,NCI, , ,299308
Chemoprevention of lung cancer with red ginseng extracts,8133545,9/30/2009 0:00,8/31/2013 0:00,Non-SBIR/STTR,2011,462108, ,OD, , ,200000
Prevention of UV-induced carcinogenesis by cyanidin-3-glucoside,8133594,8/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2011,334125, ,NIEHS, , ,334125
Exploiting mouse models of pediatric cancers and epigenetics for therapy,8133682,9/10/2004 0:00,7/31/2014 0:00,Non-SBIR/STTR,2011,807035, ,NCI, , ,807035
Stochastic dynamics for multiscale biology,8133946,9/1/2008 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,297497, ,NIGMS, , ,297497
Mechanisms of Cytotoxicity and Radiosensitization for Antimetabolites,8135035,7/8/1999 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011,258395, ,NCI, , ,258395
Biosynthesis of Adenovirus Early RNA's,8135099,4/1/1979 0:00,3/31/2011 0:00,Non-SBIR/STTR,2010,44906, ,NCI, , ,44906
Cancer cell adaptation to metabolic stress,8135234,9/10/2004 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,1189982, ,NCI, , ,1189982
"Studying the initiation, progression and therapy of lung cancer in mouse models",8135522,4/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,339987, ,NCI, , ,339987
monoclonal antibody,8135588, , ,Research Centers,2010, ,108715, , , , 
Death Receptors in Bladder Cancer Therapy,8135638, , ,Research Centers,2010, ,239184, , , , 
Repair of oxidative DNA damage in mammalian cells,8135899,3/10/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2010,75000, ,NCI, , ,75000
Regulation WRN deacetylation by SIRT1 after DNA damage,8135940,2/15/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2010,123089, ,NIA, , ,123089
ROLE OF CRYPTOCHROME IN DNA DAMAGE RESPONSES AND THE CIRCADIAN CLOCK,8136183,8/1/1982 0:00,6/30/2014 0:00,Non-SBIR/STTR,2011,510628, ,NIGMS, , ,510628
"Pubertal high fat diet: effects on inflammation, mammary development and cancer",8136539,9/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2011,451440, ,NIEHS, , ,451440
"""Protein protein interaction directed libraries""",8136604,9/1/2010 0:00,6/30/2013 0:00,Research Centers,2011,378150, ,OD, , ,378150
Functional analysis of a putative ATM/ATR substrate RFWD3,8136628,8/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,285847, ,NIGMS, , ,285847
Defining the role of the tumor-initiating cell niche in breast cancer,8136643,9/1/2010 0:00,8/31/2012 0:00,Other Research-Related,2011,139334, ,NCI, , ,139334
Chemoprevention of tobacco carcinogen-induced bladder cancer,8136673,9/1/2010 0:00,8/31/2013 0:00,Non-SBIR/STTR,2011,74690, ,NCI, , ,74690
Chemical Inhibitors of CREB-mediated Gene Transcription,8136729,9/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2011,320166, ,NIGMS, , ,320166
Functional Components of the Rb/E2F and p53 Pathways,8136767,9/30/2010 0:00,9/29/2013 0:00,Non-SBIR/STTR,2010,239423, ,NLM, , ,239423
Polyoma Virus Disrupts ARF Signaling to p53,8137006,4/1/2002 0:00,7/31/2012 0:00,Non-SBIR/STTR,2011,298913, ,NCI, , ,298913
P-4: Targeting activation of NFkB pathways in MM,8137014, , ,Research Centers,2010, ,287967, , , , 
"Allergies, Genetic Susceptibility and Adult Glioma Risk",8137065,3/10/2006 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,403962, ,NCI, , ,403962
Transcriptional Control of Stroma Dependent Apoptosis in MDS,8137076,9/2/2010 0:00,5/31/2015 0:00,Other Research-Related,2011,132957, ,NIDDK, , ,132957
"Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B",8137159, ,7/31/2013 0:00,Research Centers,2010, ,317251, , , , 
Visualizing the effect of epigenetic modifications on transcription and mutation,8137285,9/15/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2011,376893, ,OD, , ,376893
The Role of Caspase Activation in the Differentiation-Dependent Life Cycle of HPV,8137635,9/20/2008 0:00,8/31/2013 0:00,Non-SBIR/STTR,2011,241530, ,NCI, , ,241530
Structural basis for functional modulation of CBP/p300 by the HPV oncoprotein E7,8138562,9/30/2010 0:00,9/29/2013 0:00,"Training, Individual",2011,48398, ,NIGMS, , ,48398
Regulations of DNA Alkylation/Deamination Damage Repair,8138925,3/1/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2010,22366, ,NCI, , ,22366
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,8139718,9/1/2008 0:00,8/31/2013 0:00,Other Research-Related,2011,171205, ,NCI, , ,171205
Integrative genomic characterization of lung cancer metastasis in mouse and human,8139725,9/30/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2011,766975, ,NCI, , ,766975
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model,8139767,9/25/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,470159, ,NCI, , ,470159
Effects of Stochastic Gene Alterations on Intestinal Tumorigenesis in the Mouse,8139908,12/1/1983 0:00,7/31/2014 0:00,Non-SBIR/STTR,2011,405472, ,NIGMS, , ,405472
Functional Characterization of WTX in Renal Development,8141353,9/30/2007 0:00,8/31/2012 0:00,Other Research-Related,2011,137970, ,NIDDK, , ,137970
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,8141684,4/1/2011 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012, , , , , , 
CARP-1: A Potential Therapeutic Agent for Breast Cancer,8141847,1/1/2012 0:00,12/31/2015 0:00,Non-SBIR/STTR,2012, , , , , , 
P53 Activation as Novel Therapeutic Stratgey for Acute Myelogenous Leukemia,8141962, , ,Research Centers,2010, ,265624, , , , 
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia,8141970,8/5/2003 0:00,4/30/2013 0:00,Research Centers,2011,2185000, ,NCI, , ,2185000
Therapeutic Potential and Mechanism of Action of Potent Small Molecule Inhibitors,8142065, , ,Research Centers,2010, ,223544, , , , 
"Role of Soy Isoflavones, Smoking Abstinence and Molecular Markers in Prevention",8142066, , ,Research Centers,2010, ,466535, , , , 
"(IND 102,133) Inhibition of Aurora Kinase A as Treatment For Melanoma",8142146,9/10/2010 0:00,9/9/2015 0:00,Non-SBIR/STTR,2013,400000, ,FDA,269100,130900,400000
Molecular and Cellular Origins of Pancreatic Cancer,8142505,5/18/2007 0:00,9/30/2011 0:00,Other Research-Related,2010,148092, ,NCI, , ,148092
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells,8142628,4/1/2011 0:00,9/30/2015 0:00,Non-SBIR/STTR,2012, , , , , , 
p53 - Regulators and Effectors,8142921,2/16/2000 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011,1424298, ,NCI, , ,1424298
Phase 2  Irinotecan for Treatment of p53 WT Gastric Adenocarcinoma,8143323,9/10/2010 0:00,8/31/2013 0:00,Non-SBIR/STTR,2011,334719, ,FDA, , ,334719
Flow Cytometry,8144421, , ,Research Centers,2010, ,563202, , , , 
Center for digestive and liver diseases,8144540,7/1/1998 0:00,6/30/2012 0:00,Research Centers,2010,92352, ,NIDDK, , ,92352
Properties and regulation of p53 in tumor cells,8144952,3/23/1999 0:00,2/28/2015 0:00,Non-SBIR/STTR,2011,307573, ,NCI, , ,307573
Focal Adhesion Kinase - Tumor Biology and Therapeutics,8145175,9/30/1996 0:00,7/31/2015 0:00,Non-SBIR/STTR,2011,290076, ,NCI, , ,290076
Functional Components of the Rb/E2F and p53 Pathways,8145250,9/30/2010 0:00,9/29/2013 0:00,Non-SBIR/STTR,2011,229846, ,NLM, , ,229846
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,8145650,9/30/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2011,306083, ,NIDDK, , ,306083
Telomere induced senescence as a supressor of tumorigenesis,8145661,8/8/2007 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,305017, ,NCI, , ,305017
Targeting Regulators of Apoptosis in AML,8146112, , ,Non-SBIR/STTR,2010, ,354155, , , , 
THE THERAPY OF AML,8146122,5/27/1997 0:00,2/29/2016 0:00,Non-SBIR/STTR,2011,2401083, ,NCI, , ,2401083
A Role for RIP1 in Gliomagenesis,8147853,9/29/2009 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,307720, ,NINDS, , ,307720
Embryonic Stem Cell Derived Cardiac Myocytes,8148329, , ,Intramural Research,2010,609369, ,NIA, , ,609369
Immortalized Cell Lines,8148500, , ,Intramural Research,2010,373011, ,NIDA, , ,373011
Signal and Transcription Factor Network interactions in Head and Neck Cancer,8148607, , ,Intramural Research,2010,893066, ,NIDCD, , ,893066
Genomics and Proteomics of Head and Neck Cancer,8148608, , ,Intramural Research,2010,887719, ,NIDCD, , ,887719
Oral Carcinogenesis,8148625, , ,Intramural Research,2010,1608455, ,NIDCR, , ,1608455
Small Molecule Activators of p53,8148726, , ,Intramural Research,2010,389550, ,NIDDK, , ,389550
"BRCA1, DNA damage response and aging",8148851, , ,Intramural Research,2010,330677, ,NIDDK, , ,330677
"Role Of Lipids In Colon, Breast, And Other Cancers",8149031, , ,Intramural Research,2010,547454, ,NIEHS, , ,547454
Human Genes Affecting Chromosome Metabolism and Stress Response,8149046, , ,Intramural Research,2010,1248352, ,NIEHS, , ,1248352
"Nuclear receptors: action, functions, and roles in disease",8149084, , ,Intramural Research,2010,1424077, ,NIEHS, , ,1424077
The role of autophagy in aging and metabolism,8149505, , ,Intramural Research,2010,854009, ,NHLBI, , ,854009
Blood Studies of Endothelial Function and Systemic Inflammation,8149541, , ,Intramural Research,2010,155722, ,NHLBI, , ,155722
Risk for in vivo mutagenesis of the P53 gene by nucleoside analog antiviral drug,8150962,9/28/2010 0:00,9/30/2012 0:00,Non-SBIR/STTR,2011,73963, ,NCI, , ,73963
Roles and regulation of p53,8152836,9/30/2000 0:00,7/31/2016 0:00,Non-SBIR/STTR,2011,1812196, ,NCI, , ,1812196
Role of p53 polymorphisms in disparities in breast carcinogenesis and outcome .,8153295,3/13/2011 0:00,11/30/2015 0:00,Non-SBIR/STTR,2011,395000, ,NIMHD, , ,395000
Cellular Response to Short Telomeres in B-Cell Lymphoma,8153756,7/5/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2011,537001, ,NCI, , ,537001
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis,8153821,9/1/2011 0:00,8/31/2015 0:00,Non-SBIR/STTR,2011,307723, ,NCI, , ,307723
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS,8157020, , ,Intramural Research,2010,753460, ,NIAID, , ,753460
Chromosomal Proteins and Chromosomal Functions,8157160, , ,Intramural Research,2010,991401, ,NCI, , ,991401
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,8157165, , ,Intramural Research,2010,832354, ,NCI, , ,832354
Molecular Epidemiology of Human Lung Cancer,8157180, , ,Intramural Research,2010,793889, ,NCI, , ,793889
"Tumor Suppressor Protein, p53",8157187, , ,Intramural Research,2010,355956, ,NCI, , ,355956
Transgenic Models for Prostate and Breast Cancer,8157194, , ,Intramural Research,2010,1044851, ,NCI, , ,1044851
p53 Tumor Suppressor Pathway,8157196, , ,Intramural Research,2010,793889, ,NCI, , ,793889
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",8157198, , ,Intramural Research,2010,1240655, ,RMOD, , ,25000
Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis,8157200, , ,Intramural Research,2010,524637, ,NCI, , ,524637
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,8157213, , ,Intramural Research,2010,1216986, ,NCI, , ,1216986
Regulation of Lymphocyte Proliferation and Replicative Capacity,8157236, , ,Intramural Research,2010,993254, ,NCI, , ,993254
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,8157239, , ,Intramural Research,2010,433016, ,NCI, , ,433016
Molecular Cytogenetics of Solid Tumors,8157252, , ,Intramural Research,2010,1095529, ,NCI, , ,1095529
Molecular Mechanisms of Growth Factor Modulated Proliferation,8157256, , ,Intramural Research,2010,230538, ,NCI, , ,230538
Protein Structure,8157286, , ,Intramural Research,2010,1691624, ,NCI, , ,1691624
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,8157339, , ,Intramural Research,2010,824918, ,NCI, , ,824918
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,8157340, , ,Intramural Research,2010,412459, ,NCI, , ,412459
Development of Mouse Astrocytoma Model for Preclinical Testing,8157341, , ,Intramural Research,2010,137487, ,NCI, , ,137487
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,8157371, , ,Intramural Research,2010,595287, ,NCI, , ,595287
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,8157409, , ,Intramural Research,2010,116526, ,NCI, , ,116526
Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers,8157415, , ,Intramural Research,2010,647703, ,NCI, , ,647703
Metabolic Mechanisms for Programmed Cell Death,8157425, , ,Intramural Research,2010,495101, ,NCI, , ,495101
Extracellular Matrix and Stress Substrates: the Role of Prolidase,8157427, , ,Intramural Research,2010,247550, ,NCI, , ,247550
Clinical trial development in cancer vaccines,8157435, , ,Intramural Research,2010,415410, ,NCI, , ,415410
Molecular Alterations of Primary Breast Cancer and Metastasis,8157438, , ,Intramural Research,2010,220179, ,NCI, , ,220179
Differentiation of tissue- and devlopment of tumor stem cells,8157464, , ,Intramural Research,2010,534303, ,NCI, , ,534303
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,8157468, , ,Intramural Research,2010,517218, ,NCI, , ,517218
DNA Folding in Chromatin and Interaction with Transcription Factors,8157498, , ,Intramural Research,2010,609382, ,NCI, , ,609382
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,8157508, , ,Intramural Research,2010,86927, ,NCI, , ,86927
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,8157517, , ,Intramural Research,2010,876052, ,NCI, , ,876052
Tumor models for the study of inflammation and oncogenesis,8157526, , ,Intramural Research,2010,296239, ,NCI, , ,296239
Redox Mechanism Process of Angiogenesis and Wound Healing,8157527, , ,Intramural Research,2010,369445, ,NCI, , ,369445
Vaccine and radiation for the therapy of human cancers,8157554, , ,Intramural Research,2010,408968, ,NCI, , ,408968
Collaborative Pathways that Lead to Leukemia,8157557, , ,Intramural Research,2010,379492, ,NCI, , ,379492
Gene therapy of cancer,8157560, , ,Intramural Research,2010,1543070, ,NCI, , ,1543070
Immunobiology of Pediatric Tumors,8157616, , ,Intramural Research,2010,763115, ,NCI, , ,763115
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,8157628, , ,Intramural Research,2010,712415, ,NCI, , ,712415
Molecular Mechanisms of Lymphomagenesis,8157654, , ,Intramural Research,2010,105017, ,NCI, , ,105017
Inflammation and Prostate Carcinogenesis,8157670, , ,Intramural Research,2010,248153, ,NCI, , ,248153
Validation of Therapeutic Target Genes in Human Liver Cancer,8157673, , ,Intramural Research,2010,534598, ,NCI, , ,534598
Preclinical Mouse Model of Thyroid Carcinogenesis,8157686, , ,Intramural Research,2010,762355, ,NCI, , ,762355
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,8157690, , ,Intramural Research,2010,355956, ,NCI, , ,355956
Functions of IKKalpha in Skin Homeostasis and Skin Tumorigenesis,8157704, , ,Intramural Research,2010,994328, ,NCI, , ,994328
Thorarcic Cancer Research Laboratory,8157739, , ,Intramural Research,2010,1182610, ,NCI, , ,1182610
Regulation of HTLV-1 Transcription,8157740, , ,Intramural Research,2010,370756, ,NCI, , ,370756
Inhibition of p53 Tumor Suppressor Function,8157742, , ,Intramural Research,2010,370756, ,NCI, , ,370756
Mechanisms of Early Stage Mammary Tumorigenesis,8157744, , ,Intramural Research,2010,584034, ,NCI, , ,584034
CANCER AND INFLAMMATION GENETICS,8157753, , ,Intramural Research,2010,968200, ,NCI, , ,968200
Development and validation of preclinical mouse model for serous ovarian cancer,8157788, , ,Intramural Research,2010,1107608, ,NCI, , ,1107608
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,8157921, , ,Intramural Research,2010,570013, ,NCI, , ,570013
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,8157922, , ,Intramural Research,2010,4547481, ,NCI, , ,4547481
Intervention Trials in Persons at Increased Genetic Risk of Cancer,8157923, , ,Intramural Research,2010,1490914, ,NCI, , ,1490914
Studies of Rare Cancers,8157926, , ,Intramural Research,2010,934284, ,NCI, , ,934284
Mitochondrial regulation in cardiovascular and cancer biology,8158031, , ,Intramural Research,2010,978880, ,NHLBI, , ,978880
Modulation of Therapeutic Response,8158259, , ,Intramural Research,2010,649179, ,NCI, , ,649179
Molecular Pathogenesis of Multiple Myeloma,8158264, , ,Intramural Research,2010,945889, ,NCI, , ,945889
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,8158265, , ,Intramural Research,2010,418324, ,NCI, , ,418324
Nitric Oxide as a Modifier of Oxidative Stress,8158273, , ,Intramural Research,2010,369445, ,NCI, , ,369445
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,8158286, , ,Intramural Research,2010,672998, ,NCI, , ,672998
Molecular Targets Development Program,8158321, , ,Intramural Research,2010,5480271, ,NCI, , ,5480271
CCR Confocal Microscopy Core,8158330, , ,Intramural Research,2010,767104, ,NCI, , ,767104
Cell and Cancer Biology Branch Confocal Microscopy Core,8158340, , ,Intramural Research,2010,482217, ,NCI, , ,482217
Modeling Molecular of Interactions Regulating the Activity of the p53 Protein,8158364, , ,Intramural Research,2010,137273, ,NCI, , ,137273
Molecular Diagnostics Core Laboratory,8158365, , ,Intramural Research,2010,630105, ,NCI, , ,630105
Immunohistochemistry Core Laboratory,8158368, , ,Intramural Research,2010,1365228, ,NCI, , ,1365228
Bioinformatic Tools in Cancer Research,8158466, , ,Intramural Research,2010,683082, ,NCI, , ,683082
Targeted Development of Platinum Drugs,8160183,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2011,327850, ,NCI, , ,327850
The Regulation of PP1 in the Nucleus,8160374,9/1/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2011,291806, ,NIGMS, , ,291806
GENETICS OF MYELODYSPLASTIC SYNDROMES,8160381,8/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2011,380000, ,NHLBI, , ,380000
Bcl-2 as a Biomarker for Prognosis and Therapy of Head and Neck Cancer,8161596,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2011,450464, ,NIDCR, , ,450464
Mechanisms of Dicer1 Function in Lung Organogenesis and Cystic Lung Disease,8161665,6/15/2011 0:00,5/31/2015 0:00,Non-SBIR/STTR,2011,391199, ,NHLBI, , ,391199
DNA-Protein Interactions in Herpes Viruses,8166052,5/1/1997 0:00,6/30/2016 0:00,Non-SBIR/STTR,2011, ,270533, , , , 
ID PROTEIN FAMILY EXPRESSION AND FUNCTION IN PROSTATE CANCER,8166160,7/1/2010 0:00,6/30/2011 0:00,Research Centers,2010, ,239155, , , , 
"CLINICAL TRIAL: A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTO",8166764,12/1/2009 0:00,11/30/2010 0:00,Research Centers,2010, ,9920, , , , 
CD8+ T CELL ACTIVATION AND INFILTRATION INTO BREAST TUMORS POST PEPTIDE VACCINE,8167170,3/1/2010 0:00,2/28/2013 0:00,Research Centers,2010, ,24056, , , , 
THE ROLE OF PROTEIN PHOSPHATASE 5 (PP5) IN HYPOXIC STRESS AND CANCER,8167539,4/1/2010 0:00,3/31/2011 0:00,Research Centers,2010, ,33678, , , , 
BIOMARKER ARRAYS FOR TOBACCO-RELATED CANCER DIAGNOSTICS,8167611,5/1/2010 0:00,4/30/2011 0:00,Research Centers,2010, ,61179, , , , 
4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT,8167690,6/1/2010 0:00,5/31/2011 0:00,Research Centers,2010, ,250424, , , , 
GLUCOSYLCERAMIDE SYNTHASE IN A NOVEL TARGET FOR CANCER TREATMENT,8168132,7/15/2010 0:00,4/30/2011 0:00,Research Centers,2010, ,109837, , , , 
UNCOVERING THE MECHANISMS OF OSTEOSARCOMA METASTASIS SUPPRESSION BY MTBP,8168370,9/17/2004 0:00,7/31/2011 0:00,Research Centers,2010, ,177347, , , , 
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY,8168706,3/10/2010 0:00,12/31/2010 0:00,Research Centers,2010, ,9710, , , , 
PROTEOMIC BIOMARKER PROFILING OF CERVICAL SWABS,8168817,3/10/2010 0:00,12/31/2010 0:00,Research Centers,2010, ,9710, , , , 
MITOCHONDRIAL REDOX IMAGING OF COLON CANCER,8169087,6/1/2010 0:00,5/31/2011 0:00,Research Centers,2010, ,34688, , , , 
OPTICAL IMAGING OF TUMOR ANGIOGENESIS AND CHEMOTHERAPY,8169462,4/1/2010 0:00,3/31/2011 0:00,Research Centers,2010, ,2059, , , , 
HYPEROXIC RESPIRATORY CHALLENGES TO MONITOR CHEMOTHERAPY EFFECTS,8169511,4/1/2010 0:00,3/31/2011 0:00,Research Centers,2010, ,3397, , , , 
CRYSTAL STRUCTURE DETERMINATION OF MYELIN PROTEINS,8170161,5/1/2010 0:00,2/28/2011 0:00,Research Centers,2010, ,2040, , , , 
IDENT AND POST-TRANSLATIONAL MODIFICATION OF MITOTIC REGULATORY PROTEINS,8170706,7/1/2010 0:00,6/30/2011 0:00,Research Centers,2010, ,32124, , , , 
BIOMARKERS AND METABOLIC PATHWAYS IN GLIOMAS AND BRAIN METASTASIS,8171674,9/1/2010 0:00,8/31/2011 0:00,Research Centers,2010, ,41832, , , , 
CT IMAGING IN TRANSGENIC MOUSE MODELS FOR HUMAN TUMORS,8172259,9/15/2010 0:00,7/31/2011 0:00,Research Centers,2010, ,115869, , , , 
PATHOGENESIS OF LYME NEUROBORRELIOSIS IN THE RHESUS MONKEY: STUDIES IN VITRO,8172979,5/1/2010 0:00,4/30/2011 0:00,Research Centers,2010, ,61801, , , , 
Gene Regulation and Function: The B-ZIP Proteins,8175285, , ,Intramural Research,2010,1021421, ,NCI, , ,1021421
Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,8175290, , ,Intramural Research,2010,547096, ,NCI, , ,547096
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,8175294, , ,Intramural Research,2010,462576, ,NCI, , ,462576
DNA Repair,8175300, , ,Intramural Research,2010,1240102, ,NCI, , ,1240102
Role of CEBP transcription factors in regulating cell growth and tumorigenesis,8175307, , ,Intramural Research,2010,1383698, ,NCI, , ,1383698
Role of Neurotrophins in the Development of the Mammalian Nervous System,8175314, , ,Intramural Research,2010,667915, ,NCI, , ,667915
Role of Trk Receptors in the Development and Function of Non-neuronal Structures,8175315, , ,Intramural Research,2010,667915, ,NCI, , ,667915
Molecule-Guided Investigations into p53 Biology,8175349, , ,Intramural Research,2010,694547, ,NCI, , ,694547
Preclinical drug development in pancreas cancer,8175351, , ,Intramural Research,2010,746546, ,NCI, , ,746546
Epidemiology and Natural History of Cancer-Associated Viruses,8175390, , ,Intramural Research,2010,2220479, ,NCI, , ,2220479
Descriptive Studies and Record Linkage,8175392, , ,Intramural Research,2010,691140, ,NCI, , ,691140
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,8175419, , ,Intramural Research,2010,1045579, ,NCI, , ,1045579
MOLECULAR DYNAMICS IN CELLULAR AGING: A SYNTHETIC BIOLOGY APPROACH.,8175522,8/1/2011 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,161950, ,NIA, , ,161950
 Role of Angiogenesis in Colorectal Cancer using Transgenic Mouse Models ,8175652,9/26/2008 0:00,9/25/2018 0:00,R and D Contracts,2010,25000, ,NCI, , ,25000
Phenotyping pain in a mouse model of pancreatic cancer,8176475,7/1/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,75750, ,NINDS, , ,75750
Preclinical Evaluation of PK2 Antagonists for Pancreatic Cancer,8177105,7/1/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,173678, ,NCI, , ,173678
Enzymes and Substrates of the Ubiquitin Conjugating System,8177694, , ,Intramural Research,2010,685887, ,NCI, , ,685887
Zebrafish Models of Cancer,8177697, , ,Intramural Research,2010,979987, ,NCI, , ,979987
Lymphoma Studies,8177734, , ,Intramural Research,2010,349579, ,NCI, , ,349579
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci,8178935,9/7/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2011,537462, ,NCI, , ,537462
Skeletal genetic pathways of Notch and p53 in the pathogenesis of osteosarcoma,8179496,9/1/2011 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,78250, ,NIAMS, , ,78250
Targeting Inflammation for the Amelioration of Cisplatin-Hearing Loss,8180477,7/4/2011 0:00,8/31/2015 0:00,Non-SBIR/STTR,2011,436500, ,NIDCD, , ,436500
Radiation Biology,8180970,9/15/2010 0:00,5/31/2015 0:00,Research Centers,2010, ,17354, , , , 
Population-based study of DNA damage response markers of prognosis in breast canc,8181518,9/15/2010 0:00,8/31/2015 0:00,Research Centers,2010, ,199825, , , , 
Combination Chemoprevention: Prevention of Both ER-Positive & ER-Negative BC,8182280, , ,Research Centers,2009, ,156407, , , , 
Career Development Program,8182288, , ,Research Centers,2010, ,81995, , , , 
Combination Chemoprevention: Prevention of Both ER-Positive & ER-Negative BC,8182291, , ,Research Centers,2010, ,239733, , , , 
Breast Cancer Therapeutic Agents Based on Telomerase Misfunction,8182301, , ,Research Centers,2010, ,216874, , , , 
p63/p73 Signaling Axis as a Target for Treatment of Triple-Negative Breast Cancer,8182320, , ,Research Centers,2010, ,348538, , , , 
Outreach and Dissemination,8182412, , ,Research Centers,2010, ,102000, , , , 
P63 mechanisms and mediators in HNSCC,8183247,4/1/2004 0:00,7/31/2016 0:00,Non-SBIR/STTR,2011,435320, ,NIDCR, , ,435320
Mitochondrial p32 regulation of the Mdm2-p53 tumor suppression signaling and apop,8186498,7/1/2012 0:00,4/30/2017 0:00,Non-SBIR/STTR,2012,307100, ,NCI,207500,99600,307100
TOR signaling and autophagy in obesity-promoted liver tumorigenesis,8187381,7/22/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2011,352646, ,NCI, , ,352646
A comprehensive approach to breast cancer susceptibility across the risk spectrum,8187594,7/5/2011 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011,572952, ,NCI, , ,572952
Monitoring mechanisms in mammalian ribosome biogenesis,8187767,2/1/2005 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011,294450, ,NIGMS, , ,294450
Hair Cell Development,8187819,4/1/2005 0:00,6/30/2016 0:00,Non-SBIR/STTR,2011,333625, ,NIDCD, , ,333625
Restoration of Tumor Suppression Activity in Malignant Melanoma,8188169,7/1/2006 0:00,4/30/2016 0:00,Non-SBIR/STTR,2011,480848, ,NCI, , ,480848
A Phase I trial combining fenretinide and safingol to target overproduction of di,8188810,7/1/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,323700, ,NCI, , ,323700
Targeting Oncogene Expression to Skin in Transgenic Mice,8189533,8/1/1990 0:00,7/31/2016 0:00,Non-SBIR/STTR,2011,480576, ,NCI, , ,480576
PET TUMOR AND PROLIFERATION IMAGING VIA CATIONIC AMINO ACID TRANSPORT,8189751,9/1/2011 0:00,8/31/2016 0:00,Other Research-Related,2011,157715, ,NCI, , ,157715
The Role of AGR2 in a Murine Model of Pancreatic Adenocarcinoma,8189795,7/1/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,182116, ,NCI, , ,182116
The role of ribosomal proteins in the p53-MDM2 pathway,8190953,3/1/2002 0:00,12/31/2011 0:00,Non-SBIR/STTR,2011,109898, ,NCI, , ,109898
Homologous Recombination in Genome Stability and Tumor Suppression,8193118,6/8/2009 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,350219, ,NCI, , ,350219
BRCA1 and progesterone receptors in breast cancer,8193128,9/1/2009 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,314392, ,NCI,205485,108907,314392
Mechanisms of p53 activation in tumorsuppression,8193161,5/15/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2011,301949, ,NCI, , ,301949
"Interplay of Myc, Tumor Supressors and Regulators of Differentiation in Lymphoma",8193172,12/15/1997 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,363164, ,NCI, , ,363164
Mechanisms of Pituitary Tumorigenesis,8193175,12/15/1998 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,277093, ,NCI, , ,277093
Tip60 in p38 and PRAK Mediated Oncogene-Induced Senescence and Tumor Suppression,8193191,6/1/2009 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,382221, ,NCI, , ,382221
Walleye Dermal Sarcooma Virus Accessory Protein Function,8193193,6/1/2002 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,229962, ,NCI, , ,229962
Molecular Pathogenesis of Basal-like Breast Cancer,8193212,4/18/2003 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,1196635, ,NCI, , ,1196635
Role of Id1 in NSCLC Progression and Metastasis,8193233,7/17/2009 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,344596, ,NCI,206345,138251,344596
Epigenetic Regulation of Medulloblastoma,8193237,6/8/2009 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,348876, ,NCI, , ,348876
Novel Roles of p53 & ROS in Therapy of Refractory CLL,8193251,5/1/2003 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,290708, ,NCI, , ,290708
Role of hsnf5/BAF47 Loss in Human Cancer Development,8193258,3/1/2002 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,258378, ,NCI, , ,258378
Distinct Pathways of VPF/VEGF Receptors,8193287,4/1/2002 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011,394250, ,NHLBI, , ,394250
"Interactions between NEDD9, AURKA, and p53 in mammary tumor development",8193998,9/1/2010 0:00,10/4/2011 0:00,"Training, Individual",2011,4847, ,NCI, , ,4847
Mechanisms of CDX2 regulation of the IGF axis,8195254,4/1/2009 0:00,9/30/2013 0:00,Non-SBIR/STTR,2012, , , , , , 
Role of p53 homologs in DNA repair in human keratinocytes,8195895,10/1/2009 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012, , , , , , 
Characterization of Human Epidermal Stem Cells,8196340,10/1/2010 0:00,9/30/2014 0:00,Non-SBIR/STTR,2012, , , , , , 
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis,8196709,1/1/2009 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,302917, ,NCI,201275,101642,302917
p63 and p73 Signaling in Cell Growth and Cancer,8196710,3/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2012,302956, ,NCI,194203,108753,302956
Chemical Modulators for p53 Functions in Transcriptional Regulation,8196764,12/11/2009 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,307045, ,NCI,181148,125897,307045
Prostate cancer chemoprevention by penta-galloyl-glucose,8196800,1/1/2009 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,303925, ,NCI,201275,102650,303925
MDM2 regulates XIAP gene expression in cancer treatment,8196828,12/15/2007 0:00,11/30/2012 0:00,Non-SBIR/STTR,2012,249581, ,NCI,161020,88561,249581
Function and regulation of MDMX,8196878,7/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2012,264493, ,NCI,158379,106114,264493
Role of an unusual GTPase in DNA damage response and carcinogenesis,8196879,12/1/2007 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,341652, ,NCI,201275,140377,341652
Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors,8196983,12/7/2007 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,291849, ,NCI,201275,90574,291849
Anticarcinogenic Effect of ITCs Against Prostate Cancer,8197159,7/14/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,319332, ,NCI,210780,108552,319332
Regulations of DNA Alkylation/Deamination Damage Repair,8197229,3/1/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,258838, ,NCI,168624,90214,258838
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str,8197881,2/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,526470, ,NCI,417094,109376,526470
Identifying novel p53 target genes that mediate tumor suppression,8199419,7/15/2011 0:00,7/14/2014 0:00,"Training, Individual",2011,47714, ,NCI, , ,47714
Endocrine Targets for Prevention of Lung Cancer,8203950,7/6/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,77000, ,NCI, , ,77000
Optimization of DNA Repair by Abh8,8203982,3/1/2012 0:00,2/28/2015 0:00,"Training, Individual",2012,62030, ,NIEHS,62030, ,62030
Self-renewal of Normal and Leukemic Stem Cells,8204437,9/20/2004 0:00,11/30/2015 0:00,Non-SBIR/STTR,2012,290764, ,NCI,174939,115825,290764
Role of Sphingosine Kinase 1 in the p53-dependent DNA Damage Response,8204515,12/1/2009 0:00,5/31/2012 0:00,"Training, Individual",2012,26545, ,NIEHS,26545, ,26545
Role of a novel Notch1 target gene in skin carcinogenesis,8204559,3/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,308148, ,NCI,181148,127000,308148
Functional Analysis of p53 Polymorphic Variants,8204566,6/1/2005 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,316755, ,NCI,187097,129658,316755
Berberine downregulates MDM2 by interaction with DAXX in cancer cells,8204584,1/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,311976, ,NCI,201275,110701,311976
Probes for Cytometry,8204589,10/1/1990 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,389810, ,NCI,245164,144646,389810
Normal and Neoplastic Regulation of Cyclin E,8204660,7/1/2003 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,370973, ,NCI,210780,160193,370973
Mycn and Medulloblastoma,8204726,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,310970, ,NCI,201275,109695,310970
"Telomerase in Development, Senescence and Neoplasia",8204771,1/1/2000 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,632123, ,NCI,400078,232045,632123
Mechanisms of Mdm2/Mdmx in repressing p53,8204788,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,321800, ,NCI,201275,120525,321800
Investigating the role of p73 and its isoforms in tumorigenesis and metastasis,8205003,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,309964, ,NCI,201275,108689,309964
The ARF Tumor Suppressor,8205015,1/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,340759, ,NCI,201275,139484,340759
Regulation of Basal-Like and Her2+ Breast Cancer Phenotypes by IKK/NF-kappaB,8205037,2/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,296590, ,NCI,201275,95315,296590
Rad50: Roles in chromo. stab. and prev. of malignancy,8206097,1/1/1998 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011,522435, ,NIGMS, , ,522435
Molecular mechanisms of GBM radioresistance and strategies for radiosensitization,8206502,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2012,329234, ,NCI,207500,121734,329234
Mouse Models to Dissect p53 Tumor Suppressor Function,8206557,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2012,342990, ,NCI,207500,135490,342990
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention,8206642,6/1/2005 0:00,11/30/2015 0:00,Non-SBIR/STTR,2012,285581, ,NCI,187266,98315,285581
Targeting invasion and DNA DSB repair in glioma with a multi-pronged approach.,8206662,12/15/2010 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,195098, ,NCI,130500,64598,195098
"Phosphosulindac, miRNAs and cancer racial disparity",8206690,2/5/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,314194, ,NCI,201275,112919,314194
Regulation of Myc-Mediated Tumorigenesis,8206707,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2012,389664, ,NCI,250000,139664,389664
Molecular mechanisms in the regulation of p53 functions by PAD4,8206717,2/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,260799, ,NCI,181148,79651,260799
Regultion of p53 Deubiquitination,8206756,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2012,327228, ,NCI,207500,119728,327228
Nuclear Function of Abl in DNA Damage Response,8206811,8/1/1986 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,398601, ,NCI,257994,140607,398601
Lapatinib and Obatoclax combination therapy,8206853,7/7/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,338520, ,NCI,226435,112085,338520
The role of melanocyte precursors in zebrafish pigmentation disorders,8207200,1/1/2009 0:00,4/30/2012 0:00,Other Research-Related,2012,33620, ,NIAMS,31130,2490,33620
RECEPTOR-TARGETED COPPER RADIOPHARMACEUTICALS FOR CANCER IMAGING AND THERAPY,8207274,7/18/1994 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,327244, ,NCI,233470,93774,327244
Adenovirus E1B55K Functions Related to Oncolytic Replication,8207278,3/1/2009 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,268099, ,NCI,181148,86951,268099
The role of DNA polymerase eta in DNA damage response and p53 activation,8207293,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,278590, ,NCI,181148,97442,278590
Humanized Mouse Models for the p53 R72P SNP,8207922,12/1/2008 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,289698, ,NIEHS,215602,74096,289698
The Role of Syndecan-1 in Mouse Mammary Neoplasia,8208068,12/21/2001 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,286318, ,NCI,195072,91246,286318
Molecular Targeting of Diffuse Large B-cell Lymphoma,8208201,1/20/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,571087, ,NCI,403932,167155,571087
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1,8208236,4/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2012,295769, ,NCI,201275,94494,295769
Tumor Suppression,8208593, ,12/31/2011 0:00,Non-SBIR/STTR,2011, ,674249, , , , 
Growth Control and Genomic Stability,8208697, , ,Research Centers,2011, ,23578, , , , 
Career Development Program,8208778, , ,Research Centers,2011, ,78222, , , , 
Combination Chemoprevention: Prevention of Both ER-Positive & ER-Negative BC,8208781, , ,Research Centers,2011, ,227821, , , , 
Transcriptional dynamics and cellular function of p53 pulses,8208936,7/2/2010 0:00,7/1/2013 0:00,"Training, Individual",2011,51326, ,NIGMS, , ,51326
Mechanisms of Synergistic Regulation of Stem/Progenitors,8209131,4/1/1996 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,381150, ,NHLBI,247500,133650,381150
Mechanisms and Treatment of PTEN Mutant Prostate Tumorigenesis,8209199,4/1/2010 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,301376, ,NCI,161020,140356,301376
Role of MetAP-2 in Angiogenesis and Wnt Signaling,8209206,7/9/1999 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,406626, ,NCI,245695,160931,406626
p53 Family in Gastric Cancer Development,8209272,8/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,349658, ,NCI,224140,125518,349658
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells,8209289,3/17/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,491675, ,NCI,394937,96738,491675
P38 MAPK in Ras-induced Senescence and Transformation,8209298,7/1/2005 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,319767, ,NCI,168387,151380,319767
The Roles of HBXAP Gene in Ovarian Cancer,8209302,4/1/2008 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,330091, ,NCI,201275,128816,330091
Molecular Pathogenesis of Diamond Blackfan Anemia,8210812,1/7/2010 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,463934, ,NHLBI,390717,73217,463934
Prevention of Melanoma by Targeting Tyrosinase with Dietary Quercetin,8210852,1/4/2011 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,197708, ,NCI,130500,67208,197708
Mechanisms of Intestinal Tumorigenesis,8210876,1/1/2000 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,380306, ,NCI,243724,136582,380306
Targets and functions of the Kaposi's Sarcoma associated herpesvirus microRNAs,8210877,1/5/2011 0:00,12/31/2012 0:00,Non-SBIR/STTR,2012,241531, ,NCI,158381,83150,241531
Role of p300/CBP and hHR23 Proteins in p53 Regulation,8210879,4/19/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,254463, ,NCI,174781,86517,254463
Cell Growth Signaling in Cancer Development,8210915,4/8/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2012,402576, ,NCI,206449,196127,402576
Targeting ROS by a p53-activating agent for selective killing of cancer cells,8210987,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,348111, ,NCI,201275,146836,348111
Analysis of the p53  in vivo using a unique mouse model,8211077,3/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2012,330583, ,NCI,213970,116613,330583
Regulations of DNA Alkylation/Deamination Damage Repair,8211695,3/1/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2011,57705, ,NCI, , ,57705
Mechanisms of Cancer Initiation by TRIM32,8211801,5/15/2003 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,55352, ,NCI, , ,55352
The Role of Ape1 in Neurotoxicity of Cancer Treatments,8212064,4/1/2008 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,405107, ,NCI,270282,134825,405107
Coordinately regulated alternative splicing in DNA damage and cancer,8212306,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,260853, ,NCI,181148,79705,260853
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling,8212403,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2012,304127, ,NCI,201275,102852,304127
Defining critical p53 therapeutic targets and mechanisms,8212429,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,381215, ,NCI,201275,179940,381215
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12,8212478,8/1/2002 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,288173, ,NCI,165346,122827,288173
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy,8212513,3/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,303684, ,NCI,201275,102409,303684
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck Cancer,8212521,3/2/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,579943, ,NCI,376586,203357,579943
Role of p53 in cell cycle checkpoints,8212549,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,341162, ,NCI,201275,139887,341162
Oncogenic Function of a P53-Induced Phosphatase,8212550,4/1/2003 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,258838, ,NCI,168624,90214,258838
MDM2 AS A NEGATIVE REGULATOR OF P21 WAF1/CIP1,8212967,1/1/2005 0:00,8/31/2014 0:00,Non-SBIR/STTR,2009,109000, ,NCI, , ,109000
Dietary Chemopreventive Components/Oncogene Interaction and Cancer,8212971,8/1/2007 0:00,5/31/2012 0:00,Non-SBIR/STTR,2010,275500, ,NCI, , ,275500
Host Immunity to EBV Infection in Vitro and in VIvo,8213413,9/1/1981 0:00,1/31/2013 0:00,Non-SBIR/STTR,2012,404291, ,NIAID,245025,159266,404291
Functions of Papillomavirus E6,8213518,4/8/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,299935, ,NCI,194763,105172,299935
Prostate Cancer Prevention by Diallyl Trisulfide,8213680,4/1/2005 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,318883, ,NCI,210484,108399,318883
High Throughput Screening,8214137, , ,Research Centers,2011, ,120143, , , , 
Functional study of C53 protein as a novel regulator of checkpoint kinases,8214566,4/1/2008 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,249232, ,NIGMS,166617,82615,249232
Disrupting Protein-Protein Interactions With Bis-peptides,8214581,1/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2012,297520, ,NIGMS,200000,97520,297520
CDK6 in T cell development and cancer,8214597,1/15/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012,324053, ,NCI,201275,122778,324053
Dynamics of Signaling Pathways: Mechanism and Function,8214599,3/1/2008 0:00,5/31/2013 0:00,Non-SBIR/STTR,2012,315642, ,NIGMS,186219,129423,315642
A metabolic role for PML in tumor suppression,8214636,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,350219, ,NCI,201275,148944,350219
Rapamycin-Induced Selective Apoptosis in Malignant Cells,8214684,12/1/1998 0:00,1/31/2013 0:00,Non-SBIR/STTR,2012,256452, ,NCI,178092,78360,256452
Targeting of MDM2 Family Proteins in Cancer,8214728, ,1/31/2013 0:00,Non-SBIR/STTR,2011, ,312894, , , , 
Development of Proteasome Selective Inhibitors for Cancer Therapy,8214730, ,1/31/2013 0:00,Non-SBIR/STTR,2011, ,293420, , , , 
Mechanisms of Cancer Initiation by TRIM32,8214969,5/15/2003 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,334297, ,NCI,217076,117221,334297
MODELING  AND RESCUE OF DBA IN THE MOUSE,8215485,4/1/2010 0:00,9/30/2011 0:00,Non-SBIR/STTR,2010,80951, ,NIDDK, , ,80951
Genetic Mouse Models of Glioma,8215765,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,389384, ,NCI,248015,141369,389384
Role of ROS-Induced DNA Damage in Mitochondria-Regulated Apoptosis,8215775,2/1/2009 0:00,6/2/2012 0:00,"Training, Individual",2012,18000, ,NIEHS,18000, ,18000
Biological Effects of DNA Adducts Formed by Nitroaromatic Compounds,8215783,2/1/1998 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,314569, ,NIEHS,250511,64058,314569
Mechanisms of Chemoprevention by Isothiocyanates,8215897,9/1/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,315882, ,NCI,205786,110096,315882
The Role of White Matter Progenitors in Glioma Formation and Progression,8215905,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,345144, ,NINDS,214375,130769,345144
Energy Restrction and Mammary Cancer,8215928,8/1/1990 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,313329, ,NCI,213149,100180,313329
Re-replication of chromosomes and cancer,8215929,7/11/1994 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,321644, ,NCI,213149,108495,321644
The in vivo role of the mitochondrial p53 cell death program,8215931,9/15/1993 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,266225, ,NCI,170519,95706,266225
Genetic Analysis of the Breast Tumor Microenvironment,8216206,9/15/2004 0:00,5/31/2017 0:00,Non-SBIR/STTR,2012,1574165, ,NCI,1103621,470544,1574165
USC Research Center for Liver Disease,8217274,3/1/1997 0:00,2/28/2015 0:00,Research Centers,2012,1215000, ,NIDDK,750000,465000,1215000
Dysregulation of microRNAs in HPV-Positive Oropharyngeal Cancers,8217299,1/15/2010 0:00,5/31/2012 0:00,"Training, Individual",2012,19500, ,NIDCR,19500, ,19500
Mechanism of chemoresistance mediated by TGF-beta,8217621,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,348600, ,NCI,207500,141100,348600
Enhancing Direct Tumor Cell Cytotoxicity By Manipulating Growth Factor Signaling,8219259,9/7/2001 0:00, ,Non-SBIR/STTR,2011, ,200288, , , , 
Murine Model of HCV-Associated Human Liver Cancer,8219397,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,470695, ,NCI,318037,152658,470695
Mechanisms of Metabolic Gene Mutations in Cancer,8219796,3/1/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2012,357100, ,NCI,241284,115816,357100
Basal cell carcinomas: p53-dependent mechanisms of resistance,8219815,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,336150, ,NCI,207500,128650,336150
Role of the Mullerian Tract in Ovarian Cancer Development,8220923,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,326066, ,NCI,201275,124791,326066
Therapeutic Targeting of Oncogenic Stress in Cancer Treatment,8220946,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,308957, ,NCI,201275,107682,308957
In vivo murine models of metastasis for therapeutic testing,8221401,4/16/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,412209, ,NCI,343389,68820,412209
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis,8222362,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,332000, ,NCI,207500,124500,332000
Regulation WRN deacetylation by SIRT1 after DNA damage,8223204,2/15/2008 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,228872, ,NIA,165131,63741,228872
Epigenomic Markers of HNSCC Survival Across Ethnic Groups,8224636,9/22/2011 0:00,8/31/2014 0:00,Other Research-Related,2011,136119, ,NCI, , ,136119
FOXO1 Inhibition in Genotoxic Stress Response and Prostate Cancer Survival,8225265,6/16/2009 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,317411, ,NCI,201275,116136,317411
"Studying the initiation, progression and therapy of lung cancer in mouse models",8225394,4/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,338369, ,NCI,219009,119360,338369
Signal Transduction by Non-transmembrane PTPs,8225410,12/1/1988 0:00,1/31/2013 0:00,Non-SBIR/STTR,2012,332791, ,NCI,308140,24651,332791
Non-invasive sampling of DNA markers for pancreatic cancer screening,8227305,3/1/2012 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,161005, ,NCI,108750,52255,161005
Therapeutic implication of estrogen receptor-p53 interaction in mitochondria,8227316,3/1/2012 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,221025, ,NCI,130500,90525,221025
DUSP26: A Novel Therapeutic Target in Neuroblastoma,8227975,3/1/2011 0:00,2/28/2015 0:00,Non-SBIR/STTR,2012,342344, ,NINDS,218750,123594,342344
Regulation of Ionizing Radiation Induced DNA Damage Response,8228072,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,299095, ,NCI,201275,97820,299095
Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer,8228620,8/8/2012 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,212556, ,NCI,147378,65178,212556
A novel murine model for metastatic islet cell pancreas cancer,8229338,3/1/2012 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,219599, ,NCI,130500,89099,219599
Role of TRPM1 (Melastatin1) in the Biology of Human Melanocytes,8230668,3/1/2008 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,310496, ,NIAMS,209088,101408,310496
The replication checkpoint and genomic fidelity in skin,8230674,9/1/2003 0:00,2/28/2015 0:00,Non-SBIR/STTR,2012,355511, ,NIAMS,214163,141348,355511
Development of cambinol analogues as antilymphoma agents,8230766,4/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2012,354244, ,NCI,201275,152969,354244
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas,8230806,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,318015, ,NCI,201275,116740,318015
Chemopreventition and treatment of non-melanoma skin cancer by targeting MIF,8230915,4/1/2012 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,76250, ,NCI,50000,26250,76250
Hdac3 as a therapeutic target in BCL6-dependent lymphoma,8230922,2/20/2012 0:00,1/31/2017 0:00,Non-SBIR/STTR,2012,404499, ,NCI,259294,145205,404499
"Signal Transduction by the Microtubule Destabilizer, Stathmin/Oncoprotein 18",8231184,3/1/2012 0:00,9/28/2015 0:00,Non-SBIR/STTR,2012,365344, ,NIGMS,228000,137344,365344
Ecd as a regulator of cell cycle and breast oncogenesis,8231335,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2012,308138, ,NCI,207500,100638,308138
Understanding the Structural Mechanism of Puma-induced Apoptosis,8231350,4/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,329314, ,NIGMS,196020,133294,329314
c-Met/PTEN Interactions in Gliomas,8231374,7/15/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2012,324778, ,NINDS,214375,110403,324778
The Role of PKR in a Novel IL-3 Signal Transduction Pathway,8231409,4/1/1996 0:00,2/28/2013 0:00,Non-SBIR/STTR,2012,362588, ,NHLBI,247500,115088,362588
Functional Determinants of Metastatic Dormancy,8231510,4/1/2005 0:00,6/30/2015 0:00,Non-SBIR/STTR,2012,102880, ,NCI,60696,42184,102880
Molecular Epidemiology of DNA Repair in Head and Neck Cancer,8231996,3/1/2008 0:00,8/31/2013 0:00,Non-SBIR/STTR,2012,513356, ,NIEHS,333348,180008,513356
Medulloblastoma and Metastases,8232156,5/4/2010 0:00,2/28/2015 0:00,Non-SBIR/STTR,2012,488139, ,NCI,388081,100058,488139
Molecular Pathogenesis of Diamond Blackfan Anemia,8232237,1/7/2010 0:00,11/7/2011 0:00,Non-SBIR/STTR,2011,70326, ,NHLBI, , ,70326
Coordinate Regulation of p53 and c-MYC in an HTLV-1 Model of Carcinogenesis,8232612,3/1/2012 0:00,8/31/2016 0:00,Non-SBIR/STTR,2012,435686, ,NCI,300000,135686,435686
The Role of Polyoma Small T in Regulating Cell Survival,8233030,4/1/2011 0:00,3/31/2014 0:00,Non-SBIR/STTR,2011, ,561713, , , , 
Papillomavirus E2 Growth Suppression Mechanisms,8233032,4/1/2011 0:00,3/31/2014 0:00,Non-SBIR/STTR,2011, ,567154, , , , 
Biomarkers for Margin Analysis and Prognosis in HNSCC,8233426,9/1/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,402929, ,NIDCR,256066,146863,402929
Cancer Biology in the Zebrafish,8233548,7/3/2003 0:00,2/28/2013 0:00,Non-SBIR/STTR,2012,366757, ,NCI,210780,155977,366757
Repair of Endogenous Damage in Mammalian Genomes,8233795,2/11/1991 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011,332969, ,NCI, , ,332969
Plk1-Numb Cooperation in Melanomagenesis,8233812,10/1/2012 0:00,9/30/2016 0:00,Non-SBIR/STTR,2013, , , , , , 
Role of beta-endorphin in cancer therapy induced fatigue,8233976,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2012,353580, ,NCI,207500,146080,353580
Gonadotropins & Cox-2 in Ovarian Cancer Prevention,8234158,5/1/2003 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,375915, ,NCI,259444,116471,375915
Properties and regulation of p53 in tumor cells,8234200,3/23/1999 0:00,2/28/2015 0:00,Non-SBIR/STTR,2012,306934, ,NCI,191834,115100,306934
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas,8234371,5/3/2011 0:00,7/31/2013 0:00,Non-SBIR/STTR,2010,311250, ,NCI, , ,311250
Tumor Suppression,8234417,1/1/2012 0:00,12/31/2016 0:00,Non-SBIR/STTR,2012, ,622362, ,337869,284493, 
Biomarkers in Head and Neck Cancer Progression,8234862,4/17/2009 0:00,3/31/2014 0:00,Other Research-Related,2012,94454, ,NIDCR,87457,6997,94454
Aflatoxin Biosynthesis and Iterative Type I Polyketide Synthases,8235035,2/1/1978 0:00,3/31/2013 0:00,Non-SBIR/STTR,2012,434109, ,NIEHS,274873,159236,434109
Mutagenesis of p53 by reactive PAH and ROS,8235068,4/8/2008 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,307277, ,NIEHS,198470,108807,307277
Immune Therapy,8235336,12/1/2011 0:00,8/31/2017 0:00,Non-SBIR/STTR,2012, ,252787, ,210436,42351, 
Discovery of New Genes for Inherited Predisposition to Breast Cancer by Exome Seq,8235783,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2012,571278, ,NCI,366204,205074,571278
Mechanistic Studies on New Platinum Clinical Agents,8235958,9/30/1998 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,303155, ,NCI,206343,96812,303155
The Function of rpL5 and rpL11 in induction of p53,8236578,3/1/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2012,325775, ,NCI,207500,118275,325775
Mouse models of genomic instability and birth defects,8236796,4/1/2009 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,300453, ,NICHD,201960,98493,300453
Role of nutrient sensor O-GlcNAc transferase in regulating cancer,8236855,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2012,322051, ,NCI,214821,107230,322051
Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer,8236878,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2012,303988, ,NCI,207500,96488,303988
"Mitosis, Aneuploidy and Cancer",8236923,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2012,304917, ,NCI,207500,97417,304917
Role of Rb Family in Lung Epithelial Response to Injury,8237025,4/1/2005 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,378675, ,NHLBI,247500,131175,378675
PCAF/GCN5 Acetylation on p53 Transactivation,8237068,4/1/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,340975, ,NCI,216492,124483,340975
OLIG2 Phosphorylation as a Drug Target for Glioma,8237120,7/15/2007 0:00,5/31/2016 0:00,Non-SBIR/STTR,2011,432675, ,NINDS, , ,432675
Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway,8237147,7/17/1995 0:00,11/30/2016 0:00,Non-SBIR/STTR,2012,332383, ,NCI,224583,107800,332383
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy,8238648,3/1/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2012,393213, ,NCI,207500,185713,393213
Oncogene c-Myc-dependent pathways in cutaneous melanoma03,8238865,12/11/2006 0:00,11/30/2016 0:00,Non-SBIR/STTR,2012,320646, ,NCI,186942,133704,320646
Mechanisms of p53 activation during stress response,8239981,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,336129, ,NCI,201275,134854,336129
Modulation of sensitivity & imaging therapeutic response of hypoxic cancer cells,8239984,5/18/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,312178, ,NCI,201275,110903,312178
Prevention of UV-induced carcinogenesis by cyanidin-3-glucoside,8240040,8/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2012,334125, ,NIEHS,225000,109125,334125
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression,8240326,9/19/2011 0:00,8/31/2013 0:00,Other Research-Related,2011,116600, ,NCI, , ,116600
FDH: A Novel Determinant of Tumor Suppression,8240898,3/1/2005 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,248371, ,NCI,168387,79984,248371
Regulation of NF-Kappa B,8241127,9/30/2000 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,714981, ,NIAID,375318,339663,714981
"The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer",8241130,2/1/2010 0:00,11/30/2014 0:00,Non-SBIR/STTR,2012,312891, ,NCI,208374,104517,312891
Characterization of Oncogenic Transcription Factor-Associated Proteins in SCC,8241273,8/2/2012 0:00,7/31/2014 0:00,Other Research-Related,2012,134729, ,NCI,124749,9980,134729
Role of p53 polymorphisms in disparities in breast carcinogenesis and outcome .,8241660,3/13/2011 0:00,2/29/2012 0:00,Non-SBIR/STTR,2012,79000, ,NIMHD,50000,29000,79000
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8241949,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2012,323700, ,NCI,207500,116200,323700
Regulation of Lung Cancer Metastasis by miR-200,8241956,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2012,324729, ,NCI,237294,87435,324729
Novel therapeutic targets for Diamond Blackfan anemia and other ribosomopathies,8242511,4/9/2012 0:00,2/28/2017 0:00,Other Research-Related,2012,157248, ,NIDDK,145600,11648,157248
"Race, pathomolecular signature and colorectal cancer survival",8242520,9/21/2011 0:00,8/31/2016 0:00,Other Research-Related,2011,130415, ,NCI, , ,130415
Virus-gene interactions during hepatic carcinogenesis,8243431,9/12/2011 0:00,8/31/2013 0:00,Non-SBIR/STTR,2011,168019, ,NCI, , ,168019
Collaborating Mutations in Medulloblastoma,8243629,4/1/2003 0:00, ,Non-SBIR/STTR,2011, ,320629, , , , 
EWS-Fli1 fusion protein and Ewing's sarcoma,8243798,1/1/2012 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012, , , , , , 
Peripheral blood biopsy for molecular diagnosis of pancreatic cancer,8243834,3/1/2012 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,266061, ,NCI,200721,65340,266061
Characterization of prostatic stem cells and prostate cancer-initiating cells,8244661,9/1/2007 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011,56457, ,NCI, , ,56457
Molecular dissection of pancreatic ductal adenocarcinoma,8244677,9/21/2007 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,86115, ,NCI, , ,86115
Impact of molecular phenotype on glioma metabolism and growth,8245016,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2012,413275, ,NCI,339713,73562,413275
Acid- and salt-dependent interactions in proteins,8245096,5/1/1998 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,295911, ,NIGMS,259589,36322,295911
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance,8245147,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,316002, ,NCI,201275,114727,316002
Integrative genomic characterization of lung cancer metastasis in mouse and human,8245161,9/30/1999 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,741628, ,NCI,441445,300183,741628
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival,8245331,7/17/2009 0:00,12/30/2011 0:00,Non-SBIR/STTR,2010,32189, ,NCI, , ,32189
The MRAD9 Radioresistance Gene,8245890,12/1/2000 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,334719, ,NIGMS,207900,126819,334719
Quantitative Measurements and Modeling of the Mitotic Checkpoint,8245903,9/28/2007 0:00,8/31/2012 0:00,Non-SBIR/STTR,2011,25810, ,NIGMS, , ,25810
Suppression of Mammary Tumorigenesis by Stromal p53,8246042,9/15/2004 0:00,5/31/2017 0:00,Non-SBIR/STTR,2012, ,301062, ,233841,67221, 
Next generation strategies to intercept ErbB signaling,8246949,4/25/1997 0:00,3/31/2013 0:00,Non-SBIR/STTR,2012,230201, ,NCI,213149,17052,230201
Role of IL-6/STAT3 Signaling in the Neoplastic Progression of Barrett's Esophagus,8246950,10/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2012, , , , , , 
p53 Acetylation and Deacetylation in Tumorigenesis,8247132,4/1/2000 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,285072, ,NCI,179838,105234,285072
Mechanisms of cell competition that regulate growth during development,8247726,8/1/2006 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,318031, ,NIGMS,200000,118031,318031
Mechanisms of MnSOD expression in normal and tumor cells,8248797,12/1/1989 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,239153, ,NCI,161046,78107,239153
Functional Analysis of the HPV-16 E6 and E7 Oncogenes,8248998,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2012,364908, ,NCI,247943,116965,364908
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D,8249094,5/1/1995 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,430613, ,NCI,239078,191535,430613
Mechanisms of Liver Cell Injury,8249101,9/30/1992 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,323955, ,NIDDK,205425,118530,323955
Expression of Simiam Virus 40 T Antigens in Intestine,8249117,7/1/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,312819, ,NCI,225535,87284,312819
Curcumin inhbits BPDE-induced damage by lowering the threshold of p53 activation,8249259,5/1/2008 0:00,8/31/2011 0:00,"Training, Individual",2011,11052, ,NIEHS, , ,11052
The role of Aurora Kinase A in Upper Gastrointestinal Adenocarcinomas,8249502,6/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,313989, ,NCI,201275,112714,313989
Role of MicroRNA 363 in HPV-positive oral cancer,8249577,12/1/2011 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,188345, ,NIDCR,125000,63345,188345
The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAs,8249919,4/8/2010 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,339026, ,NIEHS,234779,104247,339026
DNA Methyltrasferase Gene Expression in Colon Cancer,8250014,4/1/1991 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,559188, ,NIEHS,340968,218220,559188
Molecular Pathogenesis of Multiple Myeloma,8250027,6/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,322040, ,NCI,201275,120765,322040
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis,8250149,1/16/2012 0:00,10/31/2016 0:00,Non-SBIR/STTR,2012,400910, ,NIEHS,250569,150341,400910
"Structure, Function and Inhibition of Human Methionine Aminopeptidases",8250456,6/1/2008 0:00,4/30/2013 0:00,Non-SBIR/STTR,2012,365100, ,NCI,222622,142478,365100
Cyclophilin B as a therapeutic target in glioblastoma,8250731,9/1/2011 0:00,7/31/2016 0:00,Non-SBIR/STTR,2011,344969, ,NINDS, , ,344969
Breast Cancer Therapeutic Agents Based on Telomerase Misfunction,8250839, , ,Research Centers,2011, ,179402, , , , 
GI Hormones and Other Factors in Growth of Mucosa,8251207,12/1/1977 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,509243, ,NIDDK,344083,165160,509243
Development of a Urine Test for the Early Detection of Liver Cancer,8251282,7/1/2012 0:00,6/30/2013 0:00,SBIR/STTR,2012,247245, ,NCI, , ,247245
Testing of novel anti-cancer compounds Curaxins against pancreatic cancer,8251334,9/5/2012 0:00,8/31/2014 0:00,SBIR/STTR,2012,300000, ,NCI, , ,300000
Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette Smoke,8251949,5/1/2008 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,274285, ,NCI,186238,88047,274285
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",8252212,7/1/2010 0:00,12/31/2012 0:00,Non-SBIR/STTR,2012,274495, ,NCI,193306,81189,274495
The role of p63 and p73 in cancer,8252224,1/14/2002 0:00,4/30/2013 0:00,Non-SBIR/STTR,2012,305188, ,NCI,195368,109820,305188
Early Detection of Pancreatic Cancer Using Ice COLD-PCR,8252496,8/1/2012 0:00,7/31/2013 0:00,SBIR/STTR,2012,100000, ,NCATS, , ,100000
Aspects of MUC13 Mucin in Cancer,8253728,7/1/2010 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,307413, ,NCI,210117,97296,307413
Hypoxia and Gene Repression,8253790,7/1/2000 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,324299, ,NCI,201307,122992,324299
Tumor Suppressor Qualities and Mechanisms of LZAP Activity,8253811,4/1/2000 0:00,7/31/2012 0:00,Non-SBIR/STTR,2012,301256, ,NIDCR,193113,108143,301256
Cellular plasticity and survival mechanisms in medulloblastoma stem cells,8254841,3/1/2012 0:00,2/28/2014 0:00,"Training, Individual",2012,29473, ,NCI,29473, ,29473
The role of the Ras effector Nore1a in tumor suppression,8255335,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,271722, ,NCI,181148,90574,271722
The Role of MDM Proteins in Cell Growth and Tumorigenesis,8255364,3/1/1999 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,315567, ,NCI,191834,123733,315567
In vivo function and mechanism of the r-protein-Mdm2-p53 pathway,8255365,8/1/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,309893, ,NCI,210780,99113,309893
Mechanism of P73-Dependent Tumor Suppression,8255465,5/1/1999 0:00,3/31/2016 0:00,Non-SBIR/STTR,2012,304395, ,NCI,197766,106629,304395
Dmp1-p53/YY1 interplays and their roles in lung cancer development,8256617,4/1/2004 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,258676, ,NCI,174781,83895,258676
Altered Proteoglycan Gene Expression and Cancer,8256627,9/1/1988 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,364849, ,NCI,236148,128701,364849
Molecular interactions and restoration strategies of PTEN and p53 in gliomas,8256629,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,309964, ,NCI,201275,108689,309964
Studies on the Post-translational processing of MUC1,8256635,9/1/1992 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,255282, ,NCI,173661,81621,255282
Targeting Glucose Metabolism in Cancer,8256671,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,227884, ,NCI,153976,73908,227884
Mechanisms of RelA Activation in Cancer,8257159,9/19/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,218253, ,NCI,141723,76530,218253
The Sixth International Mdm2 Workshop,8257339,9/19/2011 0:00,8/31/2012 0:00,Other Research-Related,2011,4500, ,NCI, , ,4500
PUMA-mediated apoptosis in human cancer cells,8257564,4/1/2004 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,262120, ,NCI,174781,87339,262120
Regulation of differentiation in esophageal epithelia,8257808,5/1/2006 0:00,2/29/2016 0:00,Non-SBIR/STTR,2012,343580, ,NIDDK,217500,126080,343580
Repair of oxidative DNA damage in mammalian cells,8258256,3/10/2003 0:00,5/31/2016 0:00,Non-SBIR/STTR,2013,230806, ,NCI,155425,75381,230806
Local Immunoregulation of Carcinogenesis,8258630,7/13/2003 0:00,5/31/2015 0:00,Non-SBIR/STTR,2012,349445, ,NCI,214451,134994,349445
The San Francisco Bay Area Adult Glioma Survival Study,8258656, ,4/30/2013 0:00,Research Centers,2011, ,304814, , , , 
Strategies for gene and protein delivery for cancer therapy,8259084,4/1/2010 0:00,3/31/2013 0:00,Non-SBIR/STTR,2012, , , , , , 
Pten-loss Dysregulated Pathways in Prostate Cancer,8259702,9/25/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,362588, ,NIMHD,247500,115088,362588
Imaging Based Dosimetry for Individualized Internal Emitter Therapy,8259729,4/1/1999 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,475299, ,NIBIB,305659,169640,475299
Organic cation transporter 2 and cisplatin nephrotoxicity,8260216,7/12/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,398576, ,NCI,237248,161328,398576
Non-Myeloablative Host Conditioning that Protects Against GVHD,8260363,4/1/2011 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011, ,314384, , , , 
MicroRNA Function in the Immune System,8260519,5/15/2008 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,393265, ,NIAID,245025,148240,393265
Genetic analysis of genomic instability and cancer in zebrafish,8260850,7/1/2008 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,300769, ,NCI,201275,99494,300769
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression,8261509,9/26/2011 0:00,8/31/2016 0:00,Research Centers,2011, ,131120, , , , 
Genomic stability of human pluripotent stem cells,8261878,4/1/2011 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,228310, ,NICHD,137404,107862,228310
p53-GAMT pathway in cancer cell metabolism and DNA damage-induced carcinogenesis,8264382,5/13/2010 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,338903, ,NCI,201275,137628,338903
THE ROLE OF P21 IN THE REPLICATION OF DAMAGED DNA,8264928,6/1/2011 0:00,6/1/2013 0:00,Non-SBIR/STTR,2012,52668, ,FIC,49500,3168,52668
Determinants of Metastatic Progression,8265011,7/23/2002 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,261523, ,NCI,173662,87861,261523
A Functional Census of p53 Cancer and Suppressor Mutants,8265015,8/1/2005 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,361775, ,NCI,241650,120125,361775
Role of PALB2 in the DNA damage response and breast cancer suppression,8265282,7/1/2009 0:00,6/30/2013 0:00,Non-SBIR/STTR,2012,313989, ,NCI,201275,112714,313989
"Interplay of Myc, Tumor Supressors and Regulators of Differentiation in Lymphoma",8265291,12/15/1997 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,363164, ,NCI,183416,179748,363164
Role of EGFR in DNA Repair and Radiation Response in Non Small Cell Lung Cancer,8265309,7/1/2008 0:00,8/31/2012 0:00,Non-SBIR/STTR,2012,60442, ,NCI,31485,28957,60442
INTEGRATION OF ONCOGENIC SIGNALS BY THE NUCLEOLAR ARF-NPM NETWORK,8265314,7/1/2008 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,305938, ,NCI,201275,104663,305938
Regulation and Function of the p14ARF/topoisomerase I Complex in Cancer,8265324,7/10/2008 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,362295, ,NCI,201275,161020,362295
Tip60 in p38 and PRAK Mediated Oncogene-Induced Senescence and Tumor Suppression,8265615,6/1/2009 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,382221, ,NCI,201275,180946,382221
The Role of Cul4A in Genome Stability and Cancer Development,8265657,7/9/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2012,292368, ,NCI,212950,79418,292368
Oligoclonal T Cell Expansion and Rheumatoid Arthritis,8265664,9/30/1993 0:00,5/31/2015 0:00,Non-SBIR/STTR,2012,334541, ,NIAMS,209088,125453,334541
Mechanism of p63-Dependent Tumor Suppression,8265674,7/1/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,288347, ,NCI,189702,98645,288347
Search for the Molecular Causes of Diabetic Embryopathy,8265893,8/1/1998 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,348840, ,NIDDK,216000,132840,348840
Mechanisms of Neuroprotection by Histone Deacetylase Inhibition,8265905,3/1/2008 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,334425, ,NINDS,214375,120050,334425
Transcriptional Repression by Maf1 in Yeast,8265966,3/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,458466, ,NIGMS,276184,182282,458466
P53 Activation as Novel Therapeutic Stratgey for Acute Myelogenous Leukemia,8266534, , ,Research Centers,2011, ,268501, , , , 
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia,8266543,8/5/2003 0:00,8/31/2013 0:00,Research Centers,2012,2300000, ,NCI,1644326,735736,2300000
Regulation of p53 tumor suppressor protein,8266873,2/1/1993 0:00,5/31/2013 0:00,Non-SBIR/STTR,2012,526311, ,NCI,332633,193678,526311
Regulation of p53 by BRCA1 in Breast Cancer,8267245,9/1/2011 0:00,8/31/2014 0:00,"Training, Individual",2012,53942, ,NCI,53942, ,53942
Visualizing the effect of epigenetic modifications on transcription and mutation,8267689,9/15/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2012,376893, ,OD,232650,144243,376893
Homologous Recombination in Genome Stability and Tumor Suppression,8267723,6/8/2009 0:00,5/31/2013 0:00,Non-SBIR/STTR,2012,350219, ,NCI,201275,148944,350219
The Control of Centriole Duplication and Degeneration,8268386,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,355492, ,NIGMS,186219,169273,355492
Radiation-induced Nitric Oxide & Cellular Radiosensitivity,8268474,7/10/2002 0:00,5/31/2013 0:00,Non-SBIR/STTR,2012,266245, ,NCI,178090,88155,266245
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer,8268520,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,313959, ,NCI,201275,112684,313959
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer,8269134,7/15/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2012,312443, ,NCI,202885,109558,312443
Novel Roles of p53 & ROS in Therapy of Refractory CLL,8269564,5/1/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,290708, ,NCI,189703,101005,290708
Enhancing glioma chemotherapy by suppressing Notch signaling,8269695,3/1/1988 0:00,5/31/2015 0:00,Non-SBIR/STTR,2012,352647, ,NINDS,214375,138272,352647
Targeting the MAP and PI3 Kinase Pathways in Melanoma,8270004, , ,Non-SBIR/STTR,2011, ,478396, , , , 
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity,8270007, , ,Non-SBIR/STTR,2011, ,566873, , , , 
Targeted Therapies in Melanoma,8270012,5/16/2008 0:00,8/31/2013 0:00,Non-SBIR/STTR,2012,2395590, ,NCI,1680742,714848,2395590
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,8270086,5/1/1997 0:00,5/31/2017 0:00,Non-SBIR/STTR,2012,1440175, ,NCI,902073,538102,1440175
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer,8270302,3/2/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,340706, ,NIDCR,220522,120184,340706
Role of Focal Adhesion Kinase In Tumorigenesis,8270333,7/1/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,293090, ,NCI,189702,103388,293090
Role of PUMA in EGFR targeted therapy in HNSCC,8270359,8/1/2008 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,304932, ,NCI,201275,103657,304932
p63/p73 Signaling Axis as a Target for Treatment of Triple-Negative Breast Cancer,8270582, , ,Research Centers,2011, ,347326, , , , 
Lipid-Peroxidation Induced Cyclic Adducts in Hepatocarcinogenesis,8271295,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,408225, ,NCI,304302,103923,408225
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development,8271305,7/1/2008 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,330091, ,NCI,201275,128816,330091
Mechanism of p53-Mediated Tumor Suppression,8271329,12/5/1997 0:00,5/31/2013 0:00,Non-SBIR/STTR,2012,296959, ,NCI,195368,101591,296959
Mechanisms of p53 activation in tumorsuppression,8271436,5/15/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2012,301949, ,NCI,189702,112247,301949
Regulation of Mdmx stability and subcellular localization by ubiquitination,8271769,8/14/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2012,302000, ,NCI,188750,113250,302000
Genetic and molecular epidemiology of adult glioma,8272527,5/15/1991 0:00,3/31/2016 0:00,Non-SBIR/STTR,2012,1451972, ,NCI,969656,482316,1451972
Transcriptional Control of Stroma Dependent Apoptosis in MDS,8272668,9/2/2010 0:00,5/31/2015 0:00,Other Research-Related,2012,132957, ,NIDDK,123108,9849,132957
Cell Cycle Check Points,8274463, ,4/30/2013 0:00,Non-SBIR/STTR,2011, ,347625, , , , 
Murine & Human In Vivo Models of Melanoma Formation,8274464, ,4/30/2013 0:00,Non-SBIR/STTR,2011, ,426041, , , , 
"Pubertal high fat diet: effects on inflammation, mammary development and cancer",8274666,9/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,451440, ,NIEHS,454381,236279,451440
Mechanisms of Pituitary Tumorigenesis,8274839,12/15/1998 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,277093, ,NCI,170519,106574,277093
Simultaneous Targeting of p53 to the Nucleus and Mitochondria for Cancer Therapy,8274895,7/1/2010 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,300906, ,NCI,201275,99631,300906
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma,8277112, , ,Research Centers,2011, ,576934, , , , 
Lentiviral Vectors to Model Human Gliomas in Mice,8277324,9/30/1994 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,666121, ,NHLBI,349670,316451,666121
"""Protein protein interaction directed libraries""",8277893,9/1/2010 0:00,12/31/2014 0:00,Research Centers,2012,378150, ,OD,249604,128546,378150
Functional analysis of the p53 tumor suppressor,8278422,8/15/1985 0:00,7/30/2013 0:00,Non-SBIR/STTR,2012,219151, ,NCI,202918,16233,219151
Regulation of the mTOR Pathway By Nutrients,8278465,3/23/2004 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,378696, ,NCI,194203,184493,378696
Biomarkers of survival in glioma epidemiology,8278519,7/1/2008 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,356879, ,NCI,230989,125890,356879
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman),8278588,6/1/2011 0:00,5/31/2013 0:00,Non-SBIR/STTR,2011, ,486174, , , , 
Mechanisms of Cytotoxicity and Radiosensitization for Antimetabolites,8278686,7/8/1999 0:00,6/30/2015 0:00,Non-SBIR/STTR,2012,258395, ,NCI,179771,78624,258395
Mechanisms of Dicer1 Function in Lung Organogenesis and Cystic Lung Disease,8279184,6/15/2011 0:00,5/31/2015 0:00,Non-SBIR/STTR,2012,382421, ,NHLBI,258699,123722,382421
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer,8279224,7/1/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2012,331968, ,NCI,261176,70792,331968
Overlapping Airway Basal Cell Transcriptome Reprogramming in COPD and Lung Cancer,8281468,6/15/2011 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012,1028637, ,NHLBI,787462,241175,1028637
Radiation Biology,8281612, , ,Research Centers,2011, ,15417, , , , 
Preclinical Evaluation and Clinical Development of Potent Small-Molecule,8281661, , ,Research Centers,2011, ,265240, , , , 
SPORE in Prostate Cancer,8281667,8/1/1997 0:00,5/31/2014 0:00,Research Centers,2012,2300000, ,NCI,1528689,828720,2300000
MicroRNAs and chromosome 22q in the colon,8282838,3/1/2000 0:00,8/31/2013 0:00,Non-SBIR/STTR,2012,328027, ,NIDDK,208271,119756,328027
Effect of high fat diet on pancreatic cancer in IKKa deficient mice,8285288,4/1/2012 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012,77438, ,NCI,50000,27438,77438
Molecular and cellular mechanisms of Merkel Cell Carcinoma development,8285754,9/18/2012 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,174448, ,NCI,108750,65698,174448
Functions of mir-34 microRNAs in the p53 tumor suppressor pathway,8286348,8/1/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,308957, ,NCI,201275,107682,308957
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance,8286848,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2012,346409, ,NCI,207500,138909,346409
Prevention of quinone toxicity and mutagenicity,8286868,8/1/1996 0:00,2/29/2016 0:00,Non-SBIR/STTR,2012,337500, ,NIEHS,225000,112500,337500
Role of hsnf5/BAF47 Loss in Human Cancer Development,8287094,3/1/2002 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,283306, ,NCI,192512,90794,283306
Epigenetic Regulation of Medulloblastoma,8287654,6/8/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,350219, ,NCI,201275,148944,350219
Role of p300/CBP and hHR23 Proteins in p53 Regulation,8287740,4/19/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2011,68544, ,NCI, , ,68544
Mechanisms of IGF-1 mediated rescue of radiation-induced salivary gland dysfuncti,8288027,8/1/2008 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,329562, ,NIDCR,220523,109039,329562
"Chemoprevention of Colon Cancer, HDAC Inhibition, and Histone Status",8288253,3/17/2003 0:00, ,Non-SBIR/STTR,2011, ,512871, , , , 
Terminal Differentiation of the Renal Epithelium,8288305,8/1/2003 0:00,4/30/2013 0:00,Non-SBIR/STTR,2012,279290, ,NIDDK,187443,91847,279290
Focal Adhesion Kinase - Tumor Biology and Therapeutics,8288321,9/30/1996 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,288890, ,NCI,200419,88471,288890
Training Program in Molecular Genetics of Cancer,8288884,9/30/1978 0:00,6/30/2015 0:00,"Training, Institutional",2012,419354, ,NCI,389082,30272,419354
Molecular Interactions and Regulation of p53,8288894,7/1/2011 0:00,6/30/2015 0:00,Non-SBIR/STTR,2011, ,280066, , , , 
p53 - Regulators and Effectors,8288898,2/16/2000 0:00,6/30/2015 0:00,Non-SBIR/STTR,2012,1419497, ,NCI,1030476,389021,1419497
Common Pathogenetic Mechanisms of Lung Cancer and COPD,8289566,7/1/2011 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,726338, ,NHLBI,622863,103475,726338
Mechanisms of Gene-Specific Transcriptional Regulation Within the p53 Network,8289765,5/26/2006 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,284794, ,NCI,186750,98044,284794
SBIR PROPOSAL FOR PHS 2009-1 TOPIC 266 FOR A TARGETED NANOCOMPLIX FOR EARLY DETE,8290186,9/30/2009 0:00,3/30/2012 0:00,R and D Contracts,2011,498331, ,NCI, , ,498331
The Role of AGR2 in a Murine Model of Pancreatic Adenocarcinoma,8290308,7/1/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2012,221153, ,NCI,130500,90653,221153
Phenotyping pain in a mouse model of pancreatic cancer,8290383,7/1/2011 0:00,12/30/2013 0:00,Non-SBIR/STTR,2012,75750, ,NINDS,50000,25750,75750
ROLE OF CRYPTOCHROME IN DNA DAMAGE RESPONSES AND THE CIRCADIAN CLOCK,8290428,8/1/1982 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,510673, ,NIGMS,346519,164154,510673
Sequence distribution of tobacco carcinogen-DNA adducts,8290511,12/1/2002 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,206571, ,NCI,149176,57395,206571
Interplay between Cdh1 and major regulatory pathways in human cancer,8290518,8/6/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,341075, ,NIGMS,196020,145055,341075
The role of IL8 in colitis-associated tumor initiation,8290639,6/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,303988, ,NCI,207500,96488,303988
P63 mechanisms and mediators in HNSCC,8291195,4/1/2004 0:00,7/31/2016 0:00,Non-SBIR/STTR,2012,432361, ,NIDCR,250000,182361,432361
A Phase I trial combining fenretinide and safingol to target overproduction of di,8291974,7/1/2011 0:00,6/30/2016 0:00,Non-SBIR/STTR,2012,311717, ,NCI,227750,83967,311717
Distinct Pathways of VPF/VEGF Receptors,8291977,4/1/2002 0:00,6/30/2015 0:00,Non-SBIR/STTR,2012,394250, ,NHLBI,250000,144250,394250
Identification and characterization of the functional role of miRNA in prostate c,8292080,7/9/2010 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,278892, ,NCI,181148,97744,278892
Preclinical Evaluation of PK2 Antagonists for Pancreatic Cancer,8293050,7/1/2011 0:00,12/30/2013 0:00,Non-SBIR/STTR,2012,193797, ,NCI,144966,48831,193797
Bcl-2 as a Biomarker for Prognosis and Therapy of Head and Neck Cancer,8293083,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2012,429547, ,NIDCR,295000,134547,429547
Project 4: NOX1 Involvement In Colon Cancer,8293189, , ,Non-SBIR/STTR,2011, ,276874, , , , 
Functional Genomic Dissection of Refractory Anemia,8293212,9/15/2005 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,410702, ,NHLBI,247500,163202,410702
Stress- and Promoter-Specific Mechanisms of Transcritpional Activation by p53,8293593,5/26/2006 0:00,1/31/2012 0:00,Non-SBIR/STTR,2011,42441, ,NCI, , ,42441
Apoptosis Regulation by Adenovirus and Cellular Genes,8294517,8/1/1999 0:00,4/30/2016 0:00,Non-SBIR/STTR,2012,288011, ,NCI,192007,96004,288011
Targeted Development of Platinum Drugs,8294609,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2012,327850, ,NCI,207500,120350,327850
Resolution of Epithelial Cell Hyperplasia,8294730,9/15/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,567944, ,NIEHS,262937,305007,567944
"The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer",8295104,9/1/2012 0:00,6/30/2013 0:00,Non-SBIR/STTR,2012,327850, ,NCI,207500,120350,327850
Mechanisms of preferential targeting of colon cancer by a plant-derived alkaloid,8295154,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,392500, ,NCCIH,250000,142500,392500
Functional analysis of beta-TRCP in cell cycle control and DNA damage response,8295160,5/1/2012 0:00,1/31/2016 0:00,Non-SBIR/STTR,2012,328425, ,NIGMS,188750,139675,328425
Role of Otubain 1 in the p53 Pathway,8295416,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,318205, ,NCI,207500,110705,318205
Role of ribosome impairments in X-linked Dyskeratosis Congenita pathogenesis,8295525,8/1/2006 0:00,6/30/2016 0:00,Non-SBIR/STTR,2012,279585, ,NIDDK,185000,94585,279585
Mitigation of asbestos induced alveolar epithelial cell injury,8295860,3/1/2012 0:00,12/31/2016 0:00,Non-SBIR/STTR,2012,329621, ,NIEHS,213347,116274,329621
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor,8295899,4/10/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,298980, ,NCI,198000,100980,298980
Identifying Events and Genetic Regulators of Melanoma Progression,8296046,8/1/2010 0:00,6/30/2013 0:00,Non-SBIR/STTR,2012,237005, ,NIAMS,144076,92929,237005
The Role of Fbxw7 in genetic instability and cancer,8296121,9/1/2008 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,345303, ,NCI,201275,144028,345303
Rad50: Roles in chromo. stab. and prev. of malignancy,8296267,1/1/1998 0:00,6/30/2015 0:00,Non-SBIR/STTR,2012,530410, ,NIGMS,290000,240410,530410
A comprehensive approach to breast cancer susceptibility across the risk spectrum,8296487,7/5/2011 0:00,6/30/2015 0:00,Non-SBIR/STTR,2012,544870, ,NCI,433116,111754,544870
Cellular Response to Short Telomeres in B-Cell Lymphoma,8296546,7/5/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2012,523596, ,NCI,319266,204330,523596
Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer,8297085,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,501539, ,NCI,366691,134848,501539
Structural basis for CBP/p300 transcriptional regulation,8297672,6/10/2002 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,407364, ,NCI,214968,192396,407364
Endocrine Targets for Prevention of Lung Cancer,8298135,7/6/2011 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,77000, ,NCI,50000,27000,77000
MbSOD in chemotherapeutic-Induced Cardiac Injury,8298618,9/25/2008 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,261900, ,NCI,184252,77648,261900
"UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis",8298670,9/1/2000 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,254434, ,NCI,172498,81936,254434
The Study of the Circadian Rhythm in p53 Signaling,8299153,9/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,291218, ,NCI,201274,89944,291218
The Role of ATF3 in the DNA Damage Response,8299185,9/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2012,254412, ,NCI,161020,93392,254412
The in vivo role of the Mdm2-MdmX interaction in p53 regulation,8299227,9/1/2012 0:00,6/30/2017 0:00,Non-SBIR/STTR,2012,305832, ,NCI,207500,98332,305832
Restoration of Tumor Suppression Activity in Malignant Melanoma,8299489,7/1/2006 0:00,4/30/2016 0:00,Non-SBIR/STTR,2012,458540, ,NCI,328707,129833,458540
Staff Investigator,8299699,12/1/1978 0:00,4/30/2017 0:00,Research Centers,2012, ,36850, ,24244,12606, 
Investigation of Regulatory RNAs in Tumor Development,8299785,5/1/1997 0:00,5/31/2017 0:00,Non-SBIR/STTR,2012, ,267154, ,267154, , 
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,8300236,9/30/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,308138, ,NIDDK,205425,102713,308138
LC-MS Analysis of DNA Adducts of Aromatic Amines: Relationship to Bladder Cancer,8300242,5/18/1996 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,223682, ,NCI,146343,77339,223682
Targeting the ATR pathway in p53-deficient cancers,8300806,7/13/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2012,340300, ,NCI,207500,132800,340300
TGF-beta Signaling in Pancreatic Cancer Progression,8300965,9/1/2009 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,330091, ,NCI,201275,128816,330091
Synergistic Immunosuppression by PAHs and Arsenite,8301069,5/17/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2012,336996, ,NIEHS,225000,111996,336996
Heat Shock Protein-Induced Protection Against Cisplatin-Induced Hair Cell Death,8301792,9/28/2009 0:00,9/27/2015 0:00,"Training, Individual",2012,35531, ,NIDCD,35531, ,35531
AMPK as a molecular target for chemoprevention by apigenin in preneoplastic skin,8302010,6/1/2012 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,168019, ,NCI,108750,59269,168019
Comparative functional genomics for lung cancer gene discovery,8303011,9/23/2008 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,521052, ,NCI,322189,198863,521052
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas,8303277,5/3/2011 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,316002, ,NCI,201275,114727,316002
Skeletal genetic pathways of Notch and p53 in the pathogenesis of osteosarcoma,8303280,9/1/2011 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,78250, ,NIAMS,50000,28250,78250
Impact of BRG1 Loss in Lung Cancer Development,8303359,9/27/2007 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,270000, ,NCI,184300,85700,270000
Characterizing mechanisms of transcriptional activation using live cell imaging,8303376,8/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,318641, ,NIGMS,188100,130541,318641
"Spindle Assembly Checkpoint, Chromosome Stability, and Cancer",8303945,9/1/2008 0:00,5/31/2017 0:00,Non-SBIR/STTR,2012,314977, ,NCI,201263,113714,314977
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes,8305049,9/18/2006 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,159760, ,NCI,114524,45236,159760
Therapeutic Potential and Mechanism of Action of Potent Small Molecule Inhibitors,8305073, , ,Research Centers,2011, ,195415, , , , 
"Role of Soy Isoflavones, Smoking Abstinence and Molecular Markers in Prevention",8305074, , ,Research Centers,2011, ,408840, , , , 
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis,8305136,9/15/2008 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,325059, ,NCI,201275,123784,325059
Redox Regulation of Tumor Suppression by MnSOD,8305138,9/1/1998 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,361194, ,NCI,267980,93214,361194
"Inhibitory effects of caffeine, exercise and lipectomy on UVB-induced skin cancer",8305172,9/18/2008 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,240319, ,NCI,155701,84618,240319
Induction of genomic instability by HPV E6 and E7,8305656,9/8/2008 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,297988, ,NCI,181148,116840,297988
ROLE OF HISTONE H4 N-TERMINAL TAIL IN TRANSCRIPTION REGULATION,8305726,8/1/2008 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,305823, ,NIGMS,191120,114703,305823
FRET-based Biosensors to Monitor Redox in Cell Cycle Regulation,8305728,9/1/2010 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,268436, ,NCI,172261,96175,268436
TOR signaling and autophagy in obesity-promoted liver tumorigenesis,8306100,7/22/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2012,353140, ,NCI,227832,125308,353140
Chemical Inhibitors of CREB-mediated Gene Transcription,8306277,9/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,320166, ,NIGMS,219127,101039,320166
Functional analysis of a putative ATM/ATR substrate RFWD3,8306357,8/1/2008 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,285847, ,NIGMS,186219,99628,285847
The Role of Caspase Activation in the Differentiation-Dependent Life Cycle of HPV,8307447,9/20/2008 0:00,8/31/2013 0:00,Non-SBIR/STTR,2012,241530, ,NCI,163196,78334,241530
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS,8307528,7/1/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011, ,378176, , , , 
MOLECULAR DYNAMICS IN CELLULAR AGING: A SYNTHETIC BIOLOGY APPROACH.,8307791,8/1/2011 0:00,7/31/2013 0:00,Non-SBIR/STTR,2012,194340, ,NIA,123000,71340,194340
A Role for RIP1 in Gliomagenesis,8308027,9/29/2009 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,307720, ,NINDS,196000,111720,307720
GENETICS OF MYELODYSPLASTIC SYNDROMES,8308383,8/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2012,380000, ,NHLBI,250000,130000,380000
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,8308675,6/10/2009 0:00,11/25/2013 0:00,Non-SBIR/STTR,2012,277762, ,OD,76000,0,76000
Role of Sphingosine Kinase in p53 Cancer Biology,8308977,8/1/2003 0:00,2/28/2012 0:00,Non-SBIR/STTR,2011, ,226264, , , , 
Sphingolipids in Cancer Biology and Therapy,8308982,8/1/2003 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,1169249, ,NCI,942527,226722,1169249
Cyclin E Regulation in Normal and Neoplastic Hematopoiesis,8309057,8/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,373534, ,NHLBI,247500,126034,373534
Structural and Functional Characterization of BRCA1/BARD1,8309249,12/21/1998 0:00,7/31/2013 0:00,Non-SBIR/STTR,2012,509677, ,NIGMS,330602,179075,509677
monoclonal antibody,8309431, ,7/31/2013 0:00,Research Centers,2011, ,103613, , , , 
MTOR AS A THERAPEUTIC TARGET IN PEDIATRIC SOLID TUMORS,8309811,8/1/2011 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011, ,267036, , , , 
Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,8310032,9/30/2009 0:00,8/31/2014 0:00,Other Research-Related,2012,358962, ,NIAID,245025,113937,358962
Effects of Stochastic Gene Alterations on Intestinal Tumorigenesis in the Mouse,8310127,12/1/1983 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,405954, ,NIGMS,275677,130277,405954
Intrinsic Apoptosis Phenotype and Susceptibility to Squamous Cell Carcinoma,8310814, , ,Research Centers,2011, ,263089, , , , 
Cancer Risk Assessment in Patients with Oral Premalignant Lesions,8310815, , ,Research Centers,2011, ,356374, , , , 
Image-Guided Nanoembolization for the Treatment of Pancreatic Cancer,8310828, , ,Research Centers,2011, ,204685, , , , 
Flow Cytometry,8310873, , ,Research Centers,2011, ,540453, , , , 
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,8311051,9/1/2008 0:00,8/31/2013 0:00,Other Research-Related,2012,171205, ,NCI,158523,12682,171205
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model,8311097,9/25/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,473351, ,NCI,293974,179377,473351
A Luciferase Fusion Library of High Throughput Profiling of Protein Stability,8311334,8/1/2011 0:00,7/31/2014 0:00,"Training, Individual",2012,55670, ,NCI,55670, ,55670
NYU Lung Cancer Biomarker Center,8311789,5/8/2000 0:00,6/30/2015 0:00,Non-SBIR/STTR,2012,895726, ,NCI,555587,373670,895726
Epigenetic Changes Link COPD and Lung Cancer,8312474,8/4/2011 0:00,5/30/2015 0:00,Non-SBIR/STTR,2012,807435, ,NCI,417217,390218,807435
P53 and KRAS Targeted Pigs: A Platform for Models of Human Cancer,8314714,9/1/2012 0:00,11/30/2013 0:00,SBIR/STTR,2012,167065, ,NCI, , ,167065
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma:  Environmental Co,8315740,7/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,396576, ,NCI,294040,102536,396576
Walleye Dermal Sarcooma Virus Accessory Protein Function,8316402,6/1/2002 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,236882, ,NCI,166546,70336,236882
Identifying novel p53 target genes that mediate tumor suppression,8316445,7/15/2011 0:00,10/31/2012 0:00,"Training, Individual",2012,16085, ,NCI,16085, ,16085
The role of pRb-dependent Ihh in osteogenesis and osteosarcoma,8316626,9/6/2012 0:00,9/5/2014 0:00,"Training, Individual",2012,38188, ,NCI,38188, ,38188
Roles of MiR-17-92 Cluster MicroRNAs in K-Ras-Induced Pancreatic Tumorigenesis,8316836,4/1/2012 0:00,3/31/2016 0:00,"Training, Individual",2012,28746, ,NCI,28746, ,28746
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,8317599,8/15/1999 0:00,7/31/2016 0:00,Non-SBIR/STTR,2012,271250, ,NCI,175000,96250,271250
A Chemical Biology Approach for Discovery of HDAC Inhibitors,8318029,9/1/2010 0:00,8/31/2014 0:00,Other Research-Related,2012,151965, ,NIGMS,99000,52965,151965
Graduate Training at the Chemistry Biology Interface,8318278,7/1/2004 0:00,6/30/2014 0:00,"Training, Institutional",2012,139962, ,NIGMS,131472,8490,139962
Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction,8318739,9/5/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,339003, ,NIAAA,226002,113001,339003
Nanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCV,8318745,9/15/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,366123, ,NIAAA,226002,140121,366123
Transposon-insertional Mutagenesis to Decipher Osteosarcomagenesis,8318781,9/28/2009 0:00,8/31/2014 0:00,Other Research-Related,2012,179280, ,NCI,166000,13280,179280
Research Career Development in HIV-Related Anal Dysplasia/Carcinoma Prevention an,8318836,9/15/2008 0:00,8/31/2014 0:00,Other Research-Related,2012,115450, ,NIAID,106898,8552,115450
P5 - P-53-Based Vaccine for Small Cell Lung Cancer,8319261, , ,Research Centers,2011, ,316958, , , , 
SPORE in Lung Cancer,8319266,9/15/2008 0:00,8/31/2014 0:00,Research Centers,2012,1991619, ,NCI,1458378,914243,1991619
Molecular Pathology of t-AML,8319535,9/1/2011 0:00,8/31/2013 0:00,Non-SBIR/STTR,2011, ,433379, , , , 
Pre-Clinical and Clinical Development of Silvestrol in Chronic Lymphocytic,8319547, , ,Research Centers,2011, ,256794, , , , 
Mechanisms of Delta-N-p63-alpha transcriptional repression and its role in squamo,8319690,8/1/2011 0:00,7/31/2014 0:00,"Training, Individual",2012,59432, ,NCI,59432, ,59432
Role of Cdc25A in breast cancer,8320162,9/1/2005 0:00,6/30/2016 0:00,Non-SBIR/STTR,2012,274584, ,NCI,187693,86891,274584
The PDGF alpha neural progenitor cells of the subventricular zone contributes to,8320596,2/13/2012 0:00,2/12/2013 0:00,"Training, Individual",2012,36016, ,NINDS,36016, ,36016
Molecular Pathogenesis of Basal-like Breast Cancer,8321007,4/18/2003 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,1249964, ,NCI,786950,463014,1249964
Defining novel pathways that arrest genetically unstable tetraploid cells,8321030,8/16/2011 0:00,7/31/2013 0:00,Other Research-Related,2012,149904, ,NCI,138800,11104,149904
Hepatitis C and Tumor Suppressors in Hepatocellular,8321047, ,8/31/2013 0:00,Research Centers,2011, ,276791, , , , 
Structural and Functional Characterization of BRCA1/BARD1,8321134,12/21/1998 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,115500, ,NIGMS, , ,115500
Cellular Control: Synthetic Signaling/Motility (RMI),8321614,9/30/2004 0:00,7/31/2015 0:00,Other Research-Related,2012,1, ,OD,898574,421528,1
P-4: Targeting activation of NFkB pathways in MM,8321871, , ,Research Centers,2011, ,272300, , , , 
Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M,8322182,8/15/2003 0:00, ,Non-SBIR/STTR,2011, ,733309, , , , 
Mechanisms of esophageal carcinogenesis,8322189,8/15/2003 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,1605502, ,NCI,1127559,477943,1605502
Role of the Mullerian Tract in Ovarian Cancer Development,8322886,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,29014, ,NCI, , ,29014
Role of hsnf5/BAF47 Loss in Human Cancer Development,8322896,8/1/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,37639, ,NCI, , ,37639
"UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis",8322913,9/1/2000 0:00,7/31/2013 0:00,Non-SBIR/STTR,2011,7741, ,NCI, , ,7741
"Phosphosulindac, miRNAs and cancer racial disparity",8322919,2/5/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2011,4239, ,NCI, , ,4239
"Phosphosulindac, miRNAs and cancer racial disparity",8322936,2/5/2010 0:00,7/13/2012 0:00,Non-SBIR/STTR,2011,11442, ,NCI, , ,11442
Modulation of sensitivity & imaging therapeutic response of hypoxic cancer cells,8322964,5/18/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,52003, ,NCI, , ,52003
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1,8322973,4/1/2008 0:00,1/31/2013 0:00,Non-SBIR/STTR,2011,33897, ,NCI, , ,33897
Imaging Core,8323081, , ,Non-SBIR/STTR,2011, ,325805, , , , 
Targeting Oncogene Expression to Skin in Transgenic Mice,8323224,8/1/1990 0:00,7/31/2016 0:00,Non-SBIR/STTR,2012,479145, ,NCI,329204,149941,479145
Roles and regulation of p53,8323270,9/30/2000 0:00,7/31/2016 0:00,Non-SBIR/STTR,2012,1777337, ,NCI,1441404,335933,1777337
Role of DDB2 in chemotherapeutic agents-induced apoptosis and platinum resistance,8323286,9/1/2011 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,253150, ,NCI,166000,87150,253150
Non-genotoxic p53 activation as novel therapeutic concept for lymphoma,8323548, ,8/31/2013 0:00,Research Centers,2011, ,64753, , , , 
Outreach and Dissemination,8324009, , ,Research Centers,2011, ,98943, , , , 
Chemoprevention of lung cancer with red ginseng extracts,8324234,9/30/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,418045, ,NCCIH,148655,69390,218045
Worker Genetic Susceptibility to Mutagenic Risk,8325339,7/1/2001 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,278896, ,NIOSH,174856,104040,278896
PET TUMOR AND PROLIFERATION IMAGING VIA CATIONIC AMINO ACID TRANSPORT,8325518,9/1/2011 0:00,8/31/2016 0:00,Other Research-Related,2012,157715, ,NCI,146032,11683,157715
Exploiting mouse models of pediatric cancers and epigenetics for therapy,8325652,9/10/2004 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,794452, ,NCI,690674,143331,794452
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis,8326051,9/1/2011 0:00,8/31/2015 0:00,Non-SBIR/STTR,2012,314259, ,NCI,207500,106759,314259
The role of ribosomal proteins in the p53-MDM2 pathway,8326081,3/1/2002 0:00,6/30/2016 0:00,Non-SBIR/STTR,2012,293343, ,NCI,196819,96524,293343
P3 - TARGETING THE HDM-2 E3 LIGASE IN MULTIPLE MYELOMA,8326170, , ,Research Centers,2011, ,171210, , , , 
Plk1 in Chemo-resistance of Cancer,8326573,9/1/2011 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,250860, ,NCI,166000,84860,250860
The Regulation of PP1 in the Nucleus,8326580,9/1/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2012,291371, ,NIGMS,188000,103371,291371
OLIG2 Phosphorylation as a Drug Target for Glioma,8326584,7/15/2007 0:00,5/31/2016 0:00,Non-SBIR/STTR,2012,436400, ,NINDS,328095,108305,436400
Multi-Modal Gene Therapy for Pancreatic Cancer using Targeted Nanovectors,8327146, , ,Research Centers,2011, ,192425, , , , 
Transcriptional dynamics and cellular function of p53 pulses,8327182,7/2/2010 0:00,8/31/2012 0:00,"Training, Individual",2012,11607, ,NIGMS,11607, ,11607
Role of Germ Cell Nuclear Factor in Restricting hESC Pluripotency,8327217, ,8/31/2014 0:00,Non-SBIR/STTR,2011, ,263598, , , , 
Cancer cell adaptation to metabolic stress,8327685,9/10/2004 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,1187477, ,NCI,751077,436400,1187477
Regulation of Cytokinesis and Tumor Formation by RhoA,8328727,1/1/2010 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,244752, ,NIGMS,157397,87355,244752
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci,8329613,9/7/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2012,541494, ,NCI,339080,202414,541494
Population-based study of DNA damage response markers of prognosis in breast canc,8330200, , ,Research Centers,2011, ,311890, , , , 
Phase 2  Irinotecan for Treatment of p53 WT Gastric Adenocarcinoma,8330221,9/10/2010 0:00,8/31/2013 0:00,Non-SBIR/STTR,2010,147940, ,FDA, , ,147940
P-2:  The Effect of Rad on Androgen Receptor Expression and Activity in Prostate,8330637, ,8/31/2013 0:00,Research Centers,2011, ,286241, , , , 
Ras Induced Senescence and Tumor Suppression,8330856,7/1/1999 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,356794, ,NIA,195076,161718,356794
Ras-Induced Autophagic Growth-Arrest in Immortalized Human Epithelial Cells,8330969,6/28/2010 0:00,6/27/2012 0:00,"Training, Individual",2011,27173, ,NCI, , ,27173
Functional Components of the Rb/E2F and p53 Pathways,8331380,9/30/2010 0:00,9/29/2014 0:00,Non-SBIR/STTR,2012,229754, ,NLM,153169,76585,229754
Virus-gene interactions during hepatic carcinogenesis,8331461,9/12/2011 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,201623, ,NCI,130500,71123,201623
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8332381,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2011,80925, ,NCI, , ,80925
Targeting Microenvironment / Leukemia Cell Interactions in CML,8332848, , ,Non-SBIR/STTR,2011, ,189830, , , , 
Targeting Raf in Melanoma: Mechanisms for Effect & Resistance & Opportunities for,8332866, , ,Research Centers,2011, ,294646, , , , 
Regulation of MMP-9 mRNA stability and tumor growth by alpha3 beta1 integrin,8332876,9/26/2008 0:00,7/31/2014 0:00,Non-SBIR/STTR,2013,230410, ,NCI,146758,83652,230410
p53-independent function of Mdmx in tumorigenesis,8333692,7/1/2010 0:00,6/30/2014 0:00,"Training, Individual",2011,41800, ,NCI, , ,41800
Structural basis for functional modulation of CBP/p300 by the HPV oncoprotein E7,8334023,9/30/2010 0:00,9/29/2013 0:00,"Training, Individual",2012,52190, ,NIGMS,52190, ,52190
SPORE in Lung Cancer,8334443,9/15/2008 0:00, ,Research Centers,2011,135386, ,OD, , ,135386
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression,8334638,9/19/2011 0:00,1/31/2013 0:00,Other Research-Related,2012,116600, ,NCI,107963,8637,116600
Targeting Regulators of Apoptosis in AML,8334641, ,2/29/2016 0:00,Non-SBIR/STTR,2011, ,341150, , , , 
p53-independent function of Mdmx in tumorigenesis,8334658,7/1/2010 0:00,6/30/2014 0:00,"Training, Individual",2012,42232, ,NCI,42232, ,42232
Biological Function of the Retinoblastoma Gene Product,8335512,5/3/1994 0:00,2/28/2014 0:00,Non-SBIR/STTR,2011,33021, ,NCI, , ,33021
Organic,8335542,7/21/2011 0:00,6/30/2014 0:00,Research Centers,2011, ,30031, , , , 
Danger 1:  initiating and stopping immune responses,8336144, , ,Intramural Research,2011,861751, ,NIAID, , ,861751
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS,8336243, , ,Intramural Research,2011,868802, ,NIAID, , ,868802
Molecular Regulation of B-Cell Differentiation and Function,8336246, , ,Intramural Research,2011,1265379, ,NIAID, , ,1265379
Immortalized Cell Lines,8336425, , ,Intramural Research,2011,214838, ,NIDA, , ,214838
"Role Of Lipids In Colon, Breast, And Other Cancers",8336570, , ,Intramural Research,2011,602723, ,NIEHS, , ,602723
Human Genes Affecting Chromosome Metabolism and Stress Response,8336585, , ,Intramural Research,2011,1614698, ,NIEHS, , ,1614698
"Nuclear receptors: action, functions, and roles in disease",8336619, , ,Intramural Research,2011,1461795, ,NIEHS, , ,1461795
Epigenomic Markers of HNSCC Survival Across Ethnic Groups,8336828,9/22/2011 0:00,8/31/2014 0:00,Other Research-Related,2012,136119, ,NCI,126036,10083,136119
"Race, pathomolecular signature and colorectal cancer survival",8336843,9/21/2011 0:00,8/31/2016 0:00,Other Research-Related,2012,130083, ,NCI,120755,9328,130083
The PTEN-HAUSP Interaction in Basal-like Breast Cancer,8340043,4/18/2003 0:00,8/31/2014 0:00,Non-SBIR/STTR,2011, ,234701, , , , 
Targets for Therapy for Carcinomas of the Lung,8340075,7/23/2007 0:00,8/31/2017 0:00,Non-SBIR/STTR,2012,1777814, ,NCI,1135337,642477,1777814
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression,8340131,9/23/2011 0:00,8/31/2016 0:00,Research Centers,2011, ,73925, , , , 
Stem Cell Biology And Brain Disease,8342224, , ,Intramural Research,2011,2757488, ,NINDS, , ,2757488
TAS::75 0849::TAS SBIR TOPIC 255 PHASE II DEVELOPMENT OF ANTICANCER AGENTS,8342467,9/30/2011 0:00,9/29/2013 0:00,R and D Contracts,2011,1496764, ,NCI, , ,1496764
Molecular Imaging & Targeted Therapeutics of Stem Cell-Derived Colon Cancer,8343587,9/24/2002 0:00,4/30/2017 0:00,Research Centers,2012, ,1051262, ,226962,824300, 
Mechanisms of novel cancer targets in ARF-mediated tumor suppression,8343589,9/1/2012 0:00,8/31/2017 0:00,Non-SBIR/STTR,2012,332000, ,NCI,207500,124500,332000
Oral Carcinogenesis,8344120, , ,Intramural Research,2011,1739474, ,NIDCR, , ,1739474
Biochemical Mechanisms of Enzyme Action and Cellular Regulation,8344739, , ,Intramural Research,2011,738300, ,NHLBI, , ,738300
The role of autophagy in aging and metabolism,8344792, , ,Intramural Research,2011,931038, ,NHLBI, , ,931038
Mitochondrial regulation in cardiovascular and cancer biology,8344797, , ,Intramural Research,2011,814792, ,NHLBI, , ,814792
Blood Studies of Endothelial Function and Systemic Inflammation,8344829, , ,Intramural Research,2011,148832, ,NHLBI, , ,148832
Chromosomal Proteins and Chromosomal Functions,8348861, , ,Intramural Research,2011,914243, ,NCI, , ,914243
Mammary Tumorigenesis in Inbred and Feral Mice,8348867, , ,Intramural Research,2011,1014966, ,NCI, , ,1014966
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,8348868, , ,Intramural Research,2011,686710, ,NCI, , ,686710
Gene Regulation and Function: The B-ZIP Proteins,8348873, , ,Intramural Research,2011,1022033, ,NCI, , ,1022033
Molecular Epidemiology of Human Lung Cancer,8348880, , ,Intramural Research,2011,644202, ,NCI, , ,644202
Transgenic Models for Prostate and Breast Cancer,8348892, , ,Intramural Research,2011,1095844, ,NCI, , ,1095844
p53 Tumor Suppressor Pathway,8348895, , ,Intramural Research,2011,644202, ,NCI, , ,644202
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",8348897, , ,Intramural Research,2011,1157850, ,RMOD, , ,25000
Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis,8348900, , ,Intramural Research,2011,974241, ,NCI, , ,974241
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,8348912, , ,Intramural Research,2011,1082439, ,NCI, , ,1082439
Regulation of Lymphocyte Proliferation and Replicative Capacity,8348936, , ,Intramural Research,2011,737535, ,NCI, , ,737535
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,8348940, , ,Intramural Research,2011,439729, ,NCI, , ,439729
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,8348944, , ,Intramural Research,2011,443620, ,NCI, , ,443620
Molecular Mechanisms of Growth Factor Modulated Proliferation,8348957, , ,Intramural Research,2011,193515, ,NCI, , ,193515
DNA Repair,8348962, , ,Intramural Research,2011,1333145, ,NCI, , ,1333145
Enzymes and Substrates of the Ubiquitin Conjugating System,8348963, , ,Intramural Research,2011,661090, ,NCI, , ,661090
Role of CEBP transcription factors in regulating cell growth and tumorigenesis,8348976, , ,Intramural Research,2011,1089789, ,NCI, , ,1089789
Protein Structure,8348987, , ,Intramural Research,2011,1593257, ,NCI, , ,1593257
Role of Neurotrophins in the Development of the Mammalian Nervous System,8348996, , ,Intramural Research,2011,524951, ,NCI, , ,524951
Role of Trk Receptors in the Development and Function of Non-neuronal Structures,8348997, , ,Intramural Research,2011,524951, ,NCI, , ,524951
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,8349042, , ,Intramural Research,2011,871882, ,NCI, , ,871882
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,8349043, , ,Intramural Research,2011,249109, ,NCI, , ,249109
Development of Mouse Astrocytoma Model for Preclinical Testing,8349044, , ,Intramural Research,2011,124555, ,NCI, , ,124555
Zebrafish Models of Cancer,8349046, , ,Intramural Research,2011,747679, ,NCI, , ,747679
Molecular Interaction Maps and Analysis of Bioregulatory Networks,8349049, , ,Intramural Research,2011,123627, ,NCI, , ,123627
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,8349077, , ,Intramural Research,2011,391109, ,NCI, , ,391109
Characterization of Signaling Pathways involved in Cell Death and Survival,8349080, , ,Intramural Research,2011,758637, ,NCI, , ,758637
Molecular-Targeted Radiation Therapy,8349096, , ,Intramural Research,2011,657177, ,NCI, , ,657177
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,8349116, , ,Intramural Research,2011,122100, ,NCI, , ,122100
Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers,8349121, , ,Intramural Research,2011,576145, ,NCI, , ,576145
Metabolic Mechanisms for Programmed Cell Death,8349132, , ,Intramural Research,2011,450567, ,NCI, , ,450567
Clinical trial development in cancer vaccines,8349141, , ,Intramural Research,2011,370775, ,NCI, , ,370775
Differentiation of tissue- and devlopment of tumor stem cells,8349169, , ,Intramural Research,2011,298403, ,NCI, , ,298403
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,8349173, , ,Intramural Research,2011,571994, ,NCI, , ,571994
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,8349209, , ,Intramural Research,2011,77317, ,NCI, , ,77317
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,8349218, , ,Intramural Research,2011,894521, ,NCI, , ,894521
Novel Markers for Disease Outcome in Breast Cancer,8349222, , ,Intramural Research,2011,191593, ,NCI, , ,191593
Tumor models for the study of inflammation and oncogenesis,8349227, , ,Intramural Research,2011,335423, ,NCI, , ,335423
Redox Mechanism Process of Angiogenesis and Wound Healing,8349228, , ,Intramural Research,2011,346967, ,NCI, , ,346967
Collaborative Pathways that Lead to Leukemia,8349258, , ,Intramural Research,2011,370403, ,NCI, , ,370403
Gene therapy of cancer,8349261, , ,Intramural Research,2011,1755358, ,NCI, , ,1755358
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,8349326, , ,Intramural Research,2011,634619, ,NCI, , ,634619
Inflammation and Prostate Carcinogenesis,8349366, , ,Intramural Research,2011,120119, ,NCI, , ,120119
Genomic Classification of Human Liver Cancer,8349368, , ,Intramural Research,2011,729927, ,NCI, , ,729927
Validation of Therapeutic Target Genes in Human Liver Cancer,8349369, , ,Intramural Research,2011,486618, ,NCI, , ,486618
Animal model of Pancreatic Cancer,8349376, , ,Intramural Research,2011,275615, ,NCI, , ,275615
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,8349388, , ,Intramural Research,2011,436895, ,NCI, , ,436895
Functions of IKK&945; in Skin Homeostasis and Skin Tumorigenesis,8349401, , ,Intramural Research,2011,589175, ,NCI, , ,589175
Molecule-Guided Investigations into p53 Biology,8349432, , ,Intramural Research,2011,391777, ,NCI, , ,391777
Thoracic Cancer Research Laboratory,8349437, , ,Intramural Research,2011,1402198, ,NCI, , ,1402198
Mechanisms of Early Stage Mammary Tumorigenesis,8349440, , ,Intramural Research,2011,596348, ,NCI, , ,596348
CANCER AND INFLAMMATION GENETICS,8349453, , ,Intramural Research,2011,867725, ,NCI, , ,867725
Development and validation of preclinical mouse model for serous ovarian cancer,8349495, , ,Intramural Research,2011,1449087, ,NCI, , ,1449087
Regulation of microRNA expression by Mutant p53,8349522, , ,Intramural Research,2011,189492, ,NCI, , ,189492
Function of Mutant p53-regulated microRNAs in cancer cells,8349523, , ,Intramural Research,2011,252656, ,NCI, , ,252656
Mechanisms regulating the context-dependant function of microRNAs,8349524, , ,Intramural Research,2011,94746, ,NCI, , ,94746
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,8349568, , ,Intramural Research,2011,622843, ,NCI, , ,622843
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,8349569, , ,Intramural Research,2011,3997558, ,NCI, , ,3997558
Intervention Trials in Persons at Increased Genetic Risk of Cancer,8349570, , ,Intramural Research,2011,1800935, ,NCI, , ,1800935
Epidemiology and Natural History of Cancer-Associated Viruses,8349578, , ,Intramural Research,2011,1656987, ,NCI, , ,1656987
Descriptive Studies and Record Linkage,8349582, , ,Intramural Research,2011,305167, ,NCI, , ,305167
Signal and Transcription Factor Network interactions in Head and Neck Cancer,8349633, , ,Intramural Research,2011,699174, ,NIDCD, , ,699174
Genomics and Proteomics of Head and Neck Cancer,8349634, , ,Intramural Research,2011,699174, ,NIDCD, , ,699174
Small Molecule Activators of p53,8349718, , ,Intramural Research,2011,377645, ,NIDDK, , ,377645
"BRCA1, DNA damage response and aging",8349848, , ,Intramural Research,2011,465825, ,NIDDK, , ,465825
Cancer Biology and Genetics,8350026, , ,Intramural Research,2011,1689162, ,NHGRI, , ,1689162
Modulation of Therapeutic Response,8350044, , ,Intramural Research,2011,706946, ,NCI, , ,706946
Molecular Pathogenesis of Multiple Myeloma,8350049, , ,Intramural Research,2011,876500, ,NCI, , ,876500
Lymphoma Studies,8350054, , ,Intramural Research,2011,366301, ,NCI, , ,366301
Nitric Oxide as a Modifier of Oxidative Stress,8350058, , ,Intramural Research,2011,346967, ,NCI, , ,346967
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,8350070, , ,Intramural Research,2011,688740, ,NCI, , ,688740
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,8350080, , ,Intramural Research,2011,969771, ,NCI, , ,969771
Molecular Targets Development Program,8350097, , ,Intramural Research,2011,5073784, ,NCI, , ,5073784
CCR Confocal Microscopy Core,8350105, , ,Intramural Research,2011,664432, ,NCI, , ,664432
Cell and Cancer Biology Branch Confocal Microscopy Core,8350116, , ,Intramural Research,2011,957040, ,NCI, , ,957040
Molecular Diagnostics Core Laboratory,8350139, , ,Intramural Research,2011,1844045, ,NCI, , ,1844045
Immunohistochemistry Core Laboratory,8350142, , ,Intramural Research,2011,614682, ,NCI, , ,614682
Bioinformatic Tools in Cancer Research,8350232, , ,Intramural Research,2011,754625, ,NCI, , ,754625
Regulation Of Intracellular Iron Metabolism,8351145, , ,Intramural Research,2011,816604, ,NICHD, , ,816604
SUMO family Ubiquitin-like Modifiers In Higher Eukaryotes,8351154, , ,Intramural Research,2011,664047, ,NICHD, , ,664047
Investigating microRNA miR-34a in lung cancer development and therapy,8353069,9/17/2012 0:00,8/31/2014 0:00,Other Research-Related,2012,110355, ,NCI,102181,8174,110355
Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma,8353311,8/1/2012 0:00,7/31/2017 0:00,Other Research-Related,2012,184127, ,NINDS,170488,13639,184127
Dynamics of cellular senescence in single human cells,8353599,9/1/2012 0:00,8/31/2013 0:00,Other Research-Related,2012,90000, ,NIGMS,83333,6667,90000
Alcohol and PAH-induced carcinogenesis,8354268,7/1/2012 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,73500, ,NIEHS,50000,23500,73500
Targeting p53-Dependent Repigmentation in Vitiligo,8355769,7/1/2012 0:00,6/30/2017 0:00,Other Research-Related,2012,100572, ,NIAMS,93530,7042,100572
THE MOLECULAR BASIS OF ROTHMUND-THOMSON SYNDROME AND OSTEOSARCOMA,8356707,12/1/2010 0:00,11/30/2011 0:00,Research Centers,2011, ,1187, , , , 
H-26071 ADVL0916 - A PHASE I STUDY OF VORINOSTAT AND BORTEZOMIB IN CHILDREN WITH,8356745,12/1/2010 0:00,11/30/2011 0:00,Research Centers,2011, ,14247, , , , 
G-quadruplex in Translational Regulation and Cancer Therapy,8357041,7/1/2012 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,195206, ,NCI,130500,64706,195206
ID PROTEIN FAMILY EXPRESSION AND FUNCTION IN PROSTATE CANCER,8357122,7/1/2011 0:00,6/30/2012 0:00,Research Centers,2011, ,207079, , , , 
Molecular Basis for Localization and Activation of Focal Adhesion Kinase,8358453,7/10/2012 0:00,5/31/2013 0:00,Non-SBIR/STTR,2012,79000, ,NCI,50000,29000,79000
Elucidating p53 transcriptional networks involved in pancreatic cancer suppressio,8358665,7/10/2012 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,172957, ,NCI,108750,64207,172957
DEVELOPING AN IN VIVO MODEL OF THE HUMAN PAPILLOMAVIRUS E5 ONCOGENE,8359648,4/1/2011 0:00,3/31/2012 0:00,Research Centers,2011, ,68524, , , , 
RB POCKET PROTEINS AND E2F TRANSCRIPTION FACTORS IN HCMV REPLICATION,8359698,5/1/2011 0:00,4/30/2012 0:00,Research Centers,2011, ,148691, , , , 
BIOMARKER ARRAYS FOR TOBACCO-RELATED CANCER DIAGNOSTICS,8360075,5/1/2011 0:00,4/30/2012 0:00,Research Centers,2011, ,57052, , , , 
4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT,8360266,6/1/2011 0:00,5/31/2012 0:00,Research Centers,2011, ,150866, , , , 
UNCOVERING THE MECHANISMS OF OSTEOSARCOMA METASTASIS SUPPRESSION BY MTBP,8360720,9/17/2004 0:00,7/31/2012 0:00,Research Centers,2011, ,223456, , , , 
BIOMIMETIC ASSEMBLIES,8361121,1/1/2011 0:00,12/31/2011 0:00,Research Centers,2011, ,12256, , , , 
CHARACTERIZATION OF P53-INDEPENDENT ARF PATHWAY,8361355,1/1/2011 0:00,12/31/2011 0:00,Research Centers,2011, ,12820, , , , 
PROTEOMIC BIOMARKER PROFILING OF CERVICAL SWABS,8361413,1/1/2011 0:00,12/31/2011 0:00,Research Centers,2011, ,8085, , , , 
A NOVEL NUCLEAR STRUCTURE THAT SILENCES P53 ACTIVITY,8361942,4/1/2011 0:00,3/31/2012 0:00,Research Centers,2011, ,24666, , , , 
CRYSTAL STRUCTURE DETERMINATION OF MYELIN PROTEINS,8362200,3/1/2011 0:00,2/29/2012 0:00,Research Centers,2011, ,2206, , , , 
OPTICAL IMAGING OF TUMOR ANGIOGENESIS AND CHEMOTHERAPY,8362633,4/1/2011 0:00,3/31/2012 0:00,Research Centers,2011, ,3112, , , , 
HYPEROXIC RESPIRATORY CHALLENGES TO MONITOR CHEMOTHERAPY EFFECTS,8362682,4/1/2011 0:00,3/31/2012 0:00,Research Centers,2011, ,5135, , , , 
COMPARISON OF DOSI WITH IMMUNOHISTOCHEMICAL BIOMARKERS IN BREAST TUMORS,8362725,4/1/2011 0:00,3/31/2012 0:00,Research Centers,2011, ,1556, , , , 
PRESENTATIONS/POSTERS BY CRISTIAN BADEA,8363149,7/1/2011 0:00,6/30/2012 0:00,Research Centers,2011, ,18408, , , , 
METABOLIC PROFILES OF GLIOMAS AND METASTATIC BRAIN TUMORS,8363923,9/1/2011 0:00,7/31/2012 0:00,Research Centers,2011, ,48245, , , , 
Rewiring the miRNA-MDM2-p53 network to reactivate p53 function,8364777,9/1/2012 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,166388, ,NCI,108750,57638,166388
IDENT AND POST-TRANSLATIONAL MODIFICATION OF MITOTIC REGULATORY PROTEINS,8365468,7/1/2011 0:00,6/30/2012 0:00,Research Centers,2011, ,28669, , , , 
Markers for Screening and Prognosis,8366059,2/28/1997 0:00,8/31/2017 0:00,Research Centers,2012, ,324812, ,200499,124313, 
Maternal methyl diet and epigenetic imprint in offspring mammary carcinogenesis,8367064,8/7/2012 0:00,7/31/2015 0:00,Non-SBIR/STTR,2012,285065, ,NCI,200000,85065,285065
Effect of Omega-3 Fatty Acids on Cancer Stem Cells,8368129,7/16/2012 0:00,4/30/2016 0:00,Non-SBIR/STTR,2012,315297, ,NCI,223167,92130,315297
Defective p53 synthesis following DNA damage and cancer development,8369382,4/1/2010 0:00,3/31/2013 0:00,Non-SBIR/STTR,2011,75488, ,NIEHS, , ,75488
Mechanisms Underlying Colorectal Cancer Risk in IBD (PQ6),8370935,9/12/2012 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,204885, ,NCI,130500,74385,204885
Dynamics of Signaling Pathways: Mechanism and Function,8371014,3/1/2008 0:00,4/30/2017 0:00,Non-SBIR/STTR,2013,320490, ,NIGMS,190000,130490,320490
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease,8371777,9/1/2012 0:00,5/31/2017 0:00,Non-SBIR/STTR,2012,336704, ,NIEHS,225000,111704,336704
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit,8372495,9/1/2012 0:00,6/30/2017 0:00,Non-SBIR/STTR,2012,303194, ,NCI,194980,108214,303194
Biomedical Applications of Expanded Porphyrins,8373611,8/1/1990 0:00,5/31/2016 0:00,Non-SBIR/STTR,2012,319550, ,NCI,207500,112050,319550
An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9),8374253,8/13/2012 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,164213, ,NCI,108750,55463,164213
Career Development Program,8374573, ,5/30/2013 0:00,Research Centers,2012, ,145906, ,73508,72398, 
Combination Chemoprevention: Prevention of Both ER-Positive & ER-Negative BC,8374579, ,5/30/2013 0:00,Research Centers,2012, ,224390, ,151992,72398, 
Growth Control and Genomic Stability,8374670, , ,Research Centers,2012, ,23578, ,12448,11130, 
MODELS FOR GENETIC ASSESSMENT OF TUMOR MAINTENANCE GENES IN PDAC,8374934, , ,Non-SBIR/STTR,2012, ,334533, ,334533,0, 
The Role of Polyoma Small T in Regulating Cell Survival,8375239, , ,Non-SBIR/STTR,2012, ,558699, ,387504,171195, 
Papillomavirus E2 Growth Suppression Mechanisms,8375242, , ,Non-SBIR/STTR,2012, ,563118, ,390569,172549, 
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma,8375479, , ,Research Centers,2012, ,608037, ,182238,425799, 
Collaborating Mutations in Medulloblastoma,8375494,4/1/2003 0:00, ,Non-SBIR/STTR,2012, ,306287, ,203825,102462, 
Radiation Biology,8375582, , ,Research Centers,2012, ,15066, ,15062,4, 
Preclinical Evaluation and Clinical Development of Potent Small-Molecule,8375952, ,5/31/2014 0:00,Research Centers,2012, ,278965, ,180907,98058, 
"Chemoprevention of Colon Cancer, HDAC Inhibition, and Histone Status",8376153,3/17/2003 0:00, ,Non-SBIR/STTR,2012, ,362676, ,362676,0, 
Molecular Interactions and Regulation of p53,8376273, , ,Non-SBIR/STTR,2012, ,279103, ,201299,77804, 
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman),8376299,6/1/2012 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012, ,407684, ,258663,149021, 
p63/p73 Signaling Axis as a Target for Treatment of Triple-Negative Breast Cancer,8376836, ,8/31/2013 0:00,Research Centers,2012, ,365212, ,238566,126646, 
Breast Cancer Therapeutic Agents Based on Telomerase Misfunction,8377731, ,11/30/2013 0:00,Research Centers,2012, ,222662, ,153459,69203, 
Project 4: NOX1 Involvement In Colon Cancer,8377847, ,12/31/2014 0:00,Non-SBIR/STTR,2012, ,282171, ,182051,100120, 
P53 Activation as Novel Therapeutic Stratgey for Acute Myelogenous Leukemia,8378211, ,8/31/2013 0:00,Research Centers,2012, ,221325, ,169321,52004, 
Targeting the MAP and PI3 Kinase Pathways in Melanoma,8378447, ,8/31/2013 0:00,Non-SBIR/STTR,2012, ,486670, ,384548,102122, 
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity,8378454, ,8/31/2013 0:00,Non-SBIR/STTR,2012, ,575790, ,473669,102121, 
Flow Cytometry,8379487, , ,Research Centers,2012, ,530009, ,343809,186200, 
Image-Guided Nanoembolization for the Treatment of Pancreatic Cancer,8379775, , ,Research Centers,2012, ,234600, ,234600,0, 
Organic,8379807, , ,Research Centers,2012, ,26342, ,26342,0, 
The PTEN-HAUSP Interaction in Basal-like Breast Cancer,8380087,4/18/2003 0:00, ,Non-SBIR/STTR,2012, ,222559, ,152850,69709, 
P5 - P-53-Based Vaccine for Small Cell Lung Cancer,8380101, ,8/31/2014 0:00,Research Centers,2012, ,400000, ,245032,154968, 
Intrinsic Apoptosis Phenotype and Susceptibility to Squamous Cell Carcinoma,8380160, ,7/31/2015 0:00,Research Centers,2012, ,280934, ,192082,88852, 
Cancer Risk Assessment in Patients with Oral Premalignant Lesions,8380162, ,7/31/2015 0:00,Research Centers,2012, ,380548, ,260191,120357, 
DNA-Protein Interactions in Herpes Viruses,8380188, , ,Non-SBIR/STTR,2012, ,270535, ,186541,83994, 
Targeting Microenvironment / Leukemia Cell Interactions in CML,8380191, , ,Non-SBIR/STTR,2012, ,193030, ,193030,0, 
Targeting Raf in Melanoma: Mechanisms for Effect & Resistance & Opportunities for,8380222, ,1/31/2014 0:00,Research Centers,2012, ,259801, ,259801,0, 
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression,8380453, , ,Research Centers,2012, ,73314, ,46996,26318, 
Outreach and Dissemination,8380508, , ,Research Centers,2012, ,117638, ,117638,0, 
Pre-Clinical and Clinical Development of Silvestrol in Chronic Lymphocytic,8380664, , ,Research Centers,2012, ,270040, ,206151,63889, 
Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M,8380736,8/15/2003 0:00, ,Non-SBIR/STTR,2012, ,729773, ,512015,217758, 
P3 - TARGETING THE HDM-2 E3 LIGASE IN MULTIPLE MYELOMA,8380821, , ,Research Centers,2012, ,180934, ,180934,0, 
Role of Sphingosine Kinase in p53 Cancer Biology,8381027,8/1/2003 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012, ,233846, ,188495,45351, 
Molecular Pathology of t-AML,8381376, ,8/31/2014 0:00,Non-SBIR/STTR,2012, ,444379, ,376489,67890, 
Multi-Modal Gene Therapy for Pancreatic Cancer using Targeted Nanovectors,8381582, , ,Research Centers,2012, ,191785, ,191785,0, 
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression,8381602, , ,Research Centers,2012, ,129594, ,95778,33816, 
Population-based study of DNA damage response markers of prognosis in breast canc,8381924, , ,Research Centers,2012, ,382865, ,237831,145034, 
"Metabolic Outcomes of c-MYC, p53 and mTOR Regulation by HIF",8382054,9/10/2004 0:00, ,Non-SBIR/STTR,2012, ,251172, ,158866,92306, 
Imaging Core,8382401, ,4/30/2014 0:00,Non-SBIR/STTR,2012, ,323994, ,170883,153111, 
P-4: Targeting activation of NFkB pathways in MM,8382445, ,8/31/2013 0:00,Research Centers,2012, ,283044, ,204669,78375, 
Therapeutic Potential and Mechanism of Action of Potent Small Molecule Inhibitors,8382510, ,6/30/2016 0:00,Research Centers,2012, ,204633, ,116988,87645, 
"Role of Soy Isoflavones, Smoking Abstinence and Molecular Markers in Prevention",8382512, ,6/30/2016 0:00,Research Centers,2012, ,429172, ,341527,87645, 
Regulations of DNA Alkylation/Deamination Damage Repair,8382762,3/1/2003 0:00,11/30/2013 0:00,Non-SBIR/STTR,2012,33785, ,NCI,22010,11775,33785
Mitochondrial uncoupling in prevention of carcinogenesis,8382809,7/9/2012 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,156600, ,NCI,108750,47850,156600
Targeting Leukemia Stem Cells with Dietary Selenium,8382905,8/1/2012 0:00,5/31/2017 0:00,Non-SBIR/STTR,2012,303222, ,NCI,207500,95722,303222
Chronic versus acute effects of p53 deletion on Olig2 progenitor malignancy,8384516,8/15/2012 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,86542, ,NIA,50000,36542,86542
Directing the Mediator Complex: Bivalent approaches to Reconstituting or Inhibiti,8384690,8/1/2012 0:00,5/31/2016 0:00,Non-SBIR/STTR,2012,498411, ,NCI,363883,134528,498411
Measurements of BPDE-DNA adducts by solid state nonopore & deep sequencing (PQ3,8384743,8/20/2012 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,180120, ,NCI,140831,39289,180120
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis,8384853,1/1/2009 0:00,6/1/2013 0:00,Non-SBIR/STTR,2013,46560, ,NCI,34401,12159,46560
Characterization of persistent hyperemic foci and their role in photocarcinogenes,8385329,8/13/2012 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,244720, ,NIEHS,157920,86800,244720
The Development of Novel Individualized Therapy for  Metastatic Triple Negative B,8385374,7/9/2012 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,215037, ,NCI,146372,68665,215037
Role of Id1 in NSCLC Progression and Metastasis,8385488,7/17/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2013,322898, ,NCI,193352,129546,322898
Role of MicroRNA 363 in HPV-positive oral cancer,8385514,12/1/2011 0:00,3/30/2014 0:00,Non-SBIR/STTR,2013,217141, ,NIDCR,144000,73141,217141
Tumor Suppressor Qualities and Mechanisms of LZAP Activity,8385526,4/1/2000 0:00,11/30/2016 0:00,Non-SBIR/STTR,2013,398899, ,NIDCR,240000,158899,398899
Targeted Degradation of DNA Damage Response Proteins by Autophagy,8385971,8/13/2012 0:00,7/31/2014 0:00,Non-SBIR/STTR,2012,228000, ,NIEHS,150000,78000,228000
The effects of endogenous and dietary estrogens on colonic stem cells,8386182,7/9/2012 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,155479, ,NCI,108750,46729,155479
Osteosarcoma Translational Research,8386308,7/9/2012 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,166388, ,NCI,108750,57638,166388
Regulations of DNA Alkylation/Deamination Damage Repair,8386626,3/1/2003 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,243308, ,NCI,158507,84801,243308
Function and regulation of MDMX,8387003,7/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,287378, ,NCI,171876,115502,287378
p63 and p73 Signaling in Cell Growth and Cancer,8387018,3/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,284779, ,NCI,182551,102228,284779
Anticarcinogenic Effect of ITCs Against Prostate Cancer,8387049,7/14/2003 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,300172, ,NCI,198133,102039,300172
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention,8387783,6/1/2005 0:00,11/30/2015 0:00,Non-SBIR/STTR,2013,268446, ,NCI,176030,92416,268446
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans,8389392,7/9/2012 0:00,3/1/2013 0:00,Non-SBIR/STTR,2012,342475, ,NCI,257300,85175,342475
Self-renewal of Normal and Leukemic Stem Cells,8389531,9/20/2004 0:00,11/30/2015 0:00,Non-SBIR/STTR,2013,273740, ,NCI,164443,109297,273740
Role of p53 polymorphisms in disparities in breast carcinogenesis and outcome .,8390442,3/13/2011 0:00,11/30/2015 0:00,Non-SBIR/STTR,2013,341275, ,NIMHD,233750,107525,341275
"The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer",8390487,2/1/2010 0:00,6/30/2013 0:00,Non-SBIR/STTR,2013,75704, ,NCI,56135,19569,75704
Mechanisms of CDX2 regulation of the IGF axis,8391147,4/1/2009 0:00,9/30/2013 0:00,Non-SBIR/STTR,2013, , , , , , 
Characterization of Human Epidermal Stem Cells,8391596,10/1/2010 0:00,9/30/2014 0:00,Non-SBIR/STTR,2013, , , , , , 
Regulation of Mutant P53 Expression and Oncogenic Activity,8391661,2/1/2007 0:00,5/31/2017 0:00,Non-SBIR/STTR,2012,283822, ,NCI,184300,99522,283822
Humanized Mouse Models for the p53 R72P SNP,8391757,12/1/2008 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,283904, ,NIEHS,211290,72614,283904
CARP-1: A Potential Therapeutic Agent for Breast Cancer,8392106,1/1/2012 0:00,12/31/2015 0:00,Non-SBIR/STTR,2013, , , , , , 
The role of Fyn and Srcasm in UVB-induced cutaneous neoplasia,8392412,8/1/2012 0:00,5/31/2017 0:00,Non-SBIR/STTR,2012,332000, ,NCI,207500,124500,332000
Lung Cancer Drivers and Dependencies as Therapeutic Targets,8393593,7/23/2007 0:00,8/31/2017 0:00,Non-SBIR/STTR,2012, ,372966, ,238181,134785, 
Novel Mechanism for Myc-Induced Apoptosis,8394409,9/1/2012 0:00,8/31/2015 0:00,"Training, Individual",2012,26592, ,NCI,26592, ,26592
Role of p53 homologs in DNA repair in human keratinocytes,8394601,10/1/2009 0:00,3/31/2014 0:00,Non-SBIR/STTR,2013, , , , , , 
Targeting stem cell populations in lung cancer by modulating the Wnt and p53 path,8394835,9/20/2012 0:00,8/31/2014 0:00,SBIR/STTR,2012,259451, ,NCI, , ,259451
Modulation of p53 function by tyrosine kinase networks,8396043,9/7/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2012,335113, ,NCI,207500,127613,335113
"Role of NIAM, A Putative Cancer Gene, in Chromosomal Instability and Gliobastoma",8396126,9/1/2012 0:00,8/31/2015 0:00,"Training, Individual",2012,28158, ,NCI,28158, ,28158
Role of hsnf5/BAF47 Loss in Human Cancer Development,8396591,3/1/2002 0:00,6/30/2014 0:00,Non-SBIR/STTR,2012,40657, ,NCI,27471,13186,40657
Mechanisms of Cancer Initiation by TRIM32,8396606,5/15/2003 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012,23851, ,NCI,15487,8364,23851
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1,8396626,4/1/2008 0:00,7/31/2013 0:00,Non-SBIR/STTR,2012,60861, ,NCI,42497,18364,60861
Role of the Mullerian Tract in Ovarian Cancer Development,8396652,5/1/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,58236, ,NCI,35600,22636,58236
Modulation of sensitivity & imaging therapeutic response of hypoxic cancer cells,8396656,5/18/2009 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,82591, ,NCI,53981,28610,82591
"Phosphosulindac, miRNAs and cancer racial disparity",8396672,2/5/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2012,22186, ,NCI,14131,8055,22186
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,8397570,4/1/2011 0:00,3/31/2015 0:00,Non-SBIR/STTR,2012, , , , , , 
Signaling Networks in Glioblastoma Drug Resistance,8397738,9/1/2012 0:00,8/31/2014 0:00,"Training, Individual",2012,42232, ,NCI,42232, ,42232
IGF1R: A candidate oncogene in pediatric high grade gliomas,8397779,6/1/2012 0:00,12/11/2012 0:00,"Training, Individual",2012,32135, ,NCI,32135, ,32135
"NUCKS, a novel double-strand break repair gene, implicated in cancer biology",8400362,6/28/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2012,416736, ,NIEHS,225000,191736,416736
Mechanisms of Synergistic Regulation of Stem/Progenitors,8400385,4/1/1996 0:00,6/30/2014 0:00,Non-SBIR/STTR,2013,362855, ,NHLBI,235620,127235,362855
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells,8402553,4/1/2011 0:00,9/30/2015 0:00,Non-SBIR/STTR,2013, , , , , , 
Oncogene c-Myc-dependent pathways in cutaneous melanoma03,8403046,12/11/2006 0:00,11/30/2016 0:00,Non-SBIR/STTR,2013,304852, ,NCI,175725,129127,304852
Regulation of Basal-Like and Her2+ Breast Cancer Phenotypes by IKK/NF-kappaB,8403545,2/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,278795, ,NCI,189199,89596,278795
Molecular mechanisms of GBM radioresistance and strategies for radiosensitization,8403553,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2013,310130, ,NCI,195050,115080,310130
CDK6 in T cell development and cancer,8403614,1/15/2009 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,304610, ,NCI,189199,115411,304610
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str,8403625,2/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,492966, ,NCI,389973,102993,492966
Regulation of Myc-Mediated Tumorigenesis,8403688,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2013,304016, ,NCI,195050,108966,304016
Investigating the role of p73 and its isoforms in tumorigenesis and metastasis,8403698,1/1/2009 0:00,12/31/2015 0:00,Non-SBIR/STTR,2013,291366, ,NCI,189199,102167,291366
Normal and Neoplastic Regulation of Cyclin E,8403709,7/1/2003 0:00,12/31/2013 0:00,Non-SBIR/STTR,2013,348714, ,NCI,198133,150581,348714
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells,8403753,3/17/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,459677, ,NCI,369023,90654,459677
Role of a novel Notch1 target gene in skin carcinogenesis,8403758,3/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,289308, ,NCI,170279,119029,289308
The ARF Tumor Suppressor,8403760,1/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,325422, ,NCI,189199,136223,325422
Functional Analysis of p53 Polymorphic Variants,8403786,6/1/2005 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,302498, ,NCI,175871,126627,302498
Berberine downregulates MDM2 by interaction with DAXX in cancer cells,8403808,1/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,293258, ,NCI,189199,104059,293258
Lapatinib and Obatoclax combination therapy,8403809,7/7/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,318209, ,NCI,212849,105360,318209
Mechanisms of Mdm2/Mdmx in repressing p53,8403918,1/1/2009 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,303567, ,NCI,189199,114368,303567
Molecular Targeting of Diffuse Large B-cell Lymphoma,8408794,1/20/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,493670, ,NCI,332917,160753,493670
Mouse Models to Dissect p53 Tumor Suppressor Function,8408812,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2013,322984, ,NCI,195050,127934,322984
Regultion of p53 Deubiquitination,8408814,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2013,307594, ,NCI,195050,112544,307594
Mycn and Medulloblastoma,8410037,1/1/2009 0:00,12/31/2013 0:00,Non-SBIR/STTR,2013,292312, ,NCI,189199,103113,292312
Mechanisms of Radioresistance and Cell Cycle Progression,8410606,5/1/1995 0:00,6/30/2017 0:00,Non-SBIR/STTR,2012,347814, ,NCI,217384,130430,347814
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis,8413001,1/16/2012 0:00,10/31/2016 0:00,Non-SBIR/STTR,2013,392894, ,NIEHS,245559,147335,392894
Biological Effects of DNA Adducts Formed by Nitroaromatic Compounds,8417609,2/1/1998 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,307995, ,NIEHS,245386,62609,307995
AMPK and AMPK-related kinases in lung cancer development and treatment,8420203,1/16/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2013,402550, ,NCI,207500,195050,402550
Dual Targeting of the p53 pathway for development of anti-cancer therapy,8421099,9/26/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2012,294134, ,NCI,195438,98696,294134
The Role of p53-inducible Sesn1 and Sesn2 genes in lung carcinogenesis,8422822,2/1/2013 0:00,1/31/2018 0:00,Non-SBIR/STTR,2013,284405, ,NCI,186750,97655,284405
The Role of White Matter Progenitors in Glioma Formation and Progression,8423048,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,333064, ,NINDS,206872,126192,333064
The role of melanocyte precursors in zebrafish pigmentation disorders,8423391,1/1/2009 0:00,12/31/2014 0:00,Other Research-Related,2013,126900, ,NIAMS,117500,9400,126900
DUSP26: A Novel Therapeutic Target in Neuroblastoma,8423394,3/1/2011 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,330362, ,NINDS,211094,119268,330362
Repair of oxidative DNA damage in mammalian cells,8423842,3/10/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2012,245539, ,NCI,165346,80193,245539
Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC),8425501,9/15/2012 0:00,8/31/2017 0:00,Other Research-Related,2012,172260, ,NCI,159500,12760,172260
The PDGF alpha neural progenitor cells of the subventricular zone contributes to,8426614,2/13/2012 0:00,8/12/2014 0:00,"Training, Individual",2013,42232, ,NINDS,42232, ,42232
LncRNA Pathways as Novel Diagnostic Biomarkers Derived from the Stroma of Epithel,8427147,1/11/2013 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,82000, ,NCI,50000,32000,82000
"HPV, Tumor Metabolism and Radiosensitivity in Head and Neck Cancer",8428095,9/20/2013 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,190000, ,NIDCR,125000,65000,190000
Mitigation of asbestos induced alveolar epithelial cell injury,8429439,3/1/2012 0:00,12/31/2016 0:00,Non-SBIR/STTR,2013,321871, ,NIEHS,208331,113540,321871
Hdac3 as a therapeutic target in BCL6-dependent lymphoma,8431792,2/20/2012 0:00,1/31/2017 0:00,Non-SBIR/STTR,2013,378957, ,NCI,242915,136042,378957
Regulation of differentiation in esophageal epithelia,8431797,5/1/2006 0:00,2/29/2016 0:00,Non-SBIR/STTR,2013,335821, ,NIDDK,209888,125933,335821
"Fortilin, p53, and atherosclerosis",8431876,1/15/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2013,375610, ,NHLBI,250000,125610,375610
Biomarkers in Head and Neck Cancer Progression,8432362,4/17/2009 0:00,3/31/2014 0:00,Other Research-Related,2013,94454, ,NIDCR,87457,6997,94454
USC Research Center for Liver Disease,8432474,3/1/1997 0:00,2/28/2015 0:00,Research Centers,2013,1126655, ,NIDDK,695466,431189,1126655
The role of DNA polymerase eta in DNA damage response and p53 activation,8433258,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,262230, ,NCI,170279,91951,262230
Targeting ROS by a p53-activating agent for selective killing of cancer cells,8433262,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,327225, ,NCI,189199,138026,327225
Genetic Mouse Models of Glioma,8433267,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2013,365222, ,NCI,232626,132596,365222
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy,8433432,3/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,285463, ,NCI,189199,96264,285463
A metabolic role for PML in tumor suppression,8433446,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,329206, ,NCI,189199,140007,329206
p53 Family in Gastric Cancer Development,8433451,8/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,328679, ,NCI,210692,117987,328679
Functions of Papillomavirus E6,8433455,4/8/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,281939, ,NCI,183077,98862,281939
Mechanisms and Treatment of PTEN Mutant Prostate Tumorigenesis,8433517,4/1/2010 0:00,6/30/2014 0:00,Non-SBIR/STTR,2013,286069, ,NCI,151359,134710,286069
Role of p53 in cell cycle checkpoints,8433520,3/1/2009 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,320693, ,NCI,189199,131494,320693
Prostate cancer chemoprevention by penta-galloyl-glucose,8433527,1/1/2009 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,1, ,NCI,1,0,1
Therapeutic Targeting of Oncogenic Stress in Cancer Treatment,8433534,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,290420, ,NCI,189199,101221,290420
Defining critical p53 therapeutic targets and mechanisms,8433990,3/1/2009 0:00,1/31/2014 0:00,Non-SBIR/STTR,2013,358343, ,NCI,189199,169144,358343
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck Cancer,8434265,3/2/2009 0:00,8/31/2013 0:00,Non-SBIR/STTR,2013,19849, ,NCI,12717,7132,19849
Optimization of DNA Repair by Abh8,8434318,3/1/2012 0:00,2/28/2015 0:00,"Training, Individual",2013,62030, ,NIEHS,62030, ,62030
Chemopreventition and treatment of non-melanoma skin cancer by targeting MIF,8434824,4/1/2012 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,76250, ,NCI,50000,26250,76250
The Function of rpL5 and rpL11 in induction of p53,8434834,3/1/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2013,306229, ,NCI,195050,111179,306229
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy,8434835,3/1/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2013,369620, ,NCI,195050,174570,369620
Mechanisms of Metabolic Gene Mutations in Cancer,8434844,3/1/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2013,288674, ,NCI,195050,93624,288674
Search for the Molecular Causes of Diabetic Embryopathy,8434935,8/1/1998 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,336631, ,NIDDK,208440,128191,336631
Non-invasive sampling of DNA markers for pancreatic cancer screening,8435334,3/1/2012 0:00,2/28/2014 0:00,Non-SBIR/STTR,2013,182488, ,NCI,122670,59818,182488
A novel murine model for metastatic islet cell pancreas cancer,8435352,3/1/2012 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,188490, ,NCI,102225,86265,188490
Peripheral blood biopsy for molecular diagnosis of pancreatic cancer,8435371,3/1/2012 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,185906, ,NCI,126426,59480,185906
Therapeutic implication of estrogen receptor-p53 interaction in mitochondria,8435384,3/1/2012 0:00,2/29/2016 0:00,Non-SBIR/STTR,2013,189872, ,NCI,102225,87647,189872
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer,8436668,9/11/2012 0:00,6/30/2017 0:00,Non-SBIR/STTR,2012,385406, ,NCI,232172,153234,385406
Biomarkers for Margin Analysis and Prognosis in HNSCC,8437228,9/1/1999 0:00,3/31/2016 0:00,Non-SBIR/STTR,2013,386830, ,NIDCR,246013,140817,386830
Cancer biology in the zebrafish,8437367,7/3/2003 0:00,2/28/2018 0:00,Non-SBIR/STTR,2013,368865, ,NCI,210780,158085,368865
Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport,8437899,2/5/2013 0:00,1/31/2016 0:00,Non-SBIR/STTR,2013,583778, ,NCI,511291,72487,583778
The replication checkpoint and genomic fidelity in skin,8438257,9/1/2003 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,334455, ,NIAMS,201479,132976,334455
Prevention of quinone toxicity and mutagenicity,8438269,8/1/1996 0:00,2/29/2016 0:00,Non-SBIR/STTR,2013,330750, ,NIEHS,220500,110250,330750
Defining mechanisms of extracellular communication for cancer therapy,8439983,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,323700, ,NCI,207500,116200,323700
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,8440656,2/7/2013 0:00,1/31/2018 0:00,Non-SBIR/STTR,2013,393015, ,NCI,285384,107631,393015
EWS-Fli1 fusion protein and Ewing's sarcoma,8440702,1/1/2012 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013, , , , , , 
Mouse models of genomic instability and birth defects,8441615,4/1/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2013,284801, ,NICHD,191660,93141,284801
Disrupting Protein-Protein Interactions With Bis-peptides,8442385,1/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,295290, ,NIGMS,193000,102290,295290
Nuclear Accumulation of Cyclin D1 and Oncogenesis,8443265,7/1/2001 0:00,7/31/2017 0:00,Non-SBIR/STTR,2012,297661, ,NCI,186038,111623,297661
The MRAD9 Radioresistance Gene,8443818,12/1/2000 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,323004, ,NIGMS,200624,122380,323004
FDH: A Novel Determinant of Tumor Suppression,8444313,3/1/2005 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,233469, ,NCI,158284,75185,233469
Genetic and molecular epidemiology of adult glioma,8444345,5/15/1991 0:00,3/31/2016 0:00,Non-SBIR/STTR,2013,1345020, ,NCI,893248,451772,1345020
Role of nutrient sensor O-GlcNAc transferase in regulating cancer,8444359,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2013,299058, ,NCI,201932,97126,299058
Prostate Cancer Prevention by Diallyl Trisulfide,8444500,4/1/2005 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,299750, ,NCI,197855,101895,299750
Regulation of NF-Kappa B,8444542,9/30/2000 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,672082, ,NIAID,352799,319283,672082
Modulation of sensitivity & imaging therapeutic response of hypoxic cancer cells,8444592,5/18/2009 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,293448, ,NCI,189199,104249,293448
Role of the Mullerian Tract in Ovarian Cancer Development,8444594,5/1/2009 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,306503, ,NCI,189199,117304,306503
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8444595,3/14/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2013,93129, ,NCI,59698,33431,93129
Regulation of Ionizing Radiation Induced DNA Damage Response,8444597,5/1/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2013,281150, ,NCI,189199,91951,281150
Discovery of New Genes for Inherited Predisposition to Breast Cancer by Exome Seq,8444635,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2013,491748, ,NCI,315223,176525,491748
Role of p300/CBP and hHR23 Proteins in p53 Regulation,8444644,4/19/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,245620, ,NCI,164294,81326,245620
"Vitamin D, Metabolic Flux and Breast Cancer",8444913,1/1/2013 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,195632, ,NCI,130500,65132,195632
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,8445153,4/1/2011 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013, , , , , , 
Role of IL-6/STAT3 Signaling in the Neoplastic Progression of Barrett's Esophagus,8445155,10/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013, , , , , , 
Overlapping Airway Basal Cell Transcriptome Reprogramming in COPD and Lung Cancer,8445251,6/15/2011 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,985692, ,NHLBI,762258,223434,985692
Regulation of Lung Cancer Metastasis by miR-200,8445416,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2013,305245, ,NCI,223056,82189,305245
MiR-182 overexpression in early tumorigenesis of high grade serous carcinoma,8445674,2/1/2013 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,201623, ,NCI,130500,71123,201623
Mechanisms of Chemoprevention by Isothiocyanates,8446148,9/1/2004 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,296929, ,NCI,193439,103490,296929
Re-replication of chromosomes and cancer,8446154,7/11/1994 0:00,5/31/2014 0:00,Non-SBIR/STTR,2013,302345, ,NCI,200360,101985,302345
P38 MAPK in Ras-induced Senescence and Transformation,8446172,7/1/2005 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,300581, ,NCI,158284,142297,300581
"Telomerase in Development, Senescence and Neoplasia",8446176,1/1/2000 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,587737, ,NCI,371985,215752,587737
Effect of high fat diet on pancreatic cancer in IKKa deficient mice,8446306,4/1/2012 0:00,7/31/2013 0:00,Non-SBIR/STTR,2013,72850, ,NCI,47000,25850,72850
Mitochondrial p32 regulation of the Mdm2-p53 tumor suppression signaling and apop,8446316,7/1/2012 0:00,4/30/2017 0:00,Non-SBIR/STTR,2013,288674, ,NCI,195050,93624,288674
Mechanisms of cell competition that regulate growth during development,8446367,8/1/2006 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,307482, ,NIGMS,193000,114482,307482
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis,8446960,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,312080, ,NCI,195050,117030,312080
Molecular analysis of methylated p53,8447202,8/1/2013 0:00,7/31/2017 0:00,Non-SBIR/STTR,2013,363455, ,NIGMS,243200,120255,363455
Nanotheranostics for Early Colorectal Cancer Detection and Treatment,8447326,3/6/2013 0:00,2/28/2018 0:00,Non-SBIR/STTR,2013,327850, ,NCI,207500,120350,327850
Genomic stability of human pluripotent stem cells,8447348,4/1/2011 0:00,3/31/2014 0:00,Non-SBIR/STTR,2013,232757, ,NICHD,130396,102361,232757
Signal Transduction by Non-transmembrane PTPs,8447361,12/1/1988 0:00,12/31/2015 0:00,Non-SBIR/STTR,2013,311658, ,NCI,288572,23086,311658
Coordinately regulated alternative splicing in DNA damage and cancer,8447373,4/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,245202, ,NCI,170279,74923,245202
Gonadotropins & Cox-2 in Ovarian Cancer Prevention,8447386,5/1/2003 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,353498, ,NCI,244355,109143,353498
Mechanisms of preferential targeting of colon cancer by a plant-derived alkaloid,8447422,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,380725, ,NCCIH,242500,138225,380725
p53-GAMT pathway in cancer cell metabolism and DNA damage-induced carcinogenesis,8447577,5/13/2010 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,318080, ,NCI,189198,128882,318080
Role of beta-endorphin in cancer therapy induced fatigue,8448011,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2013,331979, ,NCI,195050,136929,331979
Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer,8448015,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2013,285749, ,NCI,195050,90699,285749
Ecd as a regulator of cell cycle and breast oncogenesis,8448016,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2013,289650, ,NCI,195050,94600,289650
Mechanism of P73-Dependent Tumor Suppression,8448311,5/1/1999 0:00,3/31/2016 0:00,Non-SBIR/STTR,2013,286286, ,NCI,185900,100386,286286
The Role of Polyoma Small T in Regulating Cell Survival,8448547, ,3/31/2015 0:00,Non-SBIR/STTR,2013, ,522432, ,362431,160001, 
Papillomavirus E2 Growth Suppression Mechanisms,8448549, ,3/31/2015 0:00,Non-SBIR/STTR,2013, ,525651, ,364664,160987, 
"Studying the initiation, progression and therapy of lung cancer in mouse models",8448775,4/1/2009 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,316587, ,NCI,204911,111676,316587
Next generation strategies to intercept ErbB signaling,8449477,4/25/1997 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,216389, ,NCI,200361,16028,216389
GI Hormones and Other Factors in Growth of Mucosa,8449689,12/1/1977 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,491419, ,NIDDK,332040,159379,491419
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12,8449707,8/1/2002 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,274346, ,NCI,155425,118921,274346
Role of Rb Family in Lung Epithelial Response to Injury,8450163,4/1/2005 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,360499, ,NHLBI,235620,124879,360499
The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAs,8450201,4/8/2010 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,332245, ,NIEHS,230083,102162,332245
DNA Methyltrasferase Gene Expression in Colon Cancer,8450224,4/1/1991 0:00,9/18/2014 0:00,Non-SBIR/STTR,2013,547984, ,NIEHS,334137,213847,547984
PCAF/GCN5 Acetylation on p53 Transactivation,8450226,4/1/1999 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,318519, ,NCI,202234,116285,318519
Basal cell carcinomas: p53-dependent mechanisms of resistance,8450702,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,315981, ,NCI,195050,120931,315981
Anti-pancreatic tumorigenesis by inactivation of SAG/RBX2 E3 ubiquitin ligase,8450970,1/1/2013 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,202928, ,NCI,130500,72428,202928
Role of SAG/RBX2 E3 Ubiquitin Ligase in Skin Carcinogenesis,8451029,1/3/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2013,322663, ,NCI,207500,115163,322663
Molecular Pathogenesis of Diamond Blackfan Anemia,8452179,1/7/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,441741, ,NHLBI,371963,69778,441741
Cooperation of Mutant TP53 and PIK3CA in Breast Carcinogensis,8452415,3/8/2013 0:00,3/7/2016 0:00,"Training, Individual",2013,42232, ,NCI,42232, ,42232
Identification of natural products to treat neoplastic disease,8452440,9/26/2012 0:00,8/31/2014 0:00,SBIR/STTR,2012,342963, ,NCI, , ,342963
Hypoxia and Gene Repression,8453426,7/1/2000 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,304966, ,NCI,189229,115737,304966
The role of Aurora Kinase A in Upper Gastrointestinal Adenocarcinomas,8453440,6/1/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2013,295150, ,NCI,189199,105951,295150
Mechanisms of Intestinal Tumorigenesis,8454560,1/1/2000 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,355315, ,NCI,227274,128041,355315
Structural basis for CBP/p300 transcriptional regulation,8456071,6/10/2002 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,382922, ,NCI,202070,180852,382922
The Combinatorial Effect of p53 Dynamics and Modifications on Cell Fate Decisions,8456458,2/1/2013 0:00,1/31/2016 0:00,"Training, Individual",2013,55670, ,NIGMS,55670, ,55670
Mutant p53 has gain-of-function mechanisms to mediate tumor invasion,8456806,12/1/2013 0:00,11/30/2016 0:00,"Training, Individual",2013,28764, ,NCI,28764, ,28764
Novel therapeutic targets for Diamond Blackfan anemia and other ribosomopathies,8457124,4/9/2012 0:00,6/30/2013 0:00,Other Research-Related,2013,67167, ,NIDDK,62192,4975,67167
"Phosphosulindac, miRNAs and cancer racial disparity",8457150,2/5/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,295343, ,NCI,189199,106144,295343
Mechanisms for Selective Transcription of p53 Targets by the AcK120 Isoform,8457388,3/9/2013 0:00,3/8/2017 0:00,"Training, Individual",2013,42232, ,NCI,42232, ,42232
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor,8458103,4/10/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,281041, ,NCI,186120,94921,281041
Dmp1-p53/YY1 interplays and their roles in lung cancer development,8458153,4/1/2004 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,243155, ,NCI,164294,78861,243155
In vivo function and mechanism of the r-protein-Mdm2-p53 pathway,8458578,8/1/2003 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,291299, ,NCI,198133,93166,291299
Apoptosis Regulation by Adenovirus and Cellular Genes,8458582,8/1/1999 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,270731, ,NCI,180487,90244,270731
Expression of Simiam Virus 40 T Antigens in Intestine,8458617,7/1/2003 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,293880, ,NCI,212003,81877,293880
Mechanisms of RelA Activation in Cancer,8458623,9/19/2003 0:00,4/30/2014 0:00,Non-SBIR/STTR,2013,205159, ,NCI,133220,71939,205159
Mechanisms of Gene-Specific Transcriptional Regulation Within the p53 Network,8458938,5/26/2006 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,267706, ,NCI,175545,92161,267706
Integrative genomic characterization of lung cancer metastasis in mouse and human,8458982,9/30/1999 0:00,7/31/2014 0:00,Non-SBIR/STTR,2013,697129, ,NCI,414958,282171,697129
Cellular Response to Short Telomeres in B-Cell Lymphoma,8458990,7/5/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,491013, ,NCI,299398,191615,491013
Medulloblastoma and Metastases,8459004,5/4/2010 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,442785, ,NCI,352423,90362,442785
Impact of molecular phenotype on glioma metabolism and growth,8459342,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2013,281170, ,NCI,230927,50243,281170
Bcl-2 as a Biomarker for Prognosis and Therapy of Head and Neck Cancer,8459501,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,412075, ,NIDCR,283200,128875,412075
Collaborating Mutations in Medulloblastoma,8459549,4/1/2003 0:00,3/31/2014 0:00,Non-SBIR/STTR,2012, ,12250, ,7000,5250, 
Collaborating Mutations in Medulloblastoma,8459551,4/1/2003 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013, ,255194, ,169824,85370, 
In vivo murine models of metastasis for therapeutic testing,8459980,4/16/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,376196, ,NCI,322785,53411,376196
Common Pathogenetic Mechanisms of Lung Cancer and COPD,8459981,7/1/2011 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,668065, ,NHLBI,574942,93123,668065
Functional analysis of beta-TRCP in cell cycle control and DNA damage response,8459992,5/1/2012 0:00,1/31/2016 0:00,Non-SBIR/STTR,2013,316930, ,NIGMS,182144,134786,316930
Restoration of Tumor Suppression Activity in Malignant Melanoma,8460112,7/1/2006 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,431029, ,NCI,308985,122044,431029
Mechanisms of p53 activation during stress response,8460131,7/1/2009 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,315962, ,NCI,189199,126763,315962
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",8460147,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,319935, ,NCI,202490,117445,319935
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D,8460439,5/1/1995 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,410953, ,NCI,225509,185444,410953
The Role of MDM Proteins in Cell Growth and Tumorigenesis,8461276,3/1/1999 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,296633, ,NCI,180324,116309,296633
Altered Proteoglycan Gene Expression and Cancer,8461457,9/1/1988 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,340819, ,NCI,220595,120224,340819
Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer,8461599,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,457446, ,NCI,344455,112991,457446
Biomarkers of survival in glioma epidemiology,8461813,7/1/2008 0:00,5/31/2014 0:00,Non-SBIR/STTR,2013,253843, ,NCI,164300,89543,253843
Molecular interactions and restoration strategies of PTEN and p53 in gliomas,8461815,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,291367, ,NCI,189199,102168,291367
Targeted Development of Platinum Drugs,8461923,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,308179, ,NCI,195050,113129,308179
Molecular Pathogenesis of Multiple Myeloma,8462114,6/1/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2013,302718, ,NCI,189199,113519,302718
PUMA-mediated apoptosis in human cancer cells,8462222,4/1/2004 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,246317, ,NCI,164294,82023,246317
The role of the Ras effector Nore1a in tumor suppression,8462224,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,255419, ,NCI,170279,85140,255419
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma:  Environmental Co,8462226,7/1/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2013,326506, ,NCI,245820,80686,326506
Prevention of UV-induced carcinogenesis by cyanidin-3-glucoside,8462255,8/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2013,327443, ,NIEHS,220500,106943,327443
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance,8462458,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,297042, ,NCI,189199,107843,297042
Targeting Glucose Metabolism in Cancer,8462570,7/1/2009 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,214211, ,NCI,144737,69474,214211
The role of IL8 in colitis-associated tumor initiation,8462929,6/1/2012 0:00,8/22/2013 0:00,Non-SBIR/STTR,2013,106717, ,NCI,69908,36809,106717
Role of Otubain 1 in the p53 Pathway,8462942,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,299113, ,NCI,195050,104063,299113
Organic cation transporter 2 and cisplatin nephrotoxicity,8463143,7/12/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,374845, ,NCI,223122,151723,374845
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance,8463144,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,315659, ,NCI,195050,120609,315659
Mechanism of chemoresistance mediated by TGF-beta,8463147,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,327684, ,NCI,195050,132634,327684
BRCA1 and progesterone receptors in breast cancer,8463405,9/1/2009 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,295529, ,NCI,193156,102373,295529
Local Immunoregulation of Carcinogenesis,8463465,7/13/2003 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,326930, ,NCI,201584,125346,326930
Imaging Based Dosimetry for Individualized Internal Emitter Therapy,8463525,4/1/1999 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,430418, ,NIBIB,276796,153622,430418
"Pubertal high fat diet: effects on inflammation, mammary development and cancer",8463533,9/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,442411, ,NIEHS,295992,153915,442411
Mechanisms of MnSOD expression in normal and tumor cells,8463805,12/1/1989 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,224804, ,NCI,151383,73421,224804
Growth Control and Genomic Stability,8463955, , ,Research Centers,2013, ,22045, ,11639,10406, 
"Chemoprevention of Colon Cancer, HDAC Inhibition, and Histone Status",8464017,3/17/2003 0:00,8/31/2013 0:00,Non-SBIR/STTR,2013, ,251096, ,251096,0, 
Murine Model of HCV-Associated Human Liver Cancer,8464678,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,442453, ,NCI,298955,143498,442453
Molecular Biology of Lung Cancer among Puerto Ricans,8464841,9/25/2012 0:00,8/31/2017 0:00,Research Centers,2012, ,190379, ,123750,66629, 
Molecular Biology of Lung Cancer among Puerto Ricans,8464957,9/24/2012 0:00,8/31/2017 0:00,Research Centers,2012, ,111240, ,66018,45222, 
MOLECULAR & STRUCTURAL BIOLOGY,8465392,8/6/1997 0:00,1/31/2017 0:00,Research Centers,2012, ,75411, ,49818,25593, 
CANCER CELL BIOLOGY,8465399,8/6/1997 0:00,1/31/2017 0:00,Research Centers,2012, ,34438, ,22750,11688, 
Roles of MiR-17-92 Cluster MicroRNAs in K-Ras-Induced Pancreatic Tumorigenesis,8465753,4/1/2012 0:00,3/31/2016 0:00,"Training, Individual",2013,28746, ,NCI,28746, ,28746
GENETICS OF MYELODYSPLASTIC SYNDROMES,8465898,8/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,361760, ,NHLBI,238000,123760,361760
A Functional Census of p53 Cancer and Suppressor Mutants,8466938,8/1/2005 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,348785, ,NCI,232706,116079,348785
Simultaneous Targeting of p53 to the Nucleus and Mitochondria for Cancer Therapy,8467689,7/1/2010 0:00,5/31/2014 0:00,Non-SBIR/STTR,2013,282853, ,NCI,189199,93654,282853
The in vivo role of the mitochondrial p53 cell death program,8468574,9/15/1993 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,250252, ,NCI,160288,89964,250252
Biological Function of the Retinoblastoma Gene Product,8469107,5/3/1994 0:00,2/28/2014 0:00,Non-SBIR/STTR,2012,72087, ,NCI,46520,25567,72087
Lipid-Peroxidation Induced Cyclic Adducts in Hepatocarcinogenesis,8469737,8/1/2009 0:00,5/31/2014 0:00,Non-SBIR/STTR,2013,372667, ,NCI,278752,93915,372667
Regulation of the mTOR Pathway By Nutrients,8470552,3/23/2004 0:00,5/31/2014 0:00,Non-SBIR/STTR,2013,355974, ,NCI,182551,173423,355974
Visualizing the effect of epigenetic modifications on transcription and mutation,8470607,9/15/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,365585, ,OD,225670,139915,365585
The Control of Centriole Duplication and Degeneration,8470657,8/1/2009 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,343049, ,NIGMS,179701,163348,343049
Enhancing glioma chemotherapy by suppressing Notch signaling,8470717,3/1/1988 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,340304, ,NINDS,206872,133432,340304
Role of Focal Adhesion Kinase In Tumorigenesis,8471067,7/1/2003 0:00,5/31/2014 0:00,Non-SBIR/STTR,2013,275505, ,NCI,178320,97185,275505
TOR signaling and autophagy in obesity-promoted liver tumorigenesis,8471075,7/22/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2013,331357, ,NCI,213779,117578,331357
Lentiviral Vectors to Model Human Gliomas in Mice,8471153,9/30/1994 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,634146, ,NHLBI,332885,301261,634146
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,8471656,5/1/1997 0:00,5/31/2017 0:00,Non-SBIR/STTR,2013,1353765, ,NCI,847949,505816,1353765
AMPK as a molecular target for chemoprevention by apigenin in preneoplastic skin,8471672,6/1/2012 0:00,5/31/2016 0:00,Non-SBIR/STTR,2013,189526, ,NCI,122670,66856,189526
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia,8472926,8/5/2003 0:00,8/31/2018 0:00,Research Centers,2013,2150500, ,NCI,1571150,579350,2150500
Identification and characterization of the functional role of miRNA in prostate c,8473050,7/9/2010 0:00,5/31/2014 0:00,Non-SBIR/STTR,2013,262158, ,NCI,170279,91879,262158
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer,8473057,7/15/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,290641, ,NCI,190787,99854,290641
"The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer",8474719,9/1/2012 0:00,6/30/2017 0:00,Non-SBIR/STTR,2013,310130, ,NCI,195050,115080,310130
Epigenetic Changes Link COPD and Lung Cancer,8474726,8/4/2011 0:00,5/30/2015 0:00,Non-SBIR/STTR,2013,749117, ,NCI,387524,361593,749117
OLIG2 Phosphorylation as a Drug Target for Glioma,8474849,7/15/2007 0:00,5/31/2016 0:00,Non-SBIR/STTR,2013,421089, ,NINDS,316576,104513,421089
Organic,8475339, ,6/30/2016 0:00,Research Centers,2013, ,23949, ,23949,0, 
Radiation Biology,8475442, , ,Research Centers,2013, ,14101, ,14097,4, 
Localizing Immunotherapy to Improve Therapeutic Index,8476648,6/4/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,395388, ,NCI,255380,140008,395388
Pten-loss Dysregulated Pathways in Prostate Cancer,8477068,9/25/2009 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,339020, ,NIMHD,231413,107607,339020
Mechanisms of Dicer1 Function in Lung Organogenesis and Cystic Lung Disease,8477270,6/15/2011 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,361935, ,NHLBI,246281,115654,361935
"ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY",8477547,5/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,315400, ,NCI,207500,107900,315400
Targeting the ATR pathway in p53-deficient cancers,8478065,7/13/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2013,319882, ,NCI,195050,124832,319882
A comprehensive approach to breast cancer susceptibility across the risk spectrum,8479325,7/5/2011 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,497212, ,NCI,376702,120510,497212
Interplay between Cdh1 and major regulatory pathways in human cancer,8479373,8/6/2009 0:00,6/30/2014 0:00,Non-SBIR/STTR,2013,329137, ,NIGMS,189159,139978,329137
Inhibiting the heat shock factor 1-regulated transcriptional program in cancer,8481991,4/16/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2013,555782, ,NCI,392256,163526,555782
THE ROLE OF P21 IN THE REPLICATION OF DAMAGED DNA,8485520,6/1/2011 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,50787, ,FIC,47025,3762,50787
Graduate Training at the Chemistry Biology Interface,8486445,7/1/2004 0:00,6/30/2014 0:00,"Training, Institutional",2013,46080, ,NIGMS,131472,8490,46080
Functional Genomic Dissection of Refractory Anemia,8486470,9/15/2005 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,390988, ,NHLBI,235620,155368,390988
Novel integrative method to detect biomakers of breast cancer resistance,8486963,8/1/2013 0:00,7/31/2018 0:00,Other Research-Related,2013,82325, ,NLM,76636,5689,82325
Small Molecule Screen Targeting p53 proteolysis in HPV positive cancers,8489916,7/1/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,195391, ,NCI,115275,80116,195391
Modulation of skin cancer by PPARb/d,8490763,3/1/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,247146, ,NCI,165870,81276,247146
Role of nucleolin in regulating mRNA stability during DNA damage response (DDR),8491082,4/1/2013 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,168563, ,NCI,108750,59813,168563
Transcriptional Control of Stroma Dependent Apoptosis in MDS,8492078,9/2/2010 0:00,5/31/2015 0:00,Other Research-Related,2013,132957, ,NIDDK,123108,9849,132957
Distinct Pathways of VPF/VEGF Receptors,8492134,4/1/2002 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,375326, ,NHLBI,238000,137326,375326
The Role of JAB1 in osteosarcoma pathogenesis,8492286,4/1/2013 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,79063, ,NCI,50000,29063,79063
Mapping the Dynamic Architecture of the Human Mediator Complex,8493647,3/8/2013 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,207547, ,NCI,157905,49642,207547
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy,8494116,3/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2012,37540, ,NCI,26109,11431,37540
G-quadruplex in Translational Regulation and Cancer Therapy,8494599,7/1/2012 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,163049, ,NCI,102225,60824,163049
Role of p53 polymorphisms in disparities in breast carcinogenesis and outcome .,8494814,3/13/2011 0:00,11/30/2015 0:00,Non-SBIR/STTR,2012,292834, ,NIMHD,200000,92834,292834
Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma,8496155,8/1/2012 0:00,7/31/2017 0:00,Other Research-Related,2013,184127, ,NINDS,170488,13639,184127
Targeting stabilized mutant p53 protein,8496336,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,332817, ,NCI,211480,121337,332817
ROLE OF CRYPTOCHROME IN DNA DAMAGE RESPONSES AND THE CIRCADIAN CLOCK,8499317,8/1/1982 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,492842, ,NIGMS,334391,158451,492842
Quinone Oxidoreductases and Mammary Toxicity/Carcinogenenicity,8499515,5/15/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2013,345375, ,NIEHS,225000,120375,345375
P53 Activation as Novel Therapeutic Strategy for Acute Myelogenous Leukemia,8499746,5/1/2013 0:00,8/31/2018 0:00,Research Centers,2013, ,196339, ,196339, , 
"NUCKS, a novel double-strand break repair gene, implicated in cancer biology",8500277,6/28/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,408410, ,NIEHS,220500,187910,408410
Rad50: Roles in chromo. stab. and prev. of malignancy,8500333,1/1/1998 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,511847, ,NIGMS,279852,231995,511847
Worker Genetic Susceptibility to Mutagenic Risk,8502192,7/1/2001 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,279125, ,NIOSH,175000,104125,279125
Alcohol and PAH-induced carcinogenesis,8502499,7/1/2012 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,72030, ,NIEHS,49000,23030,72030
Toll-like Receptor Regulation of Pancreatic Tumorigenesis,8503259,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,351713, ,NCI,207500,144213,351713
Regulation of MDM2 auto-ubiquitination and molecular targeting,8503289,12/15/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,251191, ,NCI,161020,90171,251191
The Role of PI3K in Growth Regulation,8503390,4/1/1990 0:00,1/31/2014 0:00,Non-SBIR/STTR,2013,127000, ,NIGMS,73000,54000,127000
PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM,8504056,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,344401, ,NCI,264619,79782,344401
Replicative senescence as a tumor suppressive mechanism,8504468,8/8/2007 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,306706, ,NCI,184300,122406,306706
Training Program in Molecular Genetics of Cancer,8504687,9/30/1978 0:00,6/30/2015 0:00,"Training, Institutional",2013,338656, ,NCI,391238,30109,338656
Functions of mir-34 microRNAs in the p53 tumor suppressor pathway,8504742,8/1/2009 0:00,6/30/2016 0:00,Non-SBIR/STTR,2013,290420, ,NCI,189199,101221,290420
The Role of ATF3 in the DNA Damage Response,8504744,9/1/2010 0:00,9/13/2013 0:00,Non-SBIR/STTR,2013,12108, ,NCI,0,12108,12108
A Luciferase Fusion Library of High Throughput Profiling of Protein Stability,8504819,8/1/2011 0:00,5/27/2014 0:00,"Training, Individual",2013,48884, ,NCI,48884, ,48884
DNA-Protein Interactions in Herpes Viruses,8504908, , ,Non-SBIR/STTR,2013, ,254304, ,175348,78956, 
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis,8505060,9/24/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,320682, ,NCI,184300,136382,320682
The role of ribosomal proteins in the p53-MDM2 pathway,8505389,3/1/2002 0:00,6/30/2016 0:00,Non-SBIR/STTR,2013,248752, ,NCI,165284,83468,248752
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer,8505408,7/1/2011 0:00,6/30/2016 0:00,Non-SBIR/STTR,2013,307633, ,NCI,240926,66707,307633
Genetic Alterations that Initiate Follicular Thyroid Carcinogenesis,8505981,3/1/2008 0:00, ,Non-SBIR/STTR,2013, ,418489, ,306591,111898, 
"Chemoprevention by black raspberry in oral cancer induced by DB[a,l]P in mice",8506711,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,353869, ,NCI,246000,107869,353869
Therapeutic strategies for specific subsets of KRAS mutant lung cancers,8506767,8/3/2009 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,530993, ,NCI,423910,107083,530993
Transcriptional regulation of oncogenic properties of mutant p53,8506830,5/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,310213, ,NCI,207500,102713,310213
Resistance of CML Stem Cells to Imatinib (Gleevec),8506946,7/1/2003 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,314718, ,NCI,187332,127386,314718
MODELS FOR GENETIC ASSESSMENT OF TUMOR MAINTENANCE GENES IN PDAC,8507159, , ,Non-SBIR/STTR,2013, ,283905, ,270005,13900, 
Understanding the origin and pathogenesis of epithelial ovarian cancer,8507465,7/1/2011 0:00,6/30/2014 0:00,"Training, Individual",2012,55670, ,NCI,55670, ,55670
TGF-beta Signaling in Pancreatic Cancer Progression,8507614,9/1/2009 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,310286, ,NCI,189199,121087,310286
Osteosarcoma Translational Research,8507628,7/9/2012 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,187685, ,NCI,122670,65015,187685
Mitochondrial uncoupling in prevention of carcinogenesis,8507637,7/9/2012 0:00,6/30/2016 0:00,Non-SBIR/STTR,2013,176645, ,NCI,122670,53975,176645
The Development of Novel Individualized Therapy for  Metastatic Triple Negative B,8507639,7/9/2012 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,158143, ,NCI,109910,48233,158143
The effects of endogenous and dietary estrogens on colonic stem cells,8507640,7/9/2012 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,175438, ,NCI,122670,52768,175438
Rewiring the miRNA-MDM2-p53 network to reactivate p53 function,8507664,9/1/2012 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,187685, ,NCI,122670,65015,187685
Elucidating p53 transcriptional networks involved in pancreatic cancer suppressio,8508225,7/10/2012 0:00,6/30/2014 0:00,Non-SBIR/STTR,2013,194763, ,NCI,122670,72093,194763
Chemosensitization of Pancreatic Cancer Cells by Curcumin and Vitamin D Receptor,8508551,4/1/2013 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,194119, ,NCI,108750,85369,194119
Targeting p53-Dependent Repigmentation in Vitiligo,8510581,7/1/2012 0:00,6/30/2017 0:00,Other Research-Related,2013,100572, ,NIAMS,93530,7042,100572
Focal Adhesion Kinase - Tumor Biology and Therapeutics,8510585,9/30/1996 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,289079, ,NCI,206458,82621,289079
p53-independent function of Mdmx in tumorigenesis,8510599,7/1/2010 0:00,6/30/2014 0:00,"Training, Individual",2013,26837, ,NCI,26837, ,26837
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer,8510775, , ,Research Centers,2013, ,330350, ,213819,116531, 
Identification of Genetic Alterations Responsible for Primary GBM Clonal Evoluti,8510981,9/5/2001 0:00,6/30/2018 0:00,Non-SBIR/STTR,2013, ,451755, ,358383,93372, 
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma,8511195,3/18/2013 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,213747, ,NCI,142771,70976,213747
Effect of Omega-3 Fatty Acids on Cancer Stem Cells,8511593,7/16/2012 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,284864, ,NCI,195050,89814,284864
P63 mechanisms and mediators in HNSCC,8511602,4/1/2004 0:00,7/31/2016 0:00,Non-SBIR/STTR,2013,414585, ,NIDCR,240000,174585,414585
Understanding the origin and pathogenesis of epithelial ovarian cancer,8512567,7/1/2011 0:00,9/23/2013 0:00,"Training, Individual",2013,11501, ,NCI,11501, ,11501
Chemical Inhibitors of CREB-mediated Gene Transcription,8512736,9/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,308961, ,NIGMS,211458,97503,308961
LC-MS Analysis of DNA Adducts of Aromatic Amines: Relationship to Bladder Cancer,8513263,5/18/1996 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,210261, ,NCI,137562,72699,210261
NYU Lung Cancer Biomarker Center,8513264,5/8/2000 0:00,12/31/2015 0:00,Non-SBIR/STTR,2013,590723, ,NCI,518057,348705,590723
Targeting Microenvironment / Leukemia Cell Interactions in CML,8513787, , ,Non-SBIR/STTR,2013, ,282957, ,179317,103640, 
The role of Fyn and Srcasm in UVB-induced cutaneous neoplasia,8513948,8/1/2012 0:00,5/31/2017 0:00,Non-SBIR/STTR,2013,312080, ,NCI,195050,117030,312080
Cyclin E Regulation in Normal and Neoplastic Hematopoiesis,8514050,8/1/2010 0:00,7/31/2014 0:00,Non-SBIR/STTR,2013,355492, ,NHLBI,235620,119872,355492
OXIDATIVE INJURY TO GASTRIC EPITHELIAL CELLS BY H. PYLORI,8514362,9/21/2001 0:00,7/31/2016 0:00,Non-SBIR/STTR,2013,310000, ,NIDDK,200000,110000,310000
Effects of Stochastic Gene Alterations on Intestinal Tumorigenesis in the Mouse,8514622,12/1/1983 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,392200, ,NIGMS,266028,126172,392200
Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,8515310,9/30/2009 0:00,8/31/2016 0:00,Other Research-Related,2013,337425, ,NIAID,230324,107101,337425
PET TUMOR AND PROLIFERATION IMAGING VIA CATIONIC AMINO ACID TRANSPORT,8515355,9/1/2011 0:00,8/31/2016 0:00,Other Research-Related,2013,157715, ,NCI,146032,11683,157715
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,8515745,8/15/1999 0:00,7/31/2016 0:00,Non-SBIR/STTR,2013,254975, ,NCI,164500,90475,254975
Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction,8515885,9/5/2009 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,315273, ,NIAAA,210182,105091,315273
Transposon-insertional Mutagenesis to Decipher Osteosarcomagenesis,8515964,9/28/2009 0:00,8/31/2014 0:00,Other Research-Related,2013,179280, ,NCI,166000,13280,179280
Role of DDB2 in chemotherapeutic agents-induced apoptosis and platinum resistance,8516879,9/1/2011 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,237961, ,NCI,156040,81921,237961
Nanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCV,8516909,9/15/2009 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,340495, ,NIAAA,210182,130313,340495
Heat Shock Protein-Induced Protection Against Cisplatin-Induced Hair Cell Death,8517085,9/28/2009 0:00,5/27/2015 0:00,"Training, Individual",2013,35531, ,NIDCD,35531, ,35531
Targeting Oncogene Expression to Skin in Transgenic Mice,8517591,8/1/1990 0:00,7/31/2016 0:00,Non-SBIR/STTR,2013,449076, ,NCI,308589,140487,449076
Skeletal genetic pathways of Notch and p53 in the pathogenesis of osteosarcoma,8518091,9/1/2011 0:00,8/31/2014 0:00,Non-SBIR/STTR,2013,74338, ,NIAMS,47500,26838,74338
"Spindle Assembly Checkpoint, Chromosome Stability, and Cancer",8518254,9/1/2008 0:00,5/31/2017 0:00,Non-SBIR/STTR,2013,296078, ,NCI,189187,106891,296078
Role of Cdc25A in breast cancer,8519064,9/1/2005 0:00,6/30/2016 0:00,Non-SBIR/STTR,2013,256820, ,NCI,170788,86032,256820
Exploiting mouse models of pediatric cancers and epigenetics for therapy,8519311,9/10/2004 0:00,7/31/2014 0:00,Non-SBIR/STTR,2013,728812, ,NCI,600575,135568,728812
The Study of the Circadian Rhythm in p53 Signaling,8519363,9/1/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,273745, ,NCI,189198,84547,273745
Directing the Mediator Complex: Bivalent approaches to Reconstituting or Inhibiti,8519392,8/1/2012 0:00,5/31/2016 0:00,Non-SBIR/STTR,2013,451575, ,NCI,339859,111716,451575
Regulation of p53 function by Daxx,8519732,5/3/2001 0:00,5/31/2013 0:00,Non-SBIR/STTR,2012,62208, ,NCI,42808,19400,62208
Ras Induced Senescence and Tumor Suppression,8520124,7/1/1999 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,337171, ,NIA,184347,152824,337171
Regulation of Mutant P53 Expression and Oncogenic Activity,8520202,2/1/2007 0:00,5/31/2017 0:00,Non-SBIR/STTR,2013,265998, ,NCI,173242,92756,265998
Targeting Leukemia Stem Cells with Dietary Selenium,8520264,8/1/2012 0:00,5/31/2017 0:00,Non-SBIR/STTR,2013,285029, ,NCI,195050,89979,285029
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes,8521109,9/18/2006 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,150175, ,NCI,107653,42522,150175
Pre-Clinical and Clinical Development of Silvestrol in Chronic Lymphocytic,8521129, ,7/31/2015 0:00,Research Centers,2013, ,251385, ,191649,59736, 
Characterization of Oncogenic Transcription Factor-Associated Proteins in SCC,8521185,8/2/2012 0:00,8/31/2013 0:00,Other Research-Related,2013,12375, ,NCI,11458,917,12375
Mechanisms of Delta-N-p63-alpha transcriptional repression and its role in squamo,8521189,8/1/2011 0:00,8/16/2013 0:00,"Training, Individual",2013,6333, ,NCI,6333, ,6333
Cellular Control: Synthetic Signaling/Motility (RMI),8523875,9/30/2004 0:00,7/31/2015 0:00,Other Research-Related,2013,1, ,OD,437684,238537,1
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis,8524287,5/14/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,342360, ,NCI,219016,123344,342360
The role of melanocyte precursors in zebrafish pigmentation disorders,8524634,1/1/2009 0:00,12/31/2013 0:00,Other Research-Related,2012,93280, ,NIAMS,86370,6910,93280
Cyclin D3 and DNA double strand breaks: genome stability and lymphomagenesis,8525845,5/1/2013 0:00,4/30/2016 0:00,"Training, Individual",2013,42232, ,NCI,42232, ,42232
Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer,8526432,8/8/2012 0:00,7/31/2014 0:00,Non-SBIR/STTR,2013,155627, ,NCI,118090,37537,155627
Examining melanoma cell subpopulations in tumor maintenance and drug resistance,8527300,3/15/2014 0:00,3/14/2017 0:00,"Training, Individual",2013,49214, ,NCI,49214, ,49214
Mechanisms of esophageal carcinogenesis,8527490,8/15/2003 0:00,6/30/2014 0:00,Non-SBIR/STTR,2013,1501332, ,NCI,1054156,447176,1501332
Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M,8527491,8/15/2003 0:00, ,Non-SBIR/STTR,2013, ,681605, ,478586,203019, 
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer,8527499,8/1/2009 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,295122, ,NCI,189199,105923,295122
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit,8527743,9/1/2012 0:00,6/30/2017 0:00,Non-SBIR/STTR,2013,285608, ,NCI,183671,101937,285608
Role of nutrient sensor O-GlcNAc transferase in regulating cancer,8527890,8/1/2012 0:00,2/29/2016 0:00,Non-SBIR/STTR,2012,36762, ,NCI,25998,10764,36762
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8527931,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2012,45527, ,NCI,31450,14077,45527
Defining the role of the tumor-initiating cell niche in breast cancer,8528268,9/1/2010 0:00,8/31/2015 0:00,Non-SBIR/STTR,2012,248999, ,NCI,189325,59674,248999
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma,8528350, , ,Research Centers,2013, ,571498, ,171135,400363, 
SPORE in Lung Cancer,8528755,9/15/2008 0:00,8/31/2014 0:00,Research Centers,2012,94360, ,NCI,56000,38360,94360
FOXO1 Inhibition in Genotoxic Stress Response and Prostate Cancer Survival,8529197,6/16/2009 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,298367, ,NCI,189199,109168,298367
Chronic versus acute effects of p53 deletion on Olig2 progenitor malignancy,8529433,8/15/2012 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,82215, ,NIA,47250,34965,82215
An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9),8529478,8/13/2012 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,185232, ,NCI,122670,62562,185232
Genome wide analysis of p53 inhibition by high glucose,8530063,5/1/2013 0:00,4/30/2018 0:00,"Training, Individual",2013,36457, ,NCI,36457, ,36457
Regulation of Mdmx stability and subcellular localization by ubiquitination,8530183,8/14/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2013,283880, ,NCI,177425,106455,283880
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,8530225,9/30/2010 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,297353, ,NIDDK,198235,99118,297353
Flow Cytometry,8530390, , ,Research Centers,2012, ,2882, ,1824,1058, 
Altered Proteoglycan Gene Expression and Cancer,8530458,9/1/1988 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,43282, ,NCI,27924,15358,43282
Molecular Pathogenesis of Basal-like Breast Cancer,8530971,4/18/2003 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,1090942, ,NCI,687397,403545,1090942
The PTEN-HAUSP Interaction in Basal-like Breast Cancer,8530974,4/18/2003 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013, ,214396, ,133040,81356, 
p53 - Regulators and Effectors,8531164,2/16/2000 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,1329706, ,NCI,966029,363677,1329706
Molecular Interactions and Regulation of p53,8531166, , ,Non-SBIR/STTR,2013, ,261477, ,188741,72736, 
Plk1 in Chemo-resistance of Cancer,8531191,9/1/2011 0:00,8/31/2014 0:00,Non-SBIR/STTR,2013,235315, ,NCI,156040,79275,235315
Telomere induced senescence as a supressor of tumorigenesis,8533541,8/8/2007 0:00,4/30/2013 0:00,Non-SBIR/STTR,2012,25307, ,NCI,15241,10066,25307
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci,8534039,9/7/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2013,507962, ,NCI,318096,189905,507962
Measurements of BPDE-DNA adducts by solid state nonopore and deep sequencing (PQ,8534070,8/20/2012 0:00,7/31/2015 0:00,Non-SBIR/STTR,2013,188022, ,NCI,158858,29164,188022
Regulation of Cytokinesis and Tumor Formation by RhoA,8534180,1/1/2010 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,233518, ,NIGMS,150173,83345,233518
Epigenomic Markers of HNSCC Survival Across Ethnic Groups,8534458,9/22/2011 0:00,8/31/2015 0:00,Other Research-Related,2013,136119, ,NCI,126036,10083,136119
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression,8534732,9/1/2013 0:00,8/31/2016 0:00,Research Centers,2013, ,117398, ,88007,29391, 
Mechanisms of novel cancer targets in ARF-mediated tumor suppression,8535139,9/1/2012 0:00,8/31/2017 0:00,Non-SBIR/STTR,2013,312080, ,NCI,195050,117030,312080
Regulation of p53 by BRCA1 in Breast Cancer,8535539,9/1/2011 0:00,8/31/2014 0:00,"Training, Individual",2013,57734, ,NCI,57734, ,57734
Outreach and Dissemination,8535660, ,10/31/2016 0:00,Research Centers,2013, ,92894, ,92894,0, 
Functional Determinants of Metastatic Dormancy,8536224,4/1/2005 0:00,12/31/2015 0:00,Non-SBIR/STTR,2013,331223, ,NCI,197518,133705,331223
"Mechanisms of DNA damage-induced, p53-dependent repression of the Cdc25C Phosphat",8537529,11/16/2010 0:00,6/19/2012 0:00,"Training, Individual",2012,37148, ,NCI,37148, ,37148
Characterization of prostatic stem cells and prostate cancer-initiating cells,8537554,9/1/2007 0:00,8/31/2014 0:00,Non-SBIR/STTR,2012,56448, ,NCI,36069,20379,56448
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",8537556,7/1/2010 0:00,12/31/2012 0:00,Non-SBIR/STTR,2012,25807, ,NCI,21532,4275,25807
"Pubertal high fat diet: effects on inflammation, mammary development and cancer",8537641,9/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,53200, ,NIEHS,35000,18200,53200
Multi-Modal Gene Therapy for Pancreatic Cancer using Targeted Nanovectors,8537855, , ,Research Centers,2013, ,178758, ,178758,0, 
Mechanisms of Radioresistance and Cell Cycle Progression,8538302,5/1/1995 0:00,6/30/2017 0:00,Non-SBIR/STTR,2013,326945, ,NCI,204341,122604,326945
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease,8538385,9/1/2012 0:00,5/31/2017 0:00,Non-SBIR/STTR,2013,329708, ,NIEHS,220500,109208,329708
"Race, pathomolecular signature and colorectal cancer survival",8538888,9/21/2011 0:00,8/31/2016 0:00,Other Research-Related,2013,129249, ,NCI,120755,8494,129249
The Regulation of PP1 in the Nucleus,8539043,9/1/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2013,281259, ,NIGMS,181420,99839,281259
Cancer cell adaptation to metabolic stress,8539275,9/10/2004 0:00,8/31/2014 0:00,Non-SBIR/STTR,2013,1114050, ,NCI,703834,410216,1114050
"Metabolic Outcomes of c-MYC, p53 and mTOR Regulation by HIF",8539278,9/10/2004 0:00,8/31/2014 0:00,Non-SBIR/STTR,2013, ,234727, ,148296,86431, 
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis,8539347,9/1/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2013,45006, ,NCI,30135,14871,45006
IGF-1 and the initiation of non-melanoma skin cancer,8539867,7/1/2014 0:00,6/30/2018 0:00,Non-SBIR/STTR,2014, , , , , , 
Targeting MDM2 with Intracellular Antibodies,8539977,10/1/2013 0:00,9/30/2017 0:00,Non-SBIR/STTR,2014, , , , , , 
The San Francisco Bay Area Adult Glioma Survival Study,8540599, , ,Research Centers,2012, ,59989, ,38548,21441, 
Roles and regulation of p53,8540826,9/30/2000 0:00,7/31/2016 0:00,Non-SBIR/STTR,2013,1668166, ,NCI,1353104,315062,1668166
New Models and Treatments for AIDS-related Lymphoma,8541226,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2013,416873, ,NCI,280334,136539,416873
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression,8541779, , ,Research Centers,2013, ,67987, ,43581,24406, 
Modulation of p53 function by tyrosine kinase networks,8541797,9/7/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2013,315006, ,NCI,195050,119956,315006
Population-based study of DNA damage response markers of prognosis in breast canc,8543569, , ,Research Centers,2013, ,195360, ,123258,72102, 
P3 - TARGETING THE HDM-2 E3 LIGASE IN MULTIPLE MYELOMA,8543580, , ,Research Centers,2013, ,178931, ,178931,0, 
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer,8543667,9/11/2012 0:00,6/30/2017 0:00,Non-SBIR/STTR,2013,363372, ,NCI,218242,145130,363372
Mechanisms Underlying Colorectal Cancer Risk in IBD (PQ6),8543669,9/12/2012 0:00,6/30/2016 0:00,Non-SBIR/STTR,2013,160494, ,NCI,102225,58269,160494
Function of MEF in Hematopoietic Cells,8544006,1/1/1997 0:00,6/30/2013 0:00,Non-SBIR/STTR,2011,96926, ,NIDDK, , ,96926
Targets for Therapy for Carcinomas of the Lung,8544398,7/23/2007 0:00,8/31/2017 0:00,Non-SBIR/STTR,2013,1632700, ,NCI,1067734,564966,1632700
Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC),8544449,9/15/2012 0:00,5/31/2018 0:00,Other Research-Related,2013,172260, ,NCI,159500,12760,172260
Role of ribosome impairments in X-linked Dyskeratosis Congenita pathogenesis,8544473,8/1/2006 0:00,6/30/2016 0:00,Non-SBIR/STTR,2013,270607, ,NIDDK,178525,92082,270607
The Effects of Grape Seed Extract Against Lung Cancer,8544765,10/1/2013 0:00,9/30/2016 0:00,Non-SBIR/STTR,2014, , , , , , 
Image-Guided Nanoembolization for the Treatment of Pancreatic Cancer,8545726, , ,Research Centers,2013, ,158211, ,158211,0, 
Role of PALB2 in the DNA damage response and breast cancer suppression,8545923,7/1/2009 0:00,6/30/2013 0:00,Non-SBIR/STTR,2012,63510, ,NCI,42832,20678,63510
Novel Mechanism for Myc-Induced Apoptosis,8546149,9/1/2012 0:00,8/31/2015 0:00,"Training, Individual",2013,26592, ,NCI,26592, ,26592
The role of pRb-dependent Ihh in osteogenesis and osteosarcoma,8546150,9/6/2012 0:00,9/5/2014 0:00,"Training, Individual",2013,38188, ,NCI,38188, ,38188
Investigating microRNA miR-34a in lung cancer development and therapy,8546318,9/17/2012 0:00,8/31/2014 0:00,Other Research-Related,2013,110355, ,NCI,102181,8174,110355
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model,8546988,9/25/2009 0:00,8/31/2014 0:00,Non-SBIR/STTR,2013,443110, ,NCI,278118,169778,443110
Molecular and cellular mechanisms of Merkel Cell Carcinoma development,8547037,9/18/2012 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,196177, ,NCI,122670,73507,196177
SPORE: Targeted Therapies for Glioma,8548657,9/19/2013 0:00,7/31/2018 0:00,Research Centers,2013,2150500, ,NCI,1583996,566504,2150500
Cellular plasticity and survival mechanisms in medulloblastoma stem cells,8549694,3/1/2012 0:00,2/28/2014 0:00,"Training, Individual",2013,29531, ,NCI,29531, ,29531
"Role of NIAM, A Putative Cancer Gene, in Chromosomal Instability and Glioblastoma",8549696,9/1/2012 0:00,8/31/2015 0:00,"Training, Individual",2013,28158, ,NCI,28158, ,28158
Genetic Analysis of the Breast Tumor Microenvironment,8549935,9/15/2004 0:00,5/31/2017 0:00,Non-SBIR/STTR,2013,1467378, ,NCI,1037404,429974,1467378
Molecular Biology of Lung Cancer among Puerto Ricans,8550007,9/24/2012 0:00,8/31/2017 0:00,Research Centers,2012, ,111238, ,66017,45221, 
Molecular Biology of Lung Cancer among Puerto Ricans,8550010, , ,Research Centers,2013, ,200789, ,119162,81627, 
Novel Antitumor Agents,8550474,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,376379, ,NCI,248730,127649,376379
Molecular Biology of Lung Cancer among Puerto Ricans,8551283,9/1/2013 0:00,8/31/2017 0:00,Research Centers,2013, ,191687, ,126411,65276, 
Nuclear Accumulation of Cyclin D1 and Oncogenesis,8551619,7/1/2001 0:00,7/31/2014 0:00,Non-SBIR/STTR,2013,279802, ,NCI,174876,104926,279802
Defining the role of the tumor-initiating cell niche in breast cancer,8551638,9/1/2010 0:00,8/31/2015 0:00,Non-SBIR/STTR,2013,234060, ,NCI,153230,80830,234060
Dual Targeting of the p53 pathway for development of anti-cancer therapy,8551655,9/26/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2013,299836, ,NCI,199316,100520,299836
Characterization Of TGF-b Signaling In a B-cell Lymphoma Cell Line,8552324, , ,Intramural Research,2012,340431, ,NIA, , ,340431
Chromosomal Proteins and Chromosomal Functions,8552561, , ,Intramural Research,2012,994541, ,NCI, , ,994541
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,8552566, , ,Intramural Research,2012,681204, ,NCI, , ,681204
Gene Regulation and Function: The B-ZIP Proteins,8552571, , ,Intramural Research,2012,1105592, ,NCI, , ,1105592
Xenobiotic Receptors,8552586, , ,Intramural Research,2012,1094579, ,NCI, , ,1094579
Transgenic Models for Prostate and Breast Cancer,8552587, , ,Intramural Research,2012,1120018, ,NCI, , ,1120018
p53 Tumor Suppressor Pathway,8552590, , ,Intramural Research,2012,803200, ,NCI, , ,803200
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",8552592, , ,Intramural Research,2012,1242866, ,NCI, , ,1217866
Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis,8552594, , ,Intramural Research,2012,732104, ,NCI, , ,732104
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,8552606, , ,Intramural Research,2012,1153728, ,NCI, , ,1153728
Regulation of Lymphocyte Proliferation and Replicative Capacity,8552628, , ,Intramural Research,2012,479513, ,NCI, , ,479513
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,8552631, , ,Intramural Research,2012,430742, ,NCI, , ,430742
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,8552635, , ,Intramural Research,2012,489899, ,NCI, , ,489899
Molecular Mechanisms of Growth Factor Modulated Proliferation,8552648, , ,Intramural Research,2012,122710, ,NCI, , ,122710
DNA Repair,8552653, , ,Intramural Research,2012,1448626, ,NCI, , ,1448626
Enzymes and Substrates of the Ubiquitin Conjugating System,8552654, , ,Intramural Research,2012,655961, ,NCI, , ,655961
Role of CEBP transcription factors in regulating cell growth and tumorigenesis,8552666, , ,Intramural Research,2012,1327149, ,NCI, , ,1327149
Protein Structure,8552677, , ,Intramural Research,2012,1577338, ,NCI, , ,1577338
Role of Neurotrophins in the Development of the Mammalian Nervous System,8552685, , ,Intramural Research,2012,766137, ,NCI, , ,766137
Role of Trk Receptors in the Development and Function of Non-neuronal Structures,8552686, , ,Intramural Research,2012,766137, ,NCI, , ,766137
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,8552727, , ,Intramural Research,2012,840430, ,NCI, , ,840430
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,8552728, , ,Intramural Research,2012,240123, ,NCI, , ,240123
Development of Mouse Astrocytoma Model for Preclinical Testing,8552729, , ,Intramural Research,2012,120062, ,NCI, , ,120062
Zebrafish Models of Cancer,8552731, , ,Intramural Research,2012,811990, ,NCI, , ,811990
Molecular Interaction Maps and Analysis of Bioregulatory Networks,8552733, , ,Intramural Research,2012,130460, ,NCI, , ,130460
The Role of miRNA-mediated RNAI in the Biology of Cancer,8552747, , ,Intramural Research,2012,202534, ,NCI, , ,202534
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,8552754, , ,Intramural Research,2012,462328, ,NCI, , ,462328
Characterization of Signaling Pathways involved in Cell Death and Survival,8552757, , ,Intramural Research,2012,448692, ,NCI, , ,448692
Molecular-Targeted Radiation Therapy,8552771, , ,Intramural Research,2012,738236, ,NCI, , ,738236
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,8552787, , ,Intramural Research,2012,110883, ,NCI, , ,110883
Metabolic Mechanisms for Programmed Cell Death,8552800, , ,Intramural Research,2012,441041, ,NCI, , ,441041
Clinical trial development in cancer vaccines,8552809, , ,Intramural Research,2012,199105, ,NCI, , ,199105
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,8552837, , ,Intramural Research,2012,788424, ,NCI, , ,788424
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,8552867, , ,Intramural Research,2012,82409, ,NCI, , ,82409
Novel Markers for Disease Outcome in Breast Cancer,8552879, , ,Intramural Research,2012,418028, ,NCI, , ,418028
Redox Mechanism Process of Angiogenesis and Wound Healing,8552885, , ,Intramural Research,2012,391654, ,NCI, , ,391654
Collaborative Pathways that Lead to Leukemia,8552912, , ,Intramural Research,2012,312971, ,NCI, , ,312971
Gene therapy of cancer,8552915, , ,Intramural Research,2012,2209862, ,NCI, , ,2209862
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma,8552936, , ,Intramural Research,2012,652207, ,NCI, , ,652207
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,8552979, , ,Intramural Research,2012,632981, ,NCI, , ,632981
Study the role(s) of p53 in embryonic stem cells,8553009, , ,Intramural Research,2012,901143, ,NCI, , ,901143
Inflammation and Prostate Carcinogenesis,8553017, , ,Intramural Research,2012,114189, ,NCI, , ,114189
Validation of Therapeutic Target Genes in Human Liver Cancer,8553020, , ,Intramural Research,2012,381594, ,NCI, , ,381594
Animal model of Pancreatic Cancer,8553026, , ,Intramural Research,2012,304907, ,NCI, , ,304907
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,8553033, , ,Intramural Research,2012,655113, ,NCI, , ,655113
Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,8553045, , ,Intramural Research,2012,482048, ,NCI, , ,482048
Biological Implications and Translational Applications of HDMX Inhibition,8553069, , ,Intramural Research,2012,290970, ,NCI, , ,290970
Broadening the Utility of Stapled Peptides through Chemical Optimization,8553070, , ,Intramural Research,2012,145486, ,NCI, , ,145486
Thoracic Cancer Research Laboratory,8553073, , ,Intramural Research,2012,1696598, ,NCI, , ,1696598
CANCER AND INFLAMMATION GENETICS,8553089, , ,Intramural Research,2012,879352, ,NCI, , ,879352
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,8553112, , ,Intramural Research,2012,488066, ,NCI, , ,488066
Development and validation of preclinical mouse model for serous ovarian cancer,8553127, , ,Intramural Research,2012,1051828, ,NCI, , ,1051828
Structural and Biochemical Studies of p53 Family Function,8553138, , ,Intramural Research,2012,290970, ,NCI, , ,290970
Role of IKK alpha in lung squamous cell carcinoma development,8553147, , ,Intramural Research,2012,482048, ,NCI, , ,482048
Regulation of microRNA expression by Mutant p53,8553152, , ,Intramural Research,2012,237448, ,NCI, , ,237448
Function of Mutant p53-regulated microRNAs in cancer cells,8553153, , ,Intramural Research,2012,316598, ,NCI, , ,316598
Mechanisms regulating the context-dependant function of microRNAs,8553154, , ,Intramural Research,2012,118725, ,NCI, , ,118725
Role of IKKalpha in lymphoid organ development,8553173, , ,Intramural Research,2012,107122, ,NCI, , ,107122
Oral Carcinogenesis,8553329, , ,Intramural Research,2012,1707555, ,NIDCR, , ,1707555
Small Molecule Activators of p53,8553430, , ,Intramural Research,2012,254760, ,NIDDK, , ,254760
The role of Spo11 in mammalian meiosis,8553511, , ,Intramural Research,2012,524101, ,NIDDK, , ,524101
"BRCA1, DNA damage response and aging",8553551, , ,Intramural Research,2012,722485, ,NIDDK, , ,722485
Molecular Mechanisms Of Cell Adhesion And Invasion,8553682, , ,Intramural Research,2012,1565422, ,NIEHS, , ,1565422
Genetic Susceptibility To Carcinogens and Toxicants,8553703, , ,Intramural Research,2012,395184, ,NIEHS, , ,395184
"Role Of Lipids In Colon, Breast, And Other Cancers",8553722, , ,Intramural Research,2012,215456, ,NIEHS, , ,215456
Human Genes Affecting Chromosome Metabolism and Stress Response,8553736, , ,Intramural Research,2012,1547306, ,NIEHS, , ,1547306
"Nuclear receptors: action, functions, and roles in disease",8553767, , ,Intramural Research,2012,1209453, ,NIEHS, , ,1209453
Structural Biology of Genome Maintenance and DNA repair,8553800, , ,Intramural Research,2012,1341546, ,NIEHS, , ,1341546
Regulation Of Intracellular Iron Metabolism,8553882, , ,Intramural Research,2012,1000829, ,NICHD, , ,1000829
SUMO family Ubiquitin-like Modifiers In Higher Eukaryotes,8553891, , ,Intramural Research,2012,663662, ,NICHD, , ,663662
Molecular Pathogenesis of Multiple Myeloma,8554016, , ,Intramural Research,2012,545789, ,NCI, , ,545789
Lymphoma Studies,8554021, , ,Intramural Research,2012,332649, ,NCI, , ,332649
Nitric Oxide as a Modifier of Oxidative Stress,8554025, , ,Intramural Research,2012,391654, ,NCI, , ,391654
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,8554037, , ,Intramural Research,2012,694020, ,NCI, , ,694020
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,8554047, , ,Intramural Research,2012,1088811, ,NCI, , ,1088811
CCR Confocal Microscopy Core,8554075, , ,Intramural Research,2012,610439, ,NCI, , ,610439
Cell and Cancer Biology Branch Confocal Microscopy Core,8554085, , ,Intramural Research,2012,1178054, ,NCI, , ,1178054
Immunohistochemistry Core Laboratory,8554111, , ,Intramural Research,2012,261568, ,NCI, , ,261568
Advanced Mass Spectrometry Facility,8554135, , ,Intramural Research,2012,2614730, ,NIDDK, , ,2614730
Bioinformatic Tools in Cancer Research,8554224, , ,Intramural Research,2012,229859, ,NCI, , ,229859
"Characterization of Mutagenesis, Mutational Spectra and Mechanisms of Toxicity",8555147,1/15/1997 0:00,12/31/2013 0:00,Non-SBIR/STTR,2012, ,356563, ,213117,143446, 
Enhancing Direct Tumor Cell Cytotoxicity By Manipulating Growth Factor Signaling,8555153,9/7/2001 0:00,1/31/2014 0:00,Non-SBIR/STTR,2012, ,201439, ,128185,73254, 
Regulation and Interactions of the p53 Family,8555162,9/30/2000 0:00,7/31/2016 0:00,Non-SBIR/STTR,2012, ,451795, ,366401,85394, 
Genomic Analysis of the p53 Pathway in Normal and Cancer Cells,8555163,9/30/2000 0:00,7/31/2016 0:00,Non-SBIR/STTR,2012, ,459821, ,372910,86911, 
p53 and Chemosensitivity in a Mouse Lymphoma Model,8555164,9/30/2000 0:00,7/31/2016 0:00,Non-SBIR/STTR,2012, ,415443, ,336921,78522, 
Molecular Studies of the p53 Pathway in Human Cancer,8555165,9/30/2000 0:00,7/31/2016 0:00,Non-SBIR/STTR,2012, ,450278, ,365172,85106, 
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO),8555171,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,351713, ,NCI,207500,144213,351713
Impact of AICD on TCR Transduced T Cells for Adoptive Immunotherapy,8555359,9/21/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2012, ,284262, ,205915,78347, 
Lymphomas And Retroviral Pathogenesis,8555845, , ,Intramural Research,2012,485747, ,NIAID, , ,485747
Danger 1:  initiating and stopping immune responses,8555848, , ,Intramural Research,2012,591453, ,NIAID, , ,591453
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases,8555925, , ,Intramural Research,2012,872822, ,NIAID, , ,872822
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS,8555944, , ,Intramural Research,2012,735451, ,NIAID, , ,735451
Molecular Regulation of B-Cell Differentiation and Function,8555947, , ,Intramural Research,2012,1457241, ,NIAID, , ,1457241
Cancer Prevention,8557661,7/11/2012 0:00,6/30/2017 0:00,Research Centers,2012, ,23720, ,23720, , 
Cancer Prevention,8557681, , ,Research Centers,2013, ,22178, ,22178,0, 
Molecular Imaging & Targeted Therapeutics of Stem Cell-Derived Colon Cancer,8557696,9/24/2002 0:00, ,Research Centers,2013, ,917743, ,198137,719606, 
Biochemical Mechanisms of Enzyme Action and Cellular Regulation,8557891, , ,Intramural Research,2012,708889, ,NHLBI, , ,708889
The role of autophagy in aging and metabolism,8557941, , ,Intramural Research,2012,836525, ,NHLBI, , ,836525
Mitochondrial regulation in cardiovascular and cancer biology,8557946, , ,Intramural Research,2012,1113613, ,NHLBI, , ,1113613
Molecular Virology Research Program,8558292,7/1/1997 0:00,7/31/2018 0:00,Research Centers,2013, ,21169, ,12714,8455, 
Targeting the Chk1-Suppressed Apoptotic Pathway in HNSCC,8558614,7/5/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,356930, ,NCI,210703,146227,356930
Markers for Screening and Prognosis,8559515, , ,Research Centers,2013, ,303700, ,187912,115788, 
Staff Investigator,8559580, , ,Research Centers,2013, ,22668, ,22668,0, 
Investigation of Regulatory RNAs in Tumor Development,8559811, , ,Non-SBIR/STTR,2013, ,251125, ,251125,0, 
Suppression of Mammary Tumorigenesis by Stromal p53,8561790,9/15/2004 0:00, ,Non-SBIR/STTR,2013, ,281241, ,219812,61429, 
Immune Therapy,8562418, , ,Non-SBIR/STTR,2013, ,223339, ,190529,32810, 
Lung Cancer Drivers and Dependencies as Therapeutic Targets,8563896, , ,Non-SBIR/STTR,2013, ,343146, ,224407,118739, 
Modulation of p53 induction by targeting cap-dependent translation in cancer,8565086,4/1/2013 0:00,3/31/2015 0:00,Non-SBIR/STTR,2013,76250, ,NCI,50000,26250,76250
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,8565430, , ,Intramural Research,2012,554334, ,NCI, , ,554334
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,8565432, , ,Intramural Research,2012,5215430, ,NCI, , ,5215430
Intervention Trials in Persons at Increased Genetic Risk of Cancer,8565433, , ,Intramural Research,2012,1567046, ,NCI, , ,1567046
Epidemiology and Natural History of Cancer-Associated Viruses,8565441, , ,Intramural Research,2012,3301455, ,NCI, , ,3301455
Signal and Transcription Factor Network interactions in Head and Neck Cancer,8565508, , ,Intramural Research,2012,688364, ,NIDCD, , ,688364
Genomics and Proteomics of Head and Neck Cancer,8565509, , ,Intramural Research,2012,688364, ,NIDCD, , ,688364
"Understanding the origin,initiation,and progression of high-grade serous ovarian",8566138,9/24/2013 0:00,8/31/2015 0:00,Other Research-Related,2013,97200, ,NCI,90000,7200,97200
Identification and therapeutic application of miRNA-drivers in lung cancer,8566534,8/13/2013 0:00,11/15/2013 0:00,Other Research-Related,2013,99587, ,NCI,92210,7377,99587
Regulation and Interactions of the p53 Family,8566827, , ,Non-SBIR/STTR,2013, ,424401, ,344245,80156, 
Genomic Analysis of the p53 Pathway in Normal and Cancer Cells,8566828, , ,Non-SBIR/STTR,2013, ,431937, ,350358,81579, 
p53 and Chemosensitivity in a Mouse Lymphoma Model,8566829, , ,Non-SBIR/STTR,2013, ,390249, ,316544,73705, 
Molecular Studies of the p53 Pathway in Human Cancer,8566830, , ,Non-SBIR/STTR,2013, ,421579, ,341957,79622, 
Developing Mathmatical Framework to Uncover the Sequence of Genetic Events During,8566840, ,8/31/2016 0:00,Research Centers,2013, ,621050, ,523500,97550, 
"Characterization of Mutagenesis, Mutational Spectra and Mechanisms of Toxicity",8567215, ,5/31/2014 0:00,Non-SBIR/STTR,2013, ,335314, ,200338,134976, 
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia,8567405,8/7/2013 0:00,7/31/2015 0:00,Other Research-Related,2013,97945, ,NCI,90690,7255,97945
MOLECULAR & STRUCTURAL BIOLOGY,8567529, , ,Research Centers,2013, ,103905, ,69787,34118, 
CANCER CELL BIOLOGY,8567543, , ,Research Centers,2013, ,85640, ,57605,28035, 
A Strategy for Reactivating p53 in Cancer Stem Cells Using a Novel HdmX Inhibitor,8568176,7/1/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,206843, ,NCI,130500,76343,206843
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma,8568283,9/13/2013 0:00,8/31/2015 0:00,Other Research-Related,2013,102574, ,NCI,94976,7598,102574
Novel small-molecule inhibitors of Wee1 kinase for medulloblastoma treatment,8568665,7/15/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,231750, ,NINDS,150000,81750,231750
Evolutionary dynamics of melanoma metastasis,8568851,9/30/2013 0:00,6/30/2018 0:00,Non-SBIR/STTR,2013,2658675, ,OD,1500000,1158675,2658675
High throughput screen for selective inhibitors of cyclophilin B,8569355,9/1/2013 0:00,6/30/2016 0:00,Non-SBIR/STTR,2013,400363, ,NINDS,318500,81863,400363
The role of p53 redox-modification in cell fate signaling,8569469,7/1/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,204759, ,NCI,137924,66835,204759
Role of vitamin D receptor in DNA repair,8569938,7/17/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,188955, ,NIAMS,127500,61455,188955
Retention of somatic mutations in cancers by changes in pH sensing,8570284,7/1/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,205103, ,NCI,130500,74603,205103
Modeling The Etiology of P53 Mutated Cancer Cells,8571884,7/22/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2013,215197, ,NCI,151390,63807,215197
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis,8572129,1/16/2012 0:00,10/31/2016 0:00,Non-SBIR/STTR,2014,396901, ,NIEHS,248063,148838,396901
Cellular Stress Response Signaling Pathways,8575966,1/1/1992 0:00,5/31/2018 0:00,Non-SBIR/STTR,2013,353250, ,NIEHS,225000,128250,353250
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH,8576766,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,333963, ,NCI,220865,113098,333963
Targeted Therapy for Endometrial Cancer,8577242,7/17/2002 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,252448, ,NCI,167184,85264,252448
Role of Parkinson's disease gene PARK2 in GBM oncogenesis and genomic instability,8577264,9/30/2013 0:00,8/31/2016 0:00,Non-SBIR/STTR,2013,386750, ,NINDS,218750,168000,386750
P53 inactivation on MDSC development and tumor progression,8577716,7/1/2013 0:00,2/15/2014 0:00,Non-SBIR/STTR,2013,298800, ,NCI,207500,91300,298800
Identification and targeting of the signaling pathways underlying lung cancer.,8577736,3/1/2009 0:00,12/31/2018 0:00,Non-SBIR/STTR,2014,425250, ,NCI,225000,200250,425250
Small Molecule Activators of Procaspases as Anti-Cancer Agents,8577782,8/6/2007 0:00,6/30/2018 0:00,Non-SBIR/STTR,2013,451618, ,NCI,320912,130706,451618
c-Myc-regulated microRNAs in normal and pathologic cellular physiology,8578048,4/1/2007 0:00,5/31/2018 0:00,Non-SBIR/STTR,2013,293037, ,NCI,184300,108737,293037
A PTEN-dependent cell size checkpoint in human cells,8578465,5/11/2006 0:00,4/30/2017 0:00,Non-SBIR/STTR,2013,241207, ,NCI,155117,86090,241207
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia,8578767,9/11/2013 0:00,6/30/2018 0:00,Non-SBIR/STTR,2013,345488, ,NCI,207500,137988,345488
Mitochondrial Motility and Inheritance,8580422,7/1/1993 0:00,4/30/2017 0:00,Non-SBIR/STTR,2013,326131, ,NIGMS,206527,119604,326131
The Development of Novel Individualized Therapy for Triple-Negative Breast Cancer,8581422,9/1/2013 0:00,8/31/2018 0:00,Other Research-Related,2013,171720, ,NCI,159000,12720,171720
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni,8581989,8/1/2013 0:00,7/31/2016 0:00,Non-SBIR/STTR,2013,499926, ,OD,373989,125937,499926
Protein Kinase Signaling and Cell Cycle Control,8583727,12/1/2006 0:00,5/31/2018 0:00,Non-SBIR/STTR,2013,503262, ,NIEHS,322604,180658,503262
Role of SIRT1 in melanocyte biology and melanocyte transformation,8583747,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,312288, ,NCI,207500,104788,312288
Exploration of a Mutant p53 Reactivating Compound,8584686,8/16/2013 0:00,7/31/2018 0:00,Other Research-Related,2013,158958, ,NCI,147183,11775,158958
Self-renewal of Normal and Leukemic Stem Cells,8585031,9/20/2004 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,282911, ,NCI,169691,113220,282911
Function and regulation of MDMX,8585034,7/1/2004 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,256558, ,NCI,153628,102930,256558
"The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer",8585040,2/1/2010 0:00,11/30/2016 0:00,Non-SBIR/STTR,2014,308825, ,NCI,202633,106192,308825
p63 and p73 Signaling in Cell Growth and Cancer,8585780,3/1/2004 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,293867, ,NCI,188377,105490,293867
Small Molecule Inhibitors of the BCL6 Oncoprotein,8585803,8/2/2013 0:00,7/31/2014 0:00,SBIR/STTR,2013,280492, ,NCI, , ,280492
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention,8586303,6/1/2005 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,277014, ,NCI,181648,95366,277014
The ARF Tumor Suppressor,8586850,1/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2014,361188, ,NCI,195237,165951,361188
Tumor Suppressor Qualities and Mechanisms of LZAP Activity,8587209,4/1/2000 0:00,11/30/2016 0:00,Non-SBIR/STTR,2012,94432, ,NIDCR,56887,37545,94432
Functional Analysis of p53 Polymorphic Variants,8587466,6/1/2005 0:00,12/31/2014 0:00,Non-SBIR/STTR,2014,335745, ,NCI,181484,154261,335745
Perturbation of a cellular microRNA by human papillomavirus type 16.,8588183,8/1/2013 0:00,7/31/2016 0:00,"Training, Individual",2013,34099, ,NCI,34099, ,34099
Role of p53 polymorphisms in disparities in breast carcinogenesis and outcome .,8588254,3/13/2011 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,365000, ,NIMHD,250000,115000,365000
Targeting the OLIG2 Transcription Factor,8588494,9/19/2013 0:00,7/31/2018 0:00,Research Centers,2013, ,288558, ,212443,76115, 
Regultion of p53 Deubiquitination,8588904,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,317411, ,NCI,201275,116136,317411
Oncogene c-Myc-dependent pathways in cutaneous melanoma03,8589370,12/11/2006 0:00,11/30/2016 0:00,Non-SBIR/STTR,2014,299168, ,NCI,181334,117834,299168
Using Markers to Improve Pancreatic Cancer Screening,8589991,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2013,416716, ,NCI,257232,159484,416716
Mouse Models to Dissect p53 Tumor Suppressor Function,8590203,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,333902, ,NCI,201275,132627,333902
Chemical suppressors of the neural crest lineage for the treatment of melanoma,8590862,8/1/2013 0:00,7/31/2016 0:00,"Training, Individual",2013,34099, ,NCI,34099, ,34099
Functional Determinants of Metastatic Dormancy,8591377,4/1/2005 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,341794, ,NCI,203822,137972,341794
MKP-1 Effects on HIF-1alpha and Glycolytic Metabolism in Glioblastoma multiforme,8592611,7/1/2013 0:00,6/30/2017 0:00,"Training, Individual",2013,42232, ,NCI,42232, ,42232
Mitigation of asbestos induced alveolar epithelial cell injury,8593294,3/1/2012 0:00,12/31/2016 0:00,Non-SBIR/STTR,2014,325156, ,NIEHS,210457,114699,325156
Characterization and regulation of the MED17-p53 binding interface.,8594700,9/16/2013 0:00,9/15/2016 0:00,"Training, Individual",2013,32532, ,NCI,32532, ,32532
Lipidoid Nanoparticles with Simultaneous Multi-Gene Regulation for Cancer Therapy,8594926,9/1/2013 0:00,8/31/2015 0:00,"Training, Individual",2013,55670, ,NIBIB,55670, ,55670
Evaluating the role of NRG-1 receptors in MPNST tumorigenesis,8594992,7/1/2013 0:00,6/30/2016 0:00,"Training, Individual",2013,32879, ,NINDS,32879, ,32879
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells,8595295,3/17/2010 0:00,8/31/2015 0:00,Non-SBIR/STTR,2014,471844, ,NCI,378578,93266,471844
RNA Splicing Modulators for MDS/AML,8595791,9/3/2013 0:00,6/30/2018 0:00,Research Centers,2013, ,339822, ,259908,79914, 
Dissecting the roles of HIF-1a and HIF-2a in tumor response to radiation therapy,8595927,7/1/2013 0:00,6/30/2016 0:00,"Training, Individual",2013,43452, ,NCI,43452, ,43452
Novel c-Abl-directed Therapies to Alleviate Metastatic Breast Cancer,8596052,9/12/2013 0:00,8/31/2016 0:00,"Training, Individual",2013,32038, ,NCI,32038, ,32038
The role of Src kinase in estrogen receptor-positive breast cancer proliferation,8596677,1/1/2014 0:00,7/30/2014 0:00,"Training, Individual",2013,23308, ,NCI,23308, ,23308
Tumor Suppressor Qualities and Mechanisms of LZAP Activity,8596729,4/1/2000 0:00,11/30/2016 0:00,Non-SBIR/STTR,2014,416250, ,NIDCR,250000,166250,416250
DNA Repair and Tobacco Smoke in Bladder Carcinogenesis,8596898,9/12/2013 0:00,8/31/2018 0:00,Non-SBIR/STTR,2013, ,218176, ,129463,88713, 
Novel Role of XIAP in Bladder Cancer Invasion,8596899,9/12/2013 0:00,8/31/2018 0:00,Non-SBIR/STTR,2013, ,349338, ,207293,142045, 
Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 ,8597101, , ,Research Centers,2014, ,198677, ,120960,77717, 
The Seventh International Mdm2 Workshop,8597241,8/1/2013 0:00,7/31/2014 0:00,Other Research-Related,2013,4000, ,NCI,4000,0,4000
Characterization of Human Epidermal Stem Cells,8597375,10/1/2010 0:00,9/30/2014 0:00,Non-SBIR/STTR,2014, , , , , , 
Role of a novel Notch1 target gene in skin carcinogenesis,8597529,3/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2014,298542, ,NCI,175714,122828,298542
Non-canonical gene regulation through a Drosophila p53 enhancer,8597892,9/1/2013 0:00,8/31/2018 0:00,"Training, Individual",2013,29597, ,NIGMS,29597, ,29597
Plk1-Numb Cooperation in Melanomagenesis,8597912,10/1/2012 0:00,9/30/2016 0:00,Non-SBIR/STTR,2014, , , , , , 
Regulation of Myc-Mediated Tumorigenesis,8597946,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,313718, ,NCI,201275,112443,313718
EWS-Fli1 fusion protein and Ewing's sarcoma,8598017,1/1/2012 0:00,12/31/2014 0:00,Non-SBIR/STTR,2014, , , , , , 
CARP-1: A Potential Therapeutic Agent for Breast Cancer,8598030,1/1/2012 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014, , , , , , 
Regulation of Human Papillomavirus Replication via Cell Signaling Pathways,8598279,12/1/2013 0:00,11/30/2016 0:00,"Training, Individual",2013,33441, ,NCI,33441, ,33441
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str,8598461,2/1/2010 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,510814, ,NCI,404329,106485,510814
"Vitamin D, Metabolic Flux and Breast Cancer",8598862,1/1/2013 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,157987, ,NCI,105488,52499,157987
Study of Novel HHV8/KSHV Encoded Genes,8599195, , ,Non-SBIR/STTR,2013, ,417841, ,299995,117846, 
Regulation of Basal-Like and Her2+ Breast Cancer Phenotypes by IKK/NF-kappaB,8599310,2/1/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2014,287693, ,NCI,195237,92456,287693
Berberine downregulates MDM2 by interaction with DAXX in cancer cells,8599444,1/1/2010 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,65349, ,NCI,42161,23188,65349
Lapatinib and Obatoclax combination therapy,8600243,7/7/2010 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,328364, ,NCI,219642,108722,328364
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells,8600841,4/1/2011 0:00,9/30/2015 0:00,Non-SBIR/STTR,2014, , , , , , 
"Telomerase in Development, Senescence and Neoplasia",8600844,1/1/2000 0:00,12/31/2014 0:00,Non-SBIR/STTR,2014,600026, ,NCI,379763,220263,600026
Molecular Targeting of Diffuse Large B-cell Lymphoma,8601475,1/20/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2014,502192, ,NCI,338673,163519,502192
Anti-pancreatic tumorigenesis by inactivation of SAG/RBX2 E3 ubiquitin ligase,8601690,1/1/2013 0:00,12/31/2014 0:00,Non-SBIR/STTR,2014,164034, ,NCI,105488,58546,164034
"Phosphosulindac, miRNAs and cancer racial disparity",8601854,2/5/2010 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,304768, ,NCI,195237,109531,304768
Role of SAG/RBX2 E3 Ubiquitin Ligase in Skin Carcinogenesis,8602514,1/3/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2014,312983, ,NCI,201275,111708,312983
MODELS FOR GENETIC ASSESSMENT OF TUMOR MAINTENANCE GENES IN PDAC,8603769, , ,Non-SBIR/STTR,2014, ,319637, ,317425,2212, 
Prostate cancer chemoprevention by penta-galloyl-glucose,8603851,1/1/2009 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,294807, ,NCI,195236,99571,294807
"Phosphosulindac, miRNAs and cancer racial disparity",8604463,2/5/2010 0:00,12/31/2014 0:00,Non-SBIR/STTR,2013,20855, ,NCI,13283,7572,20855
LncRNA Pathways as Novel Diagnostic Biomarkers Derived from the Stroma of Epithel,8604698,1/11/2013 0:00,12/31/2014 0:00,Non-SBIR/STTR,2014,79661, ,NCI,48500,31161,79661
"Fortilin, p53, and atherosclerosis",8605069,1/15/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2014,374850, ,NHLBI,245000,129850,374850
Molecular mechanisms of GBM radioresistance and strategies for radiosensitization,8605809,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,320027, ,NCI,201275,118752,320027
AMPK and AMPK-related kinases in lung cancer development and treatment,8605862,1/16/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2014,390474, ,NCI,201275,189199,390474
Disrupting Protein-Protein Interactions With Bis-peptides,8606215,1/1/2004 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,306000, ,NIGMS,200000,106000,306000
The Role of White Matter Progenitors in Glioma Formation and Progression,8606263,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2014,341692, ,NINDS,212231,129461,341692
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy,8606326,3/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2013,48000, ,NCI,32689,15311,48000
Role of p300/CBP and hHR23 Proteins in p53 Regulation,8606421,4/19/2004 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,253459, ,NCI,169538,83921,253459
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy,8606733,3/1/2010 0:00,1/31/2017 0:00,Non-SBIR/STTR,2014,294574, ,NCI,195237,99337,294574
Functions of Papillomavirus E6,8606821,4/8/2004 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,290937, ,NCI,188920,102017,290937
The role of DNA polymerase eta in DNA damage response and p53 activation,8606823,4/1/2010 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,270599, ,NCI,175714,94885,270599
MiR-182 overexpression in early tumorigenesis of high grade serous carcinoma,8606832,2/1/2013 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,162979, ,NCI,105488,57491,162979
p53 Family in Gastric Cancer Development,8607145,8/1/2010 0:00,4/29/2016 0:00,Non-SBIR/STTR,2014,339168, ,NCI,217416,121752,339168
Functional analysis of beta-TRCP in cell cycle control and DNA damage response,8607190,5/1/2012 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,328425, ,NIGMS,188750,139675,328425
Hdac3 as a therapeutic target in BCL6-dependent lymphoma,8607465,2/20/2012 0:00,1/31/2017 0:00,Non-SBIR/STTR,2014,391041, ,NCI,250667,140374,391041
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12,8607507,8/1/2002 0:00,1/31/2015 0:00,Non-SBIR/STTR,2014,286785, ,NCI,160386,126399,286785
P38 MAPK in Ras-induced Senescence and Transformation,8607509,7/1/2005 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,267732, ,NCI,135953,131779,267732
Therapeutic Targeting of Oncogenic Stress in Cancer Treatment,8607833,4/1/2010 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,299689, ,NCI,195237,104452,299689
Mechanisms of Chemoprevention by Isothiocyanates,8607901,9/1/2004 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,306405, ,NCI,199612,106793,306405
Coordinately regulated alternative splicing in DNA damage and cancer,8608489,4/1/2010 0:00,1/31/2017 0:00,Non-SBIR/STTR,2014,289653, ,NCI,200714,88939,289653
"DNA double-strand break repair, chromosomes translocations and cancer",8608844,4/8/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2014,1778566, ,NCI,1111604,666962,1778566
The Role of CTIP in Breast Carcinogenesis,8608848, , ,Non-SBIR/STTR,2014, ,393141, ,245713,147428, 
Targeting ROS by a p53-activating agent for selective killing of cancer cells,8608940,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2014,337668, ,NCI,195237,142431,337668
Biological Effects of DNA Adducts Formed by Nitroaromatic Compounds,8609028,2/1/1998 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,310838, ,NIEHS,247768,63070,310838
Mechanisms of Intestinal Tumorigenesis,8609480,1/1/2000 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,364946, ,NCI,232686,132260,364946
"Src, p53 and estrogen receptor-positive breast cancer",8610636,9/15/2014 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,167475, ,NCI,108750,58725,167475
The Role of p53-inducible Sesn1 and Sesn2 genes in lung carcinogenesis,8610905,2/1/2013 0:00,1/31/2018 0:00,Non-SBIR/STTR,2014,276250, ,NCI,181148,95102,276250
Prostate Cancer Prevention by Diallyl Trisulfide,8611708,4/1/2005 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,309316, ,NCI,204169,105147,309316
A metabolic role for PML in tumor suppression,8611710,2/1/2010 0:00,1/31/2015 0:00,Non-SBIR/STTR,2014,339713, ,NCI,195237,144476,339713
Mechanisms of Metabolic Gene Mutations in Cancer,8611905,3/1/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2014,297887, ,NCI,201275,96612,297887
Novel therapeutic targets for Diamond Blackfan anemia and other ribosomopathies,8611919,4/9/2012 0:00,2/28/2017 0:00,Other Research-Related,2014,152874, ,NIDDK,141550,11324,152874
Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport,8613474,2/5/2013 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,546172, ,NCI,491380,54792,546172
USC Research Center for Liver Disease,8616052,3/1/1997 0:00,2/29/2016 0:00,Research Centers,2014,1215000, ,NIDDK,750000,465000,1215000
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression,8616117,9/19/2011 0:00,1/31/2016 0:00,Non-SBIR/STTR,2013,234059, ,NCI,146287,87772,234059
Defining the genetic requirements for maintenance of colorectal cancer,8616214,9/1/2014 0:00,8/31/2017 0:00,Other Research-Related,2014,194724, ,NCI,180300,14424,194724
Ecd as a regulator of cell cycle and breast oncogenesis,8616349,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,298894, ,NCI,201275,97619,298894
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,8616359,2/7/2013 0:00,1/31/2018 0:00,Non-SBIR/STTR,2014,369860, ,NCI,277219,92641,369860
Sperm Prions: A Mechanism of Epigenetic Inheritance,8616632,12/15/2013 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,224811, ,NICHD,150000,74811,224811
MOLECULAR & STRUCTURAL BIOLOGY,8616641, , ,Research Centers,2014, ,71607, ,47074,24533, 
CANCER CELL BIOLOGY,8616648, , ,Research Centers,2014, ,30899, ,20007,10892, 
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy,8616725,3/1/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2014,381417, ,NCI,201275,180142,381417
The Function of rpL5 and rpL11 in induction of p53,8616731,3/1/2012 0:00,2/28/2017 0:00,Non-SBIR/STTR,2014,316002, ,NCI,201275,114727,316002
The replication checkpoint and genomic fidelity in skin,8617226,9/1/2003 0:00,12/31/2016 0:00,Non-SBIR/STTR,2014,341668, ,NIAMS,205824,135844,341668
Modulation of skin cancer by PPARb/d,8617242,3/1/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,239732, ,NCI,160894,78838,239732
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8617816,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2014,320027, ,NCI,201275,118752,320027
Discovery of New Genes for Inherited Predisposition to Breast Cancer by Exome Seq,8617817,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,507444, ,NCI,325285,182159,507444
Prevention of quinone toxicity and mutagenicity,8617841,8/1/1996 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,334125, ,NIEHS,222750,111375,334125
Modeling p53 Mutant-Associated Cancer With LFS Patient-Derived iPSCs,8618295,3/3/2014 0:00,2/29/2016 0:00,Other Research-Related,2014,101360, ,NCI,94000,7360,101360
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8618730,3/14/2011 0:00,6/30/2013 0:00,Non-SBIR/STTR,2013,17202, ,NCI,12205,4997,17202
Regulation of Lung Cancer Metastasis by miR-200,8618869,3/14/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,319845, ,NCI,202433,117412,319845
Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer,8619513,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,294868, ,NCI,201275,93593,294868
The Combinatorial Effect of p53 Dynamics and Modifications on Cell Fate Decisions,8619518,2/1/2013 0:00,1/31/2016 0:00,"Training, Individual",2014,58946, ,NIGMS,58946, ,58946
Role of nutrient sensor O-GlcNAc transferase in regulating cancer,8619602,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,308602, ,NCI,208376,100226,308602
Defining the temporal sequence of PI3K pathway mutations in bladder cancer,8620150,1/1/2014 0:00,12/31/2018 0:00,Non-SBIR/STTR,2014,368728, ,NCI,207500,161228,368728
Cancer biology in the zebrafish,8620612,7/3/2003 0:00,2/28/2018 0:00,Non-SBIR/STTR,2014,358651, ,NCI,204457,154194,358651
"Inflammation, autoimmunity and ovarian cancer",8621880,9/9/2014 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,68300, ,NCI,55030,13270,68300
Structural basis for CBP/p300 transcriptional regulation,8623100,6/10/2002 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,395143, ,NCI,208519,186624,395143
Defining mechanisms of extracellular communication for cancer therapy,8623107,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,313989, ,NCI,201275,112714,313989
The role of IL8 in colitis-associated tumor initiation,8624541,11/1/2013 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,319021, ,NCI,201275,117746,319021
New Models and Treatments for AIDS-related Lymphoma,8624673,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,404367, ,NCI,271924,132443,404367
Murine Model of HCV-Associated Human Liver Cancer,8625280,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,456574, ,NCI,308496,148078,456574
Optimization of DNA Repair by Abh8,8625301,3/1/2012 0:00,2/28/2015 0:00,"Training, Individual",2014,63122, ,NIEHS,63122, ,63122
DUSP26: A Novel Therapeutic Target in Neuroblastoma,8625345,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,338921, ,NINDS,216563,122358,338921
Role of nutrient sensor O-GlcNAc transferase in regulating cancer,8625515,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2013,50894, ,NCI,35013,15881,50894
PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM,8625728,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,309436, ,NCI,257638,51798,309436
Role of the Mullerian Tract in Ovarian Cancer Development,8625992,5/1/2009 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,27440, ,NCI,16732,10708,27440
Reactivation of p53 and Apoptosis in Patient Derived AML Cells with Cytoplasmic S,8626572,1/1/2014 0:00,12/31/2017 0:00,Non-SBIR/STTR,2014,349642, ,NCI,250000,99642,349642
Re-replication of chromosomes and cancer,8626730,7/11/1994 0:00,5/31/2014 0:00,Non-SBIR/STTR,2013,50000, ,NCI,19779,11471,31250
Modulation of sensitivity & imaging therapeutic response of hypoxic cancer cells,8627442,5/18/2009 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,28752, ,NCI,18792,9960,28752
Signaling Networks in Glioblastoma Drug Resistance,8627474,9/1/2012 0:00,5/31/2014 0:00,"Training, Individual",2013,36724, ,NCI,36724, ,36724
Progression and regression of mammary preneoplasia,8627803,12/23/2004 0:00,11/30/2018 0:00,Non-SBIR/STTR,2014,311000, ,NCI,200000,111000,311000
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis,8627966,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,322040, ,NCI,201275,120765,322040
Mechanisms of Gene-Specific Transcriptional Regulation Within the p53 Network,8628070,5/26/2006 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,276251, ,NCI,181148,95103,276251
Quercetin as an enhancer of the efficacy of 5-FU in mouse models of colon cancer,8628386,5/1/2014 0:00,1/31/2017 0:00,Other Research-Related,2014,110250, ,NIGMS,75000,35250,110250
Role of beta-endorphin in cancer therapy induced fatigue,8628641,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,342164, ,NCI,201275,140889,342164
Genetic and molecular epidemiology of adult glioma,8628745,5/15/1991 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,1302261, ,NCI,866779,435482,1302261
Gonadotropins & Cox-2 in Ovarian Cancer Prevention,8628750,5/1/2003 0:00,9/30/2015 0:00,Non-SBIR/STTR,2014,364927, ,NCI,252662,112265,364927
MODELING THE ROLE OF DIFFERENTIATION IN T-ALL,8628780, ,2/29/2016 0:00,Research Centers,2014, ,132314, ,220909,0, 
In vivo murine models of metastasis for therapeutic testing,8628801,4/16/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,388202, ,NCI,333087,55115,388202
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",8629214,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2012,61987, ,NCI,39945,22042,61987
Oncogenic Function of ATDC in Bladder Cancer,8629316,4/10/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2014,445705, ,NCI,286627,159078,445705
p53-GAMT pathway in cancer cell metabolism and DNA damage-induced carcinogenesis,8629620,5/13/2010 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,327711, ,NCI,195237,132474,327711
Mechanism of P73-Dependent Tumor Suppression,8629699,5/1/1999 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,295423, ,NCI,191833,103590,295423
Regulation of MDM2 auto-ubiquitination and molecular targeting,8629704,12/15/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,243655, ,NCI,156189,87466,243655
Mechanisms of cell competition that regulate growth during development,8629761,8/1/2006 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,319267, ,NIGMS,200000,119267,319267
Nuclear Function of Abl in DNA Damage Response,8629994,8/1/1986 0:00,11/30/2018 0:00,Non-SBIR/STTR,2014,387500, ,NCI,250000,137500,387500
Validating the protein binding domain of replication protein A as a cancer target,8631295,4/1/2014 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,325256, ,NCI,207500,117756,325256
RB-Related Proteins and Polyomavirus Large T antigen Transformation,8631778,5/2/1994 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,311400, ,NCI,180000,131400,311400
Role of heat shock factors (Hsfs) in tumorigenesis,8632076,3/1/2000 0:00,11/30/2018 0:00,Non-SBIR/STTR,2014,270000, ,NCI,180000,90000,270000
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming,8632184,9/30/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2014,464976, ,NIA,265057,199919,464976
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor,8633015,4/10/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,290011, ,NCI,192060,97951,290011
Nanotheranostics for Early Colorectal Cancer Detection and Treatment,8633021,3/6/2013 0:00,2/28/2018 0:00,Non-SBIR/STTR,2014,318015, ,NCI,201275,116740,318015
Modeling New Therapeutic Approaches for Malignant Melanoma,8633274,10/1/2013 0:00,9/30/2017 0:00,Non-SBIR/STTR,2014, , , , , , 
Basal cell carcinomas: p53-dependent mechanisms of resistance,8633434,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,326066, ,NCI,201275,124791,326066
FDH: A Novel Determinant of Tumor Suppression,8634029,3/1/2005 0:00,4/2/2014 0:00,Non-SBIR/STTR,2014,3975, ,NCI,2695,1280,3975
Roles of MiR-17-92 Cluster MicroRNAs in K-Ras-Induced Pancreatic Tumorigenesis,8634067,4/1/2012 0:00,3/31/2016 0:00,"Training, Individual",2014,29190, ,NCI,29190, ,29190
Mapping the Dynamic Architecture of the Human Mediator Complex,8634083,3/8/2013 0:00,5/31/2015 0:00,Non-SBIR/STTR,2014,177599, ,NCI,132070,45529,177599
Cooperation of Mutant TP53 and PIK3CA in Breast Carcinogensis,8634503,3/8/2013 0:00,3/7/2016 0:00,"Training, Individual",2014,42676, ,NCI,42676, ,42676
Mechanisms for Selective Transcription of p53 Targets by the AcK120 Isoform,8634505,3/9/2013 0:00,3/8/2017 0:00,"Training, Individual",2014,42676, ,NCI,42676, ,42676
Next generation strategies to intercept ErbB signaling,8634719,4/25/1997 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,221413, ,NCI,205012,16401,221413
Role of Otubain 1 in the p53 Pathway,8634742,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,308659, ,NCI,201275,107384,308659
"Chemoprevention by black raspberry in oral cancer induced by DB[a,l]P in mice",8634758,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,316300, ,NCI,229518,86782,316300
Toll-like Receptor Regulation of Pancreatic Tumorigenesis,8635316,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,341162, ,NCI,201275,139887,341162
ATM FUNCTION DURING V(D)J RECOMBINATION,8635819,12/2/2008 0:00,11/30/2018 0:00,Non-SBIR/STTR,2014,380000, ,NIAID,250000,130000,380000
Chemosensitization of Pancreatic Cancer Cells by Curcumin and Vitamin D Receptor,8636411,4/1/2013 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,225955, ,NCI,126585,99370,225955
GI Hormones and Other Factors in Growth of Mucosa,8636426,12/1/1977 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,509243, ,NIDDK,344083,165160,509243
Regulation of NF-Kappa B,8636971,9/30/2000 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,714981, ,NIAID,375318,339663,714981
The Role of JAB1 in osteosarcoma pathogenesis,8637020,4/1/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,76873, ,NCI,48500,28373,76873
D-peptide activators of p53 as anticancer therapeutics,8637246,12/1/2013 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,200318, ,NCI,130500,69818,200318
Prognostic potential of low-level mutations in meylodysplastic syndrome,8637426,1/1/2014 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,190313, ,NCI,108750,81563,190313
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma,8637941,3/18/2013 0:00,2/28/2017 0:00,Non-SBIR/STTR,2014,170128, ,NCI,117807,52321,170128
Role of nucleolin in regulating mRNA stability during DNA damage response (DDR),8637947,4/1/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,196208, ,NCI,126586,69622,196208
Functional landscape of Eph receptor mutations in melanoma,8638686,1/1/2014 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,254475, ,NCI,130500,123975,254475
Medulloblastoma and Metastases,8639356,5/4/2010 0:00,2/28/2015 0:00,Non-SBIR/STTR,2014,455065, ,NCI,360494,94571,455065
Regulation of differentiation in esophageal epithelia,8639545,5/1/2006 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,348000, ,NIDDK,217500,130500,348000
Mechanism of chemoresistance mediated by TGF-beta,8639967,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,338142, ,NCI,201275,136867,338142
Modulation of p53 induction by targeting cap-dependent translation in cancer,8640123,4/1/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,73963, ,NCI,48500,25463,73963
Impact of molecular phenotype on glioma metabolism and growth,8640895,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,290580, ,NCI,238877,51703,290580
Targeting stabilized mutant p53 protein,8640903,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,345545, ,NCI,218873,126672,345545
"NUCKS, a novel double-strand break repair gene, implicated in cancer biology",8641360,6/28/2012 0:00,6/30/2014 0:00,Non-SBIR/STTR,2014,77959, ,NIEHS,42090,35869,77959
Overlapping Airway Basal Cell Transcriptome Reprogramming in COPD and Lung Cancer,8641461,6/15/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2013,834931, ,OD,958570,340889,834931
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis,8641665,9/24/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,311062, ,NCI,178771,132291,311062
Small Molecule Screen Targeting p53 proteolysis in HPV positive cancers,8641680,7/1/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2014,221615, ,NCI,132914,88701,221615
Prevention of UV-induced carcinogenesis by cyanidin-3-glucoside,8641690,8/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,330784, ,NIEHS,222750,108034,330784
Pilot Project 2: Therapeutic targets for doxorubicin resistant breast cancer,8641896, , ,Research Centers,2013, ,51900, ,36682,15218, 
Genome wide analysis of p53 inhibition by high glucose,8642018,5/1/2013 0:00,4/30/2018 0:00,"Training, Individual",2014,36901, ,NCI,36901, ,36901
Replicative Senescence as a Tumor Suppressive Mechanism,8642146,8/8/2007 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,284560, ,NCI,178771,118883,284560
Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer,8642610,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,425671, ,NCI,309074,116597,425671
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer,8642668, , ,Research Centers,2014, ,322750, ,208885,113865, 
Therapeutic strategies for specific subsets of KRAS mutant lung cancers,8643192,8/3/2009 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,496876, ,NCI,411193,85683,496876
The PDGF alpha neural progenitor cells of the subventricular zone contributes to,8643303,2/13/2012 0:00,8/12/2014 0:00,"Training, Individual",2014,29458, ,NINDS,29458, ,29458
The Biochemical Contributions of Ovulation to Fallopian Tube Tumorigenesis,8643405,9/1/2014 0:00,8/31/2015 0:00,"Training, Individual",2014,30080, ,NCI,30080, ,30080
Novel and Selective AMPK Activator for the Treatment of Hepatocellular Carcinoma,8644551,9/23/2014 0:00,9/22/2016 0:00,SBIR/STTR,2014,225000, ,NCI, , ,225000
Resistance of CML Stem Cells to Imatinib (Gleevec),8644783,7/1/2003 0:00,12/12/2014 0:00,Non-SBIR/STTR,2014,305276, ,NCI,181712,123564,305276
Lentiviral Vectors to Model Human Gliomas in Mice,8645672,9/30/1994 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,652800, ,NHLBI,342677,310123,652800
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",8645795,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,59329, ,NCI,40668,18661,59329
A Phase I trial combining IV fenretinide and IV safingol to target overproduction,8646688,6/1/2014 0:00,2/28/2017 0:00,SBIR/STTR,2014,190601, ,NCI, , ,190601
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer,8647283,8/1/2014 0:00,7/31/2015 0:00,SBIR/STTR,2014,224988, ,NCI, , ,224988
Chemical Probes of Endogenous Mutation: Small Molecule APOBEC3B Inhibitors,8647511,9/1/2014 0:00,8/31/2016 0:00,"Training, Individual",2014,28443, ,NCI,28443, ,28443
CLL Mutation Detection and Monitoring from Blood using AC Electrokinetics,8648605,8/5/2014 0:00,7/31/2015 0:00,SBIR/STTR,2014,224603, ,NCI, , ,224603
Development of sEphB4-HSA as Novel Therapeutic in Cancer,8648827,9/27/2013 0:00,8/31/2015 0:00,SBIR/STTR,2013,811279, ,NCI, , ,811279
Overlapping Airway Basal Cell Transcriptome Reprogramming in COPD and Lung Cancer,8649074,6/15/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,1039556, ,NHLBI,1027540,240820,1039556
Sensitization of cancers to ATR inhibition via elevated Aurora A-PLK1 activity,8649551,9/1/2014 0:00,8/31/2015 0:00,"Training, Individual",2014,58946, ,NCI,58946, ,58946
Targeting Gain-of-Function p53 Missense Mutants,8649726,7/1/2014 0:00,6/30/2017 0:00,"Training, Individual",2014,27328, ,NCI,27328, ,27328
Structural and molecular investigation of small molecule reactivation of p53,8650138,3/1/2015 0:00,2/28/2018 0:00,"Training, Individual",2014,36008, ,NCI,36008, ,36008
Mechanisms of preferential targeting of colon cancer by a plant-derived alkaloid,8651428,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,380725, ,NCCIH,242500,138225,380725
Testing of novel anti-cancer compounds Curaxins against pancreatic cancer,8651650,9/1/2013 0:00,8/31/2014 0:00,SBIR/STTR,2013,179664, ,NCI, , ,179664
The Role of SWI/SNF Alternative Splicing in Cancer,8651658,9/30/2013 0:00,9/29/2016 0:00,"Training, Individual",2013,34099, ,NCI,34099, ,34099
Understanding the Function of TRIM 24 in Mammary Epithelial Cells,8652141,11/16/2013 0:00,11/15/2015 0:00,"Training, Individual",2013,34163, ,NCI,34163, ,34163
Regulation of esophageal gene expression and function by KLF5 and p53,8652150,9/20/2013 0:00,7/31/2017 0:00,Non-SBIR/STTR,2013,348000, ,NIDDK,217500,130500,348000
The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAs,8652456,4/8/2010 0:00,9/30/2015 0:00,Non-SBIR/STTR,2014,335635, ,NIEHS,232431,103204,335635
Inhibiting the heat shock factor 1-regulated transcriptional program in cancer,8652953,4/16/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,516071, ,NCI,380488,135583,516071
GSK3 inhibition as an adjuvant therapy for Burkitt's lymphoma,8653055,1/1/2014 0:00,12/31/2015 0:00,Non-SBIR/STTR,2014,146160, ,NCI,87000,59160,146160
Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer,8654057,5/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,49881, ,NCI,32633,17248,49881
Cyclin D3 and DNA double strand breaks: genome stability and lymphomagenesis,8655784,5/1/2013 0:00,4/30/2016 0:00,"Training, Individual",2014,42676, ,NCI,42676, ,42676
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma,8656515,8/22/2013 0:00,2/28/2015 0:00,Non-SBIR/STTR,2013,20255, ,NCI,11929,8326,20255
"ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY",8656669,5/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,305938, ,NCI,201275,104663,305938
Bcl-2 as a Biomarker for Prognosis and Therapy of Head and Neck Cancer,8656976,7/1/2011 0:00,1/1/2015 0:00,Non-SBIR/STTR,2014,820972, ,NIDCR,629385,191587,820972
Transcriptional regulation of oncogenic properties of mutant p53,8657016,5/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,300907, ,NCI,201275,99632,300907
Altered Proteoglycan Gene Expression and Cancer,8657136,9/1/1988 0:00,4/30/2015 0:00,Non-SBIR/STTR,2013,50265, ,NCI,32429,17836,50265
p63 and p73 Signaling in Cell Growth and Cancer,8657362,9/1/2013 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,21297, ,NCI,14702,6595,21297
Altered Proteoglycan Gene Expression and Cancer,8657789,9/1/1988 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,349556, ,NCI,226250,123306,349556
Mechanisms of MnSOD expression in normal and tumor cells,8657793,12/1/1989 0:00,4/30/2017 0:00,Non-SBIR/STTR,2014,231979, ,NCI,156215,75764,231979
PUMA-mediated apoptosis in human cancer cells,8657820,4/1/2004 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,254099, ,NCI,169538,84561,254099
Restoration of Tumor Suppression Activity in Malignant Melanoma,8657822,7/1/2006 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,444787, ,NCI,318848,125939,444787
Organic cation transporter 2 and cisplatin nephrotoxicity,8657878,7/12/2010 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,386808, ,NCI,230242,156566,386808
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance,8657883,7/1/2010 0:00,4/30/2015 0:00,Non-SBIR/STTR,2014,306522, ,NCI,195237,111285,306522
Mitochondrial p32 regulation of the Mdm2-p53 tumor suppression signaling and apop,8657900,7/1/2012 0:00,4/30/2017 0:00,Non-SBIR/STTR,2014,297887, ,NCI,201275,96612,297887
Targeted Development of Platinum Drugs,8657913,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,318015, ,NCI,201275,116740,318015
Apoptosis Regulation by Adenovirus and Cellular Genes,8657981,8/1/1999 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,279371, ,NCI,186247,93124,279371
The Role of MDM Proteins in Cell Growth and Tumorigenesis,8657988,3/1/1999 0:00,4/30/2015 0:00,Non-SBIR/STTR,2014,306100, ,NCI,186079,120021,306100
Hypoxia and Gene Repression,8657990,7/1/2000 0:00,7/31/2015 0:00,Non-SBIR/STTR,2014,314835, ,NCI,195268,119567,314835
Effect of Omega-3 Fatty Acids on Cancer Stem Cells,8658062,7/16/2012 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,293956, ,NCI,201275,92681,293956
GENETICS OF MYELODYSPLASTIC SYNDROMES,8658143,8/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,372400, ,NHLBI,245000,127400,372400
The role of the Ras effector Nore1a in tumor suppression,8658392,7/1/2010 0:00,4/30/2017 0:00,Non-SBIR/STTR,2014,263571, ,NCI,175714,87857,263571
Molecular interactions and restoration strategies of PTEN and p53 in gliomas,8658393,7/1/2010 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,300665, ,NCI,195237,105428,300665
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",8658394,7/1/2010 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,330146, ,NCI,208953,121193,330146
Imaging Based Dosimetry for Individualized Internal Emitter Therapy,8658427,4/1/1999 0:00,10/31/2015 0:00,Non-SBIR/STTR,2014,442741, ,NIBIB,284721,158020,442741
Regulations of DNA Alkylation/Deamination Damage Repair,8658501,3/1/2003 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,62584, ,NCI,40322,22262,62584
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance,8660660,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,324496, ,NCI,201275,123221,324496
Cellular Response to Short Telomeres in B-Cell Lymphoma,8661141,7/5/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,505504, ,NCI,308234,197270,505504
Common Pathogenetic Mechanisms of Lung Cancer and COPD,8661253,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,697882, ,NHLBI,604503,93379,697882
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis,8661715,5/14/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2014,318418, ,NCI,212446,105972,318418
Quinone Oxidoreductases and Mammary Toxicity/Carcinogenenicity,8662266,5/15/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2014,341921, ,NIEHS,222750,119171,341921
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans,8662394,5/16/2013 0:00,6/30/2017 0:00,Non-SBIR/STTR,2013,306154, ,NCI,388050,165123,306154
Staff Investigator,8662715, , ,Research Centers,2014, ,34105, ,22364,11741, 
The Role of PI3K in Growth Regulation,8662786,4/1/1990 0:00,5/31/2017 0:00,Non-SBIR/STTR,2014,491550, ,NIGMS,290000,201550,491550
Visualizing the effect of epigenetic modifications on transcription and mutation,8663852,9/15/2010 0:00,3/16/2015 0:00,Non-SBIR/STTR,2014,38799, ,OD,23950,14849,38799
Transcriptional Control of Stroma Dependent Apoptosis in MDS,8663887,9/2/2010 0:00,3/1/2015 0:00,Other Research-Related,2014,150930, ,NIDDK,139750,11180,150930
Role of EGFR in DNA Repair and Radiation Response in Non Small Cell Lung Cancer,8664066,7/1/2008 0:00,5/31/2015 0:00,Non-SBIR/STTR,2012,192359, ,NCI,129535,62824,192359
"Pubertal high fat diet: effects on inflammation, mammary development and cancer",8664846,9/1/2010 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,446926, ,NIEHS,316048,164345,446926
Targeting the oncogenic mutant p53 signaling in colorectal cancer therapy,8665720,4/18/2014 0:00,10/31/2014 0:00,Non-SBIR/STTR,2014,316656, ,NCI,207500,109156,316656
Targeting Leukemia Stem Cells with Dietary Selenium,8666541,8/1/2012 0:00,5/31/2017 0:00,Non-SBIR/STTR,2014,294125, ,NCI,201275,92850,294125
Enhancing glioma chemotherapy by suppressing Notch signaling,8666671,3/1/1988 0:00,5/31/2015 0:00,Non-SBIR/STTR,2014,349120, ,NINDS,212231,136889,349120
Dynamics of Signaling Pathways: Mechanism and Function,8669003,3/1/2008 0:00,4/30/2017 0:00,Non-SBIR/STTR,2014,320531, ,NIGMS,190000,130531,320531
Localizing Immunotherapy to Improve Therapeutic Index,8670703,6/4/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,385527, ,NCI,249719,135808,385527
Molecular analysis of methylated p53,8670760,8/1/2013 0:00,7/31/2017 0:00,Non-SBIR/STTR,2014,342557, ,NIGMS,237427,105130,342557
OLIG2 Phosphorylation as a Drug Target for Glioma,8672697,7/15/2007 0:00,5/31/2016 0:00,Non-SBIR/STTR,2014,431962, ,NINDS,324740,107222,431962
Fully Synthetic Prodiginines as Probes of Protein-Protein Interactions Regulating,8673216,4/16/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2014,367879, ,NCI,246751,121128,367879
Pancreatic Cancer Vulnerabilities Downstream of Cooperating Oncogenic Mutations,8673559,6/11/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2014,412619, ,NCI,268807,143812,412619
Role of p53 family proteins in glucose metabolism,8674891,5/6/2014 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,332000, ,NCI,207500,124500,332000
Mechanisms of Dicer1 Function in Lung Organogenesis and Cystic Lung Disease,8675924,6/15/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2014,372581, ,NHLBI,253525,119056,372581
Regulation of Mutant P53 Expression and Oncogenic Activity,8676449,2/1/2007 0:00,5/31/2017 0:00,Non-SBIR/STTR,2014,274414, ,NCI,178771,95643,274414
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer,8676458,7/15/2010 0:00,5/31/2015 0:00,Non-SBIR/STTR,2014,298812, ,NCI,196959,101853,298812
TOR signaling and autophagy in obesity-promoted liver tumorigenesis,8676723,7/22/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2014,469980, ,NCI,303213,166767,469980
Targeting the ATR pathway in p53-deficient cancers,8676727,7/13/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2014,330091, ,NCI,201275,128816,330091
Local Immunoregulation of Carcinogenesis,8677732,7/13/2003 0:00,5/31/2015 0:00,Non-SBIR/STTR,2014,337364, ,NCI,208017,129347,337364
Role of Cdc25A in breast cancer,8677739,9/1/2005 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,265015, ,NCI,176238,88777,265015
"Spindle Assembly Checkpoint, Chromosome Stability, and Cancer",8677744,9/1/2008 0:00,5/31/2017 0:00,Non-SBIR/STTR,2014,305528, ,NCI,195225,110303,305528
Epigenetic Changes Link COPD and Lung Cancer,8677815,8/4/2011 0:00,5/30/2016 0:00,Non-SBIR/STTR,2014,750856, ,NCI,389470,361386,750856
Directing the Mediator Complex: Bivalent approaches to Reconstituting or Inhibiti,8677828,8/1/2012 0:00,5/31/2016 0:00,Non-SBIR/STTR,2014,481310, ,NCI,365956,115354,481310
Molecular mechanism of RNA polymerase I transcription and dysregulation in cancer,8678333,9/17/2014 0:00,8/31/2017 0:00,Other Research-Related,2014,211470, ,NCI,195806,15664,211470
p53 - Regulators and Effectors,8678848,2/16/2000 0:00,6/30/2017 0:00,Non-SBIR/STTR,2014,1366635, ,NCI,991445,375190,1366635
Molecular Interactions and Regulation of p53,8678850, ,6/30/2017 0:00,Non-SBIR/STTR,2014, ,268957, ,193919,75038, 
Genetic Analysis of the Breast Tumor Microenvironment,8678856,9/15/2004 0:00,5/31/2017 0:00,Non-SBIR/STTR,2014,1514209, ,NCI,1070513,443696,1514209
Suppression of Mammary Tumorigenesis by Stromal p53,8678858,9/15/2004 0:00, ,Non-SBIR/STTR,2014, ,290212, ,226826,63386, 
Mechanisms of Radioresistance and Cell Cycle Progression,8678868,5/1/1995 0:00,6/30/2017 0:00,Non-SBIR/STTR,2014,337379, ,NCI,210862,126517,337379
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3,8679747,6/20/2014 0:00,5/31/2016 0:00,Other Research-Related,2014,140253, ,NCI,129864,10389,140253
The role of p53 redox-modification in cell fate signaling,8680191,7/1/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2014,168441, ,NCI,112689,55752,168441
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer,8681391,9/11/2012 0:00,6/30/2017 0:00,Non-SBIR/STTR,2014,374383, ,NCI,224855,149528,374383
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit,8682792,9/1/2012 0:00,6/30/2017 0:00,Non-SBIR/STTR,2014,334466, ,NCI,215091,119375,334466
The role of Fyn and Srcasm in UVB-induced cutaneous neoplasia,8683129,8/1/2012 0:00,5/31/2017 0:00,Non-SBIR/STTR,2014,322040, ,NCI,201275,120765,322040
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH,8683133,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,310728, ,NCI,214239,96489,310728
Targeted Therapy for EGFR Pathway in HPV+ HNSCCs,8684560,3/1/2014 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,188750, ,NIDCR,125000,63750,188750
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,8685133,5/1/1997 0:00,5/31/2017 0:00,Non-SBIR/STTR,2014,1396970, ,NCI,875011,521959,1396970
Investigation of Regulatory RNAs in Tumor Development,8685135, , ,Non-SBIR/STTR,2014, ,259140, ,259140,0, 
Radiation Biology,8685157, ,5/31/2016 0:00,Research Centers,2014, ,52923, ,14299,38624, 
A comprehensive approach to breast cancer susceptibility across the risk spectrum,8685187,7/5/2011 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,573230, ,NCI,419638,153592,573230
Novel Antitumor Agents,8685206,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,365088, ,NCI,241268,123820,365088
Retention of somatic mutations in cancers by changes in pH sensing,8685920,7/1/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2014,166671, ,NCI,105488,61183,166671
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals,8686200,5/16/2014 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,325183, ,NCI,213321,111862,325183
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES,8686532,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2014,362364, ,NCI,207500,154864,362364
DNA-Protein Interactions in Herpes Viruses,8686759, , ,Non-SBIR/STTR,2014, ,262683, ,181209,81474, 
The Role of ATF3 in the DNA Damage Response,8686769,9/1/2010 0:00,6/30/2018 0:00,Non-SBIR/STTR,2015,222176, ,NCI,156189,78095,222176
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease,8686847,9/1/2012 0:00,5/31/2017 0:00,Non-SBIR/STTR,2014,332787, ,NIEHS,222750,110037,332787
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw,8687251,9/1/2014 0:00,8/31/2018 0:00,Non-SBIR/STTR,2014,845606, ,NCI,632244,213362,845606
Study of Novel HHV8/KSHV Encoded Genes,8687586, , ,Non-SBIR/STTR,2014, ,473768, ,310360,163408, 
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer,8688165,7/1/2011 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,317451, ,NCI,248615,68836,317451
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO),8688975,7/1/2013 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,341162, ,NCI,201275,139887,341162
A Strategy for Reactivating p53 in Cancer Stem Cells Using a Novel HdmX Inhibitor,8689986,7/1/2013 0:00,6/30/2015 0:00,Non-SBIR/STTR,2014,167198, ,NCI,105488,61710,167198
Regulation of Par-4 Secretion in Normal Cells for Paracrine Action in Tumor Cells,8690405,4/1/2014 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,195750, ,NCI,130500,65250,195750
A PTEN-dependent cell size checkpoint in human cells,8690786,5/11/2006 0:00,4/30/2017 0:00,Non-SBIR/STTR,2014,233970, ,NCI,150463,83507,233970
Druggable p53 misfolding in cancer: A novel in vivo molecular imaging biosensor,8691142,4/11/2014 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,174639, ,NCI,108750,65889,174639
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes,8691555,5/6/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2014,334875, ,NIEHS,225000,109875,334875
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer,8692054,8/1/2009 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,63345, ,NCI,43264,20081,63345
Targeting p53-Dependent Repigmentation in Vitiligo,8692476,7/1/2012 0:00,6/30/2017 0:00,Other Research-Related,2014,100572, ,NIAMS,93530,7042,100572
P53 inactivation on MDSC development and tumor progression,8692674,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,303590, ,NCI,201275,102315,303590
Role of SIRT1 in melanocyte biology and melanocyte transformation,8692701,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,316997, ,NCI,229534,87463,316997
Using Markers to Improve Pancreatic Cancer Screening,8692702,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,404161, ,NCI,249482,154679,404161
Rad50: Roles in chromo. stab. and prev. of malignancy,8692819,1/1/1998 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,530413, ,NIGMS,290003,240410,530413
The role of MCM8-9 in genomic instability of cancers,8693129,7/11/1994 0:00,5/31/2019 0:00,Non-SBIR/STTR,2014,355500, ,NCI,225000,130500,355500
Developmental Funds,8693594, , ,Research Centers,2014, ,32695, ,33087,0, 
MKP-1 Effects on HIF-1alpha and Glycolytic Metabolism in Glioblastoma multiforme,8693609,7/1/2013 0:00,6/30/2017 0:00,"Training, Individual",2014,42676, ,NCI,42676, ,42676
Small Molecule Activators of Procaspases as Anti-Cancer Agents,8693959,8/6/2007 0:00,6/30/2018 0:00,Non-SBIR/STTR,2014,446391, ,NCI,309208,137183,446391
The role of MDM2-MTBP axis in cancer metastasis,8694358,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2014,313325, ,NCI,207500,105825,313325
An inhibitor of multiple anti-apoptotic gene products for pancreatic cancer,8694557,4/10/2014 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,221589, ,NCI,130500,91089,221589
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors,8696462,6/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2014,402550, ,NCI,207500,195050,402550
Gammaherpesvirus interactions with host tumor suppressor p53,8696558,4/4/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2014,359998, ,NCI,245431,114567,359998
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,8696778,4/1/2011 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014, , , , , , 
Role of IL-6/STAT3 Signaling in the Neoplastic Progression of Barrett's Esophagus,8696814,10/1/2010 0:00,6/30/2015 0:00,Non-SBIR/STTR,2014, , , , , , 
Targeting the Chk1-Suppressed Apoptotic Pathway in HNSCC,8697026,7/5/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,346222, ,NCI,204382,141840,346222
Genetic Mouse Models of Glioma,8697215,3/1/2009 0:00,1/31/2019 0:00,Non-SBIR/STTR,2014,397314, ,NCI,249883,147431,397314
DACH1/Eya Cell fate determination factor and mammary tumorigenesis,8697542,7/20/2009 0:00,2/28/2019 0:00,Non-SBIR/STTR,2014,348750, ,NCI,225000,123750,348750
Genetic Alterations that Initiate Follicular Thyroid Carcinogenesis,8697754,3/1/2008 0:00, ,Non-SBIR/STTR,2014, ,407498, ,299024,108474, 
NYU Lung Cancer Biomarker Center,8698331,5/8/2000 0:00,12/31/2016 0:00,Non-SBIR/STTR,2015,630061, ,NCI,447644,299341,630061
The role of ribosomal proteins in the p53-MDM2 pathway,8698332,3/1/2002 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,256973, ,NCI,170746,86227,256973
Molecular Oncology,8698913,8/15/1997 0:00,4/30/2019 0:00,Research Centers,2014, ,38982, ,25069,13913, 
"The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer",8699974,2/1/2010 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,222575, ,NCI,139984,82591,222575
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,8700327,8/15/1999 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,263112, ,NCI,169750,93362,263112
Novel small-molecule inhibitors of Wee1 kinase for medulloblastoma treatment,8700556,7/15/2013 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,191193, ,NINDS,123750,67443,191193
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8700873,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2013,215210, ,NCI,135352,79858,215210
Role of PALB2 in the DNA damage response and breast cancer suppression,8700886,7/1/2009 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,300826, ,NCI,189199,111627,300826
Training Program in Molecular Genetics of Cancer,8701028,9/30/1978 0:00,6/30/2016 0:00,"Training, Institutional",2014,423057, ,NCI,433935,30235,423057
Cancer Prevention,8702111, , ,Research Centers,2014, ,25632, ,25632,0, 
Chemical suppressors of the neural crest lineage for the treatment of melanoma,8702912,8/1/2013 0:00,7/31/2016 0:00,"Training, Individual",2014,34543, ,NCI,34543, ,34543
Role of vitamin D receptor in DNA repair,8703015,7/17/2013 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,157463, ,NIAMS,106250,51213,157463
Targeted Therapy for Endometrial Cancer,8703028,7/17/2002 0:00,4/30/2018 0:00,Non-SBIR/STTR,2014,244874, ,NCI,162168,82706,244874
Role of PALB2 in the DNA damage response and breast cancer suppression,8703277,7/1/2009 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,60035, ,NCI,44778,22437,60035
New Aminothiol Prevention of X-Ray-Induced Mouse Mutagenesis and Tumorigenesis,8703290,4/1/2014 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,75250, ,NCI,50000,25250,75250
Distinct Pathways of VPF/VEGF Receptors,8704237,4/1/2002 0:00,6/30/2015 0:00,Non-SBIR/STTR,2014,386365, ,NHLBI,245000,141365,386365
Perturbation of a cellular microRNA by human papillomavirus type 16.,8704721,8/1/2013 0:00,7/31/2016 0:00,"Training, Individual",2014,34543, ,NCI,34543, ,34543
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans,8704891,5/16/2013 0:00,3/1/2015 0:00,Non-SBIR/STTR,2014,284046, ,NCI,222249,61797,284046
Modulation of p53 function by tyrosine kinase networks,8704895,9/7/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2014,325060, ,NCI,201275,123785,325060
Modeling The Etiology of P53 Mutated Cancer Cells,8704904,7/22/2013 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,163650, ,NCI,126126,37524,163650
Targeting Oncogene Expression to Skin in Transgenic Mice,8705408,8/1/1990 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,462072, ,NCI,317564,144508,462072
Bcl-2 as a Biomarker for Prognosis and Therapy of Head and Neck Cancer,8705631,7/1/2011 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,122000, ,NIDCR,103500,18500,122000
Focal Adhesion Kinase - Tumor Biology and Therapeutics,8706051,9/30/1996 0:00,5/31/2015 0:00,Non-SBIR/STTR,2014,289954, ,NCI,205238,84716,289954
Roles and regulation of p53,8706055,9/30/2000 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,1717762, ,NCI,1393367,324395,1717762
Regulation and Interactions of the p53 Family,8706066, , ,Non-SBIR/STTR,2014, ,437376, ,354778,82598, 
Genomic Analysis of the p53 Pathway in Normal and Cancer Cells,8706067, , ,Non-SBIR/STTR,2014, ,445144, ,361079,84065, 
p53 and Chemosensitivity in a Mouse Lymphoma Model,8706068, , ,Non-SBIR/STTR,2014, ,402181, ,326231,75950, 
Molecular Studies of the p53 Pathway in Human Cancer,8706069, , ,Non-SBIR/STTR,2014, ,433061, ,351279,81782, 
Regulation of Mdmx stability and subcellular localization by ubiquitination,8706095,8/14/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2014,292939, ,NCI,183087,109852,292939
Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma,8706995,8/1/2012 0:00,7/1/2015 0:00,Other Research-Related,2014,184127, ,NINDS,170488,13639,184127
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma,8707203, ,6/30/2017 0:00,Research Centers,2014, ,576372, ,172349,404023, 
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression,8707313,9/19/2011 0:00,1/31/2016 0:00,Non-SBIR/STTR,2014,236194, ,NCI,156715,79479,236194
"Race, pathomolecular signature and colorectal cancer survival",8707398,9/21/2011 0:00,8/31/2016 0:00,Other Research-Related,2014,129249, ,NCI,120755,8494,129249
OXIDATIVE INJURY TO GASTRIC EPITHELIAL CELLS BY H. PYLORI,8707436,9/21/2001 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,310000, ,NIDDK,200000,110000,310000
Role of ribosome impairments in X-linked Dyskeratosis Congenita pathogenesis,8707448,8/1/2006 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,348576, ,NIDDK,231000,117576,348576
Novel integrative method to detect biomakers of breast cancer resistance,8707556,8/1/2013 0:00,7/31/2015 0:00,Other Research-Related,2014,89641, ,NLM,83445,6196,89641
Development of selective substrate based inhibitors of ubiquitin isopeptidases,8707677,5/15/2014 0:00,5/14/2016 0:00,SBIR/STTR,2014,224379, ,NIGMS, , ,224379
A p53/NFkB-mediated metabolic mechanism for chemotherapy protection,8707715,4/1/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2014,335113, ,NCI,207500,127613,335113
Image-Guided Nanoembolization for the Treatment of Pancreatic Cancer,8710061, ,7/31/2016 0:00,Research Centers,2014, ,163548, ,163548,0, 
Multi-Modal Gene Therapy for Pancreatic Cancer using Targeted Nanovectors,8710074, ,10/31/2015 0:00,Research Centers,2014, ,184882, ,184882,0, 
Image-Guided Nanoembolization for the Treatment of Pancreatic Cancer,8710084, , ,Research Centers,2013, ,5398, ,3903,1495, 
Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC),8710103,9/15/2012 0:00,5/31/2016 0:00,Other Research-Related,2015,172260, ,NCI,159500,12760,172260
Cellular Control: Synthetic Signaling/Motility (RMI),8710225,9/30/2004 0:00,7/31/2015 0:00,Other Research-Related,2014,1, ,OD,71426,38927,1
MOLECULAR & STRUCTURAL BIOLOGY,8710564, , ,Research Centers,2013, ,963, ,623,340, 
CANCER CELL BIOLOGY,8710571, , ,Research Centers,2013, ,961, ,622,339, 
Role of DDB2 in chemotherapeutic agents-induced apoptosis and platinum resistance,8711333,9/1/2011 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,245556, ,NCI,161020,84536,245556
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni,8711591,8/1/2013 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,425691, ,OD,293445,132246,425691
c-Myc-regulated microRNAs in normal and pathologic cellular physiology,8712397,4/1/2007 0:00,5/31/2018 0:00,Non-SBIR/STTR,2014,284246, ,NCI,178771,105475,284246
PET TUMOR AND PROLIFERATION IMAGING VIA CATIONIC AMINO ACID TRANSPORT,8712411,9/1/2011 0:00,8/31/2016 0:00,Other Research-Related,2014,157715, ,NCI,146032,11683,157715
Chemical Inhibitors of CREB-mediated Gene Transcription,8712508,9/1/2010 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,320166, ,NIGMS,219127,101039,320166
Chemical optimization of a novel class of USP7 inhibitor for cancer treatment,8712943,8/1/2014 0:00,7/31/2015 0:00,SBIR/STTR,2014,224974, ,NCI, , ,224974
Defining the role of the tumor-initiating cell niche in breast cancer,8716683,9/1/2010 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,241530, ,NCI,156837,84693,241530
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia,8716708,8/7/2013 0:00,7/31/2016 0:00,Other Research-Related,2014,97945, ,NCI,90690,7255,97945
Bypassing mutant p53 in radiation therapy,8716978,6/15/2014 0:00,6/14/2017 0:00,"Training, Individual",2014,47676, ,NCI,47676, ,47676
Novel Mechanism for Myc-Induced Apoptosis,8717606,9/1/2012 0:00,8/31/2015 0:00,"Training, Individual",2014,27036, ,NCI,27036, ,27036
Dual Targeting of the p53 pathway for development of anti-cancer therapy,8717615,9/26/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2014,303351, ,NCI,205677,97674,303351
Regulation of Sphingosine Kinase 1 by p53 and Caspase 2,8717916,7/1/2014 0:00,6/30/2015 0:00,"Training, Individual",2014,30482, ,NCI,30482, ,30482
Aspects of MUC13 Mucin in Cancer,8718347,7/1/2010 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,295230, ,NCI,196820,98410,295230
The Tumor Suppressive Role of the mir-200 family of microRNAs,8718702,7/16/2014 0:00,7/15/2016 0:00,"Training, Individual",2014,36056, ,NCI,36056, ,36056
Protein Kinase Signaling and Cell Cycle Control,8719102,12/1/2006 0:00,5/31/2018 0:00,Non-SBIR/STTR,2014,498230, ,NIEHS,319378,178852,498230
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer,8719605,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2014,333122, ,NCI,207500,125622,333122
"Role of NIAM, A Putative Cancer Gene, in Chromosomal Instability and Glioblastoma",8719951,9/1/2012 0:00,5/15/2015 0:00,"Training, Individual",2014,20829, ,NCI,20829, ,20829
Targets for Therapy for Carcinomas of the Lung,8720705,7/23/2007 0:00,8/31/2017 0:00,Non-SBIR/STTR,2014,1684807, ,NCI,1101810,582997,1684807
Lung Cancer Drivers and Dependencies as Therapeutic Targets,8720709, , ,Non-SBIR/STTR,2014, ,357605, ,233863,123742, 
Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy,8721161,4/1/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2014,497021, ,NCI,349539,147482,497021
The Development of Novel Individualized Therapy for Triple-Negative Breast Cancer,8721743,9/1/2013 0:00,8/31/2018 0:00,Other Research-Related,2014,171720, ,NCI,159000,12720,171720
Defining novel pathways that arrest genetically unstable tetraploid cells,8722136,8/16/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2013,248999, ,NCI,152107,96892,248999
Targeting Microenvironment / Leukemia Cell Interactions in CML,8722323, ,6/30/2016 0:00,Non-SBIR/STTR,2014, ,185911, ,185911,0, 
"The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer",8722491,9/1/2012 0:00,6/30/2018 0:00,Non-SBIR/STTR,2014,106370, ,NCI,66899,39471,106370
Exploration of a Mutant p53 Reactivating Compound,8722498,8/16/2013 0:00,7/31/2018 0:00,Other Research-Related,2014,158958, ,NCI,147183,11775,158958
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8722816,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2013,42493, ,NCI,28057,14436,42493
Mitochondrial Motility and Inheritance,8723238,7/1/1993 0:00,4/30/2017 0:00,Non-SBIR/STTR,2014,327160, ,NIGMS,206527,120633,327160
High throughput screen for selective inhibitors of cyclophilin B,8723913,9/1/2013 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,392671, ,NINDS,344118,48553,392671
Dynamics of cellular senescence in single human cells,8724088,9/1/2012 0:00,8/31/2016 0:00,Non-SBIR/STTR,2013,248330, ,NIGMS,167651,80679,248330
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression,8724440, , ,Research Centers,2014, ,8321, ,5300,3021, 
Cellular Stress Response Signaling Pathways,8724500,1/1/1992 0:00,5/31/2018 0:00,Non-SBIR/STTR,2014,349718, ,NIEHS,222750,126968,349718
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus,8724829,10/1/2014 0:00,9/30/2018 0:00,Non-SBIR/STTR,2015, , , , , , 
Epigenetic Regulation of Cell and Tissue Aging,8726047,9/30/2007 0:00,8/31/2014 0:00,Non-SBIR/STTR,2013,86914, ,NIA,55536,31378,86914
Molecular Imaging & Targeted Therapeutics of Stem Cell-Derived Colon Cancer,8726908,9/24/2002 0:00, ,Research Centers,2014, ,916239, ,201029,730111, 
Defining novel pathways that arrest genetically unstable tetraploid cells,8726938,8/16/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,236254, ,NCI,144321,91933,236254
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis,8726944,9/1/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,306945, ,NCI,201275,105670,306945
Cell-cycle regulatory kinases as targets for male contraceptive drug development,8727232,5/20/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2014,235541, ,NICHD,178086,57455,235541
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci,8727268,9/7/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,523201, ,NCI,327603,195598,523201
Heat Shock Protein-Induced Protection Against Cisplatin-Induced Hair Cell Death,8727504,9/28/2009 0:00,5/27/2015 0:00,"Training, Individual",2014,23983, ,NIDCD,23983, ,23983
Markers for Screening and Prognosis,8727975, , ,Research Centers,2014, ,305324, ,189110,116214, 
Population-based study of DNA damage response markers of prognosis in breast canc,8728124, ,8/31/2017 0:00,Research Centers,2014, ,141126, ,98089,58639, 
Molecular Biology of Lung Cancer among Puerto Ricans,8728155, , ,Research Centers,2014, ,183964, ,129807,63926, 
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,8728198,9/30/2010 0:00,3/14/2016 0:00,Non-SBIR/STTR,2014,308138, ,NIDDK,205425,102713,308138
Molecular Biology of Lung Cancer among Puerto Ricans,8728618, , ,Research Centers,2014, ,205662, ,122055,83607, 
P3 - TARGETING THE HDM-2 E3 LIGASE IN MULTIPLE MYELOMA,8728776, ,8/31/2018 0:00,Research Centers,2014, ,168658, ,190013,4919, 
The Regulation of PP1 in the Nucleus,8728948,9/1/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,290828, ,NIGMS,188000,102828,290828
SPORE in Prostate Cancer,8729054,8/1/1997 0:00,5/31/2014 0:00,Research Centers,2013,560104, ,NCI,360196,199908,560104
Roles of EAF2 in androgen action in the prostate,8729157,12/18/1996 0:00,2/28/2019 0:00,Non-SBIR/STTR,2014,370620, ,NCI,241250,129370,370620
Restoration of Tumor Suppression Activity in Malignant Melanoma,8730320,7/1/2006 0:00,4/30/2016 0:00,Non-SBIR/STTR,2013,77034, ,NCI,50185,26849,77034
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression,8730569, , ,Research Centers,2014, ,29898, ,0,29898, 
P63 mechanisms and mediators in HNSCC,8731114,4/1/2004 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,431765, ,NIDCR,250000,181765,431765
Regulation of gastroesophageal reflux-associated tumorigenesis,8732012,7/1/2014 0:00,6/30/2018 0:00,Non-SBIR/STTR,2014, , , , , , 
"Chemoprevention of Colon Cancer, HDAC Inhibition, and Histone Status",8732426,3/17/2003 0:00,4/30/2017 0:00,Non-SBIR/STTR,2014, ,232797, ,197525,35272, 
Dynamics of cellular senescence in single human cells,8732676,9/1/2012 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,342003, ,NIGMS,228423,113580,342003
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia,8733134,9/11/2013 0:00,6/30/2018 0:00,Non-SBIR/STTR,2014,337136, ,NCI,201275,135861,337136
Immune Therapy,8733427, , ,Non-SBIR/STTR,2014, ,239121, ,204121,35000, 
Mechanisms of novel cancer targets in ARF-mediated tumor suppression,8733628,9/1/2012 0:00,8/31/2017 0:00,Non-SBIR/STTR,2014,322040, ,NCI,201275,120765,322040
Genetic Susceptibility To Carcinogens and Toxicants,8734075, , ,Intramural Research,2013,830841, ,NIEHS, , ,830841
Human Genes Affecting Chromosome Metabolism and Stress Response,8734106, , ,Intramural Research,2013,1306411, ,NIEHS, , ,1306411
Discovery And Functional Genomics Of Environmental Response Genes,8734126, , ,Intramural Research,2013,1780375, ,NIEHS, , ,1780375
"Nuclear receptors: action, functions, and roles in disease",8734135, , ,Intramural Research,2013,1197737, ,NIEHS, , ,1197737
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia,8734325,8/5/2003 0:00,8/31/2018 0:00,Research Centers,2014,2161448, ,NCI,1697633,590986,2161448
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma,8734350,9/13/2013 0:00,11/30/2014 0:00,Other Research-Related,2014,102574, ,NCI,94976,7598,102574
Apoptosis In Neurodegenerative Disorders,8736518, , ,Intramural Research,2013,508154, ,NIA, , ,508154
Long-Range Transcriptional Regulation of Placental and Ovary Specific Genes,8736580, , ,Intramural Research,2013,604624, ,NIA, , ,604624
Regulation Of Intracellular Iron Metabolism,8736847, , ,Intramural Research,2013,958368, ,NICHD, , ,958368
Non-canonical gene regulation through a Drosophila p53 enhancer,8737023,9/1/2013 0:00,8/31/2018 0:00,"Training, Individual",2014,30041, ,NIGMS,30041, ,30041
Regulation of esophageal gene expression and function by KLF5 and p53,8737255,9/20/2013 0:00,7/31/2017 0:00,Non-SBIR/STTR,2014,348000, ,NIDDK,217500,130500,348000
SPORE: Targeted Therapies for Glioma,8737806,9/19/2013 0:00,7/31/2018 0:00,Research Centers,2014,2144141, ,NCI,1742012,614501,2144141
"HPV, Tumor Metabolism and Radiosensitivity in Head and Neck Cancer",8738634,9/20/2013 0:00,2/28/2017 0:00,Non-SBIR/STTR,2014,228000, ,NIDCR,150000,78000,228000
Characterization and regulation of the MED17-p53 binding interface.,8738813,9/16/2013 0:00,7/16/2015 0:00,"Training, Individual",2014,29292, ,NCI,29292, ,29292
Molecular Landscape-based Innovative Therapies for Anaplastic Thyroid Carcinoma,8738872,9/19/2014 0:00,8/31/2019 0:00,Research Centers,2014, ,531224, ,338729,192495, 
Novel c-Abl-directed Therapies to Alleviate Metastatic Breast Cancer,8739020,9/12/2013 0:00,9/11/2016 0:00,"Training, Individual",2014,30552, ,NCI,30552, ,30552
Regulation of Human Papillomavirus Replication via Cell Signaling Pathways,8739151,12/1/2013 0:00,11/30/2015 0:00,"Training, Individual",2015,34329, ,NCI,34329, ,34329
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp,8739825, , ,Non-SBIR/STTR,2014, ,338854, ,247339,91515, 
"Understanding the origin,initiation,and progression of high-grade serous ovarian",8740474,9/24/2013 0:00,1/31/2016 0:00,Other Research-Related,2014,95826, ,NCI,88728,7098,95826
Mechanisms of Esophageal Carcinogenesis,8741111,8/15/2003 0:00,6/30/2019 0:00,Non-SBIR/STTR,2014,1637533, ,NCI,1174560,462973,1637533
Transformed Esophageal Epithelial Cells and the Tumor Microenvironment,8741115,8/15/2003 0:00,6/30/2019 0:00,Non-SBIR/STTR,2014, ,358285, ,256989,101296, 
Small Molecule Activators of p53,8741394, , ,Intramural Research,2013,137158, ,NIDDK, , ,137158
The role of Spo11 in mammalian meiosis,8741476, , ,Intramural Research,2013,439616, ,NIDDK, , ,439616
"BRCA1, DNA damage response and aging",8741510, , ,Intramural Research,2013,1047427, ,NIDDK, , ,1047427
RNDI- Mediated Breast Cancer Suppression,8741848,9/1/2002 0:00,6/30/2019 0:00,Non-SBIR/STTR,2014, ,506567, ,289550,217017, 
Pilot Project 2: Therapeutic targets for doxorubicin resistant breast cancer,8741941, , ,Research Centers,2014, ,54392, ,38330,16062, 
Role of Parkinson's disease gene PARK2 in GBM oncogenesis and genomic instability,8742029,9/30/2013 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,382882, ,NINDS,216562,166320,382882
Sphingolipids in Cancer Biology and Therapy,8742655,8/1/2003 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,1322890, ,NCI,892069,430821,1322890
Project 1: Role of Acid Sphingomyelinase in Breast Cancer,8742659,8/1/2003 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014, ,221835, ,142088,79747, 
Project 3: Role of Sphingosine Kinase in P53 Cancer Biology,8742661,8/1/2003 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014, ,208047, ,133257,74790, 
Evaluating the role of NRG-1 receptors in MPNST tumorigenesis,8743436,7/1/2013 0:00,7/2/2014 0:00,"Training, Individual",2014,262, ,NINDS,262, ,262
The Role of SWI/SNF Alternative Splicing in Cancer,8743815,9/30/2013 0:00,9/29/2016 0:00,"Training, Individual",2014,34785, ,NCI,34785, ,34785
Development of sEphB4-HSA as Novel Therapeutic in Cancer,8744264,9/27/2013 0:00,8/31/2015 0:00,SBIR/STTR,2014,589768, ,NCI, , ,589768
Project 5,8744321,1/1/2013 0:00,12/31/2016 0:00,Non-SBIR/STTR,2013, ,598168, ,317375,280793, 
Project 5,8744361, , ,Non-SBIR/STTR,2014, ,632154, ,331744,300410, 
Development Project 2,8744896,9/25/2013 0:00,8/31/2018 0:00,Research Centers,2013, ,108067, ,50401,57666, 
Development Project 2,8744915, , ,Research Centers,2014, ,76095, ,48889,55997, 
IMPACT OF AICD ON TCR TRANSDUCED T CELLS FOR ADOPTIVE IMMUNOTHERAPY,8744932,9/4/2013 0:00,8/31/2016 0:00,Non-SBIR/STTR,2013, ,297164, ,231652,65512, 
Identification of Genetic Alterations Responsible for Primary GBM Clonal Evoluti,8745102,9/5/2001 0:00, ,Non-SBIR/STTR,2014, ,426766, ,338506,88260, 
IMPACT OF AICD ON TCR TRANSDUCED T CELLS FOR ADOPTIVE IMMUNOTHERAPY,8745149, , ,Non-SBIR/STTR,2014, ,313532, ,243701,69831, 
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease,8745322, , ,Intramural Research,2013,799933, ,NIAID, , ,799933
Lymphomas And Retroviral Pathogenesis,8745377, , ,Intramural Research,2013,390144, ,NIAID, , ,390144
Danger 1:  initiating and stopping immune responses,8745380, , ,Intramural Research,2013,232239, ,NIAID, , ,232239
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases,8745452, , ,Intramural Research,2013,1203264, ,NIAID, , ,1203264
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS,8745467, , ,Intramural Research,2013,765771, ,NIAID, , ,765771
Mechanisms of Cellular Transformation by HTLV-1,8745469, , ,Intramural Research,2013,491219, ,NIAID, , ,491219
Molecular Regulation of B-Cell Differentiation and Function,8745470, , ,Intramural Research,2013,1170431, ,NIAID, , ,1170431
Signal and Transcription Factor Network interactions in Head and Neck Cancer,8745660, , ,Intramural Research,2013,870939, ,NIDCD, , ,870939
Genomics and Proteomics of Head and Neck Cancer,8745661, , ,Intramural Research,2013,870939, ,NIDCD, , ,870939
The role of autophagy in aging and metabolism,8746582, , ,Intramural Research,2013,762914, ,NHLBI, , ,762914
Mitochondrial regulation in cardiovascular and cancer biology,8746587, , ,Intramural Research,2013,995492, ,NHLBI, , ,995492
Preclinical Development and Clinical Testing of MEK and PI3K Targeted Therapy for KRAS-mutant NSCLC,8747047,9/30/1996 0:00,8/31/2019 0:00,Research Centers,2014, ,302512, ,241894,60618, 
Mutational and Functional Analysis of Sporadic Malignant Melanoma,8750691, , ,Intramural Research,2013,715651, ,NHGRI, , ,715651
Understanding the Function of TRIM 24 in Mammary Epithelial Cells,8753071,11/16/2013 0:00,11/15/2015 0:00,"Training, Individual",2015,35051, ,NCI,35051, ,35051
Novel oncogenic functions of Mdm2 and Mdmx,8753304,7/18/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2014,325775, ,NCI,207500,118275,325775
The role of IL8 in colitis-associated tumor initiation,8753514,11/1/2013 0:00,3/31/2017 0:00,Non-SBIR/STTR,2013,179032, ,NCI,125142,53890,179032
Bifunctional Antibodies for Melanoma Therapy,8755327,9/1/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,459361, ,NCI,309036,150325,459361
Molecular Virology Research Program,8755632, , ,Research Centers,2014, ,21305, ,12796,8509, 
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis,8756182,9/8/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,369215, ,NCI,250000,119215,369215
Electrocatalytic Studies of Toxic Pollutant Activation,8756198,3/1/1983 0:00,3/31/2019 0:00,Non-SBIR/STTR,2014,448694, ,NIEHS,322758,125936,448694
From Mechanism to Population: Modeling HPV-related Oropharyngeal Carcinogenesis,8756361,9/11/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,630151, ,NCI,409087,221064,630151
"Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe",8756885,8/1/2014 0:00,6/30/2019 0:00,Other Research-Related,2014,187380, ,NINDS,173500,13880,187380
The COMPASS family of H3K4 methylases in development and cancer,8759914,3/9/2010 0:00,10/31/2014 0:00,Non-SBIR/STTR,2014,261777, ,NCI,158653,103124,261777
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer,8760826,9/12/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,437769, ,NCI,249773,187996,437769
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma:  Environmental Co,8761249,7/1/2009 0:00,1/31/2015 0:00,Non-SBIR/STTR,2014,353787, ,NCI,247713,106074,353787
NYU Lung Cancer Biomarker Center,8761282,1/16/2014 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,258397, ,OD,156752,101645,258397
Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC),8761399,12/23/2013 0:00,3/31/2015 0:00,Other Research-Related,2014,155034, ,OD,143550,11484,155034
p53 and tumor cell metabolism,8761419,8/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2014,332000, ,NCI,207500,124500,332000
Mechanism and treatment of PTEN mutant prostate tumorigenesis,8762009,7/30/2014 0:00,6/30/2019 0:00,Non-SBIR/STTR,2014,392175, ,NCI,207500,184675,392175
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance,8762140,9/9/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,317164, ,NCI,186750,130414,317164
Chromosomal Proteins and Chromosomal Functions,8762980, , ,Intramural Research,2013,897886, ,NCI, , ,897886
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,8762985, , ,Intramural Research,2013,633738, ,NCI, , ,633738
Gene Regulation and Function: The B-ZIP Proteins,8762990, , ,Intramural Research,2013,934741, ,NCI, , ,934741
"Tumor Suppressor Protein, p53",8762998, , ,Intramural Research,2013,394528, ,NCI, , ,394528
Transgenic Models for Prostate and Breast Cancer,8763003, , ,Intramural Research,2013,1075118, ,NCI, , ,1075118
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",8763007, , ,Intramural Research,2013,957460, ,NCI, , ,957460
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,8763021, , ,Intramural Research,2013,1066926, ,NCI, , ,1066926
Regulation of Lymphocyte Proliferation and Replicative Capacity,8763041, , ,Intramural Research,2013,289880, ,NCI, , ,289880
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,8763044, , ,Intramural Research,2013,393001, ,NCI, , ,393001
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,8763048, , ,Intramural Research,2013,310746, ,NCI, , ,310746
DNA Repair,8763062, , ,Intramural Research,2013,1148001, ,NCI, , ,1148001
Enzymes and Substrates of the Ubiquitin Conjugating System,8763063, , ,Intramural Research,2013,605768, ,NCI, , ,605768
Role of CEBP transcription factors in regulating cell growth and tumorigenesis,8763075, , ,Intramural Research,2013,1206995, ,NCI, , ,1206995
Role of Neurotrophins in the Development of the Mammalian Nervous System,8763093, , ,Intramural Research,2013,834125, ,NCI, , ,834125
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,8763131, , ,Intramural Research,2013,716470, ,NCI, , ,716470
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,8763132, , ,Intramural Research,2013,204706, ,NCI, , ,204706
Development of Mouse Astrocytoma Model for Preclinical Testing,8763133, , ,Intramural Research,2013,102353, ,NCI, , ,102353
Zebrafish Models of Cancer,8763135, , ,Intramural Research,2013,590272, ,NCI, , ,590272
Molecular Interaction Maps and Analysis of Bioregulatory Networks,8763137, , ,Intramural Research,2013,117494, ,NCI, , ,117494
The Role of miRNA-mediated RNAI in the Biology of Cancer,8763149, , ,Intramural Research,2013,186705, ,NCI, , ,186705
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,8763156, , ,Intramural Research,2013,453967, ,NCI, , ,453967
Molecular-Targeted Radiation Therapy,8763171, , ,Intramural Research,2013,628965, ,NCI, , ,628965
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,8763186, , ,Intramural Research,2013,100298, ,NCI, , ,100298
Metabolic Mechanisms for Programmed Cell Death,8763196, , ,Intramural Research,2013,426567, ,NCI, , ,426567
"Role of inflammation, innate resistance, and immunity in carcinogenesis.",8763223, , ,Intramural Research,2013,872235, ,NCI, , ,872235
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,8763227, , ,Intramural Research,2013,636821, ,NCI, , ,636821
Structural Studies of Metabolic Enzymes and Their Regulation,8763239, , ,Intramural Research,2013,268071, ,NCI, , ,268071
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,8763255, , ,Intramural Research,2013,82071, ,NCI, , ,82071
Redox Mechanism Process of Angiogenesis and Wound Healing,8763268, , ,Intramural Research,2013,402444, ,NCI, , ,402444
Collaborative Pathways that Lead to Leukemia,8763292, , ,Intramural Research,2013,286548, ,NCI, , ,286548
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma,8763307, , ,Intramural Research,2013,519127, ,NCI, , ,519127
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,8763343, , ,Intramural Research,2013,378404, ,NCI, , ,378404
RNA interference approach to dissect roles of notochord regulators,8763359, , ,Intramural Research,2013,117995, ,NCI, , ,117995
Study the role(s) of p53 in embryonic stem cells,8763372, , ,Intramural Research,2013,524002, ,NCI, , ,524002
Genomic Classification of Human Liver Cancer,8763380, , ,Intramural Research,2013,865803, ,NCI, , ,865803
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,8763385, , ,Intramural Research,2013,522435, ,NCI, , ,522435
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,8763392, , ,Intramural Research,2013,591793, ,NCI, , ,591793
Biological Implications and Translational Applications of HDMX Inhibition,8763421, , ,Intramural Research,2013,72451, ,NCI, , ,72451
Broadening the Utility of Stapled Peptides through Chemical Optimization,8763422, , ,Intramural Research,2013,217353, ,NCI, , ,217353
Thoracic Cancer Research Laboratory,8763425, , ,Intramural Research,2013,1084453, ,NCI, , ,1084453
Mechanisms of Early Stage Mammary Tumorigenesis,8763428, , ,Intramural Research,2013,519127, ,NCI, , ,519127
CANCER AND INFLAMMATION GENETICS,8763440, , ,Intramural Research,2013,749761, ,NCI, , ,749761
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,8763462, , ,Intramural Research,2013,469570, ,NCI, , ,469570
Development and validation of preclinical mouse model for serous ovarian cancer,8763473, , ,Intramural Research,2013,848130, ,NCI, , ,848130
Structural and Biochemical Studies of p53 Family Function,8763478, , ,Intramural Research,2013,289804, ,NCI, , ,289804
Regulation of microRNA expression by Mutant p53,8763492, , ,Intramural Research,2013,234265, ,NCI, , ,234265
Function of Mutant p53-regulated microRNAs in cancer cells,8763493, , ,Intramural Research,2013,312351, ,NCI, , ,312351
Mechanisms regulating the context-dependant function of microRNAs,8763494, , ,Intramural Research,2013,117132, ,NCI, , ,117132
Integrative Molecular Epidemiology of Human Cancer,8763567, , ,Intramural Research,2013,1604436, ,NCI, , ,1604436
"p53, Aging, and Cancer",8763568, , ,Intramural Research,2013,802217, ,NCI, , ,802217
Study the roles of p53 and p53 mutants in mesenchymal stem cells,8763574, , ,Intramural Research,2013,524002, ,NCI, , ,524002
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,8763618, , ,Intramural Research,2013,615071, ,NCI, , ,615071
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,8763619, , ,Intramural Research,2013,5155247, ,NCI, , ,5155247
Epidemiology and Natural History of Cancer-Associated Viruses,8763628, , ,Intramural Research,2013,3542746, ,NCI, , ,3542746
Molecular Pathogenesis of Multiple Myeloma,8763679, , ,Intramural Research,2013,504284, ,NCI, , ,504284
Lymphoma Studies,8763684, , ,Intramural Research,2013,300893, ,NCI, , ,300893
Nitric Oxide as a Modifier of Oxidative Stress,8763688, , ,Intramural Research,2013,402444, ,NCI, , ,402444
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,8763699, , ,Intramural Research,2013,618976, ,NCI, , ,618976
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,8763707, , ,Intramural Research,2013,1047882, ,NCI, , ,1047882
CCR Confocal Microscopy Core,8763726, , ,Intramural Research,2013,702491, ,NCI, , ,702491
Cell and Cancer Biology Branch Confocal Microscopy Core,8763736, , ,Intramural Research,2013,1094766, ,NCI, , ,1094766
Immunohistochemistry Core Laboratory,8763761, , ,Intramural Research,2013,1778625, ,NCI, , ,1778625
The Effects of Grape Seed Extract Against Lung Cancer,8764633,10/1/2013 0:00,9/30/2016 0:00,Non-SBIR/STTR,2015, , , , , , 
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells,8764674,4/1/2011 0:00,9/30/2015 0:00,Non-SBIR/STTR,2015, , , , , , 
Plk1-Numb Cooperation in Melanomagenesis,8764681,10/1/2012 0:00,9/30/2016 0:00,Non-SBIR/STTR,2015, , , , , , 
RNA Splicing Modulators for MDS/AML,8764899, , ,Research Centers,2014, ,333788, ,301808,92580, 
Developing CRM1 inhibitors in AML,8765075,7/16/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2014,319550, ,NCI,207500,112050,319550
Molecular Tumorigenesis of Bladder Cancer,8765239, , ,Non-SBIR/STTR,2014, ,312140, ,184153,127987, 
DNA Repair and Tobacco Smoke in Bladder Carcinogenesis,8765240, , ,Non-SBIR/STTR,2014, ,212858, ,125580,87278, 
Novel Role of XIAP in Bladder Cancer Invasion,8765241, , ,Non-SBIR/STTR,2014, ,340821, ,201074,139747, 
SBIR PHASE II: SITE-SPECIFIC ANTIBODIES FOR GLCNACYLATED PROTEINS IN CANCER,8765280,9/13/2013 0:00,9/12/2015 0:00,R and D Contracts,2013,989975, ,NCI, , ,989975
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer,8768360,7/20/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2014,521237, ,NIDCR,357860,163377,521237
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis,8769278,1/1/2009 0:00,11/30/2014 0:00,Non-SBIR/STTR,2013,246129, ,NCI,154798,91331,246129
Regulation of melanogenesis via FBXO11-mediated tyrosinase degradation,8770718,7/1/2014 0:00,6/30/2017 0:00,Non-SBIR/STTR,2014,84750, ,NIAMS,50000,34750,84750
Targeting Neural Mitochondria to Treat Chemotherapy-Induced Peripheral Neuropathy,8771592,9/1/2014 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,208800, ,NCI,130500,78300,208800
Novel therapeutic targets for Diamond Blackfan anemia and other ribosomopathies,8772306,4/9/2012 0:00,2/28/2017 0:00,Other Research-Related,2013,90081, ,NIDDK,83408,6673,90081
Preclinical evaluation of a targeted Bmi1 inhibitor in pancreatic cancer,8772609,7/1/2014 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,206431, ,NCI,130500,75931,206431
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention,8773578,6/1/2005 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,285581, ,NCI,187266,98315,285581
ATM FUNCTION DURING V(D)J RECOMBINATION,8774161,12/2/2008 0:00,11/30/2018 0:00,Non-SBIR/STTR,2015,380000, ,NIAID,250000,130000,380000
Role of heat shock factors (Hsfs) in tumorigenesis,8774204,3/1/2000 0:00,11/30/2018 0:00,Non-SBIR/STTR,2015,270000, ,NCI,180000,90000,270000
D-peptide activators of p53 as anticancer therapeutics,8774207,12/1/2013 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,166931, ,NCI,108750,58181,166931
CARP-1: A Potential Therapeutic Agent for Breast Cancer,8774532,1/1/2012 0:00,12/31/2015 0:00,Non-SBIR/STTR,2015, , , , , , 
Regultion of p53 Deubiquitination,8775203,1/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,327228, ,NCI,207500,119728,327228
Ecd as a regulator of cell cycle and breast oncogenesis,8775947,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2014,49363, ,NCI,35138,14225,49363
p63 and p73 Signaling in Cell Growth and Cancer,8776003,3/1/2004 0:00,11/30/2015 0:00,Non-SBIR/STTR,2014,64872, ,NCI,45326,19546,64872
Self-renewal of Normal and Leukemic Stem Cells,8776273,9/20/2004 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,292109, ,NCI,174939,117170,292109
Oncogene c-Myc-dependent pathways in cutaneous melanoma03,8776274,12/11/2006 0:00,11/30/2015 0:00,Non-SBIR/STTR,2015,316518, ,NCI,191396,125122,316518
Role of p53 polymorphisms in disparities in breast carcinogenesis and outcome .,8777010,3/13/2011 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,365000, ,NIMHD,250000,115000,365000
Progression and regression of mammary preneoplasia,8777086,12/23/2004 0:00,11/30/2018 0:00,Non-SBIR/STTR,2015,311000, ,NCI,200000,111000,311000
Identification and Therapeutic Application of miRNA-Drivers in Lung Cancer,8777609,8/13/2013 0:00,11/30/2016 0:00,Non-SBIR/STTR,2014,241529, ,NCI,200042,41487,241529
Ubiquitin based therapy of aggressive cancer cell populations,8777725,7/7/2014 0:00,7/6/2016 0:00,SBIR/STTR,2014,224768, ,NCI, , ,224768
The Role of ATF3 in the DNA Damage Response,8780210,9/1/2010 0:00,6/30/2016 0:00,Non-SBIR/STTR,2013,227039, ,NCI,151359,75680,227039
Functional Determinants of Metastatic Dormancy,8780599,4/1/2005 0:00,12/31/2015 0:00,Non-SBIR/STTR,2015,143777, ,NCI,86191,57586,143777
Functional landscape of Eph receptor mutations in melanoma,8782473,1/1/2014 0:00,12/31/2016 0:00,Non-SBIR/STTR,2015,212063, ,NCI,108750,103313,212063
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis,8782485,1/16/2012 0:00,10/31/2015 0:00,Non-SBIR/STTR,2015,400910, ,NIEHS,250569,150341,400910
Sperm Prions: A Mechanism of Epigenetic Inheritance,8782628,12/15/2013 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,182384, ,NICHD,121875,60509,182384
Mechanisms governing tumor differentiation and metastasis,8783328,7/7/2014 0:00,7/6/2017 0:00,"Training, Individual",2014,51530, ,NCI,51530, ,51530
Non-catalytic functions of DNA-PK in DNA repair and tumorigenesis,8783374,9/1/2014 0:00,8/31/2017 0:00,"Training, Individual",2014,42676, ,NCI,42676, ,42676
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions,8783378,9/12/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,460311, ,NCI,377403,82908,460311
Regulation of Myc-Mediated Tumorigenesis,8784194,1/1/2011 0:00,1/31/2016 0:00,Non-SBIR/STTR,2015,183987, ,NCI,118119,65868,183987
The role of ATRX and H3.3 mutations in pediatric glioblastoma,8784425,9/15/2014 0:00,9/14/2017 0:00,"Training, Individual",2014,33330, ,NCI,33330, ,33330
Characterization of Calmodulin and CHK2 inhibitors for the treatment of Diamond B,8784554,12/1/2014 0:00,11/30/2016 0:00,"Training, Individual",2014,53282, ,NHLBI,53282, ,53282
Identifying the Second Hit in MYC-driven Medulloblastoma; a Role for Gfi Proteins,8785078,7/1/2014 0:00,8/31/2016 0:00,"Training, Individual",2014,31902, ,NINDS,31902, ,31902
Role of SAG/RBX2 E3 Ubiquitin Ligase in Skin Carcinogenesis,8785658,1/3/2013 0:00,12/31/2015 0:00,Non-SBIR/STTR,2015,322663, ,NCI,207500,115163,322663
AMPK and AMPK-related kinases in lung cancer development and treatment,8785659,1/16/2013 0:00,12/31/2015 0:00,Non-SBIR/STTR,2015,402550, ,NCI,207500,195050,402550
"Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.",8785755,8/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2014,580448, ,NCI,378248,202200,580448
"Fortilin, p53, and atherosclerosis",8786452,1/15/2013 0:00,12/31/2015 0:00,Non-SBIR/STTR,2015,376762, ,NHLBI,246250,130512,376762
Mouse Models to Dissect p53 Tumor Suppressor Function,8786503,1/1/2011 0:00,12/31/2015 0:00,Non-SBIR/STTR,2015,344875, ,NCI,207500,137375,344875
Defining the temporal sequence of PI3K pathway mutations in bladder cancer,8787457,1/1/2014 0:00,12/31/2018 0:00,Non-SBIR/STTR,2015,368728, ,NCI,207500,161228,368728
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression,8787676,9/19/2011 0:00,1/31/2016 0:00,Non-SBIR/STTR,2015,236784, ,NCI,147990,88794,236784
Prognostic potential of low-level mutations in meylodysplastic syndrome,8787719,1/1/2014 0:00,12/31/2016 0:00,Non-SBIR/STTR,2015,228375, ,NCI,130500,97875,228375
Mitigation of asbestos induced alveolar epithelial cell injury,8787738,3/1/2012 0:00,12/31/2015 0:00,Non-SBIR/STTR,2015,328441, ,NIEHS,212583,115858,328441
Quinone Oxidoreductases and Mammary Toxicity/Carcinogenenicity,8788022,5/15/2013 0:00,12/31/2015 0:00,Non-SBIR/STTR,2015,345375, ,NIEHS,225000,120375,345375
GSK3 inhibition as an adjuvant therapy for Burkitt's lymphoma,8788701,1/1/2014 0:00,12/31/2016 0:00,Non-SBIR/STTR,2015,255780, ,NCI,152250,103530,255780
Identification and targeting of the signaling pathways underlying lung cancer.,8788806,3/1/2009 0:00,12/31/2018 0:00,Non-SBIR/STTR,2015,432000, ,NCI,225000,207000,432000
Project 5,8788916, ,12/31/2015 0:00,Non-SBIR/STTR,2015, ,643512, ,333889,309623, 
The Combinatorial Effect of p53 Dynamics and Modifications on Cell Fate Decisions,8788937,2/1/2013 0:00,1/31/2016 0:00,"Training, Individual",2015,62066, ,NIGMS,62066, ,62066
The Role of p53-inducible Sesn1 and Sesn2 genes in lung carcinogenesis,8789160,2/1/2013 0:00,1/31/2016 0:00,Non-SBIR/STTR,2015,316438, ,NCI,207500,108938,316438
Characterization of Oncogenic Transcription Factor-Associated Proteins in SCC,8789419,8/2/2012 0:00,8/31/2014 0:00,Other Research-Related,2013,122354, ,NCI,113291,9063,122354
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,8790578,6/10/2009 0:00,4/30/2014 0:00,Non-SBIR/STTR,2012,30657, ,NCI,20037,10620,30657
The PDGF alpha neural progenitor cells of the subventricular zone contributes to,8791269,2/13/2012 0:00,8/12/2014 0:00,"Training, Individual",2013,48448, ,NINDS,48448, ,48448
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8791454,3/14/2011 0:00,2/28/2016 0:00,Non-SBIR/STTR,2014,61951, ,NCI,41547,20404,61951
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy,8791785,3/1/2010 0:00,1/31/2017 0:00,Non-SBIR/STTR,2014,49532, ,NCI,33733,15799,49532
Hdac3 as a therapeutic target in BCL6-dependent lymphoma,8791883,2/20/2012 0:00,1/31/2016 0:00,Non-SBIR/STTR,2015,403135, ,NCI,258420,144715,403135
Identification and Therapeutic Application of miRNA-Drivers in Lung Cancer,8791885,8/13/2013 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,247745, ,NCI,195938,51807,247745
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,8792347,2/7/2013 0:00,1/31/2016 0:00,Non-SBIR/STTR,2015,381420, ,NCI,285914,95506,381420
Mutant p53 has gain-of-function mechanisms to mediate tumor invasion,8792493,12/1/2013 0:00,11/30/2015 0:00,"Training, Individual",2015,29766, ,NCI,29766, ,29766
Functional analysis of beta-TRCP in cell cycle control and DNA damage response,8792536,5/1/2012 0:00,1/31/2017 0:00,Non-SBIR/STTR,2015,328425, ,NIGMS,188750,139675,328425
The role of Src kinase in estrogen receptor-positive breast cancer proliferation,8792816,1/1/2014 0:00,7/31/2018 0:00,"Training, Individual",2015,31866, ,NCI,31866, ,31866
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma,8795286,3/18/2013 0:00,2/28/2017 0:00,Non-SBIR/STTR,2014,29610, ,NCI,17438,12172,29610
Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer,8795307,5/1/2012 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,65898, ,NCI,41966,23932,65898
Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 ,8795640, , ,Research Centers,2015, ,198195, ,120630,83021, 
Molecular mechanisms of GBM radioresistance and strategies for radiosensitization,8795699,1/1/2011 0:00,9/30/2017 0:00,Non-SBIR/STTR,2015,329925, ,NCI,207500,122425,329925
Molecular mechanisms of myeloid suppressor genes on chromosome 5,8797860,2/1/2015 0:00,1/31/2020 0:00,Non-SBIR/STTR,2015,361425, ,NCI,228750,132675,361425
MOLECULAR & STRUCTURAL BIOLOGY,8798583, ,1/31/2016 0:00,Research Centers,2015, ,75206, ,49399,25807, 
CANCER CELL BIOLOGY,8798590, ,1/31/2016 0:00,Research Centers,2015, ,33961, ,22058,11903, 
Targeting the cytokine circuitry of KRAS-driven lung cancer,8798907,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2015,394578, ,NCI,228750,165828,394578
Mechanisms of obesity-induced hepatocarcinogenesis,8800619,5/8/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2015,381691, ,NCI,305005,76686,381691
Project 1: Small Molecule Enhancers of Photodynamic Therapy for Skin Cancer,8803910,8/9/2001 0:00,12/31/2019 0:00,Non-SBIR/STTR,2015, ,186781, ,140319,46462, 
Functionalizing recurrent FAT1 mutations and deletions in oral cancer,8804989,9/1/2014 0:00,8/31/2019 0:00,Other Research-Related,2014,136350, ,NIDCR,126250,10100,136350
Tumor Suppressor Qualities and Mechanisms of LZAP Activity,8805840,4/1/2000 0:00,11/30/2015 0:00,Non-SBIR/STTR,2015,416250, ,NIDCR,250000,166250,416250
Targeting GRP78 for p53 activation as anti-cancer therapy,8806081,3/1/2015 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,196403, ,NCI,130500,65903,196403
MODELS FOR GENETIC ASSESSMENT OF TUMOR MAINTENANCE GENES IN PDAC,8806422, ,8/15/2016 0:00,Non-SBIR/STTR,2015, ,366124, ,334533,31591, 
SIM2s Regulation of Senescence,8806895,12/3/2014 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,187419, ,NCI,130500,56919,187419
Mechanisms of cell competition that regulate growth during development,8807122,8/1/2006 0:00,3/31/2015 0:00,Non-SBIR/STTR,2014,17336, ,NIGMS,17336, ,17336
"Randomized, controlled pilot study of nicotinamide in polycystic kidney disease",8807460,9/10/2015 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,188750, ,NIDDK,125000,63750,188750
New transgenic animal model to study pancreatic cancer,8808340,1/1/2015 0:00,12/31/2016 0:00,Non-SBIR/STTR,2015,213881, ,NCI,140250,73631,213881
Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport,8810225,2/5/2013 0:00,1/31/2017 0:00,Non-SBIR/STTR,2015,558208, ,NCI,501721,56487,558208
Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling,8810480,2/1/2015 0:00,1/31/2018 0:00,Non-SBIR/STTR,2015,231546, ,NCI,182600,48946,231546
Targeting MDM2 with Intracellular Antibodies,8811324,10/1/2013 0:00,9/30/2017 0:00,Non-SBIR/STTR,2015, , , , , , 
Targeted Therapy for EGFR Pathway in HPV+ HNSCCs,8811417,3/1/2014 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,226500, ,NIDCR,150000,76500,226500
Defining the Role for A Lipid Kinase in the Progression of Pancreatic Cancer,8811520,3/1/2015 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,207495, ,NCI,130500,76995,207495
Cancer cell adaptation to glutamine deprivation,8811793,9/1/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,352405, ,NCI,207500,144905,352405
Cooperation of Mutant TP53 and PIK3CA in Breast Carcinogensis,8811922,3/8/2013 0:00,3/27/2015 0:00,"Training, Individual",2015,3326, ,NCI,3326, ,3326
Prevention of quinone toxicity and mutagenicity,8811950,8/1/1996 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,337500, ,NIEHS,225000,112500,337500
Novel therapeutic targets for Diamond Blackfan anemia and other ribosomopathies,8812800,4/9/2012 0:00,2/28/2017 0:00,Other Research-Related,2015,152874, ,NIDDK,141550,11324,152874
Developing cancer therapies through targeting the Six1/Eya transcriptional complex,8813757,12/18/2014 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,168789, ,NCI,108750,60039,168789
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck Cancer,8813980,3/2/2009 0:00,5/31/2015 0:00,Non-SBIR/STTR,2013,509624, ,NCI,331097,178527,509624
Information Processing by Post-translational Modification,8814029,12/15/2014 0:00,11/30/2018 0:00,Non-SBIR/STTR,2015,380042, ,NIGMS,236103,143939,380042
Identification and Targeting Therapy Resistant Osteosarcoma,8814732,1/1/2015 0:00,12/31/2016 0:00,Non-SBIR/STTR,2015,215244, ,NCI,147819,67425,215244
Novel therapeutic strategies targeting conformational plasticity of type I MAGE,8814849,12/19/2014 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,223096, ,NCI,131620,91476,223096
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy,8815096,3/1/2012 0:00,2/29/2016 0:00,Non-SBIR/STTR,2015,393213, ,NCI,207500,185713,393213
Discovery of New Genes for Inherited Predisposition to Breast Cancer by Exome Seq,8815171,3/1/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2015,523138, ,NCI,335345,187793,523138
Modeling p53 Mutant-Associated Cancer With LFS Patient-Derived iPSCs,8815283,3/3/2014 0:00,2/29/2016 0:00,Other Research-Related,2015,101520, ,NCI,94000,7520,101520
Role of ribosome impairments in X-linked Dyskeratosis Congenita pathogenesis,8815658,8/1/2006 0:00,6/30/2016 0:00,Non-SBIR/STTR,2014,16533, ,NIDDK,11501,5032,16533
Nanotheranostics for Early Colorectal Cancer Detection and Treatment,8815950,3/6/2013 0:00,2/29/2016 0:00,Non-SBIR/STTR,2015,327850, ,NCI,207500,120350,327850
Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer,8816037,3/4/2011 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,303988, ,NCI,207500,96488,303988
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway,8816646,8/19/2005 0:00,11/30/2019 0:00,Non-SBIR/STTR,2015,372875, ,NCI,237500,135375,372875
FoxM1 in tumor cell,8816823,6/1/2009 0:00,3/31/2019 0:00,Non-SBIR/STTR,2015, , , , , , 
Epigenetic regulation by tumor suppressor p53,8816892,4/1/1999 0:00,2/29/2020 0:00,Non-SBIR/STTR,2015,352848, ,NCI,223022,129826,352848
Modeling New Therapeutic Approaches for Malignant Melanoma,8817140,10/1/2013 0:00,9/30/2017 0:00,Non-SBIR/STTR,2015, , , , , , 
Targeting Gain-of-Function p53 Missense Mutants,8817144,7/1/2014 0:00,6/30/2017 0:00,"Training, Individual",2015,27772, ,NCI,27772, ,27772
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8817251,3/14/2011 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,329925, ,NCI,207500,122425,329925
Mechanisms of Metabolic Gene Mutations in Cancer,8817257,3/1/2012 0:00,2/29/2016 0:00,Non-SBIR/STTR,2015,307100, ,NCI,207500,99600,307100
Progression and Metastasis of Oral Tongue Cancer,8817640,5/10/2003 0:00,12/31/2018 0:00,Non-SBIR/STTR,2015,497857, ,NIDCR,314463,183394,497857
Role of p53 Missense Mutations on Tumorigenesis in Vivo,8817738,9/1/1999 0:00,12/31/2019 0:00,Non-SBIR/STTR,2015,342000, ,NCI,213750,128250,342000
Role of p300 in HPV-positive Head and Neck Cancer,8818485,5/6/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2015,499289, ,NIDCR,379916,119373,499289
DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations,8818545,12/1/2014 0:00,11/30/2019 0:00,Non-SBIR/STTR,2015,366000, ,NCI,228750,137250,366000
Aurora-A is a novel therapeutic target in glioblastoma,8818801,9/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2014,365877, ,NINDS,239868,126009,365877
Defining Critical p53 Therapeutic Targets and Mechanisms,8818821,3/1/2009 0:00,11/30/2019 0:00,Non-SBIR/STTR,2015,436500, ,NCI,225000,211500,436500
"Telomerase in Development, Senescence and Neoplasia",8818927,1/1/2000 0:00,12/31/2019 0:00,Non-SBIR/STTR,2015,616000, ,NCI,385000,231000,616000
Role of nutrient sensor O-GlcNAc transferase in regulating cancer,8819031,3/4/2011 0:00,2/29/2016 0:00,Non-SBIR/STTR,2015,318147, ,NCI,214821,103326,318147
The Function of rpL5 and rpL11 in induction of p53,8819106,3/1/2012 0:00,6/30/2015 0:00,Non-SBIR/STTR,2015,160535, ,NCI,54500,106035,160535
Cancer biology in the zebrafish,8819516,7/3/2003 0:00,2/29/2016 0:00,Non-SBIR/STTR,2015,371851, ,NCI,210780,161071,371851
Altered Proteoglycan Gene Expression and Cancer,8819590,9/1/1988 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,9886, ,NCI,6378,3508,9886
Regulation of Lung Cancer Metastasis by miR-200,8821586,3/14/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,329792, ,NCI,208729,121063,329792
Mechanisms of preferential targeting of colon cancer by a plant-derived alkaloid,8822834,4/1/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,380725, ,NCCIH,242500,138225,380725
Examining melanoma cell subpopulations in tumor maintenance and drug resistance,8823472,3/15/2014 0:00,3/14/2016 0:00,"Training, Individual",2015,54194, ,NCI,54194, ,54194
Regulation of differentiation in esophageal epithelia,8823607,5/1/2006 0:00,2/29/2016 0:00,Non-SBIR/STTR,2015,348000, ,NIDDK,217500,130500,348000
Berberine downregulates MDM2 by interaction with DAXX in cancer cells,8823737,1/1/2010 0:00,12/31/2016 0:00,Non-SBIR/STTR,2015,237269, ,NCI,153077,84192,237269
Whole exome sequencing of oropharyngeal carcinoma (OPX-WES),8824704,4/1/2015 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,56500, ,NCI,50000,6500,56500
Resistance of CML Stem Cells to Imatinib (Gleevec),8824879,7/1/2003 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,275378, ,NCI,187332,88046,275378
Ecd as a regulator of cell cycle and breast oncogenesis,8825337,3/1/2011 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,308138, ,NCI,207500,100638,308138
Structural basis for CBP/p300 transcriptional regulation,8825432,6/10/2002 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,407364, ,NCI,214968,192396,407364
Mechanisms of Gene-Specific Transcriptional Regulation Within the p53 Network,8825435,5/26/2006 0:00,8/31/2015 0:00,Non-SBIR/STTR,2015,160987, ,NCI,105565,55422,160987
Regulation of MDM2 auto-ubiquitination and molecular targeting,8825436,12/15/2007 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,251191, ,NCI,161020,90171,251191
Basal cell carcinomas: p53-dependent mechanisms of resistance,8825460,4/1/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,336150, ,NCI,207500,128650,336150
Mechanisms for Selective Transcription of p53 Targets by the AcK120 Isoform,8825465,3/9/2013 0:00,3/8/2016 0:00,"Training, Individual",2015,43120, ,NCI,43120, ,43120
New Models and Treatments for AIDS-related Lymphoma,8825908,4/1/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,416873, ,NCI,280334,136539,416873
Role of beta-endorphin in cancer therapy induced fatigue,8826045,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,352310, ,NCI,207500,144810,352310
Mechanism of chemoresistance mediated by TGF-beta,8826058,5/1/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,348600, ,NCI,207500,141100,348600
Murine Model of HCV-Associated Human Liver Cancer,8826063,5/1/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,470695, ,NCI,318037,152658,470695
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis,8826065,4/1/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,332000, ,NCI,207500,124500,332000
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",8826305,7/1/2010 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,57237, ,NCI,37980,19257,57237
Therapeutic strategies for specific subsets of KRAS mutant lung cancers,8826568,8/3/2009 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,512243, ,NCI,423910,88333,512243
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor,8826575,4/10/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,298980, ,NCI,198000,100980,298980
Role of Otubain 1 in the p53 Pathway,8826696,5/1/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,318205, ,NCI,207500,110705,318205
Defining mechanisms of extracellular communication for cancer therapy,8826699,4/1/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,323700, ,NCI,207500,116200,323700
"NUCKS, a novel double-strand break repair gene, implicated in cancer biology",8826743,6/28/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,345383, ,NIEHS,249732,95651,345383
Genetic and molecular epidemiology of adult glioma,8827251,5/15/1991 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,1296898, ,NCI,858494,438404,1296898
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis,8827300,5/14/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,328265, ,NCI,219016,109249,328265
Risk and penetrance of mutations from breast cancer testing panels.,8827527,9/25/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2014,1408225, ,NCI,1096736,311489,1408225
In vivo murine models of metastasis for therapeutic testing,8827705,4/16/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,400209, ,NCI,343389,56820,400209
Toll-like Receptor Regulation of Pancreatic Tumorigenesis,8827710,4/1/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,351713, ,NCI,207500,144213,351713
Targeting stabilized mutant p53 protein,8827721,4/1/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,356514, ,NCI,225642,130872,356514
New Aminothiol Prevention of X-Ray-Induced Mouse Mutagenesis and Tumorigenesis,8827722,4/1/2014 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,75250, ,NCI,50000,25250,75250
Prevention of UV-induced carcinogenesis by cyanidin-3-glucoside,8827769,8/1/2011 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,334125, ,NIEHS,225000,109125,334125
The role of IL8 in colitis-associated tumor initiation,8828111,11/1/2013 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,328888, ,NCI,207500,121388,328888
Mechanism of P73-Dependent Tumor Suppression,8828575,5/1/1999 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,304560, ,NCI,197766,106794,304560
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis,8828582,9/24/2007 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,320682, ,NCI,184300,136382,320682
Impact of molecular phenotype on glioma metabolism and growth,8828593,4/1/2011 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,298868, ,NCI,245711,53157,298868
Regulation of Par-4 Secretion in Normal Cells for Paracrine Action in Tumor Cells,8828616,4/1/2014 0:00,3/31/2018 0:00,Non-SBIR/STTR,2015,163669, ,NCI,108750,54919,163669
Inhibiting the heat shock factor 1-regulated transcriptional program in cancer,8829197,4/16/2013 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,532032, ,NCI,392256,139776,532032
A p53/NFkB-mediated metabolic mechanism for chemotherapy protection,8829205,4/1/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2015,335113, ,NCI,207500,127613,335113
Inhibition of Oncogenic MdmX by Targeting its Motion,8829451,1/12/2015 0:00,11/30/2015 0:00,"Training, Individual",2015,47256, ,NIGMS,47256, ,47256
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer,8829689, ,3/31/2016 0:00,Research Centers,2015, ,330285, ,213777,116508, 
Modulation of skin cancer by PPARb/d,8829774,3/1/2007 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,247146, ,NCI,165870,81276,247146
Roles of MiR-17-92 Cluster MicroRNAs in K-Ras-Induced Pancreatic Tumorigenesis,8829783,4/1/2012 0:00,3/31/2016 0:00,"Training, Individual",2015,29634, ,NCI,29634, ,29634
PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM,8829786,4/1/2013 0:00,10/31/2015 0:00,Non-SBIR/STTR,2015,319073, ,NCI,266297,52776,319073
"Chemoprevention by black raspberry in oral cancer induced by DB[a,l]P in mice",8829788,4/1/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,323347, ,NCI,234891,88456,323347
Validating the protein binding domain of replication protein A as a cancer target,8829791,4/1/2014 0:00,3/31/2018 0:00,Non-SBIR/STTR,2015,325775, ,NCI,207500,118275,325775
Roles of EAF2 in androgen action in the prostate,8829806,12/18/1996 0:00,2/28/2019 0:00,Non-SBIR/STTR,2015,371525, ,NCI,241250,130275,371525
Nuclear Function of Abl in DNA Damage Response,8830433,8/1/1986 0:00,11/30/2018 0:00,Non-SBIR/STTR,2015,387500, ,NCI,250000,137500,387500
Targeted Development of Platinum Drugs,8830932,7/1/2011 0:00,7/31/2017 0:00,Non-SBIR/STTR,2015,327850, ,NCI,207500,120350,327850
Cyclin D3 and DNA double strand breaks: genome stability and lymphomagenesis,8830943,5/1/2013 0:00,8/7/2015 0:00,"Training, Individual",2015,10495, ,NCI,10495, ,10495
Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer,8831609,5/1/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,476186, ,NCI,355983,120203,476186
Gammaherpesvirus interactions with host tumor suppressor p53,8831615,4/4/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2015,390916, ,NCI,266181,124735,390916
Investigating the role of Retrotransposon muERV-L reactivation in Tumorigenesis,8832362,5/1/2015 0:00,4/30/2018 0:00,"Training, Individual",2015,52406, ,NCI,52406, ,52406
Apoptosis Regulation by Adenovirus and Cellular Genes,8832573,8/1/1999 0:00,4/30/2017 0:00,Non-SBIR/STTR,2015,288011, ,NCI,192007,96004,288011
Role of SIRT1 in melanocyte biology and melanocyte transformation,8834830,7/1/2013 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,314176, ,NCI,236633,77543,314176
Original Phase 1 Title: Identifying Small Molecule Inhibitors of HdmX using Cell-based Screening Revised Title: Development of a Novel HdmX Inhibitor for Leukemia,8834956,4/1/2009 0:00,3/31/2016 0:00,SBIR/STTR,2015,775796, ,NCI, , ,775796
"DNA double-strand break repair, chromosomes translocations and cancer",8835071,4/8/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2015,1778566, ,NCI,1111604,666962,1778566
The Role of CTIP in Breast Carcinogenesis,8835076, , ,Non-SBIR/STTR,2015, ,393141, ,245713,147428, 
Localizing Immunotherapy to Improve Therapeutic Index,8835080,6/4/2013 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,395388, ,NCI,255380,140008,395388
Understanding the role of Polycomb Repressive Complex 2 in melanoma,8835287,2/15/2015 0:00,2/14/2018 0:00,"Training, Individual",2015,43120, ,NCI,43120, ,43120
Intratumoral Heterogeneity and Tumor Evolution in Lymphoma,8835412,2/10/2015 0:00,6/9/2018 0:00,"Training, Individual",2015,43120, ,NCI,43120, ,43120
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer,8835986,3/1/2015 0:00,2/28/2018 0:00,"Training, Individual",2015,56042, ,NCI,56042, ,56042
Mitochondrial p32 regulation of the Mdm2-p53 tumor suppression signaling and apop,8836493,7/1/2012 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,307100, ,NCI,207500,99600,307100
The Role of PI3K in Growth Regulation,8836861,4/1/1990 0:00,5/31/2017 0:00,Non-SBIR/STTR,2013,367815, ,NIGMS,217000,150815,367815
Dissecting the roles of HIF-1a and HIF-2a in tumor response to radiation therapy,8836901,7/1/2013 0:00,4/30/2015 0:00,"Training, Individual",2014,40582, ,NCI,40582, ,40582
"ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY",8836981,5/1/2013 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,315400, ,NCI,207500,107900,315400
Oncogenic Function of ATDC in Bladder Cancer,8836982,4/10/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2015,444631, ,NCI,286627,158004,444631
Replicative Senescence as a Tumor Suppressive Mechanism,8837573,8/8/2007 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,306860, ,NCI,184300,122560,306860
Druggable p53 misfolding in cancer: A novel in vivo molecular imaging biosensor,8837589,4/11/2014 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,209554, ,NCI,130500,79054,209554
Quercetin as an enhancer of the efficacy of 5-FU in mouse models of colon cancer,8837652,5/1/2014 0:00,1/31/2017 0:00,Other Research-Related,2015,110250, ,NIGMS,75000,35250,110250
Cellular Response to Short Telomeres in B-Cell Lymphoma,8838056,7/5/2011 0:00,4/30/2017 0:00,Non-SBIR/STTR,2015,519945, ,NCI,317040,202905,519945
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance,8838669,7/1/2011 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,244093, ,NCI,154650,89443,244093
DACH1/Eya Cell fate determination factor and mammary tumorigenesis,8838724,7/20/2009 0:00,2/28/2019 0:00,Non-SBIR/STTR,2015,348750, ,NCI,225000,123750,348750
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer,8839095,5/1/2015 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,362685, ,NCI,250977,111708,362685
Genetic Mouse Models of Glioma,8839207,3/1/2009 0:00,6/30/2015 0:00,Non-SBIR/STTR,2015,179173, ,NCI,112688,66485,179173
Fully Synthetic Prodiginines as Probes of Protein-Protein Interactions Regulating,8839222,4/16/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2015,362763, ,NCI,243429,119334,362763
Genetic Alterations that Initiate Follicular Thyroid Carcinogenesis,8839721,3/1/2008 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015, ,422953, ,310022,112931, 
Staff Investigator,8840162, ,4/30/2016 0:00,Research Centers,2015, ,34105, ,22364,11741, 
Targeting the oncogenic mutant p53 signaling in colorectal cancer therapy,8840192,4/18/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2015,357174, ,NCI,207500,149674,357174
Dynamics of Signaling Pathways: Mechanism and Function,8840265,3/1/2008 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,395538, ,NIGMS,244980,150558,395538
Targeted Therapy for Endometrial Cancer,8840817,7/17/2002 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,252448, ,NCI,167184,85264,252448
A PTEN-dependent cell size checkpoint in human cells,8840893,5/11/2006 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,241207, ,NCI,155117,86090,241207
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH,8840908,7/1/2013 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,320338, ,NCI,220865,99473,320338
GENETICS OF MYELODYSPLASTIC SYNDROMES,8841404,8/1/2011 0:00,4/30/2017 0:00,Non-SBIR/STTR,2015,374300, ,NHLBI,246250,128050,374300
Targeting the Chk1-Suppressed Apoptotic Pathway in HNSCC,8841596,7/5/2013 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,356930, ,NCI,210703,146227,356930
Dynamics of cellular senescence in single human cells Admin Supplement,8841972,9/1/2012 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,15522, ,NIGMS,10212,5310,15522
The role of MDM2-MTBP axis in cancer metastasis,8842602,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2015,313325, ,NCI,207500,105825,313325
Bcl-2 as a Biomarker for Prognosis and Therapy of Head and Neck Cancer,8842613,7/1/2011 0:00,4/30/2018 0:00,Non-SBIR/STTR,2015,662650, ,NIDCR,513279,149371,662650
Restoration of Tumor Suppression Activity in Malignant Melanoma,8842854,7/1/2006 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,96654, ,NCI,62967,33687,96654
Restoration of Tumor Suppression Activity in Malignant Melanoma,8842934,7/1/2006 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,458541, ,NCI,328707,129834,458541
Effect of Omega-3 Fatty Acids on Cancer Stem Cells,8843394,7/16/2012 0:00,4/30/2017 0:00,Non-SBIR/STTR,2015,303047, ,NCI,207500,95547,303047
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES,8843401,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2015,364993, ,NCI,207500,157493,364993
Dynamics of Signaling Pathways: Mechanism and Function,8843578,3/1/2008 0:00,4/30/2017 0:00,Non-SBIR/STTR,2014,171275, ,NIGMS,112200,59075,171275
Novel Antitumor Agents,8843732,7/1/2013 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,376379, ,NCI,248730,127649,376379
Transcriptional regulation of oncogenic properties of mutant p53,8843805,5/1/2013 0:00,9/4/2015 0:00,Non-SBIR/STTR,2015,108455, ,NCI,75200,33255,108455
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer,8843814,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2015,333127, ,NCI,207500,125627,333127
Regulation of ETS2 by mutant p53,8844134,7/1/2014 0:00,4/30/2017 0:00,Non-SBIR/STTR,2014,39766, ,NCI,26076,13690,39766
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO),8844225,7/1/2013 0:00,4/30/2019 0:00,Non-SBIR/STTR,2016,351713, ,NCI,207500,144213,351713
Regulation of Mutant P53 Expression and Oncogenic Activity,8845172,2/1/2007 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,282901, ,NCI,184300,98601,282901
Role of p53 family proteins in glucose metabolism,8846081,5/6/2014 0:00,4/30/2018 0:00,Non-SBIR/STTR,2015,332000, ,NCI,207500,124500,332000
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes,8846114,5/6/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2015,335250, ,NIEHS,225000,110250,335250
Genome wide analysis of p53 inhibition by high glucose,8846482,5/1/2013 0:00,4/30/2016 0:00,"Training, Individual",2015,37345, ,NCI,37345, ,37345
"Spindle Assembly Checkpoint, Chromosome Stability, and Cancer",8847289,9/1/2008 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,314977, ,NCI,201263,113714,314977
Targeting the ATR pathway in p53-deficient cancers,8848787,7/13/2011 0:00,5/31/2017 0:00,Non-SBIR/STTR,2015,340300, ,NCI,207500,132800,340300
The role of Fyn and Srcasm in UVB-induced cutaneous neoplasia,8848791,8/1/2012 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,332000, ,NCI,207500,124500,332000
Study of Novel HHV8/KSHV Encoded Genes,8849359, ,5/31/2016 0:00,Non-SBIR/STTR,2015, ,421563, ,304995,116568, 
Genetic Analysis of the Breast Tumor Microenvironment,8849749,9/15/2004 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,1561040, ,NCI,1103621,457419,1561040
Suppression of Mammary Tumorigenesis by Stromal p53,8849752,9/15/2004 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015, ,299187, ,233841,65346, 
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors,8849868,6/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2015,402550, ,NCI,207500,195050,402550
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals,8849870,5/16/2014 0:00,4/30/2018 0:00,Non-SBIR/STTR,2015,325181, ,NCI,213321,111860,325181
Ras Induced Senescence and Tumor Suppression,8850021,7/1/1999 0:00,5/31/2015 0:00,Non-SBIR/STTR,2014,174000, ,NIA,100000,74000,174000
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer,8850828,9/11/2012 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,365216, ,NCI,219349,145867,365216
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease,8850861,9/1/2012 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,335842, ,NIEHS,225000,110842,335842
Cell-cycle regulatory kinases as targets for male contraceptive drug development,8850887,5/20/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2015,306618, ,NICHD,293005,58044,306618
c-Myc-regulated microRNAs in normal and pathologic cellular physiology,8851527,4/1/2007 0:00,5/31/2017 0:00,Non-SBIR/STTR,2015,293037, ,NCI,184300,108737,293037
Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy,8852518,4/1/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2015,499495, ,NCI,384607,114888,499495
OLIG2 Phosphorylation as a Drug Target for Glioma,8852714,7/15/2007 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,436292, ,NINDS,327987,108305,436292
Electrocatalytic Studies of Toxic Pollutant Activation,8853281,3/1/1983 0:00,3/31/2019 0:00,Non-SBIR/STTR,2015,364577, ,NIEHS,253141,111436,364577
Mechanisms behind hyperglycemia-associated breast cancer risk and progression,8856136,7/21/2015 0:00,6/30/2019 0:00,Other Research-Related,2015,358750, ,NIGMS,250000,108750,358750
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw,8856527,9/1/2014 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,813106, ,NCI,632244,180862,813106
Cellular Stress Response Signaling Pathways,8856563,1/1/1992 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,353250, ,NIEHS,225000,128250,353250
Protein Kinase Signaling and Cell Cycle Control,8856565,12/1/2006 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,503262, ,NIEHS,322604,180658,503262
TOR signaling and autophagy in obesity-promoted liver tumorigenesis,8857110,7/22/2011 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,351277, ,NCI,226630,124647,351277
Targeting Leukemia Stem Cells with Dietary Selenium,8857113,8/1/2012 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,303222, ,NCI,207500,95722,303222
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia,8857376,9/11/2013 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,347563, ,NCI,207500,140063,347563
ERK3 Kinase Signaling in Lung Cancer,8858021,6/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2015,338550, ,NCI,228750,109800,338550
The role of ribosomal proteins in the p53-MDM2 pathway,8858540,3/1/2002 0:00,12/31/2016 0:00,Non-SBIR/STTR,2015,265220, ,NCI,176226,88994,265220
Role of Cdc25A in breast cancer,8860122,9/1/2005 0:00,12/31/2016 0:00,Non-SBIR/STTR,2015,273212, ,NCI,181689,91523,273212
HAUSP inhibitors in p53-wild type and p53-mutant tumors,8861228,5/1/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2015,366000, ,NCI,228750,137250,366000
Using Markers to Improve Pancreatic Cancer Screening,8862433,7/1/2013 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,416661, ,NCI,257198,159463,416661
Ceramide signaling in the regulation of cellular response to folate stress,8862588,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2015,347700, ,NCI,228750,118950,347700
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,8865555,5/1/1997 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,1440175, ,NCI,902073,538102,1440175
Investigation of Regulatory RNAs in Tumor Development,8865558, ,5/31/2016 0:00,Non-SBIR/STTR,2015, ,267154, ,267154,0, 
The role of MCM8-9 in genomic instability of cancers,8867150,7/11/1994 0:00,5/31/2019 0:00,Non-SBIR/STTR,2015,355500, ,NCI,225000,130500,355500
Molecular Imaging & Targeted Therapeutics of Stem Cell-Derived Colon Cancer,8867155,9/24/2002 0:00,4/29/2016 0:00,Research Centers,2015, ,288139, ,206152,81987, 
MKP-1 Effects on HIF-1alpha and Glycolytic Metabolism in Glioblastoma multiforme,8867177,7/1/2013 0:00,6/30/2016 0:00,"Training, Individual",2015,43120, ,NCI,43120, ,43120
Mitochondrial Motility and Inheritance,8867246,7/1/1993 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,328220, ,NIGMS,206527,121693,328220
Bypassing mutant p53 in radiation therapy,8867861,6/15/2014 0:00,6/14/2017 0:00,"Training, Individual",2015,48120, ,NCI,48120, ,48120
P53 inactivation on MDSC development and tumor progression,8868065,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2015,315054, ,NCI,207500,107554,315054
Pancreatic Cancer Vulnerabilities Downstream of Cooperating Oncogenic Mutations,8868072,6/11/2014 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,412619, ,NCI,268807,143812,412619
"DEPTOR/miR-181d, a novel tumor-suppressor axis for prognosis and treatment of breast cancer",8869762,8/14/2015 0:00,3/1/2016 0:00,Other Research-Related,2015,119232, ,NCI,110400,8832,119232
Cyclin E Regulation in Normal and Neoplastic Hematopoiesis,8872315,8/1/2010 0:00,7/31/2016 0:00,Non-SBIR/STTR,2014,405059, ,NHLBI,242550,162509,405059
Small Molecule Activators of Procaspases as Anti-Cancer Agents,8874138,8/6/2007 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,451299, ,NCI,312977,138322,451299
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer,8874142,7/1/2011 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,327269, ,NCI,256304,70965,327269
Regulation of gastroesophageal reflux-associated tumorigenesis,8874740,7/1/2014 0:00,6/30/2018 0:00,Non-SBIR/STTR,2015, , , , , , 
Regulation of melanogenesis via FBXO11-mediated tyrosinase degradation,8874911,7/1/2014 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,84750, ,NIAMS,50000,34750,84750
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors,8876219,6/1/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2015,464569, ,NCI,294031,170538,464569
Targeting p53-Dependent Repigmentation in Vitiligo,8876584,7/1/2012 0:00,6/30/2016 0:00,Other Research-Related,2015,100572, ,NIAMS,93530,7042,100572
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3,8876619,6/20/2014 0:00,9/25/2015 0:00,Other Research-Related,2015,140253, ,NCI,129864,10389,140253
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model,8876882,3/1/2015 0:00,2/29/2020 0:00,Non-SBIR/STTR,2015,396329, ,NCI,261399,134930,396329
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous Epithelia,8876969,4/10/2015 0:00,3/31/2019 0:00,Non-SBIR/STTR,2015,474319, ,NCI,332209,142110,474319
Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling,8877801,3/1/2015 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,208800, ,NCI,130500,78300,208800
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans,8878195,5/16/2013 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,295190, ,NCI,289406,100964,295190
Mechanisms of Radioresistance and Cell Cycle Progression,8879058,5/1/1995 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,347814, ,NCI,217384,130430,347814
P53 survival target DDR1 kinase in DNA damage response and carcinogenesis,8880424,3/1/2015 0:00,2/29/2020 0:00,Non-SBIR/STTR,2015,398025, ,NCI,228750,169275,398025
Preclinical evaluation of a targeted Bmi1 inhibitor in pancreatic cancer,8881128,7/1/2014 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,172340, ,NCI,108750,63590,172340
The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle,8881519,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,348844, ,NCI,228750,120094,348844
Defining a novel subtype of luminal-TP53 mutant breast cancer with poor prognosis,8881745,6/10/2015 0:00,5/31/2017 0:00,Non-SBIR/STTR,2015,229550, ,NCI,130500,99050,229550
HCS to Identify Inhibitors and Disruptors of AR-TIF2 Interactions,8882608,5/1/2015 0:00,4/30/2018 0:00,Non-SBIR/STTR,2015,389435, ,NCI,252880,136555,389435
ROLE OF CRYPTOCHROME IN THE CIRCADIAN CLOCK AND DNA DAMAGE RESPONSES,8882663,8/1/1982 0:00,5/31/2017 0:00,Non-SBIR/STTR,2015,452599, ,NIGMS,300046,152553,452599
Regulation of Mdmx stability and subcellular localization by ubiquitination,8883415,8/14/2012 0:00,7/31/2016 0:00,Non-SBIR/STTR,2015,302000, ,NCI,188750,113250,302000
Exploration of a Mutant p53 Reactivating Compound,8883424,8/16/2013 0:00,7/31/2016 0:00,Other Research-Related,2015,158958, ,NCI,147183,11775,158958
Targeting Autophagy in Hereditary Breast Cancer,8883937,6/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2015,485161, ,NCI,309526,175635,485161
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression,8883960,5/1/1983 0:00,4/30/2020 0:00,Non-SBIR/STTR,2015,468594, ,NCI,266398,202196,468594
Epigenetic Regulation of Human Telomeres,8884085,7/1/2010 0:00,4/30/2020 0:00,Non-SBIR/STTR,2015,442500, ,NCI,240000,202500,442500
Role of Long Intergenic Noncoding RNA in UVB-induced Apoptosis and Skin Cancer,8885048,6/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2016,335832, ,NIEHS,225000,110832,335832
Chemical suppressors of the neural crest lineage for the treatment of melanoma,8885772,8/1/2013 0:00,7/31/2016 0:00,"Training, Individual",2015,30590, ,NCI,30590, ,30590
Mdm2-p53 signaling in the DNA damage response and in tumorigenesis,8886370,3/1/1999 0:00,4/30/2020 0:00,Non-SBIR/STTR,2015,364691, ,NCI,226822,137869,364691
Biological Activity of HPV E7 in Human Epithelial Cells,8887528,4/19/1996 0:00,3/31/2020 0:00,Non-SBIR/STTR,2015,365573, ,NCI,225000,146250,365573
"Merkel cell polyomavirus infection, DNA damage response and cancer",8887559,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2015,366000, ,NCI,228750,137250,366000
RNA Splicing Modulators for MDS/AML,8889215, ,6/30/2016 0:00,Research Centers,2015, ,344994, ,264009,81177, 
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer,8889638,8/15/1999 0:00,7/31/2017 0:00,Non-SBIR/STTR,2015,271250, ,NCI,175000,96250,271250
Targeting PAK4 for Overcoming Drug Resistance in Pancreatic Cancer,8890492,3/1/2015 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,199285, ,NCI,130500,68785,199285
An inhibitor of multiple anti-apoptotic gene products for pancreatic cancer,8890729,4/10/2014 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,184658, ,NCI,108750,75908,184658
Dual Targeting of the p53 pathway for development of anti-cancer therapy,8890804,9/26/2012 0:00,7/31/2016 0:00,Non-SBIR/STTR,2015,312733, ,NCI,212038,100695,312733
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit,8891384,9/1/2012 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,347032, ,NCI,223172,123860,347032
Triad1 regulates myelopoiesis and functions as a leukemia suppressor,8891685,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2015,353419, ,NCI,228750,124669,353419
DNA-Protein Interactions in Herpes Viruses,8892096, , ,Non-SBIR/STTR,2015, ,270537, ,186542,83995, 
Defining novel pathways that arrest genetically unstable tetraploid cells,8892106,8/16/2011 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,237963, ,NCI,145365,92598,237963
Role of ribosome impairments in X-linked Dyskeratosis Congenita pathogenesis,8892175,8/1/2006 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,332928, ,NIDDK,219502,113426,332928
The role of Src kinase in estrogen receptor-positive breast cancer proliferation,8892360,1/1/2014 0:00,7/31/2018 0:00,"Training, Individual",2013,12314, ,NCI,12314, ,12314
IGF-1 and the initiation of non-melanoma skin cancer,8892803,7/1/2014 0:00,6/30/2018 0:00,Non-SBIR/STTR,2015, , , , , , 
Developing CRM1 inhibitors in AML,8893035,7/16/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2015,319550, ,NCI,207500,112050,319550
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer,8893048,7/20/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2015,491237, ,NIDCR,357860,133377,491237
Molecular analysis of methylated p53,8893094,8/1/2013 0:00,7/31/2016 0:00,Non-SBIR/STTR,2015,474983, ,NIGMS,338240,136743,474983
ROLE OF CRYPTOCHROME IN DNA DAMAGE RESPONSES AND THE CIRCADIAN CLOCK,8893684,8/1/1982 0:00,6/30/2015 0:00,Non-SBIR/STTR,2014,168682, ,NIGMS,111464,57218,168682
P63 mechanisms and mediators in HNSCC,8893942,4/1/2004 0:00,7/31/2016 0:00,Non-SBIR/STTR,2015,431669, ,NIDCR,250000,181669,431669
Oncogene c-Myc-dependent pathways in cutaneous melanoma03,8894147,12/11/2006 0:00,11/30/2016 0:00,Non-SBIR/STTR,2014,34886, ,NCI,22428,12458,34886
Novel oncogenic functions of Mdm2 and Mdmx,8894467,7/18/2014 0:00,1/31/2016 0:00,Non-SBIR/STTR,2015,135131, ,NCI,85292,49839,135131
"Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.",8894474,8/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2015,580448, ,NCI,378248,202200,580448
FDH: A Novel Determinant of Tumor Suppression,8895055,9/12/2014 0:00,3/31/2016 0:00,Non-SBIR/STTR,2014,240920, ,NCI,158500,82420,240920
Identifying the Second Hit in MYC-driven Medulloblastoma; a Role for Gfi Proteins,8895082,7/1/2014 0:00,8/31/2016 0:00,"Training, Individual",2015,32346, ,NINDS,32346, ,32346
The Role of PI3K in Growth Regulation,8895343,4/1/1990 0:00,5/31/2017 0:00,Non-SBIR/STTR,2015,491550, ,NIGMS,290000,201550,491550
Origins of Ovarian Carcinoma,8895722,5/18/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2015,358780, ,NCI,228750,130030,358780
Directing the Mediator Complex: Bivalent approaches to Reconstituting or Inhibiti,8895755,8/1/2012 0:00,5/31/2016 0:00,Non-SBIR/STTR,2015,131880, ,NCI,112168,19712,131880
The Tumor Suppressive Role of the mir-200 family of microRNAs,8896299,7/16/2014 0:00,5/31/2016 0:00,"Training, Individual",2015,33635, ,NCI,33635, ,33635
Modulation of p53 function by tyrosine kinase networks,8896554,9/7/2012 0:00,7/31/2016 0:00,Non-SBIR/STTR,2015,335113, ,NCI,207500,127613,335113
p53 and tumor cell metabolism,8897305,8/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2015,332000, ,NCI,207500,124500,332000
Mechanisms governing tumor differentiation and metastasis,8897855,7/7/2014 0:00,7/6/2017 0:00,"Training, Individual",2015,54194, ,NCI,54194, ,54194
OXIDATIVE INJURY TO GASTRIC EPITHELIAL CELLS BY H. PYLORI,8899490,9/21/2001 0:00,7/31/2017 0:00,Non-SBIR/STTR,2015,310000, ,NIDDK,200000,110000,310000
"Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe",8899651,8/1/2014 0:00,6/30/2019 0:00,Other Research-Related,2015,187380, ,NINDS,173500,13880,187380
Molecular analysis of methylated p53,8899739,8/1/2013 0:00,7/31/2017 0:00,Non-SBIR/STTR,2014,153510, ,NIGMS,106725,46785,153510
The Regulation of PP1 in the Nucleus,8899933,9/1/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2014,29912, ,NIGMS,29912, ,29912
Targeting Oncogene Expression to Skin in Transgenic Mice,8900203,8/1/1990 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,475014, ,NCI,326504,148510,475014
Mechanism and treatment of PTEN mutant prostate tumorigenesis,8900211,7/30/2014 0:00,6/30/2019 0:00,Non-SBIR/STTR,2015,398400, ,NCI,207500,190900,398400
Characterization of Oncogenic Transcription Factor-Associated Proteins in SCC,8901563,9/1/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2014,241532, ,NCI,136491,105041,241532
Investigating microRNA miR-34a in lung cancer development and therapy,8901573,9/1/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2014,249000, ,NCI,148657,100343,249000
Molecular Virology Research Program,8901938, ,7/31/2016 0:00,Research Centers,2015, ,22641, ,13598,9043, 
Developmental Funds,8901988, , ,Research Centers,2015, ,26791, ,34325,0, 
Mechanisms of Esophageal Carcinogenesis,8901992,8/15/2003 0:00,6/30/2019 0:00,Non-SBIR/STTR,2015,1607533, ,NCI,1174560,432973,1607533
Mechanisms of novel cancer targets in ARF-mediated tumor suppression,8902056,9/1/2012 0:00,8/31/2016 0:00,Non-SBIR/STTR,2015,332000, ,NCI,207500,124500,332000
Perturbation of a cellular microRNA by human papillomavirus type 16.,8902070,8/1/2013 0:00,7/31/2016 0:00,"Training, Individual",2015,30590, ,NCI,30590, ,30590
Identification of Genetic Alterations Responsible for Primary GBM Clonal Evoluti,8903706,9/5/2001 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015, ,439642, ,347700,91942, 
Antagonizing the SET Oncoprotein,8903823,6/10/2015 0:00,5/31/2017 0:00,SBIR/STTR,2015,225000, ,NCI, , ,225000
"NUCKS, a novel double-strand break repair gene, implicated in cancer biology",8905147,6/28/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2014,257914, ,NIEHS,180021,77893,257914
Roles and regulation of p53,8906762,9/30/2000 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,1767603, ,NCI,1433905,333698,1767603
Regulation and Interactions of the p53 Family,8906764, ,3/31/2017 0:00,Non-SBIR/STTR,2015, ,450429, ,365394,85035, 
Genomic Analysis of the p53 Pathway in Normal and Cancer Cells,8906765, ,3/31/2017 0:00,Non-SBIR/STTR,2015, ,458428, ,371883,86545, 
p53 and Chemosensitivity in a Mouse Lymphoma Model,8906766, ,3/31/2017 0:00,Non-SBIR/STTR,2015, ,414182, ,335991,78191, 
Molecular Studies of the p53 Pathway in Human Cancer,8906767, ,3/31/2017 0:00,Non-SBIR/STTR,2015, ,444564, ,360637,83927, 
"Race, pathomolecular signature and colorectal cancer survival",8906782,9/21/2011 0:00,8/31/2016 0:00,Other Research-Related,2015,130415, ,NCI,120755,9660,130415
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis,8907720,9/1/2011 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,246301, ,NCI,161509,84792,246301
Cancer Prevention,8907934, ,6/30/2016 0:00,Research Centers,2015, ,25632, ,25632,0, 
Defining the role of mutant XPO1 in chronic lymphocytic leukemia,8909746,5/1/2015 0:00,4/30/2020 0:00,"Training, Individual",2015,37855, ,NCI,37855, ,37855
Non-catalytic functions of DNA-PK in DNA repair and tumorigenesis,8911134,9/1/2014 0:00,8/31/2017 0:00,"Training, Individual",2015,43120, ,NCI,43120, ,43120
High throughput screen for selective inhibitors of cyclophilin B,8911876,9/1/2013 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,379313, ,NINDS,301875,77438,379313
Non-canonical gene regulation through a Drosophila p53 enhancer,8913223,9/1/2013 0:00,8/31/2016 0:00,"Training, Individual",2015,30485, ,NIGMS,30485, ,30485
The Role of SWI/SNF Alternative Splicing in Cancer,8915103,9/30/2013 0:00,9/29/2016 0:00,"Training, Individual",2015,30590, ,NCI,30590, ,30590
Regulation of esophageal gene expression and function by KLF5 and p53,8915164,9/20/2013 0:00,7/31/2016 0:00,Non-SBIR/STTR,2015,348000, ,NIDDK,217500,130500,348000
Aurora-A is a novel therapeutic target in glioblastoma,8915765,9/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2015,359357, ,NINDS,233349,126008,359357
Markers for Screening and Prognosis,8916026, ,8/31/2016 0:00,Research Centers,2015, ,307822, ,190985,116837, 
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci,8916038,9/7/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2015,538250, ,NCI,337082,201276,538250
Defining the genetic requirements for maintenance of colorectal cancer,8916057,9/1/2014 0:00,8/31/2017 0:00,Other Research-Related,2015,194724, ,NCI,180300,14424,194724
Novel c-Abl-directed Therapies to Alleviate Metastatic Breast Cancer,8916387,9/12/2013 0:00,9/11/2016 0:00,"Training, Individual",2015,34855, ,NCI,34855, ,34855
Investigating microRNA miR-34a in lung cancer development and therapy,8916640,9/1/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,249000, ,NCI,148657,100343,249000
Bifunctional Antibodies for Melanoma Therapy,8916650,9/1/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,442736, ,NCI,309036,133700,442736
Nuclear Accumulation of Cyclin D1 and Oncogenesis,8917000,7/1/2001 0:00,7/31/2017 0:00,Non-SBIR/STTR,2014,269783, ,NCI,180457,89326,269783
Development Project 2,8917125, ,8/31/2016 0:00,Research Centers,2015, ,112151, ,53432,58719, 
The Regulation of PP1 in the Nucleus,8917259,9/1/2011 0:00,8/31/2016 0:00,Non-SBIR/STTR,2015,290168, ,NIGMS,188000,102168,290168
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni,8917311,8/1/2013 0:00,7/31/2016 0:00,Non-SBIR/STTR,2015,386389, ,OD,256737,129652,386389
Characterization of Oncogenic Transcription Factor-Associated Proteins in SCC,8917871,9/1/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,241531, ,NCI,136106,105425,241531
Molecular Biology of Lung Cancer among Puerto Ricans,8917876, ,8/31/2016 0:00,Research Centers,2015, ,189565, ,123750,65815, 
Molecular Tumorigenesis of Bladder Cancer,8917894, ,8/31/2016 0:00,Non-SBIR/STTR,2015, ,321793, ,189848,131945, 
DNA Repair and Tobacco Smoke in Bladder Carcinogenesis,8917895, ,8/31/2016 0:00,Non-SBIR/STTR,2015, ,219440, ,129463,89977, 
Novel Role of XIAP in Bladder Cancer Invasion,8917896, ,8/31/2016 0:00,Non-SBIR/STTR,2015, ,351362, ,207293,144069, 
Role of Parkinson's disease gene PARK2 in GBM oncogenesis and genomic instability,8918041,9/30/2013 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,386750, ,NINDS,218750,168000,386750
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia,8918439,8/5/2003 0:00,8/31/2016 0:00,Research Centers,2015,2183683, ,NCI,1758145,625397,2183683
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression,8918514, , ,Research Centers,2015, ,27380, ,0,27380, 
SPORE: Targeted Therapies for Glioma,8918528,9/19/2013 0:00,7/31/2016 0:00,Research Centers,2015,2166955, ,NCI,1680447,529758,2166955
Functionalizing recurrent FAT1 mutations and deletions in oral cancer,8918574,9/1/2014 0:00,8/31/2019 0:00,Other Research-Related,2015,136350, ,NIDCR,126250,10100,136350
"The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer",8919276,9/1/2012 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,291169, ,NCI,183125,108044,291169
Dynamics of cellular senescence in single human cells,8919404,9/1/2012 0:00,8/31/2016 0:00,Non-SBIR/STTR,2015,279874, ,NIGMS,184128,95746,279874
Nuclear Accumulation of Cyclin D1 and Oncogenesis,8919659,7/1/2001 0:00,7/31/2017 0:00,Non-SBIR/STTR,2015,278127, ,NCI,186038,92089,278127
Cancer cell adaptation to glutamine deprivation,8919856,9/1/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,352750, ,NCI,207500,145250,352750
Targeting Neural Mitochondria to Treat Chemotherapy-Induced Peripheral Neuropathy,8920522,9/1/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,174000, ,NCI,108750,65250,174000
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma:  Environmental Co,8921129,7/1/2009 0:00,8/31/2018 0:00,Non-SBIR/STTR,2015,327043, ,NCI,247713,79330,327043
CARP-1: A Potential Therapeutic Agent for Breast Cancer,8922216,1/1/2012 0:00,12/31/2019 0:00,Non-SBIR/STTR,2016, , , , , , 
Epigenomic Markers of HNSCC Survival Across Ethnic Groups,8922403,9/22/2011 0:00,8/31/2015 0:00,Other Research-Related,2014,121647, ,NCI,112636,9011,121647
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis,8923209,9/8/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,336565, ,NCI,237541,99024,336565
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance,8925020,9/9/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,317475, ,NCI,186750,130725,317475
"Inflammation, autoimmunity and ovarian cancer",8925027,9/9/2014 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,69119, ,NCI,55386,13733,69119
"Studying the initiation, progression and therapy of lung cancer in mouse models",8925219,4/1/2009 0:00,8/31/2015 0:00,Non-SBIR/STTR,2014,31600, ,NCI,20000,11600,31600
"Src, p53 and estrogen receptor-positive breast cancer",8926363,9/15/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,200970, ,NCI,130500,70470,200970
From Mechanism to Population: Modeling HPV-related Oropharyngeal Carcinogenesis,8926370,9/11/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,639928, ,NCI,492086,265051,639928
Pilot Project 2: Therapeutic targets for doxorubicin resistant breast cancer,8926862, ,8/31/2016 0:00,Research Centers,2015, ,52045, ,36683,15362, 
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions,8926904,9/12/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,442311, ,NCI,377403,64908,442311
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer,8926908,9/12/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,439351, ,NCI,249773,189578,439351
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming,8927516,9/30/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2015,452249, ,NIA,257106,195143,452249
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp,8927536, , ,Non-SBIR/STTR,2015, ,329404, ,240082,89322, 
RB-Related Proteins and Polyomavirus Large T antigen Transformation,8927539,5/2/1994 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,311400, ,NCI,180000,131400,311400
The Development of Novel Individualized Therapy for Triple-Negative Breast Cancer,8927557,9/1/2013 0:00,8/31/2016 0:00,Other Research-Related,2015,171720, ,NCI,159000,12720,171720
Molecular mechanism of RNA polymerase I transcription and dysregulation in cancer,8928575,9/17/2014 0:00,8/31/2017 0:00,Other Research-Related,2015,211470, ,NCI,195806,15664,211470
IMPACT OF AICD ON TCR TRANSDUCED T CELLS FOR ADOPTIVE IMMUNOTHERAPY,8929165, ,8/31/2018 0:00,Non-SBIR/STTR,2015, ,334756, ,262173,72583, 
Single Cell Technologies for Rapid Detection of Tumor Heterogeneity,8929431,9/1/2015 0:00,7/31/2018 0:00,Non-SBIR/STTR,2015,251753, ,NCI,168902,82851,251753
Genetic Susceptibility To Carcinogens and Toxicants,8929721, , ,Intramural Research,2014,792813, ,NIEHS, , ,792813
Human Genes Affecting Chromosome Metabolism and Stress Response,8929748, , ,Intramural Research,2014,1461318, ,NIEHS, , ,1461318
Cellular Mechanisms Of Xenobiotic Transport,8929759, , ,Intramural Research,2014,1298507, ,NIEHS, , ,1298507
Discovery And Functional Genomics Of Environmental Response Genes,8929768, , ,Intramural Research,2014,1884786, ,NIEHS, , ,1884786
"Nuclear receptors: action, functions, and roles in disease",8929777, , ,Intramural Research,2014,701864, ,NIEHS, , ,701864
Cell Signaling of Host Defense,8929790, , ,Intramural Research,2014,2310618, ,NIEHS, , ,2310618
Sphingolipids in Cancer Biology and Therapy,8930910,8/1/2003 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,1308390, ,NCI,892069,416321,1308390
Targets for Therapy for Carcinomas of the Lung,8930911,7/23/2007 0:00,8/31/2016 0:00,Non-SBIR/STTR,2015,1736914, ,NCI,1135887,601027,1736914
Lung Cancer Drivers and Dependencies as Therapeutic Targets,8930915, ,8/31/2016 0:00,Non-SBIR/STTR,2015, ,365049, ,238731,126318, 
Apoptosis In Neurodegenerative Disorders,8931505, , ,Intramural Research,2014,546674, ,NIA, , ,546674
Functional Genomic Study of Aging and Aging Interventions,8931526, , ,Intramural Research,2014,633234, ,NIA, , ,633234
"Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis",8931548, , ,Intramural Research,2014,560378, ,NIA, , ,560378
Long-Range Transcriptional Regulation of Placental and Ovary Specific Genes,8931557, , ,Intramural Research,2014,627623, ,NIA, , ,627623
MicroRNA Therapeutics in Non-small Cell Lung Cancer,8931834,8/26/2015 0:00,7/31/2020 0:00,Research Centers,2015, ,287464, ,287464, , 
Immune Therapy,8931892, ,8/31/2016 0:00,Non-SBIR/STTR,2015, ,241511, ,210435,35895, 
Project 1 - PARP Project,8932128,9/1/2009 0:00,8/31/2020 0:00,Research Centers,2015, ,173132, ,173132, , 
EPHB4 Receptor Kinase as a Target in Prostate Cancer,8932478,8/18/2015 0:00,7/31/2020 0:00,Research Centers,2015, ,274861, ,207713,67148, 
Targeting the OLIG2 Transcription Factor,8932954, , ,Research Centers,2014, ,358334, ,270732,87602, 
Molecular Landscape-based Innovative Therapies for Anaplastic Thyroid Carcinoma,8933083, , ,Research Centers,2015, ,529155, ,338954,190201, 
RNDI- Mediated Breast Cancer Suppression,8933094,7/1/2015 0:00,6/30/2019 0:00,Non-SBIR/STTR,2015, ,509318, ,289550,219768, 
Failed tubulin inhibitor reformulated as localized adjuvant therapy for head and neck cancerPOP: 09/12/2014-06/11/2015,8933727,9/19/2014 0:00,6/18/2015 0:00,R and D Contracts,2014,223412, ,NCI, , ,223412
The role of ATRX and H3.3 mutations in pediatric glioblastoma,8933952,9/15/2014 0:00,9/14/2017 0:00,"Training, Individual",2015,54194, ,NCI,54194, ,54194
Molecular Oncology,8933990, , ,Research Centers,2015, ,38779, ,25069,13710, 
Risk and penetrance of mutations from breast cancer testing panels.,8934075,9/25/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2015,1319364, ,NCI,1070482,248882,1319364
PL Growth,8934261,12/1/2013 0:00,11/30/2018 0:00,Research Centers,2014, ,19656, ,9993,9663, 
PL Growth,8934278, , ,Research Centers,2015, ,24970, ,12872,12098, 
Preclinical Development and Clinical Testing of MEK and PI3K Targeted Therapy for KRAS-mutant NSCLC,8936002, , ,Research Centers,2015, ,283131, ,245075,58011, 
Project 1: Role of Acid Sphingomyelinase in Breast Cancer,8936019,8/1/2003 0:00, ,Non-SBIR/STTR,2015, ,221831, ,142088,79743, 
Project 3: Role of Sphingosine Kinase in P53 Cancer Biology,8936021,8/1/2003 0:00, ,Non-SBIR/STTR,2015, ,208043, ,133257,74786, 
Transformed Esophageal Epithelial Cells and the Tumor Microenvironment,8936552,8/15/2003 0:00, ,Non-SBIR/STTR,2015, ,351721, ,256989,94732, 
Targeting the OLIG2 Transcription Factor,8936616, ,7/31/2016 0:00,Research Centers,2015, ,303108, ,229007,74101, 
Chromosomal Proteins and Chromosomal Functions,8937625, , ,Intramural Research,2014,1002073, ,NCI, , ,1002073
Gene Regulation and Function: The B-ZIP Proteins,8937634, , ,Intramural Research,2014,1082840, ,NCI, , ,1082840
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,8937636, , ,Intramural Research,2014,1151039, ,NCI, , ,1151039
"Tumor Suppressor Protein, p53",8937642, , ,Intramural Research,2014,430126, ,NCI, , ,430126
Transgenic Models for Prostate and Breast Cancer,8937646, , ,Intramural Research,2014,954020, ,NCI, , ,954020
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",8937650, , ,Intramural Research,2014,972261, ,NCI, , ,972261
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,8937664, , ,Intramural Research,2014,1187307, ,NCI, , ,1187307
Regulation of Lymphocyte Proliferation and Replicative Capacity,8937680, , ,Intramural Research,2014,306017, ,NCI, , ,306017
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,8937683, , ,Intramural Research,2014,418140, ,NCI, , ,418140
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,8937687, , ,Intramural Research,2014,422080, ,NCI, , ,422080
DNA Repair,8937697, , ,Intramural Research,2014,1363940, ,NCI, , ,1363940
Enzymes and Substrates of the Ubiquitin Conjugating System,8937698, , ,Intramural Research,2014,696939, ,NCI, , ,696939
Role of CEBP transcription factors in regulating cell growth and tumorigenesis,8937710, , ,Intramural Research,2014,1346126, ,NCI, , ,1346126
Role of Neurotrophins in the Development of the Mammalian Nervous System,8937727, , ,Intramural Research,2014,751233, ,NCI, , ,751233
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,8937765, , ,Intramural Research,2014,40014, ,NCI, , ,40014
Molecular Mechanisms of Proliferation and Infiltration of MPNST and Astrocytoma,8937766, , ,Intramural Research,2014,80029, ,NCI, , ,80029
Development of Mouse Neurofibromatosis Model for Preclinical Testing,8937767, , ,Intramural Research,2014,280100, ,NCI, , ,280100
Zebrafish Models of Cancer,8937769, , ,Intramural Research,2014,591158, ,NCI, , ,591158
Molecular Interaction Maps and Analysis of Bioregulatory Networks,8937770, , ,Intramural Research,2014,62767, ,NCI, , ,62767
The Role of miRNA-mediated RNAI in the Biology of Cancer,8937779, , ,Intramural Research,2014,188734, ,NCI, , ,188734
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,8937786, , ,Intramural Research,2014,558718, ,NCI, , ,558718
Molecular-Targeted Radiation Therapy,8937800, , ,Intramural Research,2014,598232, ,NCI, , ,598232
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,8937812, , ,Intramural Research,2014,140872, ,NCI, , ,140872
Metabolic Mechanisms for Programmed Cell Death,8937821, , ,Intramural Research,2014,408864, ,NCI, , ,408864
"Role of inflammation, innate resistance, and immunity in carcinogenesis.",8937847, , ,Intramural Research,2014,811997, ,NCI, , ,811997
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,8937851, , ,Intramural Research,2014,729441, ,NCI, , ,729441
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,8937877, , ,Intramural Research,2014,36533, ,NCI, , ,36533
Novel Markers for Disease Outcome in Breast Cancer,8937885, , ,Intramural Research,2014,595046, ,NCI, , ,595046
Redox Mechanism Process of Angiogenesis and Wound Healing,8937890, , ,Intramural Research,2014,351860, ,NCI, , ,351860
Collaborative Pathways that Lead to Leukemia,8937914, , ,Intramural Research,2014,273170, ,NCI, , ,273170
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma,8937927, , ,Intramural Research,2014,560659, ,NCI, , ,560659
Cancer stem cells and human liver cancer,8937929, , ,Intramural Research,2014,1039287, ,NCI, , ,1039287
TMPRSS2-ERG chromosomal translocations and prostate cancer,8937936, , ,Intramural Research,2014,145888, ,NCI, , ,145888
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,8937956, , ,Intramural Research,2014,207228, ,NCI, , ,207228
Role of Brachyury in regulating notochord development and neoplasia,8937973, , ,Intramural Research,2014,126432, ,NCI, , ,126432
Study the role(s) of p53 in embryonic stem cells,8937985, , ,Intramural Research,2014,542071, ,NCI, , ,542071
Role of inflammation in epigenetic alterations of metastatic cancer cells,8937988, , ,Intramural Research,2014,345720, ,NCI, , ,345720
Validation of Therapeutic Target Genes in Human Liver Cancer,8937992, , ,Intramural Research,2014,311786, ,NCI, , ,311786
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,8937996, , ,Intramural Research,2014,726089, ,NCI, , ,726089
Preclinical Mouse Model of Thyroid Carcinogenesis,8938001, , ,Intramural Research,2014,744727, ,NCI, , ,744727
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,8938003, , ,Intramural Research,2014,645188, ,NCI, , ,645188
Embryonic Transcription Factor Function in Human Colorectal Cancer Stem Cells,8938004, , ,Intramural Research,2014,191728, ,NCI, , ,191728
Biological Implications and Translational Applications of HDMX Inhibition,8938031, , ,Intramural Research,2014,69710, ,NCI, , ,69710
Broadening the Utility of Stapled Peptides through Chemical Optimization,8938032, , ,Intramural Research,2014,209130, ,NCI, , ,209130
Mechanisms of Early Stage Mammary Tumorigenesis,8938036, , ,Intramural Research,2014,140165, ,NCI, , ,140165
CANCER AND INFLAMMATION GENETICS,8938046, , ,Intramural Research,2014,1216954, ,NCI, , ,1216954
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,8938065, , ,Intramural Research,2014,513579, ,NCI, , ,513579
Development and validation of preclinical mouse model for serous ovarian cancer,8938075, , ,Intramural Research,2014,1012184, ,NCI, , ,1012184
Structural and Biochemical Studies of p53 Family Function,8938080, , ,Intramural Research,2014,278840, ,NCI, , ,278840
Regulation of microRNA expression by Mutant p53,8938093, , ,Intramural Research,2014,193289, ,NCI, , ,193289
Function of Mutant p53-regulated microRNAs in cancer cells,8938094, , ,Intramural Research,2014,309261, ,NCI, , ,309261
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,8938107, , ,Intramural Research,2014,762321, ,NCI, , ,762321
Integrative Molecular Epidemiology of Human Cancer,8938159, , ,Intramural Research,2014,1586024, ,NCI, , ,1586024
"p53, Aging, and Cancer",8938160, , ,Intramural Research,2014,793011, ,NCI, , ,793011
Study the roles of p53 and p53 mutants in mesenchymal stem cells,8938166, , ,Intramural Research,2014,542071, ,NCI, , ,542071
Targeting DNA damage repair and related pathways in HRD-womens cancers,8938177, , ,Intramural Research,2014,773642, ,NCI, , ,773642
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,8938238, , ,Intramural Research,2014,452492, ,NCI, , ,452492
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,8938239, , ,Intramural Research,2014,6262586, ,NCI, , ,6262586
Epidemiology and Natural History of Cancer-Associated Viruses,8938248, , ,Intramural Research,2014,3379228, ,NCI, , ,3379228
Molecular Pathology of Pulmonary Carcinogenesis,8938377, , ,Intramural Research,2014,637151, ,NCI, , ,637151
Molecular Pathogenesis of Multiple Myeloma,8938389, , ,Intramural Research,2014,510465, ,NCI, , ,510465
Lymphoma Studies,8938394, , ,Intramural Research,2014,704359, ,NCI, , ,704359
Nitric Oxide as a Modifier of Oxidative Stress,8938398, , ,Intramural Research,2014,351860, ,NCI, , ,351860
CCR Confocal Microscopy Core,8938432, , ,Intramural Research,2014,761822, ,NCI, , ,761822
Novel Targets for Vaccine Therapy,8938441, , ,Intramural Research,2014,962130, ,NCI, , ,962130
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility,8938442, , ,Intramural Research,2014,544131, ,NCI, , ,544131
Immunohistochemistry Core Laboratory,8938466, , ,Intramural Research,2014,1101677, ,NCI, , ,1101677
Comparison of molecular factors to drug activities.,8938487, , ,Intramural Research,2014,89476, ,NCI, , ,89476
Signal and Transcription Factor Network interactions in Head and Neck Cancer,8939472, , ,Intramural Research,2014,859666, ,NIDCD, , ,859666
Genomics and Proteomics of Head and Neck Cancer,8939473, , ,Intramural Research,2014,1146221, ,NIDCD, , ,1146221
Small Molecule Activators of p53,8939538, , ,Intramural Research,2014,66782, ,NIDDK, , ,66782
"BRCA1, DNA damage response and aging",8939631, , ,Intramural Research,2014,930282, ,NIDDK, , ,930282
Roles of BRCA1 transcription target genes in tumorigenesis and aging,8939632, , ,Intramural Research,2014,930282, ,NIDDK, , ,930282
The role of autophagy in aging and metabolism,8939791, , ,Intramural Research,2014,1191414, ,NHLBI, , ,1191414
Mitochondrial regulation in cardiovascular and cancer biology,8939795, , ,Intramural Research,2014,973171, ,NHLBI, , ,973171
Olfactomedin 4 is a key regulator of colon cancer progression,8939811, , ,Intramural Research,2014,329245, ,NIDDK, , ,329245
DCP Center for Advanced Preclinical Research,8940516,9/26/2008 0:00,9/25/2018 0:00,R and D Contracts,2014,170900, ,NCI, , ,170900
Regulation Of Intracellular Iron Metabolism,8941466, , ,Intramural Research,2014,1080971, ,NICHD, , ,1080971
Suppression of mobile elements by p53 genes,8942424,8/1/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2015,318963, ,NIGMS,197500,121463,318963
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors,8942703,5/7/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2015,540936, ,NCI,360927,180009,540936
"Head Neck Cancer, beta-defensins, and immune responses",8942990,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,396250, ,NIDCR,250000,146250,396250
Modulation of cancer specific transcriptional factors with small molecules,8944511,8/1/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2015,401456, ,NCI,228750,172706,401456
Underlying Mechanisms in Angiosarcoma,8945857,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,352275, ,NCI,228750,123525,352275
Neuroendocrine mechanisms of prostate cancer progression,8945956,7/7/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,348145, ,NCI,228750,119395,348145
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease,8946288, , ,Intramural Research,2014,960291, ,NIAID, , ,960291
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS,8946422, , ,Intramural Research,2014,685757, ,NIAID, , ,685757
Defining mechanisms of extracellular communication for cancer therapy,8948042,4/1/2013 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,49361, ,NCI,33821,15540,49361
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma,8948894,9/13/2013 0:00,11/30/2017 0:00,Non-SBIR/STTR,2015,249000, ,NCI,185505,63495,249000
BACH2 in Melanoma Development and Resistance,8949027,8/9/2016 0:00,7/31/2019 0:00,Other Research-Related,2016,177344, ,NCI,164207,13137,177344
Molecular Biology of Oncogenic Papillomaviruses,8952443,1/1/2016 0:00,12/31/2022 0:00,Non-SBIR/STTR,2016,1017000, ,NCI,600000,417000,1017000
The intersection of RNA biology and tumor biology,8953055,8/12/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2015,521828, ,NCI,328442,193386,521828
Preclinical evaluation of a novel combinatory epigenetics based therapy for glioblastoma,8954745,6/15/2015 0:00,5/31/2017 0:00,Non-SBIR/STTR,2015,200000, ,NINDS,125000,75000,200000
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma,8955460,4/19/2016 0:00,8/31/2016 0:00,Non-SBIR/STTR,2016,100026, ,NCI,575815,297489,100026
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity,8955700,8/1/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2015,1144825, ,NCI,597384,547441,1144825
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis,8956056,8/14/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2015,832842, ,NCI,513541,319301,832842
Targeting Mutant KRAS for Cancer Therapy,8956254,3/1/2016 0:00,2/28/2023 0:00,Non-SBIR/STTR,2016,960504, ,NCI,606117,354387,960504
Mitochondrially Targeted p53 DBD for Treatment of Ovarian Cancer,8957167,7/7/2015 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,162038, ,NCI,108750,53288,162038
Treating pancreatic cancer with Listeria-32P,8957301,5/1/2015 0:00,8/31/2015 0:00,Non-SBIR/STTR,2015,19682, ,NCI,11785,7897,19682
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo,8957309,9/2/2015 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,207495, ,NCI,130500,76995,207495
A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia,8957874,7/1/2015 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,79500, ,NCI,50000,29500,79500
Breast Cancer Prevention Using Bitter Melon as a Natural Product,8958249,9/1/2015 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,197708, ,NCI,130500,67208,197708
Safety and anti-cancer efficacy of FACT inactivation in mice,8958313,7/1/2015 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,229028, ,NCI,130500,98528,229028
A novel multi-targeted therapy for breast cancer resistance,8958353,7/16/2015 0:00,9/10/2015 0:00,Non-SBIR/STTR,2015,16254, ,NCI,4297,11957,16254
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus,8958695,10/1/2014 0:00,9/30/2018 0:00,Non-SBIR/STTR,2016, , , , , , 
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis,8958809,1/16/2012 0:00,10/31/2017 0:00,Non-SBIR/STTR,2016,400910, ,NIEHS,250569,150341,400910
DBPs (pp: 363-418); DBP Overviews (pp 124-129) ,8958835, , ,Research Centers,2015, ,97961, ,63405,34556, 
Cracking the Ubiquitination Code by Top Down Mass Spectrometry,8959461,9/9/2015 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,189356, ,NCI,130500,58856,189356
Function and regulation of MDMX intra-molecular interactions,8960111,8/1/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2015,385444, ,NCI,228750,156694,385444
Polyploid cell cycle regulation and genome instability,8962579,8/12/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2015,308100, ,NIGMS,197500,110600,308100
Role of the AMPK-MDMX-p53 pathway in cancer,8963004,9/28/2007 0:00,8/31/2020 0:00,Non-SBIR/STTR,2015,321684, ,NCI,213750,107944,321684
Papillomavirus E6 Structural Consortium,8964034,2/1/2010 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,458004, ,NCI,332305,125699,458004
The impact of chromosome 17p lesions on leukemogeneis and therapy response,8964300,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,402371, ,NCI,228750,173621,402371
Plk1-Numb Cooperation in Melanomagenesis,8965957,10/1/2012 0:00,9/30/2016 0:00,Non-SBIR/STTR,2016, , , , , , 
Targeting MDM2 with Intracellular Antibodies,8966627,10/1/2013 0:00,9/30/2017 0:00,Non-SBIR/STTR,2016, , , , , , 
The Effects of Grape Seed Extract Against Lung Cancer,8966665,10/1/2013 0:00,9/30/2016 0:00,Non-SBIR/STTR,2016, , , , , , 
Modeling New Therapeutic Approaches for Malignant Melanoma,8966669,10/1/2013 0:00,9/30/2017 0:00,Non-SBIR/STTR,2016, , , , , , 
Role of heat shock factors (Hsfs) in tumorigenesis,8966678,3/1/2000 0:00,11/30/2018 0:00,Non-SBIR/STTR,2016,270000, ,NCI,180000,90000,270000
The role of autophagy in Kras-driven lung cancer,8966851,9/1/2015 0:00,8/31/2018 0:00,Other Research-Related,2015,209628, ,NCI,194100,15528,209628
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer,8967043,9/2/2015 0:00,7/31/2019 0:00,Non-SBIR/STTR,2015,664456, ,NCI,414998,249458,664456
IGF-1 and the initiation of non-melanoma skin cancer,8967172,7/1/2014 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016, , , , , , 
p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer,8967857,8/16/2016 0:00,7/31/2019 0:00,Other Research-Related,2016,157743, ,NCI,146058,11685,157743
Pediatric Preclinical Testing Consortium,8968109,7/7/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,357000, ,NCI,212500,144500,357000
Tumor Suppressor Qualities and Mechanisms of LZAP Activity,8968830,4/1/2000 0:00,11/30/2018 0:00,Non-SBIR/STTR,2016,416250, ,NIDCR,250000,166250,416250
Structural and molecular investigation of small molecule reactivation of p53,8970548,3/1/2015 0:00,2/28/2018 0:00,"Training, Individual",2016,48576, ,NCI,48576, ,48576
The role of keratinocyte p53 in development of pigmented lesions,8974176,7/20/2015 0:00,6/30/2018 0:00,Non-SBIR/STTR,2015,77750, ,NIAMS,50000,27750,77750
Regulation of gastroesophageal reflux-associated tumorigenesis,8974328,7/1/2014 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016, , , , , , 
Nuclear Function of Abl in DNA Damage Response,8974389,8/1/1986 0:00,11/30/2018 0:00,Non-SBIR/STTR,2016,387500, ,NCI,250000,137500,387500
Mutant p53 has gain-of-function mechanisms to mediate tumor invasion,8974390,12/1/2013 0:00,11/30/2016 0:00,"Training, Individual",2016,29885, ,NCI,29885, ,29885
Oncogene c-Myc-dependent pathways in cutaneous melanoma03,8974812,12/11/2006 0:00,11/30/2017 0:00,Non-SBIR/STTR,2016,320405, ,NCI,191530,128875,320405
Regulation of Human Papillomavirus Replication via Cell Signaling Pathways,8974817,12/1/2013 0:00,5/15/2016 0:00,"Training, Individual",2016,19600, ,NCI,19600, ,19600
Oncogene c-Myc-dependent pathways in cutaneous melanoma03,8975400,12/11/2006 0:00,11/30/2015 0:00,Non-SBIR/STTR,2015,60479, ,NCI,37011,23468,60479
Identification and Therapeutic Application of miRNA-Drivers in Lung Cancer,8975760,8/13/2013 0:00,11/30/2017 0:00,Non-SBIR/STTR,2016,244646, ,NCI,193926,50720,244646
DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations,8975763,12/1/2014 0:00,11/30/2019 0:00,Non-SBIR/STTR,2016,366000, ,NCI,228750,137250,366000
Characterization of Calmodulin and CHK2 inhibitors for the treatment of Diamond B,8976079,12/1/2014 0:00,11/30/2016 0:00,"Training, Individual",2016,58002, ,NHLBI,58002, ,58002
Progression and regression of mammary preneoplasia,8976830,12/23/2004 0:00,11/30/2018 0:00,Non-SBIR/STTR,2016,311000, ,NCI,200000,111000,311000
DEVELOPMENT OF A JBS HI-LO URINE DNA KIT,8976885,8/24/2015 0:00,7/31/2017 0:00,SBIR/STTR,2015,225000, ,NHGRI, , ,225000
Restoring the Missing Zinc: A quantitative investigation of p53 hotspot mutant reactivation by synthetic metallochaperones for cancer chemotherapy,8976960,7/1/2015 0:00,6/30/2018 0:00,"Training, Individual",2015,34331, ,NIGMS,34331, ,34331
Deciphering the Molecular Pathways Driving p53 Dependent Cell Death,8977323,8/1/2015 0:00,8/31/2015 0:00,"Training, Individual",2015,3862, ,NCI,3862, ,3862
Role of SAG/RBX2 E3 Ubiquitin Ligase in Skin Carcinogenesis,8977486,1/3/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2016,322663, ,NCI,207500,115163,322663
SIM2s Regulation of Senescence,8977493,12/3/2014 0:00,11/30/2017 0:00,Non-SBIR/STTR,2016,157708, ,NCI,108750,48958,157708
Defining the temporal sequence of PI3K pathway mutations in bladder cancer,8978299,1/1/2014 0:00,12/31/2018 0:00,Non-SBIR/STTR,2016,368728, ,NCI,207500,161228,368728
Defining the Role for A Lipid Kinase in the Progression of Pancreatic Cancer,8982220,3/1/2015 0:00,2/28/2017 0:00,Non-SBIR/STTR,2016,172913, ,NCI,108750,64163,172913
Mitigation of asbestos induced alveolar epithelial cell injury,8982232,3/1/2012 0:00,12/31/2017 0:00,Non-SBIR/STTR,2016,328441, ,NIEHS,212583,115858,328441
PL Growth,8984278, , ,Research Centers,2016, ,24971, ,12872,12099, 
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway,8984292,8/19/2005 0:00,11/30/2019 0:00,Non-SBIR/STTR,2016,372875, ,NCI,237500,135375,372875
AMPK and AMPK-related kinases in lung cancer development and treatment,8984294,1/16/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2016,402550, ,NCI,207500,195050,402550
Quinone Oxidoreductases and Mammary Toxicity/Carcinogenenicity,8984305,5/15/2013 0:00,11/1/2016 0:00,Non-SBIR/STTR,2016,345375, ,NIEHS,225000,120375,345375
Information Processing by Post-translational Modification,8984892,12/15/2014 0:00,11/30/2018 0:00,Non-SBIR/STTR,2016,362667, ,NIGMS,236103,126564,362667
p53-Mediated Tumor Immune Surveillance,8985286,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,366000, ,NCI,228750,137250,366000
Identification and targeting of the signaling pathways underlying lung cancer.,8985664,3/1/2009 0:00,12/31/2018 0:00,Non-SBIR/STTR,2016,432000, ,NCI,225000,207000,432000
Defining Critical p53 Therapeutic Targets and Mechanisms,8986160,3/1/2009 0:00,11/30/2019 0:00,Non-SBIR/STTR,2016,436500, ,NCI,225000,211500,436500
Characterization of mTOR signaling during early stages of gliomagenesis,8986322,9/1/2015 0:00,8/31/2018 0:00,"Training, Individual",2015,39768, ,NCI,39768, ,39768
Tissue-specific tumor suppressor effects of p53,8987291,7/17/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,400089, ,NCI,236041,164048,400089
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias,8987670,9/1/2015 0:00,8/31/2020 0:00,Non-SBIR/STTR,2015,408319, ,NCI,228750,179569,408319
Developing cancer therapies through targeting the Six1/Eya transcriptional complex,8989081,12/18/2014 0:00,11/30/2016 0:00,Non-SBIR/STTR,2016,202928, ,NCI,130500,72428,202928
Novel therapeutic strategies targeting conformational plasticity of type I MAGE,8989523,12/19/2014 0:00,11/30/2016 0:00,Non-SBIR/STTR,2016,182588, ,NCI,109870,72718,182588
"Fortilin, p53, and atherosclerosis",8990043,1/15/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2016,382500, ,NHLBI,250000,132500,382500
Progression and Metastasis of Oral Tongue Cancer,8990470,5/10/2003 0:00,12/31/2018 0:00,Non-SBIR/STTR,2016,482857, ,NIDCR,314463,168394,482857
Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 ,8991273, , ,Research Centers,2016, ,203571, ,120946,82625, 
Project 5,8991290, ,12/31/2017 0:00,Non-SBIR/STTR,2016, ,644371, ,335607,308764, 
Identification and Targeting Therapy Resistant Osteosarcoma,8991309,1/1/2015 0:00,12/31/2017 0:00,Non-SBIR/STTR,2016,167987, ,NCI,126274,41713,167987
Role of p53 Missense Mutations on Tumorigenesis in Vivo,8991482,9/1/1999 0:00,12/31/2019 0:00,Non-SBIR/STTR,2016,342000, ,NCI,213750,128250,342000
New transgenic animal model to study pancreatic cancer,8991487,1/1/2015 0:00,12/31/2016 0:00,Non-SBIR/STTR,2016,178234, ,NCI,116875,61359,178234
Resistance of CML Stem Cells to Imatinib (Gleevec),8993128,7/1/2003 0:00,3/31/2018 0:00,Non-SBIR/STTR,2015,275378, ,NCI,187332,88046,275378
HHV-8 vIRF interactions in the context of infection,8994365,8/1/2015 0:00,7/31/2017 0:00,Non-SBIR/STTR,2015,176175, ,NCI,108750,67425,176175
Mechanisms of Intestinal Tumorigenesis,8995416,1/1/2000 0:00,11/30/2020 0:00,Non-SBIR/STTR,2016,395000, ,NCI,250000,145000,395000
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus,8995526,8/25/2010 0:00,3/31/2021 0:00,Non-SBIR/STTR,2016,617094, ,NCI,441687,175407,617094
Alternative Mechanisms to Inactivate p53 During Oncogenesis,8995889,3/14/2011 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,63867, ,NCI,42832,21035,63867
Wee1 and HDAC inhibition in relapsed/refractory AML,8996440,7/15/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2015,938670, ,NCATS,717296,221374,938670
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer,8996935,5/5/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2016,951958, ,NCI,624640,327318,951958
Ecd as a regulator of cell cycle and breast oncogenesis,8997161,3/1/2011 0:00,2/28/2017 0:00,Non-SBIR/STTR,2015,49363, ,NCI,35138,14225,49363
Targeting Acetyltransferase Gene Inactivation in Diffuse Large B Cell Lymphoma,8997375,8/30/2016 0:00,7/31/2021 0:00,Research Centers,2016, ,381366, ,284694,96672, 
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,8997402,2/7/2013 0:00,1/31/2018 0:00,Non-SBIR/STTR,2016,381420, ,NCI,285914,95506,381420
The Role of p53-inducible Sesn1 and Sesn2 genes in lung carcinogenesis,8997468,2/1/2013 0:00,1/31/2018 0:00,Non-SBIR/STTR,2016,316438, ,NCI,207500,108938,316438
Molecular mechanisms of myeloid suppressor genes on chromosome 5,8997482,2/1/2015 0:00,1/31/2020 0:00,Non-SBIR/STTR,2016,361425, ,NCI,228750,132675,361425
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma,8997992,9/13/2013 0:00,11/30/2017 0:00,Non-SBIR/STTR,2016,246582, ,NCI,183234,63348,246582
Quercetin as an enhancer of the efficacy of 5-FU in mouse models of colon cancer,8998967,5/1/2014 0:00,1/31/2018 0:00,Other Research-Related,2016,110250, ,NIGMS,75000,35250,110250
Mammary carcinogenesis:  pubertal and adult effects of high fat diet+oxybenzone,8999647,9/30/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,889748, ,NIEHS,599303,290445,889748
FoxM1 in tumor cell,9000002,6/1/2009 0:00,3/31/2019 0:00,Non-SBIR/STTR,2016, , , , , , 
The role of Src kinase in estrogen receptor-positive breast cancer proliferation,9000136,1/1/2014 0:00,7/31/2018 0:00,"Training, Individual",2016,32322, ,NCI,32322, ,32322
Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling,9000677,2/1/2015 0:00,1/31/2018 0:00,Non-SBIR/STTR,2016,217303, ,NCI,182600,34703,217303
Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures,9000967,9/30/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2015,679233, ,NCI,390207,153181,543388
MOLECULAR & STRUCTURAL BIOLOGY,9001259, , ,Research Centers,2016, ,75246, ,49817,25429, 
CANCER CELL BIOLOGY,9001266, , ,Research Centers,2016, ,34363, ,22750,11613, 
Genetic Mouse Models of Glioma,9001312,3/1/2009 0:00,1/31/2017 0:00,Non-SBIR/STTR,2016,439544, ,NCI,249883,189661,439544
Hdac3 as a therapeutic target in BCL6-dependent lymphoma,9001316,2/20/2012 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,403135, ,NCI,258420,144715,403135
Development of Zinc Metallochaperones as Mutant p53 Targeted Anti-cancer Drugs,9005386,3/15/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2016,379853, ,NCI,260912,118941,379853
p53 Variants in Cancer Risk and Therapy,9007017,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2016,466358, ,NCI,256658,209700,466358
Targeting GRP78 for p53 activation as anti-cancer therapy,9008031,3/1/2015 0:00,2/28/2018 0:00,Non-SBIR/STTR,2016,163669, ,NCI,108750,54919,163669
Mechanisms of Metabolic Gene Mutations in Cancer,9010942,3/1/2012 0:00,2/28/2019 0:00,Non-SBIR/STTR,2016,307100, ,NCI,207500,99600,307100
Understanding the role of Polycomb Repressive Complex 2 in melanoma,9011370,2/15/2015 0:00,2/14/2018 0:00,"Training, Individual",2016,43576, ,NCI,43576, ,43576
Cancer biology in the zebrafish,9012017,7/3/2003 0:00,2/28/2018 0:00,Non-SBIR/STTR,2016,373081, ,NCI,210780,162301,373081
Roles of EAF2 in androgen action in the prostate,9013459,12/18/1996 0:00,2/28/2019 0:00,Non-SBIR/STTR,2016,371525, ,NCI,241250,130275,371525
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer,9015258,3/1/2015 0:00,2/28/2018 0:00,"Training, Individual",2016,59970, ,NCI,59970, ,59970
Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling,9015747,3/1/2015 0:00,6/14/2017 0:00,Non-SBIR/STTR,2016,6092, ,NCI,3807,2285,6092
Nanotheranostics for Early Colorectal Cancer Detection and Treatment,9015793,3/6/2013 0:00,2/28/2018 0:00,Non-SBIR/STTR,2016,327850, ,NCI,207500,120350,327850
Intratumoral Heterogeneity and Tumor Evolution in Lymphoma,9016429,2/10/2015 0:00,6/9/2018 0:00,"Training, Individual",2016,43576, ,NCI,43576, ,43576
Fully Synthetic Prodiginines as Probes of Protein-Protein Interactions Regulating,9016502,4/16/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2016,357493, ,NCI,240007,117486,357493
Ceramide signaling in the regulation of cellular response to folate stress,9016504,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2016,347700, ,NCI,228750,118950,347700
"Merkel cell polyomavirus infection, DNA damage response and cancer",9016508,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2016,366000, ,NCI,228750,137250,366000
Oncogenic Function of ATDC in Bladder Cancer,9017959,4/10/2014 0:00,2/28/2017 0:00,Non-SBIR/STTR,2016,444272, ,NCI,286627,157645,444272
Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy,9017967,4/1/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2016,480479, ,NCI,380457,100022,480479
P53 survival target DDR1 kinase in DNA damage response and carcinogenesis,9017978,3/1/2015 0:00,2/29/2020 0:00,Non-SBIR/STTR,2016,398025, ,NCI,228750,169275,398025
Regulation of epithelial-mesenchymal transition and stem cell activity by PTEN in breast cancer,9018435,4/1/2016 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,198474, ,NCI,130500,67974,198474
Gammaherpesvirus interactions with host tumor suppressor p53,9020213,4/4/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2016,359998, ,NCI,245431,114567,359998
"Novel, orally available ATM inhibitor for glioma conformal radiosensitization",9021243,12/1/2015 0:00,11/30/2017 0:00,Non-SBIR/STTR,2016,199013, ,NCI,130500,68513,199013
The Function of rpL5 and rpL11 in induction of p53,9021545,3/1/2012 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,224100, ,NCI,207500,16600,224100
Epigenetic regulation by tumor suppressor p53,9021606,4/1/1999 0:00,2/29/2020 0:00,Non-SBIR/STTR,2016,352848, ,NCI,223022,129826,352848
Novel therapeutic targets for Diamond Blackfan anemia and other ribosomopathies,9021642,4/9/2012 0:00,2/28/2017 0:00,Other Research-Related,2016,152874, ,NIDDK,141550,11324,152874
New Paradigm of Targeting COX-Catalyzed Free Radical Peroxidation in Colon Cancer,9022113,8/16/2016 0:00,7/31/2020 0:00,Non-SBIR/STTR,2016,435000, ,NIGMS,220690,99310,320000
The Eighth International Mdm2 Workshop,9022188,9/22/2015 0:00,8/31/2016 0:00,Other Research-Related,2015,7800, ,NCI,7800, ,7800
DACH1/Eya Cell fate determination factor and mammary tumorigenesis,9022417,7/20/2009 0:00,12/31/2016 0:00,Non-SBIR/STTR,2016,331084, ,NCI,213942,117142,331084
Examining melanoma cell subpopulations in tumor maintenance and drug resistance,9022443,3/15/2014 0:00,3/14/2017 0:00,"Training, Individual",2016,58002, ,NCI,58002, ,58002
Targeting PAK4 for Overcoming Drug Resistance in Pancreatic Cancer,9023516,3/1/2015 0:00,2/28/2018 0:00,Non-SBIR/STTR,2016,166840, ,NCI,108750,58090,166840
Mechanisms for Selective Transcription of p53 Targets by the AcK120 Isoform,9024468,3/9/2013 0:00,8/12/2016 0:00,"Training, Individual",2016,28092, ,NCI,28092, ,28092
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis,9024470,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2016,332000, ,NCI,207500,124500,332000
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model,9024486,3/1/2015 0:00,2/29/2020 0:00,Non-SBIR/STTR,2016,377464, ,NCI,261399,116065,377464
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes,9024527,5/6/2014 0:00,2/29/2020 0:00,Non-SBIR/STTR,2016,335250, ,NIEHS,225000,110250,335250
p53 in Melanomagenesis,9025224,1/1/2016 0:00,12/31/2017 0:00,Non-SBIR/STTR,2016,77750, ,NCI,50000,27750,77750
Building personalized avatars of human cancer to predict response to therapy,9025326,12/8/2015 0:00,11/30/2017 0:00,Non-SBIR/STTR,2016,221198, ,NCI,130500,90698,221198
Structural basis for CBP/p300 transcriptional regulation,9026569,6/10/2002 0:00,3/31/2017 0:00,Non-SBIR/STTR,2016,407364, ,NCI,214968,192396,407364
Rad50: Roles in chromo. stab. and prev. of malignancy,9026766,1/1/1998 0:00,12/31/2019 0:00,Non-SBIR/STTR,2016,472473, ,NIGMS,275655,196818,472473
Regulation of p53 by TAF1,9027084,7/15/1997 0:00,1/31/2021 0:00,Non-SBIR/STTR,2016,367135, ,NCI,237500,129635,367135
MicroRNA Targets for Chemoprevention of Squamous Cell Carcinoma,9027333,12/1/2015 0:00,8/31/2016 0:00,Non-SBIR/STTR,2016,44012, ,NCI,34370,9642,44012
Local Immuroregulation of Cutaneous Carcinogenesis,9028180,7/1/2003 0:00,11/30/2020 0:00,Non-SBIR/STTR,2016,396427, ,NCI,237500,158927,396427
REGULATION OF TUMOR SUPPRESSION BY ARF,9028907,4/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2016,348844, ,NCI,228750,120094,348844
Multi-scale enhanced sampling of disordered proteins,9029039,1/1/2016 0:00,11/30/2020 0:00,Non-SBIR/STTR,2016,288750, ,NIGMS,192500,96250,288750
The role of AXL-ABL axis in Barrett's carcinogenesis,9029157,3/1/2016 0:00,4/29/2016 0:00,Non-SBIR/STTR,2016,134527, ,NCI,45287,89240,134527
NOX4 mediates oxidative stress in ovarian tumor growth and treatment response,9029719,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2016,356850, ,NCI,228750,128100,356850
Analysis of Centrosome Dynamics,9030241,9/29/2006 0:00,12/31/2019 0:00,Non-SBIR/STTR,2016,331288, ,NIGMS,212500,118788,331288
Targeting Olig2 Co-regulators for Malignant Glioma Therapy,9030293,9/30/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2015,349149, ,NINDS,266438,82711,349149
Mechanisms of preferential targeting of colon cancer by a plant-derived alkaloid,9031049,4/1/2012 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,392500, ,NCCIH,250000,142500,392500
"DNA double-strand break repair, chromosomes translocations and cancer",9031074,4/8/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2016,1778566, ,NCI,1111604,666962,1778566
The Role of CTIP in Breast Carcinogenesis,9031078, , ,Non-SBIR/STTR,2016, ,393141, ,245713,147428, 
Development of cell-free DNA assays for HCC screening and liquid biopsy,9031242,6/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2016,432900, ,NCI,334816,98084,432900
The role of IL8 in colitis-associated tumor initiation,9031725,11/1/2013 0:00,3/31/2019 0:00,Non-SBIR/STTR,2016,328888, ,NCI,207500,121388,328888
Identification and targeting of colon cancer initiating cells,9032192,10/1/2009 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016, , , , , , 
Mechanisms of Gene-Specific Transcriptional Regulation Within the p53 Network,9032452,5/26/2006 0:00,3/31/2017 0:00,Non-SBIR/STTR,2016,284794, ,NCI,183147,101647,284794
New Models and Treatments for AIDS-related Lymphoma,9032456,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,416873, ,NCI,280334,136539,416873
Triad1 regulates myelopoiesis and functions as a leukemia suppressor,9032480,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2016,353419, ,NCI,228750,124669,353419
Targeting the oncogenic mutant p53 signaling in colorectal cancer therapy,9033082,4/18/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2016,365779, ,NCI,207500,158279,365779
Regulation of MDM2 auto-ubiquitination and molecular targeting,9033085,12/15/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,251191, ,NCI,161020,90171,251191
Role of Otubain 1 in the p53 Pathway,9033868,5/1/2012 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,318205, ,NCI,207500,110705,318205
Defining mechanisms of extracellular communication for cancer therapy,9033869,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,323700, ,NCI,207500,116200,323700
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor,9034552,4/10/2012 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,298980, ,NCI,198000,100980,298980
Whole exome sequencing of oropharyngeal carcinoma (OPX-WES),9034559,4/1/2015 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,56500, ,NCI,50000,6500,56500
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,9034718,9/30/2010 0:00,2/29/2020 0:00,Non-SBIR/STTR,2016,387111, ,NIDDK,254678,132433,387111
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer,9034830,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2016,434625, ,NCI,228750,205875,434625
Mitochondrial Motility and Inheritance,9035520,7/1/1993 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,69696, ,NIGMS,45743,23953,69696
Functional Analysis of p53 polymorphic variants,9035881,6/1/2005 0:00,11/30/2020 0:00,Non-SBIR/STTR,2016,384750, ,NCI,202500,182250,384750
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis,9036335,9/24/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,320682, ,NCI,184300,136382,320682
Modulation of skin cancer by PPARb/d,9036336,3/1/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,247146, ,NCI,165870,81276,247146
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer,9036866, , ,Research Centers,2016, ,331241, ,214395,116846, 
Developmental studies to inform clinical stratification and targeting of SHH MB,9037110,4/4/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2016,484999, ,NCI,299419,185580,484999
Validating the protein binding domain of replication protein A as a cancer target,9037504,4/1/2014 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,325775, ,NCI,207500,118275,325775
Murine Model of HCV-Associated Human Liver Cancer,9037608,5/1/2012 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,470695, ,NCI,318037,152658,470695
"Chemoprevention by black raspberry in oral cancer induced by DB[a,l]P in mice",9037613,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,315112, ,NCI,229936,85176,315112
A p53/NFkB-mediated metabolic mechanism for chemotherapy protection,9038171,4/1/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2016,335113, ,NCI,207500,127613,335113
In vivo murine models of metastasis for therapeutic testing,9038322,4/16/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2016,400209, ,NCI,343389,56820,400209
P53 inactivation on MDSC development and tumor progression,9038326,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,315400, ,NCI,207500,107900,315400
Targeting stabilized mutant p53 protein,9038330,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,356514, ,NCI,225642,130872,356514
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis,9040109,5/14/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,328265, ,NCI,219016,109249,328265
"NUCKS, a novel double-strand break repair gene, implicated in cancer biology",9040187,6/28/2012 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,344758, ,NIEHS,248479,96279,344758
"Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa",9040520,7/1/2010 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,60458, ,NCI,40190,20268,60458
Therapeutic strategies for specific subsets of KRAS mutant lung cancers,9040886,8/3/2009 0:00,3/31/2017 0:00,Non-SBIR/STTR,2016,512243, ,NCI,423910,88333,512243
Toll-like Receptor Regulation of Pancreatic Tumorigenesis,9040905,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,351713, ,NCI,207500,144213,351713
"ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY",9040906,5/1/2013 0:00,8/31/2016 0:00,Non-SBIR/STTR,2016,181640, ,NCI,119500,62140,181640
Genetic Alterations that Initiate Follicular Thyroid Carcinogenesis,9041528,3/1/2008 0:00, ,Non-SBIR/STTR,2016, ,424962, ,311830,113132, 
Targeting the cytokine circuitry of KRAS-driven lung cancer,9042321,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2016,394578, ,NCI,228750,165828,394578
Role of p53 family proteins in glucose metabolism,9042843,5/6/2014 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,332000, ,NCI,207500,124500,332000
Role of SIRT1 in melanocyte biology and melanocyte transformation,9042989,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,314176, ,NCI,236633,77543,314176
Electrocatalytic Studies of Toxic Pollutant Activation,9043066,3/1/1983 0:00,3/31/2019 0:00,Non-SBIR/STTR,2016,364615, ,NIEHS,253179,111436,364615
Mechanisms of preferential targeting of colon cancer by a plant-derived alkaloid,9044097,4/1/2012 0:00,3/31/2016 0:00,Non-SBIR/STTR,2015,67026, ,NCCIH,48598,18428,67026
Full Project 3: Molecular Pathways to Breast Cancer Mortality among African American and White Women,9044451,9/28/2010 0:00,8/31/2020 0:00,Research Centers,2015, ,196816, ,129605,67211, 
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors,9045583,6/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2016,402550, ,NCI,207500,195050,402550
Small molecule inhibitors targeting oncogenic drivers of hepatocellular carcinoma,9047453,3/1/2016 0:00,11/30/2017 0:00,SBIR/STTR,2016,298959, ,NCI, , ,298959
The role of p53 in constraining pro-tumorgenic reprogramming,9047760,5/1/2016 0:00,4/30/2019 0:00,"Training, Individual",2016,54294, ,NCI,54294, ,54294
Full Project 3: Molecular Pathways to Breast Cancer Mortality among African American and White Women,9050350,9/29/2010 0:00,8/31/2020 0:00,Research Centers,2015, ,64798, ,44999,19799, 
Novel Antitumor Agents,9052569,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,376379, ,NCI,248730,127649,376379
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous Epithelia,9052747,4/10/2015 0:00,8/31/2016 0:00,Non-SBIR/STTR,2016,234646, ,NCI,324352,97110,234646
Original Phase 1 Title: Identifying Small Molecule Inhibitors of HdmX using Cell-based Screening Revised Title: Development of a Novel HdmX Inhibitor for Leukemia,9053452,4/1/2009 0:00,3/31/2019 0:00,SBIR/STTR,2016,717790, ,NCI, , ,717790
HCS to Identify Inhibitors and Disruptors of AR-TIF2 Interactions,9053458,5/1/2015 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,350826, ,NCI,227809,123017,350826
Using Markers to Improve Pancreatic Cancer Screening,9054087,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,416661, ,NCI,257198,159463,416661
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES,9054090,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2016,364993, ,NCI,207500,157493,364993
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors,9054093,6/1/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2016,464569, ,NCI,294031,170538,464569
Cell-cycle regulatory kinases as targets for male contraceptive drug development,9054146,5/20/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2016,311334, ,NICHD,320743,59755,311334
Transcriptional regulation of oncogenic properties of mutant p53,9054217,5/1/2013 0:00,9/4/2015 0:00,Non-SBIR/STTR,2015,46499, ,NCI,30491,16008,46499
Transcriptional Regulations of Oncongenic Properties of Mutant P53,9054820,5/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,299445, ,NCI,189522,109923,299445
HAUSP inhibitors in p53-wild type and p53-mutant tumors,9054821,5/1/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,366000, ,NCI,228750,137250,366000
Regulation of SLC7A11 by p53 in cancer metabolism,9055249,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2016,366000, ,NCI,228750,137250,366000
Visualizing the effect of epigenetic modifications on transcription and mutation,9055433,9/15/2010 0:00,5/31/2017 0:00,Non-SBIR/STTR,2014,338094, ,OD,177944,160150,338094
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy,9055550,3/1/2012 0:00,2/28/2018 0:00,Non-SBIR/STTR,2016,393213, ,NCI,207500,185713,393213
Targeting the Chk1-Suppressed Apoptotic Pathway in HNSCC,9055663,7/5/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,346094, ,NCI,204185,141909,346094
p53/Rb Reactivation Modulators for HPV-positive Head and Neck Cancer,9056033,2/1/2016 0:00,1/31/2020 0:00,Non-SBIR/STTR,2016,375149, ,NIGMS,300873,74276,375149
Focus on Dicer inhibition as a novel treatment for brain tumors,9056040,9/30/2015 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,228000, ,NINDS,150000,78000,228000
"Role of the p53 C-terminal domain in tissue homeostasis, tumor suppression, and oncogenesis",9056104,12/15/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2016,616704, ,NCI,464167,152537,616704
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH,9056497,7/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,320338, ,NCI,220865,99473,320338
The role of MDM2-MTBP axis in cancer metastasis,9056506,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2016,313325, ,NCI,207500,105825,313325
Regulation of Mutant P53 Expression and Oncogenic Activity,9056536,2/1/2007 0:00,5/31/2017 0:00,Non-SBIR/STTR,2016,282901, ,NCI,184300,98601,282901
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals,9056554,5/16/2014 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,325181, ,NCI,213321,111860,325181
Mitochondrial Motility and Inheritance,9056569,7/1/1993 0:00,4/30/2017 0:00,Non-SBIR/STTR,2016,404255, ,NIGMS,253367,150888,404255
Biological Activity of HPV E7 in Human Epithelial Cells,9056591,4/19/1996 0:00,3/31/2020 0:00,Non-SBIR/STTR,2016,371250, ,NCI,225000,146250,371250
Basal cell carcinomas: p53-dependent mechanisms of resistance,9057984,4/1/2012 0:00,3/31/2017 0:00,Non-SBIR/STTR,2016,336150, ,NCI,207500,128650,336150
Dynamics of Signaling Pathways: Mechanism and Function,9058084,3/1/2008 0:00,7/31/2017 0:00,Non-SBIR/STTR,2016,320438, ,NIGMS,190000,130438,320438
Treating pancreatic cancer with Listeria-32P,9058504,5/1/2015 0:00,12/31/2018 0:00,Non-SBIR/STTR,2016,177377, ,NCI,106213,71164,177377
Localizing Immunotherapy to Improve Therapeutic Index,9059035,6/4/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,395388, ,NCI,255380,140008,395388
Defining the role of mutant XPO1 in chronic lymphocytic leukemia,9059416,5/1/2015 0:00,4/30/2020 0:00,"Training, Individual",2016,38311, ,NCI,38311, ,38311
Replicative Senescence as a Tumor Suppressive Mechanism,9060259,8/8/2007 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,306860, ,NCI,184300,122560,306860
Mitochondrial p32 regulation of the Mdm2-p53 tumor suppression signaling and apop,9060280,7/1/2012 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,307100, ,NCI,207500,99600,307100
Mdm2-p53 signaling in the DNA damage response and in tumorigenesis,9060898,3/1/1999 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,351619, ,NCI,213750,137869,351619
Targeted Therapy for Endometrial Cancer,9061618,7/17/2002 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,252448, ,NCI,167184,85264,252448
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer,9062294,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2016,333133, ,NCI,207500,125633,333133
"Spindle Assembly Checkpoint, Chromosome Stability, and Cancer",9062385,9/1/2008 0:00,10/31/2018 0:00,Non-SBIR/STTR,2016,314977, ,NCI,201263,113714,314977
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer,9062403,5/1/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,347191, ,NCI,250977,96214,347191
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression,9063100,5/1/1983 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,468594, ,NCI,266398,202196,468594
PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM,9063529,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,332401, ,NCI,266529,65872,332401
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming,9064044,9/30/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2016,466235, ,NIA,265057,201178,466235
Genome wide analysis of p53 inhibition by high glucose,9064088,5/1/2013 0:00,4/30/2018 0:00,"Training, Individual",2016,37801, ,NCI,37801, ,37801
Role of p300 in HPV-positive Head and Neck Cancer,9064131,5/6/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,485789, ,NIDCR,379916,105873,485789
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors,9064729,5/7/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,540936, ,NCI,360927,180009,540936
Investigating the role of Retrotransposon muERV-L reactivation in Tumorigenesis,9065170,5/1/2015 0:00,4/30/2018 0:00,"Training, Individual",2016,56118, ,NCI,56118, ,56118
Targeting Leukemia Stem Cells with Dietary Selenium,9065510,8/1/2012 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016,303222, ,NCI,207500,95722,303222
Mechanisms of obesity-induced hepatocarcinogenesis,9065516,5/8/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,364322, ,NCI,302017,62305,364322
The role of MCM8-9 in genomic instability of cancers,9065937,7/11/1994 0:00,5/31/2019 0:00,Non-SBIR/STTR,2016,355500, ,NCI,225000,130500,355500
Targeting Gain-of-Function p53 Missense Mutants,9066126,7/1/2014 0:00,6/30/2017 0:00,"Training, Individual",2016,28228, ,NCI,28228, ,28228
MKP-1 Effects on HIF-1alpha and Glycolytic Metabolism in Glioblastoma multiforme,9066597,7/1/2013 0:00,6/30/2017 0:00,"Training, Individual",2016,43576, ,NCI,43576, ,43576
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer,9067264,7/20/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2016,491237, ,NIDCR,357860,133377,491237
Rad50: Roles in chromo. stab. and prev. of malignancy,9067628,1/1/1998 0:00,1/31/2016 0:00,Non-SBIR/STTR,2015,170038, ,NIGMS,96668,73370,170038
Molecular Oncology,9067988, , ,Research Centers,2016, ,42485, ,27912,14573, 
p53 - Regulators and Effectors,9068414,2/16/2000 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,70000, ,NCI,41298,28702,70000
Bypassing mutant p53 in radiation therapy,9068886,6/15/2014 0:00,6/14/2017 0:00,"Training, Individual",2016,48576, ,NCI,48576, ,48576
Study of Novel HHV8/KSHV Encoded Genes,9069433, , ,Non-SBIR/STTR,2016, ,401898, ,265981,135917, 
Origins of Ovarian Carcinoma,9069746,5/18/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,358780, ,NCI,228750,130030,358780
Cellular Stress Response Signaling Pathways,9070613,1/1/1992 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016,353250, ,NIEHS,225000,128250,353250
Epigenetic Regulation of Human Telomeres,9070623,7/1/2010 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,420000, ,NCI,240000,180000,420000
Targeting Autophagy in Hereditary Breast Cancer,9070644,6/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2016,474468, ,NCI,302801,171667,474468
ERK3 Kinase Signaling in Lung Cancer,9070693,6/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2016,338550, ,NCI,228750,109800,338550
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation,9071302,5/1/1997 0:00,7/31/2017 0:00,Non-SBIR/STTR,2016,1440175, ,NCI,902073,538102,1440175
Investigation of Regulatory RNAs in Tumor Development,9071304, ,7/31/2017 0:00,Non-SBIR/STTR,2016, ,267154, ,267154,0, 
A PTEN-dependent cell size checkpoint in human cells,9071345,5/11/2006 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,241207, ,NCI,155117,86090,241207
Developing CRM1 inhibitors in AML,9071394,7/16/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2016,319550, ,NCI,207500,112050,319550
Novel oncogenic functions of Mdm2 and Mdmx,9071401,7/18/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2016,322477, ,NCI,207500,116200,322477
MECHANISMS OF ANNEXIN A6-MEDIATED BASAL-LIKE BREAST CANCER PROGRESSION,9073531,8/16/2016 0:00,7/31/2020 0:00,Other Research-Related,2016,363750, ,NIGMS,250000,113750,363750
Targeting Human Cancers with Hemizygous Deletion of TP53,9074698,4/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2016,366000, ,NCI,228750,137250,366000
Restoration of Tumor Suppression Activity in Malignant Melanoma,9074930,7/1/2006 0:00,4/30/2016 0:00,Non-SBIR/STTR,2015,96654, ,NCI,62967,33687,96654
Novel integrative method to detect biomakers of breast cancer resistance,9076623,8/1/2013 0:00,7/31/2018 0:00,Other Research-Related,2015,200109, ,NLM,130925,69184,200109
"The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer",9081527,9/1/2012 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,291169, ,NCI,183125,108044,291169
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease,9084564,9/1/2012 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016,335515, ,NIEHS,225000,110515,335515
HHV-8 vIRF interactions in the context of infection,9085244,8/1/2015 0:00,7/31/2018 0:00,Non-SBIR/STTR,2016,211410, ,NCI,130500,80910,211410
The Function of rpL5 and rpL11 in induction of p53,9085489,3/1/2012 0:00,2/28/2018 0:00,Non-SBIR/STTR,2015,165240, ,NCI,153000,12240,165240
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression,9086012,4/15/2016 0:00,3/31/2021 0:00,Other Research-Related,2016,159720, ,NIDDK,147889,11831,159720
Defining a novel subtype of luminal-TP53 mutant breast cancer with poor prognosis,9086296,6/10/2015 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016,191291, ,NCI,108750,82541,191291
Underlying Mechanisms in Angiosarcoma,9087211,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,352275, ,NCI,228750,123525,352275
Preclinical evaluation of a novel combinatory epigenetics based therapy for glioblastoma,9087367,6/15/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2016,240000, ,NINDS,150000,90000,240000
Regulation of melanogenesis via FBXO11-mediated tyrosinase degradation,9088354,7/1/2014 0:00,6/30/2017 0:00,Non-SBIR/STTR,2016,84750, ,NIAMS,50000,34750,84750
Mechanisms of Radioresistance and Cell Cycle Progression,9088373,5/1/1995 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,347814, ,NCI,217384,130430,347814
Mechanism and treatment of PTEN mutant prostate tumorigenesis,9089959,7/30/2014 0:00,6/30/2019 0:00,Non-SBIR/STTR,2016,398400, ,NCI,207500,190900,398400
MUC13 Mucin in Colorectal Cancer Health Disparity,9090537,7/11/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2016,359410, ,NCI,236454,122956,359410
Intrinsic disorder controls the function of p53 and other cancer associated IDPs,9091148,6/1/2016 0:00,5/31/2020 0:00,Non-SBIR/STTR,2016,322052, ,NIGMS,254800,67252,322052
Genetic Analysis of the Breast Tumor Microenvironment,9091435,9/15/2004 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016,1561040, ,NCI,1103621,457419,1561040
Suppression of Mammary Tumorigenesis by Stromal p53,9091438,9/15/2004 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016, ,299187, ,233841,65346, 
"Head Neck Cancer, beta-defensins, and immune responses",9091572,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,396250, ,NIDCR,250000,146250,396250
Elucidating the drivers of medulloblastoma initiation and recurrence,9092249,2/1/2016 0:00,1/31/2018 0:00,Non-SBIR/STTR,2016,230250, ,NINDS,150000,80250,230250
RNA Splicing Modulators for MDS/AML,9093727,9/3/2013 0:00,6/30/2016 0:00,Research Centers,2016, ,401522, ,277894,123628, 
The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle,9093744,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,348844, ,NCI,228750,120094,348844
Development of proteasome adaptors to catalytically deplete specific proteins from cells,9094206,4/4/2016 0:00,3/31/2019 0:00,Non-SBIR/STTR,2016,185624, ,NCI,125000,60624,185624
Function and regulation of MDMX intra-molecular interactions,9094690,8/1/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2016,393450, ,NCI,228750,164700,393450
Identifying the Second Hit in MYC-driven Medulloblastoma; a Role for Gfi Proteins,9094713,7/1/2014 0:00,8/31/2016 0:00,"Training, Individual",2016,5467, ,NINDS,5467, ,5467
Chemical biology of superstolides--a novel class of anticancer natural products,9095027,4/1/2016 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,206296, ,NCI,138591,67705,206296
Molecular mechanism of RNA polymerase I transcription and dysregulation in cancer,9095259,9/17/2014 0:00,8/31/2018 0:00,Other Research-Related,2016,211470, ,NCI,195806,15664,211470
Ect2 Function in Lung Adenocarcinoma Initiation and Maintenance,9095722,4/1/2016 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,219491, ,NCI,140250,79241,219491
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit,9096053,9/1/2012 0:00,1/31/2018 0:00,Non-SBIR/STTR,2016,350164, ,NCI,225186,124978,350164
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans,9096071,5/16/2013 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,287743, ,NCI,228367,80141,287743
"Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe",9096229,8/1/2014 0:00,6/30/2019 0:00,Other Research-Related,2016,187380, ,NINDS,173500,13880,187380
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia,9096731,9/11/2013 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,347563, ,NCI,207500,140063,347563
Targeting p53-Dependent Repigmentation in Vitiligo,9097401,7/1/2012 0:00,6/30/2018 0:00,Other Research-Related,2016,100572, ,NIAMS,93530,7042,100572
"Telomerase in Development, Senescence and Neoplasia",9097525,1/1/2000 0:00,12/31/2019 0:00,Non-SBIR/STTR,2016,616000, ,NCI,385000,231000,616000
Molecular analysis of methylated p53,9097731,8/1/2013 0:00,7/31/2018 0:00,Non-SBIR/STTR,2016,326222, ,NIGMS,225420,100802,326222
Carcinogen-specific Twist1 regulation in lung epithial cells,9098413,9/1/2016 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,137952, ,NIEHS,92585,45367,137952
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer,9098638,9/11/2012 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,355819, ,NCI,213705,142114,355819
Development of a mouse model of pediatric high-grade gliomas,9099281,5/1/2016 0:00,4/30/2018 0:00,Non-SBIR/STTR,2016,74250, ,NCI,50000,24250,74250
Identifying Mechanisms of p53 and Rb Tumor Suppression In Small Cell Lung Cancer,9099478,4/1/2016 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,174816, ,NCI,108750,66066,174816
RNDI- Mediated Breast Cancer Suppression,9099744, , ,Non-SBIR/STTR,2016, ,508979, ,289357,219622, 
Regulation of Mdmx stability and subcellular localization by ubiquitination,9099789,8/14/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2016,302000, ,NCI,188750,113250,302000
Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC),9100664,9/15/2012 0:00,5/31/2017 0:00,Other Research-Related,2016,172260, ,NCI,159500,12760,172260
Investigate the role of TPD52-AMPK pathway in tumorigenesis and cancer therapy,9101191,4/15/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2016,363713, ,NCI,228750,134963,363713
Role of the pentose phosphate pathway in tumorigenesis,9101315,8/1/2016 0:00,7/31/2018 0:00,Non-SBIR/STTR,2016,175088, ,NCI,108750,66338,175088
Papillomavirus E6 Structural Consortium,9101969,2/1/2010 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,443504, ,NCI,332305,111199,443504
Dual Targeting of the p53 pathway for development of anti-cancer therapy,9102015,9/26/2012 0:00,7/31/2018 0:00,Non-SBIR/STTR,2016,312733, ,NCI,212038,100695,312733
A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia,9102017,7/1/2015 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,79500, ,NCI,50000,29500,79500
Signaling cascades in cholangiocarcinoma development,9102504,4/5/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2016,362569, ,NCI,228750,133819,362569
The impact of chromosome 17p lesions on leukemogeneis and therapy response,9103018,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,402371, ,NCI,228750,173621,402371
p53-Mediated Tumor Immune Surveillance,9103054,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,366000, ,NCI,228750,137250,366000
Safety and anti-cancer efficacy of FACT inactivation in mice,9103059,7/1/2015 0:00,6/30/2017 0:00,Non-SBIR/STTR,2016,190856, ,NCI,108750,82106,190856
The regulation of PP1 in the nucleus,9104450,9/1/2011 0:00,12/31/2016 0:00,Non-SBIR/STTR,2016,114399, ,NIGMS,70400,43999,114399
Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm,9104709,5/1/2016 0:00,4/30/2019 0:00,Non-SBIR/STTR,2016,471755, ,NCI,304358,167397,471755
Identifying stabilizers of p53 using pocket complementarity,9106643,9/26/2016 0:00,8/31/2020 0:00,Non-SBIR/STTR,2016,348458, ,NIGMS,226730,121728,348458
Definition of the Microenvironment in Breast Cancer,9107039,8/1/2016 0:00,7/31/2021 0:00,Non-SBIR/STTR,2016,491681, ,NCI,261102,230579,491681
Mitochondrially Targeted p53 DBD for Treatment of Ovarian Cancer,9107398,7/7/2015 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,194445, ,NCI,130500,63945,194445
Pediatric Preclinical Testing Consortium,9107415,7/7/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,357000, ,NCI,212500,144500,357000
Neuroendocrine mechanisms of prostate cancer progression,9107433,7/7/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,348145, ,NCI,228750,119395,348145
Suppression of mobile elements by p53 genes,9107479,8/1/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2016,319704, ,NIGMS,197500,122204,319704
CLONAL EVOLUTION OF HEMATOPOIETIC STEM CELLS DURING CHEMOTHERAPY AND TRANSPLANTATION,9109218,4/1/2016 0:00,3/31/2021 0:00,Other Research-Related,2016,121394, ,NCI,112402,8992,121394
Identification of genetic collaborators in cancer with a brca2-mutant zebrafish model,9109355,7/1/2016 0:00,6/30/2021 0:00,Other Research-Related,2016,126900, ,OD,117500,9400,126900
Mechanisms of Esophageal Carcinogenesis,9109578,8/15/2003 0:00,6/30/2019 0:00,Non-SBIR/STTR,2016,1607533, ,NCI,1174560,432973,1607533
Transformed Esophageal Epithelial Cells and the Tumor Microenvironment,9109584,8/15/2003 0:00, ,Non-SBIR/STTR,2016, ,351721, ,256989,94732, 
p53 and tumor cell metabolism,9110020,8/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2016,332000, ,NCI,207500,124500,332000
Nuclear Accumulation of Cyclin D1 and Oncogenesis,9110138,7/1/2001 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016,278127, ,NCI,186038,92089,278127
The role of Fyn and Srcasm in UVB-induced cutaneous neoplasia,9110901,8/1/2012 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016,332000, ,NCI,207500,124500,332000
A novel multi-targeted therapy for breast cancer resistance,9111810,2/1/2016 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,154204, ,NCI,108750,54919,154204
Deciphering the Molecular Pathways Driving p53 Dependent Cell Death,9112781,8/1/2015 0:00,7/31/2018 0:00,"Training, Individual",2016,58002, ,NCI,58002, ,58002
The role of ATRX and H3.3 mutations in pediatric glioblastoma,9112960,9/15/2014 0:00,9/14/2017 0:00,"Training, Individual",2016,57002, ,NCI,57002, ,57002
Non-catalytic functions of DNA-PK in DNA repair and tumorigenesis,9112965,9/1/2014 0:00,8/31/2017 0:00,"Training, Individual",2016,43576, ,NCI,43576, ,43576
Tissue-specific tumor suppressor effects of p53,9112967,7/17/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,411953, ,NCI,243040,168913,411953
The role of keratinocyte p53 in development of pigmented lesions,9113411,7/20/2015 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,77750, ,NIAMS,50000,27750,77750
Mechanisms behind hyperglycemia-associated breast cancer risk and progression,9113516,7/21/2015 0:00,6/30/2019 0:00,Other Research-Related,2016,358750, ,NIGMS,250000,108750,358750
Identification of Genetic Alterations Responsible for Primary GBM Clonal Evoluti,9114029,9/5/2001 0:00, ,Non-SBIR/STTR,2016, ,439511, ,346047,93464, 
Small Molecule Activators of Procaspases as Anti-Cancer Agents,9114048,8/6/2007 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,442139, ,NCI,307014,135125,442139
Mechanism of Bone Marrow Failure in Fanconi Anemia,9114294,3/1/1992 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,126865, ,NIDDK,80000,46865,126865
Modulation of p53 function by tyrosine kinase networks,9114862,9/7/2012 0:00,7/31/2017 0:00,Non-SBIR/STTR,2016,335113, ,NCI,207500,127613,335113
Restoring the Missing Zinc: A quantitative investigation of p53 hotspot mutant reactivation by synthetic metallochaperones for cancer chemotherapy,9114870,7/1/2015 0:00,4/28/2017 0:00,"Training, Individual",2016,30749, ,NIGMS,30749, ,30749
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity,9115083,8/1/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2016,1129825, ,NCI,657180,617749,1129825
Exploration of a Mutant p53 Reactivating Compound,9115537,8/16/2013 0:00,7/31/2018 0:00,Other Research-Related,2016,108739, ,NCI,100684,8055,108739
Cancer cell adaptation to glutamine deprivation,9116118,9/1/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,352750, ,NCI,207500,145250,352750
Modulation of cancer specific transcriptional factors with small molecules,9116134,8/1/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2016,401456, ,NCI,228750,172706,401456
Breast Cancer Prevention Using Bitter Melon as a Natural Product,9116142,9/1/2015 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,164756, ,NCI,108750,56006,164756
Characterization of Oncogenic Transcription Factor-Associated Proteins in SCC,9116800,9/1/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2016,241531, ,NCI,136074,105457,241531
The Role of PI3K in Growth Regulation,9116865,4/1/1990 0:00,5/31/2017 0:00,Non-SBIR/STTR,2016,491550, ,NIGMS,290000,201550,491550
RB-Related Proteins and Polyomavirus Large T antigen Transformation,9118068,5/2/1994 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,311400, ,NCI,180000,131400,311400
Novel integrative method to detect biomakers of breast cancer resistance,9118386,8/1/2013 0:00,7/31/2018 0:00,Non-SBIR/STTR,2016,202054, ,NLM,132455,69599,202054
The role of the p63-RBM38 loop in tumor suppression,9118598,4/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2016,358852, ,NCI,228750,130102,358852
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer,9118938,9/12/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,439351, ,NCI,249773,189578,439351
DBPs (pp: 363-418); DBP Overviews (pp 124-129) ,9119134, , ,Research Centers,2016, ,97961, ,63405,34556, 
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance,9119782,9/9/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,317475, ,NCI,186750,130725,317475
Cancer Prevention,9120321,7/11/2012 0:00,6/30/2017 0:00,Research Centers,2016, ,36443, ,36443,0, 
Probing the Pathogenesis of North American Indian Childhood Cirrhosis (NAIC),9121276,4/1/2016 0:00,3/31/2018 0:00,"Training, Individual",2016,28224, ,NIDDK,28224, ,28224
Mechanisms of novel cancer targets in ARF-mediated tumor suppression,9121484,9/1/2012 0:00,8/31/2017 0:00,Non-SBIR/STTR,2016,332000, ,NCI,207500,124500,332000
Defining the genetic requirements for maintenance of colorectal cancer,9121510,9/1/2014 0:00,8/31/2017 0:00,Other Research-Related,2016,194724, ,NCI,180300,14424,194724
Functionalizing recurrent FAT1 mutations and deletions in oral cancer,9121530,9/1/2014 0:00,8/31/2019 0:00,Other Research-Related,2016,136350, ,NIDCR,126250,10100,136350
The role of mutant p53 and endocytic recycling in ESCC invasion and metastasis,9121719,7/1/2016 0:00,6/30/2019 0:00,"Training, Individual",2016,54294, ,NCI,54294, ,54294
Role of Nix in pancreatic ductal adenocarcinoma,9121778,4/15/2016 0:00,7/14/2019 0:00,"Training, Individual",2016,33371, ,NCI,33371, ,33371
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni,9121786,8/1/2013 0:00,7/31/2018 0:00,Non-SBIR/STTR,2016,999920, ,OD,693585,306335,999920
Hypermutation and malignant progression in an expanded cohort of TMZ treated LGG patients from different molecular subgroups,9122075,4/1/2016 0:00,3/31/2019 0:00,"Training, Individual",2016,56118, ,NCI,56118, ,56118
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis,9122350,9/8/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,356313, ,NCI,250000,106313,356313
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw,9122358,9/1/2014 0:00,8/31/2018 0:00,Non-SBIR/STTR,2017,882372, ,NCI,632243,250129,882372
Heterocyclic Triads as Potential Therapeutic Agents for Renal Cell Carcinoma,9122732,7/1/2016 0:00,6/30/2018 0:00,"Training, Individual",2016,43576, ,NCI,43576, ,43576
Investigating the Role of the Mek5-Erk5 Kinase Module in Small Cell Lung Cancer,9122752,9/30/2016 0:00,9/29/2019 0:00,"Training, Individual",2016,43576, ,NCI,43576, ,43576
Treating pancreatic cancer with Listeria-32P,9122813,5/1/2015 0:00,4/30/2017 0:00,Non-SBIR/STTR,2015,198253, ,NCI,118715,79538,198253
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia,9123547,8/5/2003 0:00,8/31/2018 0:00,Research Centers,2016,2161999, ,NCI,1613481,548518,2161999
A comprehensive approach to breast cancer susceptibility across the risk spectrum,9123792,7/5/2011 0:00,6/30/2016 0:00,Non-SBIR/STTR,2015,19878, ,NCI,13341,6537,19878
Molecular Tumorigenesis of Bladder Cancer,9124859,9/12/2013 0:00,8/31/2016 0:00,Non-SBIR/STTR,2016, ,321793, ,189848,131945, 
DNA Repair and Tobacco Smoke in Bladder Carcinogenesis,9124860,9/12/2013 0:00,8/31/2016 0:00,Non-SBIR/STTR,2016, ,219440, ,129463,89977, 
Novel Role of XIAP in Bladder Cancer Invasion,9124861,9/12/2013 0:00,8/31/2016 0:00,Non-SBIR/STTR,2016, ,351362, ,207293,144069, 
Basis of Muscle Dysfunction in Malignant Hyperthermia & Central Core Disease,9125427,4/1/2006 0:00,3/31/2021 0:00,Non-SBIR/STTR,2016,647200, ,NIAMS,482899,164301,647200
Preclinical Development and Clinical Testing of MEK and PI3K Targeted Therapy for KRAS-mutant NSCLC,9125748, , ,Research Centers,2016, ,299590, ,241796,57794, 
SPORE: Targeted Therapies for Glioma,9125763,9/19/2013 0:00,7/31/2018 0:00,Research Centers,2016,2162000, ,NCI,1633454,528546,2162000
Targeting the OLIG2 Transcription Factor,9125769,9/19/2013 0:00,7/31/2016 0:00,Research Centers,2016, ,303630, ,229401,74229, 
The intersection of RNA biology and tumor biology,9125799,8/12/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2016,772009, ,NCI,551772,327838,772009
Polyploid cell cycle regulation and genome instability,9125871,8/12/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2016,308100, ,NIGMS,197500,110600,308100
Aurora-A is a novel therapeutic target in glioblastoma,9125899,9/1/2014 0:00,7/31/2017 0:00,Non-SBIR/STTR,2016,359357, ,NINDS,233349,126008,359357
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer,9126645,8/1/2014 0:00,8/31/2017 0:00,SBIR/STTR,2015,903055, ,NCI, , ,903055
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp,9127100, , ,Non-SBIR/STTR,2016, ,272354, ,258316,14038, 
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis,9127209,8/14/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2016,974380, ,NCI,600340,374577,974380
Regulation of esophageal gene expression and function by KLF5 and p53,9127223,9/20/2013 0:00,7/31/2017 0:00,Non-SBIR/STTR,2016,348000, ,NIDDK,217500,130500,348000
"Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.",9127953,8/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2016,580448, ,NCI,378248,202200,580448
Understanding the role of κB-Ras proteins in tumorigenesis,9128324,3/1/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2016,384782, ,NCI,240489,144293,384782
Molecular Virology Research Program,9128594, , ,Research Centers,2016, ,22641, ,13598,9043, 
Non-canonical gene regulation through a Drosophila p53 enhancer,9128642,9/1/2013 0:00,8/10/2017 0:00,"Training, Individual",2016,29621, ,NIGMS,29621, ,29621
EPHB4 Receptor Kinase as a Target in Prostate Cancer,9128687, , ,Research Centers,2016, ,285799, ,222322,63477, 
The Development of Novel Individualized Therapy for Triple-Negative Breast Cancer,9128748,9/1/2013 0:00,8/31/2018 0:00,Other Research-Related,2016,171720, ,NCI,159000,12720,171720
Genetic Mouse Models of Glioma,9129214,3/1/2009 0:00,1/31/2019 0:00,Non-SBIR/STTR,2015,236930, ,NCI,134696,102234,236930
Bifunctional Antibodies for Melanoma Therapy,9129609,9/1/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2016,442736, ,NCI,309036,133700,442736
Protein Kinase Signaling and Cell Cycle Control,9129694,12/1/2006 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016,503262, ,NIEHS,322604,180658,503262
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias,9130172,9/1/2015 0:00,8/31/2020 0:00,Non-SBIR/STTR,2016,408319, ,NCI,228750,179569,408319
Sphingolipids in Cancer Biology and Therapy,9130745,8/1/2003 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,1303773, ,NCI,892069,411704,1303773
Project 1: Role of Acid Sphingomyelinase in Breast Cancer,9130750,8/1/2003 0:00, ,Non-SBIR/STTR,2016, ,222676, ,152359,70317, 
Project 3: Role of Sphingosine Kinase in P53 Cancer Biology,9130752,8/1/2003 0:00, ,Non-SBIR/STTR,2016, ,208836, ,142890,65946, 
Molecular Landscape-based Innovative Therapies for Anaplastic Thyroid Carcinoma,9130795, , ,Research Centers,2016, ,518583, ,331781,186802, 
Molecular Biology of Lung Cancer among Puerto Ricans,9132006, ,8/31/2017 0:00,Research Centers,2016, ,182347, ,124010,61706, 
Investigating microRNA miR-34a in lung cancer development and therapy,9132183,9/1/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2016,249000, ,NCI,148657,100343,249000
Risk and penetrance of mutations from breast cancer testing panels.,9132729,9/25/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,1299901, ,NCI,1061342,238559,1299901
Mechanisms of Tumorigenic Transformation of Barretts Esophagus,9132990,9/25/2015 0:00,4/29/2016 0:00,Non-SBIR/STTR,2015,99003, ,NCI,63059,35944,99003
Characterization of mTOR signaling during early stages of gliomagenesis,9133104,9/1/2015 0:00,8/31/2018 0:00,"Training, Individual",2016,40260, ,NCI,40260, ,40260
Single Cell Technologies for Rapid Detection of Tumor Heterogeneity,9133323,9/1/2015 0:00,7/31/2018 0:00,Non-SBIR/STTR,2016,238128, ,NCI,168902,69226,238128
From Mechanism to Population: Modeling HPV-related Oropharyngeal Carcinogenesis,9134093,9/11/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,639928, ,NCI,416467,223461,639928
Markers for Screening and Prognosis,9134686, ,8/31/2018 0:00,Research Centers,2016, ,285911, ,193618,118494, 
Directing the Mediator Complex: Bivalent approaches to Reconstituting or Inhibiti,9134699,8/1/2012 0:00,11/30/2017 0:00,Non-SBIR/STTR,2016,364316, ,NCI,318760,45556,364316
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo,9136078,9/2/2015 0:00,8/31/2017 0:00,Non-SBIR/STTR,2016,172913, ,NCI,108750,64163,172913
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer,9136080,9/2/2015 0:00,7/31/2019 0:00,Non-SBIR/STTR,2016,663814, ,NCI,415000,248814,663814
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,9136340,4/1/2011 0:00,3/31/2020 0:00,Non-SBIR/STTR,2016, , , , , , 
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer,9136654,8/1/2014 0:00,8/31/2020 0:00,SBIR/STTR,2016,988326, ,NCI, , ,988326
"Randomized, controlled pilot study of nicotinamide in polycystic kidney disease",9136856,9/10/2015 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,226500, ,NIDDK,150000,76500,226500
Targets for Therapy for Carcinomas of the Lung,9142255,7/23/2007 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,1736914, ,NCI,1135887,601027,1736914
Lung Cancer Drivers and Dependencies as Therapeutic Targets,9142261, ,8/31/2018 0:00,Non-SBIR/STTR,2016, ,365049, ,238731,126318, 
Cracking the Ubiquitination Code by Top Down Mass Spectrometry,9142289,9/9/2015 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,165278, ,NCI,108750,56528,165278
Genetic Susceptibility To Carcinogens and Toxicants,9143426, , ,Intramural Research,2015,866717, ,NIEHS, , ,866717
Human Genes Affecting Chromosome Metabolism and Stress Response,9143450, , ,Intramural Research,2015,1698115, ,NIEHS, , ,1698115
Discovery And Functional Genomics Of Environmental Response Genes,9143467, , ,Intramural Research,2015,1661209, ,NIEHS, , ,1661209
"Nuclear receptors: action, functions, and roles in disease",9143476, , ,Intramural Research,2015,685660, ,NIEHS, , ,685660
Structural Mechanisms of Ribosome Assembly,9143520, , ,Intramural Research,2015,1311624, ,NIEHS, , ,1311624
Immune Therapy,9143643, ,8/31/2018 0:00,Non-SBIR/STTR,2016, ,196902, ,210435,35895, 
RAS Induced Senescence and Tumor Suppression,9143835,7/1/1999 0:00,8/31/2017 0:00,Non-SBIR/STTR,2015,435000, ,NIA,250000,185000,435000
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions,9144330,9/12/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,442311, ,NCI,377403,64908,442311
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma:  Environmental Co,9144716,7/1/2009 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,312294, ,NCI,247712,64582,312294
The role of autophagy in Kras-driven lung cancer,9146270,9/1/2015 0:00,8/31/2018 0:00,Other Research-Related,2016,209628, ,NCI,194100,15528,209628
Mammary carcinogenesis:  pubertal and adult effects of high fat diet+oxybenzone,9146357,9/30/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,861517, ,NIEHS,897336,416910,861517
01 Project 1:  Cancer risks for mutations in breast cancer predisposition genes,9146502, , ,Research Centers,2016, ,478350, ,350769,127581, 
Targeting Olig2 Co-regulators for Malignant Glioma Therapy,9146681,9/30/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2016,349149, ,NINDS,266438,82711,349149
Apoptosis In Neurodegenerative Disorders,9147265, , ,Intramural Research,2015,800238, ,NIA, , ,800238
Long-Range Transcriptional Regulation of Placental and Ovary Specific Genes,9147312, , ,Intramural Research,2015,551612, ,NIA, , ,551612
Signal and Transcription Factor Network interactions in Head and Neck Cancer,9147434, , ,Intramural Research,2015,542514, ,NIDCD, , ,542514
Genomics and Proteomics of Head and Neck Cancer,9147435, , ,Intramural Research,2015,723353, ,NIDCD, , ,723353
Research Project 3: Heterogeneity in metastatic CRPC and the role of TP53 mutation as a molecular determinant,9148033,9/14/2001 0:00,8/31/2021 0:00,Research Centers,2016, ,215465, ,153952,85150, 
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells,9148333, , ,Non-SBIR/STTR,2016, ,446576, ,391602,54974, 
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3,9148427,9/26/2015 0:00,8/31/2018 0:00,Non-SBIR/STTR,2015,249000, ,NCI,163319,85681,249000
Small Molecule Activators of p53,9148766, , ,Intramural Research,2015,43553, ,NIDDK, , ,43553
Genetic Approaches To Understanding Organ Development and Function,9148878, , ,Intramural Research,2015,1682765, ,NIDDK, , ,1682765
Natural History of Familial Carcinoid Tumor,9148895, , ,Intramural Research,2015,1022820, ,NIDDK, , ,1022820
Focus on Dicer inhibition as a novel treatment for brain tumors,9149075,9/30/2015 0:00,8/31/2017 0:00,Non-SBIR/STTR,2016,190000, ,NINDS,125000,65000,190000
Role of the AMPK-MDMX-p53 pathway in cancer,9149171,9/28/2007 0:00,8/31/2020 0:00,Non-SBIR/STTR,2016,321694, ,NCI,213750,107944,321694
Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures,9149290,9/30/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,709469, ,NCI,387474,155914,543388
MicroRNA Therapeutics in Non-small Cell Lung Cancer,9149457, , ,Research Centers,2016, ,282189, ,282189,0, 
Project 1 - PARP Project,9149469,9/1/2009 0:00, ,Research Centers,2016, ,187355, ,187355,0, 
Project 1: Small Molecule Enhancers of Photodynamic Therapy for Skin Cancer,9149694,8/9/2001 0:00, ,Non-SBIR/STTR,2016, ,179777, ,140330,39447, 
Regulation Of Intracellular Iron Metabolism,9150088, , ,Intramural Research,2015,1231088, ,NICHD, , ,1231088
Mechanisms of Tumorigenic Transformation of Barretts Esophagus,9150649,9/25/2015 0:00,8/31/2020 0:00,Non-SBIR/STTR,2016,378503, ,NCI,239559,138944,378503
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3,9151696,9/26/2015 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,248999, ,NCI,146470,102529,248999
Full Project 3: Molecular Pathways to Breast Cancer Mortality among African American and White Women,9152335, , ,Research Centers,2016, ,55059, ,38236,16823, 
Full Project 3: Molecular Pathways to Breast Cancer Mortality among African American and White Women,9152345, , ,Research Centers,2016, ,200181, ,132572,68750, 
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma,9152832,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2016,446063, ,NCI,228750,217313,446063
Chromosomal Proteins and Chromosomal Functions,9153465, , ,Intramural Research,2015,765529, ,NCI, , ,765529
Gene Regulation and Function: The B-ZIP Proteins,9153474, , ,Intramural Research,2015,1111052, ,NCI, , ,1111052
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,9153475, , ,Intramural Research,2015,1105880, ,NCI, , ,1105880
"Tumor Suppressor Protein, p53",9153481, , ,Intramural Research,2015,419676, ,NCI, , ,419676
Transgenic Models for Breast Cancer,9153485, , ,Intramural Research,2015,716309, ,NCI, , ,716309
"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",9153489, , ,Intramural Research,2015,1094655, ,NCI, , ,1094655
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,9153501, , ,Intramural Research,2015,1008827, ,NCI, , ,1008827
Regulation of Lymphocyte Proliferation and Replicative Capacity,9153517, , ,Intramural Research,2015,566996, ,NCI, , ,566996
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,9153520, , ,Intramural Research,2015,406274, ,NCI, , ,406274
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,9153524, , ,Intramural Research,2015,416783, ,NCI, , ,416783
DNA repair,9153533, , ,Intramural Research,2015,1269365, ,NCI, , ,1269365
Enzymes and Substrates of the Ubiquitin Conjugating System,9153534, , ,Intramural Research,2015,846720, ,NCI, , ,846720
Role of CEBP transcription factors in regulating cell growth and tumorigenesis,9153546, , ,Intramural Research,2015,1321912, ,NCI, , ,1321912
Role of Neurotrophins in the Development of the Mammalian Nervous System,9153562, , ,Intramural Research,2015,698761, ,NCI, , ,698761
Zebrafish Models of Cancer,9153599, , ,Intramural Research,2015,188709, ,NCI, , ,188709
Molecular Interaction Maps and Analysis of Bioregulatory Networks,9153600, , ,Intramural Research,2015,59449, ,NCI, , ,59449
The Role of miRNA-mediated RNAI in the Biology of Cancer,9153609, , ,Intramural Research,2015,140913, ,NCI, , ,140913
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,9153616, , ,Intramural Research,2015,574878, ,NCI, , ,574878
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,9153641, , ,Intramural Research,2015,145652, ,NCI, , ,145652
Metabolic Mechanisms for Programmed Cell Death,9153649, , ,Intramural Research,2015,325557, ,NCI, , ,325557
"Role of inflammation, innate resistance, and immunity in carcinogenesis.",9153671, , ,Intramural Research,2015,1065311, ,NCI, , ,1065311
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,9153675, , ,Intramural Research,2015,772849, ,NCI, , ,772849
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,9153700, , ,Intramural Research,2015,33627, ,NCI, , ,33627
Redox Mechanism Process of Angiogenesis and Wound Healing,9153712, , ,Intramural Research,2015,295506, ,NCI, , ,295506
Collaborative Pathways that Lead to Leukemia,9153735, , ,Intramural Research,2015,363806, ,NCI, , ,363806
TMPRSS2-ERG chromosomal translocations and prostate cancer,9153754, , ,Intramural Research,2015,154569, ,NCI, , ,154569
Role of Brachyury in regulating notochord development and neoplasia,9153788, , ,Intramural Research,2015,121459, ,NCI, , ,121459
Role of inflammation in epigenetic alterations of metastatic cancer cells,9153803, , ,Intramural Research,2015,570247, ,NCI, , ,570247
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,9153809, , ,Intramural Research,2015,706297, ,NCI, , ,706297
CANCER AND INFLAMMATION GENETICS,9153851, , ,Intramural Research,2015,1123302, ,NCI, , ,1123302
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,9153869, , ,Intramural Research,2015,525122, ,NCI, , ,525122
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,9153905, , ,Intramural Research,2015,773675, ,NCI, , ,773675
Development of GEM and GDA models of Pancreatic Adenocarcinoma,9153931, , ,Intramural Research,2015,963457, ,NCI, , ,963457
"Biomarkers in Cancer Diagnosis,Prognosis, and Therapeutic Outcome",9153949, , ,Intramural Research,2015,1585226, ,NCI, , ,1585226
"p53, Aging, and Cancer",9153951, , ,Intramural Research,2015,792614, ,NCI, , ,792614
Study the roles of p53 and p53 mutants in mesenchymal stem cells,9153957, , ,Intramural Research,2015,541591, ,NCI, , ,541591
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,9153968, , ,Intramural Research,2015,661211, ,NCI, , ,661211
Uncover the mechanisms regulating the biogenesis and decay of miRNAs in cancer,9153987, , ,Intramural Research,2015,1289407, ,NCI, , ,1289407
Metabolic and p53 Targets of Cellular Respiration of Esophageal Cancer,9154005, , ,Intramural Research,2015,374293, ,NCI, , ,374293
Role of long non-coding RNAs in p53 signaling,9154011, , ,Intramural Research,2015,837406, ,NCI, , ,837406
Bone Marrow Histopathological Changes in Neoplastic and Non-Neoplastic Diseases,9154156, , ,Intramural Research,2015,0, , , , , 
Genetic Modifiers of Cancer Risk,9154190, , ,Intramural Research,2015,417815, ,NCI, , ,417815
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,9154191, , ,Intramural Research,2015,7232793, ,NCI, , ,7232793
Intervention Trials in Persons at Increased Genetic Risk of Cancer,9154192, , ,Intramural Research,2015,459731, ,NCI, , ,459731
Molecular Pathogenesis of Multiple Myeloma,9154249, , ,Intramural Research,2015,247846, ,NCI, , ,247846
Lymphoma Studies,9154254, , ,Intramural Research,2015,728259, ,NCI, , ,728259
Nitric Oxide as a Modifier of Oxidative Stress,9154258, , ,Intramural Research,2015,443259, ,NCI, , ,443259
CCR Confocal Microscopy Core,9154291, , ,Intramural Research,2015,702195, ,NCI, , ,702195
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility,9154298, , ,Intramural Research,2015,1167374, ,NCI, , ,1167374
Immunohistochemistry Core Laboratory,9154320, , ,Intramural Research,2015,952585, ,NCI, , ,952585
Animal Model Development-CAPR infrastructure,9154323, , ,Intramural Research,2015,1397013, ,NCI, , ,1397013
Comparison of molecular factors to drug activities.,9154340, , ,Intramural Research,2015,116266, ,NCI, , ,116266
Therapeutic strategies for targeting PARP1 in small cell lung cancer,9154442,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2016,366000, ,NCI,228750,137250,366000
The reduction of NLRX1 and its role in pulmonary aging,9157157,8/15/2016 0:00,4/30/2021 0:00,Non-SBIR/STTR,2016,343375, ,NIA,205000,138375,343375
In Vivo Function of Nonmuscle Myosin II-A,9157333, , ,Intramural Research,2015,460885, ,NHLBI, , ,460885
The role of autophagy in aging and metabolism,9157343, , ,Intramural Research,2015,980719, ,NHLBI, , ,980719
Mitochondrial regulation in cardiovascular and cancer biology,9157346, , ,Intramural Research,2015,983805, ,NHLBI, , ,983805
Genome-wide mapping of histone modifications,9157358, , ,Intramural Research,2015,964195, ,NHLBI, , ,964195
Olfactomedin 4 is a key regulator of colon cancer progression,9157362, , ,Intramural Research,2015,547494, ,NIDDK, , ,547494
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease,9161472, , ,Intramural Research,2015,1163165, ,NIAID, , ,1163165
Defining and manipulating quiescence associated DNA damage resistance in single cells,9162369,7/1/2016 0:00,6/30/2018 0:00,Other Research-Related,2016,166104, ,NCI,153800,12304,166104
Wnt pathway dynamics in breast cancer metastasis,9162624,6/6/2017 0:00,5/31/2020 0:00,Other Research-Related,2017,188042, ,NCI,174113,13929,188042
Transcriptional Regulations of Oncongenic Properties of Mutant P53,9163989,5/1/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2015,201758, ,NCI,132300,69458,201758
Role of TFIIS.h in regulation of p53 responsive apoptosis and tumor suppression,9164526,9/1/2016 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,196403, ,NCI,130500,65903,196403
Targeting Ribosomal Biogenesis in Prostate Cancer,9164870,9/15/2016 0:00,8/31/2019 0:00,Other Research-Related,2016,189681, ,NCI,175631,14050,189681
Coordinate Regulation of p53 and c-Myc in HTLV-1 and HPV-induced Carcinogenesis,9170443,8/11/2016 0:00,7/31/2020 0:00,Non-SBIR/STTR,2016,436500, ,NCI,300000,136500,436500
"The binding of small molecules to disordered proteins: specificity, affinity, and portability",9171854,8/1/2016 0:00,12/31/2020 0:00,Non-SBIR/STTR,2016,452764, ,NIGMS,300000,152764,452764
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas,9171873,9/1/2016 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,208800, ,NCI,130500,78300,208800
Deciphering the Molecular Pathways Driving p53 Dependent Cell Death,9171986,8/1/2015 0:00,7/31/2018 0:00,"Training, Individual",2015,51871, ,NCI,51871, ,51871
Pax2 loss in fallopian tube lesions and strategies for restoration in serous cancer,9172297,9/1/2016 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,196475, ,NCI,130500,65975,196475
(1) Intestinal Organoid Models for APC LOH,9172584,9/1/2016 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,232195, ,NCI,150000,82195,232195
Dim light at night alters pancreatic cell signaling and predisposes to pancreatic adenocarcinoma,9173707,7/1/2016 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,200970, ,NCI,130500,70470,200970
Regulation of RNA metabolism and cell growth control by SR protein kinases,9174483,5/1/1996 0:00,4/30/2020 0:00,Non-SBIR/STTR,2016,348750, ,NIGMS,225000,123750,348750
Genetic characterization of osteoblast-induced leukemias,9176849,9/1/2016 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,585485, ,NHLBI,365928,219557,585485
TFIIH and Transcription Regulation,9177084,9/22/2016 0:00,5/31/2020 0:00,Non-SBIR/STTR,2016,559376, ,NIGMS,455000,104376,559376
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis,9177266,6/3/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2016,382013, ,NCI,228750,153263,382013
"Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation",9177706,7/15/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2016,377438, ,NCI,228750,148688,377438
Mechanisms of Gene-Specific Transcriptional Regulation Within the p53 Network,9177824,5/26/2006 0:00,3/31/2017 0:00,Non-SBIR/STTR,2015,116494, ,NCI,74916,41578,116494
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma,9178058,9/13/2013 0:00,11/30/2017 0:00,Non-SBIR/STTR,2017,236243, ,NCI,152908,83335,236243
Role of heat shock factors (Hsfs) in tumorigenesis,9178061,3/1/2000 0:00,11/30/2018 0:00,Non-SBIR/STTR,2017,270000, ,NCI,180000,90000,270000
Role of SAG/RBX2 E3 Ubiquitin Ligase in Skin Carcinogenesis,9178647,1/3/2013 0:00,12/31/2018 0:00,Non-SBIR/STTR,2017,322663, ,NCI,207500,115163,322663
Regulation of ATDC by TP63 and its role in bladder cancer,9178727,9/1/2016 0:00,8/31/2021 0:00,Other Research-Related,2016,174960, ,NCI,162000,12960,174960
Oncogene c-Myc-dependent pathways in cutaneous melanoma03,9178977,12/11/2006 0:00,11/30/2017 0:00,Non-SBIR/STTR,2016,25593, ,NCI,29124,14111,25593
A novel oncogenic driver in Ewing sarcoma,9179478,7/27/2016 0:00,6/30/2018 0:00,Non-SBIR/STTR,2016,199013, ,NCI,130500,68513,199013
ATM FUNCTION DURING V(D)J RECOMBINATION,9180672,12/2/2008 0:00,11/30/2018 0:00,Non-SBIR/STTR,2017,419353, ,NIAID,250000,169353,419353
Defining Critical p53 Therapeutic Targets and Mechanisms,9180687,3/1/2009 0:00,11/30/2019 0:00,Non-SBIR/STTR,2017,436500, ,NCI,225000,211500,436500
DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations,9181382,12/1/2014 0:00,11/30/2019 0:00,Non-SBIR/STTR,2017,366000, ,NCI,228750,137250,366000
"Understanding the origin,initiation,and progression of high-grade serous ovarian cancer",9182056,9/24/2013 0:00,1/31/2019 0:00,Non-SBIR/STTR,2016,248999, ,NCI,159615,89384,248999
MicroRNA Targets for Chemoprevention of Squamous Cell Carcinoma (R01 CA194062-01A1),9182878,9/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2017,314760, ,NCI,183000,131760,314760
Regulation of SLC7A11 by p53 in cancer metabolism,9184541,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2017,366000, ,NCI,228750,137250,366000
"Novel, orally available ATM inhibitor for glioma conformal radiosensitization",9184543,12/1/2015 0:00,11/30/2017 0:00,Non-SBIR/STTR,2017,165844, ,NCI,108750,57094,165844
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway,9185218,8/19/2005 0:00,11/30/2019 0:00,Non-SBIR/STTR,2017,372875, ,NCI,237500,135375,372875
Nuclear Function of Abl in DNA Damage Response,9185265,8/1/1986 0:00,11/30/2018 0:00,Non-SBIR/STTR,2017,387500, ,NCI,250000,137500,387500
PL Growth,9185281, , ,Research Centers,2017, ,24969, ,12871,12098, 
AMPK and AMPK-related kinases in lung cancer development and treatment,9186506,1/16/2013 0:00,12/31/2017 0:00,Non-SBIR/STTR,2017,402550, ,NCI,207500,195050,402550
Genome instability in cancer: telomeres and DNA repair,9186655,9/2/2016 0:00,8/31/2023 0:00,Non-SBIR/STTR,2016,902733, ,NCI,532586,370147,902733
Phosphoinositides and Cancer Metabolism,9186859,9/5/2016 0:00,7/31/2023 0:00,Non-SBIR/STTR,2016,1017000, ,NCI,600000,417000,1017000
"Isolation, characterization and translational development of glioma stem cells",9186868,2/1/2017 0:00,1/31/2024 0:00,Non-SBIR/STTR,2017,1028400, ,NCI,600000,428400,1028400
p53 in Melanomagenesis,9186994,1/1/2016 0:00,12/31/2018 0:00,Non-SBIR/STTR,2017,77750, ,NCI,50000,27750,77750
Local Immuroregulation of Cutaneous Carcinogenesis,9187427,7/1/2003 0:00,11/30/2020 0:00,Non-SBIR/STTR,2017,397813, ,NCI,237500,160313,397813
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer,9187448,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2017,434625, ,NCI,228750,205875,434625
Using markers to improve pancreatic cancer screening and surveillance,9187511,7/18/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2016,983899, ,NCI,636800,347099,983899
NOX4 mediates oxidative stress in ovarian tumor growth and treatment response,9187916,12/1/2015 0:00,9/27/2017 0:00,Non-SBIR/STTR,2017,105972, ,NCI,63784,42188,105972
Mechanisms of Intestinal Tumorigenesis,9188005,1/1/2000 0:00,11/30/2020 0:00,Non-SBIR/STTR,2017,395000, ,NCI,250000,145000,395000
Information Processing by Post-translational Modification,9188014,12/15/2014 0:00,11/30/2018 0:00,Non-SBIR/STTR,2017,362667, ,NIGMS,236103,126564,362667
Progression and regression of mammary preneoplasia,9188053,12/23/2004 0:00,11/30/2018 0:00,Non-SBIR/STTR,2017,311000, ,NCI,200000,111000,311000
p53 Variants in Cancer Risk and Therapy,9188088,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2017,421358, ,NCI,256658,164700,421358
Tissue-specific tumor suppressor effects of p53,9188716,7/17/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,78178, ,NCI,46840,31338,78178
Role of p53 Missense Mutations on Tumorigenesis in Vivo,9188801,9/1/1999 0:00,12/31/2019 0:00,Non-SBIR/STTR,2017,342000, ,NCI,213750,128250,342000
Identification and targeting of the signaling pathways underlying lung cancer.,9189684,3/1/2009 0:00,12/31/2018 0:00,Non-SBIR/STTR,2017,432000, ,NCI,225000,207000,432000
Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell,9190542,7/1/2016 0:00,6/30/2019 0:00,"Training, Individual",2016,52542, ,NCI,52542, ,52542
Building personalized avatars of human cancer to predict response to therapy,9191352,12/8/2015 0:00,11/30/2017 0:00,Non-SBIR/STTR,2017,184331, ,NCI,108750,75581,184331
∆Np53 as a Regulator of p53 Biology,9192765,6/1/2016 0:00,4/30/2020 0:00,"Training, Individual",2016,35248, ,NIA,35248, ,35248
Nanotechnology enabled targeting of p53 deficiency in human cancer,9193391,7/8/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2016,371490, ,NCI,297375,74115,371490
The role of Src kinase in estrogen receptor-positive breast cancer proliferation,9193621,1/1/2014 0:00,6/16/2017 0:00,"Training, Individual",2017,37434, ,NCI,37434, ,37434
Intratumoral Heterogeneity and Tumor Evolution in Lymphoma,9193630,2/10/2015 0:00,6/9/2018 0:00,"Training, Individual",2017,44044, ,NCI,44044, ,44044
Functional Analysis of p53 polymorphic variants,9194385,6/1/2005 0:00,11/30/2020 0:00,Non-SBIR/STTR,2017,384750, ,NCI,202500,182250,384750
p53-mediated dead cell clearance in response to DNA damage and tumorigenesis,9194665,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2016,368043, ,NCI,228750,139293,368043
"Role of the p53 C-terminal domain in tissue homeostasis, tumor suppression, and oncogenesis",9195074,12/15/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2017,559746, ,NCI,440459,119287,559746
Defining the temporal sequence of PI3K pathway mutations in bladder cancer,9195705,1/1/2014 0:00,12/31/2018 0:00,Non-SBIR/STTR,2017,368728, ,NCI,207500,161228,368728
ATM FUNCTION DURING V(D)J RECOMBINATION,9195998,12/2/2008 0:00,11/30/2018 0:00,Non-SBIR/STTR,2016,419353, ,NIAID,250000,169353,419353
SIRT2 Inhibitors for the Treatment of B-cell Lymphoma,9197069,7/7/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2016,573293, ,NCI,325735,247558,573293
Molecular mechanisms of myeloid suppressor genes on chromosome 5,9197275,2/1/2015 0:00,1/31/2020 0:00,Non-SBIR/STTR,2017,361425, ,NCI,228750,132675,361425
"Fortilin, p53, and atherosclerosis",9197681,1/15/2013 0:00,12/31/2019 0:00,Non-SBIR/STTR,2017,382500, ,NHLBI,250000,132500,382500
Understanding the role of Polycomb Repressive Complex 2 in melanoma,9198213,2/15/2015 0:00,2/14/2018 0:00,"Training, Individual",2017,44044, ,NCI,44044, ,44044
Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling,9198526,2/1/2015 0:00,1/31/2018 0:00,Non-SBIR/STTR,2017,189477, ,NCI,166830,22647,189477
The Role of p53-inducible Sesn1 and Sesn2 genes in lung carcinogenesis,9198533,2/1/2013 0:00,1/31/2019 0:00,Non-SBIR/STTR,2017,316438, ,NCI,207500,108938,316438
A novel multi-targeted therapy for breast cancer resistance,9198697,2/1/2016 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,189936, ,NCI,126203,63733,189936
Progression and Metastasis of Oral Tongue Cancer,9198725,5/10/2003 0:00,12/31/2018 0:00,Non-SBIR/STTR,2017,482857, ,NIDCR,314463,168394,482857
Molecular Biology of Oncogenic Papillomaviruses,9198919,1/1/2016 0:00,12/31/2022 0:00,Non-SBIR/STTR,2017,1017000, ,NCI,649864,451655,1017000
Analysis of Centrosome Dynamics,9199096,9/29/2006 0:00,12/31/2019 0:00,Non-SBIR/STTR,2017,331288, ,NIGMS,212500,118788,331288
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer,9199211,3/1/2015 0:00,2/28/2018 0:00,"Training, Individual",2017,63078, ,NCI,63078, ,63078
Structure-activity relationship of small molecule inhibitors of human papillomavirus E6 protein will be tested.,9200070,6/14/2016 0:00,11/30/2017 0:00,SBIR/STTR,2016,225000, ,NIAID, , ,225000
Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 ,9201294, , ,Research Centers,2017, ,206355, ,125268,81087, 
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,9205218,2/7/2013 0:00,1/31/2019 0:00,Non-SBIR/STTR,2017,381420, ,NCI,285914,95506,381420
Toxicology in the 21st Century Program (Tox21)  Systems Toxicology,9205601, , ,Intramural Research,2015,100000, ,NCATS, , ,100000
Inhibitors of p53-S100B interaction for melanoma,9205744, , ,Intramural Research,2015,114000, ,NCATS, , ,114000
CARP-1: A Potential Therapeutic Agent for Breast Cancer,9206073,1/1/2012 0:00,12/31/2019 0:00,Non-SBIR/STTR,2017, , , , , , 
"Understanding the origin,initiation,and progression of high-grade serous ovarian cancer",9207067,9/24/2013 0:00,1/31/2019 0:00,Non-SBIR/STTR,2017,245221, ,NCI,156316,88905,245221
Structural and molecular investigation of small molecule reactivation of p53,9210062,3/1/2015 0:00,2/28/2018 0:00,"Training, Individual",2017,49044, ,NCI,49044, ,49044
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9210835, , ,Research Centers,2016, ,28372, ,17957,10415, 
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9210964, , ,Research Centers,2016, ,17040, ,12000,5040, 
Project 1: CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,9211122,9/30/2005 0:00, ,Research Centers,2016, ,203169, ,140001,63168, 
Rad50: Roles in chromo. stab. and prev. of malignancy,9211333,1/1/1998 0:00,12/31/2019 0:00,Non-SBIR/STTR,2017,472473, ,NIGMS,275655,196818,472473
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9211646, , ,Research Centers,2016, ,72817, ,50046,22771, 
CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,9211896,9/30/2005 0:00,8/31/2019 0:00,Research Centers,2016, ,94154, ,74618,30243, 
P53 survival target DDR1 kinase in DNA damage response and carcinogenesis,9212118,3/1/2015 0:00,2/29/2020 0:00,Non-SBIR/STTR,2017,398025, ,NCI,228750,169275,398025
p53/Rb Reactivation Modulators for HPV-positive Head and Neck Cancer,9212166,2/1/2016 0:00,1/31/2020 0:00,Non-SBIR/STTR,2017,360524, ,NIGMS,300873,59651,360524
Project 1: Small Molecule Enhancers of Photodynamic Therapy for Skin Cancer,9213349,8/9/2001 0:00, ,Non-SBIR/STTR,2017, ,180974, ,140665,40309, 
Gammaherpesvirus interactions with host tumor suppressor p53,9213350,4/4/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,384981, ,NCI,270414,114567,384981
Modeling p53 Mutant-Associated Cancer With LFS Patient-Derived iPSCs,9214571,3/3/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2016,249000, ,NCI,161688,87312,249000
P38 MAPK in Ras-induced Senescence and Transformation,9215363,7/1/2005 0:00,4/30/2016 0:00,Non-SBIR/STTR,2014,42442, ,NCI,27382,15060,42442
Epigenetic regulation by tumor suppressor p53,9215639,4/1/1999 0:00,2/29/2020 0:00,Non-SBIR/STTR,2017,352848, ,NCI,223022,129826,352848
Cancer biology in the zebrafish,9215642,7/3/2003 0:00,5/31/2018 0:00,Non-SBIR/STTR,2017,373081, ,NCI,210780,162301,373081
USP7 inhibitors for the treatment of multiple myeloma,9216507,12/15/2016 0:00,11/30/2019 0:00,Non-SBIR/STTR,2017,504721, ,NCI,289814,214907,504721
Regulation of p53 by TAF1,9217576,7/15/1997 0:00,1/31/2021 0:00,Non-SBIR/STTR,2017,368125, ,NCI,237500,130625,368125
"Precision Genomics in the WISDOM Pragmatic Clinical Trial:  An ""Embedded"" ELSI Study of Risk-based Breast Cancer Screening",9220556,1/12/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2017,664427, ,NCI,419197,245230,664427
Cellular mechanisms of androgen action and androgen-response gene EAF2 in prostate cancer,9220869,9/19/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2016,113935, ,NCI,73804,40131,113935
Non-replicative senescence of macrophages and role of HIV-1 infection,9220905,9/15/2016 0:00,5/31/2018 0:00,Non-SBIR/STTR,2016,232256, ,NIA,150000,82256,232256
"Bioinformatics approaches to solve the ""Missing Driver"" problem in solid tumors",9220917,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2016,112064, ,NCI,73646,38418,112064
Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human Cancer,9221493,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2016,264110, ,NCI,150920,113190,264110
Preclinical Models for Cancer Therapeutic Development,9221798,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2016,174117, ,NCI,90686,83431,174117
DACH1/Eya Cell fate determination factor and mammary tumorigenesis,9221991,12/1/2007 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,428056, ,NCI,287556,140500,428056
New Models and Treatments for AIDS-related Lymphoma,9222729,4/1/2013 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,416873, ,NCI,280334,136539,416873
Wnt pathway regulation of human gastric stem cell function,9223023,9/1/2017 0:00,5/31/2022 0:00,Other Research-Related,2017,92129, ,NIDDK,85305,6824,92129
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model,9223682,3/1/2015 0:00,2/29/2020 0:00,Non-SBIR/STTR,2017,377464, ,NCI,261399,116065,377464
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes,9223700,5/6/2014 0:00,2/29/2020 0:00,Non-SBIR/STTR,2018,335250, ,NIEHS,225000,110250,335250
The tumor suppressor capability of p53 is dependent on Non-muscle Myosin IIA function in Head and Neck Cancer.,9223856,9/6/2016 0:00,8/31/2019 0:00,Other Research-Related,2016,135000, ,NIDCR,125000,10000,135000
Metabolomics Administrative Supplement: Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures during pregnancy,9227585,9/30/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2016,185108, ,OD,148735,36373,185108
"Telomerase in Development, Senescence and Neoplasia",9228330,1/1/2000 0:00,12/31/2019 0:00,Non-SBIR/STTR,2017,616000, ,NCI,385000,231000,616000
Fully Synthetic Prodiginines as Probes of Protein-Protein Interactions Regulating,9228341,4/16/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,352065, ,NCI,236482,115583,352065
Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy,9229537,4/1/2014 0:00,8/31/2017 0:00,Non-SBIR/STTR,2017,191455, ,NCI,189050,2405,191455
Roles of EAF2 in androgen action in the prostate,9229538,12/18/1996 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,371525, ,NCI,241250,130275,371525
System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs,9230136,9/21/2016 0:00,8/31/2018 0:00,"Training, Individual",2016,45076, ,NCI,45076, ,45076
Identification and targeting of colon cancer initiating cells,9230216,10/1/2009 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017, , , , , , 
Nanotheranostics for Early Colorectal Cancer Detection and Treatment,9230348,3/6/2013 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,327850, ,NCI,207500,120350,327850
Triad1 regulates myelopoiesis and functions as a leukemia suppressor,9230819,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2017,353419, ,NCI,228750,124669,353419
the role of EZH2 in neuroendocrine prostate cancer,9231143,12/1/2016 0:00,11/30/2018 0:00,Non-SBIR/STTR,2017,72500, ,NCI,50000,22500,72500
Targeting the oncogenic mutant p53 signaling in colorectal cancer therapy,9231409,4/18/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,374705, ,NCI,207500,167205,374705
Understanding the role of κB-Ras proteins in tumorigenesis,9231428,3/1/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2017,384782, ,NCI,240489,144293,384782
Novel therapeutics for targeting checkpoint dysfunction in cancer,9232389,12/15/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2017,362569, ,NCI,228750,133819,362569
Modeling of pathological significance of non-coding DNA variants in cis-overlapping motifs of p53 and cMyc,9232724,9/21/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2016,476364, ,NIGMS,319522,156842,476364
Novel oncogenic functions of Mdm2 and Mdmx,9232880,7/18/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2015,190644, ,NCI,122208,68436,190644
"Merkel cell polyomavirus infection, DNA damage response and cancer",9233062,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2017,366000, ,NCI,228750,137250,366000
Elucidating the drivers of medulloblastoma initiation and recurrence,9233218,2/1/2016 0:00,1/31/2019 0:00,Non-SBIR/STTR,2017,191875, ,NINDS,125000,66875,191875
Bax/Bak activation without direct activator BH3-only proteins in cancer cells,9233294,1/1/2017 0:00,12/31/2018 0:00,Non-SBIR/STTR,2017,75250, ,NCI,50000,25250,75250
The GOF Mutant p53 Beacon System,9233416,8/24/2017 0:00,7/31/2020 0:00,Non-SBIR/STTR,2017,223150, ,NCI,150000,73150,223150
Toll-like Receptor Regulation of Pancreatic Tumorigenesis,9233927,4/1/2013 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,351713, ,NCI,207500,144213,351713
The role of AXL-ABL axis in Barrett's carcinogenesis,9233951,3/1/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2017,361425, ,NCI,228750,132675,361425
Targeting Mutant KRAS for Cancer Therapy,9233953,3/1/2016 0:00,2/28/2023 0:00,Non-SBIR/STTR,2017,924613, ,NCI,678579,370669,924613
Modeling p53 Mutant-Associated Cancer With LFS Patient-Derived iPSCs,9233977,3/3/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,243144, ,NCI,160164,86489,243144
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis,9234486,9/24/2007 0:00,3/31/2018 0:00,Non-SBIR/STTR,2017,320682, ,NCI,184300,136382,320682
Probing the Pathogenesis of North American Indian Childhood Cirrhosis (NAIC),9235141,4/1/2016 0:00,3/31/2018 0:00,"Training, Individual",2017,28692, ,NIDDK,28692, ,28692
Resistance of CML Stem Cells to Imatinib (Gleevec),9235254,7/1/2003 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,275378, ,NCI,187332,88046,275378
The role of chronic stress in regulation of mutant p53 and tumorigenesis,9235478,1/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2017,363306, ,NCI,228750,134556,363306
Dynamics of Cellular Senescence in Single Cells,9235687,2/1/2017 0:00,12/31/2020 0:00,Non-SBIR/STTR,2017,407926, ,NIGMS,242635,165291,407926
Role of the pentose phosphate pathway in tumorigenesis,9236169,8/1/2016 0:00,7/31/2018 0:00,Non-SBIR/STTR,2017,210105, ,NCI,130500,79605,210105
Mechanism of regulation of progenitor proliferation and transformation,9236615,6/15/2007 0:00,8/31/2017 0:00,Non-SBIR/STTR,2016,473415, ,NINDS,336844,136571,473415
DNA damage signaling to immune checkpoints,9236622,1/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2017,385018, ,NCI,249001,136017,385018
Role of SIRT3 in melanoma development and progression,9236949,4/1/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017, , , , , , 
Development of Zinc Metallochaperones as Mutant p53 Targeted Anti-cancer Drugs,9237238,3/15/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2017,365277, ,NCI,261086,104191,365277
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,9238502,9/30/2010 0:00,2/29/2020 0:00,Non-SBIR/STTR,2017,450899, ,NIDDK,302307,148592,450899
P63 Mechanisms and mediators in HNSCC,9238814,4/1/2004 0:00,7/31/2022 0:00,Non-SBIR/STTR,2017,398493, ,NIDCR,237500,160993,398493
Investigating CREBBP as a tumor suppressor in small cell lung cancer,9239069,12/15/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2017,441962, ,NCI,251115,190847,441962
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer,9239553,12/1/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2017,348844, ,NCI,228750,120094,348844
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism,9240261,3/2/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2017,332357, ,NCI,251075,81282,332357
Role of Vitamin D in cutaneous DNA repair,9240533,10/1/2016 0:00,9/30/2020 0:00,Non-SBIR/STTR,2017, , , , , , 
Targeting stabilized mutant p53 protein,9240601,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2017,356514, ,NCI,225642,130872,356514
Proximal Differentiation Therapy for K-Ras-Induced Lung Adenocarcinoma,9241539,10/1/2017 0:00,9/30/2021 0:00,Non-SBIR/STTR,2018, , , , , , 
Validating the protein binding domain of replication protein A as a cancer target,9241884,4/1/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,325775, ,NCI,207500,118275,325775
"DNA double-strand break repair, chromosomes translocations and cancer",9241973,4/8/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,1778566, ,NCI,1111604,666962,1778566
The Role of CTIP in Breast Carcinogenesis,9241979, , ,Non-SBIR/STTR,2017, ,393141, ,245713,147428, 
IGF-1 and the initiation of non-melanoma skin cancer,9242476,7/1/2014 0:00,6/30/2018 0:00,Non-SBIR/STTR,2015, , , , , , 
Biological Activity of HPV E7 in Human Epithelial Cells,9244727,4/19/1996 0:00,3/31/2020 0:00,Non-SBIR/STTR,2017,371250, ,NCI,225000,146250,371250
The role of the p63-RBM38 loop in tumor suppression,9244740,4/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017,359138, ,NCI,228750,130388,359138
Modulation of skin cancer by PPARb/d,9244747,3/1/2007 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,247146, ,NCI,165870,81276,247146
Electrocatalytic Studies of Toxic Pollutant Activation,9245686,3/1/1983 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,364615, ,NIEHS,253179,111436,364615
Defining mechanisms of extracellular communication for cancer therapy,9246442,4/1/2013 0:00,7/31/2018 0:00,Non-SBIR/STTR,2017,323700, ,NCI,207500,116200,323700
Regulation of MDM2 auto-ubiquitination and molecular targeting,9246456,12/15/2007 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,251191, ,NCI,161020,90171,251191
Genetic Alterations that Initiate Follicular Thyroid Carcinogenesis,9246460,3/1/2008 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017, ,384415, ,282437,101978, 
Defining mechanisms of extracellular communication for cancer therapy,9246603,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,7410, ,NCI,4750,2660,7410
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis,9246980,5/14/2013 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,328265, ,NCI,219016,109249,328265
Identification of genetic collaborators in cancer with a brca2-mutant zebrafish model,9247074,7/1/2016 0:00,6/30/2021 0:00,Other Research-Related,2017,126900, ,OD,117500,9400,126900
Ect2 Function in Lung Adenocarcinoma Initiation and Maintenance,9247188,4/1/2016 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,182909, ,NCI,116875,66034,182909
Regulation of Myc-Mediated Tumorigenesis,9247566,1/1/2011 0:00,6/30/2017 0:00,Non-SBIR/STTR,2015,139434, ,NCI,89381,50053,139434
A p53/NFkB-mediated metabolic mechanism for chemotherapy protection,9247711,4/1/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,335113, ,NCI,207500,127613,335113
CLONAL EVOLUTION OF HEMATOPOIETIC STEM CELLS DURING CHEMOTHERAPY AND TRANSPLANTATION,9247764,4/1/2016 0:00,3/31/2021 0:00,Other Research-Related,2017,121394, ,NCI,112402,8992,121394
The role of AXL-ABL axis in Barrett's carcinogenesis,9248137,3/1/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2016,289872, ,NCI,183463,106409,289872
Mechanisms of Tumorigenic Transformation of Barretts Esophagus,9248180,9/25/2015 0:00,8/31/2020 0:00,Non-SBIR/STTR,2015,277105, ,NCI,176500,100605,277105
P53 inactivation on MDSC development and tumor progression,9248356,7/1/2013 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,315400, ,NCI,207500,107900,315400
Role of Nix in pancreatic ductal adenocarcinoma,9248791,4/15/2016 0:00,7/14/2019 0:00,"Training, Individual",2017,49044, ,NCI,49044, ,49044
"ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY",9248956,5/1/2013 0:00,7/31/2019 0:00,Non-SBIR/STTR,2017,315400, ,NCI,244894,70506,315400
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous (5R01 CA194617-02),9249000,9/1/2016 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,412607, ,NCI,304703,107904,412607
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors,9249503,6/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,402550, ,NCI,207500,195050,402550
Chemical biology of superstolides--a novel class of anticancer natural products,9249515,4/1/2016 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,166555, ,NCI,141114,25441,166555
Regulation of epithelial-mesenchymal transition and stem cell activity by PTEN in breast cancer,9250104,4/1/2016 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,164495, ,NCI,108750,55745,164495
Ceramide signaling in the regulation of cellular response to folate stress,9250722,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2017,347700, ,NCI,228750,118950,347700
Targeting the oncogenic mutant p53 signaling in colorectal cancer therapy,9251083,4/18/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2016,49090, ,NCI,30454,18636,49090
Basis of Muscle Dysfunction in Malignant Hyperthermia & Central Core Disease,9251233,4/1/2006 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017,633129, ,NIAMS,483453,149676,633129
REGULATION OF TUMOR SUPPRESSION BY ARF,9251252,4/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017,348844, ,NCI,228750,120094,348844
Identifying Mechanisms of p53 and Rb Tumor Suppression In Small Cell Lung Cancer,9251264,4/1/2016 0:00,3/31/2018 0:00,Non-SBIR/STTR,2017,210105, ,NCI,130500,79605,210105
Molecular Oncology,9251767, , ,Research Centers,2017, ,39129, ,25852,14097, 
Hypermutation and malignant progression in an expanded cohort of TMZ treated LGG patients from different molecular subgroups,9252225,4/1/2016 0:00,8/31/2018 0:00,"Training, Individual",2017,56334, ,NCI,56334, ,56334
"Chemoprevention by black raspberry in oral cancer induced by DB[a,l]P in mice",9252235,4/1/2013 0:00,1/31/2020 0:00,Non-SBIR/STTR,2017,279273, ,NCI,206940,72333,279273
Cell-cycle regulatory kinases as targets for male contraceptive drug development,9253022,5/20/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,302472, ,NICHD,260470,95901,302472
Developmental studies to inform clinical stratification and targeting of SHH MB,9253355,4/4/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017,449790, ,NCI,299422,150368,449790
Development of proteasome adaptors to catalytically deplete specific proteins from cells,9253359,4/4/2016 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,186303, ,NCI,125000,61303,186303
Localizing Immunotherapy to Improve Therapeutic Index,9254203,6/4/2013 0:00,10/31/2018 0:00,Non-SBIR/STTR,2017,395388, ,NCI,255380,140008,395388
Signaling cascades in cholangiocarcinoma development,9254522,4/5/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017,362569, ,NCI,228750,133819,362569
Urine DNA Kit for monitoring HCC recurrence,9255022,9/14/2016 0:00,8/31/2018 0:00,SBIR/STTR,2016,300000, ,NCI, , ,300000
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer,9257202, ,3/31/2019 0:00,Research Centers,2017, ,340374, ,220258,120116, 
Epigenetic Regulation of Human Telomeres,9257286,7/1/2010 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,420000, ,NCI,240000,180000,420000
Mechanisms of obesity-induced hepatocarcinogenesis,9257359,5/8/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,380255, ,NCI,311587,68668,380255
Origins of Ovarian Carcinoma,9257361,5/18/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,358780, ,NCI,228750,130030,358780
Role of SIRT1 in melanocyte biology and melanocyte transformation,9257364,7/1/2013 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,312288, ,NCI,207500,104788,312288
The role of mutant p53 and endocytic recycling in ESCC invasion and metastasis,9258314,7/1/2016 0:00,6/30/2019 0:00,"Training, Individual",2017,57066, ,NCI,57066, ,57066
How does p53 binding affect eRNA-dependent transcriptional regulation?,9258753,1/1/2017 0:00,7/9/2017 0:00,"Training, Individual",2017,30701, ,NIGMS,30701, ,30701
KLF6: A driving factor of lung adenocarcinoma,9259035,2/1/2017 0:00,7/31/2018 0:00,"Training, Individual",2017,58766, ,NCI,58766, ,58766
The role of centrosome amplification in cell growth and tumorigenesis,9259438,2/1/2017 0:00,7/31/2018 0:00,"Training, Individual",2017,44044, ,NIGMS,44044, ,44044
Role of p53 family proteins in glucose metabolism,9259725,5/6/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,332000, ,NCI,207500,124500,332000
The Functions of antisense RNA AS-RBM15 in hematopoiesis,9260162,8/15/2017 0:00,7/31/2020 0:00,Non-SBIR/STTR,2017,222750, ,NIDDK,150000,72750,222750
Targeted Therapy for Endometrial Cancer,9260761,7/17/2002 0:00,1/31/2019 0:00,Non-SBIR/STTR,2017,252448, ,NCI,167184,85264,252448
Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm,9260771,5/1/2016 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,489123, ,NCI,315563,173560,489123
Role of HOS in Cell Transformation and Apoptosis,9261282,3/1/2001 0:00,11/30/2021 0:00,Non-SBIR/STTR,2017,344138, ,NCI,213750,130388,344138
HCS to Identify Inhibitors and Disruptors of AR-TIF2 Interactions,9262066,5/1/2015 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,338926, ,NCI,220082,118844,338926
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression,9262162,5/1/1983 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,468594, ,NCI,266398,202196,468594
PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM,9262164,4/1/2013 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,90971, ,NCI,58805,32166,90971
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO),9262166,7/1/2013 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,351713, ,NCI,207500,144213,351713
HAUSP inhibitors in p53-wild type and p53-mutant tumors,9262186,5/1/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,366000, ,NCI,228750,137250,366000
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals,9262193,5/16/2014 0:00,4/30/2018 0:00,Non-SBIR/STTR,2017,325181, ,NCI,213321,111860,325181
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression,9262219,4/15/2016 0:00,3/31/2021 0:00,Other Research-Related,2017,171720, ,NIDDK,159000,12720,171720
The Role of Ribosomal Proteins in the P53-MDM2 Pathway,9262620,3/1/2002 0:00,12/31/2021 0:00,Non-SBIR/STTR,2017,285950, ,NCI,190000,95950,285950
Mdm2-p53 signaling in the DNA damage response and in tumorigenesis,9262875,3/1/1999 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,351619, ,NCI,213750,137869,351619
Investigate the role of TPD52-AMPK pathway in tumorigenesis and cancer therapy,9262885,4/15/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2017,363713, ,NCI,228750,134963,363713
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors,9262888,5/7/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,540936, ,NCI,360927,180009,540936
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer,9262918,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,333139, ,NCI,207500,125639,333139
C MYC Targets in the Pathogenesis of Human Cancers,9263109,9/1/1992 0:00,6/30/2017 0:00,Non-SBIR/STTR,2017,282205, ,NCI,206429,75776,282205
Tumor suppressor p53 and its targets in checkpoint regulation,9263227,12/1/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2017,366502, ,NCI,228750,137752,366502
Targeted Therapies for Richters Transformation,9263413,2/7/2017 0:00,1/31/2022 0:00,Non-SBIR/STTR,2017,452551, ,NCI,292755,159796,452551
Replicative Senescence as a Tumor Suppressive Mechanism,9263684,8/8/2007 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,306860, ,NCI,184300,122560,306860
Targeting the cytokine circuitry of KRAS-driven lung cancer,9263834,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2017,394578, ,NCI,228750,165828,394578
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES,9263924,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,364993, ,NCI,207500,157493,364993
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH,9264484,7/1/2013 0:00,10/31/2019 0:00,Non-SBIR/STTR,2017,320338, ,NCI,220865,99473,320338
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma,9264501,9/1/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2017,904402, ,NCI,525815,378587,904402
Development of a mouse model of pediatric high-grade gliomas,9265057,5/1/2016 0:00,4/30/2018 0:00,Non-SBIR/STTR,2017,74250, ,NCI,50000,24250,74250
Using Markers to Improve Pancreatic Cancer Screening,9265299,7/1/2013 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,416661, ,NCI,257198,159463,416661
Novel Antitumor Agents,9265412,7/1/2013 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,376379, ,NCI,248730,127649,376379
ERK3 Kinase Signaling in Lung Cancer,9266383,6/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2017,338550, ,NCI,228750,109800,338550
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming,9268543,9/30/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,466235, ,NIA,265057,201178,466235
Transcriptional Regulations of Oncongenic Properties of Mutant P53,9269067,5/1/2013 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,327850, ,NCI,207500,120350,327850
The role of MCM8-9 in genomic instability of cancers,9269459,7/11/1994 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,355500, ,NCI,225000,130500,355500
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer,9269465,5/5/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017,889216, ,NCI,640529,248687,889216
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors,9269888,6/1/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,446627, ,NCI,282675,163952,446627
Role of p300 in HPV-positive Head and Neck Cancer,9269892,5/6/2015 0:00,2/5/2018 0:00,Non-SBIR/STTR,2017,481034, ,NIDCR,375161,105873,481034
Targeting the Chk1-Suppressed Apoptotic Pathway in HNSCC,9270001,7/5/2013 0:00,4/30/2018 0:00,Non-SBIR/STTR,2017,346094, ,NCI,204185,141909,346094
The role of p53 in constraining pro-tumorgenic reprogramming,9270420,5/1/2016 0:00,4/30/2019 0:00,"Training, Individual",2017,57066, ,NCI,57066, ,57066
Genome wide analysis of p53 inhibition by high glucose,9270514,5/1/2013 0:00,4/30/2018 0:00,"Training, Individual",2017,38269, ,NCI,38269, ,38269
Investigating the role of Retrotransposon muERV-L reactivation in Tumorigenesis,9271931,5/1/2015 0:00,4/30/2018 0:00,"Training, Individual",2017,59166, ,NCI,59166, ,59166
Defining the role of mutant XPO1 in chronic lymphocytic leukemia,9271932,5/1/2015 0:00,4/30/2020 0:00,"Training, Individual",2017,38779, ,NCI,38779, ,38779
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus,9272840,8/25/2010 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017,596898, ,NCI,462305,178156,596898
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,9273259,4/1/2011 0:00,3/31/2020 0:00,Non-SBIR/STTR,2017, , , , , , 
Targeting Autophagy in Hereditary Breast Cancer,9273499,6/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2017,474468, ,NCI,302801,171667,474468
Role of Long Intergenic Noncoding RNA in UVB-induced Apoptosis and Skin Cancer,9273531,6/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2017,335832, ,NIEHS,225000,110832,335832
Study of Novel HHV8/KSHV Encoded Genes,9274043, , ,Non-SBIR/STTR,2017, ,553506, ,442075,186541, 
Developing CRM1 inhibitors in AML,9274264,7/16/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,319550, ,NCI,207500,112050,319550
Purchase of a Seahorse Bioscience XF Analyzer,9274726,4/15/2017 0:00,4/14/2018 0:00,Other Research-Related,2017,188255, ,OD,188255, ,188255
Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC),9274919,9/15/2012 0:00,5/31/2021 0:00,Other Research-Related,2017,172260, ,NCI,159500,12760,172260
Investigating the Role of the Mek5-Erk5 Kinase Module in Small Cell Lung Cancer,9275243,9/30/2016 0:00,9/29/2019 0:00,"Training, Individual",2017,44044, ,NCI,44044, ,44044
Targeting MDM2 with Intracellular Antibodies,9275366,10/1/2013 0:00,9/30/2017 0:00,Non-SBIR/STTR,2017, , , , , , 
Modeling New Therapeutic Approaches for Malignant Melanoma,9275409,10/1/2013 0:00,9/30/2017 0:00,Non-SBIR/STTR,2017, , , , , , 
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus,9275433,10/1/2014 0:00,9/30/2018 0:00,Non-SBIR/STTR,2017, , , , , , 
ATM FUNCTION DURING V(D)J RECOMBINATION,9275671,12/2/2008 0:00,11/30/2018 0:00,Non-SBIR/STTR,2016,16611, ,NIAID,9800,6811,16611
Polyploid cell cycle regulation and genome instability,9276715,8/12/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,310815, ,NIGMS,197500,113315,310815
The role of MDM2-MTBP axis in cancer metastasis,9277415,5/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2017,313325, ,NCI,207500,105825,313325
The Role of the Microenvironment in Barrett's Esophagus,9277747,9/26/2011 0:00,4/30/2022 0:00,Research Centers,2017,1310083, ,NCI,978861,331222,1310083
Project 2: Characterization of microenvironmental drivers of neoplasia in BE,9277751,5/12/2017 0:00,4/30/2022 0:00,Research Centers,2017, ,244851, ,216778,28073, 
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease,9277848,9/1/2012 0:00,5/31/2018 0:00,Non-SBIR/STTR,2017,13521, ,NIEHS,8925,4596,13521
Breast Cancer Detection Consortium,9277853,9/19/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2016,479193, ,NCI,331584,147609,479193
Suppression of mobile elements by p53 genes,9278195,8/1/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,319950, ,NIGMS,197500,122450,319950
Protein Kinase Signaling and Cell Cycle Control,9279132,12/1/2006 0:00,5/31/2018 0:00,Non-SBIR/STTR,2017,503262, ,NIEHS,322604,180658,503262
Intrinsic disorder controls the function of p53 and other cancer associated IDPs,9279187,6/1/2016 0:00,5/31/2020 0:00,Non-SBIR/STTR,2017,311845, ,NIGMS,254800,57045,311845
Targeted Promoter Demethylation in Ovarian Cancer Cells,9279642,9/1/2017 0:00,7/31/2020 0:00,Other Research-Related,2017,137999, ,NIGMS,100000,37999,137999
Papillomavirus E6 Structural Consortium,9280613,2/1/2010 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,443504, ,NCI,332305,111199,443504
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma,9280912,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2017,446063, ,NCI,228750,217313,446063
Cellular Stress Response Signaling Pathways,9280950,1/1/1992 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,353250, ,NIEHS,225000,128250,353250
Roles and Regulation of wild-type and mutant forms of p53,9281453,9/30/2000 0:00,3/31/2022 0:00,Non-SBIR/STTR,2017,1945587, ,NCI,1606931,338656,1945587
Project 1: Roles of wild-type and mutant forms of p53 in cancer cell biology,9281455, , ,Non-SBIR/STTR,2017, ,338838, ,211774,127064, 
Project 2: Probing the role of the p53 network in ferroptosis,9281456, , ,Non-SBIR/STTR,2017, ,352898, ,221341,131557, 
Project 4: Mechanisms of wild-type and mutant p53 action in vivo,9281458, , ,Non-SBIR/STTR,2017, ,370833, ,355833,15000, 
Core B -The Bio-Informatics Core,9281460, , ,Non-SBIR/STTR,2017, ,201032, ,186032,15000, 
Core C - The Molecular Systems Pathology Core,9281461, , ,Non-SBIR/STTR,2017, ,262699, ,247699,15000, 
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer,9281788,7/20/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,491237, ,NIDCR,357860,133377,491237
Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research,9282298,8/4/2014 0:00,3/31/2019 0:00,SBIR/STTR,2017,656563, ,NCI, , ,656563
Development of cell-free DNA assays for HCC screening and liquid biopsy,9282418,6/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2017,472981, ,NCI,409920,63061,472981
DBPs (pp: 363-418); DBP Overviews (pp 124-129) ,9283581, , ,Research Centers,2017, ,106982, ,68776,38206, 
p53-Mediated Tumor Immune Surveillance,9284278,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,366000, ,NCI,228750,137250,366000
The roles of TRIM24 in breast cancer,9285022,3/1/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2017,402021, ,NCI,251263,150758,402021
The role of keratinocyte p53 in development of pigmented lesions,9285695,7/20/2015 0:00,6/30/2019 0:00,Non-SBIR/STTR,2017,77750, ,NIAMS,50000,27750,77750
"The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer",9285722,9/1/2012 0:00,6/30/2019 0:00,Non-SBIR/STTR,2017,291169, ,NCI,183125,108044,291169
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis,9285776,6/3/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2017,382013, ,NCI,228750,153263,382013
The impact of chromosome 17p lesions on leukemogeneis and therapy response,9288143,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,402371, ,NCI,228750,173621,402371
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer,9289422,3/8/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2017,404558, ,NCI,260359,144199,404558
ABT-199 based therapies to treat  neuroblastoma,9289519,4/1/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017,371856, ,NCI,270977,100879,371856
"Markov State Model approaches for folding, binding and design",9289836,5/1/2017 0:00,4/30/2022 0:00,Non-SBIR/STTR,2017,295617, ,NIGMS,190000,105617,295617
Neuroendocrine mechanisms of prostate cancer progression,9291444,7/7/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,348145, ,NCI,228750,119395,348145
Dim light at night alters pancreatic cell signaling and predisposes to pancreatic adenocarcinoma,9292277,7/1/2016 0:00,6/30/2019 0:00,Non-SBIR/STTR,2017,167475, ,NCI,108750,58725,167475
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia,9293268,9/11/2013 0:00,6/30/2019 0:00,Non-SBIR/STTR,2017,347563, ,NCI,207500,140063,347563
∆Np53 as a Regulator of p53 Biology,9293882,6/1/2016 0:00,4/30/2020 0:00,"Training, Individual",2017,36006, ,NIA,36006, ,36006
The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle,9294799,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,348844, ,NCI,228750,120094,348844
Novel oncogenic functions of Mdm2 and Mdmx,9296090,7/18/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,323700, ,NCI,207500,116200,323700
Pediatric Preclinical Testing Consortium,9297276,7/7/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,357000, ,NCI,212500,144500,357000
p53-mediated dead cell clearance in response to DNA damage and tumorigenesis,9300883,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2017,368043, ,NCI,228750,139293,368043
Underlying Mechanisms in Angiosarcoma,9301291,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,352275, ,NCI,228750,123525,352275
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer,9301489,5/1/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,342938, ,NCI,250977,91961,342938
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw,9302147,9/1/2014 0:00,8/31/2018 0:00,Non-SBIR/STTR,2016,918872, ,NCI,632243,286629,918872
RNF128  Regulation of TP53 in Barrett's Progression,9302157,8/31/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2017,414063, ,NCI,266994,147069,414063
Single Cell Technologies for Rapid Detection of Tumor Heterogeneity,9302327,9/1/2015 0:00,7/31/2018 0:00,Non-SBIR/STTR,2017,204524, ,NCI,147152,57372,204524
Mechanism and treatment of PTEN mutant prostate tumorigenesis,9303304,7/30/2014 0:00,6/30/2019 0:00,Non-SBIR/STTR,2017,398400, ,NCI,207500,190900,398400
Engineered precancerous cells and tissues for discovery of lung cancer drivers,9303650,8/1/2017 0:00,7/31/2019 0:00,Non-SBIR/STTR,2017,80521, ,NCI,50000,30521,80521
Role of TFIIS.h in regulation of p53 responsive apoptosis and tumor suppression,9304032,9/1/2016 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,163669, ,NCI,108750,54919,163669
Mammary carcinogenesis:  pubertal and adult effects of high fat diet+oxybenzone,9304227,9/30/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,843607, ,NIEHS,909475,410747,843607
"Head Neck Cancer, beta-defensins, and immune responses",9304793,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,396250, ,NIDCR,250000,146250,396250
Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures,9304860,9/30/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,710729, ,NIEHS,349160,145648,167341
Defining and manipulating quiescence associated DNA damage resistance in single cells,9305010,7/1/2016 0:00,1/14/2019 0:00,Other Research-Related,2017,166104, ,NCI,153800,12304,166104
Therapeutic strategies for targeting PARP1 in small cell lung cancer,9305024,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2017,366000, ,NCI,228750,137250,366000
The Role of STAT2 in Flat Non-Polypoid Colorectal Neoplasia,9305364,4/1/2017 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,78000, ,NCI,50000,28000,78000
"p53 mutation induces constitutive expression of interferon beta, enhancing the resistance of cancer cells to DNA damage",9305633,4/1/2017 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017,79250, ,NCI,50000,29250,79250
Deciphering How Esco2 Loss Acts as a Penetrance Modifier,9306665,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2017,359477, ,NCI,242072,117405,359477
PET TUMOR AND PROLIFERATION IMAGING VIA CATIONIC AMINO ACID TRANSPORT,9307100,9/1/2011 0:00,11/30/2017 0:00,Other Research-Related,2015,157715, ,NCI,146032,11683,157715
p53 and tumor cell metabolism,9307557,8/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2017,332000, ,NCI,207500,124500,332000
Nanotechnology enabled targeting of p53 deficiency in human cancer,9307738,7/8/2016 0:00,6/30/2018 0:00,Non-SBIR/STTR,2017,359138, ,NCI,297375,61763,359138
Mechanisms of Esophageal Carcinogenesis,9308851,8/15/2003 0:00,6/30/2019 0:00,Non-SBIR/STTR,2017,1607533, ,NCI,1174560,432973,1607533
Transformed Esophageal Epithelial Cells and the Tumor Microenvironment,9308864,8/15/2003 0:00, ,Non-SBIR/STTR,2017, ,351721, ,256989,94732, 
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma,9309286,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2017,390710, ,NCI,231715,158995,390710
Small Molecule Activators of Procaspases as Anti-Cancer Agents,9310218,8/6/2007 0:00,8/5/2018 0:00,Non-SBIR/STTR,2017,432711, ,NCI,300879,131832,432711
The role of PCDH7 in lung cancer pathogenesis,9310666,3/9/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2017,357482, ,NCI,222542,134940,357482
miR-200 miRNAs repress tumor metastasis in lung adenocarcinoma,9310837,8/1/2009 0:00,3/31/2022 0:00,Non-SBIR/STTR,2017,373268, ,NCI,237750,135518,373268
Systemic RNA interference to reactivate p53 tumor suppression,9311017,3/1/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2017,360354, ,NCI,232868,127486,360354
Targeting the TGIF/Twist1 network in osteosarcoma,9311684,3/15/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2017,348844, ,NCI,228750,120094,348844
RNDI- Mediated Breast Cancer Suppression,9312760, , ,Non-SBIR/STTR,2017, ,504912, ,287045,217867, 
SIRT2 Inhibitors for the Treatment of B-cell Lymphoma,9312788,7/7/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2017,574754, ,NCI,326565,248189,574754
Modeling Mdm2- and 12q amplicon-driven sarcoma,9313580,3/8/2017 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,83493, ,NCI,50000,33493,83493
MUC13 Mucin in Colorectal Cancer Health Disparity,9313845,7/11/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2017,351510, ,NCI,236673,114837,351510
Deciphering the Molecular Pathways Driving p53 Dependent Cell Death,9313849,8/1/2015 0:00,7/31/2018 0:00,"Training, Individual",2017,60990, ,NCI,60990, ,60990
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response,9314182,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2017,578379, ,NCI,373148,205231,578379
Molecular Virology Research Program,9314390, , ,Research Centers,2017, ,22641, ,13598,9043, 
Tissue-specific tumor suppressor effects of p53,9314554,7/17/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,432908, ,NCI,255403,177505,432908
Copy Number Alterations in Low Mutation Cancer,9314982,3/3/2017 0:00,9/25/2017 0:00,Other Research-Related,2017,118896, ,NCI,110089,8807,118896
Heterocyclic Triads as Potential Therapeutic Agents for Renal Cell Carcinoma,9314987,7/1/2016 0:00,8/15/2017 0:00,"Training, Individual",2017,21022, ,NCI,21022, ,21022
Exploration of a Mutant p53 Reactivating Compound,9315121,8/16/2013 0:00,7/31/2018 0:00,Other Research-Related,2017,158958, ,NCI,147183,11775,158958
Function and regulation of MDMX intra-molecular interactions,9315123,8/1/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2017,393450, ,NCI,228750,164700,393450
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer,9315124,9/2/2015 0:00,7/31/2019 0:00,Non-SBIR/STTR,2017,663150, ,NCI,415000,248150,663150
"Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation",9316337,7/15/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2017,377438, ,NCI,228750,148688,377438
Using markers to improve pancreatic cancer screening and surveillance,9317455,7/18/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2017,953081, ,NCI,801012,375445,953081
Role of DNA Replication Stress in Genome Instability and Cancer,9318365,7/1/2017 0:00,6/30/2021 0:00,Non-SBIR/STTR,2017,330739, ,NIGMS,234453,96286,330739
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias,9319018,9/1/2015 0:00,8/31/2020 0:00,Non-SBIR/STTR,2017,418613, ,NCI,228750,189863,418613
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity,9319246,8/1/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2017,1045738, ,NCI,582384,547441,1045738
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis,9319674,8/14/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2017,975963, ,NCI,600000,375963,975963
Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell,9320007,7/1/2016 0:00,1/1/2018 0:00,"Training, Individual",2017,32772, ,NCI,32772, ,32772
Defining mechanisms of extracellular communication for cancer therapy,9320095,4/1/2013 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,51271, ,NCI,36851,14420,51271
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia,9320627,9/13/2016 0:00,8/31/2019 0:00,Non-SBIR/STTR,2016,252971, ,NCI,169590,83381,252971
Definition of the Microenvironment in Breast Cancer,9320815,8/1/2016 0:00,7/31/2021 0:00,Non-SBIR/STTR,2017,491681, ,NCI,261102,230579,491681
SPORE: Targeted Therapies for Glioma,9321075,9/19/2013 0:00,7/31/2019 0:00,Research Centers,2017,2280112, ,NCI,1723366,557640,2280112
"Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.",9321270,8/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2017,580448, ,NCI,378248,202200,580448
Regulation of RNA metabolism and cell growth control by SR protein kinases,9321290,5/1/1996 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,348750, ,NIGMS,225000,123750,348750
The role of autophagy in Kras-driven lung cancer,9321425,9/1/2015 0:00,8/31/2019 0:00,Other Research-Related,2017,209628, ,NCI,194100,15528,209628
Targeting Olig2 Co-regulators for Malignant Glioma Therapy,9321481,9/30/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2017,349149, ,NINDS,266438,82711,349149
MicroRNA Targets for Chemoprevention of Squamous Cell Carcinoma (R01 CA194062-01A1),9321552,9/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2016,294989, ,NCI,171505,123484,294989
A novel oncogenic driver in Ewing sarcoma,9321922,7/27/2016 0:00,6/30/2019 0:00,Non-SBIR/STTR,2017,165844, ,NCI,108750,57094,165844
The intersection of RNA biology and tumor biology,9322345,8/12/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2017,771315, ,NCI,482025,290179,771315
"Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe",9322481,8/1/2014 0:00,6/30/2019 0:00,Other Research-Related,2017,188380, ,NINDS,174500,13880,188380
The regulation of PP1 in the nucleus,9323496,9/11/2011 0:00,8/31/2020 0:00,Non-SBIR/STTR,2017,322350, ,NIGMS,210000,112350,322350
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma,9323678,9/1/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2016,816402, ,NCI,495582,320820,816402
The reduction of NLRX1 and its role in pulmonary aging,9324115,8/15/2016 0:00,4/30/2021 0:00,Non-SBIR/STTR,2017,343375, ,NIA,205000,138375,343375
EPHB4 Receptor Kinase as a Target in Prostate Cancer,9324155, , ,Research Centers,2017, ,288070, ,244695,73550, 
Modulation of cancer specific transcriptional factors with small molecules,9324178,8/1/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2017,401456, ,NCI,228750,172706,401456
Mechanism of chemoresistance mediated by TGF-beta,9324482,5/1/2012 0:00,3/31/2018 0:00,Non-SBIR/STTR,2016,321625, ,NCI,207500,114125,321625
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,9324777,9/30/2010 0:00,2/29/2020 0:00,Non-SBIR/STTR,2016,50396, ,NIDDK,36931,13465,50396
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3,9324922,9/26/2015 0:00,8/31/2018 0:00,Non-SBIR/STTR,2017,248999, ,NCI,146470,102529,248999
Mechanisms of targeting oncoprotein SET in tumor suppression,9325174,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2017,366000, ,NCI,228750,137250,366000
The Development of Novel Individualized Therapy for Triple-Negative Breast Cancer,9325298,9/1/2013 0:00,8/31/2018 0:00,Other Research-Related,2017,171720, ,NCI,159000,12720,171720
MicroRNA Therapeutics in Non-small Cell Lung Cancer,9325322, , ,Research Centers,2017, ,384723, ,297437,97384, 
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma:  Environmental Co,9325473,7/1/2009 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,334629, ,NCI,248029,86600,334629
Novel integrative method to detect biomakers of breast cancer resistance,9325566,8/1/2013 0:00,1/31/2020 0:00,Non-SBIR/STTR,2017,194545, ,NLM,127404,67141,194545
RB-Related Proteins and Polyomavirus Large T antigen Transformation,9326149,5/2/1994 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,311400, ,NCI,180000,131400,311400
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance,9326190,9/9/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,317475, ,NCI,186750,130725,317475
Risk and penetrance of mutations from breast cancer testing panels.,9326258,9/25/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,1263145, ,NCI,996224,266921,1263145
Novel regulations of DNA damage repair,9326453,3/16/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2017,366000, ,NCI,228750,137250,366000
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia,9326913,8/5/2003 0:00,8/31/2018 0:00,Research Centers,2017,2300000, ,NCI,1798471,634214,2300000
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas,9326929,9/1/2016 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,174000, ,NCI,108750,65250,174000
Mechanisms of Tumorigenic Transformation of Barretts Esophagus,9326930,9/25/2015 0:00,3/31/2018 0:00,Non-SBIR/STTR,2017,88127, ,NCI,50389,37738,88127
Cancer cell adaptation to glutamine deprivation,9326936,9/1/2014 0:00,12/31/2017 0:00,Non-SBIR/STTR,2017,43637, ,NCI,207500,145250,43637
p53 - Regulators and Effectors,9327149,2/16/2000 0:00,6/30/2017 0:00,Non-SBIR/STTR,2016,108914, ,NCI,64256,44658,108914
Identification of Genetic Alterations Responsible for Primary GBM Clonal Evoluti,9327972,9/5/2001 0:00,6/30/2019 0:00,Non-SBIR/STTR,2017, ,458156, ,363360,94796, 
Elucidating the mechanism of anti-GSK3 adjuvant therapy for Myc-driven lymphomas,9328735,3/1/2017 0:00,2/29/2020 0:00,"Training, Individual",2017,44044, ,NCI,44044, ,44044
Role of ER stress-driven IRE1α-XBP1 Signaling in Lung Cancer Pathogenesis,9329071,7/1/2017 0:00,6/30/2020 0:00,"Training, Individual",2017,44044, ,NCI,44044, ,44044
BACH2 in Melanoma Development and Resistance,9329377,8/9/2016 0:00,7/31/2019 0:00,Other Research-Related,2017,177344, ,NCI,164207,13137,177344
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis,9329379,9/8/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,336565, ,NCI,237541,99024,336565
Targeting metabolic vulnerabilities in glioblastoma,9330449,8/7/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2017,511461, ,NCI,338438,173023,511461
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer,9331474,9/12/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,439351, ,NCI,249773,189578,439351
The role of p53 family members in epithelial lineage establishment and maintenance,9332255,3/2/2017 0:00,3/1/2019 0:00,"Training, Individual",2017,44044, ,NIGMS,44044, ,44044
Role of Set2 and H3 methylation in chromatin function,9332646,5/1/2003 0:00,4/30/2018 0:00,Non-SBIR/STTR,2017,334207, ,NIGMS,225000,119466,334207
Patient-derived glioblastoma in vitro and in vivo studies of tryptophan metabolism via the kynurenine pathway,9332670,9/1/2017 0:00,8/31/2019 0:00,"Training, Individual",2017,40478, ,NCI,40478, ,40478
Functionalizing recurrent FAT1 mutations and deletions in oral cancer,9333111,9/1/2014 0:00,8/31/2019 0:00,Other Research-Related,2017,136350, ,NIDCR,126250,10100,136350
Role of the AMPK-MDMX-p53 pathway in cancer,9333196,9/28/2007 0:00,8/31/2020 0:00,Non-SBIR/STTR,2017,321694, ,NCI,213750,107944,321694
Project 1 - PARP Project,9333234,9/1/2009 0:00, ,Research Centers,2017, ,188670, ,188670,0, 
p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer,9333279,8/16/2016 0:00,7/31/2019 0:00,Other Research-Related,2017,157743, ,NCI,146058,11685,157743
Pax2 loss in fallopian tube lesions and strategies for restoration in serous cancer,9333292,9/1/2016 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,163017, ,NCI,108750,54267,163017
MECHANISMS OF ANNEXIN A6-MEDIATED BASAL-LIKE BREAST CANCER PROGRESSION,9333293,8/16/2016 0:00,7/31/2020 0:00,Other Research-Related,2017,363750, ,NIGMS,250000,113750,363750
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni,9333462,8/1/2013 0:00,7/31/2019 0:00,Non-SBIR/STTR,2017,999911, ,OD,751632,379574,999911
From Mechanism to Population: Modeling HPV-related Oropharyngeal Carcinogenesis,9334115,9/11/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,639928, ,NCI,423914,227557,639928
Genetic characterization of osteoblast-induced leukemias,9335425,9/1/2016 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,461485, ,NHLBI,288428,173057,461485
Mechanisms behind hyperglycemia-associated breast cancer risk and progression,9335794,7/21/2015 0:00,6/30/2019 0:00,Other Research-Related,2017,358750, ,NIGMS,250000,108750,358750
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance,9336031,7/1/2011 0:00,11/30/2016 0:00,Non-SBIR/STTR,2015,89581, ,NCI,52850,36731,89581
Full Project 3: Molecular Pathways to Breast Cancer Mortality among African American and White Women,9336821, , ,Research Centers,2017, ,45738, ,36345,15991, 
Aurora-A is a novel therapeutic target in glioblastoma,9336975,9/1/2014 0:00,1/31/2020 0:00,Non-SBIR/STTR,2018,359357, ,NINDS,233349,126008,359357
Sphingolipids in Cancer Biology and Therapy,9337343,8/1/2003 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,1301994, ,NCI,892069,409925,1301994
Project 3: Role of Sphingosine Kinase in P53 Cancer Biology,9337347,8/1/2003 0:00, ,Non-SBIR/STTR,2017, ,208551, ,142890,65661, 
Project 1: Role of Acid Sphingomyelinase in Breast Cancer,9337349,8/1/2003 0:00, ,Non-SBIR/STTR,2017, ,222372, ,152359,70013, 
Full Project 3: Molecular Pathways to Breast Cancer Mortality among African American and White Women,9337359, , ,Research Centers,2017, ,192973, ,148043,76795, 
Characterization of mTOR signaling during early stages of gliomagenesis,9337387,9/1/2015 0:00,8/31/2018 0:00,"Training, Individual",2017,40728, ,NCI,40728, ,40728
(1) Intestinal Organoid Models for APC LOH,9337412,9/1/2016 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,192406, ,NCI,125000,67406,192406
Molecular Landscape-based Innovative Therapies for Anaplastic Thyroid Carcinoma,9338159, , ,Research Centers,2017, ,520414, ,353701,203727, 
Regulation of ATDC by TP63 and its role in bladder cancer,9338210,9/1/2016 0:00,8/31/2021 0:00,Other Research-Related,2017,174960, ,NCI,162000,12960,174960
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells,9338279, , ,Non-SBIR/STTR,2017, ,433726, ,382138,51588, 
Using markers to improve pancreatic cancer screening and surveillance,9338935,7/18/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2016,248872, ,NCI,152682,96190,248872
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous (5R01 CA194617-02),9339001,9/1/2016 0:00,3/31/2019 0:00,Non-SBIR/STTR,2016,194277, ,NCI,116760,77517,194277
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,9339152, , ,Intramural Research,2016,9672204, ,NCI, , ,9672204
Intervention Trials in Persons at Increased Genetic Risk of Cancer,9339153, , ,Intramural Research,2016,500914, ,NCI, , ,500914
Consultation and Collaboration,9339166, , ,Intramural Research,2016,1770645, ,NCI, , ,1770645
The role of autophagy in aging and metabolism,9339271, , ,Intramural Research,2016,1287106, ,NHLBI, , ,1287106
Mitochondrial regulation and function in cancer and cardiovascular biology,9339272, , ,Intramural Research,2016,1126512, ,NHLBI, , ,1126512
FoxM1 in tumor cell,9339464,6/1/2009 0:00,3/31/2019 0:00,Non-SBIR/STTR,2017, , , , , , 
Regulation of gastroesophageal reflux-associated tumorigenesis,9339520,7/1/2014 0:00,6/30/2018 0:00,Non-SBIR/STTR,2017, , , , , , 
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions,9339619,9/12/2014 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,442311, ,NCI,377403,64908,442311
Regulation Of Epidermal Differentiation,9339922, , ,Intramural Research,2016,1149108, ,NIAMS, , ,1149108
Initiation Of DNA Replication In Mammalian Chromosomes,9339943, , ,Intramural Research,2016,834809, ,NICHD, , ,834809
01 Project 1:  Cancer risks for mutations in breast cancer predisposition genes,9340076, , ,Research Centers,2017, ,494441, ,375469,118972, 
Preclinical Development and Clinical Testing of MEK and PI3K Targeted Therapy for KRAS-mutant NSCLC,9341100, , ,Research Centers,2017, ,318714, ,257270,61444, 
Placenta specific and ribosomal RNA genes: structure and function,9341857, , ,Intramural Research,2016,828281, ,NIA, , ,828281
Chromosomal Proteins and Chromosomal Functions,9343519, , ,Intramural Research,2016,837688, ,NCI, , ,837688
Gene Regulation and Function: The B-ZIP Proteins,9343526, , ,Intramural Research,2016,991659, ,NCI, , ,991659
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,9343527, , ,Intramural Research,2016,1194199, ,NCI, , ,1194199
"Tumor Suppressor Protein, p53",9343533, , ,Intramural Research,2016,418446, ,NCI, , ,418446
Transgenic Models for Breast Cancer,9343536, , ,Intramural Research,2016,571893, ,NCI, , ,571893
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,9343551, , ,Intramural Research,2016,1084624, ,NCI, , ,1084624
Regulation of Lymphocyte Proliferation and Replicative Capacity,9343566, , ,Intramural Research,2016,661601, ,NCI, , ,661601
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,9343569, , ,Intramural Research,2016,415450, ,NCI, , ,415450
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,9343573, , ,Intramural Research,2016,351450, ,NCI, , ,351450
Enzymes and Substrates of the Ubiquitin Conjugating System,9343583, , ,Intramural Research,2016,880528, ,NCI, , ,880528
Role of CEBP transcription factors in cell growth and tumorigenesis,9343595, , ,Intramural Research,2016,1371469, ,NCI, , ,1371469
Role of Neurotrophins in the Development of the Mammalian Nervous System,9343611, , ,Intramural Research,2016,743429, ,NCI, , ,743429
Zebrafish Models of Cancer,9343647, , ,Intramural Research,2016,107435, ,NCI, , ,107435
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,9343679, , ,Intramural Research,2016,156494, ,NCI, , ,156494
"Role of inflammation, innate resistance, and immunity in carcinogenesis",9343703, , ,Intramural Research,2016,1078868, ,NCI, , ,1078868
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,9343706, , ,Intramural Research,2016,978122, ,NCI, , ,978122
"Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer",9343720, , ,Intramural Research,2016,560918, ,NCI, , ,560918
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,9343731, , ,Intramural Research,2016,36154, ,NCI, , ,36154
Redox Mechanism Process of Angiogenesis and Wound Healing,9343741, , ,Intramural Research,2016,320951, ,NCI, , ,320951
Collaborative Pathways that Lead to Leukemia,9343760, , ,Intramural Research,2016,657818, ,NCI, , ,657818
TMPRSS2-ERG chromosomal translocations and prostate cancer,9343779, , ,Intramural Research,2016,195624, ,NCI, , ,195624
Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,9343805, , ,Intramural Research,2016,1568858, ,NCI, , ,1568858
Role of Brachyury in regulating notochord development and neoplasia,9343811, , ,Intramural Research,2016,134624, ,NCI, , ,134624
Role of inflammation in epigenetic alterations of metastatic cancer cells,9343825, , ,Intramural Research,2016,614078, ,NCI, , ,614078
Functions of KSHV microRNAs,9343828, , ,Intramural Research,2016,660097, ,NCI, , ,660097
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,9343831, , ,Intramural Research,2016,729369, ,NCI, , ,729369
Preclinical drug development in pancreatic cancer,9343856, , ,Intramural Research,2016,1131974, ,NCI, , ,1131974
Genomic and genetic studies of endocrine cancers,9343857, , ,Intramural Research,2016,558362, ,NCI, , ,558362
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,9343882, , ,Intramural Research,2016,515673, ,NCI, , ,515673
Zbtb family members in lymphocyte differentiation and function,9343922, , ,Intramural Research,2016,498864, ,NCI, , ,498864
"Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome",9343957, , ,Intramural Research,2016,1145460, ,NCI, , ,1145460
"p53, Aging, and Cancer",9343959, , ,Intramural Research,2016,1527281, ,NCI, , ,1527281
Study the roles of p53 and p53 mutants in mesenchymal stem cells,9343963, , ,Intramural Research,2016,595344, ,NCI, , ,595344
Metabolic and p53 Targets of Cellular Respiration of Esophageal Cancer,9344008, , ,Intramural Research,2016,421246, ,NCI, , ,421246
Role of long non-coding RNAs in p53 signaling,9344013, , ,Intramural Research,2016,754250, ,NCI, , ,754250
Genomic characterization and development of therapies for Rhabdomyosarcoma,9344062, , ,Intramural Research,2016,206027, ,NCI, , ,206027
Genomic dissection of tumor heterogeneity and progression,9344070, , ,Intramural Research,2016,206027, ,NCI, , ,206027
Development and Preclinical Application of Pancreatic Adenocarcinoma Models,9344074, , ,Intramural Research,2016,990320, ,NCI, , ,990320
Targeting Metabolic Pathways in Bladder Cancer,9344076, , ,Intramural Research,2016,157000, ,NCI, , ,157000
Lymphoma Studies,9344103, , ,Intramural Research,2016,782468, ,NCI, , ,782468
Nitric Oxide as a Modifier of Oxidative Stress,9344107, , ,Intramural Research,2016,481426, ,NCI, , ,481426
CCR Confocal Microscopy Core,9344140, , ,Intramural Research,2016,751703, ,NCI, , ,751703
Comparison of molecular factors to drug activities,9344187, , ,Intramural Research,2016,122922, ,NCI, , ,122922
Comparative Biomedical Scientist Training Program,9344245, , ,Intramural Research,2016,1029500, ,NCI, , ,1029500
Development of Novel Preclinical Animal Models - CAPR Infrastructure,9344247, , ,Intramural Research,2016,1237901, ,NCI, , ,1237901
Genome instability in cancer: telomeres and DNA repair,9344566,9/2/2016 0:00,8/31/2023 0:00,Non-SBIR/STTR,2017,1017000, ,NCI,600000,417000,1017000
Human Genes Affecting Chromosome Metabolism and Stress Response,9345267, , ,Intramural Research,2016,1257687, ,NIEHS, , ,1257687
Phosphoinositides and Cancer Metabolism,9346039,9/5/2016 0:00,7/31/2023 0:00,Non-SBIR/STTR,2017,1017000, ,NCI,645604,448695,1017000
The tumor suppressor capability of p53 is dependent on Non-muscle Myosin IIA function in Head and Neck Cancer.,9346608,9/6/2016 0:00,8/31/2019 0:00,Other Research-Related,2017,135000, ,NIDCR,125000,10000,135000
Regulation Of Intracellular Iron Metabolism,9348226, , ,Intramural Research,2016,991868, ,NICHD, , ,991868
Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells,9349278, , ,Intramural Research,2016,3281120, ,NIEHS, , ,3281120
p63 Regulation of Human Osteoprogenitor Maturation by Hepatocyte Growth Factor & Vitamin D Metabolites,9350492,7/1/2012 0:00,6/30/2021 0:00,Non-SBIR/STTR,2017, , , , , , 
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp,9351474, , ,Non-SBIR/STTR,2017, ,354394, ,257371,97023, 
Genetic Susceptibility To Carcinogens ,9352095, , ,Intramural Research,2016,1008257, ,NIEHS, , ,1008257
Discovery And Functional Genomics Of Environmental Response Genes,9352121, , ,Intramural Research,2016,1296330, ,NIEHS, , ,1296330
DNA Microarray Data Analysis,9352160, , ,Intramural Research,2016,97458, ,NIEHS, , ,97458
Structural Mechanisms of Ribosome Assembly,9352164, , ,Intramural Research,2016,1557340, ,NIEHS, , ,1557340
Metabolic Studies of Mouse Models of Obesity and Diabetes,9352196, , ,Intramural Research,2016,724700, ,NIDDK, , ,724700
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia,9352281,9/13/2016 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,252971, ,NCI,169590,83381,252971
Signal and Transcription Factor Network interactions in Head and Neck Cancer,9353064, , ,Intramural Research,2016,630635, ,NIDCD, , ,630635
Genomics and Proteomics of Head and Neck Cancer,9353065, , ,Intramural Research,2016,834000, ,NIDCD, , ,834000
In Vivo Function of Nonmuscle Myosin II-A,9353099, , ,Intramural Research,2016,395373, ,NHLBI, , ,395373
Non-replicative senescence of macrophages and role of HIV-1 infection,9353267,9/15/2016 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,193131, ,NIA,125000,68131,193131
Targeting Ribosomal Biogenesis in Prostate Cancer,9353330,9/15/2016 0:00,1/30/2018 0:00,Other Research-Related,2017,26010, ,NCI,24082,1928,26010
Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human Cancer,9353331,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2017,264110, ,NCI,150920,113190,264110
"Bioinformatics approaches to solve the ""Missing Driver"" problem in solid tumors",9353343,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2017,112801, ,NCI,73646,39155,112801
Preclinical Models for Cancer Therapeutic Development,9353358,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2017,174117, ,NCI,90686,83431,174117
Project 3: Molecular Markers for Early Detection of Esophageal Carcinogenesis,9353962, , ,Research Centers,2017, ,357951, ,232487,125464, 
Breast Cancer Detection Consortium,9354415,9/19/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2017,454587, ,NCI,399295,175632,454587
Cellular mechanisms of androgen action and androgen-response gene EAF2 in prostate cancer,9354416,9/19/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2017,114950, ,NCI,73804,41146,114950
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease,9354719, , ,Intramural Research,2016,1418999, ,NIAID, , ,1418999
Phenotypic Assay Design and Development for Rare and Neglected Diseases,9354991, , ,Intramural Research,2016,262502, ,NCATS, , ,262502
System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs,9355607,9/21/2016 0:00,8/31/2018 0:00,Other Research-Related,2017,41724, ,NCI,41724, ,41724
Natural History of Familial Carcinoid Tumor,9356182, , ,Intramural Research,2016,848716, ,NIDDK, , ,848716
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9356473, , ,Research Centers,2017, ,80108, ,56000,25480, 
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9356482, , ,Research Centers,2017, ,18696, ,11833,6863, 
TFIIH and Transcription Regulation,9356554,9/22/2016 0:00,5/31/2020 0:00,Non-SBIR/STTR,2017,550878, ,NIGMS,476112,74766,550878
IGF::OT::IGF CELL-FREE CIRCULATING DBA-BASED ASSAY DEVELOPMENT FOR LIVER CANCER SCREENING,9356736,9/19/2016 0:00,3/18/2017 0:00,R and D Contracts,2016,273600, ,NCI, , ,273600
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer,9356787,9/22/2017 0:00,8/31/2022 0:00,Research Centers,2017,1732856, ,NCI,1091472,641384,1732856
Project 1: High Grade Cancers: Capitalizing on PARPness in Ovarian Carcinoma,9356791, , ,Research Centers,2017, ,351522, ,219701,131821, 
Project 1:  Evolution of transcriptional programs in lung cancer progression,9356947, ,7/31/2022 0:00,Non-SBIR/STTR,2017, ,420760, ,268461,152299, 
Project 3:  Targeting epigenetic regulators in cancer,9356949, ,7/31/2022 0:00,Non-SBIR/STTR,2017, ,352717, ,229500,123217, 
Project 2: Targeting metabolic vulnerabilities in glioblastoma,9357418, , ,Research Centers,2017, ,340320, ,219443,120877, 
Project 4: Novel epigenetic treatment of IDH mutant gliomas,9357420, , ,Research Centers,2017, ,363680, ,234506,129174, 
Project 1: CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,9357537,9/30/2005 0:00, ,Research Centers,2017, ,203169, ,140001,63168, 
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9357561, , ,Research Centers,2017, ,15517, ,11935,5011, 
Identifying stabilizers of p53 using pocket complementarity,9357613,9/26/2016 0:00,8/31/2020 0:00,Non-SBIR/STTR,2017,350136, ,NIGMS,227520,122616,350136
PROJECT 4: Interrogating PP2A Signaling in Human Cancers,9358182, , ,Non-SBIR/STTR,2017, ,328830, ,186750,142080, 
Germline modifiers of tumor progression and metastasis in prostate cancer,9359841, , ,Intramural Research,2016,1107427, ,NHGRI, , ,1107427
Inhibitors of p53-S100B interaction for melanoma,9359882, , ,Intramural Research,2016,226982, ,NCATS, , ,226982
Anticancer peptide therapeutics,9366543,8/1/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2017,353419, ,NCI,228750,124669,353419
RNA Splicing Modulators for MDS/AML,9368251, , ,Research Centers,2017, ,427150, ,295635,131515, 
CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,9368969, , ,Research Centers,2017, ,104228, ,74618,30243, 
Molecular Tumorigenesis of Bladder Cancer,9369612, ,8/31/2019 0:00,Non-SBIR/STTR,2017, ,321793, ,189848,131945, 
DNA Repair and Tobacco Smoke in Bladder Carcinogenesis,9369613, ,8/31/2019 0:00,Non-SBIR/STTR,2017, ,219440, ,129463,89977, 
Novel Role of XIAP in Bladder Cancer Invasion,9369614, ,8/31/2019 0:00,Non-SBIR/STTR,2017, ,351362, ,207293,144069, 
Defining diverse roles of p53 in pancreatic cancer,9370822,8/1/2017 0:00,7/31/2022 0:00,Other Research-Related,2017,170640, ,NCI,158000,12640,170640
Novel model to study PDAC using normal human pancreatic tissue,9376212,6/9/2017 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,199013, ,NCI,130500,68513,199013
A Novel Mouse Model for Uterine Leiomyoma,9377236,9/13/2017 0:00,7/31/2019 0:00,Non-SBIR/STTR,2017,80000, ,NCI,50000,30000,80000
Protein Kinase Signaling in the Genotoxic Stress Response,9377240,9/1/2017 0:00,7/31/2025 0:00,Non-SBIR/STTR,2017,186327, ,NIEHS,117187,69140,186327
Do seizures stimulate glioma progression?,9377465,8/1/2017 0:00,7/31/2019 0:00,Non-SBIR/STTR,2017,80000, ,NINDS,50000,30000,80000
p53 Variants in Cancer Risk and Therapy,9377535,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,428330, ,NCI,228750,199580,428330
Progression and regression of mammary preneoplasia,9378091,12/23/2004 0:00,11/30/2019 0:00,Non-SBIR/STTR,2018,311000, ,NCI,200000,111000,311000
Local Immuroregulation of Cutaneous Carcinogenesis,9378092,7/1/2003 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,397813, ,NCI,237500,160313,397813
Defining Critical p53 Therapeutic Targets and Mechanisms,9378093,3/1/2009 0:00,11/30/2019 0:00,Non-SBIR/STTR,2018,436500, ,NCI,225000,211500,436500
Determining the Influence Genomic Instability During Embryogenesis has on Tumor Penetrance,9378133,9/11/2017 0:00,8/31/2019 0:00,Non-SBIR/STTR,2017,193793, ,NCI,130500,63293,193793
Role of Vitamin D in cutaneous DNA repair,9378391,10/1/2016 0:00,9/30/2020 0:00,Non-SBIR/STTR,2018, , , , , , 
DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations,9378420,12/1/2014 0:00,11/30/2019 0:00,Non-SBIR/STTR,2018,366000, ,NCI,228750,137250,366000
Role of heat shock factors (Hsfs) in tumorigenesis,9378780,3/1/2000 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,270000, ,NCI,180000,90000,270000
IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level,9378959,8/1/2017 0:00,7/31/2019 0:00,Non-SBIR/STTR,2017,80000, ,NCI,50000,30000,80000
Targeting the oncogenic mutant p53 signaling in colorectal cancer therapy,9379046,4/18/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,73225, ,NCI,41819,31406,73225
(PQ7) A multi-fluorescent intravital microscopy approach to study osteosarcoma,9379068,9/1/2017 0:00,7/31/2018 0:00,Non-SBIR/STTR,2017,191221, ,NCI,119716,71505,191221
Tissue-specific tumor suppressor effects of p53,9379113,7/17/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2017,78178, ,NCI,46840,31338,78178
Nuclear Function of Abl in DNA Damage Response,9379455,8/1/1986 0:00,11/30/2019 0:00,Non-SBIR/STTR,2018,387500, ,NCI,250000,137500,387500
Mechanisms of Intestinal Tumorigenesis,9379842,1/1/2000 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,395000, ,NCI,250000,145000,395000
Multi-scale enhanced sampling of disordered proteins,9379858,1/1/2016 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,268363, ,NIGMS,192500,75863,268363
Identification and targeting of the signaling pathways underlying lung cancer.,9380318,3/1/2009 0:00,12/31/2018 0:00,Non-SBIR/STTR,2018,432000, ,NCI,225000,207000,432000
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer,9380322,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,434625, ,NCI,228750,205875,434625
Dynamics of Signaling Pathways: Mechanism and Function,9381247,3/1/2008 0:00,5/31/2021 0:00,Non-SBIR/STTR,2017,379402, ,NIGMS,225700,153702,379402
Regulation of SLC7A11 by p53 in cancer metabolism,9382857,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,366000, ,NCI,228750,137250,366000
"Role of the p53 C-terminal domain in tissue homeostasis, tumor suppression, and oncogenesis",9383033,12/15/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,623302, ,NCI,477589,145713,623302
ATM FUNCTION DURING V(D)J RECOMBINATION,9385277,12/2/2008 0:00,12/3/2018 0:00,Non-SBIR/STTR,2018,419353, ,NIAID,250000,169353,419353
Perivascular niche for salivary gland cancer stem cells and resistance to therapy,9385473,2/10/2011 0:00,6/30/2022 0:00,Non-SBIR/STTR,2017,368125, ,NIDCR,237500,130625,368125
Information Processing by Post-translational Modification,9386755,12/15/2014 0:00,9/14/2019 0:00,Non-SBIR/STTR,2018,362667, ,NIGMS,236103,126564,362667
Engineering Antibody Drug Conjugates To Target P53-Defective Triple Negative Breast Cancer,9387634,6/13/2017 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,185933, ,NCI,142349,43584,185933
Epigenetic modulation of SEC24D and circulating miR-605 in renal cell carcinoma,9387645,6/15/2017 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,203580, ,NCI,130500,73080,203580
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway,9388256,8/19/2005 0:00,11/30/2019 0:00,Non-SBIR/STTR,2018,372875, ,NCI,237500,135375,372875
Functional Analysis of p53 polymorphic variants,9388315,6/1/2005 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,384750, ,NCI,202500,182250,384750
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade,9388827,8/28/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2017,393450, ,NCI,228750,164700,393450
Defining the temporal sequence of PI3K pathway mutations in bladder cancer,9390035,1/1/2014 0:00,12/31/2018 0:00,Non-SBIR/STTR,2018,368728, ,NCI,207500,161228,368728
Molecular Biology of Oncogenic Papillomaviruses,9390045,1/1/2016 0:00,12/31/2022 0:00,Non-SBIR/STTR,2018,1017000, ,NCI,618497,429855,1017000
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression,9390182,8/1/2017 0:00,7/31/2024 0:00,Non-SBIR/STTR,2017,899417, ,NCI,599997,299420,899417
Tumor suppressor p53 and its targets in checkpoint regulation,9390463,12/1/2016 0:00,6/7/2018 0:00,Non-SBIR/STTR,2018,366502, ,NCI,228750,137752,366502
Role of p53 Missense Mutations on Tumorigenesis in Vivo,9390761,9/1/1999 0:00,12/31/2019 0:00,Non-SBIR/STTR,2018,342000, ,NCI,213750,128250,342000
PL Growth,9390781, , ,Research Centers,2018, ,43091, ,22212,20879, 
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer,9391017,12/1/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2018,348844, ,NCI,228750,120094,348844
The Role of Ribosomal Proteins in the P53-MDM2 Pathway,9391179,3/1/2002 0:00,12/31/2021 0:00,Non-SBIR/STTR,2018,285950, ,NCI,190000,95950,285950
the role of EZH2 in neuroendocrine prostate cancer,9391655,12/1/2016 0:00,11/30/2019 0:00,Non-SBIR/STTR,2018,72500, ,NCI,50000,22500,72500
(Diversity supplement to R01CA188096) Targeting autophagaphy in hereditary breast cancer,9392413,6/1/2015 0:00,5/31/2018 0:00,Non-SBIR/STTR,2017,57707, ,NCI,36722,20985,57707
53BP1-dependent pathway in DNA repair,9392744,6/14/2017 0:00,5/31/2022 0:00,Non-SBIR/STTR,2017,366000, ,NCI,228750,137250,366000
Role of HOS in Cell Transformation and Apoptosis,9392901,3/1/2001 0:00,11/30/2021 0:00,Non-SBIR/STTR,2018,344138, ,NCI,213750,130388,344138
The role of chronic stress in regulation of mutant p53 and tumorigenesis,9392908,1/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2018,363306, ,NCI,228750,134556,363306
Physiological Role of Dynamin-Related Protein 1 in Pancreatic Ductal Adenocarcinoma,9393117,7/1/2017 0:00,6/30/2020 0:00,"Training, Individual",2017,31485, ,NCI,31485, ,31485
LINE-1 genotoxicity and cytotoxicity and its relevance to cancer,9395508,1/1/2018 0:00,12/31/2020 0:00,"Training, Individual",2017,49044, ,NCI,49044, ,49044
Bax/Bak activation without direct activator BH3-only proteins in cancer cells,9395895,1/1/2017 0:00,12/31/2019 0:00,Non-SBIR/STTR,2018,75250, ,NCI,50000,25250,75250
USP7 inhibitors for the treatment of multiple myeloma,9395902,12/15/2016 0:00,11/30/2019 0:00,Non-SBIR/STTR,2018,504721, ,NCI,289814,214907,504721
Molecular regulation and therapeutic targeting of the TSC signaling network,9396532,12/1/2017 0:00,11/30/2020 0:00,"Training, Individual",2017,57066, ,NCI,57066, ,57066
Dissecting and targetting HDMX-medicated chemoresistance in human cancer,9396622,8/1/2017 0:00,7/31/2019 0:00,"Training, Individual",2017,35722, ,NCI,35722, ,35722
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles,9396689,7/1/2017 0:00,6/30/2022 0:00,"Training, Individual",2017,49044, ,NCI,49044, ,49044
An in vivo model for CCNE1 amplified tumorigenesis,9396699,12/1/2017 0:00,11/30/2020 0:00,"Training, Individual",2017,60990, ,NCI,60990, ,60990
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer,9398810,6/14/2017 0:00,5/31/2022 0:00,Non-SBIR/STTR,2017,415275, ,NCI,240693,174582,415275
Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy,9401973,9/4/2017 0:00,8/31/2022 0:00,Non-SBIR/STTR,2017,592167, ,NCI,407125,185042,592167
Novel therapeutics for targeting checkpoint dysfunction in cancer,9402590,12/15/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2018,362569, ,NCI,228750,133819,362569
Investigating CREBBP as a tumor suppressor in small cell lung cancer,9402593,12/15/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2018,441962, ,NCI,251115,190847,441962
Progression and Metastasis of Oral Tongue Cancer,9402598,5/10/2003 0:00,12/31/2019 0:00,Non-SBIR/STTR,2018,482857, ,NIDCR,314463,168394,482857
Analysis of Centrosome Dynamics,9404455,9/29/2006 0:00,12/31/2019 0:00,Non-SBIR/STTR,2018,331288, ,NIGMS,212500,118788,331288
Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell,9404519,7/1/2016 0:00,6/30/2019 0:00,"Training, Individual",2017,2212, ,NCI,2212, ,2212
The role of mutant p53 and endocytic recycling in ESCC invasion and metastasis,9404567,7/1/2016 0:00,6/30/2019 0:00,"Training, Individual",2017,1400, ,NCI,1400, ,1400
Research Project 2: Pathological Diagnosis and Etiology of Ocular Surface Squamous Neoplasia in Zambia,9404825, , ,Research Centers,2017, ,104868, ,98889,5979, 
Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 ,9404948, , ,Research Centers,2018, ,203571, ,120946,82625, 
Rad50: Roles in chromo. stab. and prev. of malignancy,9405011,1/1/1998 0:00,12/31/2019 0:00,Non-SBIR/STTR,2018,472473, ,NIGMS,275655,196818,472473
The regulation of PP1 in the nucleus,9405128,9/11/2011 0:00,8/31/2020 0:00,Non-SBIR/STTR,2016,214286, ,NIGMS,139600,74686,214286
Structure-activity relationship of small molecule inhibitors of human papillomavirus E6 protein will be tested.,9406431,6/14/2016 0:00,11/30/2017 0:00,SBIR/STTR,2017,50000, ,NIAID, , ,50000
Clinical Efficacy Evaluation of First-in-class Imipridone ONC201 in Recurrent Type II Endometrial Cancer,9406675,8/17/2017 0:00,8/31/2018 0:00,SBIR/STTR,2017,224000, ,NCI, , ,224000
DNA damage signaling to immune checkpoints,9406817,1/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2018,376715, ,NCI,241613,135102,376715
Project 1: Small Molecule Enhancers of Photodynamic Therapy for Skin Cancer,9407015,8/9/2001 0:00, ,Non-SBIR/STTR,2018, ,181731, ,140241,41490, 
A novel combinatorial approach for treating HPV-associated malignancies,9408055,8/1/2017 0:00,7/31/2019 0:00,SBIR/STTR,2017,191115, ,NCI, , ,191115
Robust Predictor of Breast Cancer Risk,9409030,9/20/2017 0:00,8/31/2019 0:00,SBIR/STTR,2017,300000, ,NCI, , ,300000
"ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY",9409120,5/1/2013 0:00,7/31/2018 0:00,Non-SBIR/STTR,2016,133760, ,NCI,102129,31631,133760
How does p53 binding affect eRNA-dependent transcriptional regulation?,9410936,1/1/2017 0:00,12/31/2019 0:00,"Training, Individual",2018,59038, ,NIGMS,59038, ,59038
p53/Rb Reactivation Modulators for HPV-positive Head and Neck Cancer,9411749,2/1/2016 0:00,1/31/2020 0:00,Non-SBIR/STTR,2018,360524, ,NIGMS,300873,59651,360524
"Precision Genomics in the WISDOM Pragmatic Clinical Trial:  An ""Embedded"" ELSI Study of Risk-based Breast Cancer Screening",9412446,1/12/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2018,650146, ,NCI,416485,233661,650146
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus,9413976,10/1/2014 0:00,9/30/2018 0:00,Non-SBIR/STTR,2018, , , , , , 
"Isolation, characterization and translational development of glioma stem cells",9414678,2/1/2017 0:00,1/31/2024 0:00,Non-SBIR/STTR,2018,1028400, ,NCI,600000,428400,1028400
The role of centrosome amplification in cell growth and tumorigenesis,9414925,2/1/2017 0:00,7/31/2018 0:00,"Training, Individual",2018,30262, ,NIGMS,30262, ,30262
Molecular mechanisms of myeloid suppressor genes on chromosome 5,9415008,2/1/2015 0:00,1/31/2020 0:00,Non-SBIR/STTR,2018,361425, ,NCI,228750,132675,361425
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells,9416774, , ,Non-SBIR/STTR,2018, ,342009, ,201775,140234, 
"Understanding the origin,initiation,and progression of high-grade serous ovarian cancer",9416925,9/24/2013 0:00,1/31/2019 0:00,Non-SBIR/STTR,2018,236746, ,NCI,150315,86431,236746
Intratumoral Heterogeneity and Tumor Evolution in Lymphoma,9416967,2/10/2015 0:00,6/9/2018 0:00,"Training, Individual",2018,26208, ,NCI,26208, ,26208
Project 5: Tumor Suppressor and Tumor Maintenance Genes,9417201,2/10/1997 0:00,1/31/2023 0:00,Non-SBIR/STTR,2018, ,632982, ,394341,238641, 
Regulation of p53 by TAF1,9418026,7/15/1997 0:00,1/31/2021 0:00,Non-SBIR/STTR,2018,368818, ,NCI,237500,131318,368818
c-Myc Targets in the Pathogenesis of Human Cancers,9418584,9/1/1992 0:00,1/31/2022 0:00,Non-SBIR/STTR,2018,549764, ,NCI,368242,181522,549764
"Telomerase in Development, Senescence and Neoplasia",9420527,1/1/2000 0:00,12/31/2019 0:00,Non-SBIR/STTR,2018,616000, ,NCI,385000,231000,616000
Dynamics of Cellular Senescence in Single Cells,9420625,2/1/2017 0:00,12/31/2020 0:00,Non-SBIR/STTR,2018,391296, ,NIGMS,242635,148661,391296
The Inflammasome as a novel mediator and therapeutic target of GI syndrome,9423702,1/1/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2018,383156, ,NCI,228750,154406,383156
Interplay of mammary luminal cells and environmental factors in establishing p53-deficient premalignant field,9425420,12/12/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2018,374766, ,NCI,228750,146016,374766
"Tumor suppression, p53 and retrotransposons",9425729,8/24/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2018,370575, ,NCI,228750,141825,370575
Targeted Therapies for Richters Transformation,9427979,2/7/2017 0:00,1/31/2022 0:00,Non-SBIR/STTR,2018,461935, ,NCI,296905,165030,461935
Role of SIRT3 in melanoma development and progression,9431050,4/1/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018, , , , , , 
Development of a genetic and molecular prediction model for cisplatin and radiation resistance in head and neck squamous cell carcinoma,9431308,1/1/2018 0:00,12/31/2020 0:00,Other Research-Related,2018,172260, ,NIDCR,159500,12760,172260
New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss,9432056,9/19/2017 0:00,8/31/2022 0:00,Other Research-Related,2017,177120, ,NCI,164000,13120,177120
Deciphering real-time dynamics of the human genome organization in response to DNA damage and gene expression,9432293,9/15/2017 0:00,8/31/2019 0:00,Other Research-Related,2017,90000, ,NIGMS,83333,6667,90000
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer,9433803,7/20/2014 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,64192, ,NIDCR,40120,24072,64192
The regulation of mutant p53 protein accumulation and GOF activity in tumors,9436365,9/15/2017 0:00,8/31/2019 0:00,Other Research-Related,2017,30343, ,NCI,30343, ,30343
Identifying Therapeutic Vulnerabilities of c-MYC-driven Small Cell Lung Cancer,9436441,12/6/2017 0:00,11/30/2019 0:00,Non-SBIR/STTR,2018,165300, ,NCI,108750,56550,165300
Roles of EAF2 in androgen action in the prostate,9437561,12/18/1996 0:00,2/29/2020 0:00,Non-SBIR/STTR,2018,371525, ,NCI,241250,130275,371525
The role of AXL-ABL axis in Barrett's carcinogenesis,9437565,3/1/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2018,361425, ,NCI,228750,132675,361425
Modeling p53 Mutant-Associated Cancer With LFS Patient-Derived iPSCs,9437572,3/3/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2018,237098, ,NCI,153960,83138,237098
Understanding the role of κB-Ras proteins in tumorigenesis,9437579,3/1/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2018,384782, ,NCI,240489,144293,384782
Epigenetic regulation by tumor suppressor p53,9437685,4/1/1999 0:00,2/28/2019 0:00,Non-SBIR/STTR,2018,352848, ,NCI,223022,129826,352848
Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy,9437690,4/1/2014 0:00,2/28/2022 0:00,Non-SBIR/STTR,2018,491695, ,NCI,336906,154789,491695
Targeting Mutant KRAS for Cancer Therapy,9437725,3/1/2016 0:00,2/28/2023 0:00,Non-SBIR/STTR,2018,924613, ,NCI,606117,318496,924613
P53 survival target DDR1 kinase in DNA damage response and carcinogenesis,9437726,3/1/2015 0:00,6/7/2018 0:00,Non-SBIR/STTR,2018,398025, ,NCI,228750,169275,398025
Investigate the role of TPD52-AMPK pathway in tumorigenesis and cancer therapy,9437762,4/15/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2018,363713, ,NCI,228750,134963,363713
Preclinical safety and efficacy assessment of a novel PCNA inhibitor for prostate cancer therapy,9438232,8/1/2018 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,208854, ,NCI,130500,78354,208854
Targeting the oncogenic mutant p53 signaling in colorectal cancer therapy,9438485,4/18/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2018,374553, ,NCI,207500,167053,374553
Gammaherpesvirus interactions with host tumor suppressor p53,9438486,4/4/2014 0:00,2/28/2021 0:00,Non-SBIR/STTR,2018,359998, ,NCI,245431,114567,359998
Fully Synthetic Prodiginines as Probes of Protein-Protein Interactions Regulating,9438489,4/16/2014 0:00,2/28/2020 0:00,Non-SBIR/STTR,2018,346474, ,NCI,232852,113622,346474
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model,9438493,3/1/2015 0:00,2/29/2020 0:00,Non-SBIR/STTR,2018,377464, ,NCI,261399,116065,377464
Elucidating the function of cancer-associated MDM2 mutations in p53 regulation,9439126,1/1/2018 0:00,6/30/2022 0:00,Non-SBIR/STTR,2018,492000, ,NCI,300000,192000,492000
KLF6: A driving factor of lung adenocarcinoma,9439646,2/1/2017 0:00,7/31/2018 0:00,"Training, Individual",2018,28641, ,NCI,28641, ,28641
Triad1 regulates myelopoiesis and functions as a leukemia suppressor,9440362,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,353419, ,NCI,228750,124669,353419
Biological Activity of HPV E7 in Human Epithelial Cells,9440965,4/19/1996 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,371250, ,NCI,225000,146250,371250
Developmental studies to inform clinical stratification and targeting of SHH MB,9441726,4/4/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,449546, ,NCI,299422,150124,449546
Role of Nix in pancreatic ductal adenocarcinoma,9441729,4/15/2016 0:00,7/14/2019 0:00,"Training, Individual",2018,49524, ,NCI,49524, ,49524
The roles of TRIM24 in breast cancer,9441754,3/1/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2018,402021, ,NCI,251263,150758,402021
The Role of STAT2 in Flat Non-Polypoid Colorectal Neoplasia,9442724,4/1/2017 0:00,3/31/2019 0:00,Non-SBIR/STTR,2018,78000, ,NCI,50000,28000,78000
Mutant p53 as actionable cancer-specific target,9442886,4/1/2013 0:00,4/30/2023 0:00,Non-SBIR/STTR,2018,382587, ,NCI,245091,137496,382587
Systemic RNA interference to reactivate p53 tumor suppression,9443607,3/1/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2018,361766, ,NCI,237716,124050,361766
"p53 mutation induces constitutive expression of interferon beta, enhancing the resistance of cancer cells to DNA damage",9443618,4/1/2017 0:00,3/31/2019 0:00,Non-SBIR/STTR,2018,79250, ,NCI,50000,29250,79250
Reflux-Induced Oxidative DNA Damage Repair Early in Barrett's Carcinogenesis,9444286,7/1/2018 0:00,6/30/2022 0:00,Non-SBIR/STTR,2018, , , , , , 
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism,9444502,3/2/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2018,320959, ,NCI,252945,68014,320959
CLONAL EVOLUTION OF HEMATOPOIETIC STEM CELLS DURING CHEMOTHERAPY AND TRANSPLANTATION,9444509,4/1/2016 0:00,3/31/2019 0:00,Other Research-Related,2018,121394, ,NCI,112402,8992,121394
"DNA double-strand break repair, chromosomes translocations and cancer",9445410,4/8/2014 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,1778566, ,NCI,1111604,666962,1778566
The Role of CTIP in Breast Carcinogenesis,9445417, ,3/31/2020 0:00,Non-SBIR/STTR,2018, ,393141, ,245713,147428, 
p53 acetylation in ferroptosis and tumor suppression,9445700,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2018,366000, ,NCI,228750,137250,366000
DEVELOP A NOVEL REPROGRAMMING APPROACH FOR GLIOBLASTOMA MULTIFORME TREATMENT,9445731,2/15/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2018,333594, ,NINDS,218750,114844,333594
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery,9446227,9/30/2017 0:00,8/31/2019 0:00,Research Centers,2017, ,645228, ,548567,96661, 
DACH1/Eya Cell fate determination factor and mammary tumorigenesis,9446542,7/20/2009 0:00,6/30/2019 0:00,Non-SBIR/STTR,2017,428056, ,NCI,287556,140500,428056
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy,9446577,9/30/2017 0:00,8/31/2019 0:00,Research Centers,2017, ,433322, ,228490,204832, 
Targeting the TGIF/Twist1 network in osteosarcoma,9447145,3/15/2017 0:00,6/30/2018 0:00,Non-SBIR/STTR,2018,118844, ,NCI,77930,40914,118844
Mechanisms of gene expression control in the p53 network,9447433,5/26/2006 0:00,1/31/2023 0:00,Non-SBIR/STTR,2018,332381, ,NCI,213750,118631,332381
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma,9448746,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2018,414944, ,NCI,241598,173346,414944
REGULATION OF TUMOR SUPPRESSION BY ARF,9449397,4/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,348844, ,NCI,228750,120094,348844
Development of proteasome adaptors to catalytically deplete specific proteins from cells,9449404,4/4/2016 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,225428, ,NCI,150000,75428,225428
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer,9449962, , ,Research Centers,2017, ,307062, ,224999,82063, 
Modeling Mdm2- and 12q amplicon-driven sarcoma,9450484,3/8/2017 0:00,2/28/2019 0:00,Non-SBIR/STTR,2018,83493, ,NCI,50000,33493,83493
Development of Zinc Metallochaperones as Mutant p53 Targeted Anti-cancer Drugs,9450485,3/15/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2018,365277, ,NCI,261086,104191,365277
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer,9450495,3/8/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2018,395064, ,NCI,263873,131191,395064
Defining mechanisms of extracellular communication for cancer therapy,9450871,4/1/2013 0:00,7/31/2018 0:00,Non-SBIR/STTR,2017,11310, ,NCI,7250,4060,11310
Therapeutic strategies for specific subsets of KRAS mutant lung cancers,9451116,4/1/2017 0:00,9/30/2018 0:00,Non-SBIR/STTR,2017,559228, ,NCI,423890,135338,559228
The role of PCDH7 in lung cancer pathogenesis,9451280,3/9/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2018,357482, ,NCI,222542,134940,357482
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,9451282,9/30/2010 0:00,2/29/2020 0:00,Non-SBIR/STTR,2018,387111, ,NIDDK,254678,132433,387111
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma,9453874,9/15/2017 0:00,5/31/2022 0:00,Non-SBIR/STTR,2017,346719, ,NINDS,218750,127969,346719
Signaling cascades in cholangiocarcinoma development,9454340,4/5/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,362569, ,NCI,228750,133819,362569
The role of the p63-RBM38 loop in tumor suppression,9454383,4/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,359138, ,NCI,228750,130388,359138
Mechanisms of targeting oncoprotein SET in tumor suppression,9455629,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2018,366000, ,NCI,228750,137250,366000
Novel regulations of DNA damage repair,9455637,3/16/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2018,154896, ,NCI,96810,58086,154896
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response,9456696,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2018,581178, ,NCI,373148,208030,581178
Electrocatalytic Studies of Toxic Pollutant Activation,9456741,3/1/1983 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,364615, ,NIEHS,253179,111436,364615
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells,9457098,2/9/2018 0:00,1/31/2023 0:00,Non-SBIR/STTR,2018,462937, ,NCI,273254,189683,462937
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus,9457367,8/25/2010 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,706863, ,NCI,608493,203134,706863
Hypermutation and malignant progression in an expanded cohort of TMZ treated LGG patients from different molecular subgroups,9457395,4/1/2016 0:00,8/31/2018 0:00,"Training, Individual",2018,26585, ,NCI,26585, ,26585
Deciphering How Esco2 Loss Acts as a Penetrance Modifier,9457413,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2018,354725, ,NCI,238872,115853,354725
"Merkel cell polyomavirus infection, DNA damage response and cancer",9458123,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,366000, ,NCI,228750,137250,366000
Ceramide signaling in the regulation of cellular response to folate stress,9458128,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,347700, ,NCI,228750,118950,347700
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer,9458134,5/5/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,910580, ,NCI,798709,336394,910580
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma,9458146,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2018,373760, ,NCI,231715,142045,373760
Basis of Muscle Dysfunction in Malignant Hyperthermia & Central Core Disease,9460912,4/1/2006 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,633312, ,NIAMS,483636,149676,633312
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming,9460975,9/30/2014 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,466235, ,NIA,265057,201178,466235
miR-200 miRNAs repress tumor metastasis in lung adenocarcinoma,9461487,8/1/2009 0:00,3/31/2022 0:00,Non-SBIR/STTR,2018,373266, ,NCI,237749,135517,373266
Understanding Resistance to Next Generation Antiandrogens,9461905,5/1/2012 0:00,12/31/2022 0:00,Non-SBIR/STTR,2018,386325, ,NCI,225000,161325,386325
A p53/NFkB-mediated metabolic mechanism for chemotherapy protection,9461950,4/1/2014 0:00,3/31/2019 0:00,Non-SBIR/STTR,2018,335113, ,NCI,207500,127613,335113
ABT-199 based therapies to treat  neuroblastoma,9462056,4/1/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,359846, ,NCI,270977,88869,359846
The role of p53 family members in epithelial lineage establishment and maintenance,9462578,3/2/2017 0:00,3/1/2019 0:00,"Training, Individual",2018,44524, ,NIGMS,44524, ,44524
Defining the role of mutant XPO1 in chronic lymphocytic leukemia,9462812,5/1/2015 0:00,4/30/2020 0:00,"Training, Individual",2018,49524, ,NCI,49524, ,49524
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma,9463348,9/1/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2018,904242, ,NCI,525815,378587,904242
Cell-cycle regulatory kinases as targets for male contraceptive drug development,9465240,5/20/2014 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,302472, ,NICHD,224775,77697,302472
Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research,9467467,8/4/2014 0:00,3/31/2019 0:00,SBIR/STTR,2018,751587, ,NCI, , ,751587
The Role of WIP1 in Clonal Hematopoiesis,9467943,9/19/2017 0:00,9/18/2020 0:00,"Training, Individual",2017,44385, ,NIDDK,44385, ,44385
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous (5R01 CA194617-02),9468357,9/1/2016 0:00,3/31/2019 0:00,Non-SBIR/STTR,2018,382108, ,NCI,297384,84724,382108
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression,9469485,4/15/2016 0:00,2/28/2019 0:00,Other Research-Related,2018,171720, ,NIDDK,159000,12720,171720
Development of a novel platform for the identification of synthetic lethal genes in a Kras and Keap1-mutant mouse model of lung adenocarcinoma.,9469983,1/1/2018 0:00,12/31/2019 0:00,"Training, Individual",2017,42918, ,NCI,42918, ,42918
The TIFAB-USP15 Complex in the Pathogenesis of MDS and AML,9470074,7/1/2018 0:00,8/31/2018 0:00,"Training, Individual",2018,8394, ,NHLBI,8394, ,8394
Novel Chromatin Regulating Targets of p63 in Head and Neck Squamous Cell Carcinoma,9470409,3/1/2018 0:00,2/28/2021 0:00,"Training, Individual",2018,58654, ,NCI,58654, ,58654
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.,9470761,1/1/2018 0:00,5/25/2018 0:00,Non-SBIR/STTR,2018,123772, ,NCI,55266,68506,123772
Targeting Human Cancers with Hemizygous Deletion of TP53,9470862,8/9/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,360281, ,NCI,228750,131531,360281
"Markov State Model approaches for folding, binding and design",9470885,5/1/2017 0:00,4/30/2022 0:00,Non-SBIR/STTR,2018,295617, ,NIGMS,190000,105617,295617
Regulation of p53 and Checkpoint Signaling by Chromium(VI),9472017,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2018,365625, ,NIEHS,225000,140625,365625
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias,9473495,9/1/2015 0:00,8/31/2020 0:00,Non-SBIR/STTR,2017,175899, ,OD,116957,58942,175899
Wee1 and HDAC inhibition in relapsed/refractory AML,9473856,7/15/2015 0:00,5/31/2019 0:00,Non-SBIR/STTR,2017,615403, ,NCATS,484263,131140,615403
Regulation of RNA metabolism and cell growth control by SR protein kinases,9474127,5/1/1996 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,348750, ,NIGMS,225000,123750,348750
∆Np53 as a Regulator of p53 Biology,9474563,6/1/2016 0:00,4/30/2020 0:00,"Training, Individual",2018,49524, ,NIA,49524, ,49524
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO),9476936,7/1/2013 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,351713, ,NCI,207500,144213,351713
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer,9476948,5/1/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,342938, ,NCI,250977,91961,342938
The role of p53 in constraining pro-tumorgenic reprogramming,9476974,5/1/2016 0:00,4/30/2019 0:00,"Training, Individual",2018,61174, ,NCI,61174, ,61174
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression,9477417,5/1/1983 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,468594, ,NCI,266398,202196,468594
Epigenetic Regulation of Human Telomeres,9477462,7/1/2010 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,420000, ,NCI,240000,180000,420000
The role of MDM2-MTBP axis in cancer metastasis,9477467,5/1/2014 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,313325, ,NCI,207500,105825,313325
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES,9477488,5/1/2014 0:00,7/31/2019 0:00,Non-SBIR/STTR,2018,364993, ,NCI,207500,157493,364993
Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm,9477511,5/1/2016 0:00,4/30/2019 0:00,Non-SBIR/STTR,2018,489122, ,NCI,315562,173560,489122
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors,9477599,6/1/2014 0:00,4/30/2019 0:00,Non-SBIR/STTR,2018,402550, ,NCI,207500,195050,402550
Origins of Ovarian Carcinoma,9477600,5/18/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,421580, ,NCI,268750,152830,421580
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors,9477615,5/7/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,540936, ,NCI,360927,180009,540936
HAUSP inhibitors in p53-wild type and p53-mutant tumors,9477631,5/1/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,366000, ,NCI,228750,137250,366000
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer,9477640,5/1/2014 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,333147, ,NCI,207500,125647,333147
Mdm2-p53 signaling in the DNA damage response and in tumorigenesis,9478086,3/1/1999 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,351619, ,NCI,213750,137869,351619
The reduction of NLRX1 and its role in pulmonary aging,9478103,8/15/2016 0:00,4/30/2021 0:00,Non-SBIR/STTR,2018,343375, ,NIA,205000,138375,343375
Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics,9479791,4/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2018,462618, ,NINDS,297026,165592,462618
Mechanisms of obesity-induced hepatocarcinogenesis,9480703,5/8/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,337795, ,NCI,283430,54365,337795
Roles and Regulation of wild-type and mutant forms of p53,9481804,9/30/2000 0:00,3/31/2022 0:00,Non-SBIR/STTR,2018,1885586, ,NCI,1606930,278656,1885586
Project 1: Roles of wild-type and mutant forms of p53 in cancer cell biology,9481806, , ,Non-SBIR/STTR,2018, ,338840, ,211775,127065, 
Project 2: Probing the role of the p53 network in ferroptosis,9481808, , ,Non-SBIR/STTR,2018, ,352900, ,221343,131557, 
Project 4: Mechanisms of wild-type and mutant p53 action in vivo,9481810, , ,Non-SBIR/STTR,2018, ,355830, ,355830,0, 
Core B -The Bio-Informatics Core,9481812, , ,Non-SBIR/STTR,2018, ,186032, ,186032,0, 
Core C - The Molecular Systems Pathology Core,9481813, , ,Non-SBIR/STTR,2018, ,247698, ,247698,0, 
A Phase I trial combining IV fenretinide and IV safingol to target overproduction,9482840,6/1/2014 0:00,5/31/2019 0:00,SBIR/STTR,2017,648029, ,NCI, , ,648029
Molecular Oncology,9483618, , ,Research Centers,2018, ,42486, ,27912,14574, 
PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM,9483636,4/1/2013 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,203639, ,NCI,131635,72004,203639
Targeting the cytokine circuitry of KRAS-driven lung cancer,9484261,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018,394578, ,NCI,228750,165828,394578
Polyploid cell cycle regulation and genome instability,9484312,8/12/2015 0:00,8/7/2019 0:00,Non-SBIR/STTR,2018,311063, ,NIGMS,197500,113563,311063
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia,9485515,8/5/2003 0:00,8/31/2023 0:00,Research Centers,2018,1392864, ,NCI,1311999,588001,1392864
Multi-scale enhanced sampling of disordered proteins,9485621,1/1/2016 0:00,11/30/2020 0:00,Non-SBIR/STTR,2017,283238, ,NIGMS,192500,90738,283238
A Phase I trial combining IV fenretinide and IV safingol to target overproduction,9485913,6/1/2014 0:00,5/31/2020 0:00,SBIR/STTR,2018,473425, ,NCI, , ,473425
Development of cell-free DNA assays for HCC screening and liquid biopsy,9487193,6/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2018,397877, ,NCI,334816,63061,397877
MicroRNA Targets for Chemoprevention of Squamous Cell Carcinoma (R01 CA194062-01A1),9487226,9/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2018,314760, ,NCI,183000,131760,314760
MUC13 Mucin in Colorectal Cancer Health Disparity,9487227,7/11/2016 0:00,5/31/2019 0:00,Non-SBIR/STTR,2018,349014, ,NCI,236898,112116,349014
Project 1:The Carolina Breast Cancer Study,9487498, , ,Research Centers,2018, ,630076, ,406238,223838, 
Project 4: Chromatin Remodeling Drives the Adaptive Resistance Response to Targeted Kinase Inhibition in Breast Cancer,9487501, , ,Research Centers,2018, ,363561, ,234404,129157, 
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer,9487696,7/20/2014 0:00,5/31/2021 0:00,Non-SBIR/STTR,2018,491237, ,NIDCR,357860,133377,491237
The role of MCM8-9 in genomic instability of cancers,9488415,7/11/1994 0:00,1/31/2020 0:00,Non-SBIR/STTR,2018,355500, ,NCI,225000,130500,355500
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,9488995, , ,Non-SBIR/STTR,2018, ,392814, ,256741,136073, 
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis,9489070,6/3/2016 0:00,12/31/2018 0:00,Non-SBIR/STTR,2018,156196, ,NCI,93006,63190,156196
Developing CRM1 inhibitors in AML,9490280,7/16/2014 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,319550, ,NCI,207500,112050,319550
ERK3 Kinase Signaling in Lung Cancer,9490288,6/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,338550, ,NCI,228750,109800,338550
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors,9490289,6/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,446627, ,NCI,282675,163952,446627
Suppression of mobile elements by p53 genes,9490376,8/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,319950, ,NIGMS,197500,122450,319950
Oncogenic Function of ATDC in Bladder Cancer,9491077,4/10/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,485833, ,NCI,286627,199206,485833
Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis,9491226, , ,Non-SBIR/STTR,2018, ,315080, ,207500,107580, 
Core 2: Animal Model and Experimental Therapeutics Core [AMETC],9491230, , ,Non-SBIR/STTR,2018, ,253011, ,166000,87011, 
Wnt pathway regulation of human gastric stem cell function,9491795,9/1/2017 0:00,4/30/2019 0:00,Other Research-Related,2018,90629, ,NIDDK,83916,6713,90629
Role of Long Intergenic Noncoding RNA in UVB-induced Apoptosis and Skin Cancer,9491800,6/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2018,335832, ,NIEHS,225000,110832,335832
Targeting Autophagy in Hereditary Breast Cancer,9492552,6/1/2015 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,479087, ,NCI,305706,173381,479087
TFIIH and Transcription Regulation,9492572,9/22/2016 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,541730, ,NIGMS,469340,72390,541730
Cyclin-dependent kinase control of cell-division and transcription cycles,9493110,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2018,464704, ,NIGMS,275000,189704,464704
Novel oncogenic functions of Mdm2 and Mdmx,9493436,7/18/2014 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,323700, ,NCI,207500,116200,323700
Oncogenic Function of ATDC in Bladder Cancer,9493731,4/10/2014 0:00,2/29/2020 0:00,Non-SBIR/STTR,2018,485833, ,NCI,286627,199206,485833
DBPs (pp: 363-418); DBP Overviews (pp 124-129) ,9494619, , ,Research Centers,2018, ,106250, ,68329,37921, 
Environmental Regulation of Cellular Responses to DNA Damage,9498341,4/9/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2018,351750, ,NIGMS,210000,141750,351750
Wnt pathway dynamics in breast cancer metastasis,9501697,6/6/2017 0:00,5/31/2020 0:00,Other Research-Related,2018,188042, ,NCI,174113,13929,188042
Novel model to study PDAC using normal human pancreatic tissue,9502935,6/9/2017 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,165844, ,NCI,108750,57094,165844
Intrinsic disorder controls the function of p53 and other cancer associated IDPs,9503000,6/1/2016 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,311491, ,NIGMS,254800,56691,311491
Investigating immune-microbiota interaction in lung cancer,9504756,9/7/2018 0:00,8/31/2020 0:00,Other Research-Related,2018,126225, ,NCI,116875,9350,126225
Epigenetics in the extreme - investigating heritability driven by disordered RNA binding proteins in development and cancer,9504961,9/1/2018 0:00,8/31/2020 0:00,Other Research-Related,2018,90000, ,NIGMS,83333,6667,90000
Altered mRNA splicing dependent on mutant p53 identifies novel therapeutic vulnerability in pancreatic cancer,9505653,8/9/2018 0:00,7/31/2020 0:00,Other Research-Related,2018,102057, ,NCI,94497,7560,102057
Engineering Antibody Drug Conjugates To Target P53-Defective Triple Negative Breast Cancer,9505850,6/13/2017 0:00,11/30/2019 0:00,Non-SBIR/STTR,2018,207797, ,NCI,168676,39121,207797
Physiological Role of Dynamin-Related Protein 1 in Pancreatic Ductal Adenocarcinoma,9506546,7/1/2017 0:00,6/30/2020 0:00,"Training, Individual",2018,32068, ,NCI,32068, ,32068
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer,9506707,6/14/2017 0:00,5/31/2022 0:00,Non-SBIR/STTR,2018,399129, ,NCI,237841,161288,399129
53BP1-dependent pathway in DNA repair,9506708,6/14/2017 0:00,5/31/2023 0:00,Non-SBIR/STTR,2018,1, ,NCI,1,0,1
Perivascular niche for salivary gland cancer stem cells and resistance to therapy,9506729,2/10/2011 0:00,6/30/2022 0:00,Non-SBIR/STTR,2018,441428, ,NIDCR,288976,152452,441428
Epigenetic modulation of SEC24D and circulating miR-605 in renal cell carcinoma,9507792,6/15/2017 0:00,5/31/2020 0:00,Non-SBIR/STTR,2018,25595, ,NCI,16407,9188,25595
Impact of germline variants on racial and ethnic differences in somatic mutation frequency,9508239,3/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2018,356088, ,NCI,228750,127338,356088
Role of DNA Replication Stress in Genome Instability and Cancer,9509473,7/1/2017 0:00,6/30/2021 0:00,Non-SBIR/STTR,2018,284489, ,NIGMS,204453,80036,284489
"Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe",9509565,8/1/2014 0:00,6/30/2019 0:00,Other Research-Related,2018,187380, ,NINDS,173500,13880,187380
Identification of genetic collaborators in cancer with a brca2-mutant zebrafish model,9511934,7/1/2016 0:00,6/30/2019 0:00,Other Research-Related,2018,126900, ,OD,117500,9400,126900
Translational development studies of a novel combination therapy for castration-resistant prostate cancer,9512021,7/1/2018 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,214380, ,NCI,162799,51581,214380
p63 Regulation of Human Osteoprogenitor Maturation by Hepatocyte Growth Factor & Vitamin D Metabolites,9512550,7/1/2012 0:00,6/30/2019 0:00,Non-SBIR/STTR,2018, , , , , , 
p53-Mediated Tumor Immune Surveillance,9512564,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,366000, ,NCI,228750,137250,366000
"Head Neck Cancer, beta-defensins, and immune responses",9512568,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,396250, ,NIDCR,250000,146250,396250
Mechanism and treatment of PTEN mutant prostate tumorigenesis,9512732,7/30/2014 0:00,6/30/2019 0:00,Non-SBIR/STTR,2018,398400, ,NCI,207500,190900,398400
Papillomavirus E6 Structural Consortium,9512744,2/1/2010 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,443504, ,NCI,332305,111199,443504
The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle,9512770,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,348844, ,NCI,228750,120094,348844
The role of mutant p53 and endocytic recycling in ESCC invasion and metastasis,9512796,7/1/2016 0:00,6/30/2019 0:00,"Training, Individual",2018,61174, ,NCI,61174, ,61174
SIRT2 Inhibitors for the Treatment of B-cell Lymphoma,9512807,7/7/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2018,574754, ,NCI,326565,248189,574754
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma,9512810,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2018,446063, ,NCI,228750,217313,446063
Using markers to improve pancreatic cancer screening and surveillance,9512812,7/18/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2018,954328, ,NCI,766580,371579,954328
Pediatric Preclinical Testing Consortium,9512819,7/7/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,357000, ,NCI,212500,144500,357000
Neuroendocrine mechanisms of prostate cancer progression,9512850,7/7/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,348145, ,NCI,228750,119395,348145
The impact of chromosome 17p lesions on leukemogeneis and therapy response,9512854,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,402371, ,NCI,228750,173621,402371
Mechanisms of Esophageal Carcinogenesis,9513427,8/15/2003 0:00,6/30/2019 0:00,Non-SBIR/STTR,2018,1607533, ,NCI,1174560,432973,1607533
Transformed Esophageal Epithelial Cells and the Tumor Microenvironment,9513432,8/15/2003 0:00, ,Non-SBIR/STTR,2018, ,351721, ,256989,94732, 
"Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation",9513495,7/15/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2018,377438, ,NCI,228750,148688,377438
Mechanisms behind hyperglycemia-associated breast cancer risk and progression,9514050,7/21/2015 0:00,4/30/2020 0:00,Other Research-Related,2018,358750, ,NIGMS,250000,108750,358750
Activating p53 for colorectal cancer prevention,9515099,6/12/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2018,439704, ,NCI,290071,149633,439704
Molecular mechanisms regulating the establishment of cis-regulatory elements by the transcription factor p63,9515254,5/1/2018 0:00,4/30/2022 0:00,Non-SBIR/STTR,2018,449764, ,NIGMS,300000,149764,449764
Mechanisms for GH action on epithelial cells,9515551,4/1/2018 0:00,3/31/2022 0:00,Non-SBIR/STTR,2018,383625, ,NIDDK,225000,158625,383625
Ensemble Networks for Allosteric Drug Design,9516522,6/1/2018 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,482612, ,NIGMS,300000,182612,482612
Elucidating the mechanism of anti-GSK3 adjuvant therapy for Myc-driven lymphomas,9516708,3/1/2017 0:00,2/29/2020 0:00,"Training, Individual",2018,44524, ,NCI,44524, ,44524
Tissue-specific tumor suppressor effects of p53,9516715,7/17/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,409185, ,NCI,241407,167778,409185
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis,9516933,8/14/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2018,977640, ,NCI,600000,377640,977640
Therapeutic strategies for targeting PARP1 in small cell lung cancer,9517810,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2018,366000, ,NCI,228750,137250,366000
TP53 Germline Mutations: Beyond LFS,9518164,5/10/2018 0:00,4/30/2023 0:00,Non-SBIR/STTR,2018,377037, ,NCI,235648,141389,377037
Underlying Mechanisms in Angiosarcoma,9518649,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,352275, ,NCI,228750,123525,352275
Anticancer peptide therapeutics,9518796,8/1/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2018,353419, ,NCI,228750,124669,353419
Dietary Carcinogens for Colorectal Cancer,9519418,6/15/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2018,366000, ,NCI,228750,137250,366000
Genetic characterization of osteoblast-induced leukemias,9519570,9/1/2016 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,461485, ,NHLBI,288428,173057,461485
CARP-1: A Potential Therapeutic Agent for Breast Cancer,9519661,1/1/2012 0:00,12/31/2019 0:00,Non-SBIR/STTR,2018, , , , , , 
Mammary carcinogenesis:  pubertal and adult effects of high fat diet+oxybenzone,9520068,9/30/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,807731, ,NIEHS,850909,360956,807731
DNA Methylation Inhibitor Therapy for Testicular Cancer,9520636,5/1/2018 0:00,4/30/2023 0:00,Non-SBIR/STTR,2018,503327, ,NCI,366536,136791,503327
Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures,9521383,9/30/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,745675, ,NIEHS,262375,113365,202287
RNDI- Mediated Breast Cancer Suppression,9521927, ,6/30/2020 0:00,Non-SBIR/STTR,2018, ,505589, ,287430,218159, 
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites,9523620,3/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2018,418613, ,NCI,228750,189863,418613
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis,9523990,3/9/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2018,349988, ,NCI,228750,121238,349988
Dynamic modulation of p53 activity by its disordered regulatory domains,9524490,4/1/2006 0:00,3/31/2022 0:00,Non-SBIR/STTR,2018,414512, ,NIGMS,214218,200294,414512
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells,9524785, , ,Non-SBIR/STTR,2018, ,433524, ,371334,62190, 
Adaptive Clinical Efficacy Evaluation of ONC201 in Recurrent High Grade Glioma,9524880,9/1/2015 0:00,8/31/2021 0:00,SBIR/STTR,2018,999600, ,NCI, , ,999600
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles,9525588,7/1/2017 0:00,6/30/2022 0:00,"Training, Individual",2018,49524, ,NCI,49524, ,49524
p53 and tumor cell metabolism,9526447,8/1/2014 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,332000, ,NCI,207500,124500,332000
Function and regulation of MDMX intra-molecular interactions,9526455,8/1/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,393450, ,NCI,228750,164700,393450
The intersection of RNA biology and tumor biology,9527052,8/12/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2018,771837, ,NCI,482025,290179,771837
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity,9527089,8/1/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2018,1129825, ,NCI,582384,547441,1129825
MECHANISMS OF ANNEXIN A6-MEDIATED BASAL-LIKE BREAST CANCER PROGRESSION,9527624,8/16/2016 0:00,7/31/2020 0:00,Other Research-Related,2018,363750, ,NIGMS,250000,113750,363750
p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer,9527759,8/16/2016 0:00,7/31/2020 0:00,Other Research-Related,2018,157743, ,NCI,146058,11685,157743
Role of Set2 and H3 methylation in chromatin function,9527923,5/1/2003 0:00,4/30/2018 0:00,Non-SBIR/STTR,2017,55000, ,NIGMS,55000, ,55000
Genome instability in cancer: telomeres and DNA repair,9529245,9/2/2016 0:00,8/31/2023 0:00,Non-SBIR/STTR,2018,1017000, ,NCI,645794,448827,1017000
MicroRNA Therapeutics in Non-small Cell Lung Cancer,9529583, , ,Research Centers,2018, ,291784, ,291784,0, 
Engineered precancerous cells and tissues for discovery of lung cancer drivers,9529604,8/1/2017 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,80750, ,NCI,50000,30750,80750
P63 Mechanisms and mediators in HNSCC,9529609,4/1/2004 0:00,7/31/2022 0:00,Non-SBIR/STTR,2018,398493, ,NIDCR,237500,160993,398493
Defining diverse roles of p53 in pancreatic cancer,9530606,8/1/2017 0:00,7/31/2022 0:00,Other Research-Related,2018,170640, ,NCI,158000,12640,170640
Mechanisms regulating the early stages of UV-induced skin cancer,9531483,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2018,362250, ,NIEHS,225000,137250,362250
Definition of the Microenvironment in Breast Cancer,9532091,8/1/2016 0:00,7/31/2021 0:00,Non-SBIR/STTR,2018,491681, ,NCI,261102,230579,491681
PROJECT 4: Interrogating PP2A Signaling in Human Cancers,9532132, , ,Non-SBIR/STTR,2018, ,326362, ,186750,139612, 
Do seizures stimulate glioma progression?,9532312,8/1/2017 0:00,7/31/2019 0:00,Non-SBIR/STTR,2018,80000, ,NINDS,50000,30000,80000
BACH2 in Melanoma Development and Resistance,9532790,8/9/2016 0:00,7/31/2019 0:00,Other Research-Related,2018,177344, ,NCI,164207,13137,177344
RB-Related Proteins and Polyomavirus Large T antigen Transformation,9533473,5/2/1994 0:00,8/31/2019 0:00,Non-SBIR/STTR,2018,311400, ,NCI,180000,131400,311400
Modulation of cancer specific transcriptional factors with small molecules,9533490,8/1/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,401456, ,NCI,228750,172706,401456
EPHB4 Receptor Kinase as a Target in Prostate Cancer,9533493, , ,Research Centers,2018, ,287381, ,222496,64885, 
"Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.",9534008,8/1/2014 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,580448, ,NCI,378248,202200,580448
Dynamics of Signaling Pathways: Mechanism and Function,9534111,3/1/2008 0:00,5/31/2021 0:00,Non-SBIR/STTR,2018,385370, ,NIGMS,229221,156149,385370
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance,9534534,9/9/2014 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,317475, ,NCI,186750,130725,317475
Regulation of ATDC by TP63 and its role in bladder cancer,9534554,9/1/2016 0:00,8/31/2021 0:00,Other Research-Related,2018,174960, ,NCI,162000,12960,174960
Phosphoinositides and Cancer Metabolism,9535244,9/5/2016 0:00,7/31/2023 0:00,Non-SBIR/STTR,2018,1017000, ,NCI,600000,417000,1017000
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias,9535963,9/1/2015 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,418613, ,NCI,228750,189863,418613
Preclinical Models for Cancer Therapeutic Development,9535970,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,174117, ,NCI,90686,83431,174117
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer,9536451,9/2/2015 0:00,7/31/2021 0:00,Non-SBIR/STTR,2018,623508, ,NCI,414999,247475,623508
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression,9536805,8/1/2017 0:00,7/31/2024 0:00,Non-SBIR/STTR,2018,959881, ,NCI,599996,359885,959881
IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level,9537493,8/1/2017 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,80000, ,NCI,50000,30000,80000
Targeting Olig2 Co-regulators for Malignant Glioma Therapy,9537697,9/30/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,349149, ,NINDS,266438,82711,349149
Dissecting and targetting HDMX-medicated chemoresistance in human cancer,9538031,8/1/2017 0:00,7/31/2019 0:00,"Training, Individual",2018,36202, ,NCI,36202, ,36202
Preclinical analyses of advanced prostate cancer in genetically-engineered mice,9538334,8/6/2013 0:00,1/31/2023 0:00,Non-SBIR/STTR,2018,385883, ,NCI,241177,144706,385883
"Bioinformatics approaches to solve the ""Missing Driver"" problem in solid tumors",9538492,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,113415, ,NCI,73646,39769,113415
Cellular mechanisms of androgen action and androgen-response gene EAF2 in prostate cancer,9538494,9/19/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,115503, ,NCI,73804,41699,115503
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis,9538594,9/8/2014 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,336565, ,NCI,237541,99024,336565
Tumor Suppression by an African Specific Variant of p53,9538974,3/1/2018 0:00,12/31/2019 0:00,"Training, Individual",2018,59038, ,NCI,59038, ,59038
Mechanisms of Tumorigenic Transformation of Barretts Esophagus,9539591,4/5/2018 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,367330, ,NCI,239562,127768,367330
Targeting metabolic vulnerabilities in glioblastoma,9539661,8/7/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2018,500340, ,NCI,338438,161902,500340
Modulation of wild type and mutant p53 by HMGA1,9540199,7/1/2018 0:00,6/30/2021 0:00,"Training, Individual",2018,58654, ,NCI,58654, ,58654
Project 1 - PARP Project,9540820, , ,Research Centers,2018, ,188026, ,188026,0, 
From Mechanism to Population: Modeling HPV-related Oropharyngeal Carcinogenesis,9540827,9/11/2014 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,639928, ,NCI,416467,223461,639928
Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human Cancer,9540846,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,264110, ,NCI,150920,113190,264110
Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling,9541115,8/9/2017 0:00,2/28/2018 0:00,Non-SBIR/STTR,2016,165285, ,NCI,104943,60342,165285
Targeting Human Cancers with Hemizygous Deletion of TP53,9541632,8/9/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2017,360281, ,NCI,228750,131531,360281
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9542232, , ,Research Centers,2018, ,17302, ,12250,5070, 
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions,9542243,9/12/2014 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,442311, ,NCI,377403,64908,442311
Investigating the Role of the Mek5-Erk5 Kinase Module in Small Cell Lung Cancer,9542275,9/30/2016 0:00,12/31/2018 0:00,"Training, Individual",2018,24316, ,NCI,24316, ,24316
Breast Cancer Detection Consortium,9542763,9/19/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,447894, ,NCI,370017,160053,447894
The tumor suppressor capability of p53 is dependent on Non-muscle Myosin IIA function in Head and Neck Cancer.,9542783,9/6/2016 0:00,8/31/2020 0:00,Other Research-Related,2018,135000, ,NIDCR,125000,10000,135000
The Functions of antisense RNA AS-RBM15 in hematopoiesis,9542789,8/15/2017 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,222750, ,NIDDK,150000,72750,222750
"Dissecting the dynamic interplay between p53, chromatin and transcriptional bursting in single cells",9543016,4/1/2018 0:00,12/31/2018 0:00,Non-SBIR/STTR,2018,157600, ,NIGMS,93949,63651,157600
Development and Application of a Porcine Model of Pancreatic Cancer,9543122,4/1/2018 0:00,3/31/2021 0:00,Non-SBIR/STTR,2018,568591, ,NCI,373459,195132,568591
Project 2: Targeting metabolic vulnerabilities in glioblastoma,9543453, , ,Research Centers,2018, ,359605, ,230516,129089, 
Project 4: Novel epigenetic treatment of IDH mutant gliomas,9543455, , ,Research Centers,2018, ,370528, ,244947,125581, 
Project 1:  Evolution of transcriptional programs in lung cancer progression,9543955, , ,Non-SBIR/STTR,2018, ,420760, ,268461,152299, 
Project 3:  Targeting epigenetic regulators in cancer,9543958, , ,Non-SBIR/STTR,2018, ,352717, ,229500,123217, 
01 Project 1:  Cancer risks for mutations in breast cancer predisposition genes,9544090, , ,Research Centers,2018, ,508510, ,382690,125820, 
Role of the AMPK-MDMX-p53 pathway in cancer,9544905,4/1/2007 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,321694, ,NCI,213750,107944,321694
The regulation of PP1 in the nucleus,9544987,9/11/2011 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,322350, ,NIGMS,210000,112350,322350
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia,9547311,9/13/2016 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,252971, ,NCI,169590,83381,252971
Molecular Landscape-based Innovative Therapies for Anaplastic Thyroid Carcinoma,9547318, ,8/31/2020 0:00,Research Centers,2018, ,542931, ,359582,206064, 
Functionalizing recurrent FAT1 mutations and deletions in oral cancer,9547363,9/1/2014 0:00,8/31/2019 0:00,Other Research-Related,2018,136350, ,NIDCR,126250,10100,136350
Identifying stabilizers of p53 using pocket complementarity,9547447,9/26/2016 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,345871, ,NIGMS,228310,117561,345871
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer,9547645,9/12/2014 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,439351, ,NCI,249773,189578,439351
Risk and penetrance of mutations from breast cancer testing panels.,9548168,9/25/2014 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,1055961, ,NCI,854332,201629,1055961
Targeted Promoter Demethylation in Ovarian Cancer Cells,9548239,9/1/2017 0:00,7/31/2020 0:00,Other Research-Related,2018,137999, ,NIGMS,100000,37999,137999
Role of ER stress-driven IRE1α-XBP1 Signaling in Lung Cancer Pathogenesis,9548455,7/1/2017 0:00,6/30/2020 0:00,"Training, Individual",2018,44524, ,NCI,44524, ,44524
c-Myc Targets in the Pathogenesis of Human Cancers,9548835,9/1/1992 0:00,1/31/2022 0:00,Non-SBIR/STTR,2017,248583, ,NCI,164319,84264,248583
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9548931, , ,Research Centers,2018, ,77861, ,56000,25480, 
The GOF Mutant p53 Beacon System,9549014,8/24/2017 0:00,7/31/2020 0:00,Non-SBIR/STTR,2018,193776, ,NCI,125000,68776,193776
Placenta specific and ribosomal RNA genes: structure and function,9549319, , ,Intramural Research,2017,687689, ,NIA, , ,687689
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,9549598, , ,Intramural Research,2017,9903769, ,NCI, , ,9903769
Intervention Trials in Persons at Increased Genetic Risk of Cancer,9549603, , ,Intramural Research,2017,332906, ,NCI, , ,332906
Consultation and Collaboration,9549626, , ,Intramural Research,2017,910442, ,NCI, , ,910442
Signal and Transcription Factor Network interactions in Head and Neck Cancer,9549778, , ,Intramural Research,2017,624540, ,NIDCD, , ,624540
Genomics and Proteomics of Head and Neck Cancer,9549780, , ,Intramural Research,2017,832720, ,NIDCD, , ,832720
Genetic Susceptibility And The Environment In Cancer Risk,9550052, , ,Intramural Research,2017,316807, ,NIEHS, , ,316807
Human Genes Affecting Chromosome Metabolism and Stress Response,9550074, , ,Intramural Research,2017,667527, ,NIEHS, , ,667527
Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells,9550084, , ,Intramural Research,2017,3730413, ,NIEHS, , ,3730413
Structural Mechanisms of Ribosome Assembly,9550195, , ,Intramural Research,2017,1538255, ,NIEHS, , ,1538255
Regulation Of Intracellular Iron Metabolism,9550320, , ,Intramural Research,2017,1041298, ,NICHD, , ,1041298
Cell Cycle Regulation In Oogenesis,9550325, , ,Intramural Research,2017,962934, ,NICHD, , ,962934
The role of autophagy in aging and metabolism,9550525, , ,Intramural Research,2017,1938353, ,NHLBI, , ,1938353
Mitochondrial regulation and function in cancer and cardiovascular biology,9550529, , ,Intramural Research,2017,1041029, ,NHLBI, , ,1041029
Fluorescence Microscopy,9550627, , ,Intramural Research,2017,1219221, ,NIEHS, , ,1219221
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9550802, , ,Research Centers,2018, ,18423, ,18738,10867, 
Cancer Cell Adaption to Glutamine Deprivation,9550919,5/1/2018 0:00,4/30/2022 0:00,Non-SBIR/STTR,2019,301257, ,NCI,201275,99982,301257
Sphingolipids in Cancer Biology and Therapy,9550922,7/1/2002 0:00,8/31/2019 0:00,Non-SBIR/STTR,2018,1298387, ,NCI,892069,406318,1298387
Project 3: Role of Sphingosine Kinase in P53 Cancer Biology,9550924, , ,Non-SBIR/STTR,2018, ,207973, ,142890,65083, 
Project 1: Role of Acid Sphingomyelinase in Breast Cancer,9550927, , ,Non-SBIR/STTR,2018, ,221756, ,152359,69397, 
Mechanism of regulation of progenitor proliferation and transformation,9551188,9/1/2017 0:00,8/31/2021 0:00,Non-SBIR/STTR,2017,443782, ,NINDS,336843,106939,443782
Genetic Susceptibility To Carcinogens,9551293, , ,Intramural Research,2017,729214, ,NIEHS, , ,729214
Discovery And Functional Genomics Of Environmental Response Genes,9551294, , ,Intramural Research,2017,1130282, ,NIEHS, , ,1130282
Phenotypic Assay Design and Development for Rare and Neglected Diseases,9551432, , ,Intramural Research,2017,336523, ,NCATS, , ,336523
FoxM1 in tumor cell,9551495,6/1/2009 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018, , , , , , 
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade,9551571,8/28/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2018,393450, ,NCI,228750,164700,393450
CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,9552064, , ,Research Centers,2018, ,101078, ,74618,30243, 
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,9552672,4/1/2011 0:00,3/31/2020 0:00,Non-SBIR/STTR,2018, , , , , , 
Preclinical Development and Clinical Testing of MEK and PI3K Targeted Therapy for KRAS-mutant NSCLC,9552717, ,8/31/2020 0:00,Research Centers,2018, ,318713, ,257278,61435, 
Protein Kinase Signaling in the Genotoxic Stress Response,9552850,9/1/2017 0:00,7/31/2025 0:00,Non-SBIR/STTR,2018,556545, ,NIEHS,350028,206517,556545
Patient-derived glioblastoma in vitro and in vivo studies of tryptophan metabolism via the kynurenine pathway,9553356,9/1/2017 0:00,2/8/2019 0:00,"Training, Individual",2018,25210, ,NCI,25210, ,25210
Identification and targeting of colon cancer initiating cells,9553439,10/1/2009 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018, , , , , , 
Project 1: CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,9553597, , ,Research Centers,2018, ,203169, ,140001,63168, 
Targeting Ribosomal Biogenesis in Prostate Cancer,9553698,2/1/2018 0:00,8/31/2019 0:00,Other Research-Related,2018,187895, ,NCI,173845,14050,187895
RNF128  Regulation of TP53 in Barrett's Progression,9553701,8/31/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2018,422751, ,NCI,270994,151757,422751
Targeting the OLIG2 Transcription Factor,9553975, ,7/31/2019 0:00,Research Centers,2017, ,316873, ,239501,77498, 
HDM2 as a Therapeutic Target in RCC,9554121, , ,Research Centers,2017, ,237240, ,237240,0, 
HDM2 as a Therapeutic Target in RCC,9554209, , ,Research Centers,2018, ,236861, ,236861,0, 
Inhibitors of p53-S100B interaction for melanoma,9554474, , ,Intramural Research,2017,251640, ,NCATS, , ,251640
A novel small molecule FL7N-1 for treating pediatric cancer retinoblastoma,9555239,8/14/2018 0:00,7/31/2020 0:00,SBIR/STTR,2018,224919, ,NCI, , ,224919
Bone Marrow Histopathological Changes in Neoplastic and Non-Neoplastic Diseases,9555578, , ,Intramural Research,2017,0, , , , , 
Natural History of Familial Carcinoid Tumor,9555639, , ,Intramural Research,2017,1126675, ,NIDDK, , ,1126675
Chromosomal Proteins and Chromosomal Functions,9556190, , ,Intramural Research,2017,842732, ,NCI, , ,842732
Gene Regulation and Function: The B-ZIP Proteins,9556197, , ,Intramural Research,2017,953346, ,NCI, , ,953346
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,9556198, , ,Intramural Research,2017,1240024, ,NCI, , ,1240024
"Tumor Suppressor Protein, p53",9556204, , ,Intramural Research,2017,404814, ,NCI, , ,404814
Genetically Engineered Mouse Models to Study RTK Function in Melanoma,9556221, , ,Intramural Research,2017,1153319, ,NCI, , ,1153319
Regulation of Lymphocyte Proliferation and Replicative Capacity,9556235, , ,Intramural Research,2017,550436, ,NCI, , ,550436
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,9556238, , ,Intramural Research,2017,506056, ,NCI, , ,506056
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,9556242, , ,Intramural Research,2017,460819, ,NCI, , ,460819
DNA repair,9556251, , ,Intramural Research,2017,1645808, ,NCI, , ,1645808
Enzymes and Substrates of the Ubiquitin Conjugating System,9556252, , ,Intramural Research,2017,913002, ,NCI, , ,913002
Role of CEBP transcription factors in cell growth and tumorigenesis,9556264, , ,Intramural Research,2017,1386565, ,NCI, , ,1386565
Role of Neurotrophins in the Development of the Mammalian Nervous System,9556277, , ,Intramural Research,2017,731359, ,NCI, , ,731359
Immune Reconstitution,9556308, , ,Intramural Research,2017,1303403, ,NCI, , ,1303403
Zebrafish Models of Cancer,9556311, , ,Intramural Research,2017,101011, ,NCI, , ,101011
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,9556342, , ,Intramural Research,2017,135515, ,NCI, , ,135515
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,9556362, , ,Intramural Research,2017,926748, ,NCI, , ,926748
"Role of inflammation, innate resistance, and immunity in carcinogenesis",9556366, , ,Intramural Research,2017,1170282, ,NCI, , ,1170282
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,9556369, , ,Intramural Research,2017,632597, ,NCI, , ,632597
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,9556393, , ,Intramural Research,2017,38444, ,NCI, , ,38444
Development of TGF-beta antagonists for cancer therapy,9556396, , ,Intramural Research,2017,619633, ,NCI, , ,619633
Redox Mechanism Process of Angiogenesis and Wound Healing,9556402, , ,Intramural Research,2017,605866, ,NCI, , ,605866
Collaborative Pathways that Lead to Leukemia,9556417, , ,Intramural Research,2017,617725, ,NCI, , ,617725
TMPRSS2-ERG chromosomal translocations and prostate cancer,9556435, , ,Intramural Research,2017,210866, ,NCI, , ,210866
Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,9556459, , ,Intramural Research,2017,1353606, ,NCI, , ,1353606
Role of Brachyury in regulating notochord development and neoplasia,9556465, , ,Intramural Research,2017,141560, ,NCI, , ,141560
Role of inflammation in epigenetic alterations of metastatic cancer cells,9556479, , ,Intramural Research,2017,845247, ,NCI, , ,845247
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,9556484, , ,Intramural Research,2017,705721, ,NCI, , ,705721
Genomic and genetic studies of endocrine cancers,9556508, , ,Intramural Research,2017,582719, ,NCI, , ,582719
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,9556532, , ,Intramural Research,2017,661011, ,NCI, , ,661011
Systems-level analysis of the regulation and function of p53 dynamics,9556547, , ,Intramural Research,2017,468011, ,NCI, , ,468011
Zbtb family members in lymphocyte differentiation and function,9556570, , ,Intramural Research,2017,182900, ,NCI, , ,182900
"Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome",9556604, , ,Intramural Research,2017,1150123, ,NCI, , ,1150123
"p53, Aging, and Cancer",9556606, , ,Intramural Research,2017,1533497, ,NCI, , ,1533497
Study the roles of p53 and p53 mutants in mesenchymal stem cells,9556610, , ,Intramural Research,2017,643215, ,NCI, , ,643215
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,9556620, , ,Intramural Research,2017,745273, ,NCI, , ,745273
Metabolic and p53 Targets of Cellular Respiration of Esophageal Cancer,9556647, , ,Intramural Research,2017,417430, ,NCI, , ,417430
Role of long non-coding RNAs in p53 signaling,9556652, , ,Intramural Research,2017,835910, ,NCI, , ,835910
Comparative Brain Tumor Consortium,9556680, , ,Intramural Research,2017,49525, ,NCI, , ,49525
Genomic characterization and development of therapies for Rhabdomyosarcoma,9556700, , ,Intramural Research,2017,294563, ,NCI, , ,294563
Genomic dissection of tumor heterogeneity and progression,9556708, , ,Intramural Research,2017,294563, ,NCI, , ,294563
Therapeutic evaluation in ovarian and breast cancer GEMGDA models,9556710, , ,Intramural Research,2017,1283220, ,NCI, , ,1283220
Development and Preclinical Application of Pancreatic Adenocarcinoma Models,9556712, , ,Intramural Research,2017,1539864, ,NCI, , ,1539864
Targeting Metabolic Pathways in Bladder Cancer,9556714, , ,Intramural Research,2017,181249, ,NCI, , ,181249
Hypoxia signaling in cancer development,9556738, , ,Intramural Research,2017,929586, ,NCI, , ,929586
Lymphoma Disease Discovery and Definition,9556753, , ,Intramural Research,2017,799796, ,NCI, , ,799796
Lymphoma Studies,9556766, , ,Intramural Research,2017,677573, ,NCI, , ,677573
Nitric Oxide as a Modifier of Oxidative Stress,9556770, , ,Intramural Research,2017,454400, ,NCI, , ,454400
CCR Confocal Microscopy Core,9556802, , ,Intramural Research,2017,693802, ,NCI, , ,693802
CPTR - Mass Spectrometry Unit,9556842, , ,Intramural Research,2017,391811, ,NCI, , ,391811
Comparison of molecular factors to drug activities,9556847, , ,Intramural Research,2017,142167, ,NCI, , ,142167
Comparative Biomedical Scientist Training Program,9556900, , ,Intramural Research,2017,1299544, ,NCI, , ,1299544
Development of Novel Preclinical Animal Models - CAPR Infrastructure,9556902, , ,Intramural Research,2017,513288, ,NCI, , ,513288
Project 3: Molecular Markers for Early Detection of Esophageal Carcinogenesis,9556999, , ,Research Centers,2018, ,378724, ,245949,132775, 
Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy,9557007,9/4/2017 0:00,8/31/2022 0:00,Non-SBIR/STTR,2018,578917, ,NCI,407125,171792,578917
In vitro and in vivo evaluation of elephant p53 (EP53) protein nanoparticles for pediatric osteosarcoma,9559358,9/1/2018 0:00,8/31/2022 0:00,SBIR/STTR,2018,300465, ,NCI, , ,300465
The Role of the Microenvironment in Barrett's Esophagus,9559396,9/26/2011 0:00,4/30/2022 0:00,Research Centers,2018,1085045, ,NCI,1089030,250451,1085045
Project 2: Characterization of microenvironmental drivers of neoplasia in BE,9559405, , ,Research Centers,2018, ,184216, ,237862,1927, 
Combinations of Grape Seed and Milk Thistle Extracts Against Lung,9562906,10/1/2018 0:00,9/30/2022 0:00,Non-SBIR/STTR,2019, , , , , , 
Determining the Influence Genomic Instability During Embryogenesis has on Tumor Penetrance,9563230,9/11/2017 0:00,8/31/2019 0:00,Non-SBIR/STTR,2018,161494, ,NCI,108750,52744,161494
Mutant p53 rejuvenates aged stem cells through modulating epigenetic regulators,9563808,9/15/2017 0:00,8/31/2018 0:00,Non-SBIR/STTR,2017,255000, ,NIA,161905,93095,255000
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease,9563844, , ,Intramural Research,2017,1308673, ,NIAID, , ,1308673
A Novel Mouse Model for Uterine Leiomyoma,9564853,9/13/2017 0:00,1/31/2020 0:00,Non-SBIR/STTR,2018,80000, ,NCI,50000,30000,80000
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp,9565496, ,8/31/2022 0:00,Non-SBIR/STTR,2018, ,340470, ,254581,85889, 
Deciphering real-time dynamics of the human genome organization in response to DNA damage and gene expression,9565619,9/15/2017 0:00,1/31/2019 0:00,Other Research-Related,2018,37500, ,NIGMS,34722,2778,37500
Targeting Acetyltransferase Gene Inactivation in Diffuse Large B Cell Lymphoma,9565738, , ,Research Centers,2017, ,394804, ,328209,104607, 
Targeting Acetyltransferase Gene Inactivation in Diffuse Large B Cell Lymphoma,9565747, , ,Research Centers,2018, ,399034, ,301467,97567, 
Research Project 2: Pathological Diagnosis and Etiology of Ocular Surface Squamous Neoplasia in Zambia,9566138, , ,Research Centers,2018, ,104866, ,124923,18295, 
The regulation of mutant p53 protein accumulation and GOF activity in tumors,9566140,9/15/2017 0:00,3/31/2019 0:00,Other Research-Related,2018,29323, ,NCI,29323, ,29323
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma,9566325,9/15/2017 0:00,5/31/2022 0:00,Non-SBIR/STTR,2018,346719, ,NINDS,218750,127969,346719
IGF::OT::IGF TARGETED CASEIN KINASE INHIBITION AS A BREAST CANCER PREVENTION,9566457,7/1/2017 0:00,6/30/2019 0:00,R and D Contracts,2017,508124, ,NCI, , ,508124
Mechanism of regulation of progenitor proliferation and transformation,9566904,9/1/2017 0:00,8/31/2021 0:00,Non-SBIR/STTR,2018,407306, ,NINDS,322655,84651,407306
New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss,9567548,9/19/2017 0:00,8/31/2022 0:00,Other Research-Related,2018,177120, ,NCI,164000,13120,177120
Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy,9567649,4/1/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2017,289024, ,NCI,191008,98016,289024
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade,9567749, , ,Research Centers,2018, ,351750, ,210000,141750, 
Perivascular niche for salivary gland cancer stem cells and resistance to therapy,9568867,1/1/2018 0:00,12/31/2019 0:00,Non-SBIR/STTR,2018,39556, ,NIDCR,27738,11818,39556
Project 1 - Molecular Determinants of Decitabine Responses.,9569163, , ,Research Centers,2018, ,342783, ,224617,118166, 
Project 2 - Targeted Therapies for T-ALL.,9569164, , ,Research Centers,2018, ,342469, ,220237,122232, 
Regulation Of Epidermal Differentiation,9569183, , ,Intramural Research,2017,957002, ,NIAMS, , ,957002
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer,9569289, , ,Research Centers,2018, ,313704, ,221335,92369, 
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer,9569609,9/22/2017 0:00,8/31/2022 0:00,Research Centers,2018,1813624, ,NCI,1152265,661359,1813624
Project 1: High Grade Cancers: Capitalizing on PARPness in Ovarian Carcinoma,9569617, , ,Research Centers,2018, ,370022, ,231264,138758, 
Molecular Pathogenesis of Two Newly Defined Major Subgroups of PTCL,9569905, , ,Non-SBIR/STTR,2018, ,421873, ,405373,16500, 
Project 3: Using RNAi-based Spherical Nucleic Acid (SNA) Nanoconjugates Targeting Bcl2L12 to Promote Therapy-Induced Apoptosis in Glioblastoma,9570362,8/17/2018 0:00,7/31/2023 0:00,Research Centers,2018, ,255555, ,163568,91987, 
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD),9572487,8/1/2012 0:00,6/30/2023 0:00,Non-SBIR/STTR,2018,2403307, ,NHLBI,1666122,737185,2403307
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease,9572491, , ,Non-SBIR/STTR,2018, ,400551, ,277687,122864, 
Dissecting of develomental signaling pathways in bone development and osteosarcoma,9573151, , ,Research Centers,2018, ,314375, ,201887,129207, 
IGF::OT::IGF Targeting the mTOR Pathway for the Prevention of Breast Cancer,9574551,9/15/2017 0:00,3/14/2020 0:00,R and D Contracts,2017,681028, ,NCI, , ,681028
Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway,9574966,6/1/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2018,330946, ,NCI,207614,123332,330946
UBIQUITIN-PROTEASOME PATHWAY IN CANCER,9575788,9/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2018,317343, ,NIGMS,200000,117343,317343
Molecular Basis for Regulation of Cellular Stress Response Pathways by CBP/p300,9577503,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2018,506244, ,NCI,273236,233008,506244
Predicting Breast Cancer Risk after Benign Percutaneous Biopsy,9578200,7/5/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2018,640367, ,NCI,566138,74229,640367
ARF6 function in cancers driven by RAS hyperactivation,9583648,7/3/2018 0:00,6/30/2020 0:00,Other Research-Related,2018,129824, ,NCI,120207,9617,129824
Macromolecular assemblies of transcription factors initiated by pathogen infection,9583916,8/22/2019 0:00,7/31/2021 0:00,Other Research-Related,2019,154063, ,NIAID,150000,4063,154063
Improving post-surgery recovery of failing hearts by targeting cardiomyocyte senescence,9586808,9/1/2018 0:00,7/31/2022 0:00,Non-SBIR/STTR,2018,430115, ,NHLBI,265503,164612,430115
Role of MTF1 in ovarian cancer,9587594,7/24/2018 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,213180, ,NCI,140250,72930,213180
Development of a novel platform for the identification of synthetic lethal genes in a Kras and Keap1-mutant mouse model of lung adenocarcinoma.,9590127,1/1/2018 0:00,6/10/2019 0:00,"Training, Individual",2019,27314, ,NCI,27314, ,27314
How does p53 binding affect eRNA-dependent transcriptional regulation?,9590365,1/1/2017 0:00,12/31/2019 0:00,"Training, Individual",2017,25993, ,NIGMS,25993, ,25993
(PQ3) UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMAS,9590448,9/4/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2018,633992, ,NCI,398737,235255,633992
Copy Number Alterations in Low Mutation Cancer,9590813,3/1/2018 0:00,2/28/2019 0:00,Other Research-Related,2018,111497, ,NCI,103238,8259,111497
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis,9591147,9/18/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2018,442560, ,NCI,304358,138202,442560
Novel oncogenic functions of Mdm2 and Mdmx,9591352,3/1/2018 0:00,5/31/2019 0:00,Non-SBIR/STTR,2018,26400, ,NCI,16923,9477,26400
Proximal Differentiation Therapy for K-Ras-Induced Lung Adenocarcinoma,9592980,10/1/2017 0:00,9/30/2021 0:00,Non-SBIR/STTR,2019, , , , , , 
Molecular regulation and therapeutic targeting of the TSC signaling network,9593460,12/1/2017 0:00,8/31/2019 0:00,"Training, Individual",2019,50522, ,NCI,50522, ,50522
"SENP6, a novel p53 negative regulator, is an important new player in cancer",9593688,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2018,363713, ,NCI,228750,134963,363713
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice,9593737,6/7/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2018,414488, ,NCI,295489,118999,414488
Cancer Biology in the Zebrafish,9593863,7/3/2003 0:00,5/31/2023 0:00,Non-SBIR/STTR,2018,420375, ,NCI,237500,182875,420375
Nuclear Accumulation of D-type Cyclins and Oncogenesis,9594443,7/1/2001 0:00,5/31/2023 0:00,Non-SBIR/STTR,2018,319556, ,NCI,213750,105806,319556
Deregulation of COMPASS complex and enhancer chromatin in pancreatic cancer,9594690,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2018,364856, ,NCI,228750,136106,364856
Investigating the metastatic drive in pancreas cancer,9597194,8/9/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2018,474800, ,NCI,269773,205027,474800
Targeting the oncogenic mutant p53 signaling in colorectal cancer therapy,9598076,4/18/2014 0:00,2/28/2019 0:00,Non-SBIR/STTR,2018,73225, ,NCI,41819,31406,73225
Tissue-specific tumor suppressor effects of p53,9598122,7/17/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,78178, ,NCI,46840,31338,78178
Mechanisms of Intestinal Tumorigenesis,9600648,1/1/2000 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,383150, ,NCI,242500,140650,383150
Role of HOS in Cell Transformation and Apoptosis,9600650,3/1/2001 0:00,11/30/2021 0:00,Non-SBIR/STTR,2019,333813, ,NCI,207337,126476,333813
Regulation of SLC7A11 by p53 in cancer metabolism,9600655,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,355019, ,NCI,221887,133132,355019
Investigating CREBBP as a tumor suppressor in small cell lung cancer,9600661,12/15/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2019,428702, ,NCI,243581,185121,428702
"Role of the p53 C-terminal domain in tissue homeostasis, tumor suppression, and oncogenesis",9600665,12/15/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,596041, ,NCI,457845,138196,596041
p53 Variants in Cancer Risk and Therapy,9600668,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,416042, ,NCI,221887,194155,416042
Novel therapeutics for targeting checkpoint dysfunction in cancer,9600681,12/15/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2019,351691, ,NCI,221887,129804,351691
Defining Critical p53 Therapeutic Targets and Mechanisms,9601636,3/1/2009 0:00,11/30/2019 0:00,Non-SBIR/STTR,2019,423405, ,NCI,218250,205155,423405
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer,9602351,9/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2018,589596, ,NCI,471545,118051,589596
Molecular mechanisms of SCLC initiation and detection in mice and humans,9602535,9/19/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2018,588589, ,NCI,371815,216774,588589
An in vivo model for CCNE1 amplified tumorigenesis,9603089,12/1/2017 0:00,11/30/2020 0:00,"Training, Individual",2019,67730, ,NCI,67730, ,67730
Functional Analysis of p53 polymorphic variants,9603705,7/1/2003 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,373207, ,NCI,196425,176782,373207
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer,9603717,12/1/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2019,338378, ,NCI,221887,116491,338378
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer,9603718,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,421585, ,NCI,221887,199698,421585
miR-155 targeted therapeutics for precision medicine in lung cancer,9604149,8/3/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2018,536674, ,NCI,364392,172282,536674
Local Immuroregulation of Cutaneous Carcinogenesis,9604313,7/1/2003 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,385878, ,NCI,230375,155503,385878
The Role of WIP1 in Clonal Hematopoiesis,9604690,9/19/2017 0:00,9/18/2020 0:00,"Training, Individual",2018,44865, ,NIDDK,44865, ,44865
Role of p53 Missense Mutations on Tumorigenesis in Vivo,9604772,9/1/1999 0:00,1/31/2020 0:00,Non-SBIR/STTR,2019,331739, ,NCI,207337,124402,331739
USP7 inhibitors for the treatment of multiple myeloma,9604786,12/15/2016 0:00,11/30/2019 0:00,Non-SBIR/STTR,2019,510712, ,NCI,293196,217516,510712
Multi-scale enhanced sampling of disordered proteins,9604815,1/1/2016 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,268363, ,NIGMS,192500,75863,268363
Regulation of p53 and Checkpoint Signaling by Chromium(VI),9605091,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2019,365625, ,NIEHS,225000,140625,365625
Role of Vitamin D in cutaneous DNA repair,9605243,10/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019, , , , , , 
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway,9605701,8/19/2005 0:00,3/31/2020 0:00,Non-SBIR/STTR,2019,361688, ,NCI,230375,131313,361688
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells,9605814,8/17/2018 0:00,7/31/2025 0:00,Non-SBIR/STTR,2018,873370, ,NCI,547376,325994,873370
"Telomerase in Development, Senescence and Neoplasia",9606443,1/1/2000 0:00,12/31/2020 0:00,Non-SBIR/STTR,2019,597518, ,NCI,373449,224069,597518
p53 acetylation in ferroptosis and tumor suppression,9606455,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2019,355019, ,NCI,221887,133132,355019
Analysis of Centrosome Dynamics,9607097,9/29/2006 0:00,12/31/2019 0:00,Non-SBIR/STTR,2019,331288, ,NIGMS,212500,118788,331288
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC,9607153,9/10/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2018,456113, ,NCI,307967,148146,456113
Role of p53 in Kidney Development: Modeling Renal Anomalies of Li-Fraumeni Patients,9607333,8/16/2018 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,115500, ,NIDDK,75000,40500,115500
NOX4 Mediates Oxidative Stress in Ovarian Tumor growth and treatment Response,9607392,12/1/2015 0:00,5/31/2021 0:00,Non-SBIR/STTR,2017,250878, ,NCI,164966,85912,250878
Research Project 3: Cell fate decision of liver tumor-initiating stem-like cells induced by alcohol,9607961, , ,Research Centers,2019, ,133643, ,80996,52647, 
The role of chronic stress in regulation of mutant p53 and tumorigenesis,9607999,1/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2019,352406, ,NCI,221887,130519,352406
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma,9608000,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2019,543053, ,NCI,316280,226773,543053
Identifying Therapeutic Vulnerabilities of c-MYC-driven Small Cell Lung Cancer,9608726,12/6/2017 0:00,11/30/2019 0:00,Non-SBIR/STTR,2019,193042, ,NCI,126585,66457,193042
LINE-1 genotoxicity and cytotoxicity and its relevance to cancer,9610559,1/1/2018 0:00,12/31/2020 0:00,"Training, Individual",2019,50016, ,NCI,50016, ,50016
The Role of Tumor Associated Macrophages in Pediatric High-Grade Glioma,9610599,7/11/2018 0:00,7/10/2021 0:00,"Training, Individual",2018,44524, ,NCI,44524, ,44524
The role of the p53-p21 pathway in cancer cell susceptibility to ferroptosis,9611098,1/9/2019 0:00, ,"Training, Individual",2018,36437, ,NCI,36437, ,36437
Inhibiting Emergence and Progression of Castration-resistant Prostate Cancer through Enforcement of Senescence and Alteration of the Tumor Microenvironment,9611884,12/1/2018 0:00,11/30/2021 0:00,"Training, Individual",2018,39293, ,NCI,39293, ,39293
Inflammation Induced Cytosine Deamination and the Initiation of Cancer,9612182,7/1/2018 0:00,6/30/2022 0:00,"Training, Individual",2018,34059, ,NCI,34059, ,34059
Interplay of mammary luminal cells and environmental factors in establishing p53-deficient premalignant field,9613233,12/12/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2019,363522, ,NCI,221887,141635,363522
Dynamics of Cellular Senescence in Single Cells,9613252,2/1/2017 0:00,12/31/2020 0:00,Non-SBIR/STTR,2019,388655, ,NIGMS,242635,146020,388655
DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations,9613791,12/1/2014 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,355019, ,NCI,221887,133132,355019
The Role of Ribosomal Proteins in the P53-MDM2 Pathway,9614270,1/1/2019 0:00,12/31/2021 0:00,Non-SBIR/STTR,2019,277371, ,NCI,184300,93071,277371
Molecular mechanisms of myeloid suppressor genes on chromosome 5,9614271,2/1/2015 0:00,1/31/2020 0:00,Non-SBIR/STTR,2019,350581, ,NCI,221887,128694,350581
Molecular Biology of Oncogenic Papillomaviruses,9614274,1/1/2016 0:00,12/31/2022 0:00,Non-SBIR/STTR,2019,985021, ,NCI,582000,404490,985021
iSPIN iCorp Training,9614787,3/1/2018 0:00,7/31/2018 0:00,SBIR/STTR,2018,50000, ,NCI, , ,50000
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.,9616255,1/1/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2019,275381, ,NCI,222271,84864,275381
How does p53 binding affect eRNA-dependent transcriptional regulation?,9616290,1/1/2017 0:00,12/31/2019 0:00,"Training, Individual",2019,63746, ,NIGMS,63746, ,63746
"Precision Genomics in the WISDOM Pragmatic Clinical Trial:  An ""Embedded"" ELSI Study of Risk-based Breast Cancer Screening",9616772,1/12/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2019,621625, ,NCI,399757,221868,621625
DNA damage signaling to immune checkpoints,9616859,1/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2019,357312, ,NCI,228315,128997,357312
c-Myc Targets in the Pathogenesis of Human Cancers,9617198,9/1/1992 0:00,1/31/2022 0:00,Non-SBIR/STTR,2019,229065, ,NCI,145952,83113,229065
The Inflammasome as a novel mediator and therapeutic target of GI syndrome,9617669,1/1/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2019,371660, ,NCI,221887,149773,371660
p53/Rb Reactivation Modulators for HPV-positive Head and Neck Cancer,9617777,2/1/2016 0:00,1/31/2021 0:00,Non-SBIR/STTR,2019,360524, ,NIGMS,300873,59651,360524
Understanding Resistance to Next Generation Antiandrogens,9619039,5/1/2012 0:00,12/31/2022 0:00,Non-SBIR/STTR,2019,374735, ,NCI,218250,156485,374735
Evaluating candidate mediators of prostate cancer metastasis and neuro endocrine prostate cancer (NEPC) trans differentiation,9626092,9/14/2018 0:00,8/31/2024 0:00,Non-SBIR/STTR,2018,130212, ,NCI,75793,54419,130212
Targeted Therapies for Richters Transformation,9626898,2/7/2017 0:00,1/31/2022 0:00,Non-SBIR/STTR,2019,449278, ,NCI,287999,161279,449278
Understanding the role of κB-Ras proteins in tumorigenesis,9631427,3/1/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2019,373240, ,NCI,233275,139965,373240
Genomic Instability and Cancer Genetics,9632904, , ,Research Centers,2019, ,8537, ,5369,3168, 
Cancer Pharmacology,9632905, , ,Research Centers,2019, ,7153, ,4499,2654, 
Clinical Investigations and Precision Therapeutics,9632906, , ,Research Centers,2019, ,7153, ,4499,2654, 
Genomics Of Acute Myeloid Leukemia.,9633045,9/19/2003 0:00,11/30/2023 0:00,Non-SBIR/STTR,2019,2084756, ,NCI,1331049,753707,2084756
Project 3: Targeting Bax signaling to overcome treatment resistance in NSCLC,9633851,7/10/2019 0:00,5/31/2024 0:00,Research Centers,2019, ,343389, ,220121,123268, 
Regulation of p53 by TAF1,9635738,7/15/1997 0:00,1/31/2021 0:00,Non-SBIR/STTR,2019,358233, ,NCI,230375,127858,358233
Acute Kidney Injury by Cisplatin and Renoprotective Strategies,9635761,4/1/2010 0:00,2/29/2020 0:00,Non-SBIR/STTR,2019,387111, ,NIDDK,254678,132433,387111
CARP-1: A Potential Therapeutic Agent for Breast Cancer,9636448,1/1/2012 0:00,12/31/2020 0:00,Non-SBIR/STTR,2019, , , , , , 
Systemic RNA interference to reactivate p53 tumor suppression,9636522,3/1/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,343370, ,NCI,230674,112696,343370
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma,9637047,2/1/2019 0:00,1/31/2024 0:00,Non-SBIR/STTR,2019,366000, ,NCI,228750,137250,366000
Coordination of inflammatory signaling and cardiac fibrosis by small proline rich proteins,9638841,12/21/2018 0:00,11/30/2022 0:00,Non-SBIR/STTR,2019,425246, ,NHLBI,276134,149112,425246
Mechanisms of gene expression control in the p53 network,9640420,5/26/2006 0:00,1/31/2023 0:00,Non-SBIR/STTR,2019,322409, ,NCI,207337,115072,322409
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer,9640431,3/8/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,371711, ,NCI,248804,122907,371711
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential,9641773,12/3/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2019,735467, ,NCI,387088,348379,735467
The Role of p53-R249S’s GOF in HCC development,9642305,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2019,390301, ,NCI,258477,131824,390301
Analysis of the Mammalian DNA Damage Response,9642412,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2019,409463, ,NCI,228750,180713,409463
The roles of TRIM24 in breast cancer,9644035,3/1/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,389958, ,NCI,243724,146234,389958
Rad50: Roles in chromo. stab. and prev. of malignancy,9644536,1/1/1998 0:00,12/31/2020 0:00,Non-SBIR/STTR,2019,472473, ,NIGMS,275655,196818,472473
Targeting the TGIF/Twist1 network in osteosarcoma,9645032,3/15/2017 0:00,6/30/2022 0:00,Non-SBIR/STTR,2019,343925, ,NCI,221887,122038,343925
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model,9645054,3/1/2015 0:00,2/28/2021 0:00,Non-SBIR/STTR,2019,366140, ,NCI,253557,112583,366140
The role of PCDH7 in lung cancer pathogenesis,9645057,3/9/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,346759, ,NCI,215868,130891,346759
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells,9645624,2/9/2018 0:00,1/31/2023 0:00,Non-SBIR/STTR,2019,448281, ,NCI,322084,223617,448281
Mentored Clinical Scientist Research Career Development Award (Parent K08),9647288,9/1/2018 0:00,8/31/2023 0:00,Other Research-Related,2018,249042, ,NCI,230594,18448,249042
DEVELOP A NOVEL REPROGRAMMING APPROACH FOR GLIOBLASTOMA MULTIFORME TREATMENT,9647497,2/15/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2019,333594, ,NINDS,218750,114844,333594
Preclinical analyses of advanced prostate cancer in genetically-engineered mice,9648083,8/6/2013 0:00,1/31/2023 0:00,Non-SBIR/STTR,2019,374307, ,NCI,233942,140365,374307
The role of p53 in Iron Overload,9648896,9/15/2018 0:00,8/31/2019 0:00,Non-SBIR/STTR,2018,150165, ,NHLBI,85762,64403,150165
Cancer Cell Adaption to Glutamine Deprivation,9649006,5/1/2018 0:00,4/30/2020 0:00,Non-SBIR/STTR,2017,309113, ,NCI,207500,101613,309113
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism,9649079,3/2/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,308362, ,NCI,242339,66023,308362
Chemical ablation of ductal tree for breast cancer prevention,9651952,1/18/2019 0:00,12/31/2020 0:00,Non-SBIR/STTR,2019,202275, ,NCI,130500,71775,202275
Investigating the Role of Metabolic Reprogramming in Cancer Cell Death Sensitivity,9652179,9/13/2018 0:00,8/31/2020 0:00,Other Research-Related,2018,37937, ,NCI,37937, ,37937
Investigate the role of TPD52-AMPK pathway in tumorigenesis and cancer therapy,9652807,4/15/2016 0:00,2/28/2021 0:00,Non-SBIR/STTR,2019,224018, ,NCI,221887,130914,224018
Evaluation of PAK inhibitors towards targeting adaptive mechanisms of resistance in high-risk rhabdomyosarcoma,9652889,1/1/2019 0:00,12/31/2020 0:00,Non-SBIR/STTR,2019,172369, ,NCI,108750,63619,172369
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites,9653154,3/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2019,406054, ,NCI,221887,184167,406054
Project 5: Tumor Suppressor and Tumor Maintenance Genes,9653158, , ,Non-SBIR/STTR,2019, ,615496, ,385450,230046, 
Impact of germline variants on racial and ethnic differences in somatic mutation frequency,9653978,3/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2019,346144, ,NCI,221887,124257,346144
Regulators of ubiquitin signaling in malignant hematopoiesis,9654305,9/7/2018 0:00,8/31/2020 0:00,Other Research-Related,2018,38705, ,NCI,38705, ,38705
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response,9655302,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,564647, ,NCI,398063,222916,564647
Deciphering How Esco2 Loss Acts as a Penetrance Modifier,9655306,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,349845, ,NCI,235586,114259,349845
BLR&D Research Career Scientist Award Application,9655415,10/1/2018 0:00,9/30/2023 0:00,Other,2019, , , , , , 
Development of Zinc Metallochaperones as Mutant p53 Targeted Anti-cancer Drugs,9656098,3/15/2016 0:00,2/29/2020 0:00,Non-SBIR/STTR,2019,353785, ,NCI,242247,111538,353785
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon Nanotubes,9656125,5/6/2014 0:00,2/28/2021 0:00,Non-SBIR/STTR,2019,335250, ,NIEHS,225000,110250,335250
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells,9656946, , ,Non-SBIR/STTR,2019, ,331748, ,195721,136027, 
3q26 Amplified Genes as Cooperative Oncogenic Drivers of Lung Squamous Cell Carcinoma,9657208,12/14/2018 0:00,11/30/2020 0:00,Non-SBIR/STTR,2019,78250, ,NCI,50000,28250,78250
Tumor Suppression by an African Specific Variant of p53,9657544,3/1/2018 0:00,12/31/2019 0:00,"Training, Individual",2019,54930, ,NCI,54930, ,54930
"Merkel cell polyomavirus infection, DNA damage response and cancer",9657666,4/1/2015 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,355019, ,NCI,221887,133132,355019
Elucidating the mechanism of anti-GSK3 adjuvant therapy for Myc-driven lymphomas,9657689,3/1/2017 0:00,2/29/2020 0:00,"Training, Individual",2019,32083, ,NCI,32083, ,32083
Targeting Mutant KRAS for Cancer Therapy,9658375,3/1/2016 0:00,6/30/2019 0:00,Non-SBIR/STTR,2019,481415, ,NCI,313289,168382,481415
Novel regulations of DNA damage repair,9658494,3/16/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,423276, ,NCI,264548,158728,423276
Mechanisms for GH action on epithelial cells,9658533,4/1/2018 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,382500, ,NIDDK,225000,157500,382500
"Isolation, characterization and translational development of glioma stem cells",9659191,2/1/2017 0:00,1/31/2024 0:00,Non-SBIR/STTR,2019,1045270, ,NCI,581999,463271,1045270
Triad1 regulates myelopoiesis and functions as a leukemia suppressor,9659283,4/1/2015 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,342815, ,NCI,221887,120928,342815
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice,9659732,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2019,533016, ,NCI,341677,191339,533016
Transforming Mechanisms of Merkel Cell Polyoma Virus,9660123,7/1/2013 0:00,11/30/2019 0:00,Non-SBIR/STTR,2019,419188, ,NCI,237500,181688,419188
Endothelial Toll-like Receptor 3 in the pathogenesis and therapy of Pulmonary Arterial Hypertension,9661262,1/1/2019 0:00,6/30/2019 0:00,Non-SBIR/STTR,2019,682581, ,NHLBI,465855,216726,682581
Regulation of Amino-acid Transport in Human Gliomas,9661611,12/1/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2019,362569, ,NCI,228750,133819,362569
Mre11-Dependent DNA Damage Responses in Breast Cancer Pathogenesis,9662373,12/1/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2019,409161, ,NCI,267435,141726,409161
Novel Chromatin Regulating Targets of p63 in Head and Neck Squamous Cell Carcinoma,9662654,3/1/2018 0:00,2/28/2021 0:00,"Training, Individual",2019,60610, ,NCI,60610, ,60610
Role of Nix in pancreatic ductal adenocarcinoma,9663276,4/15/2016 0:00,7/14/2019 0:00,"Training, Individual",2019,16167, ,NCI,16167, ,16167
REGULATION OF TUMOR SUPPRESSION BY ARF,9663879,4/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,338377, ,NCI,221887,116490,338377
The role of AXL-ABL axis in Barrett's carcinogenesis,9663890,3/1/2016 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,98382, ,NCI,62267,36115,98382
System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs,9664427,5/1/2018 0:00,4/30/2022 0:00,Other Research-Related,2018,77166, ,NCI,71450,5716,77166
Biological Activity of HPV E7 in Human Epithelial Cells,9664515,4/19/1996 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,360112, ,NCI,218250,141862,360112
NOX4 Mediates Oxidative Stress in Ovarian Tumor growth and treatment Response,9664591,12/1/2015 0:00,5/31/2021 0:00,Non-SBIR/STTR,2018,321204, ,NCI,228750,92454,321204
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis,9664596,3/9/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2019,339487, ,NCI,221887,117600,339487
Mechanisms of targeting oncoprotein SET in tumor suppression,9664612,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,355019, ,NCI,221887,133132,355019
Novel Therapeutic Approaches Targeting Tumor Suppressor Deficiencies in Advanced Prostate Cancer,9664750,9/14/2018 0:00,8/31/2019 0:00,Other Research-Related,2018,92280, ,NCI,85444,6836,92280
Targeting Human Cancers with Hemizygous Deletion of TP53,9665681,8/9/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,349472, ,NCI,221887,127585,349472
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma,9665682,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,362546, ,NCI,224763,137783,362546
Signaling cascades in cholangiocarcinoma development,9665695,4/5/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,351691, ,NCI,221887,129804,351691
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen,9666117,6/17/2019 0:00,5/31/2024 0:00,Non-SBIR/STTR,2019,380060, ,NCI,286992,93068,380060
Developmental studies to inform clinical stratification and targeting of SHH MB,9666867,4/4/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,452783, ,NCI,290439,162344,452783
Ceramide signaling in the regulation of cellular response to folate stress,9666870,4/1/2015 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,337268, ,NCI,221887,115381,337268
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression,9666941,4/15/2016 0:00,3/31/2022 0:00,Other Research-Related,2020,172098, ,NIDDK,159350,12748,172098
USING ARGININE METABOLIC THERAPIES FOR SARCOMA,9667778,8/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2019,364659, ,NCI,232206,132453,364659
The role of the p63-RBM38 loop in tumor suppression,9668078,4/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,348363, ,NCI,221887,126476,348363
Targeting Ribosomal Biogenesis in Prostate Cancer,9669175,2/1/2018 0:00,8/31/2019 0:00,Other Research-Related,2017,163671, ,NCI,151547,12124,163671
Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC,9670435,3/8/2019 0:00,2/29/2024 0:00,Non-SBIR/STTR,2019,516606, ,NCI,293545,223061,516606
Epigenetic Regulation of Human Telomeres,9670740,7/1/2009 0:00,1/31/2021 0:00,Non-SBIR/STTR,2019,407400, ,NCI,232800,174600,407400
Project 1: Small Molecule Enhancers of Photodynamic Therapy for Skin Cancer,9671356, ,12/31/2020 0:00,Non-SBIR/STTR,2019, ,45995, ,32866,13129, 
ABT-199 based therapies to treat  neuroblastoma,9671379,4/1/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,349049, ,NCI,262847,86202,349049
Development and Application of a Porcine Model of Pancreatic Cancer,9671860,4/1/2018 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,545577, ,NCI,357607,187970,545577
Cyclin-dependent kinase control of cell-division and transcription cycles,9671959,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2019,464704, ,NIGMS,275000,189704,464704
Mechanisms regulating the early stages of UV-induced skin cancer,9672458,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2019,362250, ,NIEHS,225000,137250,362250
Dynamic modulation of p53 activity by its disordered regulatory domains,9673731,4/1/2006 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,414512, ,NIGMS,214218,200294,414512
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression,9674377,5/1/1983 0:00,8/31/2020 0:00,Non-SBIR/STTR,2019,464097, ,NCI,258406,205691,464097
Defining the role of mutant XPO1 in chronic lymphocytic leukemia,9674397,5/1/2015 0:00,4/30/2020 0:00,"Training, Individual",2019,50016, ,NCI,50016, ,50016
Epigenetic regulation by tumor suppressor p53,9674890,6/1/2018 0:00,2/28/2019 0:00,Non-SBIR/STTR,2018,54452, ,NCI,39883,14569,54452
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus,9675229,8/25/2010 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,788470, ,NCI,607672,180798,788470
miR-200 miRNAs repress tumor metastasis in lung adenocarcinoma,9675231,8/1/2009 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,362069, ,NCI,230618,131451,362069
Targeting the cytokine circuitry of KRAS-driven lung cancer,9675236,4/1/2015 0:00,3/31/2020 0:00,Non-SBIR/STTR,2019,382740, ,NCI,221887,160853,382740
Origins of Ovarian Carcinoma,9675246,5/18/2015 0:00,4/30/2021 0:00,Non-SBIR/STTR,2019,348015, ,NCI,221887,126128,348015
"Markov State Model approaches for folding, binding and design",9675303,5/1/2017 0:00,4/30/2022 0:00,Non-SBIR/STTR,2019,295617, ,NIGMS,190000,105617,295617
The mechanism through which mRNA translation enhancer elements drive cap-independent translation,9675499,2/20/2019 0:00,1/31/2023 0:00,Non-SBIR/STTR,2019,322400, ,NIGMS,238400,84000,322400
Mechanisms of obesity-induced hepatocarcinogenesis,9676241,5/8/2015 0:00,4/30/2020 0:00,Non-SBIR/STTR,2019,323994, ,NCI,271807,52187,323994
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer,9676243,5/5/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,973698, ,NCI,927699,233077,973698
"Dissecting the dynamic interplay between p53, chromatin and transcriptional bursting in single cells",9676291,4/1/2018 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,334000, ,NIGMS,200000,134000,334000
Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics,9676405,4/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2019,456274, ,NINDS,294725,161549,456274
The role of AXL-ABL axis in Barrett's carcinogenesis,9676694,3/1/2018 0:00,2/28/2021 0:00,Non-SBIR/STTR,2018,58182, ,NCI,36824,21358,58182
Environmental Regulation of Cellular Responses to DNA Damage,9677158,4/9/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2019,351750, ,NIGMS,210000,141750,351750
Mechanisms of Tumorigenic Transformation of Barretts Esophagus,9678701,4/5/2018 0:00,8/31/2020 0:00,Non-SBIR/STTR,2017,290376, ,NCI,189170,101206,290376
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,9679476, , ,Non-SBIR/STTR,2019, ,384292, ,251132,133160, 
The Role of Mutant p53 in Regulating T-cell Immune Evasion in Pancreatic Adenocarcinoma and Other Cancers,9679638,6/1/2020 0:00,5/31/2023 0:00,"Training, Individual",2019,32521, ,NCI,32521, ,32521
Reflux-Induced Oxidative DNA Damage Repair Early in Barrett's Carcinogenesis,9681202,7/1/2018 0:00,6/30/2022 0:00,Non-SBIR/STTR,2019, , , , , , 
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma,9681405,9/1/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2019,884938, ,NCI,514890,370721,884938
Mutant p53 as actionable cancer-specific target,9681414,4/1/2013 0:00,4/30/2023 0:00,Non-SBIR/STTR,2019,384974, ,NCI,255418,129556,384974
Novel Molecular Mechanisms Dictating Pancreatic Cancer Metastasis in Tip30-Deficient Kras-Mutant Mice,9681663,9/30/2018 0:00,9/29/2020 0:00,"Training, Individual",2018,28794, ,NCI,28794, ,28794
The 9th International MDM2 Workshop,9681912,9/5/2018 0:00,9/4/2019 0:00,Other Research-Related,2018,10000, ,NCI,10000, ,10000
The role of Arf tumor suppressor in translational reprogramming,9682214,3/1/2019 0:00,2/28/2021 0:00,"Training, Individual",2019,61226, ,NIGMS,61226, ,61226
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer,9682449,5/1/2015 0:00,4/30/2022 0:00,Non-SBIR/STTR,2019,332649, ,NCI,243447,89202,332649
Epithelial Cancer Cell-Derived Determinants of Immune Involvement in Breast Cancer,9682941,2/1/2019 0:00,1/31/2020 0:00,"Training, Individual",2019,65340, ,NCI,65340, ,65340
Investigating the role of DUX and miR-34a regulation in cell fate plasticity and cancer,9682978,11/1/2018 0:00,8/31/2023 0:00,"Training, Individual",2018,34069, ,NICHD,34069, ,34069
p53-Mediated Tumor Immune Surveillance,9684211,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2018,73444, ,NCI,51484,21960,73444
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,9684547,4/1/2011 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019, , , , , , 
Role of SIRT3 in melanoma development and progression,9684573,4/1/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019, , , , , , 
Mdm2-p53 signaling in the DNA damage response and in tumorigenesis,9685857,3/1/1999 0:00,4/30/2021 0:00,Non-SBIR/STTR,2019,341069, ,NCI,207337,133732,341069
Basis of Muscle Dysfunction in Malignant Hyperthermia & Central Core Disease,9687584,4/1/2006 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,633312, ,NIAMS,483636,149676,633312
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors,9688490,5/7/2015 0:00,10/31/2020 0:00,Non-SBIR/STTR,2019,524708, ,NCI,350100,174608,524708
DNA Methylation Inhibitor Therapy for Testicular Cancer,9688926,5/1/2018 0:00,4/30/2023 0:00,Non-SBIR/STTR,2019,459898, ,NCI,355633,104265,459898
HAUSP inhibitors in p53-wild type and p53-mutant tumors,9688932,5/1/2015 0:00,4/30/2021 0:00,Non-SBIR/STTR,2019,355019, ,NCI,221887,133132,355019
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis,9689258,6/3/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,370552, ,NCI,221887,148665,370552
Molecular Oncology,9692506, , ,Research Centers,2018, ,15625, ,10048,5577, 
Regulation of RNA metabolism and cell growth control by SR protein kinases,9692699,5/1/1996 0:00,10/31/2020 0:00,Non-SBIR/STTR,2019,348750, ,NIGMS,225000,123750,348750
System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs,9693196,5/1/2018 0:00,11/7/2019 0:00,Other Research-Related,2019,91119, ,NCI,84369,6750,91119
NOX4 Mediates Oxidative Stress in Ovarian Tumor growth and treatment Response,9693681,12/1/2015 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,305098, ,NCI,221887,89680,305098
Intrinsic disorder controls the function of p53 and other cancer associated IDPs,9694271,6/1/2016 0:00,8/31/2020 0:00,Non-SBIR/STTR,2019,311085, ,NIGMS,254800,56285,311085
Translation initiation factor targeting by HHV-8 vIRF-1,9694434,1/1/2019 0:00,12/31/2020 0:00,Non-SBIR/STTR,2019,178078, ,NCI,108750,69328,178078
Roles and Regulation of wild-type and mutant forms of p53,9694627,9/30/2000 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,1829019, ,NCI,1558723,270296,1829019
Project 1: Roles of wild-type and mutant forms of p53 in cancer cell biology,9694629, , ,Non-SBIR/STTR,2019, ,328671, ,205420,123251, 
Project 2: Probing the role of the p53 network in ferroptosis,9694631, , ,Non-SBIR/STTR,2019, ,342311, ,214700,127611, 
Project 4: Mechanisms of wild-type and mutant p53 action in vivo,9694633, , ,Non-SBIR/STTR,2019, ,345156, ,345156,0, 
Core B -The Bio-Informatics Core,9694635, , ,Non-SBIR/STTR,2019, ,180453, ,180453,0, 
Core C - The Molecular Systems Pathology Core,9694637, , ,Non-SBIR/STTR,2019, ,240269, ,240269,0, 
Role of P300 in HPV-positive Head and Neck Cancer,9694846,5/4/2018 0:00,4/30/2020 0:00,Non-SBIR/STTR,2018,504629, ,NIDCR,371991,132638,504629
MicroRNA Targets for Chemoprevention of Squamous Cell Carcinoma (R01 CA194062-01A1),9695869,9/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,305317, ,NCI,177510,127807,305317
Nanotechnology enabled targeting of p53 deficiency in human cancer,9696179,7/1/2018 0:00,6/30/2021 0:00,Non-SBIR/STTR,2018,353962, ,NCI,294487,59475,353962
TP53 Germline Mutations: Beyond LFS,9696815,5/10/2018 0:00,7/31/2019 0:00,Non-SBIR/STTR,2019,27533, ,NCI,17034,10499,27533
Targeting Autophagy in Hereditary Breast Cancer,9697789,6/1/2015 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,464713, ,NCI,296534,168179,464713
Development of cell-free DNA assays for HCC screening and liquid biopsy,9698305,6/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,385939, ,NCI,324770,61169,385939
Wnt pathway dynamics in breast cancer metastasis,9698316,6/6/2017 0:00,5/31/2021 0:00,Other Research-Related,2019,188042, ,NCI,174113,13929,188042
Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway,9698317,6/1/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,334742, ,NCI,199846,134896,334742
Physiological Role of Dynamin-Related Protein 1 in Pancreatic Ductal Adenocarcinoma,9699457,7/1/2017 0:00,6/30/2020 0:00,"Training, Individual",2019,50016, ,NCI,50016, ,50016
âNp53 as a Regulator of p53 Biology,9699983,6/1/2016 0:00,4/30/2020 0:00,"Training, Individual",2019,41096, ,NIA,41096, ,41096
The reduction of NLRX1 and its role in pulmonary aging,9700012,8/15/2016 0:00,4/30/2021 0:00,Non-SBIR/STTR,2019,343375, ,NIA,205000,138375,343375
Multi-scale enhanced sampling of disordered proteins: Admin Supplement Instrumentation,9700313,1/1/2016 0:00,11/30/2020 0:00,Non-SBIR/STTR,2018,140000, ,NIGMS,140000, ,140000
Polyploid cell cycle regulation and genome instability,9700960,8/12/2015 0:00,8/7/2019 0:00,Non-SBIR/STTR,2018,48516, ,NIGMS,30804,17712,48516
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer,9701169,6/14/2017 0:00,5/31/2022 0:00,Non-SBIR/STTR,2019,389319, ,NCI,225037,164282,389319
Role of ER stress-driven IRE1Î±-XBP1 Signaling in Lung Cancer Pathogenesis,9701941,7/1/2017 0:00,6/30/2021 0:00,"Training, Individual",2019,45016, ,NCI,45016, ,45016
TFIIH and Transcription Regulation,9702838,9/22/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,541730, ,NIGMS,469340,72390,541730
Project 2: TOPK/PRPK as Novel Targets for Skin Cancer Prevention,9703251, , ,Non-SBIR/STTR,2019, ,130137, ,116762,13375, 
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin,9703252, , ,Non-SBIR/STTR,2019, ,273704, ,178309,95395, 
The Role of the Microenvironment in Barrett's Esophagus,9703901,9/26/2011 0:00,4/30/2022 0:00,Research Centers,2019,1288641, ,NCI,1158477,325727,1288641
Nuclear Accumulation of D-type Cyclins and Oncogenesis,9703902,7/1/2001 0:00,7/31/2019 0:00,Non-SBIR/STTR,2019,37869, ,NCI,25331,12538,37869
Project 2: Characterization of microenvironmental drivers of neoplasia in BE,9703906, , ,Research Centers,2019, ,209606, ,243689,8201, 
Role of Long Intergenic Noncoding RNA in UVB-induced Apoptosis and Skin Cancer,9703954,6/1/2016 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,335832, ,NIEHS,225000,110832,335832
DBPs (pp: 363-418); DBP Overviews (pp 124-129) ,9703977, , ,Research Centers,2019, ,97961, ,63405,34556, 
Uncovering a new role of nucleosomes in gene regulation,9704286,9/1/2015 0:00,3/31/2023 0:00,Non-SBIR/STTR,2019,439500, ,NIGMS,300000,139500,439500
Neuroendocrine mechanisms of prostate cancer progression,9705860,7/7/2015 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,337700, ,NCI,221887,115813,337700
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma,9705938,9/15/2017 0:00,5/31/2022 0:00,Non-SBIR/STTR,2019,346719, ,NINDS,218750,127969,346719
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.,9706560,1/1/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2018,262816, ,NCI,173653,89163,262816
ERK3 Kinase Signaling in Lung Cancer,9706742,6/1/2015 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,328393, ,NCI,221887,106506,328393
Translational development studies of a novel combination therapy for castration-resistant prostate cancer,9706778,7/1/2018 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,162680, ,NCI,136817,25863,162680
p53/Rb Reactivation Modulators for HPV-positive Head and Neck Cancer,9707355,2/1/2016 0:00,1/31/2020 0:00,Non-SBIR/STTR,2018,125000, ,NIGMS,125000, ,125000
Papillomavirus E6 Structural Consortium,9707761,7/1/2008 0:00,12/31/2020 0:00,Non-SBIR/STTR,2019,430199, ,NCI,322336,107863,430199
Epigenetic modulation of SEC24D and circulating miR-605 in renal cell carcinoma,9709251,6/15/2017 0:00,1/4/2021 0:00,Non-SBIR/STTR,2019,70068, ,NCI,44916,25152,70068
Dynamics of Signaling Pathways: Mechanism and Function,9709302,3/1/2008 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,391340, ,NIGMS,232743,158597,391340
Control of Lipogenesis and Hepatic Steatosis by Caspase-2,9710269,3/15/2019 0:00,12/31/2022 0:00,Non-SBIR/STTR,2019,415961, ,NIDDK,264382,151579,415961
Tissue-specific tumor suppressor effects of p53,9710605,7/17/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2019,396908, ,NCI,234164,162744,396908
"Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation",9710617,7/15/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,366114, ,NCI,221887,144227,366114
"SENP6, a novel p53 negative regulator, is an important new player in cancer",9712878,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2019,352801, ,NCI,221887,130914,352801
Role of P300 in HPV-positive Head and Neck Cancer,9716601,5/4/2018 0:00,4/30/2022 0:00,Non-SBIR/STTR,2019,487899, ,NIDCR,368821,119078,487899
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma,9717103,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,432680, ,NCI,221887,210793,432680
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice,9717204,6/7/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,387727, ,NCI,285829,101898,387727
SIRT2 Inhibitors for the Treatment of B-cell Lymphoma,9717222,7/7/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,557510, ,NCI,316768,240742,557510
Perivascular niche for salivary gland cancer stem cells and resistance to therapy,9718194,2/10/2011 0:00,6/30/2022 0:00,Non-SBIR/STTR,2019,401656, ,NIDCR,261238,140418,401656
Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis,9718230, , ,Non-SBIR/STTR,2019, ,305795, ,201275,104520, 
Core 2: Animal Model and Experimental Therapeutics Core [AMETC],9718235, , ,Non-SBIR/STTR,2019, ,245554, ,161020,84534, 
Underlying Mechanisms in Angiosarcoma,9719409,7/1/2015 0:00,10/21/2019 0:00,Non-SBIR/STTR,2019,59555, ,NCI,38672,20883,59555
The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle,9719774,7/1/2015 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,338378, ,NCI,221887,116491,338378
The Role of the Microenvironment in Barrett's Esophagus,9720207,9/26/2011 0:00,4/30/2022 0:00,Research Centers,2018,93257, ,NCI,93257, ,93257
Project 2: Characterization of microenvironmental drivers of neoplasia in BE,9720213, , ,Research Centers,2018, ,13322, ,13322,0, 
"Head Neck Cancer, beta-defensins, and immune responses",9720680,7/1/2015 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,396250, ,NIDCR,250000,146250,396250
Activating p53 for colorectal cancer prevention,9720844,6/12/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,412063, ,NCI,281470,130593,412063
Integration of early genetic alterations and inflammation in gastroesophageal premalignancy,9721887,4/1/2019 0:00,1/31/2024 0:00,Other Research-Related,2019,158040, ,NIDDK,147074,10966,158040
p53-Mediated Tumor Immune Surveillance,9722055,7/1/2015 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,355019, ,NCI,221887,133132,355019
Cancer Biology in the Zebrafish,9722179,7/3/2003 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,407763, ,NCI,230375,177388,407763
Identifying stabilizers of p53 using pocket complementarity,9723531,9/26/2016 0:00,8/31/2020 0:00,Non-SBIR/STTR,2018,200000, ,NIGMS,200000,0,200000
Dietary Carcinogens for Colorectal Cancer,9724414,6/15/2018 0:00,7/31/2019 0:00,Non-SBIR/STTR,2019,101741, ,NCI,63588,38153,101741
Molecular Basis for Regulation of Cellular Stress Response Pathways by CBP/p300,9724424,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2019,467747, ,NCI,241730,226017,467747
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells,9724506, , ,Non-SBIR/STTR,2019, ,433447, ,371029,62418, 
The impact of chromosome 17p lesions on leukemogeneis and therapy response,9725913,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2019,398509, ,NCI,221887,176622,398509
A MULTISCALE APPROACH TO TARGET THE ACHILLES HEEL OF P53 CANCER MUTANTS,9728314,4/5/2019 0:00,3/31/2023 0:00,Non-SBIR/STTR,2019,312168, ,NIGMS,205000,107168,312168
MECHANISMS OF ANNEXIN A6-MEDIATED BASAL-LIKE BREAST CANCER PROGRESSION,9729426,8/16/2016 0:00,7/31/2021 0:00,Other Research-Related,2019,363750, ,NIGMS,250000,113750,363750
Role of DNA Replication Stress in Genome Instability and Cancer,9730511,7/1/2017 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,284489, ,NIGMS,204453,80036,284489
Limiting UV-induced genome instability with self-cycling antioxidant reagents,9730931,9/12/2019 0:00,8/31/2023 0:00,Non-SBIR/STTR,2019,461056, ,NIEHS,300000,161056,461056
Deregulation of COMPASS complex and enhancer chromatin in pancreatic cancer,9731433,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2019,353909, ,NCI,221887,132022,353909
Preclinical safety and efficacy assessment of a novel PCNA inhibitor for prostate cancer therapy,9731446,8/1/2018 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,169307, ,NCI,105487,63820,169307
Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures,9731498,9/30/2015 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,708450, ,NCI,387542,155846,543388
Mechanisms of gene expression control in the p53 network,9732737,9/1/2018 0:00,1/31/2019 0:00,Non-SBIR/STTR,2018,165008, ,OD,106114,58894,165008
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity,9733153,8/1/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2019,1095930, ,NCI,564913,531017,1095930
Mutagenic by-products of melanin synthesis,9733660,3/1/2019 0:00,2/28/2021 0:00,Non-SBIR/STTR,2019,77000, ,NCI,50000,27000,77000
Function and regulation of MDMX intra-molecular interactions,9733974,8/1/2015 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,381646, ,NCI,221887,159759,381646
Pediatric Preclinical Testing Consortium,9733977,7/7/2015 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,346290, ,NCI,206125,140165,346290
Nanotechnology enabled targeting of p53 deficiency in human cancer,9733984,7/1/2018 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,343342, ,NCI,285652,57690,343342
Identification and targeting of colon cancer initiating cells,9735036,10/1/2009 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019, , , , , , 
Using markers to improve pancreatic cancer screening and surveillance,9735144,7/18/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,927908, ,NCI,635731,292177,927908
Therapeutic strategies for targeting PARP1 in small cell lung cancer,9736242,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,355019, ,NCI,221887,133132,355019
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles,9736284,7/1/2017 0:00,6/30/2022 0:00,"Training, Individual",2019,50016, ,NCI,50016, ,50016
Genetic characterization of osteoblast-induced leukemias,9736570,9/1/2016 0:00,6/30/2020 0:00,Non-SBIR/STTR,2019,461485, ,NHLBI,288428,173057,461485
Targeted Therapy for Endometrial Cancer,9736959,7/1/2002 0:00,1/31/2024 0:00,Non-SBIR/STTR,2019,291967, ,NCI,190000,101967,291967
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53,9737182,4/12/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2019,455018, ,NCI,272466,182552,455018
Modulation of wild type and mutant p53 by HMGA1,9737697,7/1/2018 0:00,6/30/2021 0:00,"Training, Individual",2019,61610, ,NCI,61610, ,61610
ARF6 function in cancers driven by RAS hyperactivation,9737924,7/3/2018 0:00,6/30/2021 0:00,Other Research-Related,2019,129824, ,NCI,120207,9617,129824
Mammary carcinogenesis:  pubertal and adult effects of high fat diet+oxybenzone,9737937,9/30/2015 0:00,6/30/2022 0:00,Non-SBIR/STTR,2019,744137, ,NIEHS,767862,261168,744137
Predicting Breast Cancer Risk after Benign Percutaneous Biopsy,9739251,7/5/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2019,619727, ,NCI,550000,69727,619727
Exploring mechanisms of therapeutic demethylation effects in HPV-associated head and neck cancer,9739970,6/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2019,487357, ,NIDCR,384325,103032,487357
Investigating and targeting pathways of malignant peripheral nerve sheath tumor (MPNST),9740042,7/1/2019 0:00,6/30/2023 0:00,Non-SBIR/STTR,2019,625262, ,NINDS,370220,255042,625262
Defining Mechanisms of Transformation Driven By the Zinc Finger Transcription Factor PLAGL2 in the Intestinal Epithelium,9740230,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2019,357708, ,NCI,228750,128958,357708
Immune-mediated therapies in a genetically engineered murine model of diffuse intrinsic pontine glioma,9742157,4/1/2019 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,442283, ,NINDS,287662,154621,442283
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis,9742434,8/14/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2019,949950, ,NCI,582000,368035,949950
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD),9743212,8/1/2012 0:00,6/30/2023 0:00,Non-SBIR/STTR,2019,2368307, ,NHLBI,1666122,702185,2368307
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease,9743218, , ,Non-SBIR/STTR,2019, ,510000, ,300000,210000, 
CLINCIAL VALIDATION OF APC AND TP53 AS BIOMARKERS FOR CETUXIMAB RESPONSE,9743529,7/3/2019 0:00,3/31/2021 0:00,Non-SBIR/STTR,2019,339695, ,NCI,222751,116944,339695
Inflammation Induced Cytosine Deamination and the Initiation of Cancer,9743614,7/1/2018 0:00,6/30/2022 0:00,"Training, Individual",2019,34551, ,NCI,34551, ,34551
The Role of Tumor Associated Macrophages in Pediatric High-Grade Glioma,9743619,7/11/2018 0:00,1/1/2020 0:00,"Training, Individual",2019,29849, ,NCI,29849, ,29849
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression,9743755,8/1/2017 0:00,7/31/2024 0:00,Non-SBIR/STTR,2019,931087, ,NCI,581998,349089,931087
Investigation of sub-lineages in pulmonary neuroendocrine cells and identification of the cells of origin of small cell lung cancer,9744115,9/1/2019 0:00,8/31/2020 0:00,Other Research-Related,2019,83988, ,NCI,77767,6221,83988
The GOF Mutant p53 Beacon System,9744620,8/24/2017 0:00,7/31/2020 0:00,Non-SBIR/STTR,2019,188241, ,NCI,121250,66991,188241
Targeted Promoter Demethylation in Ovarian Cancer Cells,9744726,9/1/2017 0:00,4/30/2021 0:00,Other Research-Related,2019,137998, ,NIGMS,100000,37998,137998
Aurora-A is a novel therapeutic target in glioblastoma,9744817,9/1/2014 0:00,1/31/2021 0:00,Non-SBIR/STTR,2019,359357, ,NINDS,233349,126008,359357
New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss,9745557,9/19/2017 0:00,8/31/2022 0:00,Other Research-Related,2019,177120, ,NCI,164000,13120,177120
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study,9745826,3/21/2018 0:00,2/28/2021 0:00,Non-SBIR/STTR,2018,165808, ,NCI,145519,20289,165808
The intersection of RNA biology and tumor biology,9746627,8/12/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2019,748148, ,NCI,467564,281473,748148
P63 Mechanisms and mediators in HNSCC,9746691,4/1/2004 0:00,7/31/2022 0:00,Non-SBIR/STTR,2019,398493, ,NIDCR,237500,160993,398493
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer,9747113, , ,Research Centers,2019, ,308187, ,217565,90622, 
Targeting metabolic vulnerabilities in glioblastoma,9747237,8/7/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2019,555887, ,NCI,373514,182373,555887
Targeting Olig2 Co-regulators for Malignant Glioma Therapy,9747389,9/30/2015 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,349149, ,NINDS,266438,82711,349149
Developing newly combined therapeutic strategies for mature B cell lymphoma,9747600,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2019,480946, ,NCI,330546,150400,480946
RNF128  Regulation of TP53 in Barrett's Progression,9747836,8/31/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2019,410069, ,NCI,262865,147204,410069
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia,9748724,4/1/2019 0:00,1/31/2023 0:00,Non-SBIR/STTR,2019,368096, ,NIDDK,232972,135124,368096
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas,9749557,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2019,486710, ,NCI,303482,183228,486710
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade,9750072,8/28/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2019,381646, ,NCI,221887,159759,381646
PROJECT 4: Interrogating PP2A Signaling in Human Cancers,9750141, , ,Non-SBIR/STTR,2019, ,316571, ,181148,135423, 
Role of MTF1 in ovarian cancer,9750254,7/24/2018 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,172319, ,NCI,113368,58951,172319
Project 1:  Evolution of transcriptional programs in lung cancer progression,9751774, , ,Non-SBIR/STTR,2019, ,408138, ,260408,147730, 
Project 3:  Targeting epigenetic regulators in cancer,9751776, , ,Non-SBIR/STTR,2019, ,342135, ,222615,119520, 
Modulation of cancer specific transcriptional factors with small molecules,9752240,8/1/2015 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,389411, ,NCI,221887,167524,389411
EPHB4 Receptor Kinase as a Target in Prostate Cancer,9752247, ,7/31/2021 0:00,Research Centers,2019, ,255425, ,197700,57725, 
Protein Kinase Signaling in the Genotoxic Stress Response,9752562,9/1/2017 0:00,7/31/2025 0:00,Non-SBIR/STTR,2019,548626, ,NIEHS,345048,203578,548626
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer,9752901,9/1/2018 0:00,3/31/2019 0:00,SBIR/STTR,2018,210000, ,NCI, , ,210000
Defining diverse roles of p53 in pancreatic cancer,9752958,8/1/2017 0:00,7/31/2022 0:00,Other Research-Related,2019,170640, ,NCI,158000,12640,170640
Project 2: Targeting metabolic vulnerabilities in glioblastoma,9752975, , ,Research Centers,2019, ,334315, ,214305,120010, 
Project 4: Novel epigenetic treatment of IDH mutant gliomas,9752978, , ,Research Centers,2019, ,345939, ,229569,116370, 
Breast Cancer Detection Consortium,9753167,9/19/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,423712, ,NCI,306347,125333,423712
Improving post-surgery recovery of failing hearts by targeting cardiomyocyte senescence,9753360,9/1/2018 0:00,7/31/2022 0:00,Non-SBIR/STTR,2019,430115, ,NHLBI,265503,164612,430115
A multi-fluorescent intravital microscopy approach to study osteosarcoma,9753464,8/22/2018 0:00,7/31/2019 0:00,Non-SBIR/STTR,2018,176380, ,NCI,141466,34914,176380
Phosphoinositides and Cancer Metabolism,9753733,9/5/2016 0:00,7/31/2023 0:00,Non-SBIR/STTR,2019,986489, ,NCI,582000,404490,986489
Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human Cancer,9753740,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,264110, ,NCI,150920,113190,264110
Role of the AMPK-MDMX-p53 pathway in cancer,9753938,9/1/2019 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,312042, ,NCI,207337,104705,312042
Project 3: Molecular Markers for Early Detection of Esophageal Carcinogenesis,9753948, , ,Research Centers,2019, ,353410, ,229371,124039, 
Targeting Acetyltransferase Gene Inactivation in Diffuse Large B Cell Lymphoma,9754073, , ,Research Centers,2019, ,371101, ,280364,90737, 
The Functions of antisense RNA AS-RBM15 in hematopoiesis,9754123,8/15/2017 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,222750, ,NIDDK,150000,72750,222750
Definition of the Microenvironment in Breast Cancer,9754593,8/1/2016 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,476933, ,NCI,253270,223663,476933
Anticancer peptide therapeutics,9754621,8/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2019,342815, ,NCI,221887,120928,342815
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias,9754785,9/1/2015 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,414929, ,NCI,221887,193042,414929
Statistical methods and tools for cancer risk prediction in families with germline mutations in TP53,9755176,4/1/2019 0:00,3/31/2023 0:00,Non-SBIR/STTR,2019,359758, ,NCI,224849,134909,359758
miR-155 targeted therapeutics for precision medicine in lung cancer,9755389,8/3/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2019,502255, ,NCI,353461,148794,502255
Project 1 - Molecular Determinants of Decitabine Responses.,9756321, , ,Research Centers,2019, ,317882, ,218197,99685, 
Project 2 - Targeted Therapies for T-ALL.,9756322, , ,Research Centers,2019, ,319130, ,203268,115862, 
Altered mRNA splicing dependent on mutant p53 identifies novel therapeutic vulnerability in pancreatic cancer,9756353,8/9/2018 0:00,5/31/2020 0:00,Other Research-Related,2019,102057, ,NCI,94497,7560,102057
Mechanisms by which mutant p53 drives metastatic Triple Negative Breast Cancer,9757548,3/1/2019 0:00,2/28/2022 0:00,"Training, Individual",2019,61610, ,NCI,61610, ,61610
Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia,9758073,7/1/2019 0:00,6/30/2023 0:00,"Training, Individual",2019,36542, ,NCI,36542, ,36542
Clinical Efficacy Evaluation of First-in-class Imipridone ONC201 in Recurrent Type II Endometrial Cancer,9760031,8/17/2017 0:00,8/31/2018 0:00,SBIR/STTR,2018,4319, ,NCI, , ,4319
Novel Roles of p53 Post Translational Modifications in Cancer,9760795,4/1/2019 0:00,1/31/2020 0:00,"Training, Individual",2019,52830, ,NCI,52830, ,52830
"Bioinformatics approaches to solve the ""Missing Driver"" problem in solid tumors",9761491,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,113415, ,NCI,73646,39769,113415
Investigating the metastatic drive in pancreas cancer,9761505,8/9/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2019,529025, ,NCI,300583,228442,529025
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9762012, , ,Research Centers,2019, ,15671, ,11787,4879, 
Mechanisms of Tumorigenic Transformation of Barretts Esophagus,9762032,4/5/2018 0:00,8/31/2022 0:00,Non-SBIR/STTR,2019,342499, ,NCI,228853,113646,342499
Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy,9762053,9/4/2017 0:00,8/31/2022 0:00,Non-SBIR/STTR,2019,561548, ,NCI,394911,166637,561548
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia,9762850,8/5/2003 0:00,8/31/2023 0:00,Research Centers,2019,1708776, ,NCI,1205729,503047,1708776
Preclinical Models for Cancer Therapeutic Development,9763340,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,174117, ,NCI,90686,83431,174117
Regulation of ATDC by TP63 and its role in bladder cancer,9763474,9/1/2016 0:00,8/31/2021 0:00,Other Research-Related,2019,174960, ,NCI,162000,12960,174960
53BP1-dependent pathway in DNA repair,9763542,6/14/2017 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,355018, ,NCI,221886,133132,355018
The Role of WIP1 in Clonal Hematopoiesis,9763562,9/19/2017 0:00,4/18/2020 0:00,"Training, Individual",2019,29237, ,NIDDK,29237, ,29237
Project 2 - Targeted Therapies for T-ALL.,9764654, , ,Research Centers,2018, ,6633, ,4242,2391, 
Project 1 - Molecular Determinants of Decitabine Responses.,9764655, , ,Research Centers,2018, ,6632, ,4242,2390, 
Epigenetic regulation by tumor suppressor p53,9764678,4/1/1999 0:00,2/29/2024 0:00,Non-SBIR/STTR,2019,382375, ,NCI,237500,144875,382375
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9765060, , ,Research Centers,2019, ,53908, ,52983,24165, 
Cellular mechanisms of androgen action and androgen-response gene EAF2 in prostate cancer,9765227,9/19/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,115503, ,NCI,73804,41699,115503
Role of p53 in Kidney Development: Modeling Renal Anomalies of Li-Fraumeni Patients,9765314,8/16/2018 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,115500, ,NIDDK,75000,40500,115500
Targeting the TGIF/Twist1 network in osteosarcoma,9765598,3/15/2017 0:00,6/30/2022 0:00,Non-SBIR/STTR,2018,230000, ,NCI,150820,79180,230000
Use of senolytics to enhance chemotherapeutic efficacy in lung cancer,9765748,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2019,398989, ,NCI,259137,139852,398989
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade,9766214, , ,Research Centers,2019, ,332297, ,206021,126288, 
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells,9766218,8/17/2018 0:00,7/31/2025 0:00,Non-SBIR/STTR,2019,847168, ,NCI,530955,316213,847168
Project 3: Using RNAi-based Spherical Nucleic Acid (SNA) Nanoconjugates Targeting Bcl2L12 to Promote Therapy-Induced Apoptosis in Glioblastoma,9766233, , ,Research Centers,2019, ,334161, ,214166,119995, 
UBIQUITIN-PROTEASOME PATHWAY IN CANCER,9766313,9/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2019,320095, ,NIGMS,198302,121793,320095
01 Project 1:  Cancer risks for mutations in breast cancer predisposition genes,9767051, , ,Research Centers,2019, ,458126, ,348053,110073, 
MicroRNA Therapeutics in Non-small Cell Lung Cancer,9767073, , ,Research Centers,2019, ,367197, ,280851,86816, 
Dissecting of develomental signaling pathways in bone development and osteosarcoma,9767228, , ,Research Centers,2019, ,314376, ,191693,122683, 
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9767534, , ,Research Centers,2019, ,15235, ,9642,5593, 
Roles of proinflammatory chemokines linking obesity and ovarian cancer,9767548, , ,Research Centers,2018, ,11556, ,7314,4242, 
Project 1 - PARP Project,9767679, ,8/31/2021 0:00,Research Centers,2019, ,222109, ,175512,46597, 
Project 1:The Carolina Breast Cancer Study,9768358, , ,Research Centers,2019, ,258169, ,166554,91772, 
Project 4: Chromatin Remodeling Drives the Adaptive Resistance Response to Targeted Kinase Inhibition in Breast Cancer,9768361, , ,Research Centers,2019, ,258169, ,166554,91772, 
Genome instability in cancer: telomeres and DNA repair,9768895,9/2/2016 0:00,8/31/2023 0:00,Non-SBIR/STTR,2019,986492, ,NCI,582001,404491,986492
Clinical Efficacy Evaluation of First-in-class Imipridone ONC201 in Recurrent Type II Endometrial Cancer,9769184,8/17/2017 0:00,8/31/2020 0:00,SBIR/STTR,2018,714000, ,NCI, , ,714000
"Tumor suppression, p53 and retrotransposons",9769700,8/24/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2019,359457, ,NCI,221887,137570,359457
Mechanism of regulation of progenitor proliferation and transformation,9769907,9/1/2017 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,174117, ,NINDS,174117,0,174117
"Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis",9770130, , ,Intramural Research,2018,2947798, ,NIA, , ,2947798
Placenta specific and ribosomal RNA genes: structure and function,9770134, , ,Intramural Research,2018,1213799, ,NIA, , ,1213799
Oncogenic Function of FBXW7 R465 mutation reveals a new opportunity for cancer therapy,9770137, , ,Intramural Research,2018,754487, ,NIA, , ,148628
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,9770258, , ,Intramural Research,2018,7969561, ,NCI, , ,7969561
Intervention Trials in Persons at Increased Genetic Risk of Cancer,9770259, , ,Intramural Research,2018,719464, ,NCI, , ,719464
Consultation and Collaboration,9770272, , ,Intramural Research,2018,2043593, ,NCI, , ,2043593
Structural Mechanisms of Ribosome Assembly,9770346, , ,Intramural Research,2018,2046795, ,NIEHS, , ,2046795
Phenotypic Assay Design and Development for Rare and Neglected Diseases,9770404, , ,Intramural Research,2018,401338, ,NCATS, , ,401338
HDM2 as a Therapeutic Target in RCC,9771378, , ,Research Centers,2019, ,265751, ,234873,30878, 
Adaptive Clinical Efficacy Evaluation of ONC201 in Recurrent High Grade Glioma,9771388,9/1/2015 0:00,8/31/2021 0:00,SBIR/STTR,2019,999600, ,NCI, , ,999600
Research Project 2: Pathological Diagnosis and Etiology of Ocular Surface Squamous Neoplasia in Zambia,9771409, , ,Research Centers,2019, ,104868, ,98889,5979, 
Inhibitors of p53-S100B interaction for melanoma,9772051, , ,Intramural Research,2018,245080, ,NCATS, , ,245080
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer,9772410,9/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2019,560803, ,NCI,580518,163938,560803
Epigenetics in the extreme - investigating heritability driven by disordered RNA binding proteins in development and cancer,9772509,9/1/2018 0:00,8/31/2020 0:00,Other Research-Related,2019,90000, ,NIGMS,83333,6667,90000
Mentored Clinical Scientist Research Career Development Award (Parent K08),9773015,9/1/2018 0:00,2/29/2020 0:00,Other Research-Related,2019,249042, ,NCI,230594,18448,249042
The regulation of PP1 in the nucleus,9773086,9/11/2011 0:00,12/31/2020 0:00,Non-SBIR/STTR,2019,322350, ,NIGMS,210000,112350,322350
Research Project 3: Heterogeneity in metastatic CRPC and the role of TP53 mutation as a molecular determinant,9774814, , ,Research Centers,2019, ,205950, ,131254,80933, 
(PQ3) UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMAS,9775445,9/4/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2019,637580, ,NCI,400994,236586,637580
Natural History of Familial Carcinoid Tumor,9776093, , ,Intramural Research,2018,696604, ,NIDDK, , ,696604
Robust Predictor of Breast Cancer Risk,9776881,9/20/2017 0:00,8/31/2019 0:00,SBIR/STTR,2018,2000, ,NCI, , ,2000
Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations,9778053,9/5/2019 0:00,8/31/2022 0:00,SBIR/STTR,2019,224527, ,NCI, , ,224527
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens,9778546,9/12/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2019,580069, ,NCI,401477,178592,580069
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer,9778774,9/22/2017 0:00,8/31/2022 0:00,Research Centers,2019,917850, ,NCI,1071607,615064,917850
Project 1: High Grade Cancers: Capitalizing on PARPness in Ovarian Carcinoma,9778781, , ,Research Centers,2019, ,258050, ,221182,132971, 
Clinical Efficacy Evaluation of First-in-class Imipridone ONC201 in Recurrent Type II Endometrial Cancer,9778785,8/17/2017 0:00,8/31/2021 0:00,SBIR/STTR,2019,777000, ,NCI, , ,777000
Chromosomal Proteins and Chromosomal Functions,9779544, , ,Intramural Research,2018,806420, ,NCI, , ,806420
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,9779552, , ,Intramural Research,2018,1057469, ,NCI, , ,1057469
"Tumor Suppressor Protein, p53",9779557, , ,Intramural Research,2018,547981, ,NCI, , ,547981
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression,9779574, , ,Intramural Research,2018,755852, ,NCI, , ,755852
Regulation of Lymphocyte Proliferation and Replicative Capacity,9779587, , ,Intramural Research,2018,265507, ,NCI, , ,265507
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,9779590, , ,Intramural Research,2018,449811, ,NCI, , ,449811
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,9779594, , ,Intramural Research,2018,493225, ,NCI, , ,493225
DNA repair,9779603, , ,Intramural Research,2018,1845586, ,NCI, , ,1845586
Enzymes and Substrates of the Ubiquitin Conjugating System,9779604, , ,Intramural Research,2018,957415, ,NCI, , ,957415
Role of CEBP transcription factors in cell growth and tumorigenesis,9779616, , ,Intramural Research,2018,1390451, ,NCI, , ,1390451
Role of Neurotrophins in the Development of the Mammalian Nervous System,9779629, , ,Intramural Research,2018,848710, ,NCI, , ,848710
Immune Reconstitution,9779659, , ,Intramural Research,2018,1283331, ,NCI, , ,1283331
Zebrafish Models of Cancer,9779662, , ,Intramural Research,2018,105067, ,NCI, , ,105067
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,9779690, , ,Intramural Research,2018,159025, ,NCI, , ,159025
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,9779709, , ,Intramural Research,2018,573937, ,NCI, , ,573937
"Role of inflammation, innate resistance, and immunity in carcinogenesis",9779712, , ,Intramural Research,2018,1010680, ,NCI, , ,1010680
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,9779715, , ,Intramural Research,2018,655046, ,NCI, , ,655046
p53-induced Regulation of Transcription in the Chromatin Context,9779732, , ,Intramural Research,2018,151007, ,NCI, , ,151007
Development of TGF-beta antagonists for cancer therapy,9779739, , ,Intramural Research,2018,428009, ,NCI, , ,428009
Redox Mechanism Process of Angiogenesis and Wound Healing,9779745, , ,Intramural Research,2018,646842, ,NCI, , ,646842
Collaborative Pathways that Lead to Leukemia,9779758, , ,Intramural Research,2018,616241, ,NCI, , ,616241
TMPRSS2-ERG chromosomal translocations and prostate cancer,9779776, , ,Intramural Research,2018,218349, ,NCI, , ,218349
Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,9779799, , ,Intramural Research,2018,1588556, ,NCI, , ,1588556
Role of Brachyury in regulating notochord development and neoplasia,9779805, , ,Intramural Research,2018,150503, ,NCI, , ,150503
Role of mouse microbiome in cancer and inflammation,9779812, , ,Intramural Research,2018,1263350, ,NCI, , ,1263350
Role of inflammation in epigenetic alterations of metastatic cancer cells,9779817, , ,Intramural Research,2018,803915, ,NCI, , ,803915
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,9779826, , ,Intramural Research,2018,821973, ,NCI, , ,821973
Genomic and genetic studies of endocrine cancers,9779843, , ,Intramural Research,2018,476230, ,NCI, , ,476230
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,9779865, , ,Intramural Research,2018,534706, ,NCI, , ,534706
Systems-level analysis of the regulation and function of p53 dynamics,9779880, , ,Intramural Research,2018,534969, ,NCI, , ,534969
Vascular Biology Section,9779883, , ,Intramural Research,2018,1673087, ,NCI, , ,1673087
"Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome",9779933, , ,Intramural Research,2018,1711888, ,NCI, , ,1711888
"p53, Aging, and Cancer",9779935, , ,Intramural Research,2018,2282517, ,NCI, , ,2282517
Study the roles of p53 and p53 mutants in mesenchymal stem cells,9779939, , ,Intramural Research,2018,623372, ,NCI, , ,623372
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,9779948, , ,Intramural Research,2018,1058087, ,NCI, , ,1058087
Metabolic and p53 Targets of Cellular Respiration of Esophageal Cancer,9779974, , ,Intramural Research,2018,431267, ,NCI, , ,431267
Role of long non-coding RNAs in p53 signaling,9779979, , ,Intramural Research,2018,885769, ,NCI, , ,885769
Comparative Brain Tumor Consortium,9780007, , ,Intramural Research,2018,51977, ,NCI, , ,51977
Genomic characterization and development of therapies for Rhabdomyosarcoma,9780025, , ,Intramural Research,2018,551809, ,NCI, , ,551809
Genomic dissection of tumor heterogeneity and progression,9780033, , ,Intramural Research,2018,551809, ,NCI, , ,551809
Therapeutic evaluation in ovarian and breast cancer GEMGDA models,9780035, , ,Intramural Research,2018,1323540, ,NCI, , ,1323540
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models,9780037, , ,Intramural Research,2018,1588248, ,NCI, , ,1588248
Targeting Metabolic Pathways in Bladder Cancer,9780039, , ,Intramural Research,2018,217357, ,NCI, , ,217357
Hypoxia signaling in cancer development,9780060, , ,Intramural Research,2018,1013494, ,NCI, , ,1013494
Minimal Myc functional threshold for tumorigenesis,9780106, , ,Intramural Research,2018,150503, ,NCI, , ,150503
Nitric Oxide as a Modifier of Oxidative Stress,9780176, , ,Intramural Research,2018,485131, ,NCI, , ,485131
CCR Confocal Microscopy Core,9780208, , ,Intramural Research,2018,428299, ,NCI, , ,428299
Molecular Profiling of Clinical Specimens,9780227, , ,Intramural Research,2018,3261202, ,NCI, , ,3261202
CPTR - Mass Spectrometry Unit,9780247, , ,Intramural Research,2018,360216, ,NCI, , ,360216
Comparison of molecular factors to drug activities,9780251, , ,Intramural Research,2018,83227, ,NCI, , ,83227
Comparative Biomedical Scientist Training Program,9780311, , ,Intramural Research,2018,1607144, ,NCI, , ,1607144
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure,9780313, , ,Intramural Research,2018,529416, ,NCI, , ,529416
Investigating immune-microbiota interaction in lung cancer,9780459,9/7/2018 0:00,6/30/2020 0:00,Other Research-Related,2019,126225, ,NCI,116875,9350,126225
Regulators of ubiquitin signaling in malignant hematopoiesis,9780470,9/7/2018 0:00,8/31/2020 0:00,Other Research-Related,2019,37697, ,NCI,37697, ,37697
Signal and Transcription Factor Network interactions in Head and Neck Cancer,9781312, , ,Intramural Research,2018,392219, ,NIDCD, , ,392219
Genomics and Proteomics of Head and Neck Cancer,9781313, , ,Intramural Research,2018,588328, ,NIDCD, , ,588328
Reactivating p53 Function with a Novel Structure-based Peptide as a Therapeutic Approach for Overcoming Platinum Resistance,9781438,1/1/2020 0:00,12/31/2023 0:00,Non-SBIR/STTR,2020, , , , , , 
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC,9781672,9/10/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2019,419852, ,NCI,297701,122151,419852
Genetic Susceptibility To Carcinogens,9782646, , ,Intramural Research,2018,698262, ,NIEHS, , ,698262
Discovery And Functional Genomics Of Environmental Response Genes,9782647, , ,Intramural Research,2018,1735680, ,NIEHS, , ,1735680
Identifying stabilizers of p53 using pocket complementarity,9782971,9/26/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,348793, ,NIGMS,229890,118903,348793
Regulation Of Epidermal Differentiation,9784486, , ,Intramural Research,2018,1315030, ,NIAMS, , ,1315030
Investigating the Role of Metabolic Reprogramming in Cancer Cell Death Sensitivity,9784784,9/1/2019 0:00,4/2/2020 0:00,Other Research-Related,2019,36929, ,NCI,36929, ,36929
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis,9784973,5/14/2013 0:00,3/31/2019 0:00,Non-SBIR/STTR,2018,75000, ,NCI,46875,28125,75000
Human Genes Affecting Chromosome Metabolism and Stress Response,9785207, , ,Intramural Research,2018,317938, ,NIEHS, , ,317938
Evaluating candidate mediators of prostate cancer metastasis and neuro endocrine prostate cancer (NEPC) trans differentiation,9785430,9/14/2018 0:00,4/30/2024 0:00,Non-SBIR/STTR,2020,130212, ,NCI,75793,54419,130212
Project 1: Combinatorial Molecular Tumor Drivers in Basal and Supra-                 basal Urothelial Cells,9785816, , ,Non-SBIR/STTR,2019, ,343182, ,202467,140715, 
Microarray and Genome Informatics,9786019, , ,Intramural Research,2018,1073053, ,NIEHS, , ,1073053
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease,9786308, , ,Intramural Research,2018,1076811, ,NIAID, , ,1076811
Bone Marrow Histopathological Changes in Neoplastic and Non-Neoplastic Diseases,9787032, , ,Intramural Research,2018,0, , , , , 
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis,9787413,9/18/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2019,443175, ,NCI,304914,138261,443175
"Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy",9787876, , ,Intramural Research,2018,2898518, ,NHLBI, , ,2898518
Mitochondrial regulation and function in cancer and cardiovascular biology,9787890, , ,Intramural Research,2018,1307705, ,NHLBI, , ,1307705
Molecular Pathogenesis of Two Newly Defined Major Subgroups of PTCL,9788311, , ,Non-SBIR/STTR,2019, ,404457, ,389246,15211, 
Molecular mechanisms of SCLC initiation and detection in mice and humans,9788319,9/19/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2019,573067, ,NCI,360662,212405,573067
Regulation Of Intracellular Iron Metabolism,9790685, , ,Intramural Research,2018,1330964, ,NICHD, , ,1330964
Cell Cycle Regulation In Oogenesis,9790688, , ,Intramural Research,2018,1195469, ,NICHD, , ,1195469
Synergistic combinations that target apoptosis induction in PTCL,9791869,9/1/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2019, ,481543, ,361572,119971, 
Sphingolipids in Cancer Biology and Therapy,9793235,8/1/2003 0:00,8/31/2024 0:00,Non-SBIR/STTR,2019,1299443, ,NCI,823319,476124,1299443
Project 2: Role of ACER2 in Liver Cancer,9793237, , ,Non-SBIR/STTR,2019, ,198736, ,126477,72259, 
Project 3: Role of Sphingosine Kinase in P53 Cancer Biology,9793238, , ,Non-SBIR/STTR,2019, ,198271, ,127125,71146, 
Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer HHSN2612015000181 Task Order 8,9794244,9/17/2018 0:00,3/16/2021 0:00,R and D Contracts,2018,778389, ,NCI, , ,778389
03 Genetically Engineered Mouse Facility,9794658, , ,Research Centers,2019, ,488083, ,305052,183031, 
25 Cancer Genetics and Epigenetics,9794671, , ,Research Centers,2019, ,18707, ,11692,7015, 
06 Breast Cancer,9794675, , ,Research Centers,2019, ,18707, ,11692,7015, 
Overcoming cisplatin resistance by targeting fatty acid metabolism,9795719,8/1/2019 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,166936, ,NIDCR,104368,62568,166936
"Algorithmic approaches to systems biology, data integration, and evolution",9796767, , ,Intramural Research,2018,1578402, ,NLM, , ,1578402
Investigating chromatin mechanisms using viral systems,9796807,9/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2019,439710, ,NIGMS,249835,189875,439710
Transcriptional mechanisms of natural killer cell responses during mouse cytomegalovirus infection,9797970,5/6/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2019,453462, ,NIAID,296420,157042,453462
A chemical strategy to unravel tumor suppression through the ubiquitin pathway,9801098,8/5/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2019,296434, ,NIGMS,195000,101434,296434
Targeting p53 conformational defects to arrest carcinogenesis,9803279,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2019,356850, ,NCI,228750,128100,356850
Suppression of disease causingnonsense mutations by targeted mRNA pseudouridylation,9805188,7/1/2019 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,167475, ,NCI,108750,58725,167475
Investigating the non-cell autonomous immune effects of mutant p53 in pancreatic cancer,9806461,9/1/2019 0:00,8/31/2024 0:00,Other Research-Related,2019,225979, ,NCI,209240,16739,225979
"Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)",9806956,9/1/2019 0:00,6/30/2025 0:00,Non-SBIR/STTR,2019,249999, ,FDA,156249,93750,249999
Evaluation of TP53 mutations in non-cancerous tissue as novel biomarkers of ovarian cancer risk.,9807872,6/3/2019 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,169106, ,NCI,108750,60356,169106
Investigating the role of DUX and miR-34a regulation in cell fate plasticity and cancer,9812756,11/1/2018 0:00,8/31/2023 0:00,"Training, Individual",2020,35065, ,NICHD,35065, ,35065
Targeting BCL-2 family-regulated cell death for HNSCC treatment,9812923,7/1/2019 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,77625, ,NCI,50000,27625,77625
Genetic and Epigenetic Biomarkers for B-cell Lymphoma,9814315,7/3/2019 0:00,9/13/2019 0:00,Non-SBIR/STTR,2019,161115, ,NCI,101492,59623,161115
Defining and manipulating quiescence associated DNA damage resistance in single cells,9814769,1/15/2019 0:00,12/31/2021 0:00,Non-SBIR/STTR,2019,245000, ,NCI,169366,75634,245000
Target MDM2/MDMX for reducing normal tissue toxicity induced by chemotherapy,9814796,5/10/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2019,364856, ,NCI,228750,136106,364856
Copy Number Alterations in Low Mutation Cancer,9814814,12/1/2018 0:00,11/30/2021 0:00,Non-SBIR/STTR,2019,236625, ,NCI,166555,70070,236625
Precision approaches to refining TP53-associated cancer risk,9815261,9/18/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2019,1704138, ,NCI,1205129,499009,1704138
Role of Vitamin D in cutaneous DNA repair,9815328,10/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2020, , , , , , 
Combinations of Grape Seed and Milk Thistle Extracts Against Lung,9815335,10/1/2018 0:00,9/30/2022 0:00,Non-SBIR/STTR,2020, , , , , , 
Proximal Differentiation Therapy for K-Ras-Induced Lung Adenocarcinoma,9815433,10/1/2017 0:00,9/30/2021 0:00,Non-SBIR/STTR,2020, , , , , , 
BLR&D Research Career Scientist Award Application,9815917,10/1/2018 0:00,9/30/2023 0:00,Other,2020, , , , , , 
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations,9816351,8/8/2019 0:00,7/31/2026 0:00,Non-SBIR/STTR,2019,895512, ,NCI,519017,376495,895512
DNA-PKcs and PIDD interaction in DNA damage response,9817463,9/1/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2019,370575, ,NCI,228750,141825,370575
Y-Box 1 and normoxic HIF1 in Sonic hedgehog medulloblastoma tumor stem cell radiation resistance,9818221,9/1/2019 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,353750, ,NINDS,226766,126984,353750
Polypoid cell cycle regulation and genome instability,9818541,8/12/2015 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,318485, ,NIGMS,203425,115060,318485
"Mechanisms of PIDDosome Signaling, a p53-Independent Apoptotic Response to DNA Damage",9818716,7/5/2013 0:00,5/31/2024 0:00,Non-SBIR/STTR,2019,350852, ,NCI,208594,142258,350852
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment,9818740,7/4/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2019,619276, ,NCI,440016,179260,619276
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer,9819294,8/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2019,462840, ,NCI,288633,174207,462840
The structure of the telomere as a sentinel of DNA damage.,9820767,7/26/2005 0:00,1/31/2021 0:00,Non-SBIR/STTR,2019,150000, ,NIEHS,96463,53537,150000
Molecular Mechanisms of PTEN and USP7 Regulation,9822097,9/17/2019 0:00,8/31/2021 0:00,Other Research-Related,2019,100000, ,NIGMS,92593,7407,100000
Is the Eicosanoid Producing Enzyme 12-Lipoxygenase (ALOX12) a Tumor Suppressor?,9824098,12/1/2018 0:00,9/15/2019 0:00,"Training, Individual",2018,51174, ,NIAMS,51174, ,51174
Multi-scale enhanced sampling of disordered proteins,9824579,1/1/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,268363, ,NIGMS,192500,75863,268363
Investigating CREBBP as a tumor suppressor in small cell lung cancer,9825525,12/15/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,441962, ,NCI,251115,190847,441962
Novel therapeutics for targeting checkpoint dysfunction in cancer,9825532,12/15/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,362569, ,NCI,228750,133819,362569
Local Immuroregulation of Cutaneous Carcinogenesis,9827537,7/1/2003 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,397813, ,NCI,237500,160313,397813
Role of HOS in Cell Transformation and Apoptosis,9828072,3/1/2001 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,344138, ,NCI,213750,130388,344138
p53 acetylation in ferroptosis and tumor suppression,9828084,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2020,366000, ,NCI,228750,137250,366000
Functional Analysis of p53 polymorphic variants,9828520,7/1/2003 0:00,11/30/2020 0:00,Non-SBIR/STTR,2020,384750, ,NCI,202500,182250,384750
p53 Variants in Cancer Risk and Therapy,9828534,12/1/2015 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,429501, ,NCI,228750,200751,429501
Interplay of mammary luminal cells and environmental factors in establishing p53-deficient premalignant field,9828545,12/12/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2020,374766, ,NCI,228750,146016,374766
Regulation of SLC7A11 by p53 in cancer metabolism,9828546,12/1/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2020,366000, ,NCI,228750,137250,366000
Definition of the Microenvironment in Breast Cancer,9829027,8/1/2016 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,67386, ,NCI,34807,32579,67386
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer,9829039,12/1/2015 0:00,7/31/2021 0:00,Non-SBIR/STTR,2020,434625, ,NCI,228750,205875,434625
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma,9829088,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2020,559847, ,NCI,326061,233786,559847
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer,9829104,12/1/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,348844, ,NCI,228750,120094,348844
Deciphering How Esco2 Loss Acts as a Penetrance Modifier,9829267,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2019,62911, ,NCI,42364,20547,62911
Inhibiting Emergence and Progression of Castration-resistant Prostate Cancer through Enforcement of Senescence and Alteration of the Tumor Microenvironment,9829485,12/1/2018 0:00,11/30/2021 0:00,"Training, Individual",2020,40289, ,NCI,40289, ,40289
The role of AXL-ABL axis in Barrett's carcinogenesis,9829890,3/1/2016 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,85562, ,NCI,54153,31409,85562
p53-Mediated Tumor Immune Surveillance,9829891,7/1/2015 0:00,6/30/2020 0:00,Non-SBIR/STTR,2019,71240, ,NCI,49939,21301,71240
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer,9829892,5/22/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2019,614981, ,NCI,380743,234238,614981
Mre11-Dependent DNA Damage Responses in Breast Cancer Pathogenesis,9830026,12/1/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2020,409161, ,NCI,267435,141726,409161
Regulation of p53 and Checkpoint Signaling by Chromium(VI),9830068,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2020,365625, ,NIEHS,225000,140625,365625
Definition of the Microenvironment in Breast Cancer,9830093,3/1/2019 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,67352, ,NCI,34807,32545,67352
An in vivo model for CCNE1 amplified tumorigenesis,9830595,12/1/2017 0:00,6/30/2020 0:00,"Training, Individual",2020,47900, ,NCI,47900, ,47900
"Role of the p53 C-terminal domain in tissue homeostasis, tumor suppression, and oncogenesis",9830619,12/15/2015 0:00,11/30/2020 0:00,Non-SBIR/STTR,2020,603125, ,NCI,464920,138205,603125
Regulation of Amino-acid Transport in Human Gliomas,9830632,12/1/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2020,362341, ,NCI,228750,133591,362341
Mechanisms of Intestinal Tumorigenesis,9831041,1/1/2000 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,395000, ,NCI,250000,145000,395000
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential,9831151,12/3/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2020,715156, ,NCI,376398,338758,715156
Determining intracellular signaling events that control CAR T cell death in vivo.,9833381,8/1/2019 0:00,7/31/2021 0:00,"Training, Individual",2019,31828, ,NCI,31828, ,31828
Understanding Resistance to Next Generation Antiandrogens,9836789,5/1/2012 0:00,12/31/2022 0:00,Non-SBIR/STTR,2020,404100, ,NCI,225000,179100,404100
The Inflammasome as a novel mediator and therapeutic target of GI syndrome,9837428,1/1/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2020,383156, ,NCI,228750,154406,383156
Synthetic lethality based combination approaches to ARID1A mutation in ovarian cancer,9837701,7/18/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2019,509794, ,NCI,285439,224355,509794
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer,9837948,9/1/2008 0:00,6/30/2024 0:00,Non-SBIR/STTR,2019,370500, ,NCI,237500,133000,370500
PPM1D in Clonal Hematopoiesis and Malignancies,9838459,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2019,621577, ,NCI,422021,199556,621577
3q26 Amplified Genes as Cooperative Oncogenic Drivers of Lung Squamous Cell Carcinoma,9838734,12/14/2018 0:00,11/30/2020 0:00,Non-SBIR/STTR,2020,78250, ,NCI,50000,28250,78250
Metallacycle-mediated coupling in stereoselective synthesis,9839034,1/1/2020 0:00,12/31/2024 0:00,Non-SBIR/STTR,2020,338250, ,NIGMS,206250,132000,338250
Evaluation of PAK inhibitors towards targeting adaptive mechanisms of resistance in high-risk rhabdomyosarcoma,9839406,1/1/2019 0:00,12/31/2020 0:00,Non-SBIR/STTR,2020,206843, ,NCI,130500,76343,206843
Study of Interleukin 33 as a new immunotherapy of lung cancer,9839745,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2019,355409, ,NCI,228750,126659,355409
The role of chronic stress in regulation of mutant p53 and tumorigenesis,9840449,1/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2020,363306, ,NCI,228750,134556,363306
Translation initiation factor targeting by HHV-8 vIRF-1,9840465,1/1/2019 0:00,12/31/2020 0:00,Non-SBIR/STTR,2020,213694, ,NCI,130500,83194,213694
Carcinogen-specific Twist1 regulation in lung epithelial cells,9840709,9/1/2016 0:00,3/31/2021 0:00,Non-SBIR/STTR,2016,297280, ,NIEHS,195579,101701,297280
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.,9840884,1/1/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2020,316635, ,NCI,229146,87489,316635
Coordination of inflammatory signaling and cardiac fibrosis by small proline rich proteins,9841443,12/21/2018 0:00,11/30/2022 0:00,Non-SBIR/STTR,2020,425246, ,NHLBI,276134,149112,425246
The Role of p53-R249S’s GOF in HCC development,9841908,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2020,364509, ,NCI,240203,124306,364509
Copy Number Alterations in Low Mutation Cancer,9841919,12/1/2018 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,246525, ,NCI,166555,79970,246525
Analysis of the Mammalian DNA Damage Response,9841925,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2020,409463, ,NCI,228750,180713,409463
Mechanistic Modeling of Oropharyngeal Cancer Treatment and Recurrence (Supplement),9842233,12/25/2018 0:00,8/31/2021 0:00,Non-SBIR/STTR,2019,75000, ,NCI,48974,26026,75000
The Role of Ribosomal Proteins in the P53-MDM2 Pathway,9842400,1/1/2019 0:00,12/31/2021 0:00,Non-SBIR/STTR,2020,285950, ,NCI,190000,95950,285950
Dynamics of Cellular Senescence in Single Cells,9842545,2/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2020,411266, ,NIGMS,242635,168631,411266
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice,9842617,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2020,533016, ,NCI,341677,191339,533016
LINE-1 genotoxicity and cytotoxicity and its relevance to cancer,9843115,1/1/2018 0:00,12/31/2020 0:00,"Training, Individual",2020,50520, ,NCI,50520, ,50520
Molecular Biology of Oncogenic Papillomaviruses,9843492,1/1/2016 0:00,12/31/2022 0:00,Non-SBIR/STTR,2020,1017000, ,NCI,600000,417000,1017000
DNA damage signaling to immune checkpoints,9843645,1/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2020,358311, ,NCI,228953,129358,358311
Development of a genetic and molecular prediction model for cisplatin and radiation resistance in head and neck squamous cell carcinoma,9849133,1/1/2018 0:00,12/31/2020 0:00,Other Research-Related,2020,172260, ,NIDCR,159500,12760,172260
Preclinical analyses of advanced prostate cancer in genetically-engineered mice,9849748,8/6/2013 0:00,1/31/2023 0:00,Non-SBIR/STTR,2020,385883, ,NCI,241177,144706,385883
Defining and manipulating quiescence associated DNA damage resistance in single cells,9850214,1/15/2019 0:00,12/31/2021 0:00,Non-SBIR/STTR,2020,245000, ,NCI,161965,83035,245000
Targeted Therapies for Richters Transformation,9850539,2/7/2017 0:00,1/31/2022 0:00,Non-SBIR/STTR,2020,463172, ,NCI,296905,166267,463172
"Precision Genomics in the WISDOM Pragmatic Clinical Trial:  An ""Embedded"" ELSI Study of Risk-based Breast Cancer Screening",9851287,1/12/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2020,644748, ,NCI,414480,230268,644748
Understanding the role of κB-Ras proteins in tumorigenesis,9851375,3/1/2016 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,384782, ,NCI,240489,144293,384782
Phosphoinositide Signaling in the Cytosol and Nucleus,9851672,1/1/2020 0:00,12/31/2024 0:00,Non-SBIR/STTR,2020,599490, ,NIGMS,389503,209987,599490
Project 5: Tumor Suppressor and Tumor Maintenance Genes,9851824, , ,Non-SBIR/STTR,2020, ,630426, ,394341,236085, 
Chemical ablation of ductal tree for breast cancer prevention,9851836,1/18/2019 0:00,10/31/2021 0:00,Non-SBIR/STTR,2020,168563, ,NCI,108750,59813,168563
Targeting Mutant KRAS for Cancer Therapy,9852992,3/1/2016 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,873415, ,NCI,606117,267298,873415
Development of a genetic and molecular prediction model for cisplatin and radiation resistance in head and neck squamous cell carcinoma,9854347,1/1/2018 0:00,12/31/2020 0:00,Other Research-Related,2019,172260, ,NIDCR,159500,12760,172260
Driving Biomedical Projects,9854768, , ,Research Centers,2020, ,335469, ,212322,123147, 
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites,9854894,3/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2020,427763, ,NCI,228750,199013,427763
The Age-Dependence and Cell-Specificity of Breast Cancer Driven by Mutant p53,9855838,3/15/2020 0:00,1/31/2023 0:00,Other Research-Related,2020,153000, ,NIGMS,100000,53000,153000
Mechanisms of gene expression control in the p53 network,9856414,5/26/2006 0:00,1/31/2023 0:00,Non-SBIR/STTR,2020,332381, ,NCI,213750,118631,332381
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma,9856420,2/1/2019 0:00,1/31/2024 0:00,Non-SBIR/STTR,2020,366000, ,NCI,228750,137250,366000
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells,9856999,2/9/2018 0:00,1/31/2023 0:00,Non-SBIR/STTR,2020,606140, ,NCI,360109,246031,606140
"Dissecting the dynamic interplay between p53, chromatin and transcriptional bursting in single cells",9857685,4/1/2018 0:00,3/31/2022 0:00,Non-SBIR/STTR,2018,176400, ,NIGMS,106051,70349,176400
Systemic RNA interference to reactivate p53 tumor suppression,9858303,3/1/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,353176, ,NCI,242662,110514,353176
The role of PCDH7 in lung cancer pathogenesis,9859365,3/9/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,424551, ,NCI,266671,157880,424551
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges,9860246,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2020,476578, ,NINDS,301380,175198,476578
Regulation of p53 by TAF1,9860913,7/15/1997 0:00,1/31/2023 0:00,Non-SBIR/STTR,2020,369313, ,NCI,237500,131813,369313
Use of senolytics to enhance chemotherapeutic efficacy in lung cancer,9861228,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2020,398989, ,NCI,259137,139852,398989
Inhibitors of the G protein GNAS which drives pancreatic tumorigenesis,9864365,3/1/2020 0:00,2/28/2025 0:00,Non-SBIR/STTR,2020,418325, ,NCI,278495,139830,418325
Toward development of senolytic CAR T cells,9866360,5/15/2020 0:00,2/28/2025 0:00,Non-SBIR/STTR,2020,544277, ,NIA,307501,236776,544277
Targeted Therapy for Endometrial Cancer,9867664,7/1/2002 0:00,1/31/2024 0:00,Non-SBIR/STTR,2020,293550, ,NCI,190000,103550,293550
The roles of TRIM24 in breast cancer,9868916,3/1/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,402021, ,NCI,251263,150758,402021
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer,9868935,3/8/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,385147, ,NCI,240717,144430,385147
Deciphering real-time dynamics of the human genome organization in response to DNA damage and gene expression,9869319,9/15/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,249000, ,NIGMS,168590,80410,249000
Functional exploration of progenitor renewal and differentiation in oral epithelial homeostasis and cancer,9870718,9/1/2019 0:00,8/31/2021 0:00,Other Research-Related,2019,162432, ,NIDCR,150400,12032,162432
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis,9870886,3/9/2018 0:00,12/14/2020 0:00,Non-SBIR/STTR,2020,349988, ,NCI,228750,121238,349988
Novel Chromatin Regulating Targets of p63 in Head and Neck Squamous Cell Carcinoma,9875446,3/1/2018 0:00,2/28/2021 0:00,"Training, Individual",2020,67446, ,NCI,67446, ,67446
Identify tumor suppressor driver genes of pancreatic ductal adenocarcinoma,9877016,2/1/2020 0:00,1/31/2022 0:00,Non-SBIR/STTR,2020,215985, ,NCI,140250,75735,215985
Mutagenic by-products of melanin synthesis,9878077,3/1/2019 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,77000, ,NCI,50000,27000,77000
The mechanism through which mRNA translation enhancer elements drive cap-independent translation,9878118,2/20/2019 0:00,1/31/2023 0:00,Non-SBIR/STTR,2020,308400, ,NIGMS,238400,70000,308400
Growth hormone actions in prostate carcinogenesis,9878380,12/1/2019 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,171242, ,NCI,114375,56867,171242
Impact of germline variants on racial and ethnic differences in somatic mutation frequency,9878666,3/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2020,356850, ,NCI,228750,128100,356850
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism,9878786,3/2/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,316861, ,NCI,249168,67693,316861
Defining Mechanisms of Transformation Driven By the Zinc Finger Transcription Factor PLAGL2 in the Intestinal Epithelium,9878821,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2020,359996, ,NCI,228750,131246,359996
Mechanisms and biomarkers in aberrant paligenosis-induced stomach tumorigenesis,9879440,5/1/2020 0:00,4/30/2021 0:00,Non-SBIR/STTR,2020,200707, ,NCI,127500,73207,200707
Dissecting the mechanisms of immune surveillance and evasion in liver cancer,9880096,9/9/2019 0:00,8/31/2021 0:00,Other Research-Related,2019,46516, ,NCI,46516, ,46516
Mechanisms by which mutant p53 drives metastatic Triple Negative Breast Cancer,9881177,3/1/2019 0:00,2/28/2022 0:00,"Training, Individual",2020,67446, ,NCI,67446, ,67446
Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics,9881371,4/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2020,420701, ,NINDS,279798,140903,420701
Nucleolar signaling in cancer,9881762,12/15/2019 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,80500, ,NCI,50000,30500,80500
Identification of Lethal Melanomas at the Time of Diagnosis,9883462,4/1/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2020,972565, ,NCI,730081,242484,972565
Novel regulations of DNA damage repair,9883637,3/16/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,436368, ,NCI,272730,163638,436368
Role of p53 Missense Mutations on Tumorigenesis in Vivo,9883907,2/4/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2020,384750, ,NCI,237500,147250,384750
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer,9883911,2/6/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2020,389255, ,NCI,268746,120509,389255
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells,9884561, , ,Non-SBIR/STTR,2020, ,342009, ,201775,140234, 
Developmental studies to inform clinical stratification and targeting of SHH MB,9884737,4/4/2016 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,466787, ,NCI,299422,167365,466787
Elucidate the mechanism of autophagy in supporting Lkb1-deficient lung tumorigenesis and metastasis,9885542,2/1/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2020,376352, ,NCI,241251,135101,376352
Comprehensive genomic profiling of aggressive hormone sensitive prostate cancer,9886101,5/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2020,616230, ,NCI,430950,185280,616230
Research Project 3: Cell fate decision of liver tumor-initiating stem-like cells induced by alcohol,9886171, , ,Research Centers,2020, ,112052, ,67910,44142, 
Control of Lipogenesis and Hepatic Steatosis by Caspase-2,9886239,3/15/2019 0:00,12/31/2022 0:00,Non-SBIR/STTR,2020,416402, ,NIDDK,264382,152020,416402
Non-Canonical Phosphatidylinositol Kinases in Triple Negative Breast Cancer,9886909,6/1/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2020,446063, ,NCI,228750,217313,446063
Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast,9887834,12/11/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2020,356850, ,NCI,228750,128100,356850
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis,9888219,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2020,638770, ,NCI,332001,306769,638770
Deciphering How Esco2 Loss Acts as a Penetrance Modifier,9888342,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,426655, ,NCI,287310,139345,426655
Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC,9888352,3/8/2019 0:00,2/29/2024 0:00,Non-SBIR/STTR,2020,641606, ,NCI,364568,277038,641606
Integration of early genetic alterations and inflammation in gastroesophageal premalignancy,9888368,4/1/2019 0:00,1/31/2024 0:00,Other Research-Related,2020,158040, ,NIDDK,147074,10966,158040
REGULATION OF TUMOR SUPPRESSION BY ARF,9889042,4/1/2016 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,348844, ,NCI,228750,120094,348844
Mechanisms of targeting oncoprotein SET in tumor suppression,9889054,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,366000, ,NCI,228750,137250,366000
Genomic Instability and Cancer Genetics,9889061, , ,Research Centers,2020, ,30810, ,19829,10981, 
Cancer Pharmacology,9889063, , ,Research Centers,2020, ,29643, ,19095,10548, 
Clinical Investigations and Precision Therapeutics,9889067, , ,Research Centers,2020, ,29643, ,19095,10548, 
Deciphering real-time dynamics of the human genome organization in response to DNA damage and gene expression,9889153,9/15/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,249000, ,NIGMS,159616,89384,249000
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas,9891033,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2020,546808, ,NCI,339106,207702,546808
Targeting Human Cancers with Hemizygous Deletion of TP53,9891965,8/9/2017 0:00,3/31/2021 0:00,Non-SBIR/STTR,2020,360281, ,NCI,228750,131531,360281
Development and Application of a Porcine Model of Pancreatic Cancer,9891972,4/1/2018 0:00,9/30/2022 0:00,Non-SBIR/STTR,2020,629962, ,NCI,412782,217180,629962
Understanding methionine metabolism and its therapeutic potential in cancer,9892053,9/19/2019 0:00,8/31/2021 0:00,Other Research-Related,2019,96168, ,NCI,89044,7124,96168
Role of POT1 mutations in glioma initiation,9892426,9/30/2019 0:00,8/31/2024 0:00,Other Research-Related,2019,175414, ,NINDS,162420,12994,175414
Role of SIRT3 in melanoma development and progression,9892962,4/1/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2021, , , , , , 
Mechanisms for GH action on epithelial cells,9893867,4/1/2018 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,382500, ,NIDDK,225000,157500,382500
The role of Arf tumor suppressor in translational reprogramming,9894641,3/1/2019 0:00,2/28/2021 0:00,"Training, Individual",2020,65310, ,NIGMS,65310, ,65310
Epigenetic regulation by tumor suppressor p53,9894737,4/1/1999 0:00,2/29/2024 0:00,Non-SBIR/STTR,2020,346571, ,NCI,237500,144875,346571
Signaling cascades in cholangiocarcinoma development,9894769,4/5/2016 0:00,12/31/2021 0:00,Non-SBIR/STTR,2020,362569, ,NCI,228750,133819,362569
Environmental Regulation of Cellular Responses to DNA Damage,9894804,4/9/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2020,351750, ,NIGMS,210000,141750,351750
Improving Delivery of Genetic Services to High Risk Childhood Cancer Survivors: A Randomized Study of Remote Genetic Services Versus Usual Care,9895399,7/8/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2020,764736, ,NCI,651903,112833,764736
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia,9895782,4/1/2019 0:00,1/31/2023 0:00,Non-SBIR/STTR,2020,356225, ,NIDDK,233036,123189,356225
The role of AXL-ABL axis in Barrett's carcinogenesis,9897625,3/1/2016 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,397589, ,NCI,251639,145950,397589
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma,9898330,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,392992, ,NCI,229387,163605,392992
Epigenetic regulation by tumor suppressor p53,9899593,4/1/1999 0:00,12/31/2019 0:00,Non-SBIR/STTR,2019,62165, ,NCI,38612,23553,62165
ABT-199 based therapies to treat  neuroblastoma,9899951,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,359846, ,NCI,270977,88869,359846
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response,9901492,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,582111, ,NCI,373148,208963,582111
Development of a dual MDM2/XIAP inhibitor with a high therapeutic index for childhood cancers,9902255,9/15/2019 0:00,12/31/2020 0:00,SBIR/STTR,2019,299823, ,NCI, , ,299823
Genomics Of Acute Myeloid Leukemia.,9902344,9/19/2003 0:00,11/30/2023 0:00,Non-SBIR/STTR,2020,3142107, ,NCI,1996573,1145534,3142107
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus,9902346,8/25/2010 0:00,9/30/2022 0:00,Non-SBIR/STTR,2020,757530, ,NCI,606358,159477,757530
Developing newly combined therapeutic strategies for mature B cell lymphoma,9902383,4/1/2019 0:00,3/31/2021 0:00,Non-SBIR/STTR,2020,463626, ,NCI,327101,136525,463626
Statistical methods and tools for cancer risk prediction in families with germline mutations in TP53,9902384,4/1/2019 0:00,3/31/2023 0:00,Non-SBIR/STTR,2020,420173, ,NCI,267629,152544,420173
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma,9903249,9/1/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2020,921602, ,NCI,535815,385787,921602
"Dissecting the dynamic interplay between p53, chromatin and transcriptional bursting in single cells",9903386,4/1/2018 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,334000, ,NIGMS,200000,134000,334000
Cyclin-dependent kinase control of cell-division and transcription cycles,9903405,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2020,464704, ,NIGMS,275000,189704,464704
Basis of Muscle Dysfunction in Malignant Hyperthermia & Central Core Disease,9904122,4/1/2006 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,633312, ,NIAMS,483636,149676,633312
The role of the p63-RBM38 loop in tumor suppression,9904126,4/1/2016 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,359138, ,NCI,228750,130388,359138
Mechanisms regulating the early stages of UV-induced skin cancer,9904163,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2020,362250, ,NIEHS,225000,137250,362250
The role of PCDH7 in lung cancer pathogenesis,9904349,3/1/2019 0:00,2/28/2022 0:00,Non-SBIR/STTR,2019,53097, ,NCI,35504,17593,53097
Dynamic modulation of p53 activity by its disordered regulatory domains,9904664,4/1/2006 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,414512, ,NIGMS,214218,200294,414512
Clonal Evolution of Hematopoietic Stem Cells During Chemotherapy and Transplantation,9904913,4/1/2016 0:00,3/31/2021 0:00,Other Research-Related,2019,121394, ,NCI,112402,8992,121394
Roles and Regulation of wild-type and mutant forms of p53,9905331,9/30/2000 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,1885586, ,NCI,1606930,278656,1885586
Project 1: Roles of wild-type and mutant forms of p53 in cancer cell biology,9905335, , ,Non-SBIR/STTR,2020, ,338838, ,211774,127064, 
Project 2: Probing the role of the p53 network in ferroptosis,9905341, , ,Non-SBIR/STTR,2020, ,352898, ,221341,131557, 
Project 4: Mechanisms of wild-type and mutant p53 action in vivo,9905344, , ,Non-SBIR/STTR,2020, ,355831, ,355831,0, 
Core B -The Bio-Informatics Core,9905346, , ,Non-SBIR/STTR,2020, ,186033, ,186033,0, 
Core C - The Molecular Systems Pathology Core,9905347, , ,Non-SBIR/STTR,2020, ,247699, ,247699,0, 
A MULTISCALE APPROACH TO TARGET THE ACHILLES HEEL OF P53 CANCER MUTANTS,9906241,4/5/2019 0:00,3/31/2023 0:00,Non-SBIR/STTR,2020,311879, ,NIGMS,205000,106879,311879
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer,9906384,1/1/2020 0:00,12/31/2024 0:00,Non-SBIR/STTR,2020,340838, ,NCI,228750,112088,340838
Identifying the role of Ntrk1 in immunosuppression in Kras/p53 mutant lung cancer,9906415,12/9/2019 0:00,12/8/2022 0:00,"Training, Individual",2020,70146, ,NCI,70146, ,70146
Definition of the Microenvironment in Breast Cancer,9906592,8/1/2016 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,145663, ,NCI,75239,70424,145663
Definition of the Microenvironment in Breast Cancer,9906598,8/1/2016 0:00,7/31/2021 0:00,Non-SBIR/STTR,2019,145663, ,NCI,75239,70424,145663
Functional genomics approach to evaluate mechanisms of mutant p53 gain-of-function phenotypes,9908583,9/9/2019 0:00,7/8/2022 0:00,"Training, Individual",2019,29716, ,NCI,29716, ,29716
The Impact of Nucleolar Stress on Thymocyte Development and T Cell Acute Lymphoblastic Leukemia Transformation,9908655,9/9/2019 0:00,9/8/2021 0:00,"Training, Individual",2019,30942, ,NCI,30942, ,30942
Genomic incorporation of stapled peptides for cost effective discovery and synthesis of novel therapeutics,9909733,3/1/2020 0:00,2/28/2023 0:00,"Training, Individual",2020,64926, ,NCI,64926, ,64926
Investigating the mechanisms for mutant p53 stability in cancer cells,9910626,1/1/2020 0:00,12/31/2022 0:00,"Training, Individual",2019,45016, ,NCI,45016, ,45016
Fibrocytes: A novel cell population promoting obesity-induced breast tumor desmoplasia,9910691,1/1/2020 0:00,12/31/2022 0:00,"Training, Individual",2020,33963, ,NCI,33963, ,33963
Exploration of long non-coding RNAs as synthetic essential targets in Pten-deficient cancers,9910734,9/18/2020 0:00,9/17/2025 0:00,"Training, Individual",2020,43737, ,NCI,43737, ,43737
Resistance Mechanisms in ROS1-Fusion-Driven Malignancies,9911325,1/16/2020 0:00,1/15/2025 0:00,"Training, Individual",2020,50520, ,NCI,50520, ,50520
Effect of APOBEC3 on Bladder Cancer Biology and Response to Immunotherapy,9911447,2/1/2020 0:00,1/31/2023 0:00,"Training, Individual",2020,45520, ,NCI,45520, ,45520
Development of an integrated prognostic score using common risk variants and RNA-expression data from primary breast cancers for improved prognostication of outcomes across populations,9911887,7/1/2020 0:00,6/30/2021 0:00,"Training, Individual",2020,75930, ,NCI,75930, ,75930
Mechanisms of Esophageal Carcinogenesis,9912105,8/15/2003 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,1576087, ,NCI,1227677,348410,1576087
Project 1 - Transformed Esophageal Epithelial Cells and the Tumor Microenvironment,9912107, , ,Non-SBIR/STTR,2020, ,167613, ,121961,45652, 
TP53 Germline Mutations: Beyond LFS,9912116,10/15/2019 0:00,4/30/2023 0:00,Non-SBIR/STTR,2020,366000, ,NCI,228750,137250,366000
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53,9914091,4/12/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2020,455018, ,NCI,272466,182552,455018
Targeting defective necroptosis in colorectal cancer,9914466,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2020,461400, ,NCI,323748,137652,461400
The impact of coding region variants on mutant p53 biology,9914543,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2020,484057, ,NCI,297971,186086,484057
Kidney Injury by Cisplatin and Renoprotective Strategies.,9914632,9/30/2010 0:00,2/28/2024 0:00,Non-SBIR/STTR,2020,417004, ,NIDDK,271664,145340,417004
SBIR PHASE II: SITE-SPECIFIC ANTIBODIES FOR GLCNACYLATED PROTEINS IN CANCER,9915346,9/13/2013 0:00,9/12/2016 0:00,R and D Contracts,2019,10338, ,NCI, , ,10338
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment,9916522,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2020,466183, ,NCI,279955,186228,466183
Molecular analysis and therapeutic targeting of PI3K signaling in thyroid cancer,9916668,2/1/2009 0:00,11/30/2024 0:00,Non-SBIR/STTR,2020,422510, ,NCI,253000,169510,422510
Mechanisms Governing Expansion of Embryonic Progenitor Cells (EPCs) in Metaplasia,9917346,6/10/2020 0:00,5/31/2021 0:00,Non-SBIR/STTR,2020,401665, ,NCI,255093,146572,401665
c-Myc Targets in the Pathogenesis of Human Cancers,9917753,9/1/1992 0:00,1/31/2022 0:00,Non-SBIR/STTR,2020,536384, ,NCI,368242,168142,536384
DNA Methylation Inhibitor Therapy for Testicular Cancer,9919539,5/1/2018 0:00,4/30/2023 0:00,Non-SBIR/STTR,2020,449298, ,NCI,341807,107491,449298
Identification of genetic collaborators in cancer with a brca2-mutant zebrafish model,9920485,7/1/2016 0:00,6/30/2021 0:00,Other Research-Related,2019,126900, ,OD,117500,9400,126900
DNA-PKcs and PIDD interaction in DNA damage response,9920680,9/1/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020,370575, ,NCI,228750,141825,370575
Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia,9921200,7/1/2019 0:00,6/30/2023 0:00,"Training, Individual",2020,37046, ,NCI,37046, ,37046
Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway,9921312,6/1/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,367343, ,NCI,219309,148034,367343
Activating p53 for colorectal cancer prevention,9923443,6/12/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,424809, ,NCI,290176,134633,424809
"Markov State Model approaches for folding, binding and design",9923709,5/1/2017 0:00,4/30/2022 0:00,Non-SBIR/STTR,2020,295617, ,NIGMS,190000,105617,295617
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,9924304, , ,Non-SBIR/STTR,2020, ,392814, ,256741,136073, 
Transcriptional mechanisms of natural killer cell responses during mouse cytomegalovirus infection,9926225,5/6/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2020,453462, ,NIAID,296420,157042,453462
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice,9927607,6/7/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,398871, ,NCI,293821,105050,398871
Exploring mechanisms of therapeutic demethylation effects in HPV-associated head and neck cancer,9927637,6/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2020,404678, ,NIDCR,315521,89157,404678
Inflammation Induced Cytosine Deamination and the Initiation of Cancer,9928010,7/1/2018 0:00,6/30/2022 0:00,"Training, Individual",2020,35055, ,NCI,35055, ,35055
Nuclear Accumulation of D-type Cyclins and Oncogenesis,9928365,7/1/2001 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,343960, ,NCI,213750,130210,343960
Target MDM2/MDMX for reducing normal tissue toxicity induced by chemotherapy,9928397,5/10/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2020,364856, ,NCI,228750,136106,364856
Dynamics of Signaling Pathways: Mechanism and Function,9929006,3/1/2008 0:00,5/31/2022 0:00,Non-SBIR/STTR,2020,397309, ,NIGMS,236265,161044,397309
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression,9929248,4/15/2016 0:00,3/31/2021 0:00,Other Research-Related,2019,172098, ,NIDDK,159350,12748,172098
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer,9929549,5/5/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2020,1003814, ,NCI,955225,355304,1003814
Dietary Carcinogens for Colorectal Cancer,9929551,10/16/2019 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,366000, ,NCI,228750,137250,366000
Cancer Biology in the Zebrafish,9929553,7/3/2003 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,420375, ,NCI,237500,182875,420375
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma,9932516,9/15/2017 0:00,5/31/2022 0:00,Non-SBIR/STTR,2020,346719, ,NINDS,218750,127969,346719
Reflux-Induced Oxidative DNA Damage Repair Early in Barrett's Carcinogenesis,9932926,7/1/2018 0:00,6/30/2022 0:00,Non-SBIR/STTR,2020, , , , , , 
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer,9932935,6/14/2017 0:00,5/31/2022 0:00,Non-SBIR/STTR,2020,401486, ,NCI,231673,169813,401486
"Isolation, characterization and translational development of glioma stem cells",9933829,2/1/2017 0:00,1/31/2024 0:00,Non-SBIR/STTR,2020,1077600, ,NCI,600000,477600,1077600
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer,9933837,5/22/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2020,577631, ,NCI,380743,196888,577631
PPM1D in Clonal Hematopoiesis and Malignancies,9933838,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,599632, ,NCI,415076,184556,599632
Nanotechnology for targeted therapy and fundamental understanding of  therapeutic resistance in triple negative breast cancer,9934611,4/1/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2020,472539, ,NCI,373248,99291,472539
MicroRNA Targets for Chemoprevention of Squamous Cell Carcinoma (R01 CA194062-01A1),9934978,9/1/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2020,314760, ,NCI,183000,131760,314760
Role of Long Intergenic Noncoding RNA in UVB-induced Apoptosis and Skin Cancer,9935048,6/1/2016 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,335832, ,NIEHS,225000,110832,335832
The reduction of NLRX1 and its role in pulmonary aging,9936123,8/15/2016 0:00,4/30/2021 0:00,Non-SBIR/STTR,2020,343375, ,NIA,205000,138375,343375
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles,9936428,7/1/2017 0:00,6/30/2022 0:00,"Training, Individual",2020,50520, ,NCI,50520, ,50520
53BP1-dependent pathway in DNA repair,9937675,6/14/2017 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,366000, ,NCI,228750,137250,366000
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma,9937679,7/1/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2020,446063, ,NCI,228750,217313,446063
A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial,9938225,4/17/2020 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,384138, ,NIDDK,299248,84890,384138
Perivascular niche for salivary gland cancer stem cells and resistance to therapy,9938319,2/10/2011 0:00,6/30/2022 0:00,Non-SBIR/STTR,2020,368125, ,NIDCR,237500,130625,368125
Modulation of wild type and mutant p53 by HMGA1,9938476,7/1/2018 0:00,6/30/2021 0:00,"Training, Individual",2020,67446, ,NCI,67446, ,67446
"Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation",9939477,7/15/2016 0:00,6/30/2022 0:00,Non-SBIR/STTR,2020,377438, ,NCI,228750,148688,377438
Development of cell-free DNA assays for HCC screening and liquid biopsy,9940704,6/1/2016 0:00,5/31/2022 0:00,Non-SBIR/STTR,2020,397877, ,NCI,334816,63061,397877
Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis,9940708, , ,Non-SBIR/STTR,2020, ,315252, ,207500,107752, 
Core 2: Animal Model and Experimental Therapeutics Core [AMETC],9940738, , ,Non-SBIR/STTR,2020, ,253150, ,166000,87150, 
Evaluation of TP53 mutations in non-cancerous tissue as novel biomarkers of ovarian cancer risk.,9941061,6/3/2019 0:00,5/31/2022 0:00,Non-SBIR/STTR,2020,202928, ,NCI,130500,72428,202928
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity,9943767,6/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2020,403750, ,NHLBI,250000,153750,403750
Regulation of Cellular Proliferation by Novel Mitochondrial-Encoded Tumor Suppressors,9944175,9/1/2020 0:00,5/31/2024 0:00,Non-SBIR/STTR,2020,326942, ,NIGMS,200000,126942,326942
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors,9946512,5/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2020,555102, ,NCI,315399,239703,555102
SIRT2 Inhibitors for the Treatment of B-cell Lymphoma,9947892,7/7/2016 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,467882, ,NCI,265842,202040,467882
Nanotechnology enabled targeting of p53 deficiency in human cancer,9947894,7/1/2018 0:00,6/30/2022 0:00,Non-SBIR/STTR,2020,463867, ,NCI,365623,98244,463867
Deregulation of COMPASS complex and enhancer chromatin in pancreatic cancer,9947899,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,364856, ,NCI,228750,136106,364856
Targeting the TGIF/Twist1 network in osteosarcoma,9950848,3/15/2017 0:00,6/30/2022 0:00,Non-SBIR/STTR,2020,354563, ,NCI,228750,125813,354563
Using markers to improve pancreatic cancer screening and surveillance,9951009,7/18/2016 0:00,8/31/2022 0:00,Non-SBIR/STTR,2020,930050, ,NCI,751023,310441,930050
Investigating and targeting pathways of malignant peripheral nerve sheath tumor (MPNST),9952433,7/1/2019 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,586012, ,NINDS,370220,215792,586012
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer,9952742,9/2/2015 0:00,7/31/2020 0:00,Non-SBIR/STTR,2019,538965, ,NCI,419317,119648,538965
Targeting aspartate biosynthesis in pancreatic tumors,9953010,7/1/2020 0:00,11/30/2021 0:00,Other Research-Related,2020,127990, ,NCI,118509,9481,127990
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity,9953953,8/1/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,1129825, ,NCI,582384,547441,1129825
Role of DNA Replication Stress in Genome Instability and Cancer,9954111,7/1/2017 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,284489, ,NIGMS,204453,80036,284489
"Mechanisms of PIDDosome Signaling, a p53-Independent Apoptotic Response to DNA Damage",9955209,7/5/2013 0:00,5/31/2024 0:00,Non-SBIR/STTR,2020,346946, ,NCI,204688,142258,346946
Estrogen reduces HPV transcription and oncogene expression to target disease,9955796,7/1/2020 0:00,6/30/2022 0:00,Non-SBIR/STTR,2020,147488, ,NIDCR,95000,52488,147488
The Role of the Microenvironment in Barrett's Esophagus,9956592,9/26/2011 0:00,4/30/2022 0:00,Research Centers,2020,802412, ,NCI,1146163,258577,802412
Project 2: Characterization of microenvironmental drivers of neoplasia in BE,9956607, , ,Research Centers,2020, ,198070, ,198070,0, 
Molecular Basis for Regulation of Cellular Stress Response Pathways by CBP/p300,9957052,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,482214, ,NCI,249206,233008,482214
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen,9957077,6/17/2019 0:00,5/31/2024 0:00,Non-SBIR/STTR,2020,370892, ,NCI,295254,75638,370892
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD),9957122,8/1/2012 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,2368307, ,NHLBI,1666122,702185,2368307
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease,9957128, , ,Non-SBIR/STTR,2020, ,510000, ,300000,210000, 
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis,9959347,8/14/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,981304, ,NCI,600000,381304,981304
Mechanisms of Esophageal Carcinogenesis,9961087,8/15/2003 0:00,6/30/2024 0:00,Non-SBIR/STTR,2019,1638087, ,NCI,1227677,410410,1638087
Project 1 - Transformed Esophageal Epithelial Cells and the Tumor Microenvironment,9961100, , ,Non-SBIR/STTR,2019, ,481302, ,297100,184202, 
Project 1 - Molecular Determinants of Decitabine Responses.,9961536, , ,Research Centers,2020, ,346707, ,236263,110444, 
Project 2 - Targeted Therapies for T-ALL.,9961537, , ,Research Centers,2020, ,326586, ,210259,116327, 
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer,9962795,3/1/2020 0:00,2/28/2025 0:00,Non-SBIR/STTR,2020,441016, ,NCI,273075,167941,441016
Targeting BCL-2 family-regulated cell death for HNSCC treatment,9964726,7/1/2019 0:00,6/30/2022 0:00,Non-SBIR/STTR,2020,77625, ,NCI,50000,27625,77625
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance,9965116,6/1/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2020,457663, ,NCI,282508,175155,457663
Novel role of Ezh2 in age-related gastric motility dysfunctions,9965254,4/1/2020 0:00,3/31/2024 0:00,Non-SBIR/STTR,2020,357750, ,NIDDK,225000,132750,357750
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer,9965753,9/1/2008 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,370500, ,NCI,237500,133000,370500
Targeting p53 conformational defects to arrest carcinogenesis,9965897,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,356850, ,NCI,228750,128100,356850
C. Elegans as a Model of Cell Senescence and Alzheimer's Disease,9966605,9/15/2020 0:00,4/30/2022 0:00,Non-SBIR/STTR,2020,231000, ,NIA,150000,81000,231000
Investigate the role of TPD52-AMPK pathway in tumorigenesis and cancer therapy,9966720,4/15/2016 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,363713, ,NCI,228750,134963,363713
Study of Interleukin 33 as a new immunotherapy of lung cancer,9966935,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,355409, ,NCI,228750,126659,355409
Impact of P53 Mutations on Cancer Cell Iron Metabolism,9967465,9/18/2020 0:00,9/30/2022 0:00,Non-SBIR/STTR,2020,145178, ,NCI,100000,45178,145178
Suppression of disease causingnonsense mutations by targeted mRNA pseudouridylation,9968200,7/1/2019 0:00,6/30/2022 0:00,Non-SBIR/STTR,2020,200970, ,NCI,130500,70470,200970
"SENP6, a novel p53 negative regulator, is an important new player in cancer",9969351,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,363713, ,NCI,228750,134963,363713
Therapeutic strategies for targeting PARP1 in small cell lung cancer,9970194,7/1/2016 0:00,6/30/2021 0:00,Non-SBIR/STTR,2020,366000, ,NCI,228750,137250,366000
Transcriptional Regulations of Oncongenic Properties of Mutant P53,9970661,5/1/2013 0:00,4/30/2020 0:00,Non-SBIR/STTR,2019,50000, ,NCI,31348,18652,50000
Molecular mechanisms underlying lineage plasticity in prostate cancer,9970860,4/15/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2020,594606, ,NCI,341018,253588,594606
Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation,9970928,5/11/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2020,307768, ,NCI,202978,104790,307768
Genetic and Epigenetic Biomarkers for B-cell Lymphoma,9971490,1/1/2020 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,333884, ,NCI,228750,139538,333884
ATF3 Regulation of Histone Acetylation in Genome Maintenance,9972536,4/10/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2020,351418, ,NCI,228750,122668,351418
Defining diverse roles of p53 in pancreatic cancer,9972867,8/1/2017 0:00,7/31/2022 0:00,Other Research-Related,2020,170640, ,NCI,158000,12640,170640
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment,9972944,7/4/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,599526, ,NCI,440016,159510,599526
Cell fate decisions in Merkel cell carcinoma initiation and maintenance,9973721,2/20/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2020,531461, ,NCI,340680,190781,531461
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer,9974582,9/30/1997 0:00,6/30/2022 0:00,Research Centers,2020, ,282703, ,201918,80785, 
Protein Kinase Signaling in the Genotoxic Stress Response,9975171,9/1/2017 0:00,7/31/2025 0:00,Non-SBIR/STTR,2020,540470, ,NIEHS,339918,200552,540470
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression,9975793,8/1/2017 0:00,7/31/2024 0:00,Non-SBIR/STTR,2020,959881, ,NCI,599996,359885,959881
Project 3: Targeting Bax signaling to overcome treatment resistance in NSCLC,9975798, , ,Research Centers,2020, ,347015, ,235548,132597, 
RNF128  Regulation of TP53 in Barrett's Progression,9976469,8/31/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,422751, ,NCI,270994,151757,422751
P63 Mechanisms and mediators in HNSCC,9976493,4/1/2004 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,398493, ,NIDCR,237500,160993,398493
Dynamics of Signaling Pathways: Mechanism and Function,9976813,3/1/2008 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,102062, ,NIGMS,102062, ,102062
Genetics of Tumor Suppression by p53,9976877,3/4/2020 0:00,2/28/2022 0:00,Other Research-Related,2020,119031, ,NCI,110214,8817,119031
miR-155 targeted therapeutics for precision medicine in lung cancer,9976985,8/3/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2020,512231, ,NCI,364392,147839,512231
Oncogenic Roles and Therapeutic Potential of MCL1 Addiction in Primary Effusion Lymphoma,9977428,9/4/2020 0:00,8/31/2023 0:00,Other Research-Related,2020,183707, ,NCI,170099,13608,183707
Flourine-18 labeled MDM2 antagonists for PET imaging,9978523,2/10/2020 0:00,1/31/2022 0:00,Non-SBIR/STTR,2020,188169, ,NCI,116875,71294,188169
"Tumor suppression, p53 and retrotransposons",9978740,8/24/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2020,370575, ,NCI,228750,141825,370575
Improving post-surgery recovery of failing hearts by targeting cardiomyocyte senescence,9978930,9/1/2018 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,430115, ,NHLBI,265503,164612,430115
Regulation of ATDC by TP63 and its role in bladder cancer,9979790,9/1/2016 0:00,8/31/2021 0:00,Other Research-Related,2020,174960, ,NCI,162000,12960,174960
Synthetic lethality based combination approaches to ARID1A mutation in ovarian cancer,9980335,7/18/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,509794, ,NCI,285439,224355,509794
Overcoming cisplatin resistance by targeting fatty acid metabolism,9980866,8/1/2019 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,166936, ,NIDCR,104368,62568,166936
PROJECT 4: Interrogating PP2A Signaling in Human Cancers,9981674,8/1/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020, ,326362, ,186750,139612, 
Project 3: Using RNAi-based Spherical Nucleic Acid (SNA) Nanoconjugates Targeting Bcl2L12 to Promote Therapy-Induced Apoptosis in Glioblastoma,9981700, , ,Research Centers,2020, ,347798, ,222964,124834, 
Project 2: Targeting metabolic vulnerabilities in glioblastoma,9983048,8/11/2017 0:00,7/31/2022 0:00,Research Centers,2020, ,341625, ,232559,130355, 
Project 4: Novel epigenetic treatment of IDH mutant gliomas,9983050,8/11/2017 0:00,7/31/2022 0:00,Research Centers,2020, ,351815, ,248507,126056, 
Project 1:  Evolution of transcriptional programs in lung cancer progression,9983611, , ,Non-SBIR/STTR,2020, ,420760, ,268461,152299, 
Project 3:  Targeting epigenetic regulators in cancer,9983618, , ,Non-SBIR/STTR,2020, ,352717, ,229500,123217, 
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells,9983803, ,2/28/2022 0:00,Non-SBIR/STTR,2020, ,433367, ,370713,62654, 
Investigating the metastatic drive in pancreas cancer,9984316,8/9/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2020,545387, ,NCI,309879,235508,545387
New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss,9984331,9/19/2017 0:00,8/31/2022 0:00,Other Research-Related,2020,177120, ,NCI,164000,13120,177120
miR-200 miRNAs repress tumor metastasis in lung adenocarcinoma,9984861,8/1/2009 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020,278388, ,NCI,177318,101070,278388
Mutant p53 as actionable cancer-specific target,9984982,4/1/2013 0:00,4/30/2023 0:00,Non-SBIR/STTR,2020,374348, ,NCI,249191,125157,374348
The intersection of RNA biology and tumor biology,9985031,8/12/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,772204, ,NCI,482025,290179,772204
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer,9985075,8/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2020,428090, ,NCI,288633,139457,428090
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy,9985238, ,8/31/2022 0:00,Research Centers,2019, ,471200, ,362477,163422, 
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery,9985263, , ,Research Centers,2019, ,330502, ,308002,22500, 
Targeting metabolic vulnerabilities in glioblastoma,9985754,8/7/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,490971, ,NCI,332432,158539,490971
USING ARGININE METABOLIC THERAPIES FOR SARCOMA,9986712,8/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2020,365724, ,NCI,232206,133518,365724
Regulation of tumor recurrence by stress activated neutrophils,9986976,6/1/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2020,608381, ,NCI,369018,239363,608381
Project 3: Molecular Markers for Early Detection of Esophageal Carcinogenesis,9987282,9/14/2011 0:00,7/31/2022 0:00,Research Centers,2020, ,331509, ,223355,122035, 
Clonal Evolution of Hematopoietic Stem Cells During Chemotherapy and Transplantation,9987538,4/1/2016 0:00,3/31/2021 0:00,Other Research-Related,2020,121394, ,NCI,112402,8992,121394
Phosphoinositides and Cancer Metabolism,9987541,9/5/2016 0:00,7/31/2023 0:00,Non-SBIR/STTR,2020,1016999, ,NCI,600000,417000,1016999
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade,9987567,8/28/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,393450, ,NCI,228750,164700,393450
Predicting Breast Cancer Risk after Benign Percutaneous Biopsy,9987569,7/5/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,721306, ,NCI,635729,85577,721306
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells,9987578,8/17/2018 0:00,7/31/2025 0:00,Non-SBIR/STTR,2020,840979, ,NCI,547376,325994,840979
Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human Cancer,9988206,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2020,264110, ,NCI,150920,113190,264110
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade,9988375,6/1/2006 0:00,8/31/2023 0:00,Research Centers,2020, ,337216, ,210541,127322, 
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC,9988380,9/10/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020,430949, ,NCI,432112,173438,430949
Targeting Acetyltransferase Gene Inactivation in Diffuse Large B Cell Lymphoma,9988858,8/30/2016 0:00,7/31/2022 0:00,Research Centers,2020, ,379081, ,286393,92688, 
A chemical strategy to unravel tumor suppression through the ubiquitin pathway,9989142,8/5/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2020,296123, ,NIGMS,195000,101123,296123
Investigating the Impact of Telomere Specific Oxidative Base Damage in Cellular Aging,9990259,6/1/2020 0:00,5/31/2023 0:00,"Training, Individual",2020,65310, ,NIA,65310, ,65310
Adaptive Clinical Efficacy Evaluation of ONC201 in Recurrent High Grade Glioma,9990714,9/1/2015 0:00,8/31/2021 0:00,SBIR/STTR,2020,999250, ,NCI, , ,999250
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations,9990740,8/8/2019 0:00,7/31/2026 0:00,Non-SBIR/STTR,2020,1035240, ,NCI,600000,435240,1035240
Identification of genetic collaborators in cancer with a brca2-mutant zebrafish model,9990864,7/1/2016 0:00,6/30/2022 0:00,Other Research-Related,2020,126900, ,OD,117500,9400,126900
Interrogating the role of Notch signaling in lung adenocarcinoma tumorigenesis,9990915,4/1/2020 0:00,3/31/2024 0:00,"Training, Individual",2020,37283, ,NCI,37283, ,37283
BLR&D Research Career Scientist Award Application,9991223,4/1/2020 0:00,3/30/2027 0:00,Other,2020, , , , , , 
Alterations in fatty acid metabolism in the pathogenesis of leukemic stem cells from Acute Myeloid Leukemia patients,9991473,7/1/2020 0:00,6/30/2025 0:00,"Training, Individual",2020,33837, ,NCI,33837, ,33837
Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy,9991772,9/4/2017 0:00,8/31/2022 0:00,Non-SBIR/STTR,2020,578917, ,NCI,407125,171792,578917
Investigating the non-cell autonomous immune effects of mutant p53 in pancreatic cancer,9991799,9/1/2019 0:00,8/31/2021 0:00,Other Research-Related,2020,225979, ,NCI,209240,16739,225979
Cellular mechanisms of androgen action and androgen-response gene EAF2 in prostate cancer,9991812,9/19/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2020,115503, ,NCI,73804,41699,115503
Polypoid cell cycle regulation and genome instability,9991864,8/12/2015 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,318485, ,NIGMS,203425,115060,318485
Cyclin Dependent Kinase 4/6 (CDK4/6) as a Therapeutic Target in Glioblastoma,9992384,4/9/2020 0:00,4/8/2023 0:00,"Training, Individual",2020,43252, ,NCI,43252, ,43252
Mechanisms of the TFIIH-associated kinase CDK7 in p53-dependent transcriptional regulation,9993071,3/1/2020 0:00,2/28/2023 0:00,"Training, Individual",2020,37654, ,NCI,37654, ,37654
"Bioinformatics approaches to solve the ""Missing Driver"" problem in solid tumors",9993405,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2020,113415, ,NCI,73646,39769,113415
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis,9993447,9/18/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020,489764, ,NCI,337585,152179,489764
Mechanism of p53-dependent Tumor Suppression,9993812,3/15/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2020,461263, ,NCI,293798,167465,461263
Definition of the Microenvironment in Breast Cancer,9994197,8/1/2016 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,797865, ,NCI,419255,378610,797865
Project 1: Combinatorial Molecular Tumor Drivers in Basal and Supra-                 basal Urothelial Cells,9994202,9/12/2013 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020, ,343182, ,202467,140715, 
(PQ3) UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMAS,9994252,9/4/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020,640142, ,NCI,402605,237537,640142
Anticancer peptide therapeutics,9994738,8/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,353419, ,NCI,228750,124669,353419
Preclinical Models for Cancer Therapeutic Development,9996508,9/15/2016 0:00,8/31/2021 0:00,Non-SBIR/STTR,2020,174117, ,NCI,90686,83431,174117
Molecular mechanisms of SCLC initiation and detection in mice and humans,9996543,9/19/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020,593062, ,NCI,425887,244727,593062
MUC13 Mucin in Colerectal Cancer Health Disparity,9997289,6/1/2019 0:00,5/31/2021 0:00,Non-SBIR/STTR,2019,329750, ,NCI,229791,99959,329750
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors,9997309,8/19/2005 0:00,3/31/2025 0:00,Non-SBIR/STTR,2020,392929, ,NCI,260277,132652,392929
03 Genetically Engineered Mouse Facility,9997797, , ,Research Centers,2020, ,487249, ,305052,183031, 
25 Cancer Genetics and Epigenetics,9997813, , ,Research Centers,2020, ,18675, ,11692,7015, 
06 Breast Cancer,9997818, , ,Research Centers,2020, ,18675, ,11692,7015, 
03 Genetically Engineered Mouse Facility,9997846, , ,Research Centers,2019, ,5456, ,3859,1597, 
25 Cancer Genetics and Epigenetics,9997866, , ,Research Centers,2019, ,5456, ,3859,1597, 
06 Breast Cancer,9997871, , ,Research Centers,2019, ,5456, ,3859,1597, 
Y-Box 1 and normoxic HIF1 in Sonic hedgehog medulloblastoma tumor stem cell radiation resistance,9998031,9/1/2019 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,341500, ,NINDS,226764,114736,341500
Signal and Transcription Factor Network interactions in Head and Neck Cancer,9998621, , ,Intramural Research,2019,478080, ,NIDCD, , ,478080
Genomics and Proteomics of Head and Neck Cancer,9998622, , ,Intramural Research,2019,717119, ,NIDCD, , ,717119
Research Project 3: Heterogeneity in metastatic CRPC and the role of TP53 mutation as a molecular determinant,9998861,9/14/2001 0:00,8/31/2022 0:00,Research Centers,2020, ,208235, ,134077,74158, 
Breast Cancer Detection Consortium,9998907,9/19/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2020,438654, ,NCI,315073,129729,438654
Macromolecular assemblies of transcription factors initiated by pathogen infection,10000831,8/22/2019 0:00,7/31/2023 0:00,Other Research-Related,2020,103374, ,NIAID,99251,4123,103374
UBIQUITIN-PROTEASOME PATHWAY IN CANCER,10001357,9/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020,322349, ,NIGMS,196554,125795,322349
Investigating chromatin mechanisms using viral systems,10001588,9/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2020,439998, ,NIGMS,249999,189999,439998
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer,10002189,9/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020,778924, ,NCI,773175,205517,778924
Fully Synthetic Prodiginines as Probes of Protein-Protein Interactions Regulating,10002937,4/16/2014 0:00,2/28/2020 0:00,Non-SBIR/STTR,2019,40000, ,NCI,27612,12388,40000
Roles of proinflammatory chemokines linking obesity and ovarian cancer,10003185,9/23/2011 0:00,8/31/2021 0:00,Research Centers,2020, ,18960, ,12000,6960, 
Structural Mechanisms of Ribosome Assembly,10003751, , ,Intramural Research,2019,2163286, ,NIEHS, , ,2163286
Research Project 2: Pathological Diagnosis and Etiology of Ocular Surface Squamous Neoplasia in Zambia,10003988,9/15/2017 0:00,8/31/2022 0:00,Research Centers,2020, ,89850, ,98889,5979, 
Functional exploration of progenitor renewal and differentiation in oral epithelial homeostasis and cancer,10004026,9/1/2019 0:00,9/1/2021 0:00,Other Research-Related,2020,162432, ,NIDCR,150400,12032,162432
Dissecting of develomental signaling pathways in bone development and osteosarcoma,10004080,9/1/2013 0:00,8/31/2023 0:00,Research Centers,2020, ,306204, ,186719,119485, 
Targeting Mutant KRAS for Cancer Therapy,10004247,3/1/2016 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,415202, ,NCI,418536,214200,415202
Full Project 4: Molecular Pathways to Breast Cancer Mortality among African American and White Women,10004337, ,8/31/2023 0:00,Research Centers,2019, ,200595, ,139424,61347, 
Roles of proinflammatory chemokines linking obesity and ovarian cancer,10005170,9/23/2011 0:00,8/31/2021 0:00,Research Centers,2020, ,16067, ,12152,5030, 
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy,10005211,9/30/2017 0:00,8/31/2022 0:00,Research Centers,2020, ,510416, ,355549,154867, 
Synergistic combinations that target apoptosis induction in PTCL,10005245,9/1/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020, ,462042, ,361571,100471, 
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer,10005257,9/22/2017 0:00,8/31/2022 0:00,Research Centers,2020,1722942, ,NCI,1117874,642225,1722942
Project 1: High Grade Cancers: Capitalizing on PARPness in Ovarian Carcinoma,10005294,9/22/2017 0:00,8/31/2022 0:00,Research Centers,2020, ,358686, ,224062,134624, 
Placenta specific and ribosomal RNA genes: structure and function,10005761, , ,Intramural Research,2019,1044517, ,NIA, , ,1044517
Regulation Of Epidermal Differentiation,10006381, , ,Intramural Research,2019,1949798, ,NIAMS, , ,1949798
Genome instability in cancer: telomeres and DNA repair,10006509,9/2/2016 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020,1017000, ,NCI,631000,438545,1017000
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia,10006806,8/5/2003 0:00,8/31/2023 0:00,Research Centers,2020,1738656, ,NCI,1231292,507365,1738656
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,10007415, , ,Intramural Research,2019,6601269, ,NCI, , ,6601269
Intervention Trials in Persons at Increased Genetic Risk of Cancer,10007416, , ,Intramural Research,2019,335353, ,NCI, , ,335353
Consultation and Collaboration,10007429, , ,Intramural Research,2019,1701384, ,NCI, , ,1701384
Cell Cycle Regulation In Oogenesis,10007491, , ,Intramural Research,2019,1401263, ,NICHD, , ,1401263
Natural History of Familial Carcinoid Tumor,10008686, , ,Intramural Research,2019,628123, ,NIDDK, , ,628123
"Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy",10008763, , ,Intramural Research,2019,2312651, ,NHLBI, , ,2312651
Mitochondrial regulation and function in cancer and cardiovascular biology,10008774, , ,Intramural Research,2019,1347769, ,NHLBI, , ,1347769
Lysosome biogenesis and homeostasis,10008814, , ,Intramural Research,2019,1041320, ,NHLBI, , ,1041320
"Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.",10008817, , ,Intramural Research,2019,1865407, ,NHLBI, , ,1865407
Phenotypic Assay Design and Development for Rare and Neglected Diseases,10008858, , ,Intramural Research,2019,445362, ,NCATS, , ,445362
A Novel Serum Alternative for Ex-vivo Expansion of Natural Killer Cells for Immunotherapy,10011207,4/1/2020 0:00,3/31/2021 0:00,SBIR/STTR,2020,224000, ,NIGMS, , ,224000
Oncogenic Function of FBXW7 R465 mutation reveals a new opportunity for cancer therapy,10011289, , ,Intramural Research,2019,395245, ,NIA, , ,208903
Human Genes Affecting Chromosome Metabolism and Stress Response,10011336, , ,Intramural Research,2019,391895, ,NIEHS, , ,391895
Project 1:The Carolina Breast Cancer Study,10011764,8/5/1997 0:00,8/31/2023 0:00,Research Centers,2020, ,578056, ,385927,212646, 
Project 4: Chromatin Remodeling Drives the Adaptive Resistance Response to Targeted Kinase Inhibition in Breast Cancer,10011768,8/5/1997 0:00,8/31/2023 0:00,Research Centers,2020, ,333543, ,222682,122698, 
Genetic Susceptibility To Carcinogens,10012662, , ,Intramural Research,2019,480500, ,NIEHS, , ,480500
Discovery And Functional Genomics Of Environmental Response Genes,10012664, , ,Intramural Research,2019,1801873, ,NIEHS, , ,1801873
Roles of proinflammatory chemokines linking obesity and ovarian cancer,10012771,9/26/2011 0:00,8/31/2021 0:00,Research Centers,2020, ,81480, ,74407,32692, 
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery,10013152,9/30/2017 0:00, ,Research Centers,2020, ,308002, ,308002,0, 
Dissecting the mechanisms of immune surveillance and evasion in liver cancer,10013158,9/9/2019 0:00,2/28/2022 0:00,Other Research-Related,2020,45520, ,NCI,45520, ,45520
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery,10013177, ,8/31/2022 0:00,Research Centers,2019, ,6001, ,3360,2641, 
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery,10013180, , ,Research Centers,2019, ,19994, ,11195,8799, 
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery,10013181, , ,Research Centers,2019, ,19994, ,11195,8799, 
Molecular Pathogenesis of Two Newly Defined Major Subgroups of PTCL,10013191,9/19/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020, ,403141, ,403141,0, 
Nuclear Accumulation of D-type Cyclins and Oncogenesis,10013443,7/1/2001 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,291210, ,NCI,182006,109204,291210
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease,10014043, , ,Intramural Research,2019,1123750, ,NIAID, , ,1123750
Chromosomal Proteins and Chromosomal Functions,10014271, , ,Intramural Research,2019,864126, ,NCI, , ,864126
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,10014277, , ,Intramural Research,2019,1116803, ,NCI, , ,1116803
Xenobiotic receptors,10014280, , ,Intramural Research,2019,1926533, ,NCI, , ,1926533
"Tumor Suppressor Protein, p53",10014282, , ,Intramural Research,2019,517531, ,NCI, , ,517531
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression,10014307, , ,Intramural Research,2019,1008673, ,NCI, , ,1008673
Regulation of Lymphocyte Proliferation and Replicative Capacity,10014319, , ,Intramural Research,2019,296536, ,NCI, , ,296536
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,10014322, , ,Intramural Research,2019,560222, ,NCI, , ,560222
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,10014325, , ,Intramural Research,2019,466154, ,NCI, , ,466154
DNA repair,10014336, , ,Intramural Research,2019,1804298, ,NCI, , ,1804298
Enzymes and Substrates of the Ubiquitin Conjugating System,10014337, , ,Intramural Research,2019,1043252, ,NCI, , ,1043252
Identification of Genetic Factors Associated with Infectious Diseases,10014339, , ,Intramural Research,2019,364493, ,NCI, , ,364493
Role of C-EBP transcription factors in cell growth and tumorigenesis,10014350, , ,Intramural Research,2019,1583541, ,NCI, , ,1583541
Immune Reconstitution,10014395, , ,Intramural Research,2019,2322567, ,NCI, , ,2322567
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,10014425, , ,Intramural Research,2019,136375, ,NCI, , ,136375
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,10014443, , ,Intramural Research,2019,400991, ,NCI, , ,400991
"Role of inflammation, innate resistance, and immunity in carcinogenesis",10014446, , ,Intramural Research,2019,1277147, ,NCI, , ,1277147
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,10014449, , ,Intramural Research,2019,640431, ,NCI, , ,640431
p53-induced Regulation of Transcription in the Chromatin Context,10014467, , ,Intramural Research,2019,101321, ,NCI, , ,101321
Development of TGF-beta antagonists for cancer therapy,10014476, , ,Intramural Research,2019,587809, ,NCI, , ,587809
Redox Mechanism Process of Angiogenesis and Wound Healing,10014482, , ,Intramural Research,2019,737052, ,NCI, , ,737052
TMPRSS2-ERG chromosomal translocations and prostate cancer,10014513, , ,Intramural Research,2019,213477, ,NCI, , ,213477
Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,10014536, , ,Intramural Research,2019,650572, ,NCI, , ,650572
Role of Brachyury in regulating notochord development and neoplasia,10014542, , ,Intramural Research,2019,85655, ,NCI, , ,85655
Role of microbiome in cancer and inflammation,10014549, , ,Intramural Research,2019,1596434, ,NCI, , ,1596434
Role of inflammation in epigenetic alterations of metastatic cancer cells,10014554, , ,Intramural Research,2019,922232, ,NCI, , ,922232
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,10014560, , ,Intramural Research,2019,1057062, ,NCI, , ,1057062
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,10014565, , ,Intramural Research,2019,776295, ,NCI, , ,776295
The Impact of Nucleolar Stress on Thymocyte Development and T Cell Acute Lymphoblastic Leukemia Transformation,10014587,9/9/2019 0:00,8/31/2022 0:00,"Training, Individual",2020,31446, ,NCI,31446,0,31446
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,10014620, , ,Intramural Research,2019,536966, ,NCI, , ,536966
Systems-level analysis of the regulation and function of p53 dynamics,10014652, , ,Intramural Research,2019,735478, ,NCI, , ,735478
"Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome",10014704, , ,Intramural Research,2019,1147757, ,NCI, , ,1147757
"p53, Aging, and Cancer",10014706, , ,Intramural Research,2019,1912927, ,NCI, , ,1912927
Vulnerabilities in osteosarcoma and breast cancer,10014710, , ,Intramural Research,2019,738051, ,NCI, , ,738051
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,10014719, , ,Intramural Research,2019,1092801, ,NCI, , ,1092801
Role of long non-coding RNAs in p53 signaling,10014744, , ,Intramural Research,2019,1093400, ,NCI, , ,1093400
Comparative Brain Tumor Consortium,10014771, , ,Intramural Research,2019,62711, ,NCI, , ,62711
Genomic characterization and development of therapies for pediatric sarcoma,10014787, , ,Intramural Research,2019,801360, ,NCI, , ,801360
Preclinical Development of Therapeutics in Murine Models of Lung Cancer,10014795, , ,Intramural Research,2019,418616, ,NCI, , ,418616
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models,10014796, , ,Intramural Research,2019,1495060, ,NCI, , ,1495060
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models,10014798, , ,Intramural Research,2019,1794070, ,NCI, , ,1794070
Targeting Metabolic Pathways in Bladder Cancer,10014800, , ,Intramural Research,2019,240712, ,NCI, , ,240712
Hypoxia signaling in cancer development,10014822, , ,Intramural Research,2019,1877769, ,NCI, , ,1877769
Minimal Myc functional threshold for tumorigenesis,10014868, , ,Intramural Research,2019,171310, ,NCI, , ,171310
Preclinical Modelling and Therapeutic Development for Other Cancer Indications,10014878, , ,Intramural Research,2019,179407, ,NCI, , ,179407
Establish Preclinical Model for IDH-mutated Glioma,10014893, , ,Intramural Research,2019,222355, ,NCI, , ,222355
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine,10014982, , ,Intramural Research,2019,1552630, ,NCI, , ,1552630
Nitric Oxide as a Modifier of Oxidative Stress,10014993, , ,Intramural Research,2019,552789, ,NCI, , ,552789
Molecular Profiling of Clinical Specimens,10015047, , ,Intramural Research,2019,1870854, ,NCI, , ,1870854
Comparison of molecular factors to drug activities,10015071, , ,Intramural Research,2019,91343, ,NCI, , ,91343
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure,10015149, , ,Intramural Research,2019,598023, ,NCI, , ,598023
Project 2: TOPK/PRPK as Novel Targets for Skin Cancer Prevention,10015217,9/10/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020, ,116762, ,116762,0, 
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin,10015218,9/10/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020, ,276641, ,180222,96419, 
Novel Therapeutic Approaches Targeting Tumor Suppressor Deficiencies in Advanced Prostate Cancer,10015675,9/1/2019 0:00,8/31/2022 0:00,Non-SBIR/STTR,2019,249000, ,NCI,153704,95296,249000
Regulation Of Intracellular Iron Metabolism,10016019, , ,Intramural Research,2019,1346236, ,NICHD, , ,1346236
MUC13 Mucin in Colerectal Cancer Health Disparity,10016192,6/1/2019 0:00,5/31/2024 0:00,Non-SBIR/STTR,2020,339949, ,NCI,236898,103051,339949
Mechanism of regulation of progenitor proliferation and transformation,10016389,9/1/2017 0:00,8/31/2021 0:00,Non-SBIR/STTR,2020,174032, ,NINDS,174032,0,174032
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens,10017165,9/12/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020,560027, ,NCI,494141,203910,560027
Functional genomics approach to evaluate mechanisms of mutant p53 gain-of-function phenotypes,10017661,9/9/2019 0:00,7/8/2022 0:00,"Training, Individual",2020,30220, ,NCI,30220, ,30220
01 Project 1:  Cancer risks for mutations in breast cancer predisposition genes,10017906,9/22/2005 0:00,8/31/2022 0:00,Research Centers,2020, ,427056, ,326776,100702, 
Molecular Mechanisms of PTEN and USP7 Regulation,10019574,9/17/2019 0:00,8/31/2021 0:00,Other Research-Related,2020,100000, ,NIGMS,92593,7407,100000
Understanding methionine metabolism and its therapeutic potential in cancer,10020350,9/19/2019 0:00,8/31/2021 0:00,Other Research-Related,2020,96168, ,NCI,89044,7124,96168
Precision approaches to refining TP53-associated cancer risk,10020352,9/18/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020,1713253, ,NCI,1237981,475272,1713253
Novel Therapeutic Approaches Targeting Tumor Suppressor Deficiencies in Advanced Prostate Cancer,10020761,9/1/2019 0:00,8/31/2022 0:00,Non-SBIR/STTR,2020,247906, ,NCI,153704,95296,247906
Sphingolipids in Cancer Biology and Therapy,10020935,8/1/2003 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020,1299443, ,NCI,823319,476124,1299443
Project 2: Role of ACER2 in Liver Cancer,10020938,8/1/2003 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020, ,198736, ,126477,72259, 
Project 3: Role of Sphingosine Kinase in P53 Cancer Biology,10020939,8/1/2003 0:00,8/31/2024 0:00,Non-SBIR/STTR,2020, ,198271, ,127125,71146, 
Role of POT1 mutations in glioma initiation,10022347,9/30/2019 0:00,8/31/2024 0:00,Other Research-Related,2020,176414, ,NINDS,163420,12994,176414
Comparative Genomics Analysis Unit Research,10022457, , ,Intramural Research,2019,1274470, ,NHGRI, , ,1274470
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis,10023167,6/3/2016 0:00,12/31/2021 0:00,Non-SBIR/STTR,2020,382013, ,NCI,228750,153263,382013
Animal MRI/Imaging Core,10023856, , ,Intramural Research,2019,523858, ,NHLBI, , ,523858
Project 4: Therapeutic Targeting of Replication Stress Vulnerabilities in Small Cell Lung Cancer,10023868, , ,Research Centers,2020, ,472890, ,379792,104121, 
CARP-1: A Potential Therapeutic Agent for Breast Cancer,10025565,1/1/2012 0:00,12/31/2020 0:00,Non-SBIR/STTR,2020, , , , , , 
Mechanisms and Vulnerabilities of  SWI/SNF chromatin remodeling complex mutant lung cancer,10025885,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2020,472040, ,NCI,291383,180657,472040
"Project 1 - Yan Li, PhD",10026255,6/10/2016 0:00,3/31/2026 0:00,Research Centers,2021, ,218400, ,140000,78400, 
PROTACs for pancreatic cancer therapy,10027631,7/1/2020 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,393400, ,NCI,257124,136276,393400
Sensitizing High Grade Serous Cancers to Immunotherapy through the Induction of DNA Damage,10028423,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2020,356850, ,NCI,228750,128100,356850
Regulation of tumor suppression by alpha-ketoglutarate,10033018,9/1/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2020,489205, ,NCI,276387,212818,489205
The Translational Regulation of Pro-apoptotic Genes,10033497,7/14/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2020,356850, ,NCI,228750,128100,356850
Development of novel PIP4K inhibitors to treat p53-null cancer,10033704,9/10/2020 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,338769, ,NIGMS,202250,136519,338769
ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient Prostate Cancer.,10034539,6/8/2020 0:00,9/30/2020 0:00,Non-SBIR/STTR,2020,130329, ,NCI,23575,106754,130329
Tumor-TAMs crosstalk enables bypass of oncogenic KRAS dependency in pancreatic cancer,10038599,12/1/2021 0:00,11/30/2022 0:00,Other Research-Related,2022,200281, ,NCI,185445,14836,200281
ETCTN Biorepository Specimens to the University of Ottawa,10038619,8/31/2019 0:00,8/30/2020 0:00,R and D Contracts,2019,41200, ,NCI, , ,41200
TP53 Germline Mutations: Beyond LFS,10040324,10/15/2019 0:00,4/30/2023 0:00,Non-SBIR/STTR,2019,330503, ,NCI,211544,118959,330503
The role of autophagy in the escape from replicative crisis and tumorigenesis,10040400,7/1/2020 0:00,6/30/2022 0:00,Other Research-Related,2020,163080, ,NCI,151000,12080,163080
Identifying the vulnerabilities in Mdm2 overexpressing cancer cells,10040521,8/11/2020 0:00,7/31/2025 0:00,Non-SBIR/STTR,2020,83662, ,NCI,51643,32019,83662
Dietary Carcinogens for Colorectal Cancer,10040844,10/16/2019 0:00,5/31/2023 0:00,Non-SBIR/STTR,2019,253278, ,NCI,158299,94979,253278
Role of Gstt1 in metastatic maintenance and self-renewal in PDA,10041399,8/1/2020 0:00,7/30/2022 0:00,Other Research-Related,2020,156330, ,NCI,144750,11580,156330
Mutant p53 gain-of-function as an actionable target in cancer therapy,10042972,9/11/2020 0:00,8/31/2025 0:00,Non-SBIR/STTR,2020,212358, ,NCI,133140,79218,212358
Role of Vitamin D in cutaneous DNA repair,10045940,10/1/2016 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021, , , , , , 
Proximal Differentiation Therapy for K-Ras-Induced Lung Adenocarcinoma,10045952,10/1/2017 0:00,9/30/2021 0:00,Non-SBIR/STTR,2021, , , , , , 
Mechano sensitive peptide aggregates for targeted therapy,10045965,9/1/2020 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020,443477, ,NIGMS,298705,144772,443477
Combinations of Grape Seed and Milk Thistle Extracts Against Lung,10046283,10/1/2018 0:00,9/30/2022 0:00,Non-SBIR/STTR,2021, , , , , , 
Endothelial Toll-like Receptor 3 in the pathogenesis and therapy of Pulmonary Arterial Hypertension,10046465,1/1/2019 0:00,12/31/2022 0:00,Non-SBIR/STTR,2020,590163, ,NHLBI,436911,153252,590163
BLR&D Research Career Scientist Award Application,10047291,10/1/2018 0:00,9/30/2023 0:00,Other,2021, , , , , , 
Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics,10048008,4/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2020,52009, ,NINDS,36633,15376,52009
Genetic and Epigenetic Biomarkers for B-cell Lymphoma,10048471,1/1/2020 0:00,6/30/2024 0:00,Non-SBIR/STTR,2019,204885, ,NCI,127258,77627,204885
Investigating CREBBP as a tumor suppressor in small cell lung cancer,10049235,12/15/2016 0:00,11/30/2021 0:00,Non-SBIR/STTR,2021,441962, ,NCI,251115,190847,441962
Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy,10049332,8/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2020,361779, ,NCI,228750,133029,361779
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer,10049938,7/28/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2020,554502, ,NCI,462561,91941,554502
Investigating the role of DUX and miR-34a regulation in cell fate plasticity and cancer,10049986,11/1/2018 0:00,8/31/2023 0:00,"Training, Individual",2021,35581, ,NICHD,35581, ,35581
Regulation of transcriptional activation by protein disorder,10050845,6/1/2016 0:00,6/30/2024 0:00,Non-SBIR/STTR,2020,330442, ,NIGMS,262444,67998,330442
Role of HOS in Cell Transformation and Apoptosis,10051399,3/1/2001 0:00,11/30/2021 0:00,Non-SBIR/STTR,2021,344138, ,NCI,213750,130388,344138
p53 acetylation in ferroptosis and tumor suppression,10051413,12/1/2017 0:00,11/30/2021 0:00,Non-SBIR/STTR,2021,366000, ,NCI,228750,137250,366000
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms,10051566,9/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2020,369821, ,NINDS,247500,122321,369821
Understanding Richter's Transformation in the targeted therapies era,10052252,9/11/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2020,474404, ,NCI,304105,170299,474404
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes,10052896,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2020,429763, ,NCI,276820,152943,429763
Resolving the cancer relevance of predisposition gene mutations,10053431,9/1/2020 0:00,8/31/2027 0:00,Non-SBIR/STTR,2020,952518, ,NCI,599068,353450,952518
Novel therapeutics for targeting checkpoint dysfunction in cancer,10053707,12/15/2016 0:00,1/31/2022 0:00,Non-SBIR/STTR,2021,362569, ,NCI,228750,133819,362569
Inhibiting Emergence and Progression of Castration-resistant Prostate Cancer through Enforcement of Senescence and Alteration of the Tumor Microenvironment,10054174,12/1/2018 0:00,7/31/2021 0:00,"Training, Individual",2021,29841, ,NCI,29841, ,29841
Copy Number Alterations in Low Mutation Cancer,10054186,12/1/2018 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,246525, ,NCI,166555,79970,246525
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice,10054519,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2020,427654, ,NCI,265704,161950,427654
Targeting defective necroptosis in colorectal cancer,10054976,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2021,443378, ,NCI,321258,122120,443378
Exploring the role of p53 in synapse development and elimination,10055071,6/1/2020 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,397602, ,NIMH,275000,122602,397602
Epigenetic Regulation of Cutaneous Tumorigenesis,10055235,8/1/2020 0:00,7/31/2025 0:00,Other Research-Related,2020,235763, ,NCI,218299,17464,235763
"Precision Genomics in the WISDOM Pragmatic Clinical Trial:  An ""Embedded"" ELSI Study of Risk-based Breast Cancer Screening",10056075,1/12/2017 0:00,12/31/2021 0:00,Non-SBIR/STTR,2020,41342, ,NCI,25599,15743,41342
Molecular Biology of Oncogenic Papillomaviruses,10057232,1/1/2016 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,1016960, ,NCI,607870,422470,1016960
Regulation of p53 and Checkpoint Signaling by Chromium(VI),10057383,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,365625, ,NIEHS,225000,140625,365625
Tumor microenvironment at single cell level in black and white NSCLC patients,10057810,7/1/2020 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,398545, ,NCI,257126,141419,398545
Underlying Mechanisms in Angiosarcoma,10058167,1/1/2020 0:00,6/30/2021 0:00,Non-SBIR/STTR,2019,282151, ,NCI,182315,99836,282151
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma,10058246,12/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,559847, ,NCI,326061,233786,559847
Interplay of mammary luminal cells and environmental factors in establishing p53-deficient premalignant field,10061564,12/12/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,374766, ,NCI,228750,146016,374766
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer,10062480,12/1/2016 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,348844, ,NCI,228750,120094,348844
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges,10062522,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2021,461828, ,NINDS,301380,160448,461828
Identifying Cooperating Mutations Contributing to Disease Progression in Mutant p53-Driven Breast Cancer,10062646,7/1/2020 0:00,4/30/2023 0:00,"Training, Individual",2020,33014, ,NCI,33014, ,33014
Molecular analysis and therapeutic targeting of PI3K signaling in thyroid cancer,10062869,2/1/2009 0:00,11/30/2024 0:00,Non-SBIR/STTR,2021,422510, ,NCI,253000,169510,422510
Growth hormone actions in prostate carcinogenesis,10063500,12/1/2019 0:00,11/30/2021 0:00,Non-SBIR/STTR,2021,206962, ,NCI,137250,69712,206962
The impact of coding region variants on mutant p53 biology,10063505,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2021,444800, ,NCI,298014,146786,444800
Nanotechnology enabled targeting of p53 deficiency in human cancer,10063652,7/1/2018 0:00,6/30/2021 0:00,Non-SBIR/STTR,2020,42815, ,NCI,27712,15103,42815
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis,10063861,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2021,638770, ,NCI,332001,306769,638770
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment,10063864,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2021,466183, ,NCI,279955,186228,466183
Inhibitors of the G protein GNAS which drives pancreatic tumorigenesis,10063865,3/1/2020 0:00,2/28/2025 0:00,Non-SBIR/STTR,2021,403712, ,NCI,278495,125217,403712
Coordination of inflammatory signaling and cardiac fibrosis by small proline rich proteins,10063897,12/21/2018 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,425246, ,NHLBI,276134,149112,425246
Elucidate the mechanism of autophagy in supporting Lkb1-deficient lung tumorigenesis and metastasis,10063978,2/1/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2021,361630, ,NCI,231814,129816,361630
Mre11-Dependent DNA Damage Responses in Breast Cancer Pathogenesis,10064081,12/1/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2021,409161, ,NCI,267435,141726,409161
The role of chronic stress in regulation of mutant p53 and tumorigenesis,10064131,1/1/2017 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,363306, ,NCI,228750,134556,363306
Regulation of Amino-acid Transport in Human Gliomas,10064133,12/1/2018 0:00,3/31/2021 0:00,Non-SBIR/STTR,2021,140177, ,NCI,90046,50131,140177
Exploring the role of progestin and vitamin D on inflammation and oxidative stress in in vitro and in vivo models of ovarian cancer,10064375,12/1/2019 0:00,11/30/2022 0:00,Non-SBIR/STTR,2020,65068, ,NCI,41182,23886,65068
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential,10064579,12/3/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2021,715156, ,NCI,376398,338758,715156
Nucleolar signaling in cancer,10064617,12/15/2019 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,80500, ,NCI,50000,30500,80500
Determining intracellular signaling events that control CAR T cell death in vivo.,10064961,8/1/2019 0:00,7/31/2021 0:00,"Training, Individual",2020,32332, ,NCI,32332, ,32332
Elucidating the molecular determinants of p53-mediated pleiotropic effects,10065223,7/1/2020 0:00,6/30/2023 0:00,"Training, Individual",2020,45520, ,NCI,45520, ,45520
Defining the biological consequences of somatic mutations in high risk AML using integrative single cell approaches,10067246,7/8/2020 0:00,7/7/2022 0:00,"Training, Individual",2020,45520, ,NCI,45520, ,45520
Genomics Of Acute Myeloid Leukemia.,10067511,9/19/2003 0:00,11/30/2023 0:00,Non-SBIR/STTR,2021,3144604, ,NCI,1996574,1148030,3144604
The role of a histone point mutation in pediatric gliomagenesis,10068084,6/29/2020 0:00,6/28/2023 0:00,"Training, Individual",2020,39836, ,NCI,39836, ,39836
Molecular basis of gene-specific function of p53K120 acetylation in proapoptotic gene transcription - Resubmission - 1,10068519,7/1/2020 0:00,6/30/2022 0:00,"Training, Individual",2020,67446, ,NCI,67446, ,67446
The Role of RNA Editing in the DNMTi-induced interferon response in ovarian cancer,10068610,7/1/2020 0:00,6/30/2023 0:00,"Training, Individual",2020,36090, ,NCI,36090, ,36090
Targeting the Cancer Stem Cell Population in Head and Neck Squamous Cell Carcinoma,10068753,7/16/2020 0:00,7/15/2023 0:00,"Training, Individual",2020,29520, ,NCI,29520, ,29520
Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast,10070090,12/11/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2021,356850, ,NCI,228750,128100,356850
Fibrocytes: A novel cell population promoting obesity-induced breast tumor desmoplasia,10070505,1/1/2020 0:00,12/31/2022 0:00,"Training, Individual",2021,34479, ,NCI,34479, ,34479
The Role of Ribosomal Proteins in the P53-MDM2 Pathway,10070577,1/1/2019 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,285950, ,NCI,190000,95950,285950
Metallacycle-mediated coupling in stereoselective synthesis,10070625,1/1/2020 0:00,12/31/2024 0:00,Non-SBIR/STTR,2021,574000, ,NIGMS,350000,224000,574000
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice,10071873,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2021,508332, ,NCI,325854,182478,508332
The Inflammasome as a novel mediator and therapeutic target of GI syndrome,10072036,1/1/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,383156, ,NCI,228750,154406,383156
Mechanism of Therapy in high-risk AML,10072745,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2020,488415, ,NCI,307179,181236,488415
Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer,10073140,8/1/2020 0:00,12/31/2020 0:00,Non-SBIR/STTR,2020,193780, ,NCI,118667,75113,193780
Analysis of the Mammalian DNA Damage Response,10073344,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2021,409463, ,NCI,228750,180713,409463
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.,10073481,1/1/2018 0:00,6/27/2021 0:00,Non-SBIR/STTR,2021,316635, ,NCI,229146,87489,316635
The Role of p53-R249S’s GOF in HCC development,10074546,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2021,366924, ,NCI,241823,125101,366924
Reactivating p53 Function with a Novel Structure-based Peptide as a Therapeutic Approach for Overcoming Platinum Resistance,10075116,1/1/2020 0:00,12/31/2023 0:00,Non-SBIR/STTR,2021, , , , , , 
Identification and targeting of colon cancer initiating cells,10075868,10/1/2009 0:00,6/30/2022 0:00,Non-SBIR/STTR,2020, , , , , , 
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer,10075891,1/1/2020 0:00,12/31/2024 0:00,Non-SBIR/STTR,2021,340838, ,NCI,228750,112088,340838
"Precision Genomics in the WISDOM Pragmatic Clinical Trial:  An ""Embedded"" ELSI Study of Risk-based Breast Cancer Screening",10076555,1/12/2017 0:00,12/31/2023 0:00,Non-SBIR/STTR,2021,751725, ,NCI,481061,270664,751725
Research Project 3: Cell fate decision of liver tumor-initiating stem-like cells induced by alcohol,10077271,1/1/1999 0:00,12/31/2023 0:00,Research Centers,2021, ,112048, ,67908,44140, 
Phosphoinositide Signaling in the Cytosol and Nucleus,10077869,1/1/2020 0:00,12/31/2024 0:00,Non-SBIR/STTR,2021,706026, ,NIGMS,458002,248024,706026
Pediatric Preclinical Testing Consortium,10078023,7/7/2015 0:00,12/31/2020 0:00,Non-SBIR/STTR,2020,181391, ,NCI,103063,78328,181391
DNA damage signaling to immune checkpoints,10078939,1/1/2017 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,347953, ,NCI,222334,125619,347953
Control of Lipogenesis and Hepatic Steatosis by Caspase-2,10083211,3/15/2019 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,417063, ,NIDDK,264382,152681,417063
Understanding Resistance to Next Generation Antiandrogens,10083715,5/1/2012 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,404100, ,NCI,225000,179100,404100
Mechanisms of gene expression control in the p53 network,10083720,5/26/2006 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021,332381, ,NCI,213750,118631,332381
Defining and manipulating quiescence associated DNA damage resistance in single cells,10084819,1/15/2019 0:00,11/8/2021 0:00,Non-SBIR/STTR,2021,245000, ,NCI,161965,83035,245000
Targeted Therapies for Richters Transformation,10084828,2/7/2017 0:00,1/31/2022 0:00,Non-SBIR/STTR,2021,463172, ,NCI,296905,166267,463172
Identifying the role of Ntrk1 in immunosuppression in Kras/p53 mutant lung cancer,10085157,12/9/2019 0:00,12/8/2022 0:00,"Training, Individual",2021,73158, ,NCI,73158, ,73158
"Dynamics, Regulation and Function of p53 in Single Cells",10086147,1/1/2021 0:00,12/31/2025 0:00,Non-SBIR/STTR,2021,501357, ,NIGMS,296661,204696,501357
Investigating the mechanisms for mutant p53 stability in cancer cells,10086310,1/1/2020 0:00,12/31/2022 0:00,"Training, Individual",2021,46036, ,NCI,46036, ,46036
Development of a dual MDM2/XIAP inhibitor with a high therapeutic index for childhood cancers,10087056,8/1/2020 0:00,12/31/2020 0:00,SBIR/STTR,2020,55000, ,NCI, , ,55000
Project 2: Defining and exploiting genetic dependencies in complex karyotype AML,10087325,8/24/2021 0:00,6/30/2026 0:00,Research Centers,2021, ,384164, ,213900,170264, 
Targeted Therapy for Endometrial Cancer,10087894,7/1/2002 0:00,12/31/2021 0:00,Non-SBIR/STTR,2021,178025, ,NCI,113746,64279,178025
Novel regulations of DNA damage repair,10087898,3/16/2017 0:00,2/28/2024 0:00,Non-SBIR/STTR,2021,436368, ,NCI,272730,163638,436368
Mechanisms by which mutant p53 drives metastatic Triple Negative Breast Cancer,10087904,3/1/2019 0:00,5/31/2022 0:00,"Training, Individual",2021,70458, ,NCI,70458,0,70458
Resistance Mechanisms in ROS1-Fusion-Driven Malignancies,10088330,1/16/2020 0:00,1/15/2025 0:00,"Training, Individual",2021,51036, ,NCI,51036, ,51036
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer,10088424,3/8/2017 0:00,3/10/2022 0:00,Non-SBIR/STTR,2021,385147, ,NCI,240717,144430,385147
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells,10089417,2/9/2018 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021,456199, ,NCI,269314,186890,456199
Identify tumor suppressor driver genes of pancreatic ductal adenocarcinoma,10089422,2/1/2020 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021,144380, ,NCI,93500,50880,144380
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma,10089423,2/1/2019 0:00,1/31/2024 0:00,Non-SBIR/STTR,2021,366000, ,NCI,228750,137250,366000
"Isolation, characterization and translational development of glioma stem cells",10090574,2/1/2017 0:00,1/31/2024 0:00,Non-SBIR/STTR,2021,1077600, ,NCI,600000,477600,1077600
Systemic RNA interference to reactivate p53 tumor suppression,10091404,3/1/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2021,352899, ,NCI,242760,110139,352899
Preclinical analyses of advanced prostate cancer in genetically-engineered mice,10091974,8/6/2013 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021,385883, ,NCI,241177,144706,385883
Project 5: Tumor Suppressor and Tumor Maintenance Genes,10092138,2/10/1997 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021, ,630426, ,394341,236085, 
Effect of APOBEC3 on Bladder Cancer Biology and Response to Immunotherapy,10092808,2/1/2020 0:00,1/31/2023 0:00,"Training, Individual",2021,46036, ,NCI,46036, ,46036
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites,10092971,3/1/2018 0:00,2/28/2023 0:00,Non-SBIR/STTR,2021,427763, ,NCI,228750,199013,427763
Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC,10092980,3/8/2019 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,516606, ,NCI,349023,265225,516606
The mechanism through which mRNA translation enhancer elements drive cap-independent translation,10093085,2/20/2019 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021,308400, ,NIGMS,238400,70000,308400
Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy,10093308,1/1/2021 0:00,12/31/2025 0:00,Non-SBIR/STTR,2021,370575, ,NCI,228750,141825,370575
c-Myc Targets in the Pathogenesis of Human Cancers,10093977,9/1/1992 0:00,9/30/2022 0:00,Non-SBIR/STTR,2021,225384, ,NCI,154732,70652,225384
Targeting vulnerabilities of PPM1D-mutant gliomas,10097457,2/1/2021 0:00,1/31/2026 0:00,Non-SBIR/STTR,2021,403607, ,NCI,228750,174857,403607
Role of p53 Missense Mutations on Tumorigenesis in Vivo,10097999,2/4/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2021,384750, ,NCI,237500,147250,384750
The role of PCDH7 in lung cancer pathogenesis,10098305,3/9/2017 0:00,2/29/2024 0:00,Non-SBIR/STTR,2021,424551, ,NCI,266671,157880,424551
Targeting immune suppressive microenvironment in ATC,10099347,2/1/2021 0:00,1/31/2026 0:00,Non-SBIR/STTR,2021,440718, ,NCI,248993,191725,440718
Genomic Biology of the Tandem Duplicator Phenotype in Mouse and Human Cancers,10099489,12/1/2020 0:00,11/30/2025 0:00,Non-SBIR/STTR,2021,703993, ,NCI,372483,331510,703993
Leveraging canine spontaneous cancer to optimize the power of blood biopsy,10099925,6/7/2021 0:00,5/31/2026 0:00,Non-SBIR/STTR,2021,645307, ,NCI,485412,159895,645307
Epigenetic regulation by tumor suppressor p53,10101491,4/1/1999 0:00,2/29/2024 0:00,Non-SBIR/STTR,2021,382375, ,NCI,237500,144875,382375
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer,10101639,2/6/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2021,368017, ,NCI,268746,99271,368017
Flourine-18 labeled MDM2 antagonists for PET imaging,10102215,2/10/2020 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021,225803, ,NCI,140250,85553,225803
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia,10102241,4/1/2019 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021,355637, ,NIDDK,233102,122535,355637
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,10102633,4/1/2011 0:00,3/31/2022 0:00,Non-SBIR/STTR,2020, , , , , , 
Nanotechnology for targeted therapy and fundamental understanding of  therapeutic resistance in triple negative breast cancer,10103798,4/1/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2021,455670, ,NCI,373229,82441,455670
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor,10105040,1/1/2021 0:00,12/31/2025 0:00,Other Research-Related,2021,265113, ,NCI,245475,19638,265113
Identifying Novel Therapeutics for High Risk Medulloblastoma Patients,10105115,1/1/2021 0:00,12/31/2025 0:00,Other Research-Related,2021,216345, ,NINDS,200319,16026,216345
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism,10106590,3/2/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2021,398769, ,NCI,331468,67301,398769
Deciphering real-time dynamics of the human genome organization in response to DNA damage and gene expression,10107827,9/15/2017 0:00,2/28/2022 0:00,Non-SBIR/STTR,2021,249000, ,NIGMS,159616,89384,249000
Re-engineered Mitochondrially Targeted p53 Gene Therapy in Liver Cancer,10111857,1/1/2021 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,178234, ,NCI,116875,61359,178234
Contribution of Epigenome to PRKCI-Driven High-Grade Serous Ovarian Cancer,10112045,5/1/2021 0:00,4/30/2023 0:00,Non-SBIR/STTR,2021,416543, ,NCI,257125,159418,416543
Genomic incorporation of stapled peptides for cost effective discovery and synthesis of novel therapeutics,10112097,3/1/2020 0:00,2/28/2023 0:00,"Training, Individual",2021,66390, ,NCI,66390, ,66390
The role of AXL-ABL axis in Barrett's carcinogenesis,10112186,3/1/2016 0:00,2/28/2023 0:00,Non-SBIR/STTR,2021,302666, ,NCI,191561,111105,302666
Impact of germline variants on racial and ethnic differences in somatic mutation frequency,10112194,3/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,356850, ,NCI,228750,128100,356850
Cell fate decisions in Merkel cell carcinoma initiation and maintenance,10112212,2/20/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2021,526817, ,NCI,337703,189114,526817
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer,10112214,3/1/2020 0:00,2/28/2025 0:00,Non-SBIR/STTR,2021,276135, ,NCI,170982,105153,276135
Nannocystin Reagents to Elucidate the Role of Elongation Factor 1a in Apoptosis,10112421,2/9/2021 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021,78581, ,NCI,50000,28581,78581
Targeting USP10 to regulate the DNA damage response in NSCLC,10112548,12/3/2020 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,215985, ,NCI,140250,75735,215985
Genomic Instability and Cancer Genetics,10112874,3/1/1997 0:00,2/29/2024 0:00,Research Centers,2021, ,30825, ,19829,10996, 
Cancer Pharmacology,10112876,3/1/1997 0:00,2/29/2024 0:00,Research Centers,2021, ,29658, ,19095,10563, 
Clinical Investigations and Precision Therapeutics,10112877,3/1/1997 0:00,2/29/2024 0:00,Research Centers,2021, ,29658, ,19095,10563, 
Kidney Injury by Cisplatin and Renoprotective Strategies.,10112894,9/30/2010 0:00,2/28/2024 0:00,Non-SBIR/STTR,2021,418363, ,NIDDK,271664,146699,418363
Imaging Modulation of Immune Phenotype,10113064,2/1/2021 0:00,1/31/2026 0:00,Non-SBIR/STTR,2021,669526, ,NCI,438758,230768,669526
Minimizing the risk of therapy-related myeloid neoplasms by inhibiting genotoxic stress-induced expansion of leukemia-initiating cells with p53 mutations,10113420,12/1/2020 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,80500, ,NCI,50000,30500,80500
Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics,10113680,4/1/2018 0:00,2/28/2022 0:00,Non-SBIR/STTR,2021,496508, ,NINDS,333338,163170,496508
Comprehensive identification of RAS mutations and allelic co-segregation patterns in colorectal cancer,10113898,12/14/2020 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,93500, ,NCI,50000,43500,93500
Statistical methods and tools for cancer risk prediction in families with germline mutations in TP53,10114999,4/1/2019 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,358693, ,NCI,238879,119814,358693
Genetics of Tumor Suppression by p53,10115667,3/4/2020 0:00,12/1/2021 0:00,Other Research-Related,2021,119031, ,NCI,110214,8817,119031
Integration of early genetic alterations and inflammation in gastroesophageal premalignancy,10115713,4/1/2019 0:00,1/31/2024 0:00,Other Research-Related,2021,158040, ,NIDDK,147074,10966,158040
Mechanisms of the TFIIH-associated kinase CDK7 in p53-dependent transcriptional regulation,10116163,3/1/2020 0:00,1/7/2022 0:00,"Training, Individual",2021,34366, ,NCI,34366,0,34366
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas,10116327,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,497714, ,NCI,308182,189532,497714
Genetic Biomarkers for Risk of CLL Progression among high-count MBLs,10116792,1/1/2021 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,223557, ,NCI,145521,78036,223557
The roles of TRIM24 in breast cancer,10117196,3/1/2017 0:00,11/30/2022 0:00,Non-SBIR/STTR,2021,402021, ,NCI,251263,150758,402021
Mechanisms of targeting oncoprotein SET in tumor suppression,10117198,4/1/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,366000, ,NCI,228750,137250,366000
BLR&D Research Career Scientist Award Application,10118025,4/1/2020 0:00,3/30/2027 0:00,Other,2021, , , , , , 
Mechanism of p53-dependent Tumor Suppression,10118142,3/15/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2021,459133, ,NCI,295682,163451,459133
Leukemia stem cell regulation and resistance,10118568,2/15/2021 0:00,1/31/2026 0:00,Non-SBIR/STTR,2021,437368, ,NCI,297015,140353,437368
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma,10119252,4/1/2017 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,392992, ,NCI,229387,163605,392992
Suppression of mobile elements by p53 genes,10119496,8/1/2015 0:00,11/30/2024 0:00,Non-SBIR/STTR,2021,343613, ,NIGMS,210000,133613,343613
Environmental Regulation of Cellular Responses to DNA Damage,10120698,4/9/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,351750, ,NIGMS,210000,141750,351750
Dissecting and Targeting RB1-Mutant Osteosarcoma,10121207,3/1/2021 0:00,2/28/2026 0:00,Non-SBIR/STTR,2021,439831, ,NCI,295218,144613,439831
"Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer",10122414,9/1/2021 0:00,8/31/2026 0:00,Non-SBIR/STTR,2021,426729, ,NCI,330866,95863,426729
Pre-malignant mutation landscape and risk factors for progression to hematologic cancers,10122515,4/1/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2021,670935, ,NCI,395832,275103,670935
Interrogating the role of Notch signaling in lung adenocarcinoma tumorigenesis,10124047,4/1/2020 0:00,3/31/2024 0:00,"Training, Individual",2021,37799, ,NCI,37799, ,37799
Use of senolytics to enhance chemotherapeutic efficacy in lung cancer,10124340,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,398989, ,NCI,259137,139852,398989
Dynamic modulation of p53 activity by its disordered regulatory domains,10124404,4/1/2006 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,414512, ,NIGMS,214218,200294,414512
A MULTISCALE APPROACH TO TARGET THE ACHILLES HEEL OF P53 CANCER MUTANTS,10124418,4/5/2019 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,312022, ,NIGMS,205000,107022,312022
CARP-1: A Potential Therapeutic Agent for Breast Cancer,10125709,4/1/2021 0:00,3/31/2025 0:00,Non-SBIR/STTR,2021, , , , , , 
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance,10126821,6/1/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2021,457663, ,NCI,282508,175155,457663
Mechanisms for GH action on epithelial cells,10127629,4/1/2018 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,382500, ,NIDDK,225000,157500,382500
The Age-Dependence and Cell-Specificity of Breast Cancer Driven by Mutant p53,10127673,3/15/2020 0:00,1/31/2023 0:00,Other Research-Related,2021,153000, ,NIGMS,100000,53000,153000
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells,10128394,7/1/2006 0:00,2/28/2023 0:00,Non-SBIR/STTR,2021, ,342008, ,201774,140234, 
Deciphering How Esco2 Loss Acts as a Penetrance Modifier,10128403,4/1/2017 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,339281, ,NCI,228472,110809,339281
Mechanisms regulating the early stages of UV-induced skin cancer,10129959,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,362250, ,NIEHS,225000,137250,362250
Cyclin-dependent kinase control of cell-division and transcription cycles,10130553,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,464704, ,NIGMS,275000,189704,464704
Endothelial Toll-like Receptor 3 in the pathogenesis and therapy of Pulmonary Arterial Hypertension,10130598,1/1/2019 0:00,12/31/2022 0:00,Non-SBIR/STTR,2021,593180, ,NHLBI,438494,154686,593180
Transcriptional mechanisms of natural killer cell responses during mouse cytomegalovirus infection,10131106,5/6/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2021,453462, ,NIAID,296420,157042,453462
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response,10131143,4/1/2017 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,582111, ,NCI,465669,249013,582111
Identification of Lethal Melanomas at the Time of Diagnosis,10131152,4/1/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2021,918430, ,NCI,718262,200168,918430
Roles and Regulation of wild-type and mutant forms of p53,10132244,9/30/2000 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,1885586, ,NCI,1606930,278656,1885586
Project 1: Roles of wild-type and mutant forms of p53 in cancer cell biology,10132245,9/30/2000 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021, ,338839, ,211775,127064, 
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma,10132250,9/1/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,938802, ,NCI,545815,392987,938802
Project 2: Probing the role of the p53 network in ferroptosis,10132251,9/30/2000 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021, ,352899, ,221342,131557, 
Project 4: Mechanisms of wild-type and mutant p53 action in vivo,10132253,9/30/2000 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021, ,355831, ,355831,0, 
Core B -The Bio-Informatics Core,10132257,9/30/2000 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021, ,186032, ,186032,0, 
Core C - The Molecular Systems Pathology Core,10132258,9/30/2000 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021, ,247698, ,247698,0, 
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53,10132266,4/12/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,455018, ,NCI,272466,182552,455018
Novel role of Ezh2 in age-related gastric motility dysfunctions,10133065,4/1/2020 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,357750, ,NIDDK,225000,132750,357750
"Dissecting the dynamic interplay between p53, chromatin and transcriptional bursting in single cells",10133087,4/1/2018 0:00,7/31/2022 0:00,Non-SBIR/STTR,2021,334000, ,NIGMS,200000,134000,334000
Three-Dimensional Organoid Cultures to Investigate 3q26 Driver Functions in Multiple Lung Cancer Cells of Origin,10134075,4/2/1999 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,53210, ,NCI,34000,19210,53210
Defining Mechanisms of Transformation Driven By the Zinc Finger Transcription Factor PLAGL2 in the Intestinal Epithelium,10134266,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,360281, ,NCI,228750,131531,360281
DNA Methylation Inhibitor Therapy for Testicular Cancer,10135500,5/1/2018 0:00,4/30/2023 0:00,Non-SBIR/STTR,2020,52308, ,NCI,38733,13575,52308
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors,10135882,5/1/2020 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,407812, ,NCI,231711,176101,407812
The DREAM B-Myb-MuvB complex controls sensitivity to DNA replication activators and inhibitors,10136185,8/1/2019 0:00,7/31/2022 0:00,Non-SBIR/STTR,2020,90877, ,NCI,51343,39534,90877
Molecular mechanisms underlying lineage plasticity in prostate cancer,10136560,4/15/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2021,594606, ,NCI,341018,253588,594606
Investigating the Role of Metabolic Reprogramming in Cancer Cell Death Sensitivity,10139485,4/3/2020 0:00,3/31/2024 0:00,Other Research-Related,2020,89100, ,NCI,82500,6600,89100
Altered mRNA splicing dependent on mutant p53 identifies novel therapeutic vulnerability in pancreatic cancer,10139560,6/1/2020 0:00,5/31/2023 0:00,Non-SBIR/STTR,2020,249000, ,NCI,152522,96478,249000
DNA Methylation Inhibitor Therapy for Testicular Cancer,10140304,5/1/2018 0:00,4/30/2023 0:00,Non-SBIR/STTR,2021,513005, ,NCI,387727,125278,513005
The role and regulation of p53 in obesity-induced liver cancer,10140572,1/1/2021 0:00,12/31/2023 0:00,"Training, Individual",2021,66390, ,NCI,66390, ,66390
Targeted Chemical-Genetic Screen Platform for Identifying Novel AML Therapeutics,10140623,6/1/2021 0:00,5/31/2024 0:00,"Training, Individual",2021,48591, ,NCI,48591, ,48591
Functional Analysis of p53 Polymorphic Variants,10141456,6/1/2005 0:00,11/30/2025 0:00,Non-SBIR/STTR,2021,391227, ,NCI,213750,177477,391227
Telomerase-Mediated Healing of Double-Strand Breaks in Human Cells,10141463,1/1/2021 0:00,12/31/2024 0:00,"Training, Individual",2021,51036, ,NCI,51036, ,51036
Impact of the Breast Cancer Immune Microenvironment on Racial Disparities and Survivorship,10141571,3/1/2021 0:00,2/28/2023 0:00,"Training, Individual",2021,37102, ,NCI,37102, ,37102
Role of FOXO transcription factor dynamics in determining cellular fates,10141680,7/1/2021 0:00,1/21/2022 0:00,"Training, Individual",2021,37157, ,NIGMS,37157,0,37157
ATF3 Regulation of Histone Acetylation in Genome Maintenance,10143212,4/10/2020 0:00,3/31/2026 0:00,Non-SBIR/STTR,2021,352275, ,NCI,228750,123525,352275
"Markov State Model approaches for folding, binding and design",10143638,5/1/2017 0:00,4/30/2022 0:00,Non-SBIR/STTR,2020,99714, ,NIGMS,88599,11115,99714
Feasibility study of developing SEAK-114 for the treatment of pediatric cancers,10144288,9/16/2020 0:00,12/31/2022 0:00,SBIR/STTR,2020,399964, ,NCI, , ,399964
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors,10144940,8/19/2005 0:00,3/31/2025 0:00,Non-SBIR/STTR,2021,379970, ,NCI,260565,119405,379970
Driving Biomedical Projects,10145022,8/1/2015 0:00,5/31/2025 0:00,Research Centers,2021, ,327789, ,205510,122279, 
"Markov State Model approaches for folding, binding and design",10146412,5/1/2017 0:00,4/30/2022 0:00,Non-SBIR/STTR,2021,295617, ,NIGMS,190000,105617,295617
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice,10148714,6/7/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,398001, ,NCI,292951,105050,398001
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer,10148735,5/22/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2021,577631, ,NCI,380743,196888,577631
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,10149958,2/1/1997 0:00,4/30/2023 0:00,Non-SBIR/STTR,2021, ,389461, ,254437,135024, 
TP53 Germline Mutations: Beyond LFS,10151546,10/15/2019 0:00,4/30/2023 0:00,Non-SBIR/STTR,2021,366000, ,NCI,228750,137250,366000
A MULTISCALE APPROACH TO TARGET THE ACHILLES HEEL OF P53 CANCER MUTANTS (Equipment Supplement),10153341,4/1/2019 0:00,3/31/2023 0:00,Non-SBIR/STTR,2020,84000, ,NIGMS,84000,0,84000
"Mechanisms of PIDDosome Signaling, a p53-Independent Apoptotic Response to DNA Damage",10153709,7/5/2013 0:00,5/31/2024 0:00,Non-SBIR/STTR,2021,346946, ,NCI,204688,142258,346946
Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway,10153726,6/1/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,359545, ,NCI,214654,144891,359545
Investigating the Role of Metabolic Reprogramming in Cancer Cell Death Sensitivity,10153740,4/3/2020 0:00,3/31/2024 0:00,Other Research-Related,2021,92113, ,NCI,85290,6823,92113
Identifying EZH2-dependent vulnerabilities in RB deficient prostate cancer,10154294,5/25/2021 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,195173, ,NCI,116870,78303,195173
Cell lineage determinants of p53-driven fate outcomes in vivo,10154750,12/9/2020 0:00,11/30/2025 0:00,Non-SBIR/STTR,2021,667823, ,NCI,431334,236489,667823
Non-Canonical Phosphatidylinositol Kinases in Triple Negative Breast Cancer,10155445,6/1/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2021,446063, ,NCI,228750,217313,446063
Comprehensive genomic profiling of aggressive hormone sensitive prostate cancer,10155449,5/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2021,577920, ,NCI,433159,144761,577920
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma,10156048,12/10/2020 0:00,11/30/2025 0:00,Non-SBIR/STTR,2021,703320, ,NCI,414938,288382,703320
Investigating immune-microbiota interaction in lung cancer,10156469,7/1/2020 0:00,6/30/2023 0:00,Non-SBIR/STTR,2020,249000, ,NCI,165856,83144,249000
Functional characterization of 2q22.1 deletion in oral squamous cell carcinoma,10157178,9/2/2020 0:00,9/1/2024 0:00,"Training, Individual",2020,41680, ,NIDCR,41680, ,41680
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes,10159871,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,474061, ,NCI,305353,168708,474061
Dietary Carcinogens for Colorectal Cancer,10160852,10/16/2019 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,366000, ,NCI,228750,137250,366000
Toward development of senolytic CAR T cells,10161683,5/15/2020 0:00,2/28/2025 0:00,Non-SBIR/STTR,2021,539995, ,NIA,305082,234913,539995
Altered mRNA splicing dependent on mutant p53 identifies novel therapeutic vulnerability in pancreatic cancer,10161751,6/1/2020 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,245839, ,NCI,159522,86317,245839
Mutant p53 as actionable cancer-specific target,10162515,4/1/2013 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,344434, ,NCI,215946,128488,344434
Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation,10162548,5/11/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2021,333718, ,NCI,217465,116253,333718
Development of Zinc Metallochaperones as Mutant p53 Targeted Anti-cancerDrugs,10163021,3/15/2016 0:00,2/28/2022 0:00,Non-SBIR/STTR,2020,394954, ,NCI,287537,107417,394954
Nuclear Accumulation of D-type Cyclins and Oncogenesis,10163129,7/1/2001 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,344138, ,NCI,213750,130388,344138
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice,10163146,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,399051, ,NCI,265763,133288,399051
Enhancing Global Diversity in Cancer Clinical Genetics,10164921,9/18/2017 0:00,8/31/2022 0:00,Non-SBIR/STTR,2020,177651, ,NCI,145637,32014,177651
Polypoid cell cycle regulation and genome instability,10165740,8/12/2015 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,318451, ,NIGMS,203425,115026,318451
Cancer Biology in the Zebrafish,10167640,7/3/2003 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,420375, ,NCI,237500,182875,420375
Project 1:  Recruitment of the BRCA1-associated Homologous Recombination Machinery,10169646,5/1/2021 0:00,4/30/2026 0:00,Non-SBIR/STTR,2021, ,390516, ,249000,141516, 
Core 1: Mouse and Cell Modeling,10169651,5/1/2021 0:00,4/30/2026 0:00,Non-SBIR/STTR,2021, ,257774, ,164362,93412, 
Activating p53 for colorectal cancer prevention,10170288,6/12/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,424809, ,NCI,290176,134633,424809
Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia,10170297,7/1/2019 0:00,5/31/2022 0:00,"Training, Individual",2021,48883, ,NCI,48883,0,48883
Core B-Modeling & Experimental Therapeutics Core,10170994,12/1/2005 0:00,3/31/2026 0:00,Non-SBIR/STTR,2021, ,197102, ,121668,75434, 
Identifying Metabolic Vulnerabilities in Lung Cancer,10171098,6/25/2021 0:00,5/31/2026 0:00,Non-SBIR/STTR,2021,2060040, ,NCI,1250783,809257,2060040
Project 1,10171099,6/25/2021 0:00,5/31/2026 0:00,Non-SBIR/STTR,2021, ,237175, ,144004,93171, 
Project 3,10171101,6/25/2021 0:00,5/31/2026 0:00,Non-SBIR/STTR,2021, ,344951, ,209442,135509, 
Project 4,10171102,6/25/2021 0:00,5/31/2026 0:00,Non-SBIR/STTR,2021, ,341751, ,207499,134252, 
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer,10171805,6/14/2017 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,166708, ,NCI,98277,68431,166708
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma,10171926,9/15/2017 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,346719, ,NINDS,218750,127969,346719
Molecular Basis for Regulation of Cellular Stress Response Pathways by CBP/p300,10172869,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,482214, ,NCI,249206,233008,482214
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity,10172973,6/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2021,403750, ,NHLBI,250000,153750,403750
53BP1-dependent pathway in DNA repair,10173714,6/14/2017 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,366000, ,NCI,228750,137250,366000
Regulation of tumor recurrence by stress activated neutrophils,10173724,6/1/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2021,586051, ,NCI,369056,216995,586051
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen,10174866,6/17/2019 0:00,5/31/2024 0:00,Non-SBIR/STTR,2021,374788, ,NCI,299150,75638,374788
Mechanism of Therapy in high-risk AML,10176429,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,488415, ,NCI,307179,181236,488415
Understanding the role of TP53 mutation in genetic susceptibility to ovarian cancer,10180577,4/1/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2021,528617, ,NCI,348760,179857,528617
Supernumerary Centrosomes and Cell Proliferation,10180660,3/1/2021 0:00,2/28/2026 0:00,Non-SBIR/STTR,2021,493349, ,NCI,294537,198812,493349
Perivascular niche for salivary gland cancer stem cells and resistance to therapy,10180934,2/10/2011 0:00,2/28/2022 0:00,Non-SBIR/STTR,2021,368125, ,NIDCR,237500,130625,368125
The Role of the Microenvironment in Barrett's Esophagus,10183175,9/26/2011 0:00,10/31/2023 0:00,Research Centers,2021,1145406, ,NCI,1095006,264079,1145406
Project 2: Characterization of microenvironmental drivers of neoplasia in BE,10183179,9/26/2011 0:00,10/31/2023 0:00,Research Centers,2021, ,194061, ,194061,0, 
Development of tools for site-directed analysis of gene function,10185650,6/1/2016 0:00,2/29/2024 0:00,Other Research-Related,2020,31160, ,OD,23028,8132,31160
ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient ProstateCancer,10186723,6/8/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2021,367506, ,NCI,228750,138756,367506
Y-Box 1 and normoxic HIF1 in Sonic hedgehog medulloblastoma tumor stem cell radiation resistance,10186839,9/1/2019 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,341499, ,NINDS,226762,114737,341499
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation,10187125,8/1/2021 0:00,7/31/2026 0:00,Non-SBIR/STTR,2021, ,438027, ,269763,168264, 
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy,10187127,8/1/2021 0:00,7/31/2026 0:00,Non-SBIR/STTR,2021, ,443282, ,272999,170283, 
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles,10187524,7/1/2017 0:00,6/30/2022 0:00,"Training, Individual",2021,51036, ,NCI,51036, ,51036
Regulation of tumor suppression by alpha-ketoglutarate,10187535,9/1/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2021,489205, ,NCI,276387,212818,489205
The Role of Mutant p53 in Regulating T-cell Immune Evasion in Pancreatic Adenocarcinoma and Other Cancers,10189491,6/1/2020 0:00,5/31/2023 0:00,"Training, Individual",2021,33541, ,NCI,33541, ,33541
Alterations in fatty acid metabolism in the pathogenesis of leukemic stem cells from Acute Myeloid Leukemia patients,10189497,7/1/2020 0:00,6/30/2025 0:00,"Training, Individual",2021,34353, ,NCI,34353, ,34353
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment,10189534,7/4/2019 0:00,9/1/2021 0:00,Non-SBIR/STTR,2021,158415, ,NCI,83774,74641,158415
CRL3KEAP1 complex licenses genotoxic stress-induced tumor cell death,10189885,4/1/2021 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,182909, ,NCI,116875,66034,182909
Genetic and Epigenetic Biomarkers for B-cell Lymphoma,10190849,1/1/2020 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,368288, ,NCI,228750,139538,368288
Synthetic lethality based combination approaches to ARID1A mutation in ovarian cancer,10192683,7/18/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,509794, ,NCI,285439,224355,509794
Exploring mechanisms of therapeutic demethylation effects in HPV-associated head and neck cancer,10192704,6/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2021,404678, ,NIDCR,315521,89157,404678
Project 1 - Molecular Determinants of Decitabine Responses.,10194399,9/3/2013 0:00,6/30/2023 0:00,Research Centers,2021, ,276134, ,203404,86180, 
Targeting the TGIF/Twist1 network in osteosarcoma,10194400,3/15/2017 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,354563, ,NCI,228750,125813,354563
Project 2 - Targeted Therapies for T-ALL.,10194401,9/3/2013 0:00,6/30/2023 0:00,Research Centers,2021, ,276193, ,194885,94758, 
Predicting Breast Cancer Risk after Benign Percutaneous Biopsy,10194417,7/5/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,637416, ,NCI,560173,77243,637416
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer,10196959,9/1/2008 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,370500, ,NCI,237500,133000,370500
"SENP6, a novel p53 negative regulator, is an important new player in cancer",10197830,7/1/2018 0:00,6/30/2022 0:00,Non-SBIR/STTR,2021,363713, ,NCI,228750,134963,363713
PPM1D in Clonal Hematopoiesis and Malignancies,10197856,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,599632, ,NCI,415076,184556,599632
Targeting p53 conformational defects to arrest carcinogenesis,10197860,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,356850, ,NCI,228750,128100,356850
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD),10197999,8/1/2012 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,2368307, ,NHLBI,1666122,702185,2368307
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease,10198011,8/1/2012 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021, ,510000, ,300000,210000, 
"P53, DNA Repair Imbalance, and Immune Response in Breast Cancer Mortality Disparities",10198123,4/6/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2021,597226, ,NCI,391413,205813,597226
Chemo-neoepitopes as novel immunotherapy for triple negative breast cancer,10198213,5/1/2021 0:00,4/30/2024 0:00,Non-SBIR/STTR,2021,466702, ,NCI,329084,137618,466702
RNASEH2B loss to predict response to PARP inhibitor in prostate cancer,10199307,5/10/2021 0:00,4/30/2023 0:00,Non-SBIR/STTR,2021,251048, ,NCI,140250,110798,251048
Exploration of Novel Mutation Biomarkers to Repurpose EGFRi for Mutant KRAS Colorectal Cancer,10199678,7/15/2021 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,221771, ,NCI,148984,72787,221771
Improving post-surgery recovery of failing hearts by targeting cardiomyocyte senescence,10199774,9/1/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2021,430115, ,NHLBI,265503,164612,430115
Target MDM2/MDMX for reducing normal tissue toxicity induced by chemotherapy,10200710,5/10/2019 0:00,4/30/2025 0:00,Non-SBIR/STTR,2021,364856, ,NCI,228750,136106,364856
Sensitizing High Grade Serous Cancers to Immunotherapy through the Induction of DNA Damage,10200717,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,356850, ,NCI,228750,128100,356850
The role of autophagy in the escape from replicative crisis and tumorigenesis,10200720,7/1/2020 0:00,4/30/2023 0:00,Other Research-Related,2021,163080, ,NCI,151000,12080,163080
Statistical methods for cancer progression delineation and subtype identification,10201322,7/1/2021 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,74902, ,NCI,50000,24902,74902
P63 Mechanisms and mediators in HNSCC,10201563,4/1/2004 0:00,7/31/2023 0:00,Non-SBIR/STTR,2021,398493, ,NIDCR,237500,160993,398493
Estrogen reduces HPV transcription and oncogene expression to target disease,10201571,7/1/2020 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,147488, ,NIDCR,95000,52488,147488
Origins and functions of pancreatic cancer-associated fibroblasts,10201935,5/1/2021 0:00,4/30/2026 0:00,Non-SBIR/STTR,2021,355498, ,NCI,233131,122367,355498
Study of Interleukin 33 as a new immunotherapy of lung cancer,10202507,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,355409, ,NCI,228750,126659,355409
Targeting HER2-low breast cancer with 17p loss,10203209,4/1/2016 0:00,4/30/2026 0:00,Non-SBIR/STTR,2021,535448, ,NCI,337822,197626,535448
Regulation of Ferroptosis by the p53/CDK/Rb Axis.,10203213,6/1/2021 0:00,5/31/2024 0:00,Non-SBIR/STTR,2021,451500, ,NIGMS,300000,151500,451500
Ensemble Networks for Allosteric Drug Design,10203327,6/1/2018 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021,492900, ,NIGMS,300000,192900,492900
The Role of RNA Editing in the DNMTi-induced interferon response in ovarian cancer,10203828,7/1/2020 0:00,6/30/2023 0:00,"Training, Individual",2021,34416, ,NCI,34416, ,34416
Project 4: Therapeutic Targeting of Replication Stress Vulnerabilities in Small Cell Lung Cancer,10203845,9/5/1997 0:00,8/31/2025 0:00,Research Centers,2021, ,463389, ,365176,98213, 
Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis,10203862,6/8/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021, ,315252, ,207500,107752, 
Core 2: Animal Model and Experimental Therapeutics Core [AMETC],10203866,6/8/2018 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021, ,253150, ,166000,87150, 
Deregulation of COMPASS complex and enhancer chromatin in pancreatic cancer,10203868,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,364856, ,NCI,228750,136106,364856
Investigating immune-microbiota interaction in lung cancer,10203872,7/1/2020 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,249000, ,NCI,153231,95769,249000
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer,10204747,9/30/1997 0:00,9/20/2022 0:00,Research Centers,2021, ,277334, ,195972,81362, 
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer,10204766,9/30/1997 0:00,6/30/2022 0:00,Research Centers,2020, ,41756, ,30140,11616, 
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer,10204767,9/30/1997 0:00,6/30/2022 0:00,Research Centers,2020, ,41275, ,28368,12907, 
Targeting Mutant KRAS for Cancer Therapy,10204898,3/1/2016 0:00,5/31/2023 0:00,Non-SBIR/STTR,2021,839300, ,NCI,606117,233183,839300
Inflammation Induced Cytosine Deamination and the Initiation of Cancer,10206050,7/1/2018 0:00,6/30/2022 0:00,"Training, Individual",2021,35571, ,NCI,35571, ,35571
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells,10206624,4/1/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2021,421847, ,NCI,268810,153037,421847
The role of a histone point mutation in pediatric gliomagenesis,10207450,6/29/2020 0:00,6/28/2023 0:00,"Training, Individual",2021,40352, ,NCI,40352, ,40352
Mechanisms and Vulnerabilities of  SWI/SNF chromatin remodeling complex mutant lung cancer,10207560,7/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,472040, ,NCI,291383,180657,472040
Lentiviral-Induced Swine Model of Spinal Cord Glioma,10208273,6/1/2021 0:00,5/31/2026 0:00,Non-SBIR/STTR,2021,541702, ,NCI,369618,172084,541702
Anti-tumor potential of temperature-sensitive p53 mutants,10209252,3/1/2021 0:00,2/28/2026 0:00,Non-SBIR/STTR,2021,444590, ,NCI,269939,174651,444590
Project 3: Targeting Bax signaling to overcome treatment resistance in NSCLC,10210202,7/10/2019 0:00,5/31/2024 0:00,Research Centers,2021, ,338910, ,217329,121704, 
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer,10210801,3/1/2021 0:00,2/28/2026 0:00,Non-SBIR/STTR,2021,566906, ,NCI,388916,177990,566906
Role of TERRA in Telomere Maintenance and Telomere Stress Response,10210828,7/1/2010 0:00,1/31/2026 0:00,Non-SBIR/STTR,2021,434696, ,NCI,237500,197196,434696
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms,10211014,4/14/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2021,382820, ,NCI,237040,145780,382820
03 Genetically Engineered Mouse Facility,10212251,8/28/1996 0:00,6/30/2024 0:00,Research Centers,2021, ,488083, ,305052,183031, 
25 Cancer Genetics and Epigenetics,10212264,8/28/1996 0:00,6/30/2024 0:00,Research Centers,2021, ,18707, ,11692,7015, 
06 Breast Cancer,10212269,8/28/1996 0:00,6/30/2024 0:00,Research Centers,2021, ,18707, ,11692,7015, 
Identifying Cooperating Mutations Contributing to Disease Progression in Mutant p53-Driven Breast Cancer,10212279,7/1/2020 0:00,4/30/2023 0:00,"Training, Individual",2021,33530, ,NCI,33530, ,33530
Improving Delivery of Genetic Services to High Risk Childhood Cancer Survivors: A Randomized Study of Remote Genetic Services Versus Usual Care,10212342,7/8/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,694312, ,NCI,631695,62617,694312
Molecular basis of gene-specific function of p53K120 acetylation in proapoptotic gene transcription - Resubmission - 1,10212965,7/1/2020 0:00,6/30/2022 0:00,"Training, Individual",2021,72958, ,NCI,72958, ,72958
The intersection of RNA biology and tumor biology,10213661,8/12/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2021,772204, ,NCI,482025,290179,772204
A chemical strategy to unravel tumor suppression through the ubiquitin pathway,10213787,8/5/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2021,295800, ,NIGMS,195000,100800,295800
Mechanisms of Esophageal Carcinogenesis,10214543,8/15/2003 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,1573148, ,NCI,1227677,345471,1573148
Project 1 - Transformed Esophageal Epithelial Cells and the Tumor Microenvironment,10214544,8/15/2003 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021, ,167013, ,121961,45052, 
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression,10214558,8/1/2017 0:00,7/31/2024 0:00,Non-SBIR/STTR,2021,959885, ,NCI,599998,359887,959885
Therapeutic implication of RB1 loss in bladder cancer,10214853,3/5/2021 0:00,2/28/2026 0:00,Other Research-Related,2021,285729, ,NCI,264564,21165,285729
Project 1:  Evolution of transcriptional programs in lung cancer progression,10215397,5/1/1997 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021, ,420760, ,268461,152299, 
Project 3:  Targeting epigenetic regulators in cancer,10215399,5/1/1997 0:00,1/31/2023 0:00,Non-SBIR/STTR,2021, ,352717, ,229500,123217, 
"Tumor suppression, p53 and retrotransposons",10215433,8/24/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2021,370575, ,NCI,228750,141825,370575
Investigating and targeting pathways of malignant peripheral nerve sheath tumor (MPNST),10215635,7/1/2019 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,586012, ,NINDS,370220,215792,586012
Targeting the Cancer Stem Cell Population in Head and Neck Squamous Cell Carcinoma,10216158,7/16/2020 0:00,7/15/2023 0:00,"Training, Individual",2021,30036, ,NCI,30036, ,30036
Defining the biological consequences of somatic mutations in high risk AML using integrative single cell approaches,10216162,7/8/2020 0:00,7/7/2022 0:00,"Training, Individual",2021,46036, ,NCI,46036, ,46036
The Translational Regulation of Pro-apoptotic Genes,10216207,7/14/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,356850, ,NCI,228750,128100,356850
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect,10217590,4/20/2021 0:00,3/31/2025 0:00,Non-SBIR/STTR,2021,585063, ,NHLBI,378920,206143,585063
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells,10218070,8/17/2018 0:00,7/31/2025 0:00,Non-SBIR/STTR,2021,870147, ,NCI,547376,325994,870147
RNF128  Regulation of TP53 in Barrett's Progression,10219176,8/31/2017 0:00,7/31/2024 0:00,Non-SBIR/STTR,2021,422751, ,NCI,270994,151757,422751
USING ARGININE METABOLIC THERAPIES FOR SARCOMA,10219184,8/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2021,363301, ,NCI,232206,131095,363301
Protein Kinase Signaling in the Genotoxic Stress Response,10219250,9/1/2017 0:00,7/31/2025 0:00,Non-SBIR/STTR,2021,532068, ,NIEHS,334634,197434,532068
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity,10219974,8/1/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2021,1129825, ,NCI,582384,547441,1129825
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection,10220227,5/1/2021 0:00,4/30/2026 0:00,Non-SBIR/STTR,2021,632904, ,NCI,419858,213046,632904
Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer,10220909,8/1/2020 0:00,4/30/2026 0:00,Non-SBIR/STTR,2021,445665, ,NCI,350778,115222,445665
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations,10222618,8/8/2019 0:00,7/31/2026 0:00,Non-SBIR/STTR,2021,1035240, ,NCI,600000,435240,1035240
Role of Gstt1 in metastatic maintenance and self-renewal in PDA,10222628,8/1/2020 0:00,7/30/2022 0:00,Other Research-Related,2021,156330, ,NCI,144750,11580,156330
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer,10223234,8/1/2019 0:00,7/31/2024 0:00,Non-SBIR/STTR,2021,428090, ,NCI,288633,139457,428090
Epigenetic Regulation of Cutaneous Tumorigenesis,10223237,8/1/2020 0:00,7/31/2025 0:00,Other Research-Related,2021,235763, ,NCI,218299,17464,235763
Project 3: Using RNAi-based Spherical Nucleic Acid (SNA) Nanoconjugates Targeting Bcl2L12 to Promote Therapy-Induced Apoptosis in Glioblastoma,10224126,8/17/2018 0:00,7/31/2023 0:00,Research Centers,2021, ,262751, ,155812,106939, 
New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss,10224131,9/19/2017 0:00,8/31/2022 0:00,Other Research-Related,2021,177120, ,NCI,164000,13120,177120
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer,10224705,7/28/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,541500, ,NCI,462559,78941,541500
Defining diverse roles of p53 in pancreatic cancer,10224768,8/1/2017 0:00,7/31/2022 0:00,Other Research-Related,2021,170640, ,NCI,158000,12640,170640
Investigating chromatin mechanisms using viral systems,10225323,9/1/2019 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,316631, ,NIGMS,179904,136727,316631
miR-155 targeted therapeutics for precision medicine in lung cancer,10225382,8/3/2018 0:00,7/31/2023 0:00,Non-SBIR/STTR,2021,512229, ,NCI,364390,147839,512229
Targeting metabolic vulnerabilities in glioblastoma,10225454,8/7/2017 0:00,7/31/2022 0:00,Non-SBIR/STTR,2021,490971, ,NCI,332432,158539,490971
Project 2: Targeting metabolic vulnerabilities in glioblastoma,10225551,8/11/2017 0:00,7/31/2022 0:00,Research Centers,2021, ,334315, ,214305,120010, 
Project 4: Novel epigenetic treatment of IDH mutant gliomas,10225553,8/11/2017 0:00,7/31/2022 0:00,Research Centers,2021, ,337783, ,224340,113443, 
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis,10225994,8/14/2015 0:00,7/31/2022 0:00,Non-SBIR/STTR,2021,974343, ,NCI,600000,383302,974343
Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy,10226904,8/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2021,361779, ,NCI,228750,133029,361779
Phosphoinositides and Cancer Metabolism,10226926,9/5/2016 0:00,6/30/2022 0:00,Non-SBIR/STTR,2021,1017000, ,NCI,600000,417000,1017000
Project 3: Molecular Markers for Early Detection of Esophageal Carcinogenesis,10227754,9/14/2011 0:00,7/31/2023 0:00,Research Centers,2021, ,232499, ,151369,81130, 
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade,10227765,8/28/2017 0:00,7/31/2023 0:00,Non-SBIR/STTR,2021,393450, ,NCI,228750,164700,393450
PROJECT 4: Interrogating PP2A Signaling in Human Cancers,10227785,8/1/2017 0:00,7/31/2023 0:00,Non-SBIR/STTR,2021, ,326362, ,186750,139612, 
DNA-PKcs and PIDD interaction in DNA damage response,10228547,9/1/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021,370575, ,NCI,228750,141825,370575
Investigating the metastatic drive in pancreas cancer,10228721,8/9/2018 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,258637, ,NCI,146953,111684,258637
Understanding the role of TWIST1 in colorectal cancer progression and metastasis,10229284,7/1/2021 0:00,11/30/2024 0:00,"Training, Individual",2021,37751, ,NCI,37751, ,37751
Project 1: Combinatorial Molecular Tumor Drivers in Basal and Supra-                 basal Urothelial Cells,10229412,9/12/2013 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021, ,343182, ,202467,140715, 
Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy,10229424,9/4/2017 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,578917, ,NCI,407125,171792,578917
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis,10231158,9/18/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,500441, ,NCI,344958,155483,500441
Gain-of-function mutant p53 and metabolic reprogramming in colorectal cancer,10231719,4/1/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2021,440108, ,NCI,280944,159164,440108
Investigating a Wnt-telomere feedback loop in the colorectal adenoma-carcinoma sequence,10232000,3/1/2021 0:00,2/28/2025 0:00,"Training, Individual",2021,46036, ,NCI,46036, ,46036
(PQ3) UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMAS,10232093,9/4/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,629677, ,NCI,396023,233654,629677
Novel Therapeutic Approaches Targeting Tumor Suppressor Deficiencies in Advanced Prostate Cancer,10232348,9/1/2019 0:00,8/31/2022 0:00,Non-SBIR/STTR,2021,249000, ,NCI,153704,95296,249000
Investigation of sub-lineages in pulmonary neuroendocrine cells and identification of the cells of origin of small cell lung cancer,10232596,9/16/2020 0:00,8/31/2023 0:00,Non-SBIR/STTR,2020,249000, ,NCI,157169,91831,249000
Determining the Molecular Contributions of KDM2A in NSCLC Metastasis,10232826,9/1/2021 0:00,8/31/2024 0:00,"Training, Individual",2021,46036, ,NCI,46036, ,46036
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade,10234050,6/1/2006 0:00,8/31/2023 0:00,Research Centers,2021, ,332308, ,207205,125103, 
Identifying the vulnerabilities in Mdm2 overexpressing cancer cells,10236402,8/11/2020 0:00,7/31/2025 0:00,Non-SBIR/STTR,2021,83662, ,NCI,51643,32019,83662
Molecular Pathogenesis of Two Newly Defined Major Subgroups of PTCL,10237158,9/19/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021, ,408752, ,408752,0, 
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens,10238080,9/12/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021,714330, ,NCI,506182,208148,714330
Role of ER stress-driven IRE1ÃÂ±-XBP1 Signaling in Lung Cancer Pathogenesis,10238734,7/1/2017 0:00,6/30/2021 0:00,"Training, Individual",2020,45520, ,NCI,45520, ,45520
Regulation of Cellular Proliferation by Novel Mitochondrial-Encoded Tumor Suppressors,10238768,9/1/2020 0:00,5/31/2024 0:00,Non-SBIR/STTR,2021,326942, ,NIGMS,200000,126942,326942
Functional genomics approach to evaluate mechanisms of mutant p53 gain-of-function phenotypes,10240594,9/9/2019 0:00,12/31/2021 0:00,"Training, Individual",2021,10276, ,NCI,10276, ,10276
Role of POT1 mutations in glioma initiation,10240676,9/30/2019 0:00,8/31/2024 0:00,Other Research-Related,2021,176414, ,NINDS,163420,12994,176414
Evaluating candidate mediators of prostate cancer metastasis and neuro endocrine prostate cancer (NEPC) trans differentiation,10241237,9/14/2018 0:00,4/30/2024 0:00,Non-SBIR/STTR,2021,130212, ,NCI,75793,54419,130212
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC,10241289,9/10/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,458690, ,NCI,327162,131650,458690
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer,10241343,9/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,561139, ,NCI,591381,176287,561139
Research Project 2: Pathological Diagnosis and Etiology of Ocular Surface Squamous Neoplasia in Zambia,10242679,9/15/2017 0:00,10/15/2021 0:00,Research Centers,2021, ,1664, ,26948,16451, 
Genome instability in cancer: telomeres and DNA repair,10242700,9/2/2016 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,905588, ,NCI,600000,417000,905588
Regulation Of Epidermal Differentiation,10244800, , ,Intramural Research,2020,2112155, ,NIAMS, , ,2112155
Project 1:The Carolina Breast Cancer Study,10244929,8/5/1997 0:00,8/31/2023 0:00,Research Centers,2021, ,585719, ,377802,208170, 
Project 4: Chromatin Remodeling Drives the Adaptive Resistance Response to Targeted Kinase Inhibition in Breast Cancer,10244932,8/5/1997 0:00,8/31/2023 0:00,Research Centers,2021, ,337963, ,217994,120114, 
Molecular mechanisms of SCLC initiation and detection in mice and humans,10245149,9/19/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,567542, ,NCI,371817,223587,567542
Resolving the cancer relevance of predisposition gene mutations,10245286,9/1/2020 0:00,8/31/2027 0:00,Non-SBIR/STTR,2021,952518, ,NCI,661720,390415,952518
Neuroendocrine mechanisms of prostate cancer progression,10245737,7/7/2015 0:00,6/30/2021 0:00,Non-SBIR/STTR,2020,49997, ,NCI,31845,18152,49997
Regulation of transcriptional activation by protein disorder,10247077,6/1/2016 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,318706, ,NIGMS,262444,56262,318706
Full Project 3: Molecular Pathways to Breast Cancer Mortality among African American and White Women,10247136,9/28/2010 0:00,8/31/2022 0:00,Research Centers,2020, ,31100, ,20000,11100, 
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia,10247497,8/5/2003 0:00,8/31/2023 0:00,Research Centers,2021,1689836, ,NCI,1197734,492102,1689836
Sphingolipids in Cancer Biology and Therapy,10247617,8/1/2003 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021,1299443, ,NCI,823319,476124,1299443
Project 2: Role of ACER2 in Liver Cancer,10247634,8/1/2003 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021, ,198736, ,126477,72259, 
Project 3: Role of Sphingosine Kinase in P53 Cancer Biology,10247635,8/1/2003 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021, ,198271, ,127125,71146, 
HCV Infection and Innate Immunity,10248111, , ,Intramural Research,2020,0, , , , , 
UBIQUITIN-PROTEASOME PATHWAY IN CANCER,10248350,9/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,319395, ,NIGMS,194753,124642,319395
Precision approaches to refining TP53-associated cancer risk,10248481,9/18/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021,1705096, ,NCI,1233730,471366,1705096
Synergistic combinations that target apoptosis induction in PTCL,10249205,9/1/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021, ,462042, ,361571,100471, 
Genomics and Proteomics of Head and Neck Cancer,10249842, , ,Intramural Research,2020,972669, ,NIDCD, , ,972669
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms,10249969,9/1/2020 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,376348, ,NINDS,251837,124511,376348
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy,10250362,9/30/2017 0:00,8/31/2023 0:00,Research Centers,2021, ,475484, ,359103,167123, 
Placenta specific and ribosomal RNA genes: structure and function,10250874, , ,Intramural Research,2020,924081, ,NIA, , ,924081
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery,10251044,9/30/2017 0:00,8/31/2023 0:00,Research Centers,2021, ,308002, ,308002,0, 
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer,10251109,9/22/2017 0:00,8/31/2023 0:00,Research Centers,2021,1686672, ,NCI,1071608,615064,1686672
Project 1: High Grade Cancers: Capitalizing on PARPness in Ovarian Carcinoma,10251114,9/22/2017 0:00,8/31/2023 0:00,Research Centers,2021, ,344121, ,215076,129045, 
"Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis",10251664, , ,Intramural Research,2020,2144276, ,NIA, , ,2144276
Genetic Susceptibility To Carcinogens,10251694, , ,Intramural Research,2020,438205, ,NIEHS, , ,438205
Discovery And Functional Genomics Of Environmental Response Genes,10251701, , ,Intramural Research,2020,2120911, ,NIEHS, , ,2120911
Elucidating the molecular determinants of p53-mediated pleiotropic effects,10251909,7/1/2020 0:00,6/30/2023 0:00,"Training, Individual",2021,33439, ,NCI,33439, ,33439
Project 2: TOPK/PRPK as Novel Targets for Skin Cancer Prevention,10252870,9/10/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021, ,160335, ,110775,49560, 
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin,10252871,9/10/2019 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021, ,227817, ,178257,49560, 
Prevention of anal cancer in People Living with HIV (PLWH),10253321,10/1/2021 0:00,9/30/2025 0:00,Non-SBIR/STTR,2022, , , , , , 
"Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy",10253806, , ,Intramural Research,2020,2408401, ,NHLBI, , ,2408401
Mitochondrial regulation and function in cancer and cardiovascular biology,10253814, , ,Intramural Research,2020,1208174, ,NHLBI, , ,1208174
Lysosome biogenesis and homeostasis,10253872, , ,Intramural Research,2020,1008803, ,NHLBI, , ,1008803
"Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.",10253876, , ,Intramural Research,2020,1637478, ,NHLBI, , ,1637478
"microRNA, immunophenotypic, and somatic alterations in hematologic malignancies",10255218, , ,Intramural Research,2020,0, , , , , 
Bone Marrow Histopathological Changes in Neoplastic and Non-Neoplastic Diseases,10255219, , ,Intramural Research,2020,0, , , , , 
Natural History of Familial Carcinoid Tumor,10255245, , ,Intramural Research,2020,714196, ,NIDDK, , ,714196
Human Genes Affecting Chromosome Metabolism and Stress Response,10255259, , ,Intramural Research,2020,17940, ,NIEHS, , ,17940
High-throughput Screening for SHH medulloblastoma,10255327, , ,Intramural Research,2020,112360, ,NCATS, , ,112360
Oncogenic Roles and Therapeutic Potential of MCL1 Addiction in Primary Effusion Lymphoma,10255517,9/4/2020 0:00,8/31/2023 0:00,Other Research-Related,2021,158397, ,NCI,146664,11733,158397
Roll of Nitrous Oxide (NO) and Cyclic GMP in Cancer,10256298,10/1/2021 0:00,9/30/2025 0:00,Non-SBIR/STTR,2022, , , , , , 
Site-specific epigenetic activation of TP53 to improve cancer therapy,10258179,9/16/2021 0:00,9/15/2023 0:00,SBIR/STTR,2021,350000, ,NIGMS, , ,350000
Oncogenic Function of FBXW7 R465 mutation reveals a new opportunity for cancer therapy,10260262, , ,Intramural Research,2020,15316, ,NIA, , ,15316
Development of novel PIP4K inhibitors to treat p53-null cancer,10260471,9/10/2020 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,338769, ,NIGMS,202250,136519,338769
Using a chemical biology approach to develop novel inhibitors of mitochondrial oxidative phosphorylation for the treatment of ovarian cancer,10260915,4/1/2022 0:00,3/31/2026 0:00,Non-SBIR/STTR,2022, , , , , , 
Toxicology in the 21st Century Program (Tox21) - Systems Toxicology,10261234, , ,Intramural Research,2020,295462, ,NCATS, , ,295462
C. Elegans as a Model of Cell Senescence and Alzheimer's Disease,10261332,9/15/2020 0:00,4/30/2024 0:00,Non-SBIR/STTR,2021,192500, ,NIA,125000,67500,192500
Mutant p53 gain-of-function as an actionable target in cancer therapy,10261455,9/11/2020 0:00,8/31/2025 0:00,Non-SBIR/STTR,2021,212358, ,NCI,133140,79218,212358
Understanding Richter's Transformation in the targeted therapies era,10261511,9/11/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2021,474404, ,NCI,304105,170299,474404
Chromosomal Proteins and Chromosomal Functions,10262005, , ,Intramural Research,2020,916515, ,NCI, , ,916515
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,10262009, , ,Intramural Research,2020,1200776, ,NCI, , ,1200776
"Tumor Suppressor Protein, p53",10262014, , ,Intramural Research,2020,579777, ,NCI, , ,579777
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression,10262030, , ,Intramural Research,2020,1151331, ,NCI, , ,1151331
Regulation of Lymphocyte Proliferation and Replicative Capacity,10262042, , ,Intramural Research,2020,241088, ,NCI, , ,241088
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,10262045, , ,Intramural Research,2020,525449, ,NCI, , ,525449
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,10262048, , ,Intramural Research,2020,419275, ,NCI, , ,419275
DNA repair,10262056, , ,Intramural Research,2020,2074981, ,NCI, , ,2074981
Enzymes and Substrates of the Ubiquitin Conjugating System,10262057, , ,Intramural Research,2020,1057306, ,NCI, , ,1057306
Identification of Genetic Factors Associated with Infectious Diseases,10262058, , ,Intramural Research,2020,312151, ,NCI, , ,312151
Role of CEBP transcription factors in cell growth and tumorigenesis,10262069, , ,Intramural Research,2020,1500440, ,NCI, , ,1500440
Immune Reconstitution,10262110, , ,Intramural Research,2020,2241386, ,NCI, , ,2241386
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,10262136, , ,Intramural Research,2020,141496, ,NCI, , ,141496
"Role of inflammation, innate resistance, and immunity in carcinogenesis",10262154, , ,Intramural Research,2020,957864, ,NCI, , ,957864
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,10262157, , ,Intramural Research,2020,392536, ,NCI, , ,392536
p53-induced Regulation of Transcription in the Chromatin Context,10262170, , ,Intramural Research,2020,186698, ,NCI, , ,186698
Development of TGF-beta antagonists for cancer therapy,10262175, , ,Intramural Research,2020,621015, ,NCI, , ,621015
Redox Mechanism Process of Angiogenesis and Wound Healing,10262180, , ,Intramural Research,2020,644771, ,NCI, , ,644771
Gene therapy of cancer,10262196, , ,Intramural Research,2020,3270963, ,NCI, , ,3270963
TMPRSS2-ERG chromosomal translocations and prostate cancer,10262211, , ,Intramural Research,2020,196267, ,NCI, , ,196267
Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,10262232, , ,Intramural Research,2020,527174, ,NCI, , ,527174
Role of Brachyury in regulating notochord development and neoplasia,10262238, , ,Intramural Research,2020,87192, ,NCI, , ,87192
Role of microbiome in cancer and inflammation,10262245, , ,Intramural Research,2020,1915729, ,NCI, , ,1915729
Role of inflammation in epigenetic alterations of metastatic cancer cells,10262250, , ,Intramural Research,2020,985483, ,NCI, , ,985483
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,10262255, , ,Intramural Research,2020,1292352, ,NCI, , ,1292352
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,10262259, , ,Intramural Research,2020,869665, ,NCI, , ,869665
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,10262291, , ,Intramural Research,2020,676757, ,NCI, , ,676757
Precision Medicine of Cancer,10262347, , ,Intramural Research,2020,2168979, ,NCI, , ,2168979
"p53, Aging, and Cancer",10262348, , ,Intramural Research,2020,2168979, ,NCI, , ,2168979
Vulnerabilities in osteosarcoma and breast cancer,10262352, , ,Intramural Research,2020,826339, ,NCI, , ,826339
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,10262359, , ,Intramural Research,2020,1423817, ,NCI, , ,1423817
Role of long non-coding RNAs in p53 signaling,10262380, , ,Intramural Research,2020,1526340, ,NCI, , ,1526340
Comparative Brain Tumor Consortium,10262404, , ,Intramural Research,2020,74565, ,NCI, , ,74565
Genomic characterization and development of therapies for pediatric sarcoma,10262419, , ,Intramural Research,2020,743763, ,NCI, , ,743763
Preclinical Development of Therapeutics in Murine Models of Lung Cancer,10262427, , ,Intramural Research,2020,221242, ,NCI, , ,221242
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models,10262428, , ,Intramural Research,2020,1106205, ,NCI, , ,1106205
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models,10262430, , ,Intramural Research,2020,1327446, ,NCI, , ,1327446
Hypoxia signaling in cancer development,10262450, , ,Intramural Research,2020,1209802, ,NCI, , ,1209802
Minimal Myc functional threshold for tumorigenesis,10262493, , ,Intramural Research,2020,174382, ,NCI, , ,174382
Establish Preclinical Model for IDH-mutated Glioma,10262516, , ,Intramural Research,2020,353634, ,NCI, , ,353634
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system,10262667, , ,Intramural Research,2020,1603767, ,NHLBI, , ,1603767
Nitric Oxide as a Modifier of Oxidative Stress,10262700, , ,Intramural Research,2020,483577, ,NCI, , ,483577
The Evaluation of Novel Therapeutics for Genitourinary Malignancies,10262707, , ,Intramural Research,2020,488637, ,NCI, , ,488637
Molecular Profiling of Clinical Specimens,10262744, , ,Intramural Research,2020,1307467, ,NCI, , ,1307467
Comparison of molecular factors to drug activities,10262763, , ,Intramural Research,2020,95364, ,NCI, , ,95364
Comparative Biomedical Scientist Training Program,10262829, , ,Intramural Research,2020,1702988, ,NCI, , ,1702988
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure,10262831, , ,Intramural Research,2020,221242, ,NCI, , ,221242
Consultation and Collaboration,10263757, , ,Intramural Research,2020,26747, ,NCI, , ,26747
Phenotypic Assay Design and Development for Rare and Neglected Diseases,10263804, , ,Intramural Research,2020,475656, ,NCATS, , ,475656
miR-200 miRNAs repress tumor metastasis in lung adenocarcinoma,10265480,8/1/2009 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,373268, ,NCI,237750,135518,373268
Investigation of sub-lineages in pulmonary neuroendocrine cells and identification of the cells of origin of small cell lung cancer,10265579,9/16/2020 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,249000, ,NCI,157169,91831,249000
Animal MRI/Imaging Facility,10265900, , ,Intramural Research,2020,479096, ,NHLBI, , ,479096
"DNA Replication, Cancer and Chemotherapy",10266460, , ,Intramural Research,2020,1686487, ,NICHD, , ,1686487
Regulation Of Intracellular Iron Metabolism,10266478, , ,Intramural Research,2020,1758825, ,NICHD, , ,1758825
FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS,10267077, , ,Intramural Research,2020,868147, ,NHGRI, , ,868147
Identification of genetic alterations that underlie endometrial carcinosarcomas,10267109, , ,Intramural Research,2020,132679, ,NHGRI, , ,132679
Project 3: Early detection and prevention of MM progression,10270457,9/1/2015 0:00,8/31/2026 0:00,Research Centers,2021, ,396805, ,285175,111780, 
PROJECT 2: NF1-associated Glioblastoma,10270582,9/1/2015 0:00,8/31/2026 0:00,Research Centers,2021, ,433758, ,412057,21701, 
Characterization of ELP1 as a novel SHH medulloblastoma predisposition gene,10270674,4/1/2003 0:00,8/31/2026 0:00,Non-SBIR/STTR,2021, ,450558, ,251007,199551, 
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease,10272042, , ,Intramural Research,2020,937880, ,NIAID, , ,937880
A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial,10273769,5/15/2022 0:00,4/30/2027 0:00,Non-SBIR/STTR,2022,2200000, ,NIDDK,1700082,499918,2200000
"Phase I study to evaluate safety, tolerability, pharmacokinetics and anti-tumor activity of WSD0922-FU",10274704,9/1/2021 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021,286989, ,FDA,191792,95197,286989
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer,10276919,9/1/2021 0:00,8/31/2026 0:00,Non-SBIR/STTR,2021,370575, ,NCI,228750,141825,370575
A pro-metastatic secretory pathway activated by p53 loss in lung cancer,10277847,7/1/2021 0:00,6/30/2026 0:00,Non-SBIR/STTR,2021,433936, ,NCI,267862,166074,433936
PR55-alpha controlled PP2A in the regulation of the Hippo/YAP pathway,10277999,9/1/2021 0:00,8/31/2025 0:00,Non-SBIR/STTR,2021,306167, ,NIGMS,200000,106167,306167
Prevention of anthracycline-induced cardiotoxicity by Nur77 activation,10280044,7/16/2021 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,526590, ,NHLBI,337558,189032,526590
Mdm2 Alternative Splicing in DNA Damage and Cancer,10280391,9/1/2021 0:00,8/31/2026 0:00,Non-SBIR/STTR,2021,426202, ,NCI,283498,142704,426202
Insights from somatic genomics lead to novel therapeutic targets in inherited bone marrow failure syndromes: Shwachman-Diamond Syndrome as a model.,10283081,7/1/2021 0:00,3/31/2026 0:00,Other Research-Related,2021,136381, ,NIDDK,126279,10102,136381
Functional characterization of 2q22.1 deletion in oral squamous cell carcinoma,10285990,9/2/2020 0:00,9/1/2024 0:00,"Training, Individual",2021,51836, ,NIDCR,51836, ,51836
Targeted therapy against TERT oncogene-rearranged neuroblastoma,10287498,8/1/2021 0:00,7/31/2023 0:00,Non-SBIR/STTR,2021,54000, ,NCI,50000,4000,54000
Twist1 as a Target for Prevention and Treatment of Cutaneous Squamous Cell Carcinoma,10288511,7/1/2021 0:00,6/30/2026 0:00,Non-SBIR/STTR,2021,362569, ,NCI,228750,133819,362569
APC + TP53 Combinatorial Mutations Emerging as Biomarkers to Predict EGFRI Sensitivity,10289625,8/1/2021 0:00,4/16/2022 0:00,Non-SBIR/STTR,2021,213881, ,NCI,140250,73631,213881
Development of a clinically relevant mouse model of ER+ breast cancer,10290139,7/1/2021 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,191479, ,NCI,116875,74604,191479
Exploring miR-29 in melanoma progression and prevention,10290462,8/1/2021 0:00,7/31/2023 0:00,Non-SBIR/STTR,2021,192493, ,NCI,116875,75618,192493
Reflux-Induced Oxidative DNA Damage Repair Early in Barrett's Carcinogenesis,10292418,7/1/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021, , , , , , 
Investigating the Impact of Telomere Specific Oxidative Base Damage in Cellular Aging,10292913,6/1/2020 0:00,11/30/2021 0:00,"Training, Individual",2021,40206, ,NIA,40206, ,40206
Investigating the role of DUX and miR-34a regulation in cell fate plasticity and cancer,10293564,11/1/2018 0:00,8/31/2023 0:00,"Training, Individual",2022,51752, ,NICHD,51752,0,51752
BLR&D Research Career Scientist Award Application,10293576,10/1/2018 0:00,9/30/2023 0:00,Other,2022, , , , , , 
PRECISION METABOLIC THERAPY OF p53 MUTANT TRIPLE NEGATIVE BREAST CANCERS,10294457,7/20/2021 0:00,6/30/2026 0:00,Non-SBIR/STTR,2021,325732, ,NCI,219348,106384,325732
Investigating the role of dysfunctional histone H3.3 in driving early neuronal development and pediatric high-grade gliomas,10296014,6/1/2021 0:00,5/31/2026 0:00,Non-SBIR/STTR,2021,426431, ,NINDS,263229,163202,426431
Chemo-immunotherapy strategy for pediatric high grade glioma,10296214,7/15/2021 0:00,12/31/2023 0:00,Non-SBIR/STTR,2021,429000, ,NINDS,275000,154000,429000
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma,10296271,7/1/2021 0:00,6/30/2026 0:00,Non-SBIR/STTR,2021,357994, ,NCI,228750,129244,357994
Mre11-Dependent DNA Damage Responses in Breast Cancer Pathogenesis,10296655,12/1/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,422092, ,NCI,275751,146341,422092
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis,10296665,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,625994, ,NCI,325360,300634,625994
p53-mediated metabolic regulation in tumor suppression,10296735,9/1/2021 0:00,8/31/2028 0:00,Non-SBIR/STTR,2021,570812, ,NCI,352353,218459,570812
Biology of R-Spondin-Induced Sensitization to Asparaginase in Colorectal Cancer,10297173,8/1/2021 0:00,7/31/2026 0:00,Non-SBIR/STTR,2021,651421, ,NCI,491803,159618,651421
Hsp60 Regulation of Prostate Cancer Progression,10297279,9/1/2021 0:00,8/31/2026 0:00,Non-SBIR/STTR,2021,384758, ,NCI,228750,156008,384758
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization,10297588,9/16/2021 0:00,6/30/2026 0:00,Non-SBIR/STTR,2021,595609, ,NCI,377907,217702,595609
Molecular analysis and therapeutic targeting of PI3K signaling in thyroid cancer,10297852,2/1/2009 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,414060, ,NCI,247940,166120,414060
Inhibiting tumor growth and metastasis in highly aggressive breast cancers with centrosome amplification,10298311,7/1/2021 0:00,4/30/2022 0:00,Non-SBIR/STTR,2021,338913, ,NCI,228750,110163,338913
Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy,10298611,7/1/2021 0:00,6/30/2025 0:00,Non-SBIR/STTR,2021,420442, ,NCI,250263,170179,420442
Molecular mechanisms of prostate cancer metastasis,10299242,1/1/2015 0:00,6/30/2026 0:00,Non-SBIR/STTR,2021,473850, ,NCI,292500,181350,473850
Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast,10300432,12/11/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,356850, ,NCI,228750,128100,356850
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges,10301007,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,432394, ,NINDS,271946,160448,432394
Investigating the contribution of cellular senescence to the efficacy of radiation therapy.,10301229,9/1/2021 0:00,8/31/2026 0:00,Other Research-Related,2021,255045, ,NCI,236153,18892,255045
Investigating apoptotic priming as a determinant of sensitivity to leukemia-directed therapies,10301504,7/1/2021 0:00,6/30/2025 0:00,Other Research-Related,2021,255045, ,NCI,236153,18892,255045
Characterization of relation between tissue viscoelasticity and tumor progression in aging tissues,10302055,9/15/2021 0:00,6/26/2022 0:00,Other Research-Related,2021,150940, ,NIA,140500,10440,150940
Pediatric Preclinical Testing Consortium,10302056,7/7/2015 0:00,6/30/2021 0:00,Non-SBIR/STTR,2021,180518, ,NCI,102567,77951,180518
Drivers of histologic transformation in EGFR-mutant lung cancer,10302886,9/21/2021 0:00,8/31/2026 0:00,Non-SBIR/STTR,2021,404888, ,NCI,228750,176138,404888
Interplay of mammary luminal cells and environmental factors in establishing p53-deficient premalignant field,10303044,12/12/2017 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,367270, ,NCI,224175,143095,367270
Novel Mechanisms Controlling SCLC Tumor Initiation,10303538,8/1/2021 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,189256, ,NCI,124977,64279,189256
NOX4 Mediates Oxidative Stress in Ovarian Tumor growth and treatment Response,10304003,12/1/2015 0:00,8/31/2022 0:00,Non-SBIR/STTR,2020,321204, ,NCI,205900,115304,321204
ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient ProstateCancer,10304098,6/8/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2020,271155, ,NCI,205175,65980,271155
The impact of coding region variants on mutant p53 biology,10304135,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,435965, ,NCI,292114,143851,435965
Identifying the role of Ntrk1 in immunosuppression in Kras/p53 mutant lung cancer,10304891,12/9/2019 0:00,3/15/2022 0:00,"Training, Individual",2022,24777, ,NCI,24777,0,24777
Novel protein kinase signaling associated with platinum resistance in ovarian cancer,10305342,9/1/2021 0:00,8/31/2026 0:00,Non-SBIR/STTR,2021,443013, ,NCI,290500,152513,443013
MDM2 inhibitor therapy for TP53 wild-type GBM,10305366,9/1/2021 0:00,8/31/2026 0:00,Non-SBIR/STTR,2021, ,172801, ,108680,64121, 
Cyclin Dependent Kinase 4/6 (CDK4/6) as a Therapeutic Target in Glioblastoma,10305588,4/9/2020 0:00,4/8/2023 0:00,"Training, Individual",2021,43768, ,NCI,43768, ,43768
Coordination of inflammatory signaling and cardiac fibrosis by small proline rich proteins,10305604,12/21/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,425246, ,NHLBI,276134,149112,425246
Mechanisms of Esophageal Carcinogenesis,10305930,7/1/2021 0:00,7/2/2021 0:00,Non-SBIR/STTR,2021,138069, ,NCI,85228,52841,138069
Regulation of p53 and Checkpoint Signaling by Chromium(VI),10306386,12/1/2017 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,365625, ,NIEHS,225000,140625,365625
Targeting defective necroptosis in colorectal cancer,10307591,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,430693, ,NCI,312394,118299,430693
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential,10307617,12/3/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,722442, ,NCI,380233,342209,722442
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma,10308007,12/1/2017 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,406527, ,NCI,236766,169761,406527
Suppression of mobile elements by p53 genes,10308726,8/1/2015 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,344400, ,NIGMS,210000,134400,344400
Anticancer peptide therapeutics,10310407,8/1/2017 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,346350, ,NCI,224175,122175,346350
Genomic Biology of the Tandem Duplicator Phenotype in Mouse and Human Cancers,10310437,12/1/2020 0:00,11/30/2025 0:00,Non-SBIR/STTR,2022,689912, ,NCI,365033,324879,689912
Minimizing the risk of therapy-related myeloid neoplasms by inhibiting genotoxic stress-induced expansion of leukemia-initiating cells with p53 mutations,10310505,12/1/2020 0:00,11/30/2022 0:00,Non-SBIR/STTR,2022,80500, ,NCI,50000,30500,80500
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment,10311034,12/1/2019 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,456860, ,NCI,274356,182504,456860
Genomics Of Acute Myeloid Leukemia.,10311206,9/19/2003 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,3081712, ,NCI,1956642,1125070,3081712
Targeting USP10 to regulate the DNA damage response in NSCLC,10311543,12/3/2020 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,176389, ,NCI,114538,61851,176389
Mutant p53 in pathogenesis of Myelodysplastic Syndromes,10313142,1/1/2022 0:00,12/31/2024 0:00,"Training, Individual",2021,41596, ,NHLBI,41596,0,41596
Elucidating the molecular mechanisms of PRMT5i response and resistance in LUAD and PDAC,10313505,7/1/2021 0:00,6/30/2024 0:00,"Training, Individual",2021,66390, ,NCI,66390, ,66390
Determining the role of ASCL1 in neuroendocrine prostate cancer,10313551,7/9/2021 0:00,7/8/2024 0:00,"Training, Individual",2021,34656, ,NCI,34656, ,34656
EARLY DETECTION OF CLONAL HEMATOPOIESIS AND LEUKEMIA ASSOCIATED MUTATIONS IN WTC EXPOSED FIREFIGHTERS AFTER THE 9/11 ATTACKS,10315070,7/1/2021 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,488696, ,NIOSH, , ,488696
Characterization of Resistance to PRMT5 Inhibitor Therapy in Mantle Cell Lymphoma,10315465,8/16/2021 0:00,8/15/2023 0:00,"Training, Individual",2021,72707, ,NCI,72707, ,72707
Regional selectivity of oncohistone H3K27M on glial development and glioma pathogenesis,10315763,7/1/2021 0:00,6/30/2024 0:00,"Training, Individual",2021,42036, ,NCI,42036, ,42036
The regulation of mutant p53 protein accumulation in cancer: molecular basis and therapeutic potential,10315918,7/1/2021 0:00,6/30/2026 0:00,Non-SBIR/STTR,2021,413128, ,NCI,263139,149989,413128
Understanding Resistance to Next Generation Antiandrogens,10316208,5/1/2012 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022,396018, ,NCI,220500,175518,396018
Functional Analysis of p53 Polymorphic Variants,10316253,6/1/2005 0:00,11/30/2025 0:00,Non-SBIR/STTR,2022,383402, ,NCI,209475,173927,383402
Cell lineage determinants of p53-driven fate outcomes in vivo,10316263,12/9/2020 0:00,11/30/2025 0:00,Non-SBIR/STTR,2022,576567, ,NCI,392699,183868,576567
The Role of p53-R249S’s GOF in HCC development,10317044,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022,351610, ,NCI,234255,117355,351610
Metallacycle-mediated coupling in stereoselective synthesis,10317087,1/1/2020 0:00,12/31/2024 0:00,Non-SBIR/STTR,2022,574000, ,NIGMS,350000,224000,574000
Fibrocytes: A novel cell population promoting obesity-induced breast tumor desmoplasia,10317094,1/1/2020 0:00,12/31/2022 0:00,"Training, Individual",2022,35195, ,NCI,35195,0,35195
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma,10317122,12/10/2020 0:00,11/30/2025 0:00,Non-SBIR/STTR,2022,689255, ,NCI,406641,282614,689255
Re-engineered Mitochondrially Targeted p53 Gene Therapy in Liver Cancer,10317129,1/1/2021 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022,209604, ,NCI,137445,72159,209604
Comprehensive identification of RAS mutations and allelic co-segregation patterns in colorectal cancer,10318676,12/14/2020 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,93500, ,NCI,50000,43500,93500
Analysis of the Mammalian DNA Damage Response,10319546,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022,401273, ,NCI,224175,177098,401273
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer,10319568,1/1/2020 0:00,12/31/2024 0:00,Non-SBIR/STTR,2022,334021, ,NCI,224175,109846,334021
Mechanisms of gene expression control in the p53 network,10319995,5/26/2006 0:00,1/31/2023 0:00,Non-SBIR/STTR,2022,325734, ,NCI,209475,116259,325734
The Inflammasome as a novel mediator and therapeutic target of GI syndrome,10320010,1/1/2018 0:00,12/31/2022 0:00,Non-SBIR/STTR,2022,375493, ,NCI,224175,151318,375493
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis,10320158,3/1/2021 0:00,2/28/2023 0:00,Non-SBIR/STTR,2021,384018, ,NCI,253997,130021,384018
The role and regulation of p53 in obesity-induced liver cancer,10320352,1/1/2021 0:00,12/31/2023 0:00,"Training, Individual",2022,69802, ,NCI,69802,0,69802
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor,10320453,1/1/2021 0:00,12/31/2025 0:00,Other Research-Related,2022,265113, ,NCI,245475,19638,265113
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer,10320905,2/6/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2022,357342, ,NCI,263371,93971,357342
Regulators of ubiquitin signaling in malignant hematopoiesis,10321308,2/1/2021 0:00,1/31/2025 0:00,Other Research-Related,2021,87363, ,NCI,80892,6471,87363
Exploration of long non-coding RNAs as synthetic essential targets in Pten-deficient cancers,10321527,9/18/2020 0:00,9/17/2025 0:00,"Training, Individual",2021,44254, ,NCI,44254, ,44254
Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy,10321531,1/1/2021 0:00,12/31/2025 0:00,Non-SBIR/STTR,2022,363164, ,NCI,224175,138989,363164
"Dynamics, Regulation and Function of p53 in Single Cells",10321563,1/1/2021 0:00,12/31/2025 0:00,Non-SBIR/STTR,2022,668716, ,NIGMS,395105,273611,668716
Genetic Biomarkers for Risk of CLL Progression among high-count MBLs,10321662,1/1/2021 0:00,9/30/2023 0:00,Non-SBIR/STTR,2022,182662, ,NCI,119703,62959,182662
Investigating the mechanisms for mutant p53 stability in cancer cells,10321887,1/1/2020 0:00,4/30/2022 0:00,"Training, Individual",2022,14411, ,NCI,14411,0,14411
Telomerase-Mediated Healing of Double-Strand Breaks in Human Cells,10321890,1/1/2021 0:00,12/31/2024 0:00,"Training, Individual",2022,51752, ,NCI,51752,0,51752
Resistance Mechanisms in ROS1-Fusion-Driven Malignancies,10321897,1/16/2020 0:00,1/15/2025 0:00,"Training, Individual",2022,51752, ,NCI,51752,0,51752
Regulation of Amino-acid Transport in Human Gliomas,10321925,12/1/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,362043, ,NCI,224175,137868,362043
Identifying Novel Therapeutics for High Risk Medulloblastoma Patients,10322034,1/1/2021 0:00,12/31/2025 0:00,Other Research-Related,2022,216345, ,NINDS,200319,16026,216345
Research Project 3: Cell fate decision of liver tumor-initiating stem-like cells induced by alcohol,10322380,1/1/1999 0:00,12/31/2023 0:00,Research Centers,2022, ,112050, ,67909,44141, 
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice,10322419,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022,498165, ,NCI,319336,178829,498165
Molecular Biology of Oncogenic Papillomaviruses,10322439,1/1/2016 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022,996660, ,NCI,588000,408660,996660
Control of Lipogenesis and Hepatic Steatosis by Caspase-2,10322660,3/15/2019 0:00,6/30/2023 0:00,Non-SBIR/STTR,2022,417724, ,NIDDK,264382,153342,417724
Phosphoinositide Signaling in the Cytosol and Nucleus,10323007,1/1/2020 0:00,12/31/2024 0:00,Non-SBIR/STTR,2022,707148, ,NIGMS,458002,249146,707148
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma,10328878,2/1/2019 0:00,1/31/2024 0:00,Non-SBIR/STTR,2022,366000, ,NCI,228750,137250,366000
Targeted Therapy for Endometrial Cancer,10328893,7/1/2002 0:00,4/30/2024 0:00,Non-SBIR/STTR,2022,279805, ,NCI,186200,95893,279805
Elucidate the mechanism of autophagy in supporting Lkb1-deficient lung tumorigenesis and metastasis,10329966,2/1/2020 0:00,1/31/2023 0:00,Non-SBIR/STTR,2022,362982, ,NCI,231814,131168,362982
Endothelial Toll-like Receptor 3 in the pathogenesis and therapy of Pulmonary Arterial Hypertension,10330003,1/1/2019 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022,594409, ,NHLBI,440111,154298,594409
Disordered Proteins and Dynamic Interactions in Biology and Diseases.,10330292,3/1/2022 0:00,2/28/2027 0:00,Non-SBIR/STTR,2022,379812, ,NIGMS,250000,129812,379812
Project 5: Tumor Suppressor and Tumor Maintenance Genes,10330427,2/10/1997 0:00,1/31/2023 0:00,Non-SBIR/STTR,2022, ,617817, ,386454,231363, 
Cell fate decisions in Merkel cell carcinoma initiation and maintenance,10330465,2/20/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2022,514378, ,NCI,329730,184648,514378
The mechanism through which mRNA translation enhancer elements drive cap-independent translation,10330993,2/20/2019 0:00,1/31/2024 0:00,Non-SBIR/STTR,2022,308400, ,NIGMS,238400,70000,308400
The Age-Dependence and Cell-Specificity of Breast Cancer Driven by Mutant p53,10331816,3/15/2020 0:00,1/31/2024 0:00,Other Research-Related,2022,153000, ,NIGMS,100000,53000,153000
Project 2: The role of the DNA damage response in clonal competition following genotoxic stress,10332336,4/8/2022 0:00,3/31/2027 0:00,Non-SBIR/STTR,2022, ,592278, ,372087,220191, 
Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer,10332466,8/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2020,226665, ,NCI,158000,68665,226665
Targeting immune suppressive microenvironment in ATC,10333316,2/1/2021 0:00,1/31/2026 0:00,Non-SBIR/STTR,2022,431902, ,NCI,244012,187890,431902
Regulators of ubiquitin signaling in malignant hematopoiesis,10333418,2/1/2021 0:00,1/31/2025 0:00,Other Research-Related,2022,86327, ,NCI,79932,6395,86327
Translational Studies in FLASH Particle Radiotherapy,10333797,2/15/2022 0:00,1/31/2027 0:00,Non-SBIR/STTR,2022,2478484, ,NCI,1651219,827265,2478484
Project 1: FLASH vs. Standard radiotherapy for treatment of PDAC and sparing normal intestine tissues,10333798,2/15/2022 0:00,1/31/2027 0:00,Non-SBIR/STTR,2022, ,481131, ,325911,155220, 
Project 2: Mitigation of radiation toxicity in treatment of sarcoma with FLASH vs. Standard dose rates,10333799,2/15/2022 0:00,1/31/2027 0:00,Non-SBIR/STTR,2022, ,627169, ,385950,241219, 
Imaging Modulation of Immune Phenotype,10334545,2/1/2021 0:00,1/31/2026 0:00,Non-SBIR/STTR,2022,641412, ,NCI,429982,211430,641412
Integration of early genetic alterations and inflammation in gastroesophageal premalignancy,10335249,4/1/2019 0:00,1/31/2024 0:00,Other Research-Related,2022,158040, ,NIDDK,147074,10966,158040
Role of p53 Missense Mutations on Tumorigenesis in Vivo,10335754,2/4/2020 0:00,1/31/2025 0:00,Non-SBIR/STTR,2022,377055, ,NCI,232750,144305,377055
Preclinical analyses of advanced prostate cancer in genetically-engineered mice,10337025,8/6/2013 0:00,1/31/2023 0:00,Non-SBIR/STTR,2022,378165, ,NCI,236353,141812,378165
"Isolation, characterization and translational development of glioma stem cells",10337037,2/1/2017 0:00,1/31/2024 0:00,Non-SBIR/STTR,2022,1056048, ,NCI,588000,468048,1056048
Targeting vulnerabilities of PPM1D-mutant gliomas,10337234,2/1/2021 0:00,1/31/2026 0:00,Non-SBIR/STTR,2022,403607, ,NCI,228750,174857,403607
Functional Genomics of LINE-1 Retrotransposition,10337555,4/21/2022 0:00,1/31/2027 0:00,Non-SBIR/STTR,2022,643873, ,NIEHS,424999,218874,643873
Effect of APOBEC3 on Bladder Cancer Biology and Response to Immunotherapy,10338068,2/1/2020 0:00,1/31/2023 0:00,"Training, Individual",2022,46752, ,NCI,46752,0,46752
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites,10338105,3/1/2018 0:00,2/29/2024 0:00,Non-SBIR/STTR,2022,419207, ,NCI,224175,195032,419207
ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism,10339182,1/1/2022 0:00,12/31/2026 0:00,Non-SBIR/STTR,2022,665973, ,NCI,462484,203489,665973
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis,10339474,3/1/2021 0:00,2/28/2024 0:00,Non-SBIR/STTR,2022,342790, ,NCI,246729,96061,342790
Role of TERRA in Telomere Maintenance and Telomere Stress Response,10341218,7/1/2010 0:00,1/31/2026 0:00,Non-SBIR/STTR,2022,426002, ,NCI,232750,193252,426002
Targeted delivery of multimodal therapy for reducing prostate cancer disparity,10342540,12/9/2021 0:00,11/30/2026 0:00,Non-SBIR/STTR,2022,386974, ,NCI,298500,88474,386974
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer,10346091,5/22/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2021,48583, ,NCI,29267,19316,48583
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia,10348140,4/1/2019 0:00,1/31/2024 0:00,Non-SBIR/STTR,2022,355665, ,NIDDK,234724,120941,355665
Nannocystin Reagents to Elucidate the Role of Elongation Factor 1a in Apoptosis,10348198,2/9/2021 0:00,1/31/2023 0:00,Non-SBIR/STTR,2022,78558, ,NCI,50000,28558,78558
Leukemia stem cell regulation and resistance,10350652,2/15/2021 0:00,1/31/2026 0:00,Non-SBIR/STTR,2022,416737, ,NCI,291074,125663,416737
Inhibitors of the G protein GNAS which drives pancreatic tumorigenesis,10355430,3/1/2020 0:00,2/28/2025 0:00,Non-SBIR/STTR,2022,395637, ,NCI,272924,122713,395637
Targeting gain-of-function p53 and BCL-2 for small cell lung cancer treatment,10355807,2/15/2022 0:00,1/31/2024 0:00,Non-SBIR/STTR,2022,181448, ,NCI,116875,64573,181448
The role of the senescent microenvironment on cancer initiating cells in the colon.,10355956,9/30/2021 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,451960, ,NIA,329935,122025,451960
CARP-1: A Potential Therapeutic Agent for Breast Cancer,10356047,4/1/2021 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022, , , , , , 
Therapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML,10356325,1/13/2022 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022,189338, ,NCI,116875,72463,189338
Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome,10356433,1/10/2022 0:00,2/11/2022 0:00,Non-SBIR/STTR,2022,4624, ,NCI,2846,1778,4624
A Novel Treatment Strategy for Metastatic Breast Cancer,10356596,12/15/2021 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,235901, ,NCI,140250,95651,235901
Kidney Injury by Cisplatin and Renoprotective Strategies.,10356820,9/30/2010 0:00,2/28/2024 0:00,Non-SBIR/STTR,2022,418363, ,NIDDK,271664,146699,418363
Role of SIRT3 in melanoma development and progression,10357731,4/1/2017 0:00,6/30/2022 0:00,Non-SBIR/STTR,2021, , , , , , 
Genomic Instability and Cancer Genetics,10357811,3/1/1997 0:00,2/28/2023 0:00,Research Centers,2022, ,20625, ,13298,7327, 
Cancer Pharmacology,10357813,3/1/1997 0:00,2/28/2023 0:00,Research Centers,2022, ,19847, ,12806,7041, 
Clinical Investigations and Precision Therapeutics,10357814,3/1/1997 0:00,2/28/2023 0:00,Research Centers,2022, ,19847, ,12806,7041, 
Anti-tumor potential of temperature-sensitive p53 mutants,10357870,3/1/2021 0:00,2/28/2026 0:00,Non-SBIR/STTR,2022,435695, ,NCI,264538,171157,435695
Supernumerary Centrosomes and Cell Proliferation,10357971,3/1/2021 0:00,2/28/2026 0:00,Non-SBIR/STTR,2022,483482, ,NCI,288646,194836,483482
Combination Of Autophagy Selective Therapeutics (COAST) in Serous Ovarian Cancer,10357996,12/1/2021 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,75354, ,NCI,50000,25354,75354
Systematic characterization of cancer variants using single-cell functional genomics,10358184,4/1/2022 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022,440728, ,NCI,248999,191729,440728
A novel role of mutant p53 in intronic polyadenylation and impairment of DNA repair,10358369,12/8/2021 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,77500, ,NCI,50000,27500,77500
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells,10358503,2/9/2018 0:00,1/31/2024 0:00,Non-SBIR/STTR,2022,467075, ,NCI,357873,235057,467075
Dissecting and Targeting RB1-Mutant Osteosarcoma,10358587,3/1/2021 0:00,2/28/2026 0:00,Non-SBIR/STTR,2022,420814, ,NCI,292002,128812,420814
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer,10359129,3/1/2021 0:00,2/28/2026 0:00,Non-SBIR/STTR,2022,599304, ,NCI,415227,184077,599304
Epigenetic modulation of SEC24D and circulating miR-605 in renal cell carcinoma,10359448,2/25/2021 0:00,2/24/2023 0:00,Non-SBIR/STTR,2019,68684, ,NCI,43676,25008,68684
Genomic incorporation of stapled peptides for cost effective discovery and synthesis of novel therapeutics,10360415,3/1/2020 0:00,2/28/2023 0:00,"Training, Individual",2022,69802, ,NCI,69802,0,69802
Epigenetic regulation by tumor suppressor p53,10360465,4/1/1999 0:00,8/31/2022 0:00,Non-SBIR/STTR,2022,374728, ,NCI,232750,141978,374728
Mechanism of p53-dependent Tumor Suppression,10360506,3/15/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022,442977, ,NCI,291644,151333,442977
Telomere dysfunction and telomerase reactivation in the etiology and progression of liver cancer,10360832,12/13/2021 0:00,11/30/2026 0:00,Non-SBIR/STTR,2022,360281, ,NCI,228750,131531,360281
Interrogating the role of Notch signaling in lung adenocarcinoma tumorigenesis,10363626,4/1/2020 0:00,3/31/2024 0:00,"Training, Individual",2022,51752, ,NCI,51752,0,51752
Impact of the Breast Cancer Immune Microenvironment on Racial Disparities and Survivorship,10363629,3/1/2021 0:00,3/31/2022 0:00,"Training, Individual",2022,4396, ,NCI,4396,0,4396
The role of leukemia inhibitory factor in colorectal cancer,10364132,2/1/2022 0:00,1/31/2027 0:00,Non-SBIR/STTR,2022,372497, ,NCI,237259,135238,372497
Targeting mechanisms of immune evasion in chemotherapy-induced senescent cells,10364840,4/19/2022 0:00,2/28/2027 0:00,Non-SBIR/STTR,2022,432347, ,NCI,284439,147908,432347
Oncogenic functions of mutant p53,10365193,5/1/2013 0:00,12/31/2026 0:00,Non-SBIR/STTR,2022,330963, ,NCI,207500,123463,330963
Allosteric Regulation of MDMX by Protein Disorder,10365611,9/1/2009 0:00,12/31/2026 0:00,Non-SBIR/STTR,2022,382811, ,NCI,274856,107955,382811
Therapeutic implication of RB1 loss in bladder cancer,10366068,3/5/2021 0:00,2/28/2026 0:00,Other Research-Related,2022,285729, ,NCI,264564,21165,285729
A premalignant chronology of cell-state variability in basal-like breast cancer,10366411,1/1/2022 0:00,12/31/2026 0:00,Non-SBIR/STTR,2022,655486, ,NCI,412745,242741,655486
Developing newly combined therapeutic strategies for mature B cell lymphoma,10366505,4/1/2021 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,476638, ,NCI,323528,153110,476638
Circadian Clock and Myc-dependent Regulation of Cellular Transformation,10366975,1/1/2022 0:00,12/31/2026 0:00,Non-SBIR/STTR,2022,587441, ,NCI,385151,202290,587441
Understanding the role of TP53 mutation in genetic susceptibility to ovarian cancer,10368074,4/1/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2022,517103, ,NCI,336634,180469,517103
Defining Mechanisms of Transformation Driven By the Zinc Finger Transcription Factor PLAGL2 in the Intestinal Epithelium,10368956,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,353076, ,NCI,224175,128901,353076
Statistical methods and tools for cancer risk prediction in families with germline mutations in TP53,10370406,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,351518, ,NCI,234100,117418,351518
Uncovering Epigenetic and Transcriptional Drivers of Neuroendocrine Plasticity at Single-Cell Level in Patients with Small Cell Lung Cancer Transformation,10370691,12/15/2021 0:00,11/30/2026 0:00,Other Research-Related,2022,278198, ,NCI,257591,20607,278198
Cyclin-dependent kinase control of cell-division and transcription cycles,10370800,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,7332, ,NIGMS,7332, ,7332
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53,10371066,4/12/2019 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022,83068, ,NCI,61427,21641,83068
Impact of the Breast Cancer Immune Microenvironment on Racial Disparities and Survivorship,10371767,5/1/2021 0:00,2/28/2023 0:00,"Training, Individual",2021,2500, ,NCI,2500, ,2500
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas,10372935,4/1/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,494120, ,NCI,305957,188163,494120
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer,10373016,3/1/2020 0:00,2/28/2025 0:00,Non-SBIR/STTR,2022,477962, ,NCI,295952,182010,477962
CLINCIAL VALIDATION OF APC AND TP53 AS BIOMARKERS FOR CETUXIMAB RESPONSE,10373564,7/3/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,308813, ,NCI,202500,106313,308813
Impact of circadian disruption on pancreatic cancer development and progression,10373645,12/1/2021 0:00,11/30/2023 0:00,Non-SBIR/STTR,2022,209375, ,NIEHS,125000,84375,209375
Toward development of senolytic CAR T cells,10374901,5/15/2020 0:00,2/28/2025 0:00,Non-SBIR/STTR,2022,535583, ,NIA,302589,232994,535583
Molecular mechanisms underlying lineage plasticity in prostate cancer,10375455,4/15/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022,594606, ,NCI,341018,253588,594606
Investigating the Role of Metabolic Reprogramming in Cancer Cell Death Sensitivity,10375471,4/3/2020 0:00,2/28/2023 0:00,Other Research-Related,2022,96746, ,NCI,89580,7166,96746
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer,10375655,5/5/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,521230, ,NCI,398739,122491,521230
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus,10375656,8/25/2010 0:00,9/30/2022 0:00,Non-SBIR/STTR,2021,407598, ,NCI,310072,97526,407598
Environmental Regulation of Cellular Responses to DNA Damage,10376046,4/9/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2022,351750, ,NIGMS,210000,141750,351750
Cyclin Dependent Kinase 4/6 (CDK4/6) as a Therapeutic Target in Glioblastoma,10376267,4/9/2020 0:00,4/8/2023 0:00,"Training, Individual",2022,30752, ,NCI,30752,0,30752
Mechanisms regulating the early stages of UV-induced skin cancer,10376752,4/1/2018 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,362250, ,NIEHS,225000,137250,362250
Nanotechnology for targeted therapy and fundamental understanding oftherapeutic resistance in triple negative breast cancer,10376777,4/1/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022,441579, ,NCI,365844,75735,441579
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors,10377505,8/19/2005 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022,372669, ,NCI,255643,117026,372669
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer,10377785,3/1/2022 0:00,4/30/2023 0:00,SBIR/STTR,2022,420989, ,NCI, , ,420989
"Project 1 - Yan Li, PhD",10377896,6/10/2016 0:00,3/31/2026 0:00,Research Centers,2022, ,215203, ,137619,77584, 
Cyclin-dependent kinase control of cell-division and transcription cycles,10378005,4/1/2018 0:00,3/31/2023 0:00,Non-SBIR/STTR,2022,464704, ,NIGMS,275000,189704,464704
Gain-of-function mutant p53 and metabolic reprogramming in colorectal cancer,10378007,4/1/2021 0:00,3/31/2023 0:00,Non-SBIR/STTR,2022,450420, ,NCI,286892,163528,450420
Pre-malignant mutation landscape and risk factors for progression to hematologic cancers,10378484,4/1/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2022,665071, ,NCI,392372,272699,665071
CRL3KEAP1 complex licenses genotoxic stress-induced tumor cell death,10378636,4/1/2021 0:00,3/31/2023 0:00,Non-SBIR/STTR,2022,197189, ,NCI,137445,59744,197189
Origins and functions of pancreatic cancer-associated fibroblasts,10378681,5/1/2021 0:00,12/31/2022 0:00,Non-SBIR/STTR,2022,85222, ,NCI,53566,31656,85222
Novel role of Ezh2 in age-related gastric motility dysfunctions,10379343,4/1/2020 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,357750, ,NIDDK,225000,132750,357750
Identification of Lethal Melanomas at the Time of Diagnosis,10379429,4/1/2020 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022,897329, ,NCI,701164,196165,897329
Targeted Protein Stabilization Platforms,10379626,1/1/2022 0:00,5/31/2022 0:00,"Training, Individual",2022,25114, ,NCI,25114,0,25114
Harnessing the Power of p53 with Panaxynol from American Ginseng to Suppress Colitis and Prevent Colon Cancer - admin supp,10380268,7/1/2021 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,26540, ,NCI,19192,7348,26540
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression,10380456,4/15/2016 0:00,3/31/2022 0:00,Other Research-Related,2021,81567, ,NIDDK,75525,6042,81567
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma,10380625,9/1/2016 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,901735, ,NCI,549597,395711,901735
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells,10380891,4/1/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2022,396750, ,NCI,263434,133316,396750
Dissecting the mechanisms of immune surveillance and evasion in liver cancer,10381134,9/1/2021 0:00,2/28/2022 0:00,Other Research-Related,2021,22000, ,NCI,22000, ,22000
Targeting p53 conformational defects to arrest carcinogenesis,10381311,7/1/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,83115, ,NCI,53279,29836,83115
Defining the Role of Tumor-Neutral Crosstalk in head and Neck Cancer Progression and Treatment Resistance,10381327,6/1/2020 0:00,10/7/2021 0:00,Non-SBIR/STTR,2021,111906, ,NCI,69078,42828,111906
CLINCIAL VALIDATION OF APC AND TP53 AS BIOMARKERS FOR CETUXIMAB RESPONSE,10381742,7/3/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,298758, ,NCI,278302,142235,298758
Transcriptional mechanisms of natural killer cell responses during mouse cytomegalovirus infection,10382356,5/6/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2022,453462, ,NIAID,296420,157042,453462
Epigenetics in the extreme - investigating heritability driven by disordered RNA binding proteins in development and cancer,10382634,9/1/2018 0:00,11/19/2021 0:00,Non-SBIR/STTR,2021,49220, ,NIGMS,31551,17669,49220
"Uncover the role of H3.3-G343R mutation in shaping the DNA damage response, anti-tumor immunity and mechanisms of resistance in glioma.",10384185,1/15/2022 0:00,12/31/2026 0:00,Non-SBIR/STTR,2022,527929, ,NINDS,338416,189513,527929
"P53, DNA Repair Imbalance, and Immune Response in Breast Cancer Mortality Disparities",10385785,4/6/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2022,600459, ,NCI,393345,207114,600459
STING-dependent Intestinal Regeneration upon Radiation Injury,10386172,2/7/2022 0:00,1/31/2027 0:00,Non-SBIR/STTR,2022,501288, ,NCI,317354,183934,501288
Investigating chromatin mechanisms using viral systems,10386678,9/1/2019 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021,124965, ,NIGMS,124965,0,124965
Development of novel PIP4K inhibitors to treat p53-null cancer,10387119,9/10/2020 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,57347, ,NIGMS,57347, ,57347
UBIQUITIN-PROTEASOME PATHWAY IN CANCER,10389235,9/1/2018 0:00,8/31/2023 0:00,Non-SBIR/STTR,2021,32996, ,NIGMS,32996, ,32996
Regulation of Cellular Proliferation by Novel Mitochondrial-Encoded Tumor Suppressors,10389994,9/1/2020 0:00,5/31/2024 0:00,Non-SBIR/STTR,2021,167407, ,NIGMS,167407, ,167407
Targeting Shared Vulnerabilities in Alternate Telomere Lengthening (ALT) Cancers,10390601,1/1/2022 0:00,12/31/2026 0:00,Non-SBIR/STTR,2022,384099, ,NCI,251045,133054,384099
A MULTISCALE APPROACH TO TARGET THE ACHILLES HEEL OF P53 CANCER MUTANTS,10391499,4/5/2019 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,311671, ,NIGMS,205000,106671,311671
Mechanisms of Asbestos-Induced Alveolar Epithelial Cell Injury,10392322,4/1/2011 0:00,3/31/2022 0:00,Non-SBIR/STTR,2021, , , , , , 
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms,10393051,4/14/2021 0:00,3/31/2026 0:00,Non-SBIR/STTR,2022,373701, ,NCI,237040,136661,373701
Regulation of Amino-acid Transport in Human Gliomas,10393364,12/1/2018 0:00,11/30/2023 0:00,Non-SBIR/STTR,2021,224007, ,NCI,138704,85303,224007
Core B-Modeling & Experimental Therapeutics Core,10393631,12/1/2005 0:00,3/31/2026 0:00,Non-SBIR/STTR,2022, ,193158, ,119234,73924, 
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity,10394732,6/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2022,403750, ,NHLBI,250000,153750,403750
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect,10394937,4/20/2021 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022,596963, ,NHLBI,391702,205261,596963
Investigating a Wnt-telomere feedback loop in the colorectal adenoma-carcinoma sequence,10395445,3/1/2021 0:00,2/28/2025 0:00,"Training, Individual",2022,46752, ,NCI,46752,0,46752
Project 1:  Recruitment of the BRCA1-associated Homologous Recombination Machinery,10396607,5/1/2021 0:00,4/30/2023 0:00,Non-SBIR/STTR,2022, ,384311, ,244784,139527, 
Core 1: Mouse and Cell Modeling,10396613,5/1/2021 0:00,4/30/2023 0:00,Non-SBIR/STTR,2022, ,250423, ,159505,90918, 
TP53 Germline Mutations: Beyond LFS,10397062,10/15/2019 0:00,4/30/2024 0:00,Non-SBIR/STTR,2022,358677, ,NCI,224172,134505,358677
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection,10397131,5/1/2021 0:00,4/30/2026 0:00,Non-SBIR/STTR,2022,645142, ,NCI,450161,194981,645142
Targeting HER2-low breast cancer with 17p loss,10399601,4/1/2016 0:00,4/30/2026 0:00,Non-SBIR/STTR,2022,524740, ,NCI,331066,193674,524740
Parameters that determine cell fate during mitotic arrest,10409136,5/10/2022 0:00,3/31/2026 0:00,Non-SBIR/STTR,2022,143997, ,NIGMS,100000,43997,143997
Identification of genetic collaborators in cancer with a brca2-mutant zebrafish model,10409852,7/1/2021 0:00,6/30/2022 0:00,Other Research-Related,2021,96808, ,OD,89637,7171,96808
Predicting Breast Cancer Risk after Benign Percutaneous Biopsy,10411403,7/5/2018 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,102875, ,NCI,65735,37140,102875
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations,10411425,8/8/2019 0:00,7/31/2026 0:00,Non-SBIR/STTR,2021,90877, ,NCI,51343,39534,90877
Mechanisms and biomarkers in aberrant paligenosis-induced stomach tumorigenesis,10411740,5/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2021,204000, ,NCI,127500,76500,204000
Developing newly combined therapeutic strategies for mature B cell lymphoma,10412143,4/1/2021 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,454144, ,NCI,313419,140725,454144
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,10414878,2/1/1997 0:00,4/30/2024 0:00,Non-SBIR/STTR,2022, ,402455, ,266382,136073, 
C. Elegans as a Model of Cell Senescence and Alzheimer's Disease,10418204,9/15/2020 0:00,4/30/2024 0:00,Non-SBIR/STTR,2021,143650, ,NIA,91789,51861,143650
Combinations of Grape Seed and Milk Thistle Extracts Against Lung,10421238,10/1/2018 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022, , , , , , 
Non-canonical roles of Mitotic Arrest Deficient 1 (Mad1) in tumor promotion,10422315,4/1/2022 0:00,3/31/2027 0:00,Non-SBIR/STTR,2022,469883, ,NCI,312840,157043,469883
Insights from somatic genomics lead to novel therapeutic targets in inherited bone marrow failure syndromes: Shwachman-Diamond Syndrome as a model.,10425437,7/1/2021 0:00,3/31/2026 0:00,Other Research-Related,2022,134881, ,NIDDK,124890,9991,134881
"Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery",10426776,4/1/2021 0:00,3/31/2024 0:00,Non-SBIR/STTR,2021,82995, ,NCI,49402,33593,82995
Investigating immune-microbiota interaction in lung cancer,10427551,7/1/2020 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,59500, ,OD,36616,22884,59500
Using markers to improve pancreatic cancer screening and surveillance,10427584,7/18/2016 0:00,6/30/2023 0:00,Non-SBIR/STTR,2021,931728, ,NCI,692018,239710,931728
"Dynamics, Regulation and Function of p53 in Single Cells",10434169,1/1/2021 0:00,12/31/2025 0:00,Non-SBIR/STTR,2021,39602, ,NIGMS,24114,15488,39602
A novel strategy targeting TP63 for breast cancer prevention,10435255,4/11/2022 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,78500, ,NCI,50000,28500,78500
Reactivating p53 Function with a Novel Structure-based Peptide as a Therapeutic Approach for Overcoming Platinum Resistance,10436779,1/1/2020 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022, , , , , , 
Evaluation of the antitumorigenic roles of miR-122 in pancreatic cancer,10437418,4/1/2022 0:00,3/31/2024 0:00,Non-SBIR/STTR,2022,78750, ,NCI,50000,28750,78750
Delineating ARF negative regulation of PAF1C-dependent oncogenic programs,10437541,3/8/2022 0:00,2/29/2024 0:00,Non-SBIR/STTR,2022,82000, ,NCI,50000,32000,82000
Mechanisms Governing Expansion of Embryonic Progenitor Cells (EPCs) inMetaplasia,10438015,6/10/2020 0:00,5/31/2025 0:00,Non-SBIR/STTR,2021,401490, ,NCI,255619,145871,401490
Co-regulation of p53 and PD-L1 by the VPRBP-USP2 axis in transcription and ubiquitylation,10439098,3/8/2022 0:00,2/28/2027 0:00,Non-SBIR/STTR,2022,468386, ,NCI,289127,179259,468386
Salivary gland cancer stem cells,10440568,2/10/2011 0:00,4/30/2027 0:00,Non-SBIR/STTR,2022,370500, ,NIDCR,237500,133000,370500
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers,10442206,5/3/2022 0:00,2/28/2027 0:00,Non-SBIR/STTR,2022,556148, ,NIDCR,343301,212847,556148
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer,10443312,2/14/2022 0:00,1/31/2027 0:00,Non-SBIR/STTR,2022,423560, ,NCI,268927,154633,423560
Synthetic lethalities to cell cycle disruption in glioma,10443386,5/13/2022 0:00,4/30/2027 0:00,Non-SBIR/STTR,2022,668921, ,NCI,378366,290555,668921
Novel therapeutics for targeting checkpoint dysfunction in cancer,10444747,12/15/2016 0:00,1/31/2027 0:00,Non-SBIR/STTR,2022,382469, ,NCI,239043,143426,382469
"XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION",10445617,3/3/2022 0:00,2/28/2027 0:00,Non-SBIR/STTR,2022,416325, ,NCI,228750,187575,416325
Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis,10446361,5/11/2022 0:00,4/30/2027 0:00,Non-SBIR/STTR,2022,423946, ,NCI,226709,197237,423946
BLR&D Research Career Scientist Award Application,10451503,4/1/2020 0:00,3/30/2027 0:00,Other,2022, , , , , , 
ARF6 function in cancers driven by RAS hyperactivation,10451914,7/3/2018 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021,246879, ,NCI,161271,85608,246879
Ing4-deficiency enhances the regenerative capacity of multipotent progenitor cells,10452422,3/1/2022 0:00,1/31/2024 0:00,Non-SBIR/STTR,2022,106274, ,NIDDK,75000,31274,106274
Comprehensive genomic profiling of aggressive hormone sensitive prostate cancer,10453554,5/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2022,513517, ,NCI,424940,88577,513517
Pan-cancer genomic characterization of human papillomavirus associated tumors,10463445,5/1/2022 0:00,4/30/2026 0:00,"Training, Individual",2022,37288, ,NCI,37288,0,37288
Breast Cancer Detection Consortium,10463888,9/19/2016 0:00,3/31/2023 0:00,Non-SBIR/STTR,2021,179116, ,NCI,125237,53879,179116
Cooperativity of TMPRSS2-ERG fusion with p53 inactivation in prostate cancer pathogenesis,10465800,3/1/2022 0:00,2/28/2027 0:00,Non-SBIR/STTR,2022,506326, ,NCI,341937,164389,506326
The Role and Regulation of TRP53 Activity in Oocytes and Granulosa Cells After Radiation-induced Damage,10466123,4/1/2022 0:00,3/31/2024 0:00,"Training, Individual",2022,32986, ,NICHD,32986,0,32986
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells,10467371,4/4/2014 0:00,2/28/2027 0:00,Non-SBIR/STTR,2022,368072, ,NCI,245431,122641,368072
Toxicology in the 21st Century Program (Tox21) - Systems Toxicology,10469238, , ,Intramural Research,2021,297940, ,NCATS, , ,297940
Phenotypic Assay Design and Development for Rare and Neglected Diseases,10469250, , ,Intramural Research,2021,513391, ,NCATS, , ,513391
"Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis",10471680, , ,Intramural Research,2021,2432642, ,NIA, , ,2432642
Placenta specific and ribosomal RNA genes: structure and function,10471683, , ,Intramural Research,2021,1005270, ,NIA, , ,1005270
Investigating the non-cell autonomous immune effects of mutant p53 in pancreatic cancer,10472325,9/1/2019 0:00,8/31/2024 0:00,Other Research-Related,2021,225979, ,NCI,209240,16739,225979
Genetic Susceptibility To Carcinogens,10474167, , ,Intramural Research,2021,178131, ,NIEHS, , ,178131
Discovery And Functional Genomics Of Environmental Response Genes,10474176, , ,Intramural Research,2021,1425046, ,NIEHS, , ,1425046
Functional exploration of progenitor renewal and differentiation in oral epithelial homeostasis and cancer,10475404,9/2/2021 0:00,8/31/2024 0:00,Non-SBIR/STTR,2021,249000, ,NIDCR,228973,20027,249000
Human Genes Affecting Chromosome Metabolism and Stress Response,10476810, , ,Intramural Research,2021,9190, ,NIEHS, , ,9190
"Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy",10476839, , ,Intramural Research,2021,1461574, ,NHLBI, , ,1461574
Mitochondrial regulation and function in cancer and cardiovascular biology,10476842, , ,Intramural Research,2021,1145873, ,NHLBI, , ,1145873
Clinical Significance and Mechanism of Action of Exosomal microRNAs in Neuroblastoma chemoresistance,10478753,1/1/2018 0:00,12/31/2023 0:00,Non-SBIR/STTR,2022,373701, ,NCI,229146,144555,373701
Macromolecular assemblies of transcription factors initiated by pathogen infection,10481112,8/22/2019 0:00,11/30/2021 0:00,Other Research-Related,2021,39079, ,NIAID,36184,2895,39079
Natural History of Familial Carcinoid Tumor,10481651, , ,Intramural Research,2021,695592, ,NIDDK, , ,695592
Investigating chromatin mechanisms using viral systems,10481687,9/1/2019 0:00,3/31/2022 0:00,Non-SBIR/STTR,2022,31925, ,NIGMS,18139,13786,31925
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease,10482691, , ,Intramural Research,2021,686028, ,NIAID, , ,686028
"DNA Replication, Cancer and Chemotherapy",10482994, , ,Intramural Research,2021,1254803, ,NICHD, , ,1254803
Chromosomal Proteins and Chromosomal Functions,10486545, , ,Intramural Research,2021,969817, ,NCI, , ,969817
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,10486549, , ,Intramural Research,2021,917731, ,NCI, , ,917731
"Tumor Suppressor Protein, p53",10486554, , ,Intramural Research,2021,577282, ,NCI, , ,577282
"Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers",10486556, , ,Intramural Research,2021,916147, ,NCI, , ,916147
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression,10486570, , ,Intramural Research,2021,1318085, ,NCI, , ,1318085
Regulation of Lymphocyte Proliferation and Replicative Capacity,10486582, , ,Intramural Research,2021,44130, ,NCI, , ,44130
The Genetics of Susceptibility to Mouse Plasma Cell Tumors,10486585, , ,Intramural Research,2021,692220, ,NCI, , ,692220
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,10486588, , ,Intramural Research,2021,416215, ,NCI, , ,416215
DNA repair,10486595, , ,Intramural Research,2021,1866395, ,NCI, , ,1866395
Enzymes and Substrates of the Ubiquitin Conjugating System,10486596, , ,Intramural Research,2021,779451, ,NCI, , ,779451
Identification of Genetic Factors Associated with Infectious Diseases,10486597, , ,Intramural Research,2021,230098, ,NCI, , ,230098
Immune Reconstitution,10486647, , ,Intramural Research,2021,2173321, ,NCI, , ,2173321
Prostate Cancer Imaging,10486658, , ,Intramural Research,2021,3716679, ,NCI, , ,3716679
Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,10486672, , ,Intramural Research,2021,133435, ,NCI, , ,133435
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,10486690, , ,Intramural Research,2021,113380, ,NCI, , ,113380
p53-induced Regulation of Transcription in the Chromatin Context,10486703, , ,Intramural Research,2021,223765, ,NCI, , ,223765
Development of TGF-beta antagonists for cancer therapy,10486708, , ,Intramural Research,2021,784065, ,NCI, , ,784065
Redox Mechanism Process of Angiogenesis and Wound Healing,10486713, , ,Intramural Research,2021,705416, ,NCI, , ,705416
Gene therapy of cancer,10486729, , ,Intramural Research,2021,4057426, ,NCI, , ,4057426
TMPRSS2-ERG chromosomal translocations and prostate cancer,10486742, , ,Intramural Research,2021,113380, ,NCI, , ,113380
Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,10486760, , ,Intramural Research,2021,681523, ,NCI, , ,681523
Role of inflammation in epigenetic alterations of metastatic cancer cells,10486777, , ,Intramural Research,2021,1102876, ,NCI, , ,1102876
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,10486782, , ,Intramural Research,2021,1168220, ,NCI, , ,1168220
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,10486786, , ,Intramural Research,2021,865924, ,NCI, , ,865924
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis,10486817, , ,Intramural Research,2021,954297, ,NCI, , ,954297
Precision Medicine of Cancer,10486867, , ,Intramural Research,2021,2545004, ,NCI, , ,2545004
"p53, Aging, and Cancer",10486868, , ,Intramural Research,2021,1696670, ,NCI, , ,1696670
Vulnerabilities in osteosarcoma and breast cancer,10486872, , ,Intramural Research,2021,1173230, ,NCI, , ,1173230
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,10486878, , ,Intramural Research,2021,1202994, ,NCI, , ,1202994
Role of long non-coding RNAs and RNA-binding proteins in p53 signaling,10486898, , ,Intramural Research,2021,1547922, ,NCI, , ,1547922
Comparative Brain Tumor Consortium,10486921, , ,Intramural Research,2021,93023, ,NCI, , ,93023
Genomic characterization and development of therapies for pediatric sarcoma,10486936, , ,Intramural Research,2021,760170, ,NCI, , ,760170
Preclinical Development of Therapeutics in Murine Models of Lung Cancer,10486943, , ,Intramural Research,2021,164392, ,NCI, , ,164392
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models,10486944, , ,Intramural Research,2021,821958, ,NCI, , ,821958
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models,10486946, , ,Intramural Research,2021,986350, ,NCI, , ,986350
Hypoxia signaling in cancer development,10486966, , ,Intramural Research,2021,1436845, ,NCI, , ,1436845
Minimal Myc functional threshold for tumorigenesis,10487008, , ,Intramural Research,2021,180172, ,NCI, , ,180172
Establish Preclinical Model for IDH-mutated Glioma,10487030, , ,Intramural Research,2021,301613, ,NCI, , ,301613
Lymphoma Disease Discovery and Definition,10487172, , ,Intramural Research,2021,962212, ,NCI, , ,962212
Nitric Oxide as a Modifier of Oxidative Stress,10487185, , ,Intramural Research,2021,529061, ,NCI, , ,529061
The Evaluation of Novel Therapeutics for Genitourinary Malignancies,10487192, , ,Intramural Research,2021,534576, ,NCI, , ,534576
Comparison of molecular factors to drug activities,10487249, , ,Intramural Research,2021,49394, ,NCI, , ,49394
Clinical Cancer Genomics Program,10487302, , ,Intramural Research,2021,917710, ,NCI, , ,917710
Comparative Biomedical Scientist Training Program,10487319, , ,Intramural Research,2021,1271035, ,NCI, , ,1271035
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure,10487321, , ,Intramural Research,2021,164392, ,NCI, , ,164392
Regulation Of Epidermal Differentiation,10489003, , ,Intramural Research,2021,1974901, ,NIAMS, , ,1974901
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system,10490073, , ,Intramural Research,2021,1563132, ,NHLBI, , ,1563132
"Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.",10490110, , ,Intramural Research,2021,2344269, ,NHLBI, , ,2344269
Mechanisms and biomarkers in aberrant paligenosis-induced stomach tumorigenesis,10490897,5/1/2020 0:00,4/30/2025 0:00,Non-SBIR/STTR,2022,199920, ,NCI,124950,74970,199920
Genetic Modifiers of Cancer Risk,10491575, , ,Intramural Research,2021,1920922, ,NCI, , ,1920922
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,10491576, , ,Intramural Research,2021,6876295, ,NCI, , ,6876295
Intervention Trials in Persons at Increased Genetic Risk of Cancer,10491577, , ,Intramural Research,2021,175286, ,NCI, , ,175286
01 Project 1:  Cancer risks for mutations in breast cancer predisposition genes,10492092,9/22/2005 0:00,8/31/2022 0:00,Research Centers,2021, ,80648, ,50722,29926, 
Research Project 3: Heterogeneity in metastatic CRPC and the role of TP53 mutation as a molecular determinant,10492123,9/14/2001 0:00,8/31/2022 0:00,Research Centers,2021, ,123344, ,69686,53658, 
Mechanisms by which mutant p53 drives metastatic Triple Negative Breast Cancer-Child Care Supplement,10514453,3/1/2019 0:00,2/28/2022 0:00,"Training, Individual",2022,2500, ,NCI,2500, ,2500
Targeted Therapy for Endometrial Cancer,10516670,7/1/2002 0:00,4/30/2024 0:00,Non-SBIR/STTR,2021,115525, ,NCI,76254,39271,115525
Genetics of Tumor Suppression by p53,10523143,3/4/2020 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,249000, ,NCI,178717,70283,249000
Targeting aspartate biosynthesis in pancreatic tumors,10523144,7/1/2020 0:00,11/30/2024 0:00,Non-SBIR/STTR,2022,249000, ,NCI,153781,95219,249000
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites,10524086,3/1/2018 0:00,2/29/2024 0:00,Non-SBIR/STTR,2022,179359, ,NCI,95914,83445,179359
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer,10524156,1/1/2020 0:00,7/31/2022 0:00,Non-SBIR/STTR,2022,52017, ,NCI,37615,14402,52017
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment,10533132,7/4/2019 0:00,6/30/2024 0:00,Non-SBIR/STTR,2021,441111, ,NCI,356242,84869,441111
"Dynamics, Regulation and Function of p53 in Single Cells",10534806,1/1/2021 0:00,12/31/2025 0:00,Non-SBIR/STTR,2022,117440, ,NIGMS,70752,46688,117440
Molecular Mechanisms of PTEN and USP7 Regulation,10546571,9/17/2019 0:00,2/28/2025 0:00,Non-SBIR/STTR,2022,249000, ,NIGMS,150909,98091,249000
Understanding methionine metabolism and its therapeutic potential in cancer,10554637,4/1/2022 0:00,3/31/2025 0:00,Non-SBIR/STTR,2022,249000, ,NCI,173157,75843,249000
Defining and Characterizing Drivers of Lethal Metastatic Prostate Cancer,10579377,3/1/2022 0:00,2/29/2024 0:00,Research Centers,2022, ,368849, ,240249,128600, 
